PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dayan, A; Fleminger, G; Ashur-Fabian, O				Dayan, Avraham; Fleminger, Gideon; Ashur-Fabian, Osnat			Targeting the Achilles' heel of cancer cells via integrin-mediated delivery of ROS-generating dihydrolipoamide dehydrogenase	ONCOGENE			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; LIPOAMIDE DEHYDROGENASE; COMPLEX; STRATEGIES; SUBSTRATE; SEQUENCE; SUBUNIT; IMPORT; STRAIN	Cancer cells frequently exhibit higher levels of reactive oxygen species (ROS) than normal cells and when ROS levels increase beyond a cellular tolerability threshold, cancer cell death is enhanced. The mitochondrial dihydrolipoamide dehydrogenase (DLDH) is an enzyme which produces ROS in association with its oxidoreductive activity and may be thus utilized as an exogenous anticancer agent. As cancer cells often overexpress integrins that recognize RGD-containing proteins, we have bioengineered the human DLDH with RGD motifs (DLDHRGD) for integrin-mediated drug delivery. The modified protein fully retained its enzyme activity and ROS-production capability. DLDHRGD uptake by cells was shown to depend on the presence of cell-associated integrin alpha v beta 3, as comparatively demonstrated with normal kidney cells (HEK293) transfected with either beta 1 (alpha v beta 1 positive) or beta 3 integrins (alpha v beta 3 positive). The interaction with beta 3 integrins was shown to be competitively inhibited by an RGD peptide. In mice melanoma cells (B16F10), which highly express an endogenous alpha v beta 3 integrin, fast cellular uptake of DLDHRGD which resulted in cell number reduction, apoptosis induction, and a parallel intracellular ROS production was shown. Similar results were obtained with additional human melanoma cell models (A375, WM3314, and WM3682). In contrast, HEK293 beta 3 cells remained intact following DLDHRGD uptake. The high pharmacological safety profile of DLDHRGD has been observed by several modes of administrations in BALB/C or C57B1/6 mouse strains. Treatments with DLDHRGD in a subcutaneous melanoma mice model resulted in significant tumor inhibition. Our study demonstrated, in vitro and in vivo, the development of a unique platform, which targets cancer cells via integrin-mediated drug delivery of an exogenous ROS-generating drug.	[Dayan, Avraham; Fleminger, Gideon] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Mol Cell Biol & Biotechnol, Tel Aviv, Israel; [Ashur-Fabian, Osnat] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Ashur-Fabian, O (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, Tel Aviv, Israel.	osnataf@gmail.com	Ashur, Osnat/AAC-1417-2020	Ashur-Fabian, Osnat/0000-0001-8624-3182	Israeli Ministry of Economics [52679, 55869]	Israeli Ministry of Economics	The authors wish to thank Mrs. Ronit Hollander for the graphics assistance and the table of contents illustration. This research was supported by the Israeli Ministry of Economics (Projects 52679 and 55869).	Ambrus A, 2018, NEUROCHEM INT, V117, P5, DOI 10.1016/j.neuint.2017.05.018; Ambrus A, 2013, ARCH BIOCHEM BIOPHYS, V538, P145, DOI 10.1016/j.abb.2013.08.015; Babu A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15012-5; Bender T, 2016, BBA-MOL CELL RES, V1863, P2436, DOI 10.1016/j.bbamcr.2016.01.017; Bolley J, 2013, NANOSCALE, V5, P11478, DOI 10.1039/c3nr03763k; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Chen W, 2017, SMALL, V13, DOI 10.1002/smll.201601997; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; CUNNINGHAM ML, 1985, PHOTOCHEM PHOTOBIOL, V42, P125, DOI 10.1111/j.1751-1097.1985.tb01549.x; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Dayan A, 2018, RSC ADV, V8, P9112, DOI 10.1039/c7ra13777j; Dayan A, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2617; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Diebold L, 2016, FREE RADICAL BIO MED, V100, P86, DOI 10.1016/j.freeradbiomed.2016.04.198; FLEMINGER G, 1995, APPL ENVIRON MICROB, V61, P4357, DOI 10.1128/AEM.61.12.4357-4361.1995; Fu Q, 2016, INT J EXP PATHOL, V97, P351, DOI 10.1111/iep.12192; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Gandioso A, 2016, J ORG CHEM, V81, P11556, DOI 10.1021/acs.joc.6b02415; Hu ZW, 2000, P NATL ACAD SCI USA, V97, P9221, DOI 10.1073/pnas.97.16.9221; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; McCartney RG, 1998, J BIOL CHEM, V273, P24158, DOI 10.1074/jbc.273.37.24158; Nicco C, 2018, MOLECULES, V23, DOI 10.3390/molecules23010084; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Raza MH, 2017, J CANCER RES CLIN, V143, P1789, DOI 10.1007/s00432-017-2464-9; Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008; Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Sheldrake HM, 2014, J MED CHEM, V57, P6301, DOI 10.1021/jm5000547; STAMBAUGH R, 1966, J BIOL CHEM, V241, P1462; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Sun Y, 2017, DRUG DEVELOP RES, V78, P283, DOI 10.1002/ddr.21399; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TSAI CS, 1981, ARCH BIOCHEM BIOPHYS, V206, P77, DOI 10.1016/0003-9861(81)90068-0; Vanderperre B, 2015, CURR OPIN CELL BIOL, V33, P35, DOI 10.1016/j.ceb.2014.10.008; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang YC, 2007, J BIOMED SCI, V14, P203, DOI 10.1007/s11373-006-9136-0; Yu YP, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-78; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015	49	23	23	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2019	38	25					5050	5061		10.1038/s41388-019-0775-9	http://dx.doi.org/10.1038/s41388-019-0775-9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IE1KY	30872792				2022-12-26	WOS:000472145900012
J	Liu, LL; Qi, L; Knifley, T; Piecoro, DW; Rychahou, P; Liu, JP; Mitov, MI; Martin, J; Wang, C; Wu, JR; Weiss, HL; Butterfield, DA; Evers, BM; O'Connor, KL; Chen, M				Liu, Lili; Qi, Lei; Knifley, Teresa; Piecoro, Dava W.; Rychahou, Piotr; Liu, Jinpeng; Mitov, Mihail I.; Martin, Jeremiah; Wang, Chi; Wu, Jianrong; Weiss, Heidi L.; Butterfield, D. Allan; Evers, B. Mark; O'Connor, Kathleen L.; Chen, Min			S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S100 proteins; lung cancer; mitochondria; invasion; metastasis; mitochondrial respiratory chain complex; glycolysis; energy metabolism; fibroblast-specific protein-1; metastasin-1; mitochondrial complex I; NADH:ubiquinone oxidoreductase core subunit S2 (NDUFS2); S100 calcium-binding protein A4 (S100A4); cellular respiration; non-small cell lung cancer (NSCLC)	CALCIUM-BINDING PROTEIN; TUMOR PROGRESSION; GLYCOLYSIS; EXPRESSION; BIOENERGETICS; NICLOSAMIDE; INHIBITION; PGC1-ALPHA; PHENOTYPE; METFORMIN	It is generally accepted that alterations in metabolism are critical for the metastatic process; however, the mechanisms by which these metabolic changes are controlled by the major drivers of the metastatic process remain elusive. Here, we found that S100 calcium-binding protein A4 (S100A4), a major metastasis-promoting protein, confers metabolic plasticity to drive tumor invasion and metastasis of non-small cell lung cancer cells. Investigating how S100A4 regulates metabolism, we found that S100A4 depletion decreases oxygen consumption rates, mitochondrial activity, and ATP production and also shifts cell metabolism to higher glycolytic activity. We further identified that the 49-kDa mitochondrial complex I subunit NADH dehydrogenase (ubiquinone) Fe-S protein 2 (NDUFS2) is regulated in an S100A4-dependent manner and that S100A4 and NDUFS2 exhibit co-occurrence at significant levels in various cancer types as determined by database-driven analysis of genomes in clinical samples using cBioPortal for Cancer Genomics. Importantly, we noted that S100A4 or NDUFS2 silencing inhibits mitochondrial complex I activity, reduces cellular ATP level, decreases invasive capacity in three-dimensional growth, and dramatically decreases metastasis rates as well as tumor growth in vivo. Finally, we provide evidence that cells depleted in S100A4 or NDUFS2 shift their metabolism toward glycolysis by up-regulating hexokinase expression and that suppressing S100A4 signaling sensitizes lung cancer cells to glycolysis inhibition. Our findings uncover a novel S100A4 function and highlight its importance in controlling NDUFS2 expression to regulate the plasticity of mitochondrial metabolism and thereby promote the invasive and metastatic capacity in lung cancer.	[Liu, Lili; Qi, Lei; Knifley, Teresa; Rychahou, Piotr; Liu, Jinpeng; Mitov, Mihail I.; Martin, Jeremiah; Wang, Chi; Wu, Jianrong; Weiss, Heidi L.; Butterfield, D. Allan; Evers, B. Mark; O'Connor, Kathleen L.; Chen, Min] Univ Kentucky, Markey Canc Ctr, 760 Press Ave,Res Bldg 2,Rm B344, Lexington, KY 40536 USA; [Piecoro, Dava W.] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA; [Rychahou, Piotr; Martin, Jeremiah; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Liu, Jinpeng; Wang, Chi; Wu, Jianrong; Weiss, Heidi L.] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Butterfield, D. Allan] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA; [O'Connor, Kathleen L.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Chen, Min] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Liu, Lili] Guangdong Prov Hosp Occupat Dis Prevent & Treatme, Guangzhou 510300, Guangdong, Peoples R China	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	O'Connor, KL; Chen, M (corresponding author), Univ Kentucky, Markey Canc Ctr, 760 Press Ave,Res Bldg 2,Rm B344, Lexington, KY 40536 USA.	kloconnor@uky.edu; min.chen@uky.edu	O'Connor, Kathleen/H-2569-2013	O'Connor, Kathleen/0000-0002-1088-9734	American Cancer Society Institutional Research Grant [IRG-85-001-25]; Kentucky Lung Cancer Research program; National Institutes of Health COBRE Pilot Grant [P20 GM121327]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000117]; Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Grant [2017B030314152]; National Cancer Institute, National Institutes of Health [R01 CA109136, R01 CA195573]; NATIONAL CANCER INSTITUTE [R01CA195573, P30CA177558, R01CA109136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121327] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); Kentucky Lung Cancer Research program; National Institutes of Health COBRE Pilot Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Grant; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Institutional Research Grant IRG-85-001-25 (to M. C.); the Kentucky Lung Cancer Research program (to M. C.); the National Institutes of Health COBRE Pilot Grant P20 GM121327 (to M. C.); National Center for Advancing Translational Sciences, National Institutes of Health, Grant UL1TR000117 (to M. C.); Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Grant 2017B030314152 (to L. L.); National Cancer Institute, National Institutes of Health Grant R01 CA109136 (to K. L. O.); and National Cancer Institute, National Institutes of Health, Grant R01 CA195573 (to B. M. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam MM, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0082-9; Bettum IJ, 2015, CANCER LETT, V366, P71, DOI 10.1016/j.canlet.2015.06.006; Bhowmik SK, 2015, ONCOTARGET, V6, P42651, DOI 10.18632/oncotarget.4765; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen M, 2013, ONCOGENE, V32, P3754, DOI 10.1038/onc.2012.383; Chen M, 2011, AM J PHYSIOL-CELL PH, V300, pC1155, DOI 10.1152/ajpcell.00407.2010; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Elia I, 2016, HANDB EXP PHARMACOL, V233, P321, DOI 10.1007/164_2015_10; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Fei F, 2017, ONCOTARGET, V8, P73219, DOI 10.18632/oncotarget.18016; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; Grotterod I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hou XB, 2016, BIOMED PHARMACOTHER, V84, P1575, DOI 10.1016/j.biopha.2016.10.037; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li LD, 2016, NEOPLASMA, V63, P548, DOI 10.4149/neo_2016_408; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; MOREADITH RW, 1987, J CLIN INVEST, V79, P463, DOI 10.1172/JCI112834; Moreno-Sanchez R, 2009, BIOFACTORS, V35, P209, DOI 10.1002/biof.31; Ngu LH, 2012, BBA-MOL BASIS DIS, V1822, P168, DOI 10.1016/j.bbadis.2011.10.012; Orre LM, 2013, ONCOGENE, V32, P5531, DOI 10.1038/onc.2013.213; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ramanujan V. K, 2015, J CELL SCI R, V6, P211, DOI [10.4172/2157-7013.1000211, DOI 10.4172/2157-7013.1000211]; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Stewart RL, 2016, ONCOTARGET, V7, P34630, DOI 10.18632/oncotarget.8969; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wen SJ, 2013, FUTURE MED CHEM, V5, P53, DOI 10.4155/fmc.12.190; Xiong XP, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.103; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	48	31	32	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7516	7527		10.1074/jbc.RA118.004365	http://dx.doi.org/10.1074/jbc.RA118.004365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885944	hybrid, Green Published			2022-12-26	WOS:000468402900034
J	Ahmad, I; Li, SN; Li, RR; Chai, QQ; Zhang, LX; Wang, B; Yu, CQ; Zheng, YH				Ahmad, Iqbal; Li, Sunan; Li, Rongrong; Chai, Qingqing; Zhang, Lixin; Wang, Bin; Yu, Chongqing; Zheng, Yong-Hui			The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus; virus entry; host-pathogen interaction; innate immunity; viral protein; EIAV S2; HIV Nef; MLV glycoGag; restriction factor; SERINC5	EQUINE INFECTIOUS-ANEMIA; HIV-1 NEF; DOWN-REGULATION; FEBRILE EPISODES; VIRUS; GENE; FAMILY	Serine incorporator 5 (SERINC5) is a recently identified restriction factor that blocks virus entry but is antagonized by three unrelated retroviral accessory proteins. The S2 protein from equine infectious anemia virus (EIAV) has been reported to reduce SERINC5 expression at steady-state levels likely via the endocytic pathway; however, the precise mechanism is still unclear. Here, we investigated how EIAV S2 protein down-regulates SERINC5 compared with down-regulation induced by Nef from HIV-1 and glycoMA proteins from murine leukemia virus (MLV). Using bimolecular fluorescence complementation (BiFC) assay and immunoprecipitation (IP), we detected an interaction between S2 and SERINC5. We found that this interaction relies on the S2 myristoylation site, indicating that it may occur on the plasma membrane. S2 internalized SERINC5 via receptor-mediated endocytosis and targeted it to endosomes and lysosomes, resulting in a ubiquitination-dependent decrease in SERINC5 expression at steady-state levels. Both BiFC and IP detected a glycoMA-SERINC5 interaction, but a Nef-SERINC5 interaction was detected only by BiFC. Moreover, S2 and glycoMA down-regulated SERINC5 more effectively than did Nef. We further show that unlike Nef, both S2 and glycoMA effectively down-regulate SERINC2 and also SERINC5 from Xenopus tropicalis (xSERINC5). Moreover, we detected expression of the equine SERINC5 (eSERINC5) protein and observed that its expression is much weaker than expression levels of SERINC5 from other species. Nonetheless, eSERINC5 had a strong antiviral activity that was effectively counteracted by S2. We conclude that HIV-1, EIAV, and MLV share a similar mechanism to antagonize viral restriction by host SERINC5.	[Ahmad, Iqbal; Li, Sunan; Li, Rongrong; Zhang, Lixin; Wang, Bin; Yu, Chongqing; Zheng, Yong-Hui] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, CAAS Michigan State Univ Joint Lab Innate Immun, Harbin Vet Res Inst, Harbin 150069, Heilongjiang, Peoples R China; [Chai, Qingqing; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385; Yu, Changqing/0000-0002-9548-7151	National Natural Science Foundation of China [31700138, 31702270, 31873013]; Natural Science Foundation of Heilongjiang Province Grant [QC2018037]; China Postdoctoral Science Foundation [2017M620980]; Chinese Academy of Agricultural Sciences; NIAID, National Institutes of Health [AI120189, AI122863, AI138707]; Beijing Government scholarships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122863, R01AI120189, R21AI138707] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province Grant(Natural Science Foundation of Heilongjiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Agricultural Sciences; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Beijing Government scholarships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 31700138 (to S. L.), 31702270 (to C. Y.), and 31873013 (to B. W.); Natural Science Foundation of Heilongjiang Province Grant QC2018037 and China Postdoctoral Science Foundation Grant 2017M620980 (to S. L.); Chinese Academy of Agricultural Sciences and Beijing Government scholarships (to I. A.); and NIAID, National Institutes of Health Grants AI120189, AI122863, and AI138707 (to Y.-H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Chande A, 2016, P NATL ACAD SCI USA, V113, P13197, DOI 10.1073/pnas.1612044113; Cook RF, 2013, VET MICROBIOL, V167, P181, DOI 10.1016/j.vetmic.2013.09.031; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Dai WW, 2018, CELL REP, V22, P869, DOI 10.1016/j.celrep.2017.12.082; de Sousa-Pereira P, 2019, J GEN VIROL, V100, P278, DOI 10.1099/jgv.0.001201; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fagerness AJ, 2006, VIROLOGY, V349, P22, DOI 10.1016/j.virol.2005.12.041; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Li F, 2000, J VIROL, V74, P573, DOI 10.1128/JVI.74.1.573-579.2000; Li F, 2003, J VIROL, V77, P7244, DOI 10.1128/JVI.77.13.7244-7253.2003; Li SN, 2019, J VIROL, V93, DOI 10.1128/JVI.01651-18; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; PAYNE SL, 1994, J GEN VIROL, V75, P425, DOI 10.1099/0022-1317-75-2-425; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Shi J, 2018, J VIROL, V92, DOI 10.1128/JVI.00196-18; Sood C, 2017, J BIOL CHEM, V292, P6014, DOI 10.1074/jbc.M117.777714; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Zhang XF, 2017, J VIROL, V91, DOI 10.1128/JVI.00137-17; Zheng YH, 1997, J GEN VIROL, V78, P807, DOI 10.1099/0022-1317-78-4-807; Zheng YH, 2000, VIRUS RES, V68, P93, DOI 10.1016/S0168-1702(00)00147-7; Zheng YH, 1997, J VIROL, V71, P5031, DOI 10.1128/JVI.71.7.5031-5039.1997	29	17	17	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7013	7024		10.1074/jbc.RA119.007662	http://dx.doi.org/10.1074/jbc.RA119.007662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30862674	Green Published, hybrid			2022-12-26	WOS:000467394700033
J	Chen, HT; Gao, L; Yang, D; Xiao, YY; Zhang, MH; Li, CM; Wang, AH; Jin, YP				Chen, Huatao; Gao, Lei; Yang, Dan; Xiao, Yaoyao; Zhang, Manhui; Li, Cuimei; Wang, Aihua; Jin, Yaping			Coordination between the circadian clock and androgen signaling is required to sustain rhythmic expression of Elovl3 in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen; circadian clock; liver; mouse; clock gene; Elovl3	GENE; ALPHA; TRANSCRIPTION; RECRUITMENT; DIMORPHISM; COMPONENT; HORMONES; SYSTEM; TISSUE; MODEL	ELOVL3 is a very long-chain fatty acid elongase, and its mRNA levels display diurnal rhythmic changes exclusively in adult male mouse livers. This cyclical expression of hepatic Elovl3 is potentially controlled by the circadian clock, related hormones, and transcriptional factors. It remains unknown, however, whether the circadian clock, in conjunction with androgen signaling, functions in maintaining the rhythmic expression of Elovl3 in a sexually dimorphic manner. Under either zeitgeber or circadian time, WT mouse livers exhibited a robust circadian rhythmicity in the expression of circadian clock genes and Elovl3. In contrast, male Bmal1(-/-) mice displayed severely weakened expression of hepatic circadian clock genes, resulting in relatively high, but nonrhythmic, Elovl3 expression levels. ChIP assays revealed that NR1D1 binds to the Elovl3 promoter upon circadian change in WT mouse livers in vivo, and a diminished binding was observed in male Bmal1(-/-) mouse livers. Additionally, female mouse livers exhibited constant low levels of Elovl3 expression. Castration markedly reduced Elovl3 expression levels in male mouse livers but did not disrupt circadian variation of Elovl3. Injection of female mice with 5-dihydrotestosterone induced Elovl3 rhythmicity in the liver. In AML12 cells, 5-dihydrotestosterone also elevated Elovl3 expression in a time-dependent manner. In contrast, flutamide efficiently attenuated this induction effect. In conclusion, a lack of either the circadian clock or androgen signaling impairs hepatic Elovl3 expression, highlighting the observation that coordination between the circadian clock and androgen signaling is required to sustain the rhythmic expression of Elovl3 in mouse liver.	[Chen, Huatao; Gao, Lei; Yang, Dan; Xiao, Yaoyao; Zhang, Manhui; Li, Cuimei; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Dept Clin Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Wang, Aihua] Northwest A&F Univ, Coll Vet Med, Dept Prevent Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Chen, Huatao; Gao, Lei; Yang, Dan; Xiao, Yaoyao; Zhang, Manhui; Li, Cuimei; Wang, Aihua; Jin, Yaping] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China; [Yang, Dan] Kyushu Univ, Grad Sch Agr, Lab Regulat Metab & Behav, Fukuoka, Fukuoka, Japan	Northwest A&F University - China; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Kyushu University	Chen, HT; Jin, YP (corresponding author), Northwest A&F Univ, Coll Vet Med, Dept Clin Vet Med, Yangling 712100, Shaanxi, Peoples R China.	htchen@nwafu.edu.cn; yapingjin@163.com	Chen, Huatao/H-3755-2011	Chen, Huatao/0000-0002-3800-5013	National Natural Science Foundation of China [31771301, 31602125, 31772817]; China Postdoctoral Science Foundation [2017M61065, 2018T111112]; Shaanxi Postdoctoral Science Foundation [2017BSHEDZZ105]; Fundamental Research Funds for the Central Universities [2452017292]; Scientific Research Foundation for Talents of Shaanxi [A279021712]; Scientific Research Foundation for Talents of Northwest AF University [Z11021601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shaanxi Postdoctoral Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for Talents of Shaanxi; Scientific Research Foundation for Talents of Northwest AF University	This work was supported by National Natural Science Foundation of China Grants 31771301 and 31602125 (to H. C.) and 31772817 (to Y. J.), China Postdoctoral Science Foundation Grants 2017M61065 and 2018T111112 (to H. C.), Shaanxi Postdoctoral Science Foundation Grant 2017BSHEDZZ105 (to H. C.), Fundamental Research Funds for the Central Universities Grant 2452017292 (to H. C.), Scientific Research Foundation for Talents of Shaanxi Grant A279021712 (to H. C.), and Scientific Research Foundation for Talents of Northwest A&F University Grant Z11021601 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; Chao HW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02207-7; Coste H, 2002, J BIOL CHEM, V277, P27120, DOI 10.1074/jbc.M203421200; De Giorgio MR, 2010, J STEROID BIOCHEM, V122, P53, DOI 10.1016/j.jsbmb.2010.02.023; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gilardi F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004155; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Ilagan R, 2005, MOL CANCER THER, V4, P1662, DOI 10.1158/1535-7163.MCT-05-0197; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Ji LJ, 2016, ENDOCRINOLOGY, V157, P91, DOI 10.1210/en.2015-1674; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kobayashi T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1461, DOI 10.1152/ajpendo.00623.2011; LABRIE F, 1993, CANCER-AM CANCER SOC, V72, P3816, DOI 10.1002/1097-0142(19931215)72:12+<3816::AID-CNCR2820721711>3.0.CO;2-3; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pilorz V, 2018, PFLUG ARCH EUR J PHY, V470, P227, DOI 10.1007/s00424-017-2103-y; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Xiong YJ, 2017, AM J PHYSIOL-CELL PH, V312, pC341, DOI 10.1152/ajpcell.00222.2016; Xu JH, 2018, CELL TISSUE RES, V373, P499, DOI 10.1007/s00441-018-2812-3; Yang DQ, 2018, BIOL REPROD, V98, P713, DOI 10.1093/biolre/ioy044; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zheng DS, 2018, MOL CELL ENDOCRINOL, V471, P33, DOI 10.1016/j.mce.2017.05.025	45	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7046	7056		10.1074/jbc.RA118.005950	http://dx.doi.org/10.1074/jbc.RA118.005950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30862677	Green Published, hybrid			2022-12-26	WOS:000467394700036
J	Nakagawa, H; Ogawa, E; Fukunaga, K; Kinose, D; Yamaguchi, M; Nagao, T; Tanaka-Mizuno, S; Nakano, Y				Nakagawa, Hiroaki; Ogawa, Emiko; Fukunaga, Kentaro; Kinose, Daisuke; Yamaguchi, Masafumi; Nagao, Taishi; Tanaka-Mizuno, Sachiko; Nakano, Yasutaka			Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; AUTOMATED QUANTIFICATION; PROGNOSTIC-SIGNIFICANCE; EMPHYSEMA; INDEX; INDIVIDUALS; VALIDATION; DIAGNOSIS; SURVIVAL; HRCT	Background Honeycombing on high-resolution computed tomography (HRCT) images is a key finding in idiopathic pulmonary fibrosis (IPF). In IPF, honeycombing area determined by quantitative CT analysis is correlated with pulmonary function test findings. We hypothesized that quantitative CT-derived honeycombing area (HA) might predict mortality in patients with IPF. Materials and methods Chest HRCT images of 52 IPF patients with definite usual interstitial pneumonia (UIP) pattern were retrospectively evaluated. Mortality data up to July 31, 2016, were recorded. Using a computer-aided system, HA and percentage of HA (%HA) were measured quantitatively. Predictors of 3-year mortality were evaluated using logistic regression models. Results The median %HA, %predicted forced vital capacity (FVC) and composite physiologic index (CPI) were 3.8%, 83.6%, and 33.6, respectively. According to GAP (gender, age, and physiology) stage, 20, 14, and 5 patients were classified under stages I-II-III, respectively. Percentage of HA was significantly correlated with %FVC, CPI, and GAP stage (all, p < 0.001). In univariate analysis, %HA, %FVC, and CPI were statistically significant predictors of mortality. In multivariate analysis using the stepwise regression method, only %HA (odds ratio [OR], 1.27; p = 0.011) was a significant independent predictors of mortality. Patients with %HA >= 4.8% had significantly lower survival rates than those with lesser %HA (median survival time, 1.3 vs 5.0 years; log-rank test; p < 0.001). Conclusion Quantitative CT-derived HA might be an important and independent predictor of mortality in IPF patients with definite UIP pattern.	[Nakagawa, Hiroaki; Fukunaga, Kentaro; Kinose, Daisuke; Yamaguchi, Masafumi; Nagao, Taishi; Nakano, Yasutaka] Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Otsu, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan; [Tanaka-Mizuno, Sachiko] Shiga Univ Med Sci, Dept Med Stat, Otsu, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Nakano, Y (corresponding author), Shiga Univ Med Sci, Dept Internal Med, Div Resp Med, Otsu, Shiga, Japan.	nakano@belle.shiga-med.ac.jp	TANAKA, Sachiko/HCH-0787-2022	Nakano, Yasutaka/0000-0001-7516-8690	Astellas Pharma Inc.; Taisho Toyama Pharmaceutical Co., Ltd.; Pfizer Japan Inc.	Astellas Pharma Inc.(Astellas Pharmaceuticals); Taisho Toyama Pharmaceutical Co., Ltd.; Pfizer Japan Inc.(Pfizer)	Our division received research funding form from Astellas Pharma Inc., Taisho Toyama Pharmaceutical Co., Ltd., and Pfizer Japan Inc. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; Best AC, 2008, RADIOLOGY, V246, P935, DOI 10.1148/radiol.2463062200; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Bodlet A, 2013, RESP MED, V107, P1781, DOI 10.1016/j.rmed.2013.08.039; Colombi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130653; Cottin V, 2017, AM J RESP CRIT CARE, V196, P1162, DOI 10.1164/rccm.201612-2492OC; Flaherty KR, 2002, EUR RESPIR J, V19, P275, DOI 10.1183/09031936.02.00182002; Iwasawa T, 2014, EUR J RADIOL, V83, P32, DOI 10.1016/j.ejrad.2012.02.014; Iwasawa T, 2009, J THORAC IMAG, V24, P216, DOI 10.1097/RTI.0b013e3181a6527d; Jacob J, 2017, EUR RESPIR J, V49; Jacob J, 2016, J THORAC IMAG, V31, P304, DOI 10.1097/RTI.0000000000000220; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kim ES, 2015, CHEST, V147, P430, DOI 10.1378/chest.14-0453; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Maldonado F, 2014, EUR RESPIR J, V43, P204, DOI 10.1183/09031936.00071812; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Nakagawa H, 2016, EUR J RADIOL, V85, P125, DOI 10.1016/j.ejrad.2015.11.011; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nicholson AC, 2000, AM J RESP CRIT CARE, V162, P2213, DOI 10.1164/ajrccm.162.6.2003049; NISHIMURA K, 1992, RADIOLOGY, V182, P337, DOI 10.1148/radiology.182.2.1732946; Oda K, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-10; Ohkubo H, 2018, RESPIR INVESTIG, V56, P5, DOI 10.1016/j.resinv.2017.10.003; Park SO, 2011, KOREAN J RADIOL, V12, P297, DOI 10.3348/kjr.2011.12.3.297; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rosas IO, 2011, CHEST, V140, P1590, DOI 10.1378/chest.10-2545; Rudd RM, 2007, THORAX, V62, P62, DOI 10.1136/thx.2005.045591; SAKAI N, 1994, CHEST, V106, P1319, DOI 10.1378/chest.106.5.1319; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Sumikawa H, 2008, AM J RESP CRIT CARE, V177, P433, DOI 10.1164/rccm.200611-1696OC; Watadani T, 2013, RADIOLOGY, V266, P936, DOI 10.1148/radiol.12112516; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Yoon RG, 2013, EUR RADIOL, V23, P692, DOI 10.1007/s00330-012-2634-8	35	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214278	10.1371/journal.pone.0214278	http://dx.doi.org/10.1371/journal.pone.0214278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897161	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700079
J	Reed, DA; Yotsuya, M; Gubareva, P; Toth, PT; Bertagna, A				Reed, David A.; Yotsuya, Mamoru; Gubareva, Polina; Toth, Peter T.; Bertagna, Andrew			Two-photon fluorescence and second harmonic generation characterization of extracellular matrix remodeling in post-injury murine temporomandibular joint osteoarthritis	PLOS ONE			English	Article							EXPERIMENTAL DISK PERFORATION; PANNUS-LIKE TISSUE; PERICELLULAR MATRIX; ARTICULAR-CARTILAGE; MANDIBULAR CONDYLE; COLLAGEN; CELLS; MICROSCOPY; TGF-BETA-1; FIBROSIS	End stage temporomandibular joint osteoarthritis (TMJ-OA) is characterized by fibrillations, fissures, clefts, and erosion of the mandibular condylar cartilage. The goal of this study was to define changes in pericellular and interterritorial delineations of the extracellular matrix (ECM) that occur preceding and concurrent with the development of this end stage degeneration in a murine surgical instability model. Two-photon fluorescence (TPF) and second harmonic generation (SHG) microscopy was used to evaluate TMJ-OA mediated changes in the ECM. We illustrate that TPF/SHG microscopy reconstructs the three-dimensional network of key fibrillar and micro-fibrillar collagens altered during the progression of TMJ-OA. This method not only generates spatially distinct pericellular and interterritorial delineations of the ECM but distinguishes early and end stage TMJ-OA by signal organization, orientation, and composition. Early stage TMJ-OA at 4- and 8-weeks post-injury is characterized by two structurally distinct regions containing dense, large fiber collagens and superficial, small fiber collagens rich in types I, III, and VI collagen oriented along the mesiodistal axis of the condyle. At 8-weeks post-injury, type VI collagen is locally diminished on the central and medial condyle, but the type I/III rich superficial layer is still present. Twelve- and 16-weeks post-injury mandibular cartilage is characteristic of end-stage disease, with hypocellularity and fibrillations, fissures, and clefts in the articular layer that propagate along the mediolateral axis of the MCC. We hypothesize that the localized depletion of interterritorial and pericellular type VI collagen may signify an early marker for the transition from early to end stage TMJ-OA, influence the injury response of the tissue, and underlie patterns of degeneration that follow attritional modes of failure.	[Reed, David A.; Yotsuya, Mamoru; Gubareva, Polina; Bertagna, Andrew] Univ Illinois, Dept Oral Biol, Chicago, IL 60680 USA; [Yotsuya, Mamoru] Tokyo Dent Coll, Dept Fixed Prosthodont, Tokyo, Japan; [Toth, Peter T.] Univ Illinois, Res Resources Ctr Imaging Core, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tokyo Dental College; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Reed, DA (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60680 USA.	reedd@uic.edu		Toth, Peter/0000-0003-2168-0124; Reed, David/0000-0001-9121-0932	NIH/NIDCR/NCATS [3KL2TR002002-02S1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR002002] Funding Source: NIH RePORTER	NIH/NIDCR/NCATS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The study was supported with funds from NIH/NIDCR/NCATS 3KL2TR002002-02S1 awarded to DR, https://www.nidcr.nih.gov/. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01476-y; BAILEY AJ, 1975, BIOCHEM BIOPH RES CO, V66, P1160, DOI 10.1016/0006-291X(75)90480-5; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BOSANQUET A, 1991, INT J ORAL MAX SURG, V20, P177, DOI 10.1016/S0901-5027(05)80012-8; Brockbank KGM, 2008, CELL TISSUE BANK, V9, P299, DOI 10.1007/s10561-008-9070-7; Chaudhari S, 2013, IN VIVO FATE MAPPING; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Chen YJ, 2005, ORAL SURG ORAL MED O, V99, P734, DOI 10.1016/j.tripleo.2004.10.020; Chu WC, 2017, INT J ORAL SCI, V9, P43, DOI 10.1038/ijos.2016.57; CLARK JM, 1990, J ANAT, V171, P117; Fang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177826; Gerter R, 2012, MATRIX BIOL, V31, P206, DOI 10.1016/j.matbio.2012.01.007; HELMY E, 1988, J ORAL MAXIL SURG, V46, P979, DOI 10.1016/0278-2391(88)90335-7; Henderson SE, 2015, ARCH ORAL BIOL, V60, P1, DOI 10.1016/j.archoralbio.2014.08.022; Houle MA, 2015, J BIOPHOTONICS, V8, P993, DOI 10.1002/jbio.201500150; Israel HA, 2006, J ORAL MAXIL SURG, V64, P1066, DOI 10.1016/j.joms.2006.03.012; Jiao K, 2014, J DENT RES, V93, P140, DOI 10.1177/0022034513513034; KANTOMAA T, 1994, ACTA ANAT, V151, P88; Li J, 2011, J ORTHOP RES, V29, P516, DOI 10.1002/jor.21215; Li LZ, 2015, J ORAL MAXIL SURG, V73, P943, DOI 10.1016/j.joms.2014.12.038; Long E, 2016, ARCH ORAL BIOL, V67, P68, DOI 10.1016/j.archoralbio.2016.03.004; Mansfield J, 2009, J ANAT, V215, P682, DOI 10.1111/j.1469-7580.2009.01149.x; Mansfield JC, 2012, J ANAT, V220, P405, DOI 10.1111/j.1469-7580.2012.01479.x; Mansfield JC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950318; Nogami S, 2017, ORAL DIS, V23, P644, DOI 10.1111/odi.12650; Plaas A, 2011, OSTEOARTHR CARTILAGE, V19, P1081, DOI 10.1016/j.joca.2011.05.003; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Ranjit S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13378; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Robinson Jennifer, 2015, Curr Mol Biol Rep, V1, P110; Ruggiero L, 2015, ANN BIOMED ENG, V43, P2652, DOI 10.1007/s10439-015-1320-9; SALO LA, 1995, J ORAL MAXIL SURG, V53, P39, DOI 10.1016/0278-2391(95)90498-0; Scanzello CR, 2008, CURR OPIN RHEUMATOL, V20, P565, DOI 10.1097/BOR.0b013e32830aba34; Smeriglio P, 2015, TISSUE ENG PT A, V21, P840, DOI [10.1089/ten.TEA.2014.0375, 10.1089/ten.tea.2014.0375]; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Tominaga K, 2001, ARCH ORAL BIOL, V46, P539, DOI 10.1016/S0003-9969(01)00009-7; Utreja A, 2016, OSTEOARTHR CARTILAGE, V24, P335, DOI 10.1016/j.joca.2015.08.010; Vincent TL, 2007, OSTEOARTHR CARTILAGE, V15, P752, DOI 10.1016/j.joca.2007.01.021; Wang HS, 2011, HISTOPATHOLOGY, V58, P593, DOI 10.1111/j.1365-2559.2011.03783.x; Wang QY, 2012, ARCH ORAL BIOL, V57, P620, DOI 10.1016/j.archoralbio.2011.12.006; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Werkmeister E, 2010, PHOTOCHEM PHOTOBIOL, V86, P302, DOI 10.1111/j.1751-1097.2009.00648.x; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009; Xu L, 2009, OSTEOARTHR CARTILAGE, V17, P917, DOI 10.1016/j.joca.2009.01.002; Xu L, 2010, ARTHRITIS RHEUM-US, V62, P2736, DOI 10.1002/art.27582; Yang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079662; Yeh AT, 2005, OSTEOARTHR CARTILAGE, V13, P345, DOI 10.1016/j.joca.2004.12.007; Yotsuya M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37028-1; Yuan GH, 2004, OSTEOARTHR CARTILAGE, V12, P38, DOI 10.1016/j.joca.2003.08.004; Zelenski NA, 2015, ARTHRITIS RHEUMATOL, V67, P1286, DOI 10.1002/art.39034; Zhan L, 2017, GENE; Zhou SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24039	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214072	10.1371/journal.pone.0214072	http://dx.doi.org/10.1371/journal.pone.0214072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897138	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700063
J	Zhang, XL; Pan, WJ				Zhang, Xiaolei; Pan, Weijun			Exon prediction based on multiscale products of a genomic-inspired multiscale bilateral filtering	PLOS ONE			English	Article								Multiscale signal processing techniques such as wavelet filtering have proved to be particularly successful in predicting exon sequences. Traditional wavelet predictor is domain filtering, and enforces exon features by weighting nucleotide values with coefficients. Such a measure performs linear filtering and is not suitable for preserving the short coding exons and the exon-intron boundaries. This paper describes a prediction framework that is capable of non-linearly processing DNA sequences while achieving high prediction rates. There are two key contributions. The first is the introduction of a genomic-inspired multiscale bilateral filtering (MSBF) which exploits both weighting coefficients in the spatial domain and nucleotide similarity in the range. Similarly to wavelet transform, the MSBF is also defined as a weighted sum of nucleotides. The difference is that the MSBF takes into account the variation of nucleotides at a specific codon position. The second contribution is the exploitation of inter-scale correlation in MSBF domain to find the inter-scale dependency on the differences between the exon signal and the background noise. This favourite property is used to sharp the important structures while weakening noise. Three benchmark data sets have been used in the evaluation of considered methods. By comparison with four existing techniques, the prediction results demonstrate that: the proposed method reveals at least improvement of 4.1%, 50.5%, 25.6%, 2.5%, 10.8%, 15.5%, 11.1%, 12.3%, 9.2% and 2.4% on the exons length of 1-24, 25-49, 50-74, 75-99, 100-124, 125-149, 150-174, 175-199, 200-299 and 300-300+, respectively. The MSBF of its nonlinear nature is good at energy compaction, which makes it capable of locating the sharp variations around short exons. The direct scale multiplication of coefficients at several adjacent scales obviously enhanced exon features while the noise contents were suppressed. We show that the non-linear nature and correlation-based property achieved in proposed predictor is greater than that for traditional filtering, which leads to better exon prediction performance. There are some possible applications of this predictor. Its good localization and protection of sharp variations will make the predictor be suitable to perform fault diagnosis of aero-engine.	[Zhang, Xiaolei; Pan, Weijun] Civil Aviat Flight Univ China, Coll Air Traff Management, Guanghan, Peoples R China	Civil Aviation Flight University of China	Pan, WJ (corresponding author), Civil Aviat Flight Univ China, Coll Air Traff Management, Guanghan, Peoples R China.	panatc@sina.com		Zhang, Xiaolei/0000-0002-5909-5820; Pan, Weijun/0000-0002-9402-135X	National Natural Science Foundation of China [U1733203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the National Natural Science Foundation of China (Grant No. U1733203). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2017, COMPUT METH PROG BIO, V149, P11, DOI 10.1016/j.cmpb.2017.06.021; Akhtar M, 2008, IEEE J-STSP, V2, P310, DOI 10.1109/JSTSP.2008.923854; Arneodo A, 2011, PHYS REP, V498, P45, DOI 10.1016/j.physrep.2010.10.001; Audit B, 2013, NAT PROTOC, V8, P98, DOI 10.1038/nprot.2012.145; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; Butler WE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187014; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Guigo R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s2; Hu JW, 2012, INFORM FUSION, V13, P196, DOI 10.1016/j.inffus.2011.01.002; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Jiang R, 2008, PHYSICA A, V387, P4223, DOI 10.1016/j.physa.2008.02.076; Jiang R, 2008, INT J DATA MIN BIOIN, V2, P15, DOI 10.1504/IJDMB.2008.016754; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lu Y, 2015, MED PHYS, V42, P182, DOI 10.1118/1.4903283; Marhon SA, 2016, IEEE ACM T COMPUT BI, V13, P742, DOI 10.1109/TCBB.2015.2476789; Marhon SA, 2011, J COMPUT BIOL, V18, P639, DOI 10.1089/cmb.2010.0184; Mariapushpam IT, 2017, CURR BIOINFORM, V12, P57, DOI 10.2174/1574893611666160805111825; Mena-Chalco JP, 2008, IEEE ACM T COMPUT BI, V5, P198, DOI 10.1109/TCBB.2007.70259; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ramachandran P, 2012, IEEE T BIO-MED ENG, V59, P1598, DOI 10.1109/TBME.2012.2190512; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; Saberkari Hamidreza, 2013, J Med Signals Sens, V3, P139; Saeys Y, 2007, BIOINFORMATICS, V23, P414, DOI 10.1093/bioinformatics/btl639; Samala RK, 2014, MED PHYS, V41, DOI 10.1118/1.4860955; Shakya DK, 2013, IEEE ACM T COMPUT BI, V10, P1241, DOI 10.1109/TCBB.2013.76; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; Toplak T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186058; TORAICHI K, 1989, IEEE T ACOUST SPEECH, V37, P145, DOI 10.1109/29.17517; Vaidyanathan PP, 2004, J FRANKLIN I, V341, P111, DOI 10.1016/j.jfranklin.2003.12.001; Wang XH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201243; Wu YH, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061916; Wu YX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169833; Zhang GS, 2017, 2017 10TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, BIOMEDICAL ENGINEERING AND INFORMATICS (CISP-BMEI); Zhang WF, 2012, PATTERN RECOGN, V45, P947, DOI 10.1016/j.patcog.2011.08.016; Zhang XL, 2018, CURR BIOINFORM, V13, P553, DOI 10.2174/1574893612666170725121058; Zhang XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163088; Zhang XL, 2014, CHIN CONTR CONF, P7151, DOI 10.1109/ChiCC.2014.6896181; Zhao JX, 2014, CURR BIOINFORM, V9, P389, DOI 10.2174/1574893609666140702184225	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0205050	10.1371/journal.pone.0205050	http://dx.doi.org/10.1371/journal.pone.0205050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897105	gold, Green Submitted, Green Published			2022-12-26	WOS:000461889700005
J	Ruiz, GRS; Valente, RM				Ruiz, Gustavo R. S.; Valente, Roberta M.			Description of a new species of Surazomus (Arachnida: Schizomida), with comments on homology of male flagellum and mating march anchorage in the genus	PLOS ONE			English	Article							HUBBARDIIDAE; COKENDOLPHER; SYSTEMATICS; REDDELL	Surazomus saturninoae sp. nov. is described from eastern Amazon. The male has a pentagonal flagellum, similar to those of three other species in the genus. These four species are herein gathered as the arboreus-group of Surazomus. We present a brief synopsis of chaetotaxy description in hubbardiines and several homology proposals for the flagellum of the species in the arboreus-group: the posterior lobes may be homologous to the lateral lobes of hubbardiine species with trilobed flagella; the setal brush with 4-5 setae on the posterior lobe may be composed of one Dl2 seta and enlarged lobular microsetae; the single, median posterior coupling pocket may be homologous to the pair of posterior pockets seen in other hubbardiines; the single, median anterior coupling pocket may be homologous to the pair of pockets on the anterior border of the flagellum seen in other hubbardiines. Based on the morphology of these pockets and the chelicerae within Surazomus, we discuss the anchoring mechanism during the mating march.	[Ruiz, Gustavo R. S.; Valente, Roberta M.] Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil	Universidade Federal do Para	Ruiz, GRS (corresponding author), Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil.	gustavoruiz86@hotmail.com	Ruiz, Gustavo/AAB-4928-2019	Ruiz, Gustavo/0000-0002-7326-7000; de Melo Valente, Roberta/0000-0002-8249-5937				Armas L. F., 2014, REV IBERICA ARACNOLO, V25, P71; ARMAS L. F. DE, 2002, REV IBERICA ARACNOLO, V5, P3; Bonaldo A, 2007, REV BRAS ZOOL, V24, P323, DOI 10.1590/S0101-81752007000200009; Cokendolpher James C., 1992, Texas Memorial Museum Speleological Monograph, V3, P31; Cokendolpher JC, 2000, AMAZONIANA, V16, P187; de Armas L.F., 2010, B SOC ENTOMOL ARAGON, V46, P203; Giupponi APD, 2016, ZOOKEYS, P13, DOI 10.3897/zookeys.632.9337; Hansen HJ, 1905, ARK ZOOL, V2, P1; HARVEY M S, 1992, Invertebrate Taxonomy, V6, P77, DOI 10.1071/IT9920077; Harvey M.S, 2003, CATALOGUE SMALLER AR; Harvey MS, 2008, INVERTEBR SYST, V22, P167, DOI 10.1071/IS07026; Harvey MS, 2002, J ARACHNOL, V30, P357, DOI 10.1636/0161-8202(2002)030[0357:TNCWDW]2.0.CO;2; Kraus O., 1957, Senckenbergiana Biologica, V38, P245; LAWRENCE RF, 1969, T ROY SOC S AFR, V38, P123, DOI 10.1080/00359196909519080; Manzanilla OV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147012; Monjaraz-Ruedas R, 2016, ZOOL ANZ, V263, P118, DOI 10.1016/j.jcz.2016.05.003; Monjaraz-Ruedas R, 2016, ZOOL J LINN SOC-LOND, V176, P781, DOI 10.1111/zoj.12337; Monjaraz-Ruedas R, 2015, ZOOTAXA, V3915, P451, DOI 10.11646/zootaxa.3915.4.1; Moreno-Gonzalez JA, 2017, J NAT HIST, V51, P2681, DOI 10.1080/00222933.2017.1397226; Moreno-Gonzalez JA, 2014, ZOOTAXA, V3852, P227, DOI 10.11646/zootaxa.3852.2.4; Pinto-da-Rocha R, 2016, ZOOLOGIA-CURITIBA, V33, DOI 10.1590/S1984-4689zool-20150195; Reddell J.R., 2002, P387; Reddell James R., 1995, Texas Memorial Museum Speleological Monograph, V4, P1; ROWLAND JM, 1979, J ARACHNOL, V7, P89; Ruiz GRS, 2017, ZOOTAXA, V4311, P81, DOI 10.11646/zootaxa.4311.1.5; Salvatierra L, 2018, TURK J ZOOL, V42, P107, DOI 10.3906/zoo-1708-38; SHULTZ JW, 1990, CLADISTICS, V6, P1, DOI 10.1111/j.1096-0031.1990.tb00523.x; STURM H, 1958, NATURWISSENSCHAFTEN, V45, P142, DOI 10.1007/BF00641015; STURM H, 1973, Zeitschrift fuer Tierpsychologie, V33, P113; Teruel Rolando, 2007, Boletin de la SEA, V40, P39; Villarreal O, 2014, ZOOTAXA, V3765, P371, DOI 10.11646/zootaxa.3765.4.5	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213268	10.1371/journal.pone.0213268	http://dx.doi.org/10.1371/journal.pone.0213268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893324	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900035
J	Elshafee, AS; Karch, A; Ringe, KI; Shin, HO; Raatschen, HJ; Soliman, NY; Wacker, F; Vogel-Claussen, J				Elshafee, Amany Saad; Karch, Annika; Ringe, Kristina I.; Shin, Hoen-oh; Raatschen, Hans-Jurgen; Soliman, Nermin Yehia; Wacker, Frank; Vogel-Claussen, Jens			Complications of CT-guided lung biopsy with a non-coaxial semi-automated 18 gauge biopsy system: Frequency, severity and risk factors	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; CHEST TUBE PLACEMENT; MULTIVARIATE-ANALYSIS; DIAGNOSTIC YIELD; PNEUMOTHORAX; EXPERIENCE; HEMORRHAGE; MANAGEMENT	Objectives To evaluate frequency and severity of complications after CT-guided lung biopsy using the Society of Interventional Radiology (SIR) classification, and to assess risk factors for overall and major complications. Materials and methods 311 consecutive biopsies with a non-coaxial semi-automated 18 gauge biopsy system were retrospectively evaluated. Complications after biopsy were classified into minor SIR1-2 and major SIR3-6. Studied risk factors for complications were patient-related (age, sex and underlying emphysema), lesion-related (size, location, morphologic characteristic, depth from the pleura and histopathology), and technique-related (patient position during procedure, thoracic wall thickness at needle path, procedure time length and number of procedural CT images, number of pleural passes, fissure penetration and needle-to-blood vessel angle). Data were analyzed using logistic and ordinal regression. Results Complications were pneumothorax and pulmonary hemorrhage. The complications were minor SIR1-2 in 142 patients (45.6%), and major SIR3-4 in 25 patients (8%). SIR5-6 complications were not present. Emphysema, smaller deeply located lesion, increased puncture time length and number of procedural CT images, multiple pleural passes and fissure puncture were significant risk factors for complication severity in univariate analysis. Emphysema (OR = 8.8, p<0.001), lesion depth from the pleura (OR = 1.9 per cm, p<0.001), and fissure puncture (OR = 9.4, p = 0.01) were the independent factors for major complications in a multiple logistic regression model. No statistical difference of complication rates between the radiologists performing biopsies was observed. Conclusions Knowledge about risk factors influencing complication severity is important for planning and performing CT-guided lung biopsies.	[Elshafee, Amany Saad; Ringe, Kristina I.; Shin, Hoen-oh; Raatschen, Hans-Jurgen; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Elshafee, Amany Saad; Ringe, Kristina I.; Shin, Hoen-oh; Raatschen, Hans-Jurgen; Wacker, Frank; Vogel-Claussen, Jens] German Ctr Lung Res, Hannover, Germany; [Elshafee, Amany Saad; Soliman, Nermin Yehia] Mansoura Univ, Inst Diagnost & Intervent Radiol, Fac Med, Mansoura, Egypt; [Karch, Annika] Hannover Med Sch, Inst Biostat, Hannover, Germany	Hannover Medical School; Egyptian Knowledge Bank (EKB); Mansoura University; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.; Vogel-Claussen, J (corresponding author), German Ctr Lung Res, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de	Vogel-Claussen, Jens/Q-3374-2019; Elshafee, Amany/C-5841-2019	Vogel-Claussen, Jens/0000-0001-5595-6948; Elshafee, Amany/0000-0001-6415-4146	university scholarship, Cultural Affairs & Missions sector-Ministry of Higher Education-Egypt	university scholarship, Cultural Affairs & Missions sector-Ministry of Higher Education-Egypt	The first author received fund from university scholarship, Cultural Affairs & Missions sector-Ministry of Higher Education-Egypt. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2003, CLIN RADIOL, V58, P791, DOI 10.1016/S0009-9260(03)00221-6; Anzidei M, 2015, EUR J CARDIO-THORAC, V48, pe1, DOI 10.1093/ejcts/ezv172; Ayyappan AP, 2008, AM J ROENTGENOL, V191, P1725, DOI 10.2214/AJR.08.1110; Chassagnon G, 2017, DIAGN INTERV RADIOL, V23, P347, DOI 10.5152/dir.2017.160338; Guimaraes MD, 2010, CLINICS, V65, P847, DOI 10.1590/S1807-59322010000900006; Gupta S, 2010, J VASC INTERV RADIOL, V21, P969, DOI 10.1016/j.jvir.2010.01.011; Heerink WJ, 2017, EUR RADIOL, V27, P138, DOI 10.1007/s00330-016-4357-8; Herth FJF, 2006, RESPIRATION, V73, P399, DOI 10.1159/000093369; Hiraki T, 2010, AM J ROENTGENOL, V194, P809, DOI 10.2214/AJR.09.3224; Khan MF, 2008, EUR RADIOL, V18, P1356, DOI 10.1007/s00330-008-0893-1; Kuban JD, 2015, CARDIOVASC INTER RAD, V38, P1595, DOI 10.1007/s00270-015-1097-0; Lee SM, 2014, RADIOLOGY, V271, P291, DOI 10.1148/radiol.13131265; Li Y, 2013, CLIN RADIOL, V68, pE43, DOI 10.1016/j.crad.2012.09.008; Lim WH, 2018, EUR RADIOL, V28, P1328, DOI 10.1007/s00330-017-5058-7; Loh SE, 2013, ANN ACAD MED SINGAP, V42, P285; Nakatani M, 2012, MINIM INVASIV THER, V21, P415, DOI 10.3109/13645706.2012.662155; Noh Tae June, 2009, Korean Journal of Internal Medicine, V24, P343, DOI 10.3904/kjim.2009.24.4.343; Nour-Eldin NEA, 2016, CARDIOVASC INTER RAD, V39, P261, DOI 10.1007/s00270-015-1167-3; Olgun DC, 2015, EURASIAN J MED, V47, P72, DOI 10.5152/eajm.2014.51; Otto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124947; Poulou LS, 2013, ACTA RADIOL, V54, P640, DOI 10.1177/0284185113481595; Tai R, 2016, RADIOLOGY, V279, P287, DOI 10.1148/radiol.2015150381; Winer-Muram HT, 2006, RADIOLOGY, V239, P34, DOI 10.1148/radiol.2391050343; Wu CC, 2011, AM J ROENTGENOL, V196, pW678, DOI 10.2214/AJR.10.4659; Yamagami T, 2002, CHEST, V121, P1159, DOI 10.1378/chest.121.4.1159; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Yildirim E, 2009, EUR J RADIOL, V70, P57, DOI 10.1016/j.ejrad.2008.01.006	27	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213990	10.1371/journal.pone.0213990	http://dx.doi.org/10.1371/journal.pone.0213990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883575	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500044
J	Kulmatiski, A; Beard, KH				Kulmatiski, Andrew; Beard, Karen H.			Chronosequence and direct observation approaches reveal complementary community dynamics in a novel ecosystem	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; VEGETATION CHANGE; SPECIES RICHNESS; PLANT INVASIONS; LIFE; INVASIVENESS; REGENERATION; FACILITATION; DISTURBANCE; ABUNDANCE	Non-native, early-successional plants have been observed to maintain dominance for decades, particularly in semi-arid systems. Here, two approaches were used to detect potentially slow successional patterns in an invaded semi-arid system: chronosequence and direct observation. Plant communities in 25 shrub-steppe sites that represented a 50-year chronosequence of agricultural abandonment were monitored for 13 years. Each site contained a field abandoned from agriculture (ex-arable) and an adjacent never-tilled field. Ex-arable fields were dominated by short-lived, non-native plants. These weedy communities had lower species richness, diversity and ground cover, and greater annual and forb cover than communities in never-tilled fields. Never-tilled fields were dominated by long-lived native plants. Across the chronosequence, plant community composition remained unchanged in both ex-arable and never-tilled fields. In contrast, 13 years of direct observation detected directional changes in plant community composition within each field type. Despite within-community changes in both field types during direct observation, there was little evidence that native plants were invading ex-arable fields or that non-native plants were invading never-tilled fields. The more-controlled, direct observation approach was more sensitive to changes in community composition, but the chronosequence approach suggested that these changes are unlikely to manifest over longer time periods, at least in part because of disturbances in the system. Results highlight the long-term consequences of soil disturbance and the difficulty of restoring native perennials in disturbed semi-arid systems.	[Kulmatiski, Andrew; Beard, Karen H.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Kulmatiski, Andrew; Beard, Karen H.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Kulmatiski, A (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	andrew.kulmatiski@usu.edu	kulmatiski, andrew/J-2072-2015; Beard, Karen/B-7177-2011	kulmatiski, andrew/0000-0001-9977-5508; Beard, Karen/0000-0003-4997-2495	Utah Agricultural Experiment Station, Utah State University; National Science Foundation [1354129]	Utah Agricultural Experiment Station, Utah State University; National Science Foundation(National Science Foundation (NSF))	This research was supported by the Utah Agricultural Experiment Station, Utah State University and approved as journal paper #8920. Research was also supported by the National Science Foundation Award #1354129.	Alstad AO, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500975; Anderson JE, 2001, ECOL MONOGR, V71, P531, DOI 10.1890/0012-9615(2001)071[0531:LSCIPS]2.0.CO;2; [Anonymous], 2000, FIELD METHOD, DOI DOI 10.1177/1525822X0001200104; Bagchi S, 2017, ECOL APPL, V27, P1514, DOI 10.1002/eap.1544; Blossey B., 1999, Biological Invasions, V1, P301, DOI 10.1023/A:1010084724526; Bonet A, 2004, PLANT ECOL, V174, P257, DOI 10.1023/B:VEGE.0000049106.96330.9c; Briske DD, 2017, SPRINGER SER ENV MAN, P197, DOI 10.1007/978-3-319-46709-2_6; Briske DD, 2005, RANGELAND ECOL MANAG, V58, P1, DOI 10.2111/1551-5028(2005)58&lt;1:SMTARH&gt;2.0.CO;2; Chu CJ, 2014, J VEG SCI, V25, P947, DOI 10.1111/jvs.12106; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Courtois DR, 2004, J RANGE MANAGE, V57, P574, DOI 10.2307/4004011; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Csecserits A, 2001, APPL VEG SCI, V4, P63, DOI 10.1111/j.1654-109X.2001.tb00235.x; Didham RK, 2005, OIKOS, V110, P409, DOI 10.1111/j.0030-1299.2005.13883.x; Dietz H, 2002, CAN J BOT, V80, P642, DOI [10.1139/B02-048, 10.1139/b02-048]; Elton C., 1958; Flory SL, 2014, J ECOL, V102, P12, DOI 10.1111/1365-2745.12186; Foster BL, 2000, PLANT ECOL, V146, P1, DOI 10.1023/A:1009895103017; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gill RA, 2018, OECOLOGIA, V187, P755, DOI 10.1007/s00442-018-4137-z; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; Hitchcock C.L., 1973, FLORA PACIFIC NW; Jackson RD, 2002, PLANT ECOL, V162, P49, DOI 10.1023/A:1020363603900; Jauni M, 2015, OIKOS, V124, P122, DOI 10.1111/oik.01416; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kachergis E, 2014, RANGELAND ECOL MANAG, V67, P183, DOI 10.2111/REM-D-12-00066.1; Keeley JE, 2006, ECOL MONOGR, V76, P235, DOI 10.1890/0012-9615(2006)076[0235:DPOPRI]2.0.CO;2; Klinger R, 2017, J ECOL, V105, P1521, DOI 10.1111/1365-2745.12863; Krannitz PG, 2000, AM MIDL NAT, V144, P109, DOI 10.1674/0003-0031(2000)144[0109:BOABPT]2.0.CO;2; Kulmatiski A, 2008, SOIL BIOL BIOCHEM, V40, P1059, DOI 10.1016/j.soilbio.2007.11.020; Kulmatiski A, 2006, PLANT ECOL, V187, P261, DOI 10.1007/s11258-006-9140-5; Kulmatiski A, 2006, J APPL ECOL, V43, P868, DOI 10.1111/j.1365-2664.2006.01192.x; Kyle GP, 2007, PLANT ECOL, V193, P223, DOI 10.1007/s11258-006-9260-y; Lauenroth WK, 2008, J ECOL, V96, P1023, DOI 10.1111/j.1365-2745.2008.01415.x; Lenfesty CD, 1980, SOIL SURVEY OKANOGAN; Li SP, 2016, ECOL LETT, V19, P1101, DOI 10.1111/ele.12647; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Maier AM, 2001, J RANGE MANAGE, V54, P699, DOI 10.2307/4003674; Meiners SJ, 2007, ECOLOGY, V88, P1098, DOI 10.1890/06-1505; Michalet R, 2014, J VEG SCI, V25, P609, DOI 10.1111/jvs.12123; Monaco TA, 2017, RANGELAND ECOL MANAG, V70, P396, DOI 10.1016/j.rama.2016.09.008; Morris LR, 2014, RANGELAND ECOL MANAG, V67, P285, DOI 10.2111/REM-D-12-00147.1; Murcia C, 2014, TRENDS ECOL EVOL, V29, P548, DOI 10.1016/j.tree.2014.07.006; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Perryman BL, 2001, J RANGE MANAGE, V54, P166, DOI 10.2307/4003178; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Rexroad EA, 2007, WEST N AM NATURALIST, V67, P16, DOI 10.3398/1527-0904(2007)67[16:VRTAYO]2.0.CO;2; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2011, 50 YEARS INVASION EC, P432; Rinella MJ, 2009, ECOL APPL, V19, P155, DOI 10.1890/07-1482.1; Roberts DW., 2007, LABDSV ORDINATION MU; RUMBAUGH MD, 1982, J RANGE MANAGE, V35, P84, DOI 10.2307/3898526; Schlaepfer DR, 2014, RANGELAND ECOL MANAG, V67, P344, DOI 10.2111/REM-D-13-00079.1; Stark JM, 2015, OECOLOGIA, V177, P799, DOI 10.1007/s00442-014-3093-5; Strayer DL, 2012, ECOL LETT, V15, P1199, DOI 10.1111/j.1461-0248.2012.01817.x; Stylinski CD, 1999, J APPL ECOL, V36, P544, DOI 10.1046/j.1365-2664.1999.00423.x; Team RCR, 2004, LANG ENV STAT COMP; Tognetti PM, 2010, BIOL CONSERV, V143, P2494, DOI 10.1016/j.biocon.2010.06.016; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Yelenik SG, 2013, NATURE, V503, P517, DOI 10.1038/nature12798; Ziegenhagen LL, 2009, WEST N AM NATURALIST, V69, P195, DOI 10.3398/064.069.0208	62	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0207047	10.1371/journal.pone.0207047	http://dx.doi.org/10.1371/journal.pone.0207047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883554	Green Submitted, Green Published, gold			2022-12-26	WOS:000461423500003
J	Bruinenberg, VM; van Vliet, D; van der Goot, E; Counotte, DS; Kuhn, M; van Spronsen, FJ; van der Zee, EA				Bruinenberg, Vibeke M.; van Vliet, Danique; van der Goot, Els; Counotte, Danielle S.; Kuhn, Mirjam; van Spronsen, Francjan J.; van der Zee, Eddy A.			Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU)	PLOS ONE			English	Article							MEMORY; DYSFUNCTION; OUTCOMES; DECLINE; ADULTS; MICE	Introduction In phenylketonuria (PKU), a gene mutation in the phenylalanine metabolic pathway causes accumulation of phenylalanine (Phe) in blood and brain. Although early introduction of a Phe-restricted diet can prevent severe symptoms from developing, patients who are diagnosed and treated early still experience deficits in cognitive functioning indicating shortcomings of current treatment. In the search for new and/or additional treatment strategies, a specific nutrient combination (SNC) was postulated to improve brain function in PKU. In this study, a long-term dietary intervention with a low-Phe diet, a specific combination of nutrients designed to improve brain function, or both concepts together was investigated in male and female BTBR PKU and WT mice. Material & methods 48 homozygous wild-types (WT, +/+) and 96 PKU BTBRPah2 (-/-) male and female mice received dietary interventions from postnatal day 31 till 10 months of age and were distributed in the following six groups: high Phe diet (WT C-HP, PKU C-HP), high Phe plus specific nutrient combination (WT SNC-HP, PKU SNC-HP), PKU low-Phe diet (PKU C-LP), and PKU low-Phe diet plus specific nutrient combination (PKU SNC- LP). Memory and motor function were tested at time points 3, 6, and 9 months after treatment initiation in the open field (OF), novel object recognition test (NOR), spatial object recognition test (SOR), and the balance beam (BB). At the end of the experiments, brain neurotransmitter concentrations were determined. Results In the NOR, we found that PKU mice, despite being subjected to high Phe conditions, could master the task on all three time points when supplemented with SNC. Under low Phe conditions, PKU mice on control diet could master the NOR at all three time points, while PKU mice on the SNC supplemented diet could master the task at time points 6 and 9 months. SNC supplementation did not consistently influence the performance in the OF, SOR or BB in PKU mice. The low Phe diet was able to normalize concentrations of norepinephrine and serotonin; however, these neurotransmitters were not influenced by SNC supplementation. Conclusion This study demonstrates that both a long-lasting low Phe diet, the diet enriched with SNC, as well as the combined diet was able to ameliorate some, but not all of these PKU-induced abnormalities. Specifically, this study is the first long-term intervention study in BTBR PKU mice that shows that SNC supplementation can specifically improve novel object recognition.	[Bruinenberg, Vibeke M.; van der Goot, Els; van der Zee, Eddy A.] Univ Groningen, Mol Neurobiol, GELIFES, Groningen, Netherlands; [van Vliet, Danique; van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Metab Dis, Groningen, Netherlands; [Counotte, Danielle S.; Kuhn, Mirjam] Nutricia Res, Utrecht, Netherlands	University of Groningen; University of Groningen; Danone Nutricia	van der Zee, EA (corresponding author), Univ Groningen, Mol Neurobiol, GELIFES, Groningen, Netherlands.	e.a.van.der.zee@rug.nl	van der Zee, Eddy/AAZ-2120-2020	van der Zee, Eddy/0000-0002-6471-7938	Nutricia Research, Utrecht, The Netherlands	Nutricia Research, Utrecht, The Netherlands	This study was funded by Nutricia Research, Utrecht, The Netherlands. MK and DSC are employed by Nutricia Advanced Medical Nutrition. Nutricia provided support in the form of salaries for authors MK and DSC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Brouwer-Brolsma EM, 2014, BEHAV BRAIN RES, V267, P133, DOI 10.1016/j.bbr.2014.03.038; Bruinenberg VM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00233; Bruinenberg VM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040185; Cansev M, 2015, NEUROBIOL AGING, V36, P344, DOI 10.1016/j.neurobiolaging.2014.07.021; de Wilde MC, 2011, J ALZHEIMERS DIS, V27, P327, DOI 10.3233/JAD-2011-110635; Enns GM, 2010, MOL GENET METAB, V101, P99, DOI 10.1016/j.ymgme.2010.05.017; Fiori E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183430; Hovens IB, 2014, BRAIN BEHAV IMMUN, V38, P202, DOI 10.1016/j.bbi.2014.02.002; Jahja R, 2016, J INHERIT METAB DIS, V39, P355, DOI 10.1007/s10545-016-9918-0; Koch R, 1999, MOL GENET METAB, V67, P148, DOI 10.1006/mgme.1999.2863; MacPherson P, 2008, BRAIN RES, V1210, P179, DOI 10.1016/j.brainres.2008.03.008; Moyle JJ, 2007, NEUROPSYCHOL REV, V17, P91, DOI 10.1007/s11065-007-9021-2; Mulder CK, 2015, LEARN MEMORY, V22, P278, DOI 10.1101/lm.037440.114; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Palermo L, 2017, NEUROPSYCHOLOGY, V31, P255, DOI 10.1037/neu0000337; Pascucci T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084697; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Saroja SR, 2014, BEHAV BRAIN RES, V264, P1, DOI 10.1016/j.bbr.2014.01.042; Savelkoul PJM, 2012, J NEUROCHEM, V120, P631, DOI 10.1111/j.1471-4159.2011.07616.x; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Stapley NW, 2013, NEUROSCI LETT, V549, P120, DOI 10.1016/j.neulet.2013.06.032; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; van der Goot E, 2019, NEUROBIOL LEARN MEM, V160, P139, DOI 10.1016/j.nlm.2018.05.002; van der Zee EA, 2015, NEUROSCI BIOBEHAV R, V50, P77, DOI 10.1016/j.neubiorev.2014.06.012; van Dijk G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00173; van Spronsen FJ, 2017, LANCET DIABETES ENDO, V5, P743, DOI 10.1016/S2213-8587(16)30320-5; van Vliet D, 2016, AM J CLIN NUTR, V104, P1292, DOI 10.3945/ajcn.116.135996; van Vliet D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143833; van Wijk N, 2014, J ALZHEIMERS DIS, V38, P459, DOI 10.3233/JAD-130998; Weber M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0047-15.2015; Wiesmann M, 2017, THERANOSTICS, V7, P493, DOI 10.7150/thno.17559; Wurtman RJ, 2009, ANNU REV NUTR, V29, P59, DOI 10.1146/annurev-nutr-080508-141059	35	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213391	10.1371/journal.pone.0213391	http://dx.doi.org/10.1371/journal.pone.0213391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875376	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400014
J	Cougoul, A; Bailly, X; Vourc'h, G; Gasqui, P				Cougoul, Arnaud; Bailly, Xavier; Vourc'h, Gwenael; Gasqui, Patrick			Rarity of microbial species: In search of reliable associations	PLOS ONE			English	Article							NETWORK	The role of microbial interactions in defining the properties of microbiota is a topic of key interest in microbial ecology. Microbiota contain hundreds to thousands of operational taxonomic units (OTUs), most of them rare. This feature of community structure can lead to methodological difficulties: simulations have shown that methods for detecting pairwise associations between OTUs, which presumably reflect interactions, yield problematic results. The performance of association detection tools is impaired when there is a high proportion of zeros in OTU tables. Our goal was to understand the impact of OTU rarity on the detection of associations. We explored the utility of common statistics for testing associations; the sensitivity of alternative association measures; and the performance of network inference tools. We found that a large proportion of pairwise associations, especially negative associations, cannot be reliably tested. This constraint could hamper the identification of candidate biological agents that could be used to control rare pathogens. Identifying testable associations could serve as an objective method for filtering datasets in lieu of current empirical approaches. This trimming strategy could significantly reduce the computational time needed to infer networks and network inference quality. Different possibilities for improving the analysis of associations within microbiota are discussed.	[Cougoul, Arnaud; Bailly, Xavier; Vourc'h, Gwenael; Gasqui, Patrick] Univ Clermont Auvergne, UMR Epidemiol Anim & Zoonot Dis, INRA, VetAgro Sup, St Genes Champanelle, France	INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup	Cougoul, A (corresponding author), Univ Clermont Auvergne, UMR Epidemiol Anim & Zoonot Dis, INRA, VetAgro Sup, St Genes Champanelle, France.	arnaud.cougoul@inra.fr	Bailly, Xavier/C-6254-2011	Bailly, Xavier/0000-0001-6959-7974; Cougoul, Arnaud/0000-0002-7604-2536	French National Institute for Agricultural Research; INRA metaprogramm: Meta-omics of microbial ecosystems (MEM); INRA metaprogramm: Integrated management of animal health (GISA)	French National Institute for Agricultural Research; INRA metaprogramm: Meta-omics of microbial ecosystems (MEM); INRA metaprogramm: Integrated management of animal health (GISA)	The work is funded by the French National Institute for Agricultural Research (http://institut.inra.fr/en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by two INRA metaprogrammes: Meta-omics of microbial ecosystems (MEM) and Integrated management of animal health (GISA). We thank Ioana Molnar for the mathematical advice and Jessica Pearce-Duvet for proofreading the manuscript. We also thank Leo Lahti and the other anonymous reviewer for their constructive comments that helped us improve this work.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Balint M, 2016, FEMS MICROBIOL REV, V40, P686, DOI 10.1093/femsre/fuw017; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Carlson JM, 2009, ESTIMATING FALSE DIS; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chaganty NR, 2006, BIOMETRIKA, V93, P197, DOI 10.1093/biomet/93.1.197; Faust Karoline, 2016, F1000Res, V5, P1519; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gibson TE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004688; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Gonze D, 2017, ISME J, V11, P2159, DOI 10.1038/ismej.2017.60; Guilford JP, 1941, PSYCHOMETRIKA, V6, P11, DOI 10.1007/BF02288569; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Jonsson V, 2019, STAT METHODS MED RES, V28, P3712, DOI 10.1177/0962280218811354; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Layeghifard M, 2017, TRENDS MICROBIOL, V25, P217, DOI 10.1016/j.tim.2016.11.008; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li CH, 2016, METHODS, V102, P12, DOI 10.1016/j.ymeth.2016.02.019; Lo C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005915; Locey KJ, 2016, P NATL ACAD SCI USA, V113, P5970, DOI 10.1073/pnas.1521291113; Mainali KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187132; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Pearson K., 1896, PHILOS T ROYAL SOC A, V187, P253, DOI [DOI 10.1098/RSTA.1896.0007, 10.1098/rsta.1896.0007]; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118432; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; TARONE RE, 1990, BIOMETRICS, V46, P515, DOI 10.2307/2531456; Trivedi PK, 2006, FDN TRENDS EC, V1, P1, DOI [10.1561/0800000005, DOI 10.1561/0800000005]; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45; Yule GU, 1912, J R STAT SOC, V75, P579, DOI 10.2307/2340126	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0200458	10.1371/journal.pone.0200458	http://dx.doi.org/10.1371/journal.pone.0200458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875367	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400001
J	Grice, PM; Kemp, CC				Grice, Phillip M.; Kemp, Charles C.			In-home and remote use of robotic body surrogates by people with profound motor deficits	PLOS ONE			English	Article							ARM; ACCEPTANCE; GRASP; TETRAPLEGIA; AUTONOMY; REACH	By controlling robots comparable to the human body, people with profound motor deficits could potentially perform a variety of physical tasks for themselves, improving their quality of life. The extent to which this is achievable has been unclear due to the lack of suitable interfaces by which to control robotic body surrogates and a dearth of studies involving substantial numbers of people with profound motor deficits. We developed a novel, web-based augmented reality interface that enables people with profound motor deficits to remotely control a PR2 mobile manipulator from Willow Garage, which is a human-scale, wheeled robot with two arms. We then conducted two studies to investigate the use of robotic body surrogates. In the first study, 15 novice users with profound motor deficits from across the United States controlled a PR2 in Atlanta, GA to perform a modified Action Research Arm Test (ARAT) and a simulated self-care task. Participants achieved clinically meaningful improvements on the ARAT and 12 of 15 participants (80%) successfully completed the simulated self-care task. Participants agreed that the robotic system was easy to use, was useful, and would provide a meaningful improvement in their lives. In the second study, one expert user with profound motor deficits had free use of a PR2 in his home for seven days. He performed a variety of self-care and household tasks, and also used the robot in novel ways. Taking both studies together, our results suggest that people with profound motor deficits can improve their quality of life using robotic body surrogates, and that they can gain benefit with only low-level robot autonomy and without invasive interfaces. However, methods to reduce the rate of errors and increase operational speed merit further investigation.	[Grice, Phillip M.; Kemp, Charles C.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Grice, PM (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.	phillip.grice@gatech.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) via RERC TechSAge [90RE5016-01-00]; National Science Foundation Award [IIS-1150157]; National Science Foundation Graduate Research Fellowship Program Award; Residential Care Facilities for the Elderly of Fulton County Scholar Award	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) via RERC TechSAge(United States Department of Health & Human Services); National Science Foundation Award(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program Award; Residential Care Facilities for the Elderly of Fulton County Scholar Award	This work was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), grant 90RE5016-01-00 via RERC TechSAge (https://www.acl.gov/about-acl/about-national-institute-disability-independent-living-and-rehabilitation-research, CK), National Science Foundation Award IIS-1150157 (https://www.nsf.gov/div/index.jsp?div=IIS, CK), by a National Science Foundation Graduate Research Fellowship Program Award (https://www.nsfgrfp.org, PG), and the Residential Care Facilities for the Elderly of Fulton County Scholar Award (http://www.fultoncountyga.gov/appointed-boards-a-athorities/3255-residential-care-facilities-for-the-elderly-authority-of-fulton-county, PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajemian R, 2017, NATURE, V544, P416, DOI 10.1038/544416c; Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Alaiad A, 2014, INT J HEALTHC INF SY, V9, P44, DOI 10.4018/ijhisi.2014100104; Annett J, 2003, HUM FAC ER, P17; [Anonymous], 2017, ROBOTNIK RB 1 DATASH; Bien Z, 2004, AUTON ROBOT, V16, P165, DOI 10.1023/B:AURO.0000016864.12513.77; Cargo M, 2008, ANNU REV PUBL HEALTH, V29, P325, DOI 10.1146/annurev.publhealth.29.091307.083824; Chen TL, 2013, IEEE ROBOT AUTOM MAG, V20, P30, DOI 10.1109/MRA.2012.2229950; Ciocarlie M, 2012, IEEE INT C INT ROBOT, P5313, DOI 10.1109/IROS.2012.6385907; Cohen O, 2012, P IEEE RAS-EMBS INT, P314, DOI 10.1109/BioRob.2012.6290866; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Cornwall A, 1995, SOC SCI MED, V41, P1667, DOI 10.1016/0277-9536(95)00127-S; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Ezer N, 2009, LECT NOTES COMPUT SC, V5615, P39, DOI 10.1007/978-3-642-02710-9_5; Felipe S.K., 2010, P HUM FACT ERG SOC A, V54, P2005, DOI [10.1177/154193121005402321, DOI 10.1177/154193121005402321]; Gopinath D, 2017, IEEE ROBOT AUTOM LET, V2, P247, DOI 10.1109/LRA.2016.2593928; Green A, 2000, IEEE RO-MAN 2000: 9TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P161, DOI 10.1109/ROMAN.2000.892488; Grice P. M., 2013, REH ROB ICORR 2013 I, P1; Grice Phillip M, 2016, RSS 2016 WORKSH SOC; Hawkins Kelsey P., 2014, 2014 IEEE Symposium on Computational Intelligence in Robotic Rehabilitation and Assistive Technologies (CIR2AT), P16, DOI 10.1109/CIRAT.2014.7009736; Herlant L, 2016, HUMAN ROBOT INTERACT; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hutchins E. L., 1985, HUMAN COMPUTER INTER, V1, P311, DOI [DOI 10.1207/S15327051HCI0104_2, 10.1207/s15327051hci0104_2]; Inc K, 2018, KIN MOVO DAT; Iwarsson S, 2003, DISABIL REHABIL, V25, P57, DOI 10.1080/0963828021000007969; Jain A, 2013, INT J ROBOT RES, V32, P458, DOI 10.1177/0278364912471865; Jain S, 2015, INT C REHAB ROBOT, P526, DOI 10.1109/ICORR.2015.7281253; Kajita S, 2016, SPRINGER HDB ROBOTIC; Kintsch A., 2002, P STATEWIDE ASSISTIV; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Leeper A, 2012, ACMIEEE INT CONF HUM, P1; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mankoff J., 2002, ASSETS 2002. Proceedings of the Fifth International ACM SIGCAPH Conference on Assistive Technologies, P17, DOI 10.1145/638249.638255; Marion P, 2017, J FIELD ROBOT, V34, P262, DOI 10.1002/rob.21681; Meng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38565; Murphy RR, 2015, J FIELD ROBOT, V32, P189, DOI 10.1002/rob.21578; Norman D., 2013, DESIGN EVERYDAY THIN; Pages J., 2016, INT WORK ROBOT MODUL; Pandarinath C, 2017, ELIFE, V6, DOI 10.7554/eLife.18554; Park D, 2017, IEEE INT C INT ROBOT, P5406; Robinson-Smith G, 2000, ARCH PHYS MED REHAB, V81, P460, DOI 10.1053/mr.2000.3863; Romano JM, 2011, IEEE T ROBOT, V27, P1067, DOI 10.1109/TRO.2011.2162271; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Sanders EBN, 2002, DESIGN AND THE SOCIAL SCIENCES: MAKING CONNECTIONS, P1; Schuler D., 1993, PARTICIPATORY DESIGN; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Simpson Richard, 2010, Phys Med Rehabil Clin N Am, V21, P15, DOI 10.1016/j.pmr.2009.07.006; Soekadar SR, 2016, SCI ROBOT, V1, DOI 10.1126/scirobotics.aag3296; Soukoreff RW, 2004, INT J HUM-COMPUT ST, V61, P751, DOI 10.1016/j.ijhcs.2004.09.001; Spenko M., 2018, DARPA ROBOTICS CHALL, V121; Sung J, 2010, INT J SOC ROBOT, V2, P417, DOI 10.1007/s12369-010-0065-8; Tidoni E, 2017, IEEE T NEUR SYS REH, V25, P772, DOI 10.1109/TNSRE.2016.2597863; Toris R, 2015, IEEE RSJ INT C INT R; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Tsui K, 2015, PALADYN J BEHAV ROBO, V6; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Viswanathan M, 2004, Evid Rep Technol Assess (Summ), P1; Wagner J, 1999, P ICORR, V99, P250; Wang HW, 2013, J SPINAL CORD MED, V36, P333, DOI 10.1179/2045772313Y.0000000094; Wilkinson CR, 2014, DESIGN STUD, V35, P614, DOI 10.1016/j.destud.2014.06.001; Wise M., 2016, FETCH FREIGHT STANDA; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wusheng Chou, 2001, 2001 IEEE International Conference on Systems, Man and Cybernetics. e-Systems and e-Man for Cybernetics in Cyberspace (Cat.No.01CH37236), P3187, DOI 10.1109/ICSMC.2001.972009; Yamamoto T, 2018, SIGGRAPH'18: ACM SIGGRAPH 2018 EMERGING TECHNOLOGIES, DOI 10.1145/3214907.3233972; Yanco HA, 2015, J FIELD ROBOT, V32, P420, DOI 10.1002/rob.21568; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353; Zalud L, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P211, DOI 10.1109/IROS.2006.282495	69	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0212904	10.1371/journal.pone.0212904	http://dx.doi.org/10.1371/journal.pone.0212904			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875377	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400007
J	Hanson, KT; Carlson, KF; Friedemann-Sanchez, G; Meis, LA; Van Houtven, CH; Jensen, AC; Phelan, SM; Griffin, JM				Hanson, Kristine T.; Carlson, Kathleen F.; Friedemann-Sanchez, Greta; Meis, Laura A.; Van Houtven, Courtney H.; Jensen, Agnes C.; Phelan, Sean M.; Griffin, Joan M.			Family caregiver satisfaction with inpatient rehabilitation care	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SOCIAL SUPPORT; MENTAL-HEALTH; MEDICAL HOME; VETERANS; BURDEN; IMPACT; PREDICTORS; DISCHARGE; PROGRAM	Introduction Informal family caregivers play an increasingly important role in healthcare. Despite their role in ongoing management and coordination of care, caregiver satisfaction with the healthcare services care recipients receive has been understudied. We sought to assess what influences caregiver satisfaction with inpatient care provided to their care recipient among caregivers of veterans with traumatic brain injury (TBI) and polytrauma. Methods Data from the Family and Caregiver Experience Survey, a national survey of caregivers of veterans with TBI and polytrauma, was used to explore factors associated with caregiver satisfaction with the care his/her care recipient received while an inpatient at a US Department of Veterans Affairs (VA) Polytrauma Rehabilitation Center. Caregiver and care recipient demographic and injury factors and potential addressable factors including social support, caregiver training received, and caregiver perceptions of being valued by the VA were evaluated for their associations with caregivers' satisfaction with their care recipients' healthcare. Results The majority of the 524 caregivers reported being mostly or very satisfied with their care recipient's inpatient care (75%, n = 393). Higher satisfaction with inpatient care was significantly associated with greater caregiver social support, receipt of training from the VA, and perceptions of being valued by the VA, both on univariate analysis and after controlling for care recipient TBI severity and caregiver's relationship to the care recipient. Conclusions Results suggest that supporting a strong social network for caregivers, providing caregiver training, and employing practices that communicate that family caregiving is valued by providers and healthcare organizations are promising avenues for improving caregiver satisfaction.	[Hanson, Kristine T.; Phelan, Sean M.; Griffin, Joan M.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ Portland State Univ, Sch Publ Hlth, Portland, OR USA; [Friedemann-Sanchez, Greta] Univ Minnesota, Hubert H Humphrey Sch Publ Affairs, Minneapolis, MN USA; [Meis, Laura A.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Meis, Laura A.; Jensen, Agnes C.] VA Healthcare Syst, Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA; [Van Houtven, Courtney H.] Durham VA Med Ctr, Durham, NC USA; [Van Houtven, Courtney H.] Duke Univ, Sch Med, Durham, NC USA; [Phelan, Sean M.; Griffin, Joan M.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA	Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Portland State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Mayo Clinic	Griffin, JM (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.; Griffin, JM (corresponding author), Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA.	griffin.joan@mayo.edu		Van Houtven, Courtney/0000-0002-0783-1611	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Health Services Research and Development (HSRD) service [SDR-07-044]; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester MN, United States	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Health Services Research and Development (HSRD) service; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester MN, United States	This research was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and a grant from the Health Services Research and Development (HSR&D) service (SDR-07-044) (JG), https://www.hsrd.research.va.gov/.The sponsor was not involved in any aspect of the study's design and conduct; data collection, management, analysis, or interpretation of data; or the preparation, review, or approval of the manuscript. Support was also provided by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester MN, United States (http://www.mayo.edu/research/centers-programs/robert-d-patricia-e-kern-centerscience-health-care-delivery).	Alves S, 2015, SCAND J CARING SCI; [Anonymous], 2015, NHMRC STAT EV WIND H; Bertakis KD, 2011, J AM BOARD FAM MED, V24, P229, DOI 10.3122/jabfm.2011.03.100170; Bull MJ, 2000, APPL NURS RES, V13, P76, DOI 10.1016/S0897-1897(00)80004-X; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; de Labra C, 2015, ARCH GERONTOL GERIAT, V60, P380, DOI 10.1016/j.archger.2015.03.002; Epstein RM, 2011, ANN FAM MED, V9, P100, DOI 10.1370/afm.1239; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gillick MR, 2013, JAMA-J AM MED ASSOC, V310, P575, DOI 10.1001/jama.2013.7310; Griffin JM, 2017, HEALTH SOC WORK, V42, pE111, DOI 10.1093/hsw/hlx016; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hendrix CC, 2016, SUPPORT CARE CANCER, V24, P327, DOI 10.1007/s00520-015-2797-3; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI DOI 10.1136/BMJ.328.7448.1099; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LaVela SL., 2014, PATIENT EXP J, V1, P28, DOI DOI 10.1177/237437431400100206; Lopez J, 2005, ARCH GERONTOL GERIAT, V41, P81, DOI 10.1016/j.archger.2004.12.001; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Manskow US, 2014, J HEAD TRAUMA REHABN, P1, DOI [10.1097/HTR.0b013e318281966e, DOI 10.1097/HTR.0B013E318281966E]; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Patel BR, 2015, SOC WORK, V60, P9, DOI 10.1093/sw/swu043; Pourat N, 2016, MED CARE, V54, P262, DOI 10.1097/MLR.0000000000000498; Ramchand R, 2014, HIDDEN HEROES AM MIL, p[xii, 1]; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rubin R., 2014, JAMA-J AM MED ASSOC, V312, P1389; Shiba K, 2016, J EPIDEMIOL, V26, P622, DOI 10.2188/jea.JE20150263; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Tanielian T., 2013, MILITARY CAREGIVERS; Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; VanHoutven CH, 2017, MED CARE RES REV; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wentlandt K, 2016, J PAIN SYMPTOM MANAG, V51, P184, DOI 10.1016/j.jpainsymman.2015.10.006; Wolff JL, 2012, JAMA-J AM MED ASSOC, V308, P1529, DOI 10.1001/jama.2012.13366	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213767	10.1371/journal.pone.0213767	http://dx.doi.org/10.1371/journal.pone.0213767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875411	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400027
J	Kumar, S; Suyal, DC; Yadav, A; Shouche, Y; Goel, R				Kumar, Saurabh; Suyal, Deep Chandra; Yadav, Amit; Shouche, Yogesh; Goel, Reeta			Microbial diversity and soil physiochemical characteristic of higher altitude	PLOS ONE			English	Article							GANGOTRI GLACIER; ELEVATIONAL GRADIENT; BACTERIAL DIVERSITY; COMMUNITIES; MICROORGANISMS; DECOMPOSITION; TEMPERATURE; HIMALAYAS; PATTERNS; DESERT	Altitude is the major factor affecting both biodiversity and soil physiochemical properties of soil ecosystems. In order to understand the effect of altitude on soil physiochemical properties and bacterial diversity across the Himalayan cold desert, high altitude Gangotri soil ecosystem was studied and compared with the moderate altitude Kandakhal soil. Soil physiochemical analysis showed that altitude was positively correlated with soil pH, organic matter and total nitrogen content. However soil mineral nutrients and soil phosphorus were negatively correlated to the altitude. RT-PCR based analysis revealed the decreased bacterial and diazotrophic abundance at high altitude. Metagenomic study showed that Proteobacteria, Acidobacteria and Actinobacteria were dominant bacteria phyla at high altitude soil while Bacteroidetes and Fermicutes were found dominant at low altitude. High ratio of Gram-negative to Gram positive bacteria at Gangotri suggests the selective proliferation of Gram negative bacteria at high altitude with decrease in Gram positive bacteria. Moreover, Alphaproteobacteria was found more abundant at high altitude while the opposite was true for Betaproteobacteria. Abundance of Cytophaga, Flavobacterium and Bacteroides (CFB) were also found comparatively high at high altitude. Presence of many taxonomically unclassified sequences in Gangotri soil indicates the presence of novel bacterial diversity at high altitude. Further, isolation of bacteria through indigenously designed diffusion chamber revealed the existence of bacteria which has been documented in unculturable study of WIH (Western Indian Himalaya) but never been cultivated from WIH. Nevertheless, diverse functional free-living psychrotrophic diazotrophs were isolated only from the high altitude Gangotri soil. Molecular characterization revealed them as Arthrobacter humicola, Brevibacillus invocatus, Pseudomonas mandelii and Pseudomonas helmanticensis. Thus, this study documented the bacterial and psychrophilic diazotrophic diversity at high altitude and is an effort for exploration of low temperature bacteria in agricultural productivity with the target for sustainable hill agriculture.	[Kumar, Saurabh; Suyal, Deep Chandra; Goel, Reeta] Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Microbiol, Pantnagar, Uttarakhand, India; [Yadav, Amit; Shouche, Yogesh] Natl Ctr Cell Sci, Natl Ctr Microbial Resource, Pune, Maharashtra, India	Govind Ballabh Pant University of Agriculture Technology; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Kumar, S (corresponding author), Govind Ballabh Pant Univ Agr & Technol, Coll Basic Sci & Humanities, Dept Microbiol, Pantnagar, Uttarakhand, India.	saurabhkandwal@hotmail.com	Suyal, Deep Chandra/AAT-8709-2020	Suyal, Deep Chandra/0000-0003-3380-5772	Council of Scientific and Industrial Research (CSIR); G.B. Pant University of Agriculture and Technology [211]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); G.B. Pant University of Agriculture and Technology	Author SK acknowledges the Council of Scientific and Industrial Research (CSIR) for granting the SRF fellowship and DCS acknowledges the Science and Engineering Research Board (SERB) Young Scientist scheme during course of this study. We acknowledge the G.B. Pant University of Agriculture and Technology for providing the financial grant to conduct this research work (Project Code - 211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J MICROBIOL, DOI DOI 10.5897/ajmr2014.7035; [Anonymous], 2011, THE EC; Baghel VS, 2005, ENZYME MICROB TECH, V36, P654, DOI 10.1016/j.enzmictec.2004.09.005; Bhattacharya A, 2016, J GLACIOL, V62, P1115, DOI 10.1017/jog.2016.96; Bu RY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143835; CHAN YK, 1994, FEMS MICROBIOL REV, V13, P95; Charan G, 2013, J SOIL SCI PLANT NUT, V13, P267, DOI 10.4067/S0718-95162012005000016; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Demergasso C, 2004, FEMS MICROBIOL ECOL, V48, P57, DOI 10.1016/j.femsec.2003.12.013; Gao HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095011; Gao JL, 2016, INT J SYST EVOL MICR, V66, P4022, DOI 10.1099/ijsem.0.001304; Hardy DH, 2013, UNDERSTANDING SOIL T; He XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24261; Joshi D., 2017, MINING MICROBIAL WEA, P101, DOI [10.1007/978-981-10-5708-3_6, DOI 10.1007/978-981-10-5708-3_6]; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kasana RC., 2017, MINING MICROBIAL WEA, Vhttps://doi.org/10.1007/978-981-10-5708-3_5; Kumar S, 2018, J PLANT NUTR, V41, P1035, DOI 10.1080/01904167.2018.1433211; Kumar Sharad, 2018, THESIS; MacDonald ZG, 2017, BIODIVERS CONSERV, V26, P617, DOI 10.1007/s10531-016-1261-0; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; Moran-Tejeda E, 2013, GEOPHYS RES LETT, V40, P2131, DOI 10.1002/grl.50463; Sahay H, 2013, J BASIC MICROB, V53, P703, DOI 10.1002/jobm.201200126; Shedayi AA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1935-9; SHEN CC, 2015, FRONT MICROBIOL, V6, pNIL1, DOI DOI 10.3389/fpls.2015.00073; Singh P, 2006, J HYDROL, V327, P55, DOI 10.1016/j.jhydrol.2005.11.060; Skidmore M, 2005, APPL ENVIRON MICROB, V71, P6986, DOI 10.1128/AEM.71.11.6986-6997.2005; Soni R., 2010, EKOLOGIYA, V56, P94; Stal LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05715-0; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Suyal DC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00430; Suyal DC, 2015, 3 BIOTECH, V5, P433, DOI 10.1007/s13205-014-0238-5; Tallkvist J, 2015, HANDBOOK ON THE TOXICOLOGY OF METALS, VOL I & II, 4TH EDITION, P1077, DOI 10.1016/B978-0-444-59453-2.00047-0; Walz J, 2017, SOIL BIOL BIOCHEM, V110, P34, DOI 10.1016/j.soilbio.2017.03.001; Wang GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11043; Yadav AN, 2016, J BASIC MICROB, V56, P294, DOI 10.1002/jobm.201500230; Yang GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36548; Zhang YG, 2015, MICROB BIOTECHNOL, V8, P739, DOI 10.1111/1751-7915.12288	37	39	43	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213844	10.1371/journal.pone.0213844	http://dx.doi.org/10.1371/journal.pone.0213844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875404	Green Submitted, Green Published, gold			2022-12-26	WOS:000461316400035
J	Luo, CH; Chen, W; Zhang, Y; Gaspar, CM				Luo, Canhuang; Chen, Wei; Zhang, Ye; Gaspar, Carl Michael			Rapid stream stimulation can enhance the stimulus selectivity of early evoked responses to written characters but not faces	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; INVERTED FACES; SENSITIVE N170; EFFECT SIZE; ERP; WORDS; BRAIN; STATISTICS; COMPONENT; DYNAMICS	The recognition potential (RP) is an early visually evoked response (similar to 250 ms) whose magnitude is sensitive to object recognizability and related factors. The RP is often measured when objects are embedded in a rapid stream of masking stimuli (the RSS paradigm), especially in reading research. The idea is that RSS provides greater stimulus-dependent variations in RP, compared to the corresponding variations without RSS. However, this idea has never been subject to systematic evaluation. We directly test whether RSS can enhance 2 types of RP stimulus selectivity, by measuring the RP in conditions that only differ in the presence or absence of a masking stream and in the type of stimulus shown. We measure the effect of image inversion on RP for Chinese characters (experiment 1); the effect of orthographical correctness on RP for Chinese characters (experiment 3); and as a control study, the effect of image inversion on the N170 response to faces (experiment 2). To ensure a fair comparison, the earliest negative deflections (RP/N170) measured with and without RSS should at least have similar channel ranges, and topographical distributions of both amplitude and selectivity. Our first set of results clearly supports this. Our main results clearly show an increase in stimulus-selectivity for RSS over non-RSS in both of the RP (Chinese character) experiments, but no such enhancement in the N170 (face) experiment. This provides incentive for investigations into the underlying mechanisms of selectivity enhancement. Our findings may also help to explain contradictory findings between RP/N170 studies that differ only in the use of noise masks, which is sometimes treated as trivial detail in papers that do not reference the RP/RSS literature.	[Luo, Canhuang; Zhang, Ye; Gaspar, Carl Michael] Hangzhou Normal Univ, Inst Psychol Sci, Hangzhou, Zhejiang, Peoples R China; [Luo, Canhuang; Zhang, Ye; Gaspar, Carl Michael] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Luo, Canhuang; Zhang, Ye; Gaspar, Carl Michael] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Chen, Wei] New York Univ Abu Dhabi, Objects & Knowledge Lab, Abu Dhabi, U Arab Emirates	Hangzhou Normal University; Hangzhou Normal University	Zhang, Y; Gaspar, CM (corresponding author), Hangzhou Normal Univ, Inst Psychol Sci, Hangzhou, Zhejiang, Peoples R China.; Zhang, Y; Gaspar, CM (corresponding author), Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China.; Zhang, Y; Gaspar, CM (corresponding author), Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	zhangye.lucia@gmail.com; carl.michael.gaspar@icloud.com		Gaspar, Carl/0000-0002-3101-1816; Luo, Canhuang/0000-0002-1426-5232; Chen, Wei/0000-0003-0121-6172; Zhang, Ye/0000-0002-8549-8420	National Natural Science Foundation of China (NSFC) [31400974, 31371132]; Zhejiang Provincial Natural Science Foundation of China (ZJNSF) [LY18C090010]; Chinese National Hi-Tech Program; ISVISION Tech. Co. Ltd.	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China (ZJNSF)(Natural Science Foundation of Zhejiang Province); Chinese National Hi-Tech Program; ISVISION Tech. Co. Ltd.	This project was supported by grants from the National Natural Science Foundation of China (NSFC) to Ye Zhang (grant No.: 31400974) and Carl M. Gaspar (grant No.: 31371132), and Zhejiang Provincial Natural Science Foundation of China (ZJNSF) (grant No.: LY18C090010) to Ye Zhang.; The research in this paper uses the CAS-PEAL-R1 face database collected under the sponsor of the Chinese National Hi-Tech Program and ISVISION Tech. Co. Ltd.	Amihai I, 2011, EXP BRAIN RES, V209, P193, DOI 10.1007/s00221-011-2546-x; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Benwell CSY, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0182-17.2017; BOTZEL K, 1995, EXP BRAIN RES, V104, P135, DOI 10.1007/BF00229863; Chung KKH, 2012, BRAIN RES, V1472, P20, DOI 10.1016/j.brainres.2012.06.010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 2013, CORTEX, V49, P2307, DOI 10.1016/j.cortex.2013.03.008; Feng CL, 2013, PSYCHOPHYSIOLOGY, V50, P885, DOI 10.1111/psyp.12067; Fu SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041103; Gao W, 2008, IEEE T SYST MAN CY A, V38, P149, DOI 10.1109/TSMCA.2007.909557; Gaspar CM, 2011, NEUROIMAGE, V58, P620, DOI 10.1016/j.neuroimage.2011.06.052; Hinojosa JA, 2001, COGNITIVE BRAIN RES, V12, P321, DOI 10.1016/S0926-6410(01)00039-8; Hinojosa JA, 2000, CLIN NEUROPHYSIOL, V111, P552, DOI 10.1016/S1388-2457(99)00275-8; Hinojosa JA, 2001, COGNITIVE BRAIN RES, V11, P397, DOI 10.1016/S0926-6410(01)00012-X; Iglesias A, 2004, INT J PSYCHOPHYSIOL, V52, P169, DOI 10.1016/j.ijpsycho.2003.06.003; Jacques C, 2018, HUMAN BRAIN MAPPING; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Kay KN, 2017, ELIFE, V6, DOI 10.7554/eLife.22341; Koppehele-Gossel J, 2018, BRAIN COGNITION, V125, P53, DOI 10.1016/j.bandc.2018.05.011; Lawrence MA, 2013, EZ EASY ANAL VISUALI, V3; Lin SE, 2011, NEUROSCIENCE, V190, P200, DOI 10.1016/j.neuroscience.2011.05.071; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lu FD, 1978, CHUNG HWA DICT; Martin-Loeches M, 1999, BRAIN LANG, V70, P364, DOI 10.1006/brln.1999.2178; Martin-Loeches M, 2004, BIOL PSYCHOL, V65, P265, DOI 10.1016/j.biopsycho.2003.07.002; Martin-Loeches M, 2002, INT J PSYCHOPHYSIOL, V43, P155, DOI 10.1016/S0167-8760(01)00171-4; Martin-Loeches M, 2001, NEUROPSYCHOLOGIA, V39, P1086, DOI 10.1016/S0028-3932(01)00033-1; Martin-Loeches M, 2001, PSYCHOPHYSIOLOGY, V38, P114, DOI 10.1017/S004857720199105X; Martin-Loeches M, 2007, BRAIN RES REV, V53, P89, DOI 10.1016/j.brainresrev.2006.07.001; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Maxwell S. E., 2004, DESIGNING EXPT ANAL; Nguyen VT, 2014, NEUROIMAGE, V86, P492, DOI 10.1016/j.neuroimage.2013.10.047; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Philiastides MG, 2006, CEREB CORTEX, V16, P509, DOI 10.1093/cercor/bhi130; Pu J, 2005, COGNITIVE BRAIN RES, V25, P273, DOI 10.1016/j.cogbrainres.2005.06.001; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rousselet GA, 2004, J VISION, V4, P13, DOI 10.1167/4.1.2; ROUSSELET GA, 2011, FRONTIERS PSYCHOL, V2; Rousselet GA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-114; RUDELL AP, 1991, INT J NEUROSCI, V60, P85, DOI 10.3109/00207459109082040; Rudell AP, 1996, ELECTROEN CLIN NEURO, V98, P309, DOI 10.1016/0013-4694(95)00265-0; RUDELL AP, 1992, ELECTROEN CLIN NEURO, V83, P77, DOI 10.1016/0013-4694(92)90135-5; Sadeh B, 2010, NEUROIMAGE, V53, P782, DOI 10.1016/j.neuroimage.2010.06.029; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Team RC, 2014, R LANG ENV STAT COMP; Wang MY, 2011, BRAIN COGNITION, V77, P419, DOI 10.1016/j.bandc.2011.08.016; Wilcox R.R., 2011, INTRO ROBUST ESTIMAT, DOI DOI 10.1016/C2010-0-67044-1; Zhang Y, 2008, BRAIN RES, V1233, P98, DOI 10.1016/j.brainres.2008.07.080; Zhang Y, 2009, NEUROSCI LETT, V454, P86, DOI 10.1016/j.neulet.2009.02.047	53	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213637	10.1371/journal.pone.0213637	http://dx.doi.org/10.1371/journal.pone.0213637			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875416	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400019
J	Mayor, E; Daehne, M; Bianchi, R				Mayor, Eric; Daehne, Maxime; Bianchi, Renzo			How perceived substance characteristics affect ethical judgement towards cognitive enhancement	PLOS ONE			English	Article							PRESCRIPTION STIMULANTS; DECISION-MAKING; MORAL JUDGMENT; COMMUNICATION; KNOWLEDGE; ATTITUDES; VIGNETTE; COLLEGE; UTILITY; VALUES	Some individuals seek to enhance their cognitive capabilities through the use of pharmacology. Such behavior entails potential health risks and raises ethical concerns. The aim of this study was to examine whether a precursor of behavior, ethical judgement towards the use of existing biological cognitive enhancers (e.g., coffee, legal and illegal drugs), is shaped by the perceived characteristics of these cognitive enhancers. Students and employees completed an online questionnaire which measured perceived characteristics of 15 substances presented as potential cognitive enhancers and a measure of ethical judgement towards these cognitive enhancers. Results of mixed model regression analyzes show that ethical judgement is more favourable when cognitive enhancers are perceived as being legal, familiar, efficient, and safe for users' health, supporting all hypotheses. Results further show that 36% of variance (in the null model) lies at the level of cognitive enhancers and 21% at the level of participants. In conclusion, cognitive enhancers vary widely in terms of ethical judgement, which is explained by the perception of the mentioned characteristics. Implications regarding prevention and policy-making are discussed.	[Mayor, Eric; Daehne, Maxime; Bianchi, Renzo] Univ Neuchatel, Fac Sci, Inst Work & Org Psychol, Neuchatel, Switzerland	University of Neuchatel	Mayor, E (corresponding author), Univ Neuchatel, Fac Sci, Inst Work & Org Psychol, Neuchatel, Switzerland.	eric.mayor@unine.ch	Mayor, eric/AFT-8486-2022; Bianchi, Renzo/U-9777-2017	Mayor, eric/0000-0001-9441-7592; Bianchi, Renzo/0000-0003-2336-0407				Aguinis H, 2014, ORGAN RES METHODS, V17, P351, DOI 10.1177/1094428114547952; Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27; Amonini C, 2006, HEALTH EDUC RES, V21, P276, DOI 10.1093/her/cyh064; Bedzow I., 2018, J CLIN PSYCHIAT NEUR, V1, P12; Bergkvist L, 2007, J MARKETING RES, V44, P175, DOI 10.1509/jmkr.44.2.175; Bilz K, 2009, PSYCHOL LEARN MOTIV, V50, P101, DOI 10.1016/S0079-7421(08)00403-9; Bohrn IC, 2013, BRAIN LANG, V124, P1, DOI 10.1016/j.bandl.2012.10.003; Bostrom N, 2009, SCI ENG ETHICS, V15, P311, DOI 10.1007/s11948-009-9142-5; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; CARLSON JS, 1988, INT J INTERCULT REL, V12, P1, DOI 10.1016/0147-1767(88)90003-X; Clark, 2007, BLACKWELL HDB SOCIAL, P308, DOI [10.1002/9780470998557.ch12, DOI 10.1002/9780470998557.CH12]; CONRAD P, 1994, CULT MED PSYCHIAT, V18, P385, DOI 10.1007/BF01379232; Coupey E, 1998, J CONSUM RES, V24, P459, DOI 10.1086/209521; Dubljevi V., 2015, NEUROL NEUROSCI, V4, P25, DOI DOI 10.2147/NAN.S61925; Eisenberg A.E., 1998, PSYCHOL BULL, V87, P245; Faber NS, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00232; Fisher GG, 2016, J OCCUP HEALTH PSYCH, V21, P3, DOI 10.1037/a0039139; Fitz NS, 2014, NEUROETHICS-NETH, V7, P173, DOI 10.1007/s12152-013-9190-z; Forlini C, 2009, NEUROETHICS-NETH, V2, P163, DOI 10.1007/s12152-009-9043-y; Franke A. G., 2013, COGNITIVE ENHANCEMEN, P17; Franke AG, 2014, EUR ARCH PSY CLIN N, V264, pS83, DOI 10.1007/s00406-014-0537-1; Gibson BM, 2007, J EXP PSYCHOL ANIM B, V33, P244, DOI 10.1037/0097-7403.33.3.244; Glannon W, 2008, NEUROETHICS-NETH, V1, P45, DOI 10.1007/s12152-008-9005-9; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Hainmueller J, 2015, P NATL ACAD SCI USA, V112, P2395, DOI 10.1073/pnas.1416587112; Hall W., 2012, AJOB PRIMARY RES, V3, P81, DOI [DOI 10.1080/21507716.2012.720639, 10.1080/21507716.2012.720639]; HECHTER M, 1994, RATION SOC, V6, P318, DOI 10.1177/1043463194006003003; Helman CG, 2007, CULTURE HLTH ILLNESS; HOGAN R, 1973, PSYCHOL BULL, V79, P217, DOI 10.1037/h0033956; Illies C., 2003, GROUNDS ETHICAL JUDG; Judson R, 2009, PSYCHOL HEALTH MED, V14, P97, DOI 10.1080/13548500802126723; Jung N, 2011, MASS COMMUN SOC, V14, P407, DOI 10.1080/15205436.2010.496135; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Maslen H, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00107; MASSEY JL, 1986, SOC FORCES, V65, P106, DOI 10.2307/2578938; Mazanov J., 2013, PERFORM ENHANC HLTH, V2, P110, DOI [10.1016/j.peh.2013.08.017, DOI 10.1016/J.PEH.2013.08.017]; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Partridge BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028416; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Pickett JT, 2017, J EXP CRIMINOL, V13, P217, DOI 10.1007/s11292-017-9287-1; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Pohl S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01451; PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243; Raz Joseph, 2009, AUTHORITY LAW ESSAYS, V2nd; Riis J, 2008, J CONSUM RES, V35, P495, DOI 10.1086/588746; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071452; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068821; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Simmonds N, 2007, LAW AS A MORAL IDEA; Singh, 1999, J CONSUM BEHAV, V8, P321, DOI [10.1207/s15327663jcp0803_07, DOI 10.1207/S15327663JCP0803_07]; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Spector PE, 2006, ORGAN RES METHODS, V9, P221, DOI 10.1177/1094428105284955; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tobler PN, 2008, COGN AFFECT BEHAV NE, V8, P390, DOI 10.3758/CABN.8.4.390; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TYLER TOM R., 2006, CONTEMP SOCIOL, DOI [DOI 10.2307/2076193, 10.1515/9781400828609]; WALKER N, 1964, BRIT J CRIMINOL, V4, P570, DOI 10.1093/oxfordjournals.bjc.a048782; Wanous JP, 2001, ORGAN RES METHODS, V4, P361, DOI 10.1177/109442810144003; Williams B., 1973, UTILITARIANISM; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zhao JL, 2016, PERS INDIV DIFFER, V95, P29, DOI 10.1016/j.paid.2016.02.024	64	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213619	10.1371/journal.pone.0213619	http://dx.doi.org/10.1371/journal.pone.0213619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7YP	30870469	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000461166300050
J	Moonga, HB; Schoustra, SE; Linnemann, AR; Kuntashula, E; Shindano, J; Smid, EJ				Moonga, Himoonga Bernard; Schoustra, Sijmen E.; Linnemann, Anita R.; Kuntashula, Elias; Shindano, John; Smid, Eddy J.			The art of mabisi production: A traditional fermented milk	PLOS ONE			English	Article							PRODUCERS	Fermented dairy products can be rich in beneficial microbes and one such product with potential is mabisi. Mabisi is a traditional fermented milk product from Zambia made through spontaneous fermentation of raw milk at ambient temperature using a calabash (gourd), clay pot, plastic or metal container. The fermentation takes about 48 hours after which the product is stirred and ready for consumption. This study was aimed at determining the types of production methods of mabisi and identifying the critical production process parameters. A survey was conducted using interviews and observations to determine the existing production practices/technologies and to capture indigenous knowledge on mabisi production in nine provinces of Zambia. We found seven different production methods which we coined; tonga, thick-tonga, illa, barotse, backslopping, cooked and creamy types. Interestingly, the tonga-type mabisi was produced throughout the country by different ethnic groups. The main process parameters were found to be fermentation time and temperature, type of containers, presence/ absence of backslopping, agitation, heating and cooling, removal of whey and addition of raw milk. And further found that mabisi is a versatile product consumed with a wide variety of foods. This basic information is crucial for production process optimisation and microbial communities dynamics studies.	[Moonga, Himoonga Bernard; Smid, Eddy J.] Wageningen Univ, Food Microbiol Lab, Wageningen, Netherlands; [Moonga, Himoonga Bernard; Linnemann, Anita R.] Wageningen Univ, Lab Food Qual & Design, Wageningen, Netherlands; [Moonga, Himoonga Bernard; Schoustra, Sijmen E.] Wageningen Univ, Genet Lab, Wageningen, Netherlands; [Moonga, Himoonga Bernard; Schoustra, Sijmen E.; Shindano, John] Univ Zambia, Sch Agr Sci, Dept Food Sci & Nutr, Lusaka, Zambia; [Kuntashula, Elias] Univ Zambia, Sch Agr Sci, Dept Agr Econ & Extens, Lusaka, Zambia	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Zambia; University of Zambia	Smid, EJ (corresponding author), Wageningen Univ, Food Microbiol Lab, Wageningen, Netherlands.	eddy.smid@wur.nl	Schoustra, Sijmen E/H-3882-2012; Linnemann, Anita/O-7509-2014	Smid, Eddy J./0000-0002-6687-5083; Linnemann, Anita/0000-0003-3201-3343	Netherlands Organisation for Scientific Research, NWO-WOTRO Science for Global Development [W 08.250.103]	Netherlands Organisation for Scientific Research, NWO-WOTRO Science for Global Development	This research was funded by The Netherlands Organisation for Scientific Research, NWO-WOTRO Science for Global Development (https://www.nwo.nl/en/about-nwo/organisation/nwo-domains/wotro) who awarded to SES the grant under number W 08.250.103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabanda F, 2010, NATURE SCI, V8, P178, DOI DOI 10.7537/; Beukes EM, 2001, INT J FOOD MICROBIOL, V63, P189, DOI 10.1016/S0168-1605(00)00417-7; Bille PG, 2007, INT J FOOD SCI TECH, V42, P620, DOI 10.1111/j.1365-2621.2006.01381.x; Bogucki, 1984, OXFORD J ARCHAEOL, V3, P15, DOI [10.1111/j.1468-0092.1984.tb00113.x, DOI 10.1111/J.1468-0092.1984.TB00113.X]; Bryant A. T., 1967, ZULU PEOPLE THEY WER; Erkus O, 2013, ISME J, V7, P2126, DOI 10.1038/ismej.2013.108; FERESU S, 1989, MIRCEN J APPL MICROB, V5, P349, DOI 10.1007/BF01741766; Ramirez MDF, 2018, INT J FOOD MICROBIOL, V271, P15, DOI 10.1016/j.ijfoodmicro.2018.02.013; Flint JE, 1976, CAMBRIDGE HIST AFRIC, V5, P319; Fox FW, 1939, BANTU STUD, V13, P65, DOI 10.1080/02561751.1939.9676091; Heita LN, 2014, J BIOSCIENCES MED, V02, P6, DOI [10.4236/jbm.2014.29002, DOI 10.4236/JBM.2014.29002]; Karenzi E, 2013, BIOTECHNOL AGRON SOC, V17, P383; (MFL) MoFL, 2018, ANN REP 2017; Misihairabgwi J., 2017, Journal of Ethnic Foods, V4, P145, DOI 10.1016/j.jef.2017.08.001; Mpofu A, 2014, ECOL FOOD NUTR, V53, P24, DOI 10.1080/03670244.2013.767802; Mumba C., 2013, LIVESTOCK RES RURAL, V25; Musika, 2017, REV STAT LIV PROD ST; MUTUKUMIRA AN, 1995, MILCHWISSENSCHAFT, V50, P201; Nduko J, 2017, SPONTANEOUSLY FERMEN, P1; Negussie G, 2012, AFRICAN J FOOD SCI T, V3, P78; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Schoustra SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063948; Smid EJ, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S2; TLOU T, 1985, HIST NGAMILAND 1750	24	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213541	10.1371/journal.pone.0213541	http://dx.doi.org/10.1371/journal.pone.0213541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870441	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300041
J	Ivashko-Pachima, Y; Maor-Nof, M; Gozes, I				Ivashko-Pachima, Yanina; Maor-Nof, Maya; Gozes, Illana			NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies	PLOS ONE			English	Article							DEPENDENT NEUROPROTECTIVE PROTEIN; MICROTUBULE-ASSOCIATED PROTEINS; PROGRESSIVE SUPRANUCLEAR PALSY; MOUSE MODEL; DOUBLE-BLIND; BRAIN; PEPTIDE; TUBULIN; HYPERPHOSPHORYLATION; ADNP	The microtubule (MT) associated protein Tau is instrumental for the regulation of MT assembly and dynamic instability, orchestrating MT-dependent cellular processes. Aberration in Tau post-translational modifications ratio deviation of spliced Tau isoforms 3 or 4 MT binding repeats (3R/4R) have been implicated in neurodegenerative tauopathies. Activity-dependent neuroprotective protein (ADNP) is vital for brain formation and cognitive function. ADNP deficiency in mice causes pathological Tau hyperphosphorylation and aggregation, correlated with impaired cognitive functions. It has been previously shown that the ADNP-derived peptide NAP protects against ADNP deficiency, exhibiting neuroprotection, MT interaction and memory protection. NAP prevents MT degradation by recruitment of Tau and end-binding proteins to MTs and expression of these proteins is required for NAP activity. Clinically, NAP (davunetide, CP201) exhibited efficacy in prodromal Alzheimer's disease patients (Tau3R/4R tauopathy) but not in progressive supranuclear palsy (increased Tau4R tauopathy). Here, we examined the potential preferential interaction of NAP with 3R vs. 4R Tau, toward personalized treatment of tauopathies. Affinity-chromatography showed that NAP preferentially interacted with Tau3R protein from rat brain extracts and fluorescence recovery after photobleaching assay indicated that NAP induced increased recruitment of human Tau3R to MTs under zinc intoxication, in comparison to Tau4R. Furthermore, we showed that NAP interaction with tubulin (MTs) was inhibited by obstruction of Tau-binding sites on MTs, confirming the requirement of Tau-MT interaction for NAP activity. The preferential interaction of NAP with Tau3R may explain clinical efficacy in mixed vs. Tau4R pathologies, and suggest effectiveness in Tau3R neurodevelopmental disorders.	[Ivashko-Pachima, Yanina; Gozes, Illana] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem,Sagol Sch Neurosci, Elton Lab Mol Neuroendocrinol,Invest Growth Facto, Tel Aviv, Israel; [Ivashko-Pachima, Yanina] Tel Aviv Univ, Adams Super Ctr Brain Studies, Tel Aviv, Israel; [Maor-Nof, Maya] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Stanford University	Gozes, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem,Sagol Sch Neurosci, Elton Lab Mol Neuroendocrinol,Invest Growth Facto, Tel Aviv, Israel.	igozes@tauex.tau.ac.il		Gozes, Illana/0000-0001-9796-2430	ISF [1424/14]; ERA-NET neuron AUTISYN; BSF-NSF [2016746]; AMN Foundation; French Friends of Tel Aviv University; Spanish Friends of Tel Aviv University; Alicia Koplowitz Foundation	ISF(Israel Science Foundation); ERA-NET neuron AUTISYN; BSF-NSF; AMN Foundation; French Friends of Tel Aviv University; Spanish Friends of Tel Aviv University; Alicia Koplowitz Foundation	Work for this study was supported in part by the following grants, ISF 1424/14 (IG, PI), ERA-NET neuron AUTISYN (IG, Partner), BSF-NSF 2016746 (IG, Parnter), AMN Foundation (IG, PI) as well as IG PI funds: Drs. Ronith and Armand Stemmer, Mr Arthur Gerbi (French Friends of Tel Aviv University), and Spanish Friends of Tel Aviv University, Alicia Koplowitz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Amram N, 2016, MOL PSYCHIATR, V21, P1467, DOI 10.1038/mp.2015.208; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Boxer AL, 2014, LANCET NEUROL, V13, P676, DOI 10.1016/S1474-4422(14)70088-2; Bullmann T, 2010, J COMP NEUROL, V518, P2538, DOI 10.1002/cne.22351; Dehmelt L, 2005, GENOME BIOL, V6; Dickson DW, 1999, J NEUROL, V246, P6; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; Divinski I, 2006, J NEUROCHEM, V98, P973, DOI 10.1111/j.1471-4159.2006.03936.x; FRANCON J, 1982, EUR J BIOCHEM, V129, P465, DOI 10.1111/j.1432-1033.1982.tb07072.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Gozes I, 2003, J MOL NEUROSCI, V20, P315, DOI 10.1385/JMN:20:3:315; GOZES I, 1978, NATURE, V276, P411, DOI 10.1038/276411a0; GOZES I, 1982, P NATL ACAD SCI-BIOL, V79, P2579, DOI 10.1073/pnas.79.8.2579; Gozes I, 2007, CURR ALZHEIMER RES, V4, P507, DOI 10.2174/156720507783018208; Gozes I, 2017, J MOL NEUROSCI, V63, P123, DOI 10.1007/s12031-017-0983-0; Gozes Illana, 2006, Current Alzheimer Research, V3, P197; Hacohen-Kleiman G, 2018, J CLIN INVEST, V128, P4956, DOI 10.1172/JCI98199; Ivashko-Pachima Y, 2017, MOL PSYCHIATR, V22, P1335, DOI 10.1038/mp.2016.255; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; Jouroukhin Y, 2013, NEUROBIOL DIS, V56, P79, DOI 10.1016/j.nbd.2013.04.012; Kalbfuss B, 2001, J BIOL CHEM, V276, P42986, DOI 10.1074/jbc.M105113200; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Koivomagi M, 2013, NAT STRUCT MOL BIOL, V20, P1415, DOI 10.1038/nsmb.2706; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Magen I, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.65; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Mandelkow EM, 1996, STRUCTURE MICROTUBUL; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Matsuoka Y, 2007, J MOL NEUROSCI, V31, P165, DOI 10.1385/JMN/31:02:165; Morimoto BH, 2013, DEMENT GERIATR COGN, V35, P325, DOI 10.1159/000348347; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Oz S, 2014, MOL PSYCHIATR, V19, P1115, DOI 10.1038/mp.2014.97; Oz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051458; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Ramirez-Rios S, 2016, MOL BIOL CELL, V27, P2924, DOI 10.1091/mbc.E16-01-0029; Sayas CL, 2015, J NEUROCHEM, V133, P653, DOI 10.1111/jnc.13091; Schirer Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087383; Shiryaev N, 2009, NEUROBIOL DIS, V34, P381, DOI 10.1016/j.nbd.2009.02.011; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Vulih-Shultzman I, 2007, J PHARMACOL EXP THER, V323, P438, DOI 10.1124/jpet.107.129551; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042	52	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213666	10.1371/journal.pone.0213666	http://dx.doi.org/10.1371/journal.pone.0213666			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865715	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900082
J	Tonelli, M; Wiebe, N; James, MT; Naugler, C; Manns, BJ; Klarenbach, SW; Hemmelgarn, BR				Tonelli, Marcello; Wiebe, Natasha; James, Matthew T.; Naugler, Christopher; Manns, Braden J.; Klarenbach, Scott W.; Hemmelgarn, Brenda R.			Red cell distribution width associations with clinical outcomes: A population-based cohort study	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; ADMINISTRATIVE DATA; HEART-FAILURE; RISK-FACTORS; MORTALITY; PEOPLE; DEATH	Importance Higher levels of red cell distribution width (RDW) are associated with adverse outcomes, especially in selected cohorts with or at risk for chronic disease. Whether higher RDW or the related parameter standard deviation of the red blood cell distribution (SD-RBC) can predict a broader range of outcomes in the general population is unknown. Objective To evaluate the association of RDW and SD-RBC with the risk of adverse outcomes in people from the general population. Design Population-based retrospective cohort study. Setting Health care system in a Canadian province (Alberta). Participants All 3,156,863 adults living in Alberta, Canada with at least one measure of RDW and SD-RBC between 2003 and 2016. Data were analyzed in September 2018. Exposure RDW and SD-RBC, classified into percentiles (<1, 1-5, 5-25, 25-75, 75-95, 95-99, >99). Main outcomes All-cause death, first myocardial infarction, first stroke or transient ischemic attack, place ment into long-term care (LTC), progression to renal replacement therapy (initiation of chronic dialysis or pre-emptive kidney transplantation), incident solid malignancy, and first hospitalization during follow-up. Results Over median follow-up of 6.8 years, 209,991 of 3,156,863 participants (6.7%) died. The risk of death increased with increasing RDW percentile. After adjustment, and compared to RDW in the 25th to 75th percentiles, the risk of death was lower for participants in the <25th percentiles but higher for participants in the 75th-95th percentiles (HR 1.42, 95% CI 1.40,1.43), the 95th-99th percentiles (HR 1.86, 95% CI 1.83,1.89) and the >99th percentile (HR 2.18, 95% CI 2.12,2.23). Similar results were observed for MI, stroke/TIA, incident cancer, hospitalization and LTC placement, but no association was found between RDW and ESRD. Findings were generally similar for SD-RBC, except that all associations tended to be stronger than for RDW, and both lower and higher values of SD-RBC were independently associated with ESRD. Conclusion and relevance RDW and SD-RBC may be useful as prognostic markers for people in the general population, especially for outcomes related to chronic illness. SD-RBC may be superior to RDW.	[Tonelli, Marcello; James, Matthew T.; Naugler, Christopher; Manns, Braden J.; Hemmelgarn, Brenda R.] Univ Calgary, Calgary, AB, Canada; [Tonelli, Marcello; James, Matthew T.; Manns, Braden J.; Klarenbach, Scott W.; Hemmelgarn, Brenda R.] Alberta Kidney Dis Network, Edmonton, AB, Canada; [Wiebe, Natasha; Klarenbach, Scott W.] Univ Alberta, Edmonton, AB, Canada	University of Calgary; University of Alberta	Tonelli, M (corresponding author), Univ Calgary, Calgary, AB, Canada.; Tonelli, M (corresponding author), Alberta Kidney Dis Network, Edmonton, AB, Canada.	tonelli.admin@ucalgary.ca	Tonelli, Marcello/B-3028-2009; Wiebe, Natasha/V-7803-2019	Tonelli, Marcello/0000-0002-0846-3187; Wiebe, Natasha/0000-0002-5613-1582	Canadian Institutes for Health Research; Alberta Innovates-Health Solutions; Canada Foundation for Innovation; David Freeze Chair in Health Services Research at the University of Calgary; Baay Chair in Kidney Research at the University of Calgary; Svare Chair in Health Economics at the University of Calgary	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); David Freeze Chair in Health Services Research at the University of Calgary; Baay Chair in Kidney Research at the University of Calgary; Svare Chair in Health Economics at the University of Calgary	This work was supported by Foundation awards from the Canadian Institutes for Health Research (to MT, BH, BM, CN and MJ), by a team grant to the Interdisciplinary Chronic Disease Collaboration from Alberta Innovates-Health Solutions, and a Leaders Opportunity Fund grant from the Canada Foundation for Innovation. MT was supported by the David Freeze Chair in Health Services Research; BH was supported by the Baay Chair in Kidney Research and BM was supported by the Svare Chair in Health Economics, all at the University of Calgary. This study is based in part by data provided by Alberta Health and Alberta Health Services. The interpretation and conclusions contained herein are those of the researchers and do not represent the views of the Government of Alberta or Alberta Health Services. Neither the Government of Alberta nor, Alberta Health or Alberta Health Services express any opinion in relation to this study.	Alexander RT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5287; Arbel Y, 2014, THROMB HAEMOSTASIS, V111, P300, DOI 10.1160/TH13-07-0567; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; He LM, 2017, ONCOTARGET, V8, P102590, DOI 10.18632/oncotarget.21964; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hu LH, 2017, ONCOTARGET, V8, P16027, DOI 10.18632/oncotarget.13784; Kim J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29855-z; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lappegard J, 2016, THROMB HAEMOSTASIS, V115, P126, DOI 10.1160/TH15-03-0234; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; McKenzie SD, 2003, CLIN LAB HEMATOLOGY, P161; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Penberthy L, 2003, AM J EPIDEMIOL, V158, P27, DOI 10.1093/aje/kwg108; Perkins SL., 2003, WINTROBES CLIN HEMAT, P5; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Pilling LC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203504; Pinho J, 2018, THROMB RES, V1644-8; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Saliba W, 2017, J ARRYTHM, V33, P56, DOI 10.1016/j.joa.2016.06.001; Soderholm M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124957; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Tonelli M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0155-5; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weymann A, 2017, MED SCI MONIT BASIC, V23, P179, DOI 10.12659/MSMBR.903320; Ye Z, 2011, AM J CARDIOL, V107, P1241, DOI 10.1016/j.amjcard.2010.12.023; Zurauskaite G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191280	32	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212374	10.1371/journal.pone.0212374	http://dx.doi.org/10.1371/journal.pone.0212374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865651	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900019
J	Yamaguchi, T; Hayashi, M; Ida, L; Yamamoto, M; Lu, C; Kajino, T; Cheng, JL; Nakatochi, M; Isomura, H; Yamazaki, M; Suzuki, M; Fujimoto, T; Takahashi, T				Yamaguchi, Tomoya; Hayashi, Miyu; Ida, Lisa; Yamamoto, Masatoshi; Lu, Can; Kajino, Taisuke; Cheng, Jinglei; Nakatochi, Masahiro; Isomura, Hisanori; Yamazaki, Masaya; Suzuki, Motoshi; Fujimoto, Toyoshi; Takahashi, Takashi			ROR1-CAVIN3 interaction required for caveolae-dependent endocytosis and pro-survival signaling in lung adenocarcinoma	ONCOGENE			English	Article							PLASMA-MEMBRANE; PROTEINS; NKX2-1/TTF-1; ONCOGENE; ROR1	The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a transcriptional target of the lineage-survival oncogene NKX2-1/TTF-1 in lung adenocarcinomas. In addition to its kinase-dependent role, ROR1 functions as a scaffold protein to facilitate interaction between caveolin-1 (CAV1) and CAVIN1, and consequently maintains caveolae formation, which in turn sustains pro-survival signaling toward AKT from multiple receptor tyrosine kinases (RTKs), including epidermal growth factor receptor (EGFR), MET (proto-oncogene, receptor tyrosine kinase), and IGF-IR (insulin-like growth factor receptor 1). Therefore, ROR1 is an attractive target for overcoming EGFR-TKI resistance due to various mechanisms such as EGFR T790M double mutation and bypass signaling from other RTKs. Here, we report that ROR1 possesses a novel scaffold function indispensable for efficient caveolae-dependent endocytosis. CAVIN3 was found to bind with ROR1 at a site distinct from sites for CAV1 and CAVIN1, a novel function required for proper CAVIN3 subcellular localization and caveolae-dependent endocytosis, but not caveolae formation itself. Furthermore, evidence of a mechanistic link between ROR1-CAVIN3 interaction and consequential caveolae trafficking, which was found to utilize a binding site distinct from those for ROR1 interactions with CAV1 and CAVIN1, with RTK-mediated pro-survival signaling towards AKT in early endosomes in lung adenocarcinoma cells was also obtained. The present findings warrant future study to enable development of novel therapeutic strategies for inhibiting the multifaceted scaffold functions of ROR1 in order to reduce the intolerable death toll from this devastating cancer.	[Yamaguchi, Tomoya; Hayashi, Miyu; Ida, Lisa; Lu, Can; Kajino, Taisuke; Isomura, Hisanori; Suzuki, Motoshi; Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 4668550, Japan; [Yamaguchi, Tomoya; Yamamoto, Masatoshi; Yamazaki, Masaya] Kumamoto Univ, Grad Sch Med Sci, Dept Canc Biol, Kumamoto 8608556, Japan; [Yamaguchi, Tomoya; Yamamoto, Masatoshi] Kumamoto Univ, Ctr Metab Regulat Hlth Aging, Kumamoto 8608556, Japan; [Kajino, Taisuke; Isomura, Hisanori] Aichi Canc Ctr, Res Inst, Div Mol Therapeut, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan; [Cheng, Jinglei; Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4668550, Japan; [Nakatochi, Masahiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi 4668550, Japan; [Takahashi, Takashi] Aichi Canc Ctr, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan	Nagoya University; Kumamoto University; Kumamoto University; Aichi Cancer Center; Nagoya University; Nagoya University; Aichi Cancer Center	Takahashi, T (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Carcinogenesis, Nagoya, Aichi 4668550, Japan.; Takahashi, T (corresponding author), Aichi Canc Ctr, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	tak@aichi-cc.jp	Takahashi, Takashi/I-7262-2014; Fujimoto, Toyoshi/ABH-9058-2020; Nakatochi, Masahiro/Q-1247-2015; Yamaguchi, Tomoya/AAN-7524-2020	Takahashi, Takashi/0000-0003-0615-7001; Fujimoto, Toyoshi/0000-0002-3601-7977; Nakatochi, Masahiro/0000-0002-1838-4837; Yamaguchi, Tomoya/0000-0001-6933-543X; Yamazaki, Masaya/0000-0003-4151-4983	Japan Society for the Promotion of Science (JSPS); Project for Cancer Research and Therapeutic Evolution (P-CREATE) program of the Japan Agency for Medical Research and Development (AMED); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project for Cancer Research and Therapeutic Evolution (P-CREATE) program of the Japan Agency for Medical Research and Development (AMED); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Yukako Shimada and Naoe Hotta for their technical support, and Kiyoshi Yanagisawa for the valuable discussion regarding this study. We are also grateful for the expert assistance from N Tsurumaki for image analysis. This work was supported in part by grants-in-aid for Scientific Research (A) and (C) from the Japan Society for the Promotion of Science (JSPS), the Project for Cancer Research and Therapeutic Evolution (P-CREATE) program of the Japan Agency for Medical Research and Development (AMED), and a grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chaudhary N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001832; Cheng JPX, 2016, TRENDS CELL BIOL, V26, P177, DOI 10.1016/j.tcb.2015.10.010; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Echarri A, 2015, J CELL SCI, V128, P2747, DOI 10.1242/jcs.153940; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gambin Y, 2014, ELIFE, V3, DOI 10.7554/eLife.01434; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hernandez VJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00905; Ida L, 2016, CANCER SCI, V107, P155, DOI 10.1111/cas.12858; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lievens S, 2006, NAT METHODS, V3, P971, DOI 10.1038/nmeth1206-971; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Mohan J, 2015, J CELL SCI, V128, P979, DOI 10.1242/jcs.161463; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Palfy M, 2012, TRENDS CELL BIOL, V22, P447, DOI 10.1016/j.tcb.2012.06.004; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Shvets E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7867; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Xu XL, 2001, CANCER RES, V61, P7943; Yamaguchi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10060; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Zochbauer-Muller S, 2005, ONCOGENE, V24, P6249, DOI 10.1038/sj.onc.1208775	36	11	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5142	5157		10.1038/s41388-019-0785-7	http://dx.doi.org/10.1038/s41388-019-0785-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30894682				2022-12-26	WOS:000473025300003
J	Bao, DK; Zhao, J; Zhou, XC; Yang, Q; Chen, YB; Zhu, JJ; Yuan, P; Yang, J; Qin, T; Wan, SG; Xing, JL				Bao, Dengke; Zhao, Jing; Zhou, Xingchun; Yang, Qi; Chen, Yibing; Zhu, Jianjun; Yuan, Peng; Yang, Jin; Qin, Tao; Wan, Shaogui; Xing, Jinliang			Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; DYNAMICS; DRP1; MICROENVIRONMENT; CONTRIBUTES; INHIBITION; EXPRESSION; SURVIVAL; RELEASE	Tumor-associated macrophages (TAMs) contribute to hepatocellular carcinoma (HCC) progression. However, the molecular mechanism underlying the infiltration of TAMs into HCC microenvironment is largely unclear. Recent studies have reported that alteration of mitochondrial nucleoid structures induces mitochondrial DNA (mtDNA) release into the cytosol, which is recognized as mtDNA stress, and consequently regulates innate immunity. Here we aimed to investigate whether mitochondrial fission induces mtDNA stress and then promotes TAM infiltration and HCC progression. Confocal microscopy and real-time PCR were used to detect cytosolic mtDNA content in HCC cells. The relationship between the expression of mitochondrial fission key regulator dynamin-related protein 1 (Drp1) and the percentage of CD163 (a marker of TAMs)-positive cells was investigated in HCC tissues using immunohistochemistry. Finally, the effect of Drp1 overexpression in HCC cells on recruitment and polarization of TAMs was investigated. Our data showed that increased Drp1 expression was positively correlated with the infiltration of TAMs into HCC tissues. Drp1-mediated mitochondrial fission induced the cytosolic mtDNA stress to enhance the CCL2 secretion from HCC cells by TLR9-mediated NF-kappa B signaling pathway, and thus promoted the TAM recruitment and polarization. Depleting cytosolic mtDNA using DNase I or blocking TLR9 pathway by TLR9 antagonist, siRNA for TLR9 or p65 in HCC cells with Drp1 overexpression significantly decreased the recruitment and polarization of TAMs. Blocking CCR2 by antagonist significantly reduced TAM infiltration and suppressed HCC progression in mouse model. In conclusion, our findings reveal a novel mechanism of TAM infiltration in HCC by mitochondrial fission-induced mtDNA stress.	[Bao, Dengke; Zhao, Jing; Yang, Qi; Wan, Shaogui] Gannan Med Univ, Affiliated Hosp 1, Ctr Mol Pathol, Ganzhou 341000, Jiangxi, Peoples R China; [Bao, Dengke; Zhao, Jing; Zhou, Xingchun; Zhu, Jianjun; Yuan, Peng; Xing, Jinliang] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shanxi, Peoples R China; [Bao, Dengke; Zhao, Jing; Zhou, Xingchun; Zhu, Jianjun; Yuan, Peng; Xing, Jinliang] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shanxi, Peoples R China; [Bao, Dengke; Qin, Tao] Henan Univ, Henan Prov Peoples Hosp, Dept Hepatobiliary Pancreat Surg, Zhengzhou 450002, Henan, Peoples R China; [Chen, Yibing] Zhengzhou Univ, Affiliated Hosp 1, Genet & Prenatal Diag Ctr, Dept Gynecol & Obstet, Zhengzhou 450052, Henan, Peoples R China; [Yang, Jin] Northwest Univ, Sch Life Sci, Institue Prevent Genom Med, Xian 710069, Shaanxi, Peoples R China	Gannan Medical University; Air Force Military Medical University; Air Force Military Medical University; Henan University; Zhengzhou University; Zhengzhou University; Northwest University Xi'an	Wan, SG (corresponding author), Gannan Med Univ, Affiliated Hosp 1, Ctr Mol Pathol, Ganzhou 341000, Jiangxi, Peoples R China.; Xing, JL (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shanxi, Peoples R China.; Xing, JL (corresponding author), Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shanxi, Peoples R China.	wansg@gmu.edu.cn; xingjl@fmmu.edu.cn			National Natural Science Foundation of China [81320108021, U1604167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants No. 81320108021 and U1604167). We also thank Dr. Fanglin Zhang of Department of Microbiology, Fourth Military Medical University for providing the THP-1 cell line.	Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Bao DK, 2016, CANCER CHEMOTH PHARM, V78, P791, DOI 10.1007/s00280-016-3128-1; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Ishihara T, 2015, MOL CELL BIOL, V35, P211, DOI 10.1128/MCB.01054-14; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lahiri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013772; Lee JG, 2008, CELL SIGNAL, V20, P105, DOI 10.1016/j.cellsig.2007.09.003; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Liu Y, 2015, J HEPATOL, V63, P114, DOI 10.1016/j.jhep.2015.02.009; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Sun XC, 2018, LIVER INT, V38, P1263, DOI 10.1111/liv.13660; Tripathi C, 2014, ONCOTARGET, V5, P5350, DOI 10.18632/oncotarget.2110; Vilaysane A, 2009, SEMIN IMMUNOL, V21, P208, DOI 10.1016/j.smim.2009.05.006; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wan YY, 2014, ONCOL REP, V32, P619, DOI 10.3892/or.2014.3235; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Wu WX, 2016, AUTOPHAGY, V12, P1675, DOI 10.1080/15548627.2016.1193656; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Ye LY, 2016, CANCER RES, V76, P818, DOI 10.1158/0008-5472.CAN-15-0977; Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650; Zhang JY, 2018, HEPATOLOGY, V67, P1872, DOI 10.1002/hep.29681; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang Z, 2009, CANCER LETT, V286, P223, DOI 10.1016/j.canlet.2009.05.023; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zhao YX, 2018, EXP CELL RES, V363, P171, DOI 10.1016/j.yexcr.2017.12.030; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	44	60	62	5	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2019	38	25					5007	5020		10.1038/s41388-019-0772-z	http://dx.doi.org/10.1038/s41388-019-0772-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IE1KY	30894684	Green Published, hybrid			2022-12-26	WOS:000472145900009
J	Li, S; Ghoshal, S; Sojoodi, M; Arora, G; Masia, R; Erstad, DJ; Ferriera, DS; Li, Y; Wang, G; Lanuti, M; Caravan, P; Or, YS; Jiang, LJ; Tanabe, KK; Fuchs, BC				Li, Shen; Ghoshal, Sarani; Sojoodi, Mozhdeh; Arora, Gunisha; Masia, Ricard; Erstad, Derek J.; Ferriera, Diego S.; Li, Yang; Wang, Guogiang; Lanuti, Michael; Caravan, Peter; Or, Yat Sun; Jiang, Li-Juan; Tanabe, Kenneth K.; Fuchs, Bryan C.			The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction	FASEB JOURNAL			English	Article						FXR; kidney; injury; UUO; YAP1	CHRONIC KIDNEY-DISEASE; FXR; YAP; PATHOGENESIS; PIRFENIDONE; PROGRESSION; ACTIVATION; MECHANISMS; TRANSITION; INDUCTION	Farnesoid X receptor (FXR) is a nuclear receptor that has emerged as a key regulator in the maintenance of hepatic steatosis, inflammation, and fibrosis. However, the role of FXR in renal fibrosis remains to be established. Here, we investigate the effects of the FXR agonist EDP-305 in a mouse model of tubulointerstitial fibrosis via unilateral ureteral obstruction (UUO). Male C57Bl/6 mice received a UUO on their left kidney. On postoperative d 4, mice received daily treatment by oral gavage with either vehicle control (0.5% methylcellulose) or 10 or 30 mg/kg EDP-305. All animals were euthanized on postoperative d 12. EDP-305 dose-dependently decreased macrophage infiltration as measured by the F4/80 staining area and proinflammatory cytokine gene expression. EDP-305 also dose-dependently reduced interstitial fibrosis as assessed by morphometric quantification of the collagen proportional area and kidney hydroxyproline levels. Finally, yes-associated protein (YAP) activation, a major driver of fibrosis, increased after UUO injury and was diminished by EDP-305 treatment. Consistently, EDP-305 decreased TGF-beta 1-induced YAP nuclear localization in human kidney 2 cells by increasing inhibitory YAP phosphorylation. YAP inhibition may be a novel antifibrotic mechanism of FXR agonism, and EDP-305 could be used to treat renal fibrosis.-Li, S., Ghoshal, S., Sojoodi, M., Arora, G., Masia, R., Erstad, D. J., Ferriera, D. S., Li, Y., Wang, G., Lanuti, M., Caravan, P., Or, Y. S., Jiang, L.-J., Tanabe, K. K., Fuchs, B. C. The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction.	[Li, Shen; Ghoshal, Sarani; Sojoodi, Mozhdeh; Arora, Gunisha; Erstad, Derek J.; Lanuti, Michael; Tanabe, Kenneth K.; Fuchs, Bryan C.] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Div Surg Oncol, Boston, MA 02115 USA; [Masia, Ricard] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Dept Pathol, Boston, MA 02115 USA; [Caravan, Peter] Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Inst Innovat Imaging, Boston, MA 02115 USA; [Ferriera, Diego S.; Caravan, Peter] Harvard Med Sch, Massachusetts Gen Hosp, Martins Ctr Biomed Imaging, Charlestown, MA USA; [Li, Yang; Wang, Guogiang; Or, Yat Sun; Jiang, Li-Juan] Enanta Pharmaceut, Watertown, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Fuchs, BC (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Div Surg Oncol, 55 Fruit St,WRN 401, Boston, MA 02114 USA.	bfuchs@mgh.harvard.edu	dos Santos Ferreira, Diego/O-7637-2014	dos Santos Ferreira, Diego/0000-0003-1505-7950	NIDDK NIH HHS [U01 DK104302] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alikhan MA, 2013, NEPHROLOGY, V18, P81, DOI 10.1111/nep.12014; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cho ME, 2007, CLIN J AM SOC NEPHRO, V2, P906, DOI 10.2215/CJN.01050207; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; Das A, 2016, J BIOL CHEM, V291, P6096, DOI 10.1074/jbc.M115.708313; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Eardley KS, 2008, KIDNEY INT, V74, P495, DOI 10.1038/ki.2008.183; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Gai ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10168-6; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Huen SC, 2013, AM J PHYSIOL-RENAL, V305, pF477, DOI 10.1152/ajprenal.00624.2012; Hutson PR, 2003, J CHROMATOGR B, V791, P427, DOI 10.1016/S1570-0232(03)00248-4; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Jung GS, 2009, J AM SOC NEPHROL, V20, P2162, DOI 10.1681/ASN.2008121232; Li XJ, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-15; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Mann JFE, 2010, J AM SOC NEPHROL, V21, P527, DOI 10.1681/ASN.2009060593; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; NAGLE RB, 1973, LAB INVEST, V28, P456; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Schnaper HW, 2017, ADV CHRONIC KIDNEY D, V24, P107, DOI 10.1053/j.ackd.2016.11.011; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Verbeke L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33453; Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhao K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37234; Zhong JY, 2017, AM J PHYSIOL-RENAL, V312, pF375, DOI 10.1152/ajprenal.00266.2016	39	14	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7103	7112		10.1096/fj.201801699R	http://dx.doi.org/10.1096/fj.201801699R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884252	Green Published, Bronze			2022-12-26	WOS:000476114200036
J	Tashjian, TF; Danilowicz, C; Molza, AE; Nguyen, BH; Prevost, C; Prentiss, M; Godoy, VG				Tashjian, Tommy F.; Danilowicz, Claudia; Molza, Anne-Elizabeth; Nguyen, Brian H.; Prevost, Chantal; Prentiss, Mara; Godoy, Veronica G.			Residues in the fingers domain of the translesion DNA polymerase DinB enable its unique participation in error-prone double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA synthesis; DNA damage; DNA repair; homologous recombination; DinB; DNA polymerase IV; RecA	HOMOLOGOUS RECOMBINATION; RECBCD ENZYME; MOLECULAR-DYNAMICS; ACCURATE BYPASS; HIGH-FIDELITY; RECA PROTEIN; IN-VITRO; IV; COMPLEX; MUTAGENESIS	The evolutionarily conserved Escherichia coli translesion DNA polymerase IV (DinB) is one of three enzymes that can bypass potentially deadly DNA lesions on the template strand during DNA replication. Remarkably, however, DinB is the only known translesion DNA polymerase active in RecA-mediated strand exchange during error-prone double-strand break repair. In this process, a single-stranded DNA (ssDNA)-RecA nucleoprotein filament invades homologous dsDNA, pairing the ssDNA with the complementary strand in the dsDNA. When exchange reaches the 3 end of the ssDNA, a DNA polymerase can add nucleotides onto the end, using one strand of dsDNA as a template and displacing the other. It is unknown what makes DinB uniquely capable of participating in this reaction. To explore this topic, we performed molecular modeling of DinB's interactions with the RecA filament during strand exchange, identifying key contacts made with residues in the DinB fingers domain. These residues are highly conserved in DinB, but not in other translesion DNA polymerases. Using a novel FRET-based assay, we found that DinB variants with mutations in these conserved residues are less effective at stabilizing RecA-mediated strand exchange than native DinB. Furthermore, these variants are specifically deficient in strand displacement in the absence of RecA filament. We propose that the amino acid patch of highly conserved residues in DinB-like proteins provides a mechanistic explanation for DinB's function in strand exchange and improves our understanding of recombination by providing evidence that RecA plays a role in facilitating DinB's activity during strand exchange.	[Tashjian, Tommy F.; Nguyen, Brian H.; Godoy, Veronica G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Danilowicz, Claudia; Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Molza, Anne-Elizabeth; Prevost, Chantal] CNRS UPR9080, Lab Biochim Theor, F-75005 Paris, France; [Molza, Anne-Elizabeth; Prevost, Chantal] Univ Paris Diderot, IBPC, F-75005 Paris, France	Northeastern University; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Godoy, VG (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	v.godoycarter@northeastern.edu	Prentiss, Mara/AAU-2940-2021	Tashjian, Tommy/0000-0001-5675-1151; Chantal, Prevost/0000-0003-3516-6687	National Institutes of Health NIGMS [RO1GM088230]; Northeastern University; Graduate Research and Dissertation Grant, Northeastern University College of Science; Initiative d'Excellence Program of the French State Grant DYNAMO [ANR-11 - LABX-0011-01]	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Northeastern University; Graduate Research and Dissertation Grant, Northeastern University College of Science; Initiative d'Excellence Program of the French State Grant DYNAMO	This work was supported in part by National Institutes of Health NIGMS Grant RO1GM088230 (to V. G. G.) and Northeastern University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Graduate Research and Dissertation Grant, Northeastern University College of Science. Present address: Dept. of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA 01003.; Supported by Initiative d'Excellence Program of the French State Grant DYNAMO, ANR-11 - LABX-0011-01.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Benson RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019944; Berdichevsky A, 2002, MOL CELL, V10, P917, DOI 10.1016/S1097-2765(02)00679-2; Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Boudsocq F, 1997, J MOL BIOL, V270, P201, DOI 10.1006/jmbi.1997.1098; Boyer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116414; Cafarelli TM, 2014, ENVIRON MOL MUTAGEN, V55, P92, DOI 10.1002/em.21826; Cafarelli TM, 2013, J BACTERIOL, V195, P1179, DOI 10.1128/JB.01349-12; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Danilowicz C, 2015, NUCLEIC ACIDS RES, V43, P6473, DOI 10.1093/nar/gkv610; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Duan GL, 2001, MOL PHYS, V99, P1689, DOI 10.1080/00268970110063917; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Henrikus SS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007161; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Jarosz DF, 2007, CELL CYCLE, V6, P817, DOI 10.4161/cc.6.7.4065; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kottur J, 2015, STRUCTURE, V23, P56, DOI 10.1016/j.str.2014.10.019; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; LAM ST, 1974, GENETICS, V77, P425; Lee JY, 2016, J BIOL CHEM, V291, P22218, DOI 10.1074/jbc.M116.740563; Liu J, 2011, METHODS MOL BIOL, V745, P363, DOI 10.1007/978-1-61779-129-1_21; Lovett S, 2006, DNA REPAIR, V5, P1421, DOI 10.1016/j.dnarep.2006.06.008; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mallik S, 2015, J BACTERIOL, V197, P2792, DOI 10.1128/JB.00101-15; MALONE RE, 1978, J MOL BIOL, V121, P473, DOI 10.1016/0022-2836(78)90395-9; Molza AE, 2014, FARADAY DISCUSS, V169, P45, DOI 10.1039/c3fd00134b; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pomerantz RT, 2013, NAT STRUCT MOL BIOL, V20, P748, DOI 10.1038/nsmb.2573; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Rehrauer WM, 1998, J BIOL CHEM, V273, P32384, DOI 10.1074/jbc.273.49.32384; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Sharma A, 2013, NUCLEIC ACIDS RES, V41, P5104, DOI 10.1093/nar/gkt146; Shee C, 2011, P NATL ACAD SCI USA, V108, P13659, DOI 10.1073/pnas.1104681108; Sholder G, 2015, DNA REPAIR, V35, P144, DOI 10.1016/j.dnarep.2015.09.020; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Tashjian TF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00288; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Yang DR, 2015, NUCLEIC ACIDS RES, V43, P10251, DOI 10.1093/nar/gkv883; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105	56	8	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7588	7600		10.1074/jbc.RA118.006233	http://dx.doi.org/10.1074/jbc.RA118.006233			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30872406	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000470153300007
J	Yang, Y; Liu, Z; He, XQ; Yang, JJ; Wu, J; Yang, HL; Li, M; Qian, Q; Lai, R; Xu, W; Wei, L				Yang, Yang; Liu, Zhen; He, Xiaoqin; Yang, Juanjuan; Wu, Jing; Yang, Hailong; Li, Min; Qian, Qian; Lai, Ren; Xu, Wei; Wei, Lin			A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); peptides; structure-function; amino acid; drug action; drug resistance; -helix; anti-mycobacterial peptide; hydrophobic moment; mycobacteriophage; antibiotic; endolysin; immune regulation; Mycobacterium tuberculosis	ALPHA-HELICAL PEPTIDES; ANTIMICROBIAL PEPTIDES; ANTIMYCOBACTERIAL ACTIVITIES; HYDROPHOBIC MOMENT; IDENTIFICATION; TUBERCULOSIS; COMBINATION; SELECTIVITY; TRYPTOPHAN; RESISTANCE	Mycobacteriophages express various peptides/proteins to infect Mycobacterium tuberculosis (M. tb). Particular attention has been paid to mycobacteriophage-derived endolysin proteins. We herein characterized a small mycobacteriophage-derived peptide designated AK15 with potent anti-M. tb activity. AK15 adopted cationic amphiphilic -helical structure, and on the basis of this structure, we designed six isomers with increased hydrophobic moment by rearranging amino acid residues of the helix. We found that one of these isomers, AK15-6, exhibits enhanced anti-mycobacterial efficiency. Both AK15 and AK15-6 directly inhibited M. tb by trehalose 6,6-dimycolate (TDM) binding and membrane disruption. They both exhibited bactericidal activity, cell selectivity, and synergistic effects with rifampicin, and neither induced drug resistance to M. tb. They efficiently attenuated mycobacterial load in the lungs of M. tb-infected mice. We observed that lysine, arginine, tryptophan, and an -helix are key structural requirements for their direct anti-mycobacterial action. Of note, they also exhibited immunomodulatory effects, including inhibition of proinflammatory response in TDM-stimulated or M. tb-infected murine bone marrow-derived macrophages (BMDMs) and M.tb-infected mice and induction of only a modest level of cytokine (tumor necrosis factor (TNF-) and interleukin-6 (IL-6)) production in murine BMDMs and a T-cell cytokine (interferin- (IFN-) and TNF-) response in murine lung and spleen. In summary, characterization of a small mycobacteriophage-derived peptide and its improved isomer revealed that both efficiently restrain M. tb infection via dual mycobactericidal-immunoregulatory activities. Our work provides clues for identifying small mycobacteriophage-derived anti-mycobacterial peptides and improving those that have cationic amphiphilic -helices.	[Yang, Yang; Liu, Zhen; Li, Min; Qian, Qian; Xu, Wei; Wei, Lin] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Yang; Liu, Zhen; Li, Min; Qian, Qian; Xu, Wei; Wei, Lin] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [He, Xiaoqin; Lai, Ren] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [He, Xiaoqin] Jiangsu Inst Parasit Dis, Natl Hlth Commiss Key Lab Parasit Dis Control & P, Jiangsu Prov Key Lab Parasite & Vector Control Te, Wuxi 214064, Jiangsu, Peoples R China; [Yang, Juanjuan] Fuzhou Univ, Coll Biol Sci & Technol, Inst Pharmaceut Biotechnol & Engn, Fuzhou 350108, Fujian, Peoples R China; [Wu, Jing; Yang, Hailong] Kunming Med Univ, Sch Basic Med Sci, Kunming 650500, Yunnan, Peoples R China	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Kunming Institute of Zoology; Fuzhou University; Kunming Medical University	Xu, W; Wei, L (corresponding author), Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China.; Xu, W; Wei, L (corresponding author), Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn; xuweifd828@126.com; weilin1005@126.com	yang, hailong/GXH-9625-2022; Wei, Lin/AAE-3043-2022	Wei, Lin/0000-0003-3359-2471; Xu, Wei/0000-0003-2652-8244	National Natural Science Foundation of China [81402830, 31870868, 81603080, 31670930, 31700656, 81802023]; China Postdoctoral Science Foundation [2015M571815]; Ministry of Science and Technology of China [2018ZX10731301-001-006]; Natural Science Foundation of Jiangsu Province [BK20140362]; Fujian Province [2017J05050]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRTIRT1075]; Science and Technology Development of Suzhou [SNG2017050, sys2018017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fujian Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Science and Technology Development of Suzhou	This work was supported by National Natural Science Foundation of China Grants 81402830, 31870868, 81603080, 31670930, 31700656, and 81802023; China Postdoctoral Science Foundation Grant 2015M571815; Ministry of Science and Technology of China Grant 2018ZX10731301-001-006; Natural Science Foundation of Jiangsu Province Grant BK20140362 and Fujian Province Grant 2017J05050; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University Grant PCSIRTIRT1075; and Science and Technology Development of Suzhou Grants SNG2017050 and sys2018017. The authors declare that they have no conflicts of interest with the contents of this article.	Abedinzadeh M, 2015, J ANTIMICROB CHEMOTH, V70, P1285, DOI 10.1093/jac/dku570; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Arranz-Trullen J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01499; BARRIERE SL, 1992, PHARMACOTHERAPY, V12, P397; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Genoula M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00459; Gil F, 2008, MICROBIOL-SGM, V154, P1364, DOI 10.1099/mic.0.2007/014621-0; Gutsmann T, 2016, BBA-BIOMEMBRANES, V1858, P1034, DOI 10.1016/j.bbamem.2016.01.031; Haas W, 2010, J ANTIMICROB CHEMOTH, V65, P1441, DOI 10.1093/jac/dkq127; Hatfull GF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003953; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Jin L, 2016, J MED CHEM, V59, P1791, DOI 10.1021/acs.jmedchem.5b01264; Khara JS, 2014, BIOMATERIALS, V35, P2032, DOI 10.1016/j.biomaterials.2013.11.035; Khara JS, 2015, ACTA BIOMATER, V28, P99, DOI 10.1016/j.actbio.2015.09.015; Khusro A, 2016, ASIAN PAC J TROP MED, V9, P1001, DOI 10.1016/j.apjtm.2016.09.005; Lai MJ, 2015, MOLECULES, V20, P19277, DOI 10.3390/molecules201019277; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lee E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12048; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Phoenix DA, 2003, CURR PROTEIN PEPT SC, V4, P357, DOI 10.2174/1389203033487090; Pohane AA, 2015, FEBS LETT, V589, P695, DOI 10.1016/j.febslet.2015.01.036; Pohane AA, 2014, J BIOL CHEM, V289, P12085, DOI 10.1074/jbc.M113.529594; RAND KH, 1993, ANTIMICROB AGENTS CH, V37, P613, DOI 10.1128/AAC.37.3.613; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Teng TS, 2015, CELL PHYSIOL BIOCHEM, V35, P452, DOI 10.1159/000369711; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Wang Y, 2014, BIOMATERIALS, V35, P3102, DOI 10.1016/j.biomaterials.2013.12.049; Wei L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1149-y; Wei L, 2015, J BIOL CHEM, V290, P16633, DOI 10.1074/jbc.M115.642645; Wei L, 2013, FASEB J, V27, P3067, DOI 10.1096/fj.13-227454; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Welsh KJ, 2010, TRANSL RES, V156, P207, DOI 10.1016/j.trsl.2010.06.001; WHO, 2017, GLOB TUB REP 2017; Wu ML, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00445; Wu YL, 1999, J ANTIMICROB CHEMOTH, V44, P389, DOI 10.1093/jac/44.3.389	45	8	8	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7615	7631		10.1074/jbc.RA118.006968	http://dx.doi.org/10.1074/jbc.RA118.006968			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30894414	Green Published, hybrid			2022-12-26	WOS:000470153300009
J	Morgan, JLW; Evans, EGB; Zagotta, WN				Morgan, Jacob L. W.; Evans, Eric G. B.; Zagotta, William N.			Functional characterization and optimization of a bacterial cyclic nucleotide-gated channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; potassium channel; cyclic nucleotide; allosteric regulation; channel activation; bacteria; cyclic nucleotide gating; prokaryotic ion channel; voltage-gated ion channel; allostery	LIGAND-BINDING DOMAIN; ESCHERICHIA-COLI; TERMINAL REGION; PATCH-CLAMP; K+ CHANNEL; MODULATION; MECHANISM; GENE; HCN2; REARRANGEMENTS	Cyclic nucleotide-gated (CNG) channels produce the initial electrical signal in mammalian vision and olfaction. They open in response to direct binding of cyclic nucleotide (cAMP or cGMP) to a cytoplasmic region of the channel. However, the conformational rearrangements occurring upon binding to produce pore opening (i.e. gating) are not well understood. SthK is a bacterial CNG channel that has the potential to serve as an ideal model for structure-function studies of gating but is currently limited by its toxicity, native cysteines, and low open probability (P-o). Here, we expressed SthK in giant Escherichia coli spheroplasts and performed patch-clamp recordings to characterize SthK gating in a bacterial membrane. We demonstrated that the P-o in cAMP is higher than has been previously published and that cGMP acts as a weak partial SthK agonist. Additionally, we determined that SthK expression is toxic to E. coli because of gating by cytoplasmic cAMP. We overcame this toxicity by developing an adenylate cyclase-knockout E. coli cell line. Finally, we generated a cysteine-free SthK construct and introduced mutations that further increase the P-o in cAMP. We propose that this SthK model will help elucidate the gating mechanism of CNG channels.	[Morgan, Jacob L. W.; Evans, Eric G. B.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	Zagotta@uw.edu		Evans, Eric/0000-0002-8669-2663	National Institutes of Health [R01EY010329, R01MH102378, R01GM127325]; Raymond and Beverly Sackler Scholars Program; National Institutes of Health Vision Training Grant [T32EY007031]; National Institutes of Health Cardiovascular Pathology Training Grant [T32HL007312]; NATIONAL EYE INSTITUTE [R01EY010329, T32EY007031] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120553, R01GM127325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Raymond and Beverly Sackler Scholars Program; National Institutes of Health Vision Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cardiovascular Pathology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01EY010329, R01MH102378, and R01GM127325; National Institutes of Health Cardiovascular Pathology Training Grant T32HL007312 (to J. L. W. M.); and the Raymond and Beverly Sackler Scholars Program and National Institutes of Health Vision Training Grant T32EY007031 (to E. G. B. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Auerbach Anthony, 2003, Sci STKE, V2003, pre11, DOI 10.1126/stke.2003.188.re11; Brams M, 2014, P NATL ACAD SCI USA, V111, P7855, DOI 10.1073/pnas.1401917111; BRICKMAN E, 1973, J BACTERIOL, V116, P582, DOI 10.1128/JB.116.2.582-587.1973; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Carranza G, 2017, BBA-BIOMEMBRANES, V1859, P1124, DOI 10.1016/j.bbamem.2017.03.006; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Corey RA, 2018, P NATL ACAD SCI USA, V115, P7967, DOI 10.1073/pnas.1721536115; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; James ZM, 2017, P NATL ACAD SCI USA, V114, P4430, DOI 10.1073/pnas.1700248114; Jensen SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep17874; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kesters D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116369; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Laage S, 2015, BBA-BIOMEMBRANES, V1848, P260, DOI 10.1016/j.bbamem.2014.08.021; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; Martinac Boris, 2013, Methods Mol Biol, V966, P367, DOI 10.1007/978-1-62703-245-2_23; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; PERLMAN RL, 1969, BIOCHEM BIOPH RES CO, V37, P151, DOI 10.1016/0006-291X(69)90893-6; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Rheinberger J, 2018, ELIFE, V7, DOI 10.7554/eLife.39775; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Schmidpeter PAM, 2018, J GEN PHYSIOL, V150, P821, DOI 10.1085/jgp.201812023; SHIBUYA I, 1992, PROG LIPID RES, V31, P245, DOI 10.1016/0163-7827(92)90010-G; Sunderman ER, 1999, J GEN PHYSIOL, V113, P621, DOI 10.1085/jgp.113.5.621; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	49	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7503	7515		10.1074/jbc.RA119.007699	http://dx.doi.org/10.1074/jbc.RA119.007699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885945	Green Published, hybrid			2022-12-26	WOS:000468402900033
J	Wu, YL; Li, YL; Li, YY; Ma, YZ; Zhao, YL; Wang, CZ; Chi, HB; Chen, M; Ding, YH; Guo, XP; Min, L; Zhang, XL				Wu, Yuanlong; Li, Yanlong; Li, Yaoyao; Ma, Yizan; Zhao, Yunlong; Wang, Chaozhi; Chi, Huabin; Chen, Miao; Ding, Yuanhao; Guo, Xiaoping; Min, Ling; Zhang, Xianlong			Proteomic analysis reveals that sugar and fatty acid metabolisms play a central role in sterility of the male-sterile line 1355A of cotton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein expression; proteomics; glycolysis; fatty acid metabolism; pyruvate; artificial emasculation; carbohydrate metabolism; Gossypium; heterosis; male sterility	POLLEN WALL DEVELOPMENT; ACYL CARRIER PROTEIN; SPOROPOLLENIN SYNTHESIS; ANTHER DEVELOPMENT; EXINE FORMATION; COA SYNTHETASE; BIOSYNTHESIS; MICROSPOROGENESIS; PATHWAYS; TAPETUM	Cotton (Gossypium spp.) is one of the most important economic crops and exhibits yield-improving heterosis in specific hybrid combinations. The genic male-sterility system is the main strategy used for producing heterosis in cotton. To better understand the mechanisms of male sterility in cotton, we carried out two-dimensional electrophoresis (2-DE) and label-free quantitative proteomics analysis in the anthers of two near-isogenic lines, the male-sterile line 1355A and the male-fertile line 1355B. We identified 39 and 124 proteins that were significantly differentially expressed between these two lines in the anthers at the tetrad stage (stage 7) and uninucleate pollen stage (stage 8), respectively. Gene ontology-based analysis revealed that these differentially expressed proteins were mainly associated with pyruvate, carbohydrate, and fatty acid metabolism. Biochemical analysis revealed that in the anthers of line 1355A, glycolysis was activated, which was caused by a reduction in fructose, glucose, and other soluble sugars, and that accumulation of acetyl-CoA was increased along with a significant increase in C14:0 and C18:1 free fatty acids. However, the activities of pyruvate dehydrogenase and fatty acid biosynthesis were inhibited and fatty acid -oxidation was activated at the translational level in 1355A. We speculate that in the 1355A anther, high rates of glucose metabolism may promote fatty acid synthesis to enable anther growth. These results provide new insights into the molecular mechanism of genic male sterility in upland cotton.	[Wu, Yuanlong; Li, Yanlong; Li, Yaoyao; Ma, Yizan; Zhao, Yunlong; Wang, Chaozhi; Chi, Huabin; Chen, Miao; Ding, Yuanhao; Min, Ling; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Guo, Xiaoping] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Min, L (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China.	lingmin@mail.hzau.edu.cn	wu, yuanlong/GSD-8393-2022	Chi, Huabin/0000-0002-2945-6664; wu, yuanlong/0000-0002-3677-8936	National Key Research and Development Program of China [2016YFD0101402]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (2016YFD0101402). The authors declare that they have no conflicts of interest with the contents of this article.	Ahlers F, 1999, PHYTOCHEMISTRY, V50, P1095, DOI 10.1016/S0031-9422(98)00225-8; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; Chang HS, 2012, PLANT PHYSIOL, V158, P264, DOI 10.1104/pp.111.184853; Chawla M, 2017, HISTOCHEM CELL BIOL, V147, P103, DOI 10.1007/s00418-016-1481-0; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; Geng XX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020324; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Goff SA, 2013, CURR OPIN PLANT BIOL, V16, P221, DOI 10.1016/j.pbi.2013.03.009; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gonzalez-Fernandez R, 2013, J PROTEOME RES, V12, P3042, DOI 10.1021/pr3010937; Grienenberger E, 2010, PLANT CELL, V22, P4067, DOI 10.1105/tpc.110.080036; GUILFORD WJ, 1988, PLANT PHYSIOL, V86, P134, DOI 10.1104/pp.86.1.134; Hafidh S, 2016, PLANT REPROD, V29, P31, DOI 10.1007/s00497-015-0272-4; Hirsche J, 2017, PLANT CELL PHYSIOL, V58, P691, DOI 10.1093/pcp/pcx020; Huang L, 2009, J EXP BOT, V60, P301, DOI 10.1093/jxb/ern295; Jia QS, 2015, MOL PLANT, V8, P251, DOI 10.1016/j.molp.2014.10.001; Jiang J, 2013, PLANT BIOLOGY, V15, P249, DOI 10.1111/j.1438-8677.2012.00706.x; Kim SS, 2013, J PLANT BIOL, V56, P1, DOI 10.1007/s12374-012-0385-3; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Li JJ, 2016, J PROTEOMICS, V138, P72, DOI 10.1016/j.jprot.2016.02.017; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lin H, 2017, PLANT J, V92, P1076, DOI 10.1111/tpj.13744; Lou Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4855; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Matsuda H., 2016, Tropical Agriculture and Development, V60, P155; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Min L, 2013, PLANT J, V75, P823, DOI 10.1111/tpj.12245; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; Oliver SN, 2007, PLANT CELL PHYSIOL, V48, P1319, DOI 10.1093/pcp/pcm100; OWEN HA, 1995, PROTOPLASMA, V185, P7, DOI 10.1007/BF01272749; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Quilichini TD, 2015, PHYTOCHEMISTRY, V113, P170, DOI 10.1016/j.phytochem.2014.05.002; Quilichini TD, 2014, PLANT CELL, V26, P4483, DOI 10.1105/tpc.114.130484; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rounds CM, 2013, ANNU REV PLANT BIOL, V64, P243, DOI 10.1146/annurev-arplant-050312-120150; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Suzuki T, 2008, PLANT CELL PHYSIOL, V49, P1465, DOI 10.1093/pcp/pcn131; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00092; Wang XL, 2009, PLANT J, V57, P473, DOI 10.1111/j.1365-313X.2008.03700.x; Wiermann R, 2001, BIOPOLYMERS, V1, P209, DOI DOI 10.1002/3527600035.BPOL1007; Wilson ZA, 2011, J EXP BOT, V62, P1633, DOI 10.1093/jxb/err014; Wu YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09608; Xu J, 2014, PLANT CELL, V26, P1544, DOI 10.1105/tpc.114.122986; Xu ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep33342; Yang ZN, 2016, SCI CHINA LIFE SCI, V59, P1335, DOI 10.1007/s11427-016-0338-y; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zamariola L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00279; Zhang DS, 2008, MOL PLANT, V1, P599, DOI 10.1093/mp/ssn028; Zhang DB, 2016, SUBCELL BIOCHEM, V86, P315, DOI 10.1007/978-3-319-25979-6_13; Zhang DB, 2014, CURR OPIN PLANT BIOL, V17, P49, DOI 10.1016/j.pbi.2013.11.001; Zheng BB, 2014, J PROTEOME RES, V13, P2998, DOI 10.1021/pr500126g; Zhu W, 2008, EUPHYTICA, V164, P283, DOI 10.1007/s10681-008-9732-3	63	10	13	7	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7057	7067		10.1074/jbc.RA118.006878	http://dx.doi.org/10.1074/jbc.RA118.006878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30862676	Green Published, hybrid			2022-12-26	WOS:000467394700037
J	Arai, T; Azri, A				Arai, Takaomi; Azri, Azie			Diversity, occurrence and conservation of sharks in the southern South China Sea	PLOS ONE			English	Article							EXTINCTION RISK; MARINE; PATTERNS; DEPLETION; RECOVERY; COLLAPSE; CATCHES	Sharks constitute a vital sector of marine and estuarine nekton and are of great commercial importance all over the world. International concern over the fate of shark fisheries has grown recently. However, information concerning the species diversity, geographic distribution and life histories of sharks in the Indo-Pacific region is highly limited. Comprehensive research on the species composition, distribution and seasonal occurrence of sharks in the southern South China Sea (SSCS) was conducted for four years. A total of 4742 sharks belonging to 10 families and 28 species were recorded from 6 fishing ports in SSCS. The families recorded included Squalidae, Heterodontidae, Orectolobidae, Hemiscylliidae, Alopiidae, Scyliorhinidae, Triakidae, Hemigaleidae, Carcharhinidae and Sphyrnidae. Seventeen of 28 shark species were landed at various developmental stages from in the ranges of or even less than the length at birth and from newborn juveniles to fully-mature. The results suggest that these sharks were born just before fishing and landing, and reproductive-stage sharks were also fished and landed. In total, 15 species, four species and one species in 28 shark species were categorized as Near Threatened, Vulnerable and Endangered species, respectively, on the IUCN Red List. Sharks are not targeted by fisheries practices in the SSCS, but are caught as bycatch throughout the year in various developmental stages. Thus, current fisheries practices in the SSCS area might lead to further decline to critical levels and lead to extinction of some of species in the future. These results suggest that the need for gear selectivity of the commercial fishing gears in order to reduce mortality and to conserve shark stocks.	[Arai, Takaomi; Azri, Azie] Univ Brunei Darussalam, Environm & Life Sci Programme, Fac Sci, Jalan Tungku Link, Gadong, BE, Brunei	University Brunei Darussalam	Arai, T (corresponding author), Univ Brunei Darussalam, Environm & Life Sci Programme, Fac Sci, Jalan Tungku Link, Gadong, BE, Brunei.	takaomi.arai@ubd.edu.bn	Arai, Takaomi/AAX-2641-2021	Arai, Takaomi/0000-0001-9440-7933	Higher Institution Centre of Excellence (HICoE) Research Grant under the Institute of Oceanography and Environment, Universiti Malaysia Terengganu [66928]; Universiti Brunei Darussalam under the Competitive Research Grant Scheme [UBD/OVACRI/CRGWG(003)]	Higher Institution Centre of Excellence (HICoE) Research Grant under the Institute of Oceanography and Environment, Universiti Malaysia Terengganu; Universiti Brunei Darussalam under the Competitive Research Grant Scheme	TA was supported by the Higher Institution Centre of Excellence (HICoE) Research Grant (Grant No. 66928), under the Institute of Oceanography and Environment, Universiti Malaysia Terengganu and by Universiti Brunei Darussalam under the Competitive Research Grant Scheme (Grant No. UBD/OVACRI/CRGWG(003)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, FIELD GUIDE SHARKS S; Ahmad A., 1999, J OCEAN, V16, P92; Ahmad A, 2017, IDENTIFICATION GUIDE; Ahmad A, 2004, ELASMOBRANCH RESOURC; Allen G.R., 2012, REEF FISHES E INDIES, VI-III; [Anonymous], 1996, OVERVIEW WORLD TRADE; [Anonymous], 2014, MAL NAT PLAN ACT CON; Bass A.J., 1986, P67; Bass A.J., 1973, Investigational Rep Oceanogr Res lnst Durban, VNo. 33, P1; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil R., 1994, FAO FISHERIES TECHNI; Carlisle AB, 2009, MAR ECOL PROG SER, V380, P213, DOI 10.3354/meps07907; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 2005, 243 CSIRO MAR LAB, P1; Compagno L.J.V., 2005, SHARKS WORLD; Compagno LJV, 1998, LIVING MARINE RESOUR, V2; Compagno LJV., 1984, FAO FISH SYNOP, P20; Compagno LJV, 2001, SHARKS WORLD ANNOT; Compagno LJV., 1998, FAO IDENTIFICATION G, P1249; Department of Fisheries Malaysia, 2006, MAL NAT PLAN ACT CON; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Fahmi Dharmadi, 2013, FIELD GUIDE LOOK ALI; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Florida Museum of Natural History, 2005, BIOL PROF BLACKT SHA; Gambang AC, 1994, BOTTOM LONGLINE FISH; Herndon A, 2010, MAR POLICY, V34, P1239, DOI 10.1016/j.marpol.2010.05.001; Hoevel Anna, 2010, Zoologische Garten, V79, P243, DOI 10.1016/j.zoolgart.2010.12.001; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; IUCN, 2003, INT GEN FISH COUNC M; Knip DM, 2012, J FISH BIOL, V80, P767, DOI 10.1111/j.1095-8649.2012.03223.x; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Lam VYY, 2011, FISH FISH, V12, P51, DOI 10.1111/j.1467-2979.2010.00383.x; Last P.R., 2010, SHARKS RAYS BORNEO; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Last PR, 1994, SHARKS RAYS AUSTR, DOI 10.2307/1446735; Lipa BJ, 2006, J OCEANOGR, V62, P705, DOI 10.1007/s10872-006-0088-9; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClenachan L, 2016, CURR BIOL, V26, P1640, DOI 10.1016/j.cub.2016.05.026; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RF, 1999, CORAL GRAPHICS GUAM; Polidoro BA, 2012, MAR ECOL PROG SER, V448, P93, DOI 10.3354/meps09545; Riede K., 2004, 80805081 FED AG NAT; Serrano R, 2000, ARCH ENVIRON CON TOX, V38, P217, DOI 10.1007/s002449910029; Stevens JD, 2000, MAR FRESHWATER RES, V51, P127, DOI 10.1071/MF98158; Strid A, 2007, MAR POLLUT BULL, V54, P1514, DOI 10.1016/j.marpolbul.2007.04.018; Weigmann S, 2016, J FISH BIOL, V88, P837, DOI 10.1111/jfb.12874; Wetherbee BM, 2004, CRC MAR BIOL SER, P225; White W.T., 2006, EC IMPORTANT SHARKS; White WT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209387; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Yano K, 2005, SHARKS RAYS MALAYSIA	55	15	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213864	10.1371/journal.pone.0213864	http://dx.doi.org/10.1371/journal.pone.0213864			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901342	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400021
J	Jeanne, T; Parent, SE; Hogue, R				Jeanne, Thomas; Parent, Serge-Etienne; Hogue, Richard			Using a soil bacterial species balance index to estimate potato crop productivity	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNCTIONAL REDUNDANCY; MANAGEMENT-PRACTICES; ORGANIC AMENDMENTS; DIVERSITY; CARBON; FERTILIZATION; TILLAGE; IMPACTS; HEALTH	The development of 'molecular-omic' tools and computing analysis platforms have greatly enhanced our ability to assess the impacts of agricultural practices and crop management protocols on soil microbial diversity. However, biotic factors are rarely factored into agricultural management models. Today it is possible to identify specific microbiomes and define biotic components that contribute to soil quality. We assessed the bacterial diversity of soils in 51 potato production plots. We describe a strategy for identifying a potato-crop-productivity bacterial species balance index based on amplicon sequence variants. We observed a significant impact of soil texture balances on potato yields; however, the Shannon and Chao1 richness indices and Pielou's evenness index poorly correlated with these yields. Nonetheless, we were able to estimate the portion of the total bacterial microbiome related to potato yield using an integrated species balances index derived from the elements of the bacterial microbiome that positively or negatively correlate with residual potato yields. This innovative strategy based on a microbiome selection procedure greatly enhances our ability to interpret the impact of agricultural practices and cropping system management choices on microbial diversity and potato yield. This strategy provides an additional tool that will aid growers and the broader agricultural sector in their decision-making processes concerning the soil quality and crop productivity.	[Jeanne, Thomas; Hogue, Richard] IRDA, Quebec City, PQ, Canada; [Parent, Serge-Etienne] Univ Laval, Quebec City, PQ, Canada	Laval University	Jeanne, T (corresponding author), IRDA, Quebec City, PQ, Canada.	thomas.jeanne@irda.qc.ca	Parent, Serge-Étienne/AAM-9252-2020	Parent, Serge-Étienne/0000-0003-1679-2287; Hogue, Richard/0000-0002-2768-0857; Jeanne, Thomas/0000-0001-6230-5369	Quebec Agricultural Ministry (ministere de l'Agriculture, des Pecheries et de l' Alimentation du Quebec) Innov'Action agroalimentaire program	Quebec Agricultural Ministry (ministere de l'Agriculture, des Pecheries et de l' Alimentation du Quebec) Innov'Action agroalimentaire program	This project was made possible in part thanks to funding by the Quebec Agricultural Ministry (ministere de l'Agriculture, des Pecheries et de l' Alimentation du Quebec) Innov'Action agroalimentaire program. www.mapaq.gouv.qc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Aparna K, 2014, ECOL ENG, V71, P268, DOI 10.1016/j.ecoleng.2014.07.016; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Bissett A, 2013, SOIL BIOL BIOCHEM, V58, P281, DOI 10.1016/j.soilbio.2012.12.002; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bowles TM, 2014, SOIL BIOL BIOCHEM, V68, P252, DOI 10.1016/j.soilbio.2013.10.004; Brussaard L, 2007, PEDOBIOLOGIA, V50, P447, DOI 10.1016/j.pedobi.2006.10.007; Brussaard L, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P45; Bunemann EK, 2018, SOIL BIOL BIOCHEM, V120, P105, DOI 10.1016/j.soilbio.2018.01.030; Burns KN, 2015, SOIL BIOL BIOCHEM, V91, P232, DOI 10.1016/j.soilbio.2015.09.002; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen JH, 2015, APPL SOIL ECOL, V91, P68, DOI 10.1016/j.apsoil.2015.02.012; Constancias F, 2015, MICROBIOLOGYOPEN, V4, P505, DOI 10.1002/mbo3.255; de Vries FT, 2013, P NATL ACAD SCI USA, V110, P14296, DOI 10.1073/pnas.1305198110; Delgado-Baquerizo M, 2017, ENVIRON MICROBIOL, V19, P1176, DOI 10.1111/1462-2920.13642; Doran J. W., 1994, P1; Doran JW, 1996, METHODS ASSESS SOIL, P1996; Duran P, 2018, CELL, V175, P973, DOI 10.1016/j.cell.2018.10.020; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Graham EM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00196; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Gugino B.K., 2009, CORNELL SOIL HLTH AS; Gupta VVSR, 2015, SOIL BIOL BIOCHEM, V80, pA3, DOI 10.1016/j.soilbio.2014.09.002; Hartman K, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0389-9; Hermans SM, 2017, APPL ENVIRON MICROB, V83, P1; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; Leblanc MA, 2016, PROGR SOIL SCI, P253, DOI 10.1007/978-3-319-28295-4_16; Leff JW, 2018, ISME J, V12, P1794, DOI 10.1038/s41396-018-0089-x; Ling N, 2016, SOIL BIOL BIOCHEM, V99, P137, DOI 10.1016/j.soilbio.2016.05.005; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Lupatini M, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02064; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Martin-Fernandez JA, 2015, STAT MODEL, V15, DOI 10.1177/1471082X14535524; Mbuthia LW, 2015, SOIL BIOL BIOCHEM, V89, P24, DOI 10.1016/j.soilbio.2015.06.016; Moebius-Clune B.N, 2016, COMPREHENSIVE ASSESS, V3.2; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00166-16; Morton JT, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00162-16; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palarea-Albaladejo J, 2017, TREATMENT ZEROS NOND; Panke-Buisse K, 2015, ISME J, V9, P980, DOI 10.1038/ismej.2014.196; Pankhurst C, 1997, BIOL INDICATORS SOIL; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Parent LE, 2012, GEODERMA, V179, P123, DOI 10.1016/j.geoderma.2012.02.022; Parent SE, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00081; Parent SE, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00039, 10.3389/fpls.2013.00449]; Pfeiffer S, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw242; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Pierotti MER, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P218; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2018, R LANG ENV STAT COMP; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rosenzweig N, 2012, PLANT DIS, V96, P718, DOI 10.1094/PDIS-07-11-0571; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; SCHIMEL J, 1995, ECOL STU AN, V113, P239; She SY, 2017, ARCH MICROBIOL, V199, P267, DOI 10.1007/s00203-016-1301-x; Silverman JD, 2017, ELIFE, V6, DOI 10.7554/eLife.21887; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Terrat S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186766; Trivedi P, 2016, FRONT PLANT SCI, V7, P1; Trivedi P, 2015, SOIL BIOL BIOCHEM, V91, P169, DOI 10.1016/j.soilbio.2015.08.034; van den Boogaart KG, 2014, COMPOSITIONS COMPOSI; Wang R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00472-6; Willamette V, 2009, SOIL QUALITY CARD; Wu TH, 2015, APPL SOIL ECOL, V91, P58, DOI 10.1016/j.apsoil.2015.02.011; Xue D, 2018, AM J POTATO RES, V95, P696, DOI 10.1007/s12230-018-9677-6	70	10	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214089	10.1371/journal.pone.0214089	http://dx.doi.org/10.1371/journal.pone.0214089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901358	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400035
J	Sotola, VA; Craig, CA; Pfaff, PJ; Maikoetter, JD; Martin, NH; Bonner, TH				Sotola, V. Alex; Craig, Cody A.; Pfaff, Peter J.; Maikoetter, Jeremy D.; Martin, Noland H.; Bonner, Timothy H.			Effect of preservation on fish morphology over time: Implications for morphological studies	PLOS ONE			English	Article							FORMALIN FIXATION; MORPHOMETRICS; SHAPE; ALCOHOL; LENGTH; TRUSS	It has long been recognized that the process of preserving biological specimens results in alterations of body shape, though detailed studies examining the degree to which morphological changes occur throughout the preservation process are lacking. We utilize geometric morphometric analyses, an increasingly common tool for examining shape variation in a wide variety of biological disciplines, to examine the effects of formalin and ethanol preservation on the body shape of 10 freshwater fish species over time: from fresh specimens to eight weeks after preservation. We found significant changes in body shape among fresh and formalin fixed specimens. Furthermore, changes in body shape continue to occur after subsequent ethanol preservation. Two fish species collected at multiple localities show significant morphological differences for a limited number of morphometric characters. However, the significance, or lack thereof, often changed inconsistently from one stage of preservation to another. We conclude that morphometric analyses would ideally be performed on fresh specimens. However, recognizing that this is not always feasible, it is important to be aware of the morphometric changes that can occur during preservation.	[Sotola, V. Alex; Craig, Cody A.; Pfaff, Peter J.; Maikoetter, Jeremy D.; Martin, Noland H.; Bonner, Timothy H.] Texas State Univ, Dept Biol, Aquat Stn, San Marcos, TX 78666 USA	Texas State University System; Texas State University San Marcos	Sotola, VA (corresponding author), Texas State Univ, Dept Biol, Aquat Stn, San Marcos, TX 78666 USA.	vas66@txstate.edu	Craig, Cody/T-9884-2019	Craig, Cody/0000-0001-9046-0972; Maikoetter, Jeremy/0000-0002-0523-4178; Bonner, Timothy/0000-0002-8022-675X; Sotola, V. Alex/0000-0002-9304-1017				Adams D.C., GEOMORPH SOFTWARE GE; AFS (American Fisheries Society), 2004, GUIDELINES USE FISHE; Ajah PO, 2003, J APPL ICHTHYOL, V19, P391, DOI 10.1111/j.1439-0426.2003.00484.x; ANDRIGUETTO JM, 1988, AM MALACOL BULL, V6, P213; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Arrington DA, 2002, T AM FISH SOC, V131, P337, DOI 10.1577/1548-8659(2002)131<0337:PEOSIA>2.0.CO;2; Berbel WM, 2013, ICHTHYOL RES, V60, P268, DOI 10.1007/s10228-013-0339-x; Bookstein F. L., 1985, MORPHOMETRICS EVOLUT; Bower LM, 2015, J FISH BIOL, V87, P691, DOI 10.1111/jfb.12752; Davidian M., 1995, NONLINEAR MODELS REP; Dornburg A, 2011, EVOLUTION, V65, P1912, DOI 10.1111/j.1558-5646.2011.01275.x; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Fruciano C., GEOMETRICMORPHOMETRI; Fruciano C, 2017, ECOL EVOL, V7, P7034, DOI 10.1002/ece3.3256; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Greszkiewicz M, 2018, N AM J FISH MANAGE, V38, P601, DOI 10.1002/nafm.10059; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; Hyndes GA, 1997, MAR BIOL, V128, P585, DOI 10.1007/s002270050125; Jakubcinova K, 2017, J FISH BIOL, V90, P1999, DOI 10.1111/jfb.13283; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Larochelle CR, 2016, COPEIA, V104, P411, DOI 10.1643/CG-15-303; LEE JC, 1982, SYST ZOOL, V31, P266, DOI 10.2307/2413232; LESLIE JK, 1986, CAN J FISH AQUAT SCI, V43, P1079, DOI 10.1139/f86-136; Martinez PA, 2013, ZOOMORPHOLOGY, V132, P87, DOI 10.1007/s00435-012-0176-x; Moku M, 2004, COPEIA, P647, DOI 10.1643/CI-03-113R; Moody EK, 2018, J EVOLUTION BIOL, V31, P491, DOI 10.1111/jeb.13226; Parsons KJ, 2003, ENVIRON BIOL FISH, V67, P417, DOI 10.1023/A:1025895317253; Pease JE, 2018, ECOLOGY EVOLUTION; Peres-Neto PR, 2004, OECOLOGIA, V140, P352, DOI 10.1007/s00442-004-1578-3; Pinheiro J., 2021, NLME LINEAR NONLINEA; R Core Team, 2018, R LANG ENV STAT COMP; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2006, TPSDIG VER 2 1; Rohlf FJ, 2008, TPSUTIL VER 1 40; Shields Patrick A., 1996, Alaska Fishery Research Bulletin, V3, P81; Sidlauskas BL, 2011, ZOOL J LINN SOC-LOND, V162, P103, DOI 10.1111/j.1096-3642.2010.00677.x; Souissi A, 2017, ECOL EVOL, V7, P1394, DOI 10.1002/ece3.2533; STRAUSS RE, 1982, SYST ZOOL, V31, P113, DOI 10.2307/2413032; Vajargah Mohammad Forouhar, 2015, Journal of Coastal Life Medicine, V3, P518; Valentin AE, 2008, J FISH BIOL, V73, P623, DOI 10.1111/j.1095-8649.2008.01961.x; Vervust B, 2009, AMPHIBIA-REPTILIA, V30, P321, DOI 10.1163/156853809788795209; Wilke HJ, 1996, J BIOMECH, V29, P1629, DOI 10.1016/S0021-9290(96)80016-9; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	45	17	17	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213915	10.1371/journal.pone.0213915	http://dx.doi.org/10.1371/journal.pone.0213915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897173	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700046
J	Yahya, N; Sukiman, NK; Suhaimi, NA; Azmi, NA; Manan, HA				Yahya, Noorazrul; Sukiman, Nur Khalis; Suhaimi, Nani Adilah; Azmi, Nor Aniza; Manan, Hanani A.			How many roads must a Malaysian walk down? Mapping the accessibility of radiotherapy facilities in Malaysia	PLOS ONE			English	Article							RADIATION-THERAPY; TRAVEL DISTANCE; CANCER-PATIENTS; EXPERIENCE; COUNTRIES; RECEIPT; ACCESS	Background The accessibility to radiotherapy facilities may affect the willingness to undergo treatment. We sought to quantify the distance and travel time of Malaysian population to the closest radiotherapy centre and to estimate the megavoltage unit (MV)/million population based on the regions. Materials & methods Data for subdistricts in Malaysia and radiotherapy services were extracted from Department of Statistics Malaysia and Directory of Radiotherapy Centres (DIRAC). Data from DIRAC were validated by direct communication with centres. Locations of radiotherapy centres, distance and travel time to the nearest radiotherapy were estimated using web mapping service, Google Map. Results The average distance and travel time from Malaysian population to the closest radiotherapy centre were 82.5km and 83.4mins, respectively. The average distance and travel were not homogenous; East Malaysia (228.1km, 236.1mins), Central (14.4km, 20.1mins), East Coast (124.2km, 108.8mins), Northern (42.9km, 42.8mins) and Southern (36.0km, 39.8mins). The MV/million population for the country is 2.47, East Malaysia (1.76), Central (4.19), East Coast (0.54), Northern (2.40), Southern (2.36). About 25% of the population needs to travel > 100 km to get to the closest radiotherapy facility. Conclusion On average, Malaysians need to travel far and long to reach radiotherapy facilities. The accessibility to radiotherapy facilities is not equitable. The disparity may be reduced by adding centres in East Malaysia and the East Coast.	[Yahya, Noorazrul; Sukiman, Nur Khalis; Suhaimi, Nani Adilah; Azmi, Nor Aniza] Natl Univ Malaysia, Fac Hlth Sci, Diagnost Imaging & Radiotherapy Programme, Kuala Lumpur, Malaysia; [Manan, Hanani A.] Natl Univ Malaysia, Dept Radiol, Fac Med, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Yahya, N (corresponding author), Natl Univ Malaysia, Fac Hlth Sci, Diagnost Imaging & Radiotherapy Programme, Kuala Lumpur, Malaysia.	azrulyahya@ukm.edu.my	Yahya, Noorazrul/N-9436-2016	Yahya, Noorazrul/0000-0002-2736-6489; AZMI, NOR ANIZA/0000-0002-6825-2381	National University of Malaysia [GGPM-2017-095]	National University of Malaysia	This work was supported by the National University of Malaysia, GGPM-2017-095 (ukm.edu.my) to NY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MFIL, 2015, PSYCHO-ONCOLOGY, V24, P894, DOI 10.1002/pon.3740; Ambroggi M, 2015, ONCOLOGIST, V20, P1378, DOI 10.1634/theoncologist.2015-0110; Arenas M, 2015, REP PRACT ONCOL RADI, V20, P141, DOI 10.1016/j.rpor.2014.10.008; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Birch EM, 2018, ASIA-PAC J CLIN ONCO, V14, pe505, DOI 10.1111/ajco.12873; Bishr MK, 2018, INT J RADIAT ONCOL, V102, P490, DOI 10.1016/j.ijrobp.2018.06.046; Chan CMH, 2018, CANCER-AM CANCER SOC, V124, P406, DOI 10.1002/cncr.30980; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Collins IM, 2018, ASIA-PAC J CLIN ONCO, V14, pe224, DOI 10.1111/ajco.12828; Department of Statistics Malaysia, REP HOUS INC BAS AM; Edib Z, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0428-4; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gabriel G, 2015, RADIOTHER ONCOL, V117, P386, DOI 10.1016/j.radonc.2015.07.031; Grau C, 2014, RADIOTHER ONCOL, V112, P155, DOI 10.1016/j.radonc.2014.08.029; Hegney D, 2005, EUR J CANCER CARE, V14, P75, DOI 10.1111/j.1365-2354.2005.00525.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ke KM, 2012, EUR J CANCER CARE, V21, P158, DOI 10.1111/j.1365-2354.2011.01323.x; Lim GCC, 2002, JPN J CLIN ONCOL, V32, pS37, DOI 10.1093/jjco/hye132; Lin CC, 2015, J CLIN ONCOL, V33, P3177, DOI 10.1200/JCO.2015.61.1558; Mackillop WJ, 1997, J CLIN ONCOL, V15, P1261, DOI 10.1200/JCO.1997.15.3.1261; Rasid N, 2018, ADV SCI LETT, V24, P1562, DOI 10.1166/asl.2018.11109; Rosenblatt E, 2015, RADIOTHER ONCOL, V116, P35, DOI 10.1016/j.radonc.2015.06.012; Santibanez P, 2014, INT J RADIAT ONCOL, V89, P745, DOI 10.1016/j.ijrobp.2014.04.011; Sharma DK, 2016, RURAL REMOTE HEALTH, V16; Soo J, 2011, J RADIOTHER PRACT, V10, P159, DOI 10.1017/S1460396910000348; Stoker SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085959; Sundaresan P, 2017, ASIA-PAC J CLIN ONCO, V13, pE489, DOI 10.1111/ajco.12579; Tin ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153206; Wong LC, 2010, ASIA-PAC J CLIN ONCO, V6, P357, DOI 10.1111/j.1743-7563.2010.01296.x; Yahya N, 2018, ASIA-PAC J CLIN ONCO, V14, pe543, DOI 10.1111/ajco.12831; Yap ML, 2017, CLIN ONCOL-UK, V29, P72, DOI 10.1016/j.clon.2016.11.003	31	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213583	10.1371/journal.pone.0213583	http://dx.doi.org/10.1371/journal.pone.0213583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897166	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700026
J	Ciccarese, S; Carlucci, R; Ciani, E; Corcella, E; Cosentino, A; Fanizza, C; Linguiti, G; Antonacci, R				Ciccarese, Salvatrice; Carlucci, Roberto; Ciani, Elena; Corcella, Eleonora; Cosentino, Annalisa; Fanizza, Carmelo; Linguiti, Giovanna; Antonacci, Rachele			Cytochrome b marker reveals an independent lineage of Stenella coeruleoalba in the Gulf of Taranto	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; WESTERN MEDITERRANEAN SEA; NORTHERN IONIAN SEA; STRIPED DOLPHIN; TURSIOPS-TRUNCATUS; MITOCHONDRIAL-DNA; HABITAT USE; WATERS; PREFERENCES; CETACEANS	Heterogeneity in geomorphological and hydrographical conditions throughout the Mediterranean Sea could be the driving factors behind the significant differences between putative sub-populations, although the existence of a large panmictic population of striped dolphin Stenella coeruleoalba (Meyen 1833) in this marine region could not be excluded. However, understanding the ecological implications of such genetic differentiation is difficult, as inferences about gene flow are usually made on evolutionary time scales and not along the ecological time frame over which most management and conservation practices are applied. In fact, as stated by the IUCN Red List, in the case of species assessed as vulnerable, the degree of genetic exchange between populations within a biogeographic region and its ecological implications represent a fascinating challenge that should be very deeply explored. This is even more significant in the Gulf of Taranto (Northern Ionian Sea, Central-eastern Mediterranean Sea), where the geomorphological and hydrographic characteristics support the hypothesis of a separated striped dolphin population genetically diverging from its original Mediterranean counterpart. To assess this hypothesis, a genetic analysis was carried out on DNA fragments of the mitochondrial cyt b gene to explore the evolutionary origin of S. coeruleoalba in the investigated area and its genetic diversity in comparison with available sequences from other Mediterranean and Atlantic populations. Results were discussed indicating ecological implications and suggesting conservation objectives. Moreover, a delphinid systematic was also suggested.	[Ciccarese, Salvatrice; Carlucci, Roberto; Corcella, Eleonora; Cosentino, Annalisa; Linguiti, Giovanna; Antonacci, Rachele] Univ Bari Aldo Moro, Sez Genet & Biol Anim & Ambientale, Dipartimento Biol, Bari, Italy; [Ciani, Elena] Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, Bari, Italy; [Fanizza, Carmelo] Ionian Dolphin Conservat, Taranto, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Ciccarese, S; Antonacci, R (corresponding author), Univ Bari Aldo Moro, Sez Genet & Biol Anim & Ambientale, Dipartimento Biol, Bari, Italy.	salvatricemaria.ciccarese@uniba.it; rachele.antonacci@uniba.it	Carlucci, Roberto/ABC-7196-2020; Antonacci, Rachele/C-5635-2013; Ciccarese, Salvatrice/G-7801-2015; Carlucci, Roberto/C-5728-2009; Ciccarese, Salvatrice/AAD-7676-2019	Carlucci, Roberto/0000-0002-9287-6936; Antonacci, Rachele/0000-0002-5601-1118; Ciccarese, Salvatrice/0000-0003-3208-0730; Ciccarese, Salvatrice/0000-0003-3208-0730; ciani, elena/0000-0001-5673-0975	University of Bari; Apulian Universities [XXVI Cycle]	University of Bari; Apulian Universities	The financial support of the University of Bari is gratefully acknowledged: Fondi di Ateneo ex 60% (http://www.uniba.it, S. C. and R. A.). The authors also thank P. O. R. Puglia for Scholarships for attendance of Ph. D courses activated by Apulian Universities, Award Number: XXVI Cycle (G. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083645; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; [Anonymous], [No title captured]; Archer Frederick I. II, 1999, Mammalian Species, V603, P1; Azzellino A, 2008, DEEP-SEA RES PT I, V55, P296, DOI 10.1016/j.dsr.2007.11.006; Bakun A, 2001, SCI MAR, V65, P243, DOI 10.3989/scimar.2001.65n3243; Barnes L.G., 1990, P3; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birkun  Jr A, 2010, CONSERVING WHALES DO; Capezzuto F, 2010, CHEM ECOL, V26, P199, DOI 10.1080/02757541003639188; Carlucci R, 2017, AQUAT CONSERV, V28, P1; Carlucci R, 2018, ESTUAR COAST SHELF S, V204, P177, DOI 10.1016/j.ecss.2018.02.034; Carlucci R, 2016, ECOL INDIC, V69, P707, DOI 10.1016/j.ecolind.2016.05.035; Cosentino A., 2015, Biologia Marina Mediterranea, V22, P271; Cotte Cedric, 2010, Endangered Species Research, V12, P203, DOI 10.3354/esr00301; Dawkins R., 2004, ANCESTORS TALE PILGR; Duras M, 2016, MAR MAMMAL SCI, V32, P945, DOI 10.1111/mms.12305; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Farro APC, 2008, CONSERV GENET, V9, P1319, DOI 10.1007/s10592-007-9474-0; Gannier A, 2005, REV ECOL-TERRE VIE, V60, P223; Garcia-Martinez J, 1999, MOL ECOL, V8, P1069, DOI 10.1046/j.1365-294x.1999.00672.x; Gaspari S, 2007, MOL ECOL, V16, P2922, DOI 10.1111/j.1365-294X.2007.03295.x; Gaspari S, 2015, EVOL BIOL, V42, P177, DOI 10.1007/s11692-015-9309-8; Harris PT, 2011, MAR GEOL, V285, P69, DOI 10.1016/j.margeo.2011.05.008; Kerem D., 2012, Open Marine Biology Journal, V6, P6; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Linguiti G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2841-9; Matarrese R, 2011, ITAL J REMOTE SENS, V43, P39, DOI 10.5721/ItJRS20114333; Nei M., 2000, MOL EVOLUTION PHYLOG; Palumbi SR, 2003, ECOL APPL, V13, pS146; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Pescatore T., 1986, INT ASS SEDIMENTOLOG, V8, P169, DOI DOI 10.1002/9781444303810.CH8; Politi E, 2001, EVIDENCE RAREFACTION, V15; Rossi S., 1978, B SOC GEOL ITAL, V97, P423; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Spitz J, 2006, J SEA RES, V55, P309, DOI 10.1016/j.seares.2006.02.001; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanhua T, 2013, OCEAN SCI, V9, P789, DOI 10.5194/os-9-789-2013; Tiscar S., 2002, DEEP-SEA RES PT 1, V49, P2933, DOI [10.1111/J.1365-294X.2007.03295.x, DOI 10.1111/J.1365-294X.2007.03295.X]; Valsecchi E, 2004, ANIM CONSERV, V7, P139, DOI 10.1017/S1367943004001325; Waples KA, 2002, ZOO BIOL, V21, P5, DOI 10.1002/zoo.10004; Wursig B, 2017, ENCY MARINE MAMMALS, DOI [10.1186/S12864-016-2841-9, DOI 10.1186/S12864-016-2841-9]	45	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213826	10.1371/journal.pone.0213826	http://dx.doi.org/10.1371/journal.pone.0213826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893376	gold, Green Submitted, Green Published			2022-12-26	WOS:000461765900052
J	Lima-Rezende, CA; Rocha, AV; Couto, AF; Martins, ED; Vasconcelos, V; Caparroz, R				Lima-Rezende, Cassia Alves; Rocha, Amanda Vaz; Couto Junior, Antonio Felipe; Martins, Eder de Souza; Vasconcelos, Vinicius; Caparroz, Renato			Late Pleistocene climatic changes promoted demographic expansion and population reconnection of a Neotropical savanna-adapted bird, Neothraupis fasciata (Aves: Thraupidae)	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; BIODIVERSITY HOTSPOTS; DISTANCE; DIVERSIFICATION; EVOLUTION; PATTERNS; SYSTEM; PHYLOGEOGRAPHY; CONSERVATION; VEGETATION	We performed phylogeographic and genetic structure analyses of Neothraupis fasciata joined with species distribution modelling to evaluate whether: (1) the distribution of genetic variability shows a pattern expected by the isolation-by-distance model; (2) the influence of the Pleistocene climate changes on species distribution; and (3) climate/climatic stability (hypothesis of climatic stability) as a predictor of population genetic diversity. Based on two molecular datasets (ND2 and FIB-5), the isolation-by-distance hypothesis was not supported. The mitochondrial haplotype network indicated the existence of historically isolated populations at the southern range of the species distribution, and recent population expansion was identified by both neutrality tests and extended Bayesian skyline plot analysis. Thus, the climatic changes during the Pleistocene might have promoted the reconnection of the partially isolated southern populations, which may have persisted in the plateaus during the cycles of savanna contractions. Subsequently, this species (re) colonized northern areas of the species present distribution, following the continuous vegetation on the Sao Francisco and Central plateaus about 60 kyr, and also reached the Amazonian savannas likely via the central corridor. Thus, our results indicated that the intrinsic relationship between the relief heterogeneity (plateaus and depressions) and the climatic fluctuations, mainly in the Pleistocene, promoted population reconnection and demographic expansion of N. fasciata.	[Lima-Rezende, Cassia Alves; Rocha, Amanda Vaz; Caparroz, Renato] Univ Brasilia, Dept Genet & Morfol IB, Lab Genet & Biodiversidade, Brasilia, DF, Brazil; [Couto Junior, Antonio Felipe] Univ Brasilia, Fac UnB Planaltina, Planaltina, DF, Brazil; [Martins, Eder de Souza] Embrapa Cerrados, Planaltina, DF, Brazil; [Vasconcelos, Vinicius] Univ Brasilia, Dept Ecol IB, Lab Solos & Vegetacao, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia	Lima-Rezende, CA (corresponding author), Univ Brasilia, Dept Genet & Morfol IB, Lab Genet & Biodiversidade, Brasilia, DF, Brazil.	calimarezende@gmail.com	Junior, Antonio Felipe Couto/V-5619-2019; Lima‑Rezende, Cássia/AAF-7555-2019	Junior, Antonio Felipe Couto/0000-0003-3805-0540; Lima‑Rezende, Cássia/0000-0001-7615-7635; Vasconcelos, Vinicius/0000-0002-2396-8597	GENPAC - Geographical Genetics and Regional Planning for Natural Resources in Brazilian Cerrado (MCT/CNPq/FNDCT/FAPs/MEC/CAPES/PRO-CENTRO-OESTE) [031/2010, 564036/2010-2]; CNPq [14/2014, 445025/2014-0, 142456/2015-2, 234515/2014-7, 140702/2013-0]; PPBio - Rede Cerrado (CNPq) [35/2012, 457444/2012-6]; CAPES [23038.001614/2016-52]; CAPES; Fundacao de Amparo a Pesquisa do Distrito Federal	GENPAC - Geographical Genetics and Regional Planning for Natural Resources in Brazilian Cerrado (MCT/CNPq/FNDCT/FAPs/MEC/CAPES/PRO-CENTRO-OESTE); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PPBio - Rede Cerrado (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Distrito Federal(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This study is part of the GENPAC - Geographical Genetics and Regional Planning for Natural Resources in Brazilian Cerrado (MCT/CNPq/FNDCT/FAPs/MEC/CAPES/PRO-CENTRO-OESTE No 031/2010 - Proc. 564036/2010-2), and it was also supported by CNPq No 14/2014 (Proc. 445025/2014-0), PPBio - Rede Cerrado (CNPq No 35/2012 - Proc. 457444/2012-6). AVR received scholarship from CNPq (#142456/2015-2) and CAPES (#23038.001614/2016-52) and CAL-R is grateful for scholarship from CNPq (#234515/2014-7 and #140702/2013-0) and for postdoctoral fellowship from CAPES. CAL-R is also grateful for the grant from the Fundacao de Amparo a Pesquisa do Distrito Federal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Ab'Saber AN.., 1983, REV SERVIDOR PUBLICO, V111, P41; AbSaber A., 2003, DOMI NIOS NATUREZA B; Alves Maria Alice S., 1991, Ararajuba, V2, P25; ALVES MAS, 1990, CONDOR, V92, P470, DOI 10.2307/1368243; [Anonymous], 1970, REV BRASILEIRA GEOGR; Axelsson E, 2004, MOL BIOL EVOL, V21, P1538, DOI 10.1093/molbev/msh157; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bennett KD, 2004, PHILOS T R SOC B, V359, P295, DOI 10.1098/rstb.2003.1395; Bigarella JJ, 1975, S INT QUART, P1013, DOI [10.1073/pnas.1513062113, DOI 10.1073/PNAS.1513062113]; Birdlife International NatureServe, 2014, IUCN RED LIST THREAT; Bruford Michael W., 1992, P225; Bueno ML, 2017, ECOGRAPHY, V40, P403, DOI 10.1111/ecog.01860; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Burns KJ, 2014, MOL PHYLOGENET EVOL, V75, P41, DOI 10.1016/j.ympev.2014.02.006; Buzatti RSO, 2018, FRONT PLANT SCI, V9, P1, DOI [10.3389/fpls.2018.00001, DOI 10.3389/FPLS.2018.00001]; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Castric V, 2003, GENETICS, V163, P983; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Cohen K.M., 2016, GLOBAL CHRONOSTRATIG; Colli G.R., 2005, CERRADO ECOLOGIA BIO, P247; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Crispo E, 2005, CONSERV GENET, V6, P665, DOI 10.1007/s10592-005-9026-4; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; Buzatti RSD, 2017, BOT J LINN SOC, V185, P307, DOI 10.1093/botlinnean/box062; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duca C, 2014, AUK, V131, P32, DOI 10.1642/AUK-13-005.1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FORGY EW, 1965, BIOMETRICS, V21, P768; Fu YX, 1997, GENETICS, V147, P915; Gillespie RG, 2014, NATURE, V509, P297, DOI 10.1038/509297a; Haffer J., 2002, Estud. av., V16, P175, DOI 10.1590/S0103-40142002000300014; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1967, Hornero, V10, P315; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilty S., 2017, HDB BIRDS WORLD ALIV; Jenkins DG, 2010, ECOGRAPHY, V33, P315, DOI 10.1111/j.1600-0587.2010.06285.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; King L.C., 1956, REV BRASILEIRA GEOGR, V18, P147; King L.C., 1956, Q J GEOL SOC, V112, P445, DOI DOI 10.1144/GSL.JGS.1956.112.01-04.22; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leite YLR, 2016, P NATL ACAD SCI USA, V113, P1008, DOI 10.1073/pnas.1513062113; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lima-Rezende CA, 2019, BIOTROPICA, V51, P234, DOI 10.1111/btp.12623; LINK C. A., 2005, MEGADIVERSIDADE, V1, P147, DOI DOI 10.1590/S0100-69912009000400001; Manica LT, 2012, J ORNITHOL, V153, P149, DOI 10.1007/s10336-011-0718-x; Marchese C, 2015, GLOB ECOL CONSERV, V3, P297, DOI 10.1016/j.gecco.2014.12.008; Marini MA, 2002, AUK, V119, P1114, DOI 10.1642/0004-8038(2002)119[1114:AMATTC]2.0.CO;2; Mayle FE, 2004, PALAEOGEOGR PALAEOCL, V214, P11, DOI 10.1016/j.palaeo.2004.06.016; Merila J, 1997, EVOLUTION, V51, P946, DOI 10.1111/j.1558-5646.1997.tb03675.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Rambaut A., 2013, TRACER; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ribas CC, 2005, J BIOGEOGR, V32, P1409, DOI 10.1111/j.1365-2699.2005.01289.x; Ribeiro V, 2016, AUSTRAL ECOL, V41, P768, DOI 10.1111/aec.12363; Ridgely R.S., 1989, BIRDS S AM, VI; Riitters K, 2000, CONSERV ECOL, V4, DOI 10.5751/ES-00209-040203; Riitters KH, 2002, ECOSYSTEMS, V5, P815, DOI 10.1007/s10021-002-0209-2; RUBIN J, 1967, J THEOR BIOL, V15, P103, DOI 10.1016/0022-5193(67)90046-X; Santos MG, 2014, J BIOGEOGR, V41, P1506, DOI 10.1111/jbi.12291; Sick H., 2001, ORNITOLOGIA BRASILEI, V3; Silva Jose Maria Cardoso Da, 1995, Steenstrupia, V21, P49; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; TAJIMA F, 1989, GENETICS, V123, P585; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Van Andel TH, 1985, NEW VIEWS OLD PLANET; WEBB SD, 1978, ANNU REV ECOL SYST, V9, P393, DOI 10.1146/annurev.es.09.110178.002141; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Wright S, 1943, GENETICS, V28, P114	84	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0212876	10.1371/journal.pone.0212876	http://dx.doi.org/10.1371/journal.pone.0212876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893330	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900019
J	Prevedello, JA; Winck, GR; Weber, MM; Nichols, E; Sinervo, B				Prevedello, Jayme A.; Winck, Gisele R.; Weber, Marcelo M.; Nichols, Elizabeth; Sinervo, Barry			Impacts of forestation and deforestation on local temperature across the globe	PLOS ONE			English	Article							CLIMATE-CHANGE; AFFORESTATION; AREA; MICROCLIMATE; BENEFITS; ALBEDO; SHIFTS; COVER; LIFE; MAP	Changing forest cover is a key driver of local climate change worldwide, as it affects both albedo and evapotranspiration (ET). Deforestation and forestation are predicted to have opposing influences on surface albedo and ET rates, and thus impact local surface temperatures differently. Relationships between forest change, albedo, ET, and local temperatures may further vary regionally, as the strengths of warming by albedo effects and cooling by ET effects vary with latitude. Despite these important relationships, the magnitude of forest cover effects on local surface temperature across the globe remains unclear. Using recently-released global forest change data, we first show that forestation and deforestation have pervasive and opposite effects on LST, ET and albedo worldwide. Deforestation from 2000 to 2010 caused consistent warming of 0.38 +/- 0.02 (mean +/- SE) and 0.16 +/- 0.01 degrees C in tropical and temperate regions respectively, while forestation caused cooling in those regions of -0.18 +/- 0.02 and -0.19 +/- 0.02 degrees C. Tropical forests were particularly sensitive to the climate effects of forest change, with forest cover losses of similar to 50% associated with increased LST of 1.08 +/- 0.25 degrees C, whereas similar forest cover gains decreased LST by -1.11 +/- 0.26 degrees C. Secondly, based on a new structural equation model, we show that these changes on LST were largely mediated by changes in albedo and ET. Finally, based on this model, we show that predicted forest changes in Brazil associated with a business-as-usual land use scenario through 2050 may increase LST up to 1.45 degrees C. Our results contribute to a better understanding of the mechanistic inter-relationships between forest change and changes in albedo, ET and LST, and provide additional evidence that forestation has the potential to reverse deforestation impacts on local climate, especially in tropical and temperate regions.	[Prevedello, Jayme A.] Univ Estado Rio De Janeiro, Inst Biol Roberto A Gomes, Dept Ecol, Rio De Janeiro, RJ, Brazil; [Winck, Gisele R.; Weber, Marcelo M.] Univ Fed Rio de Janeiro, Inst Biol, Dept Ecol, Rio De Janeiro, RJ, Brazil; [Nichols, Elizabeth] Swarthmore Coll, Biol Dept, Swarthmore, PA 19081 USA; [Nichols, Elizabeth] Univ Sao Paulo, Inst Biol, Dept Ecol, Sao Paulo, SP, Brazil; [Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Sinervo, Barry] Univ Calif Santa Cruz, Inst Ecol & Evolutionary Study Climate Impacts, Santa Cruz, CA 95064 USA; [Winck, Gisele R.] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine, UMR 5553, Grenoble, France	Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Swarthmore College; Universidade de Sao Paulo; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Prevedello, JA (corresponding author), Univ Estado Rio De Janeiro, Inst Biol Roberto A Gomes, Dept Ecol, Rio De Janeiro, RJ, Brazil.	ja_prevedello@yahoo.com.br	Winck, Gisele/A-4148-2012; Prevedello, Jayme/A-2776-2013	Winck, Gisele/0000-0002-6876-4803; Prevedello, Jayme/0000-0003-1184-2337	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/010.002334/2016, E-26/010.000398/2016]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [424061/2016-3]; CNPq [151984/2016-6, 381247/2017-1, 206876/2017-3]; Programa Nacional de Pos-Doutorado from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD/CAPES) [1594913]; Emerging Frontiers grant from NSF [EF-1241848]; Pesquisador Visitante Especial (PVE) scholarship from CNPq	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Nacional de Pos-Doutorado from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD/CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Emerging Frontiers grant from NSF; Pesquisador Visitante Especial (PVE) scholarship from CNPq	JAP was supported by grants from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (processes n. E-26/010.002334/2016 and E-26/010.000398/2016) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; process n. 424061/2016-3); GRW received a post-doctoral fellowship and a technical grant (INCT/DTI-B) from CNPq (processes n. 151984/2016-6, 381247/2017-1), and currently receives a post-doctoral fellowship grant from CNPq (process n. 206876/2017-3); MMW received a post-doctoral fellowship grant from Programa Nacional de Pos-Doutorado from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD/CAPES, process number 1594913). BS was supported by an Emerging Frontiers grant from NSF (EF-1241848) and a Pesquisador Visitante Especial (PVE) scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkama R, 2016, SCIENCE, V351, P600, DOI 10.1126/science.aac8083; Anderson RG, 2011, FRONT ECOL ENVIRON, V9, P174, DOI 10.1890/090179; [Anonymous], 2017, NASA EOSDIS LAND PRO, DOI [10.5067/modis/mod16a3.006, DOI 10.5067/MODIS/MOD16A3.006]; Arora VK, 2011, NAT GEOSCI, V4, P514, DOI [10.1038/ngeo1182, 10.1038/NGEO1182]; Barton K., 2016, MUMIN MULTIMODEL INF; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bright RM, 2017, NAT CLIM CHANGE, V7, P296, DOI [10.1038/NCLIMATE3250, 10.1038/nclimate3250]; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chiang JCH, 2012, ANNU REV EARTH PL SC, V40, P383, DOI [10.1146/annurev-earth-042711-185545, 10.1146/annurev-earth-042711-105545]; d'Annunzio R, 2015, FOREST ECOL MANAG, V352, P124, DOI 10.1016/j.foreco.2015.03.014; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Duveiller G, 2018, EARTH SYST SCI DATA, V10, P1265, DOI 10.5194/essd-10-1265-2018; Ellison D, 2017, GLOBAL ENVIRON CHANG, V43, P51, DOI 10.1016/j.gloenvcha.2017.01.002; FAO (Food and agriculture organization of the United Nations), 2016, STAT WORLDS FOR 2016; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hardwick SR, 2015, AGR FOREST METEOROL, V201, P187, DOI 10.1016/j.agrformet.2014.11.010; Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5; Hsiang S, 2017, SCIENCE, V356, P1362, DOI 10.1126/science.aal4369; Jackson CS, 2008, J CLIMATE, V21, P6698, DOI 10.1175/2008JCLI2112.1; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lee X, 2011, NATURE, V479, P384, DOI 10.1038/nature10588; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Li Y, 2016, J GEOPHYS RES-ATMOS, V121, P14372, DOI 10.1002/2016JD024969; Li Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7603; Liu NF, 2013, HYDROL EARTH SYST SC, V17, P2121, DOI 10.5194/hess-17-2121-2013; Liu Q, 2013, INT J DIGIT EARTH, V6, P69, DOI 10.1080/17538947.2013.804601; Luskin MS, 2011, BASIC APPL ECOL, V12, P540, DOI 10.1016/j.baae.2011.06.004; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Payn T, 2015, FOREST ECOL MANAG, V352, P57, DOI 10.1016/j.foreco.2015.06.021; Peng SS, 2014, P NATL ACAD SCI USA, V111, P2915, DOI 10.1073/pnas.1315126111; Pinheiro J., 2017, NLME LINEAR NONLINEA; R Core Team, 2020, R LANG ENV STAT COMP; REDD-PAC Project, 2015, MOD LAND US CHANG BR; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Running S., 2017, NASA, DOI [10.5067/MODIS/MOD16A3.006, DOI 10.5067/MODIS/MOD16A3GF.061]; Schultz NM, 2017, J GEOPHYS RES-BIOGEO, V122, P903, DOI 10.1002/2016JG003653; Senior RA, 2017, ECOL EVOL, V7, P7897, DOI 10.1002/ece3.3262; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Suding K, 2015, SCIENCE, V348, P638, DOI 10.1126/science.aaa4216; Swann ALS, 2012, P NATL ACAD SCI USA, V109, P712, DOI 10.1073/pnas.1116706108; Tropek R, 2014, SCIENCE, V344, DOI 10.1126/science.1248753; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Warren R, 2018, CLIMATIC CHANGE, V147, P395, DOI 10.1007/s10584-018-2158-6; Wohl E, 2012, NAT CLIM CHANGE, V2, P655, DOI [10.1038/NCLIMATE1556, 10.1038/nclimate1556]; Wolff NH, 2018, GLOBAL ENVIRON CHANG, V52, P181, DOI 10.1016/j.gloenvcha.2018.07.004; Zuur Alain F., 2009, P1	56	45	47	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213368	10.1371/journal.pone.0213368	http://dx.doi.org/10.1371/journal.pone.0213368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893352	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900040
J	Grabowska, M; Grzeskowiak, BF; Szutkowski, K; Wawrzyniak, D; Glodowicz, P; Barciszewski, J; Jurga, S; Rolle, K; Mrowczynski, R				Grabowska, Malgorzata; Grzeskowiak, Bartosz F.; Szutkowski, Kosma; Wawrzyniak, Dariusz; Glodowicz, Pawel; Barciszewski, Jan; Jurga, Stefan; Rolle, Katarzyna; Mrowczynski, Radoslaw			Nano-mediated delivery of double-stranded RNA for gene therapy of glioblastoma multiforme	PLOS ONE			English	Article							DRUG-DELIVERY; BRAIN-TUMOR; NANOPARTICLES; INTERFERENCE; ACTIVATION; GLIOMA	Glioblastoma multiforme (GBM) is the most common type of malignant gliomas, characterized by genetic instability, intratumoral histopathological variability and unpredictable clinical behavior. Disappointing results in the treatment of gliomas with surgery, radiation and chemotherapy have fueled a search for new therapeutic targets and treatment modalities. Here we report new approach towards RNA interference therapy of glioblastoma multiforme based on the magnetic nanoparticles delivery of the double-stranded RNA (dsRNA) with homological sequences to mRNA of tenascin-C (TN-C), named ATN-RNA. The obtained nanocomposite consisted of polyethyleneimine (PEI) coated magnetic nanoparticles conjugated to the dsRNA show high efficiency in ATN-RNA delivery, resulting not only in significant TN-C expression level suppressesion, but also impairing the tumor cells migration. Moreover, synthesized nanomaterials show high contrast properties in magnetic resonance imaging (MRI) and low cytotoxicity combining with lack of induction of interferon response. We believe that the present work is a successful combination of effective, functional, non-immunostimulatory dsRNA delivery system based on magnetic nanoparticles with high potential for further application in GBM therapy.	[Grabowska, Malgorzata; Wawrzyniak, Dariusz; Glodowicz, Pawel; Rolle, Katarzyna] Polish Acad Sci, Inst Bioorgan Chem, Dept Mol Neurooncol, Poznan, Poland; [Grzeskowiak, Bartosz F.; Szutkowski, Kosma; Jurga, Stefan; Mrowczynski, Radoslaw] Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland; [Barciszewski, Jan] Polish Acad Sci, Inst Bioorgan Chem, Dept Epigenet, Poznan, Poland; [Rolle, Katarzyna] Ctr Adv Technol, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Rolle, K (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Dept Mol Neurooncol, Poznan, Poland.; Mrowczynski, R (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland.; Rolle, K (corresponding author), Ctr Adv Technol, Poznan, Poland.	kbug@man.poznan.pl; radoslaw.mrowczynski@amu.edu.pl	Mrówczyński, Radosław/G-6096-2017; Grabowska, Małgorzata/ABD-9470-2021; Szutkowski, Kosma/M-1541-2019; Jurga, Stefan/E-8862-2017	Mrówczyński, Radosław/0000-0003-3687-911X; Grabowska, Małgorzata/0000-0002-2711-1910; Szutkowski, Kosma/0000-0002-6091-9049; Wawrzyniak, Dariusz/0000-0002-6128-5383; Jurga, Stefan/0000-0002-1665-6077; Grzeskowiak, Bartosz/0000-0003-1563-1262	National Science Centre, Poland [2016/21/B/ST8/00477, 2014/13/D/ST5/02793]; Foundation for Polish Science (FNP)	National Science Centre, Poland(National Science Centre, Poland); Foundation for Polish Science (FNP)(Foundation for Polish Science)	The financial support under project number 2016/21/B/ST8/00477 granted by The National Science Centre, Poland to SJ is kindly acknowledged. The part of MRI studies was performed in the frame of the project number 2014/13/D/ST5/02793 supported by the National Science Centre, Poland to RM. RM is also grateful to the Foundation for Polish Science (FNP) for its support by Stypendium START scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Aigner A, 2018, NANOMEDICINE-UK, V13, P89, DOI 10.2217/nnm-2017-0230; Chertok B, 2011, J CONTROL RELEASE, V155, P393, DOI 10.1016/j.jconrel.2011.06.033; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Flak D, 2017, MAT SCI ENG C-MATER, V78, P1072, DOI 10.1016/j.msec.2017.04.107; Grzeskowiak BF, 2015, PHARM RES-DORDR, V32, P103, DOI 10.1007/s11095-014-1448-6; Jin GR, 2017, DRUG DISCOV TODAY, V22, P1285, DOI 10.1016/j.drudis.2017.08.002; Kariko K, 2004, CELLS TISSUES ORGANS, V177, P132, DOI 10.1159/000079987; Kruser TJ, 2013, EXPERT REV NEUROTHER, V13, P389, DOI [10.1586/ERN.13.7, 10.1586/ern.13.7]; Lam T, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6060100; Lozada-Delgado EL, 2017, LIFE SCI, V188, P26, DOI 10.1016/j.lfs.2017.08.027; Mahmoudi K, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00109; Mannell H, 2012, PHARM RES-DORDR, V29, P1282, DOI 10.1007/s11095-012-0678-8; Mansoori B, 2014, ADV PHARM BULL, V4, P313, DOI 10.5681/apb.2014.046; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Mathupala SP, 2006, TECHNOL CANCER RES T, V5, P261, DOI 10.1177/153303460600500313; Mrowczynski R, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8030170; Mrowczynski R, 2016, RSC ADV, V6, P5936, DOI 10.1039/c5ra24222c; Mrugala MM, 2013, DISCOV MED, V15, P221; Mykhaylyk O, 2007, NAT PROTOC, V2, P2391, DOI 10.1038/nprot.2007.352; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Ortega-Munoz M, 2016, CHEM-ASIAN J, V11, P3365, DOI 10.1002/asia.201600951; Przysiecka L, 2016, COLLOID SURFACE B, V146, P9, DOI 10.1016/j.colsurfb.2016.05.041; Rolle K, 2010, CANCER BIOL THER, V9, P396; Schonberg DL, 2014, MOL ASPECTS MED, V39, P82, DOI 10.1016/j.mam.2013.06.004; Stuplich M, 2012, J CLIN ONCOL, V30, DOI [10.1200/JCO.2011.40.3188, DOI 10.1200/JCO.2011.40.3188]; Tietze R, 2015, BIOCHEM BIOPH RES CO, V468, P463, DOI 10.1016/j.bbrc.2015.08.022; Ulbrich K, 2016, CHEM REV, V116, P5338, DOI 10.1021/acs.chemrev.5b00589; Wang XQ, 2015, RSC ADV, V5, P101569, DOI 10.1039/c5ra18464a; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wilczewska AZ, 2012, PHARMACOL REP, V64, P1020, DOI 10.1016/S1734-1140(12)70901-5; Wozniak-Budych MJ, 2017, J MATER SCI-MATER M, V28, DOI [10.1007/s10856-016-5838-7, DOI 10.1007/S10856-016-5838-7]; Xia SL, 2016, NEURO-ONCOLOGY, V18, P507, DOI 10.1093/neuonc/nov171; Zukiel R, 2006, CANCER BIOL THER, V5, P1002, DOI 10.4161/cbt.5.8.2886	34	25	25	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213852	10.1371/journal.pone.0213852	http://dx.doi.org/10.1371/journal.pone.0213852			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889203	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000035
J	Giezendanner, J; Bertuzzo, E; Pasetto, D; Guisan, A; Rinaldo, A				Giezendanner, Jonathan; Bertuzzo, Enrico; Pasetto, Damiano; Guisan, Antoine; Rinaldo, Andrea			A minimalist model of extinction and range dynamics of virtual mountain species driven by warming temperatures	PLOS ONE			English	Article							CLIMATE-CHANGE; METAPOPULATION CAPACITY; SHIFTS; DIVERSITY; PLANTS; BIODIVERSITY; ELEVATION; RICHNESS; PATTERNS; PREDICT	A longstanding question in ecology concerns the prediction of the fate of mountain species under climate change, where climatic and geomorphic factors but also endogenous species characteristics are jointly expected to control species distributions. A significant step forward would single out reliably landscape effects, given their constraining role and relative ease of theoretical manipulation. Here, we address population dynamics in ecosystems where the substrates for ecological interactions are mountain landscapes subject to climate warming. We use a minimalist model of metapopulation dynamics based on virtual species (i.e. a suitable assemblage of focus species) where dispersal processes interact with the spatial structure of the landscape. Climate warming is subsumed by an upward shift of species habitat altering the metapopulation capacity of the landscape and hence species viability. We find that the landscape structure is a powerful determinant of species survival, owing to the specific role of the predictably evolving connectivity of the various habitats. Range shifts and lags in tracking suitable habitat experienced by virtual species under warming conditions are singled out in different landscapes. The range of parameters is identified for which these virtual species (characterized by comparable viability thus restricting their possible fitnesses and niche widths) prove unable to cope with environmental change. The statistics of the proportion of species bound to survive is identified for each landscape, providing the temporal evolution of species range shifts and the related expected occupation patterns. A baseline dynamic model for predicting species fates in evolving habitats is thus provided.	[Giezendanner, Jonathan; Bertuzzo, Enrico; Pasetto, Damiano; Rinaldo, Andrea] Ecole Polytech Fed Lausanne, Lab Ecohydrol, CH-1015 Lausanne, Switzerland; [Bertuzzo, Enrico] Univ Venice Ca Foscari, Dept Environm Sci Informat & Stat, I-30123 Venice, Italy; [Guisan, Antoine] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Guisan, Antoine] Univ Lausanne, Inst Earth Surface Dynam, CH-1015 Lausanne, Switzerland; [Rinaldo, Andrea] Univ Padua, Dipartimento ICEA, I-35131 Padua, Italy	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universita Ca Foscari Venezia; University of Lausanne; University of Lausanne; University of Padua	Giezendanner, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Ecohydrol, CH-1015 Lausanne, Switzerland.	jonathan.giezendanner@epfl.ch	Guisan, Antoine/A-1057-2011; Pasetto, Damiano/R-3973-2016; Bertuzzo, Enrico/U-7129-2017	Guisan, Antoine/0000-0002-3998-4815; Pasetto, Damiano/0000-0001-6892-9826; Bertuzzo, Enrico/0000-0001-5872-0666; Giezendanner, Jonathan/0000-0001-8809-8513	H2020 European Framework Programme through ECOPOTENTIAL Project [641762]; European Research Council (ERC) [RINEC-227612]; Swiss National Science Foundation projects [200021\_124930/1, 31003A\_135622, PP00P3\_150698]; European Union's Horizon 2020 Research and Innovation Programme [641762]	H2020 European Framework Programme through ECOPOTENTIAL Project; European Research Council (ERC)(European Research Council (ERC)European Commission); Swiss National Science Foundation projects; European Union's Horizon 2020 Research and Innovation Programme	The authors gratefully acknowledge the support provided by the H2020 European Framework Programme through ECOPOTENTIAL Project 641762 (http://www.ecopotential-project.eu/).The results presented here are also in part a spinoff of the European Research Council (ERC) advanced grant programme through the RINEC-227612 project (River networks as ecological corridors for species, populations and pathogens of waterborne disease) and of Swiss National Science Foundation projects 200021\_124930/1, 31003A\_135622 and PP00P3\_150698.; The authors wish to thank Tim Keitt and Paul R. Elsen for insightful comments on previous versions of this manuscript. The authors thank Jonathan Lenoir for the thorough and insightful review provided. This work was supported by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No 641762 (Project: ECOPOTENTIAL: Improving Future Ecosystem Benefits through Earth Observations). AR acknowledges the spinoffs of his European Research Council (ERC) Advanced Grant RINEC-227612.	Alexander JM, 2016, TRENDS ECOL EVOL, V31, P831, DOI 10.1016/j.tree.2016.08.003; Balister P, 2018, P NATL ACAD SCI USA, V115, P6548, DOI 10.1073/pnas.1804484115; Banavar Jr, 2001, J STAT PHYS, V104, P1, DOI 10.1023/A:1010397325029; Barry R.G., 2009, ATMOSPHERE WEATHER C, V1st ed., DOI [10.4324/9780203871027, DOI 10.4324/9780203871027]; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bertuzzo E, 2016, P NATL ACAD SCI USA, V113, P1737, DOI 10.1073/pnas.1518922113; Bertuzzo E, 2015, WATER RESOUR RES, V51, P2696, DOI 10.1002/2015WR016946; Bertuzzo E, 2011, P NATL ACAD SCI USA, V108, P4346, DOI 10.1073/pnas.1017274108; Brown J. H., 1995, MACROECOLOGY; Carrara F, 2012, P NATL ACAD SCI USA, V109, P5761, DOI 10.1073/pnas.1119651109; Carraro L, 2018, FRESHWATER BIOL, V63, P114, DOI 10.1111/fwb.12939; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Economo EP, 2010, OIKOS, V119, P1355, DOI 10.1111/j.1600-0706.2010.18272.x; Elsen P. R., 2015, NATURE CLIMATE CHANG, V5, P5; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Fernandes RF, 2018, DIVERS DISTRIB, P1; Fernandes RF, 2018, ECOL INFORM, V48, P125, DOI 10.1016/j.ecoinf.2018.09.002; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Graae BJ, 2018, PERSPECT PLANT ECOL, V30, P41, DOI 10.1016/j.ppees.2017.09.008; Gu WD, 2002, LANDSCAPE ECOL, V17, P699, DOI 10.1023/A:1022993317717; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2000, INTEGRATED ASSESSMEN, V1, P307, DOI [DOI 10.1023/A:1018912114948, 10.1023/A:1018912114948]; Guisan A., 2017, APPL R; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I., 1999, METAPOPULATION ECOLO; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; Jacob S, 2018, P NATL ACAD SCI USA, V115, P11988, DOI 10.1073/pnas.1805574115; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; MacArthur R.H., 1972, pvii; Marquet PA, 2014, BIOSCIENCE, V64, P701, DOI 10.1093/biosci/biu098; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; Moilanen A, 2004, ECOL MODEL, V179, P533, DOI 10.1016/j.ecolmodel.2004.04.019; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Ovaskainen O, 2001, THEOR POPUL BIOL, V60, P281, DOI 10.1006/tpbi.2001.1548; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V15, P365; Pasetto D, 2018, METHODS ECOL EVOL, V9, P1810, DOI 10.1111/2041-210X.13018; Rinaldo A, 2014, P NATL ACAD SCI USA, V111, P2417, DOI 10.1073/pnas.1322700111; Rodriguez-Iturbe I., 2001, FRACTAL RIVER BASINS; Rumpf SB, 2018, P NATL ACAD SCI USA, V115, P1848, DOI 10.1073/pnas.1713936115; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Seebens H, 2018, P NATL ACAD SCI USA, V115, pE2264, DOI 10.1073/pnas.1719429115; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thibaud E, 2014, METHODS ECOL EVOL, V5, P947, DOI 10.1111/2041-210X.12203; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Wiens John A., 1997, P43, DOI 10.1016/B978-012323445-2/50005-5	61	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213775	10.1371/journal.pone.0213775	http://dx.doi.org/10.1371/journal.pone.0213775			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883574	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500029
J	Zheng, C; Tholen, J; Gurevich, VV				Zheng, Chen; Tholen, Jonas; Gurevich, Vsevolod V.			Critical role of the finger loop in arrestin binding to the receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA-ARRESTIN; VISUAL ARRESTIN; FUNCTIONAL FORMS; RHODOPSIN; SPECIFICITY; ELEMENTS; RESIDUES	We tested the interactions with four different G protein-coupled receptors (GPCRs) of arrestin-3 mutants with substitutions in the four loops, three of which contact the receptor in the structure of the arrestin-1-rhodopsin complex. Point mutations in the loop at the distal tip of the N-domain (Glu157Ala), in the C-loop (Phe255Ala), back loop (Lys313Ala), and one of the mutations in the finger loop (Gly65Pro) had mild variable effects on receptor binding. In contrast, the deletion of Gly65 at the beginning of the finger loop reduced the binding to all GPCRs tested, with the binding to dopamine D2 receptor being affected most dramatically. Thus, the presence of a glycine at the beginning of the finger loop appears to be critical for the arrestin-receptor interaction.	[Zheng, Chen; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Tholen, Jonas] Univ Appl Sci Emden Leer, Emden, Germany	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.	vsevolod.gurevich@vanderbilt.edu		Tholen, Jonas/0000-0002-0789-2692	National Institutes of Health [GM122491]; National Eye Institute [EY011500]; Vanderbilt University, Cornelius Vanderbilt Endowed Chair	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Vanderbilt University, Cornelius Vanderbilt Endowed Chair	Funded by National Institutes of Health, GM122491 (VVG); National Eye Institute, EY011500 (VVG); Vanderbilt University, Cornelius Vanderbilt Endowed Chair (VVG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2016, J BIOL CHEM, V291, P27147, DOI 10.1074/jbc.M116.754887; Anderson KR, 2018, NAT METHODS, V15, P512, DOI 10.1038/s41592-018-0011-5; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chen QY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01218-8; Donthamsetti P, 2015, CURR PROTOC PHARM, V70, p[14, 11]; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gimenez LE, 2014, CELL SIGNAL, V26, P1523, DOI 10.1016/j.cellsig.2014.03.019; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2014, CURR OPIN CELL BIOL, V27, P1, DOI 10.1016/j.ceb.2013.10.007; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Indrischek H, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1001-4; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Peterhans C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28686; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Prokop S, 2017, CELL SIGNAL, V36, P98, DOI 10.1016/j.cellsig.2017.04.021; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Samaranayake S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00203; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Stoy H, 2015, GENES DIS, V2, P108, DOI 10.1016/j.gendis.2015.02.005; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thompson MD, 2014, METHODS MOL BIOL, V1175, P153, DOI 10.1007/978-1-4939-0956-8_8; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	66	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213792	10.1371/journal.pone.0213792	http://dx.doi.org/10.1371/journal.pone.0213792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875392	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400030
J	Garcia-Mazcorro, JF; Pedreschi, R; Yuan, JL; Kawas, JR; Chew, B; Dowd, SE; Noratto, G				Garcia-Mazcorro, Jose F.; Pedreschi, Romina; Yuan, Jialing; Kawas, Jorge R.; Chew, Boon; Dowd, Scot E.; Noratto, Giuliana			Apple consumption is associated with a distinctive microbiota, proteomics and metabolomics profile in the gut of Dawley Sprague rats fed a high-fat diet	PLOS ONE			English	Article							OBESITY; COMMUNITIES; DIVERSITY; PREVENT	Apples contain bioactive compounds with the potential to alleviate clinical signs associated with obesity, a phenomenon likely related to the composition and function of the gut microbiota. The aim of this study was to investigate the effect of apple supplementation on the fecal microbiota and gut metabolites of Dawley Sprague rats fed a high-fat (HF group) or a low-fat (LF group) diet. The fecal microbiota was examined using 16S marker sequencing targeting the V4 region in a MiSeq instrument (Illumina). With the exception of Blautia, which was higher in supplemented rats compared to controls within the LF group, significant differences in fecal microbiota between supplemented rats and controls were only found in the HF group. This suggests that the effect of apple supplementation on the gut microbiota is strongly dependent on the composition of the diet, a phenomenon with potential consequences for obese human patients. Principal Coordinate Analysis of unweighted UniFrac distances revealed a clear strong separation of bacterial communities based on diet (HF and LF, P = 0.001, R = 0.69, ANOSIM test) and based on apple supplementation within the HF group, albeit less strongly (P = 0.006, R = 0.27, ANOSIM test). No differences were found for fecal SCFAs but proteomics and metabolomics analyses showed differential expression of both proteins and metabolites between supplemented rats and controls in the HF group. The results of this study can guide future explorations of the effect of apple supplementation on human health.	[Garcia-Mazcorro, Jose F.] MNA Mexico, Res & Dev, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Garcia-Mazcorro, Jose F.] UANL, Fac Vet Med, Gen Escobedo, Nuevo Leon, Mexico; [Pedreschi, Romina] Pontificia Univ Catolica Valparaiso, Escuela Agron, La Palma, Chile; [Yuan, Jialing; Noratto, Giuliana] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Kawas, Jorge R.] UANL, Fac Agron, Gen Escobedo, Nuevo Leon, Mexico; [Chew, Boon; Noratto, Giuliana] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA	Universidad Autonoma de Nuevo Leon; Pontificia Universidad Catolica de Valparaiso; Washington State University; Universidad Autonoma de Nuevo Leon; Texas A&M University System; Texas A&M University College Station	Noratto, G (corresponding author), Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA.; Noratto, G (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.	gnoratto@tamu.edu	Garcia-Mazcorro, Jose F/O-5799-2018; Chew, Boon/R-5757-2019; Pedreschi, Romina/F-9744-2016; Kawas, Jorge/AAG-4283-2021; Noratto, Giuliana/AAS-8959-2020	Garcia-Mazcorro, Jose F/0000-0001-6047-4361; Pedreschi, Romina/0000-0001-9927-2919; Kawas, Jorge/0000-0003-3543-4506; Noratto, Giuliana/0000-0003-1831-7172	Emerging Research Issues Internal Competitive Grant from Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences [10A-3057-3668]	Emerging Research Issues Internal Competitive Grant from Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences	This study was funded with an Emerging Research Issues Internal Competitive Grant from Agricultural Research Center at Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Grant No 10A-3057-3668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah A, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.47; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Blanco-Vaca F, 2019, CURR MED CHEM, V26, P6735, DOI 10.2174/0929867325666180607093111; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Chung WSF, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix127; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; Clemente-Postigo M, 2013, AM J CLIN NUTR, V97, P1053, DOI 10.3945/ajcn.112.051128; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Denis MC, 2016, CLIN SCI, V130, P2217, DOI 10.1042/CS20160524; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eren AM, 2015, ISME J, V9, P90, DOI 10.1038/ismej.2014.97; Espley RV, 2014, J NUTR, V144, P146, DOI 10.3945/jn.113.182659; Garcia-Mazcorro JF, 2018, PEERJ, V6, DOI 10.7717/peerj.4195; Garcia-Mazcorro JF, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw089; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang TT, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030126; Koeppel AF, 2013, NUCLEIC ACIDS RES, V41, P5175, DOI 10.1093/nar/gkt241; Koutsos A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060533; Koutsos A, 2015, NUTRIENTS, V7, P3959, DOI 10.3390/nu7063959; LANG JA, 1984, LAB ANIM, V18, P40, DOI 10.1258/002367784780865045; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Masumoto S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31208; Moreau RA, 2018, PROG LIPID RES, V70, P35, DOI 10.1016/j.plipres.2018.04.001; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484; Ravn-Haren G, 2013, EUR J NUTR, V52, P1875, DOI 10.1007/s00394-012-0489-z; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Samout N, 2016, BIOMED PHARMACOTHER, V83, P1233, DOI 10.1016/j.biopha.2016.08.038; Sedda S, 2015, INFLAMM BOWEL DIS, V21, P2921, DOI 10.1097/MIB.0000000000000542; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Shao YY, 2017, FOOD FUNCT, V8, P4508, DOI [10.1039/C7FO00902J, 10.1039/c7fo00902j]; Shinohara K, 2010, ANAEROBE, V16, P510, DOI 10.1016/j.anaerobe.2010.03.005; Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194; Tamura K, 2017, CELL REP, V21, P417, DOI 10.1016/j.celrep.2017.09.049; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yin XC, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy084	48	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0212586	10.1371/journal.pone.0212586	http://dx.doi.org/10.1371/journal.pone.0212586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870465	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300013
J	Li, X; Chi, WQ; Tian, H; Zhang, YQ; Zhu, ZC				Li, Xia; Chi, Wanqing; Tian, Hua; Zhang, Yongqiang; Zhu, Zichen			Probabilistic ecological risk assessment of heavy metals in western Laizhou Bay, Shandong Province, China	PLOS ONE			English	Article							SURFACE SEDIMENTS; TRACE-METALS; BOHAI SEA; CONTAMINATION ASSESSMENT; POLLUTION ASSESSMENT; SPATIAL-DISTRIBUTION; TOXICITY; QUALITY; RIVER; DISTRIBUTIONS	Considering the serious land-based pollution and the weak water exchange ability of western Laizhou Bay, it is essential to conduct an ecological risk assessment of the pollutants in this area. In this study, the ecological risk caused by heavy metals deposited in the surface sediments and those resuspended in the seawater of western Laizhou Bay was evaluated using probabilistic approaches. First, the concentrations of seven heavy metals, namely As, Cd, Cr, Cu, Hg, Pb, and Zn, in the surface sediments and seawater of western Laizhou Bay were detected during the spring and autumn of 2016. The concentrations of As, Cd, Cr, Cu, and Pb were found to be at levels comparable to those in the other global coastal systems, while those of Hg and Zn were lower than those in other coastal areas. Next, an ecological risk assessment of heavy metals in the surface sediments was performed using a typical potential ecological risk index and refined by using a Monte Carlo simulation. The results suggested low risk for the heavy metals detected in the sediments of western Laizhou Bay, with the exception of Hg in September 2016, which showed a probability (0.03%) of moderate risk. Meanwhile, the aquatic ecological risk assessment of the heavy metals was performed by applying a combination of hazard quotient (HQ) and joint probability curve. While the ecological risk of Cd, Hg, and Pb was found to be acceptable, the HQs for Cr, Cu, and Zn were greater than 1, and the overall risk probability of their adverse effects was higher than 0.05, suggesting certain ecological risk. Specifically, in the case of As, the overall risk probability was lower than 0.05, suggesting that its ecological risk was acceptable, although its HQ was greater than 1. Thus, by applying the probabilistic approaches, the ecological risk of the heavy metals in western Laizhou Bay was better characterized in this study, avoiding both overestimation and underestimation of ecological risk.	[Li, Xia; Chi, Wanqing; Zhang, Yongqiang; Zhu, Zichen] State Ocean Adm China, Inst Oceanog 1, Qingdao, Peoples R China; [Chi, Wanqing] Ocean Univ China, Coll Marine Geosci, Qingdao, Peoples R China; [Tian, Hua] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China	State Oceanic Administration; Ocean University of China; Ocean University of China	Chi, WQ (corresponding author), State Ocean Adm China, Inst Oceanog 1, Qingdao, Peoples R China.; Chi, WQ (corresponding author), Ocean Univ China, Coll Marine Geosci, Qingdao, Peoples R China.; Tian, H (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	wanqingchi@fio.org.cn; tianhua@ouc.edu.cn	Tian, Hua/GPP-4477-2022					Abigail P, 2003, AQUAT TOXICOL, V64, P155, DOI 10.1016/S0166-445X(03)00029-8; Al-Subiai SN, 2011, ECOTOX ENVIRON SAFE, V74, P1913, DOI 10.1016/j.ecoenv.2011.07.012; ALDENBERG T, 1993, ECOTOX ENVIRON SAFE, V25, P48, DOI 10.1006/eesa.1993.1006; Bai JH, 2011, ECOL MODEL, V222, P301, DOI 10.1016/j.ecolmodel.2009.12.002; Beiras R, 2004, AQUACULTURE, V230, P205, DOI 10.1016/S0044-8486(03)00432-0; Caldwell DJ, 2008, ENVIRON SCI TECHNOL, V42, P7046, DOI 10.1021/es800633q; Chen CS, 2005, CHEMOSPHERE, V61, P1142, DOI 10.1016/j.chemosphere.2005.02.077; European Commission, 2003, TECHN GUID DOC RISK, P149; Feng CL, 2012, ENVIRON SCI TECHNOL, V46, P10877, DOI 10.1021/es303500n; Firestone M., 1997, GUIDING PRINCIPLES M; Gao XL, 2015, CONT SHELF RES, V104, P25, DOI 10.1016/j.csr.2015.05.005; Gao XL, 2012, MAR POLLUT BULL, V64, P1529, DOI 10.1016/j.marpolbul.2012.04.026; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Hamer K, 2002, WASTE MANAGE, V22, P521, DOI 10.1016/S0956-053X(01)00048-4; Hill NA, 2013, ENVIRON POLLUT, V173, P182, DOI 10.1016/j.envpol.2012.09.029; Hu BQ, 2013, ENVIRON MONIT ASSESS, V185, P5071, DOI 10.1007/s10661-012-2926-0; Huang P, 2014, CONT SHELF RES, V73, P1, DOI 10.1016/j.csr.2013.11.014; Hyun S, 2007, MAR POLLUT BULL, V54, P1059, DOI 10.1016/j.marpolbul.2007.02.013; Jin XW, 2015, MAR POLLUT BULL, V94, P96, DOI 10.1016/j.marpolbul.2015.03.005; Jin XW, 2014, ENVIRON SCI TECHNOL, V48, P1256, DOI 10.1021/es403781z; Jin XW, 2012, ENVIRON SCI POLLUT R, V19, P1544, DOI 10.1007/s11356-011-0660-8; Klimisch HJ, 1997, REGUL TOXICOL PHARM, V25, P1, DOI 10.1006/rtph.1996.1076; Liu M, 2015, MAR POLLUT BULL, V100, P534, DOI 10.1016/j.marpolbul.2015.09.001; Matthiessen P, 2002, ENVIRON POLLUT, V120, P739, DOI 10.1016/S0269-7491(02)00175-6; Mu JL, 2014, ACTA OCEANOL SIN, V33, P212, DOI 10.1007/s13131-014-0575-6; NRC: National Research Council, 1994, SCI JUDGM RISK ASS C; Oh Jeong-ju, 2012, Toxicology and Environmental Health Sciences, V4, P9, DOI 10.1007/s13530-011-0107-0; Osher LJ, 2006, ESTUAR COAST SHELF S, V70, P169, DOI 10.1016/j.ecss.2006.06.009; Pekey H, 2006, ENVIRON MONIT ASSESS, V123, P219, DOI 10.1007/s10661-006-9192-y; Posthuma L., 2002, SPECIES SENSITIVITY; Qu CS, 2016, STOCH ENV RES RISK A, V30, P271, DOI 10.1007/s00477-015-1087-4; Qu MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18451; Qu MK, 2015, ENVIRON SCI-PROC IMP, V17, P120, DOI 10.1039/c4em00513a; Qu MK, 2014, HUM ECOL RISK ASSESS, V20, P764, DOI 10.1080/10807039.2013.770352; Qu MK, 2013, ECOL INFORM, V13, P99, DOI 10.1016/j.ecoinf.2012.06.005; Ribeiro CAD, 2002, ENVIRON RES, V90, P217, DOI 10.1016/S0013-9351(02)00025-7; Riccardi C, 2001, J ENVIRON SCI HEAL A, V36, P957, DOI 10.1081/ESE-100104124; Shao QX, 2000, ENVIRONMETRICS, V11, P583, DOI 10.1002/1099-095X(200009/10)11:5<583::AID-ENV456>3.0.CO;2-X; Singh KP, 2005, J HYDROL, V312, P14, DOI 10.1016/j.jhydrol.2005.01.021; Solomon K, 2000, CROP PROT, V19, P649, DOI 10.1016/S0261-2194(00)00086-7; State Oceanic Administration of China, 2017, B MAR ENV STAT CHIN; Su LY, 2011, ECOTOXICOLOGY, V20, P1107, DOI 10.1007/s10646-011-0616-2; Tang AK, 2010, PROCEDIA ENVIRON SCI, V2, P1193, DOI 10.1016/j.proenv.2010.10.129; Tian XH, 2016, MAR POLLUT BULL, V112, P393, DOI 10.1016/j.marpolbul.2016.07.052; US Environmental Protection Agency, 2009, NAT REC WAT QUAL CRI; VANDERMEER C, 1988, B ENVIRON CONTAM TOX, V40, P204, DOI 10.1007/BF01881040; Wang B, 2009, ENVIRON MONIT ASSESS, V157, P29, DOI 10.1007/s10661-008-0512-2; Wu B, 2014, MAR POLLUT BULL, V87, P247, DOI 10.1016/j.marpolbul.2014.07.052; Wu GH, 2014, MAR POLLUT BULL, V82, P194, DOI 10.1016/j.marpolbul.2014.02.033; Xu G, 2015, ENVIRON SCI POLLUT R, V22, P11634, DOI 10.1007/s11356-015-4393-y; Xu L, 2013, MAR POLLUT BULL, V74, P453, DOI 10.1016/j.marpolbul.2013.06.010; Zhang JF, 2015, MAR POLLUT BULL, V98, P320, DOI 10.1016/j.marpolbul.2015.06.035; Zhang P, 2017, MAR POLLUT BULL, V119, P429, DOI 10.1016/j.marpolbul.2017.03.046; Zhao JS, 2016, ECOTOX ENVIRON SAFE, V125, P161, DOI 10.1016/j.ecoenv.2015.11.039; Zhuang W, 2015, MAR POLLUT BULL, V99, P320, DOI 10.1016/j.marpolbul.2015.07.037; Zhuang W, 2015, MAR POLLUT BULL, V96, P502, DOI 10.1016/j.marpolbul.2015.04.023; Zhuang W, 2014, MAR POLLUT BULL, V83, P352, DOI 10.1016/j.marpolbul.2014.03.039; Zolezzi M, 2005, ENVIRON SCI TECHNOL, V39, P2920, DOI 10.1021/es049214x	58	16	18	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213011	10.1371/journal.pone.0213011	http://dx.doi.org/10.1371/journal.pone.0213011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870455	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300017
J	Suarez-Arrones, L; Lara-Lopez, P; Rodriguez-Sanchez, P; Lazaro-Ramirez, JL; Di Salvo, V; Guitart, M; Fuentes-Nieto, C; Rodas, G; Mendez-Villanueva, A				Suarez-Arrones, Luis; Lara-Lopez, Pilar; Rodriguez-Sanchez, Pablo; Luis Lazaro-Ramirez, Jose; Di Salvo, Valter; Guitart, Marc; Fuentes-Nieto, Cristobal; Rodas, Gil; Mendez-Villanueva, Alberto			Dissociation between changes in sprinting performance and Nordic hamstring strength in professional male football players	PLOS ONE			English	Article							MEDICAL-RESEARCH PROGRAM; TRAINING-PROGRAM; VERTICAL JUMP; LEG POWER; INJURIES; EXERCISE; AUDIT; SPEED; RISK	The aim of the present study was to evaluate the consequence of implementing a Nordic Hamstring exercise (NHE) protocol during the first 15 to 17 weeks of the season to assess the effect on sprinting and NHE strength (NHEs) in professional football players. The study examined 50 healthy male professional football players (age 18.8 +/- 0.8yr; height 176.8 +/- 6.9cm; weight 71.3 +/- 5.7kg) belonging to 3 of the reserve squads of three Spanish La-Liga clubs divided in 2 intervention teams [Nordic-Group1 (NG-1) and Nordic-Group2 (NG-2, extensive experience in NHE)] and 1 team as a control-group (CG). NHEs and linear sprint (T5, T10, T20-m) were evaluated at the beginning of the season and at the end of an intervention period of conditioning and football training, supplemented with a NHE protocol (24 sessions for NG-1 and 22 sessions for NG-2) or without using the NHE at all (CG). Sprint times were substantially improved in all groups (ES from -2.24 +/- 0.75 to -0.60 +/- 0.37). NHEs was enhanced absolute and relative to body-mass only in NG-1 after the training period (ES from 0.84 +/- 0.32 to 0.74 +/- 0.26), while in the NG-2 there were only improvements in average NHEs relative to body-mass (ES = 0.39 +/- 0.36). The improvements in T20-m were substantially greater in NG-2 vs. NG-1, and there were no differences in sprint performance changes between NG-1 and CG. Changes in sprinting performance and NHEs were unrelated. NHEs was largely correlated with the body-mass of the players. Results indicate that the improvements in sprint are not dependent on the NHEs changes, with no relationships between NHEs and sprint performance, and between sprint changes and changes in NHEs.	[Suarez-Arrones, Luis; Lara-Lopez, Pilar; Rodriguez-Sanchez, Pablo; Luis Lazaro-Ramirez, Jose] Pablo de Olavide Univ, Dept Sport & Informat, Sect Phys Educ & Sport, Seville, Spain; [Suarez-Arrones, Luis; Di Salvo, Valter; Mendez-Villanueva, Alberto] ASPIRE Acad, Football Performance & Sci Dept, Doha, Qatar; [Di Salvo, Valter] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Guitart, Marc; Rodas, Gil] Futbol Club Barcelona, Med & Performance Dept, Barcelona, Spain; [Fuentes-Nieto, Cristobal] Cordoba Club Futbol, SAD, Cordoba, Spain	Universidad Pablo de Olavide; Aspire Academy for Sports Excellence; Foro Italico University of Rome	Suarez-Arrones, L (corresponding author), Pablo de Olavide Univ, Dept Sport & Informat, Sect Phys Educ & Sport, Seville, Spain.; Suarez-Arrones, L (corresponding author), ASPIRE Acad, Football Performance & Sci Dept, Doha, Qatar.	ljsuamor@upo.es	Rodas, Gil/B-7235-2019; Trench, Marc Guitart/AAH-1684-2020	Rodas, Gil/0000-0002-8060-3914; Trench, Marc Guitart/0000-0002-7548-8229; Suarez Moreno-Arrones, Luis Jesus/0000-0002-5432-4786	Qatar National Research Fund (Qatar Foundation) [NPRP 6-1526-3-363]	Qatar National Research Fund (Qatar Foundation)	This study was made possible by NPRP grant #NPRP 6-1526-3-363 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funder provided support for authors LSA, AMV, VDS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Askling CM, 2007, AM J SPORT MED, V35, P197, DOI 10.1177/0363546506294679; Bahr R, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094826; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Bourne MN, 2017, BRIT J SPORT MED, V51, P469, DOI 10.1136/bjsports-2016-096130; Buchheit M, 2016, INT J SPORT PHYSIOL, V11, P721, DOI 10.1123/ijspp.2015-0513; Chelly MS, 2010, J STRENGTH COND RES, V24, P2670, DOI 10.1519/JSC.0b013e3181e2728f; Chelly MS, 2009, J STRENGTH COND RES, V23, P2241, DOI 10.1519/JSC.0b013e3181b86c40; Di Salvo V, 2013, INT J SPORTS MED, V34, P526, DOI 10.1055/s-0032-1327660; Ekstrand J, 2013, BRIT J SPORT MED, V47, P732, DOI 10.1136/bjsports-2013-092394; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Ferrete C, 2014, J STRENGTH COND RES, V28, P413, DOI 10.1519/JSC.0b013e31829b2222; Haugen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121827; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Ishoi L, 2018, J SPORT SCI, V36, P1663, DOI 10.1080/02640414.2017.1409609; Krommes K, 2017, BMC Res Notes, V10, P669, DOI 10.1186/s13104-017-2986-x; McCall A, 2015, BRIT J SPORT MED, V49, P583, DOI 10.1136/bjsports-2014-094104; Mendez-Villanueva A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161356; Mendiguchia J, 2015, SCAND J MED SCI SPOR, V25, pE621, DOI 10.1111/sms.12388; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Oakley AJ, 2018, BRIT J SPORT MED, V52, P816, DOI 10.1136/bjsports-2016-097137; Opar DA, 2015, MED SCI SPORT EXER, V47, P857, DOI 10.1249/MSS.0000000000000465; Opar DA, 2013, J ORTHOP SPORT PHYS, V43, P636, DOI 10.2519/jospt.2013.4837; Rodriguez-Rosell D, 2017, J SCI MED SPORT, V20, P695, DOI 10.1016/j.jsams.2016.11.010; Timmins RG, 2016, BRIT J SPORT MED, V50, P1524, DOI 10.1136/bjsports-2015-095362; Tonnessen E, 2011, J STRENGTH COND RES, V25, P2364, DOI 10.1519/JSC.0b013e3182023a65; van der Horst N, 2015, AM J SPORT MED, V43, P1316, DOI 10.1177/0363546515574057; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; Woods C, 2002, BRIT J SPORT MED, V36, P436, DOI 10.1136/bjsm.36.6.436	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213375	10.1371/journal.pone.0213375	http://dx.doi.org/10.1371/journal.pone.0213375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870442	Green Submitted, gold, Green Published			2022-12-26	WOS:000461166300030
J	Williams, DL; Smith, SR; Peterson, BR; Allyn, G; Cadenas, L; Epperson, RT; Looper, RE				Williams, Dustin L.; Smith, Scott R.; Peterson, Brittany R.; Allyn, Gina; Cadenas, Lousili; Epperson, Richard Tyler; Looper, Ryan E.			Growth substrate may influence biofilm susceptibility to antibiotics	PLOS ONE			English	Article							MATRIX; EFFICACY; REACTOR; MODEL; QUANTIFICATION; STRAINS; QUALITY; LAMININ; SURFACE; AGENTS	The CDC biofilm reactor is a robust culture system with high reproducibility in which biofilms can be grown for a wide variety of analyses. Multiple material types are available as growth substrates, yet data from biofilms grown on biologically relevant materials is scarce, particularly for antibiotic efficacy against differentially supported biofilms. In this study, CDC reactor holders were modified to allow growth of biofilms on collagen, a biologically relevant substrate. Susceptibility to multiple antibiotics was compared between biofilms of varying species grown on collagen versus standard polycarbonate coupons. Data indicated that in 13/18 instances, biofilms on polycarbonate were more susceptible to antibiotics than those on collagen, suggesting that when grown on a complex substrate, biofilms may be more tolerant to antibiotics. These outcomes may influence the translatability of antibiotic susceptibility profiles that have been collected for biofilms on hard plastic materials. Data may also help to advance information on antibiotic susceptibility testing of biofilms grown on biologically relevant materials for future in vitro and in vivo applications.	[Williams, Dustin L.; Smith, Scott R.; Peterson, Brittany R.; Allyn, Gina; Cadenas, Lousili; Epperson, Richard Tyler] George Wahlen Dept Vet Affairs, Salt Lake City, UT 84148 USA; [Williams, Dustin L.; Smith, Scott R.; Peterson, Brittany R.; Allyn, Gina; Cadenas, Lousili; Epperson, Richard Tyler] Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA; [Williams, Dustin L.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Williams, Dustin L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Williams, Dustin L.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA; [Looper, Ryan E.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Smith, Scott R.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Peterson, Brittany R.] Univ Utah, Hunstman Canc Inst, Salt Lake City, UT USA; [Allyn, Gina] Univ Utah, Sch Med, Salt Lake City, UT USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Uniformed Services University of the Health Sciences - USA; Utah System of Higher Education; University of Utah; Ohio State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Williams, DL (corresponding author), George Wahlen Dept Vet Affairs, Salt Lake City, UT 84148 USA.; Williams, DL (corresponding author), Univ Utah, Dept Orthopaed, Salt Lake City, UT 84112 USA.; Williams, DL (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.; Williams, DL (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Williams, DL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA.	dustin.williams@utah.edu			Department of Veterans Affairs [1I01RX001198-01A2, 1I01RX002287-01]; Center for Rehabilitation Science Research, Department of Physical Medicine & Rehabilitation, Uniformed Services University, Bethesda, MD [HU0001-11-1-0004, HU0001-15-2-0003]; Department of Orthopaedics, University of Utah; Veterans Affairs [I01RX001198, I01RX002287] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Center for Rehabilitation Science Research, Department of Physical Medicine & Rehabilitation, Uniformed Services University, Bethesda, MD; Department of Orthopaedics, University of Utah; Veterans Affairs(US Department of Veterans Affairs)	Funding in part from The Department of Veterans Affairs grant numbers 1I01RX001198-01A2 and 1I01RX002287-01 to DLW. This work was also supported in part by the Center for Rehabilitation Science Research, Department of Physical Medicine & Rehabilitation, Uniformed Services University, Bethesda, MD, awards HU0001-11-1-0004 and HU0001-15-2-0003 to DLW. Internal support was also provided in part by the Department of Orthopaedics, University of Utah. There was no additional external funding received for this study.; Funding in part from The Department of Veterans Affairs grant numbers 1I01RX001198-01A2 and 1I01RX002287-01. This work was also supported in part by the Center for Rehabilitation Science Research, Department of Physical Medicine & Rehabilitation, Uniformed Services University, Bethesda, MD, awards HU0001-11-1-0004 and HU0001-15-2-0003 to DLW. Internal support was also provided in part by the Department of Orthopaedics, University of Utah. There was no additional external funding received for this study.	Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010; COSTERTON JW, 1981, ANNU REV MICROBIOL, V35, P299, DOI 10.1146/annurev.mi.35.100181.001503; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; GIBBONS RJ, 1975, ANNU REV MICROBIOL, V29, P19, DOI 10.1146/annurev.mi.29.100175.000315; Gilmore BF, 2010, J BIOMED MATER RES B, V93B, P128, DOI 10.1002/jbm.b.31567; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; LOVELL CR, 1987, BRIT J DERMATOL, V117, P419, DOI 10.1111/j.1365-2133.1987.tb04921.x; Luppens SBI, 2002, APPL ENVIRON MICROB, V68, P4194, DOI 10.1128/AEM.68.9.4194-4200.2002; Marshall SA, 1996, J CLIN MICROBIOL, V34, P2027, DOI 10.1128/JCM.34.8.2027-2029.1996; Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114; Nallapareddy SR, 2000, INFECT IMMUN, V68, P5218, DOI 10.1128/IAI.68.9.5218-5224.2000; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; REIMER LG, 1981, ANTIMICROB AGENTS CH, V19, P1050, DOI 10.1128/AAC.19.6.1050; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Stoodley P, 2001, WATER SCI TECHNOL, V43, P113, DOI 10.2166/wst.2001.0353; SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Williams DL., 2011, RES J MICROBIOLOGY, V6, P425, DOI DOI 10.3923/JM.2011.425.429; Williams DL, 2014, ANTIMICROB AGENTS CH, V58, P2400, DOI 10.1128/AAC.01798-13; Williams DL, 2012, BIOMATERIALS, V33, P8641, DOI 10.1016/j.biomaterials.2012.08.003; Williams DL, 2012, J BIOMED MATER RES A, V100A, P1888, DOI 10.1002/jbm.a.34123; Williams DL, 2011, CURR MICROBIOL, V62, P1657, DOI 10.1007/s00284-011-9908-2; Williams DL, 2010, MICROSC MICROANAL, V16, P143, DOI 10.1017/S143192760999136X; Wolcott RD, 2010, J WOUND CARE, V19, P320, DOI 10.12968/jowc.2010.19.8.77709	29	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0206774	10.1371/journal.pone.0206774	http://dx.doi.org/10.1371/journal.pone.0206774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870411	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300004
J	Wu, CY; Hsu, WL; Tsai, MH; Chai, CY; Yen, CJ; Chen, CH; Lu, JH; Yu, HS; Yoshioka, T				Wu, Ching-Ying; Hsu, Wen-Li; Tsai, Ming-Hsien; Chai, Chee-Yin; Yen, Chia-Jung; Chen, Chu-Huang; Lu, Jian-He; Yu, Hsin-Su; Yoshioka, Tohru			A potential new approach for treating systemic sclerosis: Dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca2+ entry	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CALCIUM-CHANNELS; RECENT PROGRESS; UP-REGULATION; ACTIVATION; FIBROSIS	Transforming growth factor-beta (TGF-beta) is an important target for treating systemic sclerosis (SSc). However, our study revealed three levels of TGF-beta 1 expression in SSc patients, indicating that inhibiting TGF-beta is not sufficient to treat SSc. A previous clinical trial also displayed disappointing results. Thus, our study attempted to search for a potential novel approach. Ingenuity Pathway Analysis (IPA) indicated that the SSc pathological pathways were closely associated with store-operated Ca2+ entry (SOCE)-regulated signals, and SOCE activity was found to be increased in SSc fibroblasts. Further treatment of SSc fibroblasts with SOCE inhibitors, 2APB, and associated calcium channel inhibitors SKF96365, and indomethacin, showed that the SOCE inhibitors selectively decreased fibrosis markers and altered the cell morphology. Consequently, SOCE inhibitors, especially 2APB and indomethacin, caused the dedifferentiation of SSc fibroblasts via cytoskeleton remodeling and altered collagen secretion and restored the cell mobility. We further explained SSc pathogenesis as fibroblast differentiation with SOCE. Treatment with exogenous factors, gelatin-1, FAM20A and human albumin, which were identified from the conditioned medium of SSc fibroblasts, was important for regulating the differentiation of fibroblasts with higher levels of SOCE and alpha-SMA. Conclusively, to treat SSc, blockage of the increased SOCE activity in SSc induces the dedifferentiation of SSc fibroblasts and simultaneously changes the extracellular matrix (ECM) structure to limit SSc pathogenesis.	[Wu, Ching-Ying; Yen, Chia-Jung; Lu, Jian-He] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Wu, Ching-Ying; Hsu, Wen-Li; Yen, Chia-Jung; Yu, Hsin-Su; Yoshioka, Tohru] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Ching-Ying] Chang Gung Univ Sci & Technol, Dept Cosmet Sci, Taoyuan, Taiwan; [Hsu, Wen-Li] Natl Pingtung Univ Sci & Technol, Dept Environm Sci & Engn, Coll Engn, Emerging Cpds Res Ctr, Pingtung, Taiwan; [Tsai, Ming-Hsien] Natl Pingtung Univ Sci & Technol, Coll Humanities & Social Sci, Dept Child Care, Pingtung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Fac Med, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chen, Chu-Huang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Lipid Biosci, Kaohsiung, Taiwan; [Chen, Chu-Huang] Texas Heart Inst, Vasc & Med Res, Houston, TX 77025 USA; [Yu, Hsin-Su] Kaohsiung Med Univ, Dept Dermatol, Kaohsiung, Taiwan; [Yu, Hsin-Su] Kaohsiung Med Univ, Coll Med, Dept Dermatol, Kaohsiung, Taiwan; [Yu, Hsin-Su] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Chang Gung University of Science & Technology; National Pingtung University Science & Technology; National Pingtung University Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Texas Heart Institute; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yu, HS; Yoshioka, T (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Yu, HS (corresponding author), Kaohsiung Med Univ, Dept Dermatol, Kaohsiung, Taiwan.; Yu, HS (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Dermatol, Kaohsiung, Taiwan.; Yu, HS (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.	yup.kmu@gmail.com; yoshitohru@gmail.com		Chai, Chee-Yin/0000-0003-0486-9742; Wu, Ching-Ying/0000-0002-3645-5117	Kaohsiung Medical University, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital [kmtth-104-010, kmtth-105-043, kmtth-106-043]; Ministry of Science and Technology of Taiwan [MOST104-2314-B-037-060, 105-2628-B-037-006-MY3, MOST107-2321-B-037-002]	Kaohsiung Medical University, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Kaohsiung Medical University, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital (kmtth-104-010, kmtth-105-043, kmtth-106-043) and the Ministry of Science and Technology of Taiwan (MOST104-2314-B-037-060, 105-2628-B-037-006-MY3 and MOST107-2321-B-037-002). All the funding or sources of support received during this specific study.	ALMAHBOBI G, 1994, EUR J CELL BIOL, V63, P307; Cheng KT, 2013, CURR TOP MEMBR, V71, P149, DOI 10.1016/B978-0-12-407870-3.00007-X; Cheung A, 2000, HUM REPROD, V15, P1389, DOI 10.1093/humrep/15.6.1389; Chia HN, 2012, ACTA BIOMATER, V8, P2602, DOI 10.1016/j.actbio.2012.03.027; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Earley S, 2015, PHYSIOL REV, V95, P645, DOI 10.1152/physrev.00026.2014; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Harraz OF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00043; Hsu WL, 2015, MOLECULES, V20, P20297, DOI 10.3390/molecules201119693; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Lee WH, 2005, J INVEST DERMATOL, V124, P291, DOI 10.1111/j.0022-202X.2004.23506.x; McCoy SS, 2017, RHEUMATOLOGY, V56, P1970, DOI 10.1093/rheumatology/kex280; Mo PL, 2018, FRONT BIOSCI-LANDMRK, V23, P1241, DOI 10.2741/4641; Molotkov D, 2013, CELL CALCIUM, V53, P338, DOI 10.1016/j.ceca.2013.03.001; Mukherjee S, 2015, AM J RESP CELL MOL, V53, P450, DOI 10.1165/rcmb.2015-0009OC; Munoz E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198952; O'Reilly S, 2014, CLIN SCI, V126, P329, DOI 10.1042/CS20130367; Pannu J, 2006, ARTHRITIS RHEUM-US, V54, P3011, DOI 10.1002/art.22063; Sampson N, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/458276; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Tian CS, 2016, FUTURE MED CHEM, V8, P817, DOI 10.4155/fmc-2016-0024; Trudeau MC, 2002, P NATL ACAD SCI USA, V99, P8424, DOI 10.1073/pnas.122015999; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Varga J, 2008, CURR OPIN RHEUMATOL, V20, P720, DOI 10.1097/BOR.0b013e32830e48e8; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Wang J, 2017, MOLECULES, V22, DOI 10.3390/molecules22122256; Wu CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159299; Wu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03513-2; Xie JS, 2016, INT J CANCER, V138, P2067, DOI 10.1002/ijc.29840; Yue ZC, 2013, CURR TOP MED CHEM, V13, P270; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213400	10.1371/journal.pone.0213400	http://dx.doi.org/10.1371/journal.pone.0213400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870448	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300032
J	Chen, M; Huang, RC; Yang, LQ; Ren, DL; Hu, B				Chen, Min; Huang, Rong-Chen; Yang, Lei-Qing; Ren, Da-Long; Hu, Bing			In vivo imaging of evoked calcium responses indicates the intrinsic axonal regenerative capacity of zebrafish	FASEB JOURNAL			English	Article						regeneration; activity	CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; NEURAL ACTIVITY; MITOCHONDRIAL TRANSPORT; PTEN INHIBITION; LONG-DISTANCE; MAUTHNER CELL; ADULT CNS; NEURONS; RECOVERY	Calcium is an important messenger in the neuronal system, but its specific role in axonal regeneration has not been fully investigated. To clarify it, we constructed a noninvasive in vivo calcium-imaging model of zebrafish Mauthner cells and monitored subcellular calcium dynamics during axonal regeneration. Using the calcium indicator GCamp6f, we observed that the regenerative length correlated with the peak amplitude of the evoked calcium response before axotomy, which suggested that the evoked calcium response might serve as a useful indicator of evoked neuronal activity and axonal regenerative capacity. To investigate this possibility, we overexpressed an inward rectifying potassium channel protein, Kir2.1a, to decrease the Mauthner neuronal activity and found that the inhibition of the calcium response correlated with decreased axonal regeneration. In contrast, treatment of pentylenetetrazol and knockout of the sodium voltage-gated channel alpha subunit 1 gene increased the calcium response and thus enhanced axonal regeneration. Our results therefore increased the understanding of the correlation between the neural activity and the vertebrate axonal regeneration.-Chen, M., Huang, R.-C., Yang, L.-Q., Ren, D.-L., Hu, B. In vivo imaging of evoked calcium responses indicates the intrinsic axonal regenerative capacity of zebrafish.	[Chen, Min; Huang, Rong-Chen; Yang, Lei-Qing; Ren, Da-Long; Hu, Bing] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Ren, Da-Long; Hu, Bing] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ren, DL; Hu, B (corresponding author), Univ Sci & Technol China, 96 Jinzhai Rd, Hefei 230026, Anhui, Peoples R China.	rendl@ustc.edu.cn; bhu@ustc.edu.cn	Ren, Da-long/G-3323-2018	Huang, Rongchen/0000-0001-9521-0163	National Natural Science Foundation of China [31771183, 31571068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (31771183, 31571068). The authors declare no conflicts of interest.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Auer TO, 2014, NAT PROTOC, V9, P2823, DOI 10.1038/nprot.2014.187; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Becker CG, 2000, J COMP NEUROL, V427, P469; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 2014, CURR OPIN NEUROBIOL, V27, P186, DOI 10.1016/j.conb.2014.03.019; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Cen LP, 2018, EXP EYE RES, V177, P153, DOI 10.1016/j.exer.2018.08.010; Chen MF, 2014, TRENDS NEUROSCI, V37, P583, DOI 10.1016/j.tins.2014.08.008; Chen M, 2017, MOL NEUROBIOL, V54, P6917, DOI 10.1007/s12035-016-0233-4; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dinday MT, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0068-15.2015; English AW, 2011, ANN ANAT, V193, P354, DOI 10.1016/j.aanat.2011.02.013; Fischer D, 2012, PROG RETIN EYE RES, V31, P688, DOI 10.1016/j.preteyeres.2012.06.005; Gahtan E, 2003, J COMP NEUROL, V459, P186, DOI 10.1002/cne.10621; Gordon T, 2016, EUR J NEUROSCI, V43, P336, DOI 10.1111/ejn.13005; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Hocking JC, 2012, MECH DEVELOP, V129, P125, DOI 10.1016/j.mod.2012.05.003; Hu BB, 2018, EXP NEUROL, V300, P67, DOI 10.1016/j.expneurol.2017.10.028; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Huang RC, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00375; Huang YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140752; Jaiswal P. B., 2017, J NEUROSCI RES; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Luo XT, 2012, INT REV NEUROBIOL, V105, P141, DOI 10.1016/B978-0-12-398309-1.00008-1; Marsden KC, 2015, CELL REP, V13, P1733, DOI 10.1016/j.celrep.2015.10.060; Nagashima M, 2011, NEUROCHEM INT, V58, P888, DOI 10.1016/j.neuint.2011.02.017; Neki D, 2014, J NEUROSCI, V34, P3291, DOI 10.1523/JNEUROSCI.4610-13.2014; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; O'Brien Georgeann S, 2009, J Vis Exp, DOI 10.3791/1129; O'Donnell KC, 2013, J NEUROSCI, V33, P14778, DOI 10.1523/JNEUROSCI.1331-13.2013; Ohtake Y, 2015, NEURAL REGEN RES, V10, P1363, DOI 10.4103/1673-5374.165496; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176; Sabatier MJ, 2015, EXERC SPORT SCI REV, V43, P163, DOI 10.1249/JES.0000000000000047; Satou C, 2009, J NEUROSCI, V29, P6780, DOI 10.1523/JNEUROSCI.0801-09.2009; Sillar KT, 2009, CURR BIOL, V19, pR353, DOI 10.1016/j.cub.2009.02.025; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Vargas ME, 2015, J NEUROSCI, V35, P15026, DOI 10.1523/JNEUROSCI.2484-15.2015; Ward PJ, 2018, EUR J NEUROSCI, V47, P294, DOI 10.1111/ejn.13836; Xu Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00558; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101; Zou SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057280	62	3	3	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7721	7733		10.1096/fj.201802649R	http://dx.doi.org/10.1096/fj.201802649R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893562	Bronze			2022-12-26	WOS:000476114200084
J	Labourel, A; Basle, A; Munoz-Munoz, J; Ndeh, D; Booth, S; Nepogodiev, SA; Field, RA; Cartmell, A				Labourel, Aurore; Basle, Arnaud; Munoz-Munoz, Jose; Ndeh, Didier; Booth, Simon; Nepogodiev, Sergey A.; Field, Robert A.; Cartmell, Alan			Structural and functional analyses of glycoside hydrolase 138 enzymes targeting chain A galacturonic acid in the complex pectin rhamnogalacturonan II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme catalysis; enzyme mechanism; carbohydrate; carbohydrate metabolism; crystallography; enzyme kinetics; glycoside hydrolase (GH); pectin; gut microbe; complex glycan; carbohydrate-active enzyme (CAZyme); rhamnogalacturonan II	GUT MICROBIOTA; PLANT-CELL; POLYSACCHARIDE; HYDROLYSIS; DATABASE; REVEALS; FAMILY	The metabolism of carbohydrate polymers drives microbial diversity in the human gut microbiome. The selection pressures in this environment have spurred the evolution of a complex reservoir of microbial genes encoding carbohydrate-active enzymes (CAZymes). Previously, we have shown that the human gut bacterium Bacteroides thetaiotaomicron (Bt) can depolymerize the most structurally complex glycan, the plant pectin rhamnogalacturonan II (RGII), commonly found in the human diet. Previous investigation of the RGII-degrading apparatus in Bt identified BT0997 as a new CAZyme family, classified as glycoside hydrolase 138 (GH138). The mechanism of substrate recognition by GH138, however, remains unclear. Here, using synthetic substrates and biochemical assays, we show that BT0997 targets the d-galacturonic acid--1,2-l-rhamnose linkage in chain A of RGII and that it absolutely requires the presence of a second d-galacturonic acid side chain (linked -1,3 to l-rhamnose) for activity. NMR analysis revealed that BT0997 operates through a double displacement retaining mechanism. We also report the crystal structure of a BT0997 homolog, BPA0997 from Bacteroides paurosaccharolyticus, in complex with ligands at 1.6 angstrom resolution. The structure disclosed that the enzyme comprises four domains, including a catalytic TIM (/)(8) barrel. Characterization of several BT0997 variants identified Glu-294 and Glu-361 as the catalytic acid/base and nucleophile, respectively, and we observed a chloride ion close to the active site. The three-dimensional structure and bioinformatic analysis revealed that two arginines, Arg-332 and Arg-521, are key specificity determinants of BT0997 in targeting d-galacturonic acid residues. In summary, our study reports the first structural and mechanistic analyses of GH138 enzymes.	[Labourel, Aurore; Basle, Arnaud; Munoz-Munoz, Jose; Ndeh, Didier; Booth, Simon; Cartmell, Alan] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Nepogodiev, Sergey A.; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Labourel, Aurore] Aix Marseille Univ, BBF, UMR1163, F-13009 Marseille, France; [Munoz-Munoz, Jose] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UDICE-French Research Universities; Aix-Marseille Universite; Northumbria University	Cartmell, A (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alan.cartmell2@newcastle.ac.uk	; Munoz-Munoz, Jose/G-3506-2016	Cartmell, Alan/0000-0002-5512-249X; Labourel, Aurore/0000-0002-4762-5804; Booth, Simon/0000-0001-5585-022X; Munoz-Munoz, Jose/0000-0003-0010-948X; Basle, Arnaud/0000-0002-4899-3086; Ndeh, Didier/0000-0001-7875-1638	Priority Excellent Science, H2020 European Research Council [322820]; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Priority Excellent Science, H2020 European Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Priority Excellent Science, H2020 European Research Council Grant 322820. The authors declare that they have no conflicts of interest with the contents of this article.	Aghajari N, 2002, PROTEIN SCI, V11, P1435, DOI 10.1110/ps.0202602; Apolinar-Valiente R, 2013, J AGR FOOD CHEM, V61, P2538, DOI 10.1021/jf304987m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Carugo O, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0019-8; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Chauvin AL, 2005, J ORG CHEM, V70, P960, DOI 10.1021/jo0482864; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feller G, 1996, J BIOL CHEM, V271, P23836, DOI 10.1074/jbc.271.39.23836; Hickey CA, 2015, CELL HOST MICROBE, V17, P672, DOI 10.1016/j.chom.2015.04.002; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Munoz-Munoz J, 2017, J BIOL CHEM, V292, P13271, DOI 10.1074/jbc.M117.794578; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nepogodiev SA, 2011, ORG BIOMOL CHEM, V9, P6670, DOI 10.1039/c1ob05587a; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pitson SM, 1998, BIOCHEM BIOPH RES CO, V242, P552, DOI 10.1006/bbrc.1997.8009; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	35	6	6	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7711	7721		10.1074/jbc.RA118.006626	http://dx.doi.org/10.1074/jbc.RA118.006626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30877196	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-26	WOS:000470153300016
J	Bazilevsky, GA; Affronti, HC; Wei, XP; Campbell, SL; Wellen, KE; Marmorstein, R				Bazilevsky, Gleb A.; Affronti, Hayley C.; Wei, Xuepeng; Campbell, Sydney L.; Wellen, Kathryn E.; Marmorstein, Ronen			ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); coenzyme A (CoA); protein assembly; enzyme mechanism; metabolism; ATP-citrate lyase; citrate synthase	ACETYL-COENZYME; HISTONE ACETYLATION; RAT-LIVER; ACYL-COA; CELL; SYNTHASE; IDENTIFICATION; PHOSPHORYLATION; DENATURATION; METABOLISM	ATP-citrate lyase (ACLY) is a major source of nucleocytosolic acetyl-CoA, a fundamental building block of carbon metabolism in eukaryotes. ACLY is aberrantly regulated in many cancers, cardiovascular disease, and metabolic disorders. However, the molecular mechanisms determining ACLY activity and function are unclear. To this end, we investigated the role of the uncharacterized ACLY C-terminal citrate synthase homology domain in the mechanism of acetyl-CoA formation. Using recombinant, purified ACLY and a suite of biochemical and biophysical approaches, including analytical ultracentrifugation, dynamic light scattering, and thermal stability assays, we demonstrated that the C terminus maintains ACLY tetramerization, a conserved and essential quaternary structure in vitro and likely also in vivo. Furthermore, we show that the C terminus, only in the context of the full-length enzyme, is necessary for full ACLY binding to CoA. Together, we demonstrate that ACLY forms a homotetramer through the C terminus to facilitate CoA binding and acetyl-CoA production. Our findings highlight a novel and unique role of the C-terminal citrate synthase homology domain in ACLY function and catalysis, adding to the understanding of the molecular basis for acetyl-CoA synthesis by ACLY. This newly discovered means of ACLY regulation has implications for the development of novel ACLY modulators to target acetyl-CoA-dependent cellular processes for potential therapeutic use.	[Bazilevsky, Gleb A.; Campbell, Sydney L.; Wellen, Kathryn E.; Marmorstein, Ronen] Univ Penn, Grad Grp Cell & Mol Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bazilevsky, Gleb A.; Affronti, Hayley C.; Wei, Xuepeng; Campbell, Sydney L.; Wellen, Kathryn E.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA; [Wei, Xuepeng; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA; [Affronti, Hayley C.; Campbell, Sydney L.; Wellen, Kathryn E.] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Marmorstein, R (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA.; Marmorstein, R (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA.	marmor@upenn.edu		Bazilevsky, Gleb/0000-0001-5300-0643; Wellen, Kathryn/0000-0002-2281-0042; Campbell, Sydney/0000-0002-7861-5609; Marmorstein, Ronen/0000-0003-4373-4752	National Institutes of Health [R35 GM118090, P01 AG 031862, R01-CA228339, F31CA189559-01, F31CA217070, 4K00CA212455-03]; NATIONAL CANCER INSTITUTE [K00CA212455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118090, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R35 GM118090 and P01 AG 031862 (to R. M.), R01-CA228339 (to K. E. W.), F31CA189559-01 (to G. B.), F31CA217070 (to S. L. C.), and 4K00CA212455-03 (to H. C. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALEXANDER MC, 1982, J BIOL CHEM, V257, P2049; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; [Anonymous], 2017, J VIS EXP; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Bilen O, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0611-4; Bond DR, 2005, APPL ENVIRON MICROB, V71, P3858, DOI 10.1128/AEM.71.7.3858-3865.2005; Burke AC, 2017, CURR OPIN LIPIDOL, V28, P193, DOI 10.1097/MOL.0000000000000390; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; Chervenka C. H., 1969, MANUAL METHODS ANAL, P28; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Fan F, 2012, BIOCHEMISTRY-US, V51, P5198, DOI 10.1021/bi300611s; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gawryluk RMR, 2015, MOL PHYLOGENET EVOL, V91, P12, DOI 10.1016/j.ympev.2015.05.010; Grinberg VY, 2000, J BIOTECHNOL, V79, P269, DOI 10.1016/S0168-1656(00)00243-1; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; INOUE H, 1966, J BIOCHEM, V60, P543, DOI 10.1093/oxfordjournals.jbchem.a128474; Kanamori E, 2015, BIOPHYS PHYSICOBIOL, V12, P47, DOI 10.2142/biophysico.12.0_47; Kostanski LK, 2004, J BIOCHEM BIOPH METH, V58, P159, DOI 10.1016/j.jbbm.2003.10.001; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee Joyce V, 2013, Drug Discov Today Dis Mech, V10, pe55; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; LINN TC, 1979, J BIOL CHEM, V254, P1691; MCEVILY AJ, 1986, J BIOL CHEM, V261, P2593; McRorie D. K., 2004, SELF ASSOCIATING SYS, P8; Michnik A, 2005, BIOPHYS CHEM, V118, P93, DOI 10.1016/j.bpc.2005.06.012; Moore V, 2011, EXTREMOPHILES, V15, P327, DOI 10.1007/s00792-011-0363-6; Murphy JR, 2015, ACTA CRYSTALLOGR F, V71, P1292, DOI 10.1107/S2053230X15015939; Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o; Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pinkosky SL, 2017, TRENDS MOL MED, V23, P1047, DOI 10.1016/j.molmed.2017.09.001; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SINGH M, 1976, J BIOL CHEM, V251, P5242; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Sun TJ, 2010, J BIOL CHEM, V285, P27418, DOI 10.1074/jbc.M109.078667; Wang DY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698338; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095	49	12	12	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7259	7268		10.1074/jbc.RA118.006685	http://dx.doi.org/10.1074/jbc.RA118.006685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877197	hybrid, Green Published			2022-12-26	WOS:000468402900015
J	Howard, MJ; Foley, KG; Shock, DD; Batra, VK; Wilson, SH				Howard, Michael J.; Foley, K. Grace; Shock, David D.; Batra, Vinod K.; Wilson, Samuel H.			Molecular basis for the faithful replication of 5-methylcytosine and its oxidized forms by DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; DNA repair; DNA polymerase; base excision repair (BER); enzyme kinetics; 5-methylcytosine	MAMMALIAN DNA; KINETIC-ANALYSIS; 5-FORMYLCYTOSINE; BETA; 5-HYDROXYMETHYLCYTOSINE; EXCISION; CPG; 5-CARBOXYLCYTOSINE; OLIGONUCLEOTIDES; 8-OXOGUANINE	DNA methylation is an epigenetic mark that regulates gene expression in mammals. One method of methylation removal is through ten-eleven translocation-catalyzed oxidation and the base excision repair pathway. The iterative oxidation of 5-methylcytosine catalyzed by ten-eleven translocation enzymes produces three oxidized forms of cytosine: 5-hydroxmethylcytosine, 5-formylcytosine, and 5-carboxycytosine. The effect these modifications have on the efficiency and fidelity of the base excision repair pathway during the repair of opposing base damage, and in particular DNA polymerization, remains to be elucidated. Using kinetic assays, we show that the catalytic efficiency for the incorporation of dGTP catalyzed by human DNA polymerase is not affected when 5-methylcytosine, 5-hydroxmethylcytosine, and 5-formylcytosine are in the DNA template. In contrast, the catalytic efficiency of dGTP insertion decreases approximate to 20-fold when 5-carboxycytosine is in the templating position, as compared with unmodified cytosine. However, DNA polymerase fidelity is unaltered when these modifications are in the templating position. Structural analysis reveals that the methyl, hydroxymethyl, and formyl modifications are easily accommodated within the polymerase active site. However, to accommodate the carboxyl modification, the phosphate backbone on the templating nucleotide shifts approximate to 2.5 to avoid a potential steric/repulsive clash. This altered conformation is stabilized by lysine 280, which makes a direct interaction with the carboxyl modification and the phosphate backbone of the templating strand. This work provides the molecular basis for the accommodation of epigenetic base modifications in a polymerase active site and suggests that these modifications are not mutagenically copied during base excision repair.	[Howard, Michael J.; Foley, K. Grace; Shock, David D.; Batra, Vinod K.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel/E-6644-2019	Wilson, Samuel/0000-0002-1702-5293	National Institutes of Health [Z01ES50158, Z01ES050159, Z01ES050161]; Intramural Research Program of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, ZIAES050158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants Z01ES50158, Z01ES050159, and Z01ES050161 (to S. H. W.) from the Intramural Research Program of the NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra VK, 2012, P NATL ACAD SCI USA, V109, P113, DOI 10.1073/pnas.1112235108; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 2014, J BIOL CHEM, V289, P31411, DOI 10.1074/jbc.M114.607432; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Dai Q, 2016, ACS CHEM BIOL, V11, P470, DOI 10.1021/acschembio.5b00762; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Howard MJ, 2017, J BIOL CHEM, V292, P17473, DOI 10.1074/jbc.M117.801860; Howard MJ, 2017, NUCLEIC ACIDS RES, V45, P3822, DOI 10.1093/nar/gkx047; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iwan K, 2018, NAT CHEM BIOL, V14, P72, DOI [10.1038/NCHEMBIO.2531, 10.1038/nchembio.2531]; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Karino N, 2001, NUCLEIC ACIDS RES, V29, P2456, DOI 10.1093/nar/29.12.2456; Kasymov RD, 2013, FEBS LETT, V587, P3129, DOI 10.1016/j.febslet.2013.08.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Munzel M, 2011, CHEM-EUR J, V17, P13782, DOI 10.1002/chem.201102782; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Shibutani T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05220; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Szulik MW, 2015, BIOCHEMISTRY-US, V54, P1294, DOI 10.1021/bi501534x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Werneburg BG, 1996, BIOCHEMISTRY-US, V35, P7041, DOI 10.1021/bi9527202; Xing XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072993; Zhu CX, 2017, CELL STEM CELL, V20, P720, DOI 10.1016/j.stem.2017.02.013; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	42	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7194	7201		10.1074/jbc.RA118.006809	http://dx.doi.org/10.1074/jbc.RA118.006809			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885943	Green Published, hybrid			2022-12-26	WOS:000468402900009
J	Hsing, EW; Shiah, SG; Peng, HY; Chen, YW; Chuu, CP; Hsiao, JR; Lyu, PC; Chang, JY				Hsing, En-Wei; Shiah, Shine-Gwo; Peng, Hsuan-Yu; Chen, Ya-Wen; Chuu, Chih-Pin; Hsiao, Jenn-Ren; Lyu, Ping-Chiang; Chang, Jang-Yang			TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility	PLOS ONE			English	Article							ADHESION MOLECULES; INVASIVE ACTIVITY; CANCER; MICRORNA; SIGNATURE; CLAUDIN-1; REVEALS; DIFFERENTIATION; OVEREXPRESSION; PROLIFERATION	Distant metastasis leads oral cancer patients into a poor survival rate and a high recurrence stage. During tumor progression, dysregulated microRNAs (miRNAs) have been reported to involve tumor initiation and modulate oral cancer malignancy. MiR-450a was significantly upregulated in oral squamous cell carcinoma (OSCC) patients without functional reports. This study was attempted to uncover the molecular mechanism of novel miR-450a in OSCC. Mir-450a expression was examined by quantitative RT-PCR, both in OSCC cell lines and patients. Specific target of miR-450a was determined by software prediction, luciferase reporter assay, and correlation with target protein expression. The functions of miR-450a and TMEM182 were accessed by adhesion and transwell invasion analyses. Determination of the expression and cellular localization of TMEM182 was examined by RT-PCR and by immunofluorescence staining. The signaling pathways involved in regulation of miR-450a were investigated using the kinase inhibitors. Overexpression of miR-450a in OSCC cells impaired cell adhesion ability and induced invasiveness, which demonstrated the functional role of miR-450a as an onco-miRNA. Interestingly, tumor necrosis factor alpha (TNF-alpha)-mediated expression of TMEM182 was regulated by miR-450a induction. MiR-450areduced cellular adhesion was abolished by TMEM182 restoration. Furthermore, the oncogenic activity of TNF-alpha/miR-450a/TMEM182 axis was primarily through activating extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway. ERK1/2 inhibitor prevented the TNF-alpha-induced miR-450a expression and enhanced adhesion ability. Our data suggested that TNF-alpha-induced ERK1/2-dependent miR-450 aagainst TMEM182 expression exerted a great influence on increasing OSCC motility. Overall, our results provide novel molecular insights into how TNF-alpha contributes to oral carcinogenesis through miR-450a that targets TMEM182.	[Hsing, En-Wei; Shiah, Shine-Gwo; Peng, Hsuan-Yu; Chen, Ya-Wen; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Hsing, En-Wei; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Struct Biol Program, Hsinchu, Taiwan; [Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Hsiao, Jenn-Ren] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Otolaryngol Head & Neck,Collaborat Oncol Grp, Tainan, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Hematol & Oncol,Dept Internal Med, Tainan, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Chang, JY (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan.; Chang, JY (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Hematol & Oncol,Dept Internal Med, Tainan, Taiwan.	jychang@nhri.org.tw	Chen, Ya-Wen/AAG-7549-2019	Chen, Ya-Wen/0000-0002-6080-8859	National Health Research Institutes [NHRI-CA105-PP03, NHRI-CA106-PP03]; Ministry of Science and Technology, Taiwan [MOST-104-2314-B-400-018-MY2]; Ministry of Health and Welfare [MOHW 106-TDU-B-212-122015]; Structural Biology Program, Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Structural Biology Program, Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan	This work was supported by: National Health Research Institutes NHRI-CA105-PP03; National Health Research Institutes NHRI-CA106-PP03; Ministry of Science and Technology, Taiwan MOST-104-2314-B-400-018-MY2; and Ministry of Health and Welfare MOHW 106-TDU-B-212-122015 to SGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; En-Wei Hsing carried out his thesis research under the auspices of the Structural Biology Program, Institute of Bioinformatics and Structural Biology, National Tsing Hua University, Hsinchu, Taiwan.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bello IO, 2008, HUM PATHOL, V39, P1212, DOI 10.1016/j.humpath.2007.12.015; Brockmeyer P, 2014, INT J ONCOL, V45, P273, DOI 10.3892/ijo.2014.2394; Cheng ZP, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0193-y; Delic D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050665; Dernowsek JA, 2017, J CELL BIOCHEM, V118, P4045, DOI 10.1002/jcb.26060; Fukumoto I, 2015, BRIT J CANCER, V112, P891, DOI 10.1038/bjc.2015.19; Ghosh S, 2002, CANCER-AM CANCER SOC, V95, P2524, DOI 10.1002/cncr.10997; Gomes CC, 2008, ORAL ONCOL, V44, P910, DOI 10.1016/j.oraloncology.2008.01.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jerjes W, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-9; Jiang R, 2011, J BIOL CHEM, V286, P9127, DOI 10.1074/jbc.M110.191361; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Koperski L, 2017, ONCOTARGET, V8, P49191, DOI 10.18632/oncotarget.16788; Krishnan R, 2014, ASIAN PAC J CANCER P, V15, P7141, DOI 10.7314/APJCP.2014.15.17.7141; Lee LT, 2018, INT J ORAL MAX SURG, V47, P699, DOI 10.1016/j.ijom.2017.09.016; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lourenco SV, 2010, J CLIN PATHOL, V63, P609, DOI 10.1136/jcp.2009.070409; Lv YN, 2016, ONCOTARGET, V7, P52270, DOI 10.18632/oncotarget.10586; Lyons AJ, 2007, INT J ORAL MAX SURG, V36, P671, DOI 10.1016/j.ijom.2007.04.002; Manikandan M, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0512-8; Matsuba S, 2014, J PHARMACOL EXP THER, V351, P510, DOI 10.1124/jpet.114.217315; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Peng HY, 2016, MOL ONCOL, V10, P895, DOI 10.1016/j.molonc.2016.03.001; Qin Y, 2014, HUM MOL GENET, V23, P2428, DOI 10.1093/hmg/ddt638; Sahibzada HA, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7020021; Sappayatosok K, 2015, HEAD NECK PATHOL, V9, P173, DOI 10.1007/s12105-014-0559-z; Shiah SG, 2014, CANCER RES, V74, P7560, DOI 10.1158/0008-5472.CAN-14-0978; Stucky A, 2017, ONCOTARGET, V8, P73208, DOI 10.18632/oncotarget.18021; Su CC, 2007, J FORMOS MED ASSOC, V106, P225, DOI 10.1016/S0929-6646(09)60244-8; Tang DF, 2017, MED SCI MONIT BASIC, V23, P141, DOI 10.12659/MSMBR.903910; Thomas GJ, 2001, CRIT REV ORAL BIOL M, V12, P479, DOI 10.1177/10454411010120060301; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Weng ZH, 2011, EXP THER MED, V2, P951, DOI 10.3892/etm.2011.288; Wrzesinski T, BMC CANC; Wu Yu, 2008, BMC Res Notes, V1, P85, DOI 10.1186/1756-0500-1-85; Yoshizawa K, 2013, ONCOL REP, V29, P445, DOI 10.3892/or.2012.2161; Zeljic K, 2018, UPSALA J MED SCI, V123, P43, DOI 10.1080/03009734.2018.1439551; Zhang Y, 2017, J CELL SCI, V130, P1158, DOI 10.1242/jcs.197764; Zhang Y, 2014, GENOMICS, V104, P249, DOI 10.1016/j.ygeno.2014.06.004; Zhao LC, 2016, MOL BIOSYST, V12, P1860, DOI 10.1039/c6mb00203j; Zhou JP, 2015, AM J CANCER RES, V5, P1680	43	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213463	10.1371/journal.pone.0213463	http://dx.doi.org/10.1371/journal.pone.0213463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893332	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900042
J	Murray, S; Kishbaugh, JC; Hayek, LAC; Kutinsky, I; Dennis, PM; Devlin, W; Hope, KL; Danforth, MD; Murphy, HW				Murray, Suzan; Kishbaugh, Jennifer C.; Hayek, Lee-Ann C.; Kutinsky, Ilana; Dennis, Patricia M.; Devlin, William; Hope, Katharine L.; Danforth, Marietta D.; Murphy, Hayley W.			Diagnosing cardiovascular disease in western lowland gorillas (Gorilla gorilla gorilla) with brain natriuretic peptide	PLOS ONE			English	Article							HEART-FAILURE; UNITED-STATES; NT-PROBNP; BNP; MARKER	Cardiovascular disease is a leading cause of death in zoo-housed great apes, accounting for 41% of adult gorilla death in North American zoological institutions. Obtaining a timely and accurate diagnosis of cardiovascular disease in gorillas is challenging, relying on echocardiography which generally requires anesthetic medications that may confound findings and can cause severe side effects in cardiovascularly compromised animals. The measurement of brain natriuretic peptide (BNP) has emerged as a modality of interest in the diagnosis, prognosis and treatment of human patients with heart failure. This study evaluated records for 116 zoo-housed gorillas to determine relationships of BNP with cardiovascular disease. Elevations of BNP levels correlated with the presence of visible echocardiographic abnormalities, as well as reported clinical signs in affected gorillas. Levels of BNP greater 150 pb/mL should alert the clinician to the presence of myocardial strain and volume overload, warranting medical evaluation and intervention.	[Murray, Suzan; Kishbaugh, Jennifer C.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Global Hlth Program, Washington, DC 20008 USA; [Kishbaugh, Jennifer C.] BodeVet Inc, Rockville, MD 20850 USA; [Hayek, Lee-Ann C.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kutinsky, Ilana] William Beaumont Hosp, Dept Cardiovasc Med, Royal Oak, MI 48072 USA; [Dennis, Patricia M.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Dennis, Patricia M.] Cleveland Metropk Zoo, Cleveland, OH USA; [Devlin, William] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Hope, Katharine L.] Smithsonian Natl Zool Pk, Dept Anim Hlth, Washington, DC USA; [Danforth, Marietta D.; Murphy, Hayley W.] Zoo Atlanta, Great Ape Heart Project, Atlanta, GA USA; [Murphy, Hayley W.] Zoo Atlanta, Anim Div, Atlanta, GA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Beaumont Health; University System of Ohio; Ohio State University; Oakland University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Kishbaugh, JC (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Global Hlth Program, Washington, DC 20008 USA.; Kishbaugh, JC (corresponding author), BodeVet Inc, Rockville, MD 20850 USA.	KishbaughJ@si.edu		Danforth, Marietta/0000-0002-9021-0719	Zoo Atlanta; Institute of Museum and Library Services [LG-26-12-0526-12, MG-30-15-0035-15]	Zoo Atlanta; Institute of Museum and Library Services	The Great Ape Heart Project (MDD, HWM) is funded by Zoo Atlanta and grants from the Institute of Museum and Library Services (LG-26-12-0526-12 and MG-30-15-0035-15). Their websites are located at (https//www.imls.gov/grants/awarded/lg-26-12-0526-12) and (https II greatapeheartproject.org/about/about-imls/), respectively. This work was made possible by Msupport from the Smithsonian Conservation Biology Institute (SM, LCH) and BodeVet Inc. (JCK). The Great Ape Heart Project is funded by Zoo Atlanta and grants from the Institute of Museum and Library Services (LG-26-12-0526-12 and MG-30-15-0035-15). JCK is employed by BodeVet, Inc. BodeVet, Inc. provided support in the form of salaries for author JCK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bettencourt P, 2002, CARDIOVASC DRUG REV, V20, P27; Dhaliwal AS, 2009, J CARD FAIL, V15, P293, DOI 10.1016/j.cardfail.2008.11.007; Gamble KC, 2004, ANN C AM ASS ZOO VET, P561; Hunt PJ, 1997, CLIN ENDOCRINOL, V47, P287, DOI 10.1046/j.1365-2265.1997.2361058.x; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Maisel AS, 2004, AM HEART J, V147, P1078, DOI 10.1016/j.ahj.2004.01.013; McManamon Rita, 2012, P408; Murphy HW, 2011, J ZOO WILDLIFE MED, V42, P572, DOI 10.1638/2010-0139.1; Raizada A, 2007, INDIAN J CLIN BIOCHE, V22, P4, DOI 10.1007/BF02912873; Rush EM, 2011, J ZOO WILDLIFE MED, V42, P263, DOI 10.1638/2009-0080.1; SCHULMAN FY, 1995, J ZOO WILDLIFE MED, V26, P43; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Srisawasdi P, 2010, AM J CLIN PATHOL, V133, P14, DOI 10.1309/AJCP60HTPGIGFCNK	14	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214101	10.1371/journal.pone.0214101	http://dx.doi.org/10.1371/journal.pone.0214101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889217	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000050
J	Guasque, A; Balbastre, P; Crespo, A; Peiro, S				Guasque, Ana; Balbastre, Patricia; Crespo, Alfons; Peiro, Salva			Energy efficient partition allocation in mixed-criticality systems	PLOS ONE			English	Article								This paper addresses the problem of energy management of mixed criticality applications in a multi-core partitioned architecture. Instead of focusing on new scheduling algorithms to adjust frequency in order to save energy, we propose a partition to CPU allocation that takes into account not only the different frequencies at which the CPU can operate but the level of criticality of the partitions. The goal is to provide a set of pre-calculated allocations, called profiles, so at run time the system can switch to different modes depending on the battery level. These profiles achieve different levels of energy saving and performance applying different strategies. We also present a comparison in terms of energy saving of the most used bin-packing algorithms for partition allocation. As this is an heuristic, it is not possible to ensure that our results involve the minimum energy consumption. For this reason, we also provide a comparison with a exact method, such as constraint programming.	[Guasque, Ana; Balbastre, Patricia; Crespo, Alfons] Univ Politecn Valencia, Inst Automat & Informat Ind, Valencia, Spain; [Peiro, Salva] Fent Innovat Software Solut SL, Valencia, Spain	Universitat Politecnica de Valencia	Guasque, A (corresponding author), Univ Politecn Valencia, Inst Automat & Informat Ind, Valencia, Spain.	anguaor@ai2.upv.es	Guasque, Ana/Z-5172-2019; Guasque, Ana/L-3130-2017; Crespo, Alfons/AAB-5709-2020; Balbastre, Patricia/L-8447-2014	Guasque, Ana/0000-0002-2900-8466; Guasque, Ana/0000-0002-2900-8466; Crespo, Alfons/0000-0002-6606-7406; Balbastre, Patricia/0000-0001-9458-4083	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES) [TIN2014-56158-C4-1-P]; H2020 LEIT Information and Communication Technologies [687902]; FP7 Information and Communication Technologies [610640]	Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES); H2020 LEIT Information and Communication Technologies; FP7 Information and Communication Technologies	This work was supported by Ministerio de Economia, Industria y Competitividad, Gobierno de Espana (ES), Award Number TIN2014-56158-C4-1-P, Grant Recipient Alfons Crespo (AC) and Patricia Balbastre (PB); H2020 LEIT Information and Communication Technologies, Award Number 687902, Grant Recipient Fent Innovative Software Solutions, FentISS Salva Peiro (SP), URL http://safepower-project.eu/.The author Salva Peiro (SP) is employed by Fent Innovative Software Solutions, FentISS. Fent Innovative Software Solutions provided support in the form of salary for author SP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. This work was also supported by FP7 Information and Communication Technologies, Award Number 610640, Grant Recipient Alfons Crespo (AC), URL http://www.dreams-project.eu/. No other individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1996, ARINC653; Awan M. A., 2016, 2016 11 IEEE S IND E, P1; Aydin Hakan, 2003, P INT PAR DISTR PROC; Bambagini M, 2016, ACM T EMBED COMPUT S, V15, DOI 10.1145/2808231; Bini E, 2005, REAL-TIME SYST, V30, P129, DOI 10.1007/s11241-005-0507-9; Chen JC, 2015, PR IEEE I C PROGR IN, P521, DOI 10.1109/PIC.2015.7489902; Chen JC, 2016, REAL-TIME SYST, V52, P239, DOI 10.1007/s11241-015-9226-z; Commision E, 2012, WORKSH MIX CRIT SYST; Davis RI, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1978802.1978814; Devadas Vinay, 2010, 2010 International Conference on Green Computing (Green Comp), P61, DOI 10.1109/GREENCOMP.2010.5598261; Graydon P, 2013, SAFETY ASSURANCE DRI, P19; Heinecke H, AUTOSAR IND WIDE INI, P203; Huiting Xu, 2012, 2012 IEEE 18th International Conference on Embedded and Real-Time Computing Systems and Applications (RTCSA 2012), P98, DOI 10.1109/RTCSA.2012.10; IMA, 2011, 4000100764 IMASP ESA; Legout V, 2013, 1 WORKSH REAL TIM MI; Lenz A, 2016, 19TH EUROMICRO CONFERENCE ON DIGITAL SYSTEM DESIGN (DSD 2016), P294, DOI 10.1109/DSD.2016.64; LIU CL, 1973, J ACM, V20, P46, DOI 10.1145/321738.321743; Mittal S., 2014, CORR; Mollison Malcolm S., 2010, Proceedings of the 2010 IEEE 10th International Conference on Computer and Information Technology (CIT 2010), P1864, DOI 10.1109/CIT.2010.320; Motruk B, 2013, POWER MONITORING MIX, P13; Narayana S., 2016, 2016 IEEE REAL TIM E, P1; Rushby J., 1999, PARTITIONING AVIONIC; Vaidehi M., 2008, J RES IND, V1, P30; Vestal S, 2007, REAL TIM SYST S RTSS; Volp M, 2014, IEEE REAL TIME, P275, DOI 10.1109/RTAS.2014.6926009; Windsor J, 2009, SMC-IT 2009: THIRD IEEE INTERNATIONAL CONFERENCE ON SPACE MISSION CHALLENGES FOR INFORMATION TECHNOLOGY, PROCEEDINGS, P13, DOI 10.1109/SMC-IT.2009.11; Xu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152463	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213333	10.1371/journal.pone.0213333	http://dx.doi.org/10.1371/journal.pone.0213333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883549	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500012
J	Merson, SD; Dollar, LJ; Johnson, PJ; Macdonald, DW				Merson, Samuel D.; Dollar, Luke J.; Johnson, Paul J.; Macdonald, David W.			Retaliatory killing and human perceptions of Madagascar's largest carnivore and livestock predator, the fosa (Cryptoprocta ferox)	PLOS ONE			English	Article							SOCIAL DESIRABILITY BIAS; BUSHMEAT CONSUMPTION; RAIN-FORESTS; DENSITY; CONSERVATION; EXTINCTION; CONFLICT; PATTERNS; VALIDITY; TORPOR	Fosas (Cryptoprocta ferox) are Madagascar's largest carnivores, occupying much of the island's forested landscape. This study provides the first evaluation of fosas' conflict with humans, a problem for many small and medium sized carnivores worldwide. We examined fosas' predation of poultry, and the subsequent retaliatory killing. Over 1750 households were interviewed across four regions, encompassing Madagascar's major forest types (deciduous/rainforest) and protected area classifications (national park, reserve and unprotected forest). Predation by fosa was the third highest reported cause (15%) of poultry mortality, with little evidence that coops were effective in reducing predation. Predation of poultry was more prevalent in deciduous forests, and most common during the evenings of the dry season. Over half of all interviewees said they disliked fosas, with loss of poultry the most commonly stated reason. Respondents' that had suffered poultry depredation and those with lower educational attainment were more likely to dislike fosas. Interviewees that disliked fosas and those that were wealthier were most likely to report having killed a fosa. A minimum of thirty fosas was killed in retaliation by our respondents during the year before the interviews. Given that the fosa population is in decline, and most of Madagascar's forests are likely to be too small to support sustainable populations, these killings may be detrimental to vulnerable sub-populations. These results shed insight into the cultural perceptions and predation patterns of a medium sized carnivore, with relevance to worldwide human-wildlife conflict of often overlooked smaller carnivores. We suggest that educational programs, guard dogs, poultry disease vaccinations and robust coop construction may be effective for improving attitudes and reducing retaliatory killing.	[Merson, Samuel D.] Zool Soc London, Regents Pk, London, England; [Dollar, Luke J.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Dollar, Luke J.] Catawba Coll, Dept Environm & Sustainabil, Ctr Environm, Salisbury, NC USA; [Johnson, Paul J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	Zoological Society of London; Duke University; University of Oxford	Merson, SD (corresponding author), Zool Soc London, Regents Pk, London, England.	samuel.merson@zsl.org	Merson, Samuel/AAJ-1139-2021	Merson, Samuel/0000-0003-1544-4790	Megafaun; Duisburg Zoo; Wadham College Pollard	Megafaun; Duisburg Zoo; Wadham College Pollard	Megafaun provided funding for SDM to complete fieldwork and data collection in 2015 (http://megafaun.org/).Duisburg Zoo provided funding for SDM to complete fieldwork and data collection in 2015 (http://www.zoo-duisburg.de/artenschutz/fossa-fonds/).Wadham College Pollard fund provided funding for SDM to complete fieldwork in 2014 and 2015 (http://www.wadham.ox. ac.uk/students/graduate-students/graduate-finance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albignac R, 1973, FAUNE MADAGASCAR, V36; Alkire S., 2015, MULTIDIMENSIONAL POV, DOI 10.1093/acprof:oso/9780199689491.003.0005; [Anonymous], 2021, LANG ENV STAT COMP; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Dausmann KH, 2009, J COMP PHYSIOL B, V179, P345, DOI 10.1007/s00360-008-0318-0; Dickman A.J., 2013, KEY TOPICS CONSERVAT, P110; Dollar LJ, 2006, MORPHOMETRICS DIET C, DOI DOI 10.1126/science.1139518; Dollar L, 2007, DEV PRIMATOL-PROG PR, P63, DOI 10.1007/978-0-387-34810-0_3; Dollar Luke, 1999, Small Carnivore Conservation, V20, P7; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Farris ZJ, 2015, J ZOOL, V296, P45, DOI 10.1111/jzo.12216; Farris ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136456; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Garcia G, 2003, ORYX, V37, P115, DOI 10.1017/S0030605303000206; Gardner CJ, 2014, HUM ECOL, V42, P21, DOI 10.1007/s10745-013-9629-1; Gerber B, 2010, ORYX, V44, P219, DOI 10.1017/S0030605309991037; Gerber BD, 2012, ORYX, V46, P414, DOI 10.1017/S0030605311001116; Gerber BD, 2012, J MAMMAL, V93, P667, DOI 10.1644/11-MAMM-A-265.1; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Hardeman W, 2002, PSYCHOL HEALTH, V17, P123, DOI 10.1080/08870440290013644a; Hawkins AF, 2016, CRYPTOPROCTA FEROX I; Hawkins CE, 2005, ORYX, V39, P35, DOI 10.1017/S0030605305000074; Hawkins CE, 1998, BEHAV ECOLOGY FOSSA; Hawkins CE, 2008, J MAMMAL, V89, P64, DOI 10.1644/06-MAMM-A-366.1; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Keane A, 2011, CONSERV LETT, V4, P55, DOI 10.1111/j.1755-263X.2010.00144.x; King MF, 2000, PSYCHOL MARKET, V17, P79, DOI 10.1002/(SICI)1520-6793(200002)17:2<79::AID-MAR2>3.0.CO;2-0; KRUUK H, 1972, J ZOOL, V166, P233, DOI 10.1111/j.1469-7998.1972.tb04087.x; Logan MK, 2015, ANIM CONSERV, V18, P82, DOI 10.1111/acv.12137; Lovegrove BG, 2008, J COMP PHYSIOL B, V178, P691, DOI 10.1007/s00360-008-0257-9; Luhrs ML, 2013, BEHAV ECOL SOCIOBIOL, V67, P1731, DOI 10.1007/s00265-013-1581-y; Luhrs ML, 2012, SOCIAL ORG MATING SY; Lyman C. P., 2013, HIBERNATION TORPOR M; Macdonald D.W., 2017, BIOL CONSERVATION MU; Macdonald D. W., 2015, WILDLIFE CONSERVATIO, V2; Maminiaina OF, 2007, REV SCI TECH OIE, V26, P691, DOI 10.20506/rst.26.3.1776; Manjaribe C, 2013, INTERJ ECOL, V2013, DOI [10.1155/2013/726275, DOI 10.1155/2013/726275]; Merson S.D., 2018, THESIS; MNP. Madagascar National Parks One Association, 2014, ON MISS; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; Rakotoarivelo Andrinajoro R., 2011, Madagascar Conservation & Development, V6, P37; Razafimanahaka JH, 2012, ORYX, V46, P584, DOI 10.1017/S0030605312000579; Ruud J., 1960, TABOO STUDY MALAGASY; Schmid J, 2000, OECOLOGIA, V123, P175, DOI 10.1007/s004420051003; Sillero-Zubiri C, 2001, CONSERV BIOL SER, V5, P282; SINGER E, 1995, PUBLIC OPIN QUART, V59, P66, DOI 10.1086/269458; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Valenta Kim, 2016, Madagascar Conservation & Development, V11, P87; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zinner D, 2014, REG ENVIRON CHANGE, V14, P157, DOI 10.1007/s10113-013-0475-x	57	11	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213341	10.1371/journal.pone.0213341	http://dx.doi.org/10.1371/journal.pone.0213341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875372	gold, Green Published, Green Submitted			2022-12-26	WOS:000461316400012
J	Falcon, T; Pinheiro, DG; Ferreira-Caliman, MJ; Turatti, ICC; de Abreu, FCP; Galaschi-Teixeira, JS; Martins, JR; Elias-Neto, M; Soares, MPM; Laure, MB; Figueiredo, VLC; Lopes, NP; Simoes, ZLP; Garofalo, CA; Bitondi, MMG				Falcon, Tiago; Pinheiro, Daniel G.; Ferreira-Caliman, Maria Juliana; Turatti, Izabel C. C.; Pinto de Abreu, Fabiano C.; Galaschi-Teixeira, Juliana S.; Martins, Juliana R.; Elias-Neto, Moyses; Soares, Michelle P. M.; Laure, Marcela B.; Figueiredo, Vera L. C.; Lopes, Norberto Peporine; Simoes, Zila L. P.; Garofalo, Carlos A.; Bitondi, Marcia M. G.			Exploring integument transcriptomes, cuticle ultrastructure, and cuticular hydrocarbons profiles in eusocial and solitary bee species displaying heterochronic adult cuticle maturation	PLOS ONE			English	Article							CHITIN SYNTHASE; INSECT CUTICLE; GENE LISTS; HONEY-BEE; TRIBOLIUM-CASTANEUM; DOPA DECARBOXYLASE; ANOPHELES-GAMBIAE; DEPOSITION RHYTHM; QUALITY-CONTROL; GROWTH-FACTORS	Differences in the timing of exoskeleton melanization and sclerotization are evident when comparing eusocial and solitary bees. This cuticular maturation heterochrony may be associated with life style, considering that eusocial bees remain protected inside the nest for many days after emergence, while the solitary bees immediately start outside activities. To address this issue, we characterized gene expression using large-scale RNA sequencing (RNA-seq), and quantified cuticular hydrocarbon (CHC) through gas chromatography-mass spectrometry in comparative studies of the integument (cuticle plus its underlying epidermis) of two eusocial and a solitary bee species. In addition, we used transmission electron microscopy (TEM) for studying the developing cuticle of these and other three bee species also differing in life style. We found 13,200, 55,209 and 30,161 transcript types in the integument of the eusocial Apis mellifera and Frieseomelitta varia, and the solitary Centris analis, respectively. In general, structural cuticle proteins and chitin-related genes were upregulated in pharate-adults and newly-emerged bees whereas transcripts for odorant binding proteins, cytochrome P450 and antioxidant proteins were overrepresented in foragers. Consistent with our hypothesis, a distance correlation analysis based on the differentially expressed genes suggested delayed cuticle maturation in A. mellifera in comparison to the solitary bee. However, this was not confirmed in the comparison with F. varia. The expression profiles of 27 of 119 genes displaying functional attributes related to cuticle formation/differentiation were positively correlated between A. mellifera and F. varia, and negatively or non-correlated with C. analis, suggesting roles in cuticular maturation heterochrony. However, we also found transcript profiles positively correlated between each one of the eusocial species and C. analis. Gene co-expression networks greatly differed between the bee species, but we identified common gene interactions exclusively between the eusocial species. Except for F. varia, the TEM analysis is consistent with cuticle development timing adapted to the social or solitary life style. In support to our hypothesis, the absolute quantities of n-alkanes and unsaturated CHCs were significantly higher in foragers than in the earlier developmental phases of the eusocial bees, but did not discriminate newly-emerged from foragers in C. analis. By highlighting differences in integument gene expression, cuticle ultrastructure, and CHC profiles between eusocial and solitary bees, our data provided insights into the process of heterochronic cuticle maturation associated to the way of life.	[Falcon, Tiago; Pinto de Abreu, Fabiano C.; Martins, Juliana R.; Soares, Michelle P. M.; Laure, Marcela B.] Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil; [Falcon, Tiago] Hosp Clin Porto Alegre, Nucleo Bioinformat, Porto Alegre, RS, Brazil; [Pinheiro, Daniel G.] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Jaboticabal, Brazil; [Ferreira-Caliman, Maria Juliana; Galaschi-Teixeira, Juliana S.; Elias-Neto, Moyses; Figueiredo, Vera L. C.; Simoes, Zila L. P.; Garofalo, Carlos A.; Bitondi, Marcia M. G.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, Brazil; [Turatti, Izabel C. C.; Lopes, Norberto Peporine] Univ Sao Paulo, Dept Fis & Quim, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo	Falcon, T (corresponding author), Univ Sao Paulo, Dept Genet, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.; Falcon, T (corresponding author), Hosp Clin Porto Alegre, Nucleo Bioinformat, Porto Alegre, RS, Brazil.; Bitondi, MMG (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, Brazil.	tiagofalconlopes@gmail.com; mmgbit@usp.br	Elias-Neto, Moysés/B-6437-2012; Lopes, Tiago Falcon/U-5883-2019; Martins, Juliana Ramos/F-6726-2012; Lopes, Norberto P/C-7148-2012; Lopes, Tiago F/G-3409-2016; Guariz Pinheiro, Daniel/H-4604-2012; Martins, Juliana Ramos/AAD-4694-2021	Lopes, Norberto P/0000-0002-8159-3658; Lopes, Tiago F/0000-0002-8936-0381; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Martins, Juliana Ramos/0000-0002-7185-6477; Simoes, Zila Luz Paulino/0000-0003-2363-6178; Galaschi-Teixeira, Juliana Stephanie/0000-0002-6003-7708; Ferreira-Caliman, Maria Juliana/0000-0002-1262-780X	Sao Paulo Research Foundation (FAPESP) [2014/13136-0, 2011/03171-5, 2014/50265-3]; PNPD Programa Nacional de Pos-Doutorado CAPES/HCPA [88887.160608/2017-00]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001];  [FAPESP 2012/24284-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PNPD Programa Nacional de Pos-Doutorado CAPES/HCPA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); 	This work was supported by Sao Paulo Research Foundation (FAPESP) grants to MMGB (2014/13136-0), ZLPS (2011/03171-5), and NPL (2014/50265-3). Fellowships to TF (FAPESP 2012/24284-5 and PNPD Programa Nacional de Pos-Doutorado CAPES/HCPA 88887.160608/2017-00). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali MS, 2013, GENE, V512, P337, DOI 10.1016/j.gene.2012.09.126; Ampasala DR, 2011, ARCH INSECT BIOCHEM, V76, P83, DOI 10.1002/arch.20404; Andersen SO, 1998, INSECT BIOCHEM MOLEC, V28, P421, DOI 10.1016/S0965-1748(98)00028-9; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Andrews S., 2010, FASTQC QUALITY CONTR; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Augusto SC, 1994, ENCONTRO ABELHAS, P171; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Blomquist G.J., 1985, P117; Blomquist G. J., 2012, INSECT ENDOCRINOLOGY, P523; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; CARROLL SB, 1988, GENE DEV, V2, P883, DOI 10.1101/gad.2.7.883; Chaudhari SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004537; Chaudhari SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003268; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Costa CP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167421; Csikos G, 1999, J CELL SCI, V112, P2113; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; da Silva-Matos EV, 2000, REV BIOL TROP, V48, P657; de Jesus BMV, 2000, APIDOLOGIE, V31, P503, DOI 10.1051/apido:2000142; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; EDNEY EB, 1967, SCIENCE, V156, P1059, DOI 10.1126/science.156.3778.1059; Elias-Neto M, 2014, APIDOLOGIE, V45, P397, DOI 10.1007/s13592-013-0254-1; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Elias-Neto M, 2009, APIDOLOGIE, V40, P29, DOI 10.1051/apido:2008064; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Falcon T, 2014, INSECT BIOCHEM MOLEC, V50, P68, DOI 10.1016/j.ibmb.2014.04.006; Fay DS, 2013, WORM BOOK; Ferreira-Caliman MJ, 2010, J INSECT PHYSIOL, V56, P800, DOI 10.1016/j.jinsphys.2010.02.004; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Freiria GA, 2017, APIDOLOGIE, V48, P523, DOI 10.1007/s13592-017-0496-4; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; GAROFALO CA, 1985, ENTOMOL GEN, V11, P77; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Gibbs AG, 1998, AM ZOOL, V38, P471; Gibbs AG, 2002, J INSECT PHYSIOL, V48, P391, DOI 10.1016/S0022-1910(02)00059-8; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu J, 2013, INSECT BIOCHEM MOLEC, V43, P794, DOI 10.1016/j.ibmb.2013.06.001; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HANSELL MH, 1993, FUNCT ECOL, V7, P5, DOI 10.2307/2389861; Hepburn H.R., 1985, P1; Hill RJ, 2013, ANNU REV ENTOMOL, V58, P251, DOI 10.1146/annurev-ento-120811-153610; Hinaux H, 2018, DEV BIOL, V438, P111, DOI 10.1016/j.ydbio.2018.04.003; Hipfner DR, 1999, BIOESSAYS, V21, P718, DOI 10.1002/(SICI)1521-1878(199909)21:9<718::AID-BIES2>3.0.CO;2-Z; HIRUMA K, 1985, J COMP PHYSIOL B, V155, P659, DOI 10.1007/BF00694579; Hiruma K, 2007, MOL CELL ENDOCRINOL, V276, P71, DOI 10.1016/j.mce.2007.07.002; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG ZY, 1991, J INSECT PHYSIOL, V37, P733, DOI 10.1016/0022-1910(91)90107-B; Ikeno T, 2011, INSECT MOL BIOL, V20, P409, DOI 10.1111/j.1365-2583.2011.01075.x; Ioannidou ZS, 2014, INSECT BIOCHEM MOLEC, V52, P51, DOI 10.1016/j.ibmb.2014.06.004; Ito C, 2008, P NATL ACAD SCI USA, V105, P8446, DOI 10.1073/pnas.0800145105; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; Kapheim KM, 2015, SCIENCE, V348, P1139, DOI 10.1126/science.aaa4788; Kather R, 2011, J CHEM ECOL, V37, P205, DOI 10.1007/s10886-011-9909-4; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kramer K.J., 1985, P75; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; LOCKE M, 1971, TISSUE CELL, V3, P103, DOI 10.1016/S0040-8166(71)80034-4; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; MICHENER CD, 1974, SOCIAL BEHAV BEES; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Soares MPM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-576; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Miyazaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092875; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; Nunes TM, 2008, ANIM BEHAV, V75, P1165, DOI 10.1016/j.anbehav.2007.08.028; Osanai-Futahashi M, 2016, HEREDITY, V116, P135, DOI 10.1038/hdy.2015.74; Pan PL, 2018, P NATL ACAD SCI USA, V115, P5175, DOI 10.1073/pnas.1716951115; Paulmier I, 1999, J CHEM ECOL, V25, P471, DOI 10.1023/A:1020993518226; Pesch YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18340; PIEK T, 1964, J INSECT PHYSIOL, V10, P563, DOI 10.1016/0022-1910(64)90027-7; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Reddy KL, 2006, DEV BIOL, V289, P100, DOI 10.1016/j.ydbio.2005.10.042; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Sadd BM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0623-3; Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Shaik KS, 2012, EUR J CELL BIOL, V91, P204, DOI 10.1016/j.ejcb.2011.11.005; Shamim G, 2014, EUR J ENTOMOL, V111, P149, DOI 10.14411/eje.2014.021; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soares MPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020513; Solano F., 2014, NEW J SCI, V2014, P498276, DOI [10.1155/2014/498276, DOI 10.1155/2014/498276]; Song Q., 2012, INSECT ENDOCRINOLOGY, P93; Sonnhammer ELL, 2015, NUCLEIC ACIDS RES, V43, pD234, DOI 10.1093/nar/gku1203; Stubenhaus BM, 2016, ELIFE, V5, DOI 10.7554/eLife.14175; Sugumaran M, 2009, PIGM CELL MELANOMA R, V22, P523, DOI 10.1111/j.1755-148X.2009.00608.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; Tellam RL, 2000, EUR J BIOCHEM, V267, P6025, DOI 10.1046/j.1432-1327.2000.01679.x; THOMPSON M, 1995, ANALYST, V120, P29; Tian L, 2018, PEERJ, V6, DOI 10.7717/peerj.6089; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; WHITTEN JM, 1969, J MORPHOL, V127, P73, DOI 10.1002/jmor.1051270105; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Wilson E.O., 1975, P1; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; WRIGHT TRF, 1987, ADV GENET, V24, P127, DOI 10.1016/s0065-2660(08)60008-5; Xi Y, 2014, INSECT MOL BIOL, V23, P695, DOI 10.1111/imb.12113; Zander R. H., 2004, PHYLOINFORMATICS, V2, P1; ZELAZNY B, 1972, J INSECT PHYSIOL, V18, P1967, DOI 10.1016/0022-1910(72)90166-7; Zhao DB, 2000, DEV GENES EVOL, V210, P449, DOI 10.1007/s004270000081; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhu QS, 2008, P NATL ACAD SCI USA, V105, P6650, DOI 10.1073/pnas.0800739105; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	141	12	12	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213796	10.1371/journal.pone.0213796	http://dx.doi.org/10.1371/journal.pone.0213796			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870522	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300079
J	Karimi, K; Sargolzaei, M; Plastow, GS; Wang, ZQ; Miar, Y				Karimi, Karim; Sargolzaei, Mehdi; Plastow, Graham Stuart; Wang, Zhiquan; Miar, Younes			Opportunities for genomic selection in American mink: A simulation study	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; SINGLE-STEP; NEOVISON-VISON; VALIDATION METHODS; FULL PEDIGREE; PREDICTION; TRAITS; INFORMATION; HOLSTEIN; ACCURACIES	Genomic selection can be considered as an effective tool for developing breeding programs in American mink. However, the genetic gains for economically important traits can be influenced by the accuracy of genomic predictions. The objective of this study was to investigate the prediction accuracies of traditional best linear unbiased prediction (BLUP), multi-step genomic BLUP (GBLUP) and single-step GBLUP (ssGBLUP) methods in American mink using simulated data with different levels of heritability, marker density, training set (TS) sizes and selection designs based on either phenotypic performance or estimated breeding values (EBVs). Under EBV selection design, the accuracy of BLUP predictions was increased by 38% and 44% for h(2) = 0.10, 27% and 29% for h(2) = 0.20, and 5.8% and 6% for h(2) = 0.50 using GBLUP and ssGBLUP methods, respectively. Under phenotypic selection design, the accuracies of prediction by ssGBLUP method were 11.8% and 15.4% higher than those obtained by GBLUP for heritability of 0.10 and 0.20, respectively. However, the efficiency of ssGBLUP and GBLUP was not influenced by selection design at higher level of heritability (h(2) = 0.50). Furthermore, higher selection intensity increased the bias of predictions in both pedigree-based and genomic evaluations. Regardless of selection design, TS sizes for GBLUP and ssGBLUP methods should be at least 3000 to achieve more accuracy than using BLUP for heritability of 0.50 and marker density of 10k and 50k. Overall, more accurate predictions were obtained using ssGBLUP method particularly for lowly heritable traits and low density of markers. Our results indicated that TS sizes should be optimized in accordance with heritability level, marker density, selection design and prediction method for genomic selection in American mink. The results provided an initial framework for designing genomic selection in mink breeding programs.	[Karimi, Karim; Miar, Younes] Dalhousie Univ, Dept Anim Sci & Aquaculture, Truro, NS, Canada; [Sargolzaei, Mehdi] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Sargolzaei, Mehdi] Select Sires Inc, Plain City, OH USA; [Plastow, Graham Stuart; Wang, Zhiquan] Univ Alberta, Livestock Gentec, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Dalhousie University; University of Guelph; University of Alberta	Miar, Y (corresponding author), Dalhousie Univ, Dept Anim Sci & Aquaculture, Truro, NS, Canada.	miar@dal.ca		Miar, Younes/0000-0001-9933-5414	Mitacs; Nova Scotia Mink Breeders Association; Mink Veterinary Consulting & Research Service Ltd	Mitacs; Nova Scotia Mink Breeders Association; Mink Veterinary Consulting & Research Service Ltd	The authors are grateful to Mitacs, Nova Scotia Mink Breeders Association, and Mink Veterinary Consulting & Research Service Ltd for the financial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Select Sires Inc. provided support in the form of salaries for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Anistoroaei R, 2012, GENE, V511, P66, DOI 10.1016/j.gene.2012.08.033; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Bijma P, 2012, J ANIM BREED GENET, V129, P345, DOI 10.1111/j.1439-0388.2012.00991.x; Brito FV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-80; Brito LF, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0476-8; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Cai ZX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15169-z; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Chen CY, 2011, J ANIM SCI, V89, P23, DOI 10.2527/jas.2010-3071; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Erbe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081046; Gao HD, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-8; Gautason K, 2017, GENOMIC SELECTION MI; Goddard M.E., 2010, P 9 WORLD C GEN APPL; Gowane GR, 2018, BIORXIV; Guarini AR, 2018, J DAIRY SCI, V101, P8076, DOI 10.3168/jds.2017-14193; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Karimi K, 2018, J ANIM SCI, V96, P2596, DOI 10.1093/jas/sky178; Kennedy BW, 1988, J DAIRY SCI S2, V71, P17, DOI DOI 10.1016/S0022-0302(88)79975-0; Lecis R, 2008, CONSERV GENET, V9, P1149, DOI 10.1007/s10592-007-9428-6; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Legarra A., 2011, GS3 GENOMIC SELECTIO; Legarra A, 2014, LIVEST SCI, V166, P54, DOI 10.1016/j.livsci.2014.04.029; Lourenco DAL, 2015, J ANIM SCI, V93, P2653, DOI 10.2527/jas.2014-8836; Lourenco DAL, 2014, J DAIRY SCI, V97, P1742, DOI 10.3168/jds.2013-6916; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Mehrban H, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-016-0283-0; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2016, ANIM FRONT, V6, P6, DOI 10.2527/af.2016-0002; Misztal I., 2017, Interbull Bulletin, P38; Misztal I., 2002, P 7 WORLD C GEN APPL; Misztal I, 2013, POULTRY SCI, V92, P2530, DOI 10.3382/ps.2012-02739; Ogawa S, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-15; Olson KM, 2011, J DAIRY SCI, V94, P2613, DOI 10.3168/jds.2010-3877; Piccoli ML, 2018, CAN J ANIM SCI, V98, P565, DOI 10.1139/cjas-2017-0176; Putz AM, 2018, J ANIM BREED GENET, V135, P5, DOI 10.1111/jbg.12302; Rabier CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156086; Samore AB, 2015, ANIMAL, V9, P750, DOI 10.1017/S1751731114002924; Samore AB, 2016, ITAL J ANIM SCI, V15, P211, DOI 10.1080/1828051X.2016.1172034; Sargolzaei M., 2021, ONTARIO VET COLL; Sargolzaei M, 2009, BIOINFORMATICS, V25, P680, DOI 10.1093/bioinformatics/btp045; Silva RMO, 2016, J ANIM SCI, V94, P3613, DOI 10.2527/jas.2016-0401; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Song H, 2017, J ANIM SCI, V95, P3415, DOI 10.2527/jas.2017.1656; Su G, 2012, J DAIRY SCI, V95, P4657, DOI 10.3168/jds.2012-5379; Thirstrup JP, 2015, J ANIM SCI, V93, P3773, DOI 10.2527/jas.2015-8996; Tonussi RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181752; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Vallejo RL, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0293-6; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verbyla Klara L, 2010, BMC Proc, V4, pS5, DOI 10.1186/1753-6561-4-S1-S5; Villumsen T, 2017, P WORLD C GEN APPL L, V11, P618; Vitezica ZG, 2011, GENET RES, V93, P357, DOI 10.1017/S001667231100022X; Wang QC, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0507-5; Wiener P, 2011, P ROY SOC B-BIOL SCI, V278, P3161, DOI 10.1098/rspb.2011.1376; Zalewski A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157972; Zalewski A, 2011, DIVERS DISTRIB, V17, P757, DOI 10.1111/j.1472-4642.2011.00767.x; Zhu B, 2017, J INTEGR AGR, V16, P911, DOI 10.1016/S2095-3119(16)61474-0	66	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213873	10.1371/journal.pone.0213873	http://dx.doi.org/10.1371/journal.pone.0213873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870528	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300090
J	Miranda, S; Billoir, P; Damian, L; Thiebaut, PA; Schapman, D; Le Besnerais, M; Jouen, F; Galas, L; Levesque, H; Le Cam-Duchez, V; Joannides, R; Richard, V; Benhamou, Y				Miranda, Sebastien; Billoir, Paul; Damian, Louise; Thiebaut, Pierre Alain; Schapman, Damien; Le Besnerais, Maelle; Jouen, Fabienne; Galas, Ludovic; Levesque, Herve; Le Cam-Duchez, Veronique; Joannides, Robinson; Richard, Vincent; Benhamou, Ygal			Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; CELL-ADHESION MOLECULE-1; THROMBIN GENERATION; HYPERCOAGULABLE STATE; ANTIBODIES; MONOCYTES; ACTIVATION; INDUCTION; WARFARIN; PATHWAY	Antiphospholipid antibodies (aPL) promote endothelial dysfunction, inflammation and procoagulant state. We investigated the effect of hydroxychloroquine (HCQ) on prothrombotic state and endothelial function in mice and in human aortic endothelial cells (HAEC). Human aPL were injected to C57BL/6 mice treated or not with HCQ. Vascular endothelial function and eNOS were assessed in isolated mesenteric arteries. Thrombosis was assessed both in vitro by measuring thrombin generation time (TGT) and tissue factor (TF) expression and in vivo by the measurement of the time to occlusion in carotid and the total thrombosis area in mesenteric arteries. TGT, TF, and VCAM1 expression were evaluated in HAEC. aPL increased VCAM-1 expression and reduced endothelium dependent relaxation to acetylcholine. In parallel, aPL shortened the time to occlusion and extended thrombus area in mice. This was associated with an overexpression of TF and an increased TGT in mice and in HAEC. HCQ reduced clot formation as well as TGT, and improved endothelial-dependent relaxations. Finally, HCQ increased the p-eNOS/eNOS ratio. This study provides new evidence that HCQ improves procoagulant status and vascular function in APS by modulating eNOS, leading to an improvement in the production of NO.	[Miranda, Sebastien; Damian, Louise; Thiebaut, Pierre Alain; Le Besnerais, Maelle; Levesque, Herve; Benhamou, Ygal] Rouen Univ Hosp, Dept Internal Med, Rouen, France; [Miranda, Sebastien; Billoir, Paul; Damian, Louise; Thiebaut, Pierre Alain; Le Besnerais, Maelle; Levesque, Herve; Le Cam-Duchez, Veronique; Joannides, Robinson; Richard, Vincent; Benhamou, Ygal] Normandie Univ, UNIROUEN, INSERM, U1096,EnVI, Rouen, France; [Miranda, Sebastien; Damian, Louise; Thiebaut, Pierre Alain; Schapman, Damien; Le Besnerais, Maelle; Jouen, Fabienne; Galas, Ludovic; Levesque, Herve; Joannides, Robinson; Richard, Vincent; Benhamou, Ygal] Univ Rouen, Inst Res & Innovat Biomed, Rouen, France; [Billoir, Paul; Le Cam-Duchez, Veronique] Rouen Univ Hosp, Dept Vasc Haemostasis, Rouen, France; [Schapman, Damien; Galas, Ludovic] Univ Rouen, UNIROUEN, PRIMACEN, Cell Imaging Platform Normandy,IRIB,INSERM, Rouen, France; [Jouen, Fabienne] INSERM, U1234, Rouen, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Benhamou, Y (corresponding author), Rouen Univ Hosp, Dept Internal Med, Rouen, France.; Benhamou, Y (corresponding author), Normandie Univ, UNIROUEN, INSERM, U1096,EnVI, Rouen, France.; Benhamou, Y (corresponding author), Univ Rouen, Inst Res & Innovat Biomed, Rouen, France.	ygal.benhamou@chu-rouen.fr	Richard, Vincent/B-1059-2014; Billoir, Paul/L-9291-2019	Richard, Vincent/0000-0003-0590-0158; Billoir, Paul/0000-0001-5632-7713; Miranda, sebastien/0000-0001-6379-4272; Thiebaut, Pierre-Alain/0000-0001-5239-0854				AHMED K, 1992, CLIN EXP RHEUMATOL, V10, P503; Amengual O, 1998, THROMB HAEMOSTASIS, V79, P276, DOI 10.1055/s-0037-1614977; Benhamou Y, 2014, ARTHRITIS RHEUMATOL; Benhamou Y, 2015, VASC PHARMACOL, V71, P93, DOI 10.1016/j.vph.2015.03.014; Billoir P, 2018, THROMB RES, V169, P87, DOI 10.1016/j.thromres.2018.07.021; Charakida M, 2009, JAMA-J AM MED ASSOC, V302, P1210, DOI 10.1001/jama.2009.1346; Cohen H, 2016, LANCET HAEMATOL, V3, pE426, DOI 10.1016/S2352-3026(16)30079-5; Cuadrado MJ, 1997, ARTHRITIS RHEUM-US, V40, P834, DOI 10.1002/art.1780400509; Dienava-Verdoold I, 2011, J THROMB HAEMOST, V9, P738, DOI 10.1111/j.1538-7836.2011.04212.x; Dobado-Berrios PM, 1999, THROMB HAEMOSTASIS, V82, P1578; Edwards MH, 1997, CIRCULATION, V96, P4380; Efthymiou M, 2015, THROMB RES, V135, P1191, DOI 10.1016/j.thromres.2015.03.030; Espinola RG, 2002, THROMB HAEMOSTASIS, V87, P518; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Kaplanski G, 2000, ARTHRITIS RHEUM, V43, P55, DOI 10.1002/1529-0131(200001)43:1<55::AID-ANR8>3.0.CO;2-M; Kiney AV, 2008, LUPUS, V17, P952, DOI 10.1177/0961203308096662; KORNBERG A, 1994, J IMMUNOL, V153, P1328; Li RR, 2018, INT IMMUNOPHARMACOL, V63, P261, DOI 10.1016/j.intimp.2018.08.008; Lopez-Pedrera C, 2006, ARTHRITIS RHEUM-US, V54, P301, DOI 10.1002/art.21549; Mercanoglu F, 2004, INT J CLIN PRACT, V58, P1003, DOI 10.1111/j.1742-1241.2004.00162.x; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Muller-Calleja N, 2017, J THROMB HAEMOST, V15, P2367, DOI 10.1111/jth.13865; Muller-Calleja N, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210012; Pierangeli SS, 1999, CIRCULATION, V99, P1997, DOI 10.1161/01.CIR.99.15.1997; Pierangeli SS, 2001, CIRC RES, V88, P245; Prinz N, 2013, THROMB HAEMOSTASIS, V109, P525, DOI 10.1160/TH12-06-0421; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Rand JH, 2010, BLOOD, V115, P2292, DOI 10.1182/blood-2009-04-213520; Regnault V, 2003, THROMB HAEMOSTASIS, V89, P208, DOI 10.1055/s-0037-1613433; Reverter JC, 1996, ARTERIOSCL THROM VAS, V16, P1319, DOI 10.1161/01.ATV.16.11.1319; Reverter JC, 1998, ARTHRITIS RHEUM, V41, P1420, DOI 10.1002/1529-0131(199808)41:8<1420::AID-ART11>3.0.CO;2-U; Rikarni, 2015, Acta Med Indones, V47, P31; Sacharidou A, 2018, BLOOD, V131, P2097, DOI 10.1182/blood-2017-11-814681; Schmidt-Tanguy A, 2013, J THROMB HAEMOST, V11, P1927, DOI 10.1111/jth.12363; Schreiber K, 2018, RHEUMATOLOGY, V57, P120, DOI 10.1093/rheumatology/kex378; Tanne D, 2008, NEUROBIOL DIS, V30, P56, DOI 10.1016/j.nbd.2007.12.004; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x; Zhou H, 2004, BLOOD, V104, P2353, DOI 10.1182/blood-2004-01-0145	38	37	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0212614	10.1371/journal.pone.0212614	http://dx.doi.org/10.1371/journal.pone.0212614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870459	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300014
J	Park, J; Son, H; Chai, JS; Kim, SW; Paick, JS; Cho, MC				Park, Juhyun; Son, Hwancheol; Chai, Ji Sun; Kim, Soo Woong; Paick, Jae-Seung; Cho, Min Chul			Chronic administration of LIMK2 inhibitors alleviates cavernosal veno-occlusive dysfunction through suppression of cavernosal fibrosis in a rat model of erectile dysfunction after cavernosal nerve injury	PLOS ONE			English	Article							CORPORAL FIBROSIS; RHO-KINASE; FUNCTION RECOVERY; RADICAL PROSTATECTOMY; SIGNALING PATHWAY; SMOOTH-MUSCLE; SILDENAFIL; INVOLVEMENT; NEUROTOMY; APOPTOSIS	We evaluated whether chronic administration of LIMK2-inhibitors could improve erectile function by alleviating CVOD through suppressing cavernosal fibrosis in a rat model of cavernosal nerve crush-injury (CNCI). Forty-two 12-week-old rats were equally categorized into the three groups: sham-surgery (S), CNCI (I), and CNCI treated with LIMK2-inhibitors (L). The L-group was treated with daily intraperitoneal injection of LIMK2-inhibitors (10.0 mg/kg) for 30-days after surgery. Erectile function was assessed using dynamic-infusion-cavernosometry (DIC). Penile tissue was processed for Masson's-trichrome staining, Western-blotting, and double immunofluorescence. The I-group showed significantly higher maintenance and drop rates as well as lower papaverine response, compared to the S-group. Chronic inhibition of LIMK2 in the L-group significantly improved the DIC parameters compared to those in the I-group, although the parameters were not completely restored to normal control values. Also, the I-group showed a reduced smooth muscle (SM)-to-collagen ratio, decreased immunohistochemical staining for alpha-SM-actin, increased number of fibroblasts positive for phosphorylated Cofilin, increased LIMK2/Cofilin phosphorylation and increased protein expression of Collagen-1 or Fibronectin, compared to the S-group. The L-group showed significant improvements in SM/collagen ratio and the deposition of Collagen-1 or Fibronectin compared to the I-group, although not completely normalized. According to the densitometry and confocal microscopy results, the L-group showed restoration of LIMK2/Cofilin phosphorylation and amount of fibroblasts positive for phosphorylated Cofilin to the normal control value. In conclusion, chronic inhibition of LIMK2 can improve CVOD and ED by alleviating cavernosal fibrosis via normalizing the LIMK2/Cofilin pathway.	[Park, Juhyun; Son, Hwancheol; Cho, Min Chul] Seoul Natl Univ, Dept Urol, Boramae Med Ctr, Coll Med, Seoul, South Korea; [Chai, Ji Sun; Kim, Soo Woong; Paick, Jae-Seung] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Cho, MC (corresponding author), Seoul Natl Univ, Dept Urol, Boramae Med Ctr, Coll Med, Seoul, South Korea.	cmc1206@empal.com	CHO, MIN CHUL/R-7835-2019	Park, Juhyun/0000-0002-5549-9756; Cho, Min Chul/0000-0001-7288-1706	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014R1A1A1006572]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (grant number: NRF-2014R1A1A1006572). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capogrosso P, 2016, WORLD J MENS HEALTH, V34, P73, DOI 10.5534/wjmh.2016.34.2.73; Cho MC, 2015, J UROLOGY, V193, P1716, DOI 10.1016/j.juro.2014.10.099; Cho MC, 2011, J SEX MED, V8, P712, DOI 10.1111/j.1743-6109.2010.02147.x; Cui K, 2017, ASIAN J ANDROL, V19, P67, DOI 10.4103/1008-682X.189209; Ferrini MG, 2006, UROLOGY, V68, P429, DOI 10.1016/j.urology.2006.05.011; Ferrini MG, 2009, J SEX MED, V6, P415, DOI 10.1111/j.1743-6109.2008.01105.x; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Garnock-Jones K, 2014, DRUGS, V74, P2211, DOI 10.1007/s40265-014-0333-2; Gratzke C, 2010, J UROLOGY, V184, P2197, DOI 10.1016/j.juro.2010.06.094; Hannan JL, 2013, J UROLOGY, V189, P1155, DOI 10.1016/j.juro.2012.09.104; Harrison BA, 2015, ACS MED CHEM LETT, V6, P84, DOI 10.1021/ml500367g; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Ivanovska J, 2013, INT J BIOCHEM CELL B, V45, P1720, DOI 10.1016/j.biocel.2013.05.013; Kardassis D, 2009, FEBS J, V276, P2947, DOI 10.1111/j.1742-4658.2009.07031.x; Kovanecz I, 2008, INT J IMPOT RES, V20, P202, DOI 10.1038/sj.ijir.3901612; Kovanecz I, 2008, BJU INT, V101, P203, DOI 10.1111/j.1464-410X.2007.07223.x; Kovanecz I, 2012, J SEX MED, V9, P2814, DOI 10.1111/j.1743-6109.2012.02913.x; Leungwattanakij S, 2003, J ANDROL, V24, P239; Mahmood J, 2017, INT J RADIAT ONCOL, V99, P680, DOI 10.1016/j.ijrobp.2017.06.2449; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Moreland RB, 1998, INT J IMPOT RES, V10, P113, DOI 10.1038/sj.ijir.3900328; Morin P, 2011, EUR J CELL BIOL, V90, P13, DOI 10.1016/j.ejcb.2010.09.009; Mulhall JP, 2008, CURR OPIN UROL, V18, P613, DOI 10.1097/MOU.0b013e3283136462; Nelson CJ, 2013, J SEX MED, V10, P1636, DOI 10.1111/jsm.12135; Park J, 2018, ASIAN J ANDROLOGY; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Satoh S, 2014, CURR VASC PHARMACOL, V12, P758, DOI 10.2174/1570161112666140613115813; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Shimizu T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93187; Song SH, 2015, J SEX MED, V12, P1522, DOI 10.1111/jsm.12903; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tal R, 2009, J SEX MED, V6, P2538, DOI 10.1111/j.1743-6109.2009.01351.x; Tavukcu HH, 2016, INVESTIG CLIN UROL, V57, pS172, DOI 10.4111/icu.2016.57.S2.S172; Vignozzi L, 2008, INT J IMPOT RES, V20, P60, DOI 10.1038/sj.ijir.3901596; Weyne E, 2015, NAT REV UROL, V12, P289, DOI 10.1038/nrurol.2015.72	37	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213586	10.1371/journal.pone.0213586	http://dx.doi.org/10.1371/journal.pone.0213586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870492	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300046
J	Beard, KH; Choi, RT; Leffler, AJ; Carlson, LG; Kelsey, KC; Schmutz, JA; Welker, JM				Beard, Karen H.; Choi, Ryan T.; Leffler, A. Joshua; Carlson, Lindsay G.; Kelsey, Katharine C.; Schmutz, Joel A.; Welker, Jeffrey M.			Migratory goose arrival time plays a larger role in influencing forage quality than advancing springs in an Arctic coastal wetland	PLOS ONE			English	Article							YUKON-KUSKOKWIM DELTA; BERNICLA-NIGRICANS GOSLINGS; BROOD-REARING AREAS; GREATER SNOW GEESE; BLACK BRANT; CLIMATE-CHANGE; EMPEROR GEESE; CANADA GEESE; HATCH DATE; PHENOLOGICAL MISMATCH	With warmer springs, herbivores migrating to Arctic breeding grounds may experience phenological mismatches between their energy demands and the availability of high quality forage. Yet, how the timing of the start of the season and herbivore arrival influences forage quality is often unknown. In coastal western Alaska, approximately one million migratory geese arrive each spring to breed, where foliar %N and C:N ratios are linked to gosling survival and population growth. We conducted a three-year experiment where we manipulated the start of the growing season using warming chambers and grazing times using captive Pacific black brant (Branta bernicla nigricans) to examine how the timing of these events influences the quality of an important forage species. Our results suggest that grazing timing plays a much greater role than an advanced growing season in determining forage quality. All top models included grazing timing, and suggested that compared to typical grazing timing, early grazing significantly reduced foliar %C by 6% and C:N ratios by 16%, while late goose grazing significantly reduced foliar %N by 15% and increased foliar C:N ratios by 21%. While second-ranking top models included the effect of season, the advanced growing season effect was not significant and only reduced %N by 4%, increased %C by <1%, and increased C:N ratios by 5% compared to an ambient growing season. In summary, in years where geese arrive early, they will consume higher quality forage when they arrive and throughout the season, while in years that geese arrive late they will consume lower quality forage when they arrive and for the remainder of the season. When the growing season starts has only a minor influence on this pattern. Our findings suggest that cues determining migration and arrival times to breeding areas are important factors influencing forage quality for geese in western Alaska.	[Beard, Karen H.; Choi, Ryan T.; Carlson, Lindsay G.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Beard, Karen H.; Choi, Ryan T.; Carlson, Lindsay G.] Ecol Ctr, Logan, UT 84322 USA; [Leffler, A. Joshua] South Dakota State Univ, Dept Nat Resource Management, Brookings, SD USA; [Kelsey, Katharine C.; Welker, Jeffrey M.] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Schmutz, Joel A.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Welker, Jeffrey M.] Univ Oulu, Ecol & Genet Res Unit, UArctic, Oulu, Finland	Utah System of Higher Education; Utah State University; South Dakota State University; University of Alaska System; University of Alaska Anchorage; United States Department of the Interior; United States Geological Survey; University of Oulu	Beard, KH (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.; Beard, KH (corresponding author), Ecol Ctr, Logan, UT 84322 USA.	karen.beard@usu.edu	Carlson, Lindsay Gray/AAC-4302-2019; Carlson, Lindsay Gray/AAE-3484-2020; Beard, Karen/B-7177-2011	Carlson, Lindsay Gray/0000-0003-1592-6458; Kelsey, Katharine/0000-0002-4631-8538; Leffler, A. Joshua/0000-0002-3389-2493; Beard, Karen/0000-0003-4997-2495	NSF [1633756, 1304523, 1304879]; Utah State University Ecology Center; Utah Agricultural Experiment Station; Utah State University	NSF(National Science Foundation (NSF)); Utah State University Ecology Center; Utah Agricultural Experiment Station; Utah State University	Work was funded by NSF awards 1304523 (KHB) and 1304879 (JAW, AJL), partly off NSF award 1633756 (RTC) and the Utah State University Ecology Center (RTC, LGC). This research was supported by the Utah Agricultural Experiment Station and Utah State University, and approved as journal paper 9147 (KHB). Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet B, 2007, CONDOR, V109, P361, DOI 10.1650/0010-5422(2007)109[361:FEOGSG]2.0.CO;2; Baldassarre G., 2014, DUCKS GEESE SWANS N; Beaulieu J, 1996, J ECOL, V84, P905, DOI 10.2307/2960561; BEDARD J, 1989, ARDEA, V77, P3; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brook RW, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00708-100101; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cadieux MC, 2005, AUK, V122, P144, DOI 10.1642/0004-8038(2005)122[0144:FEOCGB]2.0.CO;2; Choi RT, J ECOLOGY; Clausen KK, 2013, OECOLOGIA, V173, P1101, DOI 10.1007/s00442-013-2681-0; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Doiron M, 2015, GLOBAL CHANGE BIOL, V21, P4364, DOI 10.1111/gcb.13057; Doiron M, 2014, J ECOL, V102, P508, DOI 10.1111/1365-2745.12213; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Eichholz MW, 1998, CONDOR, V100, P164, DOI 10.2307/1369910; Fischer J. B., 2017, NEST POPULATION SIZE; Fischer J. B., 2008, NEST POPULATION SIZE; Fischer JB, 2009, NEST POPULATION SIZE; Fox AD, 1998, OECOLOGIA, V116, P154, DOI 10.1007/s004420050574; GADALLAH FL, 1995, J APPL ECOL, V32, P276, DOI 10.2307/2405095; GADALLAH FL, 1995, J APPL ECOL, V32, P263, DOI 10.2307/2405094; Gustine D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171807; Herzog MP, 2004, AUK, V121, P210, DOI 10.1642/0004-8038(2004)121[0210:DOFBAW]2.0.CO;2; HIK DS, 1991, J ECOL, V79, P715, DOI 10.2307/2260663; Hogrefe KR, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121234; Hupp JW, 2006, CONDOR, V108, P912, DOI 10.1650/0010-5422(2006)108[912:TPIOEG]2.0.CO;2; Hupp JW, 2018, GLOBAL CHANGE BIOL, V24, P5056, DOI 10.1111/gcb.14418; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Johnson HE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2461; Jorgenson T, 2001, J COASTAL RES, V17, P124; Kelsey KC, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab698; Kerby JT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3514; Klaassen M, 2006, ARDEA, V94, P371; Kolzsch A, 2015, J ANIM ECOL, V84, P272, DOI 10.1111/1365-2656.12281; Lake BC, 2008, IBIS, V150, P527, DOI 10.1111/j.1474-919X.2008.00814.x; Lake BC, 2006, ARCTIC, V59, P252; Lameris TK, 2017, GLOBAL CHANGE BIOL, V23, P4058, DOI 10.1111/gcb.13684; Lameris TK, 2017, ECOL EVOL, V7, P2652, DOI 10.1002/ece3.2859; Larochelle, 2006, ACTA ZOOL SINICA, V52, P670; Leach AG, 2017, J WILDLIFE MANAGE, V81, P1210, DOI 10.1002/jwmg.21284; Leffler AJ, 2019, GLOBAL CHANGE BIOL, V25, P277, DOI 10.1111/gcb.14473; Lepage D, 1998, OECOLOGIA, V114, P226, DOI 10.1007/s004420050440; Lindberg MS, 2007, J WILDLIFE MANAGE, V71, P534, DOI 10.2193/2006-051; Lindberg MS, 1998, AUK, V115, P436, DOI 10.2307/4089202; LINDHOLM A, 1994, CONDOR, V96, P898, DOI 10.2307/1369100; MANSEAU M, 1993, ECOLOGY, V74, P2045, DOI 10.2307/1940850; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; MATTOCKS J G, 1971, Wildfowl, V22, P107; Mickelson P. G., 1975, WILDLIFE MONOGR, V45, P3; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Mulder CPH, 1998, ECOL MONOGR, V68, P275, DOI 10.1890/0012-9615(1998)068[0275:EOHOAI]2.0.CO;2; Nakazawa T, 2012, OIKOS, V121, P489, DOI 10.1111/j.1600-0706.2011.20171.x; Ngai JT, 2004, J ECOL, V92, P1001, DOI 10.1111/j.0022-0477.2004.00926.x; Person BT, 2003, OECOLOGIA, V135, P583, DOI 10.1007/s00442-003-1197-4; Person BT, 1998, J ECOL, V86, P243, DOI 10.1046/j.1365-2745.1998.00249.x; Poole A.F., 2013, BIRDS N AM; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; PROP J, 1992, FUNCT ECOL, V6, P180, DOI 10.2307/2389753; RAVELING DG, 1978, AUK, V95, P294; Ross MV, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01748; Ross MV, 2017, ECOLOGY, V98, P1869, DOI 10.1002/ecy.1856; Ruess RW, 1997, ECOSCIENCE, V4, P170, DOI 10.1080/11956860.1997.11682392; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Schaeffer SM, 2013, GLOBAL CHANGE BIOL, V19, P3529, DOI 10.1111/gcb.12318; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schimel JP, 1996, ECOLOGY, V77, P2142, DOI 10.2307/2265708; SCHMUTZ JA, 1993, CONDOR, V95, P222, DOI 10.2307/1369404; Schmutz JA, 2006, ARDEA, V94, P385; Sedinger JS, 2008, J ANIM ECOL, V77, P702, DOI 10.1111/j.1365-2656.2008.01403.x; Sedinger JS, 2007, AUK, V124, P1281, DOI 10.1642/0004-8038(2007)124[1281:SABAOL]2.0.CO;2; Sedinger JS, 2016, CONDOR, V118, P433, DOI 10.1650/CONDOR-15-109.1; Sedinger JS, 2011, AM NAT, V178, pE110, DOI 10.1086/662165; Sedinger JS, 2011, CONDOR, V113, P511, DOI 10.1525/cond.2011.100218; Sedinger JS, 1997, AUK, V114, P129, DOI 10.2307/4089076; SEDINGER JS, 1986, J ANIM ECOL, V55, P1083, DOI 10.2307/4435; Sedinger JS, 1997, CONDOR, V99, P836, DOI 10.2307/1370500; SEDINGER JS, 1984, J WILDLIFE MANAGE, V48, P1128, DOI 10.2307/3801773; SEDINGER JS, 1995, CONDOR, V97, P107, DOI 10.2307/1368988; Sedinger JS, 1997, CONDOR, V99, P314, DOI 10.2307/1369937; SEDINGER JS, 1991, ECOLOGY, V72, P496, DOI 10.2307/2937190; SEDINGER JS, 1990, CONDOR, V92, P174, DOI 10.2307/1368396; SEDINGER JS, 1995, CONDOR, V97, P116, DOI 10.2307/1368989; SEDINGER JS, 1989, J WILDLIFE MANAGE, V53, P726, DOI 10.2307/3809204; SEDINGER JS, 1988, OECOLOGIA, V75, P119, DOI 10.1007/BF00378824; Sullivan PF, 2005, OECOLOGIA, V142, P616, DOI 10.1007/s00442-004-1764-3; Swanson DL, 2009, J FIELD ORNITHOL, V80, P351, DOI 10.1111/j.1557-9263.2009.00241.x; Van der Jeugd HP, 1998, J ANIM ECOL, V67, P953, DOI 10.1046/j.1365-2656.1998.6760953.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Ward DH, 2016, J AVIAN BIOL, V47, P197, DOI 10.1111/jav.00774; Ward DH, 2009, ARCTIC, V62, P301; Ward DH, 2005, GLOBAL CHANGE BIOL, V11, P869, DOI 10.1111/j.1365-2486.2005.00942.x; Ward DH, 2004, CONDOR, V106, P263, DOI 10.1650/7387; Welker JM, 2005, OIKOS, V109, P167, DOI 10.1111/j.0030-1299.2005.13264.x; Zacheis A, 2002, OECOLOGIA, V130, P600, DOI 10.1007/s00442-001-0837-9; Zamin TJ, 2017, ECOL APPL, V27, P2061, DOI 10.1002/eap.1590	97	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213037	10.1371/journal.pone.0213037	http://dx.doi.org/10.1371/journal.pone.0213037			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865725	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900058
J	Dimitriadis, I; Bormann, CL; Kanakasabapathy, MK; Thirumalaraju, P; Kandula, H; Yogesh, V; Gudipati, N; Natarajan, V; Petrozza, JC; Shafiee, H				Dimitriadis, Irene; Bormann, Charles L.; Kanakasabapathy, Manoj Kumar; Thirumalaraju, Prudhvi; Kandula, Hemanth; Yogesh, Vinish; Gudipati, Neeraj; Natarajan, Vignesh; Petrozza, John C.; Shafiee, Hadi			Automated smartphone-based system for measuring sperm viability, DNA fragmentation, and hyaluronic binding assay score	PLOS ONE			English	Article								The fundamental test for male infertility, semen analysis, is mostly a manually performed subjective and time-consuming process and the use of automated systems has been cost prohibitive. We have previously developed an inexpensive smartphone-based system for at-home male infertility screening through automatic and rapid measurement of sperm concentration and motility. Here, we assessed the feasibility of using a similar smartphone-based system for laboratory use in measuring: a) Hyaluronan Binding Assay (HBA) score, a quantitative score describing the sperm maturity and fertilization potential in a semen sample, b) sperm viability, which assesses sperm membrane integrity, and c) sperm DNA fragmentation that assesses the degree of DNA damage. There was good correlation between the manual analysis and smartphone-based analysis for the HBA score when the device was tested with 31 fresh, unprocessed human semen samples. The smartphone-based approach performed with an accuracy of 87% in sperm classification when the HBA score was set at manufacturer's threshold of 80. Similarly, the sperm viability and DNA fragmentation tests were also shown to be compatible with the smartphone-based system when tested with 102 and 47 human semen samples, respectively.	[Dimitriadis, Irene; Bormann, Charles L.; Petrozza, John C.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02115 USA; [Kanakasabapathy, Manoj Kumar; Thirumalaraju, Prudhvi; Kandula, Hemanth; Yogesh, Vinish; Gudipati, Neeraj; Natarajan, Vignesh; Shafiee, Hadi] Harvard Med Sch, Brigham & Womens Hosp, Div Engn Med, Dept Med, Boston, MA 02115 USA; [Shafiee, Hadi] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Shafiee, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Engn Med, Dept Med, Boston, MA 02115 USA.; Shafiee, H (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	hshafiee@bwh.harvard.edu	thirumalaraju, Prudhvi/AAA-3214-2020; Thirumalaraju, Prudhvi/AAE-8442-2022; Kanakasabapathy, Manoj Kumar/L-3760-2017; Thirumalaraju, Prudhvi/AAO-7932-2020; Kandula, Hemanth/O-7371-2018	Kanakasabapathy, Manoj Kumar/0000-0002-0756-8585; Yogesh, Vinish/0000-0003-4309-0467; Kandula, Hemanth/0000-0003-4573-6727	National Institute of Health (NIH) [1R01AI118502, 1R21HD092828, P30ES000002]; Harvard T.H. Chan School of Public Health; Harvard Center for Environmental Health; American Board of Obstetrics and Gynecology; American College of Obstetricians and Gynecologists; American Society for Reproductive Medicine; Society for Reproductive Endocrinology and Infertility; Brigham Precision Medicine Program; National Institute of Health [1R01A18800, 1R01A1118502, R21HD092828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD092828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard T.H. Chan School of Public Health; Harvard Center for Environmental Health; American Board of Obstetrics and Gynecology; American College of Obstetricians and Gynecologists; American Society for Reproductive Medicine; Society for Reproductive Endocrinology and Infertility; Brigham Precision Medicine Program; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is partially supported by the National Institute of Health (NIH) (1R01AI118502, 1R21HD092828, and P30ES000002), Harvard T.H. Chan School of Public Health, Harvard Center for Environmental Health, and American Board of Obstetrics and Gynecology, American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, and Society for Reproductive Endocrinology and Infertility received by H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the MGH ART Laboratory staff for assisting with these analyses. We would also like to thank Biocoat for providing us with the customized slides. This work was partially supported by the Brigham Precision Medicine Program and the National Institute of Health through award numbers 1R01A18800, 1R01A1118502 and R21HD092828.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1; [Anonymous], 2010, ABNORMALLY HIGH BODY, V93, P332; [Anonymous], 2017, FERTIL STERIL S; Berg B, 2015, ACS NANO, V9, P7857, DOI 10.1021/acsnano.5b03203; Biocoat, HYAL BIND ASS INSTR; Bjorndahl L, 2004, J ANDROL, V25, P671; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Breznik BP, 2013, FERTIL STERIL, V99, P1233, DOI 10.1016/j.fertnstert.2012.11.048; Daris B, 2010, ARCH GYNECOL OBSTET, V281, P363, DOI 10.1007/s00404-009-1140-y; Draz MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06727-8; Draz MS, 2018, ACS NANO, V12, P5709, DOI 10.1021/acsnano.8b01515; Fernandez JL, 2005, FERTIL STERIL, V84, P833, DOI 10.1016/j.fertnstert.2004.11.089; Huszar G, 2003, FERTIL STERIL, V79, P1616, DOI 10.1016/S0015-0282(03)00402-3; Kanakasabapathy MK, 2017, LAB CHIP, V17, P2910, DOI 10.1039/c7lc00273d; Majzoub A, 2017, TRANSL ANDROL UROL, V6, pS422, DOI 10.21037/tau.2017.07.10; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Meistrich M. L., 2013, SPERMATOGENESIS METH, P299; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Solutions F., SPERM VIABILITY STAI; Thirumalaraju P, 2018, FERTIL STERIL, V110, pE432, DOI 10.1016/j.fertnstert.2018.08.039; Tomlinson MJ, 2010, FERTIL STERIL, V93, P1911, DOI 10.1016/j.fertnstert.2008.12.064; Trisini AT, 2004, FERTIL STERIL, V82, P1623, DOI 10.1016/j.fertnstert.2004.05.087; Urbano LF, 2017, IEEE T MED IMAGING, V36, P792, DOI 10.1109/TMI.2016.2630720; WHO, 2010, WHO STAND AC POINT L, P23; Worrilow KC, 2004, FERTIL STERIL, P82; Ye H, 2006, RELATIONSHIP HUMAN S	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212562	10.1371/journal.pone.0212562	http://dx.doi.org/10.1371/journal.pone.0212562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865652	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900025
J	Hu, XM; Zeng, QW; Liu, YS; Fu, L; Xi, RC; Chen, HF; Deng, XM				Hu, Xiao-Min; Zeng, Qing-Wen; Liu, Ya-Si; Fu, Lin; Xi, Ru-Chun; Chen, Hong-Feng; Deng, Xiao-Mei			Manglietia pubipedunculata (Magnoliaceae), a new species from Yunnan, China	PLOS ONE			English	Article							DISJUNCT SECTION RYTIDOSPERMUM; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; MAGNOLIOIDEAE; BIOGEOGRAPHY; DIVERGENCE; MORPHOLOGY	A new species, Manglietia pubipedunculata Q. W. Zeng & X. M. Hu (Magnoliaceae) is described and illustrated from Yunnan, China. In addition to macromorphological examination, we comparatively studied on micromorphology of leaf epidermis, leaf structure, and epidermal cell on the sclerotesta. This new species is similar to M. kwangtungensis in terms of having dense pubescence, however, their pubescence are quite different. Manglietia pubipedunculata has appressed, compressed, shorter and sparser pubescence consisting of single or two cells. Moreover, it differs from M. kwangtungensis by showing shorter and thicker peduncles, longer styles, basal carpels covered with sparsely brown appressed pubescence, and more ovules per carpel. Furthermore, the new species has thinner leaves, brown and rugged surfaces on sclerotesta, and the alveolate cell pattern consisting of pentagon or hexagon cells with papilla on secondary cell wall under the observation by SEM. The phylogenetic analysis from two nuclear PHYA and LEAFY and chloroplast trnH-psbA sequences of 11 taxa reveals that M. pubipedunculata is a distinct species.	[Hu, Xiao-Min; Xi, Ru-Chun; Deng, Xiao-Mei] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China; [Hu, Xiao-Min; Zeng, Qing-Wen; Liu, Ya-Si; Fu, Lin; Chen, Hong-Feng] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Hu, Xiao-Min; Xi, Ru-Chun; Deng, Xiao-Mei] State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Deng, XM (corresponding author), South China Agr Univ, Coll Forestry & Landscape Architecture, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China.; Chen, HF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.; Deng, XM (corresponding author), State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	h.f.chen@scbg.ac.cn; dxmei2006@scau.edu.cn	Hu, Xiaomin/GRY-1539-2022		special fund of Forestry Public Welfare Industry Research of China [201404116]; National Natural Science Foundation of China [30871960]; special fund of Forestry science and technology innovation of Guangdong Province [2014KJCX006, 2017KJCX023]	special fund of Forestry Public Welfare Industry Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund of Forestry science and technology innovation of Guangdong Province	This work was supported by the special fund of Forestry Public Welfare Industry Research of China (Grant Number 201404116) http://www.forestry.gov.cn/; the National Natural Science Foundation of China (Grant Number 30871960) http://www.nsfc.gov.cn/; the special fund of Forestry science and technology innovation of Guangdong Province (Grant Number 2014KJCX006, 2017KJCX023) http://lyj.gd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, ACTA PHYTOTAXON SIN; [Anonymous], 2008, FLORA CHINA; Azuma H, 1999, J PLANT RES, V112, P291, DOI 10.1007/PL00013885; Azuma H, 2001, AM J BOT, V88, P2275, DOI 10.2307/3558389; Baillon H, 1866, ADANSONIA, V7, P1; [包淑云 Bao Shuyun], 2002, [武汉植物学研究, Journal of Wuhan Botanical Research], V20, P8; BARANOVA M, 1972, Taxon, V21, P447, DOI 10.2307/1219106; Blume C.L, 1823, VERHANDELINGEN BATAV, V9, P149; CAI X, 2000, ACTA PHYTOTAX SINICA, V38, P218; Cai X, 2000, J WUHAN BOT RES, V18, P10; CANRIGHT JAMES E., 1955, JOUR ARNOLD ARBORETUM, V36, P119; CHEN BL, 1993, ANN MO BOT GARD, V80, P999, DOI 10.2307/2399942; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Dandy J, 1927, B MISC INF R BOT GAR, V1927, P257, DOI DOI 10.2307/4107601; Doyle J. J., 1987, PHYTOCHEM B, P11; Figlar RB, 2004, BLUMEA, V49, P87; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; He SZ, 2000, CHINA J CHINESE MAT, V25, P521; Jin Hong, 1999, Acta Scientiarum Naturalium Universitatis Sunyatseni, V38, P93; Karcz J, 2005, ACTA BIOL CRACOV BOT, V47, P159; Keng H., 1978, Gardens' Bulletin, V31, P127; Kim S, 2001, AM J BOT, V88, P717, DOI 10.2307/2657073; Law YW., 1996, FLORA REIPUBLICAE PO, V30, P82; Li J, 2003, PLANT SYST EVOL, V242, P33, DOI 10.1007/s00606-003-0055-5; Li Jie, 1997, Acta Botanica Yunnanica, V19, P342; Li Jie, 1997, Acta Botanica Yunnanica, V19, P131; Liang JY, 1991, FLORA OF GUANGXI, V1, P81; Liao WB, 2006, THESIS; Lin LG, 1985, FLORA OF HUNAN, V2, P69; Lin Q., 2000, FLORA OF HUNAN, V2, P482; Lin XinChun, 2004, Journal of Zhejiang Forestry College, V21, P33; [林新春 Lin Xinchun], 2004, [植物研究, Bulletin of Botanical Research], V24, P272; LIU Y, 2004, MAGNOLIAS CHINA; Liu Y.H., 2000, P INT S FAM MAGN GUA, P3; Liu Y.H., 1995, J TROP SUBTROP BOT, V3, P1; Liu Y.J., 1987, CONTRIB GEOL MINER R, V2, P1; Metcalfe CR, 1950, ANATOMY DICOTYLEDONS, V1, P16; Metcalfe CR, 1979, ANATOMY DICOTYLEDONS, V2, P149; Nie ZL, 2008, MOL PHYLOGENET EVOL, V48, P1027, DOI 10.1016/j.ympev.2008.06.004; NOOTEBOOM HP, 1985, BLUMEA, V31, P65; Pant D. D., 1966, BOT J LINN SOC, V59, P265; Qiu YL, 1995, AM J BOT, V82, P1589, DOI 10.2307/2446188; Qiu YL, 1995, AM J BOT, V82, P1582, DOI 10.2307/2446187; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Shi SH, 2000, P INT S FAM MAGN BEI, P215; Sima YK, 2010, VOUCHERED FLORA SE Y, V1, P16; Stamatakis A., 2008, RAXML 7 0 4 MANUAL; Sun Wei-Bang, 2004, Acta Botanica Yunnanica, V26, P139; Thiers B., 2013, INDEX HERBARIUM GLOB; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIFFNEY BH, 1977, BOT J LINN SOC, V75, P299, DOI 10.1111/j.1095-8339.1977.tb01491.x; TUCKER SC, 1964, AM J BOT, V51, P1051, DOI 10.2307/2439952; TUCKER SC, 1977, BOT J LINN SOC, V75, P325, DOI 10.1111/j.1095-8339.1977.tb01492.x; UEDA K, 2000, P INT S FAM MAGN, P205; Wang YL, 2006, ACTA PHYTOTAXON SIN, V44, P135, DOI 10.1360/aps040013; Wang Yu-Fei, 1993, Acta Botanica Sinica, V35, P106; Xia GuoHua, 2005, Journal of Nanjing Forestry University (Natural Sciences Edition), V29, P97; Xia NH, 2007, THESIS; Xu Feng-xia, 2004, Journal of Tropical and Subtropical Botany, V12, P313; [徐凤霞 Xu Fengxia], 2002, [植物分类学报, Acta Phytotaxonomica Sinica], V40, P260; Xu FX, 2003, BOT J LINN SOC, V142, P407, DOI 10.1046/j.1095-8339.2003.00175.x; Xu FX, 2000, SUBTROPICAL PLANT RE, V29, P5; Zhang XH, 2014, SCI HORTIC-AMSTERDAM, V176, P170, DOI 10.1016/j.scienta.2014.07.009; Zhou SB, 1997, J ANHUI NORMAL U NAT, V20, P39; Zhou ShouBiao, 1996, Journal of Nanjing Forestry University, V20, P31	65	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0210254	10.1371/journal.pone.0210254	http://dx.doi.org/10.1371/journal.pone.0210254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865636	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900005
J	Khaltabadi, RF; Shahrokhi, N; Ebrahimi-Rad, M; Ehsani, P				Khaltabadi, Reza Farahani; Shahrokhi, Nader; Ebrahimi-Rad, Mina; Ehsani, Parastoo			Salmonella Typhimurium in Iran: Contribution of molecular and IS200 PCR methods in variants detection	PLOS ONE			English	Article							MONOPHASIC VARIANT; PHASE VARIATION; MULTIPLEX PCR; ENTERICA; DIFFERENTIATION; IDENTIFICATION; ENTERITIDIS	Salmonella Typhimurium, a zoonotic pathogen, is regarded as a major health and economic concern worldwide. Recently, monophasic variants of this serovar have been significantly associated with human gastroenteritis outbreaks globally, making its accurate identification essential for epidemiological and control purposes. We have identified and analyzed 150 S. Typhimurium from 884 Salmonella genus isolated from humans, domestic animals, poultry, food items and abattoirs origins. The Salmonella isolates were obtained from Iranian National Veterinary Reference Laboratories of 9 provinces during 2007-2016, and from five hospitals in Tehran in 2015. The isolates were evaluated biochemically, serologically, and by PCR amplification of invA, mdh, STM4492, fliC, fljA, fljB, hin genes, 1S200 and DT104. invA and mdh genes were used to confirm the S. Typhimurium serotype, fliC and fljB genes for determination of monophasic variants and amplification of 1S200 to discriminate the monophasic variants from the closely related serotypes. We identified 78.6% (118/150) as classical S. Typhimurium (fliC, fljB and 1S200 positive), 12.6% (19/150) were 1S200 negative from all isolates. DT104 is another marker for S.Typhimurium serovar typing. Contrary to EFSA guidelines 20.6% (19/29) of human isolates that lacked 1S200 insertion sequence, were confirmed as S.Typhimurium. Compared to the North American/European isolates the low prevalence of fljB negative 6% (9/150) and the high abundance of fliC negative 23.3% (35/150) isolates also were indicative of a different regional atypical population. Studies have shown that the prevalence of monophasic (fljB-) S. Typhimurium worldwide is promoted by the Swine industry. Thus, one reason for this high number of different atypical strains could be inhibition of swine breeding system (house hold and industry) in Iran. These results demonstrate a need for a modified identifying protocol to overcome the regional differences.	[Khaltabadi, Reza Farahani; Ehsani, Parastoo] Pasteur Inst Iran, Dept Mol Biol, Tehran, Iran; [Khaltabadi, Reza Farahani; Shahrokhi, Nader] Iranian Vet Org, Dept Mol Biol, Natl Vet Reference Lab, Tehran, Iran; [Ebrahimi-Rad, Mina] Pasteur Inst Iran, Dept Biochem, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Ehsani, P (corresponding author), Pasteur Inst Iran, Dept Mol Biol, Tehran, Iran.	P_ehsani@pasteur.ac.ir						[Anonymous], 1995, AGR MO DATA SALMONEL; Beuzon CR, 2004, INT MICROBIOL, V7, P3; Boland C, 2017, FOOD MICROBIOLOGY; Boland C, 2015, APPL ENVIRON MICROB; Boore AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145416; Braun SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046489; Bugarel M, 2012, MICROBIOLOGYOPEN, V1, P481, DOI 10.1002/mbo3.39; de Freitas Neto O, 2010, REV BRASILEIRA AVICO, V12; Desai PT, 2013, MBIO, V4, DOI 10.1128/mBio.00198-13; Echeita MA, 1999, J CLIN MICROBIOL, V37, P3425, DOI 10.1128/JCM.37.10.3425-3425.1999; Echeita MA, 2001, J CLIN MICROBIOL, V39, P2981, DOI 10.1128/JCM.39.8.2981-2983.2001; EFSA, 2010, EFSA J, V8, P1826, DOI DOI 10.2903/J.EFSA.2010.1826; Ellis MJ, 2018, RNA BIOL, V15, P176, DOI 10.1080/15476286.2017.1403001; Forshell LP, 2006, REV SCI TECH OIE, V25, P541, DOI 10.20506/rst.25.2.1683; Herrera-Leon S, 2004, J CLIN MICROBIOL, V42, P2581, DOI 10.1128/JCM.42.6.2581-2586.2004; Ido N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104380; Leekitcharoenphon P, 2016, APPL ENVIRON MICROB; Masoumi Asl Hossein, 2015, Med J Islam Repub Iran, V29, P285; Maurischat S, 2015, INT J FOOD MICROBIOL, V193, P8, DOI 10.1016/j.ijfoodmicro.2014.10.004; Mueller-Doblies D, 2018, EPIDEMIOL INFECT, V146, P409, DOI 10.1017/S095026881800002X; Pritchett LC, 2000, J CLIN MICROBIOL, V38, P3484, DOI 10.1128/JCM.38.9.3484-3488.2000; Ranieri ML, 2013, J CLIN MICROBIOL, V51, P1786, DOI 10.1128/JCM.03201-12; Saeki EK, 2013, J FOOD SAFETY, V33, P25, DOI 10.1111/jfs.12019; Shi CL, 2015, CRIT REV MICROBIOL, V41, P309, DOI 10.3109/1040841X.2013.837862; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; Shirdelian A., FINANCIAL TRIBUNE; SILVERMAN M, 1979, P NATL ACAD SCI USA, V76, P391, DOI 10.1073/pnas.76.1.391; Soyer Y, 2009, J CLIN MICROBIOL, V47, P3546, DOI 10.1128/JCM.00546-09; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Tadesse G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-88; Vandepitte J, 2003, BASIC LAB PROCEDURES; Weill, 2007, WHO COLLABORATING CT, V9, P1, DOI DOI 10.1038/NATURE12153; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Yang XJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0137967, 10.1371/journal.pone.0125655]; Zdragas A, 2012, LETT APPL MICROBIOL, V55, P308, DOI 10.1111/j.1472-765X.2012.03298.x	35	5	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213726	10.1371/journal.pone.0213726	http://dx.doi.org/10.1371/journal.pone.0213726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865712	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900087
J	Li, XC; Tan, NL				Li, Xingchun; Tan, Nanlin			Calculation model of the equivalent spiral shear stress of conditioned sand	PLOS ONE			English	Article							SOIL; PRESSURE	Soil is the medium that balances the soil and water pressure on the excavation surface of an earth pressure balance (EPB) shield machine, and the soil flow plasticity directly affects the working performance of the shield machine. The spiral shear stress is the main determinant of the soil flow plasticity. During the progress of the EPB shield screw conveyor normal operation, the shear effects between the muck in the spiral tube and the screw shaft, as well as the flight, are different from the shear action, such as the direct shear or the vane shear. The direct or vane shear test is now widely used to evaluate soil flow plasticity. To better investigate the shear properties between the soil and the shield conveyor casing, a model screw conveyor was developed. Based on the analysis of the stress conditions and the movement of the conditioned soil plug, the theoretical calculation model of the equivalent helical shear stress of the EPB shield screw conveyor was deduced based on the steady-state equilibrium conditions of moment of momentum. The conditioned standard sand was used in the indoor tests. The results of the indoor test of the model machine verified the rationality and effectiveness of the theoretical model. The model provides an important theoretical basis and references for the design and optimization of soil conditioning during shield tunneling.	[Li, Xingchun; Tan, Nanlin] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Dept Mech Engn, Beijing, Peoples R China; [Li, Xingchun] Wuyi Univ, Dept Intelligent Mfg, Jiangmen, Guangdong, Peoples R China	Beijing Jiaotong University; Wuyi University	Tan, NL (corresponding author), Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Dept Mech Engn, Beijing, Peoples R China.	nanlintan01@163.com			National Basic Research Program of China [2015CB057802]; Jiangmen City Foundation; Theoretical Science Research Science and Technology Project [2018JC01002, 2017JC268_13]	National Basic Research Program of China(National Basic Research Program of China); Jiangmen City Foundation; Theoretical Science Research Science and Technology Project	This research was funded by the National Basic Research Program of China under Grant 2015CB057802 and the Jiangmen City Foundation and Theoretical Science Research Science and Technology Project, NO. 2018JC01002 and NO. 2017JC268_13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimasa W, 1992, J FUJITA TECHNICAL R, V2, P95; Bezuijen A, 2006, GEOTECHNICAL ASPECTS OF UNDERGROUND CONSTRUCTION IN SOFT GROUND, P195; Bezuijen A, 2006, SIMULATION EPB SHIEL; Bezuijen A., 1999, 12 EUR C SOIL MECH G; Boone SJ, 2005, C INT CHAMB; Borio L, 2011, GOSPOD SUROWCAMI MIN, V27, P85; Duarte P, 2007, FOAM SOIL CONDITIONE; Galli M, 2018, INT J CIV ENG, P1; Gharahbagh EA, 2014, TUNN UNDERGR SP TECH, V41, P127, DOI 10.1016/j.tust.2013.12.003; Houlsby G., 2001, P UND CONSTR, P128; Izadi E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195073; Jancsecz S, 1999, P WTC; [姜厚停 Jiang Houting], 2013, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V35, P284; Karmakar S., 2005, BINGHAM MODEL; Meng QL, 2011, J MECH SCI TECHNOL, V25, P2259, DOI 10.1007/s12206-011-0611-9; Merritt AS, 2006, GEOTECHNIQUE, V56, P605, DOI 10.1680/geot.2006.56.9.605; Merritt A.S., 2005, CONDITIONING CLAY SO; Messerklinger S, 2011, GEOTECH TEST J, V34, P112; Mori L., 2015, RAP EXC TUNN C NEW O, P1253; Peila D, 2007, J GEOTECH GEOENVIRON, V133, P1622, DOI 10.1061/(ASCE)1090-0241(2007)133:12(1622); Peila D, 2009, ENVIRON ENG GEOSCI, V15, P167, DOI 10.2113/gseegeosci.15.3.167; Psomas S., 2001, PROPERTIES FOAM SAND; Quebaud S, 1998, TUNN UNDERGR SP TECH, V13, P173, DOI 10.1016/S0886-7798(98)00045-5; Thewes M., 2010, GEOMECHANICS TUNNELL, V3, P256, DOI [DOI 10.1002/GE0T.201000023, DOI 10.1002/GEOT.201000023]; Vinai R, 2008, TUNN UNDERGR SP TECH, V23, P308, DOI 10.1016/j.tust.2007.04.010; Williamson GE, 1999, PROCOF RETC; [张嘎 Zhang Ga], 2003, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V25, P149; Zumsteg R, 2012, J GEOTECH GEOENVIRON, V138, P1138, DOI 10.1061/(ASCE)GT.1943-5606.0000681; Zumsteg R, 2009, INT C SOIL MECH GEOT	29	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212923	10.1371/journal.pone.0212923	http://dx.doi.org/10.1371/journal.pone.0212923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865686	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900051
J	Yang, D; Xiao, CX; Long, F; Wu, WJ; Huang, MW; Qu, LF; Liu, XH; Zhu, YZ				Yang, Di; Xiao, ChenXi; Long, Fen; Wu, WeiJun; Huang, MengWei; Qu, LeFeng; Liu, XinHua; Zhu, YiZhun			Fra-1 plays a critical role in angiotensin II-induced vascular senescence	FASEB JOURNAL			English	Article						endothelial cells; p21; p16	MUSCLE-CELL SENESCENCE; OXIDATIVE STRESS; PREMATURE SENESCENCE; C-FOS; ATHEROSCLEROSIS; DISEASE; CANCER; P53; INFLAMMATION; MECHANISMS	Vascular aging has a strong relationship with cardiovascular disease. Fos-related antigen 1 (Fra-1), also referred to as Fos-like antigen 1, is a transcription factor and has been reported to be involved in many pathologic processes. Here, we demonstrate that Fra-1 plays a critical role in angiotensin II (Ang II)-induced vascular senescence. Fra-1 expression is increased significantly in Ang II-induced rat aortic endothelial cell (RAEC) senescence and the arteries from Ang II-infused mice. Interestingly, silencing Fra-1 blocks Ang II-induced senescence phenotypes in RAECs, including decreased senescence-associated beta-galactosidase staining, and mitigated proliferation suppression and senescence-associated secretory phenotype. Further, knocking down Fra-1 inhibits vascular aging phenotypes in an Ang II-infused mice model. The up-regulated Fra-1 also exists in human atherosclerotic plaques and Ang II-induced vascular smooth muscle cells as well as in replicated senescence RAECs. Mechanistic studies reveal that Fra-1 preferentially associates with c-Jun and binds to the cyclin-dependent kinase inhibitor 1a (p21) and cyclin-dependent kinase inhibitor 2a (p16) promoter region, leading to elevated gene expression, which causes senescence-related phenotypes. In conclusion, our results identify that Fra-1 plays a novel and key role in promoting vascular aging by directly binding and transcriptionally activating p21 and p16 signaling, suggesting intervention of Fra-1 is a potential strategy for preventing aging-associated cardiovascular disorders.-Yang, D., Xiao, C., Long, F., Wu, W., Huang, M., Qu, L., Liu, X., Zhu, Y. Fra-1 plays a critical role in angiotensin II-induced vascular senescence.	[Yang, Di; Xiao, ChenXi; Long, Fen; Wu, WeiJun; Huang, MengWei; Liu, XinHua; Zhu, YiZhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China; [Yang, Di; Zhu, YiZhun] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Yang, Di; Zhu, YiZhun] Macau Univ Sci & Technol, Sch Pharm, Macau, Peoples R China; [Qu, LeFeng] Second Mil Med Univ, Changzheng Hosp, Dept Vasc Surg, Shanghai, Peoples R China	Fudan University; Macau University of Science & Technology; Macau University of Science & Technology; Naval Medical University	Liu, XH (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Sch Pharm, Room N101,Block E, Taipa 999078, Macau, Peoples R China.	liuxinhua@fudan.edu.cn; yzzhu@must.edu.mo	Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Natural Science Foundation of China [81673428, 81872861]; Macau Science and Technology Development Fund (FDCT) [055/2016/A2, 033/2017/AMJ, 067/2018/A2]; key laboratory program of the Education Commission of Shanghai Municipality [ZDSYS14005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Macau Science and Technology Development Fund (FDCT); key laboratory program of the Education Commission of Shanghai Municipality	This work was supported by grants from National Natural Science Foundation of China (81673428, 81872861), the Macau Science and Technology Development Fund (FDCT) (055/2016/A2, 033/2017/AMJ, and 067/2018/A2), and a key laboratory program of the Education Commission of Shanghai Municipality (ZDSYS14005). The authors declare no conflicts of interest.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen J, 2002, CIRC RES, V90, P1290, DOI 10.1161/01.RES.0000022161.42655.98; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fenton M, 2001, ARTERIOSCL THROM VAS, V21, P220, DOI 10.1161/01.ATV.21.2.220; He JY, 2015, INT J ONCOL, V47, P1725, DOI 10.3892/ijo.2015.3146; Herbert KE, 2008, CIRC RES, V102, P201, DOI 10.1161/CIRCRESAHA.107.158626; Iskit S, 2015, ONCOTARGET, V6, P43146, DOI 10.18632/oncotarget.6454; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kunieda T, 2006, CIRCULATION, V114, P953, DOI 10.1161/CIRCULATIONAHA.106.626606; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lu D, 2012, CANCER RES, V72, P3451, DOI 10.1158/0008-5472.CAN-11-2536; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; O'Rourke MF, 2010, VASC MED, V15, P461, DOI 10.1177/1358863X10382946; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Usui A, 2012, CANCER-AM CANCER SOC, V118, P3387, DOI 10.1002/cncr.26652; Voghel G, 2007, MECH AGEING DEV, V128, P662, DOI 10.1016/j.mad.2007.09.006; Wang CN, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0555-8; Wang JL, 2012, ARTERIOSCL THROM VAS, V32, P712, DOI 10.1161/ATVBAHA.111.227389; Wang JL, 2015, CIRCULATION, V132, P1909, DOI 10.1161/CIRCULATIONAHA.115.016457; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45; Wenzel A, 2002, J NEUROCHEM, V80, P1089, DOI 10.1046/j.0022-3042.2002.00807.x	39	15	15	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7603	7614		10.1096/fj.201801671RRRR	http://dx.doi.org/10.1096/fj.201801671RRRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30892941	Bronze			2022-12-26	WOS:000476114200075
J	Zhang, J; Lin, YB; Dai, XM; Fang, WT; Wu, XL; Chen, XC				Zhang, Jing; Lin, Yingbin; Dai, Xiaoman; Fang, Wenting; Wu, Xilin; Chen, Xiaochun			Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner	FASEB JOURNAL			English	Article						tau phosphorylation; insulin signaling; AMPK	ACTIVATED PROTEIN-KINASE; INCREASED TAU PHOSPHORYLATION; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; COGNITIVE IMPAIRMENT; INSULIN-RECEPTOR; TRANSLATIONAL CONTROL; INTRANASAL INSULIN; SIGNALING PATHWAY	Aging and apolipoprotein E4 (ApoE4) can increase the risk of cognitive impairment and neurodegenerative disorders, including Alzheimer's disease (AD), and patients with type 2 diabetes mellitus are highly susceptible to cognitive dysfunction. Recent research has indicated that metformin, a prescribed drug for type 2 diabetes, may affect cognitive function; however, findings regarding its efficacy are largely controversial. The current study reported that a 5-mo metformin administration (300 mg/kg/d) starting at 13 mo old improved the spatial memory of ApoE3-target replacement (TR) mice, not ApoE4-TR mice. It found that in aged ApoE3-TR mice, metformin treatment, at a molecular level, inhibited AMPK activity, increased insulin signaling, and activated mammalian target of rapamycin signaling, resulting in an enhanced expression of postsynaptic proteins; but the response of the neuronal AMPK activity and insulin signaling to metformin was blunt in aged ApoE4-TR mice. Meanwhile, metformin treatment also increased the phosphorylation of tau in both ApoE3-TR and ApoE4-TR mice, implying that metformin may have side effects in human. These findings suggest that metformin can improve the cognitive performance of aged mice in an APOE genotype-dependent manner, which provides empirical insights into the clinical value of metformin for ApoE4- and age-related AD prevention and treatment.-Zhang, J., Lin, Y., Dai, X., Fang, W., Wu, X., Chen, X. Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner.	[Zhang, Jing; Lin, Yingbin; Dai, Xiaoman; Fang, Wenting; Wu, Xilin; Chen, Xiaochun] Fujian Med Univ, Union Hosp, Fujian Inst Geriatr, Dept Neurol & Geriatr, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China; [Zhang, Jing; Dai, Xiaoman; Chen, Xiaochun] Fujian Med Univ, Fujian Key Lab Mol Neurol, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Chen, XC (corresponding author), Fujian Med Univ, Union Hosp, Fujian Inst Geriatr, Dept Neurol & Geriatr, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	chenxc998@mail.fjmu.edu.cn		Lin, Yingbin/0000-0002-5051-3256; CHEN, XIAOCHUN/0000-0002-2665-4155; Zhang, Jing/0000-0003-4037-9855; Wu, Xilin/0000-0003-0893-2147	National Natural Science Foundation of China [81171216, 91232709, 81401149, 81341098]; Fujian Health Education Joint Project [2018-ZQN-39, WKJ2016-2-19]; Fujian Province New Century Excellent Talents Support Program [2015B022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Health Education Joint Project; Fujian Province New Century Excellent Talents Support Program	These studies were funded by the National Natural Science Foundation of China (Grants 81171216 and 91232709 to X.C., and 81401149 and 81341098 to J.Z.), the Fujian Health Education Joint Project (2018-ZQN-39 and WKJ2016-2-19), and the Fujian Province New Century Excellent Talents Support Program (2015B022). The authors declare no conflicts of interest.	Alzoubi KH, 2014, CURR NEUROPHARMACOL, V12, P186, DOI 10.2174/1570159X11666131120223201; Ashabi G, 2014, METAB BRAIN DIS, V29, P47, DOI 10.1007/s11011-013-9475-2; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Barini E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0082-7; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Cheng C, 2014, J GERONTOL A-BIOL, V69, P1299, DOI 10.1093/gerona/glu073; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; DiTacchio KA, 2015, J ALZHEIMERS DIS, V44, P43, DOI 10.3233/JAD-141332; Garabadu Debapriya, 2017, Pharm Biol, V55, P722, DOI 10.1080/13880209.2016.1268635; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Gratuze M, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0298-9; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harris FM, 2004, J BIOL CHEM, V279, P44795, DOI 10.1074/jbc.M408127200; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Inbar D, 2010, NEURODEGENER DIS, V7, P16, DOI 10.1159/000283477; Khang R, 2014, NEUROSCI LETT, V579, P145, DOI 10.1016/j.neulet.2014.07.029; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lin LY, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0107-2; Liu DR, 2015, IEEE COMPUT INTELL M, V10, P7, DOI 10.1109/MCI.2015.2472117; Luchsinger JA, 2016, J ALZHEIMERS DIS, V51, P501, DOI 10.3233/JAD-150493; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Mostafa DK, 2016, PSYCHOPHARMACOLOGY, V233, P2513, DOI 10.1007/s00213-016-4301-2; Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901; Ong QR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03754; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Pintana H, 2012, LIFE SCI, V91, P409, DOI 10.1016/j.lfs.2012.08.017; Potts MB, 2012, CELL STEM CELL, V11, P5, DOI 10.1016/j.stem.2012.06.003; Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Rosenbloom MH, 2014, CNS DRUGS, V28, P1185, DOI 10.1007/s40263-014-0214-y; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Thal DR, 2000, EXP NEUROL, V163, P98, DOI 10.1006/exnr.2000.7380; Thangthaeng N, 2017, AGING DIS, V8, P17, DOI 10.14336/AD.2016.1010; Thome AD, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0293-1; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Vives M, 2012, REV ESP ANEST REANIM, V59, P276, DOI 10.1016/j.redar.2012.03.018; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang JZ, 2014, NEUROSCI BULL, V30, P359, DOI 10.1007/s12264-013-1415-y; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wu XL, 2017, CHINESE MED J-PEKING, V130, P2978, DOI 10.4103/0366-6999.220313; Xu H, 2016, J ENDOCRINOL, V229, P133, DOI 10.1530/JOE-15-0409; Yarchoan M, 2014, ACTA NEUROPATHOL, V128, P679, DOI 10.1007/s00401-014-1328-5; Zhang B, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0291-3; Zhao N, 2017, NEURON, V96, P115, DOI 10.1016/j.neuron.2017.09.003; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou M, 2016, CURR ALZHEIMER RES, V13, P1048, DOI 10.2174/1567205013666160415154550	67	17	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7748	7757		10.1096/fj.201802718R	http://dx.doi.org/10.1096/fj.201802718R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30894020	Bronze			2022-12-26	WOS:000476114200086
J	Wang, DD; Zhang, ZM; Cui, S; Zhao, YC; Craft, S; Fikrig, E; You, FP				Wang, Dandan; Zhang, Zeming; Cui, Shuang; Zhao, Yingchi; Craft, Samuel; Fikrig, Erol; You, Fuping			ELF4 facilitates innate host defenses against Plasmodium by activating transcription of Pf4 and Ppbp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; mouse; Plasmodium; innate immunity; transcription regulation; ELF4; PF4; PPBP	PATTERN-RECOGNITION RECEPTORS; GENOME-WIDE ANALYSIS; I INTERFERON; MALARIA; QUIESCENCE; EXPRESSION; FALCIPARUM; PRODUCTS; IMMUNITY; CELLS	Platelet factor 4 (PF4) is an anti-Plasmodium component of platelets. It is expressed in megakaryocytes and released from platelets following infection with Plasmodium. Innate immunity is crucial for the host anti-Plasmodium response, in which type I interferon plays an important role. Whether there is cross-talk between innate immune signaling and the production of anti-Plasmodium defense peptides is unknown. Here we demonstrate that E74, like ETS transcription factor 4 (ELF4), a type I interferon activator, can help protect the host from Plasmodium yoelii infection. Mechanically, ELF4 binds to the promoter of genes of two C-X-C chemokines, Pf4 and pro-platelet basic protein (Ppbp), initiating the transcription of these two genes, thereby enhancing PF4-mediated killing of parasites from infected erythrocytes. Elf4(-/-) mice are much more susceptible to Plasmodium infection than WT littermates. The expression level of Pf4 and Ppbp in megakaryocytes from Elf4(-/-) mice is much lower than in those from control animals, resulting in increased parasitemia. In conclusion, our study uncovered a distinct role of ELF4, an innate immune molecule, in host defense against malaria.	[Wang, Dandan; Zhang, Zeming; Zhao, Yingchi; You, Fuping] Peking Univ, Hlth Sci Ctr, Dept Immunol, Inst Syst Biomed, Beijing 100191, Peoples R China; [Wang, Dandan; Zhang, Zeming; Zhao, Yingchi; You, Fuping] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing Key Lab Tumor Syst Biol, Beijing 100191, Peoples R China; [Cui, Shuang] Peking Univ, Neurosci Res Inst, Key Lab Neurosci, Beijing 100191, Peoples R China; [Cui, Shuang] Minist Educ, Natl Hlth & Family Planning Commiss Peoples Repub, Beijing 100083, Peoples R China; [Craft, Samuel; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, 333 Cedar St, New Haven, CT 06520 USA; [Craft, Samuel] RI Hosp, Hasbro Childrens Hosp, Dept Emergency Med, Providence, RI 02903 USA	Peking University; Peking University; Peking University; Yale University; Hasbro Children's Hospital	You, FP (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Inst Syst Biomed, Beijing 100191, Peoples R China.; You, FP (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing Key Lab Tumor Syst Biol, Beijing 100191, Peoples R China.	erol.fikrig@yale.edu; fupingyou@hsc.pku.edu.cn		wang, Dandan/0000-0001-8643-2514	National Natural Science Foundation of China [31570891, 31872736]; National Key Research and Development Program of China [2016YFA0500302]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Natural Science Foundation of China Grant 31570891 and 31872736 National Key Research and Development Program of China Grant 2016YFA0500302. The authors declare that they have no conflicts of interest with the contents of this article.	Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Brouwers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064850; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fernandez-Arias C, 2016, CELL HOST MICROBE, V19, P194, DOI 10.1016/j.chom.2016.01.009; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Head MG, 2017, LANCET GLOB HEALTH, V5, pE772, DOI 10.1016/S2214-109X(17)30245-0; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Love MS, 2012, CELL HOST MICROBE, V12, P815, DOI 10.1016/j.chom.2012.10.017; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024837; Palomo J, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12502; RAVID K, 1991, P NATL ACAD SCI USA, V88, P1521, DOI 10.1073/pnas.88.4.1521; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Souza MC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/168937; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; Suico MA, 2017, J MOL CELL BIOL, V9, P168, DOI 10.1093/jmcb/mjw051; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unver N, 2015, CYTOKINE, V75, P330, DOI 10.1016/j.cyto.2015.07.018; Vigario AM, 2001, BLOOD, V97, P3966, DOI 10.1182/blood.V97.12.3966; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; World Health Organization, 2015, GUID TREATM MAL, Vthird; Wu J, 2015, CELL REP, V12, P661, DOI 10.1016/j.celrep.2015.06.058; Xu LL, 2013, AM J TRANSL RES, V5, P235; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001; Zhang CY, 1997, J BIOL CHEM, V272, P26236, DOI 10.1074/jbc.272.42.26236; Zhang CY, 2001, BLOOD, V98, P610, DOI 10.1182/blood.V98.3.610	38	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7787	7796		10.1074/jbc.RA118.006321	http://dx.doi.org/10.1074/jbc.RA118.006321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30898878	Green Published, hybrid			2022-12-26	WOS:000470153300021
J	Dasgupta, S; Islam, MS; Huq, M; Khan, ZH; Hasib, MR				Dasgupta, Susmita; Islam, Md. Saiful; Huq, Mainul; Khan, Zahirul Huque; Hasib, Md. Raqubul			Quantifying the protective capacity of mangroves from storm surges in coastal Bangladesh	PLOS ONE			English	Article							SEA-LEVEL RISE; CLIMATE-CHANGE; IMPACTS; ECOSYSTEMS; SERVICES; WETLANDS; FORESTS; TSUNAMI; FUTURE	Mangroves are an important ecosystem-based protection against cyclonic storm surge. As the surge moves through the mangrove forest, the tree roots, trunks, and leaves obstruct the flow of water. Damage to adjacent coastal lands is attenuated mainly by reducing (i) surge height, which determines the area and depth of inundation and (ii) water flow velocity. But the extent of mangrove protection depends on the density of tree plantings and the diameter of trunks and roots, along with an array of other forest characteristics (e.g., floor shape, bathymetry, spectral features of waves, and tidal stage at which waves enter the forest). Making efficient use of mangroves protective capacity has been hindered by a lack of location-specific information. This study helps to fill that gap by estimating reduction in storm surge height and water flow velocity from mangroves at selected sites in cyclone-prone, coastal Bangladesh. A hydrodynamic model for the Bay of Bengal, based on the MIKE21FM system, was run multiple times to simulate the surge of cyclone Sidr (2007) at the Barisal coast. Estimates of surge height and water flow velocity were recorded first without mangroves and then with mangroves of various forest widths and planting densities, including specific information on local topography, bathymetry, and Mannings coefficients estimated from species root and trunk systems. The results show a significant reduction in water flow velocity (2992%) and a modest reduction in surge height (416.5 cm). These findings suggest that healthy mangroves can contribute to significant savings in rehabilitation and maintenance costs by protecting embankments from breaching, toe-erosion, and other damage.	[Dasgupta, Susmita] World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA; [Islam, Md. Saiful; Khan, Zahirul Huque; Hasib, Md. Raqubul] Inst Water Modeling, Coast Port & Estuary Management Div, Dhaka, Bangladesh; [Huq, Mainul] World Bank, Dhaka, Bangladesh	The World Bank; The World Bank	Dasgupta, S (corresponding author), World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA.	sdasgupta@worldbank.org			South Asia Water Initiative Trust Fund	South Asia Water Initiative Trust Fund	The financial support for this research was provided by the South Asia Water Initiative Trust Fund administered by the World Bank, who provided support in the form of salaries for authors SD and MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aksornkaoe S, 1993, MALAYSIAN J TROPICAL, V24, P29; Alongi DM, 2008, ESTUAR COAST SHELF S, V76, P1, DOI 10.1016/j.ecss.2007.08.024; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], EM EV DAT EM DAT; [Anonymous], 2006, UNEP REG SEAS REP ST; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Bangladesh Water Development Board. Hydraulic modelling study for second Coastal Embankment Rehabilitation Project (CERP), 2001, HYDR MOD STUD 2 COAS; Bank World and Nations United, 2010, NAT HAZ UNN DIS EC E; BARBIER EB, 1994, LAND ECON, V70, P155, DOI 10.2307/3146319; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barik J, 2018, J COAST CONSERV, V22, P361, DOI 10.1007/s11852-017-0584-7; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Chapman V.J., 1976, MANGROVE VEGETATION; Chatenoux B, 2007, NAT HAZARDS, V40, P289, DOI 10.1007/s11069-006-0015-9; Cochard R, 2008, PERSPECT PLANT ECOL, V10, P3, DOI 10.1016/j.ppees.2007.11.001; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Dasgupta S., 2015, WORLD SCI REFERENCE, P205, DOI [10.1142/9789814578622_0031, DOI 10.1142/9789814578622_0031]; Dasgupta S, 2017, AMBIO, V46, P680, DOI 10.1007/s13280-017-0911-0; Dasgupta S, 2014, CLIM DEV, V6, P96, DOI 10.1080/17565529.2013.868335; Deb M, 2017, J HYDRO-ENVIRON RES, V17, P30, DOI 10.1016/j.jher.2016.11.005; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; FAO, 2007, 153 FAO, P77; Furakawa, 1997, P 13 AUSTR COAST OC, V2, P941; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Hansen AT, 2018, NAT GEOSCI, V11, P127, DOI 10.1038/s41561-017-0056-6; Herr D., 2012, BLUE CARBON POLICY F; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Islam SA, 2015, J BIOSCIENCE AGR RES, V03, P38; Kerr AM, 2007, BIOSCIENCE, V57, P102, DOI 10.1641/B570202; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Liu HQ, 2013, CONT SHELF RES, V64, P51, DOI 10.1016/j.csr.2013.05.015; Massel SR, 1999, FLUID DYN RES, V24, P219, DOI 10.1016/S0169-5983(98)00024-0; Mazda Y., 1997, MANGROVE SALT MARSHE, V1, P127, DOI DOI 10.1023/A:1009928003700; Mazda Yoshihiro, 2006, Wetlands Ecology and Management, V14, P365, DOI 10.1007/s11273-005-5388-0; McIvor A., 2012, NATURAL COASTAL PROT; MCIVOR A., 2012, NATURAL COSTAL PROTE, V1, P27; McLeod E., 2006, MANAGING MANGROVES R; Miyagi T., 1999, TROPICS, V8, P179; Murray B. C., 2011, Green payments for blue carbon: economic incentives for protecting threatened coastal habitats; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Pernetta John, 1993, MANGROVE FORESTS CLI; Perri S, 2018, GEOPHYS RES LETT, V45, P11669, DOI 10.1029/2018GL079766; Pinsky ML, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00080.1; Quartel S, 2007, J ASIAN EARTH SCI, V29, P576, DOI 10.1016/j.jseaes.2006.05.008; SEMENIUK V, 1994, J COASTAL RES, V10, P1050; Siddiqi NA, 2004, J TROP FOR SCI, V16, P187; SNEDAKER SC, 1995, HYDROBIOLOGIA, V295, P43, DOI 10.1007/BF00029109; Spalding M., 2014, MANGROVES COASTAL DE; Spalding M, 2014, MANGROVE COASTAL DEF; Spalding MD, 2014, OCEAN COAST MANAGE, V90, P50, DOI 10.1016/j.ocecoaman.2013.09.007; United Nations Development Programme, 2012, RED DIS RISK CHALL D; United Nations Environment Programme, 1994, REG SEAS REP STUD, V154; United Nations Environmental Program-World Conservation Monitoring Centre, 2006, FRONT LIN SHOR PROT; Waite R., 2014, COASTAL CAPITAL ECOS; Wendelberger KS, 2017, OECOLOGIA, V184, P729, DOI 10.1007/s00442-017-3896-2; WOODROFFE CD, 1990, PROG PHYS GEOG, V14, P483, DOI 10.1177/030913339001400404; World Bank, 2014, BANGL POV MAP 2010; World Bank, 2014, BANGL POV MAP 2010 T; Zhai L, 2018, ECOLOGICAL INDICATOR, V97, P51; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021	63	28	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214079	10.1371/journal.pone.0214079	http://dx.doi.org/10.1371/journal.pone.0214079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897133	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700064
J	Zhou, WK; Xiao, YN; Heffernan, JM				Zhou, Weike; Xiao, Yanni; Heffernan, Jane Marie			Optimal media reporting intensity on mitigating spread of an emerging infectious disease	PLOS ONE			English	Article							AWARENESS PROGRAMS; MATHEMATICAL-MODEL; EPIDEMIC; IMPACT; DYNAMICS	Mass media reports can induce individual behaviour change during a disease outbreak, which has been found to be useful as it reduces the force of infection. We propose a compartmental model by including a new compartment of the intensity of the media reports, which extends existing models by considering a novel media function, which is dependent both on the number of infected individuals and on the intensity of mass media. The existence and stability of the equilibria are analyzed and an optimal control problem of minimizing the total number of cases and total cost is considered, using reduction or enhancement in the media reporting rate as the control. With the help of Pontryagin's Maximum Principle, we obtain the optimal media reporting intensity. Through parameterization of the model with the 2009 A/H1N1 influenza outbreak data in the 8th Hospital of Xi'an in Shaanxi Province of China, we obtain the basic reproduction number for the formulated model with two particular media functions. The optimal media reporting intensity obtained here indicates that during the early stage of an epidemic we should quickly enhance media reporting intensity, and keep it at a maximum level until it can finally weaken when epidemic cases have decreased significantly. Numerical simulations show that media impact reduces the number of cases during an epidemic, but that the number of cases is further mitigated under the optimal reporting intensity. Sensitivity analysis implies that the outbreak severity is more sensitive to the weight a 1 (weight of media effect sensitive to infected individuals) than weight a 2 (weight of media effect sensitive to media items).	[Zhou, Weike; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Dept Appl Math, Xian 710049, Shaanxi, Peoples R China; [Heffernan, Jane Marie] York Univ, Dept Math & Stat, Toronto, ON, Canada	Xi'an Jiaotong University; York University - Canada	Xiao, YN (corresponding author), Xi An Jiao Tong Univ, Sch Math & Stat, Dept Appl Math, Xian 710049, Shaanxi, Peoples R China.	yxiao@mail.xjtu.edu.cn			National Natural Science Foundation of China (NSFC) [11631012, 11571273]; Natural Science and Engineering Research Council of Canada (NSERC); York Research Chair	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); York Research Chair	The authors were supported by the National Natural Science Foundation of China (NSFC, 11631012, 11571273), the Natural Science and Engineering Research Council of Canada (NSERC) and the York Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaba GO, 2017, MATH BIOSCI, V286, P22, DOI 10.1016/j.mbs.2017.01.009; [Anonymous], 2014, ISRN BIOMATHEMATICS, DOI DOI 10.5402/2012/581274; Collinson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141423; Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Cui JA, 2008, ROCKY MT J MATH, V38, P1323, DOI 10.1216/RMJ-2008-38-5-1323; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; d'Onofrio A, 2009, J THEOR BIOL, V256, P473, DOI 10.1016/j.jtbi.2008.10.005; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Fleming W.H., 2012, DETERMINISTIC STOCHA; Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Greenhalgh D, 2015, APPL MATH COMPUT, V251, P539, DOI 10.1016/j.amc.2014.11.091; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hou J, 2009, MATH COMPUT SIMULAT, V79, P3038, DOI 10.1016/j.matcom.2009.02.001; Kassa SM, 2015, J MATH BIOL, V70, P213, DOI 10.1007/s00285-014-0761-3; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Kristiansen IS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-48; Li YF, 2009, COMMUN NONLINEAR SCI, V14, P2353, DOI 10.1016/j.cnsns.2008.06.024; Liu R., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; Lukes D.L., 1982, DIFFERENTIAL EQUATIO; Misra AK, 2015, BIOSYSTEMS, V138, P53, DOI 10.1016/j.biosystems.2015.11.002; Misra AK, 2013, DISCRETE CONT DYN-B, V18, P1909, DOI 10.3934/dcdsb.2013.18.1909; Misra AK, 2011, J BIOL SYST, V19, P389, DOI 10.1142/S0218339011004020; Misra AK, 2011, MATH COMPUT MODEL, V53, P1221, DOI 10.1016/j.mcm.2010.12.005; Roth D., 2011, SOCIAL DISTANCING PA; Samanta S, 2013, APPL MATH COMPUT, V219, P6965, DOI 10.1016/j.amc.2013.01.009; Song PF, 2018, J MATH BIOL, V76, P1249, DOI 10.1007/s00285-017-1173-y; Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005; Tang SY, 2012, J THEOR BIOL, V295, P47, DOI 10.1016/j.jtbi.2011.10.035; Tchuenche JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S5; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wang AL, 2014, NONLINEAR ANAL-HYBRI, V11, P84, DOI 10.1016/j.nahs.2013.06.005; Wang Q, 2015, DISCRETE CONT DYN-B, V20, P215, DOI 10.3934/dcdsb.2015.20.215; Xiao YN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07838; Xiao YN, 2013, MATH BIOSCI ENG, V10, P445, DOI 10.3934/mbe.2013.10.445; Yan QL, 2016, J THEOR BIOL, V390, P1, DOI 10.1016/j.jtbi.2015.11.002	39	13	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213898	10.1371/journal.pone.0213898	http://dx.doi.org/10.1371/journal.pone.0213898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897141	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700043
J	Kondo, Y; Ishitsuka, Y; Kawabata, N; Iwamoto, N; Takahashi, R; Narita, Y; Kadowaki, D; Hirata, S; Uchino, S; Irie, T				Kondo, Yuki; Ishitsuka, Yoichi; Kawabata, Nobuhiro; Iwamoto, Nobuhide; Takahashi, Risa; Narita, Yuki; Kadowaki, Daisuke; Hirata, Sumio; Uchino, Satoru; Irie, Tetsumi			Knowledge and awareness of nonpharmacist salespersons regarding over-the-counter drug use in patients with chronic kidney disease in Japan	PLOS ONE			English	Article							PHARMACISTS; ADJUSTMENT; MEDICATION; RISK; SAFE	Introduction Patients with chronic kidney disease (CKD) depend on advice from healthcare professionals to avoid using unsuitable over-the-counter (OTC) drugs. Recently, qualified, registered non-pharmacist salespersons became licensed to sell OTC drugs in Japan. However, registered salespersons' knowledge and awareness of precautions regarding unsuitable OTC drugs for use in patients with CKD are unclear. Objectives This study aimed to clarify the awareness, knowledge, and implementation of precautions by registered salespersons regarding OTC drugs used by patients with CKD. Additionally, we evaluated the change of registered salespersons' knowledge and awareness of this topic generated by a pharmacist intervention. Methods A questionnaire survey and pharmacist intervention were applied to 175 registered salespersons. The intervention comprised a 50-minute lecture imparted by a pharmacist who was trained in nephrology. The knowledge, awareness, and implementation of precautions by participants with respect to nonsteroidal anti-inflammatory drugs (NSAIDs) and antacids were evaluated before and after the intervention. Results Approximately half of the registered salespersons reported previous experience with selling OTC drugs that were inappropriate for patients with CKD (NSAIDs, 48.0%; antacids, 39.7%). Few participants recognized the need to check renal function when selling those drugs to such patients (NSAIDs, 25.7%; antacids, 47.5%). The registered salespersons' awareness and knowledge were significantly higher after the intervention than before it. Conclusion The results indicate that before the intervention, the registered salespersons had low levels of awareness and knowledge regarding OTC drug use in patients with CKD despite having prior experience selling unsuitable OTC drugs. However, the pharmacist intervention improved the registered salespersons' awareness and knowledge. The educational program for registered salespersons might be necessary to prevent inappropriate OTC drug use by patients with CKD.	[Kondo, Yuki; Ishitsuka, Yoichi; Takahashi, Risa; Irie, Tetsumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Chuo Ku, 5-1 Oe Honmachi, Kumamoto, Japan; [Kawabata, Nobuhiro; Iwamoto, Nobuhide; Uchino, Satoru] Kagoshima Pharmaceut Assoc, 2-8-15 Yojiro, Kagoshima, Japan; [Narita, Yuki; Hirata, Sumio] Kumamoto Univ, Fac Pharmaceut Sci, Dept Clin Pharmacol, Chuo Ku, 5-1 Oe Honmachi, Kumamoto, Japan; [Kadowaki, Daisuke] Sojo Univ, Fac Pharmaceut Sci, Lab Clin Pharmaceut, 4-22-1 Ikeda, Kumamoto, Japan; [Hirata, Sumio; Irie, Tetsumi] Kumamoto Univ, Fac Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto, Japan	Kumamoto University; Kumamoto University; Sojo University; Kumamoto University	Kondo, Y (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Chuo Ku, 5-1 Oe Honmachi, Kumamoto, Japan.	ykondo@kumamoto-u.ac.jp	KONDO, Yuki/ABB-9085-2020	KONDO, Yuki/0000-0003-1456-7721; Kadowaki, Daisuke/0000-0001-5166-7145; Irie, Tetsumi/0000-0001-8664-7048	OTC Self-Medication Promotion Foundation	OTC Self-Medication Promotion Foundation	This work was supported in Grants-in-Aid for Research from the OTC Self-Medication Promotion Foundation (http://www.otc-spf.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams OP, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-135; Annual Health, LAB WELF REP 2007 20; Brata C, 2015, RES SOC ADMIN PHARM, V11, P136, DOI 10.1016/j.sapharm.2014.07.003; Driesen A, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710352; Duffy RM, 2015, ACAD PSYCHIATR, V39, P615, DOI 10.1007/s40596-014-0204-x; Gooch K, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.02.015; Guan F, 2010, CHINESE MED J-PEKING, V123, P884, DOI 10.3760/cma.j.issn.0366-6999.2010.07.022; Hassan Y, 2009, ANN PHARMACOTHER, V43, P1598, DOI 10.1345/aph.1M187; HERZOG P, 1982, SCAND J GASTROENTERO, V17, P56; Houle C. O., 1981, MOBIUS J CONTIN ED P, V1, P76, DOI [DOI 10.1002/CHP.4760010112, 10.1002/chp.4760010112]; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Kappel J, 2002, CAN MED ASSOC J, V166, P473; Kondo Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0615-0; LaCivita C, 2009, J AM PHARM ASSOC, V49, pE110, DOI 10.1331/JAPhA.2009.09005; Lenz PH, 2015, ANN AM THORAC SOC, V12, P561, DOI 10.1513/AnnalsATS.201501-024AR; Manley Harold J, 2003, BMC Nephrol, V4, P10, DOI 10.1186/1471-2369-4-10; Manley HJ, 2005, AM J KIDNEY DIS, V46, P669, DOI 10.1053/j.ajkd.2005.07.001; Pai AB, 2015, J AM PHARM ASSOC, V55, pE15, DOI 10.1331/JAPhA.2015.15506; Paige NM, 2009, MAYO CLIN PROC, V84, P180, DOI 10.1016/S0025-6196(11)60826-4; Puspitasari HP, 2013, INT J CLIN PHARM-NET, V35, P1218, DOI 10.1007/s11096-013-9854-0; RANDALL RE, 1964, ANN INTERN MED, V61, P73, DOI 10.7326/0003-4819-61-1-73; Tuot DS, 2016, CLIN J AM SOC NEPHRO, V11, P1566, DOI 10.2215/CJN.00490116; World Health Organization, 1998, ROL PHARM SELF CAR S	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213763	10.1371/journal.pone.0213763	http://dx.doi.org/10.1371/journal.pone.0213763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893364	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900050
J	Bakker, GJ; Vanbellinghen, MC; Scheithauer, TP; Verchere, CB; Stroes, ES; Timmers, NKLM; Herrema, H; Nieuwdorp, M; Verberne, HJ; van Raalte, DH				Bakker, Guido J.; Vanbellinghen, Manon C.; Scheithauer, Torsten P.; Verchere, C. Bruce; Stroes, Erik S.; Timmers, Nyanza K. L. M.; Herrema, Hilde; Nieuwdorp, Max; Verberne, Hein J.; van Raalte, Daniel H.			Pancreatic F-18-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls	PLOS ONE			English	Article							BETA-CELL; EMISSION TOMOGRAPHY; ISLET INFLAMMATION; INSULIN-RESISTANCE; GLUCOSE; TUMOR; FDG; INDIVIDUALS; MACROPHAGES; DYSFUNCTION	Introduction Increasing evidence indicates that the development of type 2 diabetes is driven by chronic low grade beta-cell inflammation. However, it is unclear whether pancreatic inflammation can be noninvasively visualized in type 2 diabetes patients. We aimed to assess pancreatic F-18-FDG uptake in type 2 diabetes patients and controls using F-18-fluorodeoxylglucose positron emission tomography/computed tomography (F-18-FDG PET/CT). Material and methods In this retrospective cross-sectional study, we enrolled 20 type 2 diabetes patients and 65 controls who had undergone a diagnostic F-18-FDG PET/CT scan and obtained standardized uptake values (SUVs) of pancreas and muscle. Pancreatic SUV was adjusted for background uptake in muscle and for fasting blood glucose concentrations. Results The maximum pancreatic SUVs adjusted for background muscle uptake (SUVmax.m) and fasting blood glucose concentration (SUVgiucose) were significantly higher in diabetes patients compared to controls (median 2.86 [IQR 2.24-4.36] compared to 2.15 [IQR 1.51-2.83], p = 0.006 and median 2.76 [IQR 1.18-4.34] compared to 1.91 [IQR 1.27-2.55], p<0.001, respectively). In linear regression adjusting for age and body mass index, diabetes remained the main predictor of SUVmax.m and SUVglucose. Conclusion Pancreatic F-18-FDG uptake adjusted for background muscle uptake and fasting blood glucose concentration was significantly increased in type 2 diabetes patients.	[Bakker, Guido J.; Vanbellinghen, Manon C.; Stroes, Erik S.; Timmers, Nyanza K. L. M.; Nieuwdorp, Max] Amsterdam Univ Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Scheithauer, Torsten P.; Herrema, Hilde; Nieuwdorp, Max] Amsterdam Univ Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [Scheithauer, Torsten P.; Nieuwdorp, Max; van Raalte, Daniel H.] Amsterdam Univ Med Ctr, Dept Internal Med, Ctr Diabet, Amsterdam, Netherlands; [Verchere, C. Bruce] Univ British Columbia, BC Childrens Hosp, Dept Surg, Vancouver, BC, Canada; [Verchere, C. Bruce] Univ British Columbia, BC Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Nieuwdorp, Max] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Nieuwdorp, Max] Amsterdam Univ Med Ctr, ICaR, Amsterdam, Netherlands; [Verberne, Hein J.] Amsterdam Univ Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands	BC Childrens Hospital; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Gothenburg	Bakker, GJ (corresponding author), Amsterdam Univ Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	g.j.bakker@amc.nl	Bakker, Guido J./AAE-2743-2020	Bakker, Guido J./0000-0002-2819-9395; Herrema, Hilde/0000-0002-0112-6348	ZonMw VIDI grant 2013 [016.146.327]; ICaR-VU talent grant; CVON Young Talent grant 2012; Dutch Diabetes Foundation [2015.81.1840]; Marie Sklodowska-Curie Actions Global Fellowship [708193]	ZonMw VIDI grant 2013; ICaR-VU talent grant; CVON Young Talent grant 2012; Dutch Diabetes Foundation; Marie Sklodowska-Curie Actions Global Fellowship	M.N. is supported by a ZonMw VIDI grant 2013 (016.146.327), ICaR-VU talent grant and CVON Young Talent grant 2012. D.H.R. is supported by a Junior Fellowship of the Dutch Diabetes Foundation (2015.81.1840) and by a Marie Sklodowska-Curie Actions Global Fellowship (708193). These are all the funding or sources of support received during this specific study. The	Bacha F, 2010, DIABETES CARE, V33, P2225, DOI 10.2337/dc10-0004; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Diederichs CG, 1998, J NUCL MED, V39, P1030; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Haroon A, 2012, CLIN INFECT DIS, V54, P1333, DOI 10.1093/cid/cis193; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Honka H, 2014, J CLIN ENDOCR METAB, V99, pE981, DOI 10.1210/jc.2013-4369; Kalliokoski T, 2005, DIABETES RES CLIN PR, V70, P217, DOI 10.1016/j.diabres.2005.04.008; Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847; Mochizuki TA, 2001, J NUCL MED, V42, P1551; Moens SJB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0397-x; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; OSULLIVAN JB, 1974, DIABETES, V23, P713, DOI 10.2337/diab.23.8.713; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Torizuka T, 1997, J NUCL MED, V38, P382; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 1999, DIABETES, V48, P2197, DOI 10.2337/diabetes.48.11.2197; Zimny M, 1999, ANN ONCOL, V10, P28, DOI 10.1023/A:1008372332584	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213202	10.1371/journal.pone.0213202	http://dx.doi.org/10.1371/journal.pone.0213202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889184	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000016
J	Kuska, MT; Behmann, J; Namini, M; Oerke, EC; Steiner, U; Mahlein, AK				Kuska, Matheus Thomas; Behmann, Jan; Namini, Mahsa; Oerke, Erich-Christian; Steiner, Ulrike; Mahlein, Anne-Katrin			Discovering coherency of specific gene expression and optical reflectance properties of barley genotypes differing for resistance reactions against powdery mildew	PLOS ONE			English	Article							F-SP HORDEI; FIELD PHENOTYPING PLATFORM; RACE-SPECIFIC RESISTANCE; BROAD-SPECTRUM; LEAVES; FUNGUS; SUSCEPTIBILITY; BIOSYNTHESIS; VULGARE; ACID	Hyperspectral imaging has proved its potential for evaluating complex plant-pathogen interactions. However, a closer link of the spectral signatures and genotypic characteristics remains elusive. Here, we show relation between gene expression profiles and specific wavebands from reflectance during three barley powdery mildew interactions. Significant synergistic effects between the hyperspectral signal and the corresponding gene activities has been shown using the linear discriminant analysis (LDA). Combining the data sets of hyperspectral signatures and gene expression profiles allowed a more precise differentiation of the three investigated barley-Bgh interactions independent from the time after inoculation. This shows significant synergistic effects between the hyperspectral signal and the corresponding gene activities. To analyze this coherency between spectral reflectance and seven different gene expression profiles, relevant wavelength bands and reflectance intensities for each gene were computed using the Relief algorithm. Instancing, xylanase activity was indicated by relevant wavelengths around 710 nm, which are characterized by leaf and cell structures. HttRuBisCO activity underlines relevant wavebands in the green and red range, elucidating the coherency of RuBisCO to the photosynthesis apparatus and in the NIR range due to the influence of RuBisCO on barley leaf cell development. These findings provide the first insights to links between gene expression and spectral reflectance that can be used for an efficient non-invasive phenotyping of plant resistance and enables new insights into plant-pathogen interactions.	[Kuska, Matheus Thomas; Behmann, Jan; Namini, Mahsa; Oerke, Erich-Christian; Steiner, Ulrike; Mahlein, Anne-Katrin] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Di, Bonn, Germany; [Mahlein, Anne-Katrin] Inst Sugar Beet Res IfZ, Gottingen, Germany	University of Bonn	Kuska, MT; Behmann, J (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Di, Bonn, Germany.	mkuska@uni-bonn.de; jbehmann@uni-bonn.de		Mahlein, Anne-Katrin/0000-0003-1091-3690	German Federal Ministry of Education and Research (BMBF) [0315529]; Daimler & Benz Foundation; Bayer AG Crop Science Division	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Daimler & Benz Foundation; Bayer AG Crop Science Division	This work could be carried out due to the financial support of the German Federal Ministry of Education and Research (BMBF) (AKM) within the scope of the competitive grants program "Networks of excellence in agricultural and nutrition research - CROP.SENSe.net" (Funding code: 0315529), junior research group "Hyperspectral phenotyping of resistance reactions of barley", and due to financial support of Daimler & Benz Foundation (AKM) and Bayer AG Crop Science Division (AKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2015, PLANT PHYSIOL, V168, P321, DOI 10.1104/pp.15.00278; BENHAMOU N, 1990, PLANT PHYSIOL, V92, P1108, DOI 10.1104/pp.92.4.1108; BOYD LA, 1995, PLANT J, V7, P959, DOI 10.1046/j.1365-313X.1995.07060959.x; BUSHNELL WR, 1975, PHYTOPATHOLOGY, V65, P310, DOI 10.1094/Phyto-65-310; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Chowdhury J, 2014, NEW PHYTOL, V204, P650, DOI 10.1111/nph.12974; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CURRAN PJ, 1989, REMOTE SENS ENVIRON, V30, P271, DOI 10.1016/0034-4257(89)90069-2; Deshmukh SD, 2007, J PLANT DIS PROTECT, V114, P263, DOI 10.1007/BF03356227; Eichmann R, 2010, MOL PLANT MICROBE IN, V23, P1217, DOI 10.1094/MPMI-23-9-1217; Faik A, 2010, PLANT PHYSIOL, V153, P396, DOI 10.1104/pp.110.154237; FREIALDENHOVEN A, 1994, PLANT CELL, V6, P983; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; Gay A, 2008, NEW PHYTOL, V179, P663, DOI 10.1111/j.1469-8137.2008.02412.x; Gregersen PL, 1997, PHYSIOL MOL PLANT P, V51, P85, DOI 10.1006/pmpp.1997.0108; Grosskinsky DK, 2015, J EXP BOT, V66, P5429, DOI 10.1093/jxb/erv345; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; HINZE K, 1991, P NATL ACAD SCI USA, V88, P3691, DOI 10.1073/pnas.88.9.3691; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KEMSLEY EK, 1994, FOOD CONTROL, V5, P241, DOI 10.1016/0956-7135(94)90023-X; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Kirchgessner N, 2017, FUNCT PLANT BIOL, V44, P154, DOI 10.1071/FP16165; Kirubakaran SI, 2007, PROTEIN EXPRES PURIF, V52, P159, DOI 10.1016/j.pep.2006.08.012; KOLSTER P, 1986, CROP SCI, V26, P903, DOI 10.2135/cropsci1986.0011183X002600050014x; Kuska M, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0073-7; Kuska MT, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01074; Kuska MT, 2017, PHYTOPATHOLOGY, V107, P1388, DOI 10.1094/PHYTO-04-17-0128-R; Leucker M, 2017, FUNCT PLANT BIOL, V44, P1, DOI 10.1071/FP16121; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahlein AK, 2013, REMOTE SENS ENVIRON, V128, P21, DOI 10.1016/j.rse.2012.09.019; Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE; Mahlein AK, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-3; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Oerke EC, 2016, J EXP BOT, V67, P5529, DOI 10.1093/jxb/erw318; Pryce-Jones E, 1999, PHYSIOL MOL PLANT P, V55, P175, DOI 10.1006/pmpp.1999.0222; Reiss E, 2001, PHYSIOL MOL PLANT P, V58, P183, DOI 10.1006/pmpp.2001.0325; Robnik-Sikonja M., 1997, MACHINE LEARNING P 1, P296, DOI [10.5555/645526.657141, DOI 10.1119/1.880454]; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Roulin S, 1997, PHYSIOL MOL PLANT P, V50, P245, DOI 10.1006/pmpp.1997.0084; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Scheler B, 2016, J EXP BOT, V67, P3263, DOI 10.1093/jxb/erw141; SCHOLES JD, 1994, NEW PHYTOL, V126, P213, DOI 10.1111/j.1469-8137.1994.tb03939.x; SCHWEIZER P, 1993, PLANT PHYSIOL, V102, P503, DOI 10.1104/pp.102.2.503; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Sicher RC, 1997, PHOTOSYNTH RES, V52, P27, DOI 10.1023/A:1005874932233; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Tenenboim H, 2016, TRENDS PLANT SCI, V21, P781, DOI 10.1016/j.tplants.2016.04.009; Thomas S, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0313-8; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Virlet N, 2017, FUNCT PLANT BIOL, V44, P143, DOI 10.1071/FP16163; von Ropenack E, 1998, J BIOL CHEM, V273, P9013, DOI 10.1074/jbc.273.15.9013; Wahabzada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116902; Wang Y, 2014, COMP SYST BIOINF C S, P497; WOLF G, 1981, PHYTOPATHOLOGY, V71, P596, DOI 10.1094/Phyto-71-596; WOLF N, 1992, MOL GEN GENET, V234, P33, DOI 10.1007/BF00272342; Xue GP, 2004, PLANT J, V37, P326, DOI 10.1046/j.1365-313X.2003.01963.x; Yin XY, 2004, TRENDS PLANT SCI, V9, P426, DOI 10.1016/j.tplants.2004.07.007; Zhao YR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27790; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337; ZIELINSKI RE, 1989, PLANT PHYSIOL, V90, P516, DOI 10.1104/pp.90.2.516	65	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213291	10.1371/journal.pone.0213291	http://dx.doi.org/10.1371/journal.pone.0213291			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889193	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000018
J	Narboux-Neme, N; Ekker, M; Levi, G; Heude, E				Narboux-Neme, Nicolas; Ekker, Marc; Levi, Giovanni; Heude, Eglantine			Posterior axis formation requires Dlx5/Dlx6 expression at the neural plate border	PLOS ONE			English	Article							HOMEOBOX GENES; TUBE CLOSURE; N-CADHERIN; CREST SPECIFICATION; BRANCHIAL ARCHES; SPINA-BIFIDA; CURLY TAIL; DLX; DEFECTS; MORPHOGENESIS	Neural tube defects (NTDs), one of the most common birth defects in human, present a multifactorial etiology with a poorly defined genetic component. The Dlx5 and Dlx6 bigenic cluster encodes two evolutionary conserved homeodomain transcription factors, which are necessary for proper vertebrate development. It has been shown that Dlx5/6 genes are essential for anterior neural tube closure, however their role in the formation of the posterior structures has never been described. Here, we show that Dlx5/6 expression is required during vertebrate posterior axis formation. Dlx5 presents a similar expression pattern in neural plate border cells during posterior neurulation of zebrafish and mouse. D/x5/6-inactivation in the mouse results in a phenotype reminiscent of NTDs characterized by open thoracic and lumbar vertebral arches and failure of epaxial muscle formation at the dorsal midline. The dlx5a/6a zebrafish morphants present posterior NTDs associated with abnormal delamination of neural crest cells showing altered expression of cell adhesion molecules and defects of motoneuronal development. Our finDlngs provide new molecular leads to decipher the mechanisms of vertebrate posterior neurulation and might help to gather a better understanDlng of human congenital NTDs etiology.	[Narboux-Neme, Nicolas; Levi, Giovanni; Heude, Eglantine] Museum Natl Hist Nat, CNRS, UMR 7221, Dept Adaptat Vivant, Paris, France; [Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); University of Ottawa	Heude, E (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7221, Dept Adaptat Vivant, Paris, France.	eglantine.heude@mnhn.fr	Heude, Eglantine/AAR-4334-2020	Heude, Eglantine/0000-0003-0563-9607; Narboux-Neme, Nicolas/0000-0002-3791-7459; Levi, Giovanni/0000-0002-7041-6787	EU Consortium HUMAN [EU-FP7-HEALTH-602757]; ANR [ANR-17-CE14-0024, ANR-17-CE37-0007]; CIHR [MOP137082]; government of Canada	EU Consortium HUMAN; ANR(French National Research Agency (ANR)); CIHR(Canadian Institutes of Health Research (CIHR)); government of Canada(CGIAR)	This research was partially supported by the EU Consortium HUMAN (EU-FP7-HEALTH-602757) to NNN/GL/EH, the ANR grants TARGETBONE (ANR-17-CE14-0024) and METACOGNITION (ANR-17-CE37-0007) to NNN/GL and by CIHR grant MOP137082 to ME. EH was a recipient of a postdoctoral fellowship from the government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, DEVELOPMENT, V126, P3795; Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Araya C, 2016, DEV DYNAM, V245, P197, DOI 10.1002/dvdy.24304; Beverdam A, 2002, GENESIS, V34, P221, DOI 10.1002/gene.10156; Birnbaum RY, 2012, HUM MOL GENET, V21, P4930, DOI 10.1093/hmg/dds336; BRONNERFRASER M, 1992, DEV BIOL, V153, P291, DOI 10.1016/0012-1606(92)90114-V; COPP AJ, 1982, J EMBRYOL EXP MORPH, V69, P151; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; Copp AJ, 2013, WIRES DEV BIOL, V2, P213, DOI 10.1002/wdev.71; Cox SG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002938; CZEIZEL A, 1987, HUM GENET, V77, P203, DOI 10.1007/BF00272395; Deng CX, 1997, DEV BIOL, V185, P42, DOI 10.1006/dbio.1997.8553; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Esterberg R, 2008, DEVELOPMENT, V135, P3891, DOI 10.1242/dev.029264; Fernandez-Garre P, 2002, DEVELOPMENT, V129, P2807; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Geerdink N, 2012, PEDIATR NEUROL, V47, P270, DOI 10.1016/j.pediatrneurol.2012.06.010; Goldman DC, 2000, DEVELOPMENT, V127, P2113; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Harrington MJ, 2010, DEV DYNAM, V239, P747, DOI 10.1002/dvdy.22184; Harrington MJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-130; Harris MJ, 2010, BIRTH DEFECTS RES A, V88, P653, DOI 10.1002/bdra.20676; Heude E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098505; Heude E, 2010, P NATL ACAD SCI USA, V107, P11441, DOI 10.1073/pnas.1001582107; Holland ND, 1996, DEVELOPMENT, V122, P2911; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; KHOURY MJ, 1989, PEDIATRICS, V84, P266; Kimura-Yoshida C, 2015, EBIOMEDICINE, V2, P513, DOI 10.1016/j.ebiom.2015.04.012; Kraus P, 2006, AM J MED GENET A, V140A, P1366, DOI 10.1002/ajmg.a.31252; Lee J, 2013, DEV GROWTH DIFFER, V55, P341, DOI 10.1111/dgd.12044; Lele Z, 2002, DEVELOPMENT, V129, P3281; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Liu CQ, 2004, DEV DYNAM, V229, P600, DOI 10.1002/dvdy.20017; Lowery LA, 2004, MECH DEVELOP, V121, P1189, DOI 10.1016/j.mod.2004.04.022; Luo T, 2001, INT J DEV BIOL, V45, P681; MacDonald RB, 2013, DEV BIOL, V381, P276, DOI 10.1016/j.ydbio.2013.05.025; MARTINEZFRIAS ML, 1994, AM J MED GENET, V49, P45, DOI 10.1002/ajmg.1320490110; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Merlo GR, 2002, GENESIS, V33, P97, DOI 10.1002/gene.10098; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Nikolopoulou E, 2017, DEVELOPMENT, V144, P552, DOI 10.1242/dev.145904; Nishida H, 2008, ENDOCRINOLOGY, V149, P2090, DOI 10.1210/en.2007-1265; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Oyen N, 2009, AM J EPIDEMIOL, V170, P46, DOI 10.1093/aje/kwp087; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Pera E, 1999, DEVELOPMENT, V126, P63; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Reichert S, 2013, DEVELOPMENT, V140, P4435, DOI 10.1242/dev.098707; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; SCHMITZ B, 1993, ROUX ARCH DEV BIOL, V202, P250, DOI 10.1007/BF00363214; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; van Straaten HWM, 2001, ANAT EMBRYOL, V203, P225, DOI 10.1007/s004290100169; Vieux-Rochas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051700; WALLIN J, 1994, DEVELOPMENT, V120, P1109; [王梦恕 Wang Mengshu], 2010, [中国工程科学, Engineering Science], V12, P4; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woda JM, 2003, DEVELOPMENT, V130, P331, DOI 10.1242/dev.00212; Yang L, 1998, J NEUROSCI, V18, P8322; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586; Zerucha T, 2000, BIOCHEM CELL BIOL, V78, P593, DOI 10.1139/bcb-78-5-593	67	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214063	10.1371/journal.pone.0214063	http://dx.doi.org/10.1371/journal.pone.0214063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889190	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000044
J	Navarrete, B; Leal-Morales, A; Serrano-Ron, L; Sarrio, M; Jimenez-Fernandez, A; Jimenez-Diaz, L; Lopez-Sanchez, A; Govantes, F				Navarrete, Blanca; Leal-Morales, Antonio; Serrano-Ron, Laura; Sarrio, Marina; Jimenez-Fernandez, Alicia; Jimenez-Diaz, Lorena; Lopez-Sanchez, Aroa; Govantes, Fernando			Transcriptional organization, regulation and functional analysis of flhF an fleN in Pseudomonas putida	PLOS ONE			English	Article							CYCLIC DI-GMP; ESCHERICHIA-COLI; FLAGELLAR NUMBER; GENE-EXPRESSION; MOLECULAR EVOLUTION; BACTERIAL FLAGELLA; BIOFILM FORMATION; BINDING-PROTEIN; BCS OPERONS; AERUGINOSA	The Pseudomonas putida flhA-flhF-fleN-fliA cluster encodes a component of the flagellar export gate and three regulatory elements potentially involved in flagellar biogenesis and other functions. Here we show that these four genes form an operon, whose transcription is driven from the upstream PflhA promoter. A second promoter, PflhF, provides additional transcription of the three distal genes. P flhA and PflhF are sigma(N)-dependent, activated by the flagellar regulator FleQ, and negatively regulated by FIeN. Motility, surface adhesion and colonization defects of a transposon insertion mutant in flhF revealed transcriptional polarity on fleN and fliA, as the former was required for strong surface adhesion and biofilm formation, and the latter was required for flagellar synthesis. On the other hand, FIhF and FIeN were necessary to attain proper flagellar location and number for a fully functional flagellar complement. FleN, along with FleQ and the second messenger c-di-GMP differentially regulated transcription of lapA and the bcsoperon, encoding a large adhesion protein and cellulose synthase. FleQ positively regulated the PlapA promoter and activation was antagonized by FIeN and c-di-GMP. PbcsD was negatively regulated by FleQ and FleN, and repression was antagonized by c-di-GMP. FleN promoted FleQ binding to both PlapA and PbcsD in vitro, while c-di-GMP antagonized interaction with PbcsD and stimulated interaction with PlapA. A single FleQ binding site in PlapA was critical to activation in vivo. Our results suggest that FleQ, FIeN and c-di-GMP cooperate to coordinate the regulation of flagellar motility and biofilm development.	[Navarrete, Blanca; Leal-Morales, Antonio; Serrano-Ron, Laura; Sarrio, Marina; Jimenez-Fernandez, Alicia; Jimenez-Diaz, Lorena; Lopez-Sanchez, Aroa; Govantes, Fernando] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Junta Andalucia, Seville, Spain; [Navarrete, Blanca; Leal-Morales, Antonio; Serrano-Ron, Laura; Sarrio, Marina; Jimenez-Fernandez, Alicia; Jimenez-Diaz, Lorena; Lopez-Sanchez, Aroa; Govantes, Fernando] Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain; [Serrano-Ron, Laura] Univ Politecn Madrid, Ctr Biotecnol & Genorn Plantas, Inst Nacl Invest & Tecnol Agr & Alimentaria, Madrid, Spain; [Jimenez-Fernandez, Alicia] Max Planck Inst Plant Breeding Res, Cologne, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad Pablo de Olavide; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Max Planck Society	Govantes, F (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Junta Andalucia, Seville, Spain.; Govantes, F (corresponding author), Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain.	fgovrom@upo.es	Jiménez-Fernández, Alicia/AAD-7751-2021; Sánchez, Aroa López/F-3465-2016; Govantes, Fernando/E-4790-2017	Sánchez, Aroa López/0000-0001-9022-3811; Serrano Ron, Laura/0000-0001-5180-6547; Govantes, Fernando/0000-0002-4866-6798; Navarrete, Blanca/0000-0002-5122-1562; Jimenez-Fernandez, Alicia/0000-0002-5696-7865	Ministerio de Ciencia e Innovacion, Spain; European Regional Development fund [BIO2010-17853, BIO2013-420173-P]; Ministerio de Economia y Competitividad, Spain; Consejo Superior de Investigaciones Cientificas, Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development fund(European Commission); Ministerio de Economia y Competitividad, Spain(Spanish Government); Consejo Superior de Investigaciones Cientificas, Spain	This work was supported by Ministerio de Ciencia e Innovacion, Spain (http://www.idi.mineco.gob.es/) and European Regional Development fund (http://ec.europa.eu/regional_ policy/en/funding/erdf/), Grant BIO2010-17853, awarded to FG; Ministerio de Economia y Competitividad, Spain (http://www.idi.mineco.gob.es/) and European Regional Development fund (http://ec.europa.eu/regional_policy/en/funding/erdf/), Grant BIO2013-420173-P, awarded to FG; and Consejo Superior de Investigaciones Cientificas, Spain (http://www.csic.es/), JAE-Predoc 2010 scholarship, awarded to AJ-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainelo H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185482; Allerberger F, 2003, FEMS IMMUNOL MED MIC, V35, P183, DOI 10.1016/S0928-8244(02)00447-9; Altegoer F, 2014, BIOTECHNOL GENET ENG, V30, P49, DOI 10.1080/02648725.2014.921500; Molina-Henares MA, 2017, RES MICROBIOL, V168, P36, DOI 10.1016/j.resmic.2016.07.005; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Balaban M, 2009, J BACTERIOL, V191, P6602, DOI 10.1128/JB.00884-09; Bange G, 2011, NAT STRUCT MOL BIOL, V18, P1376, DOI 10.1038/nsmb.2141; Baraquet C, 2016, J BACTERIOL, V198, P178, DOI 10.1128/JB.00539-15; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Blanco-Romero E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31371-z; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Camesano TA, 2002, BIOMACROMOLECULES, V3, P661, DOI 10.1021/bm015648y; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chang WS, 2003, J BACTERIOL, V185, P6199, DOI 10.1128/JB.185.20.6199-6204.2003; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; CLARK WA, 1976, J CLIN MICROBIOL, V3, P632; Corral-Lugo A, 2016, ENVIRON MICROBIOL, V18, P3355, DOI 10.1111/1462-2920.13170; Correa NE, 2005, J BACTERIOL, V187, P6324, DOI 10.1128/JB.187.18.6324-6332.2005; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Gao T, 2015, MOL MICROBIOL, V98, P571, DOI 10.1111/mmi.13141; Garcia-Gonzalez V, 2005, J BACTERIOL, V187, P155, DOI 10.1128/JB.187.1.155-167.2005; Green JCD, 2009, J MOL BIOL, V391, P679, DOI 10.1016/j.jmb.2009.05.075; Gulbronson CJ, 2016, MOL MICROBIOL, V99, P291, DOI 10.1111/mmi.13231; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARWOOD CS, 1989, J BACTERIOL, V171, P4063, DOI 10.1128/jb.171.7.4063-4066.1989; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hintsche M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16428-9; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jimenez-Fernandez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163142; Jimenez-Fernandez A, 2015, ENV MICROBIOL REP, V7, P78, DOI 10.1111/1758-2229.12153; Rodriguez-Herva JJ, 2010, ENV MICROBIOL REP, V2, P373, DOI 10.1111/j.1758-2229.2009.00084.x; Kazmierczak BI, 2013, MOL MICROBIOL, V88, P655, DOI 10.1111/mmi.12221; KIM YJ, 1995, J BACTERIOL, V177, P1850, DOI 10.1128/jb.177.7.1850-1859.1995; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; Kusumoto A, 2006, J BIOCHEM, V139, P113, DOI 10.1093/jb/mvj010; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; Lopez-Sanchez A, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw127; Lopez-Sanchez A, 2013, ENV MICROBIOL REP, V5, P679, DOI 10.1111/1758-2229.12067; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Mears PJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01916; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Monds RD, 2006, APPL ENVIRON MICROB, V72, P1910, DOI 10.1128/AEM.72.3.1910-1924.2006; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; Najafi J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar6425; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nie HL, 2017, ENV MICROBIOL REP, V9, P571, DOI 10.1111/1758-2229.12547; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; Nogales J, 2015, APPL ENVIRON MICROB, V81, P7533, DOI 10.1128/AEM.01798-15; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Ono H, 2015, MOL MICROBIOL, V98, P130, DOI 10.1111/mmi.13109; Pandza S, 2000, MOL MICROBIOL, V36, P414, DOI 10.1046/j.1365-2958.2000.01859.x; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; Rojo F, 1999, J BACTERIOL, V181, P2987, DOI 10.1128/JB.181.10.2987-2991.1999; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schuhmacher JS, 2015, P NATL ACAD SCI USA, V112, P3092, DOI 10.1073/pnas.1419388112; Schulz T, 2012, ARCH MICROBIOL, V194, P977, DOI 10.1007/s00203-012-0833-y; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Xiao YJ, 2016, ENV MICROBIOL REP, V8, P659, DOI 10.1111/1758-2229.12419	83	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214166	10.1371/journal.pone.0214166	http://dx.doi.org/10.1371/journal.pone.0214166			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889223	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000054
J	Karnath, HO; Molbert, SC; Klaner, AK; Tesch, J; Giel, KE; Wong, HY; Mohler, BJ				Karnath, Hans-Otto; Moelbert, Simone Clairee; Klaner, Anna Katharina; Tesch, Joachim; Giel, Katrin Elisabeth; Wong, Hong Yu; Mohler, Betty J.			Visual perception of one's own body under vestibular stimulation using biometric self-avatars in virtual reality	PLOS ONE			English	Article							CALORIC STIMULATION; SPATIAL NEGLECT; REMISSION; SPACE; REPRESENTATIONS; HEMINEGLECT; EXPLORATION; IMPROVEMENT; MODULATION; AWARENESS	Background and purpose Vestibular input is projected to "multisensory (vestibular) cortex" where it converges with input from other sensory modalities. It has been assumed that this multisensory integration enables a continuous perception of state and presence of one's own body. The present study thus asked whether or not vestibular stimulation may impact this perception. Methods We used an immersive virtual reality setup to realistically manipulate the length of extremities of first person biometric avatars. Twenty-two healthy participants had to adjust arms and legs to their correct length from various start lengths before, during, and after vestibular stimulation. Results Neither unilateral caloric nor galvanic vestibular stimulation had a modulating effect on the perceived size of own extremities. Conclusion Our results suggest that vestibular stimulation does not directly influence the explicit somatosensory representation of our body. It is possible that in non-brain-damaged, healthy subjects, changes in whole body size perception are principally not mediated by vestibular information. Alternatively, visual feedback and/or memory may dominate multisensory integration and thereby override possibly existing modulations of body perception by vestibular stimulation. The present observations suggest that multisensory integration and not the processing of a single sensory input is the crucial mechanism in generating our body representation in relation to the external world.	[Karnath, Hans-Otto; Moelbert, Simone Clairee; Klaner, Anna Katharina] Univ Tubingen, Hertie Inst Clin Brain Res, Div Neuropsychol, Ctr Neurol, Tubingen, Germany; [Karnath, Hans-Otto] Univ South Carolina, Dept Psychol, Columbia, SC USA; [Moelbert, Simone Clairee; Giel, Katrin Elisabeth] Univ Tubingen, Med Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Moelbert, Simone Clairee; Tesch, Joachim; Mohler, Betty J.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Wong, Hong Yu] Univ Tubingen, Inst Philosophy, Tubingen, Germany; [Mohler, Betty J.] Tech Univ Darmstadt, Inst Sports Sci, Darmstadt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of South Carolina System; University of South Carolina Columbia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Eberhard Karls University of Tubingen; Technical University of Darmstadt	Karnath, HO (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Div Neuropsychol, Ctr Neurol, Tubingen, Germany.; Karnath, HO (corresponding author), Univ South Carolina, Dept Psychol, Columbia, SC USA.	Karnath@uni-tuebingen.de	Behrens, Simone/AAB-8890-2020	Behrens, Simone/0000-0002-0430-5245	Deutsche Forschungsgemeinschaft [KA 1258/23-1]; Centre for Integrative Neuroscience Tubingen through the German Excellence Initiative [2014-03, EXC307]; Volkswagen "Finding Perspective" funding; Open Access Publishing Fund of University of Tubingen; John Templeton Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Integrative Neuroscience Tubingen through the German Excellence Initiative; Volkswagen "Finding Perspective" funding; Open Access Publishing Fund of University of Tubingen; John Templeton Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (KA 1258/23-1), by the Centre for Integrative Neuroscience Tubingen (Pool-Projekt-2014-03) through the German Excellence Initiative (EXC307), by Volkswagen "Finding Perspective" funding, the Open Access Publishing Fund of University of Tubingen, and by a grant from the John Templeton Foundation to HYW.; We thank Anne M. Scheel for statistic counseling and acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Abderhalden E., 1926, LEHRBUCH PHYSL VORLE, V3; AKBARIAN S, 1994, J COMP NEUROL, V339, P421, DOI 10.1002/cne.903390309; Andre JM, 2001, NEUROPSY NEUROPSY BE, V14, P190; [Anonymous], 2002, COGNITIVE NEURAL BAS, DOI [DOI 10.1093/ACPROF:OSO/9780198508335.003.0027, DOI 10.1177/0956797612475222]; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; BISIACH E, 1991, NEUROPSYCHOLOGIA, V29, P1029, DOI 10.1016/0028-3932(91)90066-H; Bonnier P., 1905, REV NEUROL, V13, P605, DOI [10.1016/j.yebeh.2009.09.020, DOI 10.1016/J.YEBEH.2009.09.020]; Bottini G, 2001, BRAIN, V124, P1182, DOI 10.1093/brain/124.6.1182; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; CAPPA S, 1987, NEUROPSYCHOLOGIA, V25, P775, DOI 10.1016/0028-3932(87)90115-1; Conrad J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135147; Crollen V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01158-9; Dieterich M, 2003, EXP BRAIN RES, V148, P117, DOI 10.1007/s00221-002-1267-6; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferre ER, 2013, CORTEX, V49, P748, DOI 10.1016/j.cortex.2012.01.012; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Ferre ER, 2015, MULTISENS RES, V28, P559, DOI 10.1163/22134808-00002487; Ferre ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124573; Ferre ER, 2015, NEUROPSYCHOLOGIA, V69, P140, DOI 10.1016/j.neuropsychologia.2015.01.032; Ferre ER, 2013, NEUROPSYCHOLOGIA, V51, P1445, DOI 10.1016/j.neuropsychologia.2013.04.006; Fruhmann-Berger M, 2005, J NEUROL, V252, P1194, DOI 10.1007/s00415-005-0831-y; Fu KMG, 2003, J NEUROSCI, V23, P7510; GEMINIANI G, 1992, J NEUROL NEUROSUR PS, V55, P332, DOI 10.1136/jnnp.55.4.332-a; Guldin W, 1996, CORTEX VESTIBULAIRE, P17; Guldin W. O., 1992, J COMP NEUROL, V324, P1, DOI 10.1002/cne.903240102; Jung R., 1953, HDB INNEREN MED, P1206, DOI [10.1007/978-3-642-94610-3_11, DOI 10.1007/978-3-642-94610-3_11]; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Karnath HO, 1996, EXP BRAIN RES, V109, P333; Karnath HO, 2003, EXP BRAIN RES, V153, P231, DOI 10.1007/s00221-003-1596-0; LACKNER JR, 1992, PERCEPTION, V21, P803, DOI 10.1068/p210803; Lakens D, 2018, ADV METH PRACT PSYCH, V1, P259, DOI 10.1177/2515245918770963; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Le Chapelain L, 2001, SPINAL CORD, V39, P85, DOI 10.1038/sj.sc.3101093; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Lopez C, 2015, MULTISENS RES, V28, P525, DOI 10.1163/22134808-00002490; Lopez C, 2012, NEUROPSYCHOLOGIA, V50, P1830, DOI 10.1016/j.neuropsychologia.2012.04.008; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; McDonald J.H., 2014, HDB BIOL STAT; Molbert SC, 2018, PSYCHOL MED, V48, P642, DOI 10.1017/S0033291717002008; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Piryankova IV, 2014, ACM T APPL PERCEPT, V11, DOI 10.1145/2641568; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Robinette K. M., 1999, Second International Conference on 3-D Digital Imaging and Modeling (Cat. No.PR00062), P380, DOI 10.1109/IM.1999.805368; Rode G, 1998, CORTEX, V34, P253; RODE G, 1992, CORTEX, V28, P203, DOI 10.1016/S0010-9452(13)80048-2; RUBENS AB, 1985, NEUROLOGY, V35, P1019, DOI 10.1212/WNL.35.7.1019; Sang FYP, 2006, J NEUROL NEUROSUR PS, V77, P760, DOI 10.1136/jnnp.2005.075473; Schilder P., 1936, J NERV MENT DIS, V83, P227, DOI [10.1097/00005053-193602000-00051, DOI 10.1097/00005053-193602000-00051]; Schonherr A, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00014; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Serino S, 2018, CYBERPSYCH BEH SOC N, V21, P304, DOI 10.1089/cyber.2017.0674; VALLAR G, 1995, CORTEX, V31, P589, DOI 10.1016/S0010-9452(13)80070-6; Wilkinson D, 2005, J INT NEUROPSYCH SOC, V11, P925, DOI 10.1017/S1355617705051076	57	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213944	10.1371/journal.pone.0213944	http://dx.doi.org/10.1371/journal.pone.0213944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883577	gold, Green Submitted, Green Published			2022-12-26	WOS:000461423500042
J	Ow, SGW; Ong, PY; Lee, SC				Ow, Samuel Guan Wei; Ong, Pei Yi; Lee, Soo-Chin			Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world	PLOS ONE			English	Article							MUTATION CARRIERS; RISK; OLAPARIB; BARRIERS	Background Due to historically low uptake of genetic testing, the mutational spectrum of Asians with Hereditary Breast Cancer (HBC) is not well understood. This study sought to understand the incidence and spectrum of germline mutations in Asian patients with suspected HBC in a clinic setting. Methods 1056 patients with suspected HBC were seen in our Cancer (CA) Genetics Clinic from 2000-2017, of which 460 underwent genetic testing. Results Of 460 probands tested, 93% were female, 61% Chinese, 90% had prior CA, with 19% (77/414) having >= 2 primary CA. Median age at CA-diagnosis was 43y (17-83); 70% had Breast CA (BC) and 25% Ovarian CA (OC). 34% had young-onset BC, 8% bilateral BC, and 4% BC/OC. Majority had family history of BC (53%) or OC (20%). 57% underwent multigene testing (14-49 genes), 34% targeted testing, and 8% predictive testing. 30% were found to have a pathogenic mutation: 80% in BRCA1/2 (8 novel mutations noted). Of 33 non-BRCA1/2 pathogenic mutations detected, 61% were in 11 BC genes while 39% were in non-BC genes suggestive of alternative CA syndromes. Testing beyond BRCA1/2 impacted management for 15.9% (22/138) of carriers, but extensive testing identified variants of uncertain significance (VUS) in up to 44.5% of probands. Restricting multigene panel testing to a guideline-based 20-gene panel including Lynch Syndrome genes was found to be most optimal, detecting 94.6% of mutation carriers while reducing VUS rate to 21.5%. Conclusions Evolution of CA Genetics testing strategy to a multigene approach facilitated detection of pathogenic mutations in non-BRCA1/2 genes and aided management. Guideline-based panel testing is feasible and can be offered in Asians with suspected HBC.	[Ow, Samuel Guan Wei; Ong, Pei Yi; Lee, Soo-Chin] Natl Univ Canc Inst, Dept Hematol Oncol, Singapore, Singapore; [Lee, Soo-Chin] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore	National University of Singapore; National University of Singapore	Lee, SC (corresponding author), Natl Univ Canc Inst, Dept Hematol Oncol, Singapore, Singapore.; Lee, SC (corresponding author), Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore.	csilsc@nus.edu.sg	Lee, Soo Chin/S-9111-2016	Lee, Soo Chin/0000-0002-5835-6419; OW, Samuel GW/0000-0002-2229-7971	Singapore Ministry of Health's National Medical Research Council [NMRC/CG/012/2013, NMRC/CSA/015/2009, NMRC/CSA-SI/0004/2015]	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This research is supported by the Singapore Ministry of Health's National Medical Research Council (www.nmrc.gov.sg) under its Centre Grant Programme (NMRC/CG/012/2013) and Clinician Scientist Awards (NMRC/CSA/015/2009 and NMRC/CSA-SI/0004/2015) to SCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chieng Wei-Shieng, 2006, Hered Cancer Clin Pract, V4, P126, DOI 10.1186/1897-4287-4-3-126; Chin TM, 2005, CANCER DETECT PREV, V29, P412, DOI 10.1016/j.cdp.2005.06.009; Daly MB, 2019, J NATL COMPR CANC NE; Goldberg M, 2017, J MED GENET, V54, P742, DOI 10.1136/jmedgenet-2017-104542; Harkness EF, 2015, J MED GENET, V52, P553, DOI 10.1136/jmedgenet-2015-103216; Jagsi R, 2015, J CLIN ONCOL, V33, P1584, DOI 10.1200/JCO.2014.58.5885; Kang PCE, 2014, BREAST CANCER RES TR, V144, P635, DOI 10.1007/s10549-014-2894-x; Kim H, 2013, J BREAST CANCER, V16, P357, DOI 10.4048/jbc.2013.16.4.357; Kurian AW, 2008, J CLIN ONCOL, V26, P4752, DOI 10.1200/JCO.2008.16.8310; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lindor NM, 2010, FAM CANCER, V9, P495, DOI 10.1007/s10689-010-9348-3; Lubbe SJ, 2009, J CLIN ONCOL, V27, P3975, DOI 10.1200/JCO.2008.21.6853; Mai PL, 2016, CANCER-AM CANCER SOC, V122, P3673, DOI 10.1002/cncr.30248; Pacheco MC, 2016, J PEDIATR GENET, V5, P89, DOI 10.1055/s-0036-1579758; Provenzale D, 2018, J NATL COMPR CANC NE; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Southey MC, 2016, J MED GENET, V53, P800, DOI 10.1136/jmedgenet-2016-103839; Suther S, 2009, GENET MED, V11, P655, DOI 10.1097/GIM.0b013e3181ab22aa; Tan MH, 2012, CLIN CANCER RES, V18, P400, DOI 10.1158/1078-0432.CCR-11-2283; Weitzel JN, 2007, JAMA-J AM MED ASSOC, V297, P2587, DOI 10.1001/jama.297.23.2587; Weitzel JN, 2011, CA-CANCER J CLIN, V61, P327, DOI 10.3322/caac.20128; Wong ESY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.3	22	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213746	10.1371/journal.pone.0213746	http://dx.doi.org/10.1371/journal.pone.0213746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875412	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400026
J	Scandola, M; Aglioti, SM; Avesani, R; Bertagnoni, G; Marangoni, A; Moro, V				Scandola, Michele; Aglioti, Salvatore Maria; Avesani, Renato; Bertagnoni, Gianettore; Marangoni, Anna; Moro, Valentina			Anticipation of wheelchair and rollerblade actions in spinal cord injured people, rollerbladers, and physiotherapists	PLOS ONE			English	Article							ACTION PREDICTION ABILITIES; EXPERT-NOVICE DIFFERENCES; ATTENTION-GRABBING POWER; AUTOMATIC VIGILANCE; ANOSOGNOSIA; REPRESENTATIONS; REORGANIZATION; RECOGNITION; MODULATION; MECHANISMS	Embodied Cognition Theories (ECT) postulate that higher-order cognition is heavily influenced by sensorimotor signals. We explored the active role of somatosensory afferents and motor efferents in modulating the perception of actions in people who have suffered a massive body-brain disconnection because of spinal cord injury (SCI), which leads to sensory motor loss below the lesion. We assessed whether the habitual use of a wheelchair enhances the capacity to anticipate the endings of tool-related actions, with respect to actions that have become impossible. In a Temporal Occlusion task, three groups of participants (paraplegics, rollerbladers and physiotherapists) observed two sets of videos depicting an actor who attempted to climb onto a platform using a wheelchair or rollerblades. Three different outcomes were possible, namely: a) success (the actor went up the step); b) fail (the actor stopped before the step without going up) and c) fall (the actor fell without going up). Each video set comprised 5 different durations increasing in complexity: in the shortest (600ms) only preparatory body movements were shown and in the longest (3000ms) the complete action was shown. The participants were requested to anticipate the outcome (success, fail, fall). The main result showed that the SCI group performed better with the wheelchair videos and poorer with rollerblade videos than both groups, even if the physiotherapists group never used rollerblades. In line with the ECT, this suggests that the action anticipation skills are not only influenced by motor expertise, but also by motor connection.	[Scandola, Michele; Moro, Valentina] Univ Verona, Dept Human Sci, NPSY Lab VR, Verona, Italy; [Aglioti, Salvatore Maria] Univ Rome Sapienza, Dept Psychol, Rome, Italy; [Avesani, Renato] Sacro Cuore Don Calabria Hosp, Dept Rehabil, Negrar, VR, Italy; [Bertagnoni, Gianettore; Marangoni, Anna] San Bortolo Hosp, Dept Funct Recovery & Rehabil, Vicenza, Italy	University of Verona; Sapienza University Rome; IRCCS Sacro Cuore Don Calabria; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Scandola, M (corresponding author), Univ Verona, Dept Human Sci, NPSY Lab VR, Verona, Italy.	michele.scandola@univr.it	Moro, Valentina/K-6464-2016; Scandola, Michele/D-8107-2013	Moro, Valentina/0000-0002-7119-7264; Scandola, Michele/0000-0003-0853-8975; Aglioti, Salvatore Maria/0000-0001-8175-7563	MIUR Italy [PRIN 20159CZFJK]; University of Verona (Bando di Ateneo per la Ricerca di Base 2015 project MOTOS); International Foundation for Research in Paraplegia [IRP P164]	MIUR Italy(Ministry of Education, Universities and Research (MIUR)); University of Verona (Bando di Ateneo per la Ricerca di Base 2015 project MOTOS); International Foundation for Research in Paraplegia	This work was supported by MIUR Italy (PRIN 20159CZFJK, http://attiministeriali.miur.it/anno-2016/novembre/dd-07112016-(1).aspx) to SMA, VM and MS, by funds from the University of Verona (Bando di Ateneo per la Ricerca di Base 2015 project MOTOS,) to VM and MS, and by the International Foundation for Research in Paraplegia (IRP P164, http://www.irp.ch/files/PDF/IRP_Research_Grants_2016) to VM and MS.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; ABERNETHY B, 1990, PERCEPTION, V19, P63, DOI 10.1068/p190063; Abernethy B., 1987, PHYSICAL ED REV, V10, P5; Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Abreu AM, 2017, PROG BRAIN RES, V234, P53, DOI 10.1016/bs.pbr.2017.08.006; Acock A.C, 2014, GENTLE INTRO STATA; Adams F, 2010, PHENOMENOL COGN SCI, V9, P619, DOI 10.1007/s11097-010-9175-x; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Allport D. A., 1987, PERSPECTIVES PERCEPT, V15, P395; Arrighi R, 2011, CURR BIOL, V21, pR910, DOI 10.1016/j.cub.2011.09.048; Avenanti A, 2018, CEREB CORTEX, V28, P1282, DOI 10.1093/cercor/bhx041; Avenanti A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00185; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bloch A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158396; Boyd CE, 2015, AQUACULTURE, RESOURCE USE, AND THE ENVIRONMENT, P1, DOI 10.1002/9781118857915; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Bufalari I, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00102; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Candidi M, 2014, CEREB CORTEX, V24, P435, DOI 10.1093/cercor/bhs325; Canzano L, 2014, CORTEX, V61, P148, DOI 10.1016/j.cortex.2014.05.015; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; CONOMY JP, 1973, NEUROLOGY, V23, P842, DOI 10.1212/WNL.23.8.842; Curt A, 2011, SPINAL CORD, V49, P588, DOI 10.1038/sc.2010.143; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; D'Imperio D, 2017, CORTEX, V92, P187, DOI 10.1016/j.cortex.2017.04.009; de Laplace P-S, 1825, ESSAI PHILOS PROBABI; ERDELYI MH, 1974, PSYCHOL REV, V81, P1, DOI 10.1037/h0035852; Fourkas AD, 2008, CEREB CORTEX, V18, P2382, DOI 10.1093/cercor/bhn005; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Fusco G, 2016, RESTOR NEUROL NEUROS, V34, P815, DOI 10.3233/RNN-160660; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Glenberg AM, 2015, CAN J EXP PSYCHOL, V69, P165, DOI 10.1037/cep0000056; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Hubbard R, 2008, THEOR PSYCHOL, V18, P69, DOI 10.1177/0959354307086923; Invernizzi M, 2010, DISABIL REHABIL, V32, P1194, DOI 10.3109/09638280903437246; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ionta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20144; Keller PE, 2008, Q J EXP PSYCHOL, V61, P275, DOI 10.1080/17470210601160864; Kellner, 2017, JAGSUI WRAPPER RJAGS; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kruschke J. K., 2011, DOING BAYESIAN DATA; Kruschke JK, 2010, WIRES COGN SCI, V1, P658, DOI 10.1002/wcs.72; Lenggenhager B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050757; Liddell TM, 2014, JUDGM DECIS MAK, V9, P523; Makris S, 2015, SOC COGN AFFECT NEUR, V10, P342, DOI 10.1093/scan/nsu052; McElreath R, 2016, TEXT STAT SCI, pXI; Moro V, 2015, NEUROPSYCHOL REHABIL, V25, P593, DOI 10.1080/09602011.2014.951659; Moro V, 2008, NEURON, V60, P235, DOI 10.1016/j.neuron.2008.09.022; Moro V, 2015, NEUROPSYCHOLOGIA, V78, P122, DOI 10.1016/j.neuropsychologia.2015.10.005; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; Oudgenoeg-Paz O, 2015, DEV PSYCHOL, V51, P1241, DOI 10.1037/a0039572; Panasiti MS, 2016, NEUROSCIENCE, V318, P104, DOI 10.1016/j.neuroscience.2016.01.023; Panasiti MS, 2017, NEUROPSYCHOLOGIA, V105, P92, DOI 10.1016/j.neuropsychologia.2017.05.020; Pernigo S, 2012, EUR J NEUROSCI, V36, P3509, DOI 10.1111/j.1460-9568.2012.08266.x; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; Plummer M., 2003, P 3 INT WORKSH DISTR; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; R Core Team, 2021, R LANGUAGE ENV STAT; Romano D, 2014, BRAIN, V137, P1213, DOI 10.1093/brain/awu009; Rothermund K, 2001, COGNITION EMOTION, V15, P231, DOI 10.1080/0269993004200079; Scandola M, 2017, J NEUROPSYCHOL, V11, P305, DOI 10.1111/jnp.12098; Scandola M, 2017, CONSCIOUS COGN, V49, P278, DOI 10.1016/j.concog.2017.01.010; Scandola M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24126; Scandola M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00404; Tidoni E, 2015, NEUROPSYCHOLOGIA, V79, P301, DOI 10.1016/j.neuropsychologia.2015.06.029; Tidoni E, 2014, RESTOR NEUROL NEUROS, V32, P611, DOI 10.3233/RNN-130385; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Urgesi C, 2012, PSYCHOL RES-PSYCH FO, V76, P542, DOI 10.1007/s00426-011-0383-y; Urgesi C, 2010, CEREB CORTEX, V20, P2511, DOI 10.1093/cercor/bhp292; Varela FJ, 1991, EMBODIED MIND PHILOS, DOI [10.1111/j.1468-0149.1965.tb01386.x, DOI 10.1111/J.1468-0149.1965.TB01386.X]; Weakliem DL, 1999, SOCIOL METHOD RES, V27, P359, DOI 10.1177/0049124199027003002; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Wright MJ, 2010, NEUROREPORT, V21, P94, DOI 10.1097/WNR.0b013e328333dff2	86	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213838	10.1371/journal.pone.0213838	http://dx.doi.org/10.1371/journal.pone.0213838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875399	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400034
J	Benicio, JRW; Jasper, A; Spiekermann, R; Garavaglia, L; Pires-Oliveira, EF; Machado, NTG; Uhl, D				Benicio, Jose Rafael W.; Jasper, Andre; Spiekermann, Rafael; Garavaglia, Luciane; Pires-Oliveira, Etiene Fabbrin; Galarce Machado, Neli Teresinha; Uhl, Dieter			Recurrent palaeo-wildfires in a Cisuralian coal seam: A palaeobotanical view on high-inertinite coals from the Lower Permian of the Parana Basin, Brazil	PLOS ONE			English	Article							GRANDE-DO-SUL; FAXINAL COALFIELD; CHARCOAL REMAINS; FOSSIL CHARCOAL; SANTA-CATARINA; BEARING STRATA; TONSTEIN LAYER; SOUTH-AMERICA; FIRE REGIMES; DEPOSITION	Distribution and abundance of charcoal in coal seams (in form of pyrogenic macerals of the inertinites group) have been considered as a reliable tool to interpret the local and regional palaeo-wildfire regimes in peat-forming depositional environments. Although the occurrence of inertinites is globally well documented for the Late Palaeozoic, the description of palaeobotanical evidence concerning the source plants of such charcoal is so far largely missing. In the present study, we provide the first detailed analysis of macro-charcoal preserved in the Barro Branco coal seam, Rio Bonito Formation, Cisuralian of the Parana Basin, Santa Catarina State, Brazil. Charcoal, in form of macro-charcoal and inertinites, was documented in all the six coal-bearing strata that compose the succession, confirming the occurrence of recurrent palaeo-wildfires during its deposition. Reflectance values indicated a mean charring temperature reaching similar to 515 degrees C (and up to 1,045 degrees C in excess) and the macro-charcoal exhibits anatomical features of secondary xylem of Agathoxylon. Combination of results derived from palaeobotanical and petrological data demonstrates that gymnosperm-dominated vegetation was repeatedly submitted to fire events and reinforced the hypothesis that Gondwanan mires were high-fire systems during the Cisuralian.	[Benicio, Jose Rafael W.; Jasper, Andre; Galarce Machado, Neli Teresinha; Uhl, Dieter] Univ Vale Taquari Univates, Programa Posgrad Ambiente & Desenvolvimento PPGAD, Lajeado, RS, Brazil; [Benicio, Jose Rafael W.; Jasper, Andre; Spiekermann, Rafael; Uhl, Dieter] Univates, LPEB, MCN, Lajeado, RS, Brazil; [Jasper, Andre; Uhl, Dieter] Senckenberg Forschungsinst & Nat Museum, Frankfurt, Germany; [Garavaglia, Luciane] SACT, Ctr Tecnol Carvao Limpo, Criciuma, SC, Brazil; [Pires-Oliveira, Etiene Fabbrin] Univ Fed Tocantins, Lab Paleobiol, Porto Nacl, Tocantins, Brazil	Universidade do Vale do Taquari; Senckenberg Gesellschaft fur Naturforschung (SGN); Universidade Federal do Tocantins (UFT)	Jasper, A (corresponding author), Univ Vale Taquari Univates, Programa Posgrad Ambiente & Desenvolvimento PPGAD, Lajeado, RS, Brazil.; Jasper, A (corresponding author), Univates, LPEB, MCN, Lajeado, RS, Brazil.; Jasper, A (corresponding author), Senckenberg Forschungsinst & Nat Museum, Frankfurt, Germany.	ajasper@univates.br	Benício, José Rafael Wanderley/W-8852-2019; Spiekermann, Rafael/W-6994-2019; Jasper, André/C-2772-2008	Benício, José Rafael Wanderley/0000-0002-7490-0736; Spiekermann, Rafael/0000-0001-8341-7140; Jasper, André/0000-0001-8143-9733; fabbrin pires oliveira, etiene/0000-0002-6062-8014	Centro Tecnologico SATC; CAPES/PROSUC; CAPES (Brazil) [8107-14-9]; CNPq (Brazil) [444330/2014-3, 305436/2015-5]; Alexander von Humboldt Foundation (Germany)	Centro Tecnologico SATC; CAPES/PROSUC; CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alexander von Humboldt Foundation (Germany)(Alexander von Humboldt Foundation)	This study was supported by the Centro Tecnologico SATC during field-work and access to the study area. JRW Benicio acknowledges CAPES/PROSUC for doctoral fellowship; A Jasper acknowledges CAPES (Brazil - 8107-14-9), CNPq (Brazil -444330/2014-3; 305436/2015-5) and Alexander von Humboldt Foundation (Germany).	[Anonymous], 1984, 74045 ISO, V11; [Anonymous], 1984, 74043 ISO, P4; Bamford MK, 2001, REV PALAEOBOT PALYNO, V113, P287, DOI 10.1016/S0034-6667(00)00065-8; BARRO SC, 1991, ENVIRON INT, V17, P135, DOI 10.1016/0160-4120(91)90096-9; Beerling DJ, 2002, GEOCHIM COSMOCHIM AC, V66, P3757, DOI 10.1016/S0016-7037(02)00901-8; Berner RA, 2001, GEOCHIM COSMOCHIM AC, V65, P685, DOI 10.1016/S0016-7037(00)00572-X; Blackford JJ, 2000, PALAEOGEOGR PALAEOCL, V164, P33, DOI 10.1016/S0031-0182(00)00173-5; Bortoluzzi CA, 1978, PESQUISAS, V11, P33; Bustin M, 1989, MINERALOGICAL ASS CA, P230; Clark J.S., 1997, SEDIMENT RECORDS BIO, V51, P23, DOI [10.1007/978-3-642-59171-6_3, DOI 10.1007/978-3-642-59171-6_3]; CLARK JS, 1988, QUATERNARY RES, V30, P67, DOI 10.1016/0033-5894(88)90088-9; Cohen A.D., 1987, GEOL SOC SPEC PUBL, V32, P107; Collinson ME, 2007, J GEOL SOC LONDON, V164, P87, DOI 10.1144/0016-76492005-185; CYPERT EUGENE, 1961, AMER MIDLAND NAT, V66, P485, DOI 10.2307/2423049; Davies GM, 2013, FOREST ECOL MANAG, V308, P169, DOI 10.1016/j.foreco.2013.07.051; Davis K.P., 1959, FOREST FIRE CONTROL, P584; Degani-Schmidt I, 2016, REV PALAEOBOT PALYNO, V232, P119, DOI 10.1016/j.revpalbo.2016.06.002; Degani-Schmidt I, 2016, REV PALAEOBOT PALYNO, V226, P20, DOI 10.1016/j.revpalbo.2015.12.003; Degani-Schmidt I, 2015, INT J COAL GEOL, V146, P55, DOI 10.1016/j.coal.2015.05.002; Diessel CFK, 2010, INT J COAL GEOL, V81, P251, DOI 10.1016/j.coal.2009.04.004; ELLERY WN, 1989, AFR J ECOL, V27, P7, DOI 10.1111/j.1365-2028.1989.tb00924.x; Finkelman RB, 2000, 31 INT GEOL C; Gignoux J, 1997, OECOLOGIA, V110, P576, DOI 10.1007/s004420050198; Glasspool IJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00756; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Guo Y, 1998, INT J COAL GEOL, V37, P29, DOI 10.1016/S0166-5162(98)00019-6; HARRIS TM, 1958, J ECOL, V46, P447, DOI 10.2307/2257405; HARRIS TM, 1957, PROC R SOC SER B-BIO, V147, P289, DOI 10.1098/rspb.1957.0051; He TH, 2016, J ECOL, V104, P352, DOI 10.1111/1365-2745.12513; Holz M, 2010, J S AM EARTH SCI, V29, P381, DOI 10.1016/j.jsames.2009.04.004; HORNBERG G, 1995, J VEG SCI, V6, P291, DOI 10.2307/3236224; Hudspith V, 2012, INT J COAL GEOL, V89, P13, DOI 10.1016/j.coal.2011.07.009; Int Comm Coal Organic Petrology, 2001, FUEL, V80, P459, DOI 10.1016/s0016-2361(00)00102-2; Int Committee Coal Organic Petrology, 1998, FUEL, V77, P349, DOI 10.1016/s0016-2361(98)80024-0; International Committee for Coal Petrology (ICCP), 1963, INT HDB COAL PETR, P494; Jasper A., 2011, GEONOMOS, V19, P18, DOI DOI 10.18285/GEONOMOS.V19I1.59; Jasper A, 2017, GEOL J, V52, P955, DOI 10.1002/gj.2860; Jasper A, 2013, GONDWANA RES, V24, P148, DOI 10.1016/j.gr.2012.08.017; Jasper A, 2011, PALAEOGEOGR PALAEOCL, V306, P205, DOI 10.1016/j.palaeo.2011.04.022; Jasper A, 2011, AN ACAD BRAS CIENC, V83, P471, DOI 10.1590/S0001-37652011000200009; Jasper A, 2008, J S AM EARTH SCI, V26, P435, DOI 10.1016/j.jsames.2008.08.002; Johnson B, 1984, GREAT FIRE BORNEO, P24; Jones TP, 1991, PALAEOGEOGR PALAEOCL, V97, P39, DOI 10.1016/0031-0182(91)90180-Y; JONES TP, 1991, B SOC GEOL FR, V162, P193; Jones TP, 2000, PALAEOGEOGR PALAEOCL, V164, P57, DOI 10.1016/S0031-0182(00)00175-9; Kalkreuth W, 2006, INT J COAL GEOL, V68, P79, DOI 10.1016/j.coal.2005.10.006; Kalkreuth W, 2010, INT J COAL GEOL, V84, P213, DOI 10.1016/j.coal.2010.08.008; Kurzawe F., 2010, PESQUISAS GEOCIENCIA, V37, P41, DOI 10.22456/1807-9806.17720; Lynch JA, 2004, CAN J FOREST RES, V34, P1642, DOI 10.1139/X04-071; Roy M, 2015, J GEOL SOC INDIA, V85, P567, DOI 10.1007/s12594-015-0251-2; Manfroi J, 2012, REV BRAS PALEONTOLOG, V15, P135, DOI 10.4072/rbp.2012.2.02; McParland LC, 2009, ARCHAEOL ANTHROP SCI, V1, P249, DOI 10.1007/s12520-009-0018-z; Mendonca JG, 2013, INT J COAL GEOL, V111, P23, DOI 10.1016/j.coal.2012.07.008; Milani E.J., 1998, B IG USP, V29, P125, DOI DOI 10.11606/ISSN.2316-8986.V29I0P125-173; Milani E. J., 2007, B GEOCIENCIAS PETROB, V15, P265; Nichols GJ, 2000, PALAEOGEOGR PALAEOCL, V164, P43, DOI 10.1016/S0031-0182(00)00174-7; Ohlson M, 1999, FOREST ECOL MANAG, V124, P27, DOI 10.1016/S0378-1127(99)00053-5; Ohlson M, 2000, HOLOCENE, V10, P519, DOI 10.1191/095968300667442551; Philippe M, 2008, REV PALAEOBOT PALYNO, V148, P184, DOI 10.1016/j.revpalbo.2007.09.004; Philippe M, 2006, REV PALAEOBOT PALYNO, V142, P15, DOI 10.1016/j.revpalbo.2006.05.003; Philippe M, 2015, REV PALAEOBOT PALYNO, V221, P83, DOI 10.1016/j.revpalbo.2015.06.006; Philippe M, 2011, CR PALEVOL, V10, P201, DOI 10.1016/j.crpv.2010.10.010; Potonie R., 1929, JB PREUSS GEOL LANDE, V49, P1184; Prevec R, 2009, REV PALAEOBOT PALYNO, V156, P454, DOI 10.1016/j.revpalbo.2009.04.012; Pyne S.J., 1996, INTRO WILDLAND FIRE, P769; Rasband W., 2006, IMAGEJ; Rein G, 2008, CATENA, V74, P304, DOI 10.1016/j.catena.2008.05.008; Schneider R.L., 1974, CONGRESSOBRASILEIRO, V1, P41; Scott A. C., 2014, FIRE EARTH INTRO; SCOTT AC, 1989, INT J COAL GEOL, V12, P443, DOI 10.1016/0166-5162(89)90061-X; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P1, DOI 10.1016/S0031-0182(00)00168-1; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P281, DOI 10.1016/S0031-0182(00)00192-9; SCOTT AC, 1994, PALAEOGEOGR PALAEOCL, V106, P91, DOI 10.1016/0031-0182(94)90005-1; Scott AC, 2007, INT J COAL GEOL, V70, P53, DOI 10.1016/j.coal.2006.02.009; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P11, DOI 10.1016/j.palaeo.2009.12.012; Segerstrom U, 1996, HOLOCENE, V6, P37, DOI 10.1177/095968369600600105; Shivanna M, 2017, PALAEOWORLD, V26, P638, DOI 10.1016/j.palwor.2017.05.003; Simas MW, 2013, GEOL ACTA, V11, P45, DOI 10.1344/105.000001835; Simon MF, 2012, INT J PLANT SCI, V173, P711, DOI 10.1086/665973; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; STAUB JR, 1979, J SEDIMENT PETROL, V49, P133; Stocks B. J., 1997, SEDIMENT RECORDS BIO, P169, DOI [10.1007/978-3-642-59171-6_8, DOI 10.1007/978-3-642-59171-6_8]; Uhl D, 2007, REV PALAEOBOT PALYNO, V144, P221, DOI 10.1016/j.revpalbo.2006.08.003; Uhl D, 2003, PALAEOGEOGR PALAEOCL, V199, P1, DOI 10.1016/S0031-0182(03)00482-6; Uhl D., 2012, ARCHAEOPTERYX, V30, P16; Uhl D, 2014, PALAEOBIO PALAEOENV, V94, P271, DOI 10.1007/s12549-014-0155-y; Usup A., 2004, TROPICS, V14, P1, DOI [10.3759/tropics.14.1, DOI 10.3759/TROPICS.14.1]; WEIN RW, 1987, CAN J BOT, V65, P1180, DOI 10.1139/b87-164; Yan MX, 2016, PALAEOGEOGR PALAEOCL, V459, P394, DOI 10.1016/j.palaeo.2016.07.031; Ziegler AM, 2003, LETHAIA, V36, P227, DOI 10.1080/00241160310004657	91	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213854	10.1371/journal.pone.0213854	http://dx.doi.org/10.1371/journal.pone.0213854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870527	Green Submitted, gold, Green Published			2022-12-26	WOS:000461166300089
J	Coy, SR; Alsante, AN; Van Etten, JL; Wilhelm, SW				Coy, Samantha R.; Alsante, Alyssa N.; Van Etten, James L.; Wilhelm, Steven W.			Cryopreservation of Paramecium bursaria Chlorella Virus-1 during an active infection cycle of its host	PLOS ONE			English	Article							PHYSIOLOGICAL CHARACTERIZATION; VIRUS; CHLOROVIRUS; HAPTOPHYCEAE; DINOPHYCEAE; MICROALGAE; VIABILITY; PBCV-1; ALGAE	Best practices in laboratory culture management often include cryopreservation of microbiota, but this can be challenging with some virus particles. By preserving viral isolates researchers can mitigate genetic drift and laboratory-induced selection, thereby maintaining genetically consistent strains between experiments. To this end, we developed a method to cryopreserve the model, green-alga infecting virus, Paramecium bursaria Chlorella virus 1 (PBCV-1). We explored cryotolerance of the infectivity of this virus particle, whereby freezing without cryoprotectants was found to maintain the highest infectivity (similar to 2.5%). We then assessed the cryopreservation potential of PBCV-1 during an active infection cycle in its Chlorella variabilis NC64A host, and found that virus survivorship was highest (69.5 +/- 16.5%) when the infected host is cryopreserved during mid-late stages of infection (i.e., coinciding with virion assembly). The most optimal condition for cryopreservation was observed at 240 minutes post-infection. Overall, utilizing the cell as a vehicle for viral cryopreservation resulted in 24.9-30.1 fold increases in PBCV-1 survival based on 95% confidence intervals of frozen virus particles and virus cryopreserved at 240 minutes post-infection. Given that cryoprotectants are often naturally produced by psychrophilic organisms, we suspect that cryopreservation of infected hosts may be a reliable mechanism for virus persistence in non-growth permitting circumstances in the environment, such as ancient permafrosts.	[Coy, Samantha R.; Alsante, Alyssa N.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA; [Alsante, Alyssa N.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of Tennessee System; University of Tennessee Knoxville; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Texas A&M University System; Texas A&M University College Station	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	Coy, Samantha R/Q-8147-2018; Wilhelm, Steven W/B-8963-2008	Coy, Samantha R/0000-0001-8824-1586; Wilhelm, Steven W/0000-0001-6283-8077; Alsante, Alyssa/0000-0001-6905-4769	National Science Foundation [NSF-OCE 1829641]; Gordon & Betty Moore Foundation [4971]; University of Tennessee's Open Publishing Support Fund	National Science Foundation(National Science Foundation (NSF)); Gordon & Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Tennessee's Open Publishing Support Fund	This work was support by grants from the National Science Foundation (NSF-OCE 1829641) and the Gordon & Betty Moore Foundation (#4971) to SWW. Funding for open access to this research was provided by University of Tennessee's Open Publishing Support Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarkova I, 2014, VIROLOGY, V466, P95, DOI 10.1016/j.virol.2014.07.002; Agarkova I, 2008, J VIROL, V82, P12181, DOI 10.1128/JVI.01687-08; Amaral R, 2013, CRYOBIOLOGY, V67, P312, DOI 10.1016/j.cryobiol.2013.09.006; [Anonymous], 2018, US PHARM NAT FORM 20; Benson EE, 2008, CRIT REV PLANT SCI, V27, P141, DOI 10.1080/07352680802202034; Blanc G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090989; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Bubeck JA, 2005, J GEN VIROL, V86, P2871, DOI 10.1099/vir.0.81068-0; Castberg T, 2002, J PHYCOL, V38, P767, DOI 10.1046/j.1529-8817.2002.02015.x; Claverie J-M, 2012, VIRUS TAXONOMY, P223; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Cordova A, 2003, BIOPHYS J, V85, P70, DOI 10.1016/S0006-3495(03)74455-5; Coy SR, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090487; Coy SR, 2018, LONG TERM CRYOPRESER, DOI [10.17504/protocols.io.wa2fage, DOI 10.17504/PROTOCOLS.IO.WA2FAGE]; Day JG, 1997, J APPL PHYCOL, V9, P121, DOI 10.1023/A:1007991507314; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Dunigan DD, 2016, FORMULATION MBBM MOD, DOI [10.17504/protocols.io.etwbepe, DOI 10.17504/PROTOCOLS.IO.ETWBEPE]; Dunigan DD, 2016, PBCV 1 VIRUS PLAQUE, DOI 10.17504/protocols.io.estbeen; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jeanniard A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-158; Kerepesi C, 2017, ARCH VIROL, V162, P1671, DOI 10.1007/s00705-017-3286-4; Kim J, 2015, ALGAE-SEOUL, V30, P81, DOI [10.4490/algae.2015.30.2.081, 10.4490/algae.2015.30.2.81]; Kim J, 2015, PLANT PATHOLOGY J, V31, P186, DOI 10.5423/PPJ.NT.03.2015.0029; Kim J, 2012, PLANT PATHOLOGY J, V28, P433, DOI 10.5423/PPJ.NT.07.2012.0093; Legendre M, 2015, P NATL ACAD SCI USA, V112, pE5327, DOI 10.1073/pnas.1510795112; Legendre M, 2014, P NATL ACAD SCI USA, V111, P4274, DOI 10.1073/pnas.1320670111; Long AM, 2016, ISME J, V10, P1602, DOI 10.1038/ismej.2015.240; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Nagasaki K, 2004, AQUAT MICROB ECOL, V34, P219, DOI 10.3354/ame034219; Nagasaki K, 1999, FISHERIES SCI, V65, P319, DOI 10.2331/fishsci.65.319; Nakanishi K, 2012, J APPL PHYCOL, V24, P1381, DOI 10.1007/s10811-012-9790-8; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Peck KM, 2018, J VIROL, V92, DOI 10.1128/JVI.01031-17; Rhodes L, 2006, CRYOBIOLOGY, V52, P152, DOI 10.1016/j.cryobiol.2005.10.003; Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1; Rowe JM, 2008, J PHYCOL, V44, P71, DOI 10.1111/j.1529-8817.2007.00453.x; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Short SM, 2018, VIRUSES OF MICROORGANISMS, P211, DOI 10.21775/9781910190852.10; Taylor R, 1998, J APPL PHYCOL, V10, P481, DOI 10.1023/A:1008094622412; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Waller RF, 2018, PLOS BIOL, V16, P10, DOI [10.1317/journal.pbio.20056333, DOI 10.1317/JOURNAL.PBIO.20056333]; WALLIS C, 1968, J VIROL, V2, P953, DOI 10.1128/JVI.2.9.953-954.1968; Wilhelm SW, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030046; Wilhelm SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005752; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Wilson WH, 2017, ISME J, V11, P1736, DOI 10.1038/ismej.2017.61; Wulfmeyer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030133; Yanai-Balser GM, 2010, J VIROL, V84, P532, DOI 10.1128/JVI.01698-09	55	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0211755	10.1371/journal.pone.0211755	http://dx.doi.org/10.1371/journal.pone.0211755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870463	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300010
J	Kishor, DS; Lee, C; Lee, D; Venkatesh, J; Seo, J; Chin, JH; Jin, Z; Hong, SK; Ham, JK; Koh, HJ				Kishor, D. S.; Lee, Choonseok; Lee, Dongryung; Venkatesh, Jelli; Seo, Jeonghwan; Chin, Joong Hyoun; Jin, Zhuo; Hong, Soon-Kwan; Ham, Jin-Kwan; Koh, Hee Jong			Novel allelic variant of Lpa1 gene associated with a significant reduction in seed phytic acid content in rice (Oryza sativa L.)	PLOS ONE			English	Article							LOW-PHYTATE MUTATIONS; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; MOLECULAR CHARACTERIZATION; GRAIN-YIELD; MAIZE; PHOSPHORYLATION; IDENTIFICATION; PHOSPHORUS; KINASE; ACCUMULATION	In plants, myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP(6)), also known as phytic acid (PA), is a major component of organic phosphorus (P), and accounts for up to 85% of the total P in seeds. In rice (Oryza sativa L.), PA mainly accumulates in rice bran, and chelates mineral cations, resulting in mineral deficiencies among brown rice consumers. Therefore, considerable efforts have been focused on the development of low PA (LPA) rice cultivars. In this study, we performed genetic and molecular analyses of OsLpa1, a major PA biosynthesis gene, in Sanggol, a low PA mutant variety developed via chemical mutagenesis of Ilpum rice cultivar. Genetic segregation and sequencing analyses revealed that a recessive allele, lpa1-3, at the OsLpa1 locus (Os02g0819400) was responsible for a significant reduction in seed PA content in Sanggol. The lpa1-3 gene harboured a point mutation (C623T) in the fourth exon of the predicted coding region, resulting in threonine (Thr) to isoleucine (Ile) amino acidsubstitution at position 208 (Thr208Ile). Three-dimensional analysis of Lpa1 protein structure indicated that myo-inositol 3-monophosphate [Ins(3)P-1] could bind to the active site of Lpa1, with ATP as a cofactor for catalysis. Furthermore, the presence of Thr208 in the loop adjacent to the entry site of the binding pocket suggests that Thr208Ile substitution is involved in regulating enzyme activity via phosphorylation. Therefore, we propose that Thr208Ile substitution in lpa1-3 reduces Lpa1 enzyme activity in Sanggol, resulting in reduced PA biosynthesis.	[Kishor, D. S.; Lee, Choonseok; Lee, Dongryung; Venkatesh, Jelli; Seo, Jeonghwan; Jin, Zhuo; Koh, Hee Jong] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Kishor, D. S.; Lee, Choonseok; Lee, Dongryung; Venkatesh, Jelli; Seo, Jeonghwan; Jin, Zhuo; Koh, Hee Jong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Chin, Joong Hyoun] Sejong Univ, Grad Sch Integrated Bioind, Seoul, South Korea; [Hong, Soon-Kwan] Kangwon Natl Univ, Div Biotechnol, Chunchon, Gangwon Do, South Korea; [Ham, Jin-Kwan] Gangwon Prov Agr Res & Extens Serv, Chunchon, Gangwon Do, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sejong University; Kangwon National University	Koh, HJ (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea.; Koh, HJ (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	heejkoh@snu.ac.kr	Venkatesh, Jelli/O-8942-2019; Ds, Kishor/ABF-9449-2021; Venkatesh, Jelli/E-7887-2018	Venkatesh, Jelli/0000-0002-8896-0385; Venkatesh, Jelli/0000-0002-8896-0385; D.S, Kishor/0000-0001-8704-6973	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ013165]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This work was supported by a Grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center number PJ013165), Rural Development Administration, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-12; Ali N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068161; Andaya CB, 2005, THEOR APPL GENET, V111, P489, DOI 10.1007/s00122-005-2038-0; Banerjee DK, 2005, J BIOL CHEM, V280, P4174, DOI 10.1074/jbc.M406962200; Bregitzer P, 2006, CROP SCI, V46, P1318, DOI 10.2135/cropsci2005.09-0301; Cade-Menun BJ, 2010, J ENVIRON QUAL, V39, P1647, DOI 10.2134/jeq2009.0491; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Dietterich LH, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.36; Dorsch JA, 2003, PHYTOCHEMISTRY, V62, P691, DOI 10.1016/S0031-9422(02)00610-6; DOWNES CP, 1982, BIOCHEM J, V203, P169, DOI 10.1042/bj2030169; Edwards JD, 2017, FIELD CROP RES, V205, P116, DOI 10.1016/j.fcr.2017.01.015; Foltyn VN, 2010, FEBS LETT, V584, P2937, DOI 10.1016/j.febslet.2010.05.022; Gao Y, 2007, CROP SCI, V47, P1797, DOI 10.2135/cropsci2007.03.0122; Greif DM, 2002, BIOCHEMISTRY-US, V41, P15845, DOI 10.1021/bi026732g; Guttieri M, 2004, CROP SCI, V44, P418, DOI 10.2135/cropsci2004.0418; Hitz WD, 2002, PLANT PHYSIOL, V128, P650, DOI [10.1104/pp.010585, 10.1104/pp.128.2.650]; Iwai T, 2012, PLANT PHYSIOL, V160, P2007, DOI 10.1104/pp.112.206573; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim SI, 2008, THEOR APPL GENET, V117, P1291, DOI 10.1007/s00122-008-0863-7; Kim SI, 2008, THEOR APPL GENET, V117, P769, DOI 10.1007/s00122-008-0818-z; Kim SI, 2014, MOL BREEDING, V34, P1717, DOI 10.1007/s11032-014-0127-y; Kim SI, 2010, PLANTA, V232, P1241, DOI 10.1007/s00425-010-1243-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larson SR, 2000, CROP SCI, V40, P1397, DOI 10.2135/cropsci2000.4051397x; Lee HS, 2015, PLANT CELL, V27, P417, DOI 10.1105/tpc.114.132134; Li CY, 2008, J CEREAL SCI, V47, P262, DOI 10.1016/j.jcs.2007.04.012; Li CY, 2012, J KOREAN SOC APPL BI, V55, P101, DOI 10.1007/s13765-012-0017-0; Liu QL, 2007, THEOR APPL GENET, V114, P803, DOI 10.1007/s00122-006-0478-9; Lu HP, 2016, J ZHEJIANG UNIV-SC B, V17, P100, DOI 10.1631/jzus.B1500205; Marounek M, 2010, J ANIM FEED SCI, V19, P430; Mitsuhashi N, 2008, J EXP BOT, V59, P3069, DOI 10.1093/jxb/ern161; Njukeng, 2018, J APPL CHEM-USSR, DOI [10.1155/2018/6290236, DOI 10.1155/2018/6290236]; OGAWA M, 1979, PLANT CELL PHYSIOL, V20, P19; Panzeri D, 2011, NEW PHYTOL, V191, P70, DOI 10.1111/j.1469-8137.2011.03666.x; Perera I, 2018, RICE, V11, DOI 10.1186/s12284-018-0200-y; Pilu R, 2003, THEOR APPL GENET, V107, P980, DOI 10.1007/s00122-003-1316-y; Raboy V, 1997, ADV CELL MOL BIOL PL, V4, P441; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Raboy V, 2009, PLANT SCI, V177, P281, DOI 10.1016/j.plantsci.2009.06.012; Rasmussen SK, 2010, BIOCHEM SOC T, V38, P689, DOI 10.1042/BST0380689; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Seneweera S, 1996, CEREAL CHEM, V73, P239; Shi JR, 2007, NAT BIOTECHNOL, V25, P930, DOI 10.1038/nbt1322; Shi JR, 2005, PLANT J, V42, P708, DOI 10.1111/j.1365-313X.2005.02412.x; Shi JR, 2003, PLANT PHYSIOL, V131, P507, DOI 10.1104/pp.014258; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; Sparvoli Francesca, 2015, Plants-Basel, V4, P728, DOI 10.3390/plants4040728; Stevenson-Paulik J, 2005, P NATL ACAD SCI USA, V102, P12612, DOI 10.1073/pnas.0504172102; Stevenson-Paulik J, 2002, J BIOL CHEM, V277, P42711, DOI 10.1074/jbc.M209112200; Suzuki M, 2007, GENE, V405, P55, DOI 10.1016/j.gene.2007.09.006; Xu XH, 2009, THEOR APPL GENET, V119, P75, DOI 10.1007/s00122-009-1018-1; Yadav GS, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171048; Ye HX, 2011, FUNCT INTEGR GENOMIC, V11, P103, DOI 10.1007/s10142-011-0209-4; Yoshida KT, 1999, PLANT PHYSIOL, V119, P65, DOI 10.1104/pp.119.1.65; Yuan FJ, 2007, THEOR APPL GENET, V115, P945, DOI 10.1007/s00122-007-0621-2; Zhao HJ, 2008, MOL BREEDING, V22, P603, DOI 10.1007/s11032-008-9202-6; Zhao HJ, 2008, FIELD CROP RES, V108, P206, DOI 10.1016/j.fcr.2008.05.006; Zhao HJ, 2013, THEOR APPL GENET, V126, P3009, DOI 10.1007/s00122-013-2189-3	61	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0209636	10.1371/journal.pone.0209636	http://dx.doi.org/10.1371/journal.pone.0209636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870429	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300007
J	Oei, RW; Hou, GQ; Liu, FH; Zhong, J; Zhang, JW; An, ZY; Xu, LP; Yang, YJ				Oei, Ronald Wihal; Hou, Guanqun; Liu, Fuhai; Zhong, Jin; Zhang, Jiewen; An, Zhaoyi; Xu, Luping; Yang, Yujiu			Convolutional neural network for cell classification using microscope images of intracellular actin networks	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; ARTIFICIAL-INTELLIGENCE; CANCER; ORGANIZATION; FIBROBLASTS; MOTILITY	Automated cell classification is an important yet a challenging computer vision task with significant benefits to biomedicine. In recent years, there have been several studies attempted to build an artificial intelligence-based cell classifier using label-free cellular images obtained from an optical microscope. Although these studies showed promising results, such classifiers were not able to reflect the biological diversity of different types of cell. While in terms of malignant cell, it is well-known that intracellular actin filaments are altered substantially. This is thought to be closely related to the abnormal growth features of tumor cells, their ability to invade surrounding tissues and also to metastasize. Therefore, being able to classify different types of cell based on their biological behaviors using automated technique is more advantageous. This article reveals the difference in the actin cytoskeleton structures between breast normal and cancer cells, which may provide new information regarding malignant changes and be used as additional diagnostic marker. Since the features cannot be well detected by human eyes, we proposed the application of convolutional neural network (CNN) in cell classification based on actin-labeled fluorescence microscopy images. The CNN was evaluated on a large number of actin-labeled fluorescence microscopy images of one human normal breast epithelial cell line and two types of human breast cancer cell line with different levels of aggressiveness. The study revealed that the CNN performed better in the cell classification task compared to a human expert.	[Oei, Ronald Wihal; Hou, Guanqun; Liu, Fuhai; Zhong, Jin; Zhang, Jiewen; An, Zhaoyi; Xu, Luping; Yang, Yujiu] Tsinghua Univ, Open FIESTA Ctr, Shenzhen, Peoples R China; [Xu, Luping] Tsinghua Univ, Sch Aerosp Engn, Ctr Nano & Micro Mech, Beijing, Peoples R China; [Yang, Yujiu] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Xu, LP; Yang, YJ (corresponding author), Tsinghua Univ, Open FIESTA Ctr, Shenzhen, Peoples R China.; Xu, LP (corresponding author), Tsinghua Univ, Sch Aerosp Engn, Ctr Nano & Micro Mech, Beijing, Peoples R China.; Yang, YJ (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen, Peoples R China.	lupingxu@tsinghua.edu.cn; yang.yujiu@sz.tsinghua.edu.cn	Zhang, Jiewen/GSE-5744-2022; Yang, Yujiu/AAC-1481-2019	Yang, Yujiu/0000-0002-6427-1024; Yang, Yuan-Han/0000-0002-1918-9021; Oei, Ronald Wihal/0000-0003-3435-3421				Cruz-Roa AA, 2013, LECT NOTES COMPUT SC, V8150, P403, DOI 10.1007/978-3-642-40763-5_50; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Calzado-Martin A, 2016, ACS NANO, V10, P3365, DOI 10.1021/acsnano.5b07162; Dai XF, 2017, J CANCER, V8, P3131, DOI 10.7150/jca.18457; Efremov YM, 2015, BBA-MOL CELL RES, V1853, P3117, DOI 10.1016/j.bbamcr.2015.05.008; Efremov YM, 2014, BBA-MOL CELL RES, V1843, P1013, DOI 10.1016/j.bbamcr.2014.01.032; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gao ZM, 2017, IEEE J BIOMED HEALTH, V21, P416, DOI 10.1109/JBHI.2016.2526603; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Inza I, 2010, METHODS MOL BIOL, V593, P25, DOI 10.1007/978-1-60327-194-3_2; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Meng N, 2017, 2017 15 IAPR INT C M; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Rakhlin A, 2018, DEEP CONVOLUTIONAL N; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Siuly S, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-017-0040-y; Syeda-Mahmood T, 2018, J AM COLL RADIOL, V15, P569, DOI 10.1016/j.jacr.2018.01.028; Tavares S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15237; Tripathy RK, 2014, RSC ADV, V4, P9349, DOI 10.1039/c3ra47489e; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034406; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519; Zhang BZ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2280-5	28	29	29	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213626	10.1371/journal.pone.0213626	http://dx.doi.org/10.1371/journal.pone.0213626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865716	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900079
J	Horscroft, JA; O'Brien, KA; Clark, AD; Lindsay, RT; Steel, AS; Procter, NEK; Devaux, J; Frenneaux, M; Harridge, SDR; Murray, AJ				Horscroft, James A.; O'Brien, Katie A.; Clark, Anna D.; Lindsay, Ross T.; Steel, Alice Strang; Procter, Nathan E. K.; Devaux, Jules; Frenneaux, Michael; Harridge, Stephen D. R.; Murray, Andrew J.			Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPAR alpha	FASEB JOURNAL			English	Article						heart; metabolism; mitochondria; fatty acids	HIGH-ALTITUDE HYPOXIA; NITRIC-OXIDE; DIETARY NITRATE; SKELETAL-MUSCLE; BLOOD-FLOW; COMPLEX I; NO; OXYGEN; METABOLISM; ADAPTATION	Dietary inorganic nitrate prevents aspects of cardiac mitochondrial dysfunction induced by hypoxia, although the mechanism is not completely understood. In both heart and skeletal muscle, nitrate increases fatty acid oxidation capacity, and in the latter case, this involves up-regulation of peroxisome proliferator-activated receptor (PPAR)alpha expression. Here, we investigated whether dietary nitrate modifies mitochondrial function in the hypoxic heart in a PPAR alpha-dependent manner. Wild-type (WT) mice and mice without PPAR alpha (Ppara(-/-)) were given water containing 0.7 mM NaCl (control) or 0.7 mM NaNO3 for 35 d. After 7 d, mice were exposed to normoxia or hypoxia (10% O-2) for the remainder of the study. Mitochondrial respiratory function and metabolism were assessed in saponin-permeabilized cardiac muscle fibers. Environmental hypoxia suppressed mass-specific mitochondrial respiration and additionally lowered the proportion of respiration supported by fatty acid oxidation by 18% (P < 0.001). This switch away from fatty acid oxidation was reversed by nitrate treatment in hypoxic WT but not Ppara(-/-) mice, indicating a PPAR alpha-dependent effect. Hypoxia increased hexokinase activity by 33% in all mice, whereas lactate dehydrogenase activity increased by 71% in hypoxic WT but not Ppara(-/-) mice. Our findings indicate that PPAR alpha plays a key role in mediating cardiac metabolic remodeling in response to both hypoxia and dietary nitrate supplementation.-Horscroft, J. A., O'Brien, K. A., Clark, A. D., Lindsay, R. T., Steel, A. S., Procter, N. E. K., Devaux, J., Frenneaux, M., Harridge, S. D. R., Murray, A. J. Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPAR alpha.	[Horscroft, James A.; O'Brien, Katie A.; Clark, Anna D.; Lindsay, Ross T.; Steel, Alice Strang; Devaux, Jules; Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [O'Brien, Katie A.; Harridge, Stephen D. R.] Kings Coll London, Ctr Human & Appl Physiol Sci, London, England; [Procter, Nathan E. K.; Frenneaux, Michael] Univ East Anglia, Bob Champ Res & Educ Bldg, Norwich, Norfolk, England	University of Cambridge; University of London; King's College London; University of East Anglia	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk	Jules, Devaux/GSN-5859-2022	Devaux, Jules/0000-0002-5280-3871; Lindsay, Ross/0000-0001-7760-613X; Murray, Andrew/0000-0002-0929-9315	Biotechnology and Biological Sciences Research Council, UK [BB/F016581/1]; Research Councils UK [EP/E500552/1]	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Councils UK(UK Research & Innovation (UKRI))	The authors acknowledge the support of Prof. Kieran Clarke (University of Oxford, Oxford, United Kingdom) and Prof. Martin Feelisch (University of Southampton, Southampton, United Kingdom). This work was supported by the Biotechnology and Biological Sciences Research Council, UK (Grant BB/F016581/1) and the Research Councils UK (Grant EP/E500552/1). The authors declare no conflicts of interest.	Ashmore T, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0221-6; Ashmore T, 2015, FASEB J, V29, P1102, DOI 10.1096/fj.14-263004; Ashmore T, 2014, J PHYSIOL-LONDON, V592, P4715, DOI 10.1113/jphysiol.2014.275263; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Carlstrom M, 2010, P NATL ACAD SCI USA, V107, P17716, DOI 10.1073/pnas.1008872107; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cohen BH, 2013, J CHEM INF MODEL, V4th; Cole MA, 2016, FASEB J, V30, P2684, DOI 10.1096/fj.201500094R; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dass S, 2015, CIRC-HEART FAIL, V8, P1088, DOI 10.1161/CIRCHEARTFAILURE.114.002169; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Heather LC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0268-2; Hezel MP, 2015, REDOX BIOL, V5, P234, DOI 10.1016/j.redox.2015.05.004; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Horscroft JA, 2017, P NATL ACAD SCI USA, V114, P6382, DOI 10.1073/pnas.1700527114; Horscroft JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138564; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Houle-Leroy P, 2000, J APPL PHYSIOL, V89, P1608, DOI 10.1152/jappl.2000.89.4.1608; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Larsen FJ, 2011, CELL METAB, V13, P149, DOI 10.1016/j.cmet.2011.01.004; Larsen FJ, 2010, FREE RADICAL BIO MED, V48, P342, DOI 10.1016/j.freeradbiomed.2009.11.006; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Martin DS, 2009, EUR J APPL PHYSIOL, V106, P473, DOI 10.1007/s00421-009-1023-8; McClelland GB, 2005, J EXP BIOL, V208, P515, DOI 10.1242/jeb.01423; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MITTAL CK, 1977, J CYCLIC NUCL PROT, V3, P381; Mulkareddy V., 2018, BIOCH BIOPHYS ACTA M; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; O'Brien K. A., 2018, BIOCH BIOPHYS ACTA M; PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pannala AS, 2003, FREE RADICAL BIO MED, V34, P576, DOI 10.1016/S0891-5849(02)01353-9; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Roberts LD, 2017, DIABETES, V66, P674, DOI 10.2337/db16-0843; Roberts LD, 2015, DIABETES, V64, P471, DOI 10.2337/db14-0496; SELMECI L., 1967, LIFE SCI, V6, P649, DOI 10.1016/0024-3205(67)90102-6; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Siervo M, 2011, FREE RADICAL BIO MED, V51, P795, DOI 10.1016/j.freeradbiomed.2011.05.032; TAYLOR DA, 1989, J BIOL CHEM, V264, P6207; Velmurugan S, 2013, FREE RADICAL BIO MED, V65, P1521, DOI 10.1016/j.freeradbiomed.2013.06.031; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737	58	11	11	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7563	7577		10.1096/fj.201900067R	http://dx.doi.org/10.1096/fj.201900067R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30870003	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000476114200072
J	Murthy, AMV; Sullivan, MJ; Nhu, NTK; Lo, AW; Phan, MD; Peters, KM; Boucher, D; Schroder, K; Beatson, SA; Ulett, GC; Schembri, MA; Sweet, MJ				Murthy, Ambika M., V; Sullivan, Matthew J.; Nguyen Thi Khanh Nhu; Lo, Alvin W.; Phan, Minh-Duy; Peters, Kate M.; Boucher, Dave; Schroder, Kate; Beatson, Scott A.; Ulett, Glen C.; Schembri, Mark A.; Sweet, Matthew J.			Variation in hemolysin A expression between uropathogenic Escherichia coli isolates determines NLRP3-dependent vs. -independent macrophage cell death and host colonization	FASEB JOURNAL			English	Article						alpha-hemolysin; inflammasome; ST131; UPEC; UTI	URINARY-TRACT; ALPHA-HEMOLYSIN; NLRP3 INFLAMMASOME; MURINE MODEL; IN-VITRO; ACTIVATION; BLADDER; STRAIN; PERSISTENT; PYROPTOSIS	Uropathogenic Escherichia coli (UPEC) is the major cause of urinary tract infections (UTIs). The multidrug-resistant E. coli sequence type 131 (ST131) clone is a serious threat to human health, yet its effects on immune responses are not well understood. Here we screened a panel of ST131 isolates, finding that only strains expressing the toxin hemolysin A (HlyA) killed primary human macrophages and triggered maturation of the inflammasome-dependent cytokine IL-1 beta. Using a representative strain, the requirement for the hlyA gene in these responses was confirmed. We also observed considerable heterogeneity in levels of cell death initiated by different HlyA(+ve) ST131 isolates, and this correlated with secreted HlyA levels. Investigation into the biological significance of this variation revealed that an ST131 strain producing low levels of HlyA initiated cell death that was partly dependent on the nod-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, with this response being associated with a host-protective role in a mouse UTI model. When the same ST131 strain was engineered to overexpress high HlyA levels, macrophage cell death occurred even when NLRP3 function was abrogated, and bladder colonization was significantly increased. Thus, variation in HlyA expression in UPEC affects mechanisms by which macrophages die, as well as host susceptibility vs. resistance to colonization.-Murthy, A. M. V., Sullivan, M. J., Nhu, N. T. K., Lo, A. W., Phan, M.-D., Peters, K. M., Boucher, D., Schroder, K., Beatson, S. A., Ulett, G. C., Schembri, M. A., Sweet, M. J. Variation in hemolysin A expression between uropathogenic Escherichia coli isolates determines NLRP3-dependent vs. -independent macrophage cell death and host colonization.	[Murthy, Ambika M., V; Boucher, Dave; Schroder, Kate; Sweet, Matthew J.] Univ Queensland, Ctr Inflammat & Dis Res, IMB, Brisbane, Qld 4072, Australia; [Murthy, Ambika M., V; Nguyen Thi Khanh Nhu; Lo, Alvin W.; Phan, Minh-Duy; Peters, Kate M.; Boucher, Dave; Schroder, Kate; Beatson, Scott A.; Schembri, Mark A.; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Nguyen Thi Khanh Nhu; Lo, Alvin W.; Phan, Minh-Duy; Peters, Kate M.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Sullivan, Matthew J.; Ulett, Glen C.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Sullivan, Matthew J.; Ulett, Glen C.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Griffith University; Griffith University; Menzies Health Institute Queensland	Sweet, MJ (corresponding author), Univ Queensland, Ctr Inflammat & Dis Res, IMB, Brisbane, Qld 4072, Australia.; Schembri, MA; Sweet, MJ (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.; Schembri, MA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	m.schembri@uq.edu.au; m.sweet@imb.uq.edu.au	Nguyen, Nhu/O-5696-2019; Schroder, Kate/C-6132-2008; Sullivan, Matthew J/C-3857-2009; Sweet, Matthew J/F-2229-2011; Beatson, Scott/B-6985-2013; Schembri, Mark A/C-7262-2009; Murthy, Ambika Mosale Venkatesh/C-8021-2017; Phan, Minh-Duy/I-9147-2012; Boucher, Dave/J-1830-2014	Nguyen, Nhu/0000-0002-0158-850X; Schroder, Kate/0000-0001-9261-3805; Sullivan, Matthew J/0000-0003-2276-3132; Sweet, Matthew J/0000-0002-0406-8139; Beatson, Scott/0000-0002-1806-3283; Schembri, Mark A/0000-0003-4863-9260; Murthy, Ambika Mosale Venkatesh/0000-0002-9767-1999; Phan, Minh-Duy/0000-0002-3426-1044; Ulett, Glen/0000-0002-9638-8091; Boucher, Dave/0000-0003-0075-8893	National Health and Medical Research Council of Australia (NHMRC) [GNT1068593, GNT1129273]; University of Queensland Postdoctoral Fellowship; NHMRC Career Development Fellowship [GNT1141131, GNT1090456]; NHMRC Senior Research Fellowships [GNT1107914, GNT1106930]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Postdoctoral Fellowship(University of Queensland); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Rodney Welch (University of Wisconsin, Madison, WI, USA) for providing the hemolysin A antibody, Avril Robertson (The University of Queensland) for providing MCC950, and the Australian Red Cross Blood Service for providing buffy coats that were used to isolate monocytes in these studies. This work was supported by Project Grants GNT1068593 and GNT1129273 from the National Health and Medical Research Council of Australia (NHMRC). D.B. was supported by a University of Queensland Postdoctoral Fellowship; K.S. was supported by an NHMRC Career Development Fellowship (GNT1141131); S.A.B. is supported by an NHMRC Career Development Fellowship (GNT1090456); and M.J.S. and M.A.S. were supported by NHMRC Senior Research Fellowships (GNT1107914, GNT1106930). The authors declare no conflicts of interest.	Ambite I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005848; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Barbieri NL, 2014, INFECT IMMUN, V82, P5086, DOI 10.1128/IAI.02315-14; Ben Zakour NL, 2016, MBIO, V7, DOI 10.1128/mBio.00347-16; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BHAKDI S, 1989, J EXP MED, V169, P737, DOI 10.1084/jem.169.3.737; Bhushan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028452; Bielaszewska M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003797; CAVALIERI SJ, 1982, INFECT IMMUN, V36, P455, DOI 10.1128/IAI.36.2.455-461.1982; Chen SW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007240; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Demirel I, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00081; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; Diabate M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004732; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; FELMLEE T, 1985, J BACTERIOL, V163, P88, DOI 10.1128/JB.163.1.88-93.1985; Ferrand J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00344; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gaidt MM, 2018, J MOL BIOL, V430, P133, DOI 10.1016/j.jmb.2017.11.013; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; Haugen BJ, 2007, INFECT IMMUN, V75, P278, DOI 10.1128/IAI.01319-06; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hilbert DW, 2012, MICROBES INFECT, V14, P628, DOI 10.1016/j.micinf.2012.01.010; Hohenhaus DM, 2013, IMMUNOBIOLOGY, V218, P1345, DOI 10.1016/j.imbio.2013.07.001; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; JONAS D, 1993, INFECT IMMUN, V61, P1715, DOI 10.1128/IAI.61.5.1715-1721.1993; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim JJ, 2013, J KOREAN MED SCI, V28, P1415, DOI 10.3346/jkms.2013.28.10.1415; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Leclercq SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29000; Lu YN, 2018, FASEB J, V32, P4107, DOI 10.1096/fj.201700768R; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murthy AMV, 2018, VIRULENCE, V9, P967, DOI 10.1080/21505594.2018.1465786; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; PELLETT S, 1990, INFECT IMMUN, V58, P822, DOI 10.1128/IAI.58.3.822-827.1990; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Price LB, 2013, MBIO, V4, DOI 10.1128/mBio.00377-13; Ristow LC, 2016, BBA-BIOMEMBRANES, V1858, P538, DOI 10.1016/j.bbamem.2015.08.015; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Russo TA, 2005, AM J PHYSIOL-LUNG C, V289, pL207, DOI 10.1152/ajplung.00482.2004; Schaale K, 2016, MUCOSAL IMMUNOL, V9, P124, DOI 10.1038/mi.2015.44; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Smith YC, 2008, INFECT IMMUN, V76, P2978, DOI 10.1128/IAI.00075-08; Smith YC, 2006, INFECT IMMUN, V74, P750, DOI 10.1128/IAI.74.1.750-757.2006; Stoesser N, 2016, MBIO, V7, DOI 10.1128/mBio.02162-15; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; Waldhuber A, 2016, J CLIN INVEST, V126, P2425, DOI 10.1172/JCI81916; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; WELCH RA, 1984, INFECT IMMUN, V43, P156, DOI 10.1128/IAI.43.1.156-160.1984; Welch RA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0011-2012	63	9	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7437	7450		10.1096/fj.201802100R	http://dx.doi.org/10.1096/fj.201802100R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30869997				2022-12-26	WOS:000476114200062
J	Guan, XM; Guo, CX; Mou, B; Shi, LL				Guan, Xiaoming; Guo, Caixia; Mou, Ben; Shi, Leilei			Tunnel millisecond-delay controlled blasting based on the delay time calculation method and digital electronic detonators to reduce structure vibration effects	PLOS ONE			English	Article							MITIGATION; OPERATIONS	The reasonable delay time of millisecond-delay blasting using digital electronic detonators can significantly reduce the vibration effects induced by tunnel blasting. This study proposes a method for calculating the delay time for cut holes, easer holes and periphery holes, considering the rocks breaking effect as well as wave superposition theory. And then according to the actual layout diagram of the tunnel holes, the delay time calculation formulas of different holes are put forward. Then the delay times were calculated according to the formulas and applied in the field tests. The velocities, rocks breaking and wave superposition cancellation of the vibration using different delay times are analyzed with digital electronic detonators. Then the optimum delay times of different holes were obtained and applied to New Hongyan tunnel project. The velocity and frequency of the vibration with digital electronic detonators are analyzed, compared with non-electronic detonators. The effects of charge and delay time on the velocity and principal frequency of a blasting seismic wave are discussed. The results indicate that the delay time for the holes must be prioritized to achieve breaking effects in the rock with the simultaneous formation of a new free surface, next considering the wave superposition cancellation. When the delay time of cut holes was 5 ms, the rocks breaking effect and wave superposition cancellation effect both worked well. The velocity of the vibration induced by the cut holes blasting was about only 0.46-0.51 cm/s. When the delay time was 6 ms or much longer, the rocks breaking effect would fail. With regard to the easer holes and periphery holes, the optimum delay time of them were all 5ms. The vertical peak particle velocity was reduced from 2.974 cm/s to 0.901 cm/s with digital electronic detonators. Therefore, the velocity had decreased by 69.70% than non-electronic detonators, which was caused by reducing the single simultaneous explosive charge and setting optimum delay time. The proposed delay time calculation method is demonstrated to be sufficiently accurate and can thus be used as a guideline to reduce tunnel blasting vibrations.	[Guan, Xiaoming; Mou, Ben] Qingdao Univ Technol, Dept Civil Engn, Qingdao, Peoples R China; [Guo, Caixia] Tsinghua Univ, Dept Civil Engn, Beijing, Peoples R China; [Shi, Leilei] Municipal Construct Engn Co Ltd, Beijing, Peoples R China	Qingdao University of Technology; Tsinghua University	Mou, B (corresponding author), Qingdao Univ Technol, Dept Civil Engn, Qingdao, Peoples R China.	mouben@qut.edu.cn	Mou, Ben/ABC-2893-2021; Mou, Ben/ABC-2324-2021	Mou, Ben/0000-0001-5991-1261	National Natural Science Foundation of China [51708317]; Chinese Postdoctoral Science Foundation [2017M621095]; Natural Science Foundation of Shandong Province [ZR2016EEB27, ZR2016EEB38]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work is supported by the National Natural Science Foundation of China (Project No. 51708317 to XG), http://www.nsfc.gov.cn/; the Chinese Postdoctoral Science Foundation (2017M621095 to XG), http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx and the Natural Science Foundation of Shandong Province (ZR2016EEB27 to XG, ZR2016EEB38), http://www.sdstc.gov.cn/. The funders had role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ak H, 2009, SOIL DYN EARTHQ ENG, V29, P669, DOI 10.1016/j.soildyn.2008.07.003; Aldas GGU, 2008, J APPL GEOPHYS, V66, P25, DOI 10.1016/j.jappgeo.2008.08.004; China Railway 17th Bureau Group Co. LTD., 2013, DES CONSTR SCHEM NEW; Fu HX, 2014, ROCK MECH ROCK ENG, V47, P809, DOI 10.1007/s00603-013-0419-2; [傅洪贤 Fu Hongxian], 2012, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V31, P597; Grobler H.P., 2003, FRAGBLAST, V7, P1; Henrych J., 1979, EXPLOSION DYNAMICS I; Hinzen KG, 1987, P 13 C EXPL BLAST TE, P144; Hoshino T., 2000, FRAGBLAST, V4, P139, DOI [10.1076/frag.4.2.139.7448, DOI 10.1076/FRAG.4.2.139.7448]; KUCHERYAVII F. I, 1962, SHORT DELAY BLASTS Q; Kuzu C, 2009, TUNN UNDERGR SP TECH, V24, P53, DOI 10.1016/j.tust.2008.02.001; Langefors U, 1978, MODERN TECHNIQUE ROC, V3; Ling TH, 2007, ROCK SOIL MECH, V28, P1439; [凌同华 Ling Tonghua], 2004, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V23, P2266; Lu CP, 2010, INT J ROCK MECH MIN, V47, P1046, DOI 10.1016/j.ijrmms.2010.06.009; Meng H., 2009, J RAILW ENG SOC, V11, P81; Mesec J, 2010, SOIL DYN EARTHQ ENG, V30, P1004, DOI 10.1016/j.soildyn.2010.04.011; Mogi G., 1999, J JAPAN EXPLOSIVES S, V60, P233; Monjezi M, 2011, TUNN UNDERGR SP TECH, V26, P46, DOI 10.1016/j.tust.2010.05.002; Monjezi M, 2010, SOIL DYN EARTHQ ENG, V30, P1233, DOI 10.1016/j.soildyn.2010.05.005; Sanchidrian JA, 2007, INT J ROCK MECH MIN, V44, P130, DOI 10.1016/j.ijrmms.2006.05.002; Shi XZ, 2011, SOIL DYN EARTHQ ENG, V31, P1154, DOI 10.1016/j.soildyn.2011.04.004; Wang ZY, 2013, INT J ROCK MECH MIN, V60, P389, DOI 10.1016/j.ijrmms.2012.12.032; Wei XL, 2009, ENG BLASTING, V15, P69; Wei XL, 2009, ENG BLASTING, V15, P1; Wu C.S., 2004, TUNN UNDERGR SP TECH, V19, P518; Yamamoto M, 2001, EXPLOSION, V11, P84; Zhang GX., 2009, ENG BLASTING, V15, P17, DOI [10.3969/j.issn.1006-7051.2009.03.004, DOI 10.3969/J.ISSN.1006-7051.2009.03.004]; Zhang Z. X., 2004, Fragblast, V8, P3, DOI 10.1080/13855140512331389604; Zhang ZC., 2000, EXPLOSIVE MAT, V29, P1; Zhao Y, 2012, ENG BLASTING, V18, P82	31	6	7	11	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0212745	10.1371/journal.pone.0212745	http://dx.doi.org/10.1371/journal.pone.0212745			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901327	Green Submitted, gold, Green Published			2022-12-26	WOS:000462000400005
J	Lundin, JI; Spromberg, JA; Jorgensen, JC; Myers, JM; Chittaro, PM; Zabel, RW; Johnson, LL; Neely, RM; Scholz, NL				Lundin, Jessica I.; Spromberg, Julann A.; Jorgensen, Jeffrey C.; Myers, James M.; Chittaro, Paul M.; Zabel, Richard W.; Johnson, Lyndal L.; Neely, Robert M.; Scholz, Nathaniel L.			Legacy habitat contamination as a limiting factor for Chinook salmon recovery in the Willamette Basin, Oregon, USA	PLOS ONE			English	Article							ONCORHYNCHUS-TSHAWYTSCHA; INCREASED SUSCEPTIBILITY; IMMUNE COMPETENCE; DIETARY EXPOSURE; CHRONIC TOXICITY; JUVENILE SALMON; RIVER; FISH; RESPONSES; GROWTH	In the western United States, the long-term recovery of many Pacific salmon populations is inextricably linked to freshwater habitat quality. Industrial activities from the past century have left a legacy of pollutants that persist, particularly near working waterfronts. The adverse impacts of these contaminants on salmon health have been studied for decades, but the population-scale consequences of chemical exposure for salmonids are still poorly understood. We estimated acute and delayed mortality rates for seaward migrating juvenile Chinook salmon that feed and grow in a Superfund-designated area in the Lower Willamette River in Portland, Oregon. We combined previous, field-collected exposure data for juvenile Chinook salmon together with reduced growth and disease resistance data from earlier field and laboratory studies. Estimates of mortality were then incorporated into a life cycle model to explore chemical habitat-related fish loss. We found that 54% improved juvenile survival-potentially as a result of future remediation activities-could increase adult Chinook salmon population abundance by more than 20%. This study provides a framework for evaluating pollution remediation as a positive driver for species recovery.	[Lundin, Jessica I.] NOAA, Natl Res Council Res Associateship Program, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Spromberg, Julann A.; Chittaro, Paul M.; Johnson, Lyndal L.; Scholz, Nathaniel L.] NOAA, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Jorgensen, Jeffrey C.; Zabel, Richard W.] NOAA, Fish Ecol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Myers, James M.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Neely, Robert M.] NOAA, Assessment & Restorat Div, Off Response & Restorat, Natl Ocean Serv, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Lundin, JI (corresponding author), NOAA, Natl Res Council Res Associateship Program, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Jessica.Lundin@noaa.gov	Scholz, Nathaniel L/L-1642-2013	Scholz, Nathaniel L/0000-0001-6207-0272; Jorgensen, Jeff/0000-0001-5112-4757	NOAA's Office of Response and Restoration, Assessment and Restoration Division	NOAA's Office of Response and Restoration, Assessment and Restoration Division	This work was funded by NOAA's Office of Response and Restoration, Assessment and Restoration Division. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NMFS NWFSC 66; [Anonymous], 2005, DAT INT VIS EXPL REP; Arkoosh M.R., 1991, Fish & Shellfish Immunology, V1, P261, DOI 10.1016/S1050-4648(05)80065-8; Arkoosh MR, 2004, J AQUAT ANIM HEALTH, V16, P186, DOI 10.1577/H03-071.1; Arkoosh MR, 2001, J AQUAT ANIM HEALTH, V13, P257, DOI 10.1577/1548-8667(2001)013&lt;0257:ISOJCS&gt;2.0.CO;2; Arkoosh MR, 1998, T AM FISH SOC, V127, P360, DOI 10.1577/1548-8659(1998)127&lt;0360:ISOJCS&gt;2.0.CO;2; ARKOOSH MR, 1994, IMMUNOPHARM IMMUNOT, V16, P293, DOI 10.3109/08923979409007096; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1; Beckvar N, 2005, ENVIRON TOXICOL CHEM, V24, P2094, DOI 10.1897/04-284R.1; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bols NC, 2001, DEV COMP IMMUNOL, V25, P853, DOI 10.1016/S0145-305X(01)00040-4; Bravo CF, 2011, ENVIRON TOXICOL CHEM, V30, P704, DOI 10.1002/etc.439; Carlson Erik, 2008, P489, DOI 10.1201/9780203647295.ch11; Casillas E, 1998, HYLEBOS FISH INJUR 2; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Chittaro PM, 2015, NORTHWEST SCI, V89, P93, DOI 10.3955/046.089.0107; EPA. [U. S. Environmental Protection Agency], 2017, FIN REC DEC PORTL HA; Friesen T. A., 2012, EXPERT PANEL REPORT; Friesen TA, 2007, NORTHWEST SCI, V81, P173, DOI 10.3955/0029-344X-81.3.173; G.A.O, 2002, GAO02612; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Hamilton PB, 2016, FISH FISH, V17, P545, DOI 10.1111/faf.12125; Jacobson KC, 2003, J AQUAT ANIM HEALTH, V15, P1, DOI 10.1577/1548-8667(2003)015&lt;0001:CEONAA&gt;2.0.CO;2; Johnson L. L., 2014, ORGANIC CHEM TOXICOL; Johnson LL, 2013, UNPUB; Johnson L, 2013, T AM FISH SOC, V142, P21, DOI 10.1080/00028487.2012.720627; Johnson LL, 2007, ENVIRON MONIT ASSESS, V124, P167, DOI 10.1007/s10661-006-9216-7; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Kwong RWM, 2008, ENVIRON TOXICOL CHEM, V27, P2053, DOI 10.1897/07-608.1; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Loge FJ, 2005, ENVIRON SCI TECHNOL, V39, P7329, DOI 10.1021/es0481934; Macneale KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092436; MCCARTHY MA, 1995, BIOL CONSERV, V73, P93, DOI 10.1016/0006-3207(95)00046-7; McElhany P, 2007, REVISED VIABILITY CR; Meador JP, 2006, CAN J FISH AQUAT SCI, V63, P2364, DOI 10.1139/F06-127; Meador JP, 2011, ENVIRON RES, V111, P50, DOI 10.1016/j.envres.2010.11.012; Meador JP, 2002, AQUAT CONSERV, V12, P493, DOI 10.1002/aqc.523; Meador JP, 2013, CANADIAN J FISHERIES, V71, P162; Mebane CA, 2010, HUM ECOL RISK ASSESS, V16, P1026, DOI 10.1080/10807039.2010.512243; Misumi I, 2005, FISH SHELLFISH IMMUN, V19, P97, DOI 10.1016/j.fsi.2004.11.005; Misumi I, 2009, ARCH ENVIRON CON TOX, V56, P229, DOI 10.1007/s00244-008-9187-5; Myers JM, NMFSNWFSC35 US DEP C; ( National Research Council) NRC, 1996, UPSTR SALM SOC PAC N; NIIMI AJ, 1983, CAN J FISH AQUAT SCI, V40, P1388, DOI 10.1139/f83-160; NMFS National Marine Fisheries Service, 2016, W COAST SALM STEELH; ODFW (Oregon Department of Fish and Wildlife) and NMFS (National Marine Fisheries Service), 2011, UPP WILL RIV CONS RE; Palm RC, 2003, ENVIRON TOXICOL CHEM, V22, P2986, DOI 10.1897/02-561; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Roni P, 2002, N AM J FISH MANAGE, V22, P1, DOI 10.1577/1548-8675(2002)022&lt;0001:AROSRT&gt;2.0.CO;2; Ross PS, 2013, CAN J FISH AQUAT SCI, V70, P1252, DOI 10.1139/cjfas-2012-0540; Schlenk D., 2008, TOXICOLOGY FISHES; Schmidt K, 2005, AQUAT TOXICOL, V71, P49, DOI 10.1016/j.aquatox.2004.10.012; Scholz N. L., 2015, CONSERVATION FRESHWA; Scholz NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028013; Schroeder R. K., 2015, CANADIAN J FISHERIES, V73, P921; Spromberg JA, 2006, ECOL MODEL, V199, P240, DOI 10.1016/j.ecolmodel.2006.05.007; Spromberg JA, 2005, INTEGR ENVIRON ASSES, V1, P9, DOI 10.1897/IEAM_2004a-005.1; Teel DJ, 2009, T AM FISH SOC, V138, P211, DOI 10.1577/T08-084.1; Trustee Council, 2007, PORTL HARB NAT RES T; VARANASI U, 1993, NMFSNWFSC8 NOAA; Zabel RW, 2006, CONSERV BIOL, V20, P190, DOI 10.1111/j.1523-1739.2005.00300.x; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719; Zabel RW, ASSESSING IMPACT ENV; Zabel RW, 2015, WILLAMETTE VALLEY PR	66	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214399	10.1371/journal.pone.0214399	http://dx.doi.org/10.1371/journal.pone.0214399			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901374	Green Submitted, gold, Green Published			2022-12-26	WOS:000462000400051
J	Rustad, EH; Hultcrantz, M; Yellapantula, VD; Akhlaghi, T; Ho, C; Arcila, ME; Roshal, M; Patel, A; Chen, D; Devlin, SM; Jacobsen, A; Huang, Y; Miller, JE; Papaemmanuil, E; Landgren, O				Rustad, Even H.; Hultcrantz, Malin; Yellapantula, Venkata D.; Akhlaghi, Theresia; Ho, Caleb; Arcila, Maria E.; Roshal, Mikhail; Patel, Akshar; Chen, Denise; Devlin, Sean M.; Jacobsen, Austin; Huang, Ying; Miller, Jeffrey E.; Papaemmanuil, Elli; Landgren, Ola			Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma	PLOS ONE			English	Article							FLOW-CYTOMETRY; GENE REARRANGEMENTS; CLINICAL-VALIDATION; PROGNOSTIC VALUE; IMMUNOGLOBULIN; PCR; MUTATIONS; CRITERIA; OUTCOMES; TARGET	Tracking of clonal immunoglobulin V(D)J rearrangement sequences by next generation sequencing is highly sensitive for minimal residual disease in multiple myeloma. However, previous studies have found variable rates of V(D)J sequence identification at baseline, which could limit tracking. Here, we aimed to define the factors influencing the identification of clonal V(D)J sequences. Bone marrow mononuclear cells from 177 myeloma patients underwent V(D)J sequencing by the LymphoTrack assays (Invivoscribe). As a molecular control for tumor cell content, we sequenced the samples using our in-house myeloma panel myTYPE. V(D)J sequence clonality was identified in 81% of samples overall, as compared with 95% in samples where tumor-derived DNA was detectable by myTYPE. Clonality was detected more frequently in patients with lambda-restricted disease, mainly because of increased detection of kappa gene rearrangements. Finally, we describe how the tumor cell content of bone marrow aspirates decrease gradually in sequential pulls because of hemo-dilution: From the initial pull used for aspirate smear, to the final pull that is commonly used for research. In conclusion, baseline clonality detection rates of 95% or higher are feasible in multiple myeloma. Optimal performance depends on the use of good quality aspirates and/or subsequent tumor cell enrichment.	[Rustad, Even H.; Hultcrantz, Malin; Akhlaghi, Theresia; Landgren, Ola] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA; [Rustad, Even H.] Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, Dept Clin & Mol Med, Trondheim, Norway; [Yellapantula, Venkata D.; Devlin, Sean M.; Papaemmanuil, Elli] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Ho, Caleb; Arcila, Maria E.; Roshal, Mikhail] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Patel, Akshar] Mem Sloan Kettering Canc Ctr, Dept Med, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA; [Chen, Denise] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Jacobsen, Austin; Huang, Ying; Miller, Jeffrey E.] Invivoscribe Inc, San Diego, CA USA	Memorial Sloan Kettering Cancer Center; Norwegian University of Science & Technology (NTNU); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Landgren, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA.	landgrec@mskcc.org	Ho, Caleb/T-8892-2019; Arcila, Maria/ABE-2235-2021; Yellapantula, Venkata/AAM-3996-2021; Rustad, Even/T-3535-2019	Rustad, Even/0000-0002-9320-4963; Hultcrantz, Malin/0000-0002-9045-6495	Memorial Sloan Kettering Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Memorial Sloan Kettering Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Invivoscribe, Inc., provided support in the form of salaries for authors JEM, YH and AJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. We thank Memorial Sloan Kettering Core Grant (P30 CA008748) for grant support of this work.	Delgado JA, 2017, J IMMUNOL METHODS, V442, P54, DOI 10.1016/j.jim.2016.12.006; Arcila ME, 2019, J MOL DIAGN, V21, P330, DOI 10.1016/j.jmoldx.2018.10.008; AVETLOISEAU H, 2017, BLOOD S1, V130; Bai YL, 2018, BRIT J HAEMATOL, V181, P11, DOI 10.1111/bjh.15075; Bolli N, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.72; Bolli N, LEUKEMIA, DOI [10.1038/leu.2017.344, DOI 10.1038/LEU.2017.344]; Bruggemann M, 2010, LEUKEMIA, V24, P521, DOI 10.1038/leu.2009.268; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dunn-Walters D, 2018, IMMUNOL REV, V284, P132, DOI 10.1111/imr.12659; Flanders A, 2013, BLOOD, V122, P1088, DOI 10.1182/blood-2013-05-506170; Flores-Montero J, 2017, LEUKEMIA, V31, P2094, DOI 10.1038/leu.2017.29; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gonzalez D, 2003, LEUKEMIA, V17, P1051, DOI 10.1038/sj.leu.2402937; Gonzalez D, 2007, BLOOD, V110, P3112, DOI 10.1182/blood-2007-02-069625; Ho C, 2018, SEMIN HEMATOL, V55, P13, DOI 10.1053/j.seminhematol.2018.02.007; Hultcrantz M, 2018, MYTYPE TARGETED NEXT; Kazandjian D, 2018, JAMA ONCOL, V4, P1781, DOI 10.1001/jamaoncol.2018.5457; Koning MT, 2017, BRIT J HAEMATOL, V178, P983, DOI 10.1111/bjh.14180; Korde N, 2015, JAMA ONCOL, V1, P746, DOI 10.1001/jamaoncol.2015.2010; Kumar S, 2016, LANCET ONCOL, V17, pE328, DOI 10.1016/S1470-2045(16)30206-6; Ladetto M, 2014, LEUKEMIA, V28, P1299, DOI 10.1038/leu.2013.375; Lahuerta JJ, 2017, J CLIN ONCOL, V35, P2900, DOI 10.1200/JCO.2016.69.2517; Landgren O, 2016, BONE MARROW TRANSPL, V51, P1565, DOI 10.1038/bmt.2016.222; Landgren O, 2018, SEMIN HEMATOL, V55, P1, DOI 10.1053/j.seminhematol.2018.03.003; Mailankody S, 2015, NAT REV CLIN ONCOL, V12, P286, DOI 10.1038/nrclinonc.2014.239; Martinez-Lopez J, 2017, LEUKEMIA, V31, P1446, DOI 10.1038/leu.2017.58; Martinez-Lopez J, 2014, BLOOD, V123, P3073, DOI 10.1182/blood-2014-01-550020; Mateos MV, 2018, NEW ENGL J MED, V378, P518, DOI 10.1056/NEJMoa1714678; Munshi NC, 2017, JAMA ONCOL, V3, P28, DOI 10.1001/jamaoncol.2016.3160; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Perfetti V, 2004, IMMUNOLOGY, V112, P420, DOI 10.1046/j.1365-2567.2004.01902.x; Perrot A, 2018, BLOOD, V132, P2456, DOI 10.1182/blood-2018-06-858613; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; Roshal M, 2018, SEMIN HEMATOL, V55, P4, DOI 10.1053/j.seminhematol.2018.02.011; Roshal M, 2017, BLOOD ADV, V1, P728, DOI 10.1182/bloodadvances.2016003715; Ross DS, 2017, J MOL DIAGN, V19, P244, DOI 10.1016/j.jmoldx.2016.09.010; Salem D, 2016, AM J HEMATOL, V91, pE502, DOI 10.1002/ajh.24540; Takamatsu H, 2017, ANN ONCOL, V28, P2503, DOI 10.1093/annonc/mdx340; van der Burg M, 2001, BLOOD, V97, P1001, DOI 10.1182/blood.V97.4.1001; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	43	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0211600	10.1371/journal.pone.0211600	http://dx.doi.org/10.1371/journal.pone.0211600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901326	gold, Green Published			2022-12-26	WOS:000462000400003
J	Cheung, S; Parrella, A; Rosenwaks, Z; Palermo, GD				Cheung, Stephanie; Parrella, Alessandra; Rosenwaks, Zev; Palermo, Gianpiero D.			Genetic and epigenetic profiling of the infertile male	PLOS ONE			English	Article							DNA METHYLATION; GENOME-WIDE; SPERM; SPERMATOZOA; FERTILIZATION; ABNORMALITIES; PREGNANCY; LOCI; RNAS; MEN	Evaluation of reproductive quality of spermatozoa by standard semen analysis is often inadequate to predict ART outcome. Men may be prone to meiotic error and have higher proportion of spermatozoa with fragmented chromatin, capable of affecting the conceptus' health. In men with unexplained infertility, supplementary tests may be pivotal to gain insight into the paternal contribution to the zygotic genome. A total of 113 consenting men were included in the study, with an additional 5 donor specimens used as control. Among study participants, 87 were screened for sperm aneuploidy by fluorescent in situ hybridization (FISH) and ranked according to their increasing age. A total of 18 men were assessed by whole exome sequencing and categorized according to their reproductive outcome as either fertile or infertile. Another set of men (n = 13) had their gene expression analyzed by RNA-seq and were profiled according to their reproductive capacity. FISH revealed that the average aneuploidy rate was highest for men over-55 age group (9.6%), while men >55 had the highest average disomy for chromosomes 17(1.2%) and 18(1.3%). ART results for the entire cohort comprised 157 cycles, stratified by paternal age. The youngest age group (2530 years) had a fertilization rate of 87.7% which decreased to 46.0% in the >55 age group. Clinical pregnancy rate was highest in the 25-30yr group (80.0%) while no pregnancies were attained in the >55 age groups. Pregnancy loss was characterized by a steadily increasing trend, highest in the 51-55 age group (50.0%). NGS was performed on a cohort of patients classified as having recurrent pregnancy loss. This cohort was classified as the infertile group (n = 10) and was compared to a control group (n = 8) consisting of patients successfully treated by ART. Eight couples in 17 ICSI cycles achieved a clinical pregnancy rate of 82.4% while 10 infertile couples treated in 21 cycles achieved a pregnancy rate of 23.8%, all resulting in pregnancy loss. DNA-sequencing on spermatozoa from these patients yielded overall aneuploidy of 4.0% for fertile and 8.6% for the infertile group (P<0.00001). In the infertile cohort, we identified 17 genes with the highest mutation rate, engaged in key roles of gametogenesis, fertilization and embryo development. RNA-seq was performed on patients (n = 13) with normal semen analyses. Five men unable to attain a pregnancy after ART were categorized as the infertile group, while 8 men who successfully sustained a pregnancy were established as the fertile control. Analysis resulted in 86 differentially expressed genes (P<0.001). Of them, 24 genes were overexpressed and 62 were under-expressed in the infertile cohort. DNA repair genes (APLF, CYB5R4, ERCC4 and TNRFSF21) and apoptosis-modulating genes (MORC1, PIWIL1 and ZFAND6) were remarkably under-expressed (P<0.001). Sperm aneuploidy assessment supported by information on gene mutations may indicate subtle dysfunctions of the spermatozoon. Furthermore, by querying noncoding RNA we may gather knowledge on embryo developmental competence of spermatozoa, providing crucial information on the etiology of unexplained infertility of the infertile male.	[Cheung, Stephanie; Parrella, Alessandra; Rosenwaks, Zev; Palermo, Gianpiero D.] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA	Cornell University	Palermo, GD (corresponding author), Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA.	gdpalerm@med.cornell.edu		Cheung, Stephanie/0000-0002-2092-7001; Palermo, Gianpiero D./0000-0001-8440-4560				Aston KI, 2009, J ANDROL, V30, P711, DOI 10.2164/jandrol.109.007971; Azpiazu R, 2014, HUM REPROD, V29, P1225, DOI 10.1093/humrep/deu073; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Camprubi C, 2012, EPIGENETICS-US, V7, P1115, DOI 10.4161/epi.21743; Colombero LT, 1999, FERTIL STERIL, V72, P90, DOI 10.1016/S0015-0282(99)00158-2; Furrow RE, 2011, GENETICS, V189, P1377, DOI 10.1534/genetics.111.131912; Garcia-Herrero S, 2011, REPROD BIOMED ONLINE, V22, P25, DOI 10.1016/j.rbmo.2010.09.013; Garrido N, 2009, FERTIL STERIL, V91, P1307, DOI 10.1016/j.fertnstert.2008.01.078; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Huang JYJ, 2012, BEST PRACT RES CL OB, V26, P777, DOI 10.1016/j.bpobgyn.2012.08.017; Jodar M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1287; Jodar M, 2013, HUM REPROD UPDATE, V19, P604, DOI 10.1093/humupd/dmt031; Jodar M, 2012, HUM REPROD, V27, P1431, DOI 10.1093/humrep/des021; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Klaver R, 2013, ANDROLOGY-US, V1, P731, DOI 10.1111/j.2047-2927.2013.00118.x; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Martin RH, 2006, REPROD TOXICOL, V22, P142, DOI 10.1016/j.reprotox.2006.03.013; Martinez-Heredia J, 2008, HUM REPROD, V23, P783, DOI 10.1093/humrep/den024; Montjean D, 2012, J ASSIST REPROD GEN, V29, P3, DOI 10.1007/s10815-011-9644-3; MOOSANI N, 1995, FERTIL STERIL, V64, P811, DOI 10.1016/S0015-0282(16)57859-5; Mougou-Zerelli S, 2011, J ASSIST REPROD GEN, V28, P971, DOI 10.1007/s10815-011-9621-x; O'Neill CL, 2018, J ASSIST REPROD GEN, V35, P1911, DOI 10.1007/s10815-018-1270-x; Palermo GD, 1999, HUM REPROD, V14, P741, DOI 10.1093/humrep/14.3.741; Palermo GD, 1995, FERTIL STERIL, V63, P9; Palermo GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113671; Palermo GD, 2014, FERTIL STERIL, V102, P1508, DOI 10.1016/j.fertnstert.2014.10.008; Palermo GD, 2012, FERTIL STERIL, V97, P248, DOI 10.1016/j.fertnstert.2011.12.037; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Sabanegh ES, 2011, CURR CLIN UROL, P89, DOI 10.1007/978-1-60761-193-6_10; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Steiner B, 2015, EUR J HUM GENET, V23, P466, DOI 10.1038/ejhg.2014.122; The Male Infertility Best Practice Policy Committee of the American Urological Association and The Practice Committee of the American Society for Reproductive Medicine, 2006, FERTIL STERIL, V86, pS202, DOI DOI 10.1016/J.FERTNSTERT.2006.08.029; Tohonen V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9207; Tuttelmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019426; van den Hoven L, 2015, FERTIL STERIL, V103, P53, DOI 10.1016/j.fertnstert.2014.09.036; Varet H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157022; Wiener-Megnazi Z, 2012, ASIAN J ANDROL, V14, P69, DOI 10.1038/aja.2011.69; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	40	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214275	10.1371/journal.pone.0214275	http://dx.doi.org/10.1371/journal.pone.0214275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897172	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700078
J	Lee, J; An, JN; Hwang, JH; Lee, H; Lee, JP; Kim, SG				Lee, Jeonghwan; An, Jung Nam; Hwang, Jin Ho; Lee, Hajeong; Lee, Jung Pyo; Kim, Sung Gyun			p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; OBSTRUCTIVE PULMONARY-DISEASE; RENAL FIBROSIS; DOUBLE-BLIND; MECHANISMS; RAT; INHIBITION; PATHWAY; PATHOGENESIS; EFFICACY	Activation of p38 mitogen-activated protein kinase (MAPK) is associated with tissue fibrosis, and inhibition of p38 MAPK can attenuate the progression of fibrosis. We aimed to investigate whether p38 MAPK activity in kidney tissue confirmed by immunohistochemical staining is associated with renal tubulointerstitial fibrosis in chronic kidney disease patients with IgA nephropathy. We collected kidney biopsy specimens from 341 IgA nephropathy patients and 15 control patients to identify the clinical and histopathological factors associated with kidney tubulointerstitial fibrosis and to find an association between kidney phosphorylated p38 immunoactivity and pathological grading. In addition, we aimed to investigate whether the anti-fibrotic effect of p38 MAPK inhibition can be identified by assessing the immunostaining intensity of phosphorylated p38 in kidney tissue. A renal tubulointerstitial fibrosis model was introduced using 7-week-old C57BL/6 mice subjected to unilateral ureteral obstruction (UUO). The p38 MAPK inhibitor SB-731445 was injected intraperitoneally every day for 7 days, and changes in renal fibrosis-associated markers were investigated. Assessment of kidney biopsy specimens from IgA nephropathy patients revealed that the degree of interstitial fibrosis was significantly associated with the tissue immunoactivity of phosphorylated p38. High-grade interstitial fibrosis was associated with a low glomerular filtration rate, high proteinuria, and high-grade histopathological changes, including tubular atrophy, interstitial inflammation, and glomerular sclerosis. In a mouse UUO model, renal protein expression of COL1 and phosphorylated p38 were significantly increased, and the protein expression of COL1 and phosphorylated p38 decreased in mice administered 10 mg/kg/day p38 MAPK inhibitor. We found that kidney interstitial fibrosis is associated with increased immunoactivity of phosphorylated p38 in a UUO mouse model and in human IgA nephropathy patients and that the anti-fibrotic effect of p38 MAPK inhibition can be confirmed using immunohistochemical staining for phosphorylated p38 in kidney tissue.	[Lee, Jeonghwan; Kim, Sung Gyun] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang, Gyeonggi Do, South Korea; [An, Jung Nam; Lee, Jung Pyo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul Metropolitan Govt, Seoul, South Korea; [Hwang, Jin Ho] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Hajeong] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, SG (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang, Gyeonggi Do, South Korea.	imnksk@gmail.com	Lee, Jeonghwan/C-5214-2011	Lee, Jeonghwan/0000-0003-3199-635X	Hallym University Research Fund [HURF-2014-58]	Hallym University Research Fund	This work was supported by Hallym University Research Fund 2014 (HURF-2014-58).	Aoki S, 2011, PERITON DIALYSIS INT, V31, P466, DOI 10.3747/pdi.2010.00157; Auger-Messier M, 2013, CIRC RES, V112, P48, DOI 10.1161/CIRCRESAHA.112.272963; Bohle A, 1979, Contrib Nephrol, V16, P109; Cheng XY, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/463740; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; De Borst MH, 2007, J PATHOL, V213, P219, DOI 10.1002/path.2228; Disel U, 2004, TRANSPL P, V36, P1372, DOI 10.1016/j.transproceed.2004.05.078; Dmitrieva NI, 2002, P NATL ACAD SCI USA, V99, P184, DOI 10.1073/pnas.231623498; Dodd S, 1995, Curr Top Pathol, V88, P51; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Fisk M, 2014, AM J CARDIOVASC DRUG, V14, P155, DOI 10.1007/s40256-014-0063-6; Fujita H, 2010, AM J PHYSIOL-RENAL, V299, pF648, DOI 10.1152/ajprenal.00402.2009; Gaffey K, 2013, EUR RESPIR J, V42, P28, DOI 10.1183/09031936.00170711; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; GOBE GC, 1987, LAB INVEST, V56, P273; Graziosi L, 2012, EUR J PHARMACOL, V674, P143, DOI 10.1016/j.ejphar.2011.11.015; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Hwang JH, 2017, AM J NEPHROL, V46, P501, DOI 10.1159/000485325; Hwang JH, 2016, AM J NEPHROL, V44, P481, DOI 10.1159/000452228; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Kavvadas P, 2014, KIDNEY INT SUPPL, V4, P53, DOI 10.1038/kisup.2014.10; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Kokubo S, 2012, PERITON DIALYSIS INT, V32, P10, DOI 10.3747/pdi.2010.00200; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; KUNCIO GS, 1991, KIDNEY INT, V39, P550, DOI 10.1038/ki.1991.63; Lea S, 2014, BR J CLIN PHARM; Lee JK, 2017, MOLECULES, V22, DOI 10.3390/molecules22081287; Li DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059360; Lin JH, 2015, NEPHRON, V129, P29, DOI 10.1159/000369152; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma FY, 2014, AM J PHYSIOL-RENAL, V307, pF1263, DOI 10.1152/ajprenal.00211.2014; MacNee W, 2013, THORAX, V68, P738, DOI 10.1136/thoraxjnl-2012-202744; Maruyama M, 2003, J RECEPT SIG TRANSD, V23, P173, DOI 10.1081/RRS-120025197; Matsushita T, 2017, AM J PATHOL, V187, P841, DOI 10.1016/j.ajpath.2016.12.016; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Nakagawa T, 2005, J AM SOC NEPHROL, V16, P899, DOI 10.1681/ASN.2004080689; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Page TH, 2010, ARTHRITIS RHEUM-US, V62, P3221, DOI 10.1002/art.27631; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Stambe C, 2003, KIDNEY INT, V64, P2121, DOI 10.1046/j.1523-1755.2003.00324.x; Sugiyama N, 2012, NEPHROL DIAL TRANSPL, V27, P1351, DOI 10.1093/ndt/gfr550; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang B, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2636-0; Wang DP, 2013, AM J PHYSIOL-RENAL, V304, pF938, DOI 10.1152/ajprenal.00706.2012; Wang X, 2013, INT UROL NEPHROL, V45, P899, DOI 10.1007/s11255-012-0350-6; Watz H, 2014, LANCET RESP MED, V2, P63, DOI 10.1016/S2213-2600(13)70200-5; Wissing ER, 2014, HUM MOL GENET, V23, P5452, DOI 10.1093/hmg/ddu270; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xi YT, 2006, EUR J HEART FAIL, V8, P16, DOI 10.1016/j.ejheart.2005.05.014; Yang Y, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/352371; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	56	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213981	10.1371/journal.pone.0213981	http://dx.doi.org/10.1371/journal.pone.0213981			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897126	Green Submitted, gold, Green Published			2022-12-26	WOS:000461889700051
J	Chang, YJ; Hsiao, HJ; Hsia, SH; Lin, JJ; Hwang, MS; Chung, HT; Chen, CL; Huang, YC; Tsai, MH				Chang, Yi-Jung; Hsiao, Hsiang-Ju; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Hwang, Mao-Sheng; Chung, Hung-Tao; Chen, Chyi-Liang; Huang, Yhu-Chering; Tsai, Ming-Han			Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis	PLOS ONE			English	Article							MECHANICAL CIRCULATORY SUPPORT; EXTRACORPOREAL MEMBRANE-OXYGENATION; FULMINANT MYOCARDITIS; CHEST-PAIN; CHILDREN; DIAGNOSIS	Pediatric myocarditis symptoms can be mild or as extreme as sudden cardiac arrest. Early identification of the severity of illness and timely provision of critical care is helpful; however, the risk factors associated with mortality remain unclear and controversial. We undertook a retrospective review of the medical records of pediatric patients with myocarditis in a tertiary care referral hospital for over 12 years to identify the predictive factors of mortality. Demographics, presentation, laboratory test results, echocardiography findings, and treatment outcomes were obtained. Regression analyses revealed the clinical parameters for predicting mortality. During the 12-year period, 94 patients with myocarditis were included. Of these, 16 (17%) patients died, with 12 succumbing in the first 72 hours after admission. Fatal cases more commonly presented with arrhythmia, hypotension, acidosis, gastrointestinal symptoms, decreased left ventricular ejection fraction, and elevated isoenzyme of creatine kinase and troponin I levels than nonfatal cases. In multivariate analysis, troponin I > 45 ng/mL and left ventricular ejection fraction < 42% were significantly associated with mortality. Pediatric myocarditis had a high mortality rate, much of which was concentrated in the first 72 hours after hospitalization. Children with very high troponin levels or reduced ejection fraction in the first 24 hours were at higher risk of mortality, and targeting these individuals for more intensive therapies may be warranted.	[Chang, Yi-Jung; Hsiao, Hsiang-Ju; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Hwang, Mao-Sheng; Chung, Hung-Tao; Huang, Yhu-Chering] Chang Gung Childrens Hosp, Dept Pediat, Taoyuan, Taiwan; [Chang, Yi-Jung; Hsiao, Hsiang-Ju; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Hwang, Mao-Sheng; Chung, Hung-Tao; Huang, Yhu-Chering; Tsai, Ming-Han] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Chyi-Liang; Tsai, Ming-Han] Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan; [Tsai, Ming-Han] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Taoyuan, Taiwan.; Huang, YC; Tsai, MH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Tsai, MH (corresponding author), Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan.; Tsai, MH (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan.	ychuang@adm.cgmh.org.tw; drtsai1208@gmail.com	Chen, Chyi-Liang/GVT-1758-2022	Tsai, Ming-Han/0000-0002-1619-1919; , Hsiang-Ju/0000-0002-6041-9431; Chen, Chyi-Liang/0000-0003-4591-0924				Abrar S, 2016, J CLIN DIAGN RES, V10, pSC12, DOI 10.7860/JCDR/2016/19856.7967; Butto A, 2018, PEDIATR CARDIOL, V39, P1139, DOI 10.1007/s00246-018-1871-2; Butts RJ, 2017, PEDIATR CARDIOL, V38, P1175, DOI 10.1007/s00246-017-1638-1; Canter CE, 2014, CIRCULATION, V129, P115, DOI 10.1161/CIRCULATIONAHA.113.001372; Casadonte JR, 2017, PEDIATR CARDIOL, V38, P128, DOI 10.1007/s00246-016-1493-5; Chen YS, 2005, J HEART LUNG TRANSPL, V24, P81, DOI 10.1016/j.healun.2003.09.038; Dancea A B, 2001, Paediatr Child Health, V6, P543; DRUCKER NA, 1994, CIRCULATION, V89, P252, DOI 10.1161/01.CIR.89.1.252; Duncan BW, 2001, J THORAC CARDIOV SUR, V122, P440, DOI 10.1067/mtc.2001.115243; Durani Y, 2009, AM J EMERG MED, V27, P942, DOI 10.1016/j.ajem.2008.07.032; Felker GM, 2000, J AM COLL CARDIOL, V36, P227, DOI 10.1016/S0735-1097(00)00690-2; Freedman SB, 2007, PEDIATRICS, V120, P1278, DOI 10.1542/peds.2007-1073; Fu YC, 2004, ARCH DIS CHILD, V89, P368, DOI 10.1136/adc.2003.029645; HERSKOWITZ A, 1993, AM J CARDIOL, V71, P982, DOI 10.1016/0002-9149(93)90918-3; Hsiao HJ, 2011, PEDIATR NEONATOL, V52, P135, DOI 10.1016/j.pedneo.2011.03.005; Kane DA, 2010, CONGENIT HEART DIS, V5, P366, DOI 10.1111/j.1747-0803.2010.00436.x; Kang YJ, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434844; Kobayashi D, 2012, PEDIATR CARDIOL, V33, P1040, DOI 10.1007/s00246-012-0222-y; Kuhl Uwe, 2010, Heart Fail Clin, V6, P483, DOI 10.1016/j.hfc.2010.05.009; Kuhn B, 2004, PEDIATR CARDIOL, V25, P379, DOI 10.1007/s00246-003-0568-2; Lee CH, 2006, INT J CARDIOL, V109, P142, DOI 10.1016/j.ijcard.2005.04.014; Lee KJ, 1999, HEART, V82, P226, DOI 10.1136/hrt.82.2.226; Lin KM, 2016, PEDIATR NEONATOL, V57, P480, DOI 10.1016/j.pedneo.2016.02.002; Magnani JW, 2006, AM HEART J, V151, P463, DOI 10.1016/j.ahj.2005.03.037; MATITIAU A, 1994, CIRCULATION, V90, P1310, DOI 10.1161/01.CIR.90.3.1310; McCarthy RE, 2000, NEW ENGL J MED, V342, P690, DOI 10.1056/NEJM200003093421003; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sachdeva S, 2015, AM J CARDIOL, V115, P499, DOI 10.1016/j.amjcard.2014.11.029; Schwartz MC, 2013, CARDIOL YOUNG, V23, P353, DOI 10.1017/S1047951112001278; Simpson KE, 2011, EXPERT REV CARDIOVAS, V9, P771, DOI [10.1586/erc.11.70, 10.1586/ERC.11.70]; Smith SC, 1997, CIRCULATION, V95, P163, DOI 10.1161/01.CIR.95.1.163; Soongswang J, 2005, PEDIATR CARDIOL, V26, P45, DOI 10.1007/s00246-004-0677-6; Teele SA, 2011, J PEDIATR-US, V158, P638, DOI 10.1016/j.jpeds.2010.10.015; Wilmot I, 2011, J CARD FAIL, V17, P487, DOI 10.1016/j.cardfail.2011.02.008; Wu ET, 2006, HEART, V92, P1325, DOI 10.1136/hrt.2005.077511; Wu HP, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2510695	36	15	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0214087	10.1371/journal.pone.0214087	http://dx.doi.org/10.1371/journal.pone.0214087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893383	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900068
J	Dance, MA; Rooker, JR				Dance, Michael A.; Rooker, Jay R.			Cross-shelf habitat shifts by red snapper (Lutjanus campechanus) in the Gulf of Mexico	PLOS ONE			English	Article							REEF FISH; ARTIFICIAL REEFS; CONTINENTAL-SHELF; JUVENILE; SIZE; CONNECTIVITY; TEMPERATURE; RECRUITMENT; MANAGEMENT; PREDATORS	Habitat shifts that occur during the life cycles of marine fishes influence population connectivity and structure. A generalized additive modeling approach was used to characterize relationships between environmental variables and the relative abundance of red snapper Lutjanus campechanus over unconsolidated substrate on the continental shelf (<150 m) of the U.S. Gulf of Mexico (GoM) at three different life stages: juvenile (age-0, <125 mm FL), sub-adult (age-1-2, 125-300 mm FL), and adult (age-2+, >300 mm FL). Fisheries independent data (2008-2014) were used to develop separate models for both the eastern and western GoM, and final models were used to predict the relative availability of suitable habitat for each life stage across the two regions. Predictor variables included in final models varied by age class and region, with depth, dissolved oxygen, longitude, and distance to artificial structure common to most models. Depth was among the most influential variables in all models, and preferred depth increased with increasing size/age. Regional differences in fish-habitat relationships were also observed, as relative abundance of larger red snapper over unconsolidated substrates was more closely linked to artificial structure in the eastern GoM. The location of predicted high quality habitat for juvenile red snapper was greatest on the inner Texas shelf and a smaller area east of the Mississippi River Delta, suggesting these two areas may represent important nursery grounds for the respective regions. Clear ontogenetic shifts in the spatial distribution of predicted high quality habitat were evident in both the eastern (expansion from west to east with age) and western (shift from inshore to offshore) GoM. Given the unique population dynamics between the eastern and western GoM, improving our understanding of spatial and temporal variability in habitat quality may be important to maintaining connectivity between juvenile and adult habitats, and may enhance recovery and management of red snapper stocks in the GoM.	[Dance, Michael A.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Rooker, Jay R.] Texas A&M Univ, Dept Marine Biol, Galveston Campus, Galveston, TX 77553 USA; [Rooker, Jay R.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Louisiana State University System; Louisiana State University; Texas A&M University System; Texas A&M University System; Texas A&M University College Station	Dance, MA (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	mdance1@lsu.edu			Texas Parks and Wildlife Department; Texas OneGulf Center of Excellence	Texas Parks and Wildlife Department; Texas OneGulf Center of Excellence	This research was supported by funding from the Texas OneGulf Center of Excellence and Texas Parks and Wildlife Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Addis DT, 2016, N AM J FISH MANAGE, V36, P131, DOI 10.1080/02755947.2015.1084406; Addis DT, 2013, FISH RES, V147, P349, DOI 10.1016/j.fishres.2013.07.011; Ajemian MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126354; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; [Anonymous], 2021, LANG ENV STAT COMP; Breitburg D, 2002, ESTUARIES, V25, P767, DOI 10.1007/BF02804904; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Buczkowski B.J., 2006, USSEABED GULF MEXICO, P146, DOI [10.3133/ds146, DOI 10.3133/DS146]; Bystrom P, 2003, J ANIM ECOL, V72, P156, DOI 10.1046/j.1365-2656.2003.00681.x; Cornic M, 2018, FISH RES, V201, P1, DOI 10.1016/j.fishres.2017.12.015; Cowan JH, 2011, REV FISH BIOL FISHER, V21, P187, DOI 10.1007/s11160-010-9165-7; Cowan JH, 2011, FISHERIES, V36, P319, DOI 10.1080/03632415.2011.589318; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; Dance MA, 2016, MAR ECOL PROG SER, V557, P221, DOI 10.3354/meps11878; Dance MA, 2015, ESTUAR COAST SHELF S, V167, P447, DOI 10.1016/j.ecss.2015.10.025; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; de Mutsert K, 2016, ECOL MODEL, V331, P142, DOI 10.1016/j.ecolmodel.2015.10.013; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Donelson JM, 2010, MAR ECOL PROG SER, V401, P233, DOI 10.3354/meps08366; Drexler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064458; Eby LA, 2005, MAR ECOL PROG SER, V291, P249, DOI 10.3354/meps291249; EGGLESTON DB, 1995, MAR ECOL PROG SER, V124, P9, DOI 10.3354/meps124009; Frank KT, 2018, P NATL ACAD SCI USA, V115, P6422, DOI 10.1073/pnas.1802096115; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Furey NB, 2013, J SEA RES, V76, P161, DOI 10.1016/j.seares.2012.08.007; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gallaway BJ, 1999, T AM FISH SOC, V128, P713, DOI 10.1577/1548-8659(1999)128<0713:DOEHFJ>2.0.CO;2; Garner SB, 2015, FISH B-NOAA, V113, P157, DOI 10.7755/FB.113.2.4; Gillanders BM, 2003, MAR ECOL PROG SER, V247, P281, DOI 10.3354/meps247281; Gold JR, 2007, AM FISH S S, V60, P201; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Grol MGG, 2014, MAR ECOL PROG SER, V502, P229, DOI 10.3354/meps10682; Grol MGG, 2011, OECOLOGIA, V165, P79, DOI 10.1007/s00442-010-1833-8; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Gruss A, 2018, MAR COAST FISH, V10, P40, DOI 10.1002/mcf2.10002; Gruss A, 2017, FISH RES, V193, P129, DOI 10.1016/j.fishres.2017.04.006; Hanisko DS, 2007, AM FISH S S, V60, P285; Heppell SS, 2006, ECOL APPL, V16, P238, DOI 10.1890/04-1113; Huijbers CM, 2015, HYDROBIOLOGIA, V750, P89, DOI 10.1007/s10750-014-2162-4; Jaxion-Harm J, 2015, N AM J FISH MANAGE, V35, P86, DOI 10.1080/02755947.2014.982332; Johnson DR, 2009, T AM FISH SOC, V138, P458, DOI 10.1577/T08-008.1; Karnauskas M, 2017, MAR COAST FISH, V9, P50, DOI 10.1080/19425120.2016.1255684; Kulaw DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172360; Lecchini D, 2005, MAR BIOL, V147, P47, DOI 10.1007/s00227-004-1543-z; Liu H, 2017, FISH RES, V187, P31, DOI 10.1016/j.fishres.2016.11.002; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; McMahon KW, 2012, P NATL ACAD SCI USA, V109, P15372, DOI 10.1073/pnas.1206378109; Mitchell WA, 2014, MAR COAST FISH, V6, P142, DOI 10.1080/19425120.2014.920743; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Nakazawa T, 2015, POPUL ECOL, V57, P347, DOI 10.1007/s10144-014-0448-z; Ohlmann JC, 2005, PROG OCEANOGR, V64, P45, DOI 10.1016/j.pocean.2005.02.001; Patterson WF, 2001, T AM FISH SOC, V130, P533, DOI 10.1577/1548-8659(2001)130<0533:MOTRSI>2.0.CO;2; Patterson WF, BENTHIC HABITATS EFF; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; Porch CE, 2015, MAR COAST FISH, V7, P233, DOI 10.1080/19425120.2015.1040567; Powers SP, 2018, T AM FISH SOC, V147, P791, DOI 10.1002/tafs.10081; Rester JK., 2017, SEAMAP ENV BIOL ATLA; Rooker JR, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2200; Rooker JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076080; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Rooker JR, 2004, ESTUAR COAST SHELF S, V59, P653, DOI 10.1016/j.ecss.2003.11.009; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Saul SE, 2013, FISH RES, V143, P12, DOI 10.1016/j.fishres.2013.01.002; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Schroeder W. W., 1988, GULF COAST ASS GEOL, V38, P535; SEDAR (Southeast Data Assessment and Review), 2010, UPD SEDAR 9 STOCK AS; Simard P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160695; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Streich MK, 2017, MAR COAST FISH, V9, P170, DOI 10.1080/19425120.2017.1282897; Switzer TS, 2015, T AM FISH SOC, V144, P300, DOI 10.1080/00028487.2014.991447; Szedlmayer ST, 2004, FISH B-NOAA, V102, P366; Szedlmayer ST, 2014, N AM J FISH MANAGE, V34, P443, DOI 10.1080/02755947.2014.882457; Turner RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184350; Weeks R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182396; Wells RJD, 2008, CAN J FISH AQUAT SCI, V65, P2399, DOI 10.1139/F08-145; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Williams-Grove LJ, 2016, MAR ECOL PROG SER, V553, P233, DOI 10.3354/meps11778; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	85	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213506	10.1371/journal.pone.0213506	http://dx.doi.org/10.1371/journal.pone.0213506			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870449	gold, Green Submitted, Green Published			2022-12-26	WOS:000461166300035
J	Pin, F; Novinger, LJ; Huot, JR; Harris, RA; Couch, ME; O'Connell, TM; Bonetto, A				Pin, Fabrizio; Novinger, Leah J.; Huot, Joshua R.; Harris, Robert A.; Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea			PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia	FASEB JOURNAL			English	Article						skeletal muscle atrophy; energy metabolism; chemotherapy; mitochondria	PYRUVATE-DEHYDROGENASE KINASE; HUMAN SKELETAL-MUSCLE; UP-REGULATION; GENE FAMILY; MOUSE MODEL; EXPRESSION; MECHANISMS; TRANSCRIPTION; ACTIVATION; OXIDATION	Cachexia is frequently accompanied by severe metabolic derangements, although the mechanisms responsible for this debilitating condition remain unclear. Pyruvate dehydrogenase kinase (PDK)4, a critical regulator of cellular energetic metabolism, was found elevated in experimental models of cancer, starvation, diabetes, and sepsis. Here we aimed to investigate the link between PDK4 and the changes in muscle size in cancer cachexia. High PDK4 and abnormal energetic metabolism were found in the skeletal muscle of colon-26 tumor hosts, as well as in mice fed a diet enriched in Pirinixic acid, previously shown to increase PDK4 levels. Viral-mediated PDK4 overexpression in myotube cultures was sufficient to promote myofiber shrinkage, consistent with enhanced protein catabolism and mitochondrial abnormalities. On the contrary, blockade of PDK4 was sufficient to restore myotube size in C2C12 cultures exposed to tumor media. Our data support, for the first time, a direct role for PDK4 in promoting cancer-associated muscle metabolic alterations and skeletal muscle atrophy.-Pin, F., Novinger, L. J., Huot, J. R., Harris, R. A., Couch, M. E., O'Connell, T. M., Bonetto, A. PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.	[Pin, Fabrizio; Bonetto, Andrea] Indiana Univ Purdue Univ, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Pin, Fabrizio; Huot, Joshua R.; Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Purdue Univ, Ctr Cachexia Res Innovat & Therapy, Indianapolis, IN 46202 USA; [Novinger, Leah J.; Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [Huot, Joshua R.; Bonetto, Andrea] Indiana Univ Sch Med, Dept Surg, 980 W Walnut St,R3-C522, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Couch, Marion E.; O'Connell, Thomas M.; Bonetto, Andrea] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bonetto, A (corresponding author), Indiana Univ Sch Med, Dept Surg, 980 W Walnut St,R3-C522, Indianapolis, IN 46202 USA.	abonetto@iu.edu		Bonetto, Andrea/0000-0002-3235-1871	IU Simon Cancer Center Support Grant [P30CA082709]; Department of Surgery; Department of Otolaryngology-Head and Neck Surgery at IU; V Foundation for Cancer Research [V2017-021]; American Cancer Society [132013-RSG-18-010-01-CCG]; IU Simon Cancer Center; Indiana Clinical and Translational Sciences Institute [UL1TR001108]; Showalter Research Trust; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	IU Simon Cancer Center Support Grant; Department of Surgery; Department of Otolaryngology-Head and Neck Surgery at IU; V Foundation for Cancer Research; American Cancer Society(American Cancer Society); IU Simon Cancer Center; Indiana Clinical and Translational Sciences Institute; Showalter Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank the Cancer Center at Indiana University (IU) School of Medicine funded by the IU Simon Cancer Center Support Grant (P30CA082709) for the use of the In Vivo Therapeutics Core Facility, which generated the NSG mice used in this study. The 12G10 anti-tubulin mAb developed by J. Frankel and E.M. Nelson (University of Iowa, Iowa City, IA, USA) and the MF-20 anti-myosin heavy chain antibody developed by Donald A. Fischman (Cornell University, Ithaca, NY, USA) were obtained from the Developmental Studies Hybridoma Bank, created by the U.S. National Institutes of Health, National Institute of Child Health, and maintained at the Department of Biology at The University of Iowa. The authors thank John Spence, Ph.D. for contributions in editing the manuscript, and Teresa A. Zimmers, Ph.D. (both from the IU School of Medicine) for allowing access to the equipment for in vivo characterization of cachexia. This study was supported by the Department of Surgery and the Department of Otolaryngology-Head and Neck Surgery at IU, and by grants from the V Foundation for Cancer Research (V2017-021 to A.B.), the American Cancer Society (Research Scholar Grant 132013-RSG-18-010-01-CCG to A. B.), the IU Simon Cancer Center (Associate Member Pilot Funding Mechanism to A.B.), the Indiana Clinical and Translational Sciences Institute (Core Pilot Grant UL1TR001108 to T.M.O. and A.B.),and the Showalter Research Trust (to A.B.). The authors declare no conflicts of interest.	An D, 2006, AM J PHYSIOL-HEART C, V291, pH1489, DOI 10.1152/ajpheart.00278.2006; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Asp ML, 2011, CANCER BIOL THER, V12, P957, DOI 10.4161/cbt.12.11.18134; Barreto R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00472; Barreto R, 2016, ONCOTARGET, V7, P43442, DOI 10.18632/oncotarget.9779; Bonetto A, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.101; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Bossola M, 2001, AM J PHYSIOL-REG I, V280, pR1518, DOI 10.1152/ajpregu.2001.280.5.R1518; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Chen JA, 2015, J CACHEXIA SARCOPENI, V6, P132, DOI 10.1002/jcsm.12023; Constantin-Teodosiu D, 2012, DIABETES, V61, P1017, DOI 10.2337/db11-0799; Crossland H, 2017, CLIN SCI, V131, P1437, DOI 10.1042/CS20170958; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fukawa T, 2016, NAT MED, V22, P666, DOI 10.1038/nm.4093; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Fuster G, 2007, CANCER RES, V67, P6512, DOI 10.1158/0008-5472.CAN-07-0231; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Gudiksen A, 2017, AM J PHYSIOL-ENDOC M, V312, pE204, DOI 10.1152/ajpendo.00291.2016; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; He WA, 2014, P NATL ACAD SCI USA, V111, P4525, DOI 10.1073/pnas.1402714111; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Leclerc D, 2017, BRIT J CANCER, V116, P930, DOI 10.1038/bjc.2017.38; Liu ZB, 2014, J BIOL CHEM, V289, P29739, DOI 10.1074/jbc.M114.584821; Mallinson JE, 2012, J PHYSIOL-LONDON, V590, P6389, DOI 10.1113/jphysiol.2012.238022; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Murphy KT, 2013, AM J PHYSIOL-REG I, V304, pR854, DOI 10.1152/ajpregu.00057.2013; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Peters SJ, 2003, BIOCHEM SOC T, V31, P1274, DOI 10.1042/BST0311274; Petruzzelli M, 2016, GENE DEV, V30, P489, DOI 10.1101/gad.276733.115; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Pin F., 2019, J CACHEXIA SARCOPENI; Pin F, 2018, J CACHEXIA SARCOPENI, V9, P685, DOI 10.1002/jcsm.12311; Pin F, 2015, ONCOTARGET, V6, P43202, DOI 10.18632/oncotarget.6439; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shrivastav S, 2013, MOL ENDOCRINOL, V27, P1564, DOI 10.1210/me.2012-1370; Skipworth RJE, 2007, CLIN NUTR, V26, P667, DOI 10.1016/j.clnu.2007.03.011; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Srivastava N, 2014, CELL METAB, V20, P650, DOI 10.1016/j.cmet.2014.08.003; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Tzika AA, 2013, INT J ONCOL, V43, P886, DOI 10.3892/ijo.2013.1998; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Zhang Y, 2016, J BIOL CHEM, V291, P17405, DOI 10.1074/jbc.M116.713735; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	64	30	31	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7778	7790		10.1096/fj.201802799R	http://dx.doi.org/10.1096/fj.201802799R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30894018	Green Published, Bronze, Green Submitted			2022-12-26	WOS:000476114200089
J	Chung, J; Karkhanis, V; Baiocchi, RA; Sif, S				Chung, Jihyun; Karkhanis, Vrajesh; Baiocchi, Robert A.; Sif, Said			Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/beta-catenin and AKT/GSK3 beta proliferative signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein arginine N-methyltransferase 5 (PRMT5); Wnt signaling; Akt PKB; lymphoma; histone; non-Hodgkin's lymphoma; protein arginine methyltransferase 5 (PRMT5); protein kinase B (AKT); glycogen synthase kinase 3; WNT antagonists; WNT; beta-catenin signaling	AKT KINASE TARGETS; HISTONE H3; GENE; METHYLATION; EXPRESSION; INHIBITION; PATHWAY; PHOSPHORYLATION; TRANSLOCATION; ACETYLATION	Epigenetic regulation by the type II protein arginine methyltransferase, PRMT5, plays an essential role in the control of cancer cell proliferation and tumorigenesis. In this report, we investigate the relationship between PRMT5 and WNT/-CATENIN as well as AKT/GSK3 proliferative signaling in three different types of non-Hodgkin's lymphoma cell lines, clinical samples, and mouse primary lymphoma cells. We show that PRMT5 stimulates WNT/-CATENIN signaling through direct epigenetic silencing of pathway antagonists, AXIN2 and WIF1, and indirect activation of AKT/GSK3 signaling. PRMT5 inhibition with either shRNA-mediated knockdown or a specific small molecule PRMT5 inhibitor, CMP-5, not only leads to derepression of WNT antagonists and decreased levels of active phospho-AKT (Thr-450 and Ser-473) and inactive phospho-GSK3 (Ser-9) but also results in decreased transcription of WNT/-CATENIN target genes, CYCLIN D1, c-MYC, and SURVIVIN, and enhanced lymphoma cell death. Furthermore, PRMT5 inhibition leads to reduced recruitment of co-activators CBP, p300, and MLL1, as well as enhanced recruitment of co-repressors HDAC2 and LSD1 to the WNT/-CATENIN target gene promoters. These results indicate that PRMT5 governs expression of prosurvival genes by promoting WNT/-CATENIN and AKT/GSK3 proliferative signaling and that its inhibition induces lymphoma cell death, which warrants further clinical evaluation.	[Chung, Jihyun; Karkhanis, Vrajesh; Baiocchi, Robert A.] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Sif, Said] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	University System of Ohio; Ohio State University; Qatar University	Sif, S (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar.	ssif@qu.edu.qa	Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145	Leukemia and Lymphoma Society Award [MCL7001-18]; National Research Fund (a member of Qatar Foundation) [NPRP8-617-3-131]; NATIONAL CANCER INSTITUTE [P01CA214274] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Award(Leukemia and Lymphoma Society); National Research Fund (a member of Qatar Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Leukemia and Lymphoma Society Award MCL7001-18 (to R. A. B.) and National Priorities Research Program Grant NPRP8-617-3-131 from the National Research Fund (a member of Qatar Foundation) (to S. S). The authors declare that they have no conflicts of interest with the contents of this article.	Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chung JH, 2013, J BIOL CHEM, V288, P35534, DOI 10.1074/jbc.M113.510669; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin SY, 2004, ONCOL REP, V11, P341; Liu Y, 2013, FEBS LETT, V587, P847, DOI 10.1016/j.febslet.2013.02.023; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Motllo C, 2010, CANCER GENET CYTOGEN, V203, P328, DOI 10.1016/j.cancergencyto.2010.08.018; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; PEZZELLA F, 1989, LANCET, V1, P779; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shailesh Harshita, 2018, Oncotarget, V9, P36705, DOI 10.18632/oncotarget.26404; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Srivastava S, 2017, CELL CYCLE, V16, P1515, DOI 10.1080/15384101.2017.1339846; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Swerdlow SH, 2008, WHO CLASSIFICATION T, P229; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Thorvaldsen TE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170508; Torres C Hernandez, 2018, J Assoc Genet Technol, V44, P141; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang JF, 2017, AM J PATHOL, V187, P1700, DOI 10.1016/j.ajpath.2017.04.009; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang Q, 2016, MOL ENDOCRINOL, V30, P856, DOI 10.1210/me.2015-1310; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yang LH, 2013, TUMOR BIOL, V34, P749, DOI 10.1007/s13277-012-0604-z; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang P, 2015, GENE DEV, V29, P123, DOI 10.1101/gad.254870.114; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	51	44	46	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7692	7710		10.1074/jbc.RA119.007640	http://dx.doi.org/10.1074/jbc.RA119.007640			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30885941	hybrid, Green Published			2022-12-26	WOS:000470153300015
J	Ejaz, A; Goldgur, Y; Shuman, S				Ejaz, Anam; Goldgur, Yehuda; Shuman, Stewart			Activity and structure of Pseudomonas putida MPE, a manganese-dependent single-strand DNA endonuclease encoded in a nucleic acid repair gene cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; DNA repair; enzyme structure; manganese; metalloenzyme; phosphodiesterases	ESCHERICHIA-COLI; MRE11 NUCLEASE; PROTEIN; BREAK; PHOSPHODIESTERASE; RECOGNITION; INSIGHTS; HELICASE; FAMILY; LHR	A recently identified and widely prevalent prokaryal gene cluster encodes a suite of enzymes with imputed roles in nucleic acid repair. The enzymes are as follows: MPE, a DNA endonuclease; Lhr-Core, a 3-5 DNA helicase; LIG, an ATP-dependent DNA ligase; and Exo, a metallo--lactamase-family nuclease. Bacterial and archaeal MPE proteins belong to the binuclear metallophosphoesterase superfamily that includes the well-studied DNA repair nucleases Mre11 and SbcD. Here, we report that the Pseudomonas putida MPE protein is a manganese-dependent DNA endonuclease that incises either linear single strands or the single-strand loops of stem-loop DNA structures. MPE has feeble activity on duplex DNA. A crystal structure of MPE at 2.2 resolution revealed that the active site includes two octahedrally coordinated manganese ions. Seven signature amino acids of the binuclear metallophosphoesterase superfamily serve as the enzymic metal ligands in MPE: Asp(33), His(35), Asp(78), Asn(112), His(124), His(146), and His(158). A swath of positive surface potential on either side of the active site pocket suggests a binding site for the single-strand DNA substrate. The structure of MPE differs from Mre11 and SbcD in several key respects: (i) MPE is a monomer, whereas Mre11 and SbcD are homodimers; (ii) MPE lacks the capping domain present in Mre11 and SbcD; and (iii) the topology of the sandwich that comprises the core of the metallophosphoesterase fold differs in MPE vis-a-vis Mre11 and SbcD. We surmise that MPE exemplifies a novel clade of DNA endonuclease within the binuclear metallophosphoesterase superfamily.	[Ejaz, Anam; Shuman, Stewart] Sloan Kettering Inst, Mol Biol Program, New York, NY 10065 USA; [Goldgur, Yehuda] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NCI, National Institutes of Health [P30-CA008748]; NIGMS, National Institutes of Health [P41GM103403, P41GM103473, P41GM111244]; NIH-ORIP [HEI S10RR029205]; Department of Energy [DE-AC02-06CH11357, DE-AC02-98CH10886, E-SC0012704]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103403, R35GM126945] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP; Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Memorial Sloan Kettering Cancer Center structural biology core laboratory is supported by NCI, National Institutes of Health, Grant P30-CA008748. X-ray diffraction data were collected at synchrotron facilities supported by grants and contracts from NIGMS, National Institutes of Health (P41GM103403, P41GM103473, and P41GM111244), NIH-ORIP (HEI S10RR029205), and the Department of Energy (DE-AC02-06CH11357, DE-AC02-98CH10886, and E-SC0012704).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen SF, 2004, J BIOL CHEM, V279, P31854, DOI 10.1074/jbc.M401059200; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Ejaz A, 2018, J BIOL CHEM, V293, P17491, DOI 10.1074/jbc.RA118.005296; Ejaz A, 2018, NUCLEIC ACIDS RES, V46, P442, DOI 10.1093/nar/gkx1163; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Liu S, 2014, ACTA CRYSTALLOGR D, V70, P299, DOI 10.1107/S139900471302693X; Matange N, 2015, BIOCHEM J, V467, P201, DOI 10.1042/BJ20150028; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Okada C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32822; Ordonez H, 2013, J BIOL CHEM, V288, P14125, DOI 10.1074/jbc.M113.466854; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Paull TT, 2018, MOL CELL, V71, P419, DOI 10.1016/j.molcel.2018.06.033; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Seifert FU, 2015, ACTA CRYSTALLOGR F, V71, P752, DOI 10.1107/S2053230X15007566; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sung S, 2014, EMBO J, V33, P2422, DOI 10.15252/embj.201488299; Uson ML, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00304-17; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017	25	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7931	7941		10.1074/jbc.RA119.008049	http://dx.doi.org/10.1074/jbc.RA119.008049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30894417	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000470153300032
J	Atkins, JB; Reisz, RR; Maddin, HC				Atkins, Jade B.; Reisz, Robert R.; Maddin, Hillary C.			Braincase simplification and the origin of lissamphibians	PLOS ONE			English	Article							TEMNOSPONDYLI DISSOROPHOIDEA; RICHARDS SPUR; AMPHIBAMID TEMNOSPONDYLI; MORPHOLOGICAL DIVERSITY; SKELETAL DEVELOPMENT; MEXICAN AXOLOTL; EVOLUTION; SKULL; PHYLOGENY; SALAMANDER	Dissorophoidea, a group of temnospondyl tetrapods that first appear in the Late Carboniferous, is made up of two clades - Olsoniformes and Amphibamiformes (Branchiosauridae and Amphibamidae) - the latter of which is widely thought to have given rise to living amphibians (i.e., Lissamphibia). The lissamphibian braincase has a highly derived morphology with several secondarily lost elements; however, these losses have never been incorporated into phylogenetic analyses and thus the timing and nature of these evolutionary events remain unknown. Hindering research into this problem has been the lack of phylogenetic analyses of Dissorophoidea that includes both taxonomically dense sampling and specific characters to document changes in the braincase in the lineage leading to Lissamphibia. Here we build on a recent, broadly sampled dissorophoid phylogenetic analysis to visualize key events in the evolution of the lissamphibian braincase. Our ancestral character state reconstructions show a clear, step-wise trend towards reduction of braincase ossification leading to lissamphibians, including reduction of the sphenethmoid, loss of the basioccipital at the Amphibamiformes node, and further loss of both the basisphenoid and the hypoglossal nerve foramina at the Lissamphibia node. Our analysis confirms that the highly derived condition of the lissamphibian braincase is characterized by overall simplification in terms of the number and extent of chondrocranial ossifications.	[Atkins, Jade B.; Maddin, Hillary C.] Carleton Univ, Dept Earth Sci, Ottawa, ON, Canada; [Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON, Canada; [Reisz, Robert R.] Jilin Univ, Dinosaur Evolut Res Ctr, Int Ctr Future Sci, Changchun, Jilin, Peoples R China	Carleton University; University of Toronto; University Toronto Mississauga; Jilin University	Atkins, JB (corresponding author), Carleton Univ, Dept Earth Sci, Ottawa, ON, Canada.	Jade.Atkins@Carleton.ca		Atkins, Jade/0000-0002-1073-4249	province of Ontario of an Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-04633, RGPIN-2015-482696]	province of Ontario of an Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We are grateful to our funding agencies for their support of our research, including the province of Ontario for their funding of an Ontario Graduate Scholarship to JBA and to the Natural Sciences and Engineering Research Council of Canada for their funding to HCM (RGPIN-2015-04633) and RRR (RGPIN-2015-482696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson JS, 2008, J VERTEBR PALEONTOL, V28, P61, DOI 10.1671/0272-4634(2008)28[61:GCANGA]2.0.CO;2; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; [Anonymous], 2004, RECENT ADV ORIGIN EA; Ascarrunz E, 2016, CONTRIB ZOOL, V85, P201, DOI 10.1163/18759866-08502004; Augier M, 1931, TRAITE ANATOMIE HUMA, V1, P19; Benton M.J., 2014, VERTEBRATE PALAEONTO; Bolt J.R., 1979, P529; BOLT JR, 1969, SCIENCE, V166, P888, DOI 10.1126/science.166.3907.888; BOLT JR, 1977, J PALEONTOL, V51, P235; BONEBRAKE JE, 1971, J MORPHOL, V133, P189, DOI 10.1002/jmor.1051330206; Bourget H, 2011, J VERTEBR PALEONTOL, V31, P32, DOI 10.1080/02724634.2011.539652; Boy Juergen A., 2000, Amphibian Biology, V4, P1150; Brazeau MD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2210; Cardini A, 2008, BIOL J LINN SOC, V93, P813, DOI 10.1111/j.1095-8312.2008.01011.x; CARROLL RL, 1980, ZOOL J LINN SOC-LOND, V68, P1, DOI 10.1111/j.1096-3642.1980.tb01916.x; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; Clack JA, 2010, EARTH ENV SCI T R SO, V100, P275, DOI 10.1017/S1755691010009023; CLACK JA, 1988, PALAEONTOLOGY, V31, P85; COULY GF, 1993, DEVELOPMENT, V117, P409; de Beer G., 1937, DEV VERTEBRATE SKULL; Dempster WT, 1935, J COMP NEUROL, V62, P171, DOI 10.1002/cne.900620108; ESTES R, 1965, AM ZOOL, V5, P319; Ferguson CA, 2004, DEV BIOL, V269, P70, DOI 10.1016/j.ydbio.2004.01.013; Frobisch NB, 2009, SYST BIOL, V58, P312, DOI 10.1093/sysbio/syp029; Frobisch NB, 2008, J VERTEBR PALEONTOL, V28, P1015, DOI 10.1671/0272-4634-28.4.1015; Gee BM, 2018, J VERTEBR PALEONTOL, V38, DOI 10.1080/02724634.2018.1433186; Gee BM, 2018, FOSS REC, V21, P79, DOI 10.5194/fr-21-79-2018; Gee BM, 2017, PEERJ, V5, DOI 10.7717/peerj.3727; Goswami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009517; Holmes R, 2013, CR PALEVOL, V12, P419, DOI 10.1016/j.crpv.2013.07.002; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huttenlocker AK, 2007, J VERTEBR PALEONTOL, V27, P316, DOI 10.1671/0272-4634(2007)27[316:PSGESN]2.0.CO;2; Kieren S, 2018, MOL PHYLOGENET EVOL, V121, P98, DOI 10.1016/j.ympev.2018.01.006; Laurin M, 2015, PEERJ PREPRINTS; Laurin Michel, 1997, P9, DOI 10.1016/B978-012676460-4/50003-2; Lee MSY, 2006, MOL PHYLOGENET EVOL, V40, P635, DOI 10.1016/j.ympev.2006.03.013; Lukas P, 2018, J MORPHOL, V279, P62, DOI 10.1002/jmor.20754; Maddin HC, 2014, INTEGR COMP BIOL, V54, pE130; Maddin HC, 2015, ALL ANIMALS ARE INTE, P213; Maddin HC, 2013, CR PALEVOL, V12, P447, DOI 10.1016/j.crpv.2013.06.007; Maddin HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050743; Maddin HC, 2011, J MORPHOL, V272, P850, DOI 10.1002/jmor.10953; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Milner A.R., 1988, Systematics Association Special Volume Series, P59; Milner A.R., 2014, HDB PALAOHERPETOLOGI; Milner Andrew R., 1993, Herpetological Monographs, V7, P8, DOI 10.2307/1466948; Muller H, 2006, J MORPHOL, V267, P968, DOI 10.1002/jmor.10454; Pardo JD, 2017, P NATL ACAD SCI USA, V114, pE5389, DOI 10.1073/pnas.1706752114; Pardo JD, 2017, NATURE, V546, P642, DOI 10.1038/nature22966; PARKER WK, 1876, PHILOS T ROY SOC LON, V166, P601; Pereyra MO, 2016, SCI REP-UK, V6, DOI 10.1038/srep34130; Perez-Ben CM, 2018, PALEOBIOLOGY, V44, P58, DOI 10.1017/pab.2017.22; Piekarski N, 2007, EVOL DEV, V9, P566, DOI 10.1111/j.1525-142X.2007.00197.x; Piekarski N, 2014, J MORPHOL, V275, P141, DOI 10.1002/jmor.20204; Polley BP, 2011, ZOOL J LINN SOC-LOND, V161, P789, DOI 10.1111/j.1096-3642.2010.00668.x; Rage JC, 1982, GEOBIOS, V15, P65; Rambaut A, 2014, TRACER, V1; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Romer A.S., 1962, VERTEBRATE BODY; Romer AS, 1942, J COMP NEUROL, V77, P355, DOI 10.1002/cne.900770203; Romer AS, 1942, J GEOL, V50, P925, DOI 10.1086/625101; ROMER AS, 1946, AM J SCI, V244, P149, DOI 10.2475/ajs.244.3.149; Romer AS, 1977, VERTEBRATE BODY, V5th; Rose Christopher S., 2003, Amphibian Biology, V5, P1684; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Samuels ME, 2017, PEERJ, V5, DOI 10.7717/peerj.3103; Sasson DA, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1071-3; Schoch RR, 2014, J EXP ZOOL PART B, V322, P619, DOI [10.1002/jez.b.22599, 10.1002/.22599]; Schoch RR, 2013, J SYST PALAEONTOL, V11, P673, DOI 10.1080/14772019.2012.699006; Schoch RR, 2013, HIST BIOL, V25, P155, DOI 10.1080/08912963.2012.724796; Schoch RR, 2012, FOSS REC, V15, P121, DOI 10.1002/mmng.201200010; Schoch RR, 2008, J SYST PALAEONTOL, V6, P409, DOI 10.1017/S1477201908002460; Schoch RR, 2005, J VERTEBR PALEONTOL, V25, P502, DOI 10.1671/0272-4634(2005)025[0502:TAMFTL]2.0.CO;2; Schoch RR, 2002, PALAEONTOLOGY, V45, P627, DOI 10.1111/1475-4983.00252; Schoch RR, 1999, NEUES JAHRB GEOL P-A, V213, P289, DOI 10.1127/njgpa/213/1999/289; Schoch RR, 2017, ACTA ZOOLOGICA, DOI [10.1111/azo.12164, DOI 10.1111/AZO.12164]; Scholz R W, 2018, J IND ECOL, P1; Sigurdsen T, 2010, J VERTEBR PALEONTOL, V30, P1360, DOI 10.1080/02724634.2010.501445; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TRUEB L, 1992, J MORPHOL, V214, P1, DOI 10.1002/jmor.1052140102; Trueb L., 1991, P223; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; WAKE MH, 1982, J MORPHOL, V173, P203, DOI 10.1002/jmor.1051730208; Witzmann F, 2006, J VERTEBR PALEONTOL, V26, P7, DOI 10.1671/0272-4634(2006)26[7:DPAOSI]2.0.CO;2; Witzmann F, 2012, PALAEONTOLOGY, V55, P31, DOI 10.1111/j.1475-4983.2011.01116.x	89	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213694	10.1371/journal.pone.0213694	http://dx.doi.org/10.1371/journal.pone.0213694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901341	Green Published, gold			2022-12-26	WOS:000462000400016
J	Rochet, E; Argy, N; Greigert, V; Brunet, J; Sabou, M; Marcellin, L; de-la-Torre, A; Sauer, A; Candolfi, E; Pfaff, AW				Rochet, Elise; Argy, Nicolas; Greigert, Valentin; Brunet, Julie; Sabou, Marcela; Marcellin, Luc; de-la-Torre, Alejandra; Sauer, Arnaud; Candolfi, Ermanno; Pfaff, Alexander W.			Type I ROP16 regulates retinal inflammatory responses during ocular toxoplasmosis	PLOS ONE			English	Article							IMMUNE PRIVILEGE; GONDII; ACTIVATION; RESISTANCE; INFECTION; STRAINS; MODEL; IL-12	Ocular toxoplasmosis (OT), mostly retinochorioditis, is a major feature of infection with the protozoan parasite Toxoplasma gondii. The pathophysiology of this infection is still largely elusive; especially mouse models are not yet well developed. In contrast, numerous in vitro studies showed the highly Toxoplasma strain dependent nature of the host-parasite interactions. Some distinct polymorphic virulence factors were characterized, notably the rhoptry protein ROP16. Here, we studied the strain-dependent pathophysiology in our OT mouse model. Besides of two wild type strains of the canonical I (RH, virulent) and II (PRU, avirulent) types, we used genetically engineered parasites, RH.ROP16 and PRU ROP16-I, expressing the type I allele of this virulence factor. We analyzed retinal integrity, parasite proliferation and retinal expression of cytokines. PRU parasites behaved much more virulently in the presence of a type I ROP16. In contrast, knockout of ROP16 in the RH strain led to a decrease of intraocular proliferation, but no difference in retinal pathology. Cytokine quantification in aqueous humor showed strong production of Th1 and inflammatory markers following infection with the two strains containing the ROP16-I allele. In strong contrast, immunofluorescence images showed that actual expression of most cytokines in retinal cells is rapidly suppressed by type I strain infection, with or without the involvement of its homologous ROP16 allele. This demonstrates the particular immune privileged situation of the retina, which is also revealed by the fact that parasite proliferation is nearly exclusively observed outside the retina. In summary, we further developed a promising OT mouse model and demonstrated the specific pathology in retinal tissues.	[Rochet, Elise; Argy, Nicolas; Greigert, Valentin; Brunet, Julie; Sabou, Marcela; de-la-Torre, Alejandra; Candolfi, Ermanno; Pfaff, Alexander W.] Univ Strasbourg, Inst Parasitol & Pathol Trop, EA, Federat Med Translat, Strasbourg, France; [Brunet, Julie; Sabou, Marcela; Candolfi, Ermanno; Pfaff, Alexander W.] Hop Univ Strasbourg, Ctr Natl Reference Toxoplasmose, Serv Parasitol & Mycol Med, Pole Serol, Strasbourg, France; [Marcellin, Luc] Hop Univ Strasbourg, Serv Pathol, Strasbourg, France; [de-la-Torre, Alejandra] Univ Rosario, Escuela Med & Ciencias Salud, Grp NeURos, Unidad Inmunol, Bogota, Colombia; [Sauer, Arnaud] Hop Univ Strasbourg, Serv Ophtalmol, Strasbourg, France; [Rochet, Elise] Flinders Univ S Australia, Ctr Ophthalmol Eye & Vis Res, Adelaide, SA, Australia; [Argy, Nicolas] Hop Bichat Claude Bernard, Serv Parasitol, Paris, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidad del Rosario; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Flinders University South Australia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Pfaff, AW (corresponding author), Univ Strasbourg, Inst Parasitol & Pathol Trop, EA, Federat Med Translat, Strasbourg, France.; Pfaff, AW (corresponding author), Hop Univ Strasbourg, Ctr Natl Reference Toxoplasmose, Serv Parasitol & Mycol Med, Pole Serol, Strasbourg, France.	pfaff@unistra.fr	Greigert, Valentin/J-6087-2019; de-la-Torre, Alejandra/G-6436-2016	Greigert, Valentin/0000-0002-0975-1949; de-la-Torre, Alejandra/0000-0003-0684-1989; Argy, Nicolas/0000-0002-0458-2664; Pfaff, Alexander/0000-0003-3482-1803	Fondation de Recherche Medicale (Retinal Physiopathology program); Universitede Strasbourg; Hopitaux Universitaires de Strasbourg; Fondation de France [12165, 2012-32622]	Fondation de Recherche Medicale (Retinal Physiopathology program); Universitede Strasbourg; Hopitaux Universitaires de Strasbourg; Fondation de France(Fondation de France)	Our work has been supported by the Fondation de Recherche Medicale (Retinal Physiopathology program), Universitede Strasbourg, and Hopitaux Universitaires de Strasbourg. E.R. received a Berthe Fouassier Ph.D. scholarship from the Fondation de France (www.fondationdefrance.org, grants no. 12165 and 2012-32622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0620-5; Alvarez C, 2015, J INFECT DIS, V211, P2006, DOI 10.1093/infdis/jiu833; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; de-la-Torre A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002541; Delair E, 2008, AM J OPHTHALMOL, V146, P851, DOI 10.1016/j.ajo.2008.06.027; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Jensen KDC, 2013, INFECT IMMUN, V81, P2156, DOI 10.1128/IAI.01185-12; Khan A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000404; Lahmar I, 2014, EXP PARASITOL, V144, P22, DOI 10.1016/j.exppara.2014.06.006; Lahmar I, 2010, EXP PARASITOL, V124, P190, DOI 10.1016/j.exppara.2009.09.010; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Nagineni CN, 1996, INFECT IMMUN, V64, P4188, DOI 10.1128/IAI.64.10.4188-4196.1996; Park CY, 2010, OCUL IMMUNOL INFLAMM, V18, P24, DOI 10.3109/09273940903326203; Pfaff AW, 2014, INT J PARASITOL, V44, P99, DOI 10.1016/j.ijpara.2013.09.007; Rochet E, 2015, INFECT IMMUN, V83, P2109, DOI 10.1128/IAI.02985-14; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sauer A, 2009, J FR OPHTALMOL, V32, P742, DOI 10.1016/j.jfo.2009.10.007; Sauer A, 2012, J INFECT DIS, V206, P1319, DOI 10.1093/infdis/jis486; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Song HB, 2018, PARASITOL RES, V117, P2597, DOI 10.1007/s00436-018-5950-3; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; STREILEIN JW, 1993, CURR OPIN IMMUNOL, V5, P428, DOI 10.1016/0952-7915(93)90064-Y; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214310	10.1371/journal.pone.0214310	http://dx.doi.org/10.1371/journal.pone.0214310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901349	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400048
J	de Kort, EA; de Lil, HS; Bremmers, MEJ; van Groningen, LFJ; Blijlevens, NMA; Huls, G; Bruggemann, RJM; van Dorp, S; van der Velden, WJFM				de Kort, Elizabeth A.; de Lil, Heleen S.; Bremmers, Manita E. J.; van Groningen, Lenneke F. J.; Blijlevens, Nicole M. A.; Huls, Gerwin; Bruggemann, Roger J. M.; van Dorp, Suzanne; van der Velden, Walter J. F. M.			Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; MARROW TRANSPLANTATION; CLINICAL-TRIALS; TOTAL-BODY; RISK; TACROLIMUS; RECIPIENTS; RELAPSE; BLOOD	Low plasma CsA concentrations (<300-350 ng/mL) early following allogeneic hematopoietic stem cell transplantation (HSCT) is associated with an increased risk of developing acute graft-versus-host disease (aGvHD). Nevertheless, the current optimal target trough concentration for CsA following HSCT is considered to be 200-400 ng/mL. Here, we performed a retrospective analysis of a homogeneous group of 129 patients who received HSCT after non-myeloablative conditioning, and we analyzed the impact of CsA trough concentration measured during the first four weeks (CsA W1-4) on the incidence aGvHD, relapse-free survival (RFS), non-relapse mortality (NRM), overall survival (OS), and toxicity. The 180-day incidence of grade II-IV aGvHD was 25% (32/129 patients). In multivariate analysis the incidence of grade II-IV aGvHD was significantly lower among patients with a CsA W1-4 concentration >= 350 ng/mL compared to patients with a concentration <350 ng/mL (18% versus 38%, respectively; P = 0.007), with a hazard ration (HR) of 0.38 (95% CI: 0.19-0.77). In contrast, we found no correlation between CsA trough concentration and RFS, NRM, or OS. Moreover, we found an increased incidence of hypomagnesemia at higher CsA concentrations, but no difference in the incidence of acute renal toxicity, hepatic toxicity, or electrolyte imbalance. Interestingly, 30% of patients experienced hyponatremia with no apparent cause other than the use of CsA, with urinalysis suggesting SIADH as the underlying cause. Our findings suggest that a CsA trough concentration of 350-500 ng/mL might be more appropriate in the first month following non-myeloablative HSCT.	[de Kort, Elizabeth A.; de Lil, Heleen S.; Bremmers, Manita E. J.; van Groningen, Lenneke F. J.; Blijlevens, Nicole M. A.; van Dorp, Suzanne; van der Velden, Walter J. F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands; [Huls, Gerwin] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands; [Bruggemann, Roger J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands	Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen	van der Velden, WJFM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands.	Walter.vanderVelden@radboudumc.nl	Bruggemann, Roger JM/A-7057-2015; de Kort, Elizabeth/U-1380-2019	Bruggemann, Roger JM/0000-0002-7618-725X; de Kort, Elizabeth/0000-0003-0125-9543				Afessa B, 2006, SEMIN RESP CRIT CARE, V27, P297, DOI 10.1055/s-2006-945530; Arai Y, 2013, INTERNAL MED, V52, P1223, DOI 10.2169/internalmedicine.52.0019; Armand P, 2012, BLOOD, V120, P905, DOI 10.1182/blood-2012-03-418202; Atkinson K, 1990, TRANSPL P, P22; BACIGALUPO A, 1991, BLOOD, V77, P1423; BARTON CH, 1987, AM J MED, V83, P693, DOI 10.1016/0002-9343(87)90900-4; BENNETT WM, 1991, TRANSPLANTATION, V51, P730, DOI 10.1097/00007890-199103000-00037; BENNETT WM, 1983, ANN INTERN MED, V99, P851, DOI 10.7326/0003-4819-99-6-851; Choi SW, 2014, NAT REV CLIN ONCOL, V11, P536, DOI 10.1038/nrclinonc.2014.102; Cruijsen M, 2016, BIOL BLOOD MARROW TR, V22, P1000, DOI 10.1016/j.bbmt.2016.02.003; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Ganetsky A, 2016, BONE MARROW TRANSPL, V51, P568, DOI 10.1038/bmt.2015.323; Gratwohl A, 2012, BONE MARROW TRANSPL, V47, P749, DOI 10.1038/bmt.2011.110; Harris AC, 2016, BIOL BLOOD MARROW TR, V22, P4, DOI 10.1016/j.bbmt.2015.09.001; Hegenbart U, 2006, J CLIN ONCOL, V24, P444, DOI 10.1200/JCO.2005.03.1765; Higgins R, 2004, NEPHROL DIAL TRANSPL, V19, P444, DOI 10.1093/ndt/gfg515; Hogan WJ, 2004, BLOOD, V103, P78, DOI 10.1182/blood-2003-04-1311; Holtan SG, 2015, BLOOD, V125, P1333, DOI 10.1182/blood-2014-10-609032; Iacobelli S, 2013, BONE MARROW TRANSPL, V48, pS1, DOI 10.1038/bmt.2012.282; Jagasia MH, 2015, BIOL BLOOD MARROW TR, V21, P389, DOI 10.1016/j.bbmt.2014.12.001; Malard F, 2010, BIOL BLOOD MARROW TR, V16, P28, DOI 10.1016/j.bbmt.2009.08.010; McDonald GB, 2010, HEPATOLOGY, V51, P1450, DOI 10.1002/hep.23533; MORRIS RG, 1994, THER DRUG MONIT, V16, P570, DOI 10.1097/00007691-199412000-00007; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Niederwieser D, 2003, BLOOD, V101, P1620, DOI 10.1182/blood-2002-05-1340; PRZEPIORKA D, 1991, BONE MARROW TRANSPL, V7, P461; Ram R, 2012, BIOL BLOOD MARROW TR, V18, P414, DOI 10.1016/j.bbmt.2011.08.016; Rashidi A, 2018, BONE MARROW TRANSPL, V53, P111, DOI 10.1038/bmt.2017.227; RODIGHIERO V, 1989, CLIN PHARMACOKINET, V16, P27, DOI 10.2165/00003088-198916010-00002; Rogosheske JR, 2014, BONE MARROW TRANSPL, V49, P122, DOI 10.1038/bmt.2013.139; Ruutu T, 2014, BONE MARROW TRANSPL, V49, P168, DOI 10.1038/bmt.2013.107; Saburi M, 2017, INT J HEMATOL, V106, P431, DOI 10.1007/s12185-017-2253-x; SHAW LM, 1990, CLIN CHEM, V36, P1841; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Sorror ML, 2011, JAMA-J AM MED ASSOC, V306, P1874, DOI 10.1001/jama.2011.1558; Storb R, 2013, J CLIN ONCOL, V31, P1530, DOI 10.1200/JCO.2012.45.0247; Storb R, 2013, BIOL BLOOD MARROW TR, V19, P792, DOI 10.1016/j.bbmt.2013.02.006; Suemori K, 2011, MOD RHEUMATOL, V21, P97, DOI 10.1007/s10165-010-0350-2; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; YEE GC, 1988, NEW ENGL J MED, V319, P65, DOI 10.1056/NEJM198807143190201; Zeiser R, 2017, NEW ENGL J MED, V377, P2167, DOI 10.1056/NEJMra1609337	41	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213913	10.1371/journal.pone.0213913	http://dx.doi.org/10.1371/journal.pone.0213913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897127	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700045
J	Li, PF; Boenzli, E; Hofmann-Lehmann, R; Helfer-Hungerbuehler, AK				Li, Pengfei; Boenzli, Eva; Hofmann-Lehmann, Regina; Helfer-Hungerbuehler, A. Katrin			Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; AAV VECTORS; IMMUNE-RESPONSES; FACTOR-IX; PHASE-I; HUMORAL IMMUNITY; ANIMAL-MODELS; LIVER; SAFETY; TRANSDUCTION	Adeno-associated virus (AAV) vectors represent promising candidates for gene therapy; however, pre-existing neutralizing antibodies (NAb) may reduce AAV vector delivery efficiency. In this study, the presence of AAV NAb was investigated in cats, which serve as a larger and outbred animal model for the prediction of gene therapy outcomes in humans but also in cats. Serum/plasma samples from 230 client-owned Swiss cats and 20 specified pathogen-free cats were investigated for NAb to AAV1, AAV2, AAV5, AAV6, AAV7, AAV8 and AAV9 using in vitro transduction inhibition and a beta-galactosidase assay. NAb to all tested AAV serotypes were found. Of the client-owned cats, 53% had NAb to one or more of the AAV serotypes. NAb (>= 1:10) were found at frequencies of 5% (AAV6) to 28% (AAV7). The highest titers were found against AAV7 (>= 1:160). The NAb prevalence to AAV2, AAV7 and AAV9 differed geographically. Regarding titers >= 1:10 against single AAV serotypes, age, breed and sex of the cats were not associated with the NAb prevalence. Cats with titers >= 1:20 against AAV2 and titers >= 1:40 against AAV7 were significantly younger than cats with low/no titers, and purebred cats were significantly more likely than non-purebred cats to have NAb to AAV2 (>= 1:40). Additionally, regarding NAb to all AAV combined, female cats were significantly more likely than male cats to have NAb titers >= 1:40. Preliminary data using AAV-DJ indicated that less pre-existing NAb to the hybrid AAV-DJ can be expected compared to the wild-type AAV serotypes. AAV NAb will need to be taken into account for future in vivo gene therapy studies in cats.	[Boenzli, Eva; Hofmann-Lehmann, Regina; Helfer-Hungerbuehler, A. Katrin] Univ Zurich, Vetsuisse Fac, Clin Lab, Zurich, Switzerland; [Boenzli, Eva; Hofmann-Lehmann, Regina; Helfer-Hungerbuehler, A. Katrin] Univ Zurich, Vetsuisse Fac, Ctr Clin Studies, Dept Clin Diagnost & Serv, Zurich, Switzerland; [Li, Pengfei] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Helfer-Hungerbuehler, AK (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Lab, Zurich, Switzerland.	khungerbuehler@vetclinics.uzh.ch	Hofmann-Lehmann, Regina/C-6528-2009	Hofmann-Lehmann, Regina/0000-0001-9750-4296	Swiss National Science Foundation [310030_166198]; China Scholarship Council [201608420107]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); China Scholarship Council(China Scholarship Council)	This work was supported by Swiss National Science Foundation (310030_166198) to RH, China Scholarship Council (No. 201608420107) to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1985, AM J PATHOL, V121, P531; [Anonymous], 2018, MED LETT DRUGS THER, V60, P53; Arbetman AE, 2005, J VIROL, V79, P15238, DOI 10.1128/JVI.79.24.15238-15245.2005; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bello A, 2009, GENE THER, V16, P1320, DOI 10.1038/gt.2009.82; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Bienzle D, 2014, VET IMMUNOL IMMUNOP, V159, P171, DOI 10.1016/j.vetimm.2014.02.014; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Bradbury AM, 2017, NEUROSCIENCE, V340, P117, DOI 10.1016/j.neuroscience.2016.10.047; Bradbury AM, 2015, HUM GENE THER CL DEV, V26, P27, DOI 10.1089/humc.2015.002; Buning H, 2013, EMBO MOL MED, V5, P1, DOI 10.1002/emmm.201202291; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Calcedo R, 2015, HUM GENE THER METHOD, V26, P103, DOI 10.1089/hgtb.2015.082; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Calcedo R, 2011, CLIN VACCINE IMMUNOL, V18, P1586, DOI 10.1128/CVI.05107-11; Cattori V, 2008, VET IMMUNOL IMMUNOP, V123, P124, DOI 10.1016/j.vetimm.2008.01.018; Chambers JK, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0258-3; Cotugno G, 2011, MOL THER, V19, P461, DOI 10.1038/mt.2010.257; Cunningham SC, 2009, MOL THER, V17, P1340, DOI 10.1038/mt.2009.88; D'Costa S, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.19; Dissen GA, 2017, REPROD DOMEST ANIM, V52, P354, DOI 10.1111/rda.12834; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Ferla R, 2013, HUM GENE THER, V24, P163, DOI 10.1089/hum.2012.179; Gremiao IDF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006077; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; Gao GP, 2003, P NATL ACAD SCI USA, V100, P6081, DOI 10.1073/pnas.0937739100; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2009, HUM GENE THER, V20, P930, DOI 10.1089/hum.2009.060; Geret CP, 2011, SCHWEIZ ARCH TIERH, V153, P157, DOI 10.1024/0036-7281/a000175; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hoenig Margarethe, 2012, J Diabetes Sci Technol, V6, P525; Hofmann-Lehmann R, 1998, VET IMMUNOL IMMUNOP, V65, P151, DOI 10.1016/S0165-2427(98)00150-0; Hurlbut GD, 2010, MOL THER, V18, P1983, DOI 10.1038/mt.2010.175; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kotterman MA, 2015, GENE THER, V22, P116, DOI 10.1038/gt.2014.115; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuranda K, 2018, J CLIN INVEST, V128, P5267, DOI 10.1172/JCI122372; Lerch TF, 2012, STRUCTURE, V20, P1310, DOI 10.1016/j.str.2012.05.004; Liu Q, 2013, J MED VIROL, V85, P1550, DOI 10.1002/jmv.23647; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Masat E, 2013, DISCOV MED, V15, P379; Menotti-Raymond M, 2010, INVEST OPHTH VIS SCI, V51, P2852, DOI 10.1167/iovs.09-4261; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Moskalenko M, 2000, J VIROL, V74, P1761, DOI 10.1128/JVI.74.4.1761-1766.2000; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nieto K, 2012, HUM GENE THER, V23, P733, DOI 10.1089/hum.2011.202; Palomeque J, 2007, GENE THER, V14, P989, DOI 10.1038/sj.gt.3302895; Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177; Saraiva J, 2016, J CONTROL RELEASE, V241, P94, DOI 10.1016/j.jconrel.2016.09.011; Scallan CD, 2006, BLOOD, V107, P1810, DOI 10.1182/blood-2005-08-3229; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Shin JH, 2012, HUM GENE THER, V23, P287, DOI 10.1089/hum.2011.125; Snyder RO, 1997, NAT GENET, V16, P270, DOI 10.1038/ng0797-270; Supsavhad W, 2016, VET J, V210, P7, DOI 10.1016/j.tvjl.2015.11.006; Vandamme C, 2017, HUM GENE THER, V28, P1061, DOI 10.1089/hum.2017.150; Wang LL, 2011, HUM GENE THER, V22, P1389, DOI 10.1089/hum.2011.031; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang M, 2015, GENE THER, V22, P984, DOI 10.1038/gt.2015.69; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Xiao WD, 1999, J VIROL, V73, P3994, DOI 10.1128/JVI.73.5.3994-4003.1999	68	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0212811	10.1371/journal.pone.0212811	http://dx.doi.org/10.1371/journal.pone.0212811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897117	gold, Green Published, Green Accepted			2022-12-26	WOS:000461889700012
J	Kim, EK; Park, HYL; Park, CK				Kim, Eun Kyoung; Park, Hae-Young Lopilly; Park, Chan Kee			Posterior scleral deformations around optic disc are associated with visual field damage in open-angle glaucoma patients with myopia	PLOS ONE			English	Article							PARAPAPILLARY CHORIORETINAL ATROPHY; PERIPAPILLARY ATROPHY; NERVE HEAD; TORSION; EYES; PROGRESSION; LOCATION; DEFECTS; TILT	Purpose To identify important variables associated with visual field (VF) defects in open-angle glaucoma (OAG) with myopia. Materials and methods A total of 105 OAG with myopia were enrolled in this cross-sectional study. The disc tilt ratio, disc torsion degree, disc-foveal angle, and area of peripapillary atrophy (PPA) were measured from red-free fundus photographs. Patients underwent Swept-source optical coherence tomography to measure peripapillary retinal nerve fiber layer (RNFL), subfoveal choroidal, and sufoveal scleral thicknesses. Functional evaluation was performed using 24-2 standard automated perimetry. For statistical analyses, logistic regression, artificial neural networks (ANN), and hierarchical cluster analysis were performed. Results Logistic regression demonstrated peripapillary RNFL thickness as a significant variable for the presence of VF defects, otherwise ANN identified PPA area, peripapillary RNFL thickness, disc-foveal angle, and disc torsion degree as significant clinical variables in OAG with myopia. Two clusters were made after a hierarchical cluster analysis. Cluster 2 showed significantly worse VF damage than cluster 1 (MD = -5.20 +/- 5.25 dB for cluster 2 and -1.84 +/- 3.02 dB for cluster 1, P < .001). Cluster 2 had significantly greater disc tilt ratio, disc-foveal angle, and PPA area compared with cluster 1 (P < .001, 0.005, and < .001, respectively). Conclusions Generally peripapillary RNFL thickness is considered as an important variable associated with visual field defects in glaucoma patients. ANN identified parameters associated with posterior scleral deformations around optic disc induced by myopic change including PPA area, disc torsion degree, and disc-foveal angle as significant clinical variables for visual field damage in OAG with myopia.	[Kim, Eun Kyoung; Park, Hae-Young Lopilly; Park, Chan Kee] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Kim, Eun Kyoung; Park, Hae-Young Lopilly; Park, Chan Kee] Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.; Park, CK (corresponding author), Seoul St Marys Hosp, Seoul, South Korea.	ckpark@catholic.ac.kr						Biglarian A, 2010, ASIAN PAC J CANCER P, V11, P533; Choi JA, 2015, ACTA OPHTHALMOL, V93, pE94, DOI 10.1111/aos.12492; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P4991, DOI 10.1167/iovs.14-14663; FONG DS, 1990, INT OPHTHALMOL CLIN, V30, P215, DOI 10.1097/00004397-199030030-00009; Goldbaum MH, 2012, INVEST OPHTH VIS SCI, V53, P6557, DOI 10.1167/iovs.11-8363; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P919; Jonas JB, 2005, EUR J OPHTHALMOL, V15, P41, DOI 10.1177/112067210501500107; Jonas Jost B, 2005, Curr Opin Ophthalmol, V16, P84, DOI 10.1097/01.icu.0000156135.20570.30; Kim SY, 2012, INVEST OPHTH VIS SCI, V53, P4475, DOI 10.1167/iovs.12-9682; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Lee EJ, 2011, INVEST OPHTH VIS SCI, V52, P4422, DOI 10.1167/iovs.10-6818; Lee KS, 2014, OPHTHALMOLOGY, V121, P1013, DOI 10.1016/j.ophtha.2013.11.014; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nitta K, 2017, CLIN OPHTHALMOL, V11, P1, DOI 10.2147/OPTH.S131370; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P156, DOI 10.1167/iovs.13-12327; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Park HYL, 2018, AM J OPHTHALMOL, V192, P206, DOI 10.1016/j.ajo.2018.05.027; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P4927, DOI 10.1167/iovs.14-15819; Park HYL, 2014, AM J OPHTHALMOL, V157, P550, DOI 10.1016/j.ajo.2013.11.008; Spiegelhalter D., 2002, BAYESIAN APPROACHES; Tanaka K., 1997, INTRO FUZZY LOGIC PR; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Tezel G, 1997, ARCH OPHTHALMOL-CHIC, V115, P1509, DOI 10.1001/archopht.1997.01100160679003; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Yasuzumi K, 2003, BRIT J OPHTHALMOL, V87, P1088, DOI 10.1136/bjo.87.9.1088; Yoshino T, 2016, JPN J OPHTHALMOL, V60, P78, DOI 10.1007/s10384-016-0427-3	29	5	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213714	10.1371/journal.pone.0213714	http://dx.doi.org/10.1371/journal.pone.0213714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875403	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400024
J	Ziats, CA; Grosvenor, LP; Sarasua, SM; Thurm, AE; Swedo, SE; Mahfouz, A; Rennert, OM; Ziats, MN				Ziats, Catherine A.; Grosvenor, Luke P.; Sarasua, Sara M.; Thurm, Audrey E.; Swedo, Susan E.; Mahfouz, Ahmed; Rennert, Owen M.; Ziats, Mark N.			Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment	PLOS ONE			English	Article							DELETION SYNDROME; MOLECULAR CHARACTERIZATION; SHANK3 GENE; AUTISM; BRAIN; MUTATIONS; PHENOTYPE; IDENTIFICATION; TRANSCRIPTOME; HIPPOCAMPUS	Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder characterized by varying degrees of intellectual disability, severely delayed language development and specific facial features, and is caused by a deletion within chromosome 22q13.3. SHANK3, which is located at the terminal end of this region, has been repeatedly implicated in other neurodevelopmental disorders and deletion of this gene specifically is thought to cause much of the neurologic symptoms characteristic of PMS. However, it is still unclear to what extent SHANK3 deletions contribute to the PMS phenotype, and what other genes nearby are causal to the neurologic disease. In an effort to better understand the functional landscape of the PMS region during normal neurodevelopment, we assessed RNA-sequencing (RNA-seq) expression data collected from post-mortem brain tissue from developmentally normal subjects over the course of prenatal to adolescent age and analyzed expression changes of 65 genes on 22q13. We found that the majority of genes within this region were expressed in the brain, with ATNX10, MLC1, MAPK8IP2, and SULT4A1 having the highest overall expression. Analysis of the temporal profiles of the highest expressed genes revealed a trend towards peak expression during the early post-natal period, followed by a drop in expression later in development. Spatial analysis revealed significant region specific differences in the expression of SHANK3, MAPK8IP2, and SULT4A1. Region specific expression over time revealed a consistently unique gene expression profile within the cerebellum, providing evidence for a distinct developmental program within this region. Exon-specific expression of SHANK3 showed higher expression within exons contributing to known brain specific functional isoforms. Overall, we provide an updated roadmap of the PMS region, implicating several genes and time periods as important during neurodevelopment, with the hope that this information can help us better understand the phenotypic heterogeneity of PMS.	[Ziats, Catherine A.; Rennert, Owen M.; Ziats, Mark N.] NICHHD, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Grosvenor, Luke P.; Thurm, Audrey E.; Swedo, Susan E.; Rennert, Owen M.] NIMH, Pediat & Dev Neurosci Branch, NIH, Bethesda, MD 20892 USA; [Grosvenor, Luke P.] Simons Fdn Autism Res Initiat, New York, NY USA; [Sarasua, Sara M.] Clemson Univ, Sch Nursing, Clemson, SC USA; [Mahfouz, Ahmed] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Ziats, Mark N.] Michigan Med, Dept Internal Med, Ann Arbor, MI USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Clemson University; Delft University of Technology	Ziats, CA (corresponding author), NICHHD, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	caedmonson@gmail.com	Rennert, owen/AAI-7374-2020; Mahfouz, Ahmed/ABC-4161-2020	Mahfouz, Ahmed/0000-0001-8601-2149	Intramural Research Programs of the National Institute of Child Health and Human Development, NIH; National Institute of Mental Health, NIH; Baylor College of Medicine MSTP grant; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002961] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Child Health and Human Development, NIH; National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Baylor College of Medicine MSTP grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Research Programs of the National Institute of Child Health and Human Development, NIH and the National Institute of Mental Health, NIH. MNZ was supported by the Baylor College of Medicine MSTP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Intramural Research Programs of the National Institute of Child Health and Human Development, NIH and the National Institute of Mental Health, NIH. MNZ was also supported by the Baylor College of Medicine MSTP grant. The funders had no role in this work or the decision to publish. The authors declare no conflicts of interest.	Alexandrov PN, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00670; Allen Institute for Brain Science, 2010, BRAINSPAN ATL DEV HU; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Cogill SB, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0639-x; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cortabitarte AD, 2017, AM J MED GENET B, V174, P390, DOI 10.1002/ajmg.b.32528; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Cusmano-Ozog K, 2007, AM J MED GENET C, V145C, P393, DOI 10.1002/ajmg.c.30155; De Rubeis S, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0205-9; Dhar SU, 2010, AM J MED GENET A, V152A, P573, DOI 10.1002/ajmg.a.33253; Disciglio V, 2014, AM J MED GENET A, V164, P1666, DOI 10.1002/ajmg.a.36513; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Fujita Y, 2000, AM J MED GENET, V92, P195; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Giza J, 2010, J NEUROSCI, V30, P14805, DOI 10.1523/JNEUROSCI.1161-10.2010; Greenfield J G, 1933, Proc R Soc Med, V26, P690; Ha JF, 2017, INT J PEDIATR OTORHI, V95, P121, DOI 10.1016/j.ijporl.2016.12.008; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamilton EMC, 2018, NEUROLOGY, V90, pE1395, DOI 10.1212/WNL.0000000000005334; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Jeffries AR, 2005, AM J MED GENET A, V137A, P139, DOI 10.1002/ajmg.a.30780; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kouser M, 2013, J NEUROSCI, V33, P18448, DOI 10.1523/JNEUROSCI.3017-13.2013; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Luciani JJ, 2003, J MED GENET, V40, P690, DOI 10.1136/jmg.40.9.690; Macedoni-Luksic M, 2013, GENE, V524, P386, DOI 10.1016/j.gene.2013.03.141; Mahfouz A, 2015, J MOL NEUROSCI, V57, P580, DOI 10.1007/s12031-015-0641-3; Mitz AR, 2018, EUR J HUM GENET, V26, P293, DOI 10.1038/s41431-017-0042-x; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munson J, 2006, ARCH GEN PSYCHIAT, V63, P686, DOI 10.1001/archpsyc.63.6.686; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Palumbo P, 2018, AM J MED GENET A, V176, P391, DOI 10.1002/ajmg.a.38559; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260; Phelan K, 2015, AM J MED GENET A, V167, P1679, DOI 10.1002/ajmg.a.36788; Phelan MC, 2010, MANAGEMENT GENETIC S, p285e97; Reierson G, 2017, J PSYCHIATR RES, V91, P139, DOI 10.1016/j.jpsychires.2017.03.010; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Sarasua SM, 2014, HUM GENET, V133, P847, DOI 10.1007/s00439-014-1423-7; Sarasua SM, 2014, GENET MED, V16, P318, DOI 10.1038/gim.2013.144; Sarasua SM, 2011, J MED GENET, V48, P761, DOI 10.1136/jmedgenet-2011-100225; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Tabet AC, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0035-2; Wilson HL, 2008, EUR J HUM GENET, V16, P1301, DOI 10.1038/ejhg.2008.107; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zwanenburg RJ, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9150-0	55	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213921	10.1371/journal.pone.0213921	http://dx.doi.org/10.1371/journal.pone.0213921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875393	gold, Green Published, Green Submitted			2022-12-26	WOS:000461316400039
J	Laing, AG; Fanelli, G; Ramirez-Valdez, A; Lechler, RI; Lombardi, G; Sharpe, PT				Laing, Adam G.; Fanelli, Giorgia; Ramirez-Valdez, Andrei; Lechler, Robert I.; Lombardi, Giovanna; Sharpe, Paul T.			Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; INDOLEAMINE 2,3-DIOXYGENASE; NITRIC-OXIDE; LYMPHOCYTE-PROLIFERATION; IFN-GAMMA; KINASE; MODULATION; ACTIVATION; RESPONSES; DISEASE	The physiological role of mesenchymal stem cells (MSCs) is to provide a source of cells to replace mesenchymal-derivatives in stromal tissues with high cell turnover or following stromal tissue damage to elicit repair. Human MSCs have been shown to suppress in vitro T-cell responses via a number of mechanisms including indoleamine 2,3-dioxygenase (IDO). This immunomodulatory capacity is likely to be related to their in vivo function in tissue repair where local, transient suppression of immune responses would benefit differentiation. Further understanding of the impact of locally modulated immune responses by MSCs is hampered by evidence that IDO is not produced or utilized by mouse MSCs. In this study, we demonstrate that IDO-mediated tryptophan starvation triggered by human MSCs inhibits T-cell activation and proliferation through induction of cellular stress. Significantly, we show that despite utilizing different means, immunomodulation of murine T-cells also involves cellular stress and thus is a common strategy of immunoregulation conserved between mouse and humans.	[Laing, Adam G.; Fanelli, Giorgia; Lechler, Robert I.; Lombardi, Giovanna; Sharpe, Paul T.] Kings Coll London, Sch Immunol & Microbial Sci, MRC Ctr Transplantat, London, England; [Laing, Adam G.; Ramirez-Valdez, Andrei; Sharpe, Paul T.] Kings Coll London, Ctr Craniofacial & Regenerat Biol, London, England	University of London; King's College London; University of London; King's College London	Lombardi, G; Sharpe, PT (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, MRC Ctr Transplantat, London, England.; Sharpe, PT (corresponding author), Kings Coll London, Ctr Craniofacial & Regenerat Biol, London, England.	paul.sharpe@kcl.ac.uk; giovanna.lombardi@kcl.ac.uk		fanelli, giorgia/0000-0002-2003-529X; Sharpe, Paul/0000-0003-2116-9561	Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC grant [MR/J006742/1]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC grant; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London	This research was funded by the Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC grant no. MR/J006742/1. The research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Medical Research Council (MRC) Centre for Transplantation, King's College London, UK-MRC grant no. MR/J006742/1.; The research was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author( s) and not necessarily those of the NHS, the NIHR or the Department of Health. We would also like to thank Dr Ana Angelova and Dr Yvonne Pang for providing dpMSC.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Alge DL, 2010, J TISSUE ENG REGEN M, V4, P73, DOI 10.1002/term.220; Anda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182143; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; DelaRosa O, 2009, TISSUE ENG PT A, V15, P2795, DOI [10.1089/ten.tea.2008.0630, 10.1089/ten.TEA.2008.0630]; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Fazekasova H, 2011, J TISSUE ENG REGEN M, V5, P684, DOI 10.1002/term.362; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Galleu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7828; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gotoh T, 2006, ARTERIOSCL THROM VAS, V26, P1439, DOI 10.1161/01.ATV.0000223900.67024.15; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Laing AG, 2018, IMMUNOTHERAPY-UK, V10, P201, DOI 10.2217/imt-2017-0117; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Ledesma-Martinez E, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4709572; Lei JX, 2011, CELL IMMUNOL, V271, P147, DOI 10.1016/j.cellimm.2011.06.014; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Reading JL, 2013, J IMMUNOL, V190, P4542, DOI 10.4049/jimmunol.1202710; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Shimada Y, 2011, MOL GENET METAB, V104, P566, DOI 10.1016/j.ymgme.2011.09.005; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Van De Velde LA, 2016, CELL REP, V17, P2247, DOI 10.1016/j.celrep.2016.10.079; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	44	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213170	10.1371/journal.pone.0213170	http://dx.doi.org/10.1371/journal.pone.0213170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870462	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300025
J	Klinker, S; Stindt, S; Gremer, L; Bode, JG; Gertzen, CGW; Gohlke, H; Weiergraber, OH; Hoffmann, S; Willbold, D				Klinker, Stefan; Stindt, Sabine; Gremer, Lothar; Bode, Johannes G.; Gertzen, Christoph G. W.; Gohlke, Holger; Weiergraeber, Oliver H.; Hoffmann, Silke; Willbold, Dieter			Phosphorylated tyrosine 93 of hepatitis C virus nonstructural protein 5A is essential for interaction with host c-Src and efficient viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis C virus (HCV); Src; Src homology 2 domain (SH2 domain); phosphotyrosine; viral replication; liver disease; nonstructural protein 5A; NS5A; virion assembly	PARTICLE MESH EWALD; NS5A PROTEIN; RNA REPLICATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SH2 DOMAINS; CELL-LINES; IN-VIVO; BINDING; PARAMETERS	The hepatitis C virus (HCV) nonstructural protein 5A (NS5A) plays a key role in viral replication and virion assembly, and the regulation of the assembly process critically depends on phosphorylation of both serine and threonine residues in NS5A. We previously identified SRC proto-oncogene, nonreceptor tyrosine kinase (c-Src), as an essential host component of the HCV replication complex consisting of NS5A, the RNA-dependent RNA polymerase NS5B, and c-Src. Pulldown assays revealed an interaction between NS5A and the Src homology 2 (SH2) domain of c-Src; however, the precise binding mode remains undefined. In this study, using a variety of biochemical and biophysical techniques, along with molecular dynamics simulations, we demonstrate that the interaction between NS5A and the c-Src SH2 domain strictly depends on an intact phosphotyrosine-binding competent SH2 domain and on tyrosine phosphorylation within NS5A. Detailed analysis of c-Src SH2 domain binding to a panel of phosphorylation-deficient NS5A variants revealed that phosphorylation of Tyr-93 located within domain 1 of NS5A, but not of any other tyrosine residue, is crucial for complex formation. In line with these findings, effective replication of subgenomic HCV replicons as well as production of infectious virus particles in mammalian cell culture models were clearly dependent on the presence of tyrosine at position 93 of NS5A. These findings indicate that phosphorylated Tyr-93 in NS5A plays an important role during viral replication by facilitating NS5A's interaction with the SH2 domain of c-Src.	[Klinker, Stefan; Gremer, Lothar; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany; [Stindt, Sabine; Bode, Johannes G.] Heinrich Heine Univ Dusseldorf, Dept Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Gremer, Lothar; Gertzen, Christoph G. W.; Gohlke, Holger; Weiergraeber, Oliver H.; Hoffmann, Silke; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, D-52425 Julich, Germany; [Gertzen, Christoph G. W.; Gohlke, Holger] Forschungszentrum Julich, John von Neumann Inst Comp NIC, D-52425 Julich, Germany; [Gertzen, Christoph G. W.; Gohlke, Holger] Forschungszentrum Julich, JSC, D-52425 Julich, Germany; [Gertzen, Christoph G. W.; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Gremer, Lothar/H-9128-2013; Hoffmann, Silke/H-5059-2013; Weiergräber, Oliver H./G-8940-2013; Willbold, Dieter/A-6280-2013	Gremer, Lothar/0000-0001-7065-5027; Hoffmann, Silke/0000-0003-1414-8957; Weiergräber, Oliver H./0000-0002-2410-3691; Willbold, Dieter/0000-0002-0065-7366	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [190586431-SFB 974]; Deutsche Forschungsgemeinschaft [267205415-SFB 1208]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Projektnummer 190586431-SFB 974 (to D. W. and J. G. B) and by Deutsche Forschungsgemeinschaft-Projektnummer 267205415-SFB 1208 (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aladag A, 2014, J PEPT SCI, V20, P334, DOI 10.1002/psc.2618; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Badillo A, 2017, BIOCHEMISTRY-US, V56, P3029, DOI 10.1021/acs.biochem.7b00212; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bode JG, 2009, BIOL CHEM, V390, P1013, DOI 10.1515/BC.2009.118; Case D., 2015, AMBER, V14; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Feuerstein S, 2012, J MAGN RESON, V214, P329, DOI 10.1016/j.jmr.2011.10.019; Feuerstein S, 2011, BIOMOL NMR ASSIGN, V5, P241, DOI 10.1007/s12104-011-9309-2; Hierholzer J, 1996, VIROLOGY METHODS MAN, P24; Hiyoshi M, 2012, J CELL PHYSIOL, V227, P1090, DOI 10.1002/jcp.22825; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lee JH, 2018, EBIOMEDICINE, V28, P151, DOI 10.1016/j.ebiom.2018.01.004; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakashima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046634; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; Romero-Brey I, 2015, MBIO, V6, DOI 10.1128/mBio.00759-15; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwarten M, 2013, BIOCHEMISTRY-US, V52, P6160, DOI 10.1021/bi400363v; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Solyom Z, 2015, BIOPHYS J, V109, P1483, DOI 10.1016/j.bpj.2015.06.040; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yamauchi S, 2015, J BIOL CHEM, V290, P21857, DOI 10.1074/jbc.M115.666859; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	67	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7388	7402		10.1074/jbc.RA119.007656	http://dx.doi.org/10.1074/jbc.RA119.007656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30862675	Green Published, hybrid			2022-12-26	WOS:000468402900025
J	Bianchi, F; Flisi, S; Careri, M; Riboni, N; Resimini, S; Sala, A; Conti, V; Mattarozzi, M; Taddei, S; Spadini, C; Basini, G; Grolli, S; Cabassi, CS; Ramoni, R				Bianchi, Federica; Flisi, Sara; Careri, Maria; Riboni, Nicolo; Resimini, Silvia; Sala, Andrea; Conti, Virna; Mattarozzi, Monica; Taddei, Simone; Spadini, Costanza; Basini, Giuseppina; Grolli, Stefano; Cabassi, Clotilde Silvia; Ramoni, Roberto			Vertebrate odorant binding proteins as antimicrobial humoral components of innate immunity for pathogenic microorganisms	PLOS ONE			English	Article							QUORUM SENSING MOLECULES; CANDIDA-ALBICANS; EXPRESSION; BIOMARKERS; PYOCYANIN; LIPOCALIN; LIGAND	The bacterium Pseudomonas aeruginosa (PA) and the yeast Candida albicans (CA) are pathogens that cohabit the mucosa of the respiratory tracts of animals and humans. Their virulence is largely determined by chemical communication driven by quorum sensing systems (QS), and the cross perception of their quorum sensing molecules (QSM) can modulate the prevalence of one microorganism over the other. Aiming to investigate whether some of the protein components dissolved in the mucus layering the respiratory mucosa might interfere with virulence and cross-communication of these, and eventually other microorganisms, ligand binding assays were carried out to test the scavenging potential of the bovine and porcine forms of the Lipocalin odorant binding protein (OBP) for several QSMs (farnesol, and acylhomoserine lactones), and for pyocyanin, a toxin produced by PA. In addition, the direct antimicrobial activity of the OBPs was tested by time kill assay (TKA) against CA, PA and other bacteria and yeasts. The positivity of all the ligand binding assays and the antimicrobial activity determined for CA, and for some of the other microorganisms tested, let hypothesize that vertebrate OBPs might behave as humoral components of innate immunity, active against pathogenic bacteria and fungi. In addition, TKAs with mutants of bovine OBP with structural properties different from those of the native form, and with OBP forms tagged with histidines at the amino terminal, provided information about the mechanisms responsible of their antimicrobial activity and suggested possible applications of the OBPs as alternative or co-adjuvants to antibiotic therapeutic treatments.	[Bianchi, Federica; Careri, Maria; Riboni, Nicolo; Mattarozzi, Monica] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Flisi, Sara; Resimini, Silvia; Sala, Andrea; Conti, Virna; Taddei, Simone; Spadini, Costanza; Basini, Giuseppina; Grolli, Stefano; Cabassi, Clotilde Silvia; Ramoni, Roberto] Univ Parma, Dept Vet Sci, Parma, Italy; [Riboni, Nicolo] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden	University of Parma; University of Parma; Stockholm University	Cabassi, CS; Ramoni, R (corresponding author), Univ Parma, Dept Vet Sci, Parma, Italy.	clotildesilvia.cabassi@unipr.it; roberto.ramoni@unipr.it	Bianchi, Federica/J-4912-2012; Basini, Giuseppina/AAT-1831-2021; Spadini, Costanza/HCH-7215-2022	Bianchi, Federica/0000-0001-7880-5624; Basini, Giuseppina/0000-0003-1571-7023; Spadini, Costanza/0000-0003-0211-5293; Riboni, Nicolo/0000-0002-0789-3812; Grolli, Stefano/0000-0003-4380-5725	Universita degli Studi di Parma (FIL 2017); Dipartimento di Scienze Medico-Veterinarie of the Universita degli Studi di Parma	Universita degli Studi di Parma (FIL 2017); Dipartimento di Scienze Medico-Veterinarie of the Universita degli Studi di Parma	This research was supported by a grant of the Universita degli Studi di Parma (FIL 2017) and by a grant of Dipartimento di Scienze Medico-Veterinarie of the Universita degli Studi di Parma (Ramoni - Ric. dipartimentale 2014-70%) awarded to Roberto Ramoni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiee P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2825-7; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Barr HL, 2015, EUR RESPIR J, V46, P1046, DOI 10.1183/09031936.00225214; Bianchi F, 2013, ANAL BIOANAL CHEM, V405, P1067, DOI 10.1007/s00216-012-6499-0; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Boutin S, 2018, J CYST FIBROS, V17, P348, DOI 10.1016/j.jcf.2017.12.007; Churchill MEA, 2011, METHODS MOL BIOL, V692, P159, DOI 10.1007/978-1-60761-971-0_12; Conklin SE, 2017, BIOCHEMISTRY-US, V56, P4244, DOI 10.1021/acs.biochem.7b00348; Cugini C, 2007, MOL MICROBIOL, V65, P896, DOI 10.1111/j.1365-2958.2007.05840.x; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; Fetzner S, 2015, J BIOTECHNOL, V201, P2, DOI 10.1016/j.jbiotec.2014.09.001; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Grolli S, 2006, FEBS J, V273, P5131, DOI 10.1111/j.1742-4658.2006.05510.x; Hentzer M, 2003, BIODRUGS, V17, P241, DOI 10.2165/00063030-200317040-00003; Hornby JM, 2001, APPL ENVIRON MICROB, V67, P2982, DOI 10.1128/AEM.67.7.2982-2992.2001; Jarosz LM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002312; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; Kulon K, 2008, DALTON T, P5323, DOI 10.1039/b806851h; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Macedo-Marquez A, 2014, FREE RADICAL RES, V48, P814, DOI 10.3109/10715762.2014.910867; Morales DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000886; Ovchinnikova ES, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-281; Pastells C, 2016, ANAL CHEM, V88, P1631, DOI 10.1021/acs.analchem.5b03490; Pelosi P, 2014, APPL MICROBIOL BIOT, V98, P61, DOI 10.1007/s00253-013-5383-y; PEVSNER J, 1990, J BIOL CHEM, V265, P6118; Ramon R, 2001, J BIOL CHEM, V276, P7150, DOI 10.1074/jbc.M010368200; Ramoni R, 2002, BIOCHEM J, V365, P739, DOI 10.1042/BJ20011631; Ramoni R, 2008, BBA-PROTEINS PROTEOM, V1784, P651, DOI 10.1016/j.bbapap.2008.01.010; Ramoni R, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/39/395012; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sawyer L, 2000, BBA-PROTEIN STRUCT M, V1482, P136, DOI 10.1016/S0167-4838(00)00160-6; Struss AK, 2013, ANAL CHEM, V85, P3355, DOI 10.1021/ac400032a; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wen KY, 2017, ACS SYNTH BIOL, V6, P2293, DOI 10.1021/acssynbio.7b00219; Westwater C, 2005, EUKARYOT CELL, V4, P1654, DOI 10.1128/EC.4.10.1654-1661.2005; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Zukovskaja O, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081704	43	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213545	10.1371/journal.pone.0213545	http://dx.doi.org/10.1371/journal.pone.0213545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901336	gold, Green Submitted, Green Published			2022-12-26	WOS:000462000400009
J	Marin-Palma, D; Sirois, CM; Urcuqui-Inchima, S; Hernandez, JC				Marin-Palma, Damariz; Sirois, Cherilyn M.; Urcuqui-Inchima, Silvio; Hernandez, Juan C.			Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations	PLOS ONE			English	Article							CYTOKINE PATTERNS; LIPID PROFILE; VIRUS; CHOLESTEROL; ACTIVATION; INFLAMMASOMES; PERMEABILITY; INFECTION	Introduction The triggering of severe dengue has been associated with an exacerbated inflammatory process characterized by the production of pro-inflammatory cytokines such as IL-1 beta/IL-18, which are the product of inflammasome activation. Furthermore, alteration in the levels of high-density (HDL) and low-density lipoproteins (LDL) has been observed; and HDL are known to have immunomodulatory properties, including the regulation of inflammasomes. While HDL would be expected to counteract hyperactivation of the inflammasome, the relationship between HDL and dengue severity, has not previously been explored. Methodology We conducted a cross-sectional study of 30 patients with dengue and 39 healthy controls matched by sex and age. Lipid profile and levels of C-reactive protein were quantified. Serum levels of IL-1 beta, IL-6, IL-10, IL-18, and TNF-alpha, were assessed by ELISA. Expression of inflammasome-related genes in PBMC was quantified by qPCR. Results Dengue patients presented an alteration in the parameters of the lipid profile, with a significant decrease in HDL levels, which was more pronounced in dengue patients with warning signs. Moreover, a decrease in the expression of the inflammasome-related genes NLRP1, NLRC4, caspase-1, IL-1 beta and IL-18 was observed, as well as an increase in serum levels of C-reactive protein and IL-10 in dengue patients versus healthy donors. Significant positive correlations between LDL levels and the relative expression of NLRP3, NLRC4, IL-1 beta and IL-18, were found. Conclusion The results suggest that there is a relationship between the alteration of LDL and HDL with the imbalance in the inflammatory response, which could be associated with the severity of dengue.	[Marin-Palma, Damariz; Hernandez, Juan C.] Univ Cooperat Colombia, Fac Med, Infettare, Medellin, Colombia; [Marin-Palma, Damariz; Urcuqui-Inchima, Silvio] Univ Antioquia, UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Sirois, Cherilyn M.] Springfield Coll, Dept Biol & Chem, Springfield, MA USA	Universidad Cooperativa de Colombia; Universidad de Antioquia; Springfield College	Hernandez, JC (corresponding author), Univ Cooperat Colombia, Fac Med, Infettare, Medellin, Colombia.	juankhernandez@gmail.com	Hernandez, Juan C./C-1621-2018	Hernandez, Juan C./0000-0002-9200-5698; Urcuqui-Inchima, Silvio/0000-0002-2865-3041	Colciencias [141565741029]; Universidad Cooperativa de Colombia; Universidad de Antioquia UdeA	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad Cooperativa de Colombia; Universidad de Antioquia UdeA	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Colciencias Grant 141565741029, Universidad Cooperativa de Colombia and Universidad de Antioquia UdeA. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2009, DENG GUID DIAGN TREA; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Azeredo EL, 2001, IMMUNOBIOLOGY, V204, P494, DOI 10.1078/0171-2985-00058; Barrientos-Arenas Estefanía, 2018, Rev. perú. med. exp. salud publica, V35, P15, DOI [10.17843/rpmesp.2018.351.3568, 10.17843/rpmesp.2018.351.3568.]; Bethell DB, 1998, J INFECT DIS, V177, P778, DOI 10.1086/517807; Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005; Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;335::AID-JMV13&gt;3.0.CO;2-E; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duran A, 2015, ARCH VIROL, V160, P1687, DOI 10.1007/s00705-015-2433-z; Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025; Eppy, 2016, ACTA MED INDONES, V48, P3; Estruch M, 2015, BBA-MOL CELL BIOL L, V1851, P1442, DOI 10.1016/j.bbalip.2015.08.009; Cordero JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090704; Feria MG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192845; Gomez DM, 2017, INNATE IMMUN-LONDON, V23, P697, DOI 10.1177/1753425917738331; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Im H, 2014, CLIN EXP ALLERGY, V44, P160, DOI 10.1111/cea.12206; Kameda T, 2015, J LIPIDS, V2015, DOI 10.1155/2015/592594; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Kuczera D, 2018, J INTERF CYTOK RES, V38, P69, DOI 10.1089/jir.2017.0037; KUNO G, 1994, MEM I OSWALDO CRUZ, V89, P179, DOI 10.1590/S0074-02761994000200010; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Marin-Palma D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01350; Marin-Palma D, 2017, IATREIA, V30, P423, DOI 10.17533/udea.iatreia.v30n4a06; Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Rojas F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132026; Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003; Suharti C, 2003, EUR CYTOKINE NETW, V14, P172; Tauseef A, 2016, JCPSP-J COLL PHYSICI, V26, P187, DOI 03.2016/JCPSP.187190; Thacker SG, 2016, IMMUNOLOGY, V149, P306, DOI 10.1111/imm.12638; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090	47	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214245	10.1371/journal.pone.0214245	http://dx.doi.org/10.1371/journal.pone.0214245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901375	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400045
J	Johnson, SC; Pan, A; Sun, GX; Freed, A; Stokes, JC; Bornstein, R; Witkowski, M; Li, L; Ford, JM; Howard, CRA; Sedensky, MM; Morgan, PG				Johnson, Simon C.; Pan, Amanda; Sun, Grace X.; Freed, Arielle; Stokes, Julia C.; Bornstein, Rebecca; Witkowski, Michael; Li, Li; Ford, Jeremy M.; Howard, Christopher R. A.; Sedensky, Margaret M.; Morgan, Philip G.			Relevance of experimental paradigms of anesthesia induced neurotoxicity in the mouse	PLOS ONE			English	Article							NEONATAL SEVOFLURANE EXPOSURE; SINGLE GENERAL-ANESTHESIA; TERM-MEMORY IMPAIRMENT; BETA-HYDROXYBUTYRATE; DEVELOPING BRAIN; ISOFLURANE ANESTHESIA; NEURONAL APOPTOSIS; CHILDHOOD EXPOSURE; SYNAPTIC FUNCTION; KETONE-BODIES	Routine general anesthesia is considered to be safe in healthy individuals. However, pre-clinical studies in mice, rats, and monkeys have repeatedly demonstrated that exposure to anesthetic agents during early post-natal periods can lead to acute neurotoxicity. More concerning, later-life defects in cognition, assessed by behavioral assays for learning and memory, have been reported. Although the potential for anesthetics to damage the neonatal brain is well-documented, the clinical significance of the pre-clinical models in which damage is induced remains quite unclear. Here, we systematically evaluate critical physiological parameters in post-natal day 7 neonatal mice exposed to 1.5% isoflurane for 2-4 hours, the most common anesthesia induced neurotoxicity paradigm in this animal model. We find that 2 or more hours of anesthesia exposure results in dramatic respiratory and metabolic changes that may limit interpretation of this paradigm to the clinical situation. Our data indicate that neonatal mouse models of AIN are not necessarily appropriate representations of human exposures.	[Johnson, Simon C.; Pan, Amanda; Sun, Grace X.; Freed, Arielle; Stokes, Julia C.; Bornstein, Rebecca; Witkowski, Michael; Li, Li; Ford, Jeremy M.; Howard, Christopher R. A.; Sedensky, Margaret M.; Morgan, Philip G.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Johnson, Simon C.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Freed, Arielle] Univ Washington, Sch Dent, Seattle, WA 98195 USA; [Bornstein, Rebecca] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Ford, Jeremy M.; Howard, Christopher R. A.] Seattle Childrens Res Inst, Seattle Childrens Imaginat Lab, Seattle, WA USA; [Sedensky, Margaret M.; Morgan, Philip G.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Johnson, SC (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.; Johnson, SC (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	simon.johnson@seattlechildrens.org		Li, Li/0000-0001-6131-4394; Johnson, Simon/0000-0002-1942-3674; Stokes, Julia/0000-0003-4685-5365	NIH [5R01GM118514-02, 1K99GM126147-01, T32 1T32GM095421-08]; Northwest Mitochondrial Research Guild; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM095421, R01GM118514, K99GM126147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwest Mitochondrial Research Guild; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the NIH through an R01, 5R01GM118514-02, awarded to PGM, and an NIH grant 1K99GM126147-01 to SCJ. RB was supported by NIH T32 1T32GM095421-08. Funding was also provided by the Northwest Mitochondrial Research Guild (http://www.nwmito-research.org/) to SCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado MC, 2017, BRIT J ANAESTH, V119, P517, DOI 10.1093/bja/aew473; Cheng Y, 2015, ANESTH ANALG, V121, P1325, DOI 10.1213/ANE.0000000000000714; Cheng Y, 2014, ANESTH ANALG, V118, P1284, DOI 10.1213/ANE.0000000000000030; Chinn GA, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.10.43; Chung W, 2015, PEDIATR ANESTH, V25, P1033, DOI 10.1111/pan.12694; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; Davidson AJ, 2018, ANESTHESIOLOGY, V128, P840, DOI 10.1097/ALN.0000000000001972; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; Glatz P, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.3470; Han XD, 2015, MOL MED REP, V11, P226, DOI 10.3892/mmr.2014.2751; Hershey JD, 2018, J AM ASSOC LAB ANIM, V57, P335, DOI [10.30802/AALAS-JAALAS-17-000161, 10.30802/aalas-jaalas-17-000161]; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Izumi Y, 1997, J NEUROSCI, V17, P9448; Ji MH, 2015, NEUROTOXICOLOGY, V46, P155, DOI 10.1016/j.neuro.2014.11.003; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Kayser EB, 2011, ANESTH ANALG, V112, P1321, DOI 10.1213/ANE.0b013e3182121d37; Lee JH, 2014, KOREAN J ANESTHESIOL, V67, P334, DOI 10.4097/kjae.2014.67.5.334; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Liang XL, 2017, AM J TRANSL RES, V9, P4974; Lin EP, 2017, NEUROTOXICOL TERATOL, V60, P117, DOI 10.1016/j.ntt.2016.10.008; Lin XF, 2014, GENET MOL RES, V13, P10769, DOI 10.4238/2014.December.18.18; Liu F, 2015, TOXICOL SCI, V147, P562, DOI 10.1093/toxsci/kfv150; Liu JH, 2017, CELL PHYSIOL BIOCHEM, V44, P423, DOI 10.1159/000485008; Liu JH, 2017, NEUROCHEM RES, V42, P595, DOI 10.1007/s11064-016-2114-7; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Man YG, 2015, INT J CLIN EXP MED, V8, P14397; Mann GE, 2015, INT J PEDIATR OTORHI, V79, P1379, DOI 10.1016/j.ijporl.2015.05.011; Murphy KL, 2017, NEUROTOXICOL TERATOL, V60, P87, DOI 10.1016/j.ntt.2016.11.010; Newman JC, 2014, DIABETES RES CLIN PR, V106, P173, DOI 10.1016/j.diabres.2014.08.009; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; O'Brien F, 2014, PEDIATR ANESTH, V24, P49, DOI 10.1111/pan.12326; Olufs ZPG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20720-7; Orser BA, 2018, ANESTH ANALG, V126, P1393, DOI 10.1213/ANE.0000000000002833; Satomoto M, 2016, ANESTHESIOL RES PRAC, V2016, DOI 10.1155/2016/9682703; Shen XF, 2013, NEUROTOXICOLOGY, V39, P45, DOI 10.1016/j.neuro.2013.08.007; Song Q, 2015, GENET MOL RES, V14, P18059, DOI 10.4238/2015.December.22.32; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Sun Z, 2016, BRIT J ANAESTH, V117, P80, DOI 10.1093/bja/aew064; Tagawa T, 2014, J ANESTH, V28, P815, DOI 10.1007/s00540-014-1822-x; Tao G, 2016, BIOMED RES INT BIOME, V2016, P2016, DOI DOI 10.1155/2016/7919640; Vutskits L, 2017, CURR OPIN ANESTHESIO, V30, P337, DOI 10.1097/ACO.0000000000000461; Wada H, 1997, DEV BRAIN RES, V101, P1, DOI 10.1016/S0165-3806(97)00007-2; Walters JL, 2017, NEUROTOXICOL TERATOL, V60, P2, DOI 10.1016/j.ntt.2016.11.005; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Wu BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084622; Xu G, 2017, BRIT J ANAESTH, V119, P481, DOI 10.1093/bja/aex071; Xu KX, 2015, INT J CLIN EXP MED, V8, P10444; Yang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099171; Youssef FF, 2015, NEUROL RES, V37, P211, DOI 10.1179/1743132814Y.0000000430; Zhang HF, 2015, J ANESTH, V29, P749, DOI 10.1007/s00540-015-2030-z; Zhang L, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-5; Zhou LS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11145; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274; Zou XJ, 2011, NEUROTOXICOL TERATOL, V33, P592, DOI 10.1016/j.ntt.2011.06.003	59	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213543	10.1371/journal.pone.0213543	http://dx.doi.org/10.1371/journal.pone.0213543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897103	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700022
J	Vegsund, HK; Reinfjell, T; Moksnes, UK; Wallin, AE; Hjemdal, O; Eilertsen, MEB				Vegsund, Hilde Kristin; Reinfjell, Trude; Moksnes, Unni Karin; Wallin, Alexandra Eilegard; Hjemdal, Odin; Eilertsen, Mary-Elizabeth Bradley			Resilience as a predictive factor towards a healthy adjustment to grief after the loss of a child to cancer	PLOS ONE			English	Article							PARENTAL GRIEF; FOLLOW-UP; DEATH; BEREAVEMENT; SUPPORT; INFANT; RISK; DEPRESSION; FRAMEWORK; SYMPTOMS	Introduction Grief among bereaved parents is known to cause psychological distress and physical illness, but knowledge concerning factors that can contribute to health promotion after bereavement is scarce. Childhood cancer remains the most common non-accidental cause of death among children in Norway. The aim of the present study was to explore if resilience factors among cancer-bereaved parents could predict whether they will be able to come to terms with their grief 28 years following the loss. Methods A Norwegian cross-sectional national survey was conducted among 161 cancer-bereaved parents using a study-specific questionnaire. Logistic regression was used to explore whether resilience factors predicted parents grief outcome 28 years after their loss. Results On the Resilience Scale for Adults (RSA), three of the resilience factors contributed significantly in predicting whether the parents in the present study would come to terms with their grief 28 years after the loss their child: "Perception of self " (OR 2.08, p = .048), "Social resources" (OR 2.83, p = .008) and "Family cohesion" (OR .41, p = .025). The results showed a negative relationship between time since loss (26 years) and whether the parents answered that they had come to terms with their grief (p = < .05). The loss of a parent (OR .30, p = .030) combined with the loss of their child had a negative and significant effect on whether they indicated that they had processed their grief. Conclusion The total score of RSA and three of the six resilient factors contributed significantly in predicting whether cancer-bereaved parents in the present study indicated that they had come to terms with their grief to a great extent. The present study supports hypotheses that regard resilience as an important contribution in predicting healthy outcomes in people exposed to adverse life events.	[Vegsund, Hilde Kristin; Moksnes, Unni Karin; Eilertsen, Mary-Elizabeth Bradley] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Ctr Hlth Promot Res, Trondheim, Norway; [Vegsund, Hilde Kristin; Reinfjell, Trude; Hjemdal, Odin] NTNU Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Wallin, Alexandra Eilegard] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Dalarna University	Vegsund, HK (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Ctr Hlth Promot Res, Trondheim, Norway.; Vegsund, HK (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway.	hilde.k.vegsund@ntnu.no		Vegsund, Hilde Kristin/0000-0002-4043-9697; Hjemdal, Odin/0000-0002-6430-2345	Research Council of Norway [238331]; NTNU Norwegian University of Science and Technology; Norwegian Children's Cancer Foundation	Research Council of Norway(Research Council of Norway); NTNU Norwegian University of Science and Technology; Norwegian Children's Cancer Foundation	This study was funded by: 1. The Research Council of Norway, grant number 238331, "Health Promotion - Worthwhile? Reorienting the Community Health Care Services", https://www.forskningsradet.no/no/Forsiden/1173185591033; 2. NTNU Norwegian University of Science and Technology, https://www.ntnu.no/; 3. The Norwegian Children's Cancer Foundation, https://www.barnekreftforeningen.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 2012, DEATH STUD, V36, P1, DOI 10.1080/07481187.2011.553312; Albuquerque S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178861; American Cancer Society, 2018, KEY STAT CHILDH CANC; Anderson MJ, 2005, DEATH STUD, V29, P811, DOI 10.1080/07481180500236602; Arizmendi BJ, 2015, AUST CRIT CARE, V28, P58, DOI 10.1016/j.aucc.2015.01.005; Arnold J, 2005, ARCH PSYCHIAT NURS, V19, P245, DOI 10.1016/j.apnu.2005.07.008; Arnold J, 2008, DEATH STUD, V32, P658, DOI 10.1080/07481180802215718; Boerner K., 2010, HDB ADULT RESILIENCE, P126; Buyukcan-Tetik A, 2017, J FAM PSYCHOL, V31, P409, DOI 10.1037/fam0000252; Davies R, 2004, J ADV NURS, V46, P506, DOI 10.1111/j.1365-2648.2004.03024.x; Dijkstra I, 1998, J FAMILY STUDIES, V4, P159, DOI DOI 10.5172/JFS.4.2.159; DYREGROV A, 1991, SCAND J PSYCHOL, V32, P193, DOI 10.1111/j.1467-9450.1991.tb00869.x; Dyregrov A, 2014, HVA VET VI SORG KOMP, P1; Dyregrov A, 2006, TIDSSKR PSYKOLOGFORE, V43, P779; Feigelman W, 2009, DEATH STUD, V33, P591, DOI 10.1080/07481180902979973; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Friborg O, 2006, J PSYCHOSOM RES, V61, P213, DOI 10.1016/j.jpsychores.2005.12.007; Friborg O, 2009, J INDIVID DIFFER, V30, P138, DOI 10.1027/1614-0001.30.3.138; GARMEZY N, 1993, PSYCHIATRY, V56, P127; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; Giannini GA, 2011, WESTERN J COMM, V75, P541, DOI 10.1080/10570314.2011.608406; Goodenough B, 2004, PSYCHO-ONCOLOGY, V13, P779, DOI 10.1002/pon.795; Harper M, 2014, PSYCHOL HEALTH MED, V19, P247, DOI 10.1080/13548506.2013.811274; Hawley DR, 2000, AM J FAM THER, V28, P101, DOI 10.1080/019261800261699; Helmreich I, 2017, COCHRANE DB SYST REV, V2, P1, DOI [DOI 10.1002/14651858.CD012527, 10.1002/14651858.CD012527]; Herrman H, 2011, CAN J PSYCHIAT, V56, P258, DOI 10.1177/070674371105600504; Hjemdal O, 2006, CLIN PSYCHOL PSYCHOT, V13, P194, DOI 10.1002/cpp.488; Hjemdal Odin, 2015, BMC Psychol, V3, P18, DOI 10.1186/s40359-015-0076-1; Hjemdal O, 2012, SCAND J PSYCHOL, V53, P174, DOI 10.1111/j.1467-9450.2011.00928.x; Hjemdal O, 2011, INT J TEST, V11, P53, DOI 10.1080/15305058.2010.508570; Iacoviello BM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23970; Jaaniste T, 2017, CHILDREN, V4, P1; Kazak AE, 2004, PROF PSYCHOL-RES PR, V35, P219, DOI 10.1037/0735-7028.35.3.219; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Kreicbergs U, 2004, THESIS; Kreicbergs UC, 2007, J CLIN ONCOL, V25, P3307, DOI 10.1200/JCO.2006.10.0743; LANG A, 1993, DEATH STUD, V17, P233, DOI 10.1080/07481189308252620; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Lindstrom B, 2010, HITCHHIKERS GUIDE SA; Long KA, 2011, CLIN CHILD FAM PSYCH, V14, P57, DOI 10.1007/s10567-010-0082-z; Lora A, 2009, MENTAL HLTH SYSTEMS; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mehmetoglu M., 2017, APPL STAT USING STAT, P161; Morote R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187954; Murphy SA, 2003, DEATH STUD, V27, P39, DOI 10.1080/07481180302871; Murray LK, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0938-y; Patterson RM, 2014, INT J PALLIAT NURS, V20, P318, DOI 10.12968/ijpn.2014.20.7.318; Rogers CH, 2008, J FAM PSYCHOL, V22, P203, DOI 10.1037/0893-3200.22.2.203; Romesberg T., 2004, J HOSP PALLIAT NURS, V6, P161, DOI DOI 10.1097/00129191-200407000-00012; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; Sallnow L, 2015, CRIT PUBLIC HEALTH, V25, P231, DOI 10.1080/09581596.2014.909582; Sandler IN, 2008, DEATH STUD, V32, P59, DOI 10.1080/07481180701741343; Sirkia K, 2000, ACTA PAEDIATR, V89, P717, DOI 10.1080/080352500750044070; Stata. com, EX LOG REGR; Stevenson M, 2017, QUAL HEALTH RES, V27, P649, DOI 10.1177/1049732315622189; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Stroebe M, 2017, LANCET, V389, P347, DOI 10.1016/S0140-6736(17)30189-7; Stroebe MS, 2006, SOC SCI MED, V63, P2440, DOI 10.1016/j.socscimed.2006.06.012; Tol WA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001769; VANCE JC, 1995, PEDIATRICS, V96, P933; Wender E, 2012, PEDIATRICS, V130, P1164, DOI 10.1542/peds.2012-2772; WERNER EE, 1993, DEV PSYCHOPATHOL, V5, P503, DOI 10.1017/S095457940000612X; WERNER EE, 1989, AM J ORTHOPSYCHIAT, V59, P72, DOI 10.1111/j.1939-0025.1989.tb01636.x; World Health Organisation, 2018, CANC IN CHILDR; Zeller B, 2016, TIDSSKR NORSKE LAEGE, V136, P1464, DOI 10.4045/tidsskr.16.0336	67	15	15	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214138	10.1371/journal.pone.0214138	http://dx.doi.org/10.1371/journal.pone.0214138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897157	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700069
J	Fregel, R; Ordonez, AC; Santana-Cabrera, J; Cabrera, VM; Velasco-Vazquez, J; Alberto, V; Moreno-Benitez, MA; Delgado-Darias, T; Rodriguez-Rodriguez, A; Hernandez, JC; Pais, J; Gonzalez-Montelongo, R; Lorenzo-Salazar, JM; Flores, C; Cruz-de-Mercadal, MC; Alvarez-Rodriguez, N; Shapiro, B; Arnay, M; Bustamante, CD				Fregel, Rosa; Ordonez, Alejandra C.; Santana-Cabrera, Jonathan; Cabrera, Vicente M.; Velasco-Vazquez, Javier; Alberto, Veronica; Moreno-Benitez, Marco A.; Delgado-Darias, Teresa; Rodriguez-Rodriguez, Amelia; Hernandez, Juan C.; Pais, Jorge; Gonzalez-Montelongo, Rafaela; Lorenzo-Salazar, Jose M.; Flores, Carlos; Carmen Cruz-de-Mercadal, M.; Alvarez-Rodriguez, Nuria; Shapiro, Beth; Arnay, Matilde; Bustamante, Carlos D.			Mitogenomes illuminate the origin and migration patterns of the indigenous people of the Canary Islands	PLOS ONE			English	Article							HUMAN PREHISTORIC POPULATIONS; ANCIENT DNA; MTDNA VARIATION; MITOCHONDRIAL; COLONIZATION; AFRICA; EXCHANGES; EVOLUTION; ANCESTRY; SEQUENCE	The Canary Islands' indigenous people have been the subject of substantial archaeological, anthropological, linguistic and genetic research pointing to a most probable North African Berber source. However, neither agreement about the exact point of origin nor a model for the indigenous colonization of the islands has been established. To shed light on these questions, we analyzed 48 ancient mitogenomes from 25 archaeological sites from the seven main islands. Most lineages observed in the ancient samples have a Mediterranean distribution, and belong to lineages associated with the Neolithic expansion in the Near East and Europe (T2c, J2a, X3a...). This phylogeographic analysis of Canarian ancient mitogenomes, the first of its kind, shows that some lineages are restricted to Central North Africa (H1cf, J2a2d and T2c1d3), while others have a wider distribution, including both West and Central North Africa, and, in some cases, Europe and the Near East (U6a1a1, U6a7a1, U6b, X3a, U6c1). In addition, we identify four new Canarian-specific lineages (H1e1a9, H4a1e, J2a2d1a and L3b1a12) whose coalescence dates correlate with the estimated time for the colonization of the islands (1st millennia CE). Additionally, we observe an asymmetrical distribution of mtDNA haplogroups in the ancient population, with certain haplogroups appearing more frequently in the islands closer to the continent. This reinforces results based on modern mtDNA and Y-chromosome data, and archaeological evidence suggesting the existence of two distinct migrations. Comparisons between insular populations show that some populations had high genetic diversity, while others were probably affected by genetic drift and/or bottlenecks. In spite of observing interinsular differences in the survival of indigenous lineages, modern populations, with the sole exception of La Gomera, are homogenous across the islands, supporting the theory of extensive human mobility after the European conquest.	[Fregel, Rosa; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Fregel, Rosa; Cabrera, Vicente M.] Univ La Laguna, Dept Biochem Microbiol Cell Biol & Genet, an Cristobal De La Lagu, Spain; [Ordonez, Alejandra C.; Arnay, Matilde] Univ La Laguna, Dept Prehist Anthropol & Ancient Hist, an Cristobal De La Lagu, Spain; [Santana-Cabrera, Jonathan] Univ Durham, Dept Archaeol, Durham, England; [Velasco-Vazquez, Javier; Rodriguez-Rodriguez, Amelia] Univ Las Palmas Gran Canaria, Dept Hist Sci, Las Palmas Gran Canaria, Spain; [Alberto, Veronica; Moreno-Benitez, Marco A.] Tibicena Arqueol & Patrimonio, Las Palmas Gran Canaria, Spain; [Delgado-Darias, Teresa; Carmen Cruz-de-Mercadal, M.] Museo Canario, Las Palmas Gran Canaria, Spain; [Hernandez, Juan C.; Alvarez-Rodriguez, Nuria] Museo Arqueol La Gomera, San Sebastian De La Gome, Spain; [Pais, Jorge] Museo Arqueol Benahoarita, Los Llanos De Aridane, Spain; [Gonzalez-Montelongo, Rafaela; Lorenzo-Salazar, Jose M.; Flores, Carlos] Inst Tecnol & Energias Renovables, Genom Div, Granadilla, Spain; [Flores, Carlos] Hosp Univ NS Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Shapiro, Beth] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	Stanford University; Universidad de la Laguna; Universidad de la Laguna; Durham University; Universidad de Las Palmas de Gran Canaria; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Fregel, R (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Fregel, R (corresponding author), Univ La Laguna, Dept Biochem Microbiol Cell Biol & Genet, an Cristobal De La Lagu, Spain.	rfregel@ull.edu.es	Fregel, Rosa/H-4942-2015; Rodriguez-Rodriguez, Amelia/ABG-6941-2020; Ordóñez, Alejandra C./M-1473-2018; Flores, Carlos/R-1159-2019; SALAZAR, JOSÉ MIGUEL LORENZO/H-6385-2017; Santana-Cabrera, Jonathan/G-8556-2015	Fregel, Rosa/0000-0002-2951-6508; Rodriguez-Rodriguez, Amelia/0000-0001-7112-2441; Ordóñez, Alejandra C./0000-0003-3568-3246; SALAZAR, JOSÉ MIGUEL LORENZO/0000-0002-5135-2861; Velasco-Vazquez, Javier/0000-0003-0339-3500; Flores, Carlos/0000-0001-5352-069X; Santana-Cabrera, Jonathan/0000-0002-9615-8560; Bustamante, Carlos D./0000-0002-4187-7920	National Science Foundation [1201234]; Chan Zuckerberg Biohub Investigator Award; Fundacion Canaria Dr. Manuel Morales fellowship; Direccion General de Patriomonio Cultural del Gobierno de Canarias (MITOCAN); Spanish Ministry of Science and Innovation [HAR2015-68323-P, HAR2017-83205P, RTC-2017-6471-1]; Cabildo de Tenerife; Gordon and Betty Moore Foundation [GBMF-3804]; Cabildo de Tenerife [CGIEU0000219140]; Instituto Tecnologico y de Energias Renovables (ITER) [OA17/008]	National Science Foundation(National Science Foundation (NSF)); Chan Zuckerberg Biohub Investigator Award; Fundacion Canaria Dr. Manuel Morales fellowship; Direccion General de Patriomonio Cultural del Gobierno de Canarias (MITOCAN); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cabildo de Tenerife; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cabildo de Tenerife; Instituto Tecnologico y de Energias Renovables (ITER)	C.D.B. and R.F. were funded by a grant from the National Science Foundation (1201234) and the Chan Zuckerberg Biohub Investigator Award; R.F. was funded by a Fundacion Canaria Dr. Manuel Morales fellowship and by a grant from Direccion General de Patriomonio Cultural del Gobierno de Canarias (MITOCAN); M.A. was funded by a grant from the Spanish Ministry of Science and Innovation (HAR2015-68323-P) and by the Maria Rosa Alonso grant from Cabildo de Tenerife; B.S. was funded by a grant from the Gordon and Betty Moore Foundation (GBMF-3804); A.C.R.R. was funded by a grant from the Spanish Ministry of Science and Innovation (HAR2017-83205P); R.G.M., J.M.L.S and C.F. were funded by grants from the Spanish Ministry of Science and Innovation (RTC-2017-6471-1) and Area Tenerife 2030 from Cabildo de Tenerife (CGIEU0000219140), and from the agreement OA17/008 with Instituto Tecnologico y de Energias Renovables (ITER). Tibicena Arqueologia y Patrimonio provided support in the form of salaries for authors V.A. and M.A.M.B. and radiocarbon dating of four archaeological samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arco-Aguilar MC, 2017, TALLER ROMANO PURPUR; Arnay-de-la-Rosa M, 2011, J ARCHAEOL SCI, V38, P884, DOI 10.1016/j.jas.2010.11.018; Atoche P, 2011, ANUARIO ESTUDIOS ATL, V57, P139; Atoche P, 1995, EVIDENCIAS ARQUEOLOG; Aubet M.E., 1994, TIRO COLONIAS FENICI; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Billy G., 1982, MUS CANAR, V41, P59; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Cabrera-Perez J, 1999, MAJOS PRIMITIVA POBL; Cabrera-Perez JC, 1996, PREHISTORIA FUERTEVE; Camps G, 1980, BERBERES MARGES HIST; Camps G., 1974, CIVILISATIONS PREHIS; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Clark JD, 1997, CAMBRIDGE HIST AFRIC; Crosby A. W., 1988, IMPERIALISMO ECOLOGI; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; de la Rosa JFarrujia, 2014, ARCHAEOLOGY MARGINS; DECASTRO JMB, 1989, AM J PHYS ANTHROPOL, V79, P207, DOI 10.1002/ajpa.1330790208; DECASTRO JMB, 1989, HUM BIOL, V61, P117; Curbelo MD, 2016, TRABAJOS PREHIST, V73, P90, DOI 10.3989/tp.2016.12165; DELEEUW J, 2009, J STAT SOFTW, V31, P1; Delgado T, 2009, HIST DIENTES APROXIM; Delgado-Darias T, 2018, AM J PHYS ANTHR; Delgado-Delgado JA, 2012, CANARIAS ANTIGUEDAD, V19, P9; Delgado-Delgado JA, 2001, ANCIENT HIST B, V15, P29; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Espinosa A, 1980, ORIGEN MILAGROS SANT; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; de la Rosa AJF, 2010, AFR ARCHAEOL REV, V27, P13, DOI 10.1007/s10437-010-9070-4; Ferrando A, 2015, ANIM GENET, V46, P452, DOI 10.1111/age.12302; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Forster P, 1996, AM J HUM GENET, V59, P935; Fregel R, 2011, FORENS SCI INT-GEN S, V3, pE303, DOI 10.1016/j.fsigss.2011.09.014; Fregel R, 2018, P NATL ACAD SCI US; Fregel R, 2010, EVOLUCION GENETICA P; Fregel R, 2018, P NATL ACAD SCI USA, V115, P6774, DOI 10.1073/pnas.1800851115; Fregel R, 2015, EUR J HUM GENET, V23, P1236, DOI 10.1038/ejhg.2014.251; Fregel R, 2011, MITOCHONDRION, V11, P366, DOI 10.1016/j.mito.2010.11.001; Fregel R, 2009, EUR J HUM GENET, V17, P1314, DOI 10.1038/ejhg.2009.46; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Gonzalez AM, 2006, ANN HUM GENET, V70, P631, DOI 10.1111/j.1469-1809.2006.00259.x; Gonzalez-Anton R, 2009, ANEJO CANARIAS ARQUE, V17, P9; Gonzalez-Anton R, 1998, ERES, V8, P43; Guatelli-Steinberg D, 2001, HOMO, V52, P173, DOI 10.1078/0018-442X-00027; Guerrero-Ayuso VM, 2008, SAGVNTVM PAPELES LAB, V40, P37; Guillen-Guio B, 2018, MOL BIOL EVOL, V35, P3010, DOI 10.1093/molbev/msy190; Hagenblad J, 2017, J ARCHAEOL SCI, V78, P78, DOI 10.1016/j.jas.2016.12.001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Heinz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134129; Hernandez CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139784; Hernandez-Marrero JC, 2016, QUATERN INT, V414, P337, DOI 10.1016/j.quaint.2015.11.092; Jimenez JJ, 1992, PREHISTORIA CANARIAS, V6; Kivisild T, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-015-0022-2; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Le Bohec Y, 2005, HIST AFRIQUE ROMAINE; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; LONG JC, 1991, GENETICS, V127, P417; Lopez-Pardo F, 1993, HISPANIA ANTIQUA, V17, P435; Maca-Meyer N, 2004, EUR J HUM GENET, V12, P155, DOI 10.1038/sj.ejhg.5201075; Macias-Hernandez AM, 1988, ANUARIO ESTUDIOS ATL, V34, P51; Matisoo-Smith E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190169; Matisoo-Smith EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155046; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Morales J, 2013, ARCHAEOLOGY AFRICAN, P195; Morales J, 2014, VEG HIST ARCHAEOBOT, V23, P789, DOI 10.1007/s00334-014-0444-4; Morales-Mateos J, 2017, MISCELANEA HOMENAJE; Moreno-Benitez M, 2014, B ELECT PATRIMONIO H, V2; Navarro JF, 1992, PREHISTORIA CANARIAS, V5; Navarro JF, 2005, TODO CANARIAS ABORIG; Navarro JF, 1997, ESPACIO TIEMPO FOR 1, V10, P447; Navarro-Mederos J, 1999, ANUARIO ESTUDIOS ATL, V45, P61; Nei N, 1987, MOL EVOLUTIONARY GEN; O'Rourke DH, 2000, ANNU REV ANTHROPOL, V29, P217, DOI 10.1146/annurev.anthro.29.1.217; Olalde I, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0115-7; Ordonez AC, 2017, J ARCHAEOL SCI, V78, P20, DOI 10.1016/j.jas.2016.11.004; Pico B, 2003, CANARIEN MANUSCRITOS; Pinhasi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129102; R_ Development_ Core_ Team, 2008, LANG ENV STAT COMP; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rando JC, 1999, ANN HUM GENET, V63, P413, DOI 10.1046/j.1469-1809.1999.6350413.x; Raven S, 2003, ROME IN AFRICA; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Rodriguez-Rodriguez A, 2012, TABONA, V19, P101; Rodriguez-Varela R, 2017, CURR BIOL, V27, P3396, DOI 10.1016/j.cub.2017.09.059; Ruiz-Gonzalez MT, 2008, 6 C PATR HIST ARQ CA; Rumeu de Armas A, 2006, CONQUISTA TENERIFE 1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Santana J, 2016, AM J PHYS ANTHROPOL, V159, P300, DOI 10.1002/ajpa.22879; Santana-Cabrera J, 2012, TABONA, V19, P125; Santiago-Freijanes JJ, 2018, AGROFOREST SYST, V92, P1105, DOI 10.1007/s10457-018-0212-z; Santos C, 2010, AM J PHYS ANTHROPOL, V141, P610, DOI 10.1002/ajpa.21180; Secher B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-109; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Souville G, 1998, CR ACAD INSCR BELLE, P163; Springer R, 2014, LIBYSCH BERBERISCHEN; Suarez JJ, 1988, HIST POPULAR CANARIA, V2; Tejera-Gaspar A, 1989, PARENTESCO FAMILIA M; Tejera-Gaspar A, 2011, SPAL REV PREHISTORIA, V20, P175; Tejera-Gaspar A, 2006, LIBYSCH BERBERISCHEN; van de Loosdrecht M, 2018, SCIENCE; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Velasco-Vazquez J, 2015, ORIGENES ENFOQUES IN, P23	109	36	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0209125	10.1371/journal.pone.0209125	http://dx.doi.org/10.1371/journal.pone.0209125			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893316	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000461765900002
J	Masse, S; Botrel, M; Walsh, DA; Maranger, R				Masse, Stephanie; Botrel, Morgan; Walsh, David A.; Maranger, Roxane			Annual nitrification dynamics in a seasonally ice-covered lake	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; MONOOXYGENASE AMOA GENES; COMMUNITY COMPOSITION; ENVIRONMENTAL GRADIENTS; NITRIFYING BACTERIA; OXIDATION-KINETICS; ISOTOPIC ANALYSIS; NITROUS-OXIDE; FRESH-WATER; DIVERSITY	We investigated the variability in ammonia oxidation (AO) rates and the presence of ammonia-oxidizing archaea and bacteria (AOB and AOA) over an annual cycle in the water column of a small, seasonnally ice covered, temperate shield lake. AO, the first step of nitrification, was measured in situ using N-15-labelled ammonium (NH4+) at 1% and 10% of photosynthetic active radiation during day and at the same depths during night. AO was active across seasons and light levels, ranging from undetectable to 333 nmol L-1 d(-1) with peak activity in winter under ice cover. NH4+ concentration was the single most important positive predictor of AO rates. High NH4+ concentrations and reduced chlorophyll a concentrations under ice, which favoured AO, were coherent with high nitrate concentrations and super saturation in nitrous oxide. When targeting the ammonia monooxygenase (amoA) gene in samples from the photic zone, we found AOA to be omnipresent throughout the year while AOB were observed predominantly during winter. Our results demonstrate that AO is an ongoing process in sunlit surface waters of temperate lakes and at all seasons with pronounced nitrification activity observed during winter under ice. The combination of high NH4+ concentrations due to fall overturn, reduced light availability that limited phytoplankton competition, and the presence of AOB together with AOA apparently favoured these elevated rates under ice. We suggest that lake ice could be a control point for nitrification in oli-gotrophic temperate shield lakes, characterized as a moment and place that exerts disproportionate influence on the biogeochemical behaviour of ecosystems.	[Masse, Stephanie; Botrel, Morgan; Maranger, Roxane] Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ, Canada; [Walsh, David A.] Concordia Univ, Dept Biol, Grp Rech Interuniv Limnol, Montreal, PQ, Canada	Universite de Montreal; Concordia University - Canada	Botrel, M (corresponding author), Univ Montreal, Dept Sci Biol, Grp Rech Interuniv Limnol, Montreal, PQ, Canada.	morgan.botrel@umontreal.ca	Botrel, Morgan/HCH-3627-2022	Botrel, Morgan/0000-0001-6313-8996	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche du Quebec - Nature et technologies (FRQNT); NSERC Discovery Grant; NSERC; FRQNT student scholarships; FRQNT Strategic Network grant	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Nature et technologies (FRQNT); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQNT student scholarships; FRQNT Strategic Network grant	Research was funded through the Natural Sciences and Engineering Research Council of Canada (NSERC; www.nserc-crsng.gc.ca) and Fonds de recherche du Quebec - Nature et technologies (FRQNT, http://www.frqnt.gouv.qc.ca). RM and DAW were funded through a NSERC Discovery Grant. SM and MB were funded through NSERC and FRQNT student scholarships. Part of the research was funded by a FRQNT Strategic Network grant to the Groupe de recherche interuniversitaire en limnologie (GRIL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Andersson MGI, 2006, AQUAT MICROB ECOL, V42, P149, DOI 10.3354/ame042149; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Auguet JC, 2013, FEMS MICROBIOL ECOL, V84, P154, DOI 10.1111/1574-6941.12047; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Benson BJ, 2012, CLIMATIC CHANGE, V112, P299, DOI 10.1007/s10584-011-0212-8; Bernhardt ES, 2017, ECOSYSTEMS, V20, P665, DOI 10.1007/s10021-016-0103-y; Bertilsson S, 2013, LIMNOL OCEANOGR, V58, P1998, DOI 10.4319/lo.2013.58.6.1998; Bollmann A, 2002, APPL ENVIRON MICROB, V68, P4751, DOI 10.1128/AEM.68.10.4751-4757.2002; Bollmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097068; Botrel M, 2017, BIOGEOCHEMISTRY, V135, P221, DOI 10.1007/s10533-017-0369-y; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Carignan R, 2000, LIMNOL OCEANOGR, V45, P189, DOI 10.4319/lo.2000.45.1.0189; Carini SA, 2008, LIMNOL OCEANOGR, V53, P2546, DOI 10.4319/lo.2008.53.6.2546; Christman GD, 2011, APPL ENVIRON MICROB, V77, P2026, DOI 10.1128/AEM.01907-10; Cole JJ, 2001, ENVIRON SCI TECHNOL, V35, P991, DOI 10.1021/es0015848; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; DUGDALE RC, 1986, LIMNOL OCEANOGR, V31, P673, DOI 10.4319/lo.1986.31.4.0673; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Francis CA, 2003, GEOBIOLOGY, V1, P129, DOI 10.1046/j.1472-4669.2003.00010.x; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; GLIBERT PM, 1982, LIMNOL OCEANOGR, V27, P639; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Grundle DS, 2011, MAR CHEM, V126, P173, DOI 10.1016/j.marchem.2011.06.001; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P183, DOI 10.3354/meps141183; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hampel JJ, 2018, BIOGEOSCIENCES, V15, P733, DOI 10.5194/bg-15-733-2018; Hampton SE, 2017, ECOL LETT, V20, P98, DOI 10.1111/ele.12699; Hampton SE, 2015, J PLANKTON RES, V37, P277, DOI 10.1093/plankt/fbv002; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayden CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111560; HIORNS WD, 1995, MICROBIOL-SGM, V141, P2793, DOI 10.1099/13500872-141-11-2793; Horak REA, 2013, ISME J, V7, P2023, DOI 10.1038/ismej.2013.75; Horz HP, 2000, J MICROBIOL METH, V39, P197, DOI 10.1016/S0167-7012(99)00119-0; Jobin VO, 2014, J PLANKTON RES, V36, P933, DOI 10.1093/plankt/fbu036; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; Kim OS, 2008, FEMS MICROBIOL ECOL, V66, P367, DOI 10.1111/j.1574-6941.2008.00565.x; KNOWLES R, 1987, CAN J FISH AQUAT SCI, V44, P743, DOI 10.1139/f87-090; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lavrentyev PJ, 1997, AQUAT MICROB ECOL, V13, P161, DOI 10.3354/ame013161; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Macek M, 2001, J PLANKTON RES, V23, P353, DOI 10.1093/plankt/23.4.353; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; McCarthy JJ, 1999, DEEP-SEA RES PT II, V46, P1623, DOI 10.1016/S0967-0645(99)00038-7; McIlvin MR, 2005, ANAL CHEM, V77, P5589, DOI 10.1021/ac050528s; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Newell SE, 2013, LIMNOL OCEANOGR, V58, P1491, DOI 10.4319/lo.2013.58.4.1491; Newell SE, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003940; Pedneault E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04661; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Powers SM, 2017, LIMNOL OCEANOGR LETT, V2, P177, DOI 10.1002/lol2.10048; Powers SM, 2017, BIOGEOCHEMISTRY, V136, P119, DOI 10.1007/s10533-017-0382-1; Restrepo-Ortiz CX, 2014, ENVIRON MICROBIOL, V16, P689, DOI 10.1111/1462-2920.12191; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Small GE, 2013, LIMNOL OCEANOGR, V58, P276, DOI 10.4319/lo.2013.58.1.0276; Smith JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108173; Smith JM, 2014, ISME J, V8, P1704, DOI 10.1038/ismej.2014.11; Soued C, 2016, NAT GEOSCI, V9, P116, DOI 10.1038/NGEO2611; St-Gelais NF, 2018, CAN J FISH AQUAT SCI, V75, P26, DOI 10.1139/cjfas-2016-0418; Stephen JR, 1999, APPL ENVIRON MICROB, V65, P95; Surdu CM, 2014, CRYOSPHERE, V8, P167, DOI 10.5194/tc-8-167-2014; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thurman J, 2012, FEMS MICROBIOL ECOL, V82, P449, DOI 10.1111/j.1574-6941.2012.01423.x; Verpoorter C, 2014, GEOPHYS RES LETT, V41, P6396, DOI 10.1002/2014GL060641; Vissers EW, 2013, ARCHAEA, V2013, DOI 10.1155/2013/289478; Ward BB, 2005, METHOD ENZYMOL, V397, P395, DOI 10.1016/S0076-6879(05)97024-9; Ward BB, 2005, MAR ECOL PROG SER, V292, P97, DOI 10.3354/meps292097; Ward BB, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P199, DOI 10.1016/B978-0-12-372522-6.00005-0; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002	81	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213748	10.1371/journal.pone.0213748	http://dx.doi.org/10.1371/journal.pone.0213748			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893339	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900049
J	Koenig, O; Neumann, B; Schlensak, C; Wendel, HP; Nolte, A				Koenig, Olivia; Neumann, Bernd; Schlensak, Christian; Wendel, Hans Peter; Nolte, Andrea			Hyaluronic acid/poly(ethylenimine) polyelectrolyte multilayer coatings for siRNA-mediated local gene silencing	PLOS ONE			English	Article							RNA-INTERFERENCE; SYSTEMIC DELIVERY; ELUTING BALLOONS; ACID; CHITOSAN; MICE; NANOPARTICLES; IMPLANTATION; DERIVATIVES; RELEASE	Local gene delivery systems utilizing RNA interference technology are a promising approach for therapeutic applications where site-specific release of agents is desired. Poly electrolyte multilayers (PEMs) can be constructed using the layer-by-layer (LbL) technique and serve as a depot for bioactive substances, which can then be released in a controlled manner. Multilayers of hyaluronic acid/poly(ethylenimine) HA/PEI were built up with different numbers of bilayers and PEI-siRNA particles were embedded in bioactive layers for gene silencing. The increase of the bilayers and the release of siRNA particles were demonstrated by fluorescence intensity measurement with a fluorescence reader. Two different LbL techniques were tested for the reduction of ICAM-1 expression in EA.hy926: PEM build-up by dipping or drying steps, respectively. Herein, the drying technique of the bioactive layers with ICAM siRNA mediated a significant reduction of the ICAM-1 expression from 3 to 24 bilayers. The fluorescent siRNA release study and the re-culturing of the HA/PEI films demonstrated a release of the transfection particles within the first hour. The advantage of dried built-up PEMs compared to a dried monolayer of PEI-siRNA particles with the same siRNA concentration was a significant higher amount of viable cells.	[Koenig, Olivia; Neumann, Bernd; Schlensak, Christian; Wendel, Hans Peter; Nolte, Andrea] Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, Tubingen, Baden Wuerttemb, Germany	Eberhard Karls University of Tubingen	Wendel, HP (corresponding author), Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, Tubingen, Baden Wuerttemb, Germany.	hans-peter.wendel@med.uni-tuebingen.de						Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016; Al-Qadi S, 2013, COLLOID SURFACE B, V103, P615, DOI 10.1016/j.colsurfb.2012.11.009; Alfonso F, 2017, EXPERT OPIN DRUG DEL, V14, P841, DOI 10.1080/17425247.2017.1245291; Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235; Behr JP, 1997, CHIMIA, V51, P34; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Byrne RA, 2013, LANCET, V381, P461, DOI 10.1016/S0140-6736(12)61964-3; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Castleberry S, 2013, ACS NANO, V7, P5251, DOI 10.1021/nn401011n; Choi KM, 2013, MOL PHARMACEUT, V10, P18, DOI 10.1021/mp300211a; Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Haidar ZS, 2008, BIOMATERIALS, V29, P1207, DOI 10.1016/j.biomaterials.2007.11.012; Han SE, 2009, J DRUG TARGET, V17, P123, DOI [10.1080/10611860802472461, 10.1080/10611860802472461 ]; Hartmann H, 2013, J CONTROL RELEASE, V168, P289, DOI 10.1016/j.jconrel.2013.03.026; Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065; Hoffmann N, 2011, NEUROSCI LETT, V494, P14, DOI 10.1016/j.neulet.2011.02.043; Holmes CA, 2013, ACS APPL MATER INTER, V5, P524, DOI 10.1021/am303029k; Hossfeld S, 2013, ACTA BIOMATER, V9, P6741, DOI 10.1016/j.actbio.2013.01.013; Katz MG, 2012, GENE THER, V19, P659, DOI 10.1038/gt.2012.11; Keeney M, 2013, BIOMATERIALS, V34, P10287, DOI 10.1016/j.biomaterials.2013.09.028; Kenjo E, 2013, BIOL PHARM BULL, V36, P287, DOI 10.1248/bpb.b12-00817; Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033; Kim EJ, 2009, J GENE MED, V11, P791, DOI 10.1002/jgm.1352; Kim SH, 2009, J DRUG TARGET, V17, P311, DOI 10.1080/10611860902767232; Koenig O, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010023; Koenig O, 2017, MOL THER-NUCL ACIDS, V6, P290, DOI 10.1016/j.omtn.2017.01.006; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Luc G, 2003, ATHEROSCLEROSIS, V170, P169, DOI 10.1016/S0021-9150(03)00280-6; Lutkenhaus JL, 2008, MACROMOLECULES, V41, P6047, DOI 10.1021/ma800003x; Ma XD, 2011, J PHARMACEUT BIOMED, V54, P807, DOI 10.1016/j.jpba.2010.10.027; Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052; Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075; Minuth WW, 2002, MIKROREAKTORTECHNIK; Navarro G, 2012, NANOMEDICINE-UK, V7, P65, DOI [10.2217/NNM.11.93, 10.2217/nnm.11.93]; Nishida H, 2016, J CONTROL RELEASE, V231, P29, DOI 10.1016/j.jconrel.2016.03.016; Nolte A, 2013, J BIOMATER APPL, V28, P84, DOI 10.1177/0885328212437610; Nolte A, 2011, MOL MED, V17, P1213, DOI 10.2119/molmed.2011.00143; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g; Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219; Qu YM, 2009, J VASC SURG, V50, P1452, DOI 10.1016/j.jvs.2009.08.050; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Tashiro T, 2012, SCI WORLD J, DOI 10.1100/2012/167928; Voigt J, 2012, WOUND REPAIR REGEN, V20, P317, DOI 10.1111/j.1524-475X.2012.00777.x; Wang BA, 2013, INT J CARDIOL, V163, P34, DOI 10.1016/j.ijcard.2011.05.053; Wang XL, 2007, BIOCONJUGATE CHEM, V18, P2169, DOI 10.1021/bc700285q; Wood KC, 2005, ANGEW CHEM INT EDIT, V44, P6704, DOI 10.1002/anie.200502152; Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103; Wu LJ, 2016, APPL SURF SCI, V389, P395, DOI 10.1016/j.apsusc.2016.06.051; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060034	57	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0212584	10.1371/journal.pone.0212584	http://dx.doi.org/10.1371/journal.pone.0212584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889177	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000007
J	Animut, MD; Sorrie, MB; Birhanu, YW; Teshale, MY				Animut, Megbaru Debalkie; Sorrie, Muluken Bekele; Birhanu, Yinager Workineh; Teshale, Manaye Yihune			High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							MEDICATION ADHERENCE; COGNITIVE FUNCTION; MARITAL-STATUS; ANTIRETROVIRAL THERAPY; DRUG-ABUSE; HIV; IMPAIRMENT; DEMENTIA; DEPRESSION; RISK	Background Comprehensive care given to people living with HIV/AIDS is improving over time; however, their concurrent cognitive illness is still ignored, under screened and treated particularly in developing countries. And this problem is also striking in Ethiopia. Therefore, the objective of this study was to assess HIV-associated neurocognitive disorders and associated factors among adult people living with HIV/AIDS. Methods An institution based cross sectional study was conducted from April to May, 2017 at Gamo Gofa zone public Hospitals. International HIV Dementia Scale was used to screen HIV associated neurocognitive disorders. Logistic regression analysis was used to assess predictors of neurocognitive disorders. Result A total of 684 study participants were included in this study with a response rate of 98%. Among them, 56% were females while 44% were males. The mean (+/- SD) age of the participants was 38.8 +/- 8.8years. The screening prevalence of HIV-associated neurocognitive disorder was 67.1% (95% CI; 63.6, 70.5). Body mass index 16 kg/m(2) (AOR 4.389 (1.60312.016)), being married (AOR 0.377 (0.2130.666), unemployment status (AOR 3.181 (1.7525.777) and being in WHO clinical stage T3 category/advancing stages of the disease (AOR 3.558 (1.4069.006) were the key predictors of HIV-associated neurocognitive disorders among people living with HIV/AIDS. Conclusion In this study the screening prevalence of HIV-associated neurocognitive disorder is higher than the earlier reports in Ethiopia and Africa. This indicates that early screening strategies and policies for cognitive health in people living with HIV/AIDS should be given a top priority.	[Animut, Megbaru Debalkie] Arbaminch Univ, Coll Med & Hlth Sci, Dept Nursing, Arbaminch, Ethiopia; [Sorrie, Muluken Bekele; Teshale, Manaye Yihune] Arbaminch Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Arbaminch, Ethiopia; [Birhanu, Yinager Workineh] Bahir Dar Univ, Coll Med Sci, Sch Nursing, Bahir Dar, Ethiopia; [Birhanu, Yinager Workineh] Bahir Dar Univ, Coll Hlth Sci, Sch Nursing, Bahir Dar, Ethiopia	Arba Minch University; Arba Minch University; Bahir Dar University; Bahir Dar University	Animut, MD (corresponding author), Arbaminch Univ, Coll Med & Hlth Sci, Dept Nursing, Arbaminch, Ethiopia.	megbaru4@yahoo.com	Workineh, Yinager/GZK-4021-2022	Workineh, Yinager/0000-0002-5175-1045; Bekele, Muluken/0000-0002-3464-2584				Achappa B., 2014, ASIAN J MED SCI, V5, P61, DOI [10.3126/ajms.v5i4.8724, DOI 10.3126/AJMS.V5I4.8724]; Airoldi M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/467154; Anand P, 2010, AIDS BEHAV, V14, P1213, DOI 10.1007/s10461-010-9684-1; Ances BM, 2007, SEMINARS NEUROLOGY; Antinori A, 2013, CLIN INFECT DIS, V56, P1004, DOI 10.1093/cid/cis975; Arentoft A, 2015, CLIN NEUROPSYCHOL, V29, P232, DOI 10.1080/13854046.2015.1029974; Atashili J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-86; Basu S, 2005, AIDS, V19, P2057, DOI 10.1097/01.aids.0000182518.84407.32; BEACH RS, 1992, ARCH NEUROL-CHICAGO, V49, P501, DOI 10.1001/archneur.1992.00530290089016; Becker BW, 2011, AIDS BEHAV, V15, P1888, DOI 10.1007/s10461-011-9924-z; Belete T, 2017, ETHIOP J HEALTH SCI, V27, P67, DOI 10.4314/ejhs.v27i1.9; Berkman LF, 2000, LANCET, V355, P1291, DOI 10.1016/S0140-6736(00)02107-3; Brown LAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095500; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; Chan LG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000662; Cross HM, 2013, SAMJ S AFR MED J, V103, P758, DOI [10.7196/samj.6677, 10.7196/SAMJ.6677]; Cross S, 2013, J NEUROIMMUNE PHARM, V8, P1114, DOI 10.1007/s11481-013-9505-1; Culig Josip, 2014, Coll Antropol, V38, P55; Daniel Elbirt M, 2015, IMAJ; Souza Elisa Moreira de, 2016, Dement. neuropsychol., V10, P42, DOI [10.1590/S1980-57642016DN10100008, 10.1590/s1980-57642016dn10100008]; Do TC, 2018, J VIRUS ERAD, V4, P41; EA H, 2014, HIV ASS NEUROCOGNITI; Estiasari R, 2015, NEUROL ASIA, V20, P155; Frehiwot N, 2014, NATL GUIDELINES COMP; Grov C, 2010, AIDS CARE, V22, P630, DOI 10.1080/09540120903280901; Halman M, 2014, AIDS CARE, V26, P320, DOI 10.1080/09540121.2013.819404; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Helmer C, 1999, NEUROLOGY, V53, P1953, DOI 10.1212/WNL.53.9.1953; HERZLICH BC, 1993, J INTERN MED, V233, P495, DOI 10.1111/j.1365-2796.1993.tb01005.x; Josua K., 2017, J PSYCHIAT RES; Kacanek D, 2010, JAIDS-J ACQ IMM DEF, V53, P266, DOI 10.1097/QAI.0b013e3181b720e7; Kalechstein AD, 2003, J NEUROPSYCH CLIN N, V15, P215, DOI 10.1176/appi.neuropsych.15.2.215; Kelly CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098962; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Letendre Scott, 2011, Top Antivir Med, V19, P137; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Mahadevan A, 2007, J NEUROPATH EXP NEUR, V66, P799, DOI 10.1097/NEN.0b013e3181461d3e; Martin-Thormeyer EM, 2009, NEUROPSYCHOL REV, V19, P215, DOI 10.1007/s11065-009-9101-6; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McNamara PH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw242; McQuiston M., 2009, ROLE COGNITIVE FUNCT, DOI [10.1093/jpepsy/jsn068, DOI 10.1093/JPEPSY/JSN068]; Meade CS, 2011, J BEHAV MED, V34, P128, DOI 10.1007/s10865-010-9293-5; Mossie TB., 2014, AM J PSYCHOL NEUROSC, V2, P18, DOI [10.11648/j.ajpn.20140202.11, DOI 10.11648/J.AJPN.20140202.11]; Mousavi-Nasab SMH, 2012, SCAND J PSYCHOL, V53, P1, DOI 10.1111/j.1467-9450.2011.00926.x; Nakku J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-126; Nightingale S, 2014, LANCET NEUROL, V13, P1139, DOI 10.1016/S1474-4422(14)70137-1; Okafor CN, 2017, PSYCHOL HEALTH MED, V22, P289, DOI 10.1080/13548506.2016.1199887; Paddick S- M, 2017, 16 PREVALENCE RISK F; Patel VN, 2010, INT J STD AIDS, V21, P356, DOI 10.1258/ijsa.2010.009554; Pinheiro CAT, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165344; Rao VR, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-13; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Saczynski JS, 2006, AM J EPIDEMIOL, V163, P433, DOI 10.1093/aje/kwj061; Sanders C, 2016, J ALZHEIMERS DIS, V52, P33, DOI 10.3233/JAD-150528; SHORPOSNER G, 1994, INT J PSYCHIAT MED, V24, P209, DOI 10.2190/7VD8-DA67-8T9L-UCHL; Simon SL, 2000, AM J ADDICTION, V9, P222; Steinberg TC, 2012, PREDICTORS HIV RELAT; Tadesse T, 2005, J NEUROVIROL, V11, P22, DOI 10.1080/13550280590922874; Tedaldi EM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/641913; Thaler NS, 2015, NEUROPSYCHOLOGY, V29, P919, DOI 10.1037/neu0000191; Troncoso FT, 2015, REV SOC BRAS MED TRO, V48, P390, DOI 10.1590/0037-8682-0034-2015; Tsegaw M, 2017, J PSYCHIATR RES, V85, P37, DOI 10.1016/j.jpsychires.2016.10.016; van Gelder BM, 2006, J GERONTOL B-PSYCHOL, V61, pP213, DOI 10.1093/geronb/61.4.P213; van Wijk C, 2013, S AFR J HIV MED, V14, P17, DOI 10.7196/SAJHIVMED.855; Van Wijk C., 2013, SO AFRICAN J HIV MED, V14; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; Wright EJ, 2015, HIV MED, V16, P97, DOI 10.1111/hiv.12238; Yakasai AM, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/486960; Yeh SCJ, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-9; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Yusuf Abdulkareem Jika, 2017, J Int Assoc Provid AIDS Care, V16, P48, DOI 10.1177/2325957414553839; Yusuf AJ, 2014, J INT ASS PROVIDERS	75	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0204636	10.1371/journal.pone.0204636	http://dx.doi.org/10.1371/journal.pone.0204636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883557	gold, Green Published			2022-12-26	WOS:000461423500001
J	Ehrlich, SK; Agres, KR; Guan, CT; Cheng, G				Ehrlich, Stefan K.; Agres, Kat R.; Guan, Cuntai; Cheng, Gordon			A closed-loop, music-based brain-computer interface for emotion mediation	PLOS ONE			English	Article							EEG; THERAPY; AROUSAL; RECOGNITION; PERCEPTION; COGNITION; PICTURES; ANXIETY; TOOL	Emotions play a critical role in rational and intelligent behavior; a better fundamental knowledge of them is indispensable for understanding higher order brain function. We propose a non-invasive brain-computer interface (BCI) system to feedback a person's affective state such that a closed-loop interaction between the participant's brain responses and the musical stimuli is established. We realized this concept technically in a functional prototype of an algorithm that generates continuous and controllable patterns of synthesized affective music in real-time, which is embedded within a BCI architecture. We evaluated our concept in two separate studies. In the first study, we tested the efficacy of our music algorithm by measuring subjective affective responses from 11 participants. In a second pilot study, the algorithm was embedded in a real-time BCI architecture to investigate affective closed-loop interactions in 5 participants. Preliminary results suggested that participants were able to intentionally modulate the musical feedback by self-inducing emotions (e.g., by recalling memories), suggesting that the system was able not only to capture the listener's current affective state in real-time, but also potentially provide a tool for listeners to mediate their own emotions by interacting with music. The proposed concept offers a tool to study emotions in the loop, promising to cast a complementary light on emotion-related brain research, particularly in terms of clarifying the interactive, spatio-temporal dynamics underlying affective processing in the brain.	[Ehrlich, Stefan K.; Cheng, Gordon] TUM, Dept Elect & Comp Engn, Chair Cognit Syst, Munich, Germany; [Agres, Kat R.] Agcy Sci Technol & Res, Social & Cognit Comp Dept, Inst High Performance Comp, Singapore, Singapore; [Agres, Kat R.] Natl Univ Singapore, Yong Siew Toh Conservatory Mus, Singapore, Singapore; [Guan, Cuntai] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore	Technical University of Munich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ehrlich, SK (corresponding author), TUM, Dept Elect & Comp Engn, Chair Cognit Syst, Munich, Germany.	stefan.ehrlich@tum.de	Cheng, Gordon/AAH-3554-2020; Guan, Cuntai/G-7835-2016	Cheng, Gordon/0000-0003-0770-8717; Guan, Cuntai/0000-0002-0872-3276; Ehrlich, Stefan K./0000-0002-3634-6973; Agres, Kathleen/0000-0001-7260-2447	Agency for Science Technology and Research (A*STAR), Singapore, through the Singapore International Pre-Graduate Award (SIPGA); German Research Foundation (DFG) through the International Graduate School of Science and Engineering (IGSSE) at the Technical University of Munich (TUM)	Agency for Science Technology and Research (A*STAR), Singapore, through the Singapore International Pre-Graduate Award (SIPGA); German Research Foundation (DFG) through the International Graduate School of Science and Engineering (IGSSE) at the Technical University of Munich (TUM)	This research was partially funded by the Agency for Science Technology and Research (A. STAR), Singapore, through the Singapore International Pre-Graduate Award (SIPGA) and is supported by the German Research Foundation (DFG) through the International Graduate School of Science and Engineering (IGSSE) at the Technical University of Munich (TUM).	Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Ashida S, 2000, J MUSIC THER, V37, P170, DOI 10.1093/jmt/37.3.170; Badcock NA, 2015, PEERJ, V3, DOI 10.7717/peerj.907; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Balconi M, 2008, INT J PSYCHOPHYSIOL, V67, P41, DOI 10.1016/j.ijpsycho.2007.10.002; Balconi M, 2009, INT J PSYCHOPHYSIOL, V74, P158, DOI 10.1016/j.ijpsycho.2009.08.006; Barthet M, 2013, LECT NOTES COMPUT SC, V7900, P228, DOI 10.1007/978-3-642-41248-6_13; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Blacking J, 1995, MUSIC CULTURE EXPERI; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; COLE HW, 1985, INT J PSYCHOPHYSIOL, V3, P33, DOI 10.1016/0167-8760(85)90017-0; Cross I, 2001, ANN NY ACAD SCI, V930, P28, DOI 10.1111/j.1749-6632.2001.tb05723.x; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Deuel TA, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00213; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Ehrlich S, 2017, 2017 INT C OR TECHN; Gabrielsson A., 2001, MUSIC EMOTION THEORY, P223, DOI DOI 10.1525/MP.2004.21.4.561; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; Gorn G, 2001, J CONSUM PSYCHOL, V11, P43, DOI 10.1207/S15327663JCP1101_4; Guetin S, 2009, DEMENT GERIATR COGN, V28, P36, DOI 10.1159/000229024; Hagerer GJ, 2015, P 33 ANN ACM C HUM F; Hinterberger T, 2005, IEEE MULTIMEDIA, V12, P70, DOI 10.1109/MMUL.2005.36; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P751, DOI 10.1017/S0140525X08006079; Keerthiga S., 2011, INT J ENG SCI TECHNO, V3, P3276; Keil A, 2001, CLIN NEUROPHYSIOL, V112, P2057, DOI 10.1016/S1388-2457(01)00654-X; Kim MK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/573734; Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leng X, 1991, NEURAL THEORY HIGHER; Levin YaI, 1998, Neurosci Behav Physiol, V28, P330, DOI 10.1007/BF02462965; Lin YP, 2010, IEEE T BIO-MED ENG, V57, P1798, DOI 10.1109/TBME.2010.2048568; Lucier Alvin, 1976, COMMUNICATION, P60; Magee WL, 2007, BRAIN INJURY, V21, P593, DOI 10.1080/02699050701426907; Makeig S, 2011, LECT NOTES COMPUT SC, V6975, P487, DOI 10.1007/978-3-642-24571-8_61; Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2; Miranda ER, 2005, ICMC; Molina GG, 2009, 2009 3 INT C AFF COM; Muhl C, 2014, BRAIN-COMPUT INTERFA, V1, P66, DOI 10.1080/2326263X.2014.912881; Muller MM, 1999, CLIN NEUROPHYSIOL, V110, P1913, DOI 10.1016/S1388-2457(99)00151-0; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Ochsner K.N., 2004, HDB SELF REGULATION, P229; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Patel A. D., 2007, MUSIC LANGUAGE BRAIN; Persichetti Vincent., 1961, 20 CENTURY HARMONY C; Picard RW, 2003, INT J HUM-COMPUT ST, V59, P55, DOI 10.1016/S1071-5819(03)00052-1; Ramirez R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00354; Rothgeb J., 1982, INTRO THEORY HEINRIC; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHMUCKLER MA, 1989, MUSIC PERCEPT, V7, P109; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Sloboda, 2001, MUSIC EMOTION THEORY, P413; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Sourina O, 2012, J MULTIMODAL USER IN, V5, P27, DOI 10.1007/s12193-011-0080-6; Stoll FM, 2016, CEREB CORTEX, V26, P1715, DOI 10.1093/cercor/bhv006; Thanh NN, 2010, J PEDIATR ONCOL NURS, V27, P146, DOI 10.1177/1043454209355983; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Wallis I, 2008, COMPUTER GENERATING, P712; Wallis I., 2011, P 8 INT SOUND MUS CO, P156; Wander JD, 2014, CURR OPIN NEUROBIOL, V25, P70, DOI 10.1016/j.conb.2013.11.013; Widge AS, 2014, BRAIN-COMPUT INTERFA, V1, P126, DOI 10.1080/2326263X.2014.912885; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yang YH, 2008, IEEE T AUDIO SPEECH, V16, P448, DOI 10.1109/TASL.2007.911513; Yoo MJ, 2011, IEEE COMPUT GRAPH, V31, P89, DOI 10.1109/MCG.2011.36	68	17	21	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213516	10.1371/journal.pone.0213516	http://dx.doi.org/10.1371/journal.pone.0213516			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883569	Green Published, gold			2022-12-26	WOS:000461423500019
J	Ayoub, R; Lee, Y				Ayoub, Ronald; Lee, Yugyung			RUPEE: A fast and accurate purely geometric protein structure search	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; SECONDARY-STRUCTURE; ALGORITHM; TOOL	Given the close relationship between protein structure and function, protein structure searches have long played an established role in bioinformatics. Despite their maturity, existing protein structure searches either use simplifying assumptions or compromise between fast response times and quality of results. These limitations can prevent the easy and efficient exploration of relationships between protein structures, which is the norm in other areas of inquiry. To address these limitations we have developed RUPEE, a fast and accurate purely geometric structure search combining techniques from information retrieval and big data with a novel approach to encoding sequences of torsion angles. Comparing our results to the output of mTM, SSM, and the CATHEDRAL structural scan, it is clear that RUPEE has set a new bar for purely geometric big data approaches to protein structure searches. RUPEE in top-aligned mode produces equal or better results than the best available protein structure searches, and RUPEE in fast mode demonstrates the fastest response times coupled with high quality results. The RUPEE protein structure search is available at https://ayoubresearoh.com. Code and data are available at https://github.com/rayoub/rupee.	[Ayoub, Ronald; Lee, Yugyung] Univ Missouri, Sch Comp & Engn, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Ayoub, R (corresponding author), Univ Missouri, Sch Comp & Engn, Kansas City, MO 64110 USA.	ronaldayoub@mail.umkc.edu		Ayoub, Ronald/0000-0003-2453-9214				Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Aung Z, 2004, BIOINFORMATICS, V20, P1045, DOI 10.1093/bioinformatics/bth036; Ayoub R, 2017, IEEE INT C BIOINFORM, P74; Broder A. Z., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P327, DOI 10.1145/276698.276781; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Broder AZ, 1997, COMPUT NETWORKS ISDN, V29, P1157, DOI 10.1016/S0169-7552(97)00031-7; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; Carpentier M, 2005, PROTEINS, V61, P137, DOI 10.1002/prot.20517; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; Daniluk P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-344; Dong RZ, 2018, NUCLEIC ACIDS RES, V46, pW380, DOI 10.1093/nar/gky430; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Hollingsworth Scott A, 2010, Biomol Concepts, V1, P271, DOI 10.1515/BMC.2010.022; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2010, NUCL ACIDS RES S2, V38, P1; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Joshi S, 2011, PROC VLDB ENDOW, V4, P1284; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Mavridis L, 2012, 3D BLAST 3D PROTEIN, P281; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rajaraman A, 2012, MINING MASSIVE DATAS, P53; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Redfern OC, 2007, PLOS COMPUT BIOL, V3, P2333, DOI 10.1371/journal.pcbi.0030232; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Ye Y., 2003, BIOINFORMATICS, V19, pii246, DOI DOI 10.1093/BIOINFORMATICS/BTG1086; Yuzhen Y., 2004, NUCLEIC ACIDS RES, V32, P582; Zhang L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S46; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	37	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213712	10.1371/journal.pone.0213712	http://dx.doi.org/10.1371/journal.pone.0213712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875409	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400023
J	Nijsse, B; Spikman, JM; Visser-Meily, JMA; de Kort, PLM; van Heugten, CM				Nijsse, Britta; Spikman, Jacoba M.; Visser-Meily, Johanna M. A.; de Kort, Paul L. M.; van Heugten, Caroline M.			Social cognition impairments are associated with behavioural changes in the long term after stroke	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; EMOTION RECOGNITION; MIND; GUIDELINE	Background and purpose Behavioural changes after stroke might be explained by social cognition impairments. The aim of the present study was to investigate whether performances on social cognition tests (including emotion recognition, Theory of Mind (ToM), empathy and behaviour regulation) were associated with behavioural deficits (as measured by proxy ratings) in a group of patients with relatively mild stroke. Methods Prospective cohort study in which 119 patients underwent neuropsychological assessment with tests for social cognition (emotion recognition, ToM, empathy, and behaviour regulation) 3-4 years post stroke. Test scores were compared with scores of 50 healthy controls. Behavioural problems were assessed with the Dysexecutive Questionnaire (DEX) self-rating and proxy rating scales. Pearson correlations were used to determine the relationship between the social cognition measures and DEX scores. Results Patients performed significantly worse on emotion recognition, ToM and behaviour regulation tests than controls. Mean DEX-self score did not differ significantly from the mean DEX-proxy score. DEX-proxy ratings correlated with tests for emotion recognition, empathy, and behavioural regulation (lower scores on these items were associated with more problems on the DEX-proxy scale). Conclusions Social cognition impairments are present in the long term after stroke, even in a group of mildly affected stroke patients. Most of these impairments also turned out to be associated with a broad range of behavioural problems as rated by proxies of the patients. This strengthens the proposal that social cognition impairments are part of the underlying mechanism of behavioural change. Since tests for social cognition can be administered in an early stage, this would allow for timely identification of patients at risk for behavioural problems in the long term.	[Nijsse, Britta; de Kort, Paul L. M.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Spikman, Jacoba M.] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Hoogstr Rehabil, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University	van Heugten, CM (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.; van Heugten, CM (corresponding author), Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl		Nijsse, Britta/0000-0002-3126-8793; Spikman, Jacoba/0000-0002-6477-0763	VSB foundation [89000004]	VSB foundation	This research project is funded by the VSB foundation, grant number 89000004, www.vsbfonds.nl (JMAVM, CMvH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben HP, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.9431; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; BANDURA A, 1991, ORGAN BEHAV HUM DEC, V50, P248, DOI 10.1016/0749-5978(91)90022-L; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burgess PW, 1997, HAYLING BRIXTON TEST, P858, DOI [10.1002/hbm.20547, DOI 10.1002/HBM.20547]; Collin C, 1988, Int Disabil Stud, V10, P61; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Goodglass H., 1983, ASSESSMENT APHASIA R; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Harciarek M, 2009, J CLIN EXP NEUROPSYC, V31, P322, DOI 10.1080/13803390802119930; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Herbet G, 2014, BRAIN, V137, P944, DOI 10.1093/brain/awt370; Hillis A.E., 2014, ADV MED, V2014; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Hoche F, 2016, CEREBELLUM, V15, P732, DOI 10.1007/s12311-015-0746-9; Hochstenbach J, 2005, ARCH PHYS MED REHAB, V86, P1587, DOI 10.1016/j.apmr.2004.11.050; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Lim JS, 2015, J STROKE, V17, P256, DOI 10.5853/jos.2015.17.3.256; Limongi R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00380; Mehrabian A, 2000, GENET SOC GEN PSYCH, V126, P133; Meijer R, 2006, INT J REHABIL RES, V29, P1, DOI 10.1097/01.mrr.0000175269.59788.41; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Nakajima R, 2018, NEUROPSYCHOLOGIA, V115, P179, DOI 10.1016/j.neuropsychologia.2018.01.024; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van Mierlo ML, 2014, INT J STROKE, V9, P148, DOI 10.1111/j.1747-4949.2012.00882.x; Verhage F., 1964, INTELLIGENTIE LEEFTI; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wilkos Ewelina, 2015, Neuropsychiatr Dis Treat, V11, P1031, DOI 10.2147/NDT.S78037; Wilson B. A., 1997, METHODOLOGY FRONTAL, P239; Yeh ZT, 2014, PSYCHIAT CLIN NEUROS, V68, P612, DOI 10.1111/pcn.12173; Young AW, 2002, FACIAL EXPRESSIONS E; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zinchenko O, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00227	46	13	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213725	10.1371/journal.pone.0213725	http://dx.doi.org/10.1371/journal.pone.0213725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO9WM	30875394	Green Submitted, Green Published, gold			2022-12-26	WOS:000461316400025
J	Qudsi, RA; Selzer, F; Hill, SC; Lerner, A; Hippolyte, JW; Jacques, E; Alexis, F; May, CJ; Cady, RB; Losina, E				Qudsi, Rameez A.; Selzer, Faith; Hill, Stephen C.; Lerner, Ariel; Hippolyte, Jean Wildric; Jacques, Eldine; Alexis, Francel; May, Collin J.; Cady, Robert B.; Losina, Elena			Clinical outcomes and risk-factor analysis of the Ponseti Method in a low-resource setting: Clubfoot care in Haiti	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; IDIOPATHIC CLUBFOOT; NEGLECTED CLUBFOOT; MANAGEMENT; CHILDREN; MANIPULATION; AGE; EPIDEMIOLOGY; BARRIERS; BEGIN	Purpose The Ponseti Method has dramatically altered the management of clubfoot, with particular implications for limited-resource settings. We sought to describe outcomes of care and risk factors for sub-optimal results using the Ponseti Method in Haiti. Methods We conducted a records review of patients presenting from 2011-2015 to a CURE Clubfoot clinic in Port-au-Prince, Haiti. We report patient characteristics (demographics and clinical), treatment patterns (cast number/duration and tenotomy rates), and outcomes (relapse and complications). We compared treatment with benchmarks in high-income nations and used generalized linear models to identify risk factors for delayed presentation, increased number of casts, and relapse. Results Amongst 168 children, age at presentation ranged from 0 days (birth) to 4.4 years, 62% were male, 35% were born at home, 63% had bilateral disease, and 46% had idiopathic clubfeet. Prior treatment (RR 6.33, 95% CI 3.18-12.62) was associated with a higher risk of delayed presentation. Risk factors for requiring >= 10 casts included having a non-idiopathic diagnosis (RR 2.28, 95% CI 1.08-4.83) and higher Pirani score (RR 2.78 per 0.5 increase, 95% CI 1.17-6.64). Female sex (RR 1.54, 95% CI 1.01-2.34) and higher Pirani score (RR 1.09 per 0.5 increase, 95% CI 1.00-1.17) were risk factors for relapse. Compared to North American benchmarks, children presented later (median 4.1 wks [IQR 1.6-18.1] vs. 1 wk), with longer casting (12.5 wks [SD 9.8] vs. 7.1 wks), and higher relapse (43% vs. 22%). Conclusions Higher Pirani score, prior treatment, non-idiopathic diagnosis, and female sex were associated with a higher risk of sub-optimal outcomes in this low-resource setting. Compared to high-income nations, serial casting began later, with longer duration and higher relapse. Identifying patients at risk for poor outcomes in a low-resource setting can guide counseling, program development, and resource allocation.	[Qudsi, Rameez A.; Selzer, Faith; Lerner, Ariel; Losina, Elena] Brigham & Womens Hosp, Dept Orthopaed Surg, Orthopaed & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA; [Qudsi, Rameez A.; Selzer, Faith; Losina, Elena] Brigham & Womens Hosp, Dept Orthopaed Surg, Policy & Innovat Evaluat Orthoped Treatments Ctr, 75 Francis St, Boston, MA 02115 USA; [Qudsi, Rameez A.; May, Collin J.] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Qudsi, Rameez A.] Harvard Combined Orthopaed Residency Program, Boston, MA 02138 USA; [Qudsi, Rameez A.; Selzer, Faith; Losina, Elena] Harvard Med Sch, Boston, MA 02115 USA; [Hill, Stephen C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Hippolyte, Jean Wildric] Hop Univ Etat Haiti, Port Au Prince, Haiti; [Jacques, Eldine] CURE Clubfoot, Port Au Prince, Haiti; [Alexis, Francel] Adventist Hosp, Dept Orthopaed Surg, Diquini, Haiti; [Cady, Robert B.] SUNY Upstate Med Univ, Dept Orthopaed, Syracuse, NY 13210 USA; [Cady, Robert B.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Boston University	Qudsi, RA (corresponding author), Brigham & Womens Hosp, Dept Orthopaed Surg, Orthopaed & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA.; Qudsi, RA (corresponding author), Brigham & Womens Hosp, Dept Orthopaed Surg, Policy & Innovat Evaluat Orthoped Treatments Ctr, 75 Francis St, Boston, MA 02115 USA.; Qudsi, RA (corresponding author), Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA.; Qudsi, RA (corresponding author), Harvard Combined Orthopaed Residency Program, Boston, MA 02138 USA.; Qudsi, RA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	qudsi@post.harvard.edu			T32 training grant from the National Institute of Health [AR055885-06]; K24 National Institute of Arthritis and Musculoskeletal and Skin Diseases grant [AR057827]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827, T32AR055885] Funding Source: NIH RePORTER	T32 training grant from the National Institute of Health; K24 National Institute of Arthritis and Musculoskeletal and Skin Diseases grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	RAQ has received support from a T32 training grant (AR055885-06) from the National Institute of Health. EL receives funding support from a K24 National Institute of Arthritis and Musculoskeletal and Skin Diseases grant (AR057827). The remaining authors have no other conflicts or funding.	Adegbehingbe OO, 2017, WORLD J ORTHOP, V8, P624, DOI 10.5312/wjo.v8.i8.624; Agarwal A, 2014, INT ORTHOP, V38, P569, DOI 10.1007/s00264-013-2155-3; Alves C, 2009, CLIN ORTHOP RELAT R, V467, P1271, DOI 10.1007/s11999-008-0698-1; Atria J, 2003, ACCESSIBILITY RELEVA; Ayana B, 2014, ACTA ORTHOP, V85, P641, DOI 10.3109/17453674.2014.957085; Banskota B, 2013, BONE JOINT J, V95B, P1721, DOI 10.1302/0301-620X.95B12.32173; Bashi RHZ, 2016, J PEDIATR ORTHOP B, V25, P99, DOI 10.1097/BPB.0000000000000266; Bohm S, 2013, J CHILD ORTHOP, V7, P251, DOI 10.1007/s11832-013-0497-4; Bridgens J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c355; Burfat Aziza, 2013, Iowa Orthop J, V33, P149; Cady R, GLOBAL CLUBFOOT INIT; Chalayon O, 2011, ORTHOPAEDIC KNOWLEDG, V9; Dobbs MB, 2009, CLIN ORTHOP RELAT R, V467, P1146, DOI 10.1007/s11999-009-0734-9; Faizan M, 2015, J FOOT ANKLE SURG, V54, P967, DOI 10.1053/j.jfas.2014.05.009; Goriainov V, 2010, J CHILD ORTHOP, V4, P439, DOI 10.1007/s11832-010-0287-1; Haft GF, 2007, J BONE JOINT SURG AM, V89A, P487, DOI 10.2106/JBJS.F.00169; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herzenberg JE, 2002, J PEDIATR ORTHOPED, V22, P517, DOI 10.1097/00004694-200207000-00019; Hussain H, 2014, WORLD J SURG, V38, P2217, DOI 10.1007/s00268-014-2530-2; Iltar S, 2010, J FOOT ANKLE SURG, V49, P426, DOI 10.1053/j.jfas.2010.06.010; Johnson RR, 2017, J PEDIATR ORTHOPED, V37, pE134, DOI 10.1097/BPO.0000000000000723; Khan SA, 2010, J PEDIATR ORTHOP B, V19, P385, DOI 10.1097/BPB.0b013e3283387cc8; Kingau NW, 2015, TROP DOCT, V45, P84, DOI 10.1177/0049475514564694; Lourenco AF, 2007, J BONE JOINT SURG BR, V89B, P378, DOI 10.1302/0301-620X.89B3.18313; Lu Ning, 2010, Iowa Orthop J, V30, P1; Matar HE, 2016, J CHILD ORTHOP, V10, P15, DOI 10.1007/s11832-016-0712-1; Mehtani A, 2018, J PEDIATR ORTHOP B, V27, P61, DOI 10.1097/BPB.0000000000000450; Mootha AK, 2011, J ORTHOP SCI, V16, P184, DOI 10.1007/s00776-011-0027-5; Morcuende JA, 2004, PEDIATRICS, V113, P376, DOI 10.1542/peds.113.2.376; Owen RM, 2012, J PEDIATR ORTHOP B, V21, P59, DOI 10.1097/BPB.0b013e3283499264; Parker SE, 2009, BIRTH DEFECTS RES A, V85, P897, DOI 10.1002/bdra.20625; Penny A, 2001, SCH ACCESS CHILDREN; Penny JN, 2005, TECH ORTHOP, V20, P153, DOI 10.1097/01.bto.0000162987.08300.5e; Pirani S, 2009, CLIN ORTHOP RELAT R, V467, P1154, DOI 10.1007/s11999-009-0759-0; Ponseti I. V., 1996, CONGENITAL CLUBFOOT, P37; Ponseti I, 2009, CLIN ORTHOP RELAT R, V467, P1133, DOI 10.1007/s11999-009-0720-2; PONSETI IV, 1992, J BONE JOINT SURG AM, V74A, P448, DOI 10.2106/00004623-199274030-00021; SAS Institute Inc, 2013, SAS VERS 9 4; Sinha A, 2016, INDIAN J ORTHOP, V50, P529, DOI 10.4103/0019-5413.189597; Smythe T, 2017, TROP MED INT HEALTH, V22, P269, DOI 10.1111/tmi.12833; Smythe T, 2016, TROP MED INT HEALTH, V21, P1311, DOI 10.1111/tmi.12750; Spiegel DA, 2009, CLIN ORTHOP RELAT R, V467, P1164, DOI 10.1007/s11999-008-0600-1; Staheli L., 2009, CLUBFOOT PONSETI MAN, V3rd ed.; Terrazas-Lafargue Gaston, 2007, Iowa Orthop J, V27, P24; Tindall AJ, 2005, J PEDIATR ORTHOPED, V25, P627, DOI 10.1097/01.bpo.0000164876.97949.6b; Verma A, 2012, J PEDIATR ORTHOP B, V21, P79, DOI 10.1097/BPB.0b013e328347a329; Werler MM, 2013, AM J MED GENET A, V161A, P1569, DOI 10.1002/ajmg.a.35955; Yagmurlu MF, 2011, PEDIATR INT, V53, P85, DOI 10.1111/j.1442-200X.2010.03201.x; Zionts LE, 2016, J PEDIATR ORTHOPED, V36, P558, DOI 10.1097/BPO.0000000000000514; Zionts LE, 2012, J PEDIATR ORTHOPED, V32, P515, DOI 10.1097/BPO.0b013e318259ff79; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213382	10.1371/journal.pone.0213382	http://dx.doi.org/10.1371/journal.pone.0213382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870447	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300031
J	Gupta, D; Pratama, M; Ma, ZY; Li, J; Prasad, M				Gupta, Deepak; Pratama, Mahardhika; Ma, Zhenyuan; Li, Jun; Prasad, Mukesh			Financial time series forecasting using twin support vector regression	PLOS ONE			English	Article							CLASSIFICATION; PREDICTION; MACHINES; SYSTEM	Financial time series forecasting is a crucial measure for improving and making more robust financial decisions throughout the world. Noisy data and non-stationarity information are the two key factors in financial time series prediction. This paper proposes twin support vector regression for financial time series prediction to deal with noisy data and nonstationary information. Various interesting financial time series datasets across a wide range of industries, such as information technology, the stock market, the banking sector, and the oil and petroleum sector, are used for numerical experiments. Further, to test the accuracy of the prediction of the time series, the root mean squared error and the standard deviation are computed, which clearly indicate the usefulness and applicability of the proposed method. The twin support vector regression is computationally faster than other standard support vector regression on the given 44 datasets.	[Gupta, Deepak] Natl Inst Technol, Dept Elect & Comp Engn, Yupia, Arunachal Prade, India; [Pratama, Mahardhika] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore; [Ma, Zhenyuan] Guangdong Polytech Normal Univ, Sch Math & Syst Sci, Guangzhou, Guangdong, Peoples R China; [Li, Jun; Prasad, Mukesh] Univ Technol Sydney, Fac Engn & Technol, Ctr Artificial Intelligence, Sch Software, Sydney, NSW, Australia	National Institute of Technology (NIT System); National Institute of Technology Arunachal Pradesh; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Guangdong Polytechnic Normal University; University of Technology Sydney	Pratama, M (corresponding author), Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore.	mpratama@ntu.edu.sg	Gupta, Deepak/H-4151-2019; Pratama, Mahardhika/AAG-3856-2020	Gupta, Deepak/0000-0002-6375-8615; Pratama, Mahardhika/0000-0001-6531-5087; Prasad, Mukesh/0000-0002-7745-9667	Science and Engineering Research Board, Gov. of India (SERB) [ECR/2016/001464]; Science and Technology Program of Guangzhou [201704030133, PR016-1300]	Science and Engineering Research Board, Gov. of India (SERB); Science and Technology Program of Guangzhou	This work was supported in part by the Science and Engineering Research Board, Gov. of India (SERB) under the early career research award ECR/2016/001464 and Science and Technology Program of Guangzhou (No. 201704030133), "A Knowledge-Connection and Cognitive-Style based Mining System for Massive Open Online Courses and Its Application" (Code: PR016-1300).	Achlioptas D, 2002, ADV NEURAL INFORM PR, V14; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Cao L, 2001, NEURAL COMPUT APPL, V10, P184, DOI 10.1007/s005210170010; Demsar J, 2006, J MACH LEARN RES, V7, P1; FAMA EF, 1988, J FINANC ECON, V22, P3, DOI 10.1016/0304-405X(88)90020-7; Fine S, 2002, J MACH LEARN RES, V2, P243, DOI 10.1162/15324430260185619; Goh JC, 2013, PAC-BASIN FINANC J, V22, P69, DOI 10.1016/j.pacfin.2012.10.002; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hassan R, 2005, 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, P192; Huang C, 2002, INT J REMOTE SENS, V23, P725, DOI 10.1080/01431160110040323; Jayadeva, 2007, IEEE T PATTERN ANAL, V29, P905, DOI 10.1109/TPAMI.2007.1068; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Joachims T., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P137, DOI 10.1007/BFb0026683; Joshi, 2015, IAENG INT J COMPUTER, V42; Kim KJ, 2000, EXPERT SYST APPL, V19, P125, DOI 10.1016/S0957-4174(00)00027-0; Kuo RJ, 2001, FUZZY SET SYST, V118, P21, DOI 10.1016/S0165-0114(98)00399-6; Lewellen J, 2004, J FINANC ECON, V74, P209, DOI 10.1016/j.jfineco.2002.11.002; Li X, 2018, PAC-BASIN FINANC J, V49, P1, DOI 10.1016/j.pacfin.2018.03.003; Lin CT, 2015, IEEE T SYST MAN CY-S, V45, P1389, DOI 10.1109/TSMC.2015.2406855; Lin FY, 2011, KNOWL-BASED SYST, V24, P95, DOI 10.1016/j.knosys.2010.07.009; Mangasarian OL, 2006, IEEE T PATTERN ANAL, V28, P69, DOI 10.1109/TPAMI.2006.17; Mukherjee S, 1997, NEURAL NETWORKS FOR SIGNAL PROCESSING VII, P511, DOI 10.1109/NNSP.1997.622433; Muller KR, 1999, ADVANCES IN KERNEL METHODS, P243; Osuna E, 1997, PROC CVPR IEEE, P130, DOI 10.1109/CVPR.1997.609310; Peng XJ, 2010, NEURAL NETWORKS, V23, P365, DOI 10.1016/j.neunet.2009.07.002; Pissarenko D., 2002, THESIS; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Prasad M, 2015, NEUROCOMPUTING, V167, P558, DOI 10.1016/j.neucom.2015.04.034; Prasad M, 2017, J ARTIF INTELL SOFT, V7, P33, DOI 10.1515/jaiscr-2017-0003; Prasad M, 2017, IEEE T SYST MAN CY-S, V47, P584, DOI 10.1109/TSMC.2015.2507139; Saad EW, 1998, IEEE T NEURAL NETWOR, V9, P1456, DOI 10.1109/72.728395; Shen DH, 2017, FINANC INNOV, V3, DOI 10.1186/s40854-017-0053-1; Singh J, 2016, INT J FUZZY SYST, V18, P980, DOI 10.1007/s40815-016-0254-1; Suykens J. A. K., 1999, Proceedings of the European Conference on Circuit Theory and Design. ECCTD'99, P839; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Tsang IW, 2005, P 10 INT WORKSH ART; Vapnik V.N., 1995, NATURE STAT LEARNING	38	14	14	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0211402	10.1371/journal.pone.0211402	http://dx.doi.org/10.1371/journal.pone.0211402			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865670	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000461048900009
J	Taghikhani, E; Maas, R; Fromm, MF; Konig, J				Taghikhani, Emir; Maas, Renke; Fromm, Martin F.; Koenig, Joerg			The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine	PLOS ONE			English	Article							GLYCINE AMIDINOTRANSFERASE; EXPRESSION; KIDNEY; SERUM; MULTIDRUG; MORTALITY; ARGININE; OATP1B1; DRUGS; ACID	Elevated plasma concentrations of the uremic toxin asymmetrical dimethylarginine (ADMA) and low plasma concentrations of L-homoarginine are independently associated with cardiovascular events and total mortality. Enzymes degrading ADMA [dimethylaminohydrolase 1 (DDAH1)] and synthesizing L-homoarginine [L-arginine:glycine amidinotransferase (AGAT)] are expressed in human proximal tubule cells. So far, it is not known which transport protein in the basolateral membrane of proximal tubule cells is mediating the uptake of ADMA into the cells for subsequent degradation or the export of intracellularly synthesized L-homoarginine. One study suggested that the uptake transporter OATP4C1 (gene symbol SLCO4C1) may be involved in the transport of ADMA and other uremic toxins. OATP4C1 is a member of the SLCO/SLC21 family of solute carriers, localized in the basolateral membrane of human proximal tubule cells. By using stably-transfected HEK cells overexpressing human OATP4C1, we demonstrate that ADMA and L-homoarginine are substrates of OATP4C1 with K-m values of 232.1 mu M and 49.9 mu M, respectively. ADMA and the structurally related uremic toxin SDMA (100 mu M) inhibited OATP4C1-mediated L-homoarginine uptake (P < 0.01), whereas other tested uremic toxins such as urea and p-cresyl sulfate have no effect on OATP4C1-mediated transport. Preloading experiments (300 mu M for 60 min) with subsequent efflux studies revealed that OATP4C1 also facilitates efflux e.g. of L-homoarginine. Both ADMA and L-homoarginine are substrates of human OATP4C1. Because proximal tubule cells are one site of ADMA metabolism and L-homoarginine synthesis, we postulate a protective role of OATP4C1 by mediating uptake of ADMA from and export of L-homoarginine into the systemic circulation.	[Taghikhani, Emir; Maas, Renke; Fromm, Martin F.; Koenig, Joerg] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany	University of Erlangen Nuremberg	Konig, J (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany.	joerg.koenig@fau.de		Koenig, Joerg/0000-0001-7016-5482	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by Deutsche Forschungsgemeinschaft (DFG) (KO 2120/7-1 to ET and JK). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Dr. Roos Masereeuw (Utrecht Institute for Pharmaceutical Sciences, The Netherlands) for providing uremic toxins used as potential OATP4C1-mediated transport modulators and Claudia Hoffmann and Katrin Singer for excellent experimental support. This work was supported by Grant KO 2120/7-1 from the Deutsche Forschungsgemeinschaft (DFG).	Atzler D, 2015, CURR OPIN CLIN NUTR, V18, P83, DOI 10.1097/MCO.0000000000000123; Atzler D, 2014, CLIN CHEM LAB MED, V52, P1835, DOI 10.1515/cclm-2014-0314; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Chafai A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04965-2; Choe CU, 2013, CIRCULATION, V128, P1451, DOI 10.1161/CIRCULATIONAHA.112.000580; Cui YH, 1999, MOL PHARMACOL, V55, P929; Cullen ME, 2006, CIRCULATION, V114, pI16, DOI 10.1161/CIRCULATIONAHA.105.000448; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; He JK, 2014, BIOPHARM DRUG DISPOS, V35, P253, DOI 10.1002/bdd.1890; Jacobi J, 2008, AM J NEPHROL, V28, P224, DOI 10.1159/000110092; Kimoto E, 2011, DRUG METAB DISPOS, V39, P47, DOI 10.1124/dmd.110.034298; Kleber ME, 2013, CIRC-CARDIOVASC GENE, V6, P505, DOI 10.1161/CIRCGENETICS.113.000108; Konig J, 2012, BASIC CLIN PHARMACOL, V111, P81, DOI 10.1111/j.1742-7843.2012.00865.x; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; MARESCAU B, 1992, METABOLISM, V41, P526, DOI 10.1016/0026-0495(92)90213-T; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pilz S, 2015, AMINO ACIDS, V47, P1703, DOI 10.1007/s00726-015-1993-2; Pilz S, 2014, EUR J CLIN INVEST, V44, P200, DOI 10.1111/eci.12208; Schepers E, 2014, SEMIN NEPHROL, V34, P97, DOI 10.1016/j.semnephrol.2014.02.003; Schlesinger S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165811; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Strobel J, 2013, AMINO ACIDS, V45, P989, DOI 10.1007/s00726-013-1556-3; Tomaschitz A, 2014, NEPHROL DIAL TRANSPL, V29, P663, DOI 10.1093/ndt/gft512; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; VALLANCE P, 1992, LANCET, V339, P572	28	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213747	10.1371/journal.pone.0213747	http://dx.doi.org/10.1371/journal.pone.0213747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865704	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900089
J	Joo, MS; Shin, SB; Kim, EJ; Koo, JH; Yim, H; Kim, SG				Joo, Min Sung; Shin, Sol-Bi; Kim, Eun Jung; Koo, Ja Hyun; Yim, Hyungshin; Kim, Sang Geon			Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21(cip1)	FASEB JOURNAL			English	Article						ceRNA; DNA damage response; oxidative stress; hepatocelluar carcinoma; and miR-122	ANTIOXIDANT RESPONSE ELEMENT; INDUCED DNA-DAMAGE; NONCODING RNAS; MOLECULAR-BASIS; ENHANCER RNAS; PROTEIN; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION; SURVIVAL	Long noncoding RNA (lncRNA) capable of controlling antioxidative capacity remains to be investigated. Nuclear factor erythroid-2-related factor 2 (Nrf2) is a central molecule for cellular defense that increases antioxidative capacity. We identified a novel lncRNA named Nrf2-activating lncRNA (Nrf2-lncRNA) transcribed from an upstream region of the microRNA 122 gene (MIR122). Nrf2-lncRNA existed in the cytoplasm, suggestive of its function as a competing endogenous RNA [ceRNA, microRNA (miRNA) sponge]. Nrf2-lncRNA served as a ceRNA for polo-like kinase (Plk) 2 and cyclin-dependent kinase inhibitor 1 (p21(cip1)) through binding of miRNA 128 and miRNA 224, inducing Plk2/Nrf2/p21(cip1) complexation for Nrf2 activation in the cells under p53-activating conditions (i.e., DNA damage and serum deprivation). Nrf2-lncRNA expression was suppressed with the initiation of apoptosis, being a rheostat for cell fate determination. Nrf2-lncRNA levels correlated with the recurrence-free postsurgery survival rate of patients with hepatocellular carcinoma. Collectively, Nrf2-lncRNA promotes Plk2 and p21(cip1) translation by competing for specific miRNAs and activating Nrf2 under surviving conditions from oxidative stress, implying that Nrf2-lncRNA serves as a fine-tuning rheostat for cell fate decision.-Joo, M. S., Shin, S.-B., Kim, E. J., Koo, J. H., Yim, H., Kim, S. G. Nrf2-lncRNA controls cell fate by modulating p53-dependent Nrf2 activation as an miRNA sponge for Plk2 and p21(cip1).	[Joo, Min Sung; Kim, Eun Jung; Koo, Ja Hyun; Kim, Sang Geon] Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea; [Joo, Min Sung; Kim, Sang Geon] Seoul Natl Univ, Res Inst Pharmaceut Sci, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea; [Shin, Sol-Bi; Yim, Hyungshin] Hanyang Univ, Coll Pharm, 55 Hanyangdaehak Ro, Ansan 15588, South Korea; [Shin, Sol-Bi; Yim, Hyungshin] Hanyang Univ, Inst Pharmaceut Sci & Technol, 55 Hanyangdaehak Ro, Ansan 15588, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hanyang University	Kim, SG (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea.; Kim, SG (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, 1 Gwanak Ro,San 56-1, Seoul 08826, South Korea.; Yim, H (corresponding author), Hanyang Univ, Coll Pharm, 55 Hanyangdaehak Ro, Ansan 15588, South Korea.; Yim, H (corresponding author), Hanyang Univ, Inst Pharmaceut Sci & Technol, 55 Hanyangdaehak Ro, Ansan 15588, South Korea.	hsyim@hanyang.ac.kr; sgk@snu.ac.kr	Koo, Ja Hyun/GQP-5440-2022	Koo, Ja Hyun/0000-0001-5738-1105; Joo, Min Sung/0000-0001-7857-8302	National Research Foundation (NRF) - Ministry of Science and Information and Communication Technology of the Korean government [2014M1A3A3A02034698, 2017K1A1A2004511, 2017R1A2B2012301]	National Research Foundation (NRF) - Ministry of Science and Information and Communication Technology of the Korean government	The authors thank Dr. Hye Eun Byeon (Hanyang University) for the technical support. This work was supported by National Research Foundation (NRF) grants funded by the Ministry of Science and Information and Communication Technology of the Korean government (2014M1A3A3A02034698 and 2017K1A1A2004511 to S.G.K., and 2017R1A2B2012301 to H.Y.). S.G.K. is lead contact. The authors declare no conflicts of interest.	Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Burns TF, 2003, MOL CELL BIOL, V23, P5556, DOI 10.1128/MCB.23.16.5556-5571.2003; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Ge WJ, 2017, CANCER CELL, V32, P561, DOI 10.1016/j.ccell.2017.09.008; Grafi G, 2009, TRENDS BIOTECHNOL, V27, P329, DOI 10.1016/j.tibtech.2009.02.007; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jayakumar S, 2015, MUTAT RES-FUND MOL M, V779, P33, DOI 10.1016/j.mrfmmm.2015.06.007; Jeayeng S, 2017, FREE RADICAL BIO MED, V108, P918, DOI 10.1016/j.freeradbiomed.2017.05.009; Joo MS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.427; Joo MS, 2017, JOVE-J VIS EXP, DOI 10.3791/55708; Joo MS, 2016, MOL CELL BIOL, V36, P1931, DOI 10.1128/MCB.00118-16; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim SB, 2012, P NATL ACAD SCI USA, V109, pE2949, DOI 10.1073/pnas.1207718109; Kim TH, 2018, J CLIN INVEST, V128, P5587, DOI [10.1172/JCI97831, 10.1172/jci97831]; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li JE, 2014, FREE RADICAL BIO MED, V73, P270, DOI 10.1016/j.freeradbiomed.2014.05.022; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Matsumoto T, 2009, P NATL ACAD SCI USA, V106, P14542, DOI 10.1073/pnas.0904229106; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salvi M, 2012, BBA-PROTEINS PROTEOM, V1824, P1366, DOI 10.1016/j.bbapap.2012.07.003; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Villeneuve NF, 2009, CELL CYCLE, V8, P3255, DOI 10.4161/cc.8.20.9565; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang Y, 2017, BIOMED PHARMACOTHER, V87, P548, DOI 10.1016/j.biopha.2016.12.040; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	61	23	25	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7953	7969		10.1096/fj.201802744R	http://dx.doi.org/10.1096/fj.201802744R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30897343	Bronze			2022-12-26	WOS:000476234700013
J	Huang, K; Ru, BB; Zhang, Y; Chan, WL; Chow, SC; Zhang, JW; Lo, C; Lui, WY				Huang, Kun; Ru, Beibei; Zhang, Yang; Chan, Wai-Lung; Chow, Sheung-Ching; Zhang, Jiangwen; Lo, Clive; Lui, Wing-Yee			Sertoli cell-specific coxsackievirus and adenovirus receptor knockout regulates cell adhesion and gene transcription via beta-catenin inactivation and Cdc42 activation	FASEB JOURNAL			English	Article						blood-testis barrier; ectoplasmic specialization; reproductive impairment; spermatogenesis	BLOOD-TESTIS BARRIER; GERM-CELLS; MICE; CAR; COMPLEX; BINDING; INFERTILITY; JUNCTIONS; COMPONENT; GTPASES	Blood-testis barrier (BTB) and apical ectoplasmic specialization (ES) serve as structural supports for germ cell (GC) development. We demonstrated that the Sertoli cell (SC)-specific coxsackievirus and adenovirus receptor (CXADR) knockout (SC-CXADR(-/-)), but not the GC-specific knockout, impaired spermatogenesis. An increase in GC apoptosis and premature loss of elongated spermatids were observed in SC-CXADR(-/-) testes. The BTB function was compromised in SC-CXADR(-/-) testes with dysregulation of oocludin and zonula occludens-1 expression at the basal compartment of the seminiferous epithelium. An integrated omics analyses confirmed that altered gene ontology terms identified in SC-CXADR(-/-) testes are highly associated with spermatid development and differentiation, spermatogenesis, and sperm motility and are considered as unique testicular function terms. Leptin, Nasp, Tektin3, Larp 7, and acrosin, which are highly associated with male fertility, were found to be down-regulated in SC-CXADR(-/-) testes. Based on the data from the omics analyses, we employed the CXADR-deficient SC model to further investigate the molecular mechanisms involved. We unraveled that SC-CXADRs are required for beta-catenin inactivation and cell division cycle protein 42 (Cdc42) activation, resulting in maintaining the integrity and function of the BTB and apical ES as well as inhibiting gene transcription, such as the Myc gene, in the testes. We demonstrated for the first time that CXADR is an important mediator governing beta-catenin and Cdc42 signaling that is essential for spermatogenesis. The molecular mechanisms identified herein may provide new insights to unravel the novel functions and signaling cascades of CXADR in other key CXADR-expressing tissues.-Huang, K., Ru, B., Zhang, Y., Chan, W.-L., Chow, S.-C., Zhang, J., Lo, C., Lui, W.-Y. Sertoli cell-specific coxsackievirus and adenovirus receptor knockout regulates cell adhesion and gene transcription via beta-catenin inactivation and Cdc42 activation.	[Huang, Kun; Ru, Beibei; Zhang, Yang; Chan, Wai-Lung; Chow, Sheung-Ching; Zhang, Jiangwen; Lo, Clive; Lui, Wing-Yee] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China	University of Hong Kong	Lui, WY (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China.	wylui@hku.hk	Lui, Yee/A-2743-2010; Young, Roger/C-8718-2016; Ru, Beibei/F-3830-2011	Young, Roger/0000-0001-8474-5947; 	Hong Kong Research Grants Council [GRF-HKU774213, GRF-HKU17100816]; University of Hong Kong (HKU)/Committee on Research and Conference Grants (CRCG) Seed Funding for Basic Research	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong (HKU)/Committee on Research and Conference Grants (CRCG) Seed Funding for Basic Research	The authors thank Dr. C. Yan Cheng (The Center for Biomedical Research, Population Council, New York, NY, USA) for valuable advice. This work was supported by grants from the Hong Kong Research Grants Council (GRF-HKU774213 and GRF-HKU17100816) and The University of Hong Kong (HKU)/Committee on Research and Conference Grants (CRCG) Seed Funding for Basic Research. The authors declare no conflicts of interest.	Barker P, 2008, TLS-TIMES LIT SUPPL, P5; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Caruso L, 2010, J MOL CELL CARDIOL, V48, P1194, DOI 10.1016/j.yjmcc.2010.01.022; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; Gao YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082782, 10.1371/journal.pone.0075065]; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Huang K, 2016, SEMIN CELL DEV BIOL, V59, P54, DOI 10.1016/j.semcdb.2016.01.034; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; Isotani A, 2017, BIOL REPROD, V97, P61, DOI 10.1093/biolre/iox066; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim JM, 2000, ENDOCRINOLOGY, V141, P1846, DOI 10.1210/en.141.5.1846; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Mirza M, 2007, ENDOCRINOLOGY, V148, P5459, DOI 10.1210/en.2007-0359; Mounzih K, 1997, ENDOCRINOLOGY, V138, P1190, DOI 10.1210/en.138.3.1190; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rotgers E, 2015, ANDROLOGY-US, V3, P947, DOI 10.1111/andr.12066; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schnabel D, 2005, DEV DYNAM, V233, P29, DOI 10.1002/dvdy.20292; Su LL, 2012, AM J PHYSIOL-CELL PH, V303, pC843, DOI 10.1152/ajpcell.00218.2012; Tanwar PS, 2011, MOL ENDOCRINOL, V25, P1725, DOI 10.1210/me.2011-0057; Vernet N, 2006, EMBO J, V25, P5816, DOI 10.1038/sj.emboj.7601447; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang CQF, 2007, EXP CELL RES, V313, P1373, DOI 10.1016/j.yexcr.2007.01.017; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Zhu FY, 2016, J PROTEOME RES, V15, P3528, DOI 10.1021/acs.jproteome.6b00258	42	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7588	7602		10.1096/fj.201801584R	http://dx.doi.org/10.1096/fj.201801584R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30892947				2022-12-26	WOS:000476114200074
J	Kuhnhold, H; Steinmann, N; Huang, YH; Indriana, L; Meyer, A; Kunzmann, A				Kuehnhold, Holger; Steinmann, Nuri; Huang, Yi-Hsuan; Indriana, Lisa; Meyer, Achim; Kunzmann, Andreas			Temperature-induced aerobic scope and Hsp70 expression in the sea cucumber Holothuria scabra	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; THERMAL TOLERANCE; OXYGEN LIMITATION; CLIMATE-CHANGE; STRESS; PERFORMANCE; DROSOPHILA; SALMON; LIMITS; ACCLIMATION	The Aerobic Scope (AS), which reflects the functional capacity for biological fitness, is a highly relevant proxy to determine thermal tolerance in various taxa. Despite the importance of this method, its implementation is often hindered, due to lacking techniques to accurately measure standard-(SMR) and maximal-(MMR) metabolic rates, especially in sluggish marine invertebrates with low oxygen consumption rates, such as sea cucumbers. In this study the AS concept was modified to define a Temperature-induced Aerobic Scope (TAS), based on metabolic rate changes due to temperature adjustments rather than traditionally used physical activity patterns. Consequentially, temperature dependent peak and bottom O-2 consumption rates, defined as Temperature-induced Maximal-(TMMR) and Standard Metabolic Rates (TSMR), respectively, served as MMR and SMR alternatives for the sea cucumber Holothuria scabra. TMMR and TSMR were induced through acute temperature change (2 degrees C per hour; 17-41 degrees C) until critical warm (WTcrit) and cold (CTcrit) temperatures were reached, respectively. In addition, Hsp70 gene expression linked to respiration rates served as synergistic markers to confirm critical threshold temperatures. O-2 consumption of H. scabra peaked distinctly at WTcrit of 38 degrees C (TMMR = 33.2 +/- 4.7 mu gO(2) g(-1) h(-1)). A clear metabolic bottom line was reached at CTcrit of 22 degrees C (TSMR = 2.2 +/- 1.4 mu gO(2) g(-1) h(-1)). Within the thermal window of 22-38 degrees C H. scabra sustained positive aerobic capacity, with assumed optimal performance range between 29-31.5 degrees C (13.85-18.7 mu gO(2) g(-1) h(-1)). Between 39-41 degrees C H. scabra decreased respiration progressively, while gene expression levels of Hsp70 increased significantly at 41 degrees C, indicating prioritization of heat shock response (HSR) and homeostatic disruption. At the cold end (17-22 degrees C) homeostatic disruption was visible through incrementally increasing energetic expenses to fuel basal maintenance costs, but no Hsp70 overexpression occurred. TMMR, TSMR and TAS proved to be reliable metrics, similar to the traditional energetic key parameters MMR, SMR and AS, to determine a specific aerobic performance window for the sluggish bottom dwelling species H. scabra. In addition, the linkage between respiration physiology and molecular defense mechanisms showed valuable analytical synergies in terms of mechanistic prioritization as response to thermal stress. Overall, this study will help to define lethal temperatures for aquaculture and to predict the effects of environmental stress, such as ocean warming, in H. scabra.	[Kuehnhold, Holger; Steinmann, Nuri; Huang, Yi-Hsuan; Meyer, Achim; Kunzmann, Andreas] Leibniz Ctr Trop Marine Res ZMT, Dept Ecol, Bremen, Germany; [Indriana, Lisa] Indonesian Inst Sci LIPI, Res Ctr Oceanog, Lombok, Indonesia	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Indonesian Institute of Sciences	Kuhnhold, H (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Dept Ecol, Bremen, Germany.	holger.kuehnhold@googlemail.com	Kunzmann, Andreas/O-5459-2019; Meyer, Achim/AAE-9061-2021	Kunzmann, Andreas/0000-0002-9500-4332; Kuehnhold, Holger/0000-0002-6371-679X; Meyer, Achim/0000-0002-4345-274X	Leibniz in-house funding	Leibniz in-house funding	This study was funded through Leibniz in-house funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Change I.P.o.C., 2015, CLIMATE CHANGE 2014; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark TD, 2011, J EXP BIOL, V214, P3074, DOI 10.1242/jeb.060517; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Collard M, 2014, ENVIRON SCI POLLUT R, V21, P13602, DOI 10.1007/s11356-014-3259-z; Currie S, 2000, J FISH BIOL, V56, P398, DOI 10.1111/j.1095-8649.2000.tb02114.x; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dong YW, 2016, P ROY SOC LOND B BIO, V284; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Ern R, 2016, J EXP BIOL, V219, P3376, DOI 10.1242/jeb.143495; Falfushynska HI, 2016, SCI REP-UK, V6, DOI 10.1038/srep39476; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; FRY FEJ, 1948, BIOL BULL, V94, P66, DOI 10.2307/1538211; Fujikake N, 2005, FEBS LETT, V579, P3842, DOI 10.1016/j.febslet.2005.05.074; Giomi F, 2016, J EXP BIOL, V219, P686, DOI 10.1242/jeb.128892; Giomi F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2927; Giomi F, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00110; Guderley H, 2010, CAN J ZOOL, V88, P753, DOI 10.1139/Z10-039; Klanian MG, 2013, J EXP MAR BIOL ECOL, V444, P31, DOI 10.1016/j.jembe.2013.03.008; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamel JF, 2001, ADV MAR BIOL, V41, P129, DOI 10.1016/S0065-2881(01)41003-0; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Johansen JL, 2011, GLOBAL CHANGE BIOL, V17, P2971, DOI 10.1111/j.1365-2486.2011.02436.x; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Kuhnhold H, 2017, AQUACULTURE, V467, P109, DOI 10.1016/j.aquaculture.2016.03.018; Kuhnhold H., 2017, TEMPERATURE TOLERANC; Leung JYS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16341-1; Lovatelli A, 2003, ADV SEA CUCUMBER AQU; Melzner F, 2006, J COMP PHYSIOL B, V176, P607, DOI 10.1007/s00360-006-0084-9; Mora C, 2006, J THERM BIOL, V31, P337, DOI 10.1016/j.jtherbio.2006.01.005; Murthy VS, 2016, ABIOTIC STRESS PHYSL, P71, DOI [10.1007/978-81-322-2725-0_4, DOI 10.1007/978-81-322-2725-0_4]; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Nilsson GE, 2009, GLOBAL CHANGE BIOL, V15, P1405, DOI 10.1111/j.1365-2486.2008.01767.x; Overgaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032758; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; PRIEDE IG, 1977, NATURE, V267, P610, DOI 10.1038/267610a0; Purcell SW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3296; Purcell SW, 2006, AQUACULTURE, V251, P238, DOI 10.1016/j.aquaculture.2005.04.078; Rummer JL, 2014, GLOBAL CHANGE BIOL, V20, P1055, DOI 10.1111/gcb.12455; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Schmidt-Nielsen K., 1997, Animal physiology: adaptation and environment.; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Shao YN, 2015, AQUACULTURE, V435, P390, DOI 10.1016/j.aquaculture.2014.10.023; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Somero G.N., 2002, BIOCH ADAPTATION; Song HM, 2014, CELL STRESS CHAPERON, V19, P579, DOI 10.1007/s12192-013-0485-0; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stothard P., 2000, SEQUENCE MANIPULATIO; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Sylvestre EL, 2007, J COMP PHYSIOL B, V177, P447, DOI 10.1007/s00360-007-0143-x; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazzana M, 2015, FISH SHELLFISH IMMUN, V42, P306, DOI 10.1016/j.fsi.2014.11.010; Verberk WCEP, 2016, ANN NY ACAD SCI, V1365, P73, DOI 10.1111/nyas.12876; Vinagre C, 2015, J THERM BIOL, V47, P19, DOI 10.1016/j.jtherbio.2014.10.012; Wittmann AC, 2008, CLIM RES, V37, P227, DOI 10.3354/cr00763; Wolkenhauer Svea Mara, 2008, Beche-de-mer Information Bulletin, V27, P25; Wolkenhauer SM, 2010, J MAR BIOL ASSOC UK, V90, P215, DOI 10.1017/S0025315409990518; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zarco-Perello Salvador, 2012, Galaxea - Tokyo, V14, P97	75	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214373	10.1371/journal.pone.0214373	http://dx.doi.org/10.1371/journal.pone.0214373			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901348	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400049
J	Komurlu, S; Bradley, M; Smolin, N; Imam, S; Pauszek, RF; Robia, SL; Millar, D; Nakayama, EE; Shioda, T; Campbell, EM				Komurlu, Sevnur; Bradley, Margret; Smolin, Nikolai; Imam, Sabrina; Pauszek, Raymond F., III; Robia, Seth L.; Millar, David; Nakayama, Emi E.; Shioda, Tatsuo; Campbell, Edward M.			Defects in assembly explain reduced antiviral activity of the G249D polymorphism in human TRIM5 alpha	PLOS ONE			English	Article							TRIM FAMILY PROTEINS; PARTICLE MESH EWALD; RETROVIRAL RESTRICTION; MOLECULAR-DYNAMICS; RHESUS TRIM5-ALPHA; HIV-1 INFECTION; OLD-WORLD; SUSCEPTIBILITY; DOMAIN; VARIANTS	TRIM5 alpha is an interferon inducible restriction factor which contributes to intrinsic defense against HIV infection by targeting the HIV capsid protein CA. Although human TRIM5 alpha (huTRIM5 alpha) does not potently inhibit HIV-1 infection, the ability of huTRIM5 alpha to exhibit some control of HIV-1 infection is evidenced by a single nucleotide polymorphism in huTRIM5 alpha which substitutes aspartic acid to glycine at position 249 (G249D) in the L2 region and is associated with higher susceptibility to HIV-1 infection. To understand the mechanistic basis for the reduced antiviral activity, we employed biophysical and cell biological methods coupled with molecular dynamics simulations to compare WT and the G249D polymorphism of huTRIM5 alpha. We investigated the differences in conformational dynamics of rhesus and huTRIM5 alpha Coiled Coil Linker 2 (CC-L2) dimers utilizing circular dichroism and single molecule-Fluorescence Energy Transfer (sm-FRET). These methods revealed that the G249D dimer exhibits secondary structure and conformational dynamics similar to WT huTRIM5 alpha. Homology modelling revealed that G249 was present on the hairpin of the anti parallel dimer, in a position which may act to stabilize the adjacent BBox2 domain which mediates the inter-dimeric contacts required for the formation of TRIM5 assemblies. We therefore asked if the G249D mutant forms assemblies in cells with the same efficiency as WT protein by expressing these proteins as YFP fusions and quantifying the number of assemblies in cells. In cells expressing comparable amounts of protein, the G249D mutant formed fewer assemblies than WT protein, in agreement with our homology modeling predictions and molecular dynamics simulations of dimers and higher oligomers of TRIM5 alpha, providing a mechanistic explanation of the reduced antiviral activity of the G249D polymorphism.	[Komurlu, Sevnur; Bradley, Margret; Imam, Sabrina; Campbell, Edward M.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Smolin, Nikolai; Robia, Seth L.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA; [Pauszek, Raymond F., III; Millar, David] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka, Japan	Loyola University Chicago; Loyola University Chicago; Scripps Research Institute; Osaka University	Campbell, EM (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.	ecampbell@luc.edu			National Institute of Health [R01 GM123538-06A1, 5P50GM082545-07]; National Science Foundation [ACI-1548562]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123538, P50GM082545] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Edward M. Campbell was supported by National Institute of Health under grant number R01 GM123538-06A1 and 5P50GM082545-07. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant num ber ACI-1548562.	Anokhin VV, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2742648; Battivelli E, 2011, J VIROL, V85, P11846, DOI 10.1128/JVI.05201-11; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diaz-Griffero F, 2007, VIROLOGY, V369, P400, DOI 10.1016/j.virol.2007.08.032; Diaz-Griffero F, 2007, J VIROL, V81, P10362, DOI 10.1128/JVI.00703-07; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Goldstone DC, 2014, P NATL ACAD SCI USA, V111, P9609, DOI 10.1073/pnas.1402448111; Granier C, 2013, J VIROL, V87, P10368, DOI 10.1128/JVI.01313-13; Grutter MG, 2012, CURR OPIN VIROL, V2, P142, DOI 10.1016/j.coviro.2012.02.003; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hatziioannou T, 2003, EMBO J, V22, P385, DOI 10.1093/emboj/cdg042; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Imam S, 2016, J VIROL, V90, P3400, DOI 10.1128/JVI.03033-15; Javanbakht H, 2006, VIROLOGY, V354, P15, DOI 10.1016/j.virol.2006.06.031; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar AK, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-1; Keown JR, 2016, J STRUCT BIOL, V195, P282, DOI 10.1016/j.jsb.2016.07.004; Lamichhane R, 2017, VIROLOGY, V500, P161, DOI 10.1016/j.virol.2016.10.003; Li YL, 2016, ELIFE, V5, DOI 10.7554/eLife.16269; Lienlaf M, 2011, J VIROL, V85, P8725, DOI 10.1128/JVI.00497-11; Liu FL, 2011, JAIDS-J ACQ IMM DEF, V56, P306, DOI 10.1097/QAI.0b013e318205a59b; McEwan WA, 2009, J VIROL, V83, P8270, DOI 10.1128/JVI.00670-09; Merindol N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007398; Nakajima T, 2009, AIDS, V23, P2091, DOI 10.1097/QAD.0b013e328331567a; Nakayama EE, 2013, AIDS RES HUM RETROV, V29, P919, DOI [10.1089/aid.2012.0369, 10.1089/AID.2012.0369]; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; OhAinle M, 2018, ELIFE, V7, DOI 10.7554/eLife.39823; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Price H, 2010, AIDS, V24, P1813, DOI 10.1097/QAD.0b013e32833b5256; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rahm N, 2013, VIROLOGY, V441, P162, DOI 10.1016/j.virol.2013.03.021; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ribeiro CM, 2016, NATURE; Richardson MW, 2014, MOL THER, V22, P1084, DOI 10.1038/mt.2014.52; Roganowicz MD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006686; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sastri J, 2014, J VIROL, V88, P8911, DOI 10.1128/JVI.01134-14; Sastri J, 2011, AIDS RES HUM RETROV, V27, P231, DOI [10.1089/aid.2010.0367, 10.1089/AID.2010.0367]; Sastri J, 2010, VIROLOGY, V405, P259, DOI 10.1016/j.virol.2010.06.015; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sewram S, 2009, J INFECT DIS, V199, P1657, DOI 10.1086/598861; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sun X, 2015, INT J CLIN EXP MED, V8, P16199; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Van Manen D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040018; Wagner JM, 2016, ELIFE, V5, DOI [10.7554/elife.16309, 10.7554/eLife.16309]; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yudina Z, 2015, CELL REP, V12, P788, DOI 10.1016/j.celrep.2015.06.072	68	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0212888	10.1371/journal.pone.0212888	http://dx.doi.org/10.1371/journal.pone.0212888			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889178	gold, Green Submitted, Green Published			2022-12-26	WOS:000461573000012
J	Shapson-Coe, A; Valeiras, B; Wall, C; Rada, C				Shapson-Coe, Alexander; Valeiras, Brenda; Wall, Christopher; Rada, Cristina			Aicardi-Goutieres Syndrome associated mutations of RNase H2B impair its interaction with ZMYM3 and the CoREST histone-modifying complex	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; GENE; TRANSCRIPTION; REPAIR; REPLICATION; REGULATOR; SUBUNITS; HYBRIDS; CLONING	DNA-RNA hybrids arise in all cell types, and are removed by multiple enzymes, including the trimeric ribonuclease, RNase H2. Mutations in human RNase H2 result in AicardiGoutieres syndrome (AGS), an inflammatory brain disorder notable for being a Mendelian mimic of congenital viral infection. Previous studies have shown that several AGS-associated mutations of the RNase H2B subunit do not affect trimer stability or catalytic activity and are clustered on the surface of the complex, leading us to speculate that these mutations might impair important interactions of RNase H2 with so far unidentified proteins. In this study, we show that AGS mutations in this cluster impair the interaction of RNase H2 with several members of the CoREST chromatin-silencing complex that include the histone deacetylase HDAC2 and the demethylase KDM1A, the transcriptional regulators RCOR1 and GTFII-I as well as ZMYM3, an MYM-type zinc finger protein. We also show that the interaction is mediated by the zinc finger protein ZMYM3, suggesting that ZMYM3 acts as a novel type of scaffold protein coordinating interactions between deacetylase, demethylase and RNase H type enzymes, raising the question of whether coordination between histone modifications and the degradation of RNA-DNA hybrids may be required to prevent inflammation in humans.	[Shapson-Coe, Alexander; Valeiras, Brenda; Wall, Christopher; Rada, Cristina] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge, England; [Shapson-Coe, Alexander] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	MRC Laboratory Molecular Biology; Harvard University	Shapson-Coe, A; Rada, C (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave, Cambridge, England.; Shapson-Coe, A (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	alexshapsoncoe@fas.harvard.edu; car@mrc-lmb.cam.ac.uk		Shapson-Coe, Alexander/0000-0001-9008-3783	Medical Research Council [MC_U105178806]; Stanley Elmore Studentship from Gonville and Caius College; University of Cambridge MB/PhD Programme; Milstein PhD Studentship from the Darwin Trust of Edinburgh; MRC [MC_U105178805, MC_U105178806] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stanley Elmore Studentship from Gonville and Caius College; University of Cambridge MB/PhD Programme; Milstein PhD Studentship from the Darwin Trust of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work in C.R. laboratory is supported by the Medical Research Council (MC_U105178806). A.S.C. is supported by the Stanley Elmore Studentship from Gonville and Caius College, and by the University of Cambridge MB/PhD Programme. B.V. is supported by the Milstein PhD Studentship from the Darwin Trust of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Bartsch K, 2017, HUM MOL GENET, V26, P3960, DOI 10.1093/hmg/ddx283; Benitez-Guijarro M, 2018, EMBO J, V37, DOI 10.15252/embj.201798506; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Coffin SR, 2011, J BIOL CHEM, V286, P16984, DOI 10.1074/jbc.M111.228833; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ., 2005, AICARDI GOUTIERES SY; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Heringa J, 2002, COMPUT CHEM, V26, P459, DOI 10.1016/S0097-8485(02)00008-6; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Jensen TH, 2013, MOL CELL, V52, P473, DOI 10.1016/j.molcel.2013.10.032; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Kemmerich K, 2012, NUCLEIC ACIDS RES, V40, P6016, DOI 10.1093/nar/gks259; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kind B, 2014, HUM MOL GENET, V23, P5950, DOI 10.1093/hmg/ddu319; Leung JWC, 2017, GENE DEV, V31, P260, DOI 10.1101/gad.292516.116; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rigby RE, 2014, EMBO J, V33, P542, DOI 10.1002/embj.201386117; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Smedley D, 1999, GENOMICS, V60, P244, DOI 10.1006/geno.1999.5918; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; vanderMaarel SM, 1996, HUM MOL GENET, V5, P887, DOI 10.1093/hmg/5.7.887; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Zimmermann M, 2018, NATURE, V559, P285, DOI 10.1038/s41586-018-0291-z	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213553	10.1371/journal.pone.0213553	http://dx.doi.org/10.1371/journal.pone.0213553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889214	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000022
J	Izumi, S; Otsuru, S; Adachi, N; Akabudike, N; Enomoto-Iwamoto, M				Izumi, Soutarou; Otsuru, Satoru; Adachi, Nobuo; Akabudike, Ngozi; Enomoto-Iwamoto, Motomi			Control of glucose metabolism is important in tenogenic differentiation of progenitors derived from human injured tendons	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MOHAWK; ACHILLES-TENDON; STEM-CELLS; LACTATE; SCLERAXIS; REPAIR; TENDINOPATHY; REGENERATION; HIF-1-ALPHA; CARTILAGE	Glucose metabolism is altered in injured and healing tendons. However, the mechanism by which the glucose metabolism is involved in the pathogenesis of tendon healing process remains unclear. Injured tendons do not completely heal, and often induce fibrous scar and chondroid lesion. Because previous studies have shown that tendon progenitors play roles in tendon repair, we asked whether connective tissue progenitors appearing in injured tendons alter glucose metabolism during tendon healing process. We isolated connective tissue progenitors from the human injured tendons, obtained at the time of primary surgical repair of rupture or laceration. We first characterized the change in glucose metabolism by metabolomics analysis using [1,2-C-13]-glucose using the cells isolated from the lacerated flexor tendon. The flux of glucose to the glycolysis pathway was increased in the connective tissue progenitors when they proceeded toward tenogenic and chondrogenic differentiation. The influx of glucose to the tricarboxylic acid (TCA) cycle and biosynthesis of amino acids from the intermediates of the TCA cycle were strongly stimulated toward chondrogenic differentiation. When we treated the cultures with 2-deoxy-D-glucose (2DG), an inhibitor of glycolysis, 2DG inhibited chondrogenesis as characterized by accumulation of mucopolysaccharides and expression of AGGRECAN. Interestingly, 2DG strongly stimulated expression of tenogenic transcription factor genes, SCLERAXIS and MOHAWK under both chondrogenic and tenogenic differentiation conditions. The findings suggest that control of glucose metabolism is beneficial for tenogenic differentiation of connective tissue progenitors.	[Izumi, Soutarou; Otsuru, Satoru; Akabudike, Ngozi; Enomoto-Iwamoto, Motomi] Univ Maryland, Dept Orthopaed, Baltimore, MD 21201 USA; [Izumi, Soutarou; Adachi, Nobuo] Hiroshima Univ, Dept Orthopaed Surg, Hiroshima, Japan	University System of Maryland; University of Maryland Baltimore; Hiroshima University	Akabudike, N; Enomoto-Iwamoto, M (corresponding author), Univ Maryland, Dept Orthopaed, Baltimore, MD 21201 USA.	nakabudike@som.umaryland.edu; motomi.iwamoto@som.umaryland.edu		Izumi, Soutarou/0000-0003-1178-7171	National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR070099]; AFSH Basic Science Grant, American Foundation for Surgery of The Hand [1427]; NIH [R01AR070099]; American Foundation for Surgery of The Hand, AFSH Basic Science Grant [1427]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070099] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AFSH Basic Science Grant, American Foundation for Surgery of The Hand; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Surgery of The Hand, AFSH Basic Science Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070099 to MEI), and the AFSH Basic Science Grant (1427 to N. Akabudike), American Foundation for Surgery of The Hand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Miss W. Kimberly for technical assistance, and Dr. Itzak Nissim, Ms. Y. Daikhin, O. Horyn, and Ilana Nissim for assistance with the isotopomer enrichment analysis in the Metabolomic Core facility, Children's Hospital of Philadelphia. We also thank Ms. A. Shreiber for critical reading. This study was supported by the American Foundation for Surgery of The Hand, AFSH Basic Science Grant (1427 for Akabudike) and the NIH R01AR070099 Grant (MEI).	Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Ahmed AS, 2012, J APPL PHYSIOL, V113, P1784, DOI 10.1152/japplphysiol.00767.2012; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Asai S, 2014, STEM CELLS, V32, P3266, DOI 10.1002/stem.1847; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Brown D, 1999, DEVELOPMENT, V126, P4317; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Corciulo C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15019; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Eliasson P, 2016, EUR J NUCL MED MOL I, V43, P1868, DOI 10.1007/s00259-016-3379-4; Fu YJ, 2017, ONCOTARGET, V8, P57813, DOI 10.18632/oncotarget.18175; Galatz LM, 2015, J ORTHOP RES, V33, P823, DOI 10.1002/jor.22853; Ghani QP, 2004, METHOD ENZYMOL, V381, P565; Greve K, 2012, SCAND J MED SCI SPOR, V22, pE55, DOI 10.1111/j.1600-0838.2012.01475.x; Hasegawa Y, 2018, CELL METAB, V27, P180, DOI 10.1016/j.cmet.2017.12.005; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kayama T, 2016, MOL CELL BIOL, V36, P1297, DOI 10.1128/MCB.00950-15; Korntner S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00700-z; Kwon HJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.20; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Leong DJ, 2016, ANN NY ACAD SCI, V1383, P88, DOI 10.1111/nyas.13262; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Lin YC, 2017, ONCOTARGET, V8, P17518, DOI 10.18632/oncotarget.15418; Liu H, 2019, J BONE MINER RES, V34, P557, DOI 10.1002/jbmr.3630; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Longo UG, 2009, BRIT J SPORT MED, V43, P284, DOI 10.1136/bjsm.2008.049320; Lui PPY, 2017, SCAND J MED SCI SPOR, V27, P776, DOI 10.1111/sms.12824; Lui PPY, 2013, J CELL MOL MED, V17, P55, DOI 10.1111/jcmm.12007; Mobasheri Ali, 2012, Front Endocrinol (Lausanne), V3, P153, DOI 10.3389/fendo.2012.00153; Murase Y, 2016, J CELL BIOCHEM, V117, P927, DOI 10.1002/jcb.25377; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nissim I, 2014, J BIOL CHEM, V289, P9710, DOI 10.1074/jbc.M113.544726; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; PARNIAK M, 1985, CAN J BIOCHEM CELL B, V63, P333, DOI 10.1139/o85-049; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rees J, 2016, ADV EXP MED BIOL, V920, P199, DOI 10.1007/978-3-319-33943-6_19; Schipani E, 2001, GENE DEV, V15, P2865; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Snedeker JG, 2016, ADV EXP MED BIOL, V920, P191, DOI 10.1007/978-3-319-33943-6_18; Suzuki H, 2016, P NATL ACAD SCI USA, V113, P7840, DOI 10.1073/pnas.1522054113; Thomopoulos S, 2015, J ORTHOP RES, V33, P832, DOI 10.1002/jor.22806; Trabold O, 2003, WOUND REPAIR REGEN, V11, P504, DOI 10.1046/j.1524-475X.2003.11621.x; Wu YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep44199; Yu SM, 2010, EXP MOL MED, V42, P503, DOI 10.3858/emm.2010.42.7.051; Zhang K, 2018, AM J SPORTS MED	49	8	9	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213912	10.1371/journal.pone.0213912	http://dx.doi.org/10.1371/journal.pone.0213912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883580	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500041
J	Mertens, L; Van Cauwenberg, J; Veitch, J; Deforche, B; Van Dyck, D				Mertens, Lieze; Van Cauwenberg, Jelle; Veitch, Jenny; Deforche, Benedicte; Van Dyck, Delfien			Differences in park characteristic preferences for visitation and physical activity among adolescents: A latent class analysis	PLOS ONE			English	Article							PUBLIC OPEN SPACE; LOCAL NEIGHBORHOOD; CHILDREN; HEALTH; YOUTH; PERCEPTIONS; CHILDHOOD; ADULTHOOD; TRACKING; WALKING	In order to optimize environmental interventions, the current study aimed to investigate whether there are subgroups with different preferences regarding park characteristics for park visitation and park-based PA among adolescents (1216 years). Furthermore, we examined whether the identified subgroups differed in socio-demographics, PA behavior, and park use characteristics (e.g. accompaniment to park, usual activities during park visitation, usual transportation to parks). Adolescents (1216 years) were recruited via randomly selected secondary schools, located in Flanders (Belgium). Class visits were conducted between September and November 2016 and adolescents were asked to complete an online questionnaire. Latent class analyses using Sawtooth Software were used to identify possible subgroups. A final sample of 972 adolescents (mean age 13.3 +/- 1.3 years) remained for analyses. Three subgroups of adolescents with similar preferences for park characteristics could be distinguished for both park visitation and park-based PA. Overall, current results indicate that park upkeep was the most important park characteristic for park visitation as well as park-based PA among at risk subgroups (i.e. adolescents with lower overall PA levels, girls, older adolescents,....) followed by the presence of a playground or outdoor fitness equipment. Among the more active adolescents, especially boys visiting the parks together with friends, the presence of a sport field (soccer and basketball) seems to be the best strategy to increase park visitation as well as park-based PA. Current results provide a starting point to advise policy makers and urban planners when designing or renovating parks that investing in good upkeep and maintenance of parks, and the provision of a playground or outdoor fitness equipment might be the best strategy to increase both park visitation and park-based PA among at risk adolescent subgroups.	[Mertens, Lieze; Van Dyck, Delfien] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Ghent, Belgium; [Mertens, Lieze; Van Cauwenberg, Jelle; Van Dyck, Delfien] Res Fdn Flanders FWO, Brussels, Belgium; [Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, Ghent, Belgium; [Veitch, Jenny] Deakin Univ, IPAN, Geelong, Vic, Australia; [Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Phys Act Nutr & Hlth Res Unit, Brussels, Belgium	Ghent University; Ghent University; Deakin University; Vrije Universiteit Brussel	Mertens, L (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Ghent, Belgium.; Mertens, L (corresponding author), Res Fdn Flanders FWO, Brussels, Belgium.	lieze.mertens@ugent.be	Van Dyck, Delfien/AAO-8981-2020; Mertens, Lieze/AAG-3340-2020	Van Dyck, Delfien/0000-0003-1783-9075; Veitch, Jenny/0000-0001-8962-0887; Mertens, Lieze/0000-0001-7144-2656	Research Foundation Flanders [FWO17/PDO/140, FWO 12I1117N, FWO12/PDO/158]; Australian National Heart Foundation Future Leader Fellowship [101928]	Research Foundation Flanders(FWO); Australian National Heart Foundation Future Leader Fellowship	LM (FWO17/PDO/140), JVC (FWO 12I1117N) and DVD (FWO12/PDO/158) are supported by a postdoctoral fellowship of the Research Foundation Flanders (http://www.fwo.be/).JV is supported by an Australian National Heart Foundation Future Leader Fellowship (ID 101928) (https://www.heartfoundation.org.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DJ, 2002, ARCH PEDIAT ADOL MED, V156, P1075, DOI 10.1001/archpedi.156.11.1075; Allenby GM, 2014, DEMAND HETEROGENEITY, V35, P384; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P1; Babey SH, 2005, ACCESS SAFE PARKS HE, P1; Babey SH, 2008, AM J PREV MED, V34, P345, DOI 10.1016/j.amepre.2008.01.020; Baran PK, 2014, ENVIRON BEHAV, V46, P768, DOI 10.1177/0013916512470134; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Biddle SJH, 2005, J PHYS ACT HEALTH, V2, P423, DOI [DOI 10.1123/JPAH.2.4.423, 10.1123/jpah.2.4.423]; Carver A, 2005, AM J HEALTH PROMOT, V20, P139, DOI 10.4278/0890-1171-20.2.139; Casey MM, 2009, QUAL HEALTH RES, V19, P881, DOI 10.1177/1049732309338198; Cohen DA, 2006, PEDIATRICS, V118, pE1381, DOI 10.1542/peds.2006-1226; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Cubukcu E, 2005, ENVIRON PLANN B, V32, P777, DOI 10.1068/b31191; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; de Farias JC, 2011, PREV MED, V52, P114, DOI 10.1016/j.ypmed.2010.12.002; De Meester F, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-38; Dunton GF, 2014, AM J PREV MED, V46, P136, DOI 10.1016/j.amepre.2013.10.009; Edwards N, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0178-4; Elhakeem A, 2015, INT J BEHAV NUTR PHY, V12, DOI [10.1186/s12966-015-0250-0, 10.1186/s12966-015-0274-5]; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Flemish Government, VLAAMS BEL NAAR ETN, DOI [10.1186/1479-5868-10-38, DOI 10.1186/1479-5868-10-38]; Haerens L, 2007, J SPORT MED PHYS FIT, V47, P344; Haerens L, 2007, J ADOLESCENT HEALTH, V40, P258, DOI 10.1016/j.jadohealth.2006.09.028; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Hunter RF, 2015, SOC SCI MED, V124, P246, DOI 10.1016/j.socscimed.2014.11.051; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Koohsari MJ, 2015, HEALTH PLACE, V33, P75, DOI 10.1016/j.healthplace.2015.02.009; Lloyd K, 2008, J PARK RECREAT ADM, V26, P21; Loukaitou-Sideris A, 2010, J AM PLANN ASSOC, V76, P89, DOI 10.1080/01944360903418338; Magidson J, 2002, LATENT CLASS MODELS, P20; McCormack GR, 2010, HEALTH PLACE, V16, P712, DOI 10.1016/j.healthplace.2010.03.003; Mertens L, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0058-4; Mertens L, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0088-x; Nasar JL, 2013, J PHYS ACT HEALTH, V10, P1201, DOI 10.1123/jpah.10.8.1201; Notelaers G, 2006, WORK STRESS, V20, P289, DOI 10.1080/02678370601071594; Orme BK., 2019, GETTING STARTED CONJ, V4 ed, P57; Orme BK, 2012, LATENT CLASS V4 5; Rangul V, 2008, BMC MED RES METHODOL, V8, P1; Reed JA, 2012, CHILD OBES, V8, P124, DOI 10.1089/chi.2011.0040; Reis RS, 2009, J PHYS ACT HEALTH, V6, P503, DOI 10.1123/jpah.6.4.503; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Salvy SJ, 2012, EXERC SPORT SCI REV, V40, P127, DOI 10.1097/JES.0b013e31825af07b; Seghers JSJ, 2011, JONGEREN IN BEWEGING; Shaw C., 2011, NCB RES CENT INTERNE, P63; Smith AL, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0246-9; Software S, 2004, TECH PAP SER; Telama R, 2005, J SPORTS MED PHYS FI, V28, P264; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Tester J, 2009, PREV MED, V48, P316, DOI 10.1016/j.ypmed.2009.01.010; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2002, CORRELATES ADULTS PA; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Van Hecke L, 2017, INT J ENV RES PUB HE, P14; Van Hecke L., 2017, ROLE PUBLIC OPEN SPA; Van Hecke L, 2016, INT J BEHAV NUTR PHY, V13, P1, DOI DOI 10.1186/S12966-015-0325-Y; Van Hecke L, 2018, LANDSCAPE URBAN PLAN, V178, P144, DOI 10.1016/j.landurbplan.2018.05.017; Van Hecke L, 2018, HEALTH PLACE, V51, P158, DOI 10.1016/j.healthplace.2018.03.008; Van Hecke L, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0123-2; Van Hecke L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155686; Veitch J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-017-0625-5; Veitch J, 2017, LANDSCAPE URBAN PLAN, V161, P52, DOI 10.1016/j.landurbplan.2016.12.004; Veitch J, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0391-9; Veitch J, 2012, AM J PREV MED, V42, P616, DOI 10.1016/j.amepre.2012.02.015; Vermunt JK, 2000, LATENT CLASS CLUSTER, P1; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization (WHO), 2012, INT J OBESITY, V23, ps44	71	14	15	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0212920	10.1371/journal.pone.0212920	http://dx.doi.org/10.1371/journal.pone.0212920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883562	gold, Green Published, Green Submitted			2022-12-26	WOS:000461423500008
J	Ortega, J; Martin, J; Crochet, PA; Lopez, P; Clobert, J				Ortega, Jesus; Martin, Jose; Crochet, Pierre-Andre; Lopez, Pilar; Clobert, Jean			Seasonal and interpopulational phenotypic variation in morphology and sexual signals of Podarcis liolepis lizards	PLOS ONE			English	Article							IBERIAN WALL LIZARDS; FEMALE MATE CHOICE; BODY-SIZE; BERGMANNS RULE; LIFE-HISTORY; CHEMICAL COMMUNICATION; PRECLOACAL SECRETIONS; DISTINCT POPULATIONS; GEOGRAPHIC-VARIATION; SQUAMATA LACERTIDAE	Widespread species often show extensive phenotypic variation due to the contrasting abiotic and biotic factors that shape selective pressures in different environments. In this context, the gradual and predictable patterns of variation in climatic and environmental conditions found in mountain areas offer a great opportunity to explore intraspecific phenotypic variation. For instance, temperature is negatively correlated with altitude and virtually all aspects of the behavior and physiology of ectotherms are sensitive to body temperature. In this work, we tested the hypothesis that morphology, dorsal and ventral coloration and the chemical profile of femoral secretions show interpopulational and seasonal variation in the lacertid lizard (Podarcis liolepis). We compared lizards from three populations inhabiting lowland and highland habitats in the French Pyrenees that were closely related genetically. We found that highland lizards were larger, stockier, had longer heads and more femoral pores and had a darker dorsal coloration than lowland ones. In addition, we detected inter-populational differences in both the abundance and the richness of chemical compounds in the glandular secretions, and we also found seasonal variation in the overall chemical composition. Dorsal and ventral coloration differed seasonally and between populations. Ventral and dorsal brightness were higher in lowland than in highland lizards in the reproductive season whereas the reversed trend was found in the non-reproductive season but only for dorsal brightness. In addition, all lizards had browner dorsal coloration in the non-reproductive season, and lowland lizards were greener in the reproductive season. By integrating information from both visual and chemical systems, our works offers a comprehensive view of how these lizards communicate in a multimodal context.	[Ortega, Jesus; Martin, Jose; Lopez, Pilar] Natl Museum Nat Sci, Dept Evolutionary Ecol, CSIC, Madrid, Spain; [Ortega, Jesus] Lund Univ, Dept Biol, Lund, Sweden; [Crochet, Pierre-Andre] CNRS, UMR 5175, Ctr Ecol Fonct & Evolut Montpellier, Paris, France; [Clobert, Jean] Stn Ecol Theor & Expt, Moulis, France	Consejo Superior de Investigaciones Cientificas (CSIC); Lund University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ortega, J (corresponding author), Natl Museum Nat Sci, Dept Evolutionary Ecol, CSIC, Madrid, Spain.; Ortega, J (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	jesus.ortega@biol.lu.se	Lopez, Pilar/K-6221-2014; Martin, Jose/B-1073-2014; Ortega Gimenez, Jesus/B-4637-2017	Lopez, Pilar/0000-0001-6577-1509; Martin, Jose/0000-0001-6648-3998; Ortega Gimenez, Jesus/0000-0001-6599-1675	Spanish Ministerio de Ciencia Innovacion (MICIIN) [CGL2011-24150/BOS]; Ministerio de Economia Industria y Competitividad (MINECO) [CGL2014-53523-P]; Spanish Research Council (CSIC); Frontiers in Speciation Research programme (FroSpects) of the European Foundation (ESF) [3758]	Spanish Ministerio de Ciencia Innovacion (MICIIN)(Ministry of Science and Innovation, Spain (MICINN)); Ministerio de Economia Industria y Competitividad (MINECO); Spanish Research Council (CSIC); Frontiers in Speciation Research programme (FroSpects) of the European Foundation (ESF)	Funding was provided by Spanish Ministerio de Ciencia Innovacion (MICIIN, CGL2011-24150/BOS) and Ministerio de Economia Industria y Competitividad (MINECO, CGL2014-53523-P) to JM and PL; a Pre-JAE grant from Spanish Research Council (CSIC) to JO; and the Frontiers in Speciation Research programme (FroSpects) of the European Foundation (ESF) funded part of the field work in France (Exchange grant awarded to JO: 3758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; ALBERTS AC, 1992, J CHEM ECOL, V18, P703, DOI 10.1007/BF00994608; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson Staffan, 2000, P47; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Baeckens S, 2018, FUNCT ECOL, V32, P566, DOI 10.1111/1365-2435.12984; Baeckens S, 2017, J CHEM ECOL, V43, P902, DOI 10.1007/s10886-017-0884-2; Baeckens S, 2015, BIOL J LINN SOC, V114, P44, DOI 10.1111/bij.12414; Banclia RI, 2009, STUD CERCET BIOL, V17, P43; Bergmann C., 1848, GOTTINGER STUDIEN, V3, P595; Bittner TD, 2003, OHIO J SCI, V103, P62; Bittner TD, 2002, COPEIA, P477, DOI 10.1643/0045-8511(2002)002[0477:EOBSAM]2.0.CO;2; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Carretero MA, 2002, NETH J ZOOL, V52, P43, DOI 10.1163/156854202760405177; Carretero MA, 2008, INTEGR ZOOL, V3, P247, DOI 10.1111/j.1749-4877.2008.00102.x; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Cooper WE, 1997, J CHEM ECOL, V23, P2967, DOI 10.1023/A:1022587716051; Cooper WE, 1992, BIOL REPTILIA HORMON, V18, P298; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Derryberry EP, 2007, EVOLUTION, V61, P1938, DOI 10.1111/j.1558-5646.2007.00154.x; Dobzhansky T., 1937; Driessens T, 2017, J EVOLUTION BIOL, V30, P1846, DOI 10.1111/jeb.13144; ELLINGSON JM, 1995, J COMP PHYSIOL A, V177, P559; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1983, ENVIRON BIOL FISH, V9, P173, DOI 10.1007/BF00690861; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Escobar CA, 2001, J CHEM ECOL, V27, P1677, DOI 10.1023/A:1010470611061; Escobar CM, 2003, J CHEM ECOL, V29, P629, DOI 10.1023/A:1022858919037; Espmark Y., 2000, ANIMAL SIGNALS SIGNA; FERGUSON GW, 1993, OECOLOGIA, V93, P88, DOI 10.1007/BF00321196; FIELDS PG, 1988, PHYSIOL ENTOMOL, V13, P165, DOI 10.1111/j.1365-3032.1988.tb00920.x; Fleishman LJ, 1997, J COMP PHYSIOL A, V181, P446, DOI 10.1007/s003590050128; FLEISHMAN LJ, 1993, NATURE, V365, P397, DOI 10.1038/365397a0; Gabirot Marianne, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/698520; Gabirot M, 2013, ANN ZOOL FENN, V50, P225, DOI 10.5735/085.050.0406; Gabirot M, 2013, CURR ZOOL, V59, P210, DOI 10.1093/czoolo/59.2.210; Gabirot M, 2010, BIOCHEM SYST ECOL, V38, P521, DOI 10.1016/j.bse.2010.05.008; Galan P, 2008, ANIM BIOL, V58, P173, DOI 10.1163/157075608X328026; Garcia-Roa R, 2017, PEERJ, V5, DOI 10.7717/peerj.3992; Garcia-Roa R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06323-8; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Geniez P, 2014, ZOOTAXA, V3794, P1, DOI 10.11646/zootaxa.3794.1.1; Germano DJ, 2007, SOUTHWEST NAT, V52, P46, DOI 10.1894/0038-4909(2007)52[46:OASCIC]2.0.CO;2; Gorley C.K., 2006, GETTING STARTED PRIM; Grill CP, 2000, BIOL J LINN SOC, V69, P121, DOI 10.1006/bijl.1999.0360; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Houde A.E., 1997, SEX COLOR MATE CHOIC; Huey R.B., 1982, Biology of Reptilia, V12, P25; Ibanez A, 2017, PEERJ, V5, DOI 10.7717/peerj.3689; Joos J, 2017, BIOL J LINN SOC, V122, P351, DOI 10.1093/biolinnean/blx056; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kaliontzopoulou A, 2011, BIOL J LINN SOC, V103, P779, DOI 10.1111/j.1095-8312.2011.01703.x; Kettlewell, 1973, EVOLUTION MELANISM; KING RB, 1992, EVOL ECOL, V6, P115, DOI 10.1007/BF02270706; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwiatkowski MA, 2002, EVOLUTION, V56, P2039; Leache AD, 2010, BIOL J LINN SOC, V100, P630, DOI 10.1111/j.1095-8312.2010.01462.x; Leal M, 2004, AM NAT, V163, P26, DOI 10.1086/379794; Loew ER, 2002, J EXP BIOL, V205, P927; Macedonia JM, 2002, BIOL J LINN SOC, V77, P67, DOI 10.1046/j.1095-8312.2002.00092.x; MacGregor HEA, 2017, EVOLUTION, V71, P2327, DOI 10.1111/evo.13317; Majerus M, 1998, MELANISM EVOLUTION A; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Marquis O, 2008, ECOLOGY, V89, P2575, DOI 10.1890/07-1211.1; Marshall KLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135241; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1442-z; Martin J, 2013, BIOCHEM SYST ECOL, V50, P121, DOI 10.1016/j.bse.2013.03.044; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030108; Mason Robert T., 1992, V18, P114; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCDONOUGH LM, 1989, J CHEM ECOL, V15, P779, DOI 10.1007/BF01015176; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Meiri S, 2011, GLOBAL ECOL BIOGEOGR, V20, P203, DOI 10.1111/j.1466-8238.2010.00577.x; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Molina-Borja M, 2006, J ZOOL, V268, P193, DOI 10.1111/j.1469-7998.2005.00008.x; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Montgomerie R., 2009, CLR VERSION 1 1; Muller-Schwarze D, 2006, CHEM ECOLOGY VERTEBR; NIEWIAROWSKI PH, 1993, ECOLOGY, V74, P1992, DOI 10.2307/1940842; Norris KS, 1965, LIZARD ECOLOGY S, P162; Ord TJ, 2010, EVOLUTION, V64, P3134, DOI 10.1111/j.1558-5646.2010.01056.x; Ortega J, 2017, BIOL J LINN SOC, V122, P340, DOI 10.1093/biolinnean/blx068; Ortega J, 2015, OECOLOGIA, V177, P357, DOI 10.1007/s00442-014-3185-2; de Lanuza GPI, 2016, J EVOLUTION BIOL, V29, P942, DOI 10.1111/jeb.12835; Perez i de Lanuza G, 2013, BEHAV ECOL, V24, P273; Perez i de Lanuza G, 2012, THESIS; de Lanuza GPI, 2015, BEHAV ECOL, V26, P1432, DOI 10.1093/beheco/arv075; Pincheira-Donoso D, 2008, EVOL ECOL RES, V10, P11; Pinho C, 2007, BIOL J LINN SOC, V91, P121, DOI 10.1111/j.1095-8312.2007.00774.x; PORTER WP, 1969, SCIENCE, V163, P482, DOI 10.1126/science.163.3866.482; Pruett JA, 2016, J CHEM ECOL, V42, P1164, DOI 10.1007/s10886-016-0778-8; Regnier F.E., 1977, P115; Reguera S, 2014, BIOL J LINN SOC, V112, P132, DOI 10.1111/bij.12250; Renoult Julien P., 2010, Zootaxa, V2500, P58; Renoult JP, 2009, MOL ECOL, V18, P4298, DOI 10.1111/j.1365-294X.2009.04351.x; Rosenblum EB, 2005, COPEIA, P586, DOI 10.1643/CP-04-154R1; Runemark A, 2011, J EVOLUTION BIOL, V24, P795, DOI 10.1111/j.1420-9101.2010.02214.x; Sa-Sousa P, 2002, AMPHIBIA-REPTILIA, V23, P55, DOI 10.1163/156853802320877627; Sears MW, 2005, OECOLOGIA, V143, P25, DOI 10.1007/s00442-004-1767-0; Sears MW, 2003, ECOLOGY, V84, P1624, DOI 10.1890/0012-9658(2003)084[1624:LVITSL]2.0.CO;2; Sokal R.R., 2012, BIOMETRY; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Stuart-Fox D, 2007, AM NAT, V170, P916, DOI 10.1086/522835; Stuart-Fox DM, 2004, P ROY SOC B-BIOL SCI, V271, P2249, DOI 10.1098/rspb.2004.2802; Stuart-Fox DM, 2004, EVOLUTION, V58, P1549; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; WATT WB, 1969, P NATL ACAD SCI USA, V63, P767, DOI 10.1073/pnas.63.3.767; Weldon PJ, 2008, NAT PROD REP, V25, P738, DOI 10.1039/b509854h; Wente WH, 2005, J HERPETOL, V39, P161, DOI 10.1670/0022-1511(2005)039[0161:SCCIAP]2.0.CO;2; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Zahavi A., 1997, HANDICAP PRINCIPLE; Zamora-Camacho FJ, 2014, J EVOLUTION BIOL, V27, P2820, DOI 10.1111/jeb.12546	129	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0211686	10.1371/journal.pone.0211686	http://dx.doi.org/10.1371/journal.pone.0211686			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875384	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400004
J	Girolamo, F; Errede, M; Longo, G; Annese, T; Alias, C; Ferrara, G; Morando, S; Trojano, M; de Rosbo, NK; Uccelli, A; Virgintino, D				Girolamo, Francesco; Errede, Mariella; Longo, Giovanna; Annese, Tiziana; Alias, Carlotta; Ferrara, Giovanni; Morando, Sara; Trojano, Maria; de Rosbo, Nicole Kerlero; Uccelli, Antonio; Virgintino, Daniela			Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENDOTHELIAL GROWTH-FACTOR; OLIGODENDROCYTE PRECURSOR RESPONSE; PDGF ALPHA-RECEPTOR; VI COLLAGEN; PROGENITOR CELLS; CEREBRAL-CORTEX; UP-REGULATION; FACTOR-BETA; PROTEOGLYCAN	During experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis associated with blood-brain barrier (BBB) disruption, oligodendrocyte precursor cells (OPCs) overexpress proteoglycan nerve/glial antigen 2 (NG2), proliferate, and make contacts with the microvessel wall. To explore whether OPCs may actually be recruited within the neurovascular unit (NVU), de facto intervening in its cellular and molecular composition, we quantified by immunoconfocal morphometry the presence of OPCs in contact with brain microvessels, during postnatal cerebral cortex vascularization at postnatal day 6, in wildtype (WT) and NG2 knock-out (NG2KO) mice, and in the cortex of adult naive and EAE-affected WT and NG2KO mice. As observed in WT mice during postnatal development, a higher number of juxtavascular and perivascular OPCs was revealed in adult WT mice during EAE compared to adult naive WT mice. In EAE-affected mice, OPCs were mostly associated with microvessels that showed altered claudin-5 and occludin tight junction (TJ) staining patterns and barrier leakage. In contrast, EAE-affected NG2KO mice, which did not show any significant increase in vessel-associated OPCs, seemed to retain better preserved TJs and BBB integrity. As expected, absence of NG2, in both OPCs and pericytes, led to a reduced content of vessel basal lamina molecules, laminin, collagen VI, and collagen IV. In addition, analysis of the major ligand/receptor systems known to promote OPC proliferation and migration indicated that vascular endothelial growth factor A (VEGF-A), platelet-derived growth factor-AA (PDGF-AA), and the transforming growth factor-beta (TGF-beta) were the molecules most likely involved in proliferation and recruitment of vascular OPCs during EAE. These results were confirmed by real time-PCR that showed Fgf2, Pdgfa and Tgfb expression on isolated cerebral cortex microvessels and by dual RNAscope-immunohistochemistry/ in situ hybridization (IHC/ISH), which detected Vegfa and Vegfr2 transcripts on cerebral cortex sections. Overall, this study suggests that vascular OPCs, in virtue of their developmental arrangement and response to neuroinflammation and growth factors, could be integrated among the classical NVU cell components. Moreover, the synchronized activation of vascular OPCs and pericytes during both BBB development and dysfunction, points to NG2 as a key regulator of vascular interactions.	[Girolamo, Francesco; Errede, Mariella; Longo, Giovanna; Annese, Tiziana; Trojano, Maria; Virgintino, Daniela] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Alias, Carlotta] Univ Brescia, B LabNet Environm Sustainabil Lab, Brescia, Italy; [Ferrara, Giovanni; Morando, Sara; de Rosbo, Nicole Kerlero; Uccelli, Antonio] Univ Genoa, Dept Neurosci Ophthalmol Genet Rehabil & Child Hl, Genoa, Italy; [Uccelli, Antonio] Univ Genoa, CEBR, Genoa, Italy; [Uccelli, Antonio] Osped Policlin San Martino IRCCS, Genoa, Italy	Universita degli Studi di Bari Aldo Moro; University of Brescia; University of Genoa; University of Genoa	Girolamo, F; Virgintino, D (corresponding author), Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.	francesco.girolamo@uniba.it; daniela.virgintino@uniba.it	Ferrara, Giovanni/D-8550-2015; UCCELLI, Antonio/E-7343-2012; Errede, Mariella/B-3701-2013; Alias, Carlotta/AAZ-2669-2021; Annese, Tiziana/GYA-5548-2022; Kerlero de Rosbo, Nicole/I-1134-2018	Ferrara, Giovanni/0000-0002-4442-8864; UCCELLI, Antonio/0000-0002-2008-6038; ERREDE, Mariella/0000-0002-8163-2338; Kerlero de Rosbo, Nicole/0000-0002-0493-0964; Trojano, Maria/0000-0002-6329-8946; VIRGINTINO, Daniela/0000-0003-1041-5341; Alias, Carlotta/0000-0003-4808-7363; GIROLAMO, FRANCESCO/0000-0001-8706-3386	Italian Multiple Sclerosis Foundation (FISM) [2011/R/37]; University of Bari [2015-16 Trojano00450418]; Apulia Foundation [2015.DV]	Italian Multiple Sclerosis Foundation (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); University of Bari; Apulia Foundation	This work was supported in part by the Italian Multiple Sclerosis Foundation (FISM, Grant No. 2011/R/37) to AU, in part by intramural funding from University of Bari (Grant No. 2015-16 Trojano00450418) to MT, and the Apulia Foundation (Grant No. 2015.DV) to DV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ancsin JB, 1996, J BIOL CHEM, V271, P6845, DOI 10.1074/jbc.271.12.6845; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Butt A M, 2017, C LECT NEUROGLIA BIO, P6; CALEY DW, 1970, J COMP NEUROL, V138, P31, DOI 10.1002/cne.901380104; Cattaruzza S, 2013, J MOL CELL BIOL, V5, P176, DOI 10.1093/jmcb/mjt010; Cattaruzza S, 2013, ANGIOGENESIS, V16, P309, DOI 10.1007/s10456-012-9316-7; Cejudo-Martin Pilar, 2016, Trends Cell Mol Biol, V11, P55; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Engelhardt B, 2011, J CEREBR BLOOD F MET, V31, P1969, DOI 10.1038/jcbfm.2011.98; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Errede M, 2012, J NEUROPATH EXP NEUR, V71, P840, DOI 10.1097/NEN.0b013e31826ac110; Ferrara G, 2016, ACTA NEUROPATHOL, V132, P23, DOI 10.1007/s00401-016-1563-z; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furusho M, 2012, J NEUROSCI, V32, P6631, DOI 10.1523/JNEUROSCI.6005-11.2012; Girolamo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084883; Girolamo F, 2011, NEUROBIOL DIS, V43, P678, DOI 10.1016/j.nbd.2011.05.021; Goretzki L, 1999, J BIOL CHEM, V274, P16831, DOI 10.1074/jbc.274.24.16831; Grako KA, 1999, J CELL SCI, V112, P905; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Hayakawa K, 2011, J NEUROSCI, V31, P10666, DOI 10.1523/JNEUROSCI.1944-11.2011; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Hofman P, 2001, ARCH OPHTHALMOL-CHIC, V119, P861; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; Lin W, 2017, NEURAL REGEN RES, V12, P70, DOI 10.4103/1673-5374.198982; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; McDonald DM, 1999, MICROCIRCULATION, V6, P7; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Minocha S, 2015, ELIFE, V4, DOI 10.7554/eLife.09102; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; NISHIYAMA A, 1993, MOL BIOL CELL, V4, P1097, DOI 10.1091/mbc.4.11.1097; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2000, CONN TISS, V32, P39; Nishiyama A, 2015, NEURAL SURFACE ANTIG, P120; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Ozerdem U, 2002, MICROVASC RES, V63, P129, DOI 10.1006/mvre.2001.2376; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Sakry D, 2016, BRAIN RES, V1638, P161, DOI 10.1016/j.brainres.2015.06.003; Sardone F, 2016, MATRIX BIOL, V55, P90, DOI 10.1016/j.matbio.2016.02.012; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Seo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103174; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Tsai HH, 2016, SCIENCE, V351, P379, DOI 10.1126/science.aad3839; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wen YF, 2006, J CELL BIOCHEM, V98, P115, DOI 10.1002/jcb.20768; YAMAKAGE A, 1992, J EXP MED, V175, P1227, DOI 10.1084/jem.175.5.1227; You WK, 2014, ANGIOGENESIS, V17, P61, DOI 10.1007/s10456-013-9378-1; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2015, NEUROBIOL DIS, V76, P57, DOI 10.1016/j.nbd.2015.01.006; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	72	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213508	10.1371/journal.pone.0213508	http://dx.doi.org/10.1371/journal.pone.0213508			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870435	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300036
J	Nagao, S; Kugita, M; Kumamoto, K; Yoshimura, A; Nishii, K; Yamaguchi, T				Nagao, Shizuko; Kugita, Masanori; Kumamoto, Kanako; Yoshimura, Aya; Nishii, Kazuhiro; Yamaguchi, Tamio			Increased salt intake does not worsen the progression of renal cystic disease in high water-loaded PCK rats	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; SIGNAL-REGULATED KINASE; INTRACELLULAR CALCIUM; EPITHELIAL-CELLS; TOLVAPTAN; PROLIFERATION; INHIBITION	The anti-diuretic hormone arginine vasopressin is thought to be a detrimental factor in polycystic kidney disease (PKD). We previously reported that high water intake (HWI) reduced urine osmolality and urinary arginine vasopressin, improved renal function, and reduced the kidney/body weight ratio in PCK rats, an orthologous model of human PKD. In PKD patients, however, it is reported that HWI increases total kidney volume, urine volume, and urine sodium excretion, which could be a consequence of high salt intake. In the current study, we loaded PCK rats with high salt concurrently with HWI to determine whether this human-imitated condition exacerbates disease progression. PCK rats were assigned into 4 groups: control group (CONT: distilled water), HWI group (HWI: 5% glucose in water), HWI with 0.2% NaCl group (HWI+0.2%NaCl), and HWI with 0.45% NaCl group (HWI+0.45%NaCl). Total water intake during the experimental period was increased by 1.86-, 2.02-, and 2.42-fold in HWI, HWI+0.2%NaCl, and HWI+0.45%NaCl, and sodium intake was increased by 2.55- and 5.83-fold in HWI+0.2%NaCl and HWI+0.45%NaCl, respectively, compared with CONT. Systolic blood pressure was higher in HWI+0.2%NaCl and HWI+0.45%NaCl than in both CONT and HWI. Serum urea nitrogen, kidney/body weight ratio, cAMP, cystic area, and fibrosis index were significantly lower in HWI compared with CONT, and these ameliorative effects were not abrogated in either HWI+0.2%NaCl or HWI+0.45%NaCl. The amount of sodium excreted into the urine was increased by 2.50- and 8.38-fold in HWI+0.2%NaCl and HWI+0.45%NaCl, respectively, compared with HWI. Serum sodium levels were not different between the groups. These findings indicate that the beneficial effect of HWI against the progression of cystic kidney disease was not affected even by high salt-overload in this rodent model of PKD.	[Nagao, Shizuko; Kugita, Masanori; Kumamoto, Kanako; Yoshimura, Aya] Fujita Hlth Univ, Educ & Res Facil Anim Models Human Dis, Toyoake, Aichi, Japan; [Nishii, Kazuhiro] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan; [Yamaguchi, Tamio] Suzuka Univ Med Sci, Dept Clin Nutr, Fac Hlth Sci, Suzuka, Mie, Japan	Fujita Health University; Fujita Health University	Nagao, S (corresponding author), Fujita Hlth Univ, Educ & Res Facil Anim Models Human Dis, Toyoake, Aichi, Japan.	shizun@fujita-hu.ac.jp		Nagao, Shizuko/0000-0003-2014-9411	 [15K08435]		SN Private University Research Branding Project URL: http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1379674.htm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SN Grant-in-Aid for Scientific Research (C) grant numbers: 15K08435. URL: https://www.jsps.go.jp/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvet JP, 2008, CLIN J AM SOC NEPHRO, V3, P1205, DOI 10.2215/CJN.05651207; Choi Hoon Young, 2015, Electrolyte Blood Press, V13, P46, DOI 10.5049/EBP.2015.13.2.46; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Higashihara E, 2014, NEPHROL DIAL TRANSPL, V29, P1710, DOI 10.1093/ndt/gfu093; HOLM S, 1979, SCAND J STAT, V6, P65; Hopp K, 2015, AM J PHYSIOL-RENAL, V308, pF261, DOI 10.1152/ajprenal.00345.2014; Ingelfinger JR, 2017, NEW ENGL J MED, V377, P1988, DOI 10.1056/NEJMe1714276; Kaimori J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08284-4; Kugita M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177934; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P14283, DOI 10.1073/pnas.1412323111; Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x; Nagao S, 2008, KIDNEY INT, V73, P269, DOI 10.1038/sj.ki.5002629; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2018, NEW ENGL J MED, V378, P489, DOI 10.1056/NEJMc1716478; Torres VE, 2017, NEW ENGL J MED, V377, P1930, DOI 10.1056/NEJMoa1710030; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Wallace DP, 2011, BBA-MOL BASIS DIS, V1812, P1291, DOI 10.1016/j.bbadis.2010.11.005; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yang JY, 2007, J BIOCHEM MOL BIOL, V40, P467; Yoshihara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081480; Yoshihara D, 2012, PPAR RES, V2012, DOI 10.1155/2012/695898	27	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0207461	10.1371/journal.pone.0207461	http://dx.doi.org/10.1371/journal.pone.0207461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870430	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300005
J	Banerjee, S; Siemianowski, O; Liu, ML; Lind, KR; Tian, XC; Nettleton, D; Cademartiri, L				Banerjee, Souvik; Siemianowski, Oskar; Liu, Meiling; Lind, Kara R.; Tian, Xinchun; Nettleton, Dan; Cademartiri, Ludovico			Stress response to CO2 deprivation by Arabidopsis thaliana in plant cultures	PLOS ONE			English	Article							CARBON; C-3; PHOTOSYNTHESIS; MODEL	After being the standard plant propagation protocol for decades, cultures of Arabidopsis thaliana sealed with Parafilm remain common today out of practicality, habit, or necessity (as in co-cultures with microorganisms). Regardless of concerns over the aeration of these cultures, no investigation has explored the CO2 transport inside these cultures and its effect on the plants. Thereby, it was impossible to assess whether Parafilm-seals used today or in thousands of older papers in the literature constitute a treatment, and whether this treatment could potentially affect the study of other treatments.For the first time we report the CO2 concentrations in Parafilm-sealed cultures of A. thaliana with a 1 minute temporal resolution, and the transcriptome comparison with aerated cultures. The data show significant CO2 deprivation to the plants, a drastic suppression of photosynthesis, respiration, starch accumulation, chlorophyll biosynthesis, and an increased accumulation of reactive oxygen species. Most importantly, CO2 deprivation occurs as soon as the cotyledons emerge. Gene expression analysis indicates a significant alteration of 35% of the pathways when compared to aerated cultures, especially in stress response and secondary metabolism processes. On the other hand, the observed increase in the production of glucosinolates and flavonoids suggests intriguing possibilities for CO2 deprivation as an organic biofortification treatment in high-value crops.	[Banerjee, Souvik; Siemianowski, Oskar; Lind, Kara R.; Tian, Xinchun; Cademartiri, Ludovico] Iowa State Univ Sci & Technol, Dept Mat Sci & Engn, Ames, IA 50011 USA; [Liu, Meiling; Nettleton, Dan] Iowa State Univ Sci & Technol, Dept Stat, Ames, IA 50011 USA; [Liu, Meiling] Iowa State Univ Sci & Technol, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Cademartiri, Ludovico] Iowa State Univ Sci & Technol, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Cademartiri, Ludovico] US DOE, Ames Lab, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Cademartiri, L (corresponding author), Iowa State Univ Sci & Technol, Dept Mat Sci & Engn, Ames, IA 50011 USA.; Cademartiri, L (corresponding author), Iowa State Univ Sci & Technol, Dept Chem & Biol Engn, Ames, IA 50011 USA.; Cademartiri, L (corresponding author), US DOE, Ames Lab, Ames, IA 50011 USA.	lcademar@iastate.edu	Tian, Xinchun/AAG-3419-2021; Siemianowski, Oskar/A-9904-2018; Cademartiri, Ludovico/A-4142-2008	Tian, Xinchun/0000-0002-6013-4524; Cademartiri, Ludovico/0000-0001-8805-9434; Nettleton, Dan/0000-0002-6045-1036; Siemianowski, Oskar/0000-0002-7842-8977	Plant Science Institute at Iowa State University; Arnold & Mabel Beckman Foundation; Chinese Scholarship Council	Plant Science Institute at Iowa State University; Arnold & Mabel Beckman Foundation; Chinese Scholarship Council(China Scholarship Council)	The work described in this paper has been supported by the Plant Science Institute at Iowa State University through a Faculty Scholar Award to LC and DN, and by the Arnold & Mabel Beckman Foundation through a Young Investigator award to LC. XCT is grateful for a scholarship from the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work described in this paper has been supported by the Plant Science Institute at Iowa State University through a Faculty Scholar Award to LC and DN, and by the Arnold & Mabel Beckman Foundation through a Young Investigator award to LC. XCT is grateful for a scholarship from the Chinese Scholarship Council. We thank J. Koziel for access to GC-MS instruments in the early stages of the work. We are also thankful to P. S. Schnable, S. H. Howell, M. Salas-Fernandes, and M. Castellano for valuable insight and feed.	[Anonymous], 2018, SEARCH PETRI DISH PE; [Anonymous], 2013, HANDL AR PLANTS SEED; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arabidopsis Biological Resource Center OSU, 2004, HANDL AR PLANTS SEED; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchmann N, 1998, AGR FOREST METEOROL, V89, P45, DOI 10.1016/S0168-1923(97)00059-2; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CASPAR T, 1985, PLANT PHYSIOL, V79, P11, DOI 10.1104/pp.79.1.11; Ditengou FA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7279; Farag MA, 2017, NAT PROTOC, V12, P1359, DOI 10.1038/nprot.2017.023; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Foyer C.H., 1994, ENV AGR, V44, P522, DOI [10.1201/9781351070454, DOI 10.1201/9781351070454]; Franks PJ, 2013, NEW PHYTOL, V197, P1077, DOI 10.1111/nph.12104; Fujiwara Kazuhiro, 1987, Journal of Agricultural Meteorology, V43, P21; Furner IJ, 1992, ARABIDOPSIS COMPLEAT; Gerhart LM, 2010, NEW PHYTOL, V188, P674, DOI 10.1111/j.1469-8137.2010.03441.x; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; JARVIS PG, 1986, ADV ECOL RES, V15, P1, DOI 10.1016/S0065-2504(08)60119-1; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kasote DM, 2015, INT J BIOL SCI, V11, P982, DOI 10.7150/ijbs.12096; Kestwal RM, 2011, FOOD CHEM, V126, P1164, DOI 10.1016/j.foodchem.2010.11.152; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Li XQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01493; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Lim W, 2014, J FOOD SCI, V79, pS1212, DOI 10.1111/1750-3841.12478; Lindsey BE, 2017, JOVE-J VIS EXP, DOI 10.3791/56587; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makkar H.P.S., 2003, QUANTIFICATION TANNI; Mawlong I, 2017, INT J FOOD PROP, V20, P3274, DOI 10.1080/10942912.2017.1286353; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Morimoto K, 2017, P NATL ACAD SCI USA; Nettleton D, 2008, BIOINFORMATICS, V24, P192, DOI 10.1093/bioinformatics/btm583; Paul MJ, 1997, PLANT CELL ENVIRON, V20, P110, DOI 10.1046/j.1365-3040.1997.d01-17.x; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Pierik RLM, 1997, IN VITRO CULTURE HIG; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prasch CM, 2013, PLANT PHYSIOL; Prueger JH, 2004, ENVIRON MANAGE, V33, pS330, DOI 10.1007/s00267-003-9142-1; Ramel F, 2012, PLANT PHYSIOL; Rivero L, 2014, METHODS MOL BIOL, V1062, P3, DOI 10.1007/978-1-62703-580-4_1; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Siemianowski O, 2018, TRENDS PLANT SCI, V23, P378, DOI 10.1016/j.tplants.2018.03.006; Sofo A, 2018, J TRACE ELEM MED BIO, V49, P261, DOI 10.1016/j.jtemb.2018.02.010; Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035; Sumanta N, 2014, RES J CHEM SCI; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Topping J.F., 1991, PLANT TISSUE CULT, P67; Ubierna N, 2014, PLANT CELL ENVIRON, V37, P1494, DOI 10.1111/pce.12346; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Vasil I.K., 2013, PLANT CELL TISSUE CU; Wijnker E, 2014, NAT PROTOC, V9, P761, DOI 10.1038/nprot.2014.049; Xu WF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01273; Zhang NQ, 2018, BRIT J NUTR, V119, P957, DOI [10.1017/S0007114518000600, 10.1017/s0007114518000600]	55	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212462	10.1371/journal.pone.0212462	http://dx.doi.org/10.1371/journal.pone.0212462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865661	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900023
J	Stalmans, ME; Massad, TJ; Peel, MJS; Tarnita, CE; Pringle, RM				Stalmans, Marc E.; Massad, Tara J.; Peel, Mike J. S.; Tarnita, Corina E.; Pringle, Robert M.			War-induced collapse and asymmetric recovery of large-mammal populations in Gorongosa National Park, Mozambique	PLOS ONE			English	Article							EXTINCTION RISK; TREE COVER; LAND-USE; DYNAMICS; LANDSCAPE; DECLINES; RAINFALL; PREY; SERENGETI; BIOMASS	How do large-mammal communities reassemble after being pushed to the brink of extinction? Few data are available to answer this question, as it is rarely possible to document both the decline and recovery of wildlife populations. Here we present the first in-depth quantitative account of war-induced collapse and postwar recovery in a diverse assemblage of large herbivores. In Mozambique's Gorongosa National Park, we assembled data from 15 aerial wildlife counts conducted before (1968-1972) and after (1994-2018) the Mozambican Civil War (1977-1992). Pre-war total biomass density exceeded 9,000 kg km(-2), but populations declined by >90% during the war. Since 1994, total biomass has substantially recovered, but species composition has shifted dramatically. Formerly dominant large herbivores-including elephant (Loxodonta africana), hippo (Hippopotamus amphibius), buffalo (Syncerus Gaffer), zebra (Equus quagga), and wildebeest (Connochaetes taurinus)-are now outnumbered by waterbuck (Kobus ellipsiprymnus) and other small to mid-sized antelopes. Waterbuck abundance has increased by an order of magnitude, with >55,000 individuals accounting for >74% of large-herbivore biomass in 2018. By contrast, elephant, hippo, and buffalo, which totaled 89% of pre-war biomass, now comprise just 23%. These trends mostly reflect natural population growth following the resumption of protection under the Gorongosa Restoration Project; reintroductions (465 animals of 7 species) accounted for a comparatively small fraction of the total numerical increase. Waterbuck are growing logistically, apparently as-yet unchecked by interspecific competition or predation (apex-carnivore abundance has been low throughout the post-war interval), suggesting a community still in flux. Most other herbivore populations have increased post-war, albeit at differing rates. Armed conflict remains a poorly understood driver of ecological change; our results demonstrate the potential for rapid post-war recovery of large-herbivore biomass, given sound protected-area management, but also suggest that restoration of community structure takes longer and may require active intervention.	[Stalmans, Marc E.; Massad, Tara J.] Dept Sci Serv, Beira, Sofala Province, Mozambique; [Peel, Mike J. S.] ARC Anim Prod Inst, Rangeland Ecol Grp, Nelspruit, South Africa; [Tarnita, Corina E.; Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Stalmans, ME (corresponding author), Dept Sci Serv, Beira, Sofala Province, Mozambique.	stalmans@gorongosa.net	Massad, Tara Joy/AAS-6548-2021; Massad, Tara J/E-1587-2013	Massad, Tara Joy/0000-0002-7669-3312; Stalmans, Marc/0000-0001-9779-6292; Peel, Mike/0000-0003-1284-3665	Gorongosa Project; Greg Carr Foundation	Gorongosa Project; Greg Carr Foundation	The Gorongosa Project funded all of the post-2002 aerial surveys in terms of aircraft/helicopter hire, pilot and external observers (M Peel 2014 - 2018 counts). The salaries of M Stalmans (2012 - 2018 counts) and T Massad (2014 and 2018 counts) were paid by the Gorongosa Project. R Pringle has received funding from the Greg Carr Foundation, although not tied to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilfuss R., 2008, LANDSCAPES GORONGOSA; BOTHMA JD, 1990, S AFR J WILDL RES, V20, P26; Bouley P, 2018, BIOL CONSERV, V227, P233, DOI 10.1016/j.biocon.2018.08.024; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Cromsigt JPGM, 2014, J ECOL, V102, P566, DOI 10.1111/1365-2745.12218; Cumming D. H. M., 1994, AERIAL CENSUS LARGE; Daskin JH, 2018, NATURE, V553, P328, DOI 10.1038/nature25194; Daskin JH, 2016, J ECOL, V104, P79, DOI 10.1111/1365-2745.12483; Di Marco M, 2014, CONSERV BIOL, V28, P1109, DOI 10.1111/cobi.12249; Dunham K. M., 2004, AERIAL SURVEY LARGE; Dutton P., 1997, AERIAL SURVEY GORONG; Dutton P., 1994, AFR WILDLIFE, V48, P6; Ford AT, 2015, ECOLOGY, V96, P2705, DOI 10.1890/14-2056.1.sm; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Fryxell JM, 2005, ECOL LETT, V8, P328, DOI 10.1111/j.1461-0248.2005.00727.x; Gaynor KM, 2016, FRONT ECOL ENVIRON, V14, P533, DOI 10.1002/fee.1433; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Hammill E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11042; Hanson T, 2018, ANN NY ACAD SCI, V1429, P50, DOI 10.1111/nyas.13689; Hatton J., 2001, BIODIVERSITY WAR CAS; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Holdo RM, 2009, ECOL APPL, V19, P95, DOI 10.1890/07-1954.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Li HP, 2016, P NATL ACAD SCI USA, V113, P14079, DOI 10.1073/pnas.1616804113; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163249; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Owen-Smith N, 2006, ECOL MONOGR, V76, P73, DOI 10.1890/04-1101; Owen-Smith N, 2015, OIKOS, V124, P1417, DOI 10.1111/oik.02218; Pansu J, 2018, J ECOL, V14, P948, DOI [10.1111/2041-210X.12079, DOI 10.1111/2041-210X.12079]; Pellegrini AFA, 2017, J ECOL, V105, P111, DOI 10.1111/1365-2745.12668; Pettersson T, 2015, J PEACE RES, V52, P536, DOI 10.1177/0022343315595927; Pringle RM, 2017, NATURE, V546, P91, DOI 10.1038/nature22902; Pringle RM, 2012, AM SCI, V100, P30; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; Ripple WJ, 2016, BIOSCIENCE, V66, P807, DOI 10.1093/biosci/biw092; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tinley K. L., 1977, THESIS; Turkalo AK, 2017, J APPL ECOL, V54, P153, DOI 10.1111/1365-2664.12764; Venter JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090900	46	27	27	15	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212864	10.1371/journal.pone.0212864	http://dx.doi.org/10.1371/journal.pone.0212864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865663	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900044
J	Frayon, S; Wattelez, G; Cherrier, S; Cavaloc, Y; Lerrant, Y; Galy, O				Frayon, Stephane; Wattelez, Guillaume; Cherrier, Sophie; Cavaloc, Yolande; Lerrant, Yannick; Galy, Olivier			Energy drink consumption in a pluri-ethnic population of adolescents in the Pacific	PLOS ONE			English	Article							ALCOHOL-USE; PERCEPTIONS; ADULTS; FOCUS; PREVALENCE; OVERWEIGHT; PATTERNS; HEALTH	Objective Energy drinks are very popular among teenagers but may cause health problems. Energy drink consumption is partly associated with energy drink perception, but little is known about this in the Pacific Island Countries and Territories. The aim of this cross-sectional study was to identify the relationships between energy drink consumption, energy drink perception, weight status and sociodemographic characteristics in a school-going sample of Pacific adolescents. Design A cross-sectional study carried out in the schools during school hours between July 2015 and April 2016. Setting Sociodemographic characteristics, weight status, energy drink perception, and quantity of energy drinks consumed were obtained. Chi-square tests of independence, independent t tests, multivariate logistic regressions and multiple linear regressions were used. Subjects A representative sample of 678 New Caledonian adolescents (11-16 years). Results We found that one third of New Caledonian adolescents consume energy drinks. Boys are more likely to drink them than girls and Polynesians drink significantly more than European and Melanesian adolescents. Higher energy drink consumption in the New Caledonian adolescents is associated with good or neutral perceptions of the energy drink impact on health. Moreover, sex (being male) significantly influences the total energy drink consumption per week. Energy drink consumers have a tendency toward better perceptions of energy drinks than non-consumers. Conclusions Nutritional education targeting energy drink consumers should take these results into account by providing (community-based) educational programs, especially for adolescents from low socioeconomic backgrounds, boys, or those living in rural areas.	[Frayon, Stephane; Wattelez, Guillaume; Cherrier, Sophie; Cavaloc, Yolande; Lerrant, Yannick; Galy, Olivier] Univ New Caledonia, Sch Educ, Interdisciplinary Lab Res Educ, Ave James Cook, Noumea, New Caledonia	Universite Nouvelle Caledonie	Frayon, S (corresponding author), Univ New Caledonia, Sch Educ, Interdisciplinary Lab Res Educ, Ave James Cook, Noumea, New Caledonia.	stephanefrayon@hotmail.com	GALY, Olivier/D-5345-2015	GALY, Olivier/0000-0002-4631-959X; , Guillaume/0000-0003-1564-0636; FRAYON, Stephane/0000-0001-9767-4148				Anonymous, 2020, OUR HIST ANITAB ORG; Azagba Sunday, 2013, CMAJ Open, V1, pE19, DOI 10.9778/cmajo.20120017; Baldwin HJ, 2018, PUBLIC HEALTH NUTR, V21, P3210, DOI 10.1017/S1368980018001866; Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134; Buchanan L, 2018, J NUTR EDUC BEHAV, V50, P888, DOI 10.1016/j.jneb.2018.05.022; Buchanan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171226; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Corsenac P, 2017, DIABETES RES CLIN PR, V133, P193, DOI 10.1016/j.diabres.2017.06.020; Costa BM, 2016, APPETITE, V105, P638, DOI 10.1016/j.appet.2016.07.001; Costa BM, 2014, APPETITE, V80, P183, DOI 10.1016/j.appet.2014.05.013; Dawodu A, 2017, J CHILD HEALTH CARE, V21, P446, DOI 10.1177/1367493517731948; Degirmenci N, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6236-5; Emond JA, 2014, J PEDIATR-US, V165, P1194, DOI 10.1016/j.jpeds.2014.08.050; Francis J, 2017, J NUTR EDUC BEHAV, V49, P724, DOI 10.1016/j.jneb.2017.06.007; Frayon S, 2017, PEDIAT OBES; Grimm GC, 2004, J AM DIET ASSOC, V104, P1244, DOI 10.1016/j.jada.2004.05.206; INSERM, 2008, SIT SOC COMP SANT IE; Kumar G, 2015, AM J HEALTH PROMOT, V29, P238, DOI 10.4278/ajhp.130820-QUAN-435; Kumar GS, 2014, PATIENT EDUC COUNS, V94, P250, DOI 10.1016/j.pec.2013.09.026; Larson N, 2014, J NUTR EDUC BEHAV, V46, P181, DOI 10.1016/j.jneb.2014.02.008; Longbottom PJ, 2002, J HUM NUTR DIET, V15, P271, DOI 10.1046/j.1365-277X.2002.00374.x; Loose F, 2015, REV FR MARKETING, P55; Lytle LA, 2003, J NUTR EDUC BEHAV, V35, P170, DOI 10.1016/S1499-4046(06)60331-X; McCrory C, 2017, J NUTR EDUC BEHAV, V49, P304, DOI 10.1016/j.jneb.2016.11.013; Miyake ER, 2015, ADDICT BEHAV, V43, P60, DOI 10.1016/j.addbeh.2014.12.009; Observatoire numerique de Nouvelle Caledonie, 2014, US ATT ATT NUM 15 29; Papoz L, 1996, AM J EPIDEMIOL, V143, P1018; Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536; Pichot H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112452; Reid JL, 2015, CAN J PUBLIC HEALTH, V106, pE101, DOI 10.17269/cjph.106.4684; Richards Gareth, 2016, Journal of Caffeine Research, V6, P49, DOI 10.1089/jcr.2015.0033; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Terry-McElrath YM, 2014, J ADDICT MED, V8, P6, DOI 10.1097/01.ADM.0000435322.07020.53; Trapp GSA, 2014, DRUG ALCOHOL DEPEN, V134, P30, DOI 10.1016/j.drugalcdep.2013.09.006; UN, 2022, REFUGEES MIGRANTS DE; Utter J, 2017, J PAEDIAT CHILD HLTH; Visram S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010380; Wattelez G, NUTRIENTS; Zucconi S, 2013, GATHERING CONSUMPTIO, V10	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214420	10.1371/journal.pone.0214420	http://dx.doi.org/10.1371/journal.pone.0214420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP9GF	30901361	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400053
J	Singhal, M; Khatibeghdami, M; Principe, DR; Mancinelli, GE; Schachtschneider, KM; Schook, LB; Grippo, PJ; Grimaldo, SR				Singhal, Megha; Khatibeghdami, Mahsa; Principe, Daniel R.; Mancinelli, Georgina E.; Schachtschneider, Kyle M.; Schook, Lawrence B.; Grippo, Paul J.; Grimaldo, Sam R.			TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth	PLOS ONE			English	Article							INVASION; MIGRATION; L6; APOPTOSIS	Current therapies for pancreatic ductal adenocarcinoma (PDAC) only modestly impact survival and can be highly toxic. A greater understanding of the molecules regulating this disease is critical for identifying new drug targets and developing more effective therapies. The L6 family of proteins are known to be positive regulators of tumor growth and metastasis among various cancers. However, little is known about the L6 family member TM4SF18. We investigated the expression and localization of the TM4SF18 protein in normal human pancreas and in PDAC tissue. Utilizing immunohistochemistry (IHC) and western blot analysis, our studies for the first time demonstrate that TM4SF18 is highly expressed in PDAC tumor epithelium. Furthermore, we identified TM4SF18 to be expressed in normal acinar tissue and weakly expressed in normal ducts. Although there is minimal expression in normal ducts, we observed increased TM4SF18 levels in preneoplastic ducts and tumor epithelium. To investigate a functional role of TM4SF18 in PDAC we developed stably-expressing inducible shRNA pancreatic cancer cell lines. Knockdown of the TM4SF18 protein led to a significant decrease in Capan-1 cell growth as measured by the MTT assay, demonstrating this molecule to be a novel regulator of PDAC. Uniquely there is no ortholog of the TM4SF18 gene in mouse or rat prompting us to seek other in vivo experimental models. Using IHC and western blot analysis, expression of TM4SF18 was confirmed in the porcine PDAC model, thus we establish an alternative model to investigate this gene. TM4SF18 represents a promising novel biomarker and therapeutic target for pancreatic cancer.	[Singhal, Megha; Khatibeghdami, Mahsa; Mancinelli, Georgina E.; Grippo, Paul J.; Grimaldo, Sam R.] Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60607 USA; [Principe, Daniel R.] Univ Illinois, Coll Med, Chicago, IL USA; [Schachtschneider, Kyle M.; Schook, Lawrence B.] Univ Illinois, Dept Radiol, Chicago, IL USA; [Schachtschneider, Kyle M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Schachtschneider, Kyle M.; Schook, Lawrence B.] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL USA; [Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grimaldo, SR (corresponding author), Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60607 USA.	samg@uic.edu		Schachtschneider, Kyle/0000-0002-7293-8642; Mancinelli, Georgina/0000-0002-5216-7086; Grimaldo, Sam/0000-0003-1203-2790				Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Anderson KR, 2011, DEVELOPMENT, V138, P3213, DOI 10.1242/dev.058693; Cao J, 2016, CELL PHYSIOL BIOCHEM, V39, P740, DOI 10.1159/000445664; Cao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144969; Cao R, 2018, CANCER LETT, V414, P278, DOI 10.1016/j.canlet.2017.11.015; Choi S, 2008, BBA-MOL CELL RES, V1783, P1632, DOI 10.1016/j.bbamcr.2008.04.008; Du XQ, 2018, GENE, V657, P30, DOI 10.1016/j.gene.2018.03.003; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Huang YK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050661; Kao YR, 2003, CLIN CANCER RES, V9, P2807; Kim HJ, 2017, FASEB J, V31, P1461, DOI 10.1096/fj.201600944RR; Lee MS, 2012, BBA-MOL CELL RES, V1823, P514, DOI 10.1016/j.bbamcr.2011.11.017; Muller-Pillasch F, 1998, GENE, V208, P25, DOI 10.1016/S0378-1119(97)00633-1; Overgaard NH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01301; Principe DR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30916-6; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Schachtschneider KM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00190; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sun YH, 2015, INT J CLIN EXP PATHO, V8, P9081; Wong CH, 2016, WORLD J GASTROENTERO, V22, P7046, DOI 10.3748/wjg.v22.i31.7046; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Yang JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45895; Zheng B, 2015, INT J ONCOL, V47, P490, DOI 10.3892/ijo.2015.3022	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0211711	10.1371/journal.pone.0211711	http://dx.doi.org/10.1371/journal.pone.0211711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897168	Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700010
J	Tibbels, NJ; Hendrickson, ZM; Naugle, DA; Dosso, A; Van Lith, L; Mallalieu, EC; Kouadio, AM; Kra, W; Kamara, D; Dailly-Ajavon, P; Cisse, A; Seifert-Ahanda, K; Thaddeus, S; Babalola, S; Hoffmann, CJ				Tibbels, Natalie Jean; Hendrickson, Zoe Mistrale; Naugle, Danielle Amani; Dosso, Abdul; Van Lith, Lynn; Mallalieu, Elizabeth C.; Kouadio, Anne Marie; Kra, Walter; Kamara, Diarra; Dailly-Ajavon, Patricia; Cisse, Adama; Seifert-Ahanda, Kim; Thaddeus, Sereen; Babalola, Stella; Hoffmann, Christopher J.			Men's perceptions of HIV care engagement at the facility- and provider-levels: Experiences in Cote d'Ivoire	PLOS ONE			English	Article							TRUST	Men in sub-Saharan Africa have lower rates of HIV testing and are less likely to initiate treatment compared to women. Service delivery dimensions are a key factor in facilitating engagement along the HIV treatment continuum for men and women, yet male specific overall perceptions of the service delivery environment have received little attention in West Africa. This study draws on qualitative data collected in Cote d'Ivoire to explore provider-level and structural factors affecting men's engagement in HIV testing and treatment through interviews and focus group discussions conducted with health workers and men living with HIV (some on ART) or whose HIV status was unknown. Factors influencing decisions to test or initiate treatment were considered in terms of perceived benefits and costs. Men described costs at the interpersonal (client-provider) level, such as unwanted disclosure or stigma, which were weighed against the potential for social support and clinical guidance. Likewise, fear of unwanted disclosure operated at the facility level, as the layout of facilities sometimes grouped clients living with HIV together. Notably, the benefits men described from engaging in HIV testing and care all operated at the interpersonal level and none at the facility level. In light of the fact that provider-and facility-level factors influenced the perceptions and experiences of men along the treatment continuum, we offer recommendations to reduce barriers to testing and engagement in care related to service delivery.	[Tibbels, Natalie Jean; Hendrickson, Zoe Mistrale; Naugle, Danielle Amani; Van Lith, Lynn; Mallalieu, Elizabeth C.; Babalola, Stella] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Commun Programs, Baltimore, MD 21205 USA; [Dosso, Abdul; Kamara, Diarra; Dailly-Ajavon, Patricia; Cisse, Adama] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Commun Programs, Abidjan, Cote Ivoire; [Kouadio, Anne Marie] Felix Houphouet Boigny Univ Cocody, Sociol Dept, Abidjan, Cote Ivoire; [Kra, Walter] Alassane Ouattra Univ, Sociol Dept, Bouake, Cote Ivoire; [Seifert-Ahanda, Kim] US Agcy Int Dev, Washington, DC 20523 USA; [Thaddeus, Sereen] US Agcy Int Dev, Abidjan, Cote Ivoire; [Hoffmann, Christopher J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Agency for International Development (USAID); United States Agency for International Development (USAID); Johns Hopkins University	Tibbels, NJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Commun Programs, Baltimore, MD 21205 USA.	ntibbel1@jhu.edu		Hoffmann, Christopher/0000-0002-9422-0519; Mallalieu, Elizabeth/0000-0003-0724-7826	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development [AID-OAA-A-12-00058]	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development	This work was supported by funding from the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development [cooperative agreement #AID-OAA-A-12-00058] to the Johns Hopkins Center for Communication Programs. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the United States Government, USAID, PEPFAR, or any other affiliate organizations or institutions. Co-authors who are USAID employees were involved in study design, analysis, decision to publish, and preparation of the manuscript.	Barroso J, 2017, J ASS NURSES AIDS CA; Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Cawley C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3109-7; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Hoffmann CJ, 2016, AIDS EDUC PREV, V28, P351, DOI 10.1521/aeap.2016.28.4.351; Institut National de la Statistique (INS), 2012, ENQ DEM SANT IND MUL, P2011; International AIDS Society, 2016, DIFF CAR HIV DEC FRA; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Maheu-Giroux M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002321; Maughan-Brown B, 2017, AIDS BEHAV, P1; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; Musa BM, 2017, INT HEALTH, V9, P3, DOI 10.1093/inthealth/ihw050; Nakigozi G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/470245; Osborn M, 2016, AIDS CARE, V28, P689, DOI 10.1080/09540121.2016.1140889; Ozawa S, 2013, SOC SCI MED, V91, P10, DOI 10.1016/j.socscimed.2013.05.005; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Sileo KM, 2018, AIDS BEHAV; Stern E, 2017, AJAR-AFR J AIDS RES, V16, P19, DOI 10.2989/16085906.2017.1285795; UNAIDS, 2014, 90 90 90 AMB TREATM; Underwood C, 2014, J ACQUIR IMMUNE D S3, V66, P311; WHO (World Health Organization), 2016, PROGR REP 2016 PREV	24	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0211385	10.1371/journal.pone.0211385	http://dx.doi.org/10.1371/journal.pone.0211385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897098	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700009
J	Thergarajan, G; Kumar, S; Bhassu, S; Omar, SFBS; Rampal, S				Thergarajan, Gaythri; Kumar, Suresh; Bhassu, Subha; Omar, Sharifah Faridah Binti Syed; Rampal, Sanjay			Effect of Blastocystis sp. in dengue patients-Increase in the treatment cost and exacerbation of symptoms	PLOS ONE			English	Article							CLINICAL-RELEVANCE; HOMINIS; SIR2; SURVIVAL	Increasing incidences of dengue have become a global health threat with major clinical manifestation including high fever and gastrointestinal symptoms. These symptoms were also expressed among Blastocystis sp. infected individuals, a parasite commonly seen in human stools. This parasite has been previously reported to replicate faster upon exposure to high temperature. The present study is a hospitalized-based cross-sectional study involved the collection of faecal sample from dengue patients. Stool examination was done by in vitro cultivation to isolate Blastocystis sp. Growth pattern of all the positive isolates were analyzed to identify the multiplication rate of Blastocystis sp. isolated from dengue patients. Distribution of Blastocystis sp. among dengue patients was 23.6%. Dengue patients who were positive for Blastocystis sp. infection denoted a significantly higher fever rate reaching 38.73 degrees C (p<0.05) compared to the non-Blastocystis sp. infected patients (38.44 degrees C). It was also found that Blastocystis sp. infected patients complained of frequenting the toilet more than five times a day (p<0.05) compared to those who were non-Blastocystis sp. infected. At the same time, the duration of hospitalization was significantly longer (p<0.05) for Blastocystis sp. infected dengue patients compared to the non-Blastocystis sp. infected patients. Besides, Blastocystis sp. isolated from dengue patients (in vivo thermal stress) showed a higher growth rate compared to the non-dengue isolated which was exposed to high temperature (in vitro thermal stress). Our findings suggest that presence of Blastocystis sp. during dengue infection could trigger the increase of temperature which could be due to highly elevated pro inflammatory cytokines by both parasitic and virus infection. This could justify why the temperature in Blastocystis sp. infected dengue patients is higher compared to the non-Blastocystis sp. infected patients. Higher temperature could have triggered a greater parasite multiplication rate that contributed to the aggravation of the gastrointestinal symptoms.	[Thergarajan, Gaythri; Kumar, Suresh] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Bhassu, Subha] Univ Malaya, Fac Sci, Dept Genet & Mol Biol, Kuala Lumpur, Malaysia; [Omar, Sharifah Faridah Binti Syed] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Rampal, Sanjay] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	Rampal, Sanjay/B-9691-2010; OMAR, SHARIFAH FARIDAH SFSO SYED/B-9752-2010; BHASSU, SUBHA/B-9843-2010	Rampal, Sanjay/0000-0002-0105-6407; BHASSU, SUBHA/0000-0001-8658-6900	Ministry of Higher Education (FRGS) [FP015-2017A]; University Malaya Postgraduate Research Fund (PPP) [PG141-2016A]	Ministry of Higher Education (FRGS); University Malaya Postgraduate Research Fund (PPP)	Funding for this study was provided by the Fundamental Research Grant Scheme by the Ministry of Higher Education (FRGS) (FP015-2017A) and the University Malaya Postgraduate Research Fund (PPP) (PG141-2016A). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsalam AM, 2012, PARASITOLOGY, V139, P1014, DOI 10.1017/S0031182012000340; Anuar TS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-40; Chandramathi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094567; Chung EJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2026-7; Cirioni O, 1999, EUR J EPIDEMIOL, V15, P389, DOI 10.1023/A:1007551218671; Ramirez JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172586; El Safadi D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-164; Fievet A, 2015, FRONTIERS MICROBIOLO, P6; Gaythri T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095608; Govind SK, 2002, TRENDS PARASITOL, V18, P528, DOI 10.1016/S1471-4922(02)02402-9; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; JONES WR, 1946, ANN TROP MED PARASIT, V40, P130, DOI 10.1080/00034983.1946.11685270; Kennedy D, 2014, IUBMB LIFE, V66, P327, DOI 10.1002/iub.1274; Keppel M, 2016, PARASITOL RES, V115, P2149, DOI 10.1007/s00436-016-4956-y; MARKELL EK, 1986, AM J TROP MED HYG, V35, P1023, DOI 10.4269/ajtmh.1986.35.1023; Mirza H, 2011, INFECT IMMUN, V79, P5019, DOI 10.1128/IAI.05632-11; Mohammad NA, 2017, ASIAN PACIFIC J TROP; Nihal M, 2014, CELL CYCLE, V13, P632, DOI 10.4161/cc.27523; Nithyamathi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0136709; Osman M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004496; Pongpan S, 2013, ISRN PEDIAT, P2013; Purkait B, 2015, J ANTIMICROB CHEMOTH, V70, P1343, DOI 10.1093/jac/dku534; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Salim HR, 1999, PARASITOL RES, V85, P1032, DOI 10.1007/s004360050677; Scicluna SM, 2006, PROTIST, V157, P77, DOI 10.1016/j.protis.2005.12.001; Stensvold Christen Rune, 2013, Trop Parasitol, V3, P26, DOI 10.4103/2229-5070.113896; SURESH K, 1994, PARASITOL RES, V80, P327, DOI 10.1007/BF02351875; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Taylor-Brown E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-108; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Vergnes B, 2002, GENE, V296, P139, DOI 10.1016/S0378-1119(02)00842-9; Zaman V, 1997, PARASITOL RES, V83, P731, DOI 10.1007/s004360050329; Zorzi Elisa, 2011, Cancers (Basel), V3, P3921, DOI 10.3390/cancers3043921	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0211034	10.1371/journal.pone.0211034	http://dx.doi.org/10.1371/journal.pone.0211034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893309	gold, Green Published, Green Submitted			2022-12-26	WOS:000461765900006
J	Karere, GM; Glenn, JP; Birnbaum, S; Garcia, R; VandeBerg, JL; Cox, LA				Karere, Genesio M.; Glenn, Jeremy P.; Birnbaum, Shifra; Garcia, Roy; VandeBerg, John L.; Cox, Laura A.			Identification of coordinately regulated microRNA-gene networks that differ in baboons discordant for LDL-cholesterol	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; GROWTH-FACTOR; EXPERIMENTAL ATHEROSCLEROSIS; PLASMA DIMETHYLGLYCINE; ENDOTHELIAL-CELLS; SECRETED PROTEIN; HEART-DISEASE; SPARC; EXPRESSION; APOPTOSIS	Rationale Plasma low-density lipoprotein cholesterol (plasma LDL-C), vascular endothelial cells and peripheral blood mononuclear cells (PBMCs), particularly monocytes, play key roles in initiating atherosclerosis, the primary cause of cardiovascular disease (CVD). Although the mechanisms underlying development of atherosclerosis are not well understood, LDL-C is known to influence expression of endothelial microRNAs (miRNAs) and gene-targets of miRNAs to promote cell senescence. However, the impact of LDL-C on expression of PBMC miRNAs and miRNA targeted genes in response to an atherogenic diet is not known. In this study, we used unbiased methods to identify coordinately responsive PBMC miRNA-gene networks that differ between low and high LDL-C baboons when fed a high-cholesterol, high-fat (HCHF) diet. Methods and results Using RNA Seq, we quantified PBMC mRNAs and miRNAs from half-sib baboons discordant for LDL-C plasma concentrations (low LDL-C, n = 3; high LDL-C, n = 3) before and after a 7-week HCHF diet challenge. For low LDL-C baboons, 626 genes exhibited significant change in expression (255 down-regulated, 371 up-regulated) in response to the HCHF diet, and for high LDL-C baboons 379 genes exhibited significant change in expression (162 down-regulated, 217 up-regulated) in response to the HCHF diet. We identified 494 miRNAs identical to human miRNAs and 47 novel miRNAs. Fifty miRNAs were differentially expressed in low LDL-C baboons (21 up- and 29 down-regulated) and 20 in high LDLC baboons (11 up- and 9 down-regulated) in response to the HCHF diet. Among the differentially expressed miRNAs were miR-221/222 and miR-34a-3p, which were down-regulated, and miR-148a/b-5p, which was up-regulated. In addition, gene-targets of these miRNAs, VEGFA, MAML3, SPARC, and DMGDH, were inversely expressed and are central hub genes in networks and signaling pathways that differ between low and high LDLC baboon HCHF diet response. Conclusions We have identified coordinately regulated HCHF diet-responsive PBMC miRNA-gene networks that differ between baboons discordant for LDL-C concentrations. Our findings provide potential insights into molecular mechanisms underlying initiation of atherosclerosis where LDL-C concentrations influence expression of specific miRNAs, which in turn regulate expression of genes that play roles in initiation of lesions.	[Karere, Genesio M.; Glenn, Jeremy P.; Birnbaum, Shifra; Garcia, Roy; Cox, Laura A.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX 78227 USA; [Karere, Genesio M.; Cox, Laura A.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27101 USA; [VandeBerg, John L.] Univ Texas Rio Grande Valley, Dept Human Genet, Sch Med, Brownsville, TX USA; [VandeBerg, John L.] Univ Texas Rio Grande Valley, Dept Human Genet, Sch Med, Harlingen, TX USA; [VandeBerg, John L.] Univ Texas Rio Grande Valley, Dept Human Genet, Sch Med, Edinburg, TX USA; [VandeBerg, John L.] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Sch Med, Brownsville, TX USA; [VandeBerg, John L.] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Sch Med, Harlingen, TX USA; [VandeBerg, John L.] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Sch Med, Edinburg, TX USA; [Cox, Laura A.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA	Texas Biomedical Research Institute; Wake Forest University; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; Texas Biomedical Research Institute	Karere, GM (corresponding author), Texas Biomed Res Inst, Dept Genet, San Antonio, TX 78227 USA.; Karere, GM (corresponding author), Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27101 USA.	gmkarere@txbiomed.org	karere, genesio/AAC-6989-2019		National Institutes of Health [P01 HL028972]; NIH Office of the Director [P51 OD011133, P51 RR013986];  [C06 RR14578];  [C06 RR15456];  [C06 RR013556];  [C06 RR017515]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study received support from the following: National Institutes of Health (Grant number: P01 HL028972) received by JLV; NIH Office of the Director (Grant number: P51 OD011133) received by JLV; NIH Office of the Director (Grant number: P51 RR013986) received by JLV; (Grant number: C06 RR14578; C06 RR15456; C06 RR013556; C06 RR017515). The funder supported the infrastructure that was used during the investigation of the work reported in the manuscript.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Amarenco P, 2008, ATHEROSCLEROSIS, V196, P489, DOI 10.1016/j.atherosclerosis.2007.07.033; Amarenco P, 2007, STROKE, V38, P3198, DOI 10.1161/STROKEAHA.107.493106; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Berisha SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065003; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Bruczko M, 2016, PATHOBIOLOGY, V83, P47, DOI 10.1159/000442885; Chen F, 2014, MOL BIOL REP, V41, P5505, DOI 10.1007/s11033-014-3426-9; Cox LA, 2006, GENOMICS, V88, P274, DOI 10.1016/j.ygeno.2006.03.020; Cox LA, 2009, METHODS, V49, P63, DOI 10.1016/j.ymeth.2009.06.009; Ding JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13729; Farrokhi Effat, 2015, Iranian Biomedical Journal, V19, P160, DOI 10.7508/ibj.2015.03.005; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Goedeke L, 2015, NAT MED, V21, P1280, DOI 10.1038/nm.3949; Harada-Shiba M, 1998, J BIOL CHEM, V273, P9681, DOI 10.1074/jbc.273.16.9681; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Joseph C, 2012, REPRODUCTION, V144, P361, DOI 10.1530/REP-12-0099; Karere GM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-320; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Kushwaha RS, 1998, HUM REPROD UPDATE, V4, P420, DOI 10.1093/humupd/4.4.420; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Ling HY, 2013, BIOCHEM CELL BIOL, V91, P195, DOI 10.1139/bcb-2012-0053; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Mahaney MC, 2018, J MED PRIMATOL, V47, P3, DOI 10.1111/jmp.12283; McDonald J.H., 2014, HDB BIOL STAT; MCGILL HC, 1981, ARTERIOSCLEROSIS, V1, P3, DOI 10.1161/01.ATV.1.1.3; McGregor DO, 2001, KIDNEY INT, V59, P2267, DOI 10.1046/j.1523-1755.2001.00743.x; Nagaraju GPC, 2011, CANCER TREAT REV, V37, P559, DOI 10.1016/j.ctrv.2010.12.001; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; Qin B, 2015, MOL CELL BIOCHEM, V405, P115, DOI 10.1007/s11010-015-2403-5; Qin B, 2011, BIOCHEM BIOPH RES CO, V410, P127, DOI 10.1016/j.bbrc.2011.05.118; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; ROSS R, 1992, DIABETOLOGIA, V35, pS34, DOI 10.1007/BF00586277; Said N, 2007, AM J PATHOL, V170, P1054, DOI 10.2353/ajpath.2007.060903; Schmid G, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2135-2; Spradling Kimberly D, 2013, PLoS One, V8, pe57563, DOI 10.1371/journal.pone.0057563; Svingen GFT, 2015, EUR J PREV CARDIOL, V22, P743, DOI 10.1177/2047487314529351; Takahashi M, 2001, OBES RES, V9, P388, DOI 10.1038/oby.2001.50; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Toba H, 2016, AM J PHYSIOL-ENDOC M, V310, pE1027, DOI 10.1152/ajpendo.00040.2016; Tveitevag Svingen GF, 2013, ARTERIOSCL THROM VAS, V33, P2041, DOI 10.1161/ATVBAHA.113.301714; Wagschal A, 2015, NAT MED, V21, P1290, DOI 10.1038/nm.3980; Xie KP, 2014, GENE, V543, P101, DOI 10.1016/j.gene.2014.03.059; Xu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081615; Zhang C, 2010, J COMP PATHOL, V142, P122, DOI 10.1016/j.jcpa.2009.08.159; Zhu EL, 2010, NUCLEIC ACIDS RES, V38, pW392, DOI 10.1093/nar/gkq393	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213494	10.1371/journal.pone.0213494	http://dx.doi.org/10.1371/journal.pone.0213494			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875406	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400016
J	Nielsen, C; Hui, R; Lui, WY; Solov'yov, IA				Nielsen, Claus; Hui, Ron; Lui, Wing-Yee; Solov'yov, Ilia A.			Towards predicting intracellular radiofrequency radiation effects	PLOS ONE			English	Article							OSCILLATING MAGNETIC-FIELDS; RADICAL-PAIR MECHANISM; CHEMICAL COMPASS; CHARGE-TRANSFER; Q(O)-SITE; MAGNETORECEPTION; CRYPTOCHROME; KINETICS; BIOLOGY; BINDING	Recent experiments have reported an effect of weak radiofrequency magnetic fields in the MHz-range on the concentrations of reactive oxygen species (ROS) in living cells. Since the energy that could possibly be deposited by the radiation is orders of magnitude smaller than the energy of molecular thermal motion, it was suggested that the effect was caused by the interaction of RF magnetic fields with transient radical pairs within the cells, affecting the ROS formation rates through the radical pair mechanism. It is, however, at present not entirely clear how to predict RF magnetic field effects at certain field frequency and intensity in nanoscale biomolecular systems. We suggest a possible recipe for interpreting the radiofrequency effects in cells by presenting a general workflow for calculation of the reactive perturbations inside a cell as a function of RF magnetic field strength and frequency. To justify the workflow, we discuss the effects of radiofrequency magnetic fields on generic spin systems to particularly illustrate how the reactive radicals could be affected by specific parameters of the experiment. We finally argue that the suggested workflow can be used to predict effects of radiofrequency magnetic fields on radical pairs in biological cells, which is specially important for wireless recharging technologies where one has to know of any harmful effects that exposure to such radiation might cause.	[Nielsen, Claus; Solov'yov, Ilia A.] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark; [Hui, Ron] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Peoples R China; [Lui, Wing-Yee] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China	University of Southern Denmark; University of Hong Kong; University of Hong Kong	Solov'yov, IA (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Odense M, Denmark.	ilia@sdu.dk	Lui, Yee/A-2743-2010; Solov'yov, Ilia/GLU-8851-2022; Hui, Shu Yuen Ron/E-1485-2011	Solov'yov, Ilia/0000-0002-8626-145X; Nielsen, Claus/0000-0002-5715-2422; Hui, Shu Yuen Ron/0000-0002-5992-6559	Lundbeck Foundation; Danish Council for Independent Research; DeiC National HPC Center (SDU)	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); DeiC National HPC Center (SDU)	This work was supported by the Lundbeck Foundation (https://www.lundbeckfonden.com/, IAS, CN), the Danish Council for Independent Research (https://ufm.dk/, IAS, CN), and DeiC National HPC Center (SDU) (https://www.deic.dk/en/HPCCenter_SDU).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidas K, 2014, WIRES COMPUT MOL SCI, V4, P269, DOI 10.1002/wcms.1172; Atherton N. M, 1993, PRINCIPLES ELECT SPI; Barragan AM, 2016, J PHYS CHEM B, V120, P11369, DOI 10.1021/acs.jpcb.6b07394; Barragan AM, 2015, J PHYS CHEM B, V119, P433, DOI 10.1021/jp510022w; Bittner E. R., 2010, QUANTUM DYNAMICS APP; Breuer H. P., 2007, THEORY OPEN QUANTUM, DOI 10.1093/acprof:oso/9780199213900.001.0001; Brocklehurst B, 2002, CHEM SOC REV, V31, P301, DOI 10.1039/b107250c; CANFIELD JM, 1995, CHEM PHYS, V195, P59, DOI 10.1016/0301-0104(95)00049-T; CANFIELD JM, 1994, CHEM PHYS, V182, P1, DOI 10.1016/0301-0104(93)E0442-X; Castello PR, 2014, BIOELECTROMAGNETICS, V35, P598, DOI 10.1002/bem.21858; Covic GA, 2013, P IEEE, V101, P1276, DOI 10.1109/JPROC.2013.2244536; Demtroder W., 2014, LASER SPECTROSCOPY 1; Frisch G. W., 2013, GAUSSIAN 09; Griffith D., 2005, INTRO QUANTUM MECH, V2nd edn; GRISSOM CB, 1995, CHEM REV, V95, P3, DOI 10.1021/cr00033a001; HABERKORN R, 1976, MOL PHYS, V32, P1491, DOI 10.1080/00268977600102851; Hansen MJ, 2002, CHEM PHYS LETT, V361, P219, DOI 10.1016/S0009-2614(02)00724-8; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Hiscock HG, 2017, BIOPHYS J, V113, P1475, DOI 10.1016/j.bpj.2017.07.031; Hiscock HG, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4963793; Hohwy M, 1999, J MAGN RESON, V136, P6, DOI 10.1006/jmre.1998.1593; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Hui SY, 2013, P IEEE, V101, P1290, DOI 10.1109/JPROC.2013.2246531; Husen P, 2017, J PHYS CHEM B, V121, P3308, DOI 10.1021/acs.jpcb.6b08226; Husen P, 2016, J AM CHEM SOC, V138, P12150, DOI 10.1021/jacs.6b04849; Kattnig DR, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/6/063007; Kattnig DR, 2016, PHYS CHEM CHEM PHYS, V18, P12443, DOI 10.1039/c5cp06731f; Landau L. D., 1981, QUANTUM MECH NONRELA, VIII; Levitt M. H., 2013, SPIN DYNAMICS BASICS; Lewis AM, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890659; Ludemann G, 2015, J AM CHEM SOC, V137, P1147, DOI 10.1021/ja510550g; Maeda K, 2015, PHYS CHEM CHEM PHYS, V17, P3550, DOI 10.1039/c4cp04095c; Maeda K, 2011, J AM CHEM SOC, V133, P17807, DOI 10.1021/ja206783t; MARCUS RA, 1993, REV MOD PHYS, V65, P599, DOI 10.1103/RevModPhys.65.599; Miyashita O, 2000, J PHYS CHEM B, V104, P7516, DOI 10.1021/jp000865z; Naarala J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5675086; Nielsen, 2010, QUANTUM COMPUTATION; Nielsen C, 2019, MOLSPIN FLEXIBLE EXT; Nielsen C, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0657; Pedersen JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36709; Reese A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152345; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Rodgers CT, 2009, PHYS CHEM CHEM PHYS, V11, P6569, DOI 10.1039/b906102a; Rodgers CT, 2005, J PHYS CHEM A, V109, P5035, DOI 10.1021/jp050765z; Sakurai J., 2014, MODERN QUANTUM MECH; Salo AB, 2017, J PHYS CHEM B, V121, P1771, DOI 10.1021/acs.jpcb.6b10403; Solov'yov IA, 2007, BIOPHYS J, V92, P2711, DOI 10.1529/biophysj.106.097139; Solov'yov IA, 2012, PHYS CHEM CHEM PHYS, V14, P13861, DOI 10.1039/c2cp41436h; Solov'yov IA, 2012, J PHYS CHEM B, V116, P1089, DOI 10.1021/jp209508y; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; Timmel CR, 2001, CHEM PHYS LETT, V334, P387, DOI 10.1016/S0009-2614(00)01436-6; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134; Timmel CR, 1996, CHEM PHYS LETT, V257, P401, DOI 10.1016/0009-2614(96)00466-6; Usselman RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38543; Usselman RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093065; Wang KF, 2006, MOL PHYS, V104, P1649, DOI 10.1080/00268970600564869; Worster S, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4958624	60	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213286	10.1371/journal.pone.0213286	http://dx.doi.org/10.1371/journal.pone.0213286			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870450	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300028
J	de Almeida, ABR; Smidt, ED; Amano, E				Rodrigues de Almeida, Audia Brito; Smidt, Eric de Camargo; Amano, Erika			Evolution of anatomical characters in Acianthera section Pleurobotryae (Orchidaceae: Pleurothallidinae)	PLOS ONE			English	Article							FLORAL MICROMORPHOLOGY; LEAVES; CLASSIFICATION; SYSTEMATICS; OSMOPHORES; PHYLOGENY; TRICHOMES	Acianthera section Pleurobotryae is one of ten sections of the genus Acianthera and include four species endemic to the Atlantic Forest. The objective of this study was to describe comparatively the anatomy of vegetative organs and floral micromorphology of all species of Acianthera section Pleurobotryae in order to identify diagnostic characters between them and synapomorphies for the section in relation of other sections of the genus. We analyzed roots, ramicauls, leaves and flowers of 15 species, covering eight of the nine sections of Acianthera, using light microscopy and scanning electron microscopy. Acianthera section Pleurobotryae is a monophyletic group and the cladistic analyses of anatomical and flower micromorphology data, combined with molecular data, support internal relationship hypotheses among the representatives of this section. The synapomorphies identified for A. sect. Pleurobotryae are based on leaf anatomy: unifacial leaves, round or elliptical in cross-section, round leaves with vascular bundles organized in concentric circles, and mesophyll with 28 to 30 cell layers. Within the section, the Glade (A. crepiniana + A. mantiquyrana) presented more differences in vegetative organ morphology and higher support values in combined analyses when compared to the second Glade, (A. atropurpurea + A. hatschbachii). For each of these clades an exclusive set of homoplasies of vegetative and floral organs were also identified. The results support the argument that vegetative organs are more evolutionarily stable in comparison to reproductive organs and thus helpful for inference of internal phylogenetic relationships in Acianthera, while flowers are highly variable, perhaps due to the diversity of pollinator attraction mechanisms. The analyses indicate that the elliptical leaves observed in A. crepiniana have originated from round leaves observed in the other species of this section, suggesting an adaptation to increase the area of exposure of the leaf and better the efficiency of capture of sunlight in shaded environments such as the Atlantic Forest. The presence of papillose regions in both vegetative and floral organs indicated that micromorphological characters are also useful for the delimitation of species and sections within the genus.	[Rodrigues de Almeida, Audia Brito; Smidt, Eric de Camargo; Amano, Erika] Univ Fed Parana, Setor Ciencias Biol, Programa Posgrad Bot, Curitiba, Parana, Brazil	Universidade Federal do Parana	de Almeida, ABR (corresponding author), Univ Fed Parana, Setor Ciencias Biol, Programa Posgrad Bot, Curitiba, Parana, Brazil.	audia.almeida@gmail.com	Smidt, Eric C/F-7632-2011	Smidt, Eric C/0000-0002-1177-1682; ALMEIDA, AUDIA/0000-0002-0081-7809	ABRA Masters scholarship of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	ABRA Masters scholarship of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by ABRA Masters scholarship of the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) -http//www.capes.gov.br308460/2017-0-ECS Research productivity grant by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) -http://www.cnpq.br.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROS F., 2015, LISTA ESPECIES FLORA; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; Bell AK, 2009, BOT J LINN SOC, V160, P369, DOI 10.1111/j.1095-8339.2009.00985.x; BENZING DH, 1983, AM J BOT, V70, P173, DOI 10.2307/2443261; Berlyn G.P., 1976, BOT MICROTECHNIQUE C, DOI [10.2307/2418781, DOI 10.2307/2418781]; Borba EL, 2002, ANN BOT-LONDON, V90, P219, DOI 10.1093/aob/mcf168; Borba EL, 2001, ANN BOT-LONDON, V88, P75, DOI 10.1006/anbo.2001.1434; Cameron KM, 2005, AM J BOT, V92, P1025, DOI 10.3732/ajb.92.6.1025; Carlsward BS, 2006, BOT J LINN SOC, V151, P165, DOI 10.1111/j.1095-8339.2006.00502.x; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Chiron GR, 2012, RICHARDIANA, V12, P59; Chiron GR, 2012, PHYTOTAXA, V46, P34, DOI 10.11646/phytotaxa.46.1.5; Silva Ivone Vieira da, 2010, Hoehnea, V37, P147; Davies KL, 2006, ANN BOT-LONDON, V98, P1215, DOI 10.1093/aob/mcl204; Davies KL, 2003, ANN BOT-LONDON, V91, P439, DOI 10.1093/aob/mcg038; Davies KL, 2004, ANN BOT-LONDON, V93, P75, DOI 10.1093/aob/mch007; de Melo MC, 2010, PLANT SYST EVOL, V286, P141, DOI 10.1007/s00606-010-0294-1; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FOSTER AS, 1956, PROTOPLASMA, V46, P184, DOI 10.1007/BF01248877; Foster AS, 1949, PRACTICAL PLANT ANAT; FRANKLIN GL, 1945, NATURE, V155, P51, DOI 10.1038/155051a0; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; IAWA Committee, 1989, IAWA B N S, V10, P219, DOI DOI 10.1163/22941932-90000496; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Kaiser E, 1880, BOT ZENTRALB, V180, P25; Karremans Adam P., 2016, Lankesteriana, V16, P219, DOI 10.15517/lank.v16i2.26008; Karremans Adam P., 2016, Harvard Papers in Botany, V21, P171, DOI 10.3100/hpib.v21iss2.2016.n4; Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; LIU L, 1994, PLANT J, V6, P213, DOI 10.1046/j.1365-313X.1994.6020213.x; Luer CA, 1986, MONOGRAPHS SYSTEMATI, V20; Luque R., 1996, ACTA BOT BRAS, V10, P199, DOI [DOI 10.1590/S0102-33061996000200001, 10.1590/s0102-33061996000200001]; Maddison W.P., 2016, MESQUITE MODULAR SYS; METCALFE CR, 1969, AM J BOT, V56, P782, DOI 10.2307/2440598; Nakayama H, 2013, FRONT PLANT SCI, V248, P1; NEYLAND R, 1995, BOT J LINN SOC, V117, P13, DOI 10.1006/bojl.1995.0002; Nixon K.C., 2002, WINCLADA VER 1 00 08; Nunes ELP, 2017, BOT J LINN SOC, V183, P294, DOI 10.1093/botlinnean/bow007; Nunes ELP, 2015, BOT J LINN SOC, V177, P378, DOI 10.1111/boj.12253; Nunes ELP, 2014, BOT J LINN SOC, V175, P438, DOI 10.1111/boj.12176; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; OLATUNJI OA, 1980, BOT J LINN SOC, V80, P357, DOI 10.1111/j.1095-8339.1980.tb01669.x; Oliveira V.C., 1999, BRAZ J BOT, V22, P365; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Piazza Ligia Debone, 2015, Hoehnea, V42, P171, DOI 10.1590/2236-8906-34/2014; Pridgeon A.M., 1979, SELBYANA, V5, P120; Pridgeon Alec M., 2001, Lindleyana, V16, P235; PRIDGEON AM, 1982, AM J BOT, V69, P921, DOI 10.2307/2442889; PRIDGEON AM, 1981, AM J BOT, V68, P64, DOI 10.2307/2442992; Pridgeon AM, 2005, GENERA ORCHIDACEARUM, V4; ROBARDS AW, 1978, ELECT MICROSCOPY CYT, P343; Rodrigues Vinícius Trettel, 2015, Hoehnea, V42, P615, DOI 10.1590/2236-8906-60/2015; Rodrigues VT, 2017, BRAZ J BOT, V40, P811, DOI 10.1007/s40415-017-0384-1; Ronquist F., 2005, MR BAYES 3 1 MANUAL; Saas JE, 1951, BOT MICROTECHNIQUE; Mayer JLS, 2011, FLORA, V206, P185, DOI 10.1016/j.flora.2010.09.003; Scatena V. L., 1996, Boletim de Botanica, Universidade de Sao Paulo, V15, P35; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Smidt ED, 2013, BRAZ J BOT, V36, P75, DOI 10.1007/s40415-013-0008-3; Stearn WT, 2004, BOT LATIN, P340; STERN WL, 1994, INT J PLANT SCI, V155, P716, DOI 10.1086/297210; STERN WL, 1985, BOT J LINN SOC, V91, P457, DOI 10.1111/j.1095-8339.1985.tb01015.x; STERN WL, 1987, AM J BOT, V74, P1323, DOI 10.2307/2444310; Stern WL., 2014, ANATOMY MONOCOTYLEDO, VX; STPICZYNSKA M, 1993, ACTA SOC BOT POL, V62, P5, DOI 10.5586/asbp.1993.001; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THIELE K, 1993, CLADISTICS, V9, P275, DOI 10.1111/j.1096-0031.1993.tb00226.x; Vogel S., 1962, NATURWUSSENSCHAFTLIC, V10, P598; Yamaguchi T, 2012, PLANT CELL PHYSIOL, V53, P1180, DOI 10.1093/pcp/pcs074; Yamaguchi T, 2010, PLANT CELL, V22, P2141, DOI 10.1105/tpc.110.076927; Yamaguchi T, 2010, J PLANT RES, V123, P35, DOI 10.1007/s10265-009-0255-3	75	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212677	10.1371/journal.pone.0212677	http://dx.doi.org/10.1371/journal.pone.0212677			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865720	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900031
J	Stevens, M; Neal, CR; Craciun, EC; Dronca, M; Harper, SJ; Oltean, S				Stevens, Megan; Neal, Christopher R.; Craciun, Elena C.; Dronca, Maria; Harper, Steven J.; Oltean, Sebastian			The natural drug DIAVIT is protective in a type II mouse model of diabetic nephropathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; OXIDATIVE STRESS; VEGF; ANTIOXIDANT; OVEREXPRESSION; ANGIOGENESIS; ACTIVATION; VEGF(165)B; BLUEBERRY	There is evidence to suggest that abnormal angiogenesis, inflammation, and fibrosis drive diabetic nephropathy (DN). However, there is no specific treatment to counteract these processes. We aimed to determine whether DIAVIT, a natural Vaccinium myrtillus (blueberry) and Hippophae Rhamnoides (sea buckthorn) extract, is protective in a model of type II DN. Diabetic db/db mice were administered DIAVIT in their drinking water for 14 weeks. We assessed the functional, structural, and ultra-structural phenotype of three experimental groups (lean+vehicle, db/db+vehicle, db/db+DIAVIT). We also investigated the angiogenic and fibrotic pathways involved in the mechanism of action of DIAVIT. Diabetic db/db mice developed hyperglycaemia, albuminuria, and an increased glomerular water permeability; the latter two were prevented by DIAVIT. db/db mice developed fibrotic glomeruli, endothelial insult, and glomerular ultra-structural changes, which were not present in DIAVIT-treated mice. Vascular endothelial growth factor A (VEGF-A) splicing was altered in the db/db kidney cortex, increasing the pro-angiogenic VEGF-A(165) relative to the anti-angiogenic VEGF-A(165)b. This was partially prevented with DIAVIT treatment. Delphinidin, an anthocyanin abundant in DIAVIT, increased the VEGF-A(165)b expression relative to total VEGF-A165 in cultured podocytes through phosphorylation of the splice factor SRSF6. DIAVIT, in particular delphinidin, alters VEGF-A splicing in type II DN, rescuing the DN phenotype. This study highlights the therapeutic potential of natural drugs in DN through the manipulation of gene splicing and expression.	[Stevens, Megan; Oltean, Sebastian] Univ Exeter, Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; [Stevens, Megan; Neal, Christopher R.; Harper, Steven J.; Oltean, Sebastian] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Stevens, Megan; Neal, Christopher R.; Harper, Steven J.; Oltean, Sebastian] Univ Bristol, Bristol Renal, Sch Clin Sci, Bristol, Avon, England; [Craciun, Elena C.] Univ Med & Pharm Iuliu Hatieganu Cluj Napoca, Sch Pharm, Dept Pharmaceut Biochem, Cluj Napoca, Romania; [Craciun, Elena C.] Univ Med & Pharm Iuliu Hatieganu Cluj Napoca, Clin Lab, Cluj Napoca, Romania; [Dronca, Maria] Univ Med & Pharm Iuliu Hatieganu Cluj Napoca, Sch Med, Dept Med Biochem, Cluj Napoca, Romania	University of Exeter; University of Bristol; University of Bristol; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy	Stevens, M; Oltean, S (corresponding author), Univ Exeter, Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England.; Stevens, M; Oltean, S (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.; Stevens, M; Oltean, S (corresponding author), Univ Bristol, Bristol Renal, Sch Clin Sci, Bristol, Avon, England.	m.stevens2@exeter.ac.uk; s.oltean@exeter.ac.uk	sTEVENS, Megan/GPT-0543-2022	Craciun, Elena Cristina/0000-0002-8192-1631; Oltean, Sebastian/0000-0001-7890-8439	British Heart Foundation [PG/15/53/31371]; Diabetes UK [17/0005668]; Richard Bright VEGF Research Trust; BHF [15/53/31371]; BBSRC [BB/J007293/2, BB/J007293/1, BB/P012035/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); Richard Bright VEGF Research Trust; BHF(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this study was supported by grants from British Heart Foundation to SO (PG/15/53/31371), Diabetes UK to SO (17/0005668), and Richard Bright VEGF Research Trust to SO.; We would like to thank Simon Thorpe from the Faculty of Science Mass Spectrometry Centre, University of Sheffield, for his help in determining the chemical composition of the DIAVIT extract. Work on this paper was supported by grants from Diabetes UK (17/0005668) and BHF (15/53/31371) to SO.	Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Bagchi D, 2004, BIOCHEMISTRY-MOSCOW+, V69, P75, DOI 10.1023/B:BIRY.0000016355.19999.93; Bates DO, 2002, CANCER RES, V62, P4123; Bharat D, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700601; Bhatt SR, 2014, CLIN EXP HYPERTENS, V36, P367, DOI 10.3109/10641963.2014.943402; Bunea A, 2013, PHYTOCHEMISTRY, V95, P436, DOI 10.1016/j.phytochem.2013.06.018; Bunea A, 2011, NOT BOT HORTI AGROBO, V39, P70; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Gammons MVR, 2013, INVEST OPHTH VIS SCI, V54, P5797, DOI 10.1167/iovs.13-11634; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Gnudi L, 2016, TRENDS ENDOCRIN MET, V27, P820, DOI 10.1016/j.tem.2016.07.002; Juan-Mateu J, 2018, DIABETES, V67, P423, DOI 10.2337/db17-0736; Kang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079823; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Keravis T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145291; Kim MH, 2017, ONCOL REP, V37, P777, DOI 10.3892/or.2016.5296; Kriz W, 2017, PEDIATR NEPHROL, V32, P405, DOI 10.1007/s00467-016-3358-9; Li J, 2012, J NUTR BIOCHEM, V23, P320, DOI 10.1016/j.jnutbio.2010.12.008; Liu HW, 2016, FOOD FUNCT, V7, P1941, DOI 10.1039/c6fo00078a; Ma W, 2014, J ETHNOPHARMACOL, V153, P840, DOI 10.1016/j.jep.2014.03.051; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; Martini S, 2014, J AM SOC NEPHROL, V25, P2559, DOI 10.1681/ASN.2013080906; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Nemes-Nagy E, 2008, ACTA PHYSIOL HUNG, V95, P383, DOI 10.1556/APhysiol.95.2008.4.5; Oltean S, 2015, J AM SOC NEPHROL, V26, P1889, DOI 10.1681/ASN.2014040350; Park CH, 2010, EUR J PHARMACOL, V640, P233, DOI 10.1016/j.ejphar.2010.04.028; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Qiu Y, 2010, J AM SOC NEPHROL, V21, P1498, DOI 10.1681/ASN.2009060617; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Salmon AHJ, 2006, J PHYSIOL-LONDON, V570, P141, DOI 10.1113/jphysiol.2005.099184; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Stevens M, 2017, J PHYSIOL-LONDON, V595, P6281, DOI 10.1113/JP274481; Wen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082336; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	38	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212910	10.1371/journal.pone.0212910	http://dx.doi.org/10.1371/journal.pone.0212910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865689	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000461048900046
J	Tiessen, I; Abildgaard, MH; Lubas, M; Gylling, HM; Steinhauer, C; Pietras, EJ; Diederichs, S; Frankel, LB; Lund, AH				Tiessen, Imke; Abildgaard, Marie H.; Lubas, Michal; Gylling, Helene M.; Steinhauer, Cornelia; Pietras, Elin J.; Diederichs, Sven; Frankel, Lisa B.; Lund, Anders H.			A high-throughput screen identifies the long non-coding RNA DRAIC as a regulator of autophagy	ONCOGENE			English	Article							SELECTIVE AUTOPHAGY; ACTIVATES AUTOPHAGY; CELL-PROLIFERATION; MECHANISMS; EXPRESSION; COMPLEX; LC3; TRANSCRIPTION; DISCOVERY; MIR-21	Autophagy is a conserved degradation process that occurs in all eukaryotic cells and its dysfunction has been associated with various diseases including cancer. While a number of large-scale attempts have recently identified new molecular players in autophagy regulation, including proteins and microRNAs, little is known regarding the function of long non-coding RNAs (lncRNAs) in the regulation of this process. To identify new long non-coding RNAs with functional implications in autophagy, we performed a high-throughput RNAi screen targeting more than 600 lncRNA transcripts and monitored their effects on autophagy in MCF-7 cells. We identified 63 lncRNAs that affected GFP-LC3B puncta numbers significantly. We validated the strongest hit, the lncRNA DRAIC previously shown to impact cell proliferation, and revealed a novel role for this lncRNA in the regulation of autophagic flux. Interestingly, we find DRAIC's pro-proliferative effects to be autophagy-independent. This study serves as a valuable resource for researchers from both the lncRNA and autophagy fields as it advances the current understanding of autophagy regulation by non-coding RNAs.	[Tiessen, Imke; Abildgaard, Marie H.; Lubas, Michal; Gylling, Helene M.; Steinhauer, Cornelia; Pietras, Elin J.; Frankel, Lisa B.; Lund, Anders H.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Abildgaard, Marie H.; Frankel, Lisa B.] Danish Canc Soc Res Ctr DCRC, DK-2100 Copenhagen, Denmark; [Diederichs, Sven] German Canc Res Ctr, Div RNA Biol & Canc, D-69120 Heidelberg, Germany; [Diederichs, Sven] Univ Freiburg, Fac Med, Med Ctr, Dept Thorac Surg,Div Canc Res, D-79106 Freiburg, Germany; [Diederichs, Sven] Univ Freiburg, German Canc Consortium DKTK, Partner Site Freiburg, D-79106 Freiburg, Germany	University of Copenhagen; Danish Cancer Society; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg	Frankel, LB; Lund, AH (corresponding author), Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark.; Frankel, LB (corresponding author), Danish Canc Soc Res Ctr DCRC, DK-2100 Copenhagen, Denmark.	frankel@cancer.dk; anders.lund@bric.ku.dk	Lund, Anders H./F-4786-2014; Diederichs, Sven/J-6237-2012	Lund, Anders H./0000-0002-7407-3398; Gylling, Helene Maria/0000-0002-6875-2845; Frankel, Lisa/0000-0001-7249-3607; Diederichs, Sven/0000-0001-7901-4752; Abildgaard, Marie Holm/0000-0002-6354-6102	European Union [607720]; Danish Council for Independent Research (Sapere Aude program); Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society; EU COST Action Transautophagy [CA15138]	European Union(European Commission); Danish Council for Independent Research (Sapere Aude program); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); EU COST Action Transautophagy	We thank Sudeep Sahadevan for analysis of RNA-seq data, Bettina Mentz for technical assistance, Kevin Ryan for providing pLenti-CRISPR NTC, ATG5, and ATG7 constructs [44], W Lee Kraus for providing PInducer20-DRAIC and -EV constructs [34]. Imke Tiessen was supported by the People Program (Marie Sklodowska-Curie Actions) of the European Union's Seventh Framework Program FP7-PEOPLE-2013-ITN (Grant agreement no.: 607720). Work in the Lund laboratory was supported by the Danish Council for Independent Research (Sapere Aude program), the Novo Nordisk Foundation, the Lundbeck Foundation, the Danish Cancer Society and the EU COST Action Transautophagy (CA15138).	Abada A, 2014, EMBO REP, V15, P839, DOI 10.15252/embr.201439076; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Capparelli C, 2012, CELL CYCLE, V11, P3599, DOI 10.4161/cc.21884; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen CL, 2015, BIOMATERIALS, V44, P71, DOI 10.1016/j.biomaterials.2014.12.023; Chen YN, 2016, ONCOTARGET, V7, P52673, DOI 10.18632/oncotarget.10170; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Farkas T, 2009, AUTOPHAGY, V5, P1018, DOI 10.4161/auto.5.7.9443; Figueiredo VC, 2017, CELL MOL LIFE SCI, V74, P2537, DOI 10.1007/s00018-017-2481-5; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Frankel LB, 2017, AUTOPHAGY, V13, P3, DOI 10.1080/15548627.2016.1222992; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Ge D, 2014, AUTOPHAGY, V10, P957, DOI 10.4161/auto.28363; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gomez-Sanchez R, 2016, DATA BRIEF, V7, P641, DOI 10.1016/j.dib.2016.02.085; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Guo SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21106-5; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hu YR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0743-3; Huang FT, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0845-6; Huang SY, 2015, AUTOPHAGY, V11, P2172, DOI 10.1080/15548627.2015.1106663; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klingenberg M, 2018, HEPATOLOGY, V68, P1817, DOI 10.1002/hep.30102; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu CH, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0619-z; Liu XW, 2016, NAT CELL BIOL, V18, P431, DOI 10.1038/ncb3328; Loayza-Puch F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r32; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubas M, 2018, EMBO REP, V19, DOI 10.15252/embr.201846072; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Musiwaro P, 2013, AUTOPHAGY, V9, P1407, DOI 10.4161/auto.25455; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Notzold L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02357-0; O'Prey J, 2017, METHOD ENZYMOL, V588, P79, DOI 10.1016/bs.mie.2016.09.076; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Pawar K, 2016, SCI REP-UK, V6, DOI 10.1038/srep19416; Polycarpou-Schwarz M, 2018, ONCOGENE, V37, P4750, DOI 10.1038/s41388-018-0281-5; Poulsen EG, 2016, METHODS MOL BIOL, V1449, P421, DOI 10.1007/978-1-4939-3756-1_28; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Sakurai K, 2015, MOL CANCER RES, V13, P828, DOI 10.1158/1541-7786.MCR-15-0016-T; Seiler J, 2017, NUCLEIC ACIDS RES, V45, P5458, DOI 10.1093/nar/gkx076; Song J, 2014, J ORTHOP RES, V32, P1628, DOI 10.1002/jor.22718; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun M, 2015, MOL CELL, V59, P698, DOI 10.1016/j.molcel.2015.06.023; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; van Beek N, 2018, BBA-MOL CELL RES, V1865, P803, DOI 10.1016/j.bbamcr.2018.03.002; Viereck J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1475; Wang Y, 2014, ONCOL LETT, V8, P1947, DOI 10.3892/ol.2014.2487; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; Xu ZJ, 2017, ONCOL REP, V37, P1359, DOI 10.3892/or.2017.5416; Yang L, 2016, MOL BIOSYST, V12, P2605, DOI 10.1039/c6mb00114a; Yang LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.464; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Zhang J, 2017, AUTOPHAGY, V13, P1004, DOI 10.1080/15548627.2017.1312041; Zhao Dan, 2018, Non-Coding RNA, V4, P39, DOI 10.3390/ncrna4040039; Zhao YG, 2018, CURR OPIN CELL BIOL, V53, P29, DOI 10.1016/j.ceb.2018.04.003; Zhao ZS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7212	81	25	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5127	5141		10.1038/s41388-019-0783-9	http://dx.doi.org/10.1038/s41388-019-0783-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30872794				2022-12-26	WOS:000473025300002
J	Hoffmann, L; Anders, K; Bischof, LF; Ye, X; Reimann, J; Khadouma, S; Pham, TK; van der Does, C; Wright, PC; Essen, LO; Albers, SV				Hoffmann, Lena; Anders, Katrin; Bischof, Lisa F.; Ye, Xing; Reimann, Julia; Khadouma, Sunia; Pham, Trong K.; van der Does, Chris; Wright, Phillip C.; Essen, Lars-Oliver; Albers, Sonja-Verena			Structure and interactions of the archaeal motility repression module ArnA-ArnB that modulates archaellum gene expression in Sulfolobus acidocaldarius	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; cell motility; protein phosphorylation; signal transduction; transcription regulation	FHA DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASES; A-DOMAIN; PHOSPHORYLATION; CLUSTER; SYSTEM	Phosphorylation-dependent interactions play crucial regulatory roles in all domains of life. Forkhead-associated (FHA) and von Willebrand type A (vWA) domains are involved in several phosphorylation-dependent processes of multiprotein complex assemblies. Although well-studied in eukaryotes and bacteria, the structural and functional contexts of these domains are not yet understood in Archaea. Here, we report the structural base for such an interacting pair of FHA and vWA domain-containing proteins, ArnA and ArnB, in the thermoacidophilic archaeon Sulfolobus acidocaldarius, where they act synergistically and negatively modulate motility. The structure of the FHA domain of ArnA at 1.75 resolution revealed that it belongs to the subclass of FHA domains, which recognizes double-pSer/pThr motifs. We also solved the 1.5 resolution crystal structure of the ArnB paralog vWA2, disclosing a complex topology comprising the vWA domain, a -sandwich fold, and a C-terminal helix bundle. We further show that ArnA binds to the C terminus of ArnB, which harbors all the phosphorylation sites identified to date and is important for the function of ArnB in archaellum regulation. We also observed that expression levels of the archaellum components in response to changes in nutrient conditions are independent of changes in ArnA and ArnB levels and that a strong interaction between ArnA and ArnB observed during growth on rich medium sequentially diminishes after nutrient limitation. In summary, our findings unravel the structural features in ArnA and ArnB important for their interaction and functional archaellum expression and reveal how nutrient conditions affect this interaction.	[Hoffmann, Lena; Bischof, Lisa F.; Ye, Xing; Reimann, Julia; Khadouma, Sunia; van der Does, Chris; Albers, Sonja-Verena] Univ Freiburg, Mol Biol Archaea, Inst Biol 2, Schaenzlestr 1, D-79104 Freiburg, Germany; [Bischof, Lisa F.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Anders, Katrin; Essen, Lars-Oliver] Philipps Univ, Dept Chem, D-35032 Marburg, Germany; [Essen, Lars-Oliver] LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Pham, Trong K.] Univ Sheffield, Dept Chem & Biol Engn, ChELSI Inst, Sheffield S1 3JD, S Yorkshire, England; [Wright, Phillip C.] Newcastle Univ, Fac Sci Agr & Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Freiburg; University of Freiburg; Philipps University Marburg; University of Sheffield; Newcastle University - UK	Albers, SV (corresponding author), Univ Freiburg, Mol Biol Archaea, Inst Biol 2, Schaenzlestr 1, D-79104 Freiburg, Germany.; Essen, LO (corresponding author), Univ Marburg, Dept Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de; sonja.albers@biologie.uni-freiburg.de	Essen, Lars-Oliver/L-3862-2016; Albers, Sonja-Verena/H-8689-2019	Essen, Lars-Oliver/0000-0003-4272-4026; Albers, Sonja-Verena/0000-0003-2459-2226	European Union's Horizon 2020 research and innovation program [686647]; Excellence Initiative of the German Research Foundation (Spemann Graduate School); Germany Research Council [SFB746]; Chinese Scholarship Council; Industrial Biotechnology Catalyst (Innovate UK) [BB/M018172/1, BBSRC BB/M012166/1]; Industrial Biotechnology Catalyst (BBSRC) [BB/M018172/1, BBSRC BB/M012166/1]; Industrial Biotechnology Catalyst (EPSRC) [BB/M018172/1, BBSRC BB/M012166/1];  [SFB987]; BBSRC [BB/M018172/1, BB/M012166/1] Funding Source: UKRI	European Union's Horizon 2020 research and innovation program; Excellence Initiative of the German Research Foundation (Spemann Graduate School); Germany Research Council; Chinese Scholarship Council(China Scholarship Council); Industrial Biotechnology Catalyst (Innovate UK); Industrial Biotechnology Catalyst (BBSRC); Industrial Biotechnology Catalyst (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union's Horizon 2020 research and innovation program under Grant Agreement 686647 (MARA; to S.-V. A. and L.H.); in part by the Excellence Initiative of the German Research Foundation (Spemann Graduate School (to L. F. B.)) and the Germany Research Council in frame of the SFB746 (to S.-V. A. and L. F. B.); by a Chinese Scholarship Council Ph.D. scholarship (to X. Y.); by Industrial Biotechnology Catalyst (Innovate UK, BBSRC, EPSRC) Grants BB/M018172/1 and BBSRC BB/M012166/1 (to T. K. P. and P. C. W.); and by funds from SFB987 (to L.-O. E. and S.-V. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albers SV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00023; Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bewley MA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008193; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BORK P, 1991, BIOCHEM J, V279, P908, DOI 10.1042/bj2790908; Cho KY, 1999, MOL MICROBIOL, V34, P714, DOI 10.1046/j.1365-2958.1999.01633.x; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Duan X, 2011, BIOCHEM BIOPH RES CO, V407, P242, DOI 10.1016/j.bbrc.2011.03.011; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; EDWARDS YJK, 1995, FEBS LETT, V358, P283, DOI 10.1016/0014-5793(94)01447-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Haurat MF, 2017, MOL MICROBIOL, V103, P181, DOI 10.1111/mmi.13550; Hoffmann L, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.414; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassak K, 2013, MOL MICROBIOL, V88, P125, DOI 10.1111/mmi.12173; Lassak K, 2012, MOL MICROBIOL, V83, P110, DOI 10.1111/j.1365-2958.2011.07916.x; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Li J, 2000, J CELL SCI, V113, P4143; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Nylander A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063768; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Reimann J, 2013, MOL CELL PROTEOMICS, V12, P3908, DOI 10.1074/mcp.M113.027375; Reimann J, 2012, MOL MICROBIOL, V86, P24, DOI 10.1111/j.1365-2958.2012.08186.x; Romes EM, 2016, J BIOL CHEM, V291, P882, DOI 10.1074/jbc.M115.693259; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; Takizawa M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701497; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wang B, 2010, J BACTERIOL, V192, P1956, DOI 10.1128/JB.01471-09; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7460	7471		10.1074/jbc.RA119.007709	http://dx.doi.org/10.1074/jbc.RA119.007709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30902813	Green Published, hybrid			2022-12-26	WOS:000468402900030
J	Kim, JY; Park, SJ; Kim, SK; Kim, CS; Kim, TH; Min, SH; Oh, SS; Koh, SB				Kim, Jae-Yeop; Park, Sung-Jin; Kim, Sung-Kyung; Kim, Chang-Soo; Kim, Tae-Hei; Min, Seong-Ho; Oh, Sung-Soo; Koh, Sang-Baek			Pesticide exposure and cognitive decline in a rural South Korean population	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; ORGANOCHLORINE PESTICIDES; RISK; IMPAIRMENT; DISORDERS; FARMERS; HEALTH; FEATURES; DISEASE; WEIGHT	We aimed to investigate the relationship between pesticide exposure and cognitive decline in a rural South Korean population. From July 2015 to December 2017, 200 randomly selected Korean Farmers Cohort study participants were recruited and of these, 169 participants were analyzed. Pesticide exposure was investigated using a standardized questionnaire, and the Korean-Montreal Cognitive Assessment (K-MoCA) was conducted. Cognitive decline was more frequent among those directly exposed to pesticides (P = 0.057). Pesticide exposure and cognitive decline were positively correlated in the group with direct exposure versus no exposure (crude odds ratio [OR], 2.66; 95% confidence interval [CI], 1.17-6.04); this relationship was insignificant after adjustment (adjusted OR, 1.50; 95% CI, 0.57-3.92). There was a significant difference in the K-MoCA scores for each group based on pesticide exposure (P = 0.003). When we stratified by age, differences in the K-MoCA scores depending on the degree of pesticide exposure in the those aged 60 to 69 years were identified. Overall, there was a tendency towards an association between pesticide exposure and cognitive decline in rural Korean adult farmers. In our study, chronic pesticide exposure tended to have a greater impact in certain age group (60-69 years) than in those under 60 and over 70.	[Kim, Jae-Yeop; Kim, Sung-Kyung; Oh, Sung-Soo; Koh, Sang-Baek] Wonju Severance Christian Hosp, Dept Occupat & Environm Med, Wonju, South Korea; [Kim, Jae-Yeop; Kim, Sung-Kyung; Oh, Sung-Soo; Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Kim, Jae-Yeop; Kim, Sung-Kyung; Oh, Sung-Soo; Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Inst Occupat & Environm Med, Wonju, South Korea; [Park, Sung-Jin] Yonsei Univ, Grad Sch, Seoul, South Korea; [Park, Sung-Jin] Hongseong Med Ctr, Dept Occupat & Environm Med, Hongseong, South Korea; [Kim, Chang-Soo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Chang-Soo] Yonsei Univ, Inst Human Complex & Syst Sci, Seoul, South Korea; [Kim, Tae-Hei; Min, Seong-Ho] Wonju Severance Christian Hosp, Dept Psychiat, Wonju, South Korea; [Koh, Sang-Baek] Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Wonju, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Oh, SS; Koh, SB (corresponding author), Wonju Severance Christian Hosp, Dept Occupat & Environm Med, Wonju, South Korea.; Oh, SS; Koh, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea.; Oh, SS; Koh, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Inst Occupat & Environm Med, Wonju, South Korea.; Koh, SB (corresponding author), Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Wonju, South Korea.	oss0609@yonsei.ac.kr; kohhj@yonsei.ac.kr	PARK, SUNGJIN/AAJ-3406-2020	PARK, SUNGJIN/0000-0002-9240-9684; Kim, Sung-Kyung/0000-0002-2742-6410; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2016S1A5B8925203]; Cooperative Research Program for Agriculture Science & Technology Development [PJ01250901]; Rural Development Administration, Republic of Korea; Korea Ministry of Environment (MOE) under "the Environmental Health Action Program" [2014001360002]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Korea Ministry of Environment (MOE) under "the Environmental Health Action Program"	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5B8925203). This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01250901)" and the Rural Development Administration, Republic of Korea. The study was also funded by the Korea Ministry of Environment (MOE) under "the Environmental Health Action Program" (grant number 2014001360002 awarded to CSK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5B8925203). This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01250901)" and the Rural Development Administration, Republic of Korea.	Baldi I, 2011, OCCUP ENVIRON MED, V68, P108, DOI 10.1136/oem.2009.047811; Baltazar MT, 2014, TOXICOL LETT, V230, P85, DOI 10.1016/j.toxlet.2014.01.039; Bayrami M, 2012, TOXICOL IND HEALTH, V28, P90, DOI 10.1177/0748233711407243; Campos E, 2016, NEUROTOXICOLOGY, V56, P7, DOI 10.1016/j.neuro.2016.06.002; Cha ES, 2014, CANCER EPIDEMIOL, V38, P401, DOI 10.1016/j.canep.2014.05.003; Cha ES, 2014, J AGROMEDICINE, V19, P281, DOI 10.1080/1059924X.2014.917349; Corral SA, 2017, NEUROTOXICOL TERATOL, V62, P13, DOI 10.1016/j.ntt.2017.05.003; Dosemeci M, 2002, ANN OCCUP HYG, V46, P245, DOI 10.1093/annhyg/mef011; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Hernandez AF, 2016, ENVIRON INT, V92-93, P657, DOI 10.1016/j.envint.2016.01.020; Hong SY, 2009, J PEST SCI, V82, P261, DOI 10.1007/s10340-009-0249-x; Jokanovic M, 2010, ENVIRON TOXICOL PHAR, V29, P195, DOI 10.1016/j.etap.2010.01.006; Kaneko H, 2011, J AGR FOOD CHEM, V59, P2786, DOI 10.1021/jf102567z; Kim Bokyeong, 2015, Environ Health Toxicol, V30, pe2015002, DOI 10.5620/eht.e2015002; Kim JI, 2016, J MOV DISORD, V9, P152, DOI 10.14802/jmd.16020; Kim KH, 2017, SCI TOTAL ENVIRON, V575, P525, DOI 10.1016/j.scitotenv.2016.09.009; Kim KS, 2015, ENVIRON INT, V75, P87, DOI 10.1016/j.envint.2014.11.003; Kim SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130623; Koh SB, 2017, NEUROTOXICOLOGY, V62, P181, DOI 10.1016/j.neuro.2017.07.005; Lee DH, 2016, ENVIRON INT, V89-90, P179, DOI 10.1016/j.envint.2016.02.001; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; Lee KM, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0162-3; Meyer-Baron M, 2015, ENVIRON RES, V136, P234, DOI 10.1016/j.envres.2014.09.030; Povey AC, 2014, ENVIRON RES, V135, P262, DOI 10.1016/j.envres.2014.09.008; Richardson JR, 2015, FASEB J, V29, P1960, DOI 10.1096/fj.14-260901; Ross SJM, 2010, NEUROTOXICOL TERATOL, V32, P452, DOI 10.1016/j.ntt.2010.03.004; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Stallones L, 2016, CORTEX, V74, P405, DOI 10.1016/j.cortex.2015.10.002; Terry AV, 2012, PHARMACOL THERAPEUT, V134, P355, DOI 10.1016/j.pharmthera.2012.03.001; Van Maele-Fabry G, 2010, CANCER CAUSE CONTROL, V21, P787, DOI 10.1007/s10552-010-9516-7; Wickerham EL, 2012, ENVIRON INT, V47, P80, DOI 10.1016/j.envint.2012.06.007; Faria NMX, 2014, NEUROTOXICOLOGY, V45, P347, DOI 10.1016/j.neuro.2014.05.002; Yan DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep32222	33	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213738	10.1371/journal.pone.0213738	http://dx.doi.org/10.1371/journal.pone.0213738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897108	gold, Green Submitted, Green Published			2022-12-26	WOS:000461889700033
J	Li, ZJ; Meng, MM; Li, SS; Deng, B				Li, Zhongjie; Meng, Miaomiao; Li, Shasha; Deng, Bo			The transcriptome analysis of Protaetia brevitarsis Lewis ldarvae	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; ANTIMICROBIAL PEPTIDES; MOLECULAR CHARACTERIZATION; ANTIBACTERIAL PEPTIDES; IDENTIFICATION; BEETLE; GENE; PURIFICATION; RESISTANCE; LYSOZYME	Larvae of the pest Protaetia brevitarsis are used to treat infections in traditional Chinese medicine. However, genomic information about this non-model species is currently lacking. To better understand the fundamental biology of this non-model species, its transcriptome was obtained using next generation sequencing and then analyzed. A total of 7.62 Gb of clean reads were obtained, which were assembled into 169,087 transcripts corresponding to 142,000 annotated unigenes. These unigenes were functionally classified according to Gene Ontology (GO), euKaryotic Ortholog Groups of proteins (KOG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations. A total of 41,921 unigenes were assigned to 56 GO terms, 21,454 unigenes were divided among 26 KOG categories, and 16,368 unigenes were assigned to 32 KEGG pathways. In addition, 19,144 simple sequence repeats (SSRs) were identified. Furthermore, several kinds of natural antimicrobial peptides and proteins, 4 histones with potential antimicrobial activity, and 41 potential antimicrobial peptide sequences were identified. These data are the first reported whole transcriptome sequence of P. brevitarsis larvae, which represents a valuable genomic resource for studying this species, thus promoting the utilization of its medical potential.	[Li, Zhongjie; Meng, Miaomiao; Li, Shasha; Deng, Bo] Henan Univ Sci & Technol, Coll Med, Luoyang, Peoples R China	Henan University of Science & Technology	Li, ZJ (corresponding author), Henan Univ Sci & Technol, Coll Med, Luoyang, Peoples R China.	sui_feng5217@126.com		deng, bo/0000-0003-0889-7257	Doctor Scientific Research Fund of Henan University of Science and Technology [4020-13480034]; National Natural Science Foundation of China [81703475]	Doctor Scientific Research Fund of Henan University of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Doctor Scientific Research Fund of Henan University of Science and Technology (grant number: 4020-13480034), and The National Natural Science Foundation of China (grant number: 81703475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Bjorstad A, 2005, ANTIMICROB AGENTS CH, V49, P3889, DOI 10.1128/AAC.49.9.3889-3895.2005; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Chen JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184736; Chen ZM, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/9139306; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; Dorrington T, 2011, FISH SHELLFISH IMMUN, V30, P94, DOI 10.1016/j.fsi.2010.09.006; Du XJ, 2006, MOL IMMUNOL, V43, P1633, DOI 10.1016/j.molimm.2005.09.018; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Fu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079743; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YH, 2014, FISH SHELLFISH IMMUN, V39, P321, DOI 10.1016/j.fsi.2014.05.029; Huang Y, 2015, DEV COMP IMMUNOL, V50, P129, DOI 10.1016/j.dci.2015.01.002; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Kang SW, 2016, MOL GENET GENOMICS, V291, P1999, DOI 10.1007/s00438-016-1233-9; LAMBERT J, 1989, P NATL ACAD SCI USA, V86, P262, DOI 10.1073/pnas.86.1.262; Lee J, 2013, WOUND REPAIR REGEN, V21, P876, DOI 10.1111/wrr.12112; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Luna-Ramirez K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127883; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MATSUYAMA K, 1988, J BIOL CHEM, V263, P17112; Miao N, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1700010; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nijnik A, 2009, Emerg Health Threats J, V2, pe1, DOI 10.3134/ehtj.09.001; Park JW, 2010, ADV EXP MED BIOL, V708, P163; Patat SA, 2004, EUR J BIOCHEM, V271, P4825, DOI 10.1111/j.1432-1033.2004.04448.x; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Qi XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2309-3; Qiao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075211; Sakamoto Y, 2006, PLANT PHYSIOL, V141, P793, DOI 10.1104/pp.106.076679; Sayadi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158565; Tagai C, 2011, PEPTIDES, V32, P2003, DOI 10.1016/j.peptides.2011.09.005; Tang BZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091482; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Tonk M, 2017, CURR TOP MED CHEM, V17, P554, DOI 10.2174/1568026616666160713123654; Tsuzuki S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5628; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; VIGERS AJ, 1991, MOL PLANT MICROBE IN, V4, P315, DOI 10.1094/MPMI-4-315; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01835-9; Yan W, 2015, GENET MOL RES, V14, P8359, DOI 10.4238/2015.July.28.2; Yang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179807; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Yoon HS, 2003, ARCH INSECT BIOCHEM, V52, P92, DOI 10.1002/arch.10072; You WG, 2014, FUNCT INTEGR GENOMIC, V14, P275, DOI 10.1007/s10142-014-0366-3; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102006; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291; Zou DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060881	58	7	9	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214001	10.1371/journal.pone.0214001	http://dx.doi.org/10.1371/journal.pone.0214001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897120	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700053
J	Morard, R; Vollmar, NM; Greco, M; Kucera, M				Morard, Raphaeel; Vollmar, Nele M.; Greco, Mattia; Kucera, Michal			Unassigned diversity of planktonic foraminifera from environmental sequencing revealed as known but neglected species	PLOS ONE			English	Article							RIBOSOMAL DNA; PERFORMANCE	Most research on extant planktonic foraminifera has been directed towards larger species (>0.150 mm) which can be easily manipulated, counted and yield enough calcite for geochemical analyses. This has drawn attention towards the macroperforate clade and created an impression of their numerical and ecological dominance. Drawing such conclusions from the study of such "giants" is a dangerous path. There were times in the evolutionary history of planktonic foraminifera when all species were smaller than 0.1 mm and indeed numerous small taxa, mainly from the microperforate clade, have been formally described from the modern plankton. The significance of these small, obscure and neglected species is poorly characterized and their relationship to the newly discovered hyperabundant but uncharacterized lineages of planktonic foraminifera in metabarcoding datasets is unknown. To determine, who is hiding in the metabarcoding datasets, we carried out an extensive sequencing of 18S rDNA targeted at small and obscure species. The sequences of the newly characterized small and obscure taxa match many of the previously uncharacterized lineages found in metabarcoding data. This indicates that most of the modern diversity in planktonic foraminifera has been taxonomically captured, but the role of the small and neglected taxa has been severely underestimated.	[Morard, Raphaeel; Vollmar, Nele M.; Greco, Mattia; Kucera, Michal] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany	University of Bremen	Morard, R (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany.	rmorard@marum.de	Kucera, Michal/ABH-6065-2020; Kucera, Michal/AAE-8115-2020	Kucera, Michal/0000-0002-7817-9018; Greco, Mattia/0000-0003-2416-6235; Vollmar, Nele Manon/0000-0003-4180-3443	DFG-Research Center/Cluster of Excellence 'The Ocean in the Earth System	DFG-Research Center/Cluster of Excellence 'The Ocean in the Earth System(German Research Foundation (DFG))	This work was supported by the DFG-Research Center/Cluster of Excellence 'The Ocean in the Earth System.'	Andre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104641; Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aurahs R, 2009, BIOINFORM BIOL INSIG, V3, P155; BRUMMER GJA, 1986, NATURE, V319, P50, DOI 10.1038/319050a0; Caron DA, 2018, ARE WE OVERESTIMATIN, P1, DOI [10.1016/j.tim.2018.10.009, DOI 10.1016/J.TIM.2018.10.009]; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; del Campo J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005849; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holzmann M, 2017, MAR MICROPALEONTOL, V132, P18, DOI 10.1016/j.marmicro.2017.04.002; Karstensen J, 2016, METEOR BERICHTE CRUI; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kucera M., 2013, CRUISE REPORT RV SON; Kucera M, 2014, MSM09 DFG SEN OZ, P128, DOI [10.2312/cr_msm09, DOI 10.2312/CR_MSM09]; Kucera M, 2017, J PLANKTON RES, V39, P436, DOI 10.1093/plankt/fbx018; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Morard R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20833-z; Morard R, 2016, SYST BIOL, V65, P925, DOI 10.1093/sysbio/syw031; Morard R, 2015, MOL ECOL RESOUR, V15, P1472, DOI 10.1111/1755-0998.12410; Mulitza S.., 2015, T RV MARIA S MERIAN, P89, DOI [10.2312/cr_msm39, DOI 10.2312/CR_MSM39]; Pawlowski J, 2014, J FORAMIN RES, V44, P62, DOI 10.2113/gsjfr.44.1.62; Pawlowski J, 2013, MAR MICROPALEONTOL, V100, P1, DOI 10.1016/j.marmicro.2013.04.002; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Schiebel R., 2017, PLANKTIC FORAMINIFER, DOI DOI 10.1007/978-3-662-50297-6; Schlitzer R., 2018, OCEAN DATA VIEW; Siccha M, 2016, M1132 DFG SEN OZ, DOI [10.2312/cr_m113_2, DOI 10.2312/CR_M113_2]; Spezzaferri S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128108; Weiner AKM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00255; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	30	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213936	10.1371/journal.pone.0213936	http://dx.doi.org/10.1371/journal.pone.0213936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897140	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700048
J	Ranieri, M; Di Mise, A; Difonzo, G; Centrone, M; Venneri, M; Pellegrino, T; Russo, A; Mastrodonato, M; Caponio, F; Valenti, G; Tamma, G				Ranieri, Marianna; Di Mise, Annarita; Difonzo, Graziana; Centrone, Mariangela; Venneri, Maria; Pellegrino, Tommaso; Russo, Annamaria; Mastrodonato, Maria; Caponio, Francesco; Valenti, Giovanna; Tamma, Grazia			Green olive leaf extract (OLE) provides cytoprotection in renal cells exposed to low doses of cadmium	PLOS ONE			English	Article							OXIDATIVE STRESS; ACTIN; GLUTATHIONYLATION; LEAVES; HYDROXYTYROSOL; CYTOTOXICITY; DAMAGE; BLOOD	Cadmium (Cd) is a heavy and highly toxic metal that contaminates air, food and water. Cadmium accumulates in several organs altering normal functions. The kidney is the major organ at risk of damage from chronic exposure to cadmium as a contaminant in food and water. This study aims to investigate the beneficial effects of OLE in renal collecting duct MCD4 cells exposed to a low dose cadmium (1 mu M). In MCD4 cells cadmium caused an increase in ROS production, as well as generation of lipid droplets and reduced cell viability. Moreover, cadmium exposure led to a remarkable increase in the frequency of micronuclei and DNA double-strand breaks, assessed using the alkaline comet assay. In addition, cadmium dramatically altered cell cytoskeleton architecture and caused S-glutathionylation of actin. Notably, all cadmium-induced cellular deregulations were prevented by co-treatment with OLE, possibly due to its antioxidant action and to the presence of bioactive phytocompounds. Indeed, OLE treatment attenuated Cd-induced actin S-glutathionylation, thereby stabilizing actin filaments. Taken together, these observations provide a novel insight into the biological action of OLE in renal cells and support the notion that OLE may serve as a potential adjuvant against cadmium-induced nephrotoxicity.	[Ranieri, Marianna; Di Mise, Annarita; Centrone, Mariangela; Venneri, Maria; Pellegrino, Tommaso; Russo, Annamaria; Valenti, Giovanna; Tamma, Grazia] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Difonzo, Graziana; Caponio, Francesco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Mastrodonato, Maria] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Valenti, Giovanna; Tamma, Grazia] INBB, Bari, Italy; [Valenti, Giovanna] Univ Bari, Ctr Excellence Comparat Genom CEGBA, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Tamma, G (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.; Tamma, G (corresponding author), INBB, Bari, Italy.	grazia.tamma@uniba.it	Difonzo, Graziana/AAF-6455-2019; Ranieri, Marianna/J-9421-2018; Venneri, Maria/AIB-6844-2022; Di Mise, Annarita/AAP-4176-2020; Russo, Annamaria/ABG-4681-2020	Ranieri, Marianna/0000-0003-3118-5813; Tamma, Grazia/0000-0002-8890-0278; Russo, Annamaria/0000-0002-4092-2558; Caponio, Francesco/0000-0002-0740-7677; DI MISE, Annarita/0000-0002-8132-4917; Venneri, Maria/0000-0002-1235-6157	Fondazione in rete per la Ricerca Agroalimentare - AGER 2 Project [2016-0105]; AGER 2 Project [2016-0105]	Fondazione in rete per la Ricerca Agroalimentare - AGER 2 Project; AGER 2 Project	This work has been funded by "Fondazione in rete per la Ricerca Agroalimentare - AGER 2 Project, grant no 2016-0105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work has been supported by AGER 2 Project, grant no 2016-0105.	Akesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110; Almeer RS, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8487248; Apykhtina O. L., 2018, Experimental Oncology, V40, P194; Baldantoni D, 2016, ECOTOX ENVIRON SAFE, V123, P89, DOI 10.1016/j.ecoenv.2015.05.019; Boss A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080513; Brzoska MM, 2016, CURR DRUG TARGETS, V17, P1350, DOI 10.2174/1389450116666150506114336; Caponio FD, 2018, FOOD RES INT; Cataldo I, 2017, CURR MED CHEM; Centrone M, 2017, CELL PHYSIOL BIOCHEM, V44, P515, DOI 10.1159/000485088; Chen X, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050449; Cheurfa M, 2019, FOOD CHEM TOXICOL, V123, P98, DOI 10.1016/j.fct.2018.10.002; Choong G, 2013, TOXICOL APPL PHARM, V272, P423, DOI 10.1016/j.taap.2013.07.002; Dalle-Donne I, 2003, FREE RADICAL BIO MED, V34, P23, DOI 10.1016/S0891-5849(02)01182-6; de Bock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057622; Delgado-Moreno LNR, 2017, INT J ENVIRON SCI TE, V14, P13; Difonzo G, 2018, FOOD RES INT, V108, P48, DOI 10.1016/j.foodres.2018.03.034; Difonzo G, 2017, J FUNCT FOODS, V31, P63, DOI 10.1016/j.jff.2017.01.039; El SN, 2009, NUTR REV, V67, P632, DOI 10.1111/j.1753-4887.2009.00248.x; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Gobrecht J, 2017, MUTAT RES-GEN TOX EN, V816, P12, DOI 10.1016/j.mrgentox.2017.03.001; Hallenbeck W H, 1986, Experientia Suppl, V50, P131; Imafidon CE, 2018, TOXICOL REP, V5, P324, DOI 10.1016/j.toxrep.2018.02.009; Iolascon A, 2007, NEPHRON PHYSIOL, V105, P33, DOI 10.1159/000098136; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Khemakhem I, 2018, FOOD SCI TECHNOL INT; Kim JG, 2018, J CELL PHYSIOL, V233, P6381, DOI 10.1002/jcp.26487; Kiziler AR, 2007, BIOL TRACE ELEM RES, V120, P82, DOI 10.1007/s12011-007-8020-8; Kovacs G, 2013, CELL CALCIUM, V54, P276, DOI 10.1016/j.ceca.2013.07.003; Lins PG, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00805; Magrone T, 2018, ENDOCR METAB IMMUNE, V18, P85, DOI 10.2174/1871530317666171116110537; Mallya R, 2017, J CLIN DIAGN RES, V11, pCE1, DOI 10.7860/JCDR/2017/21796.9671; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Nordberg GF, 2009, TOXICOL APPL PHARM, V238, P192, DOI 10.1016/j.taap.2009.03.015; Olga Igorevna Kulikova TNF, 2016, BIOL MED, V8, P5; Pan SX, 2018, ENVIRON POLLUT, V235, P47, DOI 10.1016/j.envpol.2017.12.044; Planchart A, 2018, CURR ENV HLTH REP, V5, P110, DOI 10.1007/s40572-018-0182-3; Procino G, 2015, CELL PHYSIOL BIOCHEM, V35, P1070, DOI 10.1159/000373933; Rajakumar S, 2017, TOXICOL RES-UK, V6, P30, DOI 10.1039/c6tx00187d; Saibandith B, 2017, MOLECULES, V22, DOI 10.3390/molecules22071082; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Satarug S, 2018, J TRACE ELEM MED BIO, V46, P32, DOI 10.1016/j.jtemb.2017.11.008; SMITH TJ, 1976, AM REV RESPIR DIS, V114, P161; Soussi R., 2018, APPL PHYSL NUTR META; Sun S, 2014, J BIOMECH, V47, P3650, DOI 10.1016/j.jbiomech.2014.09.036; Takuma M, 2018, BIOSCI BIOTECH BIOCH, V82, P1101, DOI 10.1080/09168451.2018.1451741; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495; Tamma G, 2007, AM J PHYSIOL-CELL PH, V292, pC1476, DOI 10.1152/ajpcell.00375.2006; Tamma G, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1501847; Tamma G, 2016, ANTIOXID REDOX SIGN, V25, P147, DOI 10.1089/ars.2016.6656; Tamma G, 2014, J BIOL CHEM, V289, P27807, DOI 10.1074/jbc.M114.586024; Tesse A, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00030; Toteda G, 2018, FOOD FUNCT; Verma N, 2020, J DIET SUPPL, V17, P41, DOI 10.1080/19390211.2018.1481485; Wang Z, 1996, TOXICOL APPL PHARM, V139, P115, DOI 10.1006/taap.1996.0149; Wei TS, 2017, ONCOTARGET, V8, P44944, DOI 10.18632/oncotarget.16572; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wu LX, 2018, J BIOMED RES, V32, P371, DOI 10.7555/JBR.32.20170111; Xu Y, 2018, INT J MOL SCI, V19; Zanetti SR, 2014, BBA-MOL CELL BIOL L, V1841, P151, DOI 10.1016/j.bbalip.2013.09.014; Zou X, 2012, J NUTR BIOCHEM, V23, P994, DOI 10.1016/j.jnutbio.2011.05.006	63	25	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214159	10.1371/journal.pone.0214159	http://dx.doi.org/10.1371/journal.pone.0214159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897184	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700074
J	Bonsu, AB; Ncama, BP				Bonsu, Adwoa Bemah; Ncama, Busisiwe Purity			Integration of breast cancer prevention and early detection into cancer palliative care model	PLOS ONE			English	Article							TRIAL; WOMEN	Background Breast cancer is common among Ghanaian women. Late stage presentation has been credited to knowledge deficit and lack of breast cancer prevention and early detection services for women. Objective This study aimed to develop a model to facilitate the integration of breast cancer prevention and early detection into cancer palliative care. Method This study used synthesized concepts emerging from a single case study research. The case was a tertiary health care facility, embedded with sub-units of analysis. Mixed-method approach was used to collect data from 102 participants. The study examined the experiences and views of the participants on breast cancer and screening pathways in Ghana. Thematic analysis and descriptive statistics ware used to analyze the qualitative and quantitative data respectively. This was followed with a cross-case analysis across the sub-units of analysis. A theory development approach was further used towards the development of a model, following three steps: concept analysis, statement synthesis and theory synthesis. Results Six key concepts synthesized from the data were used to develop the model: initiate and sustain breast cancer prevention and early detection program, collaboration of health professionals, patients, families and micro-communities, conducive environment of the health care facility and needed resources, actions, services, and lastly diffusing innovation into the community through agents. Conclusion A model has been developed based on the experiences shared by women diagnosed with advanced breast cancer, their first degree relatives, micro-communities as well as clinicians working in a palliative care setting. This model will aid clinicians to provide breast cancer education, teach breast self-examination and offer clinical breast examination to families and micro-communities of advanced breast cancer patients receiving supportive care in a resource-limited setting.	[Bonsu, Adwoa Bemah; Ncama, Busisiwe Purity] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Nursing, Durban, South Africa; [Bonsu, Adwoa Bemah] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana	University of Kwazulu Natal; Kwame Nkrumah University Science & Technology	Bonsu, AB; Ncama, BP (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Nursing, Durban, South Africa.; Bonsu, AB (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana.	Ncamab@ukzn.ac.za; bbemahc2000@gmail.com		Boamah Mensah, ADWOA Bemah/0000-0002-1114-702X	University of KwaZulu-Natal College of Health Sciences Scholarship	University of KwaZulu-Natal College of Health Sciences Scholarship	Research reported in this publication was supported by the University of KwaZulu-Natal College of Health Sciences Scholarship. The content is solely the responsibility of the authors and does not represent the official view of the funder. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. ABB received the scholarship award.	Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; [Anonymous], 2010, FREE DICT FARL; Anyebe E, 2014, CANCER, V4; BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407; Bellamy R, 2004, MED TEACH, V26, P359, DOI 10.1080/01421590410001679398; Bertram RM, 2015, RES SOCIAL WORK PRAC, V25, P477, DOI 10.1177/1049731514537687; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Biritwum R. B., 2000, GHANA MED J, V34, P197; Bonsu AB, 2019, RECOGNIZING APPRAISI, V14, DOI [10.1371/journal.pone.0208773, DOI 10.1371/JOURNAL.PONE.0208773]; Cambridge University Press, 2018, CAMBRIDGE BUSINESS E; Chinn P., 2013, INTEGRATED THEORY KN; Chinn P.L., 2008, INTEGRATED THEORY KN; Chinn PL, 2015, KNOWLEDGE DEV NURSIN, V9th; Clegg-Lamptey J N A, 2009, West Afr J Med, V28, P114; Collis J., 2013, BUSINESS RES PRACTIC, P54; Creswell J. W., 2017, QUAL INQ; Dakubo J, 2014, BREAST CANC, V204; Dickoff J, 1969, NURS RES, V17, P29; Edmund DM, 2013, AM J CLIN PATHOL, V140, P97, DOI 10.1309/AJCPW7TZLS3BFFIU; Feng Y, 2018, GENES DIS; Grol R, 2013, IMPROVING PATIENT CARE: THE IMPLEMENTATION OF CHANGE IN HEALTH CARE, 2ND EDITION, P1, DOI 10.1002/9781118525975; Guba E., 1989, 4 GENERATION EVALUAT; Husserl Edmund., 2013, CARTESIAN MEDITATION; Kaminski, 2011, CANADIAN J NURSING I, V6, DOI DOI 10.1097/CIN.0000000000000072; Laryea DO, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-362; Lemon SC, 2004, PREV MED, V39, P253, DOI 10.1016/j.ypmed.2004.03.039; Lincoln Y.S., 2011, SAGE HDB QUALITATIVE, V4th; Love S.M., 2015, SUSAN LOVES BREAST B; Mena M, 2014, INT J CANCER, V134, P913, DOI 10.1002/ijc.28412; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Miles M.B., 1994, ANAL DONNEES QUALITA, V2nd; Ministry of Health Ghana, 2014, HLTH SECT MED TERM D; Mitchell SM, 2000, MILBANK Q, V78, P241, DOI 10.1111/1468-0009.00170; Obrist M, 2014, BREAST, V23, P821, DOI 10.1016/j.breast.2014.08.014; Oche MO, 2013, INT J MED MED SCI, V5, P184; Ohene-Yeboah M, 2012, GHANA MED J, V46; Opoku SY, 2012, PAN AFR MED J, V11; Polit D. F., 2012, NURSING RES GENERATI; Rogers E., 2010, DIFFUSION INNOVATION, DOI [10.1097/IMI.0b013e3181cf897d, DOI 10.1097/IMI.0B013E3181CF897D]; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Scherber Samuel, 2014, Breast Dis, V34, P139, DOI 10.3233/BD-140372; Scott T, 2003, INT J QUAL HEALTH C, V15, P111, DOI 10.1093/intqhc/mzg021; Stark A, 2010, CANCER-AM CANCER SOC, V116, P4926, DOI 10.1002/cncr.25276; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Union for International Cancer Control, 2017, 2017 CANC RES TOOL B; Uwuseba L., 2010, KNOWLEDGE ATTITUDES; W. H. Organization, 2008, CANC CONTR KNOWL ACT; Walker L.O., 2008, STRATEGIES THEORY CO; World Health Organization, 2007, CANC CONTR KNOWL ACT; Yin R. K., 2017, CASE STUDY RES APPLI; Zelle SG, 2012, TROP MED INT HEALTH, V17, P1031, DOI 10.1111/j.1365-3156.2012.03021.x	51	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0212806	10.1371/journal.pone.0212806	http://dx.doi.org/10.1371/journal.pone.0212806			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893313	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900015
J	Chia, J; Tay, F; Bard, F				Chia, Joanne; Tay, Felicia; Bard, Frederic			The GalNAc-T Activation (GALA) Pathway: Drivers and markers	PLOS ONE			English	Article							O-GLYCOSYLATION; SRC; BREAST; COLOCALIZATION; EXPRESSION; CARCINOMA; GROWTH	The enzymes GALNTs add GaINAc sugar to Ser and Thr residues, forming the Tn glycan. GALNTs are activated by trafficking from Golgi to ER, a process driven by the Src kinase and negatively regulated by ERK8. This GALNTs activation (aka GALA) pathway induces high Tn levels and is a key driver of liver tumor growth. Recently, Tabak and colleagues have contested our previous data that EGF stimulation can induce GALNTs relocation. Here, we show that relocation induced by EGF is actually detectable in the very images acquired by Tabak et al. Furthermore, we show that over-expression of EGFR strongly enhances EGF-induced relocation and that EGFR appears required to drive relocation induced by ERK8 depletion. Direct co-localisation of GALNT with the ER marker Calnexin is observed after EGF stimulation. We furthermore propose that quantification of o-glycosylation of the ER resident protein PDIA4 provides a mean to quantify GALA independently of imaging. In sum, we demonstrate that the claimed non-reproducibility was due to experimental imaging conditions, that EGFR is indeed a driver of GALA and propose additional markers to facilitate the study of this pathway.	[Chia, Joanne; Tay, Felicia; Bard, Frederic] Inst Mol & Cell Biol, Singapore, Singapore; [Bard, Frederic] Natl Univ Singapore, Dept Biochem, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Bard, F (corresponding author), Inst Mol & Cell Biol, Singapore, Singapore.; Bard, F (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore, Singapore.	fbard@imcb.a-star.edu.sg	Bard, Frederic Andre Jean/G-9914-2011	Bard, Frederic Andre Jean/0000-0002-3783-4805				Nguyen AT, 2017, CANCER CELL, V32, P639, DOI 10.1016/j.ccell.2017.10.001; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bard F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180005; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chia J, 2014, ELIFE, V3, DOI 10.7554/eLife.01828; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Frattini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15377; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Herbomel GG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179241; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ju TZ, 2014, CANCER BIOMARK, V14, P63, DOI 10.3233/CBM-130375; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Leek JT, 2017, ANN REV; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Munkley J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030275; Parks EE, 2014, J BIOL CHEM, V289, P25537, DOI 10.1074/jbc.M114.579581; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Rodriguez E, 2018, NAT REV IMMUNOL, V18, P204, DOI 10.1038/nri.2018.3; Sasaki T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546318; Song K, 2015, J BIOL CHEM, V290, P20159, DOI 10.1074/jbc.M115.654483; SPRINGER GF, 1989, MOL IMMUNOL, V26, P1, DOI 10.1016/0161-5890(89)90013-8; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; van der Valk J, 2018, ALTEX-ALTERN ANIM EX, V35, P99, DOI 10.14573/altex.1705101; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Yoo NJ, 2008, APMIS, V116, P154, DOI 10.1111/j.1600-0463.2008.00965.x	34	12	13	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214118	10.1371/journal.pone.0214118	http://dx.doi.org/10.1371/journal.pone.0214118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889231	Green Submitted, gold, Green Published			2022-12-26	WOS:000461573000051
J	Florencio, RB; Aliverti, A; Fagundes, MLLC; Batista, IPD; da Nobrega, AJS; Resqueti, VR; Fregonezi, GAD				Florencio, Rencio Bento; Aliverti, Andrea; Lima Cabral Fagundes, Marina Lyra; dos Santos Batista, Ilsa Priscila; Sarmento da Nobrega, Antonio Jose; Resqueti, Vanessa Regiane; de Freitas Fregonezi, Guilherme Augusto			Acute effects of three pulmonary reexpansion modalities on thoracoabdominal motion of healthy subjects: Randomized crossover study	PLOS ONE			English	Article							CHEST-WALL VOLUMES; ORIENTED INCENTIVE SPIROMETRY; POSITIVE EXPIRATORY PRESSURE; RESPIRATORY PRESSURES; MOVEMENT; EXERCISE; PATTERN; SURGERY	Background Chest physiotherapy can be an alternative to increase lung volumes through pulmonary expansion therapies, but there is still inconsistency in the literature in order to determine which device can promote a greater volume increase at the expense of a better ventilatory pattern. Therefore, the aim of this study was to evaluate and compare the chest wall kinematics of healthy subjects submitted to the use of three different devices for pulmonary reexpansion. Methods Chest wall compartmental and operational volumes, breathing pattern and thoracoabdominal asynchrony were evaluated in 12 healthy individuals through optoelectronic plethysmography during quiet breathing, pulmonary reexpansion and recovery. Three different devices (volume-oriented incentive spirometer IS-v; positive expiratory pressure PEP; and incentive spirometer volume and pressure oriented IS-vp) were administered in a random order with at least 48h between the devices. Results A greater volume variation in the chest wall and its compartments was observed when the IS-vp was used in comparison with the other devices (p<0.05). Furthermore, the IS-vp mobilizes a greater amount of volume accompanied by greater synchronism between the compartments when compared to IS-v (p <0.05). Conclusion The IS-vp may be able to increase total and compartmental chest wall volumes, as well as improve synchrony among compartments when compared to IS-v and PEP devices, thus constituting an important tool for treating patients with restrictive ventilatory pattern.	[Florencio, Rencio Bento; Lima Cabral Fagundes, Marina Lyra; dos Santos Batista, Ilsa Priscila; Sarmento da Nobrega, Antonio Jose; Resqueti, Vanessa Regiane; de Freitas Fregonezi, Guilherme Augusto] Univ Fed Rio Grande do Norte, Dept Fisioterapia, Empresa Brasileira Serv Hosp EBSERH, Hosp Univ Onofre Lopes,PneumoCardioVasc Lab, Natal, RN, Brazil; [Florencio, Rencio Bento; Lima Cabral Fagundes, Marina Lyra; dos Santos Batista, Ilsa Priscila; Sarmento da Nobrega, Antonio Jose; Resqueti, Vanessa Regiane; de Freitas Fregonezi, Guilherme Augusto] Univ Fed Rio Grande do Norte, Dept Fisioterapia, Lab Inovacao Tecnol Reabil, Natal, RN, Brazil; [Aliverti, Andrea] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Polytechnic University of Milan	Fregonezi, GAD (corresponding author), Univ Fed Rio Grande do Norte, Dept Fisioterapia, Empresa Brasileira Serv Hosp EBSERH, Hosp Univ Onofre Lopes,PneumoCardioVasc Lab, Natal, RN, Brazil.; Fregonezi, GAD (corresponding author), Univ Fed Rio Grande do Norte, Dept Fisioterapia, Lab Inovacao Tecnol Reabil, Natal, RN, Brazil.	fregonezi@ufrnet.br	Fregonezi, Guilherme AF/B-2186-2019; Andrea, Aliverti/A-3901-2015; Sarmento, Antonio/K-9999-2018; Fregonezi, Guilherme/AAQ-1493-2020	Fregonezi, Guilherme AF/0000-0003-4938-7018; Andrea, Aliverti/0000-0002-2950-0231; Sarmento, Antonio/0000-0001-6391-5652; Fregonezi, Guilherme/0000-0003-4938-7018; Florencio, Rencio/0000-0003-2853-7988	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES) [PROCAD 2013 88881.068409/2014-01]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Programa Geral de Cooperacao Internacional [PGCI -23038.007514/2014-78]; CNPq [310091/2015-2, 307353/2015-0]	"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Programa Geral de Cooperacao Internacional(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study received financial support from the "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES), PROCAD 2013 88881.068409/2014-01 and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Programa Geral de Cooperacao Internacional -PGCI -23038.007514/2014-78 to Guilherme Augusto de Freitas Fregonezi. Guilherme Augusto de Freitas Fregonezi received a grant from CNPq number 307353/2015-0 and Vanessa Regiane Resqueti received a grant from CNPq number 310091/2015-2.	Alaparthi G. K., 2013, INT J BIOMEDICAL ADV, V4, P118; Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Aliverti A, 2003, Monaldi Arch Chest Dis, V59, P12; Aliverti A, 2009, EUR RESPIR J, V33, P49, DOI 10.1183/09031936.00141607; ALLEN JL, 1990, AM REV RESPIR DIS, V141, P337, DOI 10.1164/ajrccm/141.2.337; [Anonymous], 1991, Respir Care, V36, P1402; Arcencio L, 2008, REV BRAS CIR CARDIOV, V23, P400, DOI 10.1590/S0102-76382008000300019; Barbalho-Moulim Marcela C., 2009, Fisioter. Pesqui., V16, P166; Brilhante Silvia Angélica, 2017, Fisioter. Pesqui., V24, P311, DOI 10.1590/1809-2950/17015824032017; Cabral EEA, 2017, BRAZ J PHYS THER, V21, P416, DOI 10.1016/j.bjpt.2017.06.006; Cala SJ, 1996, J APPL PHYSIOL, V81, P2680, DOI 10.1152/jappl.1996.81.6.2680; Cohen J.E., 1988, STAT POWER ANAL BEHA; Ferreira GM, 2010, ARQ BRAS CARDIOL, V94, P246, DOI 10.1590/S0066-782X2010000200017; França Eduardo Ériko Tenório de, 2012, Rev. bras. ter. intensiva, V24, P6; Frazao M, 2014, RESP PHYSIOL NEUROBI, V198, P42, DOI 10.1016/j.resp.2014.04.002; Freitas ERFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004466.pub2; Haeffener MP, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.08.006; Lima INDF, 2014, RESP CARE, V59, P1101, DOI 10.4187/respcare.02651; Lunardi AC, 2014, RESP CARE, V59, P420, DOI 10.4187/respcare.02665; Manzano RM, 2008, SAO PAULO MED J, V126, P269, DOI 10.1590/S1516-31802008000500005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Osadnik CR, 2014, THORAX, V69, P137, DOI 10.1136/thoraxjnl-2013-203425; Paisani DD, 2013, RESP CARE, V58, P1360, DOI 10.4187/respcare.02037; Parreira VF, 2012, BRAZ J PHYS THER, V16, P439; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Priori R, 2013, J APPL PHYSIOL, V114, P1066, DOI 10.1152/japplphysiol.00414.2012; Reychler G, 2018, PHYSIOTHER THEORY PR, P1, DOI DOI 10.1080/09593985.2018.1443185; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Schultz K, 2016, J BRAS PNEUMOL, V42, P341, DOI 10.1590/S1806-37562016000000091; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Sezer N, 2004, FUNCT NEUROL, V19, P233; Teixeira-Salmela LF, 2005, ARCH PHYS MED REHAB, V86, P1974, DOI 10.1016/j.apmr.2005.03.035; Tomich GM, 2007, BRAZ J MED BIOL RES, V40, P1409, DOI 10.1590/S0100-879X2006005000165	34	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213773	10.1371/journal.pone.0213773	http://dx.doi.org/10.1371/journal.pone.0213773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889207	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000031
J	Pineros-Leano, M; Tabb, K; Liechty, J; Castaneda, Y; Williams, M				Pineros-Leano, Maria; Tabb, Karen; Liechty, Janet; Castaneda, Yvette; Williams, Melissa			Feeding decision-making among first generation Latinas living in non-metropolitan and small metro areas	PLOS ONE			English	Article							UNITED-STATES; FOCUS GROUPS; US; ACCULTURATION; OBESITY; MOTHERS; HEALTH; WEIGHT; PREVALENCE; IMMIGRANTS	Background Worldwide, overweight and obesity rates have more than tripled over the past three decades. Overweight and obesity rates are particularly high among Latinos. In order to determine some of the potential reasons, it is imperative to investigate how first-generation Latina mothers living in non-metropolitan and small metro areas decide how and what to feed their children. Using the Socio-Ecological Model, this study aimed to understand how Latina immigrant mothers make feeding decisions for their children. Methods A total of 29 semi-structured interviews were conducted with a purposive sample of immigrant mothers from Latin American countries whose preschoolers were enrolled in a Women, Infant, and Children supplemental nutrition program located in non-metropolitan and small metro areas. All interviews were recorded and transcribed verbatim in Spanish, and analyzed by a bilingual team. Results Multi-stage qualitative analysis was employed to analyze the data. Nineteen participants originated from Mexico, four from Central America, and six from South America. Five themes emerged that helped illuminate mother's decision-making around feeding choices: 1) culture as all-encompassing, 2) location and access to fresh and traditional foods, 3) disjunction between health provider advice and cultural knowledge 4) responsiveness to family needs and wants as determinants of food choices, 5) intrapersonal conflict stemming from childhood poverty and food insufficiency. Conclusion Findings suggest that Latina immigrant mothers engage in a difficult and even conflicting process when deciding how to feed their children. Future interventions should focus on implementing hands-on activities that can help consolidate, promote, and encourage healthy feeding choices.	[Pineros-Leano, Maria] Boston Coll, Sch Social Work, Boston, MA 02467 USA; [Pineros-Leano, Maria; Liechty, Janet] I TOPP, Urbana, IL 61801 USA; [Tabb, Karen; Liechty, Janet] Univ Illinois, Sch Social Work, Urbana, IL 61801 USA; [Liechty, Janet] Univ Illinois, Coll Med Urbana, Urbana, IL 61801 USA; [Liechty, Janet] Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA; [Castaneda, Yvette] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Williams, Melissa] Univ Illinois, Off Minor Student Affairs, Champaign, IL 61820 USA	Boston College; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pineros-Leano, M (corresponding author), Boston Coll, Sch Social Work, Boston, MA 02467 USA.; Pineros-Leano, M (corresponding author), I TOPP, Urbana, IL 61801 USA.	maria.pinerosleano@bc.edu	Pineros-Leano, Maria/X-7041-2019; Pineros-Leano, Maria/AAB-5459-2019	Pineros-Leano, Maria/0000-0001-7057-8316; Tabb Dina, Karen/0000-0002-4722-9502	National Institute of Food and Agriculture, U.S. Department of Agriculture [2011-67001-30101]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	The National Institute of Food and Agriculture, U.S. Department of Agriculture provided funding for this study under award 2011-67001-30101. MPL was supported by award 2011-67001-30101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, LATINO HLTH PARADOXE; Akresh IR, 2007, J HEALTH SOC BEHAV, V48, P404, DOI 10.1177/002214650704800405; Ayala GX, 2008, J AM DIET ASSOC, V108, P1330, DOI 10.1016/j.jada.2008.05.009; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Chaidez V, 2011, APPETITE, V56, P629, DOI 10.1016/j.appet.2011.02.015; Colon-Ramos U, 2017, PUBLIC HEALTH NUTR, P1; Creswell JW, 2013, RES DESIGN QUALITATI; Evans A, 2011, J AM DIET ASSOC, V111, P1031, DOI 10.1016/j.jada.2011.04.007; Flores A., 2017, FACTS US LATINOS 201; Goel MS, 2004, JAMA-J AM MED ASSOC, V292, P2860, DOI 10.1001/jama.292.23.2860; Greaney ML, 2012, J NUTR EDUC BEHAV, V44, P448, DOI 10.1016/j.jneb.2011.11.008; Kaushal N, 2009, HEALTH ECON, V18, P291, DOI 10.1002/hec.1368; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Lincoln Y.S., 1985, ESTABLISHING TRUSTWO, P289, DOI [10.1016/0147-1767(85)90062-8, http://dx.doi.org/10.1016/0147-1767(85)90062-8]; Lindsay AC, 2011, PUBLIC HEALTH NURS, V28, P107, DOI 10.1111/j.1525-1446.2010.00906.x; Martinez SM, 2015, J ACAD NUTR DIET, V115, pS34, DOI 10.1016/j.jand.2015.02.028; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Mena NZ, 2015, CHILD OBES, V11, P347, DOI 10.1089/chi.2014.0118; Mitchell GL, 2013, APPETITE, V60, P85, DOI 10.1016/j.appet.2012.09.014; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Oza-Frank R, 2010, OBES REV, V11, P271, DOI 10.1111/j.1467-789X.2009.00610.x; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Perez-Escamilla R, 2011, AM J CLIN NUTR, V93, p1163S, DOI 10.3945/ajcn.110.003467; Roshania R, 2008, OBESITY, V16, P2669, DOI 10.1038/oby.2008.425; Ruiz JM, 2016, GROUP PROCESS INTERG, V19, P462, DOI 10.1177/1368430216638540; Saldana J., 2015, CODING MANUAL QUALIT, V3rd; Sharkey JR, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-101; Sharkey JR, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-26; Sisson S B, 2017, Prev Med Rep, V6, P33, DOI 10.1016/j.pmedr.2017.02.003; Smith TM, 2016, PUBLIC HEALTH NUTR, V19, P841, DOI 10.1017/S1368980015001949; Sussner KM, 2008, J IMMIGR MINOR HEALT, V10, P497, DOI 10.1007/s10903-008-9137-3; Tovar A, 2013, J IMMIGR MINOR HEALT, V15, P357, DOI 10.1007/s10903-012-9665-8; World Health Organization, 2018, CONTR GLOB OB EP	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213442	10.1371/journal.pone.0213442	http://dx.doi.org/10.1371/journal.pone.0213442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883597	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500016
J	Moorhouse, AJ; Power, JM				Moorhouse, Andrew J.; Power, John M.			Making light work of fine-tuning channelrhodopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The development of genetically engineered proteins that can control cell excitability with light have revolutionized our understanding of the nervous system. The most widely used of these optogenetic tools is the light-gated ion channel, channelrhodopsin 2 (ChR2). A new study by Cho et al. describes the development of ChR2 variants with improved photocurrents and more selective ion permeability using an automated multifaceted fluorescence-based screening. This methodological framework holds promise not only in refining features of ChR2, but also for other proteins in which fluorescence phenotyping is possible.	[Moorhouse, Andrew J.; Power, John M.] UNSW Sydney, Sch Med Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Moorhouse, AJ (corresponding author), UNSW Sydney, Sch Med Sci, Sydney, NSW 2052, Australia.	a.moorhouse@unsw.edu.au	Power, John M/B-4762-2008; Moorhouse, Andrew J/B-8526-2011	Power, John M/0000-0002-2478-8416; Moorhouse, Andrew J/0000-0001-7957-2498				Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Cho YK, 2019, J BIOL CHEM, V294, P3806, DOI 10.1074/jbc.RA118.006996; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100	8	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3822	3823		10.1074/jbc.H119.007749	http://dx.doi.org/10.1074/jbc.H119.007749			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30877261	hybrid, Green Published			2022-12-26	WOS:000461854400002
J	Williams, J; Jordan, A; Harasti, D; Davies, P; Ingleton, T				Williams, Joel; Jordan, Alan; Harasti, David; Davies, Peter; Ingleton, Tim			Taking a deeper look: Quantifying the differences in fish assemblages between shallow and mesophotic temperate rocky reefs	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; CONTINENTAL-SHELF; MARINE; PATTERNS; COMPLEXITY; ABUNDANCE; AREAS; BIODIVERSITY; MANAGEMENT; AUSTRALIA	The spatial distribution of a species assemblage is often determined by habitat and climate. In the marine environment, depth can become an important factor as declining light and water temperature leads to changes in the biological habitat structure. To date, much of the focus of ecological fish research has been based on reefs in less than 40 m with little research on the ecological role of mesophotic reefs. We deployed baited remote underwater stereo video systems (stereo-BRUVS) on temperate reefs in two depth categories: shallow (20-40 m) and mesophotic (80-120 m), off Port Stephens, Australia. Sites were selected using data collected by swath acoustic sounder to ensure stereo-BRUVS were deployed on reef. The sounder also provided rugosity, slope and relief data for each stereo-BRUVS deployment. Multivariate analysis indicates that there are significant differences in the fish assemblages between shallow and mesophotic reefs, primarily driven by Ophthalmolepis lineolatus and Notolabrus gymnogenis only occurring on shallow reefs and schooling species of fish that were unique to each depth category: Atypichthys strigatus on shallow reefs and Centroberyx affinis on mesophotic reefs. While shallow reefs had a greater species richness and abundance of fish when compared to mesophotic reefs, mesophotic reefs hosted the same species richness of fishery-targeted species. Chrysophrys auratus and Nemodactylus douglassii are two highly targeted species in this region. While C. auratus was numerically more abundant on shallow reefs, mesophotic reefs provide habitat for larger fish. In comparison, N. douglassii were evenly distributed across all sites sampled. Generalized linear models revealed that depth and habitat type provided the most parsimonious model for predicting the distribution of C. auratus, while habitat type alone best predicted the distribution of N. douglassii. These results demonstrate the importance of mesophotic reefs to fishery-targeted species and therefore have implications for informing the management of these fishery resources on shelf rocky reefs.	[Williams, Joel; Jordan, Alan; Harasti, David] NSW Dept Primary Ind, Fisheries Res, Nelson Bay, NSW, Australia; [Davies, Peter; Ingleton, Tim] New South Wales Off Environm & Heritage, Sydney, NSW, Australia	NSW Department of Primary Industries; Office of Environment & Heritage - New South Wales	Williams, J (corresponding author), NSW Dept Primary Ind, Fisheries Res, Nelson Bay, NSW, Australia.	joel.williams@dpi.nsw.gov.au	Williams, Joel/R-8997-2019	Williams, Joel/0000-0002-4173-3855	National Environmental Science Program; Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO; Geoscience Australia; Australian Institute of Marine Science; Museum Victoria; Charles Darwin University; University of Western Australia; NSW Office of Environment and Heritage; NSW Department of Primary Industries; Integrated Marine Observing System	National Environmental Science Program; Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Geoscience Australia; Australian Institute of Marine Science; Museum Victoria; Charles Darwin University; University of Western Australia; NSW Office of Environment and Heritage; NSW Department of Primary Industries; Integrated Marine Observing System	This work was undertaken for the Marine Biodiversity Hub, a collaborative partnership supported through funding from the National Environmental Science Program (and previously through the National Environmental ResearchProgram). NESP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University, University of Western Australia, NSW Office of Environment and Heritage, NSW Department of Primary Industries and the Integrated Marine Observing System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was conducted with the support of the NSW Department of Primary Industries and the NSW Office of Environment and Heritage. We would like to thank Roger Laird and Tom Davis for their assistance with the field work. Thank you to Bob Creese who provided valuable feedback and revisions. We would also like to thank the editor and two reviewers for taking the time to provide valuable suggestions to make this a better manuscript. Photos are courtesy of David Harasti, Reef Life Survey and Fishes of Australia.	Andradi-Brown DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156641; [Anonymous], 2018, LANG ENV STAT COMP; Armstrong RA, 2012, ELSEV INSIGHT, P365, DOI 10.1016/B978-0-12-385140-6.00024-4; Baker E, 2016, MESOPHOTIC CORAL ECO, P11; Bax N, 1999, OCEANOL ACTA, V22, P705, DOI 10.1016/S0399-1784(00)88961-6; Bax NJ, 2001, MAR FRESHWATER RES, V52, P491, DOI 10.1071/MF00003; Beck MW, 2000, J EXP MAR BIOL ECOL, V249, P29, DOI 10.1016/S0022-0981(00)00171-4; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bo M, 2014, BIOL CONSERV, V171, P167, DOI 10.1016/j.biocon.2014.01.011; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Booth DJ, 2007, ESTUAR COAST SHELF S, V72, P102, DOI 10.1016/j.ecss.2006.10.003; Borcard D., 2018, NUMERICAL ECOLOGY R, DOI DOI 10.1016/j.foreco.2007.07.028; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bulman C, 2001, MAR FRESHWATER RES, V52, P537, DOI 10.1071/MF99152; Cameron MJ, 2014, MAR ECOL PROG SER, V506, P213, DOI 10.3354/meps10788; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; Collins DL, 2017, METHODS ECOL EVOL, V8, P116, DOI 10.1111/2041-210X.12650; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Curley BG, 2013, REV FISH BIOL FISHER, V23, P435, DOI 10.1007/s11160-013-9309-7; Davies P, 2016, MAPPING SHELF ROCKY; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; Englebert N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170336; Ferreira CEL, 2001, ENVIRON BIOL FISH, V61, P353, DOI 10.1023/A:1011609617330; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Fitzpatrick C, 2013, FISH RES, V146, P41, DOI 10.1016/j.fishres.2013.03.016; Fowler AJ, 2017, MAR FRESHWATER RES, V68, P1438, DOI 10.1071/MF16121; Frank KT, 2018, P NATL ACAD SCI USA, V115, P6422, DOI 10.1073/pnas.1802096115; Harasti D., 2015, Marine Biodiversity Records, V8, pe49, DOI 10.1017/S1755267215000263; Harasti D, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00208; Harasti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142454; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harman N, 2003, MAR FRESHWATER RES, V54, P177, DOI 10.1071/MF02040; Harris PT, 2008, MAR GEOL, V251, P85, DOI 10.1016/j.margeo.2008.02.010; Harvey ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080955; Heyns-Veale ER, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2933-8; Hill NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110831; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hobday AJ, 2011, MAR FRESHWATER RES, V62, P1000, DOI 10.1071/MF10302; Jordan A, 2010, SEABED HABITAT MAPPI; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kelaher BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085825; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Langlois TJ, 2018, MARINE SAMPLING FIEL; Lecours V, 2015, MAR ECOL PROG SER, V535, P259, DOI 10.3354/meps11378; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; Logan JM, 2017, MAR ECOL PROG SER, V582, P181, DOI 10.3354/meps12326; Loya Y, 2016, CORAL REEFS, V35, P1, DOI 10.1007/s00338-016-1410-7; Lucieer V., 2016, COLLATION EXISTING S; MacDonald C, 2016, MAR ECOL PROG SER, V561, P217, DOI 10.3354/meps11953; Macpherson E, 1991, BATHYMETRIC TRENDS D; Malcolm HA, 2018, ESTUAR COAST SHELF S, V212, P118, DOI 10.1016/j.ecss.2018.07.003; Malcolm HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127616; Malcolm Hamish A., 2010, Marine Biodiversity, V40, P181, DOI 10.1007/s12526-010-0042-3; McLean DL, 2016, ESTUAR COAST SHELF S, V178, P36, DOI 10.1016/j.ecss.2016.05.026; Methratta ET, 2007, J FISH BIOL, V70, P1669, DOI 10.1111/j.1095-8649.2007.01428.x; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Morueta-Holme N, 2013, ECOL LETT, V16, P1446, DOI 10.1111/ele.12184; Nichol S, 2016, GEOMORPHOLOGICAL CLA; Nimbs Matt J., 2016, Marine Biodiversity Records, V9, P27, DOI 10.1186/s41200-016-0027-4; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pearson R, 2015, MAR ECOL PROG SER, V532, P184, DOI 10.3354/meps11351; Pinheiro HT, 2016, CORAL REEFS, V35, P139, DOI 10.1007/s00338-015-1381-0; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Puglise K., 2009, INT WORKSH PRIOR RES; Rees MJ, 2018, BIOL CONSERV, V224, P100, DOI 10.1016/j.biocon.2018.04.040; Rees MJ, 2014, DIVERS DISTRIB, V20, P284, DOI 10.1111/ddi.12134; Ridgway KR, 2007, GEOPHYS RES LETT, DOI [10.1029/2007GL030393/full, DOI 10.1029/2007GL030393/FULL]; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Sih TL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11452-1; Soares MD, 2018, MAR BIODIVERS, V48, P1631, DOI 10.1007/s12526-016-0615-x; Stewart J, 2009, FISH RES, V96, P267, DOI 10.1016/j.fishres.2008.12.005; Suthers IM, 2011, DEEP-SEA RES PT II, V58, P538, DOI 10.1016/j.dsr2.2010.09.029; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thomas CJ, 2015, DIVERS DISTRIB, V21, P1254, DOI 10.1111/ddi.12360; Trembanis AC, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00051; Turner JA, 2017, ICES J MAR SCI, V74, P2309, DOI 10.1093/icesjms/fsx085; UNDERWOOD AJ, 1991, AUST J ECOL, V16, P231, DOI 10.1111/j.1442-9993.1991.tb01050.x; Visconti V, 2018, J FISH BIOL, V92, P470, DOI 10.1111/jfb.13529; West LD, 2015, 149 NSW DEP PRIM IND; Whitmarsh SK, 2017, REV FISH BIOL FISHER, V27, P53, DOI 10.1007/s11160-016-9450-1; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024; Winston MS, 2017, CORAL REEFS, V36, P663, DOI 10.1007/s00338-017-1559-8	90	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0206778	10.1371/journal.pone.0206778	http://dx.doi.org/10.1371/journal.pone.0206778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875385	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000461316400002
J	Jones, EA; Linas, BP; Truong, V; Burgess, JF; Lasser, KE				Jones, Eric A.; Linas, Benjamin P.; Ve Truong; Burgess, James F.; Lasser, Karen E.			Budgetary impact analysis of a primary care-based hepatitis C treatment program: Effects of 340B Drug Pricing Program	PLOS ONE			English	Article							COST-EFFECTIVENESS; VIRUS-INFECTION; UNITED-STATES; SOFOSBUVIR; REGIMENS; PEOPLE; HEALTH; MODEL	Purpose Safety-net health systems, which serve a disproportionate share of patients at high risk for hepatitis C virus (HCV) infection, may use revenue generated by the federal drug discount pricing program, known as 340B, to support multidisciplinary care. Budgetary impacts of repealing the drug-pricing program are unknown. Our objective was to conduct a budgetary impact analysis of a multidisciplinary primary care-based HCV treatment program, with and without 340B support. Methods We conducted a budgetary impact analysis from the perspective of a large safety-net medical center in Boston, Massachusetts. Participants included 302 HCV-infected patients (mean age 45, 75% male, 53% white, 77% Medicaid) referred to the primary care-based HCV treatment program from 2015-2016. Main measures included costs and revenues associated with the treatment program. Our main outcomes were net cost with and without 340B Drug Pricing support. Results Total program costs were $942,770, while revenues totaled $1.2 million. With the 340B Drug Pricing Program the hospital received a net revenue of $930 per patient referred to the HCV treatment program. In the absence of the 340B program, the hospital would lose $370 per patient referred. Ninety-seven percent (68/70) of patients who initiated treatment in the program achieved a sustained virologic response (SVR) at a net cost of $4,150 each, among this patient subset. Conclusions The 340B Drug Pricing Program enabled a safety-net hospital to deliver effective primary care-based HCV treatment using a multidisciplinary care team. Efforts to sustain the 340B program could enable dissemination of similar HCV treatment models elsewhere.	[Jones, Eric A.; Burgess, James F.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Linas, Benjamin P.; Lasser, Karen E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Ve Truong; Lasser, Karen E.] Boston Med Ctr, Sect Gen Internal Med, Boston, MA 02118 USA	Boston University; Boston University; Boston Medical Center	Lasser, KE (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Lasser, KE (corresponding author), Boston Med Ctr, Sect Gen Internal Med, Boston, MA 02118 USA.	Karen.Lasser@bmc.org			National Institute on Drug Abuse (NIDA) [P30 DA040500-01]; Boston Providence Center for AIDS Research (CFAR) [P30AI042853]; "Center for Health Economics of Treatment Interventions for Substance use Disorder, HCV, and HIV"; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA040500] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Boston Providence Center for AIDS Research (CFAR); "Center for Health Economics of Treatment Interventions for Substance use Disorder, HCV, and HIV"; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse (NIDA) (P30 DA040500-01-pilot grant, awarded to KEL), "Center for Health Economics of Treatment Interventions for Substance use Disorder, HCV, and HIV" and the Boston Providence Center for AIDS Research (CFAR) (P30AI042853 to KEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for the Study of Liver Disease; Infectious Dis- eases Society of America, 2017, HCV GUID REC TEST MA; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Assoumou SA, 2017, CLIN INFECT DIS, V9, DOI [10.1093/cid/ciw633, DOI 10.1093/CID/CIW633]; Boyer JL, 2003, HIV CLIN TRIALS, V4, P55; Chahal HS, 2016, JAMA INTERN MED, V176, P65, DOI 10.1001/jamainternmed.2015.6011; Chhatwal J, 2016, HEPATOLOGY, V64, P1442, DOI 10.1002/hep.28571; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Felt-Lisk S, 2002, HEALTH AFFAIR, V21, P277, DOI 10.1377/hlthaff.21.5.277; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Hellard M, 2014, HEPATOLOGY, V60, P1861, DOI 10.1002/hep.27403; Konerman MA, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.50; Lasser KE, 2017, ANN FAM MED, V15, P258, DOI 10.1370/afm.2069; Leidner AJ, 2015, HEPATOLOGY, V61, P1860, DOI 10.1002/hep.27736; Linas BP, 2015, ANN INTERN MED, V162, P619, DOI 10.7326/M14-1313; Linas BP, 2017, COST EFFECTIVENESS C, V1; Liu S, 2016, MED DECIS MAKING, V1, P1; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; McGowan CE, 2012, LIVER INT, V32, P151, DOI 10.1111/j.1478-3231.2011.02706.x; Miller L, 2012, J NATL MED ASSOC, V104, P244, DOI 10.1016/S0027-9684(15)30161-9; Mitchell GK, 2008, MED J AUSTRALIA, V188, pS61; Mitruka K, 2014, MMWR-MORBID MORTAL W, V63, P393; Mulcahy AW, 2014, 340B PRESCRIPTION DR; National Institutes of Health, 2017, MICR SOURC INF; Neumann PJ, 2016, COST EFFECTIVENESS H; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Sabouni D., 2010, PRIM CARE COMPANION, V12; Turner BJ, 2015, HEPATOLOGY, V62, P1388, DOI 10.1002/hep.28018; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Younossi ZM, 2015, HEPATOLOGY, V61, P1471, DOI 10.1002/hep.27757	31	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213745	10.1371/journal.pone.0213745	http://dx.doi.org/10.1371/journal.pone.0213745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870475	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300066
J	Lipnick, SL; Agniel, DM; Aggarwal, R; Makhortova, NR; Finlayson, SG; Brocato, A; Palmer, N; Darras, BT; Kohane, I; Rubin, LL				Lipnick, Scott L.; Agniel, Denis M.; Aggarwal, Rahul; Makhortova, Nina R.; Finlayson, Samuel G.; Brocato, Alexandra; Palmer, Nathan; Darras, Basil T.; Kohane, Isaac; Rubin, Lee L.			Systemic nature of spinal muscular atrophy revealed by studying insurance claims	PLOS ONE			English	Article							CARDIAC DEFECTS; MOUSE MODELS; HISTORY; MICE; ASSOCIATION; SMN-DELTA-7; PHENOTYPE; SURVIVAL	Objective We investigated the presence of non-neuromuscular phenotypes in patients affected by Spinal Muscular Atrophy (SMA), a disorder caused by a mutation in the Survival of Motor Neuron (SMN) gene, and whether these phenotypes may be clinically detectable prior to clinical signs of neuromuscular degeneration and therefore independent of muscle weakness. Methods We utilized a de-identified database of insurance claims to explore the health of 1,038 SMA patients compared to controls. Two analyses were performed: (1) claims from the entire insurance coverage window; and (2) for SMA patients, claims prior to diagnosis of any neuromuscular disease or evidence of major neuromuscular degeneration to increase the chance that phenotypes could be attributed directly to reduced SMN levels. Logistic regression was used to determine whether phenotypes were diagnosed at significantly different rates between SMA patients and controls and to obtain covariate-adjusted odds ratios. Results Results from the entire coverage window revealed a broad spectrum of phenotypes that are differentially diagnosed in SMA subjects compared to controls. Moreover, data from SMA patients prior to their first clinical signs of neuromuscular degeneration revealed numerous non-neuromuscular phenotypes including defects within the cardiovascular, gastrointestinal, metabolic, reproductive, and skeletal systems. Furthermore, our data provide evidence of a potential ordering of disease progression beginning with these non-neuromuscular phenotypes. Conclusions Our data point to a direct relationship between early, detectable non-neuromuscular symptoms and SMN deficiency. Our findings are particularly important for evaluating the efficacy of SMN-increasing therapies for SMA, comparing the effectiveness of local versus systemically delivered therapeutics, and determining the optimal therapeutic treatment window prior to irreversible neuromuscular damage.	[Lipnick, Scott L.; Makhortova, Nina R.; Brocato, Alexandra; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lipnick, Scott L.; Agniel, Denis M.; Aggarwal, Rahul; Finlayson, Samuel G.; Palmer, Nathan; Kohane, Isaac] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Lipnick, Scott L.; Aggarwal, Rahul] Massachusetts Gen Hosp, CATCH, Boston, MA 02114 USA; [Makhortova, Nina R.; Darras, Basil T.] Boston Childrens Hosp, Boston, MA USA; [Rubin, Lee L.] Harvard Stem Cell Inst, Cambridge, MA USA; [Agniel, Denis M.] RAND Corp, Santa Monica, CA USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; RAND Corporation	Rubin, LL (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Rubin, LL (corresponding author), Harvard Stem Cell Inst, Cambridge, MA USA.	lee_rubin@harvard.edu		Rubin, Lee/0000-0002-8658-841X	SMA Foundation; National Institute of Neurological Disorders and Stroke [P01 NS066888]; Harvard Stem Cell Institute; MGH Center for Assessment Technology and Continuous Health; NIH [T32GM007753, T15LM007092]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	SMA Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Harvard Stem Cell Institute; MGH Center for Assessment Technology and Continuous Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the SMA Foundation (L.L.R.), National Institute of Neurological Disorders and Stroke grant P01 NS066888 (L.L.R.), the Harvard Stem Cell Institute (L.L.R.), and the MGH Center for Assessment Technology and Continuous Health (S.L.L). S.G.F was supported by NIH training grants T32GM007753 and T15LM007092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032821; Armstrong EP, 2016, J MED ECON, V19, P822, DOI 10.1080/13696998.2016.1198355; Bebee TW, 2012, HUM GENET, V131, P1277, DOI 10.1007/s00439-012-1171-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berchick E.R., 2018, CURRENT POPULATION R, P60; Bertini E, 2018, NAT REV NEUROL, V14, P197, DOI 10.1038/nrneurol.2017.189; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Finkel RS, 2016, LANCET, V388, P3017, DOI 10.1016/S0140-6736(16)31408-8; Finkel RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035462; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Groen E. J., 2018, HUM MOL GENET; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2015, GENE DEV, V29, P288, DOI 10.1101/gad.256644.114; Johnson M. E., 2018, TRENDS NEUROSCI; Kaufmann P, 2012, NEUROLOGY, V79, P1889, DOI 10.1212/WNL.0b013e318271f7e4; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kottke TE, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lefebvre S, 2002, HUM MOL GENET, V11, P1017, DOI 10.1093/hmg/11.9.1017; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo J, 2016, BIOMED INFORM INSIGH, V8, P1, DOI 10.4137/BII.S31559; Miotto R, 2017, BRIEF BIOINFORM; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Ng SY, 2015, CELL STEM CELL, V17, P569, DOI 10.1016/j.stem.2015.08.003; Ottesen EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20193; Paez-Colasante X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075866; RICHERT JR, 1986, J NEUROL NEUROSUR PS, V49, P606, DOI 10.1136/jnnp.49.5.606-a; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Schreml J, 2013, EUR J HUM GENET, V21, P643, DOI 10.1038/ejhg.2012.222; Scoto M, 2017, GENE THER, V24, P514, DOI 10.1038/gt.2017.45; Shababi M, 2014, J ANAT, V224, P15, DOI 10.1111/joa.12083; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Singh RN, 2017, BBA-GENE REGUL MECH, V1860, P299, DOI 10.1016/j.bbagrm.2016.12.008; Swaiman K. F., 2017, SWAIMANS PEDIAT NEUR; Team RC, 2015, R LANG ENV STAT COMP; Tizzano EF, 2017, NEUROMUSCULAR DISORD, V27, P883, DOI 10.1016/j.nmd.2017.05.011; Wirth B, 2015, EXPERT OPIN EMERG DR, V20, P353, DOI 10.1517/14728214.2015.1041375; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025; Zerres K, 1997, J NEUROL SCI, V146, P67, DOI 10.1016/S0022-510X(96)00284-5; Zhou HY, 2015, HUM MOL GENET, V24, P6265, DOI 10.1093/hmg/ddv329	48	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213680	10.1371/journal.pone.0213680	http://dx.doi.org/10.1371/journal.pone.0213680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870495	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300058
J	McLaskey, AK; Keister, JE; Schoo, KL; Olson, MB; Love, BA				McLaskey, Anna K.; Keister, Julie E.; Schoo, Katherina L.; Olson, M. Brady; Love, Brooke A.			Direct and indirect effects of elevated CO2 are revealed through shifts in phytoplankton, copepod development, and fatty acid accumulation	PLOS ONE			English	Article							OCEAN ACIDIFICATION; EGG-PRODUCTION; CALANUS-GLACIALIS; ACARTIA-TONSA; CHEMICAL-COMPOSITION; EMILIANIA-HUXLEYI; COASTAL WATERS; CARBONIC-ACID; FOOD QUALITY; LIFE STAGES	Change in the nutritional quality of phytoplankton is a key mechanism through which ocean acidification can affect the function of marine ecosystems. Copepods play an important role transferring energy from phytoplankton to higher trophic levels, including fatty acids (FA)essential macronutrients synthesized by primary producers that can limit zooplankton and fisheries production. We investigated the direct effects of pCO(2) on phytoplankton and cope-pods in the laboratory, as well as the trophic transfer of effects of pCO(2) on food quality. The marine cryptophyte Rhodomonas salina was cultured at 400, 800, and 1200 mu atm pCO(2) and fed to adult Acartia hudsonica acclimated to the same pCO(2) levels. We examined changes in phytoplankton growth rate, cell size, carbon content, and FA content, and copepod FA content, grazing, respiration, egg production, hatching, and naupliar development. This single-factor experiment was repeated at 12 degrees C and at 17 degrees C. At 17 degrees C, the FA content of R. salina responded non-linearly to elevated pCO(2) with the greatest FA content at intermediate levels, which was mirrored in A. hudsonica; however, differences in ingestion rate indicate that copepods accumulated FA less efficiently at elevated pCO(2). A. hudsonica nauplii developed faster at elevated pCO(2) at 12 degrees C in the absence of strong food quality effects, but not at 17 degrees C when food quality varied among treatments. Our results demonstrate that changes to the nutritional quality of phytoplankton are not directly translated to their grazers, and that studies that include trophic links are key to unraveling how ocean acidification will drive changes in marine food webs.	[McLaskey, Anna K.; Keister, Julie E.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Schoo, Katherina L.; Olson, M. Brady; Love, Brooke A.] Western Washington Univ, Shannon Point Marine Ctr, Anacortes, WA USA	University of Washington; University of Washington Seattle; Western Washington University	McLaskey, AK (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	mclaskey@uw.edu	Keister, Julie/AAD-5734-2019	Keister, Julie/0000-0002-9385-5889; McLaskey, Anna/0000-0002-4399-6130	National Science Foundation [1220664, 1220381]; National Science Foundation Graduate Research Fellowship Program [DGE-1256082]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This study was funded through National Science Foundation grants 1220664 (MBO, BAL) and 1220381 (JEK). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1256082 (AKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera VM, 2016, MAR ECOL-EVOL PERSP, V37, P215, DOI 10.1111/maec.12282; Aguilera VM, 2013, ESTUAR COAST, V36, P1084, DOI 10.1007/s12237-013-9615-2; Anderson TR, 2000, LIMNOL OCEANOGR, V45, P1162, DOI 10.4319/lo.2000.45.5.1162; Bailey A, 2017, ICES J MAR SCI, V74, P996, DOI 10.1093/icesjms/fsw066; Bell MV, 2007, J PLANKTON RES, V29, P417, DOI 10.1093/plankt/fbm025; Bermudez JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27749; Bermudez R, 2016, BIOGEOSCIENCES, V13, P6625, DOI 10.5194/bg-13-6625-2016; Bermudez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123945; Bi R, 2017, LIMNOL OCEANOGR, V62, P334, DOI 10.1002/lno.10429; Bi R, 2014, J PHYCOL, V50, P117, DOI 10.1111/jpy.12140; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; Cripps G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151739; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; DURBIN EG, 1992, LIMNOL OCEANOGR, V37, P342, DOI 10.4319/lo.1992.37.2.0342; DURBIN EG, 1992, LIMNOL OCEANOGR, V37, P361, DOI 10.4319/lo.1992.37.2.0361; Engstrom-Ost J, 2014, MAR FRESHW BEHAV PHY, V47, P173, DOI 10.1080/10236244.2014.919096; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; FOLCH J, 1957, J BIOL CHEM, V226, P497; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Gallo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123074; Garzke J, 2017, AQUAT SCI, V79, P733, DOI 10.1007/s00027-017-0532-5; Garzke J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155952; Gaylord B, 2015, ECOLOGY, V96, P3, DOI 10.1890/14-0802.1; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Isari S, 2016, ICES J MAR SCI, V73, P650, DOI 10.1093/icesjms/fsv078; Isari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084742; Jacob BG, 2017, J MAR BIOL ASSOC UK, V97, P225, DOI 10.1017/S0025315416001570; JONASDOTTIR SH, 1995, MAR ECOL PROG SER, V119, P87, DOI 10.3354/meps119087; JONASDOTTIR SH, 1994, MAR BIOL, V121, P67, DOI 10.1007/BF00349475; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; King AL, 2015, MAR ECOL PROG SER, V537, P59, DOI 10.3354/meps11458; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Leu E, 2013, BIOGEOSCIENCES, V10, P1143, DOI 10.5194/bg-10-1143-2013; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Lewis E, 2012, ORNLCDIAC105 US DEP; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Love BA, 2017, BIOGEOSCIENCES, V14, P2675, DOI 10.5194/bg-14-2675-2017; Malzahn AM, 2010, OECOLOGIA, V162, P35, DOI 10.1007/s00442-009-1458-y; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meyers MT, 2016, THESIS; Olson MB, 2017, J EXP MAR BIOL ECOL, V488, P72, DOI 10.1016/j.jembe.2016.12.008; Pan TCF, 2015, P NATL ACAD SCI USA, V112, P4696, DOI 10.1073/pnas.1416967112; Parrish CC, 2012, J PLANKTON RES, V34, P356, DOI 10.1093/plankt/fbs003; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; Pond D, 1996, MAR ECOL PROG SER, V143, P45, DOI 10.3354/meps143045; Reinfelder JR, 2012, MAR ECOL PROG SER, V466, P57, DOI 10.3354/meps09905; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Runge JA, 2016, ICES J MAR SCI, V73, P937, DOI 10.1093/icesjms/fsv258; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Stumpp M, 2013, NAT CLIM CHANGE, V3, P1044, DOI 10.1038/NCLIMATE2028; Sunday JM, 2017, NAT CLIM CHANGE, V7, P81, DOI [10.1038/NCLIMATE3161, 10.1038/nclimate3161]; TESTER PA, 1990, J EXP MAR BIOL ECOL, V141, P169, DOI 10.1016/0022-0981(90)90222-X; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Torstensson A, 2013, BIOGEOSCIENCES, V10, P6391, DOI 10.5194/bg-10-6391-2013; UYE S, 1981, J EXP MAR BIOL ECOL, V50, P255, DOI 10.1016/0022-0981(81)90053-8; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Wang TF, 2017, MAR ENVIRON RES, V132, P51, DOI 10.1016/j.marenvres.2017.10.010; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Wynn-Edwards C, 2014, WATER-SUI, V6, P1840, DOI 10.3390/w6061840; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9	75	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213931	10.1371/journal.pone.0213931	http://dx.doi.org/10.1371/journal.pone.0213931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870509	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300095
J	Tchakounte, A; Tchouakui, M; Chiang, MC; Tchapga, W; Kopia, E; Soh, PT; Njiokou, F; Riveron, JM; Wondji, CS				Tchakounte, Ange; Tchouakui, Magellan; Chiang Mu-Chun; Tchapga, Williams; Kopia, Edmond; Soh, Patrice Takam; Njiokou, Flobert; Riveron, Jacob Miranda; Wondji, Charles S.			Exposure to the insecticide-treated bednet PermaNet 2.0 reduces the longevity of the wild African malaria vector Anopheles funestus but GSTe2-resistant mosquitoes live longer	PLOS ONE			English	Article							TRANSMISSION INTENSITY; PYRETHROID RESISTANCE; MOLECULAR-FORMS; GAMBIAE; CULICIDAE; DIPTERA; VILLAGE	Background Despite the increased report of insecticide resistance in malaria vectors, its impact on mosquito's life-traits after exposure to insecticide-treated nets remains under investigated. Here, we assessed the effects of exposure to PermaNet 2.0 on several life traits of An. gambiae s. l. and An. funestus s.l. field mosquitoes in Cameroon. Methodology Female Anopheles mosquitoes were collected indoor using electric aspirators in southern Cameroon (Obout) in 2016. After assessing the resistance status of F1 from the field collected-mosquitoes, progeny of the first generation (An. funestus s. l.) and seventh generation (An. gambiae s.l.) were used to assess the long-term effect of exposure to PermaNet 2.0 on several life-traits of these vectors (longevity, blood feeding ability, fecundity and fertility) in comparison to untreated net. In addition, the L119F-GSTe2 mutation associated with DDT / pyrethroids resistance in An. funestus was genotyped to assess its association with increased life-span post-exposure. Principal Both An. funestus and An. gambiae were resistant to pyrethroids and DDT with a greater level in the latter. Pyrethroid-only nets PermaNet 2.0 (17.5% mortality) and Olyset (0% mortality) exhibited a significantly reduced efficacy against An. funestus in contrast to a greater efficacy for PBO-based Nets Olyset Plus (65% mortality), PermaNet 3.0 top (100% mortality). In both species, mosquitoes that survived exposure to PermaNet 2.0 exhibited a significantly reduced longevity than those non-exposed (6.95 days vs 12.46 for An. funestus P<0.001; 8.87 vs 11.25 days for An. gambiae; P<0.001). However, no significant difference was observed for blood feeding and fecundity in both species. In addition, molecular analysis of the L119F-GSTe2 mutation revealed that this mutation is associated with an increase in the chance of surviving after exposure to this net in An. funestus. Conclusions These results show that although the PermaNet 2.0 presents a reduced efficacy against resistant populations, it remains efficient after exposure by reducing the life expectancy of the vectors which could contribute in the reduction of malaria incidence.	[Tchakounte, Ange; Tchouakui, Magellan; Tchapga, Williams; Njiokou, Flobert; Riveron, Jacob Miranda; Wondji, Charles S.] CRID, Yaounde, Cameroon; [Tchakounte, Ange; Tchouakui, Magellan; Tchapga, Williams; Kopia, Edmond; Njiokou, Flobert; Wondji, Charles S.] Res Unit LSTM OCEAC, Yaounde, Cameroon; [Tchakounte, Ange; Tchouakui, Magellan; Kopia, Edmond] Univ Yaounde, Dept Anim Biol & Physiol, Fac Sci, Yaounde, Cameroon; [Chiang Mu-Chun; Riveron, Jacob Miranda; Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool, Merseyside, England; [Soh, Patrice Takam] Univ Yaounde, Dept Math, Fac Sci, Yaounde, Cameroon	University of Yaounde I; Liverpool School of Tropical Medicine; University of Liverpool; University of Yaounde I	Tchouakui, M; Wondji, CS (corresponding author), CRID, Yaounde, Cameroon.; Tchouakui, M; Wondji, CS (corresponding author), Res Unit LSTM OCEAC, Yaounde, Cameroon.; Tchouakui, M (corresponding author), Univ Yaounde, Dept Anim Biol & Physiol, Fac Sci, Yaounde, Cameroon.; Wondji, CS (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Pembroke Pl, Liverpool, Merseyside, England.	magellan.tchouakui@crid-cam.net; charles.wondji@lstmed.ac.uk	Soh, Patrice Takam/AAS-5887-2020; Wondji, Charles/AAG-1510-2020	Tchapga, Williams/0000-0001-9823-8364; Wondji, Charles S./0000-0003-0791-3673; Tchouakui, Magellan/0000-0002-1683-8057	Wellcome Trust [101893/Z/13/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Wellcome Trust (Welcome senior 101893/Z/13/Z) awarded to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; [Anonymous], 2019, GUID LAB FIELD TEST; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2417-9; Antonio-Nkondjio C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0675-6; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; BRENGUES J, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P107; Carnevale P, 2009, MARSEILLES, V402, P16; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; di Deco M.A., 1980, Parassitologia (Rome), V22, P304; Ferguson HM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-106; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gillies M, 1987, ANOPHELINAE AFRICA S; Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; LIVAK KJ, 1984, GENETICS, V107, P611; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Menze BD, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2467-2; Menze BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163261; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Nwane Philippe, 2011, BMC Res Notes, V4, P463, DOI 10.1186/1756-0500-4-463; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Protopopoff N, 2018, LANCET, V391, P1577, DOI [10.1016/S0140-6736(18)30427-6, 10.1016/s0140-6736(18)30427-6]; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Riveron JM, 2018, J INFECT DIS, V217, P320, DOI 10.1093/infdis/jix570; Riveron JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0877-y; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Suchel JB, 1988, THESIS, V4, P1188; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; Tchouakui M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120645; Tene BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061408; Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; WHO, 2018, WORLD MAL REP 2018; WHO, 2012, GLOB PLAN INS RES MA, V978, P4; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; World Health Organization, 2017, WORLD MAL REP 2016	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213949	10.1371/journal.pone.0213949	http://dx.doi.org/10.1371/journal.pone.0213949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870507	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300097
J	Haft-Javaherian, M; Fang, LJ; Muse, V; Schaffer, CB; Nishimura, N; Sabuncu, MR				Haft-Javaherian, Mohammad; Fang, Linjing; Muse, Victorine; Schaffer, Chris B.; Nishimura, Nozomi; Sabuncu, Mert R.			Deep convolutional neural networks for segmenting 3D in vivo multiphoton images of vasculature in Alzheimer disease mouse models	PLOS ONE			English	Article							2-PHOTON MICROSCOPY; BLOOD-FLOW; BRAIN; CORTEX; ARCHITECTURE; CAPILLARIES; ALGORITHM; TERM; TOOL	The health and function of tissue rely on its vasculature network to provide reliable blood perfusion. Volumetric imaging approaches, such as multiphoton microscopy, are able to generate detailed 3D images of blood vessels that could contribute to our understanding of the role of vascular structure in normal physiology and in disease mechanisms. The segmentation of vessels, a core image analysis problem, is a bottleneck that has prevented the systematic comparison of 3D vascular architecture across experimental populations. We explored the use of convolutional neural networks to segment 3D vessels within volumetric in vivo images acquired by multiphoton microscopy. We evaluated different network architectures and machine learning techniques in the context of this segmentation problem. We show that our optimized convolutional neural network architecture with a customized loss function, which we call DeepVess, yielded a segmentation accuracy that was better than state-of-the-art methods, while also being orders of magnitude faster than the manual annotation. To explore the effects of aging and Alzheimer's disease on capillaries, we applied DeepVess to 3D images of cortical blood vessels in young and old mouse models of Alzheimer's disease and wild type littermates. We found little difference in the distribution of capillary diameter or tortuosity between these groups, but did note a decrease in the number of longer capillary segments (>75 mu m) in aged animals as compared to young, in both wild type and Alzheimer's disease mouse models.	[Haft-Javaherian, Mohammad; Fang, Linjing; Muse, Victorine; Schaffer, Chris B.; Nishimura, Nozomi; Sabuncu, Mert R.] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA; [Sabuncu, Mert R.] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14850 USA	Cornell University; Cornell University	Sabuncu, MR (corresponding author), Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.; Sabuncu, MR (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14850 USA.	msabuncu@cornell.edu	Javaherian, Mohammad Haft/P-1379-2014; Sabuncu, Mert Rory/ABE-2284-2021; Schaffer, Chris B./A-7409-2008	Javaherian, Mohammad Haft/0000-0002-8551-5008; Schaffer, Chris B./0000-0002-7800-9596; Sabuncu, Mert/0000-0002-7068-719X; Muse, Victorine P./0000-0003-1583-6970	European Research Council [615102]; National Institutes of Health [AG049952, R01LM012719, R01AG053949]; National Science Foundation Cornell NeuroNex Hub [1707312]; National Science Foundation [1748377]; NATIONAL INSTITUTE ON AGING [R21AG050122, R01AG053949] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012719] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Cornell NeuroNex Hub; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the European Research Council grant 615102 (NN), the National Institutes of Health grant AG049952 (CS), the National Institutes of Health grants R01LM012719 and R01AG053949 (MS), the National Science Foundation Cornell NeuroNex Hub grant (1707312, MS and CS) and the National Science Foundation (1748377 to MS).	Abadi  M., 2016, ARXIV160304467; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bates Russell, 2017, ARXIV170509597; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Cruz Hernandez JC., 2019, NATURE NEUROSCIENCE; Cudmore RH, 2016, J CEREBRAL BLOOD FLO; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dorr A, 2012, BRAIN, V135, P3039, DOI 10.1093/brain/aws243; Drew PJ, 2011, P NATL ACAD SCI USA, V108, P8473, DOI 10.1073/pnas.1100428108; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Fu HZ, 2016, I S BIOMED IMAGING, P698, DOI 10.1109/ISBI.2016.7493362; Gal Y, 2016, PR MACH LEARN RES, V48; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gutierrez-Jimenez E, 2016, J CEREBR BLOOD F MET, V36, P2072, DOI 10.1177/0271678X16631560; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Heinzer S, 2004, P SOC PHOTO-OPT INS, V5535, P65, DOI 10.1117/12.559514; Heinzer S, 2008, NEUROIMAGE, V39, P1549, DOI 10.1016/j.neuroimage.2007.10.054; Heinzer S, 2006, NEUROIMAGE, V32, P626, DOI 10.1016/j.neuroimage.2006.03.043; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Huazhu Fu, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P132, DOI 10.1007/978-3-319-46723-8_16; HUNZIKER O, 1979, J GERONTOL, V34, P345, DOI 10.1093/geronj/34.3.345; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jones JS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00969; Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; Lai AY, 2015, BRAIN, V138, P1046, DOI 10.1093/brain/awv023; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Lin L, 2017, J BIOPHOTONICS, V10, P792, DOI 10.1002/jbio.201600236; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lorthois S, 2014, MICROVASC RES, V91, P99, DOI 10.1016/j.mvr.2013.11.003; Maninis Kevis-Kokitsi, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P140, DOI 10.1007/978-3-319-46723-8_17; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; Mille Julien, 2009, 2009 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P149, DOI 10.1109/CVPR.2009.5204049; Milliken G.A., 2009, ANAL MESSY DATA, V1; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Riddle DR, 2003, AGEING RES REV, V2, P149, DOI 10.1016/S1568-1637(02)00064-8; Ronneberger O, INT C MED IM COMP CO; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339; Sonntag WE, BRAIN AGING MODELS M; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C., P IEEE C COMP VIS PA; Tang J, 2017, J CEREBRAL BLOOD FLO; Teikari P, 2016, ARXIV160602382; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Verant P, 2007, J CEREBR BLOOD F MET, V27, P1072, DOI 10.1038/sj.jcbfm.9600415; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; WILKINSON JH, 1981, NEUROPATH APPL NEURO, V7, P451, DOI 10.1111/j.1365-2990.1981.tb00245.x; Wu AR, 2016, I S BIOMED IMAGING, P1363, DOI 10.1109/ISBI.2016.7493520; Yi J, 2003, INT J IMAG SYST TECH, V13, P208, DOI 10.1002/ima.10059; Zoumi A, 2004, BIOPHYS J, V87, P2778, DOI 10.1529/biophysj.104.042887	65	26	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213539	10.1371/journal.pone.0213539	http://dx.doi.org/10.1371/journal.pone.0213539			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865678	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900074
J	Kim, SW; Han, SJ; Kim, Y; Jun, JW; Giri, SS; Chi, C; Yun, S; Kim, HJ; Kim, SG; Kang, JW; Kwon, J; Oh, WT; Cha, J; Han, S; Lee, BC; Park, T; Kim, BY; Park, SC				Kim, Sang Wha; Han, Se Jin; Kim, Yonggab; Jun, Jin Woo; Giri, Sib Sankar; Chi, Cheng; Yun, Saekil; Kim, Hyoun Joong; Kim, Sang Guen; Kang, Jeong Woo; Kwon, Jun; Oh, Woo Taek; Cha, Jehyun; Han, Seunghee; Lee, Byeong Chun; Park, Taesung; Kim, Byung Yeop; Park, Se Chang			Heavy metal accumulation in and food safety of shark meat from Jeju island, Republic of Korea	PLOS ONE			English	Article							TRACE-METALS; TOTAL MERCURY; PERSIAN-GULF; FISH; MUSCLE; METHYLMERCURY; LIVER; LEAD; OFFSHORE; SELENIUM	Shark meat is consumed as a food source worldwide, especially in Asian countries. However, since sharks are apex predators in the ocean food chain, they are prone to bioaccumulation of heavy metals. More than 100 million sharks are caught annually for human consumption, and the safety of shark meat cannot be overemphasized. Here, we examined heavy metal concentration in the muscle tissue of 6 shark species including 3 migratory species (Carcharhinus brachyurus, Carcharhinus obscurus, and Isurus oxyrinchus) and 3 local species (Triakis scyllium, Mustelus manazo, and Cephaloscyllium umbratile) from fish markets in Jeju Island, Republic of Korea. The concentrations of 11 heavy metals (Cr, Fe, Cu, Zn, As, Se, Cd, Sn, Sb, Pb, and Hg) and MeHg were analyzed. The result showed that the average concentrations of all metals, except for that of As, were below the regulatory maximum limits of many organizations, including the Codex standard. Hg and MeHg were significantly correlated with body length, body weight, and age, and the concentration of Hg was expected to exceed the limit in C. brachyurus with a body length or weight of over 130 cm or 25 kg, respectively. Our results indicate that shark meat can expose consumers to a high level of As and that copper sharks bigger than the predicted size should be avoided for excessive Hg. Considering these findings, a detailed guideline on consumption of meat of different shark species should be suggested based on further investigation.	[Kim, Sang Wha; Han, Se Jin; Giri, Sib Sankar; Yun, Saekil; Kim, Hyoun Joong; Kim, Sang Guen; Kang, Jeong Woo; Kwon, Jun; Oh, Woo Taek; Park, Se Chang] Seoul Natl Univ, Coll Vet Med, Lab Aquat Biomed, Seoul, South Korea; [Kim, Sang Wha; Han, Se Jin; Giri, Sib Sankar; Yun, Saekil; Kim, Hyoun Joong; Kim, Sang Guen; Kang, Jeong Woo; Kwon, Jun; Oh, Woo Taek; Park, Se Chang] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea; [Kim, Yonggab; Park, Taesung] Seoul Natl Univ, Dept Stat, Coll Nat Sci, Seoul, South Korea; [Jun, Jin Woo] Korea Natl Coll Agr & Fisheries, Dept Aquaculture, Jeonju, South Korea; [Chi, Cheng] Nanjing Agr Univ, Coll Anim Sci & Technol, Lab Aquat Nutr & Ecol, Nanjing, Jiangsu, Peoples R China; [Cha, Jehyun] Hanyang Univ, Sch Mech Engn, Seoul, South Korea; [Han, Seunghee] Gwangju Inst Sci & Technol, Sch Earth Sci & Environm Engn, Gwangju, South Korea; [Lee, Byeong Chun] Seoul Natl Univ, Dept Theriogenol & Biotechnol, Coll Vet Med, Seoul, South Korea; [Kim, Byung Yeop] Jeju Natl Univ, Dept Marine Ind & Maritime Police, Coll Ocean Sci, Jeju, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Nanjing Agricultural University; Hanyang University; Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Jeju National University	Park, SC (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Aquat Biomed, Seoul, South Korea.; Park, SC (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea.; Kim, BY (corresponding author), Jeju Natl Univ, Dept Marine Ind & Maritime Police, Coll Ocean Sci, Jeju, South Korea.	kimby@jejunu.ac.kr; parksec@snu.ac.kr	Giri, Sib Sankar/AAK-8909-2021; kim, sang guen/AAT-9683-2021; Han, Seunghee/AAZ-6456-2020; Park, Chang/AAT-3439-2021	Han, Seunghee/0000-0002-3284-0106; Park, Chang/0000-0001-9821-387X	Rural Development Administration, Republic of Korea [PJ013985032018]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2018R1D1A1A02086128]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea)	This study was carried out with the support of "Cooperative Research Program for Agriculture Science and Technology Development (Supportive managing project of Center for Companion Animals Research, PJ013985032018)" Rural Development Administration, Republic of Korea. This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1D1A1A02086128). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel M, 2018, FOOD CHEM TOXICOL, V113, P198, DOI 10.1016/j.fct.2018.01.027; Adel M, 2016, FOOD CHEM TOXICOL, V97, P135, DOI 10.1016/j.fct.2016.09.002; Al-Yousuf MH, 2000, SCI TOTAL ENVIRON, V256, P87, DOI 10.1016/S0048-9697(99)00363-0; [Anonymous], 2018, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.EN; [Anonymous], 2002, LIM TEST HEAV MET FO; Becker W., 2007, RISKS BENEFITS FISH; Branco V, 2007, ENVIRON POLLUT, V150, P373, DOI 10.1016/j.envpol.2007.01.040; BRAUNE BM, 1987, ARCH ENVIRON CON TOX, V16, P311, DOI 10.1007/BF01054948; Burger J, 2011, SCI TOTAL ENVIRON, V409, P1418, DOI 10.1016/j.scitotenv.2010.12.034; Carvalho ML, 2005, ANAL BIOANAL CHEM, V382, P426, DOI 10.1007/s00216-004-3005-3; CODEX, 2015, 1931995 CODEX; Compagno L.J.V., 1989, GUIDE SHARKS RAYS SO; Compagno LJV, 1984, SHARKS WORLD ANNOTAT; de Pinho AP, 2002, ENVIRON RES, V89, P250, DOI 10.1006/enrs.2002.4365; Dent Felix, 2015, FAO Fisheries and Aquaculture Technical Paper, V590, P1; DOUBEN PET, 1989, ECOTOX ENVIRON SAFE, V18, P35, DOI 10.1016/0147-6513(89)90090-0; Duffy C., 2003, SSG AUSTR OC REG WOR, DOI [10.2305/IUCN.UK.2003.RLTS.T41741A10551730.en, DOI 10.2305/IUCN.UK.2003.RLTS.T41741A10551730.EN]; EFSA NDA Panel, 2006, TOL UPP INT LEV VIT; Endo T, 2008, MAR POLLUT BULL, V56, P1774, DOI 10.1016/j.marpolbul.2008.06.003; Endo T, 2007, CHEMOSPHERE, V67, P51, DOI 10.1016/j.chemosphere.2006.09.086; Endo T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147797; EPA RCRA, 2002, WAST SAMPL DRAFT TEC; EPA US, 2000, QAG9 EPA; EPSTEIN O, 1983, POSTGRAD MED J, V59, P88; FAO, 2010, SUSTAINABLE DIETS BI, V91, P1; Fishstat, FISH COMM GLOB PROD; Forsyth DS, 2004, FOOD ADDIT CONTAM A, V21, P849, DOI 10.1080/02652030400004259; Garcia-Fernandez AJ, 2009, ECOTOX ENVIRON SAFE, V72, P557, DOI 10.1016/j.ecoenv.2008.05.003; Gusso-Choueri PK, 2018, SCI TOTAL ENVIRON, V628-629, P621, DOI 10.1016/j.scitotenv.2018.02.005; Jang Jae-Yeon, 2014, J Prev Med Public Health, V47, P18, DOI 10.3961/jpmph.2014.47.1.18; Kehrig HD, 2009, ENVIRON SCI POLLUT R, V16, P10, DOI 10.1007/s11356-008-0038-8; KFDA, 2017, KOR FOOD COD; Kim IS, 2005, ILLUSTRATED BOOK KOR; Kim SJ, 2016, MAR POLLUT BULL, V102, P210, DOI 10.1016/j.marpolbul.2015.11.038; Korkmaz S, 2014, R J, V6, P151, DOI 10.32614/rj-2014-031; Lack M, 2011, FUTURE SHARKS REV AC, P44; Lavoie RA, 2010, SCI TOTAL ENVIRON, V408, P5529, DOI 10.1016/j.scitotenv.2010.07.053; Lozano-Bilbao E, 2018, ENVIRON SCI POLLUT R, V25, P21251, DOI 10.1007/s11356-018-2550-9; MARCOVECCHIO JE, 1991, MAR ENVIRON RES, V31, P263, DOI 10.1016/0141-1136(91)90016-2; Mertz W, 1986, TRACE ELEMENTS HUMAN; National Research Council, 1999, ARS DRINK WAT, P310; Nordberg GF, 2015, HDB TOXICOLOGY METAL, V1; Nordberg GF, 2015, HDB TOXICOLOGY METAL, V2; Papp A, 2006, J APPL TOXICOL, V26, P374, DOI 10.1002/jat.1152; Pethybridge H, 2010, MAR ENVIRON RES, V69, P18, DOI 10.1016/j.marenvres.2009.07.006; R Core Team, 2017, R LANGUAGE ENV STAT; Soest N., 2016, THESIS; Storelli MM, 2002, MAR POLLUT BULL, V44, P1354, DOI 10.1016/S0025-326X(02)00223-0; Storelli MM, 2000, B ENVIRON CONTAM TOX, V64, P333, DOI 10.1007/s001280000004; Tajimi M, 2005, CHEMOSPHERE, V61, P1256, DOI 10.1016/j.chemosphere.2005.03.096; Traore A, 1999, ARCH TOXICOL, V73, P289, DOI 10.1007/s002040050620; UNEP, 2008, GUID ID POP RISK MER, DOI [10.18356/8574b2d5-en, DOI 10.18356/8574B2D5-EN]; Vandermeersch G, 2015, ENVIRON RES, V143, P29, DOI 10.1016/j.envres.2015.06.011; Vannuccini S., 1999, FAO FISHERIES TECHNI, P66; VELILLA S, 1993, STAT PROBABIL LETT, V17, P259, DOI 10.1016/0167-7152(93)90200-3; VITALIANO JJ, 1992, MAR POLLUT BULL, V24, P364, DOI 10.1016/0025-326X(92)90374-F; Widianarko B, 2000, ECOTOX ENVIRON SAFE, V46, P101, DOI 10.1006/eesa.1999.1879	57	21	23	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212410	10.1371/journal.pone.0212410	http://dx.doi.org/10.1371/journal.pone.0212410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865667	gold, Green Published, Green Submitted			2022-12-26	WOS:000461048900020
J	Lavelle, AM; Bury, NR; O'Shea, FT; Chadwick, MA				Lavelle, Anna M.; Bury, Nic R.; O'Shea, Francis T.; Chadwick, Michael A.			Influence of urban river restoration on nitrogen dynamics at the sediment-water interface	PLOS ONE			English	Article							STREAM ECOSYSTEM FUNCTION; AMMONIUM UPTAKE; CHANNEL RESTORATION; TRANSIENT STORAGE; CLIMATE-CHANGE; RETENTION; DENITRIFICATION; URBANIZATION; SATURATION; CHEMISTRY	River restoration projects focused on altering flow regimes through use of in-channel structures can facilitate ecosystem services, such as promoting nitrogen (N) storage to reduce eutrophication. In this study we use small flux chambers to examine ammonium (NH4+) and nitrate (NO3-) cycling across the sediment-water interface. Paired restored and unrestored study sites in 5 urban tributaries of the River Thames in Greater London were used to examine N dynamics following physical disturbances (0-3 min exposures) and subsequent bio-geochemical activity (3-10 min exposures). Average ambient NH4+ concentrations were significantly different amongst all sites and ranged from 28.0 to 731.7 mu g L-1, with the highest concentrations measured at restored sites. Average NO3- concentrations ranged from 9.6 to 26.4 mg L-1, but did not significantly differ between restored and unrestored sites. Average NH4+ fluxes at restored sites ranged from -8.9 to 5.0 mu g N m(-2) sec(-1), however restoration did not significantly influence NH4+ uptake or regeneration (i.e., a measure of release to surface water) between 0-3 minutes and 3-10 minutes. Further, average NO3- fluxes amongst sites responded significantly between 0-3 minutes ranging from -33.6 to 97.7 mu g N m(-2) sec(-1). Neither NH4+ nor NO3- fluxes correlated to sediment chlorophyll-a, total organic matter, or grain size. We attributed variations in overall N fluxes to N-specific sediment storage capacity, biogeochemical transformations, potential legacy effects associated with urban pollution, and variations in river-specific restoration actions.	[Lavelle, Anna M.; O'Shea, Francis T.; Chadwick, Michael A.] Kings Coll London, Dept Geog, London, England; [Bury, Nic R.] Univ Suffolk, Sch Sci Technol & Engn, Ipswich, Suffolk, England; [Bury, Nic R.] Univ Suffolk, Suffolk Sustainabil Inst, Ipswich, Suffolk, England	University of London; King's College London	Bury, NR (corresponding author), Univ Suffolk, Sch Sci Technol & Engn, Ipswich, Suffolk, England.; Bury, NR (corresponding author), Univ Suffolk, Suffolk Sustainabil Inst, Ipswich, Suffolk, England.	n.bury@uos.ac.uk	Bury, Nicolas R/A-1855-2018; Chadwick, Michael/ABF-6431-2020; O'Shea, Francis/D-7447-2016	Bury, Nicolas R/0000-0001-6048-6338; Chadwick, Michael/0000-0003-4891-4357; O'Shea, Francis/0000-0002-0808-7441	Natural Environment Research Council [NE/L002485/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AL received funds from Natural Environment Research Council (https://nerc.ukri.orgy London DTP (https:/london-nerc-dtp.org/)) grant reference NE/L002485/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Alexander RB, 2009, BIOGEOCHEMISTRY, V93, P91, DOI 10.1007/s10533-008-9274-8; [Anonymous], 2017, AMM IN RIV; Bernhardt ES, 2007, FRESHWATER BIOL, V52, P738, DOI 10.1111/j.1365-2427.2006.01718.x; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bernot MJ, 2005, ECOSYSTEMS, V8, P442, DOI 10.1007/s10021-003-0143-y; Booth DB, 2016, FRESHW SCI, V35, P412, DOI 10.1086/684940; Brown D., 2014, CATCHMENT PLAN RIVER; Bukaveckas PA, 2007, ENVIRON SCI TECHNOL, V41, P1570, DOI 10.1021/es061618x; Chadwick MA, 2006, ECOL APPL, V16, P1796, DOI 10.1890/1051-0761(2006)016[1796:UASEFB]2.0.CO;2; Clavero V, 2000, MAR ECOL PROG SER, V198, P51, DOI 10.3354/meps198051; Cook H, 2015, LOND J, V40, P225, DOI 10.1179/1749632215Y.0000000009; Covino TP, 2018, FRESHW SCI, V37, P448, DOI 10.1086/699202; Craig LS, 2008, FRONT ECOL ENVIRON, V6, P529, DOI 10.1890/070080; Davies G., 2011, WATER QUALITY ANAL R; Filoso S, 2011, ECOL APPL, V21, P1989, DOI 10.1890/10-0854.1; Floury M, 2013, GLOBAL CHANGE BIOL, V19, P1085, DOI 10.1111/gcb.12124; Grimm NB, 2005, J N AM BENTHOL SOC, V24, P626, DOI 10.1899/04-027.1; Hall RO, 2009, LIMNOL OCEANOGR, V54, P653, DOI 10.4319/lo.2009.54.3.0653; Halliday SJ, 2015, HYDROL PROCESS, V29, P3388, DOI 10.1002/hyp.10453; Harrison MD, 2011, J ENVIRON QUAL, V40, P634, DOI 10.2134/jeq2010.0335; Hines SL, 2011, INLAND WATERS, V1, P133, DOI 10.5268/IW-1.2.395; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Johnson ZC, 2015, LIMNOL OCEANOGR, V60, P57, DOI 10.1002/lno.10006; Kasahara T, 2006, HYDROL PROCESS, V20, P4287, DOI 10.1002/hyp.6174; Kaushal SS, 2008, ECOL APPL, V18, P789, DOI 10.1890/07-1159.1; Kaushal SS, 2012, URBAN ECOSYST, V15, P409, DOI 10.1007/s11252-012-0226-7; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Kim YH, 2008, THEOR APPL CLIMATOL, V92, P239, DOI 10.1007/s00704-007-0319-z; Klocker CA, 2009, AQUAT SCI, V71, P411, DOI 10.1007/s00027-009-0118-y; Lijklema L, 1993, WATER SCI TECHNOL, V28; Maksymowska-Brossard D., 2001, OCEANOLOGIA, V43, P113; Marker AFH, 1994, CHLOROPHYLL SCA METH, V1st ed; MARTENS CS, 1984, GEOCHIM COSMOCHIM AC, V48, P1987, DOI 10.1016/0016-7037(84)90380-6; Mekonnen MM, 2015, ENVIRON SCI TECHNOL, V49, P12860, DOI 10.1021/acs.est.5b03191; Meyer JL, 2005, J N AM BENTHOL SOC, V24, P602, DOI 10.1899/04-021.1; Minaudo C, 2015, BIOGEOSCIENCES, V12, P2549, DOI 10.5194/bg-12-2549-2015; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Neal C, 2006, SCI TOTAL ENVIRON, V365, P84, DOI 10.1016/j.scitotenv.2006.02.039; Neale MW, 2016, ECOL ENG, V87, P175, DOI 10.1016/j.ecoleng.2015.11.043; O'Brien JM, 2007, BIOGEOCHEMISTRY, V84, P31, DOI 10.1007/s10533-007-9073-7; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pecorelli J., 2017, AUDIT SURFACE WATER; Pennino MJ, 2014, BIOGEOCHEMISTRY, V121, P247, DOI 10.1007/s10533-014-9958-1; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Reisinger AJ, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw198; River Restoration Centre, 2008, RIV BRENT TOK PARK T; Roberts BJ, 2007, J N AM BENTHOL SOC, V26, P38, DOI 10.1899/0887-3593(2007)26[38:EOUDAI]2.0.CO;2; Roley SS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001950; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; Rueda J, 2002, WATER AIR SOIL POLL, V140, P425, DOI 10.1023/A:1020190227581; Simon KS, 2010, ENVIRON MONIT ASSESS, V171, P83, DOI 10.1007/s10661-010-1532-2; Sivirichi GM, 2011, J ENVIRON MONITOR, V13, P288, DOI 10.1039/c0em00055h; Smith B, 2014, FUND APPL LIMNOL, V185, P7, DOI 10.1127/fal/2014/0581; Sudduth EB, 2011, ECOL APPL, V21, P1972, DOI 10.1890/10-0653.1; Tank JL, 2018, ECOL MONOGR, V88, P120, DOI 10.1002/ecm.1280; Valett HM, 1996, LIMNOL OCEANOGR, V41, P333, DOI 10.4319/lo.1996.41.2.0333; Vietz GJ, 2016, PROG PHYS GEOG, V40, P480, DOI 10.1177/0309133315605048; Vilmin L, 2018, GLOBAL PLANET CHANGE, V163, P67, DOI 10.1016/j.gloplacha.2018.02.007; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Webster JR, 2003, FRESHWATER BIOL, V48, P1329, DOI 10.1046/j.1365-2427.2003.01094.x; Wohl E, 2015, WATER RESOUR RES, V51, P5974, DOI 10.1002/2014WR016874; Wu YH, 2012, BIORESOURCE TECHNOL, V107, P10, DOI 10.1016/j.biortech.2011.12.088; Zhou QQ, 2014, WATER-SUI, V6, P976, DOI 10.3390/w6040976	67	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212690	10.1371/journal.pone.0212690	http://dx.doi.org/10.1371/journal.pone.0212690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865649	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900032
J	Silva, DAS; Chaput, JP; Tremblay, MS				Santos Silva, Diego Augusto; Chaput, Jean-Philippe; Tremblay, Mark S.			Participation frequency in physical education classes and physical activity and sitting time in Brazilian adolescents	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; HEALTH-SURVEY; CHILDREN; SCHOOL; ASSOCIATIONS; LESSONS; YOUTH	Introduction To examine the association between participation frequency per week in physical education (PE) classes and physical activity (PA) and sitting time levels in adolescents according to the economic development level of the region of residence. Methods A cross-sectional study with a sample representative of Brazil was carried out with 12,220 students aged 11-19 years. Participation frequency per week in PE classes, moderate-to-vigorous PA (MVPA), PA during PE classes, active commuting, PA outside of school hours, total accumulated PA, time sitting in front of the TV and total sitting time were assessed by using a self-administered questionnaire. Results Adolescents who reported having PE classes were more likely to meet MVPA recommendations (1-2 PE class/week OR: 1.3, 95%Cl: 1.1-1.5; >= 3 PE class/week OR: 2.0, 95%Cl: 1.7-2.5), spent more time in PA outside of school hours (1-2 PE class/week OR: 1.6, 95%Cl: 1.4-1.9; >= 3 PE class/week OR: 2.0, 95%Cl: 1.5-2.6), and accumulated more PA (1-2 PE class/week OR: 1.9, 95%Cl: 1.6-2.2; >= 3 PE class/week OR: 6.0, 95%Cl: 4.0-8.9) than students who reported not taking PE classes. Boys from regions with higher Human Development Index (HDI) who took >= 3 PE classes/week were more likely to have higher levels of active commuting (OR: 1.4, 95%Cl: 1.1-1.9) and less likely of getting in front of TV (OR: 0.7, 95%Cl: 0.5-0.9). Adolescents from regions with higher HDI were more likely to have more time spent in PA during PE classes (Male OR: 2.7, 95%Cl: 2.4-3.1; Female OR = 3.2, 95%Cl: 2.8-3.7). Conclusions Having PE classes is associated with a higher level of PA in both sexes and in both regions and lower level of sitting time in boys from regions with higher HDI.	[Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil; [Chaput, Jean-Philippe; Tremblay, Mark S.] Childrens Hosp Eastern Ontario Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON, Canada	Universidade Federal de Santa Catarina (UFSC); University of Ottawa; Children's Hospital of Eastern Ontario	Tremblay, MS (corresponding author), Childrens Hosp Eastern Ontario Res Inst, Hlth Act Living & Obes Res Grp, Ottawa, ON, Canada.	diegoaugustoss@yahoo.com.br	Tremblay, Mark/AAF-2981-2019; Silva, Diego/GRF-5446-2022; Chaput, Jean-Philippe/ABE-6307-2020; Tremblay, Mark/ABI-5477-2020; Silva, Diego Augusto Santos/AAB-9249-2020	Chaput, Jean-Philippe/0000-0002-5607-5736; Silva, Diego Augusto Santos/0000-0002-0489-7906				Brazilian Institute of Geography and Statistics, 2016, NAT SURV SCH HLTH; Brazilian Ministry of Education, 2003, PHYS ED MAND DISC; Calahorro-Canada F, 2017, SCAND J MED SCI SPOR, V27, P1417, DOI 10.1111/sms.12740; Centers for Disease Control and Prevention, 2010, STRAT IMPR QUAL PHYS; Chen SL, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-150; Costa BGG, 2017, J SCI MED SPORT, V20, P70, DOI [10.1016/j.jsams.2016.06.004, DOI 10.1016/J.JSAMS.2016.06.004]; De Meester A, 2016, J SPORT SCI, V34, P2027, DOI 10.1080/02640414.2016.1149608; de Oliveira MM, 2017, EPIDEMIOL SERV SAUDE, V26, P605, DOI 10.5123/S1679-49742017000300017; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dishman RK, 2010, PSYCHOPHYSIOLOGY, V47, P1066, DOI 10.1111/j.1469-8986.2010.01014.x; Klakk H, 2014, SCAND J PUBLIC HEALT, V42, P128, DOI 10.1177/1403494813505726; Loprinzi PD, 2018, AM J HEALTH PROMOT, V32, P613, DOI 10.1177/0890117117698088; McGrath LJ, 2015, SPORTS MED, V45, P841, DOI 10.1007/s40279-015-0301-3; Moller NC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0121-0; Park JW, 2017, J EXERC REHABIL, V13, P168, DOI 10.12965/jer.1734948.474; Physical and Health Education, 2017, CAN CHECK UP PHYS ED; Ponti M, 2017, PAED CHILD HEALT-CAN, V22, P461, DOI 10.1093/pch/pxx123; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Silva DAS, 2018, MED SCI SPORT EXER, V50, P995, DOI 10.1249/MSS.0000000000001524; Skrondal A, 2003, PSYCHOMETRIKA, V68, P267, DOI 10.1007/BF02294801; Szwarcwald CL, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0432-7; Tavares LF, 2014, CAD SAUDE PUBLICA, V30, P1861, DOI 10.1590/0102-311X00151913; Telford RD, 2012, AM J PUBLIC HEALTH, V102, P368, DOI 10.2105/AJPH.2011.300220; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pIII, DOI [10.1139/apnm-2016-0203, 10.1139/apnm-2016-0151]; United Nations, 2010, MUN HUM DEV IND 2010; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wilkin TJ, 2011, INT J OBESITY, V35, P1270, DOI 10.1038/ijo.2011.163; World Health Organization, 2009, 2009 MAN COND GLOB S	28	14	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213785	10.1371/journal.pone.0213785	http://dx.doi.org/10.1371/journal.pone.0213785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865705	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900091
J	Chen, SX; Sandford, S; Kirman, JR; Rehm, BHA				Chen, Shuxiong; Sandford, Sarah; Kirman, Joanna R.; Rehm, Bernd H. A.			Innovative antigen carrier system for the development of tuberculosis vaccines	FASEB JOURNAL			English	Article						polyester particle; particulate vaccine; bioengineering; Mycobacterium tuberculosis	PARTICLE-SIZE; POLYHYDROXYALKANOATE GRANULES; EFFICIENT PROTECTION; POLYESTER INCLUSIONS; BOVINE TUBERCULOSIS; IMMUNE-RESPONSE; DENDRITIC CELLS; T-CELLS; SURFACE; VACCINATION	A major obstacle to tuberculosis (TB)-subunit-vaccine development has been the induction of inadequate levels of protective immunity due to the limited breadth of antigen in vaccine preparations. In this study, immunogenic mycobacterial fusion peptides Ag85B-TB10.4 and Ag85B-TB10.4-Rv2660c were covalently displayed on the surface of self-assembled polyester particles. This study investigated whether polyester particles displaying mycobacterial antigens could provide augmented immunogenicity (i.e., offer an innovative vaccine formulation) when compared with free soluble antigens. Herein, polyester particle-based particulate vaccines were produced in an endotoxin-free Escherichia coli strain and emulsified with the adjuvant dimethyl dioctadecyl ammonium bromide. C57BL/6 mice were used to study the immunogenicity of formulated particulate vaccines. The result of humoral immunity showed the antibodies only interacted with target antigens and not with PhaC and the background proteins of the production host. The analysis of T helper 1 cellular immunity indicated that a relatively strong production of cellular immunity biomarkers, IFN-gamma and IL-17A cytokines, was induced by particulate vaccines when compared with the respective soluble controls. This study demonstrated that polyester particles have the potential to perform as a mycobacterial antigen-delivery agent to induce augmented antigen-specific immune responses in contrast to free soluble vaccines.-Chen, S., Sandford, S., Kirman, J. R., Rehm, B. H. A. Innovative antigen carrier system for the development of tuberculosis vaccines.	[Chen, Shuxiong] Massey Univ Manawatu, Inst Fundamental Sci, Palmerston North, New Zealand; [Sandford, Sarah; Kirman, Joanna R.] Univ Otago, Microbiol & Immunol Dept, Dunedin, New Zealand; [Rehm, Bernd H. A.] Griffith Univ, Ctr Cell Factories & Biopolymers, Griffith Inst Drug Discovery, Nathan Campus,Don Young Rd, Brisbane, Qld 4111, Australia	Massey University; University of Otago; Griffith University	Rehm, BHA (corresponding author), Griffith Univ, Ctr Cell Factories & Biopolymers, Griffith Inst Drug Discovery, Nathan Campus,Don Young Rd, Brisbane, Qld 4111, Australia.	b.rehm@griffith.edu.au	Chen, Shuxiong/ABE-3430-2020	Chen, Shuxiong/0000-0002-5275-0757; Kirman, Joanna/0000-0002-4802-7048; Sandford, Sarah/0000-0002-2901-4516	Massey University (Palmerston North, New Zealand); Griffith University (Brisbane, QLD, Australia)	Massey University (Palmerston North, New Zealand); Griffith University (Brisbane, QLD, Australia)	The authors thank research technician Michelle Wilson for the great support and advice with flow cytometry. The authors acknowledge the Manawatu Microscopy and Imaging Centre for preparation and development of transmission electron microscopic imaging. The authors are grateful to technicians at the University of Otago Department of Pathology for animal husbandry. Funding was provided by Massey University (Palmerston North, New Zealand) and Griffith University (Brisbane, QLD, Australia). The authors declare no conflicts of interest.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Amara AA, 2003, BIOCHEM J, V374, P413, DOI 10.1042/BJ20030431; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Anderson L., 2018, GLOBAL TUBERCULOSIS; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Billeskov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072185; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Blatchford PA, 2012, BIOTECHNOL BIOENG, V109, P1101, DOI 10.1002/bit.24402; Burel JG, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87499; Campisano A, 2008, J BIOTECHNOL, V133, P442, DOI 10.1016/j.jbiotec.2007.11.007; Chan J, 2014, SEMIN IMMUNOL, V26, P588, DOI 10.1016/j.smim.2014.10.005; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen SX, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201800118; Chen SX, 2014, APPL ENVIRON MICROB, V80, P2526, DOI 10.1128/AEM.04168-13; Chung CW, 2003, INT J BIOL MACROMOL, V32, P17, DOI 10.1016/S0141-8130(03)00020-5; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Deng YH, 2015, INFECT DIS-NOR, V47, P168, DOI 10.3109/00365548.2014.982167; Dey AK, 2014, EXPERT REV VACCINES, V13, P671, DOI 10.1586/14760584.2014.907528; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Fox Christopher B, 2013, Ther Adv Vaccines, V1, P7, DOI 10.1177/2051013613480144; Geldenhuys H, 2015, VACCINE, V33, P3592, DOI 10.1016/j.vaccine.2015.05.036; Gonzalez-Miro M, 2018, ACS BIOMATER SCI ENG, V4, P3413, DOI 10.1021/acsbiomaterials.8b00579; Gonzalez-Miro M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20205-7; Grage K, 2009, BIOMACROMOLECULES, V10, P660, DOI 10.1021/bm801394s; Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8; He H, 2015, EUR J CLIN MICROBIOL, V34, P1103, DOI 10.1007/s10096-015-2335-8; Hezayen FF, 2002, ARCH BIOCHEM BIOPHYS, V403, P284, DOI 10.1016/S0003-9861(02)00234-5; Honary S, 2013, TROP J PHARM RES, V12, P255, DOI 10.4314/tjpr.v12i2.19; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Jahns AC, 2012, MICROB BIOTECHNOL, V5, P188, DOI 10.1111/j.1751-7915.2011.00293.x; Katare YK, 2005, INT J PHARMACEUT, V301, P149, DOI 10.1016/j.ijpharm.2005.05.028; Kaufmann SHE, 2010, J INTERN MED, V267, P337, DOI 10.1111/j.1365-2796.2010.02216.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee JW, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02289-16; Legat A, 2010, APPL MICROBIOL BIOT, V87, P1119, DOI 10.1007/s00253-010-2611-6; Lewinsohn DA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01262; Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Lopez-Sagaseta J, 2016, COMPUT STRUCT BIOTEC, V14, P58, DOI 10.1016/j.csbj.2015.11.001; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p; Parlane NA, 2016, CLIN VACCINE IMMUNOL, V23, P19, DOI 10.1128/CVI.00462-15; Parlane NA, 2012, CLIN VACCINE IMMUNOL, V19, P37, DOI 10.1128/CVI.05505-11; Parlane NA, 2011, APPL ENVIRON MICROB, V77, P8516, DOI 10.1128/AEM.06420-11; Parlane NA, 2009, APPL ENVIRON MICROB, V75, P7739, DOI 10.1128/AEM.01965-09; Peters V, 2005, FEMS MICROBIOL LETT, V248, P93, DOI 10.1016/j.femsle.2005.05.027; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rehm BHA, 2007, CURR ISSUES MOL BIOL, V9, P41; Rehm BHA, 2017, CURR OPIN BIOTECH, V48, P42, DOI 10.1016/j.copbio.2017.03.018; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Rehm BHA, 2002, BBA-PROTEIN STRUCT M, V1594, P178, DOI 10.1016/S0167-4838(01)00299-0; Reyes PR, 2016, INT J MED MICROBIOL, V306, P624, DOI 10.1016/j.ijmm.2016.10.002; Rubio-Reyes P, 2017, MICROB BIOTECHNOL, V10, P1434, DOI 10.1111/1751-7915.12754; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Snapper CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00598; Steinmann B, 2010, APPL ENVIRON MICROB, V76, P5563, DOI 10.1128/AEM.00612-10; Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390; Umemura M, 2016, IMMUN INFLAMM DIS, V4, P401, DOI 10.1002/iid3.121; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Woodard R. W., 2012, VIABLE NONTOXIC GRAM; Zhang JY, 2018, MAT SCI ENG C-MATER, V86, P144, DOI 10.1016/j.msec.2017.12.035	66	13	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7505	7518		10.1096/fj.201802501RR	http://dx.doi.org/10.1096/fj.201802501RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30870010	Bronze			2022-12-26	WOS:000476114200067
J	Meng, LK; Liu, XY; Teng, X; Gu, HY; Yuan, W; Meng, J; Li, J; Zheng, Z; Wei, YJ; Hu, SS				Meng, Liukun; Liu, Xiaoyan; Teng, Xiao; Gu, Haiyong; Yuan, Wen; Meng, Jian; Li, Jun; Zheng, Zhe; Wei, Yingjie; Hu, Shengshou			Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt	FASEB JOURNAL			English	Article						congenital heart disease; pulmonary vascular remodeling; OPN	MUSCLE CELL-MIGRATION; VASCULAR-DISEASE; MICE LACKING; INTEGRIN; ALPHA(V)BETA(3); PROLIFERATION; HYPERTROPHY; FIBROBLASTS; DEPOSITION; BLOCKADE	Recent studies indicated that osteopontin (OPN) was involved in the genesis and progression of pulmonary arterial hypertension (PAH); however, its role in congenital heart disease-associated PAH (CHD/PAH) remains unknown. Our results showed that OPN was increased in lungs and plasma of patients with Eisenmenger syndrome; moreover, OPN and alpha(V)beta(3)-integrin expression levels were augmented in rat lungs exposed to systemic-to-pulmonary shunt. Cell culture assay demonstrated that distal pulmonary arterial smooth muscle cells (PASMCs) from rat lungs suffering from volume and pressure overload exhibited enhanced proliferation compared with those from healthy rats. Mechanical stretch (20% at 1 Hz) increased OPN expression and activated ERK1/2 and protein kinase B (Akt) signal pathway in distal PASMCs from healthy rats. Interestingly, OPN enhanced the proliferation and migration of PASMCs while blocking alpha(V)beta(3)-integrin with neutralizing antibody LM609 or Arg-Gly-Asp peptidomimetic antagonist cyclo(Ala-Arg-Gly-Asp-3-aminomethylbenzoyl) (XJ735), rectified the proliferative and migratory effects of OPN, which were partially mediated via ERK1/2 and Akt signaling pathways. Furthermore, surgical correction of systemic-to-pulmonary shunt, particularly XJ735 supplementation after surgical correction of systemic-to-pulmonary shunt, significantly alleviated the pulmonary hypertensive status in terms of pulmonary hemodynamic indices, pulmonary vasculopathy, and right ventricular hypertrophy. In summary, OPN alteration in lungs exposed to systemic-to-pulmonary shunt exerts a deteriorative role in pulmonary vascular remodeling through modulating the proliferation and migration of PASMCs, at least in part, via alpha nu beta 3-ERK1/2 and alpha nu beta 3-Akt signaling pathways. Antagonizing OPN receptor alpha nu beta 3-integrin accelerated the regression of pulmonary vasculopathy after surgical correction of systemic-to-pulmonary shunt, indicating a potential therapeutic strategy for patients with CHD/PAH.-Meng, L., Liu, X., Teng, X., Gu, H., Yuan, W., Meng, J., Li, J., Zheng, Z., Wei, Y., Hu, S. Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt.	[Meng, Liukun; Teng, Xiao; Meng, Jian; Li, Jun; Zheng, Zhe; Wei, Yingjie; Hu, Shengshou] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Peking Union Med Coll, State Key Lab Cardiovasc Dis,Fuwai Hosp, Beijing, Peoples R China; [Liu, Xiaoyan; Yuan, Wen] Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China; [Liu, Xiaoyan] Capital Med Univ, Beijing Chaoyang Hosp, Beijing Key Lab Hypertens Res, Beijing, Peoples R China; [Gu, Haiyong] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Capital Medical University; Capital Medical University; Shanghai Jiao Tong University	Hu, SS (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beilishi Rd 167, Beijing 100037, Peoples R China.; Hu, SS (corresponding author), Peking Union Med Coll, Fuwai Hosp, Beilishi Rd 167, Beijing 100037, Peoples R China.	huss@fuwaihospital.org			National Natural Science Foundation [81500038, 81470424]; Beijing Natural Science Foundation [7172182, 7172078]; Fuwai Hospital Youth Fund [2014-F03]; Beijing Chaoyang Hospital Affiliated to Capital Medical University 1351 Talent Training Program [CYXX-2017-36]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Fuwai Hospital Youth Fund; Beijing Chaoyang Hospital Affiliated to Capital Medical University 1351 Talent Training Program	This work was supported by research grants from the National Natural Science Foundation (81500038, and 81470424), the Beijing Natural Science Foundation (7172182 and 7172078), the Fuwai Hospital Youth Fund (2014-F03), and Beijing Chaoyang Hospital Affiliated to Capital Medical University Talent Training Program (CYXX-2017-36). The authors declare no conflicts of interest.	Anwar A, 2012, AM J PHYSIOL-LUNG C, V303, pL1, DOI 10.1152/ajplung.00050.2012; Bai YY, 2011, CARDIOLOGY, V120, P157, DOI 10.1159/000334431; Cascella T, 2010, ENDOCRINOLOGY, V151, P5851, DOI 10.1210/en.2010-0350; Chaulet H, 2001, CIRC RES, V89, P772, DOI 10.1161/hh2101.098617; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Fadel E, 2004, J THORAC CARDIOV SUR, V127, P1009, DOI 10.1016/j.jtcvs.2003.07.048; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Han M, 2007, CARDIOVASC PATHOL, V16, P283, DOI 10.1016/j.carpath.2007.04.002; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; Isoda K, 2002, CIRC RES, V91, P77, DOI 10.1161/01.RES.0000025268.10302.0C; Kokubo T, 2007, J VASC SURG, V45, p33A, DOI 10.1016/j.jvs.2007.02.069; Liaw L, 1997, ARTERIOSCL THROM VAS, V17, P188, DOI 10.1161/01.ATV.17.1.188; LIAW L, 1995, CIRC RES, V77, P665, DOI 10.1161/01.RES.77.4.665; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Liaw L, 1998, J CLIN INVEST, V101, P1468; Liu QF, 2013, BIOCHEM BIOPH RES CO, V439, P235, DOI 10.1016/j.bbrc.2013.08.051; Liu XY, 2013, MATRIX BIOL, V32, P23, DOI 10.1016/j.matbio.2012.11.014; Lorenzen JM, 2011, CHEST, V139, P1010, DOI 10.1378/chest.10-1146; Meng LK, 2013, J THORAC CARDIOV SUR, V146, P1220, DOI 10.1016/j.jtcvs.2013.01.018; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Myers DL, 2003, ARTERIOSCL THROM VAS, V23, P1021, DOI 10.1161/01.ATV.0000073312.34450.16; Ochoa CD, 2008, AM J RESP CELL MOL, V39, P105, DOI 10.1165/rcmb.2007-0283OC; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; Peng GY, 2017, CYTOTECHNOLOGY, V69, P831, DOI 10.1007/s10616-017-0081-8; Rosenberg M, 2012, EUR J CLIN INVEST, V42, P933, DOI 10.1111/j.1365-2362.2012.02671.x; Saker M, 2016, ARTERIOSCL THROM VAS, V36, P1879, DOI 10.1161/ATVBAHA.116.307839; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Singh M, 2014, LIFE SCI, V118, P1, DOI 10.1016/j.lfs.2014.09.014; Singh M, 2010, J MOL CELL CARDIOL, V48, P538, DOI 10.1016/j.yjmcc.2009.06.015; Srivatsa SS, 1997, CARDIOVASC RES, V36, P408, DOI 10.1016/S0008-6363(97)00184-3; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Umesh A, 2011, J VASC RES, V48, P525, DOI 10.1159/000329593; WAGENVOORT CA, 1985, HISTOPATHOLOGY, V9, P417, DOI 10.1111/j.1365-2559.1985.tb02825.x; Weissberg P L, 1995, Blood Press Suppl, V2, P68; Xie ZL, 2004, HYPERTENSION, V44, P826, DOI 10.1161/01.HYP.0000148458.03202.48; YUE TL, 1994, EXP CELL RES, V214, P459, DOI 10.1006/excr.1994.1282	40	10	10	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7236	7251		10.1096/fj.201802121RR	http://dx.doi.org/10.1096/fj.201802121RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893567	Bronze			2022-12-26	WOS:000476114200047
J	Nakane, T; Angata, K; Sato, T; Kaji, H; Narimatsu, H				Nakane, Takahiro; Angata, Kiyohiko; Sato, Takashi; Kaji, Hiroyuki; Narimatsu, Hisashi			Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; glycosyltransferase; carbohydrate structure; glycoprotein; endoplasmic reticulum (ER); Golgi; B3GALNT2; LC; MS analysis; type-I LacdiNAc; WFA; Wisteria floribunda agglutinin (WFA); intracellular glycoproteins; endoplasmic reticulum; Golgi	WISTERIA-FLORIBUNDA AGGLUTININ; N-ACETYLGALACTOSAMINE; MASS-SPECTROMETRY; MOLECULAR-CLONING; OLIGOSACCHARIDES; PROTEINS; BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE; N,N'-DIACETYLLACTOSEDIAMINE; BETA-4GALNAC-T3; DYSTROGLYCAN	The type-I LacdiNAc (LDN; GalNAc1-3GlcNAc) has rarely been observed in mammalian cells except in the O-glycan of -dystroglycan, in contrast to type-II LDN structures (GalNAc1-4GlcNAc) in N- and O-glycans that are present in many mammalian glycoproteins, such as pituitary and hypothalamic hormones. Although a 1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2; type-I LDN synthase) has been cloned, the function of type-I LDN in mammalian cells is still unclear, as its carrier protein(s) has not been identified. In this study, using HeLa cells, we demonstrate that inhibition of Golgi-resident glycosyltransferase increases the abundance of B3GALNT2-synthesized type-I LDN structures, recognized by Wisteria floribunda agglutinin (WFA). Using isotope-coded glycosylation site-specific tagging (IGOT)-LC/MS analysis of Lec8 Chinese hamster cells lacking galactosylation and of cells transfected with the B3GALNT2 gene, we identified the glycoproteins that carry B3GALNT2-generated type-I LDN in their N-glycans. Our results further revealed that LDN presence on low-density lipoprotein receptor-related protein 1 and nicastrin depends on B3GALNT2, indicating the occurrence of type-I LDN in vivo in mammalian cells. Our analysis also uncovered that most of the identified glycoproteins localize to intracellular organelles, particularly to the endoplasmic reticulum. Whereas B4GALNT3 and B4GALNT4 synthesized LDN on extracellular glycoproteins, B3GALNT2 primarily transferred LDN to intracellular glycoproteins, thereby clearly delineating proteins that carry type-I or type-II LDNs. Taken together, our results indicate the presence of mammalian glycoproteins carrying type-I LDN on N-glycans and suggest that type-I and type-II LDNs have different roles in vivo.	[Nakane, Takahiro; Angata, Kiyohiko; Sato, Takashi; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Glycosci & Glycotechnol Res Grp, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Tsukuba, Ibaraki 3058568, Japan; [Nakane, Takahiro; Narimatsu, Hisashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Clin Sci, Tsukuba, Ibaraki 3058575, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Glycosci & Glycotechnol Res Grp, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Tsukuba, Ibaraki 3058568, Japan.; Narimatsu, H (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Clin Sci, Tsukuba, Ibaraki 3058575, Japan.	h.narimatsu@aist.go.jp	Kaji, Hiroyuki/L-7122-2018; Angata, Kiyohiko/M-2749-2018; Narimatsu, Hisashi/M-4757-2018	Kaji, Hiroyuki/0000-0002-0910-9999; Angata, Kiyohiko/0000-0001-5561-1368; Narimatsu, Hisashi/0000-0002-8402-133X	Japan Society for the Promotion of Science, KAKENHI [JP13313213, JP15641201]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, grants-in-aid for Scientific Research, KAKENHI Grant numbers JP13313213 and JP15641201. The authors declare that they have no conflicts of interest with the contents of this article.	Abo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145834; Anderson DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182561; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; BERGWERFF AA, 1995, EUR J BIOCHEM, V228, P1009; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P24085, DOI 10.1074/jbc.M116.750463; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; Holliday GL, 2017, METHODS MOL BIOL, V1446, P111, DOI 10.1007/978-1-4939-3743-1_9; Hu D, 2015, MOLECULES, V20, P7637, DOI 10.3390/molecules20057637; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kanagawa Motoi, 2017, J Neuromuscul Dis, V4, P259, DOI 10.3233/JND-170255; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Maroofian R, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0505-2; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Ohkura T, 2002, J BIOCHEM, V132, P891, DOI 10.1093/oxfordjournals.jbchem.a003302; SAMPATH D, 1992, J BIOL CHEM, V267, P4440; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Sato T, 2017, GLYCOBIOLOGY, V27, P743, DOI 10.1093/glycob/cwx038; Sframeli M, 2017, NEUROMUSCULAR DISORD, V27, P793, DOI 10.1016/j.nmd.2017.06.008; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Sugahara D, 2015, PROTEOMICS, V15, P2921, DOI 10.1002/pmic.201400443; Sugahara D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00680; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; VANLEUVEN F, 1994, GENOMICS, V24, P78, DOI 10.1006/geno.1994.1584; Xue J, 2015, J PROTEOMICS, V112, P224, DOI 10.1016/j.jprot.2014.07.013; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	41	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7433	7444		10.1074/jbc.RA118.006892	http://dx.doi.org/10.1074/jbc.RA118.006892			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30898876	Green Published, hybrid			2022-12-26	WOS:000468402900028
J	Alfuqaha, OA; Alkawareek, MY; Alsharah, HS				Alfuqaha, Othman A.; Alkawareek, Mahmoud Y.; Alsharah, Hussein S.			Self-evaluation and professional status as predictors of burnout among nurses in Jordan	PLOS ONE			English	Article							STRESS	The aim of this study is to evaluate the contribution of self-evaluation, professional status and several demographic factors in predicting burnout among nurses in Jordan. This study was performed on a stratified convenience sample of 350 nurses from 6 hospitals. Modified versions of burnout inventory, self-evaluation scale, and professional status scale were developed, validated and used in this study. Burnout, self-evaluation, and professional status are all found to be at moderate levels. Furthermore, self-evaluation and professional status are found to be important predictors of burnout. On the other hand, although type of hospital and educational level are found to be associated with the level of burnout, overall none of the studied demographic factors was found to be a significant predictor of burnout among nurses in Jordan.	[Alfuqaha, Othman A.; Alsharah, Hussein S.] Univ Jordan, Sch Educ Sci, Amman, Jordan; [Alfuqaha, Othman A.] Jordan Univ Hosp, Amman, Jordan; [Alkawareek, Mahmoud Y.] Univ Jordan, Sch Pharm, Amman, Jordan	University of Jordan; University of Jordan; University of Jordan	Alfuqaha, OA (corresponding author), Univ Jordan, Sch Educ Sci, Amman, Jordan.; Alfuqaha, OA (corresponding author), Jordan Univ Hosp, Amman, Jordan.	Othman_alfoqaha@yahoo.com	Alfuqaha, Othman A./G-5568-2019; Alfuqaha, Othman A./M-2832-2019; Alkawareek, Mahmoud/H-5871-2012	Alfuqaha, Othman A./0000-0002-4847-6388; Alfuqaha, Othman A./0000-0002-4847-6388; Alsharah, Hussein/0000-0003-1774-2273; Alkawareek, Mahmoud/0000-0002-4852-0617				Abarghouei Mohammad Reza, 2016, Electron Physician, V8, P2625, DOI 10.19082/2625; Alfuqaha O, 2018, ARCH PSYCHIATR PSYCH, V20, P55, DOI 10.12740/APP/80168; Altun I, 2002, NURS ETHICS, V9, P269, DOI 10.1191/0969733002ne509oa; Ang SY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6960184; Azeem SM, 2014, INT J ACED RES BUS S, V4, P420, DOI DOI 10.6007/IJARBSS/V4-I3/720; Bentley MA, 2013, PREHOSP EMERG CARE, V17, P330, DOI 10.3109/10903127.2012.761307; Best RG, 2005, J OCCUP HEALTH PSYCH, V10, P441, DOI 10.1037/1076-8998.10.4.441; Brashier J, 2013, NURSE BURNOUT EXAMIN; Chuang CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005629; Cishahayo E. U., 2017, INT J RES MED SCI, V5, P5121, DOI [10.18203/2320-6012.ijrms20175430, DOI 10.18203/2320-6012.IJRMS20175430]; Coopersmith S., 1967, ANTECEDENTS SELF-EST; Franca SPD, 2012, ACTA PAUL ENFERM, V25, P68, DOI 10.1590/S0103-21002012000100012; Cheng F, 2015, Int J Nurs Sci, V2, P153, DOI 10.1016/j.ijnss.2015.04.004; Finkelman A., 2013, PROFESSIONAL NURSING; Galletta M, 2016, INTENS CRIT CARE NUR, V34, P59, DOI 10.1016/j.iccn.2015.11.004; Gentile Paola, 2016, FITISPOS INT J, V3, P174, DOI [10.37536/FITISPos-IJ.2016.3.0.110, DOI 10.37536/FITISPOS-IJ.2016.3.0.110]; Goltan H., 2013, JORDANIAN J ED SCI, V9, P419; Hansen N, 2009, INT J NURS STUD, V46, P96, DOI 10.1016/j.ijnurstu.2008.08.002; Hashemi M., 2012, J N KHORASAN U MED S, V4, P95, DOI DOI 10.29252/JNKUMS.4.1.95; Hashemian AH, 2015, ADV BIOL RES, V9, P117; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Katyal S., 2013, STUD HOME COMMUN SCI, V7, P83, DOI [10.1080/09737189.2013.11885396, DOI 10.1080/09737189.2013.11885396]; Lahana E, 2017, BMC NURS, V16, DOI 10.1186/s12912-017-0209-3; Lee HF, 2015, COMMUNITY MENT HLT J, V51, P733, DOI 10.1007/s10597-014-9818-4; Lian PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087152; Mohammadpoorasl Asghar, 2012, Iran J Nurs Midwifery Res, V17, P524; Mudallal RH, 2017, INQUIRY-J HEALTH CAR, V54, DOI 10.1177/0046958017724944; Nehring WM, 2009, SIMULAT GAMING, V40, P528, DOI 10.1177/1046878109332282; Ohue T, 2011, JPN J NURS SCI, V8, P76, DOI 10.1111/j.1742-7924.2010.00161.x; Okwaraji FE, 2014, AFR HEALTH SCI, V14, P237, DOI 10.4314/ahs.v14i1.37; Peng JX, 2016, J HEALTH PSYCHOL, V21, P50, DOI 10.1177/1359105314521478; Rashedi V, 2014, GALEN MED J, V3, P232; Roomaney Rizwana, 2017, Curationis, V40, P1, DOI 10.4102/curationis.v40i1.1695; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sabbah I., 2012, Health, V4, P644; Salami B, 2014, INT NURS REV, V61, P479, DOI 10.1111/inr.12125; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Sun JW, 2017, J CLIN NURS, V26, P4286, DOI 10.1111/jocn.13754; Tohidi S, 2016, RES J MED SCI, V10, P124	39	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213935	10.1371/journal.pone.0213935	http://dx.doi.org/10.1371/journal.pone.0213935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP9GF	30901363	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400025
J	Kobayashi, M; Kato, T; Washiyama, K; Ihara, M; Mizutani, A; Nishi, K; Flores, LG; Nishii, R; Kawai, K				Kobayashi, Masato; Kato, Toshitaka; Washiyama, Kohshin; Ihara, Masaaki; Mizutani, Asuka; Nishi, Kodai; Flores, Leo G.; Nishii, Ryuichi; Kawai, Keiichi			The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to alpha-melanocyte-stimulating hormone analogues for melanoma imaging	PLOS ONE			English	Article							MALIGNANT-MELANOMA; IN-VIVO; RECEPTOR; DIAGNOSIS; THERAPY	Background Although a 3-arm DOTA construct, which has three carboxylic acids, h has been applied for conjugation to many peptides, we investigated if a 4-arm DOTA construct conjugated to peptides improves chemical properties for melanoma imaging of the melanocortin 1 receptor compared to 3-arm DOTA-conjugated peptides. Methods Specific activities, radiolabeling efficiencies, and partition coefficients were evaluated using In-111-labeled 3-arm and 4-arm DOTA-alpha-melanocyte-stimulating hormone (MSH). For assessment of MC1-R affinity and accumulation in tumor cells in vitro, B16-F1 melanoma and/or 4T1 breast cancer cells were incubated with In-111-labeled 3-arm and 4-arm DOTA-alpha-MSH with and without alpha-MSH as a substrate. The stability was evaluated using mouse liver homogenates and plasma. Biological distribution and whole-body single photon emission computed tomography imaging of In-111-labeled 3-arm and 4-arm DOTA-alpha-MSH were obtained using B16-F1 melanoma-bearing mice. Results Specific activities and radiolabeling efficiencies of both radiotracers were about 1.2 MBq/nM and 90-95%, respectively. The partition coefficients were -0.28 +/- 0.03 for In-111-labeled 3-arm DOTA-alpha-MSH and -0.13 +/- 0.04 for 111 In-labeled 4-arm DOTA-alpha-MSH. Although accumulation was significantly inhibited by alpha-MSH in B16-F1 cells, the inhibition rate of In-111-labeled 4-arm DOTA-alpha-MSH was lower than that of In-111-labeled 3-arm DOTA-alpha-MSH. In-111-labeled 4-arm DOTA-alpha-MSH was taken up early into B16-F1 cells and showed higher accumulation than In-111-labeled 3-arm DOTA-alpha-MSH after 10 min of incubation. Although these stabilities were relatively high, the stability of In-111-labeled 4-arm DOTA-alpha-MSH was higher than that of In-111-labeled 3-arm DOTA-alpha-MSH. Regarding biological distribution, In-111-labeled 4-arm DOTA-alpha-MSH showed significantly lower average renal accumulation (1.38-fold) and significantly higher average melanoma accumulation (1.32-fold) than In-111-labeled 3-arm DOTA-alpha-MSH at all acquisition times. In-111-labeled 4-arm DOTA-alpha-MSH showed significantly higher melanoma-to-kidney, melanoma-to-blood, and melanoma-to-muscle ratios than In-111-labeled 3-arm DOTA-alpha-MSH. Conclusions The 4-arm DOTA construct has better chemical properties for peptide radiotracers than the 3-arm DOTA construct.	[Kobayashi, Masato] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa, Japan; [Kobayashi, Masato; Kato, Toshitaka; Washiyama, Kohshin; Ihara, Masaaki; Mizutani, Asuka; Kawai, Keiichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Hlth Sci, Kanazawa, Ishikawa, Japan; [Washiyama, Kohshin] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Adv Clin Res Ctr, Fukushima, Japan; [Nishi, Kodai] Nagasaki Univ, Atom Bomb Dis Inst, Dept Radioisotope Med, Nagasaki, Japan; [Flores, Leo G.] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Nishii, Ryuichi] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba, Japan; [Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui, Japan	Kanazawa University; Kanazawa University; Fukushima Medical University; Nagasaki University; University of Texas System; UTMD Anderson Cancer Center; National Institutes for Quantum Science & Technology; University of Fukui	Kobayashi, M (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa, Japan.; Kobayashi, M (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Hlth Sci, Kanazawa, Ishikawa, Japan.	kobayasi@mhs.mp.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [15K09949, 16KK0020, 15K15452]; Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Nagasaki University; Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Fukushima Medical University; Nakatani Foundation for measuring technologies in biomedical engineering	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Nagasaki University; Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Fukushima Medical University; Nakatani Foundation for measuring technologies in biomedical engineering	This study was partly funded by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 15K09949 and 16KK0020 for Masato Kobayashi and 15K15452 for Keiichi Kawai), the Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and Fukushima Medical University, and the Nakatani Foundation for measuring technologies in biomedical engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, WHAT AR KEY STAT MEL; Behr TM, 1998, EUR J NUCL MED, V25, P201, DOI 10.1007/s002590050216; Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Froidevaux S, 2005, J NUCL MED, V46, P887; GHANEM GE, 1988, INT J CANCER, V41, P248, DOI 10.1002/ijc.2910410216; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; KannengieRer S, 2013, OPTIMIZATION SYNTHES, P229; KAWAI K, 1991, J NUCL MED, V32, P819; Kobayashi M, 2015, NUCL MED BIOL, V42, P536, DOI 10.1016/j.nucmedbio.2015.02.004; LERNER AB, 1961, NATURE, V189, P176, DOI 10.1038/189176a0; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lopez MN, 2007, INVEST OPHTH VIS SCI, V48, P1219, DOI 10.1167/iovs.06-0090; Maguire WF, 2014, J NUCL MED, V55, P1492, DOI 10.2967/jnumed.114.138347; Popp I, 2017, NUCL MED BIOL, V45, P22, DOI 10.1016/j.nucmedbio.2016.11.004; Price EW, 2014, CHEM SOC REV, V43, P260, DOI 10.1039/c3cs60304k; Pujatti PB, 2015, APPL RADIAT ISOTOPES, V96, P91, DOI 10.1016/j.apradiso.2014.11.006; Quinn T, 2010, GIORN ITAL DERMAT V, V145, P245; Roosenburg S, 2014, MOL PHARMACEUT, V11, P3930, DOI 10.1021/mp500283k; Salazar-Onfray F, 2002, BRIT J CANCER, V87, P414, DOI 10.1038/sj.bjc.6600441; SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754; SAWYER TK, 1990, PEPTIDES, V11, P351, DOI 10.1016/0196-9781(90)90092-J; Schioth HB, 1997, NEUROPEPTIDES, V31, P565, DOI 10.1016/S0143-4179(97)90002-0; Slastnikova TA, 2017, INT J NANOMED, V12, P395, DOI 10.2147/IJN.S125359; Wadas TJ, 2010, CHEM REV, V110, P2858, DOI 10.1021/cr900325h; Zhang C, 2017, APPL SPECTROSC, V71, P1717, DOI 10.1177/0003702817708321	25	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213397	10.1371/journal.pone.0213397	http://dx.doi.org/10.1371/journal.pone.0213397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901323	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400007
J	Koivuniemi, M; Kurkilahti, M; Niemi, M; Auttila, M; Kunnasranta, M				Koivuniemi, Meeri; Kurkilahti, Mika; Niemi, Marja; Auttila, Miina; Kunnasranta, Mervi			A mark-recapture approach for estimating population size of the endangered ringed seal (Phoca hispida saimensis)	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; CAPTURE-RECAPTURE; ABUNDANCE; SAIMAA; PHOTOIDENTIFICATION; SURVIVAL; IDENTIFICATION; CLIMATE	Reliable population estimates are fundamental to the conservation of endangered species. We evaluate here the use of photo-identification (photo-ID) and mark-recapture techniques for estimating the population size of the endangered Saimaa ringed seal (Phoca hispida saimensis). Photo-ID data based on the unique pelage patterns of individuals were collected by means of camera traps and boat-based surveys during the molting season in two of the species' main breeding areas, over a period of five years in the Pihlajavesi basin and eight years in the Haukivesi basin. An open model approach provided minimum population estimates for these two basins. The results indicated high survival rates and site fidelity among the adult seals. More accurate estimates can be obtained in the future by increasing the surveying effort both spatially and temporally. The method presented here proved effective for evaluating population size objectively, whereas the results of the current snow lair censuses are dependent on varying winter conditions, for instance. We therefore suggest that a photo-ID-based non-invasive mark-recapture method should be used for estimating Saimaa ringed seal abundances in order to ensure reliable, transparent population monitoring under changing climatic conditions.	[Koivuniemi, Meeri; Niemi, Marja; Kunnasranta, Mervi] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Kurkilahti, Mika] Nat Resources Inst Finland, Turku, Finland; [Auttila, Miina] Pk & Wildlife Finland, Metsahallitus, Savonlinna, Finland; [Kunnasranta, Mervi] Nat Resources Inst Finland, Joensuu, Finland	University of Eastern Finland; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Koivuniemi, M (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.	meeri.koivuniemi@uef.fi			WWF Finland [2421/02.07.02./2010]; Raija and Ossi Tuuliainen Foundation [2485/02.07.02/2010]; Elma, Eino and Veikko Jumppanen foundation [13.6.2014]	WWF Finland; Raija and Ossi Tuuliainen Foundation; Elma, Eino and Veikko Jumppanen foundation	This study was financially supported by WWF Finland (https://wwf.fi/en/, #2421/02.07.02./2010 to Mkun), Raija and Ossi Tuuliainen Foundation (http://www.tuuliaisensaatio.fi/, #2485/02.07.02/2010 to Mkun), Elma, Eino and Veikko Jumppanen foundation (13.6.2014 to MKun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062636; [Anonymous], 2015, PROGRAM MARK GENTLE; Auttila M., 2015, THESIS U E FINLAND J; Auttila M, 2014, ANN ZOOL FENN, V51, P526, DOI 10.5735/086.051.0601; Best P.B., 1990, Reports of the International Whaling Commission Special Issue, P183; Brown AM, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00004; Burnham KP, 2002, MODEL SELECTION MULT, P66; BURNS JJ, 1972, ARCTIC, V25, P280; CALAMBOKIDIS J, 1990, REP INT WHAL COMM SP, V12, P325; Canu A, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00355; Carroll EL, 2011, MAR BIOL, V158, P2565, DOI 10.1007/s00227-011-1757-9; Chan SCY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174029; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cordes LS, 2015, POPUL ECOL, V57, P467, DOI 10.1007/s10144-015-0496-z; Cunningham Louise, 2009, Aquatic Mammals, V35, P319, DOI 10.1578/AM.35.3.2009.319; Felix Fernando, 2011, Journal of Cetacean Research and Management, P301; Forcada J, 2000, MAR MAMMAL SCI, V16, P767, DOI 10.1111/j.1748-7692.2000.tb00971.x; Forcada J, 2006, POLAR BIOL, V29, P1052, DOI 10.1007/s00300-006-0149-y; Gailey G, 2012, DISCOVERY PHOTOIDENT; Gerondeau M, 2007, J MAR BIOL ASSOC UK, V87, P365, DOI 10.1017/S0025315407054586; Harkonen Tero, 1998, NAMMCO Scientific Publications, V1, P167; Hastings KK, 2012, J MAMMAL, V93, P1368, DOI 10.1644/11-MAMM-A-291.1; Helle E, 1984, ACTA ZOOL FENN, V72, P125; HIBY L, 1987, WILDLIFE SOC B, V15, P438; Hiby L., 2007, NAMMCO SCI PUBL, V6, P163, DOI [10.7557/3.2731, DOI 10.7557/3.2731]; HYVARINEN H, 1995, MAR MAMMAL SCI, V11, P324, DOI 10.1111/j.1748-7692.1995.tb00288.x; Hyvarinen H., 1999, SAIMAA LIVING LAKE, P126; Jounela P, 2019, ENDANG SPECIES RES; Jylha K, 2004, BOREAL ENVIRON RES, V9, P127; Kelly BP, 2001, FINGERPRINTS OF CLIMATE CHANGE, P43; Kivinen S, 2017, CLIMATE, V5, DOI 10.3390/cli5010016; Koivuniemi M, 2016, ENDANGER SPECIES RES, V30, P29, DOI 10.3354/esr00723; Kokko H, 1999, ANN ZOOL FENN, V36, P65; Kokko H, 1998, ANIM CONSERV, V1, P47, DOI 10.1111/j.1469-1795.1998.tb00225.x; Koskelal JT, 2002, ANN ZOOL FENN, V39, P59; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kuningas S, 2014, J MAR BIOL ASSOC UK, V94, P1277, DOI 10.1017/S0025315413000933; Kunnasranta M, 2001, THESIS; Kunnasranta Mervi, 2016, Suomen Riista, V62, P71; Kuusisto E., 1999, SAIMAA LIVING LAKE P, P21; Laake J, 2018, PROGRAM MARK GENTLE, P1; Laake JL, 2013, RMARK R INTERFACE AN; Lunn NJ, 1997, CAN J FISH AQUAT SCI, V54, P914, DOI 10.1139/cjfas-54-4-914; MacKenzie DI, 2012, DESIGN ANAL LONG TER, P406; Martinho F, 2015, MAR BIOL RES, V11, P144, DOI 10.1080/17451000.2014.894244; Metsahallitus Parks & Wildlife Finland, 2017, SAIM NORPP; Niemi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210266; Niemi M, 2013, ENDANGER SPECIES RES, V22, P115, DOI 10.3354/esr00541; Niemi M, 2013, MAR MAMMAL SCI, V29, P1, DOI 10.1111/j.1748-7692.2011.00521.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pollock KH, 1990, WILD MONOGR, V6, P288; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032666; R Core Team, 2018, R LANG ENV STAT COMP; Raisanen J, 2012, CLIM DYNAM, V38, P2575, DOI 10.1007/s00382-011-1076-3; Ratamaki O, 2015, EUR COUNTRYS, V7, P1, DOI 10.1515/euco-2015-0001; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SCHWARZ CJ, 2019, PROGRAM MARK GENTLE; Sipila T., 1990, Finnish Game Research, V47, P3; Sipila T, 2003, THESIS U HELSINKI; Speakman Todd R., 2010, Journal of Cetacean Research and Management, V11, P153; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; THOMPSON PM, 1990, J APPL ECOL, V27, P924, DOI 10.2307/2404387; Valtonen M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-22; Valtonen M, 2012, CONSERV GENET, V13, P1231, DOI 10.1007/s10592-012-0367-5; Velli E, 2015, EUR J WILDLIFE RES, V61, P657, DOI 10.1007/s10344-015-0936-2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Zheng X, 2016, J ZOOL, V300, P247, DOI 10.1111/jzo.12377	70	12	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214269	10.1371/journal.pone.0214269	http://dx.doi.org/10.1371/journal.pone.0214269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901354	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400047
J	Cardil, A; Otsu, K; Pla, M; Silva, CA; Brotons, L				Cardil, Adrian; Otsu, Kaori; Pla, Magda; Silva, Carlos Alberto; Brotons, Lluis			Quantifying pine processionary moth defoliation in a pine-oak mixed forest using unmanned aerial systems and multispectral imagery	PLOS ONE			English	Article							CATERPILLAR THAUMETOPOEA-PITYOCAMPA; SCOTS PINE; TREE DIVERSITY; LAND ABANDONMENT; CLIMATE-CHANGE; BEETLE DAMAGE; UAV; CLASSIFICATION; LEPIDOPTERA; RESISTANCE	Pine processionary moth (PPM) feeds on conifer foliage and periodically result in outbreaks leading to large scale defoliation, causing decreased tree growth, vitality and tree reproduction capacity. Multispectral high-resolution imagery acquired from a UAS platform was successfully used to assess pest tree damage at the tree level in a pine-oak mixed forest. We generated point clouds and multispectral orthomosaics from UAS through photogrammetric processes. These were used to automatically delineate individual tree crowns and calculate vegetation indices such as the normalized difference vegetation index (NDVI) and excess green index (ExG) to objectively quantify defoliation of trees previously identified. Overall, our research suggests that UAS imagery and its derived products enable robust estimation of tree crowns with acceptable accuracy and the assessment of tree defoliation by classifying trees along a gradient from completely defoliated to non-defoliated automatically with 81.8% overall accuracy. The promising results presented in this work should inspire further research and applications involving a combination of methods allowing the scaling up of the results on multispectral imagery by integrating satellite remote sensing information in the assessments over large spatial scales.	[Cardil, Adrian] Univ Lleida, Sch Agrifood & Forestry Sci & Engn, Lleida, Spain; [Cardil, Adrian] Tecnosylva SL, Parque Tecnol Leon, Leon, Spain; [Otsu, Kaori; Brotons, Lluis] CREAF, Cerdanyola Del Valles, Spain; [Pla, Magda; Brotons, Lluis] CTFC CREAF Solsona, InForest Joint Res Unit, Solsona, Spain; [Silva, Carlos Alberto] NASA, Goddard Space Flight Ctr, Biospher Sci Lab, Greenbelt, MD USA; [Silva, Carlos Alberto] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Brotons, Lluis] CSIC, Cerdanyola Del Valles, Spain	Universitat de Lleida; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Consejo Superior de Investigaciones Cientificas (CSIC)	Cardil, A (corresponding author), Univ Lleida, Sch Agrifood & Forestry Sci & Engn, Lleida, Spain.; Cardil, A (corresponding author), Tecnosylva SL, Parque Tecnol Leon, Leon, Spain.; Brotons, L (corresponding author), CREAF, Cerdanyola Del Valles, Spain.; Brotons, L (corresponding author), CTFC CREAF Solsona, InForest Joint Res Unit, Solsona, Spain.; Brotons, L (corresponding author), CSIC, Cerdanyola Del Valles, Spain.	adriancardil@gmail.com; Iluis.brotons@ctfc.cat	Pla, Magda/M-4425-2014; Forradellas, Adrián/T-9461-2019; Cardil Forradellas, Adrian/O-7993-2015	Otsu, Kaori/0000-0001-7835-0949; Pla, Magda/0000-0002-7060-6783; Cardil Forradellas, Adrian/0000-0002-0185-3959; Silva, Carlos Alberto/0000-0002-7844-3560	Programa Torres Quevedo, Ministerio de Ciencia, Innovacion y Universidades (Spain) [PTQ-15-07588]	Programa Torres Quevedo, Ministerio de Ciencia, Innovacion y Universidades (Spain)	Funded by AC, Programa Torres Quevedo, (Ref. PTQ-15-07588), Ministerio de Ciencia, Innovacion y Universidades (Spain), https://sede.micinn.gob.es/portal/site/eSede/menuitem.df29f2378d5d10a0cee63510223041a0? vgnextoid-e7ac1339c3f03410VgnVCM1000001d04140aRCRD&&lang_choosen=en LB, Parrot Innovation Grant. The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Tecnosylva, S.L. provided support in the form of salaries for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaldo PS, 2010, IFOREST, V3, P159, DOI 10.3832/ifor0553-003; AURENHAMMER F, 1991, COMPUT SURV, V23, P345, DOI 10.1145/116873.116880; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Battisti A, 2008, IFOREST, V1, P1, DOI 10.3832/ifor0210-0010001; Battisti A., 2015, PROCESSIONARY MOTHS, P15, DOI DOI 10.1007/978-94-017-9340-7_2; Berryman, 2002, POPULATION CYCLES CA, DOI 10.1093/oso/9780195140989.001.0001; Cardil A, 2015, THEOR APPL CLIMATOL, V122, P219, DOI 10.1007/s00704-014-1295-8; Cardil A, 2014, NAT HAZARD EARTH SYS, V14, P3005, DOI 10.5194/nhess-14-3005-2014; Cardil A, 2017, FORESTS, V8, DOI 10.3390/f8100402; Cayuela L, 2014, FOREST ECOL MANAG, V328, P319, DOI 10.1016/j.foreco.2014.05.051; Cayuela L, 2011, FOREST ECOL MANAG, V261, P1732, DOI 10.1016/j.foreco.2011.01.022; Dandois JP, 2013, REMOTE SENS ENVIRON, V136, P259, DOI 10.1016/j.rse.2013.04.005; Dash JP, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10081216; Dash JP, 2017, ISPRS J PHOTOGRAMM, V131, P1, DOI 10.1016/j.isprsjprs.2017.07.007; de Dios VR, 2007, NEW FOREST, V33, P29, DOI 10.1007/s11056-006-9011-x; Dennison PE, 2009, REMOTE SENS ENVIRON, V113, P1462, DOI 10.1016/j.rse.2008.05.022; Deshayes M, 2006, CONTRIBUTION REMOTE; Eklundh L, 2009, REMOTE SENS ENVIRON, V113, P1566, DOI 10.1016/j.rse.2009.03.008; Feng QL, 2015, REMOTE SENS-BASEL, V7, P1074, DOI 10.3390/rs70101074; Filho WL, 2017, INT J SUST DEV WORLD, V24, P554, DOI 10.1080/13504509.2016.1240113; Gini R, 2014, EUR J REMOTE SENS, V47, P251, DOI 10.5721/EuJRS20144716; Guyot V, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1037; Haase J, 2015, OIKOS, V124, P1674, DOI 10.1111/oik.02090; Hodar JA, 2004, ACTA OECOL, V26, P203, DOI 10.1016/j.actao.2004.05.004; Hodar JA, 2003, BIOL CONSERV, V110, P123, DOI 10.1016/S0006-3207(02)00183-0; Hung C, 2014, REMOTE SENS-BASEL, V6, P12037, DOI 10.3390/rs61212037; Isenburg M., 2015, LASTOOLS; Jaafar WSWM, 2018, FORESTS, V9, DOI 10.3390/f9120759; Jactel H, 2006, FOREST ECOL MANAG, V235, P96, DOI 10.1016/j.foreco.2006.08.002; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Kanat M, 2005, ANN FOREST SCI, V62, P91, DOI 10.1051/forest:2004095; Kantola T, 2013, FORESTS, V4, P386, DOI 10.3390/f4020386; Kattenborn T., 2014, INT ARCH PHOTOGRAMME, V40, P139, DOI [DOI 10.5194/ISPRSARCHIVES-XL-3-139-2014, 10.5194/isprsarchives-XL-3-139-2014]; Kraus K, 1998, ISPRS J PHOTOGRAMM, V53, P193, DOI 10.1016/S0924-2716(98)00009-4; Lasanta T, 2017, CATENA, V149, P810, DOI 10.1016/j.catena.2016.02.024; Lehmann JRK, 2015, FORESTS, V6, P594, DOI 10.3390/f6030594; Lisein J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141006; Lottes Philipp, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P3024, DOI 10.1109/ICRA.2017.7989347; Lucieer A, 2014, INT J APPL EARTH OBS, V27, P53, DOI 10.1016/j.jag.2013.05.011; Fernandez-Guisuraga JM, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020586; Michez A, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-4996-2; Mohan M, 2017, FORESTS, V8, DOI 10.3390/f8090340; Moore B, 2008, FBS34E; Nasi R, 2015, REMOTE SENS-BASEL, V7, P15467, DOI 10.3390/rs71115467; Ortiz SM, 2013, REMOTE SENS-BASEL, V5, P1912, DOI 10.3390/rs5041912; Puliti S, 2017, REMOTE SENS ENVIRON, V194, P115, DOI 10.1016/j.rse.2017.03.019; Puliti S, 2015, REMOTE SENS-BASEL, V7, P9632, DOI 10.3390/rs70809632; Robinet C, 2014, ANN FOREST SCI, V71, P149, DOI 10.1007/s13595-013-0287-7; Rullan-Silva CD, 2013, FOREST SYST, V22, P377, DOI 10.5424/fs/2013223-04417; Sanguesa-Barreda G, 2014, FOREST ECOL MANAG, V320, P171, DOI 10.1016/j.foreco.2014.03.008; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Silva C.A., 2017, RLIDAR R PACKAGE REA; Solberg S, 2010, INT J REMOTE SENS, V31, P1227, DOI 10.1080/01431160903380672; Sperlich M., 2014, GEM TAG, V23, P1; Tamburini G, 2013, CLIMATIC CHANGE, V121, P701, DOI 10.1007/s10584-013-0966-2; Tian JY, 2017, INT J APPL EARTH OBS, V61, P22, DOI 10.1016/j.jag.2017.05.002; Torres-Sanchez J, 2015, COMPUT ELECTRON AGR, V114, P43, DOI 10.1016/j.compag.2015.03.019; Torresan C, 2017, INT J REMOTE SENS, V38, P2427, DOI 10.1080/01431161.2016.1252477; Townsend PA, 2012, REMOTE SENS ENVIRON, V119, P255, DOI 10.1016/j.rse.2011.12.023; Wang J., 2010, OPEN GEOGRAPHY J, V3, P28, DOI [10.2174/1874923201003010028, DOI 10.2174/1874923201003010028]; Whitehead K, 2014, J UNMANNED VEH SYST, V2, P69, DOI 10.1139/juvs-2014-0006; Wulder MA, 2006, FOREST ECOL MANAG, V221, P27, DOI 10.1016/j.foreco.2005.09.021; Zhang J, 2016, BIOL CONSERV, V198, P60, DOI 10.1016/j.biocon.2016.03.027; Zhen Z, 2016, INT GEOSCI REMOTE SE, P3186, DOI 10.1109/IGARSS.2016.7729824	64	27	28	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213027	10.1371/journal.pone.0213027	http://dx.doi.org/10.1371/journal.pone.0213027			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889176	gold, Green Published, Green Submitted			2022-12-26	WOS:000461573000013
J	Yannai, S; Zonszain, J; Donyo, M; Ast, G				Yannai, Sivan; Zonszain, Jonathan; Donyo, Maya; Ast, Gil			Combinatorial treatment increases IKAP levels in human cells generated from Familial Dysautonomia patients	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DOPAMINERGIC STABILIZERS PRIDOPIDINE; 5' SPLICE-SITE; MESSENGER-RNA; SIGMA-1 RECEPTORS; IKBKAP GENE; ELONGATOR; TRANSCRIPTION; IMPAIRMENT; EXPRESSION	Familial Dysautonomia (FD) is an autosomal recessive congenital neuropathy that results from a point mutation at the 5' splice site of intron 20 in the IKBKAP gene. This mutation decreases production of the IKAP protein, and treatments that increase the level of the full-length IKBKAPtranscript are likely to be of therapeutic value. We previously found that phosphatidylserine (PS), an FDA-approved food supplement, elevates IKAP levels in cells generated from FD patients. Here we demonstrate that combined treatment of cells generated from FD patients with PS and kinetin or PS and the histone deacetylase inhibitor trichostatin A (TSA) resulted in an additive elevation of IKAP compared to each drug alone. This indicates that the compounds influence different pathways. We also found that pridopidine enhances production of IKAP in cells generated from FD patients. Pridopidine has an additive effect on IKAP levels when used in combination with kinetin or TSA, but not with PS; suggesting that PS and pridopidine influence IKBKAP levels through the same mechanism. Indeed, we demonstrate that the effect of PS and pridopidine is through sigma-1 receptor-mediated activation of the BDNF signaling pathway. A combination treatment with any of these drugs with different mechanisms has potential to benefit FD patients.	[Yannai, Sivan; Zonszain, Jonathan; Donyo, Maya; Ast, Gil] Tel Aviv Univ, Dept Human Mol Genet & Biochemestry, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Ast, G (corresponding author), Tel Aviv Univ, Dept Human Mol Genet & Biochemestry, Sackler Fac Med, Tel Aviv, Israel.	gilast@post.tau.ac.il			Israel Science Foundation (ISF) [142/13, 1439/14]; Teva Pharmaceutical Industries Ltd. [590531]; Dysautonomia Foundation; Teva Pharmaceutical Industries Ltd. under the Israeli National Network of Excellence in Neuroscience [1326239]	Israel Science Foundation (ISF)(Israel Science Foundation); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Dysautonomia Foundation; Teva Pharmaceutical Industries Ltd. under the Israeli National Network of Excellence in Neuroscience	Funding for this work was provided by grants from the Israel Science Foundation (ISF) [142/13,1439/14], Teva Pharmaceutical Industries Ltd. [590531], and the Dysautonomia Foundation. SY was supported by grants from Teva Pharmaceutical Industries Ltd. under the Israeli National Network of Excellence in Neuroscience [1326239]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abashidze A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113428; Al-Keilani MS, 2018, CLIN PHARMACOL-ADV A, V10, P135, DOI 10.2147/CPAA.S174074; Anderson SL, 2005, BIOCHEM BIOPH RES CO, V336, P150, DOI 10.1016/j.bbrc.2005.08.054; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V310, P627, DOI 10.1016/j.bbrc.2003.09.019; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bochner R, 2013, HUM MOL GENET, V22, P2785, DOI 10.1093/hmg/ddt126; Bolden JE, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.9; Bruun GH, 2018, NUCLEIC ACIDS RES, V46, P7938, DOI 10.1093/nar/gky395; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Cheishvili D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094612; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dietrich P, 2016, GENET MOL BIOL; Donadon I, 2018, HUM MOL GENET, V27, P2466, DOI 10.1093/hmg/ddy151; Donyo M, 2016, HUM MOL GENET; Dyhring T, 2010, EUR J PHARMACOL, V628, P19, DOI 10.1016/j.ejphar.2009.11.025; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Geva M, 2016, HUM MOL GENET, V25, P3975, DOI 10.1093/hmg/ddw238; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Hunnicutt BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032050; Jackson MZ, 2014, DEVELOPMENT, V141, P2452, DOI 10.1242/dev.107797; Karlsborn T, 2014, BIOCHEM BIOPH RES CO, V454, P441, DOI 10.1016/j.bbrc.2014.10.116; Kasemeier-Kulesa JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9281; Keren H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015884; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Lefcort F, 2017, CLIN AUTON RES, V27, P235, DOI 10.1007/s10286-017-0438-2; Lehavi O, 2003, GENET TEST, V7, P139, DOI 10.1089/109065703322146830; Nguyen L, 2015, J PHARMACOL SCI, V127, P17, DOI 10.1016/j.jphs.2014.12.005; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Naftelberg S, 2017, NEURAL REGEN RES, V12, P534, DOI 10.4103/1673-5374.205082; Naftelberg S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006486; Nguyen L, 2017, ADV EXP MED BIOL, V964, P133, DOI 10.1007/978-3-319-50174-1_10; Nguyen L, 2014, EUR J PHARMACOL, V743, P42, DOI 10.1016/j.ejphar.2014.09.022; Norcliffe-Kaufmann L, 2017, PROG NEUROBIOL, V152, P131, DOI 10.1016/j.pneurobio.2016.06.003; Ohe K, 2017, RNA, V23, P1393, DOI 10.1261/rna.059428.116; Puppin C, 2011, ONCOL REP, V25, P393, DOI 10.3892/or.2010.1075; Ryskamp D, 2017, NEUROBIOL DIS, V97, P46, DOI 10.1016/j.nbd.2016.10.006; Salani M, 2018, SLAS DISCOV; Salani M, 2013, PHOSPHATIDYLSERINE P; Sasi M, 2017, PFLUG ARCH EUR J PHY, V469, P593, DOI 10.1007/s00424-017-1964-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simson GG, 2009, PEDIATR RES, V65, P341, DOI 10.1203/PDR.0b013e318194fd52; Sinha R, 2018, NUCLEIC ACIDS RES, V46, P4833, DOI 10.1093/nar/gky249; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2002, CURR OPIN GENET DEV, V12, P307, DOI 10.1016/S0959-437X(02)00303-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; WALKER JM, 1990, PHARMACOL REV, V42, P355; Waters S, 2014, J NEURAL TRANSM, V121, P1337, DOI 10.1007/s00702-014-1231-1; Xu H, 2015, P NATL ACAD SCI US; Xu Q, 2015, PSYCHOPHARMACOLOGY, V232, P1779, DOI 10.1007/s00213-014-3809-6; Yoshida M, 2015, P NATL ACAD SCI USA, V112, P2764, DOI 10.1073/pnas.1415525112; Zhang QC, 2012, ASIAN PAC J CANCER P, V13, P3471, DOI 10.7314/APJCP.2012.13.7.3471	66	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0211602	10.1371/journal.pone.0211602	http://dx.doi.org/10.1371/journal.pone.0211602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889183	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000004
J	Prabhakar, SM; Tagami, T; Liu, N; Samsudin, MI; Ng, JCJ; Koh, ZX; Ong, MEH				Prabhakar, Sumanth Madhusudan; Tagami, Takashi; Liu, Nan; Samsudin, Mas'uud Ibnu; Ng, Janson Cheng Ji; Koh, Zhi Xiong; Ong, Marcus Eng Hock			Combining quick sequential organ failure assessment score with heart rate variability may improve predictive ability for mortality in septic patients at the emergency department	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; IN-HOSPITAL MORTALITY; EARLY WARNING SCORES; NONLINEAR DYNAMICS; SEPSIS; DETERIORATION; CRITERIA; SHOCK	Background Although the quick Sequential Organ Failure Assessment (qSOFA) score was recently introduced to identify patients with suspected infection/sepsis, it has limitations as a predictive tool for adverse outcomes. We hypothesized that combining qSOFA score with heart rate variability (HRV) variables improves predictive ability for mortality in septic patients at the emergency department (ED). Methods This was a retrospective study using the electronic medical record of a tertiary care hospital in Singapore between September 2014 and February 2017. All patients aged 21 years or older who were suspected with infection/sepsis in the ED and received electrocardiography monitoring with ZOLL X Series Monitor (ZOLL Medical Corporation, Chelmsford, MA) were included. We fitted a logistic regression model to predict the 30-day mortality using one of the HRV variables selected from one of each three domains those previously reported as strong association with mortality (i.e. standard deviation of NN [SDNN], ratio of low frequency to high frequency power [LF/HF], detrended fluctuation analysis alpha-2 [DFA alpha-2]) in addition to the qSOFA score. The predictive accuracy was assessed with other scoring systems (i.e. qSOFA alone, National Early Warning Score, and Modified Early Warning Score) using the area under the receiver operating characteristic curve. Results A total of 343 septic patients were included. Non-survivors were significantly older (survivors vs. non-survivors, 65.7 vs. 72.9, p < 0.01) and had higher qSOFA (0.8 vs. 1.4, p < 0.01) as compared to survivors. There were significant differences in HRV variables between survivors and non-survivors including SDNN (23.7s vs. 31.8s, p = 0.02), LF/HF (2.8 vs. 1.5, p = 0.02), DFA alpha-2 (1.0 vs. 0.7, P < 0.01). Our prediction model using DFA-alpha-2 had the highest c-statistic of 0.76 (95% CI, 0.70 to 0.82), followed by qSOFA of 0.68 (95% CI, 0.62 to 0.75), National Early Warning Score at 0.67 (95% CI, 0.61 to 0.74), and Modified Early Warning Score at 0.59 (95% CI, 0.53 to 0.67). Conclusions Adding DFA-alpha-2 to the qSOFA score may improve the accuracy of predicting in-hospital mortality in septic patients who present to the ED. Further multicenter prospective studies are required to confirm our results.	[Prabhakar, Sumanth Madhusudan] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Tagami, Takashi; Liu, Nan; Ong, Marcus Eng Hock] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [Tagami, Takashi] Tama Nagayama Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan; [Liu, Nan] Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore; [Samsudin, Mas'uud Ibnu] Duke NUS Med Sch, Singapore, Singapore; [Ng, Janson Cheng Ji; Koh, Zhi Xiong; Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore, Singapore	National University of Singapore; National University of Singapore; Nippon Medical School; National University of Singapore; Singapore General Hospital	Tagami, T; Liu, N (corresponding author), Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore.; Tagami, T (corresponding author), Tama Nagayama Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan.; Liu, N (corresponding author), Singapore Hlth Serv, Hlth Serv Res Ctr, Singapore, Singapore.	t-tagami@nms.ac.jp; liu.nan@singhealth.com.sg	Tagami, Takashi/HGA-3038-2022; Liu, Nan/HCS-2632-2022	Tagami, Takashi/0000-0001-6953-1932; Liu, Nan/0000-0003-3610-4883				Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Araujo F, 2006, INT J CARDIOL, V107, P333, DOI 10.1016/j.ijcard.2005.03.044; Aronson D, 2001, J CARDIOVASC ELECTR, V12, P294, DOI 10.1046/j.1540-8167.2001.00294.x; Barnaby D, 2002, ACAD EMERG MED, V9, P661, DOI 10.1111/j.1553-2712.2002.tb02143.x; Barnaby DP, 2019, SHOCK, V51, P416, DOI 10.1097/SHK.0000000000001192; Barnaby DP, 2018, EMERG MED J, V35, P96, DOI 10.1136/emermed-2017-206625; Chen WL, 2008, AM J EMERG MED, V26, P395, DOI 10.1016/j.ajem.2007.06.016; Chen WL, 2007, ACAD EMERG MED, V14, P392, DOI 10.1197/j.aem.2006.12.015; CHIALVO DR, 1987, NATURE, V330, P749, DOI 10.1038/330749a0; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Corfield AR, 2014, EMERG MED J, V31, P482, DOI 10.1136/emermed-2012-202186; de Castilho FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180060; Ernst G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00240; Freund Y, 2017, JAMA-J AM MED ASSOC, V317, P301, DOI 10.1001/jama.2016.20329; Goulden R, 2018, EMERG MED J, V35, P345, DOI 10.1136/emermed-2017-207120; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Hamilton F, 2018, J INFECTION, V76, P241, DOI 10.1016/j.jinf.2018.01.002; Heldeweg MLA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1367-5; Huang CT, 2014, CRIT CARE, V18, DOI 10.1186/cc13705; Keppler U, 2018, ANAESTHESIST, V67, P647, DOI 10.1007/s00101-018-0465-y; Kon H, 2006, INT HEART J, V47, P867, DOI 10.1536/ihj.47.867; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Krogh-Madsen T, 2012, ANNU REV BIOMED ENG, V14, P179, DOI [10.1146/annurev-bioeng-071811-150106, 10.1146/annurev.bioeng-071811-150106]; Levy MM, 2018, INTENS CARE MED, V44, P925, DOI 10.1007/s00134-018-5085-0; Liu VX, 2016, AM J RESP CRIT CARE, V193, P1264, DOI 10.1164/rccm.201507-1489OC; Maitra S, 2018, CLIN MICROBIOL INFEC, V24, P1123, DOI 10.1016/j.cmi.2018.03.032; Malave HA, 2003, CHEST, V123, P716, DOI 10.1378/chest.123.3.716; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Ong MEH, 2012, CRIT CARE, V16, DOI 10.1186/cc11396; Quinten VM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018259; Rodriguez RM, 2018, EMERG MED J, V35, P350, DOI 10.1136/emermed-2017-207383; Rudd KE, 2018, JAMA-J AM MED ASSOC, V319, P2202, DOI 10.1001/jama.2018.6229; Samsudin MI, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010866; Serafim R, 2018, CHEST, V153, P646, DOI 10.1016/j.chest.2017.12.015; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Song JU, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1952-x; Straburzynska-Migaj E, 2005, KARDIOL POL, V63, P486; Straburzynska-Migaj Ewa, 2005, Kardiol Pol, V63, P478; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521	41	12	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213445	10.1371/journal.pone.0213445	http://dx.doi.org/10.1371/journal.pone.0213445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883595	Green Submitted, gold, Green Published			2022-12-26	WOS:000461423500017
J	Sumi, A; Kobayashi, N				Sumi, Ayako; Kobayashi, Nobumichi			Time-series analysis of geographically specific monthly number of newly registered cases of active tuberculosis in Japan	PLOS ONE			English	Article							VITAMIN-D; SEASONALITY	Background Understanding seasonality of tuberculosis (TB) epidemics may lead to identify potentially modifiable risk factors. Studies conducted outside Japan have found seasonal variation among reported TB cases, with peaks in spring and summer and low prevalence in fall and winter. One hypothesis regarding spring or summer peaks in TB epidemics is that TB transmission likely increases in winter because of indoor crowding and poor ventilation, with development of primary TB among socially vulnerable people in spring and summer. Another plausible explanation is that vitamin D deficiency in winter depresses immunity, increasing the TB reactivation risk in these seasons. Previous studies suggest latitude-dependent factors, including reduced winter sunlight and its effect on vitamin D levels. Here, we investigated mechanisms of seasonality in TB epidemics in Japan, according to the effects of crowding and latitude. Methods We used time-series analysis consisting of spectral analysis and least-squares method, to analyse geographically specific monthly number of newly registered cases of all forms of active TB in all 47 prefectures of Japan during 1998-2015. Results In all power spectral densities for the 47 prefectures, spectral lines were observed at frequency positions corresponding to a 1-year cycle. The degree of this seasonality was associated with population density. We did not detect greater amplitude of seasonality at higher latitudes, suggesting that latitude-dependent factors, including reduced winter sunlight and its potential effect on vitamin D levels, do not contribute significantly to seasonality in Japan. Discussion and conclusion In districts with high population density, measures are needed to address two specific types of active infection risk in adolescents and middle-aged adults: (i) public transport use, and (ii) irregular employment with no periodic medical examinations. To control active TB epidemics, investigating periodic structures in the temporal patterns of active TB in each district and each age group is important.	[Sumi, Ayako; Kobayashi, Nobumichi] Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan	Sapporo Medical University	Sumi, A (corresponding author), Sapporo Med Univ, Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan.	sumi@sapmed.ac.jp			Japan Society for the Promotion of Science [JP16K09061, JP17H04664]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by the Japan Society for the Promotion of Science (JP16K09061 to AS) and (JP17H04664 to NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Armitage P, 2012, STAT METHODS MED RES; Chen BH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2640-1; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Harigane K, 2015, EPIDEMIOL INFECT, V143, P2666, DOI 10.1017/S095026881400363X; Hoshino Hitoshi, 2009, Kekkaku, V84, P1; Japan Meteorological Agency, PUBL PER; Japan Ministry of Health and Welfare, STAT TB 1999 2016; Kohei Y, 2016, EPIDEMIOL INFECT, V144, P2401, DOI 10.1017/S0950268816000546; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Nagayama N, 2006, INT J TUBERC LUNG D, V10, P1117; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Nelson RJ, 2005, SEASONAL PATTERNS ST, P58; Ohtomo N., 1994, JPN J APPL PHYS, V33, P2321; Schaaf HS, 1996, TUBERCLE LUNG DIS, V77, P43, DOI 10.1016/S0962-8479(96)90074-X; Sumi A, 2013, EPIDEMIOLOGY INFECT, V141, P2666; The Tuberculosis Surveillance Center, MONTHL REP TUB; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wacker M, 2013, NUTRIENTS, V5, P111, DOI 10.3390/nu5010111; WHO, GLOB TUB REP 2018; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213856	10.1371/journal.pone.0213856	http://dx.doi.org/10.1371/journal.pone.0213856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883581	gold, Green Submitted, Green Published			2022-12-26	WOS:000461423500036
J	White, ML; Zhang, Y; Yu, F; Shonka, N; Aizenberg, MR; Adapa, P; Kazmi, SAJ				White, Matthew L.; Zhang, Yan; Yu, Fang; Shonka, Nicole; Aizenberg, Michele R.; Adapa, Pavani; Kazmi, Syed A. Jaffar			Post-operative perfusion and diffusion MR imaging and tumor progression in high-grade gliomas	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; MAPS FDMS; RESECTION; CONTRAST; COEFFICIENT; SURVIVAL; SITE	Purpose Perfusion and diffusion magnetic resonance imaging (MRI) provide important biomarkers for brain tumor analysis. Our aim was to investigate if regions of increased perfusion or tumor with restricted diffusion on the immediate post-operative MRI examination would be predictive of time to tumor progression in patients with high-grade gliomas. Materials and methods Twenty-three patients with high-grade gliomas were retrospectively analyzed. We measured the perfusion at the resection area and evaluated the presence or absence of the restricted diffusion in residual tumor masses. The associations of the perfusion, diffusion and contrast enhancement (delayed static enhancement (DSE)) characteristics with time to tumor progression were statistically calculated. We also evaluated if the location of the tumor progression was concordant to the areas of the elevated perfusion, tumor type restricted diffusion and enhancement. Results Patients with >200 days to progression are more likely to have no elevated relative cerebral blood volume (rCBV) ratio (p = 0.0004), no tumor restriction (p = 0.024), and no DSE (p = 0.052). The elevated mean rCBV ratio (p<0.001) and tumor type restricted diffusion (p = 0.002) were significantly associated with a higher risk of progression. All cases with rCBV ratio of >1.5 progressed in 275 days or earlier. Tumors tended to progress at the area where patients with post-operative MRIs showed elevated perfusion (p = 0.006), tumor-type restricted diffusion (p = 0.005) and DSE (p = 0.008). Conclusions Post-operative analysis of rCBV, tumor type restricted diffusion and enhancement characteristics are predictive of time to progression, risk of progression and where tumor progression is likely to occur.	[White, Matthew L.; Zhang, Yan] Univ Nebraska Med Ctr, Radiol, Omaha, NE 68198 USA; [Yu, Fang] Univ Nebraska Med Ctr, Biostat, Omaha, NE USA; [Shonka, Nicole] Univ Nebraska Med Ctr, Div Hematol & Oncol, Internal Med, Omaha, NE USA; [Aizenberg, Michele R.] Univ Nebraska Med Ctr, Neurosurg, Omaha, NE USA; [Adapa, Pavani] South Texas Radiol Grp, San Antonio, TX USA; [Kazmi, Syed A. Jaffar] Geisinger Med Ctr, Anat Pathol, Danville, PA 17822 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Geisinger Medical Center	White, ML (corresponding author), Univ Nebraska Med Ctr, Radiol, Omaha, NE 68198 USA.	matthewwhite@unmc.edu	Aizenberg, Michele/ABB-9791-2020	Aizenberg, Michele/0000-0001-6689-8907				ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Blasel S, 2011, J NEURO-ONCOL, V103, P575, DOI 10.1007/s11060-010-0421-4; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Ellingson BM, 2012, NEURO-ONCOLOGY, V14, P333, DOI 10.1093/neuonc/nor220; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; ELSTER AD, 1990, RADIOLOGY, V174, P93, DOI 10.1148/radiology.174.1.2294578; Essock-Burns E, 2013, J MAGN RESON IMAGING, V38, P388, DOI 10.1002/jmri.23982; Ewelt C, 2011, J NEURO-ONCOL, V103, P611, DOI 10.1007/s11060-010-0429-9; Faramarz-Allandini, 2010, WORLD NEUROSURG, V73, P128, DOI 10.1016/j.wneu.2009.06.001; Holodny AI, 2010, AM J NEURORADIOL, V31, P1042, DOI 10.3174/ajnr.A1989; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Kang Y, 2011, RADIOLOGY, V261, P882, DOI 10.1148/radiol.11110686; Kreth FW, 2013, ANN ONCOL, V24, P3117, DOI 10.1093/annonc/mdt388; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lee EK, 2015, KOREAN J RADIOL, V16, P1341, DOI 10.3348/kjr.2015.16.6.1341; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Pirzkall A, 2009, NEURO-ONCOLOGY, V11, P842, DOI 10.1215/15228517-2009-005; Smets T, 2013, EUR RADIOL, V23, P1467, DOI 10.1007/s00330-012-2762-1; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7	21	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213905	10.1371/journal.pone.0213905	http://dx.doi.org/10.1371/journal.pone.0213905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883579	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500039
J	Aubry, P; Guillemain, M				Aubry, Philippe; Guillemain, Matthieu			Attenuating the nonresponse bias in hunting bag surveys: The multiphase sampling strategy	PLOS ONE			English	Article							HARVEST SURVEY; WATERFOWL; QUESTIONNAIRE; MANAGEMENT; HUNTERS; DESIGN; ERRORS; POPULATIONS; FRAME	Reliable hunting bag statistics are a prerequisite for sustainable harvest management based on quantitative modeling. Estimating the total hunting bag for a given game species is faced with a multiplicity of error sources. Of particular concern is the nonresponse error. We consider that the major cause of nonresponse bias is when the reluctance to respond is related to a null harvest, which leads to a potentially important overestimation. For tackling the nonresponse bias issue, we advocate the repeated subsampling of nonrespondents, with a final phase of personal interview by phone, intended to be without nonresponse. When a 100% response rate is actually reached at the last phase, both total and sampling variance can be estimated without bias, whatever the response rates at the previous phases. The actual case of imperfect response at the last phase is studied using Monte Carlo simulations. For imperfect response at the last phase, we show that the estimators we advocate are biased downwards but that these bias remain very moderate if the response rate at the last phase is high enough, depending on the circumstances. Furthermore, we illustrate that increasing the number of phases improves the nonresponse bias attenuation. In case of a hunting bag collecting scheme prone to a high nonresponse rate, for obtaining a very satisfying nonresponse bias attenuation we advocate relying on the multiphase sampling strategy with two- or three-phases, and a response rate in the last phase of at least 90%.	[Aubry, Philippe] Off Natl Chasse & Faune Sauvage, Cellule Appui Methodol, Direct Rech & Expertise, BP 20, F-78612 St Benoist, Le Perray En Yv, France; [Guillemain, Matthieu] Off Natl Chasse & Faune Sauvage, Unite Avifaune Migratrice, Direct Rech & Expertise, F-13200 Arles, France		Aubry, P (corresponding author), Off Natl Chasse & Faune Sauvage, Cellule Appui Methodol, Direct Rech & Expertise, BP 20, F-78612 St Benoist, Le Perray En Yv, France.	philippe.aubry@oncfs.gouv.fr		Aubry, Philippe/0000-0002-0964-1942				Anderson Michael G., 2015, International Journal of Environmental Studies, V72, P810, DOI 10.1080/00207233.2015.1019296; Anderson WL, 1996, WILDLIFE SOC B, V24, P233; Arnab R., 2017, SURVEY SAMPLING THEO; Artelle KA, 2019, AM SCI, V107, P38; Artelle KA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao0167; Artelle KA, 2014, SCIENCE, V343, P1311, DOI 10.1126/science.343.6177.1311-a; Asferg T, 2008, MANGLENDE INDBERETNI; ATWOOD EARL L., 1956, JOUR WILDLIFE MANAGEMENT, V20, P1, DOI 10.2307/3797241; ATWOOD EL, 1958, BIOMETRICS, V14, P132; Aubry P, 2016, REV FAUNE SAUVAGE, V310, P1; Aubry P, 2017, FAUNE SAUVAGE, V315, P4; BARKER RJ, 1991, J WILDLIFE MANAGE, V55, P126, DOI 10.2307/3809249; BARKER RJ, 1992, J WILDLIFE MANAGE, V56, P337, DOI 10.2307/3808832; Beaman J, 2005, J WILDLIFE MANAGE, V69, P967, DOI 10.2193/0022-541X(2005)069[0967:CPIHRO]2.0.CO;2; Beaman J., 2005, HUMAN DIMENSIONS WIL, V10, P285, DOI DOI 10.1080/10871200500292876; Beaman J, 2002, HUMAN DIMENSIONS WIL, V7, P67, DOI DOI 10.1080/108712002753574792; Bethlehem J., 1999, RES METHODOLOGY SOCI, P110; Bethlehem Jelke., 2002, SURVEY NONRESPONSE, P275; Brick JM, 2009, HANDB STAT, V29A, P163, DOI 10.1016/S0169-7161(08)00008-4; Chapman DG, 1959, METHODS ESTIMATING D; Chaudhuri A., 2005, SURVEY SAMPLING THEO, DOI 10.1201/9781420028638; Chaudhuri A., 2014, MODERN SURVEY SAMPLI; Christensen T.K., 2017, VILDTUDBYTTESTATISTI; Chu A, 1992, J OFF STAT, V8, P19; CLAUSEN JA, 1947, J AM STAT ASSOC, V42, P497, DOI 10.2307/2280007; Cochran WG., 1963, SAMPLING TECHNIQUES; Couling LM, 1982, RELIABILITY KILL ACT; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Dykes L, 2015, COMMUN STAT-THEOR M, V44, P3403, DOI 10.1080/03610926.2013.841932; Eberhardt L, 1960, P SOCIAL STAT SECTIO, P182; ELBADRY MA, 1956, J AM STAT ASSOC, V51, P209, DOI 10.2307/2281342; Enders C. K., 2010, APPL MISSING DATA AN; Filion F. L., 1980, Wildlife management techniques manual, P441; FILION FL, 1976, PUBLIC OPIN QUART, V39, P482; FILION FL, 1981, J WILDLIFE MANAGE, V45, P873, DOI 10.2307/3808096; Foradori GT., 1961, THESIS; Franzen R, 1945, J PSYCHOL, V20, P293, DOI 10.1080/00223980.1945.9917260; Guillemain M, 2016, WILDFOWL, V66, P126; Gupta A.K., 2011, THEORY SAMPLE SURVEY; HANSEN MH, 1946, J AM STAT ASSOC, V41, P517, DOI 10.2307/2280572; Hawkins A. S., 1984, FLYWAYS PIONEERING W, P259; Hayne DW, 1964, INVESTIGATION MAIL S; Hedayat A. S., 1991, DESIGN INFERENCE FIN; Hidiroglou M, 2013, P JOINT STAT M MONTR, P1478; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; HUGHES E, 1979, COMMUN STAT A-THEOR, V8, P1551, DOI 10.1080/03610927908827851; Jebe EH, 2006, ENCY STAT SCI, V8, P5051; JEYARATNAM S, 1984, FOREST SCI, V30, P484; Johnson FA, 2018, ECOL APPL, V28, P427, DOI 10.1002/eap.1659; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Johnston DC, 1982, THESIS; L'Ecuyer P, 1999, OPER RES, V47, P159, DOI 10.1287/opre.47.1.159; Landry P, 1983, WORK GROUP GAM STAT, P25; Lessler JT, 1992, NONSAMPLING ERROR SU; Lohr S.L., 2010, SAMPLING DESIGN ANAL, Vsecond; MACDONALD D, 1968, J WILDLIFE MANAGE, V32, P119, DOI 10.2307/3798246; Madsen J, 2015, AEWA TECHNICAL SERIE, V62; Madsen J, 2017, AMBIO, V46, P275, DOI 10.1007/s13280-016-0888-0; Mangat N. S., 1996, ELEMENTS SURVEY SAMP; Martin EM, 1977, RESOURCE PUBLICATION, V130; MARTINSON R. K., 1964, TRANS N AMER WILDLIFE NATUR RESOURCES CONF, V29, P287; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; MILLER CA, 2002, HUMAN DIMENSIONS WIL, V7, P55, DOI DOI 10.1080/108712002753574783; Mukhopadhyay P, 2009, THEORY METHODS SURVE, V2; Nichols JD, 2007, J ORNITHOL, V148, pS343, DOI 10.1007/s10336-007-0256-8; Overton W.S., 1953, P ANN C SE ASS GAM F, P71; PENDLETON GW, 1992, J WILDLIFE MANAGE, V56, P344, DOI 10.2307/3808833; Peterson RA, 2000, CONSTRUCTING EFFECTI; Raj D., 1998, SAMPLE SURVEY THEORY; RAMAKRISHNAN MK, 1969, SANKHYA SER A, V31, P333; RAO JNK, 1973, BIOMETRIKA, V60, P125, DOI 10.1093/biomet/60.1.125; RAO JNK, 1968, J AM STAT ASSOC, V63, P87, DOI 10.2307/2283829; Rao PSRS, 1983, INCOMPLETE DATA SAMP, V2, P97; Rubin DB, 2004, MULTIPLE IMPUTATION; Rupp SP, 2000, WILDLIFE SOC B, V28, P570; Ryel LA, 1980, P S HELD 41 MIDW FIS, P37; Saris W., 2007, DESIGN EVALUATION AN, V2, DOI 10.1002/9780470165195; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Sarndal CE, 2005, WILEY SER SURV METH, P1; Schmidt JI, 2015, J WILDLIFE MANAGE, V79, P1164, DOI 10.1002/jwmg.928; SEN AR, 1971, J ROY STAT SOC C-APP, V20, P139; SEN AR, 1973, J WILDLIFE MANAGE, V37, P485, DOI 10.2307/3800313; SEN AR, 1972, J WILDLIFE MANAGE, V36, P951, DOI 10.2307/3799455; SEN AR, 1976, J AM STAT ASSOC, V71, P43, DOI 10.2307/2285728; SEN AR, 1970, J WILDLIFE MANAGE, V34, P703, DOI 10.2307/3799134; SEN AR, 1970, BIOMETRICS, V26, P315, DOI 10.2307/2529078; Sheriff SL, 2002, HARVEST INFORM PROGR, P51; Siripornpibul S, 2001, THESIS; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Skalski JR, 2006, WILDLIFE SOC B, V34, P329, DOI 10.2193/0091-7648(2006)34[329:TIOHPQ]2.0.CO;2; SRINATH KP, 1971, J AM STAT ASSOC, V66, P583, DOI 10.2307/2283533; Strickland M.D., 1996, RES MANAGEMENT TECHN, P445; Sukhatme PV, 1984, SAMPLING THEORY SURV; Taylor CE, 2000, WILDLIFE SOC B, V28, P717; Tille Y., 2006, SPR S STAT; Trost RE, 1989, P 6 INT WAT S, P134; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Williams BD, 2016, ILLINOIS WATERFOWL H; WILSON BC, 1995, WILDLIFE SOC B, V23, P472; WRIGHT VL, 1978, J WILDLIFE MANAGE, V42, P251, DOI 10.2307/3800262	101	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213670	10.1371/journal.pone.0213670	http://dx.doi.org/10.1371/journal.pone.0213670			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875395	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400020
J	Ayuningrum, D; Liu, Y; Riyanti; Sibero, MT; Kristiana, R; Asagabaldan, MA; Wuisan, ZG; Trianto, A; Radjasa, OK; Sabdono, A; Schaberle, TF				Ayuningrum, Diah; Liu, Yang; Riyanti; Sibero, Mada T.; Kristiana, Rhesi; Asagabaldan, Meezan A.; Wuisan, Zerlina G.; Trianto, Agus; Radjasa, Ocky Karna; Sabdono, Agus; Schaeberle, Till F.			Tunicate-associated bacteria show a great potential for the discovery of antimicrobial compounds	PLOS ONE			English	Article							HOSPITAL-ACQUIRED INFECTIONS; SECONDARY METABOLITES; MARINE; RESISTANCE	Tunicates (Ascidians, sea squirts) are marine protochordates, which live sedentary or sessile in colonial or solitary forms. These invertebrates have to protect themselves against predators and invaders. A most successful strategy, to not being eaten by predators and prevent pathogenic microorganisms to settle, is the usage of chemical molecules for defence. To accomplish this, tunicates take advantage of the specialized metabolites produced by the bacteria associated with them. Therefore, the microbiome of the tunicates can be regarded as a promising bioresource for bacterial strains producing compounds with antibacterial activity. The aim of this study was to test this hypothesis by (i) isolation of tunicate-associated bacteria, (ii) analysis of the antibacterial activities of these strains, and (iii) purification and structure elucidation of an active compound derived from this bioresource. In total, 435 bacterial strains were isolated and thereof 71 (16%) showed antibacterial activity against multi drug resistant (MDR) bacteria. Therefrom, the ethyl acetate crude extracts from liquid fermentations of 25 strains showed activity against MDR Extended-Spectrum Beta-Lactamase (MDR-ESBL) Escherichia coli, MDR Bacillus cereus, Micrococcus lute us, and Bacillus megaterium. Phenotypic analysis based on 16S rDNA sequencing revealed the active strains belonging to different genera and phyla, like Bacillus, Pantoea, Pseudoalteromonas, Salinicola, Streptomyces, Vibrio and Virgibacillus. To obtain first insights into the molecules responsible for the antibacterial activities observed, strain Pseudoalteromonas rubra TKJD 22 was selected for large-scale fermentation and the active compound was isolated. This allowed the purification and structure elucidation of isatin, a compound known for its strong biological effects, thereunder inhibition of Gram-positive and Gram-negative pathogens.	[Ayuningrum, Diah; Kristiana, Rhesi; Asagabaldan, Meezan A.] Diponegoro Univ, Dept Coastal Resource Management, Fac Fisheries & Marine Sci, Semarang, Indonesia; [Ayuningrum, Diah] Diponegoro Univ, Trop Marine Biotechnol Lab, Semarang, Indonesia; [Liu, Yang; Riyanti; Wuisan, Zerlina G.; Schaeberle, Till F.] Justus Liebig Univ Giessen, Inst Insect Biotechnol, Giessen, Germany; [Liu, Yang; Schaeberle, Till F.] Fraunhofer Inst Mol Biol & Appl Ecol, Dept Bioresources, Giessen, Germany; [Sibero, Mada T.; Trianto, Agus; Radjasa, Ocky Karna; Sabdono, Agus] Diponegoro Univ, Dept Marine Sci, Semarang, Indonesia; [Radjasa, Ocky Karna] Minist Res Technol & Higher Educ, Directorate Res & Community Serv, Jakarta, Indonesia; [Schaeberle, Till F.] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Giessen, Germany; [Ayuningrum, Diah] Diponegoro Univ, Dept Aquat Resource Management, Fac Fisheries & Marine Sci, Semarang, Indonesia	Diponegoro University; Diponegoro University; Justus Liebig University Giessen; Fraunhofer Gesellschaft; Diponegoro University; German Center for Infection Research; Diponegoro University	Schaberle, TF (corresponding author), Justus Liebig Univ Giessen, Inst Insect Biotechnol, Giessen, Germany.; Schaberle, TF (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol, Dept Bioresources, Giessen, Germany.; Schaberle, TF (corresponding author), German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Giessen, Germany.	till.f.schaeberle@agrar.uni-giessen.de	Asagabaldan, Meezan A./AAI-6918-2020; SIBERO, Dr. MADA TRIANDALA/CAH-3815-2022; Ayuningrum, Diah/AAX-9302-2020; Trianto, Agus/AAC-3640-2019; Radjasa, Ocky/AAG-7355-2021	Asagabaldan, Meezan A./0000-0002-3340-6707; SIBERO, Dr. MADA TRIANDALA/0000-0001-5832-4399; Ayuningrum, Diah/0000-0001-8822-5535	Ministry of Research, Technology and Higher Education, Indonesia [315-10/UN7.5.1/PP/2017]; Enhancing International Publication Program (PKPI) [2064.23/D3/PG/2017]; Federal Ministry of Education and Research (BMBF) [16GW0117K]	Ministry of Research, Technology and Higher Education, Indonesia; Enhancing International Publication Program (PKPI); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	DA was supported by No. 315-10/UN7.5.1/PP/2017 Ministry of Research, Technology and Higher Education, Indonesia, under the scheme Master Program of Education Leading to Doctoral Degree for Excellent Graduates (PMDSU), and No. 2064.23/D3/PG/2017 Enhancing International Publication Program (PKPI). TFS was supported by Federal Ministry of Education and Research (BMBF, grant 16GW0117K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Jaffar Ali H, 2016, ASCIDIANS COASTAL WA; Al-Wabli RI, 2017, MOLECULES, V22, DOI 10.3390/molecules22111958; Arunachalam K., 2013, FREE RADIC ANTIOXID, V3, P47, DOI DOI 10.1016/J.FRA.2013.04.004; Asagabaldan MA, 2017, IOP C SER EARTH ENV, V55, DOI 10.1088/1755-1315/55/1/012019; Ayuningrum D, 2017, IOP C SER EARTH ENV, V55, DOI 10.1088/1755-1315/55/1/012029; Benson H. J, 2002, MICROBIOLOGICAL APPL; Bitzer J, 2006, J ANTIBIOT, V59, P86, DOI 10.1038/ja.2006.12; Burgess JG, 2003, BIOFOULING, V19, P197, DOI 10.1080/0892701031000061778; Carter GT, 2016, MARINE BIOMEDICINE B, P612; CDC, 2013, ANTIBIOTIC RESISTANC; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Garden SJ, 2001, J BRAZIL CHEM SOC, V12, P52; Giddens SR, 2002, MOL MICROBIOL, V45, P15; Hirose E, 2004, ENDOCYT CELL RES, V15, P12; Joint I, 2010, MICROB BIOTECHNOL, V3, P564, DOI 10.1111/j.1751-7915.2010.00188.x; Kalinovskaya NI, 2004, CURR MICROBIOL, V48, P441, DOI 10.1007/s00284-003-4240-0; Kamber T, 2012, APPL ENVIRON MICROB, V78, P4412, DOI 10.1128/AEM.07351-11; Konstantinovic SS, 2008, J SERB CHEM SOC, V73, P7, DOI 10.2298/JSC0801007K; Kott P, 2004, ZOOTAXA, P1; Kristiana R, 2017, IOP C SER EARTH ENV, V55, DOI 10.1088/1755-1315/55/1/012056; Lestari ES, 2009, ANTIMICROBIAL RESIST; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Majik MS, 2014, BIOORG CHEM, V54, P89, DOI 10.1016/j.bioorg.2014.05.001; Manivasagan P, 2014, MICROBIOL RES, V169, P262, DOI 10.1016/j.micres.2013.07.014; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; Mendes RE, 2013, ANTIMICROB AGENTS CH, V57, P5721, DOI 10.1128/AAC.01121-13; Mohan Gopi, 2016, Biotechnol Rep (Amst), V11, P44, DOI 10.1016/j.btre.2016.06.001; Mondol MAM, 2013, MAR DRUGS, V11, P2846, DOI 10.3390/md11082846; Monniot Francoise, 1999, Journal of East African Natural History, V86, P1, DOI 10.2982/0012-8317(1997)86[1:ACIT]2.0.CO;2; Nangino Glaucio de Oliveira, 2012, Rev. bras. ter. intensiva, V24, P357, DOI 10.1590/S0103-507X2012000400011; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Offret C, 2016, MAR DRUGS, V14, DOI 10.3390/md14070129; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Piel J, 2006, CURR MED CHEM, V13, P39, DOI 10.2174/092986706775197971; Rath CM, 2011, ACS CHEM BIOL, V6, P1244, DOI 10.1021/cb200244t; Sakai R, 1992, P NATI ACAD SCI, V89, P5; Schmidt EW, 2012, J NAT PROD, V75, P295, DOI 10.1021/np200665k; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Shaikh S, 2015, SAUDI J BIOL SCI, V22, P90, DOI 10.1016/j.sjbs.2014.08.002; Sigel MM, 1983, AM ZOOL, V24, P8; Sings HL, 1996, J IN DMICROBIOL, V17, P12; Sulardiono B, 2017, INDONESIAN J FISHERI, V12, P5; Vanneste JL, 2002, P INT WORKSH FIR BLI; Vervoort HC, 1997, J ORG CHEM, V62, P1486, DOI 10.1021/jo961789s; VINE KL, 2007, INVESTIGATION CYTOTO; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wietz M, 2010, MAR DRUGS, V8, P2946, DOI 10.3390/md8122946; World Health Organization, 2014, ANT RES GLOB REP SUR; Wright SAI, 2001, APPL ENVIRON MICROB, V67, P284, DOI 10.1128/AEM.67.1.284-292.2001	50	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213797	10.1371/journal.pone.0213797	http://dx.doi.org/10.1371/journal.pone.0213797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875400	Green Submitted, Green Published, gold			2022-12-26	WOS:000461316400031
J	Miraglia, JL; Mafra, ACCN; Monteiro, CN; Borges, LM				Miraglia, Joao Luiz; Cintra Nunes Mafra, Ana Carolina; Monteiro, Camila Nascimento; Borges, Luciana Morais			The variation of the burden of hypertension and diabetes in two large districts of the city of Sao Paulo, Brazil, based on primary health care routinely-collected data	PLOS ONE			English	Article								Background Noncommunicable diseases (NCDs) were responsible for 72.3% of global deaths in 2016, with cardiovascular diseases accounting for almost half of those deaths and low-and middle-income countries carrying the biggest burden. As a result, the prevention and control of NCDs is recognized as urgent, while better surveillance at the country level could result in more effective policies. Hence, the objective of this study was to obtain more detailed information on the distribution of the prevalence of hypertension and diabetes among the population of two large districts of the city of Sao Paulo in Brazil, and to compare these findings to the results of a citywide health survey. Methods and findings This cross-sectional study used primary health care (PHC) routinely-collected data. The study population included 187,110 individuals 20 years of age or older registered in 13 public PHC facilities at two districts of the city of Sao Paulo in 2015. Data extracted from SIAB, a primary care database, was used to calculate age and sex directly standardized prevalences for diabetes and hypertension for each PHC facility. The prevalence of hypertension among women was significantly higher than the prevalence among men in the entire study population, and in every PHC facility. There was great variation among PHC facilities that was more pronounced among women. The prevalence of diabetes among women was significantly higher than the prevalence among men in the entire study population, and in every PHC facility, but there was little variation among PHC facilities. Conclusions This study provided information that could help with policy planning and allocation of resources, and demonstrated the use of PHC routinely-collected data to generate important insights that if replicated could have a substantial impact given the broad coverage of the national public PHC program in Brazil.	[Miraglia, Joao Luiz; Cintra Nunes Mafra, Ana Carolina; Monteiro, Camila Nascimento; Borges, Luciana Morais] Hosp Israelita Albert Einstein, Inst Israelita Responsabilidade Social, Programas Govt, Sao Paulo, Brazil; [Monteiro, Camila Nascimento] Univ Sao Paulo, Fac Med, Dept Med Prevent, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade de Sao Paulo	Miraglia, JL (corresponding author), Hosp Israelita Albert Einstein, Inst Israelita Responsabilidade Social, Programas Govt, Sao Paulo, Brazil.	joao.miraglia@einstein.br	Mafra, Ana Carolina CN/H-1030-2015	Mafra, Ana Carolina CN/0000-0001-9004-7176; Miraglia, Joao Luiz/0000-0002-4788-6254				[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bertram MY, 2018, LANCET, V391, P2071, DOI [10.1016/S0140-6736(18)30665-2, 10.1016/s0140-6736(18)30665-2]; Boccolini CS, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0444-3; Brant Luisa Campos Caldeira, 2017, Rev. bras. epidemiol., V20, P116, DOI 10.1590/1980-5497201700050010; Curtin L R, 1995, Healthy People 2000 Stat Notes, P1; DAB/Ministerio da Saude, 2018, HIST COB SAUD FAM; Desa U, 2016, TRANSF OUR WORLD 203; Francisco Priscila Maria Stolses Bergamo, 2011, Rev. bras. epidemiol., V14, P5, DOI 10.1590/S1415-790X2011000500002; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Hemkens LG, 2016, CAN MED ASSOC J, V188, pE158, DOI 10.1503/cmaj.150653; Bernal RTI, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051000171, 10.1590/s1518-8787.2017051000171]; Kandasamy S, 2018, CAN J CARDIOL, V34, P450, DOI 10.1016/j.cjca.2018.01.017; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Ministerio da Saude, 2015, VIGITEL BRAS 2015 VI; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Niessen LW, 2018, LANCET, V391, P2036, DOI [10.1016/S0140-6736(18)30482-3, 10.1016/s0140-6736(18)30482-3]; Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Rasella D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4014; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Heidemann ITSB, 2015, ACTA PAUL ENFERM, V28, P152, DOI 10.1590/1982-0194201500026; SEADE/SPG/Governo do Estado de Paulo, 2010, IND PAUL VULN SOC VE; SEADE/SPG/Governo do Estado de Paulo, 2018, SIST SEAD PROJ POP; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2016, DRAFT UPD APP 3 WHO; World Health Organization, 2013, GLOB ACT PLAN PREV C	28	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213998	10.1371/journal.pone.0213998	http://dx.doi.org/10.1371/journal.pone.0213998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875401	Green Submitted, Green Published, gold			2022-12-26	WOS:000461316400041
J	Garcia-Roche, M; Casal, A; Mattiauda, DA; Ceriani, M; Jasinsky, A; Mastrogiovanni, M; Trostchansky, A; Carriquiry, M; Cassina, A; Quijano, C				Garcia-Roche, Mercedes; Casal, Alberto; Mattiauda, Diego A.; Ceriani, Mateo; Jasinsky, Alejra; Mastrogiovanni, Mauricio; Trostchansky, Andres; Carriquiry, Mariana; Cassina, Adriana; Quijano, Celia			Impaired hepatic mitochondrial function during early lactation in dairy cows: Association with protein lysine acetylation	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; LIPID-PEROXIDATION; ACID OXIDATION; INSULIN-RESISTANCE; GENE-EXPRESSION; HUMAN-CELLS; IN-VIVO; SIRT3; PREGNANCY; PASTURE	Early lactation is an energy-deming period for dairy cows which may lead to negative energy balance, threatening animal health consequently productivity. Herein we studied hepatic mitochondrial function in Holstein-Friesian multiparous dairy cows during lactation, under two different feeding strategies. During the first 180 days postpartum the cows were fed a total mixed ration (70% forage: 30% concentrate) ad libitum (non-grazing group, G0) or grazed Festuca arundinacea or Mendicago sativa plus supplementation (grazing group, G1). From 180 to 250 days postpartum, all cows grazed Festuca arundinacea were supplemented with total mixed ration. Mitochondrial function was assessed measuring oxygen consumption rate in liver biopsies revealed that maximum respiratory rate decreased significantly in grazing cows during early lactation, yet was unchanged in non-grazing cows during the lactation curve. While no differences could be found in mitochondrial content or oxidative stress markers, a significant increase in protein lysine acetylation was found in grazing cows during early lactation but not in cows from the non-grazing group. Mitochondrial acetylation positively correlated with liver triglycerides beta-hydroxybutyrate plasma levels, well-known markers of negative energy balance, while a negative correlation was found with the maximum respiratory rate sirtuin 3 levels. To our knowledge this is the first report of mitochondrial function in liver biopsies of dairy cows during lactation. On the whole our results indicate that mitochondrial function is impaired during early lactation in grazing cows that acetylation may account for changes in mitochondrial function in this period. Additionally, our results suggest that feeding total mixed ration during early lactation may be an efficient protective strategy.	[Garcia-Roche, Mercedes; Mastrogiovanni, Mauricio; Trostchansky, Andres; Cassina, Adriana; Quijano, Celia] Univ Republica, Fac Med, Dept Bioquim, Ctr Free Radical Biomed Res CEINBIO, Montevideo, Uruguay; [Garcia-Roche, Mercedes; Carriquiry, Mariana] Univ Republica, Fac Agron, Dept Prod Anim & Pasturas, Montevideo, Uruguay; [Casal, Alberto; Mattiauda, Diego A.; Ceriani, Mateo; Jasinsky, Alejra] Univ Republ, Fac Agron, Estn Expt Mario A Cassinoni, Dept Prod Anim & Pasturas, Paysu, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Cassina, A; Quijano, C (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Ctr Free Radical Biomed Res CEINBIO, Montevideo, Uruguay.; Carriquiry, M (corresponding author), Univ Republica, Fac Agron, Dept Prod Anim & Pasturas, Montevideo, Uruguay.	mariana.carriquiry@gmail.com; acassina@fmed.edu.uy; celia.quijano@gmail.com	Garcia-Roche, Mercedes/CAF-8926-2022; Trostchansky, Andres/I-5624-2019	Trostchansky, Andres/0000-0002-9721-7577	Agencia Nacional de Investigacion e Innovacion [FSA_12612, POS_NAC_2015_1_110049, POS_NAC_2014_1_102302]	Agencia Nacional de Investigacion e Innovacion	This work was supported by grants of Agencia Nacional de Investigacion e Innovacion (www.anii.org.uy): FSA_12612 awarded to M.C.; POS_NAC_2015_1_110049 awarded to M.G.R; POS_NAC_2014_1_102302 awarded to A. Casal. Espacio Interdisciplinario-Centros, UDELAR 2015 (www.ei.udelar.edu.uy): A. Cassina and C. Q; CSIC grupos I+D 2014 (www.csic.edu.uy): 767, A. Cassina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; [Anonymous], 2001, NRC NUTR REQ DAIR CA; [Anonymous], 2011, ASSESSING MITOCHONDR, V312, P297, DOI [10.1042/BJ20110162, DOI 10.1042/BJ20110162]; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Astessiano AL, 2017, REPROD DOMEST ANIM, V52, P798, DOI 10.1111/rda.12981; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; Baumgard LH, 2017, J DAIRY SCI, V100, P10353, DOI 10.3168/jds.2017-13242; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carriquiry M, 2009, J DAIRY SCI, V92, P4889, DOI 10.3168/jds.2008-1676; Castillo C, 2005, VET J, V169, P286, DOI 10.1016/j.tvjl.2004.02.001; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Chilibroste P., 2005, Quantitative aspects of ruminant digestion and metabolism, P681, DOI 10.1079/9780851998145.0681; Chilibroste P, 2015, ANIM PROD SCI, V55, P328, DOI 10.1071/AN14484; CHILLIARD Y, 1984, REPROD NUTR DEV, V24, P469, DOI 10.1051/rnd:19840412; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Gao WW, 2018, J CELL MOL MED, V22, P3408, DOI 10.1111/jcmm.13617; Garcia-Roche M, 2018, REDOX BIOL, V17, P207, DOI 10.1016/j.redox.2018.03.008; GRUM DE, 1994, COMP BIOCHEM PHYS B, V109, P281, DOI 10.1016/0305-0491(94)90012-4; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HERDT TH, 1988, VET CLIN N AM-FOOD A, V4, P269, DOI 10.1016/S0749-0720(15)31048-3; Hills JL, 2015, J DAIRY SCI, V98, P1363, DOI 10.3168/jds.2014-8475; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ingvartsen KL, 2013, ANIMAL, V7, P112, DOI 10.1017/S175173111200170X; Johnson HD, 1961, J DAIRY SCI, P44; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kirovski D., 2017, SMALL MED J GASTROEN, V3, P1; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kolver E. S., 2002, Proceedings of the New Zealand Society of Animal Production, V62, P246; Kolver ES, 1998, J DAIRY SCI, V81, P1403, DOI 10.3168/jds.S0022-0302(98)75704-2; Kramer P.A., 2014, JOVE-J VIS EXP, V85, P1; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; Meikle A, 2013, ANIM FEED SCI TECH, V186, P139, DOI 10.1016/j.anifeedsci.2013.10.003; Mizutani H, 1999, VET RES COMMUN, V23, P475, DOI 10.1023/A:1006358222037; Mudron P, 1999, J VET MED A, V46, P219, DOI 10.1046/j.1439-0442.1999.00206.x; Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Noziere P, 2011, ANIMAL, V5, P403, DOI 10.1017/S1751731110002016; Osborne B, 2014, BBA-GEN SUBJECTS, V1840, P1295, DOI 10.1016/j.bbagen.2013.08.016; Pessayre D, 2005, J HEPATOL, V42, P928, DOI 10.1016/j.jhep.2005.03.004; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Porter WH, 1997, AM J CLIN PATHOL, V107, P353, DOI 10.1093/ajcp/107.3.353; Pougovkina O, 2014, HUM MOL GENET, V23, P3513, DOI 10.1093/hmg/ddu059; Quijano C, 2016, REDOX BIOL, V8, P28, DOI 10.1016/j.redox.2015.11.010; Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Roche JR, 2013, ANIM PROD SCI, V53, P1000, DOI 10.1071/AN12293; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Schumann G, 2002, CLIN CHEM LAB MED, V40, P725, DOI 10.1515/CCLM.2002.125; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P519, DOI 10.1089/ars.2016.6776; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Thapa D, 2017, AM J PHYSIOL-HEART C, V313, pH265, DOI 10.1152/ajpheart.00752.2016; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; van der Kolk JH, 2017, VET QUART, V37, P262, DOI 10.1080/01652176.2017.1354561; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wagner Gregory R, 2011, J Aging Res, V2011, P234875, DOI 10.4061/2011/234875; Wales WJ, 2013, ANIM PROD SCI, V53, P1167, DOI 10.1071/AN13207; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; White HM, 2015, ANIMALS-BASEL, V5, P793, DOI 10.3390/ani5030384; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Yesilova Z, 2005, AM J GASTROENTEROL, V100, P850, DOI 10.1111/j.1572-0241.2005.41500.x	78	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213780	10.1371/journal.pone.0213780	http://dx.doi.org/10.1371/journal.pone.0213780			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870481	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300072
J	Lee, FCH; Man, SS; Chan, AHS				Lee, Fion Choi Hung; Man, Siu Shing; Chan, Alan Hoi Shou			Effects of magnification modes and location cues on visual inspection performance	PLOS ONE			English	Article							LOBE SHAPE CHARACTERISTICS; SCREEN MAGNIFIERS; EYE-MOVEMENTS; SEARCH; DISPLAY; DESIGN; OLDER	Image magnification often results in disorientation through loss of orientation and location during inspection. This study investigated the effects of three different magnification modes viz. full screen, circular, and fixed-area on visual inspection performance. Also, to improve participants' global orientation with respect to the original product, location cues in the form of halftone landmarks were introduced as a job aid and their effectiveness on inspection performance was examined. Twenty-eight undergraduates participated in the experiment. Significant magnification mode effect was found, but the location cue effect was found nonsignificant. The results suggested that the presentation of content/contextual information on one single screen should be considered together with the nature of the visual task and participants' search behaviors, and that the aid of location cues might be useful when the visual task demanded a high level of search memory and/or an unsystematic search strategy was employed by inspectors.	[Lee, Fion Choi Hung] City Univ, Div Business, UOW Coll Hong Kong, Community Coll, Hong Kong, Peoples R China; [Man, Siu Shing; Chan, Alan Hoi Shou] City Univ Hong Kong, Dept Syst Engn & Engn Management, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong	Man, SS (corresponding author), City Univ Hong Kong, Dept Syst Engn & Engn Management, Hong Kong, Peoples R China.	ssman6-c@my.cityu.edu.hk			Research Grants Council of the Hong Kong Special Administrative Region, China [111005]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	FCH Lee and AHS Chan received a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China [Project No. CityU 111005]. The URL of the funder is https://www.ugc.edu.hk/eng/rgc/about.html.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blenkhorn P, 2003, IEEE COMPUT GRAPH, V23, P54, DOI 10.1109/MCG.2003.1231178; CARD SK, 1984, ATTENTION PERFORM, V10, P97; Chan A., 2000, THEORETICAL ISSUES E, V1, P157, DOI [10.1080/14639220050171315, DOI 10.1080/14639220050171315]; Chan AHS, 2007, TRAV HUMAIN, V70, P343, DOI 10.3917/th.704.0343; Chan AHS, 2000, INT J IND ERGONOM, V25, P359, DOI 10.1016/S0169-8141(99)00024-4; Chan AHS, 1998, PERCEPT MOTOR SKILL, V87, P251, DOI 10.2466/pms.1998.87.1.251; Chan AHS, 2010, HUM FACTOR ERGON MAN, V20, P367, DOI 10.1002/hfm.20158; Chevalier A, 2006, INT J HUM-COMPUT ST, V64, P1031, DOI 10.1016/j.ijhcs.2006.06.002; Connolly C, 2006, ASSEMBLY AUTOM, V26, P283, DOI 10.1108/01445150610705191; DRURY CG, 1990, VISUAL SEARCH, P263; Fang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121035; GALLWEY TJ, 1986, HUM FACTORS, V28, P595, DOI 10.1177/001872088602800509; Goonetilleke RS, 2002, INT J HUM-COMPUT ST, V57, P447, DOI 10.1006/ijhc.2002.1027; HART S G, 1988, P139; Hoyer WJ, 2011, J GERONTOL B-PSYCHOL, V66, P402, DOI 10.1093/geronb/gbr022; Jung ES, 2000, INT J IND ERGONOM, V26, P445, DOI 10.1016/S0169-8141(00)00006-8; Kotani K, 2012, HUM FACTOR ERGON MAN, V22, P296, DOI 10.1002/hfm.20276; Kristjansson A, 2000, PSYCHOL SCI, V11, P328, DOI 10.1111/1467-9280.00265; Kugler G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145910; Lee FCH, 2015, HUM FACTOR ERGON MAN, V25, P453, DOI 10.1002/hfm.20561; Lee FCH, 2009, ERGONOMICS, V52, P1501, DOI 10.1080/00140130903229553; Lee FCH, 2009, APPL ERGON, V40, P410, DOI 10.1016/j.apergo.2008.11.005; Leech N., 2013, SPSS INTERMEDIATE ST; Lin CL, 2014, HUM FACTOR ERGON MAN, V24, P124, DOI 10.1002/hfm.20360; Liu N, 2017, ERGONOMICS, V60, P1667, DOI 10.1080/00140139.2017.1342870; McAnally K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149217; Melloy BJ, 2006, HUM FACTORS, V48, P540, DOI 10.1518/001872006778606840; Peterson MS, 2001, PSYCHOL SCI, V12, P287, DOI 10.1111/1467-9280.00353; Sarac A, 2007, THEOR ISS ERGON SCI, V8, P531, DOI 10.1080/14639220500078591; Somanathan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168452; Wahn B, 2016, ERGONOMICS, V59, P781, DOI 10.1080/00140139.2015.1099742; Yang LD, 2018, ERGONOMICS, V61, P273, DOI 10.1080/00140139.2017.1353138; Yu RF, 2014, ERGONOMICS, V57, P1300, DOI 10.1080/00140139.2014.921328; Zhao ZX, 2009, INT J HUM-COMPUT ST, V67, P663, DOI 10.1016/j.ijhcs.2009.03.006	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213805	10.1371/journal.pone.0213805	http://dx.doi.org/10.1371/journal.pone.0213805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7YP	30870515	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300081
J	Nayyeri, MD; Burgmer, M; Pfleiderer, B				Nayyeri, Mahboobeh Dehghan; Burgmer, Markus; Pfleiderer, Bettina			Impact of pressure as a tactile stimulus on working memory in healthy participants	PLOS ONE			English	Article							2ND SOMATOSENSORY AREA; N-BACK TASK; SPATIAL ATTENTION; BRAIN ACTIVATION; CORTICAL NETWORK; CORTEX; LOAD; FMRI; CONGRUENCY; SALIENCE	Studies on cross-modal interaction have demonstrated attenuated as well as facilitated effects for both neural responses as well as behavioral performance. The goals of this pilot study were to investigate possible cross-modal interactions of tactile stimulation on visual working memory and to identify possible neuronal correlates by using functional magnetic resonance imaging (fMRI). During fMRI, participants (n = 12 females, n = 12 males) performed a verbal n-back task (0-back and 2-back tasks) while tactile pressure to the left thumbnail was delivered. Participants presented significantly lower behavioral performances (increased error rates, and reaction times) during the 2-back task as compared to the 0-back task. Task performance was independent of pressure in both tasks. This means that working memory performance was not impacted by a low salient tactile stimulus. Also in the fMRI data, no significant interactions of n-back x pressure were observed. In conclusion, the current study found no influence of tactile pressure on task-related brain activity during n-back (0-back and 2-back) tasks.	[Nayyeri, Mahboobeh Dehghan; Pfleiderer, Bettina] Univ Hosp Muenster, Med Fac, Munster, Germany; [Nayyeri, Mahboobeh Dehghan; Pfleiderer, Bettina] Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany; [Nayyeri, Mahboobeh Dehghan] Heinrich Heine Univ Duesseldorf, Med Fac, LVR Clin, Dept Psychosomat Med & Psychotherapy, Dusseldorf, Germany; [Burgmer, Markus] Univ Hosp Muenster, Dept Psychosomat & Psychotherapy, Munster, Germany	University of Munster; University of Munster; Heinrich Heine University Dusseldorf; University of Munster	Pfleiderer, B (corresponding author), Univ Hosp Muenster, Med Fac, Munster, Germany.; Pfleiderer, B (corresponding author), Univ Hosp Muenster, Inst Clin Radiol, Munster, Germany.	pfleide@uni-muenster.de		dehghan-nayyeri, mahboobeh/0000-0001-6365-7024; Pfleiderer, Bettina/0000-0002-1238-6225	Deutsche Forschungsgemeinschaft [BU 2621/4-1]; Open Access Publication Fund of the University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Muenster	The work is part of a study funded by a grant of the Deutsche Forschungsgemeinschaft (BU 2621/4-1) to MB. We also acknowledge support by the Open Access Publication Fund of the University of Muenster.	BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Burton H, 2008, HUM BRAIN MAPP, V29, P207, DOI 10.1002/hbm.20384; Caclin A, 2002, PERCEPT PSYCHOPHYS, V64, P616, DOI 10.3758/BF03194730; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chung YG, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0207-x; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dalton P, 2009, Q J EXP PSYCHOL, V62, P635, DOI 10.1080/17470210802483503; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2007, CEREB CORTEX, V17, P1800, DOI 10.1093/cercor/bhl090; Eimer M, 2000, PSYCHOPHYSIOLOGY, V37, P697, DOI 10.1111/1469-8986.3750697; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fujiwara N, 2002, COGNITIVE BRAIN RES, V14, P389, DOI 10.1016/S0926-6410(02)00141-6; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Haroush K, 2010, J COGNITIVE NEUROSCI, V22, P1440, DOI 10.1162/jocn.2009.21284; Hartmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003831; Hoechstetter K, 2000, NEUROREPORT, V11, P2461, DOI 10.1097/00001756-200008030-00024; Huettel SA, 2014, FUNCTIONAL MAGNETIC RESONANCE IMAGING, THIRD EDITION, P1; Ide M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03453; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; Kim J, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01070; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Macaluso E, 2001, NEUROPSYCHOLOGIA, V39, P1304, DOI 10.1016/S0028-3932(01)00119-1; Malinen S, 2006, EXP BRAIN RES, V174, P297, DOI 10.1007/s00221-006-0465-z; Martuzzi R, 2014, HUM BRAIN MAPP, V35, P213, DOI 10.1002/hbm.22172; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otten LJ, 2000, NEUROREPORT, V11, P875, DOI 10.1097/00001756-200003200-00043; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Raveh D, 2015, ATTEN PERCEPT PSYCHO, V77, P483, DOI 10.3758/s13414-014-0776-2; Regenbogen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052267; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Schmidt H, 2009, HUM BRAIN MAPP, V30, P3609, DOI 10.1002/hbm.20783; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Schubert R, 2008, CEREB CORTEX, V18, P2686, DOI 10.1093/cercor/bhn029; Schulze Evan T, 2011, J Aging Res, V2011, P606871, DOI 10.4061/2011/606871; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Singh-Curry V, 2009, NEUROPSYCHOLOGIA, V47, P1434, DOI 10.1016/j.neuropsychologia.2008.11.033; Spence C., 2010, CROSSMODAL SPATIAL A; Spence C, 2007, CAN J EXP PSYCHOL, V61, P196, DOI 10.1037/cjep2007021; Spence C, 2004, COGN AFFECT BEHAV NE, V4, P148, DOI 10.3758/CABN.4.2.148; Staines WR, 2002, NEUROIMAGE, V15, P190, DOI 10.1006/nimg.2001.0953; Summers IR, 2009, J ACOUST SOC AM, V125, P1033, DOI 10.1121/1.3056399; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; Van Hulle L, 2013, EXP BRAIN RES, V224, P295, DOI 10.1007/s00221-012-3311-5; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wacker E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024860; Wiens S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146567; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107; Zhang P, 2006, NEUROIMAGE, V33, P715, DOI 10.1016/j.neuroimage.2006.07.015; Zimmer U, 2007, EUR J NEUROSCI, V26, P1681, DOI 10.1111/j.1460-9568.2007.05784.x	66	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213070	10.1371/journal.pone.0213070	http://dx.doi.org/10.1371/journal.pone.0213070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7YP	30870456	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300019
J	Rytlewski, J; Deng, SB; Xie, T; Davis, C; Robins, H; Yusko, E; Bienkowska, J				Rytlewski, Julie; Deng, Shibing; Xie, Tao; Davis, Craig; Robins, Harlan; Yusko, Erik; Bienkowska, Jadwiga			Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood	PLOS ONE			English	Article								Current methods to quantify T-cell clonal expansion only account for variance due to random sampling from a highly diverse repertoire space. We propose a beta-binomial model to incorporate time-dependent variance into the assessment of differentially abundant T-cell clones, identified by unique T Cell Receptor (TCR) beta-chain rearrangements, and show that this model improves specificity for detecting clinically relevant clonal expansion. Using blood samples from ten healthy donors, we modeled the variance of T-cell clones within each subject over time and calibrated the dispersion parameters of the beta distribution to fit this variance. As a validation, we compared pre-versus post-treatment blood samples from urothelial cancer patients treated with atezolizumab, where clonal expansion (quantified by the earlier binomial model) was previously reported to correlate with benefit. The beta-binomial model significantly reduced the false-positive rate for detecting differentially abundant clones over time compared to the earlier binomial method. In the urothelial cancer cohort, the beta-binomial model enriched for tumor infiltrating lymphocytes among the clones detected as expanding in the peripheral blood in response to therapy compared to the binomial model and improved the overall correlation with clinical benefit. Incorporating timedependent variance into the statistical framework for measuring differentially abundant Tcell clones improves the model's specificity for T-cells that correlate more strongly with the disease and treatment setting of-interest. Reducing background-level clonal expansion, therefore, improves the quality of clonal expansion as a biomarker for assessing the T cell immune response and correlations with clinical measures.	[Rytlewski, Julie; Robins, Harlan; Yusko, Erik] Adapt Biotechnol, Seattle, WA 98102 USA; [Deng, Shibing; Xie, Tao; Davis, Craig; Bienkowska, Jadwiga] Pfizer Inc, La Jolla, CA 92037 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA	Pfizer; Fred Hutchinson Cancer Center	Yusko, E (corresponding author), Adapt Biotechnol, Seattle, WA 98102 USA.; Bienkowska, J (corresponding author), Pfizer Inc, La Jolla, CA 92037 USA.	eyusko@adaptivebiotech.com; jadwiga.r.bienkowska@pfizer.com	Rytlewski, Julie/O-6811-2019	Rytlewski, Julie/0000-0001-5244-6790; Davis, Craig/0000-0002-1703-451X				Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Davis CB, 2018, KEYSTONE MONTREAL, P1; DeWitt WS, 2015, J VIROL, V89, P4517, DOI 10.1128/JVI.03474-14; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Hecht JR, 2017, EFFICACY SAFETY IMMU, P1; Hopkins AC, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122092; Hsu MS, 2016, CANCER IMMUNOL RES, V4, P412, DOI 10.1158/2326-6066.CIR-15-0240; Kruschke J. K., 2011, DOING BAYESIAN DATA; Navarro D, 2010, IEEE P 4 EUR C ANT P, P1; Page DB, 2016, CANCER IMMUNOL RES, V4, P835, DOI 10.1158/2326-6066.CIR-16-0013; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Snyder A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002309; Sveinbjornsson B, 2017, LTX 315 1 CLASS ONCO, P1	13	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213684	10.1371/journal.pone.0213684	http://dx.doi.org/10.1371/journal.pone.0213684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870493	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300059
J	Fournier, AL; Yazdanpanah, Y; Verdon, R; Lariven, S; Mackoumbou-Nkouka, C; Phung, BC; Papot, E; Parienti, JJ; Landman, R; Champenois, K				Fournier, Anna Lucie; Yazdanpanah, Yazdan; Verdon, Renaud; Lariven, Sylvie; Mackoumbou-Nkouka, Claude; Phung, Bao-Chau; Papot, Emmanuelle; Parienti, Jean-Jacques; Landman, Roland; Champenois, Karen			Incidence of and risk factors for medical care interruption in people living with HIV in recent years	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; FOLLOW-UP; DEPRIVATION INDEX; RETENTION; MORTALITY; OUTCOMES; COHORT	Objectives With HIV treatment as a prevention strategy, retention in care remains a key for sustained viral suppression. We sought to identify HIV-infected patients at risk for medical care interruption (MCI) in a high-income country. Methods The HIV-infected patients enrolled had to attend the clinic at least twice between January 2010 and October 2014 and were followed up until May 2016. MCI was defined as patients not seeking care in or outside the clinic for at least 18 months, regardless of whether they returned to care after the interruption. The association between MCI and sociodemographic, clinical, and immuno-virological characteristics at HIV diagnosis and during follow-up was assessed using Cox models. Results The incidence rate of MCI was 2.5 per 100 persons-years (95% confidence interval [CI] = 2.3-2.7). MCI was more likely in patients who accessed care >6 months after diagnosis (hazard ratio [HR] = 1.30, 95% CI = 1.10-1.54 vs. <= 6 months) or did not report a primary care physician (HR = 2.40; 95% CI = 2.03-2.84). MCI was less likely in patients born in sub-Saharan Africa (HR = 0.75, 95% CI = 0.62-0.91 vs. born in France). During follow-up, the risk of MCI increased when the last CD4 count was <= 350 (HR = 2.85, 95% CI = 2.02-4.04 vs. >500 cells/mm(3)) and when the patient was not on antiretroviral therapy (HR = 3.67, 95% CI = 2.90-4.66). Conclusions The incidence of MCI is low in this hospital that serves a large proportion of migrants. Low or no recorded CD4 counts for a medical visit could alert of a higher risk of MCI, even more in patients who accessed HIV care late or did not report a primary care physician.	[Fournier, Anna Lucie; Yazdanpanah, Yazdan; Papot, Emmanuelle; Champenois, Karen] Paris Diderot Univ, Sorbonne Paris Cite, INSERM, IAME,UMR1137, Paris, France; [Fournier, Anna Lucie; Verdon, Renaud; Parienti, Jean-Jacques] Normandie Univ, UNICAEN, Normandie Univ Hosp, Infect & Trop Dis Dept, Caen, France; [Yazdanpanah, Yazdan; Lariven, Sylvie; Mackoumbou-Nkouka, Claude; Phung, Bao-Chau; Papot, Emmanuelle; Landman, Roland] Bichat Claude Bernard Univ Hosp, AP HP, Infect & Trop Dis Dept, Paris, France; [Verdon, Renaud; Parienti, Jean-Jacques] Normandie Univ, UNICAEN, Normandie Univ Hosp, GRAM 2 0,EA2656, Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie	Fournier, AL (corresponding author), Paris Diderot Univ, Sorbonne Paris Cite, INSERM, IAME,UMR1137, Paris, France.; Fournier, AL (corresponding author), Normandie Univ, UNICAEN, Normandie Univ Hosp, Infect & Trop Dis Dept, Caen, France.	annafournier87@gmail.com	Parienti, Jean-Jacques/AAD-1701-2021; Fournier, Anna/AAJ-5905-2021	Parienti, Jean-Jacques/0000-0002-4774-5590; Anna, Fournier/0000-0001-5865-9033				Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Cuzin L, 2016, EPIDEMIOL INFECT, V144, P2363, DOI 10.1017/S0950268816000625; Direction de l'Information Legale et Administrative, AID MED ET; Eberhart MG, 2015, JAIDS-J ACQ IMM DEF, V69, pS37, DOI 10.1097/QAI.0000000000000587; Goswami ND, 2016, JAIDS-J ACQ IMM DEF, V72, P65, DOI 10.1097/QAI.0000000000000914; Gueler A, 2017, AIDS, V31, P427, DOI 10.1097/QAD.0000000000001335; Guillaume E, 2016, J EPIDEMIOL COMMUN H, V70, P493, DOI 10.1136/jech-2015-205729; Hoen B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19034; Holtzman CW, 2015, AIDS CARE, V27, P817, DOI 10.1080/09540121.2015.1009362; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; INSEE: Institut National de la Statistique et des Etudes Economiques, 2013, REV PAUVR MEN; INSEE: Institut National de la Statistique et des Etudes Economiques, TAUX PAUVR SEL SOURC; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Koenig SP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002357; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lebouche B, 2006, HIV MED, V7, P140, DOI 10.1111/j.1468-1293.2006.00357.x; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Nacher M, 2010, AIDS CARE, V22, P1086, DOI 10.1080/09540121003599232; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Pugliese P, 2003, PRESSE MED, V32, P299; Rice BD, 2011, SEX TRANSM DIS, V38, P685, DOI 10.1097/OLQ.0b013e318214b92e; Ridolfo AL, 2017, JAIDS-J ACQ IMM DEF, V75, P315, DOI 10.1097/QAI.0000000000001388; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; UNAIDS, 2014, 90 90 90 AMB TREATM; Vandenhende MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129550	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213526	10.1371/journal.pone.0213526	http://dx.doi.org/10.1371/journal.pone.0213526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865722	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900073
J	Peng, F; Campos, EO; Sullivan, JG; Berry, N; Song, BB; Daniel, TL; Bradshaw, HD				Peng, Foen; Campos, Eric O.; Sullivan, Joseph Garret; Berry, Nathan; Song, Bo Bin; Daniel, Thomas L.; Bradshaw, H. D., Jr.			Morphospace exploration reveals divergent fitness optima between plants and pollinators	PLOS ONE			English	Article							EVOLUTION; BEHAVIOR; FLOWERS; BIOLOGY	The obligate mutualism and exquisite specificity of many plant-pollinator interactions lead to the expectation that flower phenotypes (e.g., corolla tube length) and corresponding pollinator traits (e.g., hawkmoth proboscis length) are congruent as a result of coevolution by natural selection. However, the effect of variation in flower morphology on the fitness of plants and their pollinators has not been quantified systematically. In this study, we employed the theoretical morphospace paradigm using a combination of 3D printing, electronic sensing, and machine vision technologies to determine the influence of two flower morphological features (corolla curvature and nectary diameter) on the fitness of both parties: the artificial flower and its hawkmoth pollinator. Contrary to the expectation that the same flower morphology maximizes the fitness of both plant and pollinator, we found that the two parties have divergent optima for corolla curvature, with non-overlapping fitness peaks in flower morphospace. The divergent fitness optima between plants and pollinators could lead to evolutionary diversification in both groups.	[Peng, Foen; Campos, Eric O.; Sullivan, Joseph Garret; Berry, Nathan; Song, Bo Bin; Daniel, Thomas L.; Bradshaw, H. D., Jr.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Peng, Foen] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	University of Washington; University of Washington Seattle; University of Connecticut	Bradshaw, HD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	toby@uw.edu		Peng, Foen/0000-0001-5549-7753	Benjamin D. Hall International Student Fellowship; Bank of America Endowed Fellowship; University of Washington; National Science Foundation [DBI-0939454, DGE-0718124]; Komen Endowed Chair; Air Force Office of Scientific Research [FA9550-14-1-0398]; National Institutes of Health [5R01GM088805]	Benjamin D. Hall International Student Fellowship; Bank of America Endowed Fellowship; University of Washington(University of Washington); National Science Foundation(National Science Foundation (NSF)); Komen Endowed Chair(Susan G. Komen Breast Cancer Foundation); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	F.P. was supported by a Benjamin D. Hall International Student Fellowship. E.O.C. was supported by a Bank of America Endowed Fellowship, Graduate Opportunities & Minority Achievement Program (GO-MAP) Fellowship from the University of Washington, and National Science Foundation grants (DBI-0939454 and DGE-0718124). T.L.D was supported by a Komen Endowed Chair and a grant from the Air Force Office of Scientific Research (FA9550-14-1-0398). H.D.B. was supported by a National Institutes of Health grant (5R01GM088805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2008, EVOLUTION, V62, P220, DOI 10.1111/j.1558-5646.2007.00275.x; Bronstein JL, MUTUALISM; Campos EO, 2017, THESIS; Campos EO, 2015, FUNCT ECOL, V29, P462, DOI 10.1111/1365-2435.12378; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; McGhee G.R., 2006, GEOMETRY EVOLUTION; Micheneau C, 2009, BOT J LINN SOC, V161, P1, DOI 10.1111/j.1095-8339.2009.00995.x; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Pauw A, 2009, EVOLUTION, V63, P268, DOI 10.1111/j.1558-5646.2008.00547.x; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Sprayberry JDH, 2007, J EXP BIOL, V210, P37, DOI 10.1242/jeb.02616; van der Kooi CJ, 2016, CURR BIOL, V26, pR1143, DOI 10.1016/j.cub.2016.08.071; Vereecken NJ, 2013, ANN BOT-LONDON, V111, P1155, DOI 10.1093/aob/mct081; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216	17	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213029	10.1371/journal.pone.0213029	http://dx.doi.org/10.1371/journal.pone.0213029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865672	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900057
J	Park, JE; Dutta, B; Tse, SW; Gupta, N; Tan, CF; Low, JK; Yeoh, KW; Kon, OL; Tam, JP; Sze, SK				Park, Jung Eun; Dutta, Bamaprasad; Tse, Shun Wilford; Gupta, Nikhil; Tan, Chee Fan; Low, Jee Keem; Yeoh, Kheng Wei; Kon, Oi Lian; Tam, James P.; Sze, Siu Kwan			Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift	ONCOGENE			English	Article							HEAVY-CHAIN FERRITIN; CANCER-CELLS; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; DENDRITIC CELL; M2 MACROPHAGE; PROGRESSION; SECRETION; MIGRATION; RECEPTOR	Developing tumors rapidly outgrow their oxygen supply and are subject to hypoxia, which stimulates hypersecretion of tumor-derived exosomes that promote angiogenesis, metastasis, and immunosuppression, but the molecular mediators of these pathological effects remain poorly defined. Using quantitative proteomics, we identified that exosomes produced by hypoxic tumor cells are highly enriched in immunomodulatory proteins and chemokines including CSF-1, CCL2, FTH, FTL, and TGF beta. Modeling exosome effects on tumor-infiltrating immune cells, we observed a potent ability of these hypoxia-induced vesicles to influence macrophage recruitment and promote M2-like polarization both in vitro and in vivo. In addition, hypoxic, but not normoxic, tumor exosomes enhanced oxidative phosphorylation in bone marrow-derived macrophages via transfer of let-7a miRNA, resulting in suppression of the insulin-Akt-mTOR signaling pathway. Together, these data demonstrate that hypoxia promotes tumor secretion of biomolecule-loaded exosomes that can modify the immunometabolic profile of infiltrating monocyte-macrophages to better evade host immunity and enhance tumor progression.	[Park, Jung Eun; Dutta, Bamaprasad; Tse, Shun Wilford; Gupta, Nikhil; Tan, Chee Fan; Tam, James P.; Sze, Siu Kwan] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Low, Jee Keem] Tan Tock Seng Hosp, Dept Surg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore; [Yeoh, Kheng Wei] Natl Canc Ctr Singapore, Dept Radiat Oncol, 11 Hosp Dr, Singapore 169610, Singapore; [Kon, Oi Lian] Natl Canc Ctr Singapore, Div Med Sci, 11 Hosp Dr, Singapore 169610, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS)	Park, JE; Sze, SK (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	jepark@ntu.edu.sg; sksze@ntu.edu.sg	Tam, James P/A-2176-2011; Dutta, Bamaprasad/AAH-4006-2020; Sze, Siu Kwan/AAO-3342-2020	Tam, James P/0000-0003-4433-198X; Dutta, Bamaprasad/0000-0002-2309-8771; Sze, Siu Kwan/0000-0002-5652-1687; Tan, Chee Fan/0000-0002-4109-8724	Singapore Ministry of Education [MOE2014-T2-2-043, MOE2016-T2-2-018, MOE2016-T3-1-003]; National Medical Research Council of Singapore [NMRC-OF-IRG-0003-2016]	Singapore Ministry of Education(Ministry of Education, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work is in part supported by grants from the Singapore Ministry of Education (MOE2014-T2-2-043, MOE2016-T2-2-018, and MOE2016-T3-1-003) and the National Medical Research Council of Singapore (NMRC-OF-IRG-0003-2016).	Alkhateeb AA, 2013, BBA-REV CANCER, V1836, P245, DOI 10.1016/j.bbcan.2013.07.002; Alkhateeb AA, 2013, BREAST CANCER RES TR, V137, P733, DOI 10.1007/s10549-012-2405-x; Balogh KN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197702; Bellomo C, 2016, BRIT J CANCER, V115, P761, DOI 10.1038/bjc.2016.255; Biswas SK, 2015, IMMUNITY, V43, P435, DOI 10.1016/j.immuni.2015.09.001; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Chen SC, 2012, J PATHOL, V228, P158, DOI 10.1002/path.3988; Chen X, 2004, CURR CANCER DRUG TAR, V4, P267, DOI 10.2174/1568009043333041; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Dueck A, 2012, NUCLEIC ACIDS RES, V40, P9850, DOI 10.1093/nar/gks705; Elliott LA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00086; Espinoza JL, 2012, HAEMATOL-HEMATOL J, V97, P1295, DOI 10.3324/haematol.2011.058529; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Geeraerts X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00289; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gray CP, 2003, CLIN CANCER RES, V9, P2551; Gray CP, 2002, BLOOD, V99, P3326, DOI 10.1182/blood.V99.9.3326; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Hoffman RM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3426; Hu JM, 2017, ONCOTARGET, V8, P21526, DOI 10.18632/oncotarget.15630; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jezequel P, 2012, INT J CANCER, V131, P426, DOI 10.1002/ijc.26397; Jia WZ, 2013, AM J PATHOL, V182, P1821, DOI 10.1016/j.ajpath.2013.01.017; KAO J, 1994, J BIOL CHEM, V269, P25106; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kindt N, 2016, ONCOL LETT, V12, P2247, DOI 10.3892/ol.2016.4929; Kore RA, 2018, BIOCHEM BIOPHYS REP, V14, P104, DOI 10.1016/j.bbrep.2018.03.008; Kucharzewska P, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20304; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; LEBRUN JJ, 2012, ISRN MOL BIOL, V2012, P28; Leca J, 2016, J CLIN INVEST, V126, P4140, DOI 10.1172/JCI87734; Lee DD, 2016, AM J RESP CELL MOL, V55, P602, DOI 10.1165/rcmb.2016-0091OC; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25474; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Lobb RJ, 2017, SEMIN CELL DEV BIOL, V67, P3, DOI 10.1016/j.semcdb.2017.01.004; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Mogami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080359; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nielsen SR, 2017, MEDIAT INFLAMM, V2017, P11; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Otero-Albiol D, 2016, CANC TRANSL MED, V2, P175, DOI DOI 10.3892/OL.2016.4316; Park JE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40569; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qi HB, 2015, ONCOL LETT, V10, P1947, DOI 10.3892/ol.2015.3498; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Storm MP, 2016, JOVE-J VIS EXP, DOI 10.3791/53431; Sudan B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00253; Vo TTL, 2018, ANN NY ACAD SCI, V1431, P3, DOI 10.1111/nyas.13929; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Torrisani J, 2007, CURR GENOMICS, V8, P229; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Wang DZ, 2018, GENET TEST MOL BIOMA, V22, P366, DOI 10.1089/gtmb.2018.0009; Wargo JA, 2016, CURR OPIN IMMUNOL, V41, P23, DOI 10.1016/j.coi.2016.05.006; Wenes M, 2016, CELL METAB, V24, P701, DOI 10.1016/j.cmet.2016.09.008; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665; Wu LJ, 2016, TUMOR BIOL, V37, P12169, DOI 10.1007/s13277-016-5071-5; Wu TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149361; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zhou JB, 2016, ONCOTARGET, V7, P50698, DOI 10.18632/oncotarget.9333; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu Q, 2015, NAT METHODS, V12, P211, DOI [10.1038/NMETH.3249, 10.1038/nmeth.3249]	80	140	146	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5158	5173		10.1038/s41388-019-0782-x	http://dx.doi.org/10.1038/s41388-019-0782-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30872795				2022-12-26	WOS:000473025300004
J	Barr, T; Lewis, SA; Sureshchandra, S; Doratt, B; Grant, KA; Messaoudi, I				Barr, Tasha; Lewis, Sloan A.; Sureshchandra, Suhas; Doratt, Brianna; Grant, Kathleen A.; Messaoudi, Ilhem			Chronic ethanol consumption alters lamina propria leukocyte response to stimulation in a region-dependent manner	FASEB JOURNAL			English	Article						gastrointestinal tract; mucosal immunology; nonhuman primate; alcohol and immunity	DIFFERENTIAL EXPRESSION ANALYSIS; ALCOHOL-CONSUMPTION; GENE-EXPRESSION; LYMPHOCYTES; TURNOVER; DRINKING; IMMUNITY; MONKEYS; MUCOSA; CELLS	Chronic heavy alcohol consumption, also referred to as chronic heavy drinking (CHD), results in intestinal injury characterized by increased permeability, dysbiosis, nutrient malabsorption, potentially higher susceptibility to infection, and increased risk of colorectal cancer. However, our understanding of the mechanisms by which CHD results in intestinal damage remains incomplete. Here, we investigated the impact of chronic drinking on transcriptional and functional responses of lamina propria leukocytes (LPLs) isolated from the 4 major gut sections. Although no significant differences were detected between LPLs isolated from the ethanol and control groups at resting state within each major gut section, our analysis uncovered key regional differences in composition and function of LPLs independent of alcohol consumption. However, in response to phorbol myristate acetate and ionomycin, duodenal LPLs from ethanol-drinking animals generated a dampened response, whereas jejunal and ileal LPLs from ethanol-drinking animals produced a heightened response. Transcriptional responses following stimulation were pronounced in ileal and duodenal LPLs from the ethanol-drinking group but less evident in jejunal and colonic LPLs compared with controls, suggesting a more significant impact of alcohol on these gut regions. The altered intestinal LPL function detected in our study reveals remarkable region specificity and novel insight into potential mechanisms of intestinal injury associated with CHD.-Barr, T., Lewis, S. A., Sureshchandra, S., Doratt, B., Grant, K. A., Messaoudi, I. Chronic ethanol consumption alters lamina propria leukocyte response to stimulation in a region-dependent manner.	[Barr, Tasha; Lewis, Sloan A.; Sureshchandra, Suhas; Doratt, Brianna; Messaoudi, Ilhem] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Grant, Kathleen A.; Messaoudi, Ilhem] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	University of California System; University of California Irvine; Oregon Health & Science University; Oregon National Primate Research Center	Messaoudi, I (corresponding author), Univ Calif Irvine, 2400 Biol Sci 3, Irvine, CA 92697 USA.	imessaou@uci.edu	Sureshchandra, Suhas/AAW-4606-2021		U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) [F31 AA025278, R21 AA021947, R21 AA024981, U01 AA013510, R24 AA109431]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013510, R24AA019431, F31AA025278, R21AA024981] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Grants F31 AA025278 (to T.B.), R21 AA021947 (to I.M.), R21 AA024981 (to I.M.), U01 AA013510 (to K.A.G.), and R24 AA109431 (to K.A.G.). The authors declare no conflicts of interest.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Asquith M, 2014, ALCOHOL CLIN EXP RES, V38, P980, DOI 10.1111/acer.12325; Backman TWH, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1241-0; Baker EJ, 2014, ALCOHOL CLIN EXP RES, V38, P2835, DOI 10.1111/acer.12547; Barr T, 2018, GUT MICROBES, V9, P338, DOI 10.1080/19490976.2018.1441663; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1016/S1521-6918(03)00034-9; BROZINSKY S, 1978, DIS COLON RECTUM, V21, P329, DOI 10.1007/BF02586661; Cervera-Juanes R, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.266; Cervera-Juanes R, 2017, ALCOHOL, V60, P103, DOI 10.1016/j.alcohol.2016.11.003; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Frishberg A, 2016, BIOINFORMATICS, V32, P3842, DOI 10.1093/bioinformatics/btw535; Gaddini GW, 2015, BONE, V71, P227, DOI 10.1016/j.bone.2014.10.025; Grant KA, 2008, ALCOHOL CLIN EXP RES, V32, P1824, DOI 10.1111/j.1530-0277.2008.00765.x; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Iancu OD, 2018, ADDICT BIOL, V23, P196, DOI 10.1111/adb.12501; Jerrells TR, 1998, ALCOHOL CLIN EXP RES, V22, p212S, DOI 10.1111/j.1530-0277.1998.tb04004.x; Jimenez VA, 2017, NEUROPHARMACOLOGY, V122, P127, DOI 10.1016/j.neuropharm.2017.03.027; Kaiko GE, 2014, TRENDS IMMUNOL, V35, P538, DOI 10.1016/j.it.2014.08.002; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Maier A, 1999, DIGEST DIS SCI, V44, P691, DOI 10.1023/A:1026697305769; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Poonia B, 2006, JAIDS-J ACQ IMM DEF, V41, P537, DOI 10.1097/01.qai.0000209907.43244.ee; Rajendram R, 2005, DIGEST DIS, V23, P214, DOI 10.1159/000090168; Riva A, 2018, GUT, V67, P918, DOI 10.1136/gutjnl-2017-314458; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUBIN E, 1972, GASTROENTEROLOGY, V63, P801; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi N, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0122-9; SIBLEY DA, 1995, ALCOHOL CLIN EXP RES, V19, P324, DOI 10.1111/j.1530-0277.1995.tb01510.x; Souza HSP, 2003, ALCOHOL, V30, P183, DOI 10.1016/S0741-8329(03)00134-4; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Veazey RS, 2015, ALCOHOL CLIN EXP RES, V39, P1373, DOI 10.1111/acer.12784; ZEITZ M, 1991, IMMUNOL RES, V10, P199, DOI 10.1007/BF02919693; Zhu X, 2000, ALCOHOL ALCOHOLISM, V35, P25, DOI 10.1093/alcalc/35.1.25	41	3	3	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7767	7777		10.1096/fj.201802780R	http://dx.doi.org/10.1096/fj.201802780R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30897342	Green Published			2022-12-26	WOS:000476114200088
J	Sawada, A; Wang, SS; Jian, MY; Leem, J; Wackerbarth, J; Egawa, J; Schilling, JM; Platoshyn, O; Zemljic-Harpf, A; Roth, DM; Patel, HH; Patel, PM; Marsala, M; Head, BP				Sawada, Atsushi; Wang, Shanshan; Jian, Minyu; Leem, Joseph; Wackerbarth, Jesse; Egawa, Junji; Schilling, Jan M.; Platoshyn, Oleksandr; Zemljic-Harpf, Alice; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Marsala, Martin; Head, Brian P.			Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1(G93A) mice	FASEB JOURNAL			English	Article						neuroplasticity; motor neurons; MLR; TrkB; mitochondria	AXONAL-TRANSPORT; LIPID RAFTS; TRANSGENE EXPRESSION; MOTOR-NEURONS; GENE-THERAPY; RECEPTOR; SOD1; ALS; MITOCHONDRIA; METABOLISM	Interventions that preserve motor neurons or restore functional motor neuroplasticity may extend longevity in amyotrophic lateral sclerosis (ALS). Delivery of neurotrophins may potentially revive degenerating motor neurons, yet this approach is dependent on the proper subcellular localization of neurotrophin receptor (NTR) to plasmalemmal signaling microdomains, termed membrane/lipid rafts (MLRs). We previously showed that overexpression of synapsin-driven caveolin-1 (Cav-1) (SynCav1) increases MLR localization of NTR [e.g., receptor tyrosine kinase B (TrkB)], promotes hippocampal synaptic and neuroplasticity, and significantly improves learning and memory in aged mice. The present study crossed a SynCav1 transgene-positive (SynCav1(+)) mouse with the mutant human superoxide dismutase glycine to alanine point mutation at amino acid 93 (hSOD1(G93A)) mouse model of ALS. When compared with hSOD1(G93A), hSOD1(G93A)/SynCav1(+) mice exhibited greater body weight and longer survival as well as better motor function. Microscopic analyses of hSOD1(G93A)/SynCav1(+) spinal cords revealed preserved spinal cord alpha-motor neurons and preserved mitochondrial morphology. Moreover, hSOD1(G93A)/SynCav1(+) spinal cords contained more MLRs (cholera toxin subunit B positive) and MLR-associated TrkB and Cav-1 protein expression. These findings demonstrate that SynCav1 delays disease progression in a mouse model of ALS, potentially by preserving or restoring NTR expression and localization to MLRs.-Sawada, A., Wang, S., Jian, M., Leem, J., Wackerbarth, J., Egawa, J., Schilling, J. M., Platoshyn, O., Zemljic-Harpf, A., Roth, D. M., Patel, H. H., Patel, P. M., Marsala, M., Head, B. P. Neuron-targeted caveolin-1 improves neuromuscular function and extends survival in SOD1(G93A) mice.	[Sawada, Atsushi; Wang, Shanshan; Jian, Minyu; Leem, Joseph; Wackerbarth, Jesse; Egawa, Junji; Schilling, Jan M.; Zemljic-Harpf, Alice; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Sawada, Atsushi; Wang, Shanshan; Jian, Minyu; Leem, Joseph; Wackerbarth, Jesse; Egawa, Junji; Schilling, Jan M.; Platoshyn, Oleksandr; Zemljic-Harpf, Alice; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Marsala, Martin; Head, Brian P.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Sawada, Atsushi] Sapporo Med Univ, Dept Anesthesiol, Sapporo, Hokkaido, Japan; [Jian, Minyu] Capital Med Univ, Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Egawa, Junji] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara, Japan; [Platoshyn, Oleksandr; Marsala, Martin] Sanford Consortium Regenerat Med, La Jolla, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Sapporo Medical University; Capital Medical University; Nara Medical University	Head, BP (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.; Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.	bhead@ucsd.edu			U.S. National Institutes of Health (NIH) Office of the Director Award [S10OD023527]; Veteran Affairs Merit Award from the Department of Veterans Affairs [BX003671, BX000783, BX001963]; NIH National Institute of Neurological Disorders and Stroke [NS073653]; NIH National Heart, Lung, and Blood Institute [HL091071, HL107200]; NIH National Institute of General Medical Sciences [GM085179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085179] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023527] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001963, I01BX003671, I01BX000783] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Office of the Director Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs Merit Award from the Department of Veterans Affairs; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Ying Jones, Vanessa Taupin, and Timo Meerlo [University of California-San Diego (UCSD) Electron Microscopy Core] for preparation of the spinal cord samples and training on electron microscopy. The authors also thank Dr. Marilyn Farquhar (UCSD) for consultation on the project. The electron micrographs were taken in the Cellular and Molecular Medicine Electron Microscopy Core Facility, which is supported, in part, by the U.S. National Institutes of Health (NIH) Office of the Director Award S10OD023527. Work in the researchers' laboratories was supported by a Veteran Affairs Merit Award from the Department of Veterans Affairs BX003671 (to B.P.H.), BX000783 (to D.M.R.), and BX001963 (to H.H.P.), and NIH National Institute of Neurological Disorders and Stroke Grant NS073653 (to B.P.H.), NIH National Heart, Lung, and Blood Institute Grants HL091071 and HL107200 (to H.H.P.), and NIH National Institute of General Medical Sciences Grant GM085179 (to P.M.P.). D.M.R., P.M.P., H.H.P., and B.P.H. are scientific founders of CavoGene LifeSciences LLC, and hold equity interest in the company. A.S. and S.W. share equal first authorship. The authors declare no other conflicts of interest.	Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Bartlett SE, 1998, IMMUNOL CELL BIOL, V76, P419, DOI 10.1046/j.1440-1711.1998.00767.x; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Brahimi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162307; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Buk DM, 2004, J CELL SCI, V117, P2063, DOI 10.1242/jcs.01049; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Egawa J, 2018, CEREB CORTEX, V28, P3255, DOI 10.1093/cercor/bhx196; Egawa J, 2017, FASEB J, V31, P3403, DOI 10.1096/fj.201601288RRR; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; GEISLER FH, 1993, ANN EMERG MED, V22, P1041, DOI 10.1016/S0196-0644(05)82748-9; Geisler Fred H., 1993, Journal of Emergency Medicine, V11, P49; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Haller J, 2016, J AM ACAD ORTHOP SUR, V24, P160, DOI 10.5435/JAAOS-D-14-00314; Hardiman O, 2017, LANCET NEUROL, V16, P490, DOI 10.1016/S1474-4422(17)30163-1; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Head BP, 2011, J BIOL CHEM, V286, P33310, DOI 10.1074/jbc.M111.255976; Hefferan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042614; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Keifer OP, 2014, PHARMACOL THERAPEUT, V141, P261, DOI 10.1016/j.pharmthera.2013.10.009; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Korkmaz OT, 2014, NEUROSCI LETT, V566, P286, DOI 10.1016/j.neulet.2014.02.058; Laurenzana A, 2015, CELL MOL LIFE SCI, V72, P1537, DOI 10.1007/s00018-014-1814-x; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Mandyam CD, 2017, BIOL PSYCHIAT, V81, P101, DOI 10.1016/j.biopsych.2015.09.020; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Nathanson NM, 2012, NEUROCHEM INT, V61, P874, DOI 10.1016/j.neuint.2012.01.018; O'Connor DM, 2015, TRENDS MOL MED, V21, P504, DOI 10.1016/j.molmed.2015.06.001; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Pasqua T, 2016, CELL TISSUE RES, V363, P693, DOI 10.1007/s00441-015-2316-3; Pearn ML, 2018, BRIT J ANAESTH, V120, P745, DOI 10.1016/j.bja.2017.12.033; Romanelli RJ, 2009, J NEUROSCI RES, V87, P3369, DOI 10.1002/jnr.22099; Rosenberg JB, 2018, HUM GENE THER CL DEV, V29, P24, DOI 10.1089/humc.2017.231; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Silva-Hucha S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178616; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Tovar-y-Romo LB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00061; Wang JW, 2014, ANESTHESIOLOGY, V121, P538, DOI 10.1097/ALN.0000000000000295; Yamashita N, 2016, CURR OPIN NEUROBIOL, V39, P139, DOI 10.1016/j.conb.2016.06.004; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	51	13	13	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7545	7554		10.1096/fj.201802652RR	http://dx.doi.org/10.1096/fj.201802652RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30894019	Green Published			2022-12-26	WOS:000476114200070
J	Ben Ouirane, K; Boulard, Y; Bressanelli, S				Ben Ouirane, Kaouther; Boulard, Yves; Bressanelli, Stephane			The hepatitis C virus RNA-dependent RNA polymerase directs incoming nucleotides to its active site through magnesium-dependent dynamics within its F motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA virus; viral polymerase; molecular dynamics; nucleoside; nucleotide transport; protein motif; RNA-dependent RNA polymerase (RdRp); Single-stranded; positive-sense RNA virus; structural biology	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CATALYSIS; FIDELITY; COMPLEX; SIMULATIONS; MECHANISM; INSIGHTS	RNA viruses synthesize new genomes in the infected host thanks to dedicated, virally-encoded RNA-dependent RNA polymerases (RdRps). As such, these enzymes are prime targets for antiviral therapy, as has recently been demonstrated for hepatitis C virus (HCV). However, peculiarities in the architecture and dynamics of RdRps raise fundamental questions about access to their active site during RNA polymerization. Here, we used molecular modeling and molecular dynamics simulations, starting from the available crystal structures of HCV NS5B in ternary complex with template-primer duplexes and nucleotides, to address the question of ribonucleotide entry into the active site of viral RdRp. Tracing the possible passage of incoming UTP or GTP through the RdRp-specific entry tunnel, we found two successive checkpoints that regulate nucleotide traffic to the active site. We observed that a magnesium-bound nucleotide first binds next to the tunnel entry, and interactions with the triphosphate moiety orient it such that its base moiety enters first. Dynamics of RdRp motifs F1 + F3 then allow the nucleotide to interrogate the RNA template base prior to nucleotide insertion into the active site. These dynamics are finely regulated by a second magnesium dication, thus coordinating the entry of a magnesium-bound nucleotide with shuttling of the second magnesium necessary for the two-metal ion catalysis. The findings of our work suggest that at least some of these features are general to viral RdRps and provide further details on the original nucleotide selection mechanism operating in RdRps of RNA viruses.	[Ben Ouirane, Kaouther; Boulard, Yves; Bressanelli, Stephane] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Boulard, Y; Bressanelli, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France.	yves.boulard@cea.fr; stephane.bressanelli@i2bc.paris-saclay.fr		Bressanelli, Stephane/0000-0002-0921-6727	Agence Nationale de la Recherche sur le Sida et single-stranded, positive sense RNA ((+)-ssRNA) viruses or in les hepatites virales (France REcherche Nord and sud SIDA-hiv Hepatites) Grant [AAP 2014-2]; Universite 'Paris-Saclay Graduate Student Fellowship	Agence Nationale de la Recherche sur le Sida et single-stranded, positive sense RNA ((+)-ssRNA) viruses or in les hepatites virales (France REcherche Nord and sud SIDA-hiv Hepatites) Grant; Universite 'Paris-Saclay Graduate Student Fellowship	This work was supported by Agence Nationale de la Recherche sur le Sida et single-stranded, positive sense RNA ((+)-ssRNA) viruses or in les hepatites virales (France REcherche Nord and sud SIDA-hiv Hepatites) Grant AAP 2014-2 (to S. B.) and a Universite 'Paris-Saclay Graduate Student Fellowship (to K. B. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelnabi R, 2017, J VIROL, V91, DOI 10.1128/JVI.00487-17; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Da LT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004624; Davis BC, 2013, BIOCHEMISTRY-US, V52, P4541, DOI 10.1021/bi400251g; Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Duan BG, 2014, BIOPHYS J, V107, P2130, DOI 10.1016/j.bpj.2014.09.038; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Freedman H, 2018, J BIOL CHEM, V293, P9696, DOI 10.1074/jbc.RA118.002588; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin ZN, 2017, ANTIVIR RES, V143, P151, DOI 10.1016/j.antiviral.2017.04.005; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Mendieta J, 2008, PROTEINS, V71, P565, DOI 10.1002/prot.21711; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Ovchinnikov V, 2012, J PHYS CHEM B, V116, P8584, DOI 10.1021/jp212634z; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Selisko B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020059; Shu B, 2017, RNA BIOL, V14, P1314, DOI 10.1080/15476286.2017.1300221; Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Tubiana T, 2018, J CHEM INF MODEL, V58, P2178, DOI 10.1021/acs.jcim.8b00512; Wu JQ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010024; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	45	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7573	7587		10.1074/jbc.RA118.005209	http://dx.doi.org/10.1074/jbc.RA118.005209			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30867194	Green Published, hybrid			2022-12-26	WOS:000470153300006
J	Callahan, AM; Dardick, CD; Scorza, R				Callahan, Ann M.; Dardick, Chris D.; Scorza, Ralph			Multilocation comparison of fruit composition for 'HoneySweet', an RNAi based plum pox virus resistant plum	PLOS ONE			English	Article							BONE LOSS; SUPPLEMENTATION; ACIDS; CULTIVARS; QUALITY; FLAVOR; SUGARS; MODEL; PTH	'HoneySweet', a transgenic plum (Prunus domestica) resistant to plum pox virus through RNAi, was deregulated in the U.S. in 2011. The compositional study of 'HoneySweet' fruit was expanded to include locations outside of the US as well as utilizing a wide variety of comparators and different collection years to see the variability possible. The results revealed that plums have a wide variation in composition and that variation among locations was greater than variation among cultivars. This was also the case for different years at one location. The results supported the supposition that the transgene and insertion event had no significant effect on the composition of 'HoneySweet' fruit even under virus pressure, and that it fell in the normal range of composition of commercially grown plums. It also suggested that the effect of environment is as great as that of genetics on the fruit composition of plums.	[Callahan, Ann M.; Dardick, Chris D.; Scorza, Ralph] ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV 25430 USA; [Scorza, Ralph] Ralph Scorza LLC, Shepherdstown, WV USA	United States Department of Agriculture (USDA)	Callahan, AM (corresponding author), ARS, USDA, Appalachian Fruit Res Stn, Kearneysville, WV 25430 USA.	ann.callahan@ars.usda.gov			United States Department of Agriculture-Agriculture Research Service; United States Department of Agriculture-Foreign Agriculture Service (FAS TASC)	United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA)); United States Department of Agriculture-Foreign Agriculture Service (FAS TASC)	United States Department of Agriculture-Agriculture Research Service funded this project through in-house funding. The funder provided support in the form of salaries for authors [AMC, CD, RS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The United States Department of Agriculture-Foreign Agriculture Service provided funds (FAS TASC 2009 AMC, CDD to RS) to offset the cost of the composition analyses. Ralph Scorza LLC provided no financial assistance and played no role in this project.	Aherne SA, 2009, PLANT FOOD HUM NUTR, V64, P250, DOI 10.1007/s11130-009-0136-x; Alimentarius Codex, 2003, CODEX PRINCIPLES GUI; Arjmandi BH, 2002, J WOMEN HEALTH GEN-B, V11, P61, DOI 10.1089/152460902753473471; Arjmandi BH., 2001, JANA, V4, P50; Attaluri A, 2011, ALIMENT PHARM THER, V33, P822, DOI 10.1111/j.1365-2036.2011.04594.x; Baldwin EA, 2002, SHEFF BIOL SCI, P89; Bu SY, 2007, OSTEOPOROSIS INT, V18, P931, DOI 10.1007/s00198-007-0335-y; Connor AM, 2005, J AM SOC HORTIC SCI, V130, P527, DOI 10.21273/JASHS.130.4.527; DeFrancesco L, 2013, NAT BIOTECHNOL, V31, P794, DOI 10.1038/nbt.2686; Deyhim F, 2005, MENOPAUSE, V12, P755, DOI 10.1097/01.gme.0000185486.55758.5b; Farinati S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01247; Franklin M, 2006, BONE, V39, P1331, DOI 10.1016/j.bone.2006.05.024; Gallusci P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00807; Hooshmand S, 2009, AGEING RES REV, V8, P122, DOI 10.1016/j.arr.2009.01.002; Josuttis M, 2013, J AGR FOOD CHEM, V61, P790, DOI 10.1021/jf303725g; Kayano S, 2003, J AGR FOOD CHEM, V51, P1480, DOI 10.1021/jf025929c; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Marsh KB, 2006, FOOD QUAL PREFER, V17, P376, DOI 10.1016/j.foodqual.2005.04.011; Mubarak A, 2012, J AGR FOOD CHEM, V60, P10256, DOI 10.1021/jf302903k; OECD, 2002, SER HARM REG OV BIOT, V24; RANKOVIC M, 1989, Acta Horticulturae (Wageningen), P283; Ravelonandro M., 2013, Food and Nutrition Sciences, V4, P45; Rendina E, 2012, J NUTR BIOCHEM, V23, P60, DOI 10.1016/j.jnutbio.2010.10.010; SCORZA R, 1994, PLANT CELL REP, V14, P18, DOI 10.1007/BF00233291; Scorza R, 1999, HORTSCIENCE, V34, P1129, DOI 10.21273/HORTSCI.34.6.1129; Scorza R, 2001, TRANSGENIC RES, V10, P201, DOI 10.1023/A:1016644823203; Scorza R, 2016, HORTSCIENCE, V51, P601, DOI 10.21273/HORTSCI.51.5.601; Sikdar MSI, 2016, TRANSGENIC RES, V25, P19, DOI 10.1007/s11248-015-9911-7; Smith BJ, 2014, BONE, V58, P151, DOI 10.1016/j.bone.2013.10.005; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stacewicz-Sapuntzakis M, 2013, CRIT REV FOOD SCI, V53, P1277, DOI 10.1080/10408398.2011.563880; Usenik V, 2014, SCI HORTIC-AMSTERDAM, V167, P127, DOI 10.1016/j.scienta.2014.01.002; Usenik V, 2008, FOOD CHEM, V111, P830, DOI 10.1016/j.foodchem.2008.04.057; Usenik V, 2017, J SCI FOOD AGR, V97, P2154, DOI 10.1002/jsfa.8023; Van den Ende W, 2014, ENVIRON EXP BOT, V108, P4, DOI 10.1016/j.envexpbot.2013.09.017; Vangdal E, 2005, ACTA HORTIC, P613, DOI 10.17660/ActaHortic.2005.674.81; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Zheng J, 2009, J SCI FOOD AGR, V89, P2011, DOI 10.1002/jsfa.3682	38	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213993	10.1371/journal.pone.0213993	http://dx.doi.org/10.1371/journal.pone.0213993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901368	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400028
J	Guo, JL; Zhang, L; Qin, D; Chen, W; Dong, WC; Hou, ZY; Zhang, YZ				Guo, Jialiang; Zhang, Li; Qin, Di; Chen, Wei; Dong, Weichong; Hou, Zhiyong; Zhang, Yingze			Changes in ankle joint alignment after proximal fibular osteotomy	PLOS ONE			English	Article							HIGH TIBIAL OSTEOTOMY; OSTEOARTHRITIS; KNEE	The purpose of this study was to assess the effect of proximal fibular osteotomy (PFO) on ankle joint. 49 patients or 53 lower limbs were included and followed-up with a minimum of one year in the study prospectively. Patients were evaluated radiographically and clinically. The questionnaires of the American Knee Society Score (KSS), the Ankle-Hindfoot Scale of the American Orthopedic Foot and Ankle Society (AOFAS), Visual Analogue Scale/Score (VAS) were used to assess the patients clinically. Radiographic evaluations were measured by the hip-knee-ankle angle (HKA), the femoro-tibial angle (FTA), tibial inclination (TI), distal tibial articural surface (TAS), talar tilt (TT), length of fibular (FL), and hind foot alignment such as hindfoot alignment view angle (HAVA), hindfoot alignment ratio (HAR), and hindfoot moment arm (HMA). Of the 53 subjects, no significant differences were exhibited in AOFAS, VAS scores and FL in ankle joint, but a significant differences were demonstrated in KSS score, HKA, FTA, TI, TT, HAVA, HAR and HMA after PFO. Due to the structural improvements of ankle joint, PFO not only improves joint function but also the alignment of ankle joint radiographically, and is still recommended as a safe surgery in treating medial compartment osteoarthritis of knee.	[Guo, Jialiang; Zhang, Li; Qin, Di; Chen, Wei; Hou, Zhiyong; Zhang, Yingze] Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Guo, Jialiang; Qin, Di; Chen, Wei; Hou, Zhiyong; Zhang, Yingze] Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Guo, Jialiang; Qin, Di; Chen, Wei; Zhang, Yingze] Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China; [Dong, Weichong] Hebei Med Univ, Hosp 2, Dept Pharm, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yingze] Chinese Acad Engn, Beijing, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Dept Orthopaed Surg, Hosp 3, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Key Lab Orthopaed Biomech Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Orthopaed Res Inst Hebei Prov, Shijiazhuang, Hebei, Peoples R China.; Zhang, YZ (corresponding author), Chinese Acad Engn, Beijing, Peoples R China.	dryzzhang@126.com	Chen, Wei/GRX-2231-2022	Hou, Zhiyong/0000-0001-5838-4025; Zhang, YIngze/0000-0001-8042-6105	Main Medical Scientific Research of Hebei [20180451]	Main Medical Scientific Research of Hebei	This research was supported by the Main Medical Scientific Research of Hebei (Award Number 20180451). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Baldini T, 2018, ORTHOPEDICS, V41, pE496, DOI 10.3928/01477447-20180424-05; CUSHNAGHAN J, 1991, ANN RHEUM DIS, V50, P8, DOI 10.1136/ard.50.1.8; FERRARI DA, 1994, J BONE JOINT SURG BR, V76B, P187, DOI 10.1302/0301-620X.76B2.8113273; Jeong BO, 2014, FOOT ANKLE INT, V35, P725, DOI 10.1177/1071100714531230; KOSHINO T, 1989, ORTHOP CLIN N AM, V20, P227; Lee HS, 2009, FOOT ANKLE INT, V30, P475, DOI 10.3113/FAI.2009.0475; Liu B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197980; Qin D, 2018, J INT MED RES, V46, P3114, DOI 10.1177/0300060518772715; SALTZMAN CL, 1995, FOOT ANKLE INT, V16, P572, DOI 10.1177/107110079501600911; Takeuchi R, 2008, KNEE, V15, P196, DOI 10.1016/j.knee.2008.02.002; Tanaka Y, 2006, J BONE JOINT SURG BR, V88B, P909, DOI 10.1302/0301-620X.88B7.17325; Yang ZY, 2015, ORTHOPEDICS, V38, pE1110, DOI 10.3928/01477447-20151120-08	13	9	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214002	10.1371/journal.pone.0214002	http://dx.doi.org/10.1371/journal.pone.0214002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901350	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400029
J	Winter, SC; Dreibelbis, R; Dzombo, MN; Barchi, F				Winter, Samantha Cristine; Dreibelbis, Robert; Dzombo, Millicent Ningoma; Barchi, Francis			A mixed-methods study of women's sanitation utilization in informal settlements in Kenya	PLOS ONE			English	Article							WATER; HEALTH; HYGIENE; DISEASE; BURDEN; IMPACT; GENDER; SLUMS	While access to safe sanitation is a global issue, there are large disparities in access. Women living in informal settlements, in particular, are disproportionately affected by lack of access to sanitation. Without adequate sanitation, these women may resort to unsafe strategies to manage their sanitation needs, but limited research has focused specifically on this issue. Qualitative and quantitative data were collected from women in the Mathare informal settlement in Nairobi, Kenya in 2016. A latent class analysis (LCA) using the quantitative data yielded five distinct sanitation profiles (SP) among women in Mathare. In-depth interviews and sanitation walks with women added further detail about the characteristics of and motivations underlying each profile. Womens sanitation profiles in these settlements are complex. A majority of women in this study utilized an unsafe method of disposal at least once in a 24-hour period that increased their risk of direct exposure to waste and harmful pathogens.	[Winter, Samantha Cristine; Barchi, Francis] Rutgers State Univ, Edward J Bloustein Sch Planning & Publ Policy, New Brunswick, NJ 08901 USA; [Dreibelbis, Robert] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Dzombo, Millicent Ningoma] Univ Nairobi, Dept Sociol & Social Work, Nairobi, Kenya	Rutgers State University New Brunswick; University of London; London School of Hygiene & Tropical Medicine; University of Nairobi	Winter, SC (corresponding author), Rutgers State Univ, Edward J Bloustein Sch Planning & Publ Policy, New Brunswick, NJ 08901 USA.	winter.samantha@gmail.com		Winter, Samantha/0000-0001-6629-7642	National Security Education Program (NSEP); PEO International	National Security Education Program (NSEP); PEO International	The National Security Education Program (NSEP) and PEO International provided fellowship funding to specific researchers that made this project possible; however, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Population Health Research Center, 2002, POP HLTH DYN NAIR IN; [Anonymous], 2014, STAT SAN NAIR COUNT; [Anonymous], 2009, NEGL TROP DIS HIDD S; [Anonymous], 2010, INS IND WOM EXP SLUM; [Anonymous], 2017, EM PREP RESP CHOL KE; ArcGis Desktop, 2022, LOC ALL AN; Bartram J, 2005, LANCET, V365, P810, DOI 10.1016/S0140-6736(05)71007-2; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Bongartz P, 2016, SUSTAINABLE SANITATI; Bosch C., 2001, WATER SANITATION POV; Burt Z., 2016, GENDER EQUALITY SANI; Caruso BA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070755; Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330; COHRE WaterAid SDC UN-HABITAT., 2008, SAN HUM RIGHTS IMP; Corbett JJ, 2015, J METHANE EMISSIONS, P1, DOI DOI 10.1155/2015/; Corburn J, 2016, HEALTH PROMOT INT, V31, P258, DOI 10.1093/heapro/dau100; Fisher J, 2008, P I CIVIL ENG-MUNIC, V161, P223, DOI 10.1680/muen.2008.161.4.223; Garn JV, 2017, INT J HYG ENVIR HEAL, V220, P329, DOI 10.1016/j.ijheh.2016.10.001; Gosling L., 2015, NOWHERE GO LACK SAFE; Gulyani S., 2006, INSIDE INFORMALITY P; Hirai M, 2016, J WATER SANIT HYG DE, V6, P151, DOI 10.2166/washdev.2016.128; Interagency Task Force on Gender and Water, 2006, GEND WAT SAN POL BRI; Isunju JB, 2011, PUBLIC HEALTH, V125, P368, DOI 10.1016/j.puhe.2011.03.008; Khanna T, 2016, GLOB PUBLIC HEALTH, V11, P1185, DOI 10.1080/17441692.2015.1062905; Khosla R, 2000, SOC CHANGE, V30, P192, DOI DOI 10.1177/004908570003000213; Kish L, 1965, SURVEY SAMPLING; Lundine J., 2012, CHILD YOUTH ENV, V22, P214, DOI [10.7721/chilyoutenvi.22.2.0214, DOI 10.7721/CHILYOUTENVI.22.2.0214]; Mahon T., 2010, Gender and Development, V18, P99, DOI 10.1080/13552071003600083; Massey K., 2011, INSECURITY SHAME EXP; Montgomery MA, 2007, ENVIRON SCI TECHNOL, V41, P17, DOI 10.1021/es072435t; Norstrom A, 2007, SWED WATER HOUSE REP, V21, P1; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Routray P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178042; Ruhiu J, 2009, STRATEGIC GUIDELINES; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Schonlau, 2012, STATA ADO PACKAGE HO; Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7; Tumwebaze IK, 2013, INT J ENVIRON HEAL R, V23, P191, DOI 10.1080/09603123.2012.713095; Unilever Domestos WaterAid (WSSCC) WSSCC, 2013, WE CANT WAIT REP SAN; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; WHO UNICEF, 2015, PROGR DRINK WAT SAN	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214114	10.1371/journal.pone.0214114	http://dx.doi.org/10.1371/journal.pone.0214114			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897125	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700067
J	Feldman, RE; Delman, BN; Pawha, PS; Dyvorne, H; Rutland, JW; Yoo, J; Fields, MC; Marcuse, LV; Balchandani, P				Feldman, Rebecca Emily; Delman, Bradley Neil; Pawha, Puneet Singh; Dyvorne, Hadrien; Rutland, John Watson; Yoo, Jiyeoun; Fields, Madeline Cara; Marcuse, Lara Vanessa; Balchandani, Priti			7T MRI in epilepsy patients with previously normal clinical MRI exams compared against healthy controls	PLOS ONE			English	Article							SURGICAL-TREATMENT; SURGERY; OUTCOMES; ADULT; QUANTIFICATION; RESECTION	Objective To compare by 7 Tesla (7T) magnetic resonance imaging (MRI) in patients with focal epilepsy who have non-lesional clinical MRI scans with healthy controls. Methods 37 patients with focal epilepsy, based on clinical and electroencephalogram (EEG) data, with non-lesional MRIs at clinical field strengths and 21 healthy controls were recruited for the 7T imaging study. The MRI protocol consisted of high resolution T-1-weighted, T-2-weighted and susceptibility weighted imaging sequences of the entire cortex. The images were read by two neuroradiologists, who were initially blind to clinical data, and then reviewed a second time with knowledge of the seizure onset zone. Results A total of 25 patients had findings with epileptogenic potential. In five patients these were definitely related to their epilepsy, confirmed through surgical intervention, in three they co-localized to the suspected seizure onset zone and likely caused the seizures. In seven patients the imaging findings co-localized to the suspected seizure onset zone but were not the definitive cause, and ten had cortical lesions with epileptogenic potential that did not localize to the suspected seizure onset zone. There were multiple other findings of uncertain significance found in both epilepsy patients and healthy controls. The susceptibility weighted imaging sequence was instrumental in guiding more targeted inspection of the other structural images and aiding in the identification of cortical lesions. Significance Information revealed by the improved resolution and enhanced contrast provided by 7T imaging is valuable in noninvasive identification of lesions in epilepsy patients who are non-lesional at clinical field strengths.	[Feldman, Rebecca Emily; Dyvorne, Hadrien; Rutland, John Watson; Balchandani, Priti] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Feldman, Rebecca Emily; Delman, Bradley Neil; Pawha, Puneet Singh; Dyvorne, Hadrien; Rutland, John Watson; Balchandani, Priti] Icahn Sch Med Mt Sinai, Radiol, New York, NY 10029 USA; [Yoo, Jiyeoun; Fields, Madeline Cara; Marcuse, Lara Vanessa] Mt Sinai Hosp, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Feldman, RE (corresponding author), Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA.; Feldman, RE (corresponding author), Icahn Sch Med Mt Sinai, Radiol, New York, NY 10029 USA.	rebecca.feldman2@mountsinai.org		Yoo, Ji Yeoun/0000-0001-7242-9779; Delman, Bradley/0000-0002-9792-8942	National Institutes of Health - National Institute of Neurological Disorders and Stroke [R00 NS070821]; Icahn School of Medicine Capital Campaign; Translational and Molecular Imaging Institute; Department of Radiology, Icahn School of Medicine at Mount Sinai	National Institutes of Health - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Icahn School of Medicine Capital Campaign; Translational and Molecular Imaging Institute; Department of Radiology, Icahn School of Medicine at Mount Sinai	This work was supported by the National Institutes of Health - National Institute of Neurological Disorders and Stroke - R00 NS070821, www.ninds.nih.gov/(PB); Icahn School of Medicine Capital Campaign (PB); Translational and Molecular Imaging Institute (PB); Department of Radiology, Icahn School of Medicine at Mount Sinai (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon G, 2006, J NEUROL NEUROSUR PS, V77, P474, DOI 10.1136/jnnp.2005.077289; Balchandani P, 2015, AM J NEURORADIOL, V36, P1204, DOI 10.3174/ajnr.A4180; BARKOVICH AJ, 1988, AM J NEURORADIOL, V9, P939; Barrett TF, 2017, WORLD NEUROSURG S, pS1878; Baumann CR, 2007, EPILEPSIA, V48, P559, DOI 10.1111/j.1528-1167.2006.00941.x; Berg AT, 2003, EPILEPSIA, V44, P1425, DOI 10.1046/j.1528-1157.2003.24203.x; Bertalanffy H, 2002, NEUROSURG REV, V25, P1, DOI 10.1007/s101430100179; Bien CG, 2009, ARCH NEUROL-CHICAGO, V66, P1491, DOI 10.1001/archneurol.2009.283; Breyer T, 2010, ACAD RADIOL, V17, P421, DOI 10.1016/j.acra.2009.10.013; Cappabianca P, 2002, MINIM INVAS NEUROSUR, V45, P193, DOI 10.1055/s-2002-36197; Chapman K, 2005, J NEUROL NEUROSUR PS, V76, P710, DOI 10.1136/jnnp.2003.026757; Colon AJ, 2016, ACTA NEUROL BELG, V116, P259, DOI 10.1007/s13760-016-0662-x; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Nguyen DK, 2013, CAN J NEUROL SCI, V40, P198, DOI 10.1017/S0317167100013731; De Ciantis A, 2015, AM J NEURORADIOL, V36, P309, DOI 10.3174/ajnr.A4116; De Ciantis A, 2016, EPILEPSIA, V57, P445, DOI 10.1111/epi.13313; Deblaere K, 2008, EUR RADIOL, V18, P119, DOI 10.1007/s00330-007-0710-2; Derix J, 2014, HUM BRAIN MAPP, V35, P4316, DOI 10.1002/hbm.22477; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; ENGEL J, 1993, NEUROLOGY, V43, P1612, DOI 10.1212/WNL.43.8.1612; Feldman RE, 2015, P ANN M INT SOC MAGN; Feldman RE, 2018, SEIZURE-EUR J EPILEP, V54, P11, DOI 10.1016/j.seizure.2017.11.004; Henry TR, 2011, RADIOLOGY, V261, P199, DOI 10.1148/radiol.11101651; Ikushima I, 1999, BRIT J RADIOL, V72, P1046, DOI 10.1259/bjr.72.863.10700819; Knake S, 2005, NEUROLOGY, V65, P1026, DOI 10.1212/01.wnl.0000179355.04481.3c; Krsek P, 2009, NEUROLOGY, V72, P217, DOI 10.1212/01.wnl.0000334365.22854.d3; KUZNIECKY R, 1993, ARCH NEUROL-CHICAGO, V50, P65, DOI 10.1001/archneur.1993.00540010059018; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lee SK, 2005, ANN NEUROL, V58, P525, DOI 10.1002/ana.20569; Madan N, 2009, EPILEPSIA, V50, P9, DOI 10.1111/j.1528-1167.2009.02292.x; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Nowell M, 2014, J NEUROL NEUROSUR PS, V85, P1273, DOI 10.1136/jnnp-2013-307069; O'Halloran R, 2017, NEUROREPORT, V28, P457, DOI 10.1097/WNR.0000000000000788; Phal PM, 2008, AM J ROENTGENOL, V191, P890, DOI 10.2214/AJR.07.3933; RYVLIN P, 1995, BRAIN, V118, P677, DOI 10.1093/brain/118.3.677; Schlamann M, 2010, ACAD RADIOL, V17, P3, DOI 10.1016/j.acra.2009.10.001; Spencer D, 2014, EPILEPSY CURR, V14, P261, DOI 10.5698/1535-7597-14.5.261; Stefan H, 2004, ACTA NEUROL SCAND, V110, P393, DOI 10.1111/j.1600-0404.2004.00333.x; Striano S, 2000, NEUROL SCI, V21, P151, DOI 10.1007/s100720070090; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Thompson JE, 1997, AM J NEURORADIOL, V18, P307; Veersema TJ, 2016, EPILEPTIC DISORD, V18, P315, DOI 10.1684/epd.2016.0838; Voets NL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16046-5; Wang ZI, 2013, MODERN PATHOL, V26, P1051, DOI 10.1038/modpathol.2013.52; Winston GP, 2013, EPILEPSY RES, V105, P349, DOI 10.1016/j.eplepsyres.2013.02.022	47	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213642	10.1371/journal.pone.0213642	http://dx.doi.org/10.1371/journal.pone.0213642			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889199	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000024
J	Gad, H; Khan, A; Akhtar, N; Kamran, S; El-Sotouhy, A; Dargham, SR; Petropoulos, IN; Ponirakis, G; Shuaib, A; Streletz, LJ; Malik, RA				Gad, Hoda; Khan, Adnan; Akhtar, Naveed; Kamran, Saadat; El-Sotouhy, Ahmed; Dargham, Soha R.; Petropoulos, Ioannis N.; Ponirakis, Georgios; Shuaib, Ashfaq; Streletz, Leopold J.; Malik, Rayaz A.			Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; CEREBROVASCULAR REACTIVITY; DIABETES-MELLITUS; FIBER NEUROPATHY; RISK; MANAGEMENT; DIAGNOSIS; DISEASE; TIA	Objective To determine if corneal confocal microscopy can identify corneal nerve and endothelial cell abnormalities and may be useful in the prognostication of patients with transient ischemic attack [1] or minor ischemic stroke (IS). Methods Thirty-six patients admitted with TIA (n = 14) or minor IS (n = 22) underwent transcranial Doppler evaluation and corneal confocal microscopy and were compared with 18 healthy controls. Results Corneal nerve fiber density (P = 0.002), branch density (P = 0.004) and fiber length (P = 0.004) were significantly lower in patients with TIA or minor IS compared to controls, with no difference between patients with TIA and minor IS. Endothelial cell density (P = 0.003) was lower and endothelial cell area (P = 0.003) and perimeter (P = 0.006) were significantly higher in patients with TIA or minor IS compared to controls, with no difference between patients with TIA and minor IS. There were no differences in corneal nerve or endothelial cell morphology between patients with and without abnormal cerebrovascular reactivity. HbA1c was independently associated with CNFL, and endothelial cell polymegathism and pleomorphism were associated with both HbA1c and total cholesterol. Conclusion Corneal confocal microscopy identifies corneal nerve fiber loss and endothelial cell abnormalities in patients with TIA and minor IS and independent associations with HbA1c and cholesterol.	[Gad, Hoda; Khan, Adnan; Petropoulos, Ioannis N.; Ponirakis, Georgios; Streletz, Leopold J.; Malik, Rayaz A.] Weill Cornell Med Qatar, Dept Med, Doha, Qatar; [Akhtar, Naveed; Kamran, Saadat; Shuaib, Ashfaq; Streletz, Leopold J.] Hamad Med Corp, Inst Neurosci, Doha, Qatar; [El-Sotouhy, Ahmed] Hamad Med Corp, Dept Radiol, Doha, Qatar; [Dargham, Soha R.] Weill Cornell Med Qatar, Biostat Epidemiol & Biomath Res Core, Doha, Qatar; [Shuaib, Ashfaq] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Malik, Rayaz A.] Univ Manchester, Inst Cardiovasc Med, Manchester, Lancs, England	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Alberta; University of Manchester	Malik, RA (corresponding author), Weill Cornell Med Qatar, Dept Med, Doha, Qatar.; Malik, RA (corresponding author), Univ Manchester, Inst Cardiovasc Med, Manchester, Lancs, England.	ram2045@qatar-med.cornell.edu	Kamran, Saadat/AAG-7499-2019; Ponirakis, Georgios/T-7207-2019; Malik, Rayaz/H-9231-2019; Streletz, Leopold J/AAN-8247-2020	Kamran, Saadat/0000-0002-0260-2086; Ponirakis, Georgios/0000-0002-6936-1248; Malik, Rayaz/0000-0002-7188-8903; Streletz, Leopold J/0000-0001-6250-2098; Khan, Adnan/0000-0003-4647-6672; Dargham, Soha/0000-0003-2695-6564	Qatar National Research Fund (QNRF) (Qatar Foundation) [6-565-3-141]	Qatar National Research Fund (QNRF) (Qatar Foundation)	This publication was made possible by NPRP grant [6-565-3-141] from the Qatar National Research Fund (QNRF) (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors.	Al-Fahdawi S, 2018, COMPUT METH PROG BIO, V160, P11, DOI 10.1016/j.cmpb.2018.03.015; Aoi MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046794; Asghar O, 2014, DIABETES CARE, V37, P2643, DOI 10.2337/dc14-0279; Baird TA, 2002, J CLIN NEUROSCI, V9, P618, DOI 10.1054/jocn.2002.1081; Beer CD, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-46; Benamer HTS, 2009, J NEUROL SCI, V284, P18, DOI 10.1016/j.jns.2009.04.029; Bitirgen G, 2014, DIABETIC MED, V31, P431, DOI 10.1111/dme.12324; Deeb A, 2016, DIABETES TECHNOL THE, V18, P539, DOI 10.1089/dia.2016.0197; Dehghani C, 2014, INVEST OPHTH VIS SCI, V55, P3195, DOI 10.1167/iovs.14-13959; Duca A, 2016, EMERG MED CLIN N AM, V34, P811, DOI 10.1016/j.emc.2016.06.007; Ferdousi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139394; Ferrari G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00278; Gao EZ, 1998, AM J PHYSIOL-HEART C, V274, pH1023, DOI 10.1152/ajpheart.1998.274.3.H1023; He ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep29047; Kass-Iliyya L, 2015, PARKINSONISM RELAT D, V21, P1454, DOI 10.1016/j.parkreldis.2015.10.019; Khan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35298-3; Khan A, 2017, STROKE, V48, P3012, DOI 10.1161/STROKEAHA.117.018289; KIYOHARA Y, 1990, J HYPERTENS, V8, pS9; Knottnerus ILH, 2009, CEREBROVASC DIS, V27, P519, DOI 10.1159/000212672; Li XL, 2017, J CLIN NEUROSCI, V40, P34, DOI 10.1016/j.jocn.2017.01.018; Llwyd O, 2018, CEREBROVASC DIS EXTR, V8, P80, DOI 10.1159/000487514; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Mikolajczak J, 2017, MULT SCLER J, V23, P1847, DOI 10.1177/1352458516677590; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; Petropoulos IN, 2014, INVEST OPHTH VIS SCI, V55, P2071, DOI 10.1167/iovs.13-13787; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; SAGE H, 1981, ARTERIOSCLEROSIS, V1, P427, DOI 10.1161/01.ATV.1.6.427; Santos-Garcia D, 2011, CEREBROVASC DIS, V32, P155, DOI 10.1159/000328651; SHUAIB A, 1992, CEREBROVAS BRAIN MET, V4, P329; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 1996, STROKE, V27, P1970, DOI 10.1161/01.STR.27.11.1970; Stevenson SF, 2010, STROKE, V41, pE434, DOI 10.1161/STROKEAHA.109.569855; Szalai E, 2016, INVEST OPHTH VIS SCI, V57, P853, DOI 10.1167/iovs.15-18735; Tavakoli M, 2015, DIABETES CARE, V38, P838, DOI 10.2337/dc14-2311; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tavakoli M, 2010, EXP NEUROL, V223, P245, DOI 10.1016/j.expneurol.2009.08.033; Vagenas D, 2012, OPTOMETRY VISION SCI, V89, P812, DOI 10.1097/OPX.0b013e31824ee8c9; Wardlaw JM, 2015, NEUROLOGY, V85, P373, DOI 10.1212/WNL.0000000000001780; Wijnhoud AD, 2006, J CLIN ULTRASOUND, V34, P70, DOI 10.1002/jcu.20193; Yaghi S, 2016, NEUROL-CLIN PRACT, V6, P157, DOI 10.1212/CPJ.0000000000000234; Zerna C, 2018, STROKE, V49, P919, DOI 10.1161/STROKEAHA.117.017429; Zerna C, 2016, STROKE, V47, P2236, DOI 10.1161/STROKEAHA.116.013418	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213319	10.1371/journal.pone.0213319	http://dx.doi.org/10.1371/journal.pone.0213319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875374	gold, Green Submitted, Green Published			2022-12-26	WOS:000461316400011
J	Trutnovsky, G; Robledo, KP; Shek, KL; Dietz, HP				Trutnovsky, Gerda; Robledo, Kristy P.; Shek, Ka Lai; Dietz, Hans Peter			Definition of apical descent in women with and without previous hysterectomy: A retrospective analysis	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; FLOOR DISORDERS; SYMPTOMS; PREVALENCE; SEVERITY; SUPPORT	Background While normal pelvic organ support has been defined for women with intact uterus, this is not the case for post- hysterectomy vault descent. A recent systematic review found that definitions of apical prolapse are highly variable. Objectives To investigate the relationship between prolapse symptoms and apical POP-Q measurements and establish cutoffs for 'significant apical descent using receiver operator characteristics (ROC) statistics. Study design Retrospective analysis of patients seen at a tertiary urogynecological unit. Evaluation included a standardized interview and clinical assessment using the Pelvic Organ Prolapse Quantification (POP-Q) system. ROC curves were prepared for the relationship between prolapse symptoms and POP-Q measure "C". Results The records of 3010 women were available for analysis. Prolapse symptoms were reported by 52.3% (n = 1573), with a mean bother of 5.9 (SD 3.0, range 0-10). POP-Q point "C" was associated with symptoms of prolapse (p <0.0001) and prolapse bother (p <0.0001) on both univariate and multivariate analysis. ROC curves for women with and without uterus were similar, although the relationship between apical descent and symptoms of prolapse was stronger for women with uterus (AUC 0.728 versus 0.678). After controlling for multi-compartment prolapse, the models improved, resulting in AUCs of 0.782 and 0.720. For prediction of prolapse symptoms, cutoffs were set at C = -5 (sensitivity 0.73, specificity 0.67 with uterus in situ, sensitivity 0.59, specificity, 0.73 after hysterectomy). Conclusion A cut-off for 'significant central compartment descent' of 5 cm above the hymen on Valsalva seems valid regardless of previous hysterectomy.	[Trutnovsky, Gerda] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria; [Trutnovsky, Gerda; Dietz, Hans Peter] Univ Sydney, Dept Obstet & Gynaecol, Nepean Clin Sch, Sydney, NSW, Australia; [Robledo, Kristy P.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Shek, Ka Lai] Western Sydney Univ, Dept Obstet & Gynaecol, Liverpool Clin Sch, Liverpool, Merseyside, England	Medical University of Graz; University of Sydney; University of Sydney; Western Sydney University	Trutnovsky, G (corresponding author), Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria.; Trutnovsky, G (corresponding author), Univ Sydney, Dept Obstet & Gynaecol, Nepean Clin Sch, Sydney, NSW, Australia.	gerda.trutnovsky@medunigraz.at	liu, wei/AAU-1999-2021	Robledo, Kristy/0000-0003-0213-7652; Trutnovsky, Gerda/0000-0001-6445-2418				Abdel-fattah M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000206; Barber MD, 2005, CLIN OBSTET GYNECOL, V48, P648, DOI 10.1097/01.grf.0000170424.11993.73; Blain G, 2008, AUST NZ J OBSTET GYN, V48, P317, DOI 10.1111/j.1479-828X.2008.00872.x; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Dietz HP, 2007, ULTRASOUND OBST GYN, V29, P688, DOI 10.1002/uog.4024; Dietz HP, 2014, INT UROGYNECOL J, V25, P451, DOI 10.1007/s00192-013-2307-4; Dietz HP, 2010, INT UROGYNECOL J, V21, pS66, DOI 10.1007/s00192-010-1329-4; Digesu GA, 2005, BJOG-INT J OBSTET GY, V112, P971, DOI 10.1111/j.1471-0528.2005.00568.x; Ghetti C, 2005, AM J OBSTET GYNECOL, V193, P53, DOI 10.1016/j.ajog.2004.12.004; Gutman RE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.028; Meister MRL, 2017, AM J OBSTET GYNECOL, V216, P232, DOI 10.1016/j.ajog.2016.09.078; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Orejuela FJ, 2012, INT UROGYNECOL J, V23, P175, DOI 10.1007/s00192-011-1533-x; Shek KL, 2015, INT UROGYNECOL J, V26, P1783, DOI 10.1007/s00192-015-2792-8; Smith FJ, 2010, OBSTET GYNECOL, V116, P1096, DOI 10.1097/AOG.0b013e3181f73729; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; Ulrich D, 2014, ULTRASOUND OBST GYN, V43, P693, DOI 10.1002/uog.13222; Wu JM, 2009, OBSTET GYNECOL, V114, P1278, DOI 10.1097/AOG.0b013e3181c2ce96	19	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213617	10.1371/journal.pone.0213617	http://dx.doi.org/10.1371/journal.pone.0213617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875415	gold, Green Published			2022-12-26	WOS:000461316400018
J	Ulmer, M; Ziegelmeier, L; Topaz, CM				Ulmer, M.; Ziegelmeier, Lori; Topaz, Chad M.			A topological approach to selecting models of biological experiments	PLOS ONE			English	Article							PERSISTENCE; TOOLS	We use topological data analysis as a tool to analyze the fit of mathematical models to experimental data. This study is built on data obtained from motion tracking groups of aphids in [Nilsen et al., PLOS One, 2013] and two random walk models that were proposed to describe the data. One model incorporates social interactions between the insects via a functional dependence on an aphid's distance to its nearest neighbor. The second model is a control model that ignores this dependence. We compare data from each model to data from experiment by performing statistical tests based on three different sets of measures. First, we use time series of order parameters commonly used in collective motion studies. These order parameters measure the overall polarization and angular momentum of the group, and do not rely on a priori knowledge of the models that produced the data. Second, we use order parameter time series that do rely on a priori knowledge, namely average distance to nearest neighbor and percentage of aphids moving. Third, we use computational persistent homology to calculate topological signatures of the data. Analysis of the a priori order parameters indicates that the interactive model better describes the experimental data than the control model does. The topological approach performs as well as these a priori order parameters and better than the other order parameters, suggesting the utility of the topological approach in the absence of specific knowledge of mechanisms underlying the data.	[Ulmer, M.; Ziegelmeier, Lori] Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA; [Topaz, Chad M.] Williams Coll, Dept Math & Stat, Williamstown, MA 01267 USA	Macalester College; Williams College	Ziegelmeier, L (corresponding author), Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA.	lziegel1@macalester.edu		Ziegelmeier, Lori/0000-0002-1544-4937	National Science Foundation [NSF DMS-1813752]; Macalester College Wallace Scholarly Activities Grant	National Science Foundation(National Science Foundation (NSF)); Macalester College Wallace Scholarly Activities Grant	This research was funded by the National Science Foundation NSF DMS-1813752 to CMT and the Macalester College Wallace Scholarly Activities Grant to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H, 2017, J MACH LEARN RES, V18; Burnham K P, 2003, MODEL SELECT MULTIMO; Carlsson G, 2009, DISCRETE COMPUT GEOM, V42, P71, DOI 10.1007/s00454-009-9176-0; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Corcoran P, 2017, IEEE ACCESS, V5, P18534, DOI 10.1109/ACCESS.2017.2749319; Crossley M.D., 2006, ESSENTIAL TOPOLOGY; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; Edelsbrunner H, 2000, ANN IEEE SYMP FOUND, P454; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Ghrist R, 2008, B AM MATH SOC, V45, P61, DOI 10.1090/s0273-0979-07-01191-3; Giusti C, 2016, J COMPUT NEUROSCI, V41, P1, DOI 10.1007/s10827-016-0608-6; Giusti C, 2015, P NATL ACAD SCI USA, V112, P13455, DOI 10.1073/pnas.1506407112; Hatcher A., 2005, ALGEBRAIC TOPOLOGY; Huepe C, 2008, PHYSICA A, V387, P2809, DOI 10.1016/j.physa.2008.01.081; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kim W., 2017, ARXIV171204064; Lesnick M, 2015, ARXIV E PRINTS; Munkres J.R., 1993, ELEMENTS ALGEBRAIC T; Nicolau M, 2011, P NATL ACAD SCI USA, V108, P7265, DOI 10.1073/pnas.1102826108; Nilsen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083343; Otter N, 2017, EPJ DATA SCI, V6, DOI 10.1140/epjds/s13688-017-0109-5; Taylor D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8723; Topaz CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126383; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Xia KL, 2015, J COMPUT CHEM, V36, P1502, DOI 10.1002/jcc.23953; Zomorodian A, 2005, DISCRETE COMPUT GEOM, V33, P249, DOI 10.1007/s00454-004-1146-y	26	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213679	10.1371/journal.pone.0213679	http://dx.doi.org/10.1371/journal.pone.0213679			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875410	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400022
J	Iqbal, M; Ezzeldin, E; Herqash, RN; Alam, O				Iqbal, Muzaffar; Ezzeldin, Essam; Herqash, Rashed Naji; Alam, Ozair			Ultra-performance hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry for simultaneous determination of allopurinol, oxypurinol and lesinurad in rat plasma: Application to pharmacokinetic study in rats	PLOS ONE			English	Article							SERUM URATE; URIC-ACID; PHARMACODYNAMICS; HYPERURICEMIA; FEBUXOSTAT; OXIPURINOL; GOUT; MANAGEMENT; DRUG	A fixed dose combination of lesinurad and allopurinol has been recently approved by USFDA and EMA for treatment of gout-associated hyperuricemia in patients who have not achieved target serum uric acid levels with allopurinol alone. In this study, an ultra-performance hydrophilic interaction liquid chromatography (UPHILIC) coupled with tandem mass spectrometry method was developed and validated for simultaneous determination of allopurinol, oxypurinol and lesinurad in rat plasma. Liquid liquid extraction using ethyl acetate as extracting agent was used for samples extraction procedure. Acquity UPLC HILIC column (100 mm x 2.1, 1.7 mu m) was used for separation of allopurinol, oxypurinol, lesinurad and internal standard (5-Florouracil). The mobile phase consisting of acetonitrile, water and formic acid (95: 5: 0.1, v/v/v), were eluted at 0.3 mL/min flow rate having total chromatographic run time of 3 min per sample. The analytes were detected on Acquity triple quadrupole mass spectrometer equipped with a Z-Spray electrospray ionization (ESI). The ESI source was operated in negative mode and multiple reaction monitoring was used for ion transition for all compounds. The precursor to product ion transition of m/z 134.94 > 64.07 for allopurinol, 150.89 > 41.91 for oxypurinol, 401.90 > 176.79 for lesinurad and 128.85 > 41.92 for internal standard were used for identification and quantification. The calibration curves for all analytes were found to be linear with weighing factor of 1/x(2) using regression analysis. The developed assay was successfully applied in an oral pharmacokinetic study of allopurinol, oxypurinol and lesinurad in rats.	[Iqbal, Muzaffar; Ezzeldin, Essam; Herqash, Rashed Naji] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Iqbal, Muzaffar; Ezzeldin, Essam] King Saud Univ, Coll Pharm, Bioavailabil Lab, Riyadh, Saudi Arabia; [Alam, Ozair] Jamia Hamdard, Dept Pharmaceut Chem, Sch Pharmaceut Educ & Res, Med Chem & Mol Modelling Lab, New Delhi, India	King Saud University; King Saud University; Jamia Hamdard University	Iqbal, M (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia.; Iqbal, M (corresponding author), King Saud Univ, Coll Pharm, Bioavailabil Lab, Riyadh, Saudi Arabia.	muziqbal@ksu.edu.sa	Iqbal, Muzaffar/GXF-8249-2022; Herqash, Rashed/AAE-5349-2019	Herqash, Rashed/0000-0002-4502-9507; ALAM, OZAIR/0000-0003-0322-2509; Iqbal, Muzaffar/0000-0001-5821-5600	Deanship of Scientific Research at King Saud University [RGP-203]	Deanship of Scientific Research at King Saud University(King Saud University)	Study is funded by Deanship of Scientific Research at King Saud University through the research group project no. RGP-203. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasya G, 2018, J PHARMACEUT BIOMED, V154, P285, DOI 10.1016/j.jpba.2018.03.021; [Anonymous], 2018, JAMA, V319, P188, DOI 10.1001/jama.2017.20189; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Cardillo C, 1997, HYPERTENSION, V30, P57, DOI 10.1161/01.HYP.30.1.57; Chung Y, 2008, AM J MED SCI, V335, P219, DOI 10.1097/MAJ.0b013e31815acb10; Day RO, 2007, CLIN PHARMACOKINET, V46, P623, DOI 10.2165/00003088-200746080-00001; DEVRIES JX, 1993, ARZNEIMITTEL-FORSCH, V43-2, P1072; ELION GB, 1968, AM J MED, V45, P69, DOI 10.1016/0002-9343(68)90008-9; European Medical Agency, ASS REP ZUR LES; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Liu X, 2013, J CHROMATOGR B, V941, P10, DOI 10.1016/j.jchromb.2013.09.028; McGill NW, 2011, OPEN ACCESS RHEUMATO, V3, P73, DOI 10.2147/OARRR.S10313; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Perez-Ruiz F, 2010, ARTHRIT CARE RES, V62, P1299, DOI 10.1002/acr.20221; Rathod DM, 2017, J PHARM ANAL, V7, P56, DOI 10.1016/j.jpha.2016.05.005; Reinders MK, 2007, J PHARMACEUT BIOMED, V45, P312, DOI 10.1016/j.jpba.2007.08.002; Saag KG, 2016, ARTHRITIS RHEUMATOL, V68, P2035, DOI 10.1002/art.39654; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Shen ZC, 2015, DRUG DES DEV THER, V9, P3423, DOI 10.2147/DDDT.S85193; Stamp LK, 2011, CLIN PHARMACOL THER, V90, P392, DOI 10.1038/clpt.2011.113; Stocker SL, 2012, BRIT J CLIN PHARMACO, V74, P477, DOI 10.1111/j.1365-2125.2012.04207.x; Stocker SL, 2010, J CHROMATOGR B, V878, P2363, DOI 10.1016/j.jchromb.2010.07.017; Tada H, 2003, J CLIN PHARM THER, V28, P229, DOI 10.1046/j.1365-2710.2003.00488.x; Turnheim K, 1999, BRIT J CLIN PHARMACO, V48, P501; US Food and drug administration, 2001, GUID IND BIOAN METH; WALTERSACK I, 1993, CLIN INVESTIGATOR, V71, P240; YU TF, 1964, AM J MED, V37, P885, DOI 10.1016/0002-9343(64)90131-7; Zhou XY, 2017, CHEM CENT J, V11, P1, DOI 10.1186/s13065-017-0353-6	28	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213786	10.1371/journal.pone.0213786	http://dx.doi.org/10.1371/journal.pone.0213786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870504	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300075
J	Mao, WH; Huang, YY; Chen, W				Mao, Wenhui; Huang, Yunyu; Chen, Wen			An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China	PLOS ONE			English	Article								Background The National Essential Medicine Policy and the Zero Mark-up Policy was introduced to improve the rational use and affordability of medicine. This study analyzed the changes of medicine use at different Health Care Institutions in Hangzhou city after the implementation of National Essential Medicine Policy and the Zero Mark-up Policy. Methods Facility based survey was conducted in 17 Health Care Institutions and 16406 outpatient prescriptions in 2011 and 2013 were collected. Average number of medicines, average number of antibiotics and average expenditure per prescription were analyzed. Comparisons between 2011 and 2013, among different levels of Health Care Institutions and age groups were conducted. Results The average number of medicines per prescription, use of antibiotics, intramuscular (IM) injections and intravenous (IV) injections decreased while the use of hormones increased. No significant change of the average medicine expenditure per prescription was observed. Disparities among different levels of Health Care Institutions and different age groups existed. Conclusion The problems of poly-pharmacy, overuse of antibiotics, intramuscular (IM) injections and intravenous (IV) injections and hormones still existed, however mitigated after the implementation of The National Essential Medicine Policy and the Zero Mark-up Policy.	[Mao, Wenhui; Huang, Yunyu; Chen, Wen] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Mao, Wenhui] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Fudan University; Duke University	Chen, W (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.	wenchen@fudan.edu.cn	Mao, Wenhui/T-3573-2019	Mao, Wenhui/0000-0001-9214-7787	Alliance for Health Policy and Systems Research (AHPSR), the World Health Organization [ATM2012-01-CHINA]	Alliance for Health Policy and Systems Research (AHPSR), the World Health Organization	This research was funded by Alliance for Health Policy and Systems Research (AHPSR), the World Health Organization (ATM2012-01-CHINA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen MS, 2014, PHARMACOECONOMICS, V32, P245, DOI 10.1007/s40273-013-0068-z; China National Health Development Research Center of Ministry of Health of the People's of Republic of China, 2013, CHIN NAT HLTH ACC RE; Eggleston K, 2008, HEALTH ECON, V17, P149, DOI 10.1002/hec.1306; Health Department of Hangzhou, 2013, NOT 2013 WORK EMPH H; Health Department of Hangzhou, NOT OP IMPL NAT ESS; Hu Shanlian, 2013, J Med Econ, V16, P289, DOI 10.3111/13696998.2012.751176; Mao WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117710; Mao WH, 2013, EXPERT REV PHARM OUT, V13, P693, DOI 10.1586/14737167.2013.856266; Ministry of Health Statistics Information Center of the People's of Republic of China, 2012, 2012 HLTH STAT YB; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082359; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Pileggi C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413912; Rieckert A, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0789-3; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; Tang JB, 1995, CHINA PHARM, V6, P5; Tang S, 2007, PHARM POLICIES CHINA; The Statistics Website of Hangzhou, 2015, 2014 HANGZH STAT YB; World Health Organization, EQ ACC ESS MED FRAM; World Health Organization, 2012, PURS RESP US MED SHA; World Health Organization, 1993, INVESTIGATE DRUG USE; World Health Organization, 2004, POLICY PERSPECTIVES, V3, P1; World Health Organization and OECD, 2014, MEAS PROGR UN HLTH C, DOI [10.1787/health_glance_ap-2014-en, DOI 10.1787/HEALTH_GLANCE_AP-2014-EN]; Yang L, 2013, B WORLD HEALTH ORGAN, V91, P184, DOI 10.2471/BLT.11.097998	23	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213638	10.1371/journal.pone.0213638	http://dx.doi.org/10.1371/journal.pone.0213638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870490	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300052
J	Morimoto, J; Senior, A; Ruiz, K; Wali, JA; Pulpitel, T; Solon-Biet, SM; Cogger, VC; Raubenheimer, D; Le Couteur, DG; Simpson, SJ; Eberhard, J				Morimoto, Juliano; Senior, Alistair; Ruiz, Kate; Wali, Jibran A.; Pulpitel, Tamara; Solon-Biet, Samantha M.; Cogger, Victoria C.; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.; Eberhard, Joerg			Sucrose and starch intake contribute to reduced alveolar bone height in a rodent model of naturally occurring periodontitis	PLOS ONE			English	Article							INFECTION; ECOLOGY; IMPACT; DIETS; AGE	While there is a burgeoning interest in the effects of nutrition on systemic inflammatory diseases, how dietary macronutrient balance impacts local chronic inflammatory diseases in the mouth has been largely overlooked. Here, we used the Geometric Framework for Nutrition to test how the amounts of dietary macronutrients and their interactions, as well as carbohydrate type (starch vs sucrose vs resistant starch) influenced periodontitis-associated alveolar bone height in mice. Increasing intake of carbohydrates reduced alveolar bone height, while dietary protein had no effect. Whether carbohydrate came from sugar or starch did not influence the extent of alveolar bone height. In summary, the amount of carbohydrate in the diet modulated periodontitis-associated alveolar bone height independent of the source of carbohydrates.	[Morimoto, Juliano; Senior, Alistair; Ruiz, Kate; Wali, Jibran A.; Pulpitel, Tamara; Solon-Biet, Samantha M.; Cogger, Victoria C.; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.; Eberhard, Joerg] Charles Perkins Ctr, Camperdown, NSW, Australia; [Morimoto, Juliano] Univ Fed Parana, Programa Posgrad Ecol & Conservacao, Curitiba, Parana, Brazil; [Morimoto, Juliano] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Senior, Alistair] Univ Sydney, Sch Math & Stat, Camperdown, NSW, Australia; [Senior, Alistair; Wali, Jibran A.; Pulpitel, Tamara; Solon-Biet, Samantha M.; Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Sch Life & Environm Sci, Camperdown, NSW, Australia; [Ruiz, Kate; Eberhard, Joerg] Univ Sydney, Dent Sch, Fac Hlth & Med, Sydney, NSW, Australia; [Cogger, Victoria C.; Le Couteur, David G.] Ctr Educ & Res Ageing, Concord, NSW, Australia; [Cogger, Victoria C.; Le Couteur, David G.] Concord Repatriat Gen Hosp, Concord, NSW, Australia	University of Sydney; Universidade Federal do Parana; Macquarie University; University of Sydney; University of Sydney; University of Sydney; Concord Repatriation General Hospital	Eberhard, J (corresponding author), Charles Perkins Ctr, Camperdown, NSW, Australia.; Eberhard, J (corresponding author), Univ Sydney, Dent Sch, Fac Hlth & Med, Sydney, NSW, Australia.	joerg.eberhard@sydney.edu.au	Wali, Jibran/K-9843-2019; Morimoto, Juliano/AAE-5517-2020; Eberhard, Joerg/AAY-9034-2020; Senior, Alistair/AAH-8409-2021; Solon-Biet, Samantha/R-6551-2017	Wali, Jibran/0000-0002-8524-5773; Morimoto, Juliano/0000-0003-3561-1920; Eberhard, Joerg/0000-0001-8060-2893; Simpson, Stephen J./0000-0003-0256-7687; Solon-Biet, Samantha/0000-0003-0608-958X; Raubenheimer, David/0000-0001-9050-1447	Strategic Research Excellence Initiative 2020 (SREI2020), University of Sydney; University of Sydney HMR + Implementation Funding Grant	Strategic Research Excellence Initiative 2020 (SREI2020), University of Sydney; University of Sydney HMR + Implementation Funding Grant	This research project was funded in part by the Strategic Research Excellence Initiative 2020 (SREI2020), University of Sydney to JE and the University of Sydney HMR + Implementation Funding Grant to VC, DLC and SS.	Adegboye ARA, 2012, NUTRIENTS, V4, P1219, DOI 10.3390/nu4091219; Andersson U, 2010, DIABETES OBES METAB, V12, P976, DOI 10.1111/j.1463-1326.2010.01288.x; Bartold PM, 2017, PERIODONTOL 2000, V75, P317, DOI 10.1111/prd.12169; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumgartner S, 2009, J PERIODONTOL, V80, P759, DOI 10.1902/jop.2009.080376; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Eberhard J, 2002, J CLIN PERIODONTOL, V29, P364, DOI 10.1034/j.1600-051X.2002.290413.x; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Ericsson JS, 2009, SWED DENT J, V33, P131; Gatej SM, 2018, J CLIN PERIODONTOL, V45, P204, DOI 10.1111/jcpe.12838; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Le Couteur DG, 2016, CELL MOL LIFE SCI, V73, P1237, DOI 10.1007/s00018-015-2120-y; Li YH, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011014, 10.1371/journal.pone.0015219]; Liang S, 2010, J PERIODONTAL RES, V45, P574, DOI 10.1111/j.1600-0765.2009.01245.x; Lima HR, 2010, J CLIN PERIODONTOL, V37, P248, DOI 10.1111/j.1600-051X.2009.01531.x; Linden GJ, 2013, J PERIODONTOL, V84, pS20, DOI [10.1111/jcpe.12091, 10.1902/jop.2013.1340020]; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; MORMANN JE, 1981, CARIES RES, V15, P166; Napimoga MH, 2013, J NAT PROD, V76, P2316, DOI 10.1021/np400691n; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pitts NB, 2017, NAT REV DIS PRIMERS, V3, P1, DOI 10.1038/nrdp.2017.30; Polak D, 2009, J CLIN PERIODONTOL, V36, P406, DOI 10.1111/j.1600-051X.2009.01393.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raubenheimer D, 2016, ANNU REV NUTR, V36, P603, DOI 10.1146/annurev-nutr-071715-051118; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SHAW JH, 1961, ARCH ORAL BIOL, V5, P301, DOI 10.1016/0003-9969(61)90066-8; Simpson Stephen J, 2017, Nutr Healthy Aging, V4, P217, DOI 10.3233/NHA-170027; Slawik S, 2011, EUR J CLIN NUTR, V65, P857, DOI 10.1038/ejcn.2011.45; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Trombone APF, 2009, J PERIODONTAL RES, V44, P443, DOI 10.1111/j.1600-0765.2008.01133.x; VANDERVELDEN U, 1991, J CLIN PERIODONTOL, V18, P380; Woelber JP, 2016, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0257-1; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	35	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212796	10.1371/journal.pone.0212796	http://dx.doi.org/10.1371/journal.pone.0212796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865648	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900040
J	Dal Pizzol, TD; Fontanella, AT; Ferreira, MBC; Bertoldi, AD; Borges, RB; Mengue, SS				Dal Pizzol, Tatiane da Silva; Fontanella, Andreia Turmina; Cardoso Ferreira, Maria Beatriz; Bertoldi, Andrea Damaso; Borges, Rogerio Boff; Mengue, Sotero Serrate			Analgesic use among the Brazilian population: Results from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM)	PLOS ONE			English	Article							PRESCRIPTION; PREVALENCE; METAMIZOLE; PATTERN; SAFETY; GENDER; IMPACT; DRUG	Purpose To estimate the prevalence of use of analgesics in Brazil; and to characterize this use, according to sociodemographic and health-related characteristics. Methods A cross-sectional population-based study (National Survey on Access, Use and Promotion of Rational Use of Medicines, PNAUM) was conducted between September 2013 and February 2014. A total of 41,433 people of all ages in Brazilian urban households were interviewed. Occasional use (within the last 15 days) and continuous use of non-opioid analgesics, opioid analgesics and non-steroidal anti-inflammatory drugs were investigated, regardless of whether this use occurred through prescription or self-medication. The main outcome was the use of at least one analgesic. Results The majority of the individuals were female (52.8%), aged between 20 and 59 years (57.2%), with 1 to 8 years of schooling (45.6%). The overall prevalence of analgesic use was 22.8% [95% CI: 21.4-24.2]. The use of analgesics was significantly higher among women, adults and elderly (20 years or more), highly educated individuals and respondents who referred: diagnosis of one or more chronic diseases, using three or more medications, possession of health insurance and with one or more emergency care admittances or hospitalizations within the last year. Non-opioid analgesics were the agents most used (18.5% of the sample), followed by non-steroidal anti-inflammatory drugs (6.9%) and opioid analgesics (0.5%). The most commonly used drugs were metamizole (37.8% of all analgesics), paracetamol (25.3%) and diclofenac (10.7%). These drugs were used mainly to manage occasional health conditions, particularly pain. Conclusion One in five Brazilians used some analgesic, especially non-opioid analgesics, to manage acute health problems such as painful conditions.	[Dal Pizzol, Tatiane da Silva] Univ Fed Rio Grande do Sul, Sch Pharm, Dept Prod & Control Med, Porto Alegre, RS, Brazil; [Dal Pizzol, Tatiane da Silva; Fontanella, Andreia Turmina; Borges, Rogerio Boff; Mengue, Sotero Serrate] Univ Fed Rio Grande do Sul, Sch Med, Grad Program Epidemiol, Porto Alegre, RS, Brazil; [Cardoso Ferreira, Maria Beatriz] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Pharmacol, Porto Alegre, RS, Brazil; [Bertoldi, Andrea Damaso] Fed Univ Pelotas UFPEL, Grad Program Epidemiol, Pelotas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas	Dal Pizzol, TD (corresponding author), Univ Fed Rio Grande do Sul, Sch Pharm, Dept Prod & Control Med, Porto Alegre, RS, Brazil.; Dal Pizzol, TD (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Grad Program Epidemiol, Porto Alegre, RS, Brazil.	tatiane.silva@ufrgs.br	Ferreira, Maria Beatriz C/G-6561-2012; Boff Borges, Rogério/AFJ-8172-2022; Bertoldi, Andrea Dâmaso/AAG-7396-2021	Boff Borges, Rogério/0000-0002-2548-1889; Turmina Fontanella, Andreia/0000-0003-0455-9429; Mengue, Sotero/0000-0002-3349-8541	Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia of Brazil [25000.111834/2]	Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia of Brazil	The National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM) was supported by Ministerio da Saude, Secretaria de Ciencia e Tecnologia Insumos Estrategicos, Departamento de Assistencia Farmaceutica e Insumos Estrategicos e Departamento de Ciencia e Tecnologia of Brazil (Processo 25000.111834/2).	Andrade S, 2016, J CLIN PHARM THER, V41, P459, DOI 10.1111/jcpt.12422; [Anonymous], 2013, CLASS ASS BRAS EMPR; Antonov KIM, 1998, ANN PHARMACOTHER, V32, P485, DOI 10.1345/aph.16409; Blaser LS, 2015, EUR J CLIN PHARMACOL, V71, P209, DOI 10.1007/s00228-014-1781-z; Castellsague J, 2012, DRUG SAF, V20; Cooney N, 2015, THERAPEUTICS CLIN RI, V1061; Dale O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1774-6; Arrais PSD, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006117, 10.1590/S1518-8787.2016050006117]; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Isacson D, 2002, EUR J ANAESTH, V19, P5, DOI 10.1097/00003643-200219261-00003; Lewis JD, 2006, PHARMACOEPIDEM DR S, V15, P39, DOI 10.1002/pds.1134; Lindsley CW, 2016, ACS CHEM NEUROSCI, V7, P842, DOI 10.1021/acschemneuro.6b00177; Lindsley CW, 2015, ACS CHEM NEUROSCI, V6, P505, DOI 10.1021/acschemneuro.5b00098; Mengue SS, 2016, REV SAU PUBLICA, V50; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008659.pub3; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010794.pub2; Moraes Cassia Garcia, 2017, Rev. bras. epidemiol., V20, P324, DOI 10.1590/1980-5497201700020012; Motola D, 2004, EUR J CLIN PHARMACOL, V60, P731, DOI 10.1007/s00228-004-0826-0; Paulose-Ram R, 2003, PHARMACOEPIDEM DR S, V12, P315, DOI 10.1002/pds.755; Porteous T., 2004, FAM PRACT, V22, P78; Rotermann M, 2014, HLTH REPORTS, V25, P9; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Samuelsen PJ, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0016-y; SANTOS LUIZA GOMES, 2017, Coluna/Columna, V16, P198, DOI 10.1590/s1808-185120171603165890; Sarganas G, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0028-7; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; WHO Collaborating Centre, WHOCC ATC DDD IND; Zin CS, 2014, EUR J PAIN, V18, P1343, DOI 10.1002/j.1532-2149.2014.496.x	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214329	10.1371/journal.pone.0214329	http://dx.doi.org/10.1371/journal.pone.0214329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897156	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700083
J	Martin, A; Gravelle, TB; Baekkeskov, E; Lewis, J; Kashima, Y				Martin, Aaron; Gravelle, Timothy B.; Baekkeskov, Erik; Lewis, Jenny; Kashima, Yoshi			Enlisting the support of trusted sources to tackle policy problems: The case of antimicrobial resistance	PLOS ONE			English	Article							TELEPHONE; POLARIZATION; ANTIBIOTICS; INTERNET	Antimicrobial resistance represents one of the world's most pressing public health problems. Governments around the world have-and will continue to-develop policy proposals to deal with this problem. However, the capacity of government will be constrained by very low levels of trust in government. This stands in contrast to 'medical scientists' who are highly trusted by the public. This article tests to what extent trusted sources can alter attitudes towards a policy proposal to regulate the use of antibiotics. We find that respondents are much more likely to support a policy put forward by 'medical scientists.' This article provides some initial evidence that medical scientists could be used to gain support for policies to tackle pressing policy challenges such as AMR.	[Martin, Aaron; Baekkeskov, Erik; Lewis, Jenny] Univ Melbourne, Sch Social & Polit Sci, Fac Arts, Melbourne, Vic, Australia; [Gravelle, Timothy B.] Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia; [Kashima, Yoshi] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne; University of Queensland; University of Melbourne	Martin, A (corresponding author), Univ Melbourne, Sch Social & Polit Sci, Fac Arts, Melbourne, Vic, Australia.	aaron.martin@unimelb.edu.au	Gravelle, Timothy B./I-3077-2019; Baekkeskov, Erik/HGB-4962-2022	Gravelle, Timothy B./0000-0002-7091-206X; Lewis, Jenny M/0000-0001-5858-8634	Australian Research Council (Understanding the Causes of Political Trust) [DE160100603]; Policy Lab, University of Melbourne	Australian Research Council (Understanding the Causes of Political Trust); Policy Lab, University of Melbourne	This research was supported by grants from the Australian Research Council (Understanding the Causes of Political Trust, DE160100603) (https://www.arc.gov.au/) to AM and the Policy Lab, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansolabehere S, 2014, POLIT ANAL, V22, P285, DOI 10.1093/pan/mpt025; Australian Government (AG), 2015, AUSTR GOVT AG RESPON; Baker R, 2013, J SUVERY STATE METHO, V1, P90, DOI [DOI 10.1093/JSSAM/SMT008, 10.1093/jssam/smt008, https:/doi.org/10.1093/jssam/smt008]; Bilodeau A, 2011, ETHNIC RACIAL STUD, V34, P1088, DOI 10.1080/01419870.2010.550630; Breton C, 2017, CAN J POLIT SCI, V50, P1005, DOI 10.1017/S0008423917000610; Brogan DM, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0147-y; Broom A, 2015, SOC SCI MED, V146, P95, DOI 10.1016/j.socscimed.2015.10.037; Broom A, 2014, SOC SCI MED, V110, P81, DOI 10.1016/j.socscimed.2014.03.030; Carlet J, 2014, CLIN MICROBIOL INFEC, V20, P949, DOI 10.1111/1469-0691.12767; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Dalton R., 2008, CITIZEN POLITICS PUB; Degeling C, 2018, HEALTH EXPECT, V21, P90, DOI 10.1111/hex.12589; Egan PJ, 2012, PARTISAN PRIORITIES; Fox J, 2008, APPL REGRESSION ANAL; Funk C., 2018, PUBLIC CONFIDENCE SC; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Hetherington M. J., 2005, WHY TRUST MATTERS DE; Hetherington Marc J., 2015, WHY WASHINGTON WONT; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Ipsos MORI, VER IND 2017 IPS MOR; Kettl D.F., 2017, CAN GOVT EARN OUR TR; Lamberts Rod, 2017, AUSTR BELIEFS ATTITU; Lewis JM, 2006, SOC SCI MED, V62, P2125, DOI 10.1016/j.socscimed.2005.10.004; Lupia A., 2002, THINKING POLITICAL P, P51, DOI DOI 10.1017/CBO9780511510632; Lupia A., 1998, DEMOCRATIC DILEMMA; McAllister I, 2016, TRENDS AUSTR POLITIC; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; Mounk Y., 2018, PEOPLE VERSUS DEMOCR; Petty R. E., 1998, HDB SOCIAL PSYCHOL, P323; Pharr SJ, 2000, DISAFFECTED DEMOCRAC; Pornpitakpan C., 2014, J APPL SOC PSYCHOL, V34, P243; Radyowijati A, 2013, SOC SCI MED, V57, P733; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Scott Long J., 2014, REGRESSION MODELS CA, V3rd; Searle S, 2014, DO AUSTR ENGAGE SCI; Stephenson LB, 2011, INT J PUBLIC OPIN R, V23, P24, DOI 10.1093/ijpor/edq025; Tranter B, 2013, AUST J POLIT HIST, V59, P397, DOI 10.1111/ajph.12023; Trubiano JA, 2016, J ANTIMICROB CHEMOTH, V71, P1715, DOI 10.1093/jac/dkw008; Wallinga D, 2015, PUBLIC HEALTH, V129, P1314, DOI 10.1016/j.puhe.2015.08.012; Wang L, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0167-7; Weier N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182460; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Wilson E.J., 1993, J ACAD MARKET SCI, V21, P101, DOI [10.1007/BF02894421, DOI 10.1007/BF02894421, https://doi.org/10.1007/BF02894421]; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0212993	10.1371/journal.pone.0212993	http://dx.doi.org/10.1371/journal.pone.0212993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897112	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700013
J	Dorigo, AS; Rosa-Fontana, AD; Soares-Lima, HM; Galaschi-Teixeira, JS; Nocelli, RCF; Malaspina, O				Dorigo, Adna Suelen; Rosa-Fontana, Annelise de Souza; Soares-Lima, Hellen Maria; Galaschi-Teixeira, Juliana Stephanie; Ferreira Nocelli, Roberta Cornelio; Malaspina, Osmar			In vitro larval rearing protocol for the stingless bee species Melipona scutellaris for toxicological studies	PLOS ONE			English	Article							HYMENOPTERA	Brazil has the highest biodiversity of native stingless bees in the world. However, Brazilian regulations are based on protocols standardized by the Organization for Economic Cooperation and Development (OECD), which uses Apis mellifera as a model organism. The safety of the use of an exotic species as a substitute for a native species is a problem that concerns members of the academy and the government agencies responsible for studies of this nature in the neotropical regions where there are occurrences of stingless bee species. Regarding the exposure of larvae to pesticides, several indicators suggest that the same rearing method for A. mellifera cannot be applied to stingless bees, mainly because of their different feeding systems. Thus, it is necessary to establish an in vitro rearing method for native social bees. We developed a larval rearing method for the stingless bee species Melipona scutellaris and evaluated parameters such as the defecation rate, pupation, emergence, mortality and morphometry of the newly emerged workers. The control was represented by the morphometry of individuals that emerged from natural combs (in vivo). In addition, we determined the average lethal concentration (LC50) of the insecticide dimethoate, the standard active ingredient used for the validation of toxicity tests. Procedures conducted prior to the in vitro bioassays allowed us to obtain the actual dimensions of the rearing cells for making acrylic plates for use in establishing how much each larva consumes during its development, that is, determining how much larval food should be placed in every artificial cell. Tests performed with M. scutellaris indicated an average of 80.2% emergence of individuals relative to the larvae, 92.61% relative to the pupae and a mean of 7.42% larval mortality. The mean of the intertegular distance, head width and wing asymmetry parameters were not significantly different between individuals from the in vitro and in vivo rearing methods. The LC50 value determined was 27.48 ng dimethoate / mu L diet. The method described for M. scutellaris showed development rates above OECD standards, which requires at least 75% emergence, and produced newly emerged workers with similar dimensions to those produced under natural conditions; thus these results enable their use as a rearing protocol for this species (or genus) and, consequently, their use in toxicity tests. The results produced with M. scutellaris are the first steps for a proposed toxicity test protocol for stingless bee larvae that can be standardized and included as a protocol in the OECD.	[Dorigo, Adna Suelen; Rosa-Fontana, Annelise de Souza; Soares-Lima, Hellen Maria; Malaspina, Osmar] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, CEIS, Rio Claro, SP, Brazil; [Galaschi-Teixeira, Juliana Stephanie] Inst Tecnol Vale Belem II, ITVDS, Belem, PA, Brazil; [Ferreira Nocelli, Roberta Cornelio] Univ Fed Sao Carlos UFSCar SP, Dept Ciencias Nat Matemat & Educ, Araras, SP, Brazil	Universidade Estadual Paulista; Instituto Tecnologico Vale Desenvolvimento Sustentavel	Dorigo, AS (corresponding author), Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, CEIS, Rio Claro, SP, Brazil.	adnadorigoo@gmail.com	Dorigo, Adna Suelen/T-6336-2019; Malaspina, Osmar/AAL-9167-2021; Rosa-Fontana, Annelise/AAD-7719-2022; Nocelli, Roberta/AAE-7402-2020; Nocelli, elvis0307%/AAD-7652-2022; Nocelli, Roberta/E-7354-2012	Dorigo, Adna Suelen/0000-0002-0430-0372; Malaspina, Osmar/0000-0002-1650-257X; Rosa-Fontana, Annelise/0000-0002-7978-9459; Galaschi-Teixeira, Juliana Stephanie/0000-0002-6003-7708; Soares Lima, Hellen Maria/0000-0001-8564-9826; Nocelli, Roberta/0000-0003-2900-6310	Coordenacao de aperfeicoamento de pessoal de nivel superior [001]; Fundacao de amparo a pesquisa do Estado de Sao Paulo [2016/00328-4]	Coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	A. DORIGO received scholarship from Coordenacao de aperfeicoamento de pessoal de nivel superior (grant number 001) (url: http://www.capes.gov.br) and A. ROSA-FONTANA received scholarship from Fundacao de amparo a pesquisa do Estado de Sao Paulo (grant number 2016/00328-4). (url: http://www.fapesp.br).	[Anonymous], 2014, HONEY BEE APIS MELLI, P1; [Anonymous], 2013, HON BEEE AP MELL LAR; Aupinel P, 2005, B INSECTOLOGY; Aupinel P, 2007, PEST MANAGEMENT SCI; Brittain C, 2011, BASIC APPL ECOLOGY; Brodschneider R, 2009, APIDOLOGIE, DOI [10.1051/apido/2008069, DOI 10.1051/APIDO/2008069]; Camargo C. A. de, 1972, Journal of the Kansas Entomological Society, V45, P520; Camargo João M. F., 2004, Rev. Bras. entomol., V48, P353, DOI 10.1590/S0085-56262004000300012; Costa EM, 2014, APIDOLOGIE; Cresswell JE, 2012, ZOOLOGY; da Silva CI, 2015, GUIA ILUSTRADO ABELH; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Dorigo AS, 2018, SOCIOBIOLOGY, V65, P777, DOI 10.13102/sociobiology.v65i4.2878; Giannini TC, 2015, J EC ENTOMOL; GOUGH HJ, 1994, J APICULT RES, V33, P119, DOI 10.1080/00218839.1994.11100859; Goulson D., 2013, J APPL ECOLOGY; Hartfelder K, 2006, APIDOLOGIE; Haydak H M., 1970, ANN REV ENTOMOL; IBAMA, 2017, NOT TECN AV RISC AGR, P18; Imperatriz-Fonseca VL, 2011, BIOTA NEOTROP, V11, P631, DOI 10.1590/S1676-06032011000500029; Kessler SC, 2015, NATURE; Klatt BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072724; Klein AM, 2002, CONSERV BIOL, V16, P1003, DOI 10.1046/j.1523-1739.2002.00499.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 1998, P R SOC B; Klingenberg CP, 2015, SYMMETRY; Lourenco CT, 2012, B ENV CONTAM TOXICOL; Menezes C, 2013, APIDOLOGIE; Michener CD, 2013, POT HONEY LEGACY STI; Pacheco AG, 2013, MAR ENVIRON RES, V91, P41, DOI 10.1016/j.marenvres.2013.08.003; Palmer AR, 1986, ANN REV ECOL SYST; Pedro SRM, 2014, SOCIOBIOLOGY, V61, P348; Pires C.S.S., 2018, SELECAO ESPECIES ABE; Potts SG, 2010, TRENDS ECOLOGY EVOLU; Rortais A., 2005, APIDOLOGIE; Rosa A de S, 2016, APIDOLOGIE; ROUBIK DW, 1982, J KANSAS ENTOMOL SOC, V55, P789; Slaa EJ, 2006, STINGLESS BEES APPL; van Tome H V., 2012, PLOS ONE; Velthuis BJ, 1998, NATURWISSENSCHAFTEN; Zerbo AD, 2001, COMP BIOCHEM PHYS B, V129, P139	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213109	10.1371/journal.pone.0213109	http://dx.doi.org/10.1371/journal.pone.0213109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893338	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900028
J	Kojima, H; Hirooka, K; Sonoda, S; Sakamoto, T; Kiuchi, Y				Kojima, Hirokazu; Hirooka, Kazuyuki; Sonoda, Shozo; Sakamoto, Taiji; Kiuchi, Yoshiaki			Changes in choroidal area following trabeculectomy: Long-term effect of intraocular pressure reduction	PLOS ONE			English	Article							AXIAL LENGTH; THICKNESS; GLAUCOMA	Purpose To evaluate changes in the macula and peripapillary choroidal area at one year after trabeculectomy in order to determine the effect of intraocular pressure (IOP) changes. Methods This prospective longitudinal study examined 30 eyes of 30 patients with glaucoma that was uncontrolled by medical therapy. At 1 day before and at 1 year after the trabeculectomy surgery, macular and peripapillary choroidal images were recorded by enhanced depth imaging optical coherence tomography (EDI-OCT). Luminal and interstitial areas were converted to binary images using the Niblack method. Factors influencing the macular choroidal and peripapillary area were examined by multivariate analysis. Results After trabeculectomy, the mean IOP was 10.8 +/- 3.2 mmHg compared to 17.8 +/- 7.2 mmHg at baseline (P < 0.001). The total macular choroidal area after the surgery increased from 317,735 +/- 77,380 to 338,120 +/- 90,700 mu m(2), while the interstitial area increased from 108,598 +/- 24,502 to 119,172 +/- 31,495 mu m(2) (all P < 0.05). The total peripapillary choroidal area after the surgery also increased from 1,557,487 +/- 431,798 to 1,650,253 +/- 466,672 mu m(2), while the interstitial area increased from 689,891 +/- 149,476 to 751,816 +/- 162,457 mu m(2) (all P < 0.05). However, there were no significant differences observed in the luminal area before and after the surgery. A decrease in the IOP was among the factors associated with the changes in the peripapillary choroidal area. Conclusions IOP reductions after trabeculectomy led to increases in the macular and peripapillary choroidal areas for at least 1 year postoperative. Increases in the interstitial areas were the primary reason for observed changes in the choroidal area after trabeculectomy.	[Kojima, Hirokazu; Hirooka, Kazuyuki] Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa, Japan; [Hirooka, Kazuyuki; Kiuchi, Yoshiaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Kagawa University; Hiroshima University; Kagoshima University	Hirooka, K (corresponding author), Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa, Japan.; Hirooka, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Ophthalmol & Visual Sci, Hiroshima, Japan.	khirooka9@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26462689]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 26462689 to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SD, 2014, INVEST OPHTH VIS SCI, V55, P2608, DOI 10.1167/iovs.13-13595; CRISTINI G, 1991, OPHTHALMOLOGICA, V202, P81, DOI 10.1159/000310179; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; HAYREH SS, 1969, BRIT J OPHTHALMOL, V53, P721, DOI 10.1136/bjo.53.11.721; Hirooka K, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-29; Januleviciene I, 2015, J GLAUCOMA, V24, pe52, DOI 10.1097/IJG.0000000000000055; Kadziauskiene A, 2016, ACTA OPHTHALMOL, V94, P586, DOI 10.1111/aos.13057; Kara N, 2013, EYE, V27, P940, DOI 10.1038/eye.2013.116; Kinoshita T, 2017, BRIT J OPHTHALMOL, V101, P360, DOI 10.1136/bjophthalmol-2016-308594; Kojima H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204183; Kojima H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201973; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Park HYL, 2014, J GLAUCOMA, V23, P225, DOI 10.1097/IJG.0000000000000045; Song YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158447; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spraul CW, 2002, VISION RES, V42, P923, DOI 10.1016/S0042-6989(02)00022-6; Stanga PE, 2003, OPHTHALMOLOGY, V110, P15, DOI 10.1016/S0161-6420(02)01563-4; Usui S, 2013, CLIN OPHTHALMOL, V7, P1155, DOI 10.2147/OPTH.S44884; Usui S, 2012, AM J OPHTHALMOL, V153, P10, DOI 10.1016/j.ajo.2011.05.037; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Yin ZQ, 1997, J GLAUCOMA, V6, P23; Zhang XM, 2017, INVEST OPHTH VIS SCI, V58, P3278, DOI 10.1167/iovs.17-21598	24	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0209145	10.1371/journal.pone.0209145	http://dx.doi.org/10.1371/journal.pone.0209145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893300	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900003
J	Trachsel, S; Dhliwayo, T; Perez, LG; Lugo, JAM; Trachsel, M				Trachsel, Samuel; Dhliwayo, Thanda; Gonzalez Perez, Lorena; Mendoza Lugo, Jose Alberto; Trachsel, Mathias			Estimation of physiological genomic estimated breeding values (PGEBV) combining full hyperspectral and marker data across environments for grain yield under combined heat and drought stress in tropical maize (Zea mays L.)	PLOS ONE			English	Article							VEGETATION INDEXES; CANOPY TEMPERATURE; GROWTH-STAGES; SELECTION; PREDICTION; REGRESSION; IDENTIFICATION; ACCURACY; PACKAGE; TRAITS	High throughput phenotyping technologies are lagging behind modern marker technology impairing the use of secondary traits to increase genetic gains in plant breeding. We aimed to assess whether the combined use of hyperspectral data with modern marker technology could be used to improve across location pre-harvest yield predictions using different statistical models. A maize bi-parental doubled haploid (DH) population derived from F1, which consisted of 97 lines was evaluated in testcross combination under heat stress as well as combined heat and drought stress during the 2014 and 2016 summer season in Ciudad Obregon, Sonora, Mexico (27 degrees 20 '' N, 109 degrees 54 '' W, 38 m asl). Full hyperspectral data, indicative of crop physiological processes at the canopy level, was repeatedly measured throughout the grain filling period and related to grain yield. Partial least squares regression (PLSR), random forest (RF), ridge regression (RR) and Bayesian ridge regression (BayesB) were used to assess prediction accuracies on grain yield within (two-fold cross-validation) and across environments (leave-one-environment-out-cross-validation) using molecular markers (M), hyperspectral data (H) and the combination of both (HM). Highest prediction accuracy for grain yield averaged across within and across location predictions (rGP) were obtained for BayesB followed by RR, RF and PLSR. The combined use of hyperspectral and molecular marker data as input factor on average had higher predictions for grain yield than hyperspectral data or molecular marker data alone. The highest prediction accuracy for grain yield across environments was measured for BayesB when molecular marker data and hyperspectral data were used as input factors, while the highest within environment prediction was obtained when BayesB was used in combination with hyperspectral data. It is discussed how the combined use of hyperspectral data with molecular marker technology could be used to introduce physiological genomic estimated breeding values (PGEBV) as a pre-harvest decision support tool to select genetically superior lines.	[Trachsel, Samuel; Dhliwayo, Thanda] Int Maize & Wheat Improvement Ctr CIMMYT, Global Maize Program, Texcoco, Edo De Mex, Mexico; [Gonzalez Perez, Lorena; Mendoza Lugo, Jose Alberto] Int Maize & Wheat Improvement Ctr CIMMYT, Sustainable Intensificat Program, Obregon, Sonora, Mexico; [Trachsel, Mathias] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Wisconsin System; University of Wisconsin Madison	Trachsel, S (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Global Maize Program, Texcoco, Edo De Mex, Mexico.	trachselsam@gmail.com		Dhliwayo, Thanda/0000-0001-8583-129X				Aguate FM, 2017, CROP SCI, V57, P2517, DOI 10.2135/cropsci2017.01.0007; Battenfield SD, 2016, PLANT GENOME, V9; Breiman L, 2009, RANDOMFOREST BREIMAN; Cairns JE, 2013, CROP SCI, V53, P1335, DOI 10.2135/cropsci2012.09.0545; Calus MPL, 2013, ANIMAL, V7, P183, DOI 10.1017/S1751731112001450; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; Cao S, 2017, PLANT GENOME, V10; Cerrudo D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00366; Cerrudo D, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030235; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Crain J, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.05.0043; Crossa J., 2015, META R MULTI ENV TRA; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; CURRAN PJ, 1989, REMOTE SENS ENVIRON, V30, P271, DOI 10.1016/0034-4257(89)90069-2; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gueymard CA, 2001, SOL ENERGY, V71, P325, DOI 10.1016/S0038-092X(01)00054-8; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; HANWAY JJ, 1963, AGRON J, V55, P487, DOI 10.2134/agronj1963.00021962005500050024x; Hatfield JL, 2010, REMOTE SENS-BASEL, V2, P562, DOI 10.3390/rs2020562; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Meuwissen THE, 2001, GENETICS, V157, P1819; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Montesinos-Lopez OA, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-016-0154-2; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Neiff N, 2015, J CROP IMPROV, V29, P669, DOI 10.1080/15427528.2015.1073643; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Pirouz D.M., 2006, OVERVIEW PARTIAL LEA; R Core Team, 2018, R LANG ENV STAT COMP; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ribaut JM, 2007, MOL BREEDING, V20, P15, DOI 10.1007/s11032-006-9041-2; Rutkoski J, 2016, G3-GENES GENOM GENET, V6, P2799, DOI 10.1534/g3.116.032888; Serbin SP, 2014, ECOL APPL, V24, P1651, DOI 10.1890/13-2110.1; Singh A, 2016, TRENDS PLANT SCI, V21, P110, DOI 10.1016/j.tplants.2015.10.015; Tattaris M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01131; Thomas S, 2018, J PLANT DIS PROTECT, V125, P5, DOI 10.1007/s41348-017-0124-6; Trachsel S, 2017, CROP SCI, V57, P229, DOI 10.2135/cropsci2016.06.0562; Trachsel S, 2016, CROP SCI, V56, P3031, DOI 10.2135/cropsci2016.03.0182; Yang G, 2015, FRONTIERS PLANT SCI, V8; Yendrek CR, 2015, PLANT PHYSIOL, V173, P614	46	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0212200	10.1371/journal.pone.0212200	http://dx.doi.org/10.1371/journal.pone.0212200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893307	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900010
J	Bagdatli, MC				Bagdatli, M. Cuneyt			Effects of different irrigation levels on European corn borer (Ostrinia nubilalis (Hubner)) populations	PLOS ONE			English	Article							RESISTANCE; ACID	In In this study, the effects of different irrigation treatments (l(100), I-50, I-30) on the European corn borer (Ostrinia nubilalis hubner) populations in different corn genotypes (Ada-9510, Samada-07, Ada-523, Kompozit Arifiye) were investigated. As the average, the highest yield (1582.33 kg da(-1)), low number of live larva + pupa per plant (2.70), tunnel length (7.73 cm) were observed in I-100 x ADA-523 interaction while the lowest yield (896.00 kg da(-1)) was observed in I-30 x Kompozit Arifiye interaction. The largest European corn borer population was observed in full irrigation (I-100) and the lowest population was observed in excessive water deficit (I-30) treatment. The European corn borer preferred the Kompozit Arifiye genotype. It was concluded that the genotypes should be tested under water-stressed and non water-stressed conditions for resistance to the European corn borer and live larva and tunnel length could be used as a screening parameter.	[Bagdatli, M. Cuneyt] Nevsehir Haci Bektas Veli Univ, Engn & Architecture Fac, Dept Biosyst Engn, Nevsehir, Turkey	Nevsehir Haci Bektas Veli University	Bagdatli, MC (corresponding author), Nevsehir Haci Bektas Veli Univ, Engn & Architecture Fac, Dept Biosyst Engn, Nevsehir, Turkey.	cuneytbagdatli@gmail.com		BAGDATLI, M. Cuneyt/0000-0003-0276-4437				Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Bohn M, 2000, THEOR APPL GENET, V101, P907, DOI 10.1007/s001220051561; Cardinal AJ, 2005, THEOR APPL GENET, V111, P1, DOI 10.1007/s00122-004-1831-5; Cardinal AJ, 2001, CROP SCI, V41, P835, DOI 10.2135/cropsci2001.413835x; Castanera P, 1986, 4 JORN TECN MAIZ LER, P1; Cerit L Sarihan H, 2006, MISIR KURDU OSTRINIA; DEPAULA FM, 1993, PLANT PHYSIOL BIOCH, V31, P707; Der G., 2002, HDB STAT ANAL USING, P3431; Gozuacik C., 2005, J AGR FAC HRU, V9, P11; Gullu M, 2000, THESIS, P198; Gungor Y, 2006, ANKARAU U ZIRAAT FAK, V1592, P424; Guthherie W.D., 1987, P INT S METH DEV HOS, P290; Hunt JCR, 1988, P C TRANS PHEN MULT; Jampatong C, 2002, CROP SCI, V42, P584, DOI 10.2135/cropsci2002.0584; Kayapmar A., 1998, P S CORN BOR CONTR M, P87; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Larue P, 1984, PHYTOMA, P163; Sahin U, 2007, J AGRON CROP SCI, V193, P146, DOI 10.1111/j.1439-037X.2006.00248.x; Salama KHA, 2007, ACTA PHYSIOL PLANT, V29, P351, DOI 10.1007/s11738-007-0044-3; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Simsek N., 1992, TURK 2 ENT K BILD 28, P501; Simsek N., 1988, P S CORN BOR CONTR M, P44; Suzuki N, 2013, PLANT CELL, V25, P3553, DOI 10.1105/tpc.113.114595; Trepanier M, 2005, APPL ENVIRON MICROB, V71, P5341, DOI 10.1128/AEM.71.9.5341-5347.2005; Tsitsipis J.A., 1988, P171; Turkay M.A., 2011, AS MAIZ C 7 NOV NANN, P18; Turkay MA, 2011, TURK TARL BITK K, P413; Turkay MA, 2011, TURK TARL BITK K, P538; Tuzuner A, 1990, TOPRAK ANALIZ LABORA; Ucak A. B., 2017, Fresenius Environmental Bulletin, V26, P8211; Ucak A.B., 2011, GAP 6 TAR K 09 12 MA, P40; Xing JS, 2000, PHYSIOL MOL PLANT P, V56, P217, DOI 10.1006/pmpp.2000.0268; Zeren O., 1988, P S CORN BOR CONTR M, P1	33	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0212595	10.1371/journal.pone.0212595	http://dx.doi.org/10.1371/journal.pone.0212595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889175	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000008
J	Harkness, L; Chen, XL; Gillard, M; Gray, PP; Davies, AM				Harkness, Linda; Chen, Xiaoli; Gillard, Marianne; Gray, Peter Paul; Davies, Anthony Mitchell			Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential	PLOS ONE			English	Article							FOCAL ADHESION KINASE; COLONY MORPHOLOGY; DERIVATION; CULTURE; MODELS; PROPENSITY; TENSION	Undifferentiated human embryonic stem cells have a distinct morphology (hESC). Changes in cell morphology during culture can be indicative of differentiation. hESC, maintained in diverse medias, demonstrated alterations in morphological parameters and subsequent alterations in underlying transcript expression and lineage differentiation. Analysis of morphological parameters showed distinct and significant differences between the undefined, less defined and Xeno-free medias while still maintaining pluripotency markers. This suggested that the less defined media may be creating dynamic instability in the cytoskeleton, with the cytoskeleton becoming more stabilised in the Xeno-free media as demonstrated by smaller and rounder cells. Examination of early lineage markers during undirected differentiation using d5 embryoid bodies demonstrated increased mesodermal lineage preference as compared to endodermal or ectoderm in cells originally cultured in Xeno-free media. Undefined media showed preference for mesoderm and ectoderm lineages, while less defined media (BSA present) demonstrated no preference. These data reveal that culture media may produce fundamental changes in cell morphology which are reflected in early lineage differentiation choice.	[Harkness, Linda; Chen, Xiaoli; Gillard, Marianne; Gray, Peter Paul] Univ Queensland, AIBN, Brisbane, Qld, Australia; [Davies, Anthony Mitchell] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Translat Cell Imaging Queensland, Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT)	Harkness, L (corresponding author), Univ Queensland, AIBN, Brisbane, Qld, Australia.	l.harkness@uq.edu.au	Gray, Peter/AAC-3737-2019	GILLARD, Marianne/0000-0002-2233-9975	Stem Cells Australia, an Australian Research Council Strategic Initiative in Stem Cell Science [SR110001002]; JEM Research Foundation; Merchant Charitable Foundation; University of Queensland; Therapeutic Innovation Australia (TIA); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program	Stem Cells Australia, an Australian Research Council Strategic Initiative in Stem Cell Science; JEM Research Foundation; Merchant Charitable Foundation; University of Queensland(University of Queensland); Therapeutic Innovation Australia (TIA); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program(Australian GovernmentDepartment of Industry, Innovation and Science)	The PPG and LH would like to acknowledge funding from Stem Cells Australia, an Australian Research Council Strategic Initiative in Stem Cell Science (SR110001002). PPG, LH and XC would like to acknowledge funding from the JEM Research Foundation philanthropic funding, The Merchant Charitable Foundation and the University of Queensland for their support and funding of this work. MG and PPG acknowledge this research utilised the facilities, and the scientific and technical assistance of the National Biologics Facility (NBF) at The University of Queensland. NBF is supported by Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge funding from Stem Cells Australia, an Australian Research Council Strategic Initiative in Stem Cell Science (SR110001002), the JEM Research Foundation philanthropic funding, The Merchant Charitable Foundation and the University of Queensland for their support and funding of this work. Elements of this research utilised the facilities, and the scientific and technical assistance of the National Biologics Facility (NBF) at the University of Queensland. NBF is supported by Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program. The authors declare no conflict of interest.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; [Anonymous], 2018, SCIENCEDAILY; Arpornmaeklong P, 2009, STEM CELLS DEV; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Buckley ST, 2012, NANOMED-NANOTECHNOL, V8, P355, DOI 10.1016/j.nano.2011.06.021; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; Butler JT, 2009, J CELL BIOCHEM, V107, P609, DOI 10.1002/jcb.22183; Cascione M, 2017, EXP CELL RES, V360, P303, DOI 10.1016/j.yexcr.2017.09.020; Chang KH, 2004, BIOTECHNOL BIOENG, V88, P287, DOI 10.1002/bit.20242; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Courtot AM, 2014, BIORESEARCH OPEN ACC, V3, P206, DOI 10.1089/biores.2014.0028; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]; Efremov YM, 2015, BBA-MOL CELL RES, V1853, P3117, DOI 10.1016/j.bbamcr.2015.05.008; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Hagmann S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-223; Hannoun Z, 2010, CELL REPROGRAM, V12, P133, DOI 10.1089/cell.2009.0099; Harkness L, 2011, BONE, V48, P231, DOI 10.1016/j.bone.2010.09.023; Harkness L, 2008, STEM CELL RES, V1, P219, DOI 10.1016/j.scr.2008.06.001; Horvath P, 2016, NAT REV DRUG DISCOV, V15, P751, DOI 10.1038/nrd.2016.175; Ji LJ, 2012, EUR CELLS MATER, V23, P135, DOI 10.22203/eCM.v023a10; Kato R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34009; Kinney MA, 2014, ANN BIOMED ENG, V42, P352, DOI 10.1007/s10439-013-0953-9; Klapholz B, 2017, J CELL SCI, V130, P2435, DOI 10.1242/jcs.190991; Liu E, 2010, CELL CYCLE, V9, P2108, DOI 10.4161/cc.9.11.11864; Liu WW, 2013, J BIOCHEM MOL TOXIC, V27, P17, DOI 10.1002/jbt.21470; Ludwig Tenneille, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c02s2; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mahla R.S., 2016, INT J CELL BIOL, V2016, DOI [10.1155/2016/6940283, DOI 10.1155/2016/6940283]; Mahmood A, 2012, STEM CELLS DEV, V21, P3114, DOI 10.1089/scd.2012.0035; Maldonado M, 2016, ADV HEALTHC MATER, V5, P1408, DOI 10.1002/adhm.201600141; Maldonado M, 2015, BIOMATERIALS, V50, P10, DOI 10.1016/j.biomaterials.2015.01.037; Martino F, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00824; Mathieu J, 2017, DEVELOPMENT, V144, P541, DOI 10.1242/dev.128389; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Muir A, 2018, SCIENCE, V360, P962, DOI 10.1126/science.aar5986; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Perestrelo T, 2018, STEM CELL REP, V11, P607, DOI 10.1016/j.stemcr.2018.07.016; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Sun CB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192625; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Tonge PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010901; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Tremoleda FL, 2008, CLONING STEM CELLS, V10, P119, DOI [10.1089/clo.2007.0R36, 10.1089/clo.2007.OR36]; Tsankov AM, 2015, NAT BIOTECHNOL, V33, P1182, DOI 10.1038/nbt.3387; van der Sanden B, 2010, J CELL BIOCHEM, V111, P801, DOI 10.1002/jcb.22847; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Villa-Diaz LG, 2016, STEM CELLS, V34, P1753, DOI 10.1002/stem.2349; Vitillo L, 2016, STEM CELL REP, V7, P167, DOI 10.1016/j.stemcr.2016.07.006; Wakui T, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.044003; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang YHK, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0876-3; Yu LQ, 2018, STEM CELL REP, V11, P142, DOI 10.1016/j.stemcr.2018.06.003; Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165	69	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213678	10.1371/journal.pone.0213678	http://dx.doi.org/10.1371/journal.pone.0213678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889226	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000025
J	Kokubun, T; Yamamoto, K; Sato, K; Akaishi, T; Shimazaki, A; Nakamura, M; Shiga, Y; Tsuda, S; Omodaka, K; Nakazawa, T				Kokubun, Taiki; Yamamoto, Kotaro; Sato, Kota; Akaishi, Takahiro; Shimazaki, Atsushi; Nakamura, Masatsugu; Shiga, Yukihiro; Tsuda, Satoru; Omodaka, Kazuko; Nakazawa, Toru			The effectiveness of colchicine combined with mitomycin C to prolong bleb function in trabeculectomy in rabbits	PLOS ONE			English	Article							AQUEOUS-HUMOR; GLAUCOMA; FIBROBLAST; ANTIBODY; SURGERY; PROTEIN-1; EXPOSURES; MIGRATION; FIBROSIS; FAILURE	Purpose To investigate the potential of colchicine to improve bleb function after trabeculectomy. Methods To find the maximum usable colchicine concentration, an ocular irritation study was performed with the Draize test at concentrations of 0.001%, 0.01% and 0.1%. Additionally, the synergistic effect of topical colchicine instillation and MMC application to surgical site was evaluated in a rabbit model by measuring changes after trabeculectomy in intraocular pressure (IOP) and bleb morphology score at 3, 7, 14, 21, 28, 35, 42, and 49 days. Results Experiments with a rabbit model of trabeculectomy showed that 0.04% MMC plus 0.01% colchicine was more effective than saline and 0.04% MMC alone in maintaining IOP reduction at days 7-49 (P < 0.01 at all time points) and day 49 (P < 0.05), respectively, while 0.04% MMC alone was more effective than saline only at days 7-35 (P < 0.05 at all time points). 0.04% MMC plus 0.01% colchicine and 0.04% MMC alone were more effective than saline at preserving bleb score at days 7-21 and 35-49 (P < 0.05 at all time points) and at days 7-35 (P < 0.05 at all time points), respectively. Conclusion Colchicine may be a promising adjuvant for strengthening the effect of MMC and improving the survival of the filtering bleb in trabeculectomy.	[Kokubun, Taiki; Yamamoto, Kotaro; Sato, Kota; Shiga, Yukihiro; Tsuda, Satoru; Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Sato, Kota; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Collaborat Program Ophthalm Drug Discovery, Sendai, Miyagi, Japan; [Akaishi, Takahiro; Shimazaki, Atsushi; Nakamura, Masatsugu] Santen Pharmaceut Co Ltd, Res & Dev Div, Nara, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Ophthalmol, Dept Retinal Dis Control, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Santen Pharmaceutical Co Ltd; Tohoku University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Collaborat Program Ophthalm Drug Discovery, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Ophthalmol, Dept Retinal Dis Control, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp		Kokubun, Taiki/0000-0003-2743-9550	Santen Pharmaceutical Co., Ltd.; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan	Santen Pharmaceutical Co., Ltd.; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank Mr. Tim Hilts for reviewing and editing the language of the manuscript and Dr. Kazuichi Maruyama for providing valuable comments. This work was supported by Santen Pharmaceutical Co., Ltd., the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ADDICKS EM, 1983, ARCH OPHTHALMOL-CHIC, V101, P795; Akiyama H, 2006, J CELL PHYSIOL, V207, P407, DOI 10.1002/jcp.20583; Bass PD, 2013, CHEM REV, V113, P6816, DOI 10.1021/cr3001059; BERGSTROM TJ, 1991, ARCH OPHTHALMOL-CHIC, V109, P1725, DOI 10.1001/archopht.1991.01080120109038; CAIRNS J E, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P384; Cordeiro MF, 1999, INVEST OPHTH VIS SCI, V40, P1975; COSTA VP, 1993, OPHTHALMIC SURG LAS, V24, P152; DEHM P, 1972, BIOCHIM BIOPHYS ACTA, V264, P375, DOI 10.1016/0304-4165(72)90302-9; DIEGELMA.RF, 1972, P NATL ACAD SCI USA, V69, P892, DOI 10.1073/pnas.69.4.892; Disel U, 2004, TRANSPL P, V36, P1372, DOI 10.1016/j.transproceed.2004.05.078; Entzian P, 1997, LUNG, V175, P41, DOI 10.1007/PL00007555; Fontana H, 2006, OPHTHALMOLOGY, V113, P930, DOI 10.1016/j.ophtha.2006.01.062; Fuller JR, 2002, BRIT J OPHTHALMOL, V86, P1352, DOI 10.1136/bjo.86.12.1352; Greenfield DS, 1996, ARCH OPHTHALMOL-CHIC, V114, P943, DOI 10.1001/archopht.1996.01100140151007; Grehn F, 2007, OPHTHALMOLOGY, V114, P1831, DOI 10.1016/j.ophtha.2007.06.028; HARRIS ED, 1971, ARTHRITIS RHEUM-US, V14, P669, DOI 10.1002/art.1780140602; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; HAYASAKA S, 1988, AM J OPHTHALMOL, V106, P715, DOI 10.1016/0002-9394(88)90706-4; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; JAMPEL HD, 1992, ARCH OPHTHALMOL-CHIC, V110, P1049, DOI 10.1001/archopht.1992.01080200029011; JOSEPH JP, 1989, CURR EYE RES, V8, P203, DOI 10.3109/02713688908995193; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; KAWASE K, 1992, OPHTHALMOLOGY, V99, P203; KHAW PT, 1993, ARCH OPHTHALMOL-CHIC, V111, P263, DOI 10.1001/archopht.1993.01090020117035; Kitazawa Y, 1996, AUST NZ J OPHTHALMOL, V24, P327, DOI 10.1111/j.1442-9071.1996.tb01603.x; KITAZAWA Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1693, DOI 10.1001/archopht.1991.01080120077030; Kokubun T., 2018, CURR EYE RES, P1; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LEMOR M, 1986, ARCH OPHTHALMOL-CHIC, V104, P1223; Li JJ, 2009, AM J PHYSIOL-RENAL, V297, pF200, DOI 10.1152/ajprenal.90649.2008; MALAWISTA SE, 1968, ARTHRITIS RHEUM-US, V11, P191, DOI 10.1002/art.1780110210; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Mietz H, 1996, GRAEF ARCH CLIN EXP, V234, P364, DOI 10.1007/BF00190712; Ng GF, 2015, OPEN OPHTHALMOL J, V9, P136, DOI 10.2174/1874364101509010136; Occleston NL, 1997, INVEST OPHTH VIS SCI, V38, P1998; Okuda T, 2009, J GLAUCOMA, V18, P220, DOI 10.1097/IJG.0b013e31817eee32; Ozmen N, 2018, ANTI-CANCER AGENT ME, V18, P1927, DOI 10.2174/1871520618666180821102047; Pan LH, 1996, PATHOL INT, V46, P91, DOI 10.1111/j.1440-1827.1996.tb03584.x; Perkins TW, 2002, ARCH OPHTHALMOL-CHIC, V120, P941, DOI 10.1001/archopht.120.7.941; Seet LF, 2012, J CELL MOL MED, V16, P1245, DOI 10.1111/j.1582-4934.2011.01400.x; SINGH G, 1988, OPHTHALMOLOGY, V95, P813; Siriwardena D, 2002, OPHTHALMOLOGY, V109, P427, DOI 10.1016/S0161-6420(01)00997-6; Tzortzaki EG, 2007, RESP MED, V101, P1821, DOI 10.1016/j.rmed.2007.02.006; Wilhelmus KR, 2001, SURV OPHTHALMOL, V45, P493, DOI 10.1016/S0039-6257(01)00211-9; Yang Y, 2007, EUR J PHARMACOL, V576, P26, DOI 10.1016/j.ejphar.2007.07.067; Yu Y S, 1987, Korean J Ophthalmol, V1, P59; Yuan Hui-ping, 2009, Zhonghua Yan Ke Za Zhi, V45, P168	47	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213811	10.1371/journal.pone.0213811	http://dx.doi.org/10.1371/journal.pone.0213811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889194	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000033
J	Khan, TA; Nadeem, F; Chen, LL; Wang, XF; Zeng, ZH; Hu, YG				Khan, Tariful Alam; Nadeem, Faisal; Chen, Lili; Wang, Xiaofen; Zeng, Zhaohai; Hu, Yuegao			Enhancing naked oat (Avena nuda L.) productivity with minimal indirect nitrogen loss and maximum nitrogen use efficiency through integrated use of different nitrogen sources	PLOS ONE			English	Article							SOIL MICROBIAL BIOMASS; GROWTH-PROMOTING BACTERIA; NUTRIENT USE EFFICIENCY; PLANT-GROWTH; AMMONIA VOLATILIZATION; BIOCHEMICAL-PROPERTIES; INORGANIC FERTILIZERS; BIOLOGICAL-ACTIVITY; IMPROVING GROWTH; ORGANIC-MATTER	Oat (Avena nuda L.) is a nutritious grain crop, rich in dietary fibers and phytochemicals. Application of efficient nitrogen (N) sources and dose is very important to obtain higher crop productivity and to achieve environmental sustainability. The exploitation of natural beneficial microbes and organic nitrogen in combination with chemical nitrogen would be effective to boost soil N for plant uptake. Hence, a field experiment was conducted during 2016 and 2017 with the aim to ameliorate the use of chemical N (CN) with organic nitrogen (ON) and microbial fertilizer (MBF) without compromising the productivity of oat. T1 = control, T2 = 100% CN, T3 = 100% CN+MBF, T4 = 75% CN+25% ON+MBF, T5 = 50% CN+50% ON+MBF, T6 = 100% ON+MBF, T7 = 100% ON were the treatments. 50% CN + 50% ON+MBF treatment proved to be an efficient combination regarding enhanced biomass and grain yield, nitrogen uptake and NUE as compared to rest of the treatments in both years. During the critical stages of the crop, when most of the applied CN was leached from the top 20 cm soil depth, a substantial N came from the PM mineralization through enhanced microbial activity by the addition of MBF. Lastly, the application of ON supplemented with MBF improved the rhizosphere soil properties, i.e. mineral N concentration, total N (TN), soil organic carbon (SOC), microbial biomass carbon (MBC), microbial biomass nitrogen (MBN), soil respiration rate and enzymatic activity. A balanced and source conscious application of CN, ON and MBF reduced N losses and added a substantial amount of N into the soil N pool. We concluded that organic N combined with chemical N and MBF proved to be effective in improving soil properties ensuring less N loss and increasing oat production in the semi-arid region.	[Khan, Tariful Alam; Chen, Lili; Wang, Xiaofen; Zeng, Zhaohai; Hu, Yuegao] China Agr Univ, Coll Agron, Beijing, Peoples R China; [Nadeem, Faisal] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Hu, YG (corresponding author), China Agr Univ, Coll Agron, Beijing, Peoples R China.	huyuegao@cau.edu.cn			China Agriculture Research System [CARS-08-B-1]	China Agriculture Research System	This study was supported by the China Agriculture Research System (CARS-08-B-1). YH received this funding award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi MK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01038; Abbast MK, 2010, EXP AGR, V46, P211, DOI 10.1017/S0014479709991050; Afreh D, 2018, SOIL TILL RES, V180, P259, DOI 10.1016/j.still.2018.03.016; [Anonymous], 2010, COMMUN SOIL SCI PLAN, V41, P231, DOI [10.1080/00103620903460757, DOI 10.1080/00103620903460757]; Ardakani Mohammad Reza, 2011, Physiology and Molecular Biology of Plants, V17, P181, DOI 10.1007/s12298-011-0065-7; Ata-Ul-Karim ST, 2014, FIELD CROP RES, V167, P76, DOI 10.1016/j.fcr.2014.07.010; Bayu W, 2006, J PLANT NUTR, V29, P391, DOI 10.1080/01904160500320962; Bhardwaj D, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-66; Bolan NS, 2010, WORLD POULTRY SCI J, V66, P673, DOI 10.1017/S0043933910000656; Caravaca F, 2002, SOIL TILL RES, V68, P23, DOI 10.1016/S0167-1987(02)00080-6; CASIDA L. E., 1964, SOIL SCI, V98, P371, DOI 10.1097/00010694-196412000-00004; Chandna P, 2011, ENVIRON MONIT ASSESS, V178, P545, DOI 10.1007/s10661-010-1712-0; Chen GC, 2000, COMMUN SOIL SCI PLAN, V31, P655, DOI 10.1080/00103620009370467; Dent D., 2017, Agriculture and Food Security, V6, DOI 10.1186/s40066-016-0084-2; Devkota KP, 2018, SOIL TILL RES, V181, P46, DOI 10.1016/j.still.2018.04.001; Dijkstra FA, 2009, SOIL BIOL BIOCHEM, V41, P1080, DOI 10.1016/j.soilbio.2009.02.013; Duan YH, 2014, J INTEGR AGR, V13, P588, DOI 10.1016/S2095-3119(13)60716-9; Egamberdiyeva D, 2004, J ARID ENVIRON, V56, P293, DOI 10.1016/S0140-1963(03)00050-8; Egamberdiyeva D, 2007, APPL SOIL ECOL, V36, P184, DOI 10.1016/j.apsoil.2007.02.005; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Emilsson T, 2007, ECOL ENG, V29, P260, DOI 10.1016/j.ecoleng.2006.01.001; Garcia-Ruiz R, 2008, SOIL BIOL BIOCHEM, V40, P2137, DOI 10.1016/j.soilbio.2008.03.023; Gheysari M, 2009, AGR WATER MANAGE, V96, P946, DOI 10.1016/j.agwat.2009.01.005; GILSOTRES F, 1992, BIOL FERT SOILS, V13, P25, DOI 10.1007/BF00337233; Han KH, 2004, BIOL FERT SOILS, V39, P193, DOI 10.1007/s00374-003-0704-4; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Huang S, 2016, FIELD CROP RES, V192, P118, DOI 10.1016/j.fcr.2016.04.023; Jannoura R, 2014, EUR J AGRON, V52, P259, DOI 10.1016/j.eja.2013.09.001; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Ojeda JJ, 2018, AGR FOREST METEOROL, V259, P1, DOI 10.1016/j.agrformet.2018.04.014; Ju X T, 2010, FUNDAMENTAL RES FATE, P55; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Ke J, 2017, FIELD CROP RES, V205, P147, DOI 10.1016/j.fcr.2016.12.027; Khaliq A, 2006, BIORESOURCE TECHNOL, V97, P967, DOI 10.1016/j.biortech.2005.05.002; Khan MS, 2007, TURK J AGRIC FOR, V31, P355; Kumar S, 2014, ECOL ENG, V71, P432, DOI 10.1016/j.ecoleng.2014.07.007; Li PF, 2017, ENVIRON SCI POLLUT R, V24, P11722, DOI 10.1007/s11356-017-8825-8; Liang YC, 2005, SOIL BIOL BIOCHEM, V37, P1185, DOI 10.1016/j.soilbio.2004.11.017; Madejon E, 2009, SOIL TILL RES, V105, P55, DOI 10.1016/j.still.2009.05.007; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; Manoj Kumar, 2012, Journal of Crop Science and Biotechnology, V15, P137, DOI 10.1007/s12892-012-0024-z; Melero S, 2006, SOIL TILL RES, V90, P162, DOI 10.1016/j.still.2005.08.016; Mondal S, 2016, ARCH AGRON SOIL SCI, V62, P1521, DOI 10.1080/03650340.2016.1148808; Muhammad Yousaf, 2014, International Journal of Agriculture Innovations and Research, V2, P645; Nadeem F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00205; Narula Neeru, 2005, Archives of Agronomy and Soil Science, V51, P79, DOI 10.1080/03650340400029382; Naveed M, 2008, PAK J BOT, V40, P1243; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; NELSON DW, 1980, J ASSOC OFF ANA CHEM, V63, P770; Ojeda JJ, 2018, EUR J AGRON, V92, P84, DOI 10.1016/j.eja.2017.10.004; Olanrewaju OS, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2364-9; Peake A., 2008, GLOBAL ISSUES PADDOC; Pindi P., 2012, J BIOFERTILIZERS BIO, V3, P1, DOI [10. 4172/2155-6202.10 0 0124, DOI 10.4172/2155-6202.1000124]; Rashid MI, 2016, MICROBIOL RES, V183, P26, DOI 10.1016/j.micres.2015.11.007; Rawat SK, 2012, J ENVIRON BIOL, V33, P51; Rokhzadi A, 2011, AUST J CROP SCI, V5, P44; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Salamanca EF, 2002, APPL SOIL ECOL, V21, P211, DOI 10.1016/S0929-1393(02)00091-4; Salantur A, 2005, PLANT SOIL, V275, P147, DOI 10.1007/s11104-005-8094-z; Santos VB, 2012, GEODERMA, V170, P227, DOI 10.1016/j.geoderma.2011.11.007; Sepaskhah AR, 2012, AGR WATER MANAGE, V112, P55, DOI 10.1016/j.agwat.2012.06.005; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Shaharoona B, 2008, APPL MICROBIOL BIOT, V79, P147, DOI 10.1007/s00253-008-1419-0; Smolander A, 2002, SOIL BIOL BIOCHEM, V34, P651, DOI 10.1016/S0038-0717(01)00227-9; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; TABATABAI MA, 1970, SOIL SCI SOC AM PRO, V34, P62; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Tewolde H, 2005, J PLANT NUTR, V28, P605, DOI 10.1081/PLN-200052633; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang Q, 2010, PLANT SOIL, V337, P325, DOI 10.1007/s11104-010-0530-z; Wei WL, 2016, AGR ECOSYST ENVIRON, V225, P86, DOI 10.1016/j.agee.2016.04.004; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Xu MG, 2013, AGRON J, V105, P277, DOI 10.2134/agronj2012.0222; Yaduvanshi NPS, 2003, J AGR SCI, V140, P161, DOI 10.1017/S0021859603002934; Yang J, 2015, SOIL TILL RES, V151, P67, DOI 10.1016/j.still.2015.03.008; Zaidi A, 2005, J PLANT NUTR, V28, P2079, DOI 10.1080/01904160500320897; Zaman M., 2010, Agricultural Journal, V5, P309, DOI 10.3923/aj.2010.309.312; Zhang J, 2017, ENVIRON SCI POLLUT R, V24, P8916, DOI 10.1007/s11356-015-5125-z; Zhao DL, 2005, EUR J AGRON, V22, P391, DOI 10.1016/j.eja.2004.06.005; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	83	4	4	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213808	10.1371/journal.pone.0213808	http://dx.doi.org/10.1371/journal.pone.0213808			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883582	gold, Green Submitted, Green Published			2022-12-26	WOS:000461423500031
J	Nlend, AEN; Guessong, CO; Motaze, ACN; Soffo, C; Ndombo, POK; Tsambang, L; Fokam, J				Nlend, Anne Esther Njom; Guessong, Cathya Ornella; Motaze, Annie Carole Nga; Soffo, Claudian; Ndombo, Paul Olivier Koki; Tsambang, Lionel; Fokam, Joseph			Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaounde, Cameroon	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; DRUG-RESISTANCE; VIROLOGICAL FAILURE; PROFILES; ADULTS	Background There are limited data on protease inhibitor (PI)-based antiretroviral therapy (ART) amongst children in resource-limited settings, for informing on optimal paediatric regimens. Objective To evaluate therapeutic response to PI-based ART amongst HIV-infected Cameroonian children. Methods A retrospective study was conducted amongst children aged 2-18 years receiving a PI-based ART at the Essos Hospital Centre (EHC), Yaounde, Cameroon. Primary end points were therapeutic success on PI-based ART, defined as clinical success (WHO I/II clinical stage), immunological success (CD4 >= 500/mm(3)) and viral suppression (viral load [VL] <1000 copies/ml). Factors associated with therapeutic success were assessed in uni- and multivariate analysis using SPSS software v. 2.0; with p<0.05 considered statistically significant. Results A total of 71 eligible children on PI-based ART were enrolled (42 on initial and 29 on substituted regimens), with a median age of 8 [IQR: 5-12] years and mean duration on ART of 7 years. Following therapeutic responses, all (100%) experienced clinical success, 95.2% experienced immunological success (91.7% on initial and 97.2% on substituted PI/r-based regimens) and 74.7% viral suppression. In univariate analysis, viral suppression was associated with: younger age (p<0.0001), living with parents as opposed to guardians (p = 0.049), and the educational level (p<0.0001). In multivariate analysis, only the age ranges of 10-14 years (OR: 0.22 [0.07-0.73]) and 15-18 years (OR: 0.08 [0.02-0.57]), were determinants of poor viral suppression. Conclusion Among these Cameroonian children, PI-based ART confers favourable clinical and immunological outcomes. The poor rate of viral suppression was mainly attributed to adolescence (10-18 years).	[Nlend, Anne Esther Njom; Motaze, Annie Carole Nga] Essos Hosp Ctr, Natl Insurance Fund, Yaounde, Cameroon; [Nlend, Anne Esther Njom; Guessong, Cathya Ornella; Tsambang, Lionel] Univ Douala, Dept Clin Sci, Higher Inst Med Technol Nkolondom, Douala, Cameroon; [Nlend, Anne Esther Njom; Soffo, Claudian] Cameroon Assoc Support Persons & Families Affecte, Yaounde, Cameroon; [Ndombo, Paul Olivier Koki; Fokam, Joseph] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Ndombo, Paul Olivier Koki] Chantal BIYA Fdn, Mother Child Ctr, Yaounde, Cameroon; [Fokam, Joseph] Minist Publ Hlth, Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon; [Fokam, Joseph] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Virol Lab, Yaounde, Cameroon	University of Yaounde I	Nlend, AEN (corresponding author), Essos Hosp Ctr, Natl Insurance Fund, Yaounde, Cameroon.; Nlend, AEN (corresponding author), Univ Douala, Dept Clin Sci, Higher Inst Med Technol Nkolondom, Douala, Cameroon.; Nlend, AEN (corresponding author), Cameroon Assoc Support Persons & Families Affecte, Yaounde, Cameroon.	anne.njom@gmail.com	NLEND, ANNE ESTHER NJOM/AAZ-8748-2020					[Anonymous], 2016, START FREE STAY FREE; [Anonymous], 2016, UNAIDS REP GLOB AIDS; [Anonymous], 2016, 7 STOCKTAKING REPORT; Boender TS, 2016, J ANTIMICROB CHEMOTH, V71, P2918, DOI 10.1093/jac/dkw218; Boerma RS, 2015, J INT AIDS SOC, V18, P24, DOI 10.7448/IAS.18.7.20265; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Charpentier C, 2012, AIDS RES HUM RETROV, V28, P87, DOI [10.1089/aid.2011.0035, 10.1089/AID.2011.0035]; Davies Mary-Ann, 2015, J Int AIDS Soc, V18, P20770, DOI 10.7448/IAS.18.7.20770; Dehority W, 2015, DRUGS, V75, P1483, DOI 10.1007/s40265-015-0446-2; Fokam J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187566; Fokam J, 2011, PEDIATR INFECT DIS J, V30, P1062, DOI 10.1097/INF.0b013e31822db54c; Meyers T, 2015, PEDIATR INFECT DIS J, V34, P175, DOI 10.1097/INF.0000000000000544; Musiime V, 2013, AIDS RES HUM RETROV, V29, P449, DOI 10.1089/aid.2012.0283; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nlend AEN, 2017, PEDIATR INFECT DIS J, V36, P1067, DOI [10.1097/INF.0000000000001672, 10.1097/inf.0000000000001672]; Puthanakit T, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-20; Sanchez PR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173168; Siberry GK, 2017, J INFECT DIS, V216, pS838, DOI 10.1093/infdis/jix407; Suaysod R, 2015, CLIN INFECT DIS, V61, P95, DOI 10.1093/cid/civ271; Van Dyke RB, 2016, CLIN INFECT DIS, V63, P133, DOI 10.1093/cid/ciw213; Weijsenfeld AM, 2016, CLIN INFECT DIS, V63, P1105, DOI 10.1093/cid/ciw487; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2016, CONS GUID US ANT DRU; Zamora Laura, 2014, Enferm Infecc Microbiol Clin, V32 Suppl 3, P2, DOI 10.1016/S0213-005X(14)70160-0	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213900	10.1371/journal.pone.0213900	http://dx.doi.org/10.1371/journal.pone.0213900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883591	Green Submitted, gold, Green Published			2022-12-26	WOS:000461423500038
J	Van Sant, F; Hassan, SM; Reavill, D; McManamon, R; Howerth, EW; Seguel, M; Bauer, R; Loftis, KM; Gregory, CR; Ciembor, PG; Ritchie, BW				Van Sant, Fern; Hassan, Sayed M.; Reavill, Drury; McManamon, Rita; Howerth, Elizabeth W.; Seguel, Mauricio; Bauer, Richard; Loftis, Kathy M.; Gregory, Christopher R.; Ciembor, Paula G.; Ritchie, Branson W.			Evidence of bromethalin toxicosis in feral San Francisco "Telegraph Hill" conures	PLOS ONE			English	Article							ENCEPHALITIS; TOXICITY	During 2018, four free-ranging conures, from a naturalized flock in San Francisco, presented with a characteristic set of neurologic signs that had been reported in other individuals from this flock. The cause of morbidity or mortality in historic cases has not been identified. From these four subjects, fresh feces were collected during their initial days of hospitalization and submitted to the University of Georgia Infectious Diseases Laboratory and Center for Applied Isotope Studies for bromethalin and desmethyl-bromethalin quantitation. Using High Performance Liquid Chromatography, the laboratory detected bromethalin, a non-anticoagulant, single-dose rodenticide, in fecal samples from three subjects; half of these samples were also positive for desmethyl-bromethalin, bromethalins active metabolite. In three subjects that died, the UGA laboratory screened brain and liver samples and found bromethalin in all samples; desmethyl-bromethalin was detected in all but one brain sample, which was below the detection limit. Our findings suggest the conures are more resistant to bromethalin than are other species in which bromethalin has been studied, and/or that the conures may be ingesting the toxin at a sublethal dose. More data is needed to better assess the long-term effects of bromethalin on animals exposed at the subacute/chronic levels, and also to better understand the compartmentalization of bromethalin and desmethyl-bromethalin in a wider variety of species.	[Van Sant, Fern] Birds, San Jose, CA USA; [Hassan, Sayed M.; Bauer, Richard; Loftis, Kathy M.] Univ Georgia, Ctr Appl Isotope Studies, Athens, GA 30602 USA; [Reavill, Drury] Zoo Exot Pathol Serv, Carmichael, CA USA; [McManamon, Rita] Univ Georgia, Infect Dis Lab, Zoo & Exot Anim Pathol Serv, Athens, GA 30602 USA; [McManamon, Rita] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Howerth, Elizabeth W.; Seguel, Mauricio] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Gregory, Christopher R.; Ciembor, Paula G.; Ritchie, Branson W.] Univ Georgia, Infect Dis Lab, Athens, GA 30602 USA; [Ritchie, Branson W.] Univ Georgia, New Mat Inst, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ritchie, BW (corresponding author), Univ Georgia, Infect Dis Lab, Athens, GA 30602 USA.; Ritchie, BW (corresponding author), Univ Georgia, New Mat Inst, Athens, GA 30602 USA.	kygilmor@uga.edu	Seguel, Mauricio/AAQ-1103-2020; Reavill, Drury/W-3069-2019	Seguel, Mauricio/0000-0002-0465-236X; Reavill, Drury/0000-0002-4725-3174				Bates MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0554-y; Bautista AC, 2014, J VET DIAGN INVEST, V26, P154, DOI 10.1177/1040638713510296; Brutlag A., 2014, RODENTICIDE UPDATE E; Daniels D., 2013, SUMMARY 2 GENERATION; Daniels D., 2013, 2 GENERATION ANTICOA; Dorman D C, 1990, J Vet Diagn Invest, V2, P123; DORMAN DC, 1992, VET PATHOL, V29, P139, DOI 10.1177/030098589202900206; DREIKORN BA, 1984, ACS SYM SER, V255, P45; Erickson W., 2004, POTENTIAL RISKS 9 RO; Filigenzi MS, 2015, J AGR FOOD CHEM, V63, P5146, DOI 10.1021/jf5052706; Independent Television Service, WILD PARR TEL HILL M; Jackson WB, 1982, P 10 VERT PEST C FEB; Kent M, 2017, VET NEUROLOGY ALERT; Lezmi S, 2007, J VET MED A, V54, P186, DOI 10.1111/j.1439-0442.2007.00925.x; Mineau P, 2001, REV ENVIRON CONTAM T, V170, P13; Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1; Peterson ME, 2013, TOP COMPANION ANIM M, V28, P21, DOI 10.1053/j.tcam.2013.03.005; PubChem Compound Database, COMP SUMM CID 44465; Rimoldi G, 2013, J VET DIAGN INVEST, V25, P775, DOI 10.1177/1040638713502981; Spaulding SR, 1988, P 13 VERT PEST C MAR; Swartz M.E., 1997, ANAL METHOD DEV VALI; The Bio-Integral Resource Center, 2013, PROT RAPT ROD, P1; The Oasis Sanctuary Foundation Ltd, 2015, WILD PARR TEL HILL; Thurston County Health Department, BROM; Tourdot R., 2017, DECONTAMINATION DILE; U. S. Environmental Protection Agency, 1998, EPA738F98004; VANLIER RBL, 1988, FUND APPL TOXICOL, V11, P664, DOI 10.1016/0272-0590(88)90129-7	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213248	10.1371/journal.pone.0213248	http://dx.doi.org/10.1371/journal.pone.0213248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883548	Green Submitted, Green Published, gold			2022-12-26	WOS:000461423500010
J	Dong, AX; Wang, JJ; Zhang, HL; Xin, HB; Zhao, ZN; Liang, F; Li, ZJ; Cong, RC; Lin, Y; Song, LN; Tan, LL; Zhang, PW; Cui, RF				Dong, Aixiang; Wang, Jingjing; Zhang, Huali; Xin, Haibo; Zhao, Zhengnan; Liang, Fang; Li, Zijing; Cong, Richen; Lin, Yan; Song, Lina; Tan, Lingling; Zhang, Pengwei; Cui, Rongfeng			Comparative transcriptomic analysis provides insights into the development of a Salvia splendens Ker-Gawler mutant, SX919M	PLOS ONE			English	Article							PLANT-GROWTH; ESTERASE; BARLEY; FAMILY; AUXIN	Salvia splendens is a perennial, ornamental herbaceous flower that is widely cultivated as a bedding plant in gardens. The development of novel S. splendens cultivars and investigating the relevant molecular mechanisms are of great significance. In this study, RNA-sequencing and real-time PCR methods were used to analyze the possible molecular mechanism of S. splendens mutant, SX919M. From the wild-type S. splendens 919CK, we firstly selected a natural mutant, SX919M, which displayed multiple branches, clustered spheroids, and radial symmetrical inflorescence with higher numbers of calyces, ovules, stamens, and perianth tubes. Further, the RNA-seq was used to identify the differentially expressed genes (DEGs) in the mutant which included a total of 3568 upregulated and 3290 downregulated unigenes. We further observed that the indole alkaloid biosynthesis pathway showed the highest DEG enrichment, which was supported by a significant increase in the IAA content in mutant SX919M. In addition, we validated three DEGs, namely, CL2200.Contig2_All encoding methyl IAA esterase, CL12462.Contig1_All and CL12462.Contig2_All, which encoded strictosidine synthase, upregulated in mutant SX919M. We selected a novel S. splendens germplasm SX919M with a high ornamental value and determined that the upregulation of IAA biogenesis may be associated with its development.	[Dong, Aixiang; Zhang, Huali; Xin, Haibo; Zhao, Zhengnan; Liang, Fang; Li, Zijing; Cong, Richen; Lin, Yan; Song, Lina; Cui, Rongfeng] Beijing Inst Landscape Architecture, Beijing Key Lab Greening Plants Breeding, Beijing, Peoples R China; [Wang, Jingjing] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Beijing, Peoples R China; [Tan, Lingling] Qingdao Agr Univ, Sch Life Sci, Qingdao, Shandong, Peoples R China; [Zhang, Pengwei] ShiJiaZhuang Acad Agr & Forestry Sci, Shijiazhuang, Hebei, Peoples R China	Beijing Forestry University; Qingdao Agricultural University	Cui, RF (corresponding author), Beijing Inst Landscape Architecture, Beijing Key Lab Greening Plants Breeding, Beijing, Peoples R China.	cuirongfeng@163.com	WANG, JINGYI/GSJ-1241-2022; wang, jing/GVT-8700-2022; wang, jing/GRS-7509-2022		National Natural Science Fund Project [31100865]; Beijing Natural Science Foundation Project [6172015]; Science Project of Beijing Park Management Center [ZX 2016025]	National Natural Science Fund Project(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Project(Beijing Natural Science Foundation); Science Project of Beijing Park Management Center	This study was funded by the National Natural Science Fund Project (31100865), the Beijing Natural Science Foundation Project (6172015) and the Science Project of Beijing Park Management Center (ZX 2016025). The funders had no role in the study design, data collection analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2018, P NATL ACAD SCI; Clebsch B., 2003, NEW BOOK SALVIAS SAG, P39; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; Gao F, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.196, 10.1038/nplants.2015.196]; Ge X, 2014, PLOS ONE, V93; Gonzalez-Lamothe R, 2012, PLANT CELL, V24, P762, DOI 10.1105/tpc.111.095190; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths M., 1994, INDEX GARDEN PLANTS; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Kawaguchi M, 1996, PLANT CELL PHYSIOL, V37, P1043, DOI 10.1093/oxfordjournals.pcp.a029051; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Normanly J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001594; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piatczak E, 2006, PLANT CELL REP, V25, P1308, DOI 10.1007/s00299-006-0155-0; Regnault-Roger C, 1997, INTEGRATED PEST MANA, V21, P25; Sohani MM, 2009, PLANT BIOLOGY, V11, P105, DOI 10.1111/j.1438-8677.2008.00139.x; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Tombuloglu G, 2015, GENE, V557, P71, DOI 10.1016/j.gene.2014.12.012; Tombuloglu H, 2013, MOL GENET GENOMICS, V288, P141, DOI 10.1007/s00438-013-0740-1; Yang Y, 2008, PLANT PHYSIOL, V147, P1034, DOI 10.1104/pp.108.118224	22	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213446	10.1371/journal.pone.0213446	http://dx.doi.org/10.1371/journal.pone.0213446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870444	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300034
J	Longhini, ALF; Salazar, TE; Vieira, C; Trinh, T; Duan, YQ; Pay, LM; Li Calzi, S; Losh, M; Johnston, NA; Xie, HS; Kim, M; Hunt, RJ; Yoder, MC; Santoro, D; McCarrel, TM; Grant, MB				Longhini, Ana Leda F.; Salazar, Tatiana E.; Vieira, Cristiano; Thao Trinh; Duan, Yaqian; Pay, Louise M.; Li Calzi, Sergio; Losh, Megan; Johnston, Nancy A.; Xie, Huisheng; Kim, Minsu; Hunt, Robert J.; Yoder, Mervin C.; Santoro, Domenico; McCarrel, Taralyn M.; Grant, Maria B.			Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses	PLOS ONE			English	Article							BONE-MARROW ASPIRATION; STROMAL CELLS; MOBILIZATION; EXPRESSION; INJECTION; STERNUM; INDUCE	Previously, we showed that mesenchymal stem cells (MSC) can be mobilized into peripheral blood using electroacupuncture (EA) at acupoints, LI-4, LI-11, GV-14, and GV-20. The purpose of this study was to determine whether EA-mobilized MSC could be harvested and expanded in vitro to be used as an autologous cell therapy in horses. Peripheral blood mononuclear cells (PBMC) isolated from young and aged lame horses (n = 29) showed a marked enrichment for MSCs. MSC were expanded in vitro (n = 25) and administered intravenously at a dose of 50 x 10(6) (n = 24). Treatment resulted in significant improvement in lameness as assessed by the American Association of Equine Practitioners (AAEP) lameness scale (n = 23). MSCs exhibited immunomodulatory function by inhibition of lymphocyte proliferation and induction of IL-10. Intradermal testing showed no immediate or delayed immune reactions to MSC (1 x 10(6) to 1 x 10(4)). In this study, we demonstrated an efficient, safe and reproducible method to mobilize and expand, in vitro, MSCs in sufficiently high concentrations for therapeutic administration. We confirm the immunomodulatory function of these cells in vitro. This non-pharmacological and non-surgical strategy for stem cell harvest has a broad range of biomedical applications and represents an improved clinically translatable and economical cell source for humans.	[Longhini, Ana Leda F.; Vieira, Cristiano; Li Calzi, Sergio; Grant, Maria B.] Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL 35294 USA; [Salazar, Tatiana E.; Thao Trinh; Duan, Yaqian; Pay, Louise M.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Losh, Megan] Indiana Univ, Sch Med IACUC, Off Vice President Res, Indianapolis, IN 46204 USA; [Johnston, Nancy A.] Indiana Univ, Lab Anim Resource Ctr, Indianapolis, IN 46204 USA; [Xie, Huisheng; Santoro, Domenico; McCarrel, Taralyn M.] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Kim, Minsu] Seoul Natl Univ, Dept Clin Sci, Coll Vet Med, Seoul, South Korea; [Kim, Minsu] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea; [Hunt, Robert J.] Hagyard Equine Med Inst, Lexington, KY USA; [Yoder, Mervin C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida; Seoul National University (SNU); Seoul National University (SNU); Indiana University System; Indiana University Bloomington	Grant, MB (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol & Visual Sci, Birmingham, AL 35294 USA.	mariagrant@uabmc.edu	Vieira, Cristiano Pedrozo/L-2517-2014; McCarrel, Taralyn/G-8888-2019	McCarrel, Taralyn/0000-0002-3124-4054; P Vieira, Cristiano/0000-0002-6937-5009; Santoro, Domenico/0000-0002-4893-4289; Trinh, Thao/0000-0002-0615-4874; Yoder, Mervin/0000-0003-4354-7631	NIH [EY0126001, EY028037, EY007739, HL110170]; Research to Prevent Blindness; University of Alabama; NATIONAL EYE INSTITUTE [R01EY012601, R01EY028037] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Alabama; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants: EY0126001, EY028037, EY007739, HL110170 to MBG, and Research to Prevent Blindness unrestricted grant awarded to the Department of Ophthalmology at IUPUI and University of Alabama.	Ahern BJ, 2011, AM J VET RES, V72, P127, DOI 10.2460/ajvr.72.1.127; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Carrade DD, 2013, COMPARATIVE MED, V63, P207; Carrade DD, 2011, CYTOTHERAPY, V13, P1180, DOI 10.3109/14653249.2011.602338; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Crovace Antonio, 2010, Vet Med Int, V2010, P250978, DOI 10.4061/2010/250978; de Witte SFH, 2018, STEM CELLS, V36, P602, DOI 10.1002/stem.2779; Delling U, 2012, CAN J VET RES, V76, P52; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1, DOI 10.1111/j.1600-0609.1995.tb01618.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferris DJ, 2009, CLIN FOLLOW UP HORSE, P59; Fukuda Kentaro, 2017, Journal of Equine Science, V28, P31, DOI 10.1294/jes.28.31; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x; Kasashima Y, 2011, EQUINE VET J, V43, P288, DOI 10.1111/j.2042-3306.2010.00215.x; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Kimura K, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/620785; Kumar S, 2012, BONE, V50, P1012, DOI 10.1016/j.bone.2012.01.027; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Luz-Crawford P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt216; Metcalf GL, 2016, CAN J VET RES, V80, P294; Remacha AR, 2015, VET IMMUNOL IMMUNOP, V165, P107, DOI 10.1016/j.vetimm.2015.04.004; Salazar TE, 2017, STEM CELLS, V35, P1303, DOI 10.1002/stem.2613; Sangiorgi B, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9434250; Seo J, 2013, RES VET SCI, V95, P693, DOI 10.1016/j.rvsc.2013.04.024; Smith RKW, 2003, EQUINE VET J, V35, P99, DOI 10.2746/042516403775467388; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wong DM, 2005, AM J VET RES, V66, P1348, DOI 10.2460/ajvr.2005.66.1348; Wong DM, 2005, AM J VET RES, V66, P1341, DOI 10.2460/ajvr.2005.66.1341; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	34	19	19	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0212642	10.1371/journal.pone.0212642	http://dx.doi.org/10.1371/journal.pone.0212642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870461	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300015
J	Wei, F; Xu, HF; Yan, CX; Rong, CL; Liu, BY; Zhou, HZ				Wei, Feng; Xu, Huafeng; Yan, Changxin; Rong, Chunli; Liu, Bingyu; Zhou, Haizhou			Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China	PLOS ONE			English	Article							GUT MICROBIOTA	Objective The human gut harbors diverse microbes that play a fundamental role in the well-being of their hosts. Microbes can cause autoimmunity, trigger autoimmunity in genetically susceptible individuals or prevent autoimmunity. There were reports about intestinal flora changes in Systemic Lupus Erythematosus (SLE) patients, but no data were available in northeast China. In this study, we investigated the intestinal flora changes of SLE patients in Heilongjiang province located in northeast China. Methods Feces from 16 SLE patients and 14 healthy volunteers were employed to extract bacterial DNA, amplify 16s RNA of bacteria, and analyze the biological information by sequencing. The statistical analysis used the SPSS version of 17. Result We found that there were 1 phylums, 4 families and 9 genera in the intestinal flora of SLE patients. And the nine differences genera can be used to distinguish SLE patients from normal people. Conclusion We found an increase of Proteobacteria and a decrease of Ruminococcaceae in SLE patients in different regions. In addition, we found that some proteins, enzymes, and diseases were significantly associated with SLE.	[Wei, Feng; Yan, Changxin; Rong, Chunli; Liu, Bingyu; Zhou, Haizhou] Harbin Med Univ, Affiliated Hosp 1, Dept Lab Diag, Harbin, Heilongjiang, Peoples R China; [Xu, Huafeng] Heilongjiang Prov Hosp, Dept Radioimmun, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Zhou, HZ (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Lab Diag, Harbin, Heilongjiang, Peoples R China.	haizhouzhou@163.com	haizhou, zhou/AAK-1128-2020		National Natural Science Foundation of China [81772261]; Heilongjiang Provincial Health and Family Planning Commission [2017-459]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Health and Family Planning Commission	The National Natural Science Foundation of China Grant no. 81772261 and Heilongjiang Provincial Health and Family Planning Commission (2017-459) to HZ.	An P, 2018, CHIN J CELL BIOL, V40; Arakawa T, 2008, NEPHROL DIAL TRANSPL, V23, P3418, DOI 10.1093/ndt/gfn314; Brown CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025792; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Chen H, 2008, MED RECAPITULATE, V14, P1465; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Findlay J, 2012, CLIN MICROBIOL INFEC, V18, P140, DOI 10.1111/j.1469-0691.2011.03515.x; Guo W, 2018, PRAC J MED PHARM, V35, P654; Han Meng-yao, 2018, Yaoxue Xuebao, V53, P1080, DOI 10.16438/j.0513-4870.2018-0170; He ZX, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0146-9; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Li Z., 2017, GASTROINTESTINAL SYS; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Mu QH, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00608; Patel NB, 2015, ANAEROBE, V32, P43, DOI 10.1016/j.anaerobe.2014.12.002; Ran GQ, 2018, PROG MOD BIOMED, V18, P2792; Scheperjans F, 2016, NEURODEGENER DIS MAN, V6, P81, DOI 10.2217/nmt-2015-0012; Shang QS, 2016, FOOD FUNCT, V7, P3224, DOI [10.1039/c6fo00309e, 10.1039/C6FO00309E]; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Yang NA, 2016, J HUBEI U NATL MED E, V33, P14; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhao XR, 2001, J MED STUDIES, V3, P33; [钟建泳 Zhong Jianyong], 2005, [上海医学, Shanghai medical journal], V28, P132; Zhu WF., 2018, ALTERATION GUT MICRO	25	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213063	10.1371/journal.pone.0213063	http://dx.doi.org/10.1371/journal.pone.0213063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870437	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300018
J	Bai, N; Gu, M; Liu, MJ; Jia, Q; Pan, SH; Zhang, ZY				Bai, Nan; Gu, Min; Liu, Mingjie; Jia, Qian; Pan, Shihui; Zhang, Zhiyu			Corn gluten meal induces enteritis and decreases intestinal immunity and antioxidant capacity in turbot (Scophthalmus maximus) at high supplementation levels	PLOS ONE			English	Article							JUVENILE GOLDEN POMPANO; REPLACING FISH-MEAL; GILTHEAD SEA BREAM; SOYBEAN-MEAL; GROWTH-PERFORMANCE; DIETARY CARBOHYDRATE; FEED-UTILIZATION; DIGESTIVE ENZYMES; SPARUS-AURATA; OXIDATIVE STATUS	Corn gluten meal (CGM) is an important alternative protein source in aquafeed production. However, in turbot (Scophthalmus maximus), CGM could not be effectively utilized because of its low digestibility, the reason for which is still unclear. The purpose of the present study was to investigate and elucidate the cause for the poor utilization of CGM by turbot from the view of gut health. An 8-week feeding trial was conducted with turbot individuals (initial body weight 11.4 +/- 0.2 g), which were fed with one of four isonitrogenous and isolipidic diets formulated to include 0%, 21.2%, 31.8%, and 42.6% CGM to progressively replace 0%, 33%, 50%, and 67% fish meal (FM) protein in a FM-based diet, respectively. The results showed that CGM caused dose-dependent decreases in (1) growth performance, nutrient digestibility, and feed utilization; (2) activities of brush-border membrane enzymes; (3) intestinal anti-oxidant indices of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase activities, and reduced glutathione level; (4) intestinal immune parameters of acid phosphatase activity, complement 3, complement 4, and IgM concentrations. Dose-dependent increases in the severity of the inflammation, with concomitant alterations on microvilli structure and increasing expression of inflammatory cytokine genes of 11-1 beta, 11-8, and Tnf-alpha were observed but without a change in the intracellular junctions and the epithelial permeability established by the plasma diamine oxidase activity and D-lactate level examinations. In conclusion, the present work proved that CGM negatively affected the gut health of turbot by inducing enteritis and by decreasing intestinal immunity and antioxidant capacity, which could be one of the reasons for the reduced utilization of CGM by turbot.	[Bai, Nan; Gu, Min; Liu, Mingjie; Jia, Qian; Pan, Shihui; Zhang, Zhiyu] Shandong Univ Weihai, Marine Coll, Weihai, Shandong, Peoples R China	Shandong University	Gu, M (corresponding author), Shandong Univ Weihai, Marine Coll, Weihai, Shandong, Peoples R China.	GUMIN@SDU.EDU.CN		Bai, Nan/0000-0002-4532-2666	National Science Foundation of China [31502174, 31702363]; Key Research and Development Program of Shandong Province [2018GHY115035]; China Postdoctoral Science Foundation [2017M610428, 2018M632678]; Key Laboratory of Mariculture (KLM), Ministry of Education, Ocean University of China [KLM2018001]; Shandong University, Weihai [2016WHWLJH04, 2018WHWLJH04]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Laboratory of Mariculture (KLM), Ministry of Education, Ocean University of China; Shandong University, Weihai	This study was jointly supported by the National Science Foundation of China (Grant No. 31502174 to MG and 31702363 to NB), Key Research and Development Program of Shandong Province (2018GHY115035 to MG), China Postdoctoral Science Foundation (Grant No. 2017M610428 to MG and 2018M632678 to NB), The Key Laboratory of Mariculture (KLM), Ministry of Education, Ocean University of China (Grant No. KLM2018001 to MG) and the Young Scholars Program of Shandong University, Weihai (Grant No. 2016WHWLJH04 to MG and 2018WHWLJH04 to NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoghaibi MA, 2013, WORLD J GASTROENTERO, V19, P6540, DOI 10.3748/wjg.v19.i39.6540; Anderson TJ, 2011, CEREAL CHEM, V88, P159, DOI 10.1094/CCHEM-06-10-0091; AOAC, 1990, OFFICIAL METHODS ANA; Bai N, 2017, AQUACULTURE, V476, P141, DOI 10.1016/j.aquaculture.2017.04.005; Bian F, 2017, AQUACULT NUTR, V23, P1429, DOI 10.1111/anu.12518; Castro C, 2016, AQUACULTURE, V464, P665, DOI 10.1016/j.aquaculture.2016.08.005; Deng KY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25412-w; Deng YP, 2014, AQUACULTURE, V434, P66, DOI 10.1016/j.aquaculture.2014.07.026; FAO, 2015, I4899E10815 UN FAO; Fernandez F, 2007, J EXP MAR BIOL ECOL, V343, P1, DOI 10.1016/j.jembe.2006.10.057; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross B, 2016, AQUAFEED FORMULATION, P33, DOI 10.1016/B978-0-12-800873-7.00003-8; Grosell M., 2010, FISH PHYSIOL BIOCHEM, DOI [10.1016/s1546-5098(10)03014-1, DOI 10.1016/S1546-5098(10)03014-1]; Gu M, 2018, FISH SHELLFISH IMMUN, V77, P264, DOI 10.1016/j.fsi.2018.04.004; Gu M, 2017, FISH SHELLFISH IMMUN, V70, P95, DOI 10.1016/j.fsi.2017.08.048; Gu M, 2017, AQUACULTURE, V468, P597, DOI 10.1016/j.aquaculture.2016.11.022; Gu M, 2016, AQUACULTURE, V464, P286, DOI 10.1016/j.aquaculture.2016.06.035; Hansen AC, 2013, AQUACULT NUTR, V19, P641, DOI 10.1111/anu.12078; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Hartviksen M, 2014, FISH PHYSIOL BIOCHEM, V40, P1621, DOI 10.1007/s10695-014-9953-4; Hooton D, 2015, REV PHYSIOL BIOCH P, V168, P59, DOI 10.1007/112_2015_24; Nguyen HP, 2017, FISHERIES SCI, V83, P99, DOI 10.1007/s12562-016-1049-x; Jaworski NW, 2015, J ANIM SCI, V93, P1103, DOI 10.2527/jas.2014-8147; Jiang J, 2018, FISH PHYSIOL BIOCHEM, V44, P319, DOI 10.1007/s10695-017-0437-1; Jiang WD, 2015, AQUACULTURE, V444, P134, DOI 10.1016/j.aquaculture.2015.04.005; Kaushik SJ, 1998, AQUAT LIVING RESOUR, V11, P355, DOI 10.1016/S0990-7440(98)80007-7; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Knudsen D, 2008, BRIT J NUTR, V100, P120, DOI 10.1017/S0007114507886338; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Krogdahl A, 2015, J AGR FOOD CHEM, V63, P3887, DOI 10.1021/jf506242t; Kumar V, 2011, AQUACULT NUTR, V17, P451, DOI 10.1111/j.1365-2095.2010.00825.x; Li XY, 2015, AQUAC RES, V46, P2851, DOI 10.1111/are.12437; Li Y, 2014, AQUAC RES, V45, P1051, DOI 10.1111/are.12042; Lin SM, 2018, FISH SHELLFISH IMMUN, V78, P121, DOI 10.1016/j.fsi.2018.04.046; Lin YH, 2017, AQUACULTURE, V469, P106, DOI 10.1016/j.aquaculture.2016.11.032; Liu YZ, 2014, AQUACULTURE, V433, P476, DOI 10.1016/j.aquaculture.2014.07.002; LUK GD, 1983, J CLIN INVEST, V71, P1308, DOI 10.1172/JCI110881; Luo YW, 2013, J OCEAN U CHINA, V12, P418, DOI 10.1007/s11802-013-2021-3; Martinez-Llorens S, 2012, AQUACULTURE, V338, P124, DOI 10.1016/j.aquaculture.2012.01.029; Men KK, 2014, AQUACULTURE, V428, P303, DOI 10.1016/j.aquaculture.2014.03.028; Mosberian-Tanha P, 2018, AQUACULT NUTR, V24, P112, DOI 10.1111/anu.12539; NRC, 2011, CARB FIBR NUTR REQ F, P135, DOI [10.1007/s10499-011-9480-6, DOI 10.1007/S10499-011-9480-6]; Overland M, 2009, AQUACULTURE, V288, P305, DOI 10.1016/j.aquaculture.2008.12.012; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Pereira TG, 2003, AQUAC RES, V34, P1111, DOI 10.1046/j.1365-2109.2003.00909.x; Peres H, 2008, AQUACULTURE, V275, P283, DOI 10.1016/j.aquaculture.2007.12.015; Peterson TS., 2015, MUCOSAL HLTH AQUACUL, P55, DOI [DOI 10.1016/B978-0-12-417186-2.00003-0, 10.1016/B978-0-12-417186-2.00003-0]; Refstie S, 2006, AQUACULTURE, V261, P1382, DOI 10.1016/j.aquaculture.2006.07.046; Refstie S, 2006, AQUACULTURE, V261, P392, DOI 10.1016/j.aquaculture.2006.08.005; Regost C, 1999, AQUACULTURE, V180, P99, DOI 10.1016/S0044-8486(99)00026-5; Salinas I., 2015, MUCOSAL HLTH AQUACUL, P135, DOI [10.1016/b978-0-12-417186-2.00006-6, DOI 10.1016/B978-0-12-417186-2.00006-6]; Silva FCP, 2010, AQUACULTURE, V306, P233, DOI 10.1016/j.aquaculture.2010.05.018; Singh Z, 2014, IRANIAN J PUBLIC HLT; SMITH SM, 1989, J CLIN MICROBIOL, V27, P1430; Song WB, 2009, WORLD J GASTROENTERO, V15, P3916, DOI 10.3748/wjg.15.3916; Sottero B, 2018, CURR MED CHEM, V25, P1311, DOI 10.2174/0929867324666170619104105; Stone DAJ, 2003, REV FISH SCI, V11, P337, DOI 10.1080/10641260390260884; Tacon A.G..J., 1998, AGRIS, V22, P11; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tan Q, 2007, J APPL ICHTHYOL, V23, P605, DOI 10.1111/j.1439-0426.2007.00846.x; Tan XH, 2016, AQUACULTURE, V465, P100, DOI 10.1016/j.aquaculture.2016.08.034; Teves JFC, 2016, REV AQUACULT, V8, P154, DOI 10.1111/raq.12089; Trushenski J., 2015, NUTR IMPACTS FISH MU, P199, DOI DOI 10.1016/B978-0-12-417186-2/00008-X; Ursini F, 2016, REDOX BIOL, V8, P205, DOI 10.1016/j.redox.2016.01.010; Wang L, 2016, AQUACULTURE, V464, P87, DOI 10.1016/j.aquaculture.2016.06.026; Wang LN, 2014, AQUACULTURE, V426, P41, DOI 10.1016/j.aquaculture.2014.01.022; Wang Q, 2016, AQUACULT NUTR, V22, P752, DOI 10.1111/anu.12296; Wei Y, 2015, ISRAELI J AQUACULTUR, P67; Wu CL, 2016, FISH SHELLFISH IMMUN, V49, P132, DOI 10.1016/j.fsi.2015.12.030; Zhang CX, 2018, AQUACULTURE, V483, P173, DOI 10.1016/j.aquaculture.2017.10.029; Zhang YX, 2012, AQUACULTURE, V354, P68, DOI 10.1016/j.aquaculture.2012.03.038; Zhang Y, 2012, AQUACULTURE, V344, P100, DOI 10.1016/j.aquaculture.2012.03.012; Zheng L, 2018, FISH SHELLFISH IMMUN, V77, P53, DOI 10.1016/j.fsi.2018.03.024; Zhou CP, 2015, AQUACULTURE, V437, P390, DOI 10.1016/j.aquaculture.2014.12.016; Zhou CP, 2014, FISH SHELLFISH IMMUN, V41, P183, DOI 10.1016/j.fsi.2014.08.024; Zhou H, 2016, ISRAELI J AQUACULTUR, P1338; Zhou L, 2018, ZEBRAFISH, V15, P340, DOI 10.1089/zeb.2017.1526; Zhou L, 2018, ENVIRON POLLUT, V235, P245, DOI 10.1016/j.envpol.2017.12.073; Zhou Z, 2018, AQUACULT NUTR, V24, P644, DOI 10.1111/anu.12532	79	23	24	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213867	10.1371/journal.pone.0213867	http://dx.doi.org/10.1371/journal.pone.0213867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865702	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900093
J	Damian, DJ; Ngahatilwa, D; Fadhili, H; Mkiza, JG; Mahande, MJ; Ngocho, JS; Msuya, SE				Damian, Damian J.; Ngahatilwa, Diana; Fadhili, Hatibu; Mkiza, Johnston G.; Mahande, Michael J.; Ngocho, James S.; Msuya, Sia E.			Factors associated with HIV status disclosure to partners and its outcomes among HIV positive women attending Care and Treatment Clinics at Kilimanjaro region, Tanzania	PLOS ONE			English	Article							DAR-ES-SALAAM; PREGNANT-WOMEN; SEROSTATUS DISCLOSURE; SEXUAL PARTNERS; TRANSMISSION	Background Sub Saharan Africa continues to be the epicenter of HIV with 70% of people living with HIV globally. Women form nearly 60% of those living with HIV. Studies have shown disclosure of one's HIV status is important in HIV prevention, in increasing partners who are tested and getting into care early as well as in improving retention in PMTCT and ART programs. This study aimed to determine the prevalence, factors and outcomes of HIV status disclosure to partners among HIV-positive women attending HIV care-and-treatment clinics (CTCs) at Kilimanjaro region, northern Tanzania. Methods A cross-sectional study was conducted from January to June 2014 in 3 out of the 7 districts of Kilimanjaro region. The study population was HIV-positive women aged 15-49, who were attending for routine HIV care at 19 selected clinics. Face-to-face interviews were conducted with consenting women to collect necessary information. Multivariate logistic regression analyses were used to determine the independent predictors of HIV status disclosure to partner. Results A total of 672 HIV-positive women in Moshi municipal, Hai and Mwanga districts were enrolled. Of them, 609 HIV-positive women reported to have a regular partner. Prevalence of serostatus disclosure to partners was 66%. Of the 400 who had disclosed; 56% did so within the first month of knowing their HIV status. In a multiple logistic regression model, HIV serostatus disclosure was higher among women who: were married/cohabiting (AOR = 4.16, 95% CI: 2.39-7.25; p<0.001), currently on ART (AOR = 2.06, 95% CI: 1.11-3.82; p = 0.020), and who reported had ever communicated with partners on number of children (AOR = 1.85, 95% CI: 1.15-2.98; p= 0.010) and contraceptives use (AOR = 2.01, 95% CI: 1.27-3.20; p = 0.208). Most of the women (81%) who disclosed their HIV status to did not reported negative outcomes. Conclusion In this setting still a third of the HIV-positive women (34%) fail to disclose their HIV-serostatus to partners. Interventions to impart skills in communication and negotiation between partners may help in improving disclosure of HIV. Efforts to involve men in general sexual and reproductive health including couple counseling and testing will contribute in improving disclosure and communication on HIV among partners.	[Damian, Damian J.; Mahande, Michael J.; Ngocho, James S.; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll KCMUCo, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Damian, Damian J.; Msuya, Sia E.] KCMC, Community Hlth Dept, Moshi, Tanzania; [Ngahatilwa, Diana; Fadhili, Hatibu] Kilimanjaro Christian Med Univ Coll KCMUCo, Moshi, Tanzania; [Mkiza, Johnston G.; Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll KCMUCo, Inst Publ Hlth, Dept Community Hlth, Moshi, Tanzania		Damian, DJ (corresponding author), Kilimanjaro Christian Med Univ Coll KCMUCo, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.; Damian, DJ (corresponding author), KCMC, Community Hlth Dept, Moshi, Tanzania.	d_jeremy5@yahoo.com	Ngocho, James/Q-4477-2019; Mahande, Michael Johnson J/I-6359-2015	Mahande, Michael Johnson J/0000-0002-7750-7657	US National Institute of Health; HRSA [T84HA21123-02]	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This project was made possible by the Mentored Research Program (MTRP) in collaboration with the HRSA-funded KCMC MEPI grant #T84HA21123-02; US National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-746; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Elopre L, 2015, AIDS PATIENT CARE ST, V29, P646, DOI 10.1089/apc.2015.0205; Genet Minichil, 2015, BMC Res Notes, V8, P109, DOI 10.1186/s13104-015-1056-5; Kiarie JN, 2003, AIDS, V17, P65, DOI 10.1097/00002030-200301030-00009; Kilewo C, 2001, J ACQ IMMUN DEF SYND, V28, P458, DOI 10.1097/00042560-200112150-00009; Kiula ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-433; Makin JD, 2008, AIDS PATIENT CARE ST, V22, P907, DOI 10.1089/apc.2007.0194; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Mcheto P, 2011, PAN AFRICAN MED J, V8, P51; Medley A, 2004, B WHO, V80; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; National Bureau of Statistics [Tanzania] and ORC Marco, 2012, TANZ HIV AIDS MAL IN; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Norman A, 2007, AM J PUBLIC HLTH, V97; Sullivan K, 2010, WOMEN HEALTH, V50, P506, DOI 10.1080/03630242.2010.516697; The United Republic of Tanzania, 2013, 2012 POP HOUS CENS P; Trinh TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163594; UNAIDS, GLOB AIDS EP UPD 201; UNAIDS, 2016, AIDS NUMB AIDS IS NO; UNAIDS, 2016, PREV GAP REP SUMM; UNAIDS & WHO, 2000, UNAIDS WHO OP HIV AI; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Walcott MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1115	25	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0211921	10.1371/journal.pone.0211921	http://dx.doi.org/10.1371/journal.pone.0211921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865633	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900012
J	Ibarra, AD; Mariano, NA; Sorani, V; Flores-Franco, G; Alquicira, ER; Wehncke, EV				De Leon Ibarra, Alejandra; Mariano, Nestor A.; Sorani, Valentino; Flores-Franco, Gabriel; Rendon Alquicira, Evodio; Wehncke, Elisabet V.			Physical environmental conditions determine ubiquitous spatial differentiation of standing plants and seedbanks in Neotropical riparian dry forests	PLOS ONE			English	Article							SOIL SEED BANK; SAN-PEDRO RIVER; TEMPORAL PATTERNS; HABITAT SELECTION; INVASIVE TAMARIX; SPECIES RICHNESS; TROPICAL FOREST; VEGETATION; WATER; FLOW	Mexican tropical dry forests are remarkably extensive and floristically diverse despite manifesting alarming rates of deforestation. Riparian habitats within dry forests provide critical ecological benefits that may mitigate negative impacts, but processes underlying riparian functions are still not well understood. We identified physical environmental conditions affecting the composition and abundance of standing vegetation assemblages and woody and herbaceous components in soil seedbank assemblages of riparian corridors in central Mexico using mainly NMDS ordination techniques, permuted analysis of variance (PERMANOVA), permuted analysis of multivariate dispersions and constrained ordination (CAP). We then determined representative species associated with particular environmental conditions using an indicator species analysis and assessed the effects of physical environmental variables/factors on total seed abundances by fitting a mixed-effect model. For the standing vegetation study, we assessed the effects of the type of the river condition (differing in surface flow permanence), location, and height above river level on the community composition based on three species importance criteria (abundance, coverage and DBH). For the soil seedbank study, we assessed the effects of these variables/factors plus season and land use. Spatial heterogeneity was a prevailing feature in riparian vegetation, in the standing vegetation and soil seedbank of both woody and herbaceous components. Height above river level had a significant effect on the three species importance criteria of standing vegetation and so did the interaction between surface flow permanence and height on coverage. The soil seedbank of woody and herbaceous plants showed significant differences between seasons; Taxodium mucronatum was an indicator tree species in dry seasons. Land use, height, surface flow permanence and the interaction between land use and surface flow permanence had significant effects on the soil seedbank of herbaceous plants. Total seed abundances in the soil varied between years and were higher at lower height values, during the dry seasons, and when rivers were permanent. Tree communities, commonly the most important elements in riparian ecosystems, were preserved in the soil seedbank of cultivated areas for >30 years. Seeds of herbaceous communities were predominant and ecologically relevant as indicator species because of their high sensitivity to several key environmental factors, constituting a critical component of Mexican tropical dry forests riparian corridors.	[De Leon Ibarra, Alejandra; Sorani, Valentino; Flores-Franco, Gabriel; Rendon Alquicira, Evodio; Wehncke, Elisabet V.] Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico; [Mariano, Nestor A.] Univ Nacl Chilecito, Inst Ambiente Montana & Reg Aridas, Chilecito, La Rioja, Argentina	Universidad Autonoma del Estado de Morelos; Universidad Nacional de Chilecito (UNDEC)	Wehncke, EV (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biodiversidad & Conservac, Cuernavaca, Morelos, Mexico.	lizwehncke@uaem.mx		Wehncke, Elisabet/0000-0003-4650-9825; Sorani, Valentino/0000-0002-7431-1894	CONACYT [257073/213871]; Postgraduate Program of Natural Sciences of the Autonomous University of Morelos State	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Postgraduate Program of Natural Sciences of the Autonomous University of Morelos State	The authors are grateful to CONACYT for the support provided by the scholarship 257073/213871 to ADLI and to the Postgraduate Program of Natural Sciences of the Autonomous University of Morelos State. These funders were fundamental in the process of data collection and analysis.	Aguilera-Gómez Luis Isaac, 2016, Polibotánica, P1, DOI 10.18387/polibotanica.41.1; Andersson E, 2000, J BIOGEOGR, V27, P1095, DOI 10.1046/j.1365-2699.2000.00481.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Banner A, 1998, RIPARIAN AREAS PROVI; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BAZZAZ FA, 1991, AM NAT, V137, pS116, DOI 10.1086/285142; BECKER P, 1988, J TROP ECOL, V4, P173, DOI 10.1017/S0266467400002674; BELL KR, 1980, WATER RESOUR RES, V16, P796, DOI 10.1029/WR016i004p00796; Binh LH, 1998, P 3 REG M FOR SMALLH, P67; Bolongaro A., 2006, ANALISIS VULNERABILI, P95; Botschek J, 1996, GEODERMA, V72, P119, DOI 10.1016/0016-7061(96)00026-2; Bourgeois B, 2017, J VEG SCI, V28, P787, DOI 10.1111/jvs.12536; Bourgeois B, 2016, ECOL APPL, V26, P2103, DOI 10.1890/15-1368.1; Brooks SS, 2007, RESTOR ECOL, V15, P584, DOI 10.1111/j.1526-100X.2007.00253.x; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Carta A, 2013, PLANT ECOL, V214, P339, DOI 10.1007/s11258-013-0174-1; CARTER V, 1994, ECOL APPL, V4, P189, DOI 10.2307/1942128; Ceccon E, 2009, REV BIOL TROP, V57, P257; Celentano D, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-11; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Chimner RA, 2004, PLANT SOIL, V260, P225, DOI 10.1023/B:PLSO.0000030190.70085.e9; Cintron G, 1983, INTR ECOLOGICA MANGL; Cleverly JR, 1997, OECOLOGIA, V111, P12, DOI 10.1007/s004420050202; Clifton E., 2004, MURRUMBIDGEE WETLAND, P21; CONANP-SEMARNAT, 2005, PROGR CONS MAN RES B; Corella J., 2001, CIENCIA FORESTAL MEX, V26, P73; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dalton RL, 2017, APPL VEG SCI, V20, P446, DOI 10.1111/avsc.12313; Dawson TE, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P165; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; de la O-Toris J, 2012, BOT SCI, V90, P469, DOI 10.17129/botsci.475; De Leon-Ibarra MA, 2005, THESIS; DEFERRARI CM, 1994, J VEG SCI, V5, P247, DOI 10.2307/3236157; Dovciak AL, 2002, ENVIRON MANAGE, V30, P365, DOI 10.1007/s00267-002-2529-6; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dwire KA, 2006, J AM WATER RESOUR AS, V42, P1, DOI 10.1111/j.1752-1688.2006.tb03817.x; Eckel PM, 2001, CLINTONIA, V16, P4; Esper-Reyes KA, 2017, THESIS; Esper-Reyes KA, 2018, J VEG SCI, V29, P62, DOI 10.1111/jvs.12595; Espiritu C, 2012, THESIS; Esquivel-Puente PS, 2012, 22 C NAC HIDR 2012 N, P1; Eufracio-Torres AE, 2016, ETHNOBIOL CONSERV, V5, DOI 10.15451/ec2016-11-5.8-1-35; Fossati J, 1999, J ARID ENVIRON, V43, P63, DOI 10.1006/jare.1999.0526; Fraaije RGA, 2015, J ECOL, V103, P1634, DOI 10.1111/1365-2745.12460; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; Fritz KM, 2006, HYDROBIOLOGIA, V556, P265, DOI 10.1007/s10750-005-1154-9; GARCIAFAYOS P, 1995, J VEG SCI, V6, P691, DOI 10.2307/3236439; GEFFEN E, 1992, OECOLOGIA, V91, P75, DOI 10.1007/BF00317244; Geissler K, 2008, AQUAT BOT, V89, P283, DOI 10.1016/j.aquabot.2008.03.001; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gomes LC, 2012, HYDROBIOLOGIA, V685, P97, DOI 10.1007/s10750-011-0870-6; Gonzalez E, 2017, BIOL CONSERV, V213, P106, DOI 10.1016/j.biocon.2017.06.043; Gonzalez E, 2017, ECOL APPL, V27, P1789, DOI 10.1002/eap.1566; Gonzalez OJ, 1996, BIOTROPICA, V28, P618, DOI 10.2307/2389048; Gonzalez-Barrios JL, 2011, RETOS INVESTIGACION, P105; Gordon E, 2000, REV BIOL TROP, V48, P25; GORSKI T, 1978, FLORA, V167, P289; Greet J, 2013, J VEG SCI, V24, P157, DOI 10.1111/j.1654-1103.2012.01445.x; Greet J, 2012, FRESHWATER BIOL, V57, P2568, DOI 10.1111/fwb.12028; Greet J, 2011, FRESHWATER BIOL, V56, P2514, DOI 10.1111/j.1365-2427.2011.02676.x; Greet J, 2011, FRESHWATER BIOL, V56, P1231, DOI 10.1111/j.1365-2427.2011.02564.x; Gurnell A, 2006, EARTH SURF PROC LAND, V31, P1558, DOI 10.1002/esp.1342; Hacke UG, 2000, OECOLOGIA, V124, P495, DOI 10.1007/PL00008875; Hernandez AJ, 2008, CONTAMINACION SUELOS, P545; Holanda Francisco S. R., 2008, Rev. bras. eng. agríc. ambient., V12, P570, DOI 10.1590/S1415-43662008000600002; Holmes PM, 2008, S AFR J BOT, V74, P538, DOI 10.1016/j.sajb.2008.01.182; Holzel N, 2001, J VEG SCI, V12, P209, DOI 10.2307/3236605; Huang YM, 2015, CATENA, V125, P135, DOI 10.1016/j.catena.2014.09.010; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; HUPP CR, 1992, ECOLOGY, V73, P1209, DOI 10.2307/1940670; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Jaramillo V., 2010, DIVERSIDAD AMENAZAS, V1st, P235; KALISZ S, 1993, OECOLOGIA, V95, P314, DOI 10.1007/BF00320982; Keeland BD, 1999, WETLANDS, V19, P149, DOI 10.1007/BF03161743; Keeland BD, 1997, AM J BOT, V84, P131, DOI 10.2307/2445890; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; Kuznetsova A., 2015, R PACKAGE VERSION PA; Lammert M, 1999, ENVIRON MANAGE, V23, P257, DOI 10.1007/s002679900184; Landsberg J, 2017, TREE PHYSIOL, V37, P18, DOI 10.1093/treephys/tpw102; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; Lemenih Mulugeta, 2006, Tropical Ecology, V47, P1; Leon-De la Luz J, 2012, MEXICO BOT SCI, V90, P143; Leyer I, 2006, J VEG SCI, V17, P407, DOI 10.1111/j.1654-1103.2006.tb02461.x; Lite SJ, 2005, J ARID ENVIRON, V63, P785, DOI 10.1016/j.jaridenv.2005.03.026; MADSEN S. B., 1962, Proceedings of the International Seed Testing Association, V27, P920; Magliano Patricio N., 2016, Ecol. austral, V26, P95; Maldonado B, 2013, ECON BOT, V67, P17, DOI 10.1007/s12231-013-9222-y; Matayaya Grace, 2017, International Journal of Biodiversity Science Ecosystem Services & Management, V13, P181, DOI 10.1080/21513732.2017.1299222; McDonough OT, 2011, RIVER ECOSYSTEMS DYN, P259; Merritt DM, 2010, FRESHWATER BIOL, V55, P206, DOI 10.1111/j.1365-2427.2009.02206.x; Mills M.G.L., 1984, Koedoe, V27, P129; Morales-Casique E, 2016, HYDROGEOL J, V24, P1873, DOI 10.1007/s10040-016-1423-x; Mortenson SG, 2009, THESIS; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Neitsch SL, 2011, TEXAS WATER RESOURCE, DOI DOI 10.1016/J.SCITOTENV.2015.11.063; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pascual MS, 2017, B I GEOGRAFIA, V92, P51; Piedade MTF, 2010, ECOSISTEMAS, V19, P52; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Postel S, 2003, RIVERS LIFE MANAGING; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; R Core Team, 2021, R LANGUAGE ENV STAT; R Development Core Team, 2016, VERS 2 4 1 R LANG EN; Renofalt BM, 2005, J BIOGEOGR, V32, P2025, DOI 10.1111/j.1365-2699.2005.01328.x; Richardson DM, 2007, DIVERS DISTRIB, V13, P126, DOI 10.1111/j.1366-9516.2006.00314.x; Richter R, 2005, BIODIVERS CONSERV, V14, P993, DOI 10.1007/s10531-004-7844-1; RICOGRAY V, 1992, J VEG SCI, V3, P617, DOI 10.2307/3235828; Riis T, 2014, ECOL ENG, V66, P103, DOI 10.1016/j.ecoleng.2013.05.006; Rincon PA, 2000, ECOL FRESHW FISH, V9, P1, DOI 10.1034/j.1600-0633.2000.90101.x; Ruiz de Velasco F, 1937, HIST EVOLUCIONES CUL; Rzedowski J., 1991, ACTA BOT MEX, V15, P47, DOI [DOI 10.21829/ABM15.1991.620, 10.21829/abm15.1991.620]; Savadogo P, 2017, J PLANT ECOL, V10, P349, DOI 10.1093/jpe/rtw025; Schilling KE, 2018, LANDSCAPE ECOL, V33, P141, DOI 10.1007/s10980-017-0589-5; Schultz RC, 2004, AGROFOREST SYST, V61-2, P35, DOI 10.1023/B:AGFO.0000028988.67721.4d; Shafroth PB, 2005, ENVIRON MANAGE, V35, P231, DOI 10.1007/s00267-004-0099-5; SMN, 2009, NAT MET SERV; Souther RF, 2000, WETLANDS, V20, P697, DOI 10.1672/0277-5212(2000)020[0697:TEOSAL]2.0.CO;2; STAHLE DW, 1988, SCIENCE, V240, P1517, DOI 10.1126/science.240.4858.1517; Stevens WD, 2001, FLORA NICARAGUA, V85, P943; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Stromberg JC, 2005, RIVER RES APPL, V21, P925, DOI 10.1002/rra.858; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Stromberg JC, 2016, FRESHWATER BIOL, V61, P1259, DOI 10.1111/fwb.12686; Stromberg JC, 2009, WETLANDS, V29, P330, DOI 10.1672/08-124.1; Suzan H, 1997, ECOL APPL, V7, P948, DOI 10.1890/1051-0761(1997)007[0948:EACOIO]2.0.CO;2; Tabacchi E, 1998, FRESHWATER BIOL, V40, P497, DOI 10.1046/j.1365-2427.1998.00381.x; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Tolentino Martínez Jessica Mariela, 2014, Estud. soc, V22, P39; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Vargas Velazquez S, 2006, GESTION AGUA CUENCA; Villarreal Q. José Á., 2006, Act. Bot. Mex, P1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Warren PL, 1985, RIPARIAN ECOSYSTEMS, P150; Western AW, 1999, WATER RESOUR RES, V35, P797, DOI 10.1029/1998WR900065; Whitmore T. C., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P549; Williams CJ, 2016, RANGELAND ECOL MANAG, V69, P4, DOI 10.1016/j.rama.2015.10.001; Wilson DJ, 2005, ADV WATER RESOUR, V28, P43, DOI 10.1016/j.advwatres.2004.09.007; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Xu HL, 2009, ENVIRON GEOL, V58, P1749, DOI 10.1007/s00254-008-1674-5; YOUNG PJ, 1995, AM MIDL NAT, V133, P206, DOI 10.2307/2426385; Zarco-Espinosa VM, 2010, Universidad y ciencia, V26, P1; Zhao CH, 2016, LAND DEGRAD DEV, V27, P748, DOI 10.1002/ldr.2423; Zhao DD, 2007, APPL SOIL ECOL, V37, P118, DOI 10.1016/j.apsoil.2007.06.003	151	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212185	10.1371/journal.pone.0212185	http://dx.doi.org/10.1371/journal.pone.0212185			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865660	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900014
J	Komtenza, B; Satyanarayana, S; Takarinda, KC; Mukungunugwa, SH; Mugurungi, O; Chonzi, P; Sithole, N; Bvochora, T; Mushavi, A				Komtenza, Brian; Satyanarayana, Srinath; Takarinda, Kudakwashe C.; Mukungunugwa, Solomon H.; Mugurungi, Owen; Chonzi, Prosper; Sithole, Ngwarai; Bvochora, Talent; Mushavi, Angela			Identifying high or low risk of mother to child transmission of HIV: How Harare City, Zimbabwe is doing?	PLOS ONE			English	Article							PREVENTION; INFANTS	Background Despite high antiretroviral (ARV) treatment coverage among pregnant women for prevention of mother-to-child transmission (PMTCT) of Human Immunodeficiency Virus (HIV) in Zimbabwe, the MTCT rate is still high. Therefore in 2016, the country adopted World Health Organization recommendations of stratifying pregnant women into "High" or"Low" MTCT risk for subsequent provision of HIV exposed infant (HEI) with appropriate follow-up care according to risk status. Objective The study sought to ascertain, among pregnant women who delivered in clinics of Harare in August 2017: the extent to which high risk MTCT pregnancies were identified at time of delivery; and whether their newborns were initiated on appropriate ARV prophylaxis, cotrimoxazole prophylaxis, subjected to early HIV diagnostic testing and initiated on ARV treatment. Methods Cross-sectional study using review of records of routinely collected program data. Results Of the 1,786 pregnant women who delivered in the selected clinics, HIV status at the time of delivery was known for 1,756 (98%) of whom 197 (11%) were HIV seropositive. Only 19 (10%) could be classified as "high risk" for MTCT and the remaining 90% lacked adequate information to classify them into high or low risk for MTCT due to missing data. Of the 197 live births, only two (1%) infants had a nucleic-acid test (NAT) at birth and 32 (16%) infants had NAT at 6 weeks. Of all 197 infants, 183 (93%) were initiated on single ARV prophylaxis (Nevirapine), 15 (7%) infants' ARV prophylaxis status was not documented and one infant got dual ARV prophylaxis (Nevirapine+Zidovudine). Conclusion There was paucity of data requisite for MTCT risk stratification due to poor recording of data; "high risk" women were missed in the few circumstances where sufficient data were available. Thus "high risk" HEI are deprived of dual ARV prophylaxis and priority HIV NAT at birth and onwards which they require for PMTCT. Health workers need urgent training, mentorship and supportive supervision to master data management and perform MTCT risk stratification satisfactorily.	[Komtenza, Brian; Takarinda, Kudakwashe C.; Mukungunugwa, Solomon H.; Mugurungi, Owen; Sithole, Ngwarai; Mushavi, Angela] Govt Zimbabwe, AIDS & TB Unit, Minist Hlth & Child Care, Harare, Zimbabwe; [Satyanarayana, Srinath] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France; [Chonzi, Prosper; Bvochora, Talent] City Harare Hlth Serv Dept, Harare, Zimbabwe		Komtenza, B (corresponding author), Govt Zimbabwe, AIDS & TB Unit, Minist Hlth & Child Care, Harare, Zimbabwe.	beekomtenza@gmail.com		Komtenza, Brian/0000-0002-7851-5237; Satyanarayana, Srinath/0000-0002-5420-2551	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch (Luxembourg); United States Agency for International Development (USAID) through Challenge TB; Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); National AIDS Council Zimbabwe	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch (Luxembourg); United States Agency for International Development (USAID) through Challenge TB(United States Agency for International Development (USAID)); Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); National AIDS Council Zimbabwe	This work was supported by United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch (Luxembourg); the United States Agency for International Development (USAID) through Challenge TB; The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) and the National AIDS Council Zimbabwe to BK.	Abrams EJ, 2017, PEDIATR INFECT DIS J, V36, P595, DOI [10.1097/inf.0000000000001507, 10.1097/INF.0000000000001507]; Dorward J, 2018, LANCET HIV, V5, pE8, DOI 10.1016/S2352-3018(17)30211-4; Fowler MG, 2014, JAIDS-J ACQ IMM DEF, V65, P366, DOI 10.1097/QAI.0000000000000052; Go Z, 2013, OP PLAN NAT TRANS OP; Newell ML, 2001, B WORLD HEALTH ORGAN, V79, P1138; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; The National Medicine and Therapeutics Policy Advisory Committee (NMTPAC) and The AIDS and TB Directorate Ministry of Health and Child Care (MOHCC) H, 2016, GUID ANT THER PREV T; UNAIDS, 2016, UNAIDS AIDS DAT 2016; UNAIDS, 2015, SUP FAST TRACK FRAM; WHO/UNAIDS, 2015, GLOB AIDS RESP PROGR; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2014, CRIT PROC VAL EL MOT	13	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212848	10.1371/journal.pone.0212848	http://dx.doi.org/10.1371/journal.pone.0212848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865646	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900042
J	Santamaria-Martos, F; Benitez, I; Zapater, A; Giron, C; Pinilla, L; Fernandez-Real, JM; Barbe, F; Ortega, FJ; Sanchez-de-la-Torre, M				Santamaria-Martos, Fernando; Benitez, Ivan; Zapater, Andrea; Giron, Cristina; Pinilla, Lucia; Manuel Fernandez-Real, Jose; Barbe, Ferran; Jose Ortega, Francisco; Sanchez-de-la-Torre, Manuel			Identification and validation of circulating miRNAs as endogenous controls in obstructive sleep apnea	PLOS ONE			English	Article							MICRORNA EXPRESSION; PRECISION MEDICINE; CANCER; PLASMA; SERUM; NORMALIZERS; GENES; POPULATION; PREVALENCE; BIOMARKERS	microRNAs (miRNAs) are non-coding RNAs highly relevant as biomarkers for disease. A seminal study that explored the role of miRNAs in obstructive sleep apnea syndrome (OSA) demonstrated their usefulness in clinical management. Nevertheless, the miRNAs that may act as endogenous controls (ECs) have not yet been established. The identification of ECs would contribute to the standardization of these biomarkers in OSA. The objective of the study is to identify miRNAs that can be used as ECs in OSA. We evaluated 100 patients divided into two different cohorts: a learning cohort of 10 non-OSA and 30 OSA patients, and a validation cohort (20 non-OSA and 40 OSA patients). In the learning cohort, a profile of 188 miRNAs was determined in plasma by TaqMan Low Density Array. The best EC candidates were identified by mean center+SD normalization and concordance correlation restricted normalization. The results were validated using NormFinder and geNorm to assess the stability of those ECs. Eight miRNAs were identified as EC candidates. The combination miRNA-106a/miRNA-186 was identified as the most stable among all candidates. We identified a set of ECs to be used in the determination of circulating miRNA in OSA that may contribute to the homogeneity of results.	[Santamaria-Martos, Fernando; Benitez, Ivan; Zapater, Andrea; Giron, Cristina; Pinilla, Lucia; Barbe, Ferran; Sanchez-de-la-Torre, Manuel] Hosp Univ Arnau de Vilanova & Santa Maria, Grp Translat Res Resp Med, IRB Lleida, Lleida, Spain; [Benitez, Ivan; Barbe, Ferran; Sanchez-de-la-Torre, Manuel] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Manuel Fernandez-Real, Jose; Jose Ortega, Francisco] Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Manuel Fernandez-Real, Jose; Jose Ortega, Francisco] CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid, Spain; [Manuel Fernandez-Real, Jose; Jose Ortega, Francisco] Inst Salud Carlos III, Madrid, Spain	University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Sanchez-de-la-Torre, M (corresponding author), Hosp Univ Arnau de Vilanova & Santa Maria, Grp Translat Res Resp Med, IRB Lleida, Lleida, Spain.; Sanchez-de-la-Torre, M (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.; Ortega, FJ (corresponding author), Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain.; Ortega, FJ (corresponding author), CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid, Spain.; Ortega, FJ (corresponding author), Inst Salud Carlos III, Madrid, Spain.	fortega@idibgi.org; sanchezdelatorre@gmail.com	Santamaria-Martos, Fernando/AAF-9078-2019; Pinilla, LucÃa/AAF-5633-2021; Fernández-Real, Jose Manuel/AGH-3599-2022; Girón, Cristina/A-1391-2013; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Sánchez-de-la-Torre, Manuel/AAC-9514-2022; Barbé, Ferran/A-5988-2010; Ortega, Francisco José J/F-3883-2016; Benítez, Iván David/AAI-9379-2020	Santamaria-Martos, Fernando/0000-0002-0823-1255; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Barbé, Ferran/0000-0002-2340-8928; Ortega, Francisco José J/0000-0003-2111-769X; Benitez, Ivan David/0000-0002-3558-5948; Pinilla, Lucia/0000-0003-2825-4056	Instituto de Salud Carlos III (ISCIII) [PI 14/01266, PI 18/00449]; Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Pneumologia (SOCAP); IRBLleida Biobank [B.0000682]; PLATAFORMA BIOBANCOS [PT17/0015/0027]; AGAUR-University of Lleida; Convocatoria d'Ajuts 2018 de Promocioa la Recerca en Salut	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Societat Catalana de Pneumologia (SOCAP); IRBLleida Biobank; PLATAFORMA BIOBANCOS; AGAUR-University of Lleida; Convocatoria d'Ajuts 2018 de Promocioa la Recerca en Salut	The project is supported by PI 14/01266 and PI 18/00449 from the Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER), Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) and Societat Catalana de Pneumologia (SOCAP). The work is supported by IRBLleida Biobank (B.0000682) and PLATAFORMA BIOBANCOS PT17/0015/0027". We thank all the investigators of Sleep Unit of Santa Maria Hospital. F.S.-M. is the recipient of a predoctoral fellowship from "AGAUR-University of Lleida" and Convocatoria d'Ajuts 2018 de Promocioa la Recerca en Salut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anfossi S, 2018, NAT REV CLIN ONCOL, V15, P541, DOI 10.1038/s41571-018-0035-x; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Holm A, 2014, SLEEP, V37, P1525, DOI 10.5665/sleep.4004; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Latorre J, 2017, INT J OBESITY, V41, P620, DOI 10.1038/ijo.2017.21; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; McDermott AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083718; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Morata-Tarifa C, 2017, SCI REP-UK, V7, DOI 10.1038/srep39782; Ortega FJ, 2015, J CLIN ENDOCR METAB, V100, pE1467, DOI 10.1210/jc.2015-2357; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Pack AI, 2016, ANN AM THORAC SOC, V13, P1456, DOI 10.1513/AnnalsATS.201604-235PS; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qi RQ, 2012, HEPATOLOGY, V55, P1640, DOI 10.1002/hep.25558; Sanchez-de-la-Torre M, 2017, EXPERT REV PRECIS ME, V2, P217, DOI 10.1080/23808993.2017.1361319; Sanchez-de-la-Torre M, 2015, J AM COLL CARDIOL, V66, P1023, DOI 10.1016/j.jacc.2015.06.1315; Sanchez-de-la-Torre M, 2013, LANCET RESP MED, V1, P61, DOI 10.1016/S2213-2600(12)70051-6; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Solayman MHM, 2016, MOL BIOTECHNOL, V58, P179, DOI 10.1007/s12033-015-9912-z; Suarez-Arriaga MC, 2017, ONCOL LETT, V13, P3109, DOI 10.3892/ol.2017.5816; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Torres A, 2013, GYNECOL ONCOL, V130, P588, DOI 10.1016/j.ygyno.2013.06.026; Torres G, 2016, ARCH BRONCONEUMOL, V52, P455, DOI 10.1016/j.arbres.2016.02.004; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, REAL TIME PCR CURREN, P1; Wang Y, 2013, J APPL TOXICOL, V33, P1330, DOI 10.1002/jat.2864; Wylie Dennis, 2011, BMC Res Notes, V4, P555, DOI 10.1186/1756-0500-4-555; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211	38	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213622	10.1371/journal.pone.0213622	http://dx.doi.org/10.1371/journal.pone.0213622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865706	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900078
J	Yao, YX; Bi, Z; Wu, RF; Zhao, YL; Liu, YH; Liu, Q; Wang, YZ; Wang, XX				Yao, Yongxi; Bi, Zhen; Wu, Ruifan; Zhao, Yuanling; Liu, Youhua; Liu, Qing; Wang, Yizhen; Wang, Xinxia			METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBP beta pathway via an m(6)A-YTHDF2-dependent manner	FASEB JOURNAL			English	Article						m(6)A methylation; adipogenesis; porcine model; stem cells	MESENCHYMAL STEM-CELLS; MESSENGER-RNA; REGULATES ADIPOGENESIS; SIGNAL TRANSDUCERS; CALVARIAL DEFECTS; M(6)A METHYLATION; BINDING-PROTEIN; 3T3-L1 CELLS; NUCLEAR-RNA; EXPRESSION	Bone marrow stem cells (BMSCs) are multipotent stem cells that can regenerate mesenchymal tissues, such as adipose tissue, bone, and muscle. Recent studies have shown that N-6-methyladenosine (m(6)A) methylation, one of the most prevalent epigenetic modifications, is involved in the development process. However, whether it plays roles in BMSC differentiation is still elusive. Here, we found that the deletion of m(6)A "writer" protein methyltransferase-like (METTL)3 in porcine BMSCs (pBMSCs) could promote adipogenesis and janus kinase (JAK)1 protein expression via an m(6)A-dependent way. Knockdown of METTL3 decreased mRNA m(6)A levels of JAK1, leading to enhanced YTH m(6)A RNA binding protein 2 (YTHDF2)-dependent JAK1 mRNA stability. We further demonstrated that JAK1 activated signal transducer and activator of transcription (STAT) 5 through regulation of its phosphorylation to bind to the promoter of CCAAT/enhancer binding protein (C/EBP) beta, which could ultimately lead to a modulated adipogenic process. Collectively, our results reveal an orchestrated network linking the m(6)A methylation and JAK1/STAT5/C/EBP beta pathway in pBMSCs adipogenic differentiation. Our findings provide novel insights into the underlying molecular mechanisms of m(6)A modification in the regulation of BMSCs differentiating into adipocytes, which may pave a way to develop more effective therapeutic strategies in stem cell regenerative medicine and the treatment of obesity.-Yao, Y., Bi, Z., Wu, R., Zhao, Y., Liu, Y., Liu, Q., Wang, Y., Wang, X. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBP beta pathway via an m(6)A-YTHDF2-dependent manner.	[Yao, Yongxi; Bi, Zhen; Wu, Ruifan; Zhao, Yuanling; Liu, Youhua; Liu, Qing; Wang, Yizhen; Wang, Xinxia] Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Yizhen; Wang, Xinxia] Minist Agr, Key Lab Anim Nutr & Feed Sci Eastern China, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Ministry of Agriculture & Rural Affairs	Wang, XX (corresponding author), Zhejiang Univ, Coll Anim Sci, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	xinxiawang@zju.edu.cn	Wu, Ruifan/AHH-6097-2022	Wu, Ruifan/0000-0003-4917-5197; wang, yizhen/0000-0002-3908-7102	National Natural Science Foundation of China [31572413]; Natural Science Foundation of Zhejiang Province [LZ17C17001]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant 31572413), the Natural Science Foundation of Zhejiang Province (Grant LZ17C17001), and the Fundamental Research Funds for the Central Universities. The authors declare no conflicts of interest.	Babaei R, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aai7838; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Derecka M, 2012, CELL METAB, V16, P814, DOI 10.1016/j.cmet.2012.11.005; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fuentes L, 2016, CONTRACEPTION, V93, P292, DOI 10.1016/j.contraception.2015.12.017; Gao P, 2015, CELL SIGNAL, V27, P2434, DOI 10.1016/j.cellsig.2015.09.010; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Harp JB, 2001, BIOCHEM BIOPH RES CO, V281, P907, DOI 10.1006/bbrc.2001.4460; Hellgren G, 2001, J INTERF CYTOK RES, V21, P75, DOI 10.1089/107999001750069935; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Huang JB, 2018, GENOM PROTEOM BIOINF, V16, P85, DOI 10.1016/j.gpb.2018.03.001; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jia YY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111085; Kawai M, 2007, J MOL ENDOCRINOL, V38, P19, DOI 10.1677/jme.1.02154; Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020; Kusuyama J, 2018, J CELL PHYSIOL, V233, P2549, DOI 10.1002/jcp.26130; Lee K, 2016, BBA-GEN SUBJECTS, V1860, P2416, DOI 10.1016/j.bbagen.2016.07.009; Li HB, 2017, NATURE, V548, P338, DOI 10.1038/nature23450; Li SW, 2015, STEM CELL TRANSL MED, V4, P359, DOI 10.5966/sctm.2014-0150; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Song XB, 2011, ACTA BIOCH BIOPH SIN, V43, P796, DOI 10.1093/abbs/gmr074; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; Tanaka Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30929-1; Wakao Hiroshi, 2011, Environmental Health and Preventive Medicine, V16, P247, DOI 10.1007/s12199-010-0193-7; Wang L, 2018, FASEB J, V32, P4714, DOI 10.1096/fj.201701314R; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XX, 2018, INT J OBESITY, V42, P1912, DOI 10.1038/s41366-018-0027-z; Wang XX, 2015, BIOCHEM BIOPH RES CO, V459, P201, DOI 10.1016/j.bbrc.2015.02.048; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wei XJ, 2016, INT J BIOCHEM CELL B, V77, P109, DOI 10.1016/j.biocel.2016.06.003; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Wu RF, 2018, BBA-MOL CELL BIOL L, V1863, P1323, DOI 10.1016/j.bbalip.2018.08.008; Wu RF, 2018, INT J OBESITY, V42, P1378, DOI 10.1038/s41366-018-0082-5; Wu RF, 2016, MOL BIOTECHNOL, V58, P450, DOI 10.1007/s12033-016-9947-9; Xiao W, 2016, MOL CELL, V61, P925, DOI 10.1016/j.molcel.2016.03.004; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yuan YY, 2017, BIOCHEM BIOPH RES CO, V482, P1360, DOI 10.1016/j.bbrc.2016.12.042; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang KM, 2011, J CELL BIOCHEM, V112, P488, DOI 10.1002/jcb.22936; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhao X, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0486-0; Zong C, 2010, EUR CELLS MATER, V20, P109; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005	64	67	75	6	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7529	7544		10.1096/fj.201802644R	http://dx.doi.org/10.1096/fj.201802644R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865855	Bronze			2022-12-26	WOS:000476114200069
J	Sonntag, Y; Gena, P; Maggio, A; Singh, T; Artner, I; Oklinski, MK; Johanson, U; Kjellbom, P; Nieland, JD; Nielsen, S; Calamita, G; Rutzler, M				Sonntag, Yonathan; Gena, Patrizia; Maggio, Anna; Singh, Tania; Artner, Isabella; Oklinski, Michal K.; Johanson, Urban; Kjellbom, Per; Nieland, John Dirk; Nielsen, Soren; Calamita, Giuseppe; Ruetzler, Michael			Identification and characterization of potent and selective aquaporin-3 and aquaporin-7 inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; molecular docking; glycerol; inhibitor; hydrogen peroxide; aquaporin inhibitor; calcein; CHO cell assay; HyPer; residual pore	HYDROGEN-PEROXIDE TRANSPORT; WATER CHANNEL; COLLECTING DUCT; GLYCEROL TRANSPORT; CELL-MIGRATION; MESSENGER-RNA; CLUSTAL-W; PERMEABILITY; EXPRESSION; PROTEIN	The aquaglyceroporins are a subfamily of aquaporins that conduct both water and glycerol. Aquaporin-3 (AQP3) has an important physiological function in renal water reabsorption, and AQP3-mediated hydrogen peroxide (H2O2) permeability can enhance cytokine signaling in several cell types. The related aquaglyceroporin AQP7 is required for dendritic cell chemokine responses and antigen uptake. Selective small-molecule inhibitors are desirable tools for investigating the biological and pathological roles of these and other AQP isoforms. Here, using a calcein fluorescence quenching assay, we screened a library of 7360 drug-like small molecules for inhibition of mouse AQP3 water permeability. Hit confirmation and expansion with commercially available substances identified the ortho-chloride-containing compound DFP00173, which inhibited mouse and human AQP3 with an IC50 of approximate to 0.1-0.4 m but had low efficacy toward mouse AQP7 and AQP9. Surprisingly, inhibitor specificity testing revealed that the methylurea-linked compound Z433927330, a partial AQP3 inhibitor (IC50, approximate to 0.7-0.9 m), is a potent and efficacious inhibitor of mouse AQP7 water permeability (IC50, approximate to 0.2 m). Stopped-flow light scattering measurements confirmed that DFP00173 and Z433927330 inhibit AQP3 glycerol permeability in human erythrocytes. Moreover, DFP00173, Z433927330, and the previously identified AQP9 inhibitor RF03176 blocked aquaglyceroporin H2O2 permeability. Molecular docking to AQP3, AQP7, and AQP9 homology models suggested interactions between these inhibitors and aquaglyceroporins at similar binding sites. DFP00173 and Z433927330 constitute selective and potent AQP3 and AQP7 inhibitors, respectively, and contribute to a set of isoform-specific aquaglyceroporin inhibitors that will facilitate the evaluation of these AQP isoforms as drug targets.	[Sonntag, Yonathan; Johanson, Urban; Kjellbom, Per] Lund Univ, Dept Chem, Div Biochem & Struct Biol, S-22100 Lund, Sweden; [Gena, Patrizia; Maggio, Anna; Calamita, Giuseppe] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Singh, Tania; Artner, Isabella] Lund Univ, Stem Cell Ctr, S-22184 Lund, Sweden; [Oklinski, Michal K.; Nieland, John Dirk; Nielsen, Soren; Ruetzler, Michael] Aalborg Univ, Dept Hlth Sci & Technol, DK-9220 Aalborg, Denmark	Lund University; Universita degli Studi di Bari Aldo Moro; Lund University; Aalborg University	Rutzler, M (corresponding author), Fredrik Bajers Vej 7E,Room 4-110, DK-9220 Aalborg O, Denmark.	miru@hst.aau.dk	Oklinski, Michal Krystian/S-9651-2017; Oklinski, Michal K./AAT-9152-2020; Johanson, Urban/AHE-8231-2022; Sonntag, Yonathan/GRF-4277-2022; Gena, patrizia/AAC-3396-2022	Oklinski, Michal K./0000-0002-7713-4731; Johanson, Urban/0000-0001-8862-128X; Sonntag, Yonathan/0000-0002-8063-0285; Nieland, John/0000-0001-7423-0122; Artner, Isabella/0000-0002-2895-5664	Aalborg University; Danish Research Council; Stiftelsen Olle Engkvist Byggmastare	Aalborg University; Danish Research Council(Det Frie Forskningsrad (DFF)); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council)	This work was supported by funds from Aalborg University, the Danish Research Council, and Stiftelsen Olle Engkvist Byggmastare. The authors declare that they have no conflicts of interest with the contents of this article.	Bertolotti M, 2016, J LEUKOCYTE BIOL, V100, P1071, DOI 10.1189/jlb.2AB0116-045R; Bertolotti M, 2013, ANTIOXID REDOX SIGN, V19, P1447, DOI 10.1089/ars.2013.5330; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Calamita G, 2008, AM J PHYSIOL-GASTR L, V295, pG682, DOI 10.1152/ajpgi.90226.2008; Calamita G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00851; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteva-Font C, 2016, MOL PHARMACOL, V89, P686, DOI 10.1124/mol.116.103929; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; FRIGERI A, 1995, J CELL SCI, V108, P2993; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hara-Chikuma M, 2016, BIOCHEM BIOPH RES CO, V471, P603, DOI 10.1016/j.bbrc.2016.02.010; Hara-Chikuma M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8454; Hara-Chikuma M, 2012, J EXP MED, V209, P1743, DOI 10.1084/jem.20112398; Hara-Chikuma M, 2012, FASEB J, V26, P211, DOI 10.1096/fj.11-186627; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Hibuse T, 2009, CARDIOVASC RES, V83, P34, DOI 10.1093/cvr/cvp095; Ikezoe K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25781; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Karreman C, 2002, BIOINFORMATICS, V18, P884, DOI 10.1093/bioinformatics/18.6.884; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Madeira A, 2014, CHEMBIOCHEM, V15, P1487, DOI 10.1002/cbic.201402103; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Martins AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037435; Matsumura K, 2007, MOL CELL BIOL, V27, P6026, DOI 10.1128/MCB.00384-07; Medrano-Fernandez I, 2016, ANTIOXID REDOX SIGN, V24, P1031, DOI 10.1089/ars.2016.6636; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moniaga CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15319; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Ramirez-Lorca R, 1999, PFLUG ARCH EUR J PHY, V438, P94, DOI 10.1007/s004240050884; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Roudier N, 2002, J BIOL CHEM, V277, P45854, DOI 10.1074/jbc.M208999200; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Satooka H, 2016, MOL CELL BIOL, V36, P1206, DOI 10.1128/MCB.00971-15; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sogaard R, 2008, PFLUG ARCH EUR J PHY, V456, P285, DOI 10.1007/s00424-007-0392-2; Sohara E, 2005, AM J PHYSIOL-RENAL, V289, pF1195, DOI 10.1152/ajprenal.00133.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Umenishi F, 1996, DNA CELL BIOL, V15, P475, DOI 10.1089/dna.1996.15.475; Van Huyen JPD, 1998, J MEMBRANE BIOL, V164, P79; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wacker SJ, 2013, MOL MEMBR BIOL, V30, P246, DOI 10.3109/09687688.2013.773095; Watanabe S, 2016, BIOCHEM BIOPH RES CO, V471, P191, DOI 10.1016/j.bbrc.2016.01.153; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Xia H, 2014, EXP PHYSIOL, V99, P974, DOI 10.1113/expphysiol.2014.078527; Xiong GS, 2017, BIOCHEM BIOPH RES CO, V485, P627, DOI 10.1016/j.bbrc.2017.02.013; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022	63	23	23	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7377	7387		10.1074/jbc.RA118.006083	http://dx.doi.org/10.1074/jbc.RA118.006083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30862673	Green Published, hybrid			2022-12-26	WOS:000468402900024
J	De Massis, F; Zilli, K; Di Donato, G; Nuvoloni, R; Pelini, S; Sacchini, L; D'Alterio, N; Di Giannatale, E				De Massis, Fabrizio; Zilli, Katiuscia; Di Donato, Guido; Nuvoloni, Roberta; Pelini, Sandro; Sacchini, Lorena; D'Alterio, Nicola; Di Giannatale, Elisabetta			Distribution of Brucella field strains isolated from livestock, wildlife populations, and humans in Italy from 2007 to 2015	PLOS ONE			English	Article							ABORTUS INFECTION; DIFFERENTIATION; OSTEOMYELITIS; POLYMORPHISM; MELITENSIS	Brucellosis is a major public health problem still prevalent as a neglected endemic zoonosis requiring proactive attention in many communities worldwide. The present study involved analysis of Brucella field strains submitted for typing to the Italian National Reference Laboratory for Brucellosis from 2007 to 2015. Strains were identified at the species and biovar levels by classic and molecular techniques according to the World Organisation for Animal Health Manual. In total, 5,784 strains were typed: 3,089 Brucella abortus (53.4%), 2,497 B. melitensis (43.2%), 10 B. ovis (0.2%), 181 B. suis (3.1%), and 7 B. ceti (0.1%). The 2,981 strains from cattle were typed as B. abortus biovars 1, 3, and 6 (90.1%) and B. melitensis biovar 3 (9.9%). The 318 strains from water buffalo were typed as B. abortus biovars 1, 3 (95.9%) and B. melitensis biovar 3 (4.1%). The 2,279 strains from sheep and goats were typed as B. abortus biovars 1 and 3 (4.3%); B. melitensis biovars 1, 3, (95.3%); and B. ovis (0.4%). The 173 strains from wild boar were typed as B. suis biovar 2 (98.3%) and B. melitensis biovar 3 (1.7%). The 11 strains from pigs were typed as B. suis biovar 2. The 13 strains from humans were typed as B. melitensis biovar 3. The two strains from horses were typed as B. abortus biovar 1, while the seven strains from dolphins were typed as B. ceti. This additional knowledge on the epidemiology of brucellosis in Italy may be useful to formulate policies and strategies for the control and eradication of the disease in animal populations. The animal species affected, biovars typed, geographical origins, and spatial distributions of isolates are herein analyzed and discussed.	[De Massis, Fabrizio; Zilli, Katiuscia; Di Donato, Guido; Pelini, Sandro; Sacchini, Lorena; D'Alterio, Nicola; Di Giannatale, Elisabetta] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Natl & OIE Reference Lab Brucellosis, Campo Boario, Teramo, Italy; [Nuvoloni, Roberta] Univ Pisa, Dept Vet Sci, Pisa, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; University of Pisa	Di Donato, G (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Natl & OIE Reference Lab Brucellosis, Campo Boario, Teramo, Italy.	gu.didonato@izs.it	Sacchini, Lorena/B-6847-2016; De Massis, Fabrizio/ABG-8949-2021; Di Donato, Guido/GON-5596-2022; De Massis, Fabrizio/P-9099-2016; Di Donato, Guido/D-3828-2016; Di Giannatale, Elisabetta/J-9010-2016; NUVOLONI, ROBERTA/P-8754-2015	Sacchini, Lorena/0000-0001-6939-1378; De Massis, Fabrizio/0000-0001-9811-699X; Di Donato, Guido/0000-0001-8606-5291; De Massis, Fabrizio/0000-0001-9811-699X; Di Donato, Guido/0000-0001-8606-5291; Di Giannatale, Elisabetta/0000-0001-8874-5856; NUVOLONI, ROBERTA/0000-0002-7469-571X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding for this research was provided by the Italian Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakpo A. J., 1987, Revue Scientifique et Technique, Office International des Epizooties, V6, P981; Al Dahouk S, 2007, EMERG INFECT DIS, V13, P1895, DOI 10.3201/eid1312.070527; Algers B., 2009, EFSA J, V1144, P1; Alton G. G., 1988, Techniques for the brucellosis laboratory.; Ancora M, 2016, MED BIOD C 2016 MUNC; [Anonymous], 2015, GUIDANCE REGULATIONS; Barlozzari G, 2015, VET ITAL, V51, P151, DOI 10.12834/VetIt.50.3384.1; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Brew SD, 1999, VET REC, V144, P483; BRICKER BJ, 1994, J CLIN MICROBIOL, V32, P2660, DOI 10.1128/JCM.32.11.2660-2666.1994; BRICKER BJ, 1995, J CLIN MICROBIOL, V33, P1640, DOI 10.1128/JCM.33.6.1640-1642.1995; Carmichael L. E., 1990, Animal brucellosis., P335; CLOECKAERT A, 1995, MICROBIOL-UK, V141, P2111, DOI 10.1099/13500872-141-9-2111; COLLINS JD, 1971, VET REC, V88, P321, DOI 10.1136/vr.88.13.321; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Corbel MJ, 1984, BERGEYS MANUAL SYSTE, P377; Crawford RP, 1990, ANIMAL BRUCELLOSIS, P132; De Massis F, 2005, Clin Microbiol Infect, V11, P632, DOI 10.1111/j.1469-0691.2005.01204.x; De Massis F, 2012, VET ITAL, V48, P397; Denny H R, 1973, Equine Vet J, V5, P121, DOI 10.1111/j.2042-3306.1973.tb03208.x; DENNY HR, 1972, VET REC, V90, P86, DOI 10.1136/vr.90.4.86; Di Giannatale Elisabetta, 2008, Vet Ital, V44, P383; EFSA (European Food Safety Authority), 2009, EFSA J, V7, P358, DOI [10.2903/j.efsa.2009.1438, DOI 10.2903/J.EFSA.2009.1438, 10.2903/j.efsa.2010.1496]; Euzeby JP, 2010, LIST PROKARYOTIC NAM; Farina R, 1998, MALATTIE INFETTIVE A, P157; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Garofolo G, 2017, P 18 INT S WORLD ASS, P41; Garofolo G, 2017, VET ITALIANA COLLANA, V26, P78; Garofolo Giuliano, 2016, BMC Res Notes, V9, P277, DOI 10.1186/s13104-016-2074-7; Garofolo G, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01402-15; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; IATA-Infectious Substances Shipping Guidelines, 2006, WHOHSEGHR201212, P1; Janowicz A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00517-18, 10.1128/jcm.00517-18]; Latesson JJ, 1987, ANIMAL BRUCELLOSIS, P1887; Lucero NE, 2010, EPIDEMIOL INFECT, V138, P280, DOI 10.1017/S0950268809990525; LUCHSINGER DW, 1979, AM J VET RES, V40, P1307; MACMILLAN AP, 1985, VET REC, V117, P638, DOI 10.1136/vr.117.24.638; MACMILLAN AP, 1982, RES VET SCI, V33, P351, DOI 10.1016/S0034-5288(18)32315-4; Makita K, 2008, ANN NY ACAD SCI, V1149, P309, DOI 10.1196/annals.1428.015; MCCAUGHEY WJ, 1967, VET REC, V80, P186, DOI 10.1136/vr.80.5.186; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Nomura A, 2010, EMERG INFECT DIS, V16, P1183, DOI 10.3201/eid1607.090209; OIE Terrestrial Manual, 2017, MANUAL DIAGNOSTIC 2; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Shirima GM, 2010, TANZ J HLTH RES, V12; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; Verger JM, 1985, BRUCELLA MELITENSIS, P270; Vergnaud G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01545; Vizcaino N, 1997, MICROBIOL-UK, V143, P2913, DOI 10.1099/00221287-143-9-2913; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; Whatmore AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02049; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; World Health Organization (WHO), 1997, WHOEMC973	58	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213689	10.1371/journal.pone.0213689	http://dx.doi.org/10.1371/journal.pone.0213689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901346	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400015
J	Austin, V; Miller, A; Vlahos, R				Austin, Victoria; Miller, Alyson; Vlahos, Ross			Prior cigarette smoke exposure does not affect acute post-stroke outcomes in mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDUCED LUNG INFLAMMATION; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS; NEUROPEPTIDE-Y; COPD; STROKE; AIRWAYS; WEIGHT; RISK	Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death globally and is characterized by airflow limitation that is progressive and not fully reversible. Cigarette smoking is the major cause of COPD. Fifty percent of deaths in the COPD population are due to a cardiovascular event and it is now recognised that COPD is a risk factor for stroke. Whether COPD increases stroke severity has not been explored. The aim of this study was to investigate whether functional and histological endpoints of stroke outcomes in mice after transient middle cerebral artery occlusion (tMCAo) were more severe in mice exposed to cigarette smoke (CS). 7-week-old male C57BL/6 mice were exposed to room air or CS generated from 9 cigarettes/day, 5 days/week for 2, 8 and 12 weeks. Following air or CS exposure, mice underwent tMCAO surgery with an ischaemic period of 30-40 min or sham surgery. Mice were euthanised 24 h following the induction of ischaemia and bronchoalveolar lavage fluid (BALF), lungs and brains collected. Mice exposed to CS for 2 weeks and subjected to a stroke had similar BALF macrophages to air-exposed and stroke mice. However, CS plus stroke mice had significantly more BALF total cells, neutrophils and lymphocytes than air plus stroke mice. Mice exposed to CS for 8 and 12 weeks had significantly greater BALF total cells, macrophages, neutrophils and lymphocytes than air-exposed mice, but stroke did not affect CS-induced BALF cellularity. Prior CS exposure did not worsen stroke-induced neurological deficit scores, reduced foregrip strength, infarct and oedema volumes. Collectively, we found that although CS exposure caused significant BALF inflammation, it did not worsen acute post-stroke outcomes in mice. This data suggests that while patients with COPD are at increased risk of stroke, it may not translate to COPD patients having more severe stroke outcomes.	[Austin, Victoria; Miller, Alyson; Vlahos, Ross] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Miller, Alyson] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Royal Melbourne Institute of Technology (RMIT); University of Glasgow	Vlahos, R (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia.	ross.vlahos@rmit.edu.au	Vlahos, Ross/AAM-3837-2020	Vlahos, Ross/0000-0001-8443-7071	National Health and Medical Research Council of Australia [1120522]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	RV and AM were supported by the National Health and Medical Research Council of Australia [Project Grant ID 1120522]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti Alvar, 2012, Proc Am Thorac Soc, V9, P43, DOI 10.1513/pats.201108-050MS; Austin V, 2016, CLIN SCI, V130, P1039, DOI 10.1042/CS20160043; Barbu C, 2011, ROM J MORPHOL EMBRYO, V52, P21; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Barnes PJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000220; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bozinovski S, 2015, CLIN SCI, V129, P785, DOI 10.1042/CS20140703; Broughton BRS, 2014, STROKE, V45, P835, DOI 10.1161/STROKEAHA.113.001499; Chen H, 2005, NEUROPSYCHOPHARMACOL, V30, P713, DOI 10.1038/sj.npp.1300597; Chen H, 2008, BRAIN RES, V1228, P81, DOI 10.1016/j.brainres.2008.06.067; Chen H, 2006, AM J RESP CRIT CARE, V173, P1248, DOI 10.1164/rccm.200506-977OC; De Silva TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028393; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Duong C, 2010, AM J PHYSIOL-LUNG C, V299, pL425, DOI 10.1152/ajplung.00038.2010; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Institute of Medicine Committee on a National Surveillance System for C Select Chronic D, 2011, NAT FRAM WORK SURV C; Ku JM, 2016, CLIN SCI, V130, P1545, DOI 10.1042/CS20160077; Kunisaki KM, 2018, AM J RESP CRIT CARE, V198, P51, DOI 10.1164/rccm.201711-2239OC; Lekoubou Alain, 2017, eNeurologicalSci, V6, P21, DOI 10.1016/j.ensci.2016.11.007; Lin CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169429; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Maclay JD, 2013, CHEST, V143, P798, DOI 10.1378/chest.12-0938; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Oostwoud LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20983; Oudijk EJD, 2003, EUR RESPIR J, V22, p5S, DOI 10.1183/09031936.03.00004603a; Park GW, 2015, ANN REHABIL MED-ARM, V39, P218, DOI 10.5535/arm.2015.39.2.218; Portegies MLP, 2016, AM J RESP CRIT CARE, V193, P251, DOI 10.1164/rccm.201505-0962OC; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2005, CAN J PHYSIOL PHARM, V83, P8, DOI 10.1139/Y04-116; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Srivastava K, 2015, PHARMACOECONOMICS, V33, P467, DOI 10.1007/s40273-015-0252-4; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2018, RESPIROLOGY; Vlahos R, 2010, AM J RESP CRIT CARE, V182, P34, DOI 10.1164/rccm.200912-1794OC; Wouters Emiel F M, 2005, Proc Am Thorac Soc, V2, P26, DOI 10.1513/pats.200408-039MS	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214246	10.1371/journal.pone.0214246	http://dx.doi.org/10.1371/journal.pone.0214246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897180	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700077
J	Sims, D; Onambele-Pearson, G; Burden, A; Payton, C; Morse, C				Sims, David; Onambele-Pearson, Gladys; Burden, Adrian; Payton, Carl; Morse, Christopher			Whole-body and segmental analysis of body composition in adult males with achondroplasia using dual X-ray absorptiometry	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OBESITY; AREAL; DXA; FAT; MORTALITY; CHILDREN; WALKING; GROWTH; RESISTANCE	Achondroplasia is a condition characterized by a genetic mutation affecting long bone endplate development. Current data suggests that the bone mineral content (BMC) and bone mineral density (BMD) of achondroplasic populations are below age matched individuals of average stature (controls). Due to the disproportionate limb-to-torso length compared to controls however, the lower BMC and BMD may be nullified when appropriately presented. The aim of this study was to measure whole-body and segmental body composition in adult males with achondroplasia (N = 10, 22 +/- 3 yrs), present data relative to whole-body and whole-limb values and compare all values to age matched controls (N = 17, 22 +/- 2 yrs). Dual X-ray absorptiometry (DEXA) was used to measure the in vivo mass of the whole-body and 15 segments, from which BMD, BMC, fat free mass (FFM) and body fat mass were measured. BMC of lumbar vertebrae (L1-4) was also measured and presented as a volumetric BMD (BMDVOL). The achondroplasic group had less BMC, BMD and FFM, and more body fat mass than controls as a whole-body measure. The lower achondroplasic BMC and BMD was somewhat nullified when presented relative to whole-body and whole-limb values respectively. There was no difference in lumbar BMDVOL between groups. Whole-body BMD measures presented the achondroplasic group as 'osteopenic'. When relative to whole-limb measures however, achondroplasic BMD descriptions were normal. Further work is needed to create a body composition database for achondroplasic population's, or for clinicians to present achondroplasic body composition values relative to the whole-limb.	[Sims, David; Onambele-Pearson, Gladys; Burden, Adrian; Payton, Carl; Morse, Christopher] Manchester Metropolitan Univ, Hlth Exercise & Act Living Res, Manchester, Lancs, England	Manchester Metropolitan University	Sims, D (corresponding author), Manchester Metropolitan Univ, Hlth Exercise & Act Living Res, Manchester, Lancs, England.	d.sims@mmu.ac.uk	Morse, Christopher/AAE-7913-2022; Onambele-Pearson, Gladys/F-1679-2013	Morse, Christopher/0000-0002-5261-2637; Payton, Carl/0000-0001-8896-9753; Onambele-Pearson, Gladys/0000-0002-1466-3265; Sims, David/0000-0003-0152-866X				Arita ES, 2013, CLIN RHEUMATOL, V32, P399, DOI 10.1007/s10067-012-2126-x; Baujat G, 2008, BEST PRACT RES CL RH, V22, P3, DOI 10.1016/j.berh.2007.12.008; Beavers KM, 2017, J GERONTOL A-BIOL, V72, P1582, DOI 10.1093/gerona/glx048; Bianchi ML, 2007, BONE, V41, P486, DOI 10.1016/j.bone.2007.07.008; Blake GM, 2006, BONE, V38, P935, DOI 10.1016/j.bone.2005.11.007; Bredella MA, 2010, OBESITY, V18, P2227, DOI 10.1038/oby.2010.5; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Chang SH, 2012, MATURITAS, V72, P175, DOI 10.1016/j.maturitas.2012.04.004; Dempster WT, 1955, 7214 WRIGHT AIR DEV; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Durkin JL, 2003, J BIOMECH ENG-T ASME, V125, P515, DOI 10.1115/1.1590359; Durkin JL, 2002, J BIOMECH, V35, P1575, DOI 10.1016/S0021-9290(02)00227-0; Freedman DS, 2013, AM J CLIN NUTR, V98, P1417, DOI 10.3945/ajcn.113.065961; French AR, 2002, J RHEUMATOL, V29, P1065; Garcia-Hoyos M, 2017, OSTEOPOROSIS INT, V28, P965, DOI 10.1007/s00198-016-3814-1; Glickman SG, 2004, J APPL PHYSIOL, V97, P509, DOI 10.1152/japplphysiol.01234.2003; Grabowski AM, 2008, J APPL BIOMECH, V24, P288, DOI 10.1123/jab.24.3.288; Hart NH, 2015, J SPORT SCI MED, V14, P620; HECHT JT, 1987, AM J HUM GENET, V41, P454; HECHT JT, 1988, AM J MED GENET, V31, P597, DOI 10.1002/ajmg.1320310314; HORTON WA, 1978, J PEDIATR-US, V93, P435, DOI 10.1016/S0022-3476(78)81152-4; Horton WA, 2006, AM J MED GENET A, V140A, P166, DOI 10.1002/ajmg.a.31029; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Horton William A, 2002, Rev Endocr Metab Disord, V3, P381, DOI 10.1023/A:1020914026829; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Khoo BCC, 2009, OSTEOPOROSIS INT, V20, P1539, DOI 10.1007/s00198-008-0820-y; Kihara S, 2015, CURR CARDIOVASC RISK, V9, DOI 10.1007/s12170-015-0439-4; Krakow D, 2010, GENET MED, V12, P327, DOI 10.1097/GIM.0b013e3181daae9b; KROGER H, 1995, BONE, V17, P157, DOI 10.1016/S8756-3282(95)00162-X; KROGER H, 1992, BONE MINER, V17, P75, DOI 10.1016/0169-6009(92)90712-M; Kullberg J, 2009, BRIT J RADIOL, V82, P123, DOI 10.1259/bjr/80083156; Lu PW, 1996, J CLIN ENDOCRINOLOGY, V81; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Matsushita M, 2016, PEDIATR INT, V58, P705, DOI 10.1111/ped.12890; MINETTI AE, 1994, EUR J APPL PHYSIOL O, V68, P285, DOI 10.1007/BF00571444; NEHME AME, 1976, CLIN ORTHOP RELAT R, P8; Ott SM, 1997, BONE, V20, P553, DOI 10.1016/S8756-3282(97)00057-4; OWEN OE, 1990, MEDICINE, V69, P56, DOI 10.1097/00005792-199001000-00005; Park KW, 2015, YONSEI MED J, V56, P1656, DOI 10.3349/ymj.2015.56.6.1656; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; Rabkin SW, 2014, METAB SYNDR RELAT D, V12, P31, DOI 10.1089/met.2013.0107; SABIN MA, 1995, CALCIFIED TISSUE INT, V56, P210, DOI 10.1007/BF00298612; Schepens B, 2004, J EXP BIOL, V207, P587, DOI 10.1242/jeb.00793; Sims DT, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00410; Sims DT, 2018, J APPL PHYSIOL, V124, P696, DOI 10.1152/japplphysiol.00638.2017; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Tabensky AD, 1996, J BONE MINER RES, V11, P1981; Tasoglu O, 2014, CLIN RHEUMATOL, V33, P733, DOI 10.1007/s10067-014-2577-3; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Venkatesh KP, 2009, J BONE JOINT SURG BR, V91B, P1612, DOI 10.1302/0301-620X.91B12.22418; Vincent KR, 2002, MED SCI SPORT EXER, V34, P17, DOI 10.1097/00005768-200201000-00004; Wynn J, 2007, AM J MED GENET A, V143A, P2502, DOI 10.1002/ajmg.a.31919; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	57	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213806	10.1371/journal.pone.0213806	http://dx.doi.org/10.1371/journal.pone.0213806			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889196	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000461573000032
J	Amouroux, P; Crochard, D; Correa, M; Groussier, G; Kreiter, P; Roman, C; Guerrieri, E; Garonna, A; Malausa, T; Zaviezo, T				Amouroux, Paul; Crochard, Didier; Correa, Margarita; Groussier, Geraldine; Kreiter, Philippe; Roman, Carola; Guerrieri, Emilio; Garonna, Antonio; Malausa, Thibaut; Zaviezo, Tania			Natural enemies of armored scales (Hemiptera: Diaspididae) and soft scales (Hemiptera: Coccidae) in Chile: Molecular and morphological identification	PLOS ONE			English	Article							HYMENOPTERA; PARASITOIDS; ENCYRTIDAE; DISCOVERY; SEQUENCE; MARKERS	Scale insects (Hemiptera: Sternorrhyncha: Coccomorpha) are key pests of agricultural crops and ornamental plants worldwide. Their populations are difficult to control, even with insecticides, due to their cryptic habits. Moreover, there is growing concern over the use of synthetic pesticides for their control, due to deleterious environmental effects and the emergence of resistant populations of target pests. In this context, biological control may be an effective and sustainable approach. Hymenoptera Chalcidoidea includes natural enemies of scale insects that have been successfully used in many biological control programs. However, the correct identification of pest scale species and their natural enemies is particularly challenging because these insects are very small and highly specialized. Integrative taxonomy, coupling DNA barcoding and morphological analysis, has been successfully used to characterize pests and natural enemy species. In this study, we performed a survey of parasitoids and predators of armored and soft scales in Chile, based on 28S and COI barcodes. Fifty-three populations of Diaspididae and 79 populations of Coccidae were sampled over the entire length of the country, from Arica (18 degrees S) to Frutillar (41 degrees S), between January 2015 and February 2016. The phylogenetic relationships obtained by Bayesian inference from multilocus haplotypes revealed 41 putative species of Chalcidoidea, five Coccinellidae and three Neuroptera. Species delimitation was confirmed using ABGD, GMYC and PTP model. In Chalcidoidea, 23 species were identified morphologically, resulting in new COI barcodes for 12 species and new 28S barcodes for 14 species. Two predator species (Rhyzobius lophantae and Coccidophilus transandinus) were identified morphologically, and two parasitoid species, Chartocerus niger and Signiphora bifasciata, were recorded for the first time in Chile.	[Amouroux, Paul; Zaviezo, Tania] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Fruticultura & Enol, Santiago, Chile; [Crochard, Didier; Correa, Margarita; Groussier, Geraldine; Kreiter, Philippe; Malausa, Thibaut] Univ Cote Azur, CNRS, INRA, ISA, Sophia Antipolis, France; [Correa, Margarita] Univ Talca, Ctr Mol & Funct Ecol Agroecosyst, Talca, Chile; [Roman, Carola] Xilema ANASAC Control Biol, San Pedro, Quillota, Chile; [Guerrieri, Emilio] CNR, Ist Protez Sostenibile Piante, Portici, NA, Italy; [Guerrieri, Emilio] Nat Hist Museum, Dept Life Sci, London, England; [Garonna, Antonio] Univ Napoli Federico II, Dipartimento Agr, Portici, NA, Italy	Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Universidad de Talca; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Natural History Museum London; University of Naples Federico II	Amouroux, P (corresponding author), Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Fruticultura & Enol, Santiago, Chile.; Guerrieri, E (corresponding author), CNR, Ist Protez Sostenibile Piante, Portici, NA, Italy.; Guerrieri, E (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.	pamourou@yahoo.fr; emilio.guerrieri@ipsp.cnr.it	Zaviezo, Tania/AAM-5707-2020; Amouroux, Paul/AAL-6052-2021; Zaviezo, Tania/F-3099-2014; Guerrieri, Emilio/ABB-7498-2020	Zaviezo, Tania/0000-0002-4993-0386; Amouroux, Paul/0000-0002-3321-7842; Zaviezo, Tania/0000-0002-4993-0386; Correa, Margarita C.G./0000-0003-2343-8809; GARONNA, Antonio Pietro/0000-0002-8441-5208	CONICYT -Fondo Nacional de Desarrollo Cientifico y Tecnologico [3180344]; Fundacion para la Innovacion Agraria [PYT-2015-0230]; EU FP7 Marie Curie IAPP Project "Colbics" [324475]; "Fundacion para la Innovacion Agraria" (FIA) [PYT-2015-0230]; CONICYT FONDECYT [3180344]	CONICYT -Fondo Nacional de Desarrollo Cientifico y Tecnologico; Fundacion para la Innovacion Agraria; EU FP7 Marie Curie IAPP Project "Colbics"; "Fundacion para la Innovacion Agraria" (FIA); CONICYT FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by: P.A. #3180344, CONICYT -Fondo Nacional de Desarrollo Cientifico y Tecnologico, Postdoc grant, http://www.conicyt.cl/fondecyt/, No; M.C. #PYT-2015-0230, Fundacion para la Innovacion Agraria, http://www.fia.cl/, No; T.M. #324475, EU FP7 Marie Curie IAPP Project "Colbics", http://ec.europa.eu/research/fp7/index_en.cfm, No.; We would like to thank all the growers who allowed us access to their orchards for sample collection. We thank Paula Molina and Angela Romo for technical assistance in the laboratory. We also thank all those who helped us to collect samples throughout Chile: Hugo Herrera, Francisco Bugueno, Sebastian Catalan and Isaac Vera from Xilema-ANASAC (Quillota); Claudio Salas from Instituto de Investigaciones Agropecuarias (INIA Intihuasi-La Serena); Marta Godoy from Cabilfrut (Ovalle); Leonardo Fuentes from Pontificia Universidad Catolica de Valparaiso (Quillota); Alda Romero from Pontificia Universidad Catolica de Chile (Santiago); Jean-Claude Malausa from Institut National de la Recherche Agronomique (Sophia-Antipolis, France). This project was supported by the EU FP7 Marie Curie IAPP Project "Colbics" #324475, the "Fundacion para la Innovacion Agraria" (FIA) #PYT-2015-0230 and CONICYT FONDECYT Postdoctorado No. 3180344.	Amouroux P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01997-6; Becker RA, 2013, MAPS DRAW GEOGRAPHIC; Buzzetti KA, 2016, J APPL ENTOMOL, V140, P507, DOI 10.1111/jen.12283; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chesters D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037655; COMPERE H., 1931, Proceedings of the United States National Museum, V78; Cooper ML, 2011, DEV MULTIPLEX PCR ID, P1595; Correa MCG, 2016, BIOCONTROL, V61, P639, DOI 10.1007/s10526-016-9752-1; Correa MCG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16483; Daane KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193852; De Leon JH, 2010, J ECON ENTOMOL, V103, P908, DOI 10.1603/EC09316; Ramirez-Ahuja MD, 2015, REV MEX BIODIVERS, V86, P337, DOI 10.1016/j.rmb.2015.04.026; Dormann C.F., 2008, R NEWS, V8, P8; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Gonzalez G, 2006, COCCINELLIDAE CHILE; Guerrieri E, 2000, SYST ENTOMOL, V25, P147, DOI 10.1046/j.1365-3113.2000.00099.x; Guillemaud T., 2016, SUSTAIN AGR REV, V19, P35, DOI [10.1007/978-3-319-26777-7_2, DOI 10.1007/978-3-319-26777-7_2]; Gwiazdowski RA, 2011, BIOL J LINN SOC, V104, P47, DOI 10.1111/j.1095-8312.2011.01716.x; Henry CS, 2013, BIOL REV, V88, P787, DOI 10.1111/brv.12027; Heraty JM, 2013, CLADISTICS, V29, P466, DOI 10.1111/cla.12006; Klein C., 1977, B SERV PLAGAS, V3, P121; Kondo T., 2013, ENCY PEST MANAGEMENT, P1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Malausa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157965; Morales M. G., 2016, DATABASE J BIOL DATA, V2016; Myartseva S.N., 2012, SERIE AVISPAS PARASI, V8; NIKOLSKAYA MN, 1966, OPREDELITELI FAUNE S, V91, P1; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Noyes JS., 2018, WORLD WIDE WEB ELECT; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Paradis AE, 2011, PACKAGE APE; Price BW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121127; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Qin YG, 2018, ECOL EVOL, V8, P7879, DOI 10.1002/ece3.4344; RCore Team, 2020, R LANG ENV STAT COMP; Ripa R., 2008, MANEJO PLAGAS PALTOS, V23; Rojas S, 2005, CONTROL BIOL PLAGAS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN D, 1979, SERIES ENTOMOLOGICA, V17; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Senal D, 2017, PHYTOPARASITICA, V45, P175, DOI 10.1007/s12600-017-0581-2; Stucky Brian J, 2012, J Biomol Tech, V23, P90, DOI 10.7171/jbt.12-2303-004; Swofford D., 1998, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Viggiani G, 1989, B LAB ENT AGR FILIPP, V45, P113; Wang XB, 2015, B ENTOMOL RES, V105, P545, DOI 10.1017/S0007485315000413; Woolley JB, 2017, ZOOTAXA, V4315, P1, DOI 10.11646/zootaxa.4315.1.1; Xilema, 2018, XIL CONTR BIOL; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou QS, 2018, ZOOL J LINN SOC-LOND, V182, P38, DOI 10.1093/zoolinnean/zlx019; ZUNIGA-S E, 1985, Agricultura Tecnica (Santiago), V45, P175	52	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0205475	10.1371/journal.pone.0205475	http://dx.doi.org/10.1371/journal.pone.0205475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883559	Green Submitted, Green Published, gold			2022-12-26	WOS:000461423500002
J	Chizhov, AV; Amakhin, DV; Zaitsev, AV				Chizhov, Anton V.; Amakhin, Dmitry V.; Zaitsev, Aleksey V.			Mathematical model of Na-K-Cl homeostasis in ictal and interictal discharges	PLOS ONE			English	Article							SEIZURE-LIKE EVENTS; POTASSIUM DYNAMICS; SPREADING DEPRESSION; INTERSTITIAL SPACE; LIMBIC SYSTEM; NETWORK; SYNCHRONIZATION; CORTEX; ONSET; ACCUMULATION	Despite big experimental data on the phenomena and mechanisms of the generation of ictal and interictal discharges (IDs and IIDs), mathematical models that can describe the synaptic interactions of neurons and the ionic dynamics in biophysical detail are not well-established. Based on experimental recordings of combined hippocampal-entorhinal cortex slices from rats in a high-potassium and a low-magnesium solution containing 4-aminopyridine as well as previous observations of similar experimental models, this type of mathematical model has been developed. The model describes neuronal excitation through the application of the conductance-based refractory density approach for three neuronal populations: two populations of glutamatergic neurons with hyperpolarizing and depolarizing GABAergic synapses and one GABAergic population. The ionic dynamics account for the contributions of voltage gated and synaptic channels, active and passive transporters, and diffusion. The relatively slow dynamics of potassium, chloride, and sodium ion concentrations determine the transitions from pure GABAergic IIDs to IDs and GABA-glutamatergic IIDs. The model reproduces different types of IIDs, including those initiated by interneurons; repetitive IDs; tonic and bursting modes of an ID composed of clustered IID-like events. The simulations revealed contributions from different ionic channels to the ion concentration dynamics before and during ID generation. The proposed model is a step forward to an optimal mathematical description of the mechanisms of epileptic discharges.	[Chizhov, Anton V.] Ioffe Inst, Computat Phys Lab, St Petersburg, Russia; [Chizhov, Anton V.; Amakhin, Dmitry V.; Zaitsev, Aleksey V.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Lab Mol Mechanisms Neural Interact, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Chizhov, AV (corresponding author), Ioffe Inst, Computat Phys Lab, St Petersburg, Russia.; Chizhov, AV (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Lab Mol Mechanisms Neural Interact, St Petersburg, Russia.	anton.chizhov@mail.ioffe.ru	Chizhov, Anton V/C-1773-2014; Amakhin, Dmitry V/F-2783-2017; Zaitsev, Aleksey/A-5648-2008	Chizhov, Anton V/0000-0002-7993-6770; Zaitsev, Aleksey/0000-0002-4503-0647; Amakhin, Dmitry/0000-0002-7098-4768	Russian Science Foundation [16-15-10201]; Russian Science Foundation [19-15-13025] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (project 16-15-10201).	Amakhin DV, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00233; Antonio LL, 2016, J NEUROSCI METH, V260, P33, DOI 10.1016/j.jneumeth.2015.08.014; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Avoli M, 2016, J NEUROPHYSIOL, V115, P3229, DOI 10.1152/jn.01128.2015; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Bashkirtseva I, 2016, INT J BIFFURCATION C, V26; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; BEAULIEU C, 1993, BRAIN RES, V609, P284, DOI 10.1016/0006-8993(93)90884-P; Borg-Graham L.J., 1999, CEREBRAL CORTEX MODE, P19, DOI DOI 10.1007/978-1-4615-4903-1_2; Buchin A, 2016, J NEUROSCI, V36, P11619, DOI 10.1523/JNEUROSCI.4228-15.2016; Chizhov AV, 2019, BIOCHEM BIOPH RES CO, V508, P1245, DOI 10.1016/j.bbrc.2018.12.070; Chizhov AV, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006186; Chizhov AV, 2017, BIOL CYBERN, V111, P353, DOI 10.1007/s00422-017-0727-9; Chizhov AV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185752; Chizhov AV, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062704; Chizhov AV, 2014, J COMPUT NEUROSCI, V36, P297, DOI 10.1007/s10827-013-0473-5; Chizhov AV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011910; Chizhov AV, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011924; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; de Curtis M, 2016, EPILEPSIA, V57, P679, DOI 10.1111/epi.13370; Eggert J, 2001, NEURAL COMPUT, V13, P1923, DOI 10.1162/089976601750399254; FERTZIGER AP, 1970, EXP NEUROL, V26, P571, DOI 10.1016/0014-4886(70)90150-0; Frohlich F, 2008, NEUROSCIENTIST, V14, P422, DOI 10.1177/1073858408317955; Gentiletti D, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500046; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Gnatkovsky V, 2008, ANN NEUROL, V64, P674, DOI 10.1002/ana.21519; Gonzalez OC, 2018, NEUROBIOL DIS, V109, P137, DOI 10.1016/j.nbd.2017.10.011; Gonzalez OC, 2015, J NEUROSCI, V35, P13448, DOI 10.1523/JNEUROSCI.5038-14.2015; Ho ECY, 2016, J COMPUT NEUROSCI, V41, P225, DOI 10.1007/s10827-016-0615-7; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; Jirsa VK, 2014, BRAIN, V137, P2210, DOI 10.1093/brain/awu133; Johansson S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00182; Kager H, 2007, J COMPUT NEUROSCI, V22, P105, DOI 10.1007/s10827-006-0001-y; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Krishnan GP, 2015, J NEUROPHYSIOL, V113, P3356, DOI 10.1152/jn.00460.2014; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Librizzi L, 2017, J NEUROSCI, V37, P10398, DOI 10.1523/JNEUROSCI.3906-16.2017; Loebel A, 2002, J COMPUT NEUROSCI, V13, P111, DOI 10.1023/A:1020110223441; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Ostby I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000272; Owen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073820; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Raimondo JV, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00419; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Ullah G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004414; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Uva L, 2015, J NEUROSCI, V35, P3048, DOI 10.1523/JNEUROSCI.3692-14.2015; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Wei YN, 2014, J NEUROPHYSIOL, V112, P213, DOI 10.1152/jn.00541.2013; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Yelhekar TD, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0019-17.2017	60	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213904	10.1371/journal.pone.0213904	http://dx.doi.org/10.1371/journal.pone.0213904			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875397	gold, Green Published, Green Submitted			2022-12-26	WOS:000461316400038
J	Ricci-Lopez, J; Vidal-Limon, A; Zunniga, M; Jimenez, VA; Alderete, JB; Brizuela, CA; Aguila, S				Ricci-Lopez, Joel; Vidal-Limon, Abraham; Zunniga, Matias; Jimenez, Veronica A.; Alderete, Joel B.; Brizuela, Carlos A.; Aguila, Sergio			Molecular modeling simulation studies reveal new potential inhibitors against HPV E6 protein	PLOS ONE			English	Article							DRUG DISCOVERY; PAPILLOMAVIRUS; INFECTION; IDENTIFICATION; DEGRADATION; ONCOPROTEIN; ACCURACY; SOFTWARE; DYNAMICS; DOCKING	High-risk strains of human papillomavirus (HPV) have been identified as the etiologic agent of some anogenital tract, head, and neck cancers. Although prophylactic HPV vaccines have been approved; it is still necessary a drug-based treatment against the infection and its oncogenic effects. The E6 oncoprotein is one of the most studied therapeutic targets of HPV, it has been identified as a key factor in cell immortalization and tumor progression in HPV-positive cells. E6 can promote the degradation of p53, a tumor suppressor protein, through the interaction with the cellular ubiquitin ligase E6AP. Therefore, preventing the formation of the E6-E6AP complex is one of the main strategies to inhibit the viability and proliferation of infected cells. Herein, we propose an in silico pipeline to identify small-molecule inhibitors of the E6-E6AP interaction. Virtual screening was carried out by predicting the ADME properties of the molecules and performing ensemble-based docking simulations to E6 protein followed by binding free energy estimation through MM/PB(GB)SA methods. Finally, the top-three compounds were selected, and their stability in the E6 docked complex and their effect in the inhibition of the E6-E6AP interaction was corroborated by molecular dynamics simulation. Therefore, this pipeline and the identified molecules represent a new starting point in the development of anti-HPV drugs.	[Ricci-Lopez, Joel; Vidal-Limon, Abraham; Aguila, Sergio] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico; [Zunniga, Matias; Jimenez, Veronica A.] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Concepcion, Chile; [Alderete, Joel B.] Univ Concepcion, Fac Ciencias Quim, Dept Quim Organ, Concepcion, Chile; [Alderete, Joel B.] Univ Talca, Inst Quim Recursos Nat, Talca, Chile; [Brizuela, Carlos A.] CICESE Res Ctr, Dept Comp Sci, Comp Sci Dept, Ensenada, Baja California, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Andres Bello; Universidad de Concepcion; Universidad de Talca; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Aguila, S (corresponding author), Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico.; Brizuela, CA (corresponding author), CICESE Res Ctr, Dept Comp Sci, Comp Sci Dept, Ensenada, Baja California, Mexico.	cbrizuel@cicese.edu.mx; aguila@cnyn.unam.mx	Alderete, Joel B/AAL-3839-2020; Vidal-Limon, Abraham/G-2941-2019; Vidal, Abraham/CAF-6686-2022; Jiménez, Verónica A/B-8789-2017; Aguila, Sergio A./E-2709-2016	Alderete, Joel B/0000-0001-5880-6371; Vidal-Limon, Abraham/0000-0001-5674-7881; Vidal, Abraham/0000-0001-5674-7881; Zuniga-Bustos, Matias/0000-0003-2448-9376; Aguila, Sergio A./0000-0002-8497-2821; Jimenez, Veronica/0000-0002-6783-5657	DGTIC-UNAM [LANCAD-UNAM-DGTIC-286]; Universidad Andres Bello (UNAB), Chile [FONDECYT 1160060]; JRL [CONACYT 693115]; DGAPA-UNAM	DGTIC-UNAM; Universidad Andres Bello (UNAB), Chile; JRL; DGAPA-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by LANCAD-UNAM-DGTIC-286 grant at DGTIC-UNAM; FONDECYT 1160060 grant at Universidad Andres Bello (UNAB), Chile; CONACYT 693115 scholarship grant of JRL and DGAPA-UNAM fellowship of AVL. The funders had NO role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Derek B, 2016, J Am Soc Cytopathol, V5, P203, DOI 10.1016/j.jasc.2015.12.001; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, SCHROD REL 2017 1 LI; [Anonymous], 2017, SCHROD REL 2017 1 QI; Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Basu P, 2013, ASIAN PAC J CANCER P, V14, P5753, DOI 10.7314/APJCP.2013.14.10.5753; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brown SP, 2007, J CHEM INF MODEL, V47, P1493, DOI 10.1021/ci700041j; Bruni L, 2017, HUMAN PAPILLOMAVIRUS, P60; Case D. A., 2016, AMBER 2016; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Garcia FAR, 2014, GYNECOL ONCOL, V132, P377, DOI 10.1016/j.ygyno.2013.12.034; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Guo ZJ, 2016, J CHEM INF MODEL, V56, P35, DOI 10.1021/acs.jcim.5b00503; Ham S, 2014, ONCOL REP, V31, P2683, DOI 10.3892/or.2014.3157; Hampson L, 2015, EXPERT OPIN INV DRUG, V24, P1529, DOI 10.1517/13543784.2015.1099628; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen FH, 2011, ANTICANCER RES, V31, P4417; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malecka KA, 2014, ACS CHEM BIOL, V9, P1603, DOI 10.1021/cb500229d; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mittal S, 2017, MUTAT RES-REV MUTAT, V772, P23, DOI 10.1016/j.mrrev.2016.08.001; Monie A, 2008, BIOL-TARGETS THER, V2, P107; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Motta S, 2017, J CHEM INF MODEL, V57, P1563, DOI 10.1021/acs.jcim.7b00125; Murgueitio Manuela S, 2012, Drug Discov Today Technol, V9, pe219, DOI 10.1016/j.ddtec.2012.07.009; Nomine Y, 2003, BIOCHEMISTRY-US, V42, P4909, DOI 10.1021/bi026980c; Offutt TL, 2016, J CHEM INF MODEL, V56, P1923, DOI 10.1021/acs.jcim.6b00261; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oprea TL, 2002, MOLECULES, V7, P51, DOI 10.3390/70100051; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PoHs RO, 1995, PHARM RES OFF J AM A, DOI [10.1023/A:1016236932339, DOI 10.1023/A:1016236932339]; Rietz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149845; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sali A., 2013, MODELLER PROGRAM PRO, P779; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Shah M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13446; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi L, 2007, CLIN PHARMACOL THER, V81, P259, DOI 10.1038/sj.clpt.6100055; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Tian S, 2014, J CHEM INF MODEL, V54, P2664, DOI 10.1021/ci500414b; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wagner JR, 2017, J CHEM THEORY COMPUT, V13, P4584, DOI 10.1021/acs.jctc.7b00500; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yuan CH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.391; Zanier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112514; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001	65	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213028	10.1371/journal.pone.0213028	http://dx.doi.org/10.1371/journal.pone.0213028			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875378	gold, Green Published, Green Submitted			2022-12-26	WOS:000461316400009
J	Barrett, MT; Lenkiewicz, E; Malasi, S; Stanton, M; Slack, J; Andrews, P; Pagliaro, L; Bryce, AH				Barrett, Michael T.; Lenkiewicz, Elzbieta; Malasi, Smriti; Stanton, Melissa; Slack, James; Andrews, Paul; Pagliaro, Lance; Bryce, Alan H.			Clonal analyses of refractory testicular germ cell tumors	PLOS ONE			English	Article							GENE; AMPLIFICATION; EVOLUTION	Testicular germ cell tumors (TGCTs) are unique amongst solid tumors in terms of the high cure rates using chemotherapy for metastatic disease. Nevertheless, TGCTs still kill approximately 400 men per year, at a median age of 30 years, in the United States. This young age of mortality dramatically amplifies the impact of these deaths for the patients and their often young families. Furthermore the high cure rate makes it difficult to conduct further clinical trials of non curable disease. TGCTs are characterized by a marked aneuploidy and the presence of gain of chromosomal region 12p. Genomic testing may offer the ability to identify potentially lethal TGCTs at the time of initial diagnosis. However sequencing based studies have shown a paucity of somatic mutations in TGCT genomes including those that drive refractory disease. Furthermore these studies may be limited by genetic heterogeneity in primary tumors and the evolution of sub populations during disease progression. Herein we applied a systematic approach combining DNA content flow cytometry, whole genome copy number and whole exome sequence analyses to interrogate tumor heterogeneity in primary and metastatic refractory TGCTs. We identified both known and novel somatic copy number aberrations (12p, MDM2, and RHBDD1) and mutations (XRCC2, PIK3CA, RITA1) including candidate markers for platinum resistance that were present in a primary tumor of mixed histology and that remained after tandem autologous stem cell transplant.	[Barrett, Michael T.] Mayo Clin, Div Hematol & Oncol, Phoenix, AZ USA; [Barrett, Michael T.; Lenkiewicz, Elzbieta; Malasi, Smriti] Mayo Clin, Dept Res, Scottsdale, AZ USA; [Stanton, Melissa] Mayo Clin, Div Anat Pathol, Scottsdale, AZ USA; [Slack, James; Andrews, Paul; Bryce, Alan H.] Mayo Clin, Coll Med, Phoenix, AZ 85054 USA; [Pagliaro, Lance] Mayo Clin, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Bryce, AH (corresponding author), Mayo Clin, Coll Med, Phoenix, AZ 85054 USA.	bryce.alan@mayo.edu	Bryce, Alan/W-1765-2019	Bryce, Alan/0000-0002-0206-3895	Christian Haub Family Foundation	Christian Haub Family Foundation	AHB and MTB received funding from a Christian Haub Family Foundation grant "Molecular determinants of clinical responses in testicular cancer". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagrodia A, 2016, J CLIN ONCOL, V34, P4000, DOI 10.1200/JCO.2016.68.7798; Barrett MT, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1004-0; Barrett MT, 2017, BRIT J CANCER, V117, P572, DOI 10.1038/bjc.2017.209; Batool A, 2019, CELL MOL LIFE SCI, V76, P1713, DOI 10.1007/s00018-019-03022-7; Boublikova L, 2014, CRIT REV ONCOL HEMAT, V89, P366, DOI 10.1016/j.critrevonc.2013.10.001; Brabrand S, 2015, NEOPLASIA, V17, P167, DOI 10.1016/j.neo.2014.12.005; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384; Cheng L, 2017, HUM PATHOL, V59, P10, DOI 10.1016/j.humpath.2016.08.002; Cutcutache I, 2015, EUR UROL, V68, P77, DOI 10.1016/j.eururo.2014.12.040; Danoy P, 2007, BIOCHEM BIOPH RES CO, V352, P763, DOI 10.1016/j.bbrc.2006.11.083; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Evers L, 2014, GENOME MED, V6, DOI 10.1186/gm526; Harle A, 2016, TARGET ONCOL, V11, P363, DOI 10.1007/s11523-015-0404-7; Holley T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050586; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Kopp HG, 2006, DRUGS, V66, P641, DOI 10.2165/00003495-200666050-00005; Koychev D, 2011, INT J ANDROL, V34, pE266, DOI 10.1111/j.1365-2605.2011.01145.x; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Litchfield K, 2016, NAT REV UROL, V13, P409, DOI 10.1038/nrurol.2016.107; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6973; Mayer F, 2003, ONCOGENE, V22, P3859, DOI 10.1038/sj.onc.1206469; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; OOSTERHUIS JW, 1989, LAB INVEST, V60, P14; Przybytkowski E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-579; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Sheikine Y, 2012, AM J CANCER RES, V2, P153; Shen H, 2018, CELL REP, V23, P3392, DOI 10.1016/j.celrep.2018.05.039; Society AC, 2019, CANC FACTS FIG 2019; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Taylor-Weiner A, 2016, NATURE, V540, P114, DOI 10.1038/nature20596; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Thompson BA, 2013, HUM MUTAT, V34, P255, DOI 10.1002/humu.22214; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wang Y, 2008, CELL MOL LIFE SCI, V65, P3822, DOI 10.1007/s00018-008-8452-0; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-25; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213815	10.1371/journal.pone.0213815	http://dx.doi.org/10.1371/journal.pone.0213815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870501	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300082
J	Klimenko, K; Rosenberg, SA; Dybdahl, M; Wedebye, EB; Nikolov, NG				Klimenko, Kyrylo; Rosenberg, Sine A.; Dybdahl, Marianne; Wedebye, Eva B.; Nikolov, Nikolai G.			QSAR modelling of a large imbalanced aryl hydrocarbon activation dataset by rational and random sampling and screening of 80,086 REACH pre-registered and/or registered substances	PLOS ONE			English	Article							MECHANISMS; ESTROGENS; ENZYMES	The Aryl hydrocarbon receptor (AhR) plays important roles in many normal and pathological physiological processes, including endocrine homeostasis, foetal development, cell cycle regulation, cellular oxidation/antioxidation, immune regulation, metabolism of endogenous and exogenous substances, and carcinogenesis. An experimental data set for human in vitro AhR activation comprising 324,858 substances, of which 1,982 were confirmed actives, was used to test an in-house-developed approach to rationally select Quantitative Structure-Activity Relationship (QSAR) training set substances from an unbalanced data set. In the first iteration, active and inactive substances were selected by random to make QSAR models. Then, more inactive substances were added to the training set in two further iterations based on incorrect or out-of-domain predictions to produce larger models. The resulting 'rational' model, comprising 832 actives and four times as many inactives, i.e. 3,328, was compared to a model with a training set of same size and proportion of inactives chosen entirely by random. Both models underwent robust cross-validation and external validation showing good statistical performance, with the rational model having external validation sensitivity of 85.1% and specificity of 97.1%, compared to the random model with sensitivity 89.1% and specificity 91.3%. Furthermore, we integrated the training sets for both models with the 93 external validation test set actives and 372 randomly selected inactives to make two final models. They also underwent external validations for specificity and cross-validations, which confirmed that good predictivity was maintained. All developed models were applied to predict 80,086 EU REACH substances. The rational and random final models had 63.1% and 56.9% coverage of the REACH set, respectively, and predicted 1,256 and 3,214 substances as actives. The final models as well as predictions for AhR activation for 650,000 substances will be published in the Danish (Q) SAR Database and can, for example, be used for priority setting, in read-across predictions and in weight-of-evidence assessments of chemicals.	[Klimenko, Kyrylo; Rosenberg, Sine A.; Dybdahl, Marianne; Wedebye, Eva B.; Nikolov, Nikolai G.] Tech Univ Denmark, Div Diet Dis Prevent & Toxicol, Natl Food Inst, Lyngby, Denmark	Technical University of Denmark	Nikolov, NG (corresponding author), Tech Univ Denmark, Div Diet Dis Prevent & Toxicol, Natl Food Inst, Lyngby, Denmark.	nign@food.dtu.dk		Nikolov, Nikolai Georgiev/0000-0002-9212-9201; Wedebye, Eva Bay/0000-0002-2848-3273; Klimenko, Kyrylo/0000-0001-7250-7300; Dybdahl, Marianne/0000-0002-6721-4068	Danish 3R Center for 'Development of computer models to predict chemicals interference with thyroid hormones'; Danish EPA; Danish Environmental Protection Agency; Danish 3R Center	Danish 3R Center for 'Development of computer models to predict chemicals interference with thyroid hormones'; Danish EPA; Danish Environmental Protection Agency; Danish 3R Center	SAR received a grant from the Danish 3R Center for 'Development of computer models to predict chemicals interference with thyroid hormones' (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EBW, MD, NGN received financing from Danish EPA (the funding is not specific for this work). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for support from the Danish Environmental Protection Agency and the Danish 3R Center.	[Anonymous], 2018, AOP150; [Anonymous], 2018, AOP57; [Anonymous], 2018, AOP131; [Anonymous], 2018, AOP41; [Anonymous], 2018, AOP21; [Anonymous], 2017, AOP8; Badawi AF, 2001, METABOLISM, V50, P1001, DOI 10.1053/meta.2001.25592; Bortoli Sylvie, 2018, Current Opinion in Toxicology, V8, P34, DOI 10.1016/j.cotox.2017.12.001; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Crofton KM, 2008, INT J ANDROL, V31, P209, DOI 10.1111/j.1365-2605.2007.00857.x; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Fourches D, 2015, NAT CHEM BIOL, V11, P535, DOI 10.1038/nchembio.1881; Guillemette C, 2004, BREAST CANCER RES, V6, P246, DOI 10.1186/bcr936; Huang RL, 2016, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00085; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Li QL, 2009, BIOINFORMATICS, V25, P3310, DOI 10.1093/bioinformatics/btp589; MARTUCCI CP, 1993, PHARMACOL THERAPEUT, V57, P237, DOI 10.1016/0163-7258(93)90057-K; Murk AJ, 2013, TOXICOL IN VITRO, V27, P1320, DOI 10.1016/j.tiv.2013.02.012; Nikolov N, 2006, J CHEM INF MODEL, V46, P2537, DOI 10.1021/ci060142y; Norinder U, 2017, J MOL GRAPH MODEL, V72, P256, DOI 10.1016/j.jmgm.2017.01.008; OpenTox, 2011, FIN DAT ADD CONT; QSARDB, 2015, DAN Q SAR DAT; Roberts G, 2000, J CHEM INF COMP SCI, V40, P1302, DOI 10.1021/ci0000631; Rosenberg S. A., 2017, Computational Toxicology, V4, P11, DOI 10.1016/j.comtox.2017.07.006; Rosenberg S. A., 2017, Computational Toxicology, V1, P39, DOI 10.1016/j.comtox.2017.01.001; Sartor MA, 2009, ENVIRON HEALTH PERSP, V117, P7, DOI [10.1289/ehp.11294, DOI 10.1289/EHP.11294]; Steinmetz FP, 2014, SCI TOTAL ENVIRON, V482, P358, DOI 10.1016/j.scitotenv.2014.02.115; Thatcher TH, 2016, IMMUNOLOGY, V147, P41, DOI 10.1111/imm.12540; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Valerio LG, 2010, EXPERT OPIN DRUG MET, V6, P505, DOI 10.1517/17425250903499286; Yousef WA, 2014, COMPUT STAT DATA AN, V74, P181, DOI 10.1016/j.csda.2013.05.021; Zakharov AV, 2014, J CHEM INF MODEL, V54, P705, DOI 10.1021/ci400737s	35	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213848	10.1371/journal.pone.0213848	http://dx.doi.org/10.1371/journal.pone.0213848			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870500	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300087
J	Nuvey, FS; Edu-Quansah, EP; Kuma, GK; Eleeza, J; Kenu, E; Sackey, S; Ameme, D; Abakar, MF; Kreppel, K; Ngandolo, RB; Afari, E; Bonfoh, B				Nuvey, Francis Sena; Edu-Quansah, Elijah Paa; Kuma, George Khumalo; Eleeza, John; Kenu, Ernest; Sackey, Samuel; Ameme, Donne; Abakar, Mahamat Fayiz; Kreppel, Katharina; Ngandolo, Richard Bongo; Afari, Edwin; Bonfoh, Bassirou			Evaluation of the sentinel surveillance system for influenza-like illnesses in the Greater Accra region, Ghana, 2018	PLOS ONE			English	Article								Background Influenza-like Illness (ILI) is a medical diagnosis of possible influenza or another respiratory illness with a common set of symptoms. The deaths of four schoolchildren, during a pandemic influenza outbreak in December 2017 in Ghana, raised doubts about the ILI surveillance system's performance. We evaluated the ILI surveillance system in the Greater Accra region, Ghana, to assess the system's attributes and its performance on set objectives. Methods CDC guidelines were used to evaluate the data of the ILI surveillance system between 2013 and 2017. We interviewed the surveillance personnel on the system's description and operation. Additionally, routinely entered ILI data from the National Influenza Center provided by the six sentinel sites in Accra was extracted. We sampled and reviewed 120 ILI case-investigation forms from these sites. Surveillance activities were examined on system's performance indicators, each being scored on a scale of 1 to 3 (poorest to best performance). Results All population and age groups were under ILI surveillance over the period evaluated. Overall, 2948 suspected case-patients, including 392 (13.3%) children under-five were reported, with 219 being positive for influenza virus (Predictive value positive = 7.4%). The predominant influenza subtype was H3N2, recorded in 90 (41.1%) of positive case-patients. The system only met two out of its four objectives. None of the six sentinel sites consistently met their annual 260 suspected case-detection quota. Samples reached the laboratory on average 48 hours after collection and results were disseminated within 7 days. Of 120 caseinvestigation forms sampled, 91 (76.3%) were completely filled in. Conclusions The ILI surveillance system in the Greater Accra region is only partially meeting its objectives. While it is found to be sensitive, representative and timely, the data quality was suboptimal. We recommend the determination of thresholds for alert and outbreak detection and ensuring that sentinel sites meet their weekly case-detection targets.	[Nuvey, Francis Sena; Edu-Quansah, Elijah Paa; Kuma, George Khumalo; Kenu, Ernest; Sackey, Samuel; Ameme, Donne; Afari, Edwin] Univ Ghana, Sch Publ Hlth, Dept Epidemiol & Dis Control, Ghana Field Epidemiol & Lab Training Program, Accra, Ghana; [Nuvey, Francis Sena; Kuma, George Khumalo; Eleeza, John; Kenu, Ernest; Ameme, Donne] Minist Hlth, Ghana Hlth Serv, Accra, Ghana; [Abakar, Mahamat Fayiz; Ngandolo, Richard Bongo] Inst Rech Elevage Dev, Ndjamena, Chad; [Kreppel, Katharina] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Bonfoh, Bassirou] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bonfoh, Bassirou] Univ Basel, Basel, Switzerland	University of Ghana; Ghana Health Service; Nelson Mandela African Institution of Science & Technology; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Nuvey, FS (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Epidemiol & Dis Control, Ghana Field Epidemiol & Lab Training Program, Accra, Ghana.; Nuvey, FS (corresponding author), Minist Hlth, Ghana Hlth Serv, Accra, Ghana.	fsnuvey@gmail.com	Kreppel, Katharina/AAQ-8865-2021; Kenu, Ernest/AAA-1386-2020	Kreppel, Katharina/0000-0001-7743-6919; Ameme, Donne Kofi/0000-0002-1017-7155	DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008]; African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust [107753/A/15/Z]; UK government	DELTAS Africa Initiative; African Academy of Sciences (AAS); Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This study was conducted within the framework of the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008]. Afrique One-African Science Partnership for Intervention Research Excellence (ASPIRE) is funded by a consortium of donors including the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Wellcome Trust [107753/A/15/Z] and the UK government. The funders had no role in the study.	Abakar MF., 2017, CREATING FRAMEWORK I; Bonney JHK, 2012, J INFECT DIS, V206, pS108, DOI 10.1093/infdis/jis577; Budgell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120226; German R R, 2001, MMWR Recomm Rep, V50, P1; Ghana Health Service/Ministry of Health, 2017, GHANA WKLY EPIDEMIOL, V2, P1; Ghana Statistical Service, 2016, POP PROJ DISTR 2015; GHS, 2017, GHAN HLTH SERV 2016; Gong M, 2015, GLOB HEAR, V27, P320; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Kasolo F, 2010, TECHNICAL GUIDELINES, P1; LeDuc JW, 2004, EMERG INFECT DIS J, V10; Ly S, 2017, WPSAR, V8, P1, DOI [10.5365/WPSAR.2016.7.2.013, DOI 10.5365/WPSAR.2016.7.2.013]; Noguchi Memorial Institute of Medical Research, 2015, RES REP 2012 2014; Organization W. H., 2017, INFL SEAS FACT SHEET; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Rakotoarisoa A, 2017, B WORLD HEALTH ORGAN, V95, P375, DOI [10.2471/BLT.16.171280, 10.2471/blt.16.171280]; Sullivan SG, 2016, COMMUNICABLE DIS INT; Tay EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077244; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x; WHO, 2012, WHO INT GLOB EP SURV; WHO, 2013, GLOB EP SURV STAND I; World Health Organization, 2015, INFL HUM AN INT SUM; World Health Organization, 2011, COMM CAS MAN INFL OU; Zinsstag J, 2015, ONE HEALTH: THE THEORY AND PRACTICE OF INTEGRATED HEALTH APPROACHES, P53, DOI 10.1079/9781780643410.0053	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213627	10.1371/journal.pone.0213627	http://dx.doi.org/10.1371/journal.pone.0213627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870489	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000461166300051
J	Lee, HJ; Ko, HJ; Kim, SH; Jung, YJ				Lee, Hyo-Ji; Ko, Hyun-Jeong; Kim, Seung Hyun; Jung, Yu-Jin			Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages	PLOS ONE			English	Article							EURYCOMA-LONGIFOLIA JACK; HOST-DIRECTED THERAPIES; CELL-DEATH; IMMUNITY; ANTIBIOTICS; METABOLISM; APOPTOSIS; BACTERIAL	Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (Mtb) and remains a major health problem worldwide. Thus, identification of new and more effective drugs to treat emerging multidrug-resistant TB (MDR-TB) and to reduce the side effects of anti-TB drugs, such as liver toxicity and other detrimental changes, is urgently needed. In this study, to develop a novel candidate drug for effective TB treatment with few side effects in the host, we selected pasakbumin A isolated from Eurycoma longifolia (E. longifolia) Jack, which protected host cells against Mtb infection-induced death. Pasakbumin A significantly inhibited intracellular Mtb growth by inducing the autophagy via the ERK1/2-mediated signaling pathway in Mtb-infected macrophages. We further investigated whether pasakbumin A could be used as a potential adjuvant for TB treatment. Treatment with pasakbumin A and anti-TB drug rifampicin (RMP) potently suppressed intracellular Mtb killing by promoting autophagy as well as TNF-alpha production via the ERK1/2-and NF-KB-mediated signaling pathways in Mtb-infected cells. Our results suggest that pasakbumin A could be developed as a novel anti-TB drug or host-directed therapeutic (HDT) strategy to protect against host cell death and improve host defense mechanisms against Mtb infection in macrophages.	[Lee, Hyo-Ji; Jung, Yu-Jin] Kangwon Natl Univ, Dept Biol Sci, Chunchon, South Korea; [Lee, Hyo-Ji; Jung, Yu-Jin] Kangwon Natl Univ, Inst Life Sci, Chunchon, South Korea; [Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Kim, Seung Hyun] Yonsei Univ, Coll Pharm, Incheon, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University	Jung, YJ (corresponding author), Kangwon Natl Univ, Dept Biol Sci, Chunchon, South Korea.; Jung, YJ (corresponding author), Kangwon Natl Univ, Inst Life Sci, Chunchon, South Korea.	yjjung@kangwon.ac.kr	Jung, Yu-Jin/GNH-4544-2022	Jung, Yu-Jin/0000-0002-4942-677X; Ko, Hyun-Jeong/0000-0002-3844-928X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of the Republic of Korea [HI15C0450]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2017R1A6A3A11032251, 2018R1D1A1B07049097]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of the Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare of the Republic of Korea (HI15C0450), and the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (2017R1A6A3A11032251, 2018R1D1A1B07049097).	Arbex MA, 2010, J BRAS PNEUMOL, V36, P626, DOI 10.1590/S1806-37132010000500016; Bhat R, 2010, FITOTERAPIA, V81, P669, DOI 10.1016/j.fitote.2010.04.006; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Cho JH, 2017, ONCOTARGET, V8, P24932, DOI 10.18632/oncotarget.15326; Domingo-Gonzalez R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0018-2016; Duan L, 2016, BIOCHEM BIOPH RES CO, V473, P1229, DOI 10.1016/j.bbrc.2016.04.045; Farouk AE, 2007, SAUDI MED J, V28, P1422; Forget EJ, 2006, EXPERT OPIN DRUG SAF, V5, P231, DOI 10.1517/14740338.5.2.231; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harper Ian, 2010, Anthropol Med, V17, P201, DOI 10.1080/13648470.2010.493606; HAUSER WE, 1982, AM J MED, V72, P711, DOI 10.1016/0002-9343(82)90534-4; Hayat M., 2017, AUTOPHAGY CANC OTHER, P234; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Lee H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00924; Lee HJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00541; Lee HJ, 2015, MOL CELLS, V38, P26, DOI 10.14348/molcells.2015.2136; Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081; Nguyen L, 2016, ARCH TOXICOL, V90, P1585, DOI 10.1007/s00204-016-1727-6; MENZIES R, 1993, TUBERCLE LUNG DIS, V74, P32, DOI 10.1016/0962-8479(93)90066-7; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Mortaz E, 2015, J CLIN IMMUNOL, V35, P1, DOI 10.1007/s10875-014-0103-7; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Park S, 2014, BIOORG MED CHEM LETT, V24, P3835, DOI 10.1016/j.bmcl.2014.06.058; Park WB, 2010, J INFECTION, V61, P323, DOI 10.1016/j.jinf.2010.07.009; Petrini B, 1999, INT J ANTIMICROB AG, V13, P93, DOI 10.1016/S0924-8579(99)00111-9; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Rehman SU, 2016, MOLECULES, V21, DOI 10.3390/molecules21030331; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8; Saraav I, 2014, IMMUNOL CELL BIOL, V92, P741, DOI 10.1038/icb.2014.52; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Shibutani ST, 2015, NAT IMMUNOL, V16, P1014, DOI 10.1038/ni.3273; Stephenson HN, 2016, CURR OPIN IMMUNOL, V38, P59, DOI 10.1016/j.coi.2015.11.004; Sulis G, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.78; Tee TT, 2007, ANTICANCER RES, V27, P3425; Tousif S, 2014, J BIOL CHEM, V289, P30190, DOI 10.1074/jbc.C114.598946; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Yakar F, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-13; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	47	12	12	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0199799	10.1371/journal.pone.0199799	http://dx.doi.org/10.1371/journal.pone.0199799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865638	gold, Green Submitted, Green Published			2022-12-26	WOS:000461048900001
J	Lur, G; Fariborzi, M; Higley, MJ				Lur, Gyorgy; Fariborzi, Mona; Higley, Michael J.			Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission	PLOS ONE			English	Article							NMDA RECEPTOR BLOCKADE; DEPRESSION; COMORBIDITY; ANTAGONIST; MODULATION; ACTIVATION; MECHANISMS; REGULATOR; PROTEINS	A growing body of literature has demonstrated the potential for ketamine in the treatment of major depression. Sub-anesthetic doses produce rapid and sustained changes in depressive behavior, both in patients and rodent models, associated with reorganization of glutamatergic synapses in the prefrontal cortex (PFC). While ketamine is known to regulate Nmethyl-D-aspartate (NMDA)-type glutamate receptors (NMDARs), the full complement of downstream cellular consequences for ketamine administration are not well understood. Here, we combine electrophysiology with 2-photon imaging and glutamate uncaging in acute slices of mouse PFC to further examine how ketamine alters glutamatergic synaptic transmission. We find that four hours after ketamine treatment, glutamatergic synapses themselves are not significantly affected. However, levels of the neuromodulatory Regulator of G-protein Signaling (RGS4) are dramatically reduced. This loss of RGS4 activity is associated with disruption of the normal compartmentalization of synaptic neuromodulation. Thus, under control conditions, alpha 2 adrenergic receptors and type B gamma-aminobutyric acid (GABA(B)) receptors selectively inhibit alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) and NMDARs, respectively. After ketamine administration and reduction in RGS4 activity, this selectivity is lost, with both modulatory systems broadly inhibiting glutamatergic transmission. These results suggest a novel mechanism by which ketamine may influence synaptic signaling and provide new avenues for the exploration of therapeutics directed at treating neuropsychiatric disorders, such as depression.	[Lur, Gyorgy; Higley, Michael J.] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurosci, New Haven, CT 06520 USA; [Lur, Gyorgy; Fariborzi, Mona] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	Yale University; University of California System; University of California Irvine	Lur, G (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurosci, New Haven, CT 06520 USA.; Lur, G (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	glur@uci.edu			Brain and Behavior Research Foundation (NARSAD Young Investigator Award); Smith Family Foundation; NIH [R01 MH099045]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099045] Funding Source: NIH RePORTER	Brain and Behavior Research Foundation (NARSAD Young Investigator Award); Smith Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	These studies were funded by grants from the Brain and Behavior Research Foundation (NARSAD Young Investigator Award, GL), the Smith Family Foundation (MJH), and the NIH (R01 MH099045, MJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fukumoto K, 2017, J PHARMACOL EXP THER, V361, P9, DOI 10.1124/jpet.116.239228; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Kavalaii ET, 2012, AM J PSYCHIAT, V169, P1150, DOI 10.1176/appi.ajp.2012.12040531; Kazavchinsky L, 2019, J PHARMACOL TOX MET, V95, P12, DOI 10.1016/j.vascn.2018.11.007; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; Lepack AE, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu033; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Lur G, 2015, CELL REP, V12, P326, DOI 10.1016/j.celrep.2015.06.029; MACDONALD JF, 1987, J NEUROPHYSIOL, V58, P251, DOI 10.1152/jn.1987.58.2.251; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; Mineur YS, 2015, PSYCHOPHARMACOLOGY, V232, P3539, DOI 10.1007/s00213-015-4001-3; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pozzi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083879; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Salat K, 2015, NEUROPHARMACOLOGY, V99, P301, DOI 10.1016/j.neuropharm.2015.07.037; Sleigh J, 2014, TRENDS ANAESTH CRIT, V4, P76, DOI 10.1016/j.tacc.2014.03.002; Stratinaki M, 2013, P NATL ACAD SCI USA, V110, P8254, DOI 10.1073/pnas.1214696110; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wohleb ES, 2017, CURR NEUROPHARMACOL, V15, P11, DOI 10.2174/1570159X14666160309114549; Yang Y, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00229; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213721	10.1371/journal.pone.0213721	http://dx.doi.org/10.1371/journal.pone.0213721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865708	gold, Green Published, Green Submitted			2022-12-26	WOS:000461048900085
J	Carneros, D; Santamaria, EM; Larequi, E; Velez-Ortiz, JM; Reboredo, M; Mancheno, U; Perugorria, MJ; Navas, P; Romero-Gomez, M; Prieto, J; Hervas-Stubbs, S; Bustos, M				Carneros, David; Santamaria, Eva M.; Larequi, Eduardo; Miguel Velez-Ortiz, Jose; Reboredo, Mercedes; Mancheno, Uxua; Jesus Perugorria, Maria; Navas, Placido; Romero-Gomez, Manuel; Prieto, Jesus; Hervas-Stubbs, Sandra; Bustos, Matilde			Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization	FASEB JOURNAL			English	Article						interleukin-6; gp130; M1; IL-6; STAT3	ALTERNATIVE ACTIVATION; ONCOSTATIN M; INTERLEUKIN-6; RECEPTOR; INJURY; IL-6; EXPRESSION; MICE; ENDOTOXEMIA; MECHANISMS	Macrophages play a central role in tissue remodeling, repair, and resolution of inflammation. Macrophage polarization to M1 or M2 activation status may determine the progression or resolution of the inflammatory response. We have previously reported that cardiotrophin-1 (CT-1) displays both cytoprotective and metabolic activities. The role of CT-1 in inflammation remains poorly understood. Here, we employed recombinant CT-1 (rCT-1) and used CT-1-null mice and myeloid-specific CT-1 transgenic mice to investigate whether CT-1 might play a role in the modulation of the inflammatory response. We observed that CT-1 deficiency was associated with enhanced release of inflammatory mediators and with stronger activation of NF-kappa B in response to LPS, whereas the inflammatory response was attenuated in CT-1 transgenic mice or by administering rCT-1 to wild-type animals prior to LPS challenge. We found that CT-1 promoted IL-6 expression only by nonhematopoietic cells, whereas LPS up-regulated IL-6 expression in both hematopoietic and nonhematopoietic cells. Notably, rCT-1 inhibited LPS-mediated soluble IL-6R induction. Using IL-6(-/-) mice, we showed that rCT-1 inhibited LPS-induced TNF-alpha and IFN-gamma response in an IL-6-independent manner. Importantly, we demonstrated that CT-1 primes macrophages for IL-4-dependent M2 polarization by inducing IL-4 receptor expression. Mechanistic analyses showed that the signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 axis mediates this effect. Our findings support the notion that CT-1 is a critical regulator of inflammation and suggest that rCT-1 could be a molecule with potential therapeutic application in inflammatory conditions.-Carneros, D., Santamaria, E. M., Larequi, E., Velez-Ortiz, J. M., Reboredo, M., Mancheno, U., Perugorria, M. J., Navas, P., Romero-Gomez, M., Prieto, J., Hervas-Stubbs, S., Bustos, M. Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4-induced M2 macrophage polarization.	[Carneros, David; Miguel Velez-Ortiz, Jose; Romero-Gomez, Manuel; Bustos, Matilde] Univ Seville, Virgen del Rocio Univ Hosp, CSIC, Inst Biomed Seville IBiS, Avda Manuel Siurot S-N, Seville 41013, Spain; [Santamaria, Eva M.; Larequi, Eduardo; Reboredo, Mercedes; Prieto, Jesus] Univ Navarra, Ctr Appl Med Res CIMA, Div Hepatol, Pamplona, Spain; [Mancheno, Uxua; Hervas-Stubbs, Sandra] Univ Navarra, Ctr Appl Med Res CIMA, Div Immunol & Immunotherapy, Pamplona, Spain; [Santamaria, Eva M.; Reboredo, Mercedes; Jesus Perugorria, Maria; Romero-Gomez, Manuel; Prieto, Jesus] Inst Salud Carlos III, CIBEREHD, Madrid, Spain; [Navas, Placido] Inst Salud Carlos III, CIBERER, Madrid, Spain; [Mancheno, Uxua; Hervas-Stubbs, Sandra] Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Jesus Perugorria, Maria] Univ Basque Country, Donostia Univ Hosp, Biodonostia Hlth Res Inst, UPV EHU, San Sebastian, Spain; [Navas, Placido] Univ Pablo Olavide, CSIC, CABD, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Bustos, M (corresponding author), Univ Seville, Virgen del Rocio Univ Hosp, CSIC, Inst Biomed Seville IBiS, Avda Manuel Siurot S-N, Seville 41013, Spain.	mbustos-ibis@us.es	NAVAS, PLACIDO/R-5943-2019; Romero-Gomez, Manuel/L-8030-2014; Santa María Monasteri, Eva/Z-4537-2019; Hervas-Stubbs, Sandra/C-9053-2018; Mancheno, Uxua/D-2873-2018	NAVAS, PLACIDO/0000-0002-4115-7966; Romero-Gomez, Manuel/0000-0001-8494-8947; Santa María Monasteri, Eva/0000-0003-0629-6175; Hervas-Stubbs, Sandra/0000-0003-3391-1516; Bustos, Matilde/0000-0003-2306-9548; Velez-Ortiz, Jose Miguel/0000-0002-4861-3856; Mancheno, Uxua/0000-0003-1533-0371	Instituto de Salud Carlos III (ISCIII); Fondo de Investigacion Sanitaria [PI13/01851, PI16/01791, PI15/02027]; Federacion Espanola de Enfermedades Raras (FEDER) funds	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Federacion Espanola de Enfermedades Raras (FEDER) funds	The authors thank Dr. Bettina Holtmann (University of Wurzburg, Wurzburg, Germany) who donated the CT-1-null mice. The authors also thank Dr. J. Vitorica (University of Seville) for providing the IL-4 knockout mice. This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) and the Fondo de Investigacion Sanitaria (PI13/01851 and PI16/01791 to M.B. and PI15/02027 to S.H.-S.). Centro de Investigacion Biomedica en Red Enfermedades Raras (CIBERER) and Enfermedades Hepaticas y Digestivas (CIBEREHD) are initiatives of the ISCIII of Spain, supported by Federacion Espanola de Enfermedades Raras (FEDER) funds. M.B. and S.H.-S. share senior authorship. The authors declare no conflicts of interest.	Aguilar-Melero P, 2013, J SURG RES, V181, pE83, DOI 10.1016/j.jss.2012.07.046; Alisi A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8162421; Appari M, 2018, ANTIOXID REDOX SIGN, V29, P297, DOI 10.1089/ars.2017.7060; Benigni F, 1996, AM J PATHOL, V149, P1847; Beraza N, 2005, HEPATOLOGY, V41, P460, DOI 10.1002/hep.20590; Castano D, 2014, J HEPATOL, V60, P1017, DOI 10.1016/j.jhep.2013.12.012; Cichy J, 1997, J IMMUNOL, V159, P5648; Cron L, 2016, J EXP BIOL, V219, P259, DOI 10.1242/jeb.129213; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Garcia-Cenador MB, 2013, TRANSPLANTATION, V96, P1034, DOI 10.1097/TP.0b013e3182a74db4; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lopez-Yoldi M, 2015, CYTOKINE GROWTH F R, V26, P523, DOI 10.1016/j.cytogfr.2015.07.009; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mauer J, 2015, TRENDS IMMUNOL, V36, P92, DOI 10.1016/j.it.2014.12.008; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Pulido EJ, 1999, J SURG RES, V84, P240, DOI 10.1006/jsre.1999.5655; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Richards CD, 1996, J INTERF CYTOK RES, V16, P69, DOI 10.1089/jir.1996.16.69; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tanimoto K, 2005, CIRC J, V69, P1412, DOI 10.1253/circj.69.1412; Vinay DS, 2004, J IMMUNOL, V173, P4218, DOI 10.4049/jimmunol.173.6.4218; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; WARING PM, 1995, P NATL ACAD SCI USA, V92, P1337, DOI 10.1073/pnas.92.5.1337; Weber MA, 2005, LAB INVEST, V85, P276, DOI 10.1038/labinvest.3700216; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yan CG, 2013, FASEB J, V27, P2967, DOI 10.1096/fj.12-225797; Zaki OS, 2018, INFLAMMATION, V41, P20, DOI 10.1007/s10753-017-0659-5; Zhao JP, 2016, AM J PHYSIOL-LUNG C, V311, pL868, DOI 10.1152/ajplung.00281.2016	45	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7578	7587		10.1096/fj.201801563R	http://dx.doi.org/10.1096/fj.201801563R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30892966				2022-12-26	WOS:000476114200073
J	Jouval, F; Latreille, AC; Bureau, S; Adjeroud, M; Penin, L				Jouval, Florian; Latreille, Anne Catherine; Bureau, Sophie; Adjeroud, Mehdi; Penin, Lucie			Multiscale variability in coral recruitment in the Mascarene Islands: From centimetric to geographical scale	PLOS ONE			English	Article							WESTERN INDIAN-OCEAN; GREAT-BARRIER-REEF; FRENCH-POLYNESIA; REUNION-ISLAND; PHASE-SHIFTS; SCLERACTINIAN CORALS; ADULT DISTRIBUTION; LARVAL SETTLEMENT; MARINE RESERVES; ALGAL TURFS	Coral recruitment refers to the processes allowing maintenance and renewal of coral communities. Recruitment success is therefore indispensable for coral reef recovery after disturbances. Recruitment processes are governed by a variety of factors occurring at all spatial and temporal scales, from centimetres to hundreds of kilometres. In the present context of rising disturbances, it is thus of major importance to better understand the relative importance of different scales in this variation, and when possible, the factors associated with these scales. Multiscale spatio-temporal variability of scleractinian coral recruitment was investigated at two of the Mascarene Islands: Reunion and Rodrigues. Recruitment rates and taxonomic composition were examined during three consecutive six-month periods from regional to micro-local scales (i. e. from hundreds of kilometres to few centimetres) and between two protection levels (no-take zones and general protection zones). Very low recruitment rates were observed. Rodrigues displayed lower recruitment rates than Reunion. Recruit assemblage was dominated by Pocilloporidae (77.9%), followed by Acroporidae (9.9%) and Poritidae (5.2%). No protection effect was identified on coral recruitment, despite differences in recruitment rates among sites within islands. Recruits were patchily distributed within sites but no aggregative effect was detected, i. e. the preferentially colonised tiles were not spatially grouped. Recruits settled mainly on the sides of the tiles, especially at Rodrigues, which could be attributed to the high concentration of suspended matter. The variability of recruitment patterns at various spatial scales emphasises the importance of micro-to macro-local variations of the environment in the dynamics and maintenance of coral populations. High temporal variability was also detected, between seasons and years, which may be related to the early 2016 bleaching event at Rodrigues. The low recruitment rates and the absence of protection effect raise questions about the potential for recovery from disturbances of coral reefs in the Mascarene Islands.	[Jouval, Florian; Bureau, Sophie; Penin, Lucie] Univ La Reunion, Fac Sci & Technol, UMR 9220 ENTROPIE, St Denis, Reunion, France; [Jouval, Florian; Bureau, Sophie; Penin, Lucie] Univ La Reunion, Lab Excellence CORAIL, St Denis, Reunion, France; [Latreille, Anne Catherine] Univ La Reunion, UMR 249 PIMIT, INSERM, CNRS,IRD,Plateforme Technol CYROI, St Denis, Reunion, France; [Adjeroud, Mehdi] Univ Perpignan Via Domitia, IRD, UMR 9220 ENTROPIE, Perpignan, France; [Adjeroud, Mehdi] Univ Perpignan Via Domitia, Lab Excellence CORAIL, Perpignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of La Reunion; University of La Reunion; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Institut de Recherche pour le Developpement (IRD)	Jouval, F (corresponding author), Univ La Reunion, Fac Sci & Technol, UMR 9220 ENTROPIE, St Denis, Reunion, France.; Jouval, F (corresponding author), Univ La Reunion, Lab Excellence CORAIL, St Denis, Reunion, France.	florian.jouval@univ-reunion.fr	Penin, Lucie/B-3163-2009; Adjeroud, Mehdi/J-6411-2016	Adjeroud, Mehdi/0000-0002-6825-8759; Penin, Lucie/0000-0001-7754-1698	Western Indian Ocean Marine Scientific Association [MARG I_2015_19]; Direction des Relations Internationales, Universite de La Reunion; CALIBIOME Fonds Europeen de Developpement Regional (FEDER), PO FEDER	Western Indian Ocean Marine Scientific Association; Direction des Relations Internationales, Universite de La Reunion; CALIBIOME Fonds Europeen de Developpement Regional (FEDER), PO FEDER	This work was supported by: Western Indian Ocean Marine Scientific Association, MARG I_2015_19 (WIOMSA) (https://www.wiomsa.org) to FJ; Direction des Relations Internationales, Universite de La Reunion (https://www.univ-reunion.fr/page-accueil-lien-direct-services/dri-direction-des-relations-internationales) AAP DRI 2017 no1 to LP; Direction des Relations Internationales, Universite de La Reunion, AAP DRI 2018 no1 (https://www.univ-reunion.fr/page-accueil-lien-direct-services/dri-direction-des-relations-internationales) to LP; CALIBIOME Fonds Europeen de Developpement Regional (FEDER), PO FEDER 2014-2020 (www.feder.public.lu/) to LP & MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 2005, MAR POLLUT BULL, V50, P576, DOI 10.1016/j.marpolbul.2005.02.021; Adjeroud M, 2010, MAR POLLUT BULL, V61, P375, DOI 10.1016/j.marpolbul.2010.06.015; Adjeroud M., 2017, MARINE ANIMAL FOREST, P549, DOI DOI 10.1007/978-3-319-21012-4_12; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Adjeroud M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27891-3; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; Babcock RC, 2003, ZOOL STUD, V42, P211; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baird AH, 2005, CURR BIOL, V15, P1926, DOI 10.1016/j.cub.2005.09.036; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bauman AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127874; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Camoin GF, 1997, CORAL REEFS, V16, P247, DOI 10.1007/s003380050080; CHABANET P, 1995, J EXP MAR BIOL ECOL, V188, P29, DOI 10.1016/0022-0981(94)00184-F; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; Chui APY, 2017, MAR POLLUT BULL, V124, P668, DOI 10.1016/j.marpolbul.2017.06.005; Combosch DJ, 2013, ECOL EVOL, V3, P3379, DOI 10.1002/ece3.721; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Crochelet E, 2016, REG STUD MAR SCI, V7, P159, DOI 10.1016/j.rsma.2016.06.007; Crochelet E, 2013, OCEAN COAST MANAGE, V86, P13, DOI 10.1016/j.ocecoaman.2013.10.002; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dunstan PK, 1998, CORAL REEFS, V17, P71, DOI 10.1007/s003380050098; Edgar G.J., 2007, MARINE ECOLOGY, P534; Edmunds PJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185167; Edmunds PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107525; Edmunds PJ, 2010, MAR ECOL PROG SER, V414, P75, DOI 10.3354/meps08728; Edwards AJ, 2001, MAR POLLUT BULL, V42, P7, DOI 10.1016/S0025-326X(00)00200-9; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; Gelin P, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3428-6; Gelin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169692; Glassom D, 2006, CORAL REEFS, V25, P485, DOI 10.1007/s00338-006-0117-6; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; GLEASON DF, 1993, NATURE, V365, P836, DOI 10.1038/365836a0; Gleason MG, 1996, J EXP MAR BIOL ECOL, V207, P79, DOI 10.1016/S0022-0981(96)02647-0; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Green DH, 2011, J EXP MAR BIOL ECOL, V397, P220, DOI 10.1016/j.jembe.2010.12.004; Guest JR, 2008, INVERTEBR REPROD DEV, V51, P145, DOI 10.1080/07924259.2008.9652264; Guest JR, 2005, INVERTEBR REPROD DEV, V48, P207, DOI 10.1080/07924259.2005.9652186; Halpern BS, 2003, ECOL APPL, V13, pS117; Hardman E., 2007, ATOLL RES BULL, V555, P1; Hardman E, 2010, AQUAT CONSERV, V20, P357, DOI 10.1002/aqc.1102; Harii S, 2003, CORAL REEFS, V22, P188, DOI 10.1007/s00338-003-0302-9; HARRIOTT VJ, 1987, MAR ECOL PROG SER, V37, P201, DOI 10.3354/meps037201; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heyward AJ, 2012, SCIENCE, V335, P1064, DOI 10.1126/science.1216055; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hsu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107366; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Huntington BE, 2011, CORAL REEFS, V30, P1077, DOI 10.1007/s00338-011-0809-4; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kuffner IB, 2004, CORAL REEFS, V23, P455, DOI 10.1007/s00338-004-0416-8; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lukoschek V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065363; Luter HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153184; Machendiranathan M, 2017, REG STUD MAR SCI, V15, P10, DOI 10.1016/j.rsma.2017.06.004; MAIDA M, 1994, J EXP MAR BIOL ECOL, V180, P189, DOI 10.1016/0022-0981(94)90066-3; MAIDA M, 1995, MAR ECOL PROG SER, V121, P191, DOI 10.3354/meps121191; Mangubhai S, 2007, MAR ECOL PROG SER, V348, P149, DOI 10.3354/meps07090; McClanahan TR, 2008, MAR BIOL, V153, P755, DOI 10.1007/s00227-007-0844-4; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; NAIM O, 1993, MAR ECOL PROG SER, V99, P137; Naim Odile, 2013, Atoll Research Bulletin, P1; Nozawa Y, 2006, MAR BIOL, V149, P1047, DOI 10.1007/s00227-006-0285-5; Nozawa Y, 2011, ZOOL STUD, V50, P53; OLIVER J, 1992, BIOL BULL, V183, P409, DOI 10.2307/1542017; Pasnin O, 2016, OCEAN COAST MANAGE, V130, P213, DOI 10.1016/j.ocecoaman.2016.06.014; Penin L, 2007, B MAR SCI, V80, P379; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Penin L, 2011, HYDROBIOLOGIA, V663, P259, DOI 10.1007/s10750-010-0569-0; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Rees SA, 2005, PHILOS T R SOC A, V363, P101, DOI 10.1098/rsta.2004.1481; Ruiz-Zarate MA, 2004, CORAL REEFS, V23, P584, DOI 10.1007/s00338-0040420-z; Salinas-de-Leon P, 2013, MAR BIOL, V160, P97, DOI 10.1007/s00227-012-2066-7; SAMMARCO PW, 1982, MAR ECOL PROG SER, V10, P57, DOI 10.3354/meps010057; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sola E, 2015, AFR J MAR SCI, V37, P557, DOI 10.2989/1814232X.2015.1113201; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; van Woesik R, 2010, P R SOC B, V277, P715, DOI 10.1098/rspb.2009.1524; Vermeij MJA, 2011, MAR ECOL PROG SER, V422, P1, DOI 10.3354/meps08964; Vermeij MJA, 2005, MAR ECOL PROG SER, V295, P123, DOI 10.3354/meps295123; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	104	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214163	10.1371/journal.pone.0214163	http://dx.doi.org/10.1371/journal.pone.0214163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901355	gold, Green Published			2022-12-26	WOS:000462000400040
J	Van Bortel, T; Martin, S; Anjara, S; Nellums, LB				Van Bortel, Tine; Martin, Steven; Anjara, Sabrina; Nellums, Laura B.			Perceived stressors and coping mechanisms of female migrant domestic workers in Singapore	PLOS ONE			English	Article							MENTAL-HEALTH; IMMIGRANT WOMEN; SOCIAL SUPPORT; PSYCHOLOGICAL DISTRESS; DEPRESSION; MIGRATION; PREDICTORS; ANXIETY; EXPERIENCES; ADJUSTMENT	Introduction Worldwide, there are between 50-67 million migrant domestic workers, the majority of whom are women. In many countries, provisions are not in place to protect female migrant domestic workers. These women may be at risk of occupational and social stressors, including exploitation and abuse, which may negatively impact on their quality of life, including psychological health. Research examining the occupational, social, and psychological needs of FMDWs from a public health perspective is critical to guide the development of policies which ensure wellbeing, prevent abuse, and align with international priorities to improve population health. Though there have been a number of high-profile incidents of exploitation and abuse, there has been limited research on the stressors experienced by these communities, their perceived impact, or coping mechanisms. Materials and methods Thematic analysis was used to analyse qualitative free-text written responses collected as part of a cross-sectional survey on the relationship between social and occupational stressors and the health and quality of life of FMDWs in Singapore. Responses correspond to open-ended questions in the qualitative component of the survey examining three domains: causes of stress, coping strategies, and what people can do to help with stress. Results Responses from 182 FMDWs were analysed. Key themes were identified around causes of stress (including 'work and agency', 'the pervasiveness of financial need', and 'family and obligation'), coping strategies, and social support. Each theme describes key factors which contribute to the occupational and social stressors experienced and reported by FMDWs. Discussion This research highlights the stressors FMDWs in Singapore experience, as well as key coping mechanisms. There is a clear need for policies which facilitate FMDWs' ability to utilise these coping resources, and which protect against coercive or exploitative employment conditions. Strategies are also needed to monitor and evaluate policies intended to protect FMDWs, and to strengthen the implementation of global frameworks targeted at improving workplace conditions and workers' rights.	[Van Bortel, Tine; Martin, Steven] Univ East London, Inst Hlth & Human Dev, London, England; [Van Bortel, Tine; Anjara, Sabrina] Univ Cambridge, Cambridge Inst Publ Hlth, Sch Clin Med, Cambridge, England; [Nellums, Laura B.] St Georges Univ London, Inst Infect & Immun, London, England; [Nellums, Laura B.] Imperial Coll London, Dept Med, Sect Infect Dis & Immun, London, England	University of East London; University of Cambridge; St Georges University London; Imperial College London	Nellums, LB (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.; Nellums, LB (corresponding author), Imperial Coll London, Dept Med, Sect Infect Dis & Immun, London, England.	LNellums@sgul.ac.uk		Anjara, Sabrina G/0000-0002-1024-4899; Van Bortel, Tine/0000-0003-0467-6393; Nellums, Laura/0000-0002-2534-6951	Wellcome Trust [209993/z/17/2]; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) through the ESCMID Study Group for Infections in Travellers and Migrants (ESGITM)	Wellcome Trust(Wellcome TrustEuropean Commission); European Society for Clinical Microbiology and Infectious Diseases (ESCMID) through the ESCMID Study Group for Infections in Travellers and Migrants (ESGITM)	LBN is supported by funding from the Wellcome Trust (grant number 209993/z/17/2), and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) research funding through the ESCMID Study Group for Infections in Travellers and Migrants (ESGITM).	Abas MA, 1997, PSYCHOL MED, V27, P59, DOI 10.1017/S0033291796004163; Ahonen EQ, 2010, AM J IND MED, V53, P405, DOI 10.1002/ajim.20710; Anjara SG, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0442-7; [Anonymous], INTR HLTH WORKPL MOD; [Anonymous], 2014, WORK PERM FOR DOM WO; [Anonymous], 2015, SHARP EYES BOOSTING; Bagley C, 1997, INT SOC WORK, V40, P373, DOI 10.1177/002087289704000402; Carswell Kenneth, 2011, Int J Soc Psychiatry, V57, P107, DOI 10.1177/0020764008105699; Chou KL, 2009, J AFFECT DISORDERS, V114, P85, DOI 10.1016/j.jad.2008.06.005; Chuang JA, 2010, N CAROLINA LAW REV, V88; Coker AL, 2002, J WOMEN HEALTH GEN-B, V11, P465, DOI 10.1089/15246090260137644; Cole E., 1992, WOMEN THER, V13, P1; Constable N., 2007, MAID ORDER HONG KONG; Darvishpour M, 2002, J COMP FAM STUD, V33, P271, DOI 10.3138/jcfs.33.2.271; Devasahayam TW, 2010, J ASIA PAC ECON, V15, P45, DOI 10.1080/13547860903488229; Fenton S, 1996, SOCIOL HEALTH ILL, V18, P66, DOI 10.1111/1467-9566.ep10934418; Gask L, 2011, J AFFECT DISORDERS, V128, P49, DOI 10.1016/j.jad.2010.06.023; Graham J, 2005, OVERCOMING ADVERSITY; HAUFF E, 1995, BRIT J PSYCHIAT, V166, P360, DOI 10.1192/bjp.166.3.360; Hiott Ann, 2006, Fam Syst Health, V24, P137, DOI 10.1037/1091-7527.24.2.137; Hochschild A.R., 2000, EDGE LIVING GLOBAL C, P130, DOI DOI 10.4324/9781315633794-21; Hovey JD, 2002, COMMUNITY MENT HLT J, V38, P223, DOI 10.1023/A:1015215723786; Hovey JD, 2002, J PSYCHOL, V136, P493, DOI 10.1080/00223980209605546; Huang S., 2007, MOBILITIES-UK, V2, P195, DOI [DOI 10.1080/17450100701381557, 10.1080/17450100701381557]; Huang S., 2003, ASIAN PAC MIGR J, V12, P75, DOI DOI 10.1177/011719680301200104; Isaksen LW, 2008, AM BEHAV SCI, V52, P405, DOI 10.1177/0002764208323513; Johnson H, 2009, ETHNIC HEALTH, V14, P407, DOI 10.1080/13557850802621449; Karasz A, 2005, SOC SCI MED, V60, P1625, DOI 10.1016/j.socscimed.2004.08.011; KRAUSE IB, 1989, SOC SCI MED, V29, P563, DOI 10.1016/0277-9536(89)90202-5; Lawrence V, 2006, GERONTOLOGIST, V46, P23, DOI 10.1093/geront/46.1.23; LEE ES, 1966, DEMOGRAPHY, V3, P47, DOI 10.2307/2060063; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Mendoza NB, 2017, PSYCHIAT RES, V255, P263, DOI 10.1016/j.psychres.2017.05.037; Miranda J, 2005, PSYCHIAT SERV, V56, P717, DOI 10.1176/appi.ps.56.6.717; Papadopoulos I, 2004, ETHNIC HEALTH, V9, P55, DOI 10.1080/1355785042000202745; Parrenas R.S., 2001, SERVANTS GLOBALIZATI; Patel V., 1995, Central African Journal of Medicine, V41, P209; Piper N, 2008, THIRD WORLD Q, V29, P1287, DOI 10.1080/01436590802386427; Schweitzer R, 2006, AUST NZ J PSYCHIAT, V40, P179, DOI 10.1111/j.1440-1614.2006.01766.x; Shah N M, 1997, Asian Pac Migr J, V6, P5; Shattell M., 2009, HISPANIC HLTH CARE I, V7, P190, DOI [10.1891/1540-4153.7.4.190, DOI 10.1891/1540-4153.7.4.190]; Silveira E, 2001, INT J SOC WELF, V10, P309, DOI 10.1111/1468-2397.00188; Siriwardhana C, 2013, J IMMIGR MINOR HEALT, V17, P885; Sokoloff NJ., 2004, WOMENS STUDIES Q, V32, P139; Taloyan M, 2008, SCAND J PUBLIC HEALT, V36, P190, DOI 10.1177/1403494807085077; Ting L, 2010, HEALTH CARE WOMEN IN, V31, P345, DOI 10.1080/07399330903348741; Tummala-Narra P., 2007, J AGGRESS MALTREAT T, V14, P33, DOI [DOI 10.1300/J146V14N01_03, 10.1300/J146v14n01_03]; Varia N., 2010, SLOW REFORM PROTECTI; VEGA WA, 1991, HUM ORGAN, V50, P154, DOI 10.17730/humo.50.2.p340266397214724; VEGA WA, 1987, INT MIGR REV, V21, P512, DOI 10.2307/2546608; Wong DFK, 2008, SOC PSYCH PSYCH EPID, V43, P483, DOI 10.1007/s00127-008-0341-1; Yakushko O, 2005, J COUNS DEV, V83, P292, DOI 10.1002/j.1556-6678.2005.tb00346.x; Yeates Nicola., 2004, INT FEM J POLIT, V6, P369, DOI [10.1080/1461674042000235573, DOI 10.1080/1461674042000235573]; Yeoh BSA, 2010, MOBILITIES-UK, V5, P219, DOI 10.1080/17450101003665036	54	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0210717	10.1371/journal.pone.0210717	http://dx.doi.org/10.1371/journal.pone.0210717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893317	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000461765900005
J	Dantas, LF; Marchesi, JF; Peres, IT; Hamacher, S; Bozza, FA; Neira, RAQ				Dantas, Leila F.; Marchesi, Janaina F.; Peres, Igor T.; Hamacher, Silvio; Bozza, Fernando A.; Quintano Neira, Ricardo A.			Public hospitalizations for stroke in Brazil from 2009 to 2016	PLOS ONE			English	Article							CASE-FATALITY RATES; MORTALITY; TRENDS; EPIDEMIOLOGY; OUTCOMES; DISEASE	Background Stroke is the third major cause of death in the world and the second in Brazil. The purpose of this work was to assess the stroke-related hospitalization, in-hospital mortality, and case fatality rates under the Brazilian Unified Health System (SUS) from 2009 to 2016. Methods We evaluated the hospital admissions for stroke and their associated outcomes using data from the Hospital Information available at the Informatics Department of SUS. We selected hospitalization registries according to stroke diagnosis codes from the International Statistical Classification of Diseases and Related Health Problems (ICD-10). We identified the association of age and sex with patient death through multiple logistic regression and calculated the rates of hospitalization, mortality and case-fatality per 100,000 inhabitants using age-adjustment methodology. Results We analyzed 1,113,599 stroke hospitalizations. From 2009 to 2016, the number of admissions increased from 131,122 to 146,950 and the absolute number of in-hospital deaths increased from 28,731 to 31,937. Younger age and male sex were significantly associated with patient survival. Our results showed that the annual age-adjusted hospitalization and in-hospital mortality rates decreased by 11.8% and 12.6%, respectively, but the case fatality rate increased for patients older than 70 years. Conclusions Although the age-adjusted hospitalization and in-hospital mortality rates declined, the total number of hospitalization and deaths have increased. It is expected a continuous increase over the next years of stroke admissions with the rapid aging of the Brazilian population. Efforts should be renewed targeting risk factors, access to hospital and rehabilitation in particular for the elderly population.	[Dantas, Leila F.; Marchesi, Janaina F.; Peres, Igor T.; Hamacher, Silvio; Quintano Neira, Ricardo A.] Pontifical Catolic Univ Rio De Janeiro, Dept Ind Engn, Rio De Janeiro, RJ, Brazil; [Bozza, Fernando A.] Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Bozza, Fernando A.] DOr Inst Res & Educ, IDOR, Rio De Janeiro, RJ, Brazil	Pontificia Universidade Catolica do Rio de Janeiro; Fundacao Oswaldo Cruz; IDOR - Instituto D'Or de Ensino e Pesquisa	Bozza, FA (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil.; Bozza, FA (corresponding author), DOr Inst Res & Educ, IDOR, Rio De Janeiro, RJ, Brazil.	bozza.fernando@gmail.com	Dantas, Leila Figueiredo/U-5407-2019; Bozza, Fernando A/A-2618-2013; hamacher, silvio/C-3325-2013; Marchesi, Janaina/AFL-9964-2022; Peres, Igor Tona/GWQ-6665-2022; Peres, Igor Tona/ABI-1502-2020; Marchesi, Janaina/AAH-2233-2022	Bozza, Fernando A/0000-0003-4878-0256; hamacher, silvio/0000-0002-3980-0342; Marchesi, Janaina/0000-0002-0262-5384; Peres, Igor/0000-0001-9863-4690	National Council for Scientific and Technological Development (CNPq) [306802/2015-5, 403863/2016-3, 140511/2018-0, 169049/2017-5]; Carlos Chagas Filho Foundation (FAPERJ) [E-26/201.959/2017]; Coordination for theImprovement of Higher Education Personnel (CAPES); Pontifical Catholic University of Rio de Janeiro; Philips Research; Brazilian National Council for Scientific and Technological Development (CNPq)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for theImprovement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pontifical Catholic University of Rio de Janeiro; Philips Research; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the National Council for Scientific and Technological Development (CNPq) http://cnpq.br/[grant numbers 306802/2015-5 and 403863/2016-3 to SH; 140511/2018-0 to RAQN; 169049/2017-5 to LED]; Carlos Chagas Filho Foundation (FAPERJ) http://www.faperj.br/. [grant number E-26/201.959/2017 to JFM]; the Coordination for theImprovement of Higher Education Personnel (CAPES) http://www.capes.gov.br/; and the Pontifical Catholic University of Rio de Janeiro http://www.puc-rio.br/english/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank Coordination for the Improvement of Higher Education Personnel (CAPES), the Pontifical Catholic University of Rio de Janeiro, Philips Research and the Brazilian National Council for Scientific and Technological Development (CNPq) for their financial support.	Adami F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152739; Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; Bejot Y, 2016, REV NEUROL-FRANCE, V172, P59, DOI 10.1016/j.neurol.2015.07.013; Bejot Y, 2016, PRESSE MED, V45, pE391, DOI 10.1016/j.lpm.2016.10.003; Cabral NL, 2009, J NEUROL NEUROSUR PS, V80, P749, DOI 10.1136/jnnp.2008.164475; CSIS, BRAZ SIST UN SAUD SU; de Santana Nathalia Matos, 2018, BMC Res Notes, V11, P735, DOI 10.1186/s13104-018-3842-3; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; de Carvalho JJF, 2011, STROKE, V42, P3341, DOI 10.1161/STROKEAHA.111.626523; Garritano CR, 2012, ARQ BRAS CARDIOL, V98, P519, DOI 10.1590/S0066-782X2012005000041; Goulart AC, 2010, INT J STROKE, V5, P284, DOI 10.1111/j.1747-4949.2010.00441.x; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Iser BPM, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0185-x; Kamal N, 2015, CAN J NEUROL SCI, V42, P168, DOI 10.1017/cjn.2015.20; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lotufo PA, 2007, ARQ NEURO-PSIQUIAT, V65, P752, DOI 10.1590/S0004-282X2007000500004; Lotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510; Malachias MVB, 2016, 7A DIRETRIZ BRASELLE; Malta DC, 2015, SCIELO PUBLIC HLTH, V20, P631; Mansur AD, 2016, ARQ BRAS CARDIOL, V107, P137, DOI 10.5935/abc.20160102; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829; Minelli C, 2007, STROKE, V38, P2906, DOI 10.1161/STROKEAHA.107.484139; Monteiro CA, 2017, VIGITEL BRASIL 2006; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Passos VMA, 2016, ARQ NEURO-PSIQUIAT, V74, P376, DOI 10.1590/0004-282X20160055; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Rolim CLRC, 2011, CAD SAUDE PUBLICA, V27, P2105; Sarfo FS, 2015, J NEUROL SCI, V357, P240, DOI 10.1016/j.jns.2015.07.043; Team RStudio, 2015, INT DEV R; Thrift AG, 2014, INT J STROKE, V9, P6, DOI 10.1111/ijs.12245; World Health Organization, 2007, INT CLASS DIS	33	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213837	10.1371/journal.pone.0213837	http://dx.doi.org/10.1371/journal.pone.0213837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889198	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000034
J	Negron, C; Pearlman, DA; del Angel, G				Negron, Christopher; Pearlman, David A.; del Angel, Guillermo			Predicting mutations deleterious to function in beta-lactamase TEM1 using MM-GBSA	PLOS ONE			English	Article							PROTEIN; CONSEQUENCES; LANDSCAPE; STABILITY; SEQUENCE; SERVER	Missense mutations can have disastrous effects on the function of a protein. And as a result, they have been implicated in numerous diseases. However, the majority of missense variants only have a nominal impact on protein function. Thus, the ability to distinguish these two classes of missense mutations would greatly aid drug discovery efforts in target identification and validation as well as medical diagnosis. Monitoring the co-occurrence of a given missense mutation and a disease phenotype provides a pathway for classifying functionally disrupting missense mutations. But, the occurrence of a specific missense variant is often extremely rare making statistical links challenging to infer. In this study, we benchmark a physics-based approach for predicting changes in stability, MMGBSA, and apply it to classifying mutations as functionally disrupting. A large and diverse dataset of 990 residue mutations in beta-lactamase TEM1 is used to assess performance as it is rich in both functionally disrupting mutations and functionally neutral/beneficial mutations. On this dataset, we compare the performance of MM-GBSA to alternative strategies for predicting functionally disrupting mutations. We observe that the MM-GBSA method obtains an area under the curve (AUC) of 0.75 on the entire dataset, outperforming all other predictors tested. More importantly, MM-GBSA's performance is robust to various divisions of the dataset, speaking to the generality of the approach. Though there is one notable exception: Mutations on the surface of the protein are the mutations that are the most difficult to classify as functionally disrupting for all methods tested. This is likely due to the many mechanisms available to surface mutations to disrupt function, and thus provides a direction of focus for future studies.	[Negron, Christopher; Pearlman, David A.] Schrodinger, New York, NY USA; [del Angel, Guillermo] Alexion Pharmaceut Inc, Boston, MA 02421 USA		del Angel, G (corresponding author), Alexion Pharmaceut Inc, Boston, MA 02421 USA.	Guillermo.delAngel@alexion.com		Pearlman, David/0000-0002-2574-6066	Schrodinger, Inc.; Alexion Pharmaceuticals	Schrodinger, Inc.; Alexion Pharmaceuticals	Schrodinger, Inc. and Alexion Pharmaceuticals funded the study. Schrodinger, Inc. provided support in the form of salary for authors CN and DP; Alexion Pharmaceuticals provided support in the form of salary for author GdA, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei I, 2015, CURRENT PROTOCOLS HU, V7; Beard H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082849; Darby N.J., 1993, PROTEIN STRUCTURE; Foley SB, 2015, EBIOMEDICINE, V2, P74, DOI 10.1016/j.ebiom.2014.12.003; Ford MC, 2017, EXAMINING FEASIBILIT; Forster SC, 2016, NUCLEIC ACIDS RES, V44, pD604, DOI 10.1093/nar/gkv1216; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guidugli L, 2018, AM J HUM GENET, V102, P233, DOI 10.1016/j.ajhg.2017.12.013; Hauser K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0075-x; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Jacquier H, 2013, P NATL ACAD SCI USA, V110, P13067, DOI 10.1073/pnas.1215206110; Karras GI, 2017, CELL, V168, P856, DOI 10.1016/j.cell.2017.01.023; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khafizov K, 2014, P NATL ACAD SCI USA, V111, P3733, DOI 10.1073/pnas.1321614111; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu M., 2015, IEEE SENS J, V16, P1; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; PAKULA AA, 1986, P NATL ACAD SCI USA, V83, P8829, DOI 10.1073/pnas.83.23.8829; Pauwels K, 2007, MOL MICROBIOL, V64, P917, DOI 10.1111/j.1365-2958.2007.05718.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramsey DC, 2011, GENETICS, V188, P479, DOI 10.1534/genetics.111.128025; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Steinbrecher T, 2017, J MOL BIOL, V429, P948, DOI 10.1016/j.jmb.2016.12.007; Team R. Core, 2016, R LANG ENV STAT COMP; Venables WN., 2002, MODERN APPL STAT S 4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhou X, 2005, J AM STAT ASSOC, V100, P51, DOI 10.1198/016214504000001817; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214015	10.1371/journal.pone.0214015	http://dx.doi.org/10.1371/journal.pone.0214015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889230	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000043
J	Campbell, LG; Naraine, SGU; Dusfresne, J				Campbell, Lesley G.; Naraine, Steve G. U.; Dusfresne, Jaimie			Phenotypic plasticity influences the success of clonal propagation in industrial pharmaceutical Cannabis sativa	PLOS ONE			English	Article							VEGETATIVE PROPAGATION; STEM CUTTINGS; GROWTH; PHOTOSYNTHESIS; PERCEPTION; SHADELIGHT; IRRADIANCE; CAPACITY; SIGNAL; PLANTS	The burgeoning cannabis market requires evidence-based science such that farmers can quickly and efficiently generate new plants. In part, horticultural operations are limited by the success of cloning procedures. Here, we measured the role of environmental conditions and cultivar identity on the success of generating long branch material with many meristems in planting stock (mothers) and in rooting success of stem-derived clones. To evaluate the influence of lighting treatments on the optimal production of branching mothers, four lighting conditions (Fluorescent High Output T5s [T5], Metal halide lamps [MH], Plasma lamps [PL], or Metal halide lamps augmented with far red LED lights [MH+FR]) were applied to two cultivars of container grown plants (Cannabis sativa L. 'Bubba Kush', 'Ghost Train Haze') grown in peat-based organic substrates in mylar grow tents. To evaluate the influence of lighting, cutting tool (secateurs or scalpels), and stem wounding (present/absent) on optimal rooting of stems, three lighting conditions (Fluorescent T8s, T5, PL) were applied to three cultivars of peat pellet grown plants (C. sativa L. 'Bubba Kush', 'Ghost Train Haze', 'Headband'). Mothers grown under T5 and MH (vs MH+FR) produced similar to 30% more meristems. However, growing mothers under MH+FR were 19% taller than mothers under T5, with similar to 25% longer internodes on dominant stems than plants under any other lighting condition. Canopies were denser under T5 because petiole length was similar to 30% shorter under T5 and fan leaves were longer and narrower under MH+FR and MH+FR and PL, respectively, than under other lighting conditions. Cultivar Ghost Train Haze stems rooted most frequently and most quickly. Wounded stems were 162% more likely to root than unwounded stems and rooted 1.5 days earlier. Our results will guide producers attempting to maximize the rate of clone production in licensed facilities; although results may differ among cultivars, where cultivars differed in their average phenotype as mother plants, and their propensity to root from cuttings, and the speed with which they produced those roots.	[Campbell, Lesley G.; Naraine, Steve G. U.; Dusfresne, Jaimie] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada	Toronto Metropolitan University	Campbell, LG (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.	lesley.g.campbell@ryerson.ca			Natural Sciences and Engineering Research Council [462134-13, 402305-2011]; Ryerson University	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ryerson University	Funds from Natural Sciences and Engineering Research Council (EGP #462134-13 and DG (#402305-2011 to LGC), and Ryerson University (to LGC) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahkami AH, 2009, NEW PHYTOL, V181, P613, DOI 10.1111/j.1469-8137.2008.02704.x; Al-Salem MM, 2001, HORTSCIENCE, V36, P976, DOI 10.21273/HORTSCI.36.5.976; Alem O.P, 2010, THESIS CLEMSON U COU; Assaf SA E., 2007, 8 INT C JOJ AS; Bates D, 2014, ARXIV14065823; Birnbaum E, 1985, JOJ P 6 INT C JOJ IT; BUSCHMANN C, 1978, PHOTOCHEM PHOTOBIOL, V27, P195, DOI 10.1111/j.1751-1097.1978.tb07587.x; Campbell LG, 2005, HEREDITY, V94, P526, DOI 10.1038/sj.hdy.6800653; Caplan D, 2018, CANADIAN J PLANT SCI; Cope K., 2013, NATIV PLANTS J, V14, P76, DOI [10.3368/npj.14.2.76, DOI 10.3368/NPJ.14.2.76]; Davis MJ, 1989, HOST COLONIZATION PA, P33; de Andres EF, 2004, AGROFOREST SYST, V63, P7, DOI 10.1023/B:AGFO.0000049428.12140.af; Dirr M. A., 1987, REFERENCE MANUAL WOO; DORRELL DG, 1974, CAN J PLANT SCI, V54, P197, DOI 10.4141/cjps74-029; Garner R.J, 2013, GRAFTERS HDB; GILBERT IR, 1995, PLANT CELL ENVIRON, V18, P475, DOI 10.1111/j.1365-3040.1995.tb00549.x; Gilbert IR, 2001, NATURE, V411, P792, DOI 10.1038/35081062; Haile G, 2011, J ARID ENVIRON, V75, P873, DOI 10.1016/j.jaridenv.2011.04.007; Haissig BE, 1974, NZJ SCI, V4, P1; HARTNETT DC, 1985, J ECOL, V73, P407, DOI 10.2307/2260483; HINESLEY LE, 1981, CAN J FOREST RES, V11, P316; Inc. D, 2016, RECR MAR INS OPP; Jansen MAK, 2002, PHYSIOL PLANTARUM, V116, P423, DOI 10.1034/j.1399-3054.2002.1160319.x; Krizek D. T., 1998, Biotronics, V27, P81; Lichtenthaler H. K., 1980, The blue light syndrome [Senger, H. (Editor)]., P485; LYDON J, 1987, PHOTOCHEM PHOTOBIOL, V46, P201, DOI 10.1111/j.1751-1097.1987.tb04757.x; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Matsuda R, 2008, PLANT CELL PHYSIOL, V49, P664, DOI 10.1093/pcp/pcn041; Meinen E, 7 INT S LIGHT HORT S, V956; MORGAN DC, 1981, NEW PHYTOL, V88, P239, DOI 10.1111/j.1469-8137.1981.tb01720.x; Munoz-Gutierrez L, 2009, NEW FOREST, V38, P187, DOI 10.1007/s11056-009-9139-6; PALZKILL DA, 1993, J AM OIL CHEM SOC, V70, P1221, DOI 10.1007/BF02564229; Pellicer V, 1998, FOREST ECOL MANAG, V102, P323, DOI 10.1016/S0378-1127(97)00172-2; Potter DJ, 2012, J FORENSIC SCI, V57, P618, DOI 10.1111/j.1556-4029.2011.02024.x; Preece JE, 2003, HORTSCIENCE, V38, P1015, DOI 10.21273/HORTSCI.38.5.1015; Proffitt CE, 2003, ECOL APPL, V13, P180, DOI 10.1890/1051-0761(2003)013[0180:GAEISA]2.0.CO;2; Russo EB, 2007, CHEM BIODIVERS, V4, P1614, DOI 10.1002/cbdv.200790144; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Small E., 2017, CANNABIS SATIVA L BO, DOI [10.1007/978-3-319-54564-6_1, DOI 10.1007/978-3-319-54564-6_1]; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Thorpe TA, 2012, CELL CULTURE SOMATIC, V1, P49; Toonen M, 2006, J FORENSIC SCI, V51, P1050, DOI 10.1111/j.1556-4029.2006.00228.x; Vanhove W, 2011, FORENSIC SCI INT, V212, P158, DOI 10.1016/j.forsciint.2011.06.006; WARRINGTON IJ, 1989, PLANT CELL ENVIRON, V12, P343, DOI 10.1111/j.1365-3040.1989.tb01951.x; Whitelam G.C., 2008, ANN PLANT REV LIGHT	45	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213434	10.1371/journal.pone.0213434	http://dx.doi.org/10.1371/journal.pone.0213434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883573	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500015
J	Ringheim, I; Indahl, A; Roeleveld, K				Ringheim, Inge; Indahl, Aage; Roeleveld, Karin			Reduced muscle activity variability in lumbar extensor muscles during sustained sitting in individuals with chronic low back pain	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; ACTIVATION; TRAPEZIUS; CONTRACTION; ADAPTATION; MANAGEMENT; STRATEGY; FATIGUE; EMG	The purpose of this study was to investigate muscle activity variability within and between the right and left side of lumbar muscles in patients with chronic low back pain (cLBP) compared to healthy controls (HCs) during sustained quiet sitting. Surface electromyographic (EMG) signals were collected bilaterally from the lumbar muscles with 2 high density surface EMG grids of 9x14 electrodes. Root mean square values (RMS) over 1-sec epochs of all bipolar EMG leadings were obtained. Between-sides alternating activation was computed, as well as temporal-and spatial variability within the electrode grids through the coefficient of variation and correlations between RMS distributions. The subjective influence of sitting was evaluated by the rating of perceived exertion and the amount of LBP on a numeric pain rating scale. Compared to HCs, the patients with cLBP had lower temporal (p = 0.03) and similar spatial muscle activity variability during sitting, despite a more variable sitting position. This did not result in increased muscle fatigue indicated by EMG, but the patients with cLBP reported higher levels of RPE during-and more LBP after the sitting and as a consequence ended the sitting earlier than HCs (p < 0.01). Present findings lend support to the presence of less tolerance for low-level static muscle load in patients with cLBP.	[Ringheim, Inge; Roeleveld, Karin] NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway; [Ringheim, Inge; Indahl, Aage] Vestfold Hosp Trust, Clin Phys Med & Rehabil, Stavern, Norway	Norwegian University of Science & Technology (NTNU)	Ringheim, I (corresponding author), NTNU Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway.; Ringheim, I (corresponding author), Vestfold Hosp Trust, Clin Phys Med & Rehabil, Stavern, Norway.	inge.ringheim@siv.no	Roeleveld, Karin/AAD-5943-2021					Abboud J, 2014, EUR J APPL PHYSIOL, V114, P2645, DOI 10.1007/s00421-014-2985-8; Afsharipour B, 2016, J ELECTROMYOGR KINES, V31, P144, DOI 10.1016/j.jelekin.2016.10.003; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Bogduk N, 2005, CLIN ANATOMY LUMBAR, VXII; Cattarello P, 2018, J ELECTROMYOGR KINES, V42, P92, DOI 10.1016/j.jelekin.2018.06.013; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Falla D, 2008, EXP BRAIN RES, V191, P363, DOI 10.1007/s00221-008-1530-6; Falla D, 2008, J ELECTROMYOGR KINES, V18, P255, DOI 10.1016/j.jelekin.2006.11.001; Falla D, 2014, PAIN, V155, P944, DOI 10.1016/j.pain.2014.01.027; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Freddolini M, 2014, J ELECTROMYOGR KINES, V24, P947, DOI 10.1016/j.jelekin.2014.09.009; Geisser ME, 2005, J PAIN, V6, P711, DOI 10.1016/j.jpain.2005.06.008; Geisser ME, 2004, CLIN J PAIN, V20, P61, DOI 10.1097/00002508-200403000-00001; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Holm Sten, 2002, J Electromyogr Kinesiol, V12, P219, DOI 10.1016/S1050-6411(02)00028-7; Holtermann A, 2010, J ELECTROMYOGR KINES, V20, P241, DOI 10.1016/j.jelekin.2009.04.011; Holtermann A, 2011, J ELECTROMYOGR KINES, V21, P519, DOI 10.1016/j.jelekin.2011.01.004; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Indahl A, 1997, SPINE, V22, P2834, DOI 10.1097/00007632-199712150-00006; Indahl A, 1995, SPINE, V20, P2652, DOI 10.1097/00007632-199512150-00006; Indahl A, 1999, J SPINAL DISORD, V12, P325; Jones SL, 2012, J ELECTROMYOGR KINES, V22, P13, DOI 10.1016/j.jelekin.2011.10.006; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Kouzaki M, 2006, J APPL PHYSIOL, V101, P715, DOI 10.1152/japplphysiol.01309.2005; Lamoth CJC, 2006, EUR SPINE J, V15, P23, DOI 10.1007/s00586-004-0825-y; Maher C, 2017, LANCET, V389, P736, DOI 10.1016/S0140-6736(16)30970-9; Mork PJ, 2009, CLIN BIOMECH, V24, P169, DOI 10.1016/j.clinbiomech.2008.11.001; Nairn BC, 2013, J ELECTROMYOGR KINES, V23, P1421, DOI 10.1016/j.jelekin.2013.09.001; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Richmond H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134192; Ringheim I, 2015, GAIT POSTURE, V42, P584, DOI 10.1016/j.gaitpost.2015.09.008; Ringheim I, 2014, J ELECTROMYOGR KINES, V24, P380, DOI 10.1016/j.jelekin.2014.01.011; Schinkel-Ivy A, 2013, J ELECTROMYOGR KINES, V23, P778, DOI 10.1016/j.jelekin.2013.02.001; van der Hulst M, 2010, J ELECTROMYOGR KINES, V20, P31, DOI 10.1016/j.jelekin.2009.03.009; van Dieen JH, 2009, J ELECTROMYOGR KINES, V19, P398, DOI 10.1016/j.jelekin.2007.11.010; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5	37	7	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213778	10.1371/journal.pone.0213778	http://dx.doi.org/10.1371/journal.pone.0213778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870487	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300070
J	Norkaew, T; Brown, JL; Bansiddhi, P; Somgird, C; Thitaram, C; Punyapornwithaya, V; Punturee, K; Vongchan, P; Somboon, N; Khonmee, J				Norkaew, Treepradab; Brown, Janine L.; Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote; Punyapornwithaya, Veerasak; Punturee, Khanittha; Vongchan, Preeyanat; Somboon, Nopphamas; Khonmee, Jaruwan			Influence of season, tourist activities and camp management on body condition, testicular and adrenal steroids, lipid profiles, and metabolic status in captive Asian elephant bulls in Thailand	PLOS ONE			English	Article							LIPOPROTEIN CONCENTRATIONS; NONINVASIVE ASSESSMENT; LOW TESTOSTERONE; FECAL CORTISOL; GLYCEMIC INDEX; ZOO VISITORS; OBESITY; INSULIN; GLUCOSE; BEHAVIOR	We previously found relationships between body condition and physiological function affecting health and welfare of female tourist camp elephants in Thailand, and used that approach to conduct a similar study of bull elephants in the same camps (n = 13). A body condition score (BCS) was done every other month, and fecal glucocorticoid metabolite (FGM) concentrations were measured twice monthly for 1 year. Effects of season, camp management and tourist activity on lipid profiles [total cholesterol (TC), low density lipoproteins (LDL), high density lipoproteins (HDL), triglycerides (TG)] and metabolic factors [insulin, glucose, fructosamine, glucose to insulin ratio (G:I)] were determined and correlated to measures of body condition, testosterone and FGM. Positive correlations were found between BCS and TG, between FGM and TG, HDL and glucose, and between testosterone and HDL, whereas BCS and testosterone were negatively associated with the G:I. There was a significant positive relationship between FGM and testosterone. Elevated FGM concentrations were associated with altered lipid and metabolic profiles and were higher in winter compared to summer and rainy seasons. Insulin and glucose levels were higher, while the G:I was lowest in the winter season. Strong positive associations were found between TC and HDL, LDL and HDL and glucose, and glucose and insulin. By contrast, negative relationships were found between the G:I and HDL and glucose, and between insulin and G:I. Differences also were found between High and Low tourist season months for FGM, insulin, and G:I. Last, there was notable variation among the camps in measured parameters, which together with tourist season effects suggests camp management may affect physiological function and welfare; some negatively like feeding high calorie treats, others positively, like exercise. Last, compared to females, bull elephants appear to be in better physical health based on normal BCSs, lower insulin levels and higher G:I ratios.	[Norkaew, Treepradab; Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote; Khonmee, Jaruwan] Chiang Mai Univ, Fac Vet Med, Ctr Excellence Elephant & Wildlife Res, Chiang Mai, Thailand; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Somgird, Chaleamchat; Thitaram, Chatchote] Chiang Mai Univ, Fac Vet Med, Dept Compan Anim & Wildlife Clin, Chiang Mai, Thailand; [Punyapornwithaya, Veerasak] Chiang Mai Univ, Fac Vet Med, Vet Publ Hlth Ctr Asia Pacific, Chiang Mai, Thailand; [Punturee, Khanittha; Vongchan, Preeyanat] Chiang Mai Univ, Dept Med Technol, Fac Associated Med Sci, Chiang Mai, Thailand; [Somboon, Nopphamas] Chiang Mai Univ, Fac Vet Med, Small Anim Teaching Hosp, Chiang Mai, Thailand; [Khonmee, Jaruwan] Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Publ Hlth, Chiang Mai, Thailand	Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Ctr Excellence Elephant & Wildlife Res, Chiang Mai, Thailand.; Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Publ Hlth, Chiang Mai, Thailand.	jaruwan.khonmee@cmu.ac.th	Punyapornwithaya, Veerasak/ABE-5119-2020; Punyapornwithaya, Verasak/V-9323-2019; Thitaram, Chatchote/AHD-1584-2022	Punyapornwithaya, Verasak/0000-0001-9870-7773; Bansiddhi, Pakkanut/0000-0001-6699-4819; Khonmee, Jaruwan/0000-0002-3806-9746	Faculty of Veterinary Medicine, Chiang Mai University [R000017077]; Center of Excellence in Elephant and Wildlife Research, Chiang Mai University [002/2559]	Faculty of Veterinary Medicine, Chiang Mai University; Center of Excellence in Elephant and Wildlife Research, Chiang Mai University	Faculty of Veterinary Medicine, Chiang Mai University (grant number R000017077) www.vet.cmu.ac.th, Center of Excellence in Elephant and Wildlife Research, Chiang Mai University (grant number 002/2559) www.asianelephantresearch.com.	Akishita M, 2010, HYPERTENS RES, V33, P587, DOI 10.1038/hr.2010.43; Bansiddhi P, 2018, PEERJ, V6, DOI 10.7717/peerj.5996; Bertin FR, 2017, EQUINE VET J, V49, P570, DOI 10.1111/evj.12703; Birke L, 2002, ANIM WELFARE, V11, P189; Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Chapter Boden G., 2015, GLUCOSE INTAKE UTILI, P95; Clark FE, 2012, ZOO BIOL, V31, P306, DOI 10.1002/zoo.20396; Clubb R, 2009, ANIM WELFARE, V18, P237; DANTZER R, 1983, J ANIM SCI, V57, P6, DOI 10.2527/jas1983.5716; Davis N, 2005, APPL ANIM BEHAV SCI, V90, P131, DOI 10.1016/j.applanim.2004.08.020; de Laat MA, 2016, J VET INTERN MED, V30, P1732, DOI 10.1111/jvim.14577; Diaz-Arjonilla M, 2009, INT J IMPOT RES, V21, P89, DOI 10.1038/ijir.2008.42; Donner DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138019; Fowler M, 2008, BIOL MED SURG ELEPHA; Fui MNT, 2014, ASIAN J ANDROL, V16, P223, DOI 10.4103/1008-682X.122365; Goh VHH, 2007, ASIAN J ANDROL, V9, P787, DOI 10.1111/j.1745-7262.2007.00294.x; HAFFNER SM, 1993, J CLIN ENDOCR METAB, V77, P1610, DOI 10.1210/jc.77.6.1610; Haring R, 2011, EUR J CARDIOV PREV R, V18, P86, DOI 10.1097/HJR.0b013e32833c1a8d; Harris DM, 2008, WELFARE HOUSING HUSB; Herbut P, 2012, ANIM SCI PAP REP, V30, P363; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; Garcia AI, 2015, ENDOCRINOL NUTR, V62, P130, DOI 10.1016/j.endonu.2014.11.007; Jeusette IC, 2005, AM J VET RES, V66, P81, DOI 10.2460/ajvr.2005.66.81; Jung HS, 2014, OBESITY, V22, P1880, DOI 10.1002/oby.20751; Kalyani RR, 2013, ENDOCRIN METAB CLIN, V42, P333, DOI 10.1016/j.ecl.2013.02.010; Kelly DM, 2013, J ENDOCRINOL, V217, pR25, DOI 10.1530/JOE-12-0455; Khonmee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091633; Khonmee J, 2014, ANIM REPROD SCI, V146, P70, DOI 10.1016/j.anireprosci.2014.02.008; Kumar V, 2014, GEN COMP ENDOCR, V201, P37, DOI 10.1016/j.ygcen.2014.03.024; Lanktree MB, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P1006, DOI 10.1016/B978-0-12-382227-7.00083-5; Larsen MJ, 2014, APPL ANIM BEHAV SCI, V154, P76, DOI 10.1016/j.applanim.2014.02.005; Lee L, 2012, PEDIATR REV, V33, P459, DOI 10.1542/pir.33-10-459; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Malikhao P, 2017, COMMUN CULT CHANGE A, V3, P127, DOI 10.1007/978-981-10-4125-9_9; Mallapur A, 2002, ZOO BIOL, V21, P585, DOI 10.1002/zoo.10063; Marechal L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155920; Marcilla AM, 2012, GEN COMP ENDOCR, V176, P259, DOI 10.1016/j.ygcen.2012.02.001; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Morfeld KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188701; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Mudron P, 2005, ACTA VET BRNO, V74, P37, DOI 10.2754/avb200574010037; Norkaew T., 2018, THESIS; Norkaew T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204965; Patel R, 2014, MOL ENDOCRINOL, V28, P999, DOI 10.1210/me.2014-1062; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Pena C, 2014, J VET MED SCI, V76, P1305, DOI 10.1292/jvms.13-0475; Pifarre M, 2012, APPL ANIM BEHAV SCI, V136, P57, DOI 10.1016/j.applanim.2011.11.015; Proctor CM, 2015, J ZOO AQUAR RES, V3, P1; R Development Core Team, 2017, R LANG ENV STAT COMP; Rabasa C, 2016, CURR OPIN BEHAV SCI, V9, P71, DOI 10.1016/j.cobeha.2016.01.011; Ralston SL, 2002, VET CLIN N AM-EQUINE, V18, P295, DOI 10.1016/S0749-0739(02)00014-7; Schmidt-Burbach J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139092; Selvin E, 2013, DIABETOLOGIA, V56, P2549, DOI 10.1007/s00125-013-3078-7; Somgird C, 2016, THERIOGENOLOGY, V85, P1225, DOI 10.1016/j.theriogenology.2015.12.003; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Stevens J., 2013, J ZOO AQUAR RES, V1, P31, DOI [10.19227/JZAR.V1I1.20, DOI 10.19227/JZAR.V1I1.20]; Thongtip N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-9; Tong PCY, 2005, J CLIN ENDOCR METAB, V90, P6418, DOI 10.1210/jc.2005-0228; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; van der Kolk JH, 2011, VET QUART, V31, P99, DOI 10.1080/01652176.2011.585793; Van Pottelbergh I, 2003, ATHEROSCLEROSIS, V166, P95, DOI 10.1016/S0021-9150(02)00308-8; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Watson R, 2013, GEN COMP ENDOCR, V186, P16, DOI 10.1016/j.ygcen.2013.02.001; WATSON TDG, 1990, VET REC, V127, P498; Weerasinghe D, 2017, ATHEROSCLEROSIS, V263, pE267, DOI 10.1016/j.atherosclerosis.2017.06.862; Wells DL, 2005, APPL ANIM BEHAV SCI, V93, P13, DOI 10.1016/j.applanim.2005.06.019; WOO J, 1992, CLIN CHEM, V38, P2190; Yamka R. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P282; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	73	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0210537	10.1371/journal.pone.0210537	http://dx.doi.org/10.1371/journal.pone.0210537			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865634	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900006
J	Rabiger, FV; Bismarck, D; Protschka, M; Kohler, G; Moore, PF; Buttner, M; von Buttlar, H; Alber, G; Eschke, M				Rabiger, Friederike V.; Bismarck, Doris; Protschka, Martina; Koehler, Gabriele; Moore, Peter F.; Buettner, Mathias; von Buttlar, Heiner; Alber, Gottfried; Eschke, Maria			Canine tissue-associated CD4(+)CD8 alpha(+) double-positive T cells are an activated T cell subpopulation with heterogeneous functional potential	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; PERIPHERAL-BLOOD; INTRAEPITHELIAL LYMPHOCYTES; CD4(+); EXPRESSION; FOXP3; CD8-ALPHA-ALPHA; PURIFICATION; CORECEPTOR; ANTIBODIES	Canine CD4(+)CD8 alpha(+) double-positive (dp) T cells of peripheral blood are a unique effector memory T cell subpopulation characterized by an increased expression of activation markers in comparison with conventional CD4(+) or CD8 alpha(+) single-positive (sp) T cells. In this study, we investigated CD4(+)CD8 alpha(+) dp T cells in secondary lymphatic organs (i.e. mesenteric and tracheobronchial lymph nodes, spleen, Peyer's patches) and non-lymphatic tissues (i.e. lung and epithelium of the small intestine) within a homogeneous group of healthy Beagle dogs by multi-color flow cytometry. The aim of this systematic analysis was to identify the tissue-specific localization and characteristics of this distinct T cell subpopulation. Our results revealed a mature extrathymic CD1a(-)CD4(+)CD8 alpha(+) dp T cell population in all analyzed organs, with highest frequencies within Peyer's patches. Constitutive expression of the activation marker CD25 is a feature of many CD4(+)CD8 alpha(+) dp T cells independent of their localization and points to an effector phenotype. A proportion of lymph node CD4(+)CD8 alpha(+) dp T cells is FoxP3(+) indicating regulatory potential. Within the intestinal environment, the cytotoxic marker granzyme B is expressed by CD4(+)CD8 alpha(+) dp intraepithelial lymphocytes. In addition, a fraction of CD4(+)CD8 alpha(+) dp intraepithelial lymphocytes and of mesenteric lymph node CD4(+)CD8 alpha(+) dp T cells is TCR gamma delta(+). However, the main T cell receptor of all tissue-associated CD4(+)CD8 alpha(+) dp T cells could be identified as TCR alpha beta. Interestingly, the majority of the CD4(+)CD8 alpha(+) dp T cell subpopulation expresses the unconventional CD8 alpha alpha homodimer, in contrast to CD8 alpha(+) sp T cells, and CD4(+)CD8 alpha+ dp thymocytes which are mainly CD8 alpha beta(+). The presented data provide the basis for a functional analysis of tissue-specific CD4(+)CD8 alpha(+) dp T cells to elucidate their role in health and disease of dogs.	[Rabiger, Friederike V.; Bismarck, Doris; Protschka, Martina; Buettner, Mathias; von Buttlar, Heiner; Alber, Gottfried; Eschke, Maria] Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, Leipzig, Germany; [Koehler, Gabriele] Klinikum Fulda gAG, Inst Pathol, Fulda, Germany; [Moore, Peter F.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bismarck, Doris] Laboklin GmbH & Co KG, Bad Kissingen, Germany; [von Buttlar, Heiner] Bundeswehr Inst Microbiol, Munich, Germany	Leipzig University; Klinikum Fulda; University of California System; University of California Davis; LABOKLIN GmbH & Co. KG; Bundeswehr Institute of Microbiology (IMB)	Alber, G (corresponding author), Univ Leipzig, Coll Vet Med, Ctr Biotechnol & Biomed, Inst Immunol Mol Pathogenesis, Leipzig, Germany.	alber@rz.uni-leipzig.de		von Buttlar, Heiner/0000-0003-4373-0823; Alber, Gottfried/0000-0001-7475-4858	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL 371/8-3]; Foundation of German Business (Stiftung der Deutschen Wirtschaft, sdw)	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Foundation of German Business (Stiftung der Deutschen Wirtschaft, sdw)	This study was supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), AL 371/8-3, http://www.dfg.de/, to GA; and a doctoral stipend from the Foundation of German Business (Stiftung der Deutschen Wirtschaft, sdw), https://www.sdw.org/, to FR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1998, EUR J GASTROEN HEPAT, V10, P325, DOI 10.1097/00042737-199804000-00009; Akari H, 1997, INT IMMUNOL, V9, P591, DOI 10.1093/intimm/9.4.591; Alexandre-Pires G, 2010, VET IMMUNOL IMMUNOP, V137, P275, DOI 10.1016/j.vetimm.2010.06.007; Aranda R, 1997, J IMMUNOL, V158, P3464; Bang K, 2001, BRIT J DERMATOL, V144, P1140, DOI 10.1046/j.1365-2133.2001.04223.x; Bismarck D, 2014, VET IMMUNOL IMMUNOP, V162, P72, DOI 10.1016/j.vetimm.2014.09.008; Bismarck D, 2012, VET IMMUNOL IMMUNOP, V149, P157, DOI 10.1016/j.vetimm.2012.06.014; BLUE ML, 1986, J IMMUNOL, V137, P1202; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Chizzolini C, 2003, ARTHRITIS RHEUM-US, V48, P2593, DOI 10.1002/art.11129; Das G, 2003, P NATL ACAD SCI USA, V100, P5324, DOI 10.1073/pnas.0831037100; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; He YW, 1997, J IMMUNOL, V158, P2592; Hillemeyer P, 2002, CELL IMMUNOL, V215, P173, DOI 10.1016/S0008-8749(02)00024-2; Hoshino Y, 2008, J VET MED SCI, V70, P581, DOI 10.1292/jvms.70.581; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Junginger J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-23; Kaser T, 2008, VET IMMUNOL IMMUNOP, V125, P92, DOI 10.1016/j.vetimm.2008.05.007; Kato M, 2007, J VET MED SCI, V69, P481, DOI 10.1292/jvms.69.481; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kitchen SG, 2004, P NATL ACAD SCI USA, V101, P8727, DOI 10.1073/pnas.0401500101; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; Luckschander N, 2009, VET RES, V40, DOI 10.1051/vetres/2009042; Luhtala M, 1997, EUR J IMMUNOL, V27, P189, DOI 10.1002/eji.1830270128; Mayassi T, 2018, MUCOSAL IMMUNOL, V11, P1281, DOI 10.1038/s41385-018-0016-5; McGill JL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01585; McNicol AM, 2007, EUR J IMMUNOL, V37, P1634, DOI 10.1002/eji.200636900; Mizuno T, 2009, J VET MED SCI, V71, P1561, DOI 10.1292/jvms.001561; MORRISSEY PJ, 1995, J IMMUNOL, V154, P2678; MOSLEY RL, 1990, INT IMMUNOL, V2, P361, DOI 10.1093/intimm/2.4.361; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Olivares-Villagomez D, 2018, TRENDS IMMUNOL, V39, P264, DOI 10.1016/j.it.2017.11.003; Oliveira LD, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/3067126; Otani I, 2008, J VET MED SCI, V70, P285, DOI 10.1292/jvms.70.285; Overgaard NH, 2015, J LEUKOCYTE BIOL, V97, P31, DOI 10.1189/jlb.1RU0814-382; PESCOVITZ MD, 1985, J IMMUNOL, V134, P37; Reboldi A, 2016, IMMUNOL REV, V271, P230, DOI 10.1111/imr.12400; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; Rothe K, 2017, VET IMMUNOL IMMUNOP, V185, P48, DOI 10.1016/j.vetimm.2017.01.005; Rutgen BC, 2015, VET CLIN PATH, V44, P58, DOI 10.1111/vcp.12221; SAALMULLER A, 1987, EUR J IMMUNOL, V17, P1297, DOI 10.1002/eji.1830170912; Sarrabayrouse G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001833; Schutze N, 2009, VET MICROBIOL, V137, P260, DOI 10.1016/j.vetmic.2009.01.035; Sinkora M, 2000, J IMMUNOL, V165, P1832, DOI 10.4049/jimmunol.165.4.1832; Solano-Aguilar GI, 2000, J IMMUNOL METHODS, V241, P185, DOI 10.1016/S0022-1759(00)00209-X; Sonea IM, 2000, VET IMMUNOL IMMUNOP, V77, P103, DOI 10.1016/S0165-2427(00)00230-0; Spolski R, 2018, NAT REV IMMUNOL, V18, P648, DOI 10.1038/s41577-018-0046-y; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Takeuchi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00194; TAKIMOTO H, 1992, EUR J IMMUNOL, V22, P159, DOI 10.1002/eji.1830220124; Van Kaer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067821; Zuckermann FA, 1999, VET IMMUNOL IMMUNOP, V72, P55, DOI 10.1016/S0165-2427(99)00118-X; Zuckermann FA, 1996, IMMUNOLOGY, V87, P493, DOI 10.1046/j.1365-2567.1996.494570.x	58	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213597	10.1371/journal.pone.0213597	http://dx.doi.org/10.1371/journal.pone.0213597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865691	gold, Green Submitted, Green Published			2022-12-26	WOS:000461048900076
J	Wood, NH; Ayo-Yusuf, OA; Gugushe, TS; Bogers, JP				Wood, Neil H.; Ayo-Yusuf, Olalekan A.; Gugushe, Tshepo S.; Bogers, John-Paul			Tobacco use and oral sex practice among dental clinic attendees	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; GENOTYPE DISTRIBUTION; HETEROSEXUAL COUPLES; HPV INFECTION; RISK-FACTORS; NECK-CANCER; HEAD; PREVALENCE; WOMEN	Tobacco use and oral sex (OS) are important risk factors for oral and oropharyngeal Human papillomavirus (HPV) infection. Little is known about the prevalence of OS practice in South Africa. This study aimed to determine the prevalence of OS practice and tobacco use in a South African patient population. This cross-sectional study used a structured questionnaire to collect socio-demographic characteristics, tobacco use, betel nut use and OS practice data from consenting adults (>= 18 years; n = 850). Oral sex practices were recorded for patients 18-45 years-old (n = 514). Data analysis included chi-square and multiple logistic regression analyses. Of the study population, 55.2% (n = 468) were female, 88% (n = 748) self-identified as black Africans and 45.1% (n = 383) were unemployed. Furthermore, 19.7% (n = 167), 6.4% (n = 54) and 2.1% (n = 18) were current smokers, snuff users and betel nut users, respectively. Out of the 514 who answered the questionnaire in relation to OS, 22.8% (n = 115) reported to practice it. Oral sex practice in the age group 18-45 years was most common among the self-identified white participants (41.9%); and among tobacco users than among non-tobacco users (30.9% vs. 20.5%; p = 0.022). A multivariable-adjusted regression model showed that white South Africans were more likely to use tobacco than black Africans (OR = 5.25; 95% CI = 2.21-12.47). The practice of OS was more likely among those 18-35 years-old (OR = 1.67; 95% CI = 1.01-2.74), but had no significant association with tobacco use (OR = 1.06; 95% CI = 0.62-1.83). The observed age and ethnic differences in both risk behaviours suggest a need for targeted population intervention in order to reduce the risk for oral HPV infection.	[Wood, Neil H.] Sefako Makgatho Hlth Sci Univ, Sch Oral Hlth Sci, Dept Periodontol & Oral Med, Pretoria, South Africa; [Ayo-Yusuf, Olalekan A.] Sefako Makgatho Hlth Sci Univ, Africa Ctr Tobacco Ind Monitoring & Policy Res, Pretoria, South Africa; [Gugushe, Tshepo S.] Sefako Makgatho Hlth Sci Univ, Sch Oral Hlth Sci, Pretoria, South Africa; [Bogers, John-Paul] Univ Antwerp, Appl Mol Biol Res Grp AMBIOR, Fac Med & Hlth Sci, Antwerp, Belgium; [Bogers, John-Paul] Lab Cell Biol & Histol, Antwerp, Belgium	Sefako Makgatho Health Sciences University; Sefako Makgatho Health Sciences University; Sefako Makgatho Health Sciences University; University of Antwerp	Wood, NH (corresponding author), Sefako Makgatho Hlth Sci Univ, Sch Oral Hlth Sci, Dept Periodontol & Oral Med, Pretoria, South Africa.	neil.wood@smu.ac.za	Ayo-Yusuf, Olalekan/A-1512-2008	Ayo-Yusuf, Olalekan/0000-0003-0689-7018; Wood, Neil/0000-0001-8950-7999				Ayo-Yusuf O A, 2013, SADJ, V68, P168; D'Souza G, 2017, ANN ONCOL, V28, P3065, DOI 10.1093/annonc/mdx535; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Davidson CL, 2014, SAMJ S AFR MED J, V104, P358, DOI [10.7196/SAMJ.7542, 10.7196/samj.7542]; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Fakhry C, 2014, JAMA-J AM MED ASSOC, V312, P1465, DOI 10.1001/jama.2014.13183; Farsi NJ, 2015, CANCER EPIDEMIOL, V39, P1036, DOI 10.1016/j.canep.2015.08.010; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Giuliano AR, 2002, CANCER CAUSE CONTROL, V13, P839, DOI 10.1023/A:1020668232219; Gupta A, 2019, ORAL DIS, V25, P609, DOI 10.1111/odi.12997; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; International Agency for Research on Cancer (IARC), 1986, IARC MONOGR EVAL CAR, V38; Jelihovschi I, 2015, MED-SURG J, V119, P502; JOHNSON EH, 1994, J NATL MED ASSOC, V86, P745; Johnson N, 2001, J Dent Educ, V65, P328; Kero K, 2012, EUR UROL, V62, P1063, DOI 10.1016/j.eururo.2012.06.045; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Ma QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067092; Marais DJ, 2008, J MED VIROL, V80, P953, DOI 10.1002/jmv.21166; Mbulawa ZZA, 2014, J INFECTION, V68, P185, DOI 10.1016/j.jinf.2013.10.012; Mbulawa ZZA, 2013, J INFECTION, V67, P51, DOI 10.1016/j.jinf.2013.03.009; Mbulawa ZZA, 2009, J INFECT DIS, V199, P1514, DOI 10.1086/598220; Paquette C, 2013, HEAD NECK PATHOL, V7, P361, DOI 10.1007/s12105-013-0453-0; Peer N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19216; Peer N, 2009, SAMJ S AFR MED J, V99, P744; Petti S, 2009, ORAL ONCOL, V45, P340, DOI 10.1016/j.oraloncology.2008.05.018; Reddy P, 2015, SAMJ S AFR MED J, V105, P648, DOI [10.7196/SAMJnew.7932, 10.7196/SAMJNEW.7932]; Richter KL, 2008, J ORAL PATHOL MED, V37, P555, DOI 10.1111/j.1600-0714.2008.00670.x; Rintala M, 2006, J CLIN VIROL, V35, P89, DOI 10.1016/j.jcv.2005.05.012; Sela Y, 2015, PERS INDIV DIFFER, V73, P61, DOI 10.1016/j.paid.2014.09.020; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Smith EM, 2012, J ONCOL, V2012, DOI 10.1155/2012/571862; Stanley M, 2007, GYNECOL ONCOL, V107, pS19, DOI 10.1016/j.ygyno.2007.07.068; Syrjanen S, 2007, NEW ENGL J MED, V356, P1993, DOI 10.1056/NEJMe078004; Upile T, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-31; van der Waal I, 2010, ORAL ONCOL, V46, P423, DOI 10.1016/j.oraloncology.2010.02.016; Vannier SA, 2013, ARCH SEX BEHAV, V42, P1573, DOI 10.1007/s10508-013-0130-0; Vannier SA, 2012, J YOUTH ADOLESCENCE, V41, P572, DOI 10.1007/s10964-012-9745-z; Vogt SL, 2013, FRONT ONCOL, V3, P1, DOI [DOI 10.3389/FONC.2013.00001, 10.3389/fonc.2013.00001]; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213729	10.1371/journal.pone.0213729	http://dx.doi.org/10.1371/journal.pone.0213729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865709	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900088
J	Yamamura, A; Nayeem, MJ; Al Mamun, A; Takahashi, R; Hayashi, H; Sato, M				Yamamura, Aya; Nayeem, Md Junayed; Al Mamun, Abdullah; Takahashi, Rie; Hayashi, Hisaki; Sato, Motohiko			Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension	FASEB JOURNAL			English	Article						imatinib; NPS2143; pulmonary hypertension; STAT1; 3; vascular remodeling	SMOOTH-MUSCLE-CELLS; ION CHANNELS; SILDENAFIL; EXPRESSION; CA2+; ANTIPROLIFERATION; ACTIVATION; STRATEGIES; TARGETS; LUNG	Pulmonary arterial hypertension (PAH) is a progressive and fatal disease associated with remodeling of the pulmonary artery. We previously reported that the Ca2+-sensing receptor (CaSR) is up-regulated in pulmonary arterial smooth muscle cells (PASMCs) from patients with idiopathic PAH (IPAH) and contributes to enhanced Ca2+ responses and excessive cell proliferation. However, the mechanisms underlying the up-regulation of CaSR have not yet been elucidated. We herein examined involvement of platelet-derived growth factor (PDGF) on CaSR expression, Ca2+ responses, and proliferation in PASMCs. The expression of PDGF receptors was higher in PASMCs from patients with IPAH than in PASMCs from normal subjects. In addition, PDGF-induced activation of PDGF receptors and their downstream molecules [ERK1/2, p38, protein kinase B, and signal transducer and activator of transcription (STAT) 1/3] were sustained longer in PASMCs from patients with IPAH. The PDGF-induced CaSR up-regulation was attenuated by small interfering RNA knockdown of PDGF receptors and STAT1/3, and by the treatment with imatinib. In monocrotaline-induced pulmonary hypertensive rats, the up-regulation of CaSR was reduced by imatinib. The combination of NPS2143 and imatinib additively inhibited the development of pulmonary hypertension. These results suggest that enhanced PDGF signaling is involved in CaSR up-regulation, leading to excessive PASMC proliferation and vascular remodeling in patients with IPAH. The linkage between CaSR and PDGF signals is a novel pathophysiological mechanism contributing to the development of PAH.-Yamamura, A., Nayeem, M. J., Al Mamun, A., Takahashi, R., Hayashi, H., Sato, M. Platelet-derived growth factor up-regulates Ca2+-sensing receptors in idiopathic pulmonary arterial hypertension.	[Yamamura, Aya; Nayeem, Md Junayed; Al Mamun, Abdullah; Takahashi, Rie; Hayashi, Hisaki; Sato, Motohiko] Aichi Med Univ, Dept Physiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan	Aichi Medical University	Yamamura, A; Sato, M (corresponding author), Aichi Med Univ, Dept Physiol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	ayamamur@aichi-med-u.ac.jp; motosato@aichi-med-u.ac.jp	Mamun, Abdullah/HHM-9898-2022	Al Mamun, Md. Abdullah/0000-0003-3839-9603	Japan Society for the Promotion of Science [17K08320]; YOKOYAMA Foundation for Clinical Pharmacology [YRY-1710]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); YOKOYAMA Foundation for Clinical Pharmacology(Yokoyama Foundation for Clinical Pharmacology)	The authors thank Dr. Jason X.-J. Yuan (University of Arizona, Tucson, AZ, USA) for providing pulmonary arterial smooth muscle cell lines from patients with idiopathic pulmonary arterial hypertension. The authors also thank Dr. Hisao Yamamura (Nagoya City University, Nagoya, Japan) for valuable comments. This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (17K08320; to A.Y.). This investigation was also supported by a grant-in-aid from the YOKOYAMA Foundation for Clinical Pharmacology (YRY-1710; to A.Y.). The authors declare no conflicts of interest.	Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Chiarini A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00134; Ciuclan L, 2013, AM J RESP CRIT CARE, V187, P78, DOI 10.1164/rccm.201206-1028OC; Dahal Bhola K, 2011, Pulm Circ, V1, P259, DOI 10.4103/2045-8932.83448; Frumkin LR, 2012, PHARMACOL REV, V64, P583, DOI 10.1124/pr.111.005587; Guibert C, 2007, CURR PHARM DESIGN, V13, P2443; Hendy GN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00394; Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Kunichika N, 2004, AM J RESP CRIT CARE, V170, P1101, DOI 10.1164/rccm.200312-1668OC; Li B, 2007, ANESTH ANALG, V105, P1034, DOI 10.1213/01.ane.0000278736.81133.26; Lythgoe MP, 2016, PHARMACOL THERAPEUT, V164, P195, DOI 10.1016/j.pharmthera.2016.04.012; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540; Montani D, 2014, PHARMACOL THERAPEUT, V141, P172, DOI 10.1016/j.pharmthera.2013.10.002; Montani D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-97; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Nakamura K, 2012, INT J CARDIOL, V159, P100, DOI 10.1016/j.ijcard.2011.02.024; Noskovicova N, 2015, AM J RESP CELL MOL, V52, P263, DOI 10.1165/rcmb.2014-0294TR; Ogawa A, 2012, AM J PHYSIOL-CELL PH, V302, pC405, DOI 10.1152/ajpcell.00337.2011; Olschewski A, 2014, PHARMACOL THERAPEUT, V144, P349, DOI 10.1016/j.pharmthera.2014.08.001; Pankey EA, 2013, AM J PHYSIOL-HEART C, V305, pH1288, DOI 10.1152/ajpheart.00329.2013; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Selimovic N, 2009, EUR RESPIR J, V34, P662, DOI 10.1183/09031936.00174908; Tang HY, 2016, AM J PHYSIOL-LUNG C, V310, pL846, DOI 10.1152/ajplung.00050.2016; Tantini B, 2005, BASIC RES CARDIOL, V100, P131, DOI 10.1007/s00395-004-0504-5; ten Freyhaus H, 2015, ARTERIOSCL THROM VAS, V35, P1236, DOI 10.1161/ATVBAHA.114.304864; Tu L, 2013, HANDB EXP PHARMACOL, V218, P409, DOI 10.1007/978-3-642-38664-0_17; Yamamura A, 2017, EUR J PHARMACOL, V810, P44, DOI 10.1016/j.ejphar.2017.06.010; Yamamura A, 2016, EUR J PHARMACOL, V784, P15, DOI 10.1016/j.ejphar.2016.04.059; Yamamura A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138384; Yamamura A, 2013, CIRC RES, V112, P640, DOI 10.1161/CIRCRESAHA.113.300897; Yamamura A, 2012, CIRC RES, V111, P469, DOI 10.1161/CIRCRESAHA.112.266361; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400	40	16	21	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7363	7374		10.1096/fj.201802620R	http://dx.doi.org/10.1096/fj.201802620R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865840	Bronze			2022-12-26	WOS:000476114200056
J	Shanbhogue, P; Hoffmann, RM; Airola, MV; Maini, R; Hamelin, DJ; Garcia-Diaz, M; Burke, JE; Hannun, YA				Shanbhogue, Prajna; Hoffmann, Reece M.; Airola, Michael V.; Maini, Rohan; Hamelin, David J.; Garcia-Diaz, Miguel; Burke, John E.; Hannun, Yusuf A.			The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; enzyme mechanism; lipid; sphingolipid; sphingomyelinase	NECROSIS-FACTOR-ALPHA; AMYLOID-BETA; CERAMIDE; MECHANISM; NSMASE2; PROTEIN; IDENTIFICATION; STRESS; PREDICTION; SECRETION	Neutral sphingomyelinase 2 (nSMase2) produces the bioactive lipid ceramide and has important roles in neurodegeneration, cancer, and exosome formation. Although nSMase2 has low basal activity, it is fully activated by phosphatidylserine (PS). Previous work showed that interdomain interactions within nSMase2 are needed for PS activation. Here, we use multiple approaches, including small angle X-ray scattering, hydrogen-deuterium exchange-MS, circular dichroism and thermal shift assays, and membrane yeast two-hybrid assays, to define the mechanism mediating this interdomain interactions within nSMase2. In contrast to what we previously assumed, we demonstrate that PS binding at the N-terminal and juxtamembrane regions of nSMase2 rather acts as a conformational switch leading to interdomain interactions that are critical to enzyme activation. Our work assigns a unique function for a class of linkers of lipid-activated, membrane-associated proteins. It indicates that the linker actively participates in the activation mechanism via intramolecular interactions, unlike the canonical linkers that typically aid protein dimerization or localization.	[Shanbhogue, Prajna; Airola, Michael V.; Maini, Rohan; Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Garcia-Diaz, Miguel; Hannun, Yusuf A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Shanbhogue, Prajna; Hannun, Yusuf A.] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Hoffmann, Reece M.; Hamelin, David J.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8N 1A1, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Victoria	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Burke, John/H-3922-2019; Shanbhogue, Prajna/ABB-6599-2021	Burke, John/0000-0001-7904-9859; Hamelin, David/0000-0001-8201-0664; Airola, Michael/0000-0003-4981-1253	NIGMS, National Institutes of Health [P41 GM111244]; Department of Energy Office of Biological and Environmental Research [KP1605010]; National Institutes of Health [S10 OD012331]; Department of Energy Office of Science [DE-SC0012704]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100021, P41GM111244, R35GM118128, R35GM128666] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We also thank Dr. Lin Yang and Dr. Shirish Chodankar at Brookhaven National Lab National Synchrotron Light Source II for their help with SAXS data collection and data processing. The LiX Beamline is part of the Life Science Biomedical Technology Research resource, jointly supported by the NIGMS, National Institutes of Health under Grant P41 GM111244 and by the Department of Energy Office of Biological and Environmental Research under Grant KP1605010, with additional support from National Institutes of Health Grant S10 OD012331. National Synchrotron Light Source II is a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Brookhaven National Laboratory under Contract DE-SC0012704. We would also like to thank Dr. Erwin London for help with circular dichroism data collection and analysis. We thank Dr. Lina Marie Obeid and Dr. Chiara Luberto for helpful discussions and feedback.	Airola MV, 2017, P NATL ACAD SCI USA, V114, pE5549, DOI 10.1073/pnas.1705134114; Chaube R, 2012, BBA-MOL CELL BIOL L, V1821, P313, DOI 10.1016/j.bbalip.2011.10.015; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; de Andrade SA, 2005, BIOCHEM BIOPH RES CO, V327, P117, DOI 10.1016/j.bbrc.2004.11.146; Dornan GL, 2018, J MOL BIOL, V430, P3129, DOI 10.1016/j.jmb.2018.07.020; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Gorelik A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12196; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Horres CR, 2012, NEUROCHEM RES, V37, P1137, DOI 10.1007/s11064-011-0692-y; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kolmakova A, 2004, ARTERIOSCL THROM VAS, V24, P264, DOI 10.1161/01.ATV.0000112036.72200.ac; Kong JN, 2015, INT J CANCER, V137, P1610, DOI 10.1002/ijc.29542; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lu B, 2014, J BIOL CHEM, V289, P22161, DOI 10.1074/jbc.M114.569327; Lucic I, 2018, P NATL ACAD SCI USA, V115, pE3940, DOI 10.1073/pnas.1716109115; Matsuda I, 2000, BIOCHEM BIOPH RES CO, V275, P565, DOI 10.1006/bbrc.2000.3351; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; Sagy-Bross C, 2013, NEUROCHEM INT, V63, P541, DOI 10.1016/j.neuint.2013.09.007; Shamseddine AA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.268; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Shanbhogue P, 2020, HANDB EXP PHARMACOL, V259, P19, DOI 10.1007/164_2018_179; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Wu BX, 2011, J BIOL CHEM, V286, P22362, DOI 10.1074/jbc.M110.156471; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	43	11	11	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7488	7502		10.1074/jbc.RA118.007288	http://dx.doi.org/10.1074/jbc.RA118.007288			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30890560	Green Published, hybrid			2022-12-26	WOS:000468402900032
J	Abd Rahim, MS; Cherniayskyi, YK; Tieleman, DP; Dames, SA				Abd Rahim, Munirah S.; Cherniayskyi, Yevhen K.; Tieleman, D. Peter; Dames, Sonja A.			NMR- and MD simulation-based structural characterization of the membrane-associating FATC domain of ataxia telangiectasia mutated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase; membrane; nuclear magnetic resonance (NMR); molecular dynamics (MD) simulation; signal transduction; ataxia telangiectasia mutated; phosphatidylinositol 3-kinase-related kinase; protein membrane interactions; signaling at membranes; structural dynamics; FATC domain; solution structure	PHOSPHATIDYLINOSITOL 3-KINASE-RELATED KINASES; PARTICLE MESH EWALD; ATM PROTEIN-KINASE; CELLULAR-RESPONSE; GENE-PRODUCT; DNA-PKCS; RAPAMYCIN; TARGET; PEPTIDES; ACTIVATION	The Ser/Thr protein kinase ataxia telangiectasia mutated (ATM) plays an important role in the DNA damage response, signaling in response to redox signals, the control of metabolic processes, and mitochondrial homeostasis. ATM localizes to the nucleus and at the plasma membrane, mitochondria, peroxisomes, and other cytoplasmic vesicular structures. It has been shown that the C-terminal FATC domain of human ATM (hATMfatc) can interact with a range of membrane mimetics and may thereby act as a membrane-anchoring unit. Here, NMR structural and N-15 relaxation data, NMR data using spin-labeled micelles, and MD simulations of micelle-associated hATMfatc revealed that it binds the micelle by a dynamic assembly of three helices with many residues of hATMfatc located in the headgroup region. We observed that none of the three helices penetrates the micelle deeply or makes significant tertiary contacts to the other helices. NMR-monitored interaction experiments with hATMfatc variants in which two conserved aromatic residues (Phe(3049) and Trp(3052)) were either individually or both replaced by alanine disclosed that the double substitution does not abrogate the interaction with micelles and bicelles at the high concentrations at which these aggregates are typically used, but impairs interactions with small unilamellar vesicles, usually used at much lower lipid concentrations and considered a better mimetic for natural membranes. We conclude that the observed dynamic structure of micelle-associated hATMfatc may enable it to interact with differently composed membranes or membrane-associated interaction partners and thereby regulate ATM's kinase activity. Moreover, the FATC domain of ATM may function as a membrane-anchoring unit for other biomolecules.	[Abd Rahim, Munirah S.; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany; [Cherniayskyi, Yevhen K.; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cherniayskyi, Yevhen K.; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Dames, Sonja A.] Helmholtz Zentrum Munchen, Inst Struct Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Technical University of Munich; University of Calgary; University of Calgary; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de	Abd Rahim, Munirah Sufiyah/GZL-3432-2022	Abd Rahim, Munirah Sufiyah/0000-0003-4027-0817; Dames, Sonja/0000-0001-7495-6943	German Research Foundation [DA 1195/3-2]; Canada Research Chairs program; German Academic Exchange Service (DAAD); Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation; Natural Sciences and Engineering Research Council of Canada; Technische Universitat Munchen (TUM) diversity and talent management office Laura-Bassi award; Helmholtz portfolio theme "metabolic dysfunction and common disease" of the Helmholtz Zentrum Munchen	German Research Foundation(German Research Foundation (DFG)); Canada Research Chairs program(Canada Research Chairs); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Technische Universitat Munchen (TUM) diversity and talent management office Laura-Bassi award; Helmholtz portfolio theme "metabolic dysfunction and common disease" of the Helmholtz Zentrum Munchen	This work was supported by German Research Foundation Grant DA 1195/3-2 (to S. A. D.). This work was undertaken, in part, with the support of funding from the Canada Research Chairs program. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a German Academic Exchange Service (DAAD) Ph.D. stipend.; The Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation. Work in this author's group was supported by the Natural Sciences and Engineering Research Council of Canada.; Supported by the Technische Universitat Munchen (TUM) diversity and talent management office Laura-Bassi award and the Helmholtz portfolio theme "metabolic dysfunction and common disease" of the Helmholtz Zentrum Munchen.	Abd Rahim MS, 2018, BIOMOL NMR ASSIGN, V12, P149, DOI 10.1007/s12104-018-9798-3; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baretic D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700933; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Camargo DCR, 2012, BIOCHEMISTRY-US, V51, P4909, DOI 10.1021/bi3002133; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Cremona CA, 2014, ONCOGENE, V33, P3351, DOI 10.1038/onc.2013.275; Czarny P, 2015, INT J MOL SCI, V16, P2641, DOI 10.3390/ijms16022641; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404; Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Cicco M, 2018, PROTEIN SCI, V27, P546, DOI 10.1002/pro.3321; De Cicco M, 2015, MEMBRANES, V5, P553, DOI 10.3390/membranes5040553; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoke SMT, 2010, CURR GENET, V56, P447, DOI 10.1007/s00294-010-0313-3; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau WCY, 2016, CELL CYCLE, V15, P1117, DOI 10.1080/15384101.2016.1158362; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lin CM, 2012, LANGMUIR, V28, P689, DOI 10.1021/la203755v; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Llorca O, 2003, ONCOGENE, V22, P3867, DOI 10.1038/sj.onc.1206649; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Luchette PA, 2001, BBA-BIOMEMBRANES, V1513, P83, DOI 10.1016/S0005-2736(01)00358-3; Ma YX, 2018, BBA-MOL CELL RES, V1865, P1293, DOI 10.1016/j.bbamcr.2018.06.011; Marinoglou Konstantina, 2012, Yale Journal of Biology and Medicine, V85, P469; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Myers GA, 2012, J AM CHEM SOC, V134, P19652, DOI 10.1021/ja306074k; Pancholi NJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0269; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Quek H, 2018, IMMUNOL CELL BIOL, V96, P8, DOI 10.1111/imcb.1001; Sawicka M, 2016, J BIOL CHEM, V291, P13436, DOI 10.1074/jbc.M115.708263; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen CX, 2013, P NATL ACAD SCI USA, V110, P11869, DOI 10.1073/pnas.1220898110; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Sommer LAM, 2014, J PHYS CHEM B, V118, P4817, DOI 10.1021/jp501533d; Sommer LAM, 2014, FEBS LETT, V588, P1755, DOI 10.1016/j.febslet.2014.03.031; Sommer LAM, 2013, J BIOL CHEM, V288, P20046, DOI 10.1074/jbc.M113.467233; Sommer LAM, 2012, PROTEIN SCI, V21, P1566, DOI 10.1002/pro.2127; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11655; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Weschayanwiwat P, 2005, J SURFACTANTS DETERG, V8, P65, DOI 10.1007/s11743-005-0332-8; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yagi H, 2010, J BIOMOL NMR, V47, P143, DOI 10.1007/s10858-010-9416-x; Yan J, 2000, INT J RADIAT BIOL, V76, P1025, DOI 10.1080/09553000050111497; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017	86	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7098	7112		10.1074/jbc.RA119.007653	http://dx.doi.org/10.1074/jbc.RA119.007653			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30867195	Green Published, hybrid			2022-12-26	WOS:000467394700040
J	Bell, SY; Fraser, MW; Statton, J; Kendrick, GA				Bell, Sahira Y.; Fraser, Matthew W.; Statton, John; Kendrick, Gary A.			Salinity stress drives herbivory rates and selective grazing in subtidal seagrass communities	PLOS ONE			English	Article							TURTLEGRASS THALASSIA-TESTUDINUM; ANTARCTICA LABILL SONDER; SHARK BAY; FISH ASSEMBLAGES; WESTERN-AUSTRALIA; CONSUMPTION; TEMPERATE; PLANT; TROPICALIZATION; PHOSPHORUS	The role of environmental-stress gradients in driving trophic processes like grazing, has potential to shape ecosystem responses to environmental change. In subtidal seagrass systems, however, the variation in top-down processes along stress gradients are poorly understood. We deployed herbivory assays using the five most common seagrass species of Shark Bay, to determine whether herbivory pressure changed across a salinity-stress gradient from oceanic (38 PSU) to hyper-saline (51 PSU) conditions. Seagrass tissue removed from herbivory assays by fishes decreased as environmental stress increased, and herbivores consumed greater amounts of tropical seagrass species compared to the temperate species that dominate seagrass cover in Shark Bay. This heightened consumption was correlated with enriched seagrass nutrient concentrations. Our work suggests there's a fundamental relationship between trophic interactions and environmental conditions within complex marine settings. Abiotic stressors like salinity directly impact seagrass communities physiologically; however we show that salinity stressors also shift biotic interactions, indirectly influencing grazing rates and thus having a greater effect on seagrasses than physiological impacts alone. In Shark Bay where restoration efforts are being employed to address large scale loss of seagrasses, the relationship between herbivory pressure and salinity-stress could therefore prove crucial to restoration success.	[Bell, Sahira Y.; Fraser, Matthew W.; Statton, John; Kendrick, Gary A.] Univ Western Australia, Fac Sci, Sch Biol Sci, Crawley, WA, Australia; [Bell, Sahira Y.; Fraser, Matthew W.; Statton, John; Kendrick, Gary A.] Univ Western Australia, Fac Sci, UWA Oceans Inst, Crawley, WA, Australia; [Bell, Sahira Y.] Balu Blue Fdn, Port Lincoln, SA, Australia	University of Western Australia; University of Western Australia	Bell, SY (corresponding author), Univ Western Australia, Fac Sci, Sch Biol Sci, Crawley, WA, Australia.; Bell, SY (corresponding author), Univ Western Australia, Fac Sci, UWA Oceans Inst, Crawley, WA, Australia.; Bell, SY (corresponding author), Balu Blue Fdn, Port Lincoln, SA, Australia.	sahira.bell@research.uwa.edu.au		Kendrick, Gary/0000-0002-0276-6064; Fraser, Matthew/0000-0003-2309-8074; Bell, Sahira/0000-0001-9237-7507	NHT II Caring for Country Project [OC11-00643]; ARC Linkage Grant [LP130100155]; School of Biological Sciences, UWA	NHT II Caring for Country Project; ARC Linkage Grant(Australian Research Council); School of Biological Sciences, UWA	A NHT II Caring for Country Project grant (OC11-00643) coordinated by the Western Australian Marine Science Institute (https://www.wamsi.org.au/) and awarded to G.A.K., and an ARC Linkage Grant (LP130100155) awarded to G.A.K. and J.S funded this research. Additional funding for M.W.F. was received through a Ph.D. grant from the School of Biological Sciences, UWA. S.Y.B. was supported by an Honours grant from the School of Biological Sciences, UWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; ANSARI ZA, 1995, ESTUAR COAST SHELF S, V41, P593, DOI 10.1016/0272-7714(95)90029-2; Arias-Ortiz A, 2018, NAT CLIM CHANGE, V8, P338, DOI 10.1038/s41558-018-0096-y; Armitage AR, 2006, J EXP MAR BIOL ECOL, V339, P65, DOI 10.1016/j.jembe.2006.07.013; ATKINSON MJ, 1987, ESTUAR COAST SHELF S, V24, P335, DOI 10.1016/0272-7714(87)90054-0; Bakker ES, 2016, ECOGRAPHY, V39, P162, DOI 10.1111/ecog.01651; Belicka LL, 2012, MAR FRESHWATER RES, V63, P1085, DOI 10.1071/MF12027; Bennett S, 2015, ECOL LETT; Bessey C, 2015, MAR ECOL PROG SER, V541, P195, DOI 10.3354/meps11542; Burkholder DA, 2012, MAR FRESHWATER RES, V63, P1051, DOI 10.1071/MF12029; Burling MC, 2003, ESTUAR COAST SHELF S, V57, P725, DOI 10.1016/S0272-7714(02)00343-8; Cebrian J, 1996, MAR ECOL PROG SER, V130, P147, DOI 10.3354/meps130147; Cebrian J, 2002, LIMNOL OCEANOGR, V47, P11, DOI 10.4319/lo.2002.47.1.0011; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; Darnell KM, 2013, J EXP MAR BIOL ECOL, V440, P225, DOI 10.1016/j.jembe.2012.12.012; de los Santos CB, 2016, MAR ECOL PROG SER, V551, P81, DOI 10.3354/meps11717; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P201, DOI 10.3354/meps067201; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P83, DOI 10.1016/0022-0981(95)00084-4; Fraser MW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01703; Fraser MW, 2014, J ECOL, V102, P1528, DOI 10.1111/1365-2745.12300; Fraser MW, 2012, MAR FRESHWATER RES, V63, P1015, DOI 10.1071/MF12026; FRITZ RS, 1992, PLANT RESISTANCE HER; Garrote-Moreno A, 2015, AQUAT BOT, V120, P315, DOI 10.1016/j.aquabot.2014.09.011; Garrote-Moreno A, 2015, MAR BIOL, V162, P55, DOI 10.1007/s00227-014-2565-9; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Heck KL, 2015, MAR ECOL PROG SER, V520, P165, DOI 10.3354/meps11104; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Heithaus ER, 2011, MAR ECOL PROG SER, V428, P49, DOI 10.3354/meps09052; Heithaus MR, 2004, B MAR SCI, V75, P79; Hetzel Y, 2013, CONT SHELF RES, V66, P36, DOI 10.1016/j.csr.2013.06.015; Hyndes GA, 2003, MAR BIOL, V142, P1195, DOI 10.1007/s00227-003-1010-2; Hyndes GA, 2016, BIOSCIENCE, V66, P938, DOI 10.1093/biosci/biw111; Jackson G, 2007, FISH RES REP; Kendrick GA, 2012, MAR FRESHWATER RES, V63, P941, DOI [10.1071/MF12280, 10.1071/MF12101]; KIKUCHI T, 1977, SEAGRASS ECOSYSTEMS, P147; Kirsch KD, 2002, MAR ECOL PROG SER, V227, P71, DOI 10.3354/meps227071; KLUMPP DW, 1983, AUST J MAR FRESH RES, V34, P745; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; MONTAGUE CL, 1993, ESTUARIES, V16, P703, DOI 10.2307/1352429; Nowicki R.J., 2018, SEAGRASSES AUSTR STR, P491, DOI 10.1007/978-3-319-71354-0_16; Pages JF, 2014, FUNCT ECOL, V28, P1440, DOI 10.1111/1365-2435.12286; Paul D, 2007, RAPID COMMUN MASS SP, V21, P3006, DOI 10.1002/rcm.3185; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Prado P, 2008, MAR ECOL PROG SER, V371, P11, DOI 10.3354/meps07662; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; Preen AR, 1997, WILDLIFE RES, V24, P185, DOI 10.1071/WR95078; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Smith TM, 2010, J ANIM ECOL, V79, P275, DOI 10.1111/j.1365-2656.2009.01605.x; SOGARD SM, 1989, J EXP MAR BIOL ECOL, V133, P15, DOI 10.1016/0022-0981(89)90155-X; Statton J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137778; Team RC, 2014, R LANG ENV STAT COMP; THAYER GW, 1977, J EXP MAR BIOL ECOL, V30, P109, DOI 10.1016/0022-0981(77)90007-7; Thomson JA, 2015, GLOBAL CHANGE BIOL, V21, P1463, DOI 10.1111/gcb.12694; Travers MJ, 2002, J FISH BIOL, V61, P764, DOI 10.1006/jfbi.2002.2107; Valentine JF, 2000, MAR ECOL PROG SER, V200, P213, DOI 10.3354/meps200213; Valentine JF, 1999, MAR ECOL PROG SER, V176, P291, DOI 10.3354/meps176291; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Walker D, 2012, CARING OUR COUNTRY S; WALKER DI, 1985, AQUAT BOT, V23, P13, DOI 10.1016/0304-3770(85)90017-8; WALKER DI, 1990, AQUAT BOT, V36, P359, DOI 10.1016/0304-3770(90)90052-M; WALKER DI, 1988, AQUAT BOT, V30, P305, DOI 10.1016/0304-3770(88)90063-0; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745	63	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214308	10.1371/journal.pone.0214308	http://dx.doi.org/10.1371/journal.pone.0214308			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897150	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700081
J	Davis, DA; Mondo, K; Stern, E; Annor, AK; Murch, SJ; Coyne, TM; Brand, LE; Niemeyer, ME; Sharp, S; Bradley, WG; Cox, PA; Mash, DC				Davis, David A.; Mondo, Kiyo; Stern, Erica; Annor, Ama K.; Murch, Susan J.; Coyne, Thomas M.; Brand, Larry E.; Niemeyer, Misty E.; Sharp, Sarah; Bradley, Walter G.; Cox, Paul Alan; Mash, Deborah C.			Cyanobacterial neurotoxin BMAA and brain pathology in stranded dolphins	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; AMYOTROPHIC-LATERAL-SCLEROSIS; HARMFUL ALGAL BLOOMS; INDIAN RIVER LAGOON; TURSIOPS-TRUNCATUS; NEURODEGENERATIVE DISEASE; CYCAD NEUROTOXINS; FLYING FOXES; ALS-PDC; FLORIDA	Dolphin stranding events occur frequently in Florida and Massachusetts. Dolphins are an excellent sentinel species for toxin exposures in the marine environment. In this report we examine whether cyanobacterial neurotoxin, beta-methylamino-L-alanine (BMAA), is present in stranded dolphins. BMAA has been shown to bioaccumulate in the marine food web, including in the muscles and fins of sharks. Dietary exposure to BMAA is associated with the occurrence of neurofibrillary tangles and beta-amyloid plaques in nonhuman primates. The findings of protein-bound BMAA in brain tissues from patients with Alzheimer's disease has advanced the hypothesis that BMAA may be linked to dementia. Since dolphins are apex predators and consume prey containing high amounts of BMAA, we examined necropsy specimens to determine if dietary and environmental exposures may result in the accumulation of BMAA in the brains of dolphins. To test this hypothesis, we measured BMAA in a series of brains collected from dolphins stranded in Florida and Massachusetts using two orthogonal analytical methods: 1) high performance liquid chromatography, and 2) ultra-performance liquid chromatography with tandem mass spectrometry. We detected high levels of BMAA (20-748 mu g/g) in the brains of 13 of 14 dolphins. To correlate neuropathological changes with toxin exposure, gross and microscopic examinations were performed on cortical brain regions responsible for acoustico-motor navigation. We observed increased numbers of beta-amyloid(+) plaques and dystrophic neurites in the auditory cortex compared to the visual cortex and brainstem. The presence of BMAA and neuropathological changes in the stranded dolphin brain may help to further our understanding of cyanotoxin exposure and its potential impact on human health.	[Davis, David A.; Mondo, Kiyo; Stern, Erica; Annor, Ama K.; Bradley, Walter G.; Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Murch, Susan J.] Univ British Columbia, Dept Chem, Kelowna, BC, Canada; [Coyne, Thomas M.] Off Dist 21 Med Examiner, Ft Myers, FL USA; [Brand, Larry E.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Brand, Larry E.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, NSF NIEHS Oceans & Human Hlth Ctr, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Niemeyer, Misty E.; Sharp, Sarah] IFAW, Marine Mammal Rescue & Res, Yarmouth Port, MA USA; [Cox, Paul Alan] Inst Ethnomed, Brain Chem Labs, Jackson Hole, WY USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami; University of British Columbia; University of Miami; National Science Foundation (NSF); University of Miami; University of Miami	Davis, DA; Mash, DC (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.; Mash, DC (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	d.davis12@med.miami.edu; dmash@med.miami.edu	Murch, Susan/AAA-6703-2021	Murch, Susan/0000-0001-5803-9483; Cox, Paul/0000-0001-6401-2981; Davis, David/0000-0002-9323-6180	Herbert W. Hoover Foundation; National Science Foundation [0742285]	Herbert W. Hoover Foundation; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Herbert W. Hoover Foundation Award 2012-2017: Cyanobacterial toxin BMAA in the Marine Food Web, Cyanobacterial toxin BMAA in Stranded Dolphins, and Cyanobacterial Toxin BMAA and the Marine Environment: Findings in Stranded Dolphins, BMAA in Marine Environments, Cyanobacterial Toxin BMAA in Dolphins, http://www.hwhfoundation.org/; to D.M. and D.D. D.M. and L.B. were supported by a National Science Foundation Award 2008-2009, Award Abstract #0742285, "BMAA in the food web of South Florida coastal waters," https://www.nsf.gov/awardsearch/showAward?AWD_ID=0742285.	ANDREW A, 2018, MUSCLE NERVE; Badylak S, 2004, J PLANKTON RES, V26, P1229, DOI 10.1093/plankt/fbh114; Baker TC, 2018, NEUROTOX RES, V33, P43, DOI 10.1007/s12640-017-9764-3; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Barco S.G., 2016, COLLABORATIVE DEV RE; Berry DL, 2015, MICROB ECOL, V70, P361, DOI 10.1007/s00248-014-0564-5; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bonsembiante F, 2017, J VET MED SCI, V79, P1013, DOI 10.1292/jvms.17-0023; Bradley WG, 2009, AMYOTROPH LATERAL SC, V10, P7, DOI 10.3109/17482960903286009; Brand LE, 2010, HARMFUL ALGAE, V9, P620, DOI 10.1016/j.hal.2010.05.002; Brown A, 2018, HARMFUL ALGAE, V76, P22, DOI 10.1016/j.hal.2018.04.011; Buratti FM, 2017, ARCH TOXICOL, V91, P1049, DOI 10.1007/s00204-016-1913-6; Caller TA, 2012, AMYOTROPH LATERAL SC, V13, P25, DOI 10.3109/17482968.2011.621436; Caller TA, 2009, AMYOTROPH LATERAL SC, V10, P101, DOI 10.3109/17482960903278485; Chapra SC, 2017, ENVIRON SCI TECHNOL, V51, P8933, DOI 10.1021/acs.est.7b01498; Clark LS, 2005, ANAT REC PART A, V282A, P67, DOI 10.1002/ar.a.20147; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2002, NEUROLOGY, V58, P956, DOI 10.1212/WNL.58.6.956; Cox PA, 2016, NEUROTOXICOLOGY; Cox PA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2397; Dunlop RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075376; Eiser AR, 2017, BRAIN RES, V1671, P14, DOI 10.1016/j.brainres.2017.06.032; Erdner DL, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-S2-S2; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; Glover WB, 2015, J AOAC INT, V98, P1559, DOI 10.5740/jaoacint.15-084; Glover WB, 2014, AMINO ACIDS, V46, P2553, DOI 10.1007/s00726-014-1812-1; Gunn-Moore D, 2017, ALZHEIMERS DEMENT; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; Jepson PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060953; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; LAPOINTE BE, 1994, B MAR SCI, V54, P696; Lobner D, 2007, NEUROBIOL DIS, V25, P360, DOI 10.1016/j.nbd.2006.10.002; Main BJ, 2018, AMINO ACIDS, V50, P397, DOI 10.1007/s00726-017-2525-z; Masseret E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083406; MIRRA SS, 1993, ARCH PATHOL LAB MED, V117, P132; Mondo K, 2014, FOOD CHEM TOXICOL, V70, P26, DOI 10.1016/j.fct.2014.04.015; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Villalba MCM, 2017, DIS AQUAT ORGAN, V123, P13, DOI 10.3354/dao03085; Moran-Blanco Sagrario., 2017, NACIONES UNIDAS SOC, P1; Morton S, 2014, BIOL CHEM PHYS DATA; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; NOAA, 2015, 2013 2015 BOTTL DOLP; Nunn PB, 2017, PHYTOCHEMISTRY, V144, P271, DOI 10.1016/j.phytochem.2017.10.002; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; Parsons ECM, 2008, MAR POLLUT BULL, V56, P1248, DOI 10.1016/j.marpolbul.2008.04.025; Pintore MD, 2018, J WILDLIFE DIS, V54, P295, DOI 10.7589/2017-02-035; Rush T, 2012, NEUROREPORT, V23, P216, DOI 10.1097/WNR.0b013e32834fe6d6; Sarasa M, 2009, CURR ALZHEIMER RES, V6, P171, DOI 10.2174/156720509787602834; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Sehein T, 2016, J APPL PHYCOL, V28, P1677, DOI 10.1007/s10811-015-0681-7; Sneed JM, 2017, HARMFUL ALGAE, V69, P75, DOI 10.1016/j.hal.2017.10.002; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; Stolen Megan K., 2007, Florida Scientist, V70, P45; Torbick N, 2018, NEUROTOX RES, V33, P199, DOI 10.1007/s12640-017-9740-y; Torbick N, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-1; Twiner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017394; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Venn-Watson SK, 2015, JAVMA-J AM VET MED A, V246, P893, DOI 10.2460/javma.246.8.893; Xie XB, 2013, NEUROREPORT, V24, P779, DOI 10.1097/WNR.0b013e328363fd89; Yan XC, 2017, WATER RES, V125, P449, DOI 10.1016/j.watres.2017.09.008	62	23	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213346	10.1371/journal.pone.0213346	http://dx.doi.org/10.1371/journal.pone.0213346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893348	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900037
J	Moya-Costa, R; Cuenca-Bescos, G; Bauluz, B				Moya-Costa, Raquel; Cuenca-Bescos, Gloria; Bauluz, Blanca			Protocol for the reconstruction of micromammals from fossils. Two case studies: The skulls of Beremendia fissidens and Dolinasorex glyphodon	PLOS ONE			English	Article							EARLY PLEISTOCENE; SHREWS; MAMMALIA; ENAMEL; INSECTIVORA; SORICIDAE; IMAGEJ; SIZE	We have developed a protocol for reconstructing 3D models of the skulls of extinct species of small mammals. For the first time, the reconstruction uses fragments of fossils from a mixture of different specimens and from related extant species. We use free software and commercial computers to make the process reproducible and usable for the scientific community. We present a semi-quantitative protocol to face the problem of making 3D reconstructions of fossil species that are incomplete in the fossil record and/or represented by a mixture of different individuals, as usually occurs with small vertebrates. Therefore this approach is useful when no complete skull is available. The protocol combines the use of microCT scan technology with a subsequent computer treatment using different software tools for 3D reconstruction from microCT and 3D design and printing (e.g. Fiji, SPIERS, Meshlab, Meshmixer) in a defined order. This kind of free and relatively simple software, plus the detailed description, makes this protocol practicable for researchers who do not necessarily have great deal of experience in working with 3D. As an example, we have performed virtual reconstructions of the skulls of two species of insectivore small mammals (Eulipotyphla): Beremendia fissidens and Dolinasorex glyphodon. The resulting skulls, plus models of the extant shrews Blarina brevicauda, Neomys fodiens, Crocidura russula and Sorex coronatus, make it possible to compare characteristics that can only be observed by means of microCT 3D reconstructions, and given the characteristics of the material, using this protocol. Among the characters we can compare are the position of the mandibles, the spatial relations among all the teeth, the shape of the snout and, in general, all parameters related with the anatomy of the rostrum. Moreover, these reconstructions can be used in different types of context: for anatomical purposes, especially to see internal features or characteristics at whole-skull scale, for bioengineering, animation, or other techniques that need a digital model.	[Moya-Costa, Raquel; Cuenca-Bescos, Gloria; Bauluz, Blanca] Univ Zaragoza, Dept Earth Sci, Aragosaurus IUCA, Zaragoza, Spain	University of Zaragoza	Moya-Costa, R (corresponding author), Univ Zaragoza, Dept Earth Sci, Aragosaurus IUCA, Zaragoza, Spain.	raquelmc@unizar.es	Gloria, Cuenca-Bescós/A-3616-2013; Moya-Costa, Raquel/AAT-4727-2021; Bauluz Lazaro, Blanca/N-9802-2018	Gloria, Cuenca-Bescós/0000-0001-5125-9651; Moya-Costa, Raquel/0000-0002-2405-341X; Bauluz Lazaro, Blanca/0000-0002-4970-6333	predoctoral fellowship "Formacion de Profesorado Universitario" (FPU) from the MECD (Ministerio de Educacion, Cultura y Deporte) [FPU14/05528]; MINECO/FEDER (Ministerio de Educacion, Cultura y deporte/Fondo Europeo de Desarrollo Regional) project "GEOLOGIA, GEOCRONOLOGIA Y PALEOBIOLOGIA DE LOS YACIMIENTOS DE LA SIERRA DE ATAPUERCA VI" [CGL2015-65387-C3-2-P]; Grupos de Investigacion del Gobierno de Aragon: GRUPO DE REFERENCIA ARAGOSAURUS: RECURSOS GEOLOGICOS Y PALEOAMBIENTALES [E18_17R]; Instituto Universitario de Investigacion en Ciencias Ambientales de Aragon (IUCA)	predoctoral fellowship "Formacion de Profesorado Universitario" (FPU) from the MECD (Ministerio de Educacion, Cultura y Deporte)(German Research Foundation (DFG)); MINECO/FEDER (Ministerio de Educacion, Cultura y deporte/Fondo Europeo de Desarrollo Regional) project "GEOLOGIA, GEOCRONOLOGIA Y PALEOBIOLOGIA DE LOS YACIMIENTOS DE LA SIERRA DE ATAPUERCA VI"; Grupos de Investigacion del Gobierno de Aragon: GRUPO DE REFERENCIA ARAGOSAURUS: RECURSOS GEOLOGICOS Y PALEOAMBIENTALES; Instituto Universitario de Investigacion en Ciencias Ambientales de Aragon (IUCA)	RMC is the beneficiary of a predoctoral fellowship "Formacion de Profesorado Universitario" (FPU) from the MECD (Ministerio de Educacion, Cultura y Deporte) with number FPU14/05528 (http://www.educacionyfp.gob.es/serviciosal-ciudadano-mecd/catalogo/general/educacion/998758/ficha/998758-2014.html).The work was funded by: the MINECO/FEDER (Ministerio de Educacion, Cultura y deporte/Fondo Europeo de Desarrollo Regional) project CGL2015-65387-C3-2-P "GEOLOGIA, GEOCRONOLOGIA Y PALEOBIOLOGIA DE LOS YACIMIENTOS DE LA SIERRA DE ATAPUERCA VI" (http://www.ciencia.gob.es/; http://ec.europa.eu/regional_ policy/es/funding/erdf/), to which GCB and RMC belong; by Grupos de Investigacion del Gobierno de Aragon (http://www.aragon.es/) E18_17R: GRUPO DE REFERENCIA ARAGOSAURUS: RECURSOS GEOLOGICOS Y PALEOAMBIENTALES to which RMC, GCB and BB belong. Publication fees were funded by the Instituto Universitario de Investigacion en Ciencias Ambientales de Aragon (IUCA) (http://iuca.unizar.es/) to which RMC, GCB and BB belong with the "Convocatoria Ayudas a Publicaciones IUCA 2018". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, AUTODESK MESHMIXER; Bennasar Serra M., 2010, THESIS; Cardini A, 2015, EVOL BIOL, V42, P169, DOI 10.1007/s11692-015-9308-9; Cardini A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3458; Churchfield S., 1990, NATURAL HIST SHREWS; Cifelli RL, 1996, OKLAHOMA GEOLOGICAL, P96; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cuenca-Bescos G, 2007, NATURWISSENSCHAFTEN, V94, P113, DOI 10.1007/s00114-006-0163-5; Cuenca-Bescos G, 2016, CR PALEVOL, V15, P621, DOI 10.1016/j.crpv.2015.09.006; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; Daams R., 1988, SCR GEOL SPECIAL ISS, V1, P3; DAPSON RW, 1968, J MAMMAL, V49, P205, DOI 10.2307/1377976; Di Vincenzo F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14437-2; Dolgov B., 1968, SB T ZOOL MUZJEJA MG, V10, P222; DOTSCH C, 1978, Z SAUGETIERKD, V43, P65; Dumont M, 2014, J STRUCT BIOL, V186, P38, DOI 10.1016/j.jsb.2014.02.006; Esteve J, 2017, PALAEONTOLOGY, V60, P423, DOI 10.1111/pala.12294; FELDHAMER GA, 1993, MAMMALIA, V57, P115, DOI 10.1515/mamm.1993.57.1.115; Furio M, 2017, REV ECOSISTEMAS, V27, P38; Furio M, 2010, J VERTEBR PALEONTOL, V30, P928, DOI 10.1080/02724631003762930; Garwood R, 2014, J PALEONTOL, V88, P735, DOI 10.1666/13-088; GENOUD M, 1988, MAMMAL REV, V18, P173, DOI 10.1111/j.1365-2907.1988.tb00083.x; Gougelet P., 2016, XNVIEW LIBFORMAT VER; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; Gureev AA, 1971, ALEKSEI A SHREWS SOR; Hofmann P, 2009, COMPUTATIONAL VISION, P395; Canudo JI, 2018, GEOHERITAGE, V10, P385, DOI 10.1007/s12371-017-0228-1; Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101; Kowalski K, 2018, J MAMMAL, V99, P351, DOI 10.1093/jmammal/gyy013; Kowalski K, 2017, FRONT ZOOL, V14, DOI 10.1186/s12983-017-0230-0; Lautenschlager S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160342; Lazaro J, 2017, CURR BIOL, V27, pR1106, DOI 10.1016/j.cub.2017.08.055; Lopez-Fuster MJ, 1979, MISCEL LANEA ZOOL, P109; LOPEZFUSTER MJ, 1990, ACTA THERIOL, V35, P269, DOI 10.4098/AT.arch.90-32; Martin Arnal FA, 2017, 15 ENC JOV INV PAL 1, P51; Mclntosh AF, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160568; Moska Magdalena, 2008, Zoologica Poloniae, V53, P49; Moya-Costa R, 2018, QUATERN INT, V481, P52, DOI 10.1016/j.quaint.2017.04.039; Neeser R, 2009, AM J PHYS ANTHROPOL, V140, P1, DOI 10.1002/ajpa.21023; Paramo A, 2018, LIFE FINDS A WAY, P87; Profico A, 2019, ANAT REC, V302, P1104, DOI 10.1002/ar.24077; Profico A, 2018, AM J PHYS ANTHROPOL, V166, P979, DOI 10.1002/ajpa.23493; Pucek Z., 1984, KEYS MAMMALS POLAND, P60; Rahman IA, 2014, J PALEONTOL, V88, P633, DOI 10.1666/13-001I; Reumer Jelle W.F., 1994, Cranium, V11, P9; Reumer Jelle W.F., 1998, P5; Rofes J, 2009, CR PALEVOL, V8, P21, DOI 10.1016/j.crpv.2008.08.004; Rofes J, 2009, ZOOL J LINN SOC-LOND, V155, P904, DOI 10.1111/j.1096-3642.2008.00470.x; Rohlf F J., 2013, TPSDIG ECOLOGY EVOLU; Rzebik-Kowalska Barbara, 1998, P23; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlager S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194073; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senck S, 2015, ANAT REC, V298, P827, DOI 10.1002/ar.23104; Shiino Y, 2012, J THEOR BIOL, V300, P29, DOI 10.1016/j.jtbi.2012.01.012; Sutton M, 2012, DS P 2012 UNDEFINED; Sutton Mark, 2016, Paleontological Society Papers, V22, P1; Tamagnini D, 2017, EVOL BIOL, V44, P476, DOI 10.1007/s11692-017-9421-z; van Dam JA, 2011, PALAEOGEOGR PALAEOCL, V311, P103, DOI 10.1016/j.palaeo.2011.08.010; Veneziano A, 2018, AM J PHYS ANTHROPOL, V166, P473, DOI 10.1002/ajpa.23431; Zidarova S, 2015, ACTA ZOOL BULGAR, V67, P19; Zollikofer CPE, 2002, EVOL ANTHROPOL, V11, P64, DOI 10.1002/evan.10059	63	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213174	10.1371/journal.pone.0213174	http://dx.doi.org/10.1371/journal.pone.0213174			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893322	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900031
J	Zein, B; Woelfing, B; Dahne, M; Schaffeld, T; Ludwig, S; Rye, JH; Baltzer, J; Ruser, A; Siebert, U				Zein, Beate; Woelfing, Benno; Daehne, Michael; Schaffeld, Tobias; Ludwig, Stefan; Rye, Jacob Hansen; Baltzer, Johannes; Ruser, Andreas; Siebert, Ursula			Time and tide: Seasonal, diel and tidal rhythms in Wadden Sea Harbour porpoises (Phocoena phocoena)	PLOS ONE			English	Article							HABITAT PREFERENCES; NORTH-SEA; ECHOLOCATION BEHAVIOR; AERIAL SURVEYS; MARSDIEP AREA; ABUNDANCE; PREY; VARIABILITY; DENSITY; TRENDS	Odontocetes have evolved a rich diversity of prey-and habitat-specific foraging strategies, which allows them to feed opportunistically on locally and temporally abundant prey. While habitat-specific foraging strategies have been documented for some odontocete species, this is less known for the harbour porpoise (Phocoena phocoena). We collected multiple years of acoustic data using echolocation click loggers to analyse porpoise occurrence and buzzing behaviour, indicating feeding, in the German Wadden Sea (North Sea). Seasonal, diel and tidal effects were studied using Generalised Estimating Equations (GEE-GAMs). Locally season, time of day and tidal time significantly influenced the probability of porpoise detections and detection of foraging sequences (buzzes). Hunting strategies, and therefore frequency of buzzes, were likely affected by prey distribution and large differences between POD locations indicated that porpoises used highly specific behaviour adapted to tide and time of day to efficiently feed on the available prey. Strong seasonal and spatial variation in diel and tidal effects underline the importance of long-term observations. Studies on porpoise behaviour are often based on short-term observations and might rather reflect a seasonal than a general pattern. The results of this study show clearly that significant changes in porpoise behaviour can be found in short and long-term observations. Here some features are based on short term determinants and others are stable over years and care should be taken about drawing general conclusions based on local patterns. Highly variable spatio-temporal patterns indicate a high flexibility of porpoises in a highly variable environment and address a challenge for complex conservation management plans.	[Zein, Beate; Woelfing, Benno; Schaffeld, Tobias; Baltzer, Johannes; Ruser, Andreas; Siebert, Ursula] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Busum, Germany; [Zein, Beate] Univ St Andrews, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Daehne, Michael] German Oceanog Museum, Stralsund, Mecklenburg Vor, Germany; [Ludwig, Stefan] German Navy Headquarters, METOC Support, Geoinformat Div, Rostock, Germany; [Rye, Jacob Hansen] Minist Environm & Food Denmark, Danish Coastal Author, Lemvig, Denmark	University of Veterinary Medicine Hannover, Foundation; University of St Andrews	Ruser, A (corresponding author), Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, Busum, Germany.	andreas.ruser@tiho-hannover.de	Schaffeld, Tobias/AAP-9710-2020	Schaffeld, Tobias/0000-0002-2576-6534; Zein, Beate/0000-0002-5487-8535	Schleswig-Holstein's Government-Owned Company for Coastal Protection, National Parks and Ocean Protection, Wadden Sea National Park Administration of Lower Saxony; German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety [FKZ: 0329946B, FKZ: 03 275 20]; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation	Schleswig-Holstein's Government-Owned Company for Coastal Protection, National Parks and Ocean Protection, Wadden Sea National Park Administration of Lower Saxony; German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	The study was partly funded by the Schleswig-Holstein's Government-Owned Company for Coastal Protection, National Parks and Ocean Protection, Wadden Sea National Park Administration of Lower Saxony (Richard Czeck) and the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (FKZ: 03 275 20 and FKZ: 0329946B). This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. We thank Kai Eskildsen from the National Park Administration Schleswig-Holstein for the coordination of MINOSplus and the water and shipping authorities especially Wilhelmshaven and Tonning/Husum for their continued support of the project with the vessels M/V Schilling and M/V Oland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundin M., 1991, THESIS; [Anonymous], 2014, R LANG ENV STAT COMP; Au W. W., 1993, SONAR DOLPHINS; Benjamins S, 2017, DEEP-SEA RES PT II, V141, P191, DOI 10.1016/j.dsr2.2016.07.002; Benjamins S, 2016, MAR ECOL PROG SER, V549, P275, DOI 10.3354/meps11677; BENKE H, 1996, REPORTS INT WHALING; Boonstra Michelle, 2013, Lutra, V56, P59; Booth CG, 2013, MAR ECOL PROG SER, V478, P273, DOI 10.3354/meps10239; Borges L, 1996, EUROPEAN RES CETACEA; Brandt MJ, 2014, MAR MAMMAL SCI, V30, P1109, DOI 10.1111/mms.12112; BROCKMANN UH, 1990, NETH J SEA RES, V26, P239, DOI 10.1016/0077-7579(90)90092-U; Camphuysen Kees C. J., 2004, Lutra, V47, P113; Cardinale M, 2003, AQUAT LIVING RESOUR, V16, P283, DOI 10.1016/S0990-7440(03)00007-X; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Clausen KT, 2010, BIOACOUSTICS, V20, P1; Cox S., 2016, DEEP SEA RES 2, V141, P178; Cox Tara M., 2001, Journal of Cetacean Research and Management, V3, P81; Dahne M, 2013, J ACOUST SOC AM, V134, P2514, DOI 10.1121/1.4816578; Dahne M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025002; Dahne M, 2014, AKUSTISCHES MONITORI; de Boer MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086331; DeRuiter SL, 2009, J EXP BIOL, V212, P3100, DOI 10.1242/jeb.030825; Didrikas T, 2009, ICES J MAR SCI, V66, P388, DOI 10.1093/icesjms/fsn173; Elliser CR, 2018, MAR MAMMAL SCI, V34, P365, DOI 10.1111/mms.12459; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Evans PGH, 2003, UK CETACEAN STATUS R; Flater D, 2015, XTIDE VERSION 2 2 7; Forney KA, 2017, ENDANGER SPECIES RES, V32, P391, DOI 10.3354/esr00820; Gallus Anja, 2012, Endangered Species Research, V18, P265, DOI 10.3354/esr00448; Geelhoed Steve C. V., 2013, Lutra, V56, P45; Gilles A, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1367; Gilles A. A., 2008, THESIS; Gilles Anita, 2011, Endangered Species Research, V14, P157, DOI 10.3354/esr00344; Gilles A, 2009, MAR ECOL PROG SER, V383, P295, DOI 10.3354/meps08020; Goodwin Lissa, 2008, Aquatic Mammals, V34, P44, DOI 10.1578/AM.34.1.2008.44; Haelters J, 2011, BELG J ZOOL, V141, P75; Hall A.R., 2004, THESIS; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Hammond PS, 2008, PHOCOENA PHOCOENA; Hanna NK, 2018, MAR POLLUT BULL, V129, P633, DOI 10.1016/j.marpolbul.2017.10.051; Hocking, 2013, METHODS APPL LINEAR; Hoekendijk JPA, 2018, MAR MAMMAL SCI, V34, P258, DOI 10.1111/mms.12446; Holdman AK, 2018, MARINE MAMMAL SCI, V9999, P1; Ijsseldijk LL, 2015, J SEA RES, V103, P129, DOI 10.1016/j.seares.2015.07.010; Isojunno S, 2012, MAR ECOL PROG SER, V448, P155, DOI 10.3354/meps09415; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Koopman HN, 1998, J MAMMAL, V79, P260, DOI 10.2307/1382862; Koschinski Sven, 2008, Journal of Cetacean Research and Management, V10, P147; Kyhn L, 2005, THESIS; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; Lockyer C., 2003, NAMMCO Scientific Publications, V5, P71; LOCKYER C, 1986, CAN J FISH AQUAT SCI, V43, P142, DOI 10.1139/f86-015; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; Nuuttila HK, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3081-5; Onken R, 2007, CONT SHELF RES, V27, P1656, DOI 10.1016/j.csr.2007.01.029; Peschko V, 2016, ECOL INDIC, V60, P174, DOI 10.1016/j.ecolind.2015.06.030; Pierpoint C, 2008, J MAR BIOL ASSOC UK, V88, P1167, DOI 10.1017/S0025315408000507; Pirotta E, 2014, FUNCT ECOL, V28, P206, DOI 10.1111/1365-2435.12146; Santos MB, 2004, MAR MAMMAL SCI, V20, P1, DOI 10.1111/j.1748-7692.2004.tb01138.x; Schaffeld T, 2016, MAR ECOL PROG SER, V547, P257, DOI 10.3354/meps11627; Scheidat M, 2009, C12509 IMARES; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; Sorensen PM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28022-8; Sveegaard S, 2012, MAR ECOL PROG SER, V468, P245, DOI 10.3354/meps09959; Sveegaard S, 2012, MAR BIOL, V159, P1029, DOI 10.1007/s00227-012-1883-z; Sveegaard S, 2011, MAR MAMMAL SCI, V27, P230, DOI 10.1111/j.1748-7692.2010.00379.x; Thomsen F, 2006, HELGOLAND MAR RES, V60, P189, DOI 10.1007/s10152-006-0021-z; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; van Aken HM, 2008, J SEA RES, V60, P227, DOI 10.1016/j.seares.2008.09.001; van der Kooij J, 2008, J SEA RES, V60, P201, DOI 10.1016/j.seares.2008.07.003; Verfuss UK, 2005, J EXP BIOL, V208, P3385, DOI 10.1242/jeb.01786; Verfuss UK, 2007, J MAR BIOL ASSOC UK, V87, P165, DOI 10.1017/S0025315407054938; Verfuss UK, 2013, J ACOUST SOC AM, V134, P2462, DOI 10.1121/1.4816571; Verfuss UK, 2009, J EXP BIOL, V212, P823, DOI 10.1242/jeb.022137; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Weir CR, 2007, J MAR BIOL ASSOC UK, V87, P327, DOI 10.1017/S0025315407052721; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; White G.C., 1990, ANAL WILDLIFE RADIO; Wisniewska DM, 2015, ELIFE, V4, DOI 10.7554/eLife.05651; Wisniewska DM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2314; Wisniewska DM, 2016, CURR BIOL, V26, P1441, DOI 10.1016/j.cub.2016.03.069; YASUI WY, 1986, OPHELIA, V25, P183, DOI 10.1080/00785326.1986.10429749; Zamon JE, 2003, MAR ECOL PROG SER, V261, P243, DOI 10.3354/meps261243	87	7	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213348	10.1371/journal.pone.0213348	http://dx.doi.org/10.1371/journal.pone.0213348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893334	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900038
J	Graham, C; Bailey, D; Hart, S; Hutchison, A; Sandercock, P; Doubal, F; Sudlow, C; Farrall, A; Wardlaw, J; Dennis, M; Whiteley, W				Graham, Catriona; Bailey, David; Hart, Simon; Hutchison, Aidan; Sandercock, Peter; Doubal, Fergus; Sudlow, Cathie; Farrall, Andrew; Wardlaw, Joanna; Dennis, Martin; Whiteley, William			Clinical diagnosis of TIA or minor stroke and prognosis in patients with neurological symptoms: A rapid access clinic cohort	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; INTEROBSERVER AGREEMENT; EARLY RISK	Background The long-term risk of stroke or myocardial infarction (MI) in patients with minor neurological symptoms who are not clinically diagnosed with transient ischaemic attack (TIA) or minor stroke is uncertain. Methods We used data from a rapid access clinic for patients with suspected TIA or minor stroke and follow-up from four overlapping data sources for a diagnosis of ischaemic or haemorrhagic stroke, MI, major haemorrhage and death. We identified patients with and without a clinical diagnosis of TIA or minor stroke. We estimated hazard ratios of stroke, MI, major haemorrhage and death in early and late time periods. Results 5,997 patients were seen from 2005-2013, who were diagnosed with TIA or minor stroke (n = 3604, 60%) or with other diagnoses (n = 2392, 40%). By 5 years the proportion of patients who had a subsequent ischaemic stroke or MI, in patients with a clinical diagnosis of minor stroke or TIA was 19% [95% confidence interval (CI): 17-20%], and in patients with other diagnoses was 10% (95%CI: 8-15%). Patients with clinical diagnosis of TIA or minor stroke had three times the hazard of stroke or MI compared to patients with other diagnoses [hazard ratio (HR)2.83 95%CI:2.13-3.76, adjusted age and sex] by 90 days post-event; however from 90 days to end of follow up, this difference was attenuated (HR 1.52, 95%CI:1.25-1.86). Older patients and those who had a history of vascular disease had a high risk of stroke or MI, whether or not they were diagnosed with minor stroke or TIA. Conclusions Careful attention to vascular risk factors in patients presenting with transient or minor neurological symptoms not thought to be due to stroke or TIA is justified, particularly those who are older or have a history of vascular disease.	[Graham, Catriona] Western Gen Hosp, Wellcome Trust Clin Res Facil, Edinburgh, Midlothian, Scotland; [Bailey, David] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Hart, Simon; Hutchison, Aidan; Sandercock, Peter; Doubal, Fergus; Sudlow, Cathie; Farrall, Andrew; Wardlaw, Joanna; Dennis, Martin; Whiteley, William] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; NHS National Services Scotland; University of Edinburgh	Whiteley, W (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	william.whiteley@ed.ac.uk	Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019	Wardlaw, Joanna M/0000-0002-9812-6642; Sudlow, Cathie/0000-0002-7725-7520; Whiteley, William/0000-0002-4816-8991	Lothian Stroke Endowment; MRC Clinician Scientist Fellowship [G0902303]; CSO Senior Clinical Fellowship; MRC [G0902303] Funding Source: UKRI	Lothian Stroke Endowment; MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CSO Senior Clinical Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The data linkage and statistical analysis for this study was supported by a grant from the Lothian Stroke Endowment. WW was supported by an MRC Clinician Scientist Fellowship (G0902303) and is now supported by a CSO Senior Clinical Fellowship.	Amarenco P, 2018, NEW ENGL J MED, V378, P2182, DOI 10.1056/NEJMoa1802712; [Anonymous], 1995, J Clin Epidemiol, V48, P1441; Bos MJ, 2007, JAMA-J AM MED ASSOC, V298, P2877, DOI 10.1001/jama.298.24.2877; Brazzelli M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007424, DOI 10.1002/14651858.CD007424]; Cameron AC, 2011, INT J STROKE, V6, P306, DOI 10.1111/j.1747-4949.2011.00591.x; Castle J, 2010, STROKE, V41, P1367, DOI 10.1161/STROKEAHA.109.577650; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Ferro JM, 1996, STROKE, V27, P2225, DOI 10.1161/01.STR.27.12.2225; Gibson LM, 2013, J ROY COLL PHYS EDIN, V43, P114, DOI 10.4997/JRCPE.2013.205; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Harley K, 1996, Health Bull (Edinb), V54, P410; Kerr E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3265; KOUDSTAAL PJ, 1992, LANCET, V340, P630, DOI 10.1016/0140-6736(92)92170-K; KOUDSTAAL PJ, 1986, STROKE, V17, P723, DOI 10.1161/01.STR.17.4.723; KRAAIJEVELD CL, 1984, STROKE, V15, P723, DOI 10.1161/01.STR.15.4.723; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Nadarajan V, 2014, Pract Neurol, V14, P23, DOI 10.1136/practneurol-2013-000782; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Swain S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a786; Whiteley W, 2010, J NEUROL NEUROSUR PS, V81, pE28, DOI 10.1136/jnnp.2010.226340.47; Woodfield R, 2013, INT J STROKE, V8, P41	21	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0210452	10.1371/journal.pone.0210452	http://dx.doi.org/10.1371/journal.pone.0210452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889185	Green Published, gold			2022-12-26	WOS:000461573000003
J	Render, A; Jansen, P				Render, Anna; Jansen, Petra			Dopamine and sense of agency: Determinants in personality and substance use	PLOS ONE			English	Article							INTENTIONAL BINDING; SELF-ESTEEM; FREE WILL; REWARD; NARCISSISM; AWARENESS; KETAMINE; IMPLICIT; MODEL; BIAS	Sense of agency refers to the feeling of control over one's own actions. The strength of this sense varies inter-individually. This means that people differ in their perception concerning the intensity of their intentions and actions. The current study aims to determine the factors influencing this sense of agency on a personality level. Furthermore, it gives insight into the correlative relation between the strength of the sense of agency and substance use. The study involved 210 participants who were tested for the experiment (intentional binding paradigm for sense of agency, hand paradigm for intentionality bias, questionnaires FAD-Plus, NI-20, substance use). Significant determinants in personality were narcissism (vulnerable subtype) and substance use (consumption in general beyond cannabis, and particularly for the substances cannabis, ecstasy, and cocaine). Both personality types were associated with a weaker sense of agency compared to controls. For both results, alterations in the dopaminergic system need to be discussed. The present results confirm prior hypotheses that dopamine seems to play a crucial role in perception of agency. Possibly a higher accessibility of dopamine increases sense of agency (hyper-binding), whereas a lower accessibility of dopamine decreases sense of agency (hypo-binding). A second aim of the study was to see whether there is a connection between sense of agency and intentionality bias. The perception of intention in others differs widely; some people tend to see arbitrary or accidental actions as unintentional, and others quickly label actions as 'intentional' although the information is not distinct for a categorization. This cognitive error is called intentionality bias. Results could not confirm a relationship between the two constructs one's own intention and judging intention in others. This may be due to a lack of connection between the two constructs or to methodological aspects. Further directions and limitations are discussed.	[Render, Anna; Jansen, Petra] Univ Regensburg, Fac Psychol Pedag & Sport Sci, Bavaria, Germany	University of Regensburg	Render, A (corresponding author), Univ Regensburg, Fac Psychol Pedag & Sport Sci, Bavaria, Germany.	anna-katharina.render@ur.de		Render, Anna/0000-0001-6671-0695				Aarts H, 2012, SOC NEUROSCI-UK, V7, P105, DOI 10.1080/17470919.2011.590602; Aarts H, 2011, PSYCHOL SCI, V22, P532, DOI 10.1177/0956797611399294; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Babor T, 2001, AUDIT ALKOHOL USE DI; Bachner-Melman R, 2007, AM J MED GENET B, V144B, P748, DOI 10.1002/ajmg.b.30505; Barlas Z, 2014, CONSCIOUS COGN, V28, P94, DOI 10.1016/j.concog.2014.06.013; BATTAGLIA G, 1988, PHARMACOL BIOCHEM BE, V29, P269, DOI 10.1016/0091-3057(88)90155-4; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; CARLSSON A, 1976, J NEURAL TRANSM, V38, P271, DOI 10.1007/BF01249444; Chen KC, 2012, PSYCHIAT RES-NEUROIM, V201, P218, DOI 10.1016/j.pscychresns.2011.07.003; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; Daig I, 2010, PSYCHOPATHOLOGY, V43, P150, DOI 10.1159/000288636; Dewey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110118; Dimaggio G, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00325; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Falkai P., 2018, DIAGNOSTISCHES STAT; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Garaizar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32689; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Graham K. T., 2015, PSYCHOL CONSCIOUS, V2, P269, DOI [10.1037/cns0000067, DOI 10.1037/cns0000067, DOI 10.1037/CNS0000067]; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; Haggard P, 2003, NEUROREPORT, V14, P1081, DOI 10.1097/01.wnr.0000073684.00308.c0; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hascalovitz A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00013; Hauser M, 2011, SCHIZOPHR RES, V126, P20, DOI 10.1016/j.schres.2010.10.031; Howes OD, 2013, SCHIZOPHRENIA BULL, V39, P807, DOI 10.1093/schbul/sbr195; Hur JW, 2014, SCHIZOPHR RES, V152, P58, DOI 10.1016/j.schres.2013.08.042; KAROUM F, 1990, EUR J PHARMACOL, V186, P1; Keeton CP, 2008, J FAM PSYCHOL, V22, P212, DOI 10.1037/0893-3200.22.2.212; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Krugel LK, 2009, P NATL ACAD SCI USA, V106, P17951, DOI 10.1073/pnas.0905191106; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Marona-Lewicka D, 2005, PSYCHOPHARMACOLOGY, V180, P427, DOI 10.1007/s00213-005-2183-9; Miles GJ, 2019, PERS INDIV DIFFER, V141, P143, DOI 10.1016/j.paid.2019.01.004; Moore JW, 2014, Q J EXP PSYCHOL, V67, P2218, DOI 10.1080/17470218.2014.911332; Moore JW, 2013, NEUROPSYCHOLOGIA, V51, P377, DOI 10.1016/j.neuropsychologia.2012.07.005; Moore JW, 2012, CONSCIOUS COGN, V21, P1748, DOI 10.1016/j.concog.2012.10.005; Moore JW, 2011, COGN NEUROPSYCHIATRY, V16, P364, DOI 10.1080/13546805.2010.546074; Moore JW, 2010, NEUROPSYCHOLOGIA, V48, P1125, DOI 10.1016/j.neuropsychologia.2009.12.014; Narendran R, 2005, AM J PSYCHIAT, V162, P2352, DOI 10.1176/appi.ajp.162.12.2352; Nichols CD, 2002, NEUROPSYCHOPHARMACOL, V26, P634, DOI 10.1016/S0893-133X(01)00405-5; Obhi SS, 2013, EXP BRAIN RES, V229, P497, DOI 10.1007/s00221-012-3372-5; Oswald WD., 1987, ZAHLEN VERBINDUNGS T; Paulhus DL, 2011, J PERS ASSESS, V93, P96, DOI 10.1080/00223891.2010.528483; Pockett S, 2007, CONSCIOUS COGN, V16, P241, DOI 10.1016/j.concog.2006.09.002; PONZIO F, 1982, NEUROBIOL AGING, V3, P23, DOI 10.1016/0197-4580(82)90057-4; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; RICAURTE GA, 1984, BRAIN RES, V303, P359, DOI 10.1016/0006-8993(84)91221-6; Rosset E, 2008, COGNITION, V108, P771, DOI 10.1016/j.cognition.2008.07.001; Rosset E, 2014, J COGN CULT, V14, P27, DOI 10.1163/15685373-12342108; Saito N, 2015, CONSCIOUS COGN, V37, P1, DOI 10.1016/j.concog.2015.07.011; Schoeneich F, 2000, PSYCHOTHER PSYCH MED, V50, P396, DOI 10.1055/s-2000-9095; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Synofzik M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00127; Taurisano P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00235; Tomer R, 2014, J COGNITIVE NEUROSCI, V26, P1039, DOI 10.1162/jocn_a_00544; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Urban NBL, 2012, BIOL PSYCHIAT, V71, P677, DOI 10.1016/j.biopsych.2011.12.018; Vaillancourt DE, 2013, MOVEMENT DISORD, V28, P1920, DOI 10.1002/mds.25687; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; VERNON PA, 1993, PERS INDIV DIFFER, V14, P35, DOI 10.1016/0191-8869(93)90172-Y; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Volkow ND, 1990, ANN REV ADDICTIONS R, P97; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; WATSON PJ, 1991, PERS INDIV DIFFER, V12, P575, DOI 10.1016/0191-8869(91)90253-8; Wen W, 2015, CONSCIOUS COGN, V36, P87, DOI 10.1016/j.concog.2015.06.004; WINK P, 1991, J PERS SOC PSYCHOL, V61, P590; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zalla T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01278; Zeigler-Hill V, 2008, J PERS, V76, P753, DOI 10.1111/j.1467-6494.2008.00503.x; Zeigler-Hill V, 2011, PERS INDIV DIFFER, V51, P51, DOI 10.1016/j.paid.2011.03.009	73	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214069	10.1371/journal.pone.0214069	http://dx.doi.org/10.1371/journal.pone.0214069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP3JN	30889224	gold, Green Submitted, Green Published			2022-12-26	WOS:000461573000046
J	Kleene, SJ; Siroky, BJ; Landero-Figueroa, JA; Dixon, BP; Pachciarz, NW; Lu, L; Kleene, NK				Kleene, Steven J.; Siroky, Brian J.; Landero-Figueroa, Julio A.; Dixon, Bradley P.; Pachciarz, Nolan W.; Lu, Lu; Kleene, Nancy K.			The TRPP2-dependent channel of renal primary cilia also requires TRPM3	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; CALCIUM-CHANNEL; GENE; ASSOCIATION; CONDUCTANCE; DYSFUNCTION; MEMBRANE; ENCODES; PATHWAY; SULFATE	Primary cilia of renal epithelial cells express several members of the transient receptor potential (TRP) class of cation-conducting channel, including TRPC1, TRPM3, TRPM4, TRPP2, and TRPV4. Some cases of autosomal dominant polycystic kidney disease (ADPKD) are caused by defects in TRPP2 (also called polycystin-2, PC2, or PKD2). A large-conductance, TRPP2-dependent channel in renal cilia has been well described, but it is not known whether this channel includes any other protein subunits. To study this question, we investigated the pharmacology of the TRPP2-dependent channel through electrical recordings from the cilia of mIMCD-3 cells, a murine cell line of renal epithelial origin. The pharmacology was found to match that of TRPM3 channels. The ciliary TRPP2-dependent channel is known to be activated by depolarization and by increasing cytoplasmic Ca2+. This activation was greatly enhanced by external pregnenolone sulfate, an agonist of TRPM3 channels. Pregnenolone sulfate did not change the single-channel current-voltage relation. The channels were effectively blocked by isosakuranetin, a specific inhibitor of TRPM3 channels. Both pregnenolone sulfate and isosakuranetin were effective at concentrations as low as 1 mu M. Knocking out TRPM3 by CRISPR/Cas9 genome editing eliminated the ciliary channel. Thus the channel is both TRPM3-dependent and TRPP2-dependent, suggesting that it may include both types of subunit. Knocking out TRPM3 did not change the level of TRPP2 protein in the cilia, so it is unlikely that the absence of functional ciliary channels results from a failure of trafficking.	[Kleene, Steven J.; Kleene, Nancy K.] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA; [Siroky, Brian J.; Pachciarz, Nolan W.; Lu, Lu] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA; [Landero-Figueroa, Julio A.] Univ Cincinnati, Dept Chem, Cincinnati, OH USA; [Dixon, Bradley P.] Univ Colorado, Renal Sect, Dept Pediat, Sch Med, Aurora, CO USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Colorado System; University of Colorado Anschutz Medical Campus	Kleene, SJ (corresponding author), Univ Cincinnati, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45221 USA.	steven.kleene@uc.edu		Dixon, Bradley/0000-0003-3704-0922; Kleene, Steven/0000-0001-7663-3590; Landero, Julio/0000-0001-8641-0497	UAB Hepato/Renal Fibrocystic Diseases Core Center; National Institute of Diabetes and Kidney Disease, National Institutes of Health [P30 DK074038]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER	UAB Hepato/Renal Fibrocystic Diseases Core Center; National Institute of Diabetes and Kidney Disease, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SJK, NJS, BPD, NWP, and NKK were supported by a subcontract from the UAB Hepato/Renal Fibrocystic Diseases Core Center, which is supported by the National Institute of Diabetes and Kidney Disease (https://www.nidcd.nih.gov/), National Institutes of Health, under award P30 DK074038 (Bradley K. Yoder, Principal Investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Majeed S, 2011, BBA-MOL BASIS DIS, V1812, P1281, DOI 10.1016/j.bbadis.2010.09.016; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Battini L, 2008, HUM MOL GENET, V17, P2819, DOI 10.1093/hmg/ddn180; Bennett TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104000; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; Brown RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121688; Calvet JP, 2015, POLYCYSTIC KIDNEY DISEASE, P169; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chebib FT, 2015, NAT REV NEPHROL, V11, P451, DOI 10.1038/nrneph.2015.39; Cheng W, 2010, PROTEIN CELL, V1, P802, DOI 10.1007/s13238-010-0108-9; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Drews A, 2014, BRIT J PHARMACOL, V171, P1019, DOI 10.1111/bph.12521; Flannery RJ, 2015, AM J PHYSIOL-RENAL, V309, pF697, DOI 10.1152/ajprenal.00294.2015; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Harteneck C, 2013, MOLECULES, V18, P12012, DOI 10.3390/molecules181012012; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Jin XJ, 2014, BBA-MOL BASIS DIS, V1842, P1518, DOI 10.1016/j.bbadis.2014.06.001; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kleene Nancy K, 2012, Cilia, V1, DOI 10.1186/2046-2530-1-17; KLEENE SJ, 1992, PFLUG ARCH EUR J PHY, V421, P374, DOI 10.1007/BF00374226; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kleene SJ, 2017, AM J PHYSIOL-RENAL, V312, pF96, DOI 10.1152/ajprenal.00272.2016; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Liu XW, 2018, ELIFE, V7, DOI 10.7554/eLife.33183; Marshall-Gradisnik S, 2016, APPL CLIN GENET, V9, P39, DOI 10.2147/TACG.S99405; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Narayanankutty A, 2016, LUNG, V194, P273, DOI 10.1007/s00408-016-9852-9; Nauli SM, 2016, CURR OPIN NEPHROL HY, V25, P452, DOI 10.1097/MNH.0000000000000251; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Oberwinkler J, 2014, HANDB EXP PHARMACOL, V222, P427, DOI 10.1007/978-3-642-54215-2_17; Oztuzcu S, 2015, IN VIVO, V29, P763; Pablo JL, 2017, J GEN PHYSIOL, V149, P37, DOI 10.1085/jgp.201611696; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Sanchez-Guijo A, 2015, J LIPID RES, V56, P1843, DOI 10.1194/jlr.D061499; Sigg MA, 2017, DEV CELL, V43, P744, DOI 10.1016/j.devcel.2017.11.014; Siroky BJ, 2017, AM J PHYSIOL-RENAL, V312, pF791, DOI 10.1152/ajprenal.00465.2015; Straub I, 2013, MOL PHARMACOL, V84, P736, DOI 10.1124/mol.113.086843; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/NMETH.2647, 10.1038/nmeth.2647]; TANG JM, 1990, PFLUG ARCH EUR J PHY, V416, P347, DOI 10.1007/BF00392072; Thiel G, 2017, PHARMACOL RES, V124, P92, DOI 10.1016/j.phrs.2017.07.014; Tran PV, 2014, BIRTH DEFECTS RES C, V102, P159, DOI 10.1002/bdrc.21065; Vandewauw I, 2018, NATURE, V555, P662, DOI 10.1038/nature26137; Vriens J, 2014, NAT CHEM BIOL, V10, P188, DOI [10.1038/nchembio.1428, 10.1038/NCHEMBIO.1428]; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WARD CJ, 1994, CELL, V77, P881; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yuan SL, 2015, CURR BIOL, V25, P556, DOI 10.1016/j.cub.2014.12.051; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zhang ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073424; Zhao PY, 2015, INVEST OPHTH VIS SCI, V56, P1916, DOI 10.1167/iovs.14-15738	61	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0214053	10.1371/journal.pone.0214053	http://dx.doi.org/10.1371/journal.pone.0214053			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883612	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500048
J	Panpisut, P; Khan, MA; Main, K; Arshad, M; Xia, W; Petridis, H; Young, AM				Panpisut, Piyaphong; Khan, Muhammad Adnan; Main, Kirsty; Arshad, Mayda; Xia, Wendy; Petridis, Haralampos; Young, Anne Margaret			Polymerization kinetics stability, volumetric changes, apatite precipitation, strontium release and fatigue of novel bone composites for vertebroplasty	PLOS ONE			English	Article							FREE-RADICAL POLYMERIZATION; METHYL-METHACRYLATE; FLEXURAL STRENGTH; DENTAL COMPOSITES; DIMETHACRYLATE MONOMERS; POLYMETHYL METHACRYLATE; OXYGEN INHIBITION; CEMENT LEAKAGE; PHOTO-DSC; CONVERSION	Purpose The aim was to determine effects of diluent monomer and monocalcium phosphate monohydrate (MCPM) on polymerization kinetics and volumetric stability, apatite precipitation, strontium release and fatigue of novel dual-paste composites for vertebroplasty. Materials and methods Polypropylene (PPGDMA) or triethylene (TEGDMA) glycol dimethacrylates (25 wt%) diluents were combined with urethane dimethacrylate (70 wt%) and hydroxyethyl methacrylate (5 wt%). 70 wt% filler containing glass particles, glass fibers (20 wt%) and polylysine (5 wt%) was added. Benzoyl peroxide and MCPM (10 or 20 wt%) or N-tolyglycine glycidyl methacrylate and tristrontium phosphate (15 wt%) were included to give initiator or activator pastes. Commercial PMMA (Simplex) and bone composite (Cortoss) were used for comparison. ATR-FTIR was used to determine thermal activated polymerization kinetics of initiator pastes at 5080 degrees C. Paste stability, following storage at 437 degrees C, was assessed visually or through mixed paste polymerization kinetics at 25 degrees C. Polymerization shrinkage and heat generation were calculated from final monomer conversions. Subsequent expansion and surface apatite precipitation in simulated body fluid (SBF) were assessed gravimetrically and via SEM. Strontium release into water was assessed using ICP-MS. Biaxial flexural strength (BFS) and fatigue properties were determined at 37 degrees C after 4 weeks in SBF. Results Polymerization profiles all exhibited an inhibition time before polymerization as predicted by free radical polymerization mechanisms. Initiator paste inhibition times and maximum reaction rates were described well by Arrhenius plots. Plot extrapolation, however, underestimated lower temperature paste stability. Replacement of TEGDMA by PPGDMA, enhanced paste stability, final monomer conversion, water-sorption induced expansion and strontium release but reduced polymerization shrinkage and heat generation. Increasing MCPM level enhanced volume expansion, surface apatite precipitation and strontium release. Although the experimental composite flexural strengths were lower compared to those of commercially available Simplex, the extrapolated low load fatigue lives of all materials were comparable. Conclusions Increased inhibition times at high temperature give longer predicted shelf-life whilst stability of mixed paste inhibition times is important for consistent clinical application. Increased volumetric stability, strontium release and apatite formation should encourage bone integration. Replacing TEGDMA by PPGDMA and increasing MCPM could therefore increase suitability of the above novel bone composites for vertebroplasty. Long fatigue lives of the composites may also ensure long-term durability of the materials.	[Panpisut, Piyaphong; Khan, Muhammad Adnan; Main, Kirsty; Arshad, Mayda; Xia, Wendy; Young, Anne Margaret] UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England; [Petridis, Haralampos] UCL Eastman Dent Inst, Dept Restorat Dent, Unit Prosthodont, London, England; [Panpisut, Piyaphong] Thammasat Univ, Fac Dent, Pathum Thani, Thailand; [Khan, Muhammad Adnan] Khyber Teaching Hosp MTI, Khyber Coll Dent, Sci Dent Mat, Peshawar, Pakistan	University of London; University College London; University of London; University College London; Thammasat University	Young, AM (corresponding author), UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England.	Anne.Young@ucl.ac.uk	Panpisut, Piyaphong/AAW-1712-2020; Panpisut, Piyaphong/AAJ-5419-2021	Panpisut, Piyaphong/0000-0002-8649-857X; Young, Anne/0000-0001-8485-2056	Royal Thai Government, Ministry of Sciences and Technology; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre [NIHR UCL BRC: BRC522a/OH/AY/110380]; National Institute for Health Research (NIHR) [NIHR: II-LB-0214-20002]; Engineering and Physical Sciences Research Council [EPSRC: EP/I022341/1]; Wellcome Trust [ISSF/FHCE/0079]; National Institute for Health Research (NIHR) under its Invention for Innovation (i4i) Programme [II-LB-0214-20002]; EPSRC [EP/I022341/1] Funding Source: UKRI; MRC [MC_PC_15037] Funding Source: UKRI	Royal Thai Government, Ministry of Sciences and Technology; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) under its Invention for Innovation (i4i) Programme(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by: 1) PP: The Royal Thai Government, Ministry of Sciences and Technology (http://www.most.go.th); 2) WX and AY: The National Institute for Health Research, University College London Hospitals, Biomedical Research Centre (NIHR UCL BRC: BRC522a/OH/AY/110380)(www.uclhospitals.brc.nihr.ac.uk); National Institute for Health Research (NIHR) (NIHR: II-LB-0214-20002)(https://www.nihr.ac.uk); The Engineering and Physical Sciences Research Council (EPSRC: EP/I022341/1) (https://epsrc.ukri.org); Wellcome Trust (ISSF/FHCE/0079) (https://wellcome.ac.uk).This paper presents independent research in part funded by the National Institute for Health Research (NIHR) under its Invention for Innovation (i4i) Programme (Grant Reference Number II-LB-0214-20002). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman H, 2013, SPINE J, V13, P1809, DOI 10.1016/j.spinee.2013.05.053; Achilias DS, 2004, MACROMOLECULES, V37, P4254, DOI 10.1021/ma049803n; Ali U, 2015, POLYM REV, V55, P678, DOI 10.1080/15583724.2015.1031377; Aljabo A, 2015, DENT MATER, V31, P1279, DOI 10.1016/j.dental.2015.08.149; Aljabo A, 2016, MAT SCI ENG C-MATER, V60, P285, DOI 10.1016/j.msec.2015.11.047; [Anonymous], 2002, 58332002 BS ISO; [Anonymous], 2012, 233172012 BS ISO; Ayre WN, 2014, J MECH BEHAV BIOMED, V32, P76, DOI 10.1016/j.jmbbm.2013.12.010; Bae H, 2010, SPINE, V35, pE1030, DOI 10.1097/BRS.0b013e3181dcda75; Belbakra Z, 2014, POLYM DEGRAD STABIL, V110, P298, DOI 10.1016/j.polymdegradstab.2014.09.012; Belli R, 2014, DENT MATER, V30, P381, DOI 10.1016/j.dental.2014.01.009; BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E; Benzel EC, 2012, VERTEBROPLASTY KYPHO, P1253; Boyd D, 2008, J MATER SCI-MATER M, V19, P1745, DOI 10.1007/s10856-007-3363-4; CAPEK I, 1989, CHEM PAP, V43, P527; Cardoso S.A, 2014, APPL ADHESION SCI, V2, DOI [10.1186/s40563-014-0026-9, DOI 10.1186/S40563-014-0026-9]; Chen H, 2014, WORLD J ORTHOP, V5, P486, DOI 10.5312/wjo.v5.i4.486; Corcione CE, 2008, EUR POLYM J, V44, P2010, DOI 10.1016/j.eurpolymj.2008.04.030; Corcione CE, 2009, POLYM TEST, V28, P157, DOI 10.1016/j.polymertesting.2008.11.002; Dewaele M, 2006, DENT MATER, V22, P359, DOI 10.1016/j.dental.2005.03.014; Dorozhkin SV, 2009, MATERIALS, V2, P221, DOI 10.3390/ma2010221; Erbe EM, 2001, EUR SPINE J, V10, pS147, DOI 10.1007/s005860100288; Finan L, 2013, DENT MATER, V29, P906, DOI 10.1016/j.dental.2013.05.008; Gauthier MA, 2005, J DENT RES, V84, P725, DOI 10.1177/154405910508400808; Goncalves F, 2009, EUR J ORAL SCI, V117, P442, DOI 10.1111/j.1600-0722.2009.00636.x; Hadley C, 2010, NEUROIMAG CLIN N AM, V20, P159, DOI 10.1016/j.nic.2010.02.002; Harmata AJ, 2015, J MECH BEHAV BIOMED, V51, P345, DOI 10.1016/j.jmbbm.2015.07.027; Hoppe S, 2016, EUR SPINE J, V25, P3450, DOI 10.1007/s00586-015-3920-3; Huang L, 2017, MAT SCI ENG C-MATER, V70, P955, DOI 10.1016/j.msec.2016.05.115; Kane RJ, 2010, J MECH BEHAV BIOMED, V3, P504, DOI 10.1016/j.jmbbm.2010.05.007; Khan MA, 2014, PIONEERING FUTURE BI; Koster U, 2013, J MATER SCI-MATER M, V24, P1395, DOI 10.1007/s10856-013-4909-2; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Kuehn KD, 2005, ORTHOP CLIN N AM, V36, P17, DOI 10.1016/j.ocl.2004.06.010; Kurtz SM, 2005, BIOMATERIALS, V26, P3699, DOI 10.1016/j.biomaterials.2004.09.055; Lee TY, 2004, POLYMER, V45, P6155, DOI 10.1016/j.polymer.2004.06.060; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398; Lewis G, 2017, J BIOMED MATER RES B, V105, P1260, DOI 10.1002/jbm.b.33643; Li YA, 2012, SPINE, V37, P179, DOI 10.1097/BRS.0b013e3181f72b05; Lieberman Isador H, 2005, Spine J, V5, p305S, DOI 10.1016/j.spinee.2005.02.020; Lin J, 2016, SPINE J, V16, pS262, DOI [10.1016/j.spinee.2016.07.352, DOI 10.1016/J.SPINEE.2016.07.352]; Liu J, 2016, DENT MATER, V32, P412, DOI 10.1016/j.dental.2015.12.013; Loeffel M, 2008, SPINE, V33, P1352, DOI 10.1097/BRS.0b013e3181732aa9; Mehbod A, 2003, EUR SPINE J, V12, pS155, DOI 10.1007/s00586-003-0607-y; Mehdawi IM, 2013, DENT MATER, V29, P473, DOI 10.1016/j.dental.2013.01.010; Middleton ET, 2008, BRIT J NEUROSURG, V22, P252, DOI 10.1080/02688690701824354; Montesi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172100; Nakamura T, 2013, J PHARM SCI-US, V102, P1495, DOI 10.1002/jps.23486; Nakamura Y, 2015, MACROMOLECULES, V48, P6450, DOI 10.1021/acs.macromol.5b01532; Nomura Y, 2006, J MATER SCI-MATER M, V17, P29, DOI 10.1007/s10856-006-6326-2; Odian G., 2004, PRINCIPLES POLYM, P198, DOI [10.1002/047147875X, DOI 10.1002/047147875X.CH3]; Panpisut P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164653; Pittayachawan P, 2007, DENT MATER, V23, P1018, DOI 10.1016/j.dental.2006.09.003; Pomrink GJ, 2003, BIOMATERIALS, V24, P1023, DOI 10.1016/S0142-9612(02)00443-X; Robo C, 2018, ACTA BIOMATER, V72, P362, DOI 10.1016/j.actbio.2018.03.014; Rohlmann A, 2010, EUR SPINE J, V19, P1585, DOI 10.1007/s00586-010-1386-x; Schmitt S, 2004, BIOMED TECH, V49, P61, DOI 10.1515/BMT.2004.012; Schumacher M, 2016, ACTA BIOMATER, V37, P184, DOI 10.1016/j.actbio.2016.04.016; Schumacher M, 2015, J MATER CHEM B, V3, P4626, DOI 10.1039/c5tb00654f; Shah DU, 2013, COMPOS SCI TECHNOL, V74, P139, DOI 10.1016/j.compscitech.2012.10.015; Shahid S, 2014, DENT MATER, V30, P308, DOI 10.1016/j.dental.2013.12.003; Shim JB, 2005, BIOMATERIALS, V26, P4181, DOI 10.1016/j.biomaterials.2004.10.027; Shingala M.C., 2015, INT J NEW TECHNOL SC, V2, P22, DOI DOI 10.1109/ISIT.2014.6875215; Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8; Sideridou ID, 2006, MACROMOLECULES, V39, P2072, DOI 10.1021/ma0521351; Srivastava R, 2017, EUR POLYM J, V90, P334, DOI 10.1016/j.eurpolymj.2017.03.027; Tome-Bermejo F, 2014, SPINE, V39, pE693, DOI 10.1097/BRS.0000000000000294; Vallo CI, 2002, J BIOMED MATER RES, V63, P627, DOI 10.1002/jbm.10334; Walters NJ, 2016, DENT MATER, V32, P264, DOI 10.1016/j.dental.2015.11.017; Wang JL, 2012, J BIOMECH, V45, P1372, DOI 10.1016/j.jbiomech.2012.03.003; Wilke HJ, 2006, SPINE, V31, P2934, DOI 10.1097/01.brs.0000248423.28511.44; Ye S, 2011, MACROMOLECULES, V44, P490, DOI 10.1021/ma101296j; Zhang L, 2016, DENT MATER, V32, P285, DOI 10.1016/j.dental.2015.11.015	74	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0207965	10.1371/journal.pone.0207965	http://dx.doi.org/10.1371/journal.pone.0207965			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883564	gold, Green Published, Green Submitted			2022-12-26	WOS:000461423500004
J	Saetae, T; Pongpirul, K; Samransamruajkit, R				Saetae, Thansinee; Pongpirul, Krit; Samransamruajkit, Rujipat			Assessment of early goal-directed therapy guideline adherence: Balancing clinical importance and feasibility	PLOS ONE			English	Article							SURVIVING SEPSIS CAMPAIGN; SEPTIC SHOCK; MANAGEMENT; OUTCOMES; IMPLEMENTATION; RESUSCITATION; PROTOCOL	Background Assessing adherence to Early goal-directed therapy (EGDT) is challenging and might account for the negative findings and generalisability of the major trials to a real-life setting. This study was aimed (1) to extract key components of pediatric EGDT guidelines potentially becoming adherence criteria; (2) to classify adherence criteria into complete, clinically important, and feasible; and (3) to compare percent adherence to selected guidelines using the three approaches. Methods This study started with review of existing evidence to extract key components of pediatric EGDT guidelines. Modified Delphi method was then conducted in two rounds among national experts to identify feasible and/or clinically important criteria. Data from the national prospective multicenter study "Clinical Effectiveness of the Utilization of Bundled Care for Severe Sepsis and Septicemia Children" at King Chulalongkorn Memorial Hospital (KCMH) during 1 June 2012 and 28 February 2014 was used to compare percentage of adherence across the three approaches. Results Of 28 components extracted from the review, 10 were identified by the national experts through the Modified Delphi as feasible whereas 8 were identified as clinically important. Thirty-one severe sepsis patients (48.39% male, median age 3.4 years) were reviewed. Sepsis mortality was 9.7%, a significant reduction from 19% and 42% in 2010 and 2007, respectively. Based on the complete adherence criteria, the percent adherence varied from 60.71% to 89.29% (overall mean 76.84%), with lower adherence in the dead than the survived cases (73.81% vs 77.17%; p = 0.55). The percent adherence varied by criteria used: 69.35%, 76.84%, and 84.52% for clinical importance, complete, and feasibility criteria, respectively. Conclusion Adherence determination based on selected clinical importance alone might result in an incorrectly estimated clinical benefit of EGDT guidelines, especially in a resource-limited setting. Both clinical importance and feasibility should be integrated into the development of adherence assessment criteria.	[Saetae, Thansinee; Samransamruajkit, Rujipat] Chulalongkorn Univ, Dept Pediat, Fac Med, Bangkok, Thailand; [Pongpirul, Krit] Chulalongkorn Univ, Dept Prevent & Social Med, Fac Med, Bangkok, Thailand; [Pongpirul, Krit] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Chulalongkorn University; Chulalongkorn University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pongpirul, K (corresponding author), Chulalongkorn Univ, Dept Prevent & Social Med, Fac Med, Bangkok, Thailand.; Pongpirul, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	doctorkrit@gmail.com	Pongpirul, Krit/H-4064-2019; Samransamruajkit, Rujipat/V-7046-2019; Samransamruajkit, Rujipat/AFO-8542-2022	Pongpirul, Krit/0000-0003-3818-9761; 	National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This study received funding support from the National Research Council of Thailand. The funding body did not involve in the study design, data collection, data analysis, data interpretation, or manuscript preparation.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; Carlbom DJ, 2007, CRIT CARE MED, V35, P2525, DOI 10.1097/01.ccm.0000298122.49245.d7; Crowe CA, 2010, AM J EMERG MED, V28, P689, DOI 10.1016/j.ajem.2009.03.007; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Jones AE, 2005, CRIT CARE MED, V33, P974, DOI [10.1097/01.CCM.0000162495.03291.C2, 10.1097/01.CCM.0000166872.78449.B1]; Jones AE, 2007, CHEST, V132, P425, DOI 10.1378/chest.07-0234; Kawasaki T, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0240-1; Kortgen A, 2006, CRIT CARE MED, V34, P943, DOI 10.1097/01.CCM.0000206112.32673.D4; Micek ST, 2006, CRIT CARE MED, V34, P2707, DOI 10.1097/01.CCM.0000241151.25426.D7; Mikkelsen ME, 2010, CHEST, V138, P551, DOI 10.1378/chest.09-2210; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2007, ACAD EMERG MED, V14, P1079, DOI 10.1111/j.1553-2712.2007.tb02392.x; O'Neill R, 2012, J EMERG MED, V42, P503, DOI 10.1016/j.jemermed.2011.03.024; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Samransamruajkit R, 2014, INDIAN J CRIT CARE M, V18, P70, DOI 10.4103/0972-5229.126075; Sankar J, 2014, PEDIATR CRIT CARE ME, V15, pE157, DOI 10.1097/PCC.0000000000000073; Shapiro NI, 2006, CRIT CARE MED, V34, P1025, DOI 10.1097/01.CCM.0000206104.18647.A8; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	22	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213802	10.1371/journal.pone.0213802	http://dx.doi.org/10.1371/journal.pone.0213802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875402	gold, Green Submitted, Green Published			2022-12-26	WOS:000461316400032
J	dos Santos, LM; Donassolo, RA; Berne, ME; Leite, FPL; Avila, LFD; Scaini, CJ; Moreira, AN; Conceicao, FR				dos Santos, Lucas Moreira; Donassolo, Rafael Amaral; Berne, Maria Elisabeth; Leivas Leite, Fabio Pereira; da Costa Avila, Luciana Farias; Scaini, Carlos James; Moreira, Angela Nunes; Conceicao, Fabricio Rochedo			The serodiagnostic potential of recombinant proteins TES-30 and TES-120 in an indirect ELISA in the diagnosis of toxocariasis in cattle, horses, and sheep	PLOS ONE			English	Article							SEROLOGICAL DIAGNOSIS; CANINE TOXOCARIASIS; RISK-FACTORS; ANTIGEN; SEROPREVALENCE; TOXASCARIS; INFECTION; VITULORUM; LARVAE; IGG	Toxocariasis is a zoonotic disease that affects humans and animals alike. Although recombinant proteins are widely used for its diagnosis in humans, their performance in companion and production animals remains unknown. This study aimed to investigate the serodiagnostic potential of the recombinant proteins rTES-30 and rTES-120 from Toxocara canis in an indirect ELISA for cattle, horses, and sheep. Serum samples collected from the animals were tested with indirect ELISA and Western Blotting using T. canis TES-30 and TES-120 recombinant proteins produced in Escherichia coli, as well as native-TES. In the ELISA, rTES-30 showed high serodiagnostic potential in sheep and horses (92.6% and 85.2%, respectively), while the sensitivity of rTES-120 was higher in cattle and horses (97.2% and 92.6%, respectively). Furthermore, a highly positive association was observed between native and recombinant proteins in seropositive samples, while a moderately positive association was observed in seronegative samples, probably due to the lower specificity of native TES. In conclusion, our study indicates that the use of recombinant proteins in an indirect ELISA is an effective tool for the serodiagnosis of toxocariasis in animals, with the choice of protein being species-dependent.	[dos Santos, Lucas Moreira; Donassolo, Rafael Amaral; Leivas Leite, Fabio Pereira; Moreira, Angela Nunes; Conceicao, Fabricio Rochedo] Univ Fed Pelotas, Dept Biotechnol, Pelotas, RS, Brazil; [Berne, Maria Elisabeth] Univ Fed Pelotas, Dept Parasitol, Pelotas, RS, Brazil; [da Costa Avila, Luciana Farias; Scaini, Carlos James] Univ Fed Rio Grande, Fac Med, Rio Grande, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal do Rio Grande	dos Santos, LM (corresponding author), Univ Fed Pelotas, Dept Biotechnol, Pelotas, RS, Brazil.	lucass1@hotmail.com	Avila, Luciana/F-9402-2013; Santos, Lucas/AAQ-6837-2021; Moreira, Angela/D-1278-2019	Santos, Lucas/0000-0002-2402-8580; Donassolo, Rafael/0000-0002-9919-6845; Moreira, Angela/0000-0001-5347-8559	Programa de Pesquisa para o SUS (PPSUS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	Programa de Pesquisa para o SUS (PPSUS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partly funded by: Programa de Pesquisa para o SUS (PPSUS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), finance code 001 to LMS.	Charlier J, 2016, IRISH VET J, V69, DOI 10.1186/s13620-016-0073-6; Cunha RC, 2012, REV BRAS PARASITOL V, V21, P254, DOI 10.1590/S1984-29612012000300014; de Aquino FM, 2018, REV BRAS PARASITOL V, V27, P123, DOI [10.1590/S1984-296120180024, 10.1590/s1984-296120180024]; DESAVIGNY DH, 1979, J CLIN PATHOL, V32, P284, DOI 10.1136/jcp.32.3.284; Despommier D, 2003, CLIN MICROBIOL REV, V16, P265, DOI 10.1128/CMR.16.2.265-272.2003; dos Santos LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208991; dos Santos LM, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12568; Farmer A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005818; Fong Mun-Yik, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P723; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Nguyen HH, 2017, IRAN J PARASITOL, V12, P69; Jin Y, 2015, J KOREAN MED SCI, V30, P549, DOI 10.3346/jkms.2015.30.5.549; Johnson NP, 2004, STAT MED, V23, P2257, DOI 10.1002/sim.1835; Kagenda GA, 2018, TROP ANIM HEALTH PRO, V50, P1599, DOI 10.1007/s11250-018-1600-0; Li K, 2016, KOREAN J PARASITOL, V54, P645, DOI 10.3347/kjp.2016.54.5.645; MARTI H, 1993, J CLIN MICROBIOL, V31, P3044, DOI 10.1128/JCM.31.11.3044-3045.1993; Mohamad S, 2009, J CLIN MICROBIOL, V47, P1712, DOI 10.1128/JCM.00001-09; Moraes CM, 2014, ARQ BRAS MED VET ZOO, V66, P1015, DOI 10.1590/1678-6034; Nunes Caris Maroni, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P253, DOI 10.1590/S0036-46651997000500002; Ozkoc S, 2012, MIKROBIYOL BUL, V46, P456; PAGE AP, 1991, PARASITOLOGY, V103, P451, DOI 10.1017/S0031182000059977; Peixoto PL, 2011, MEM I OSWALDO CRUZ, V106, P200, DOI 10.1590/S0074-02762011000200014; Rast L, 2014, PREV VET MED, V113, P211, DOI 10.1016/j.prevetmed.2013.10.021; Moreiral GMSG, 2014, TRENDS PARASITOL, V30, P456, DOI 10.1016/j.pt.2014.07.003; Schoenardie ER, 2014, REV BRAS PARASITOL V, V23, P403, DOI 10.1590/S1984-29612014060; Regis SCS, 2011, ACTA TROP, V120, P46, DOI 10.1016/j.actatropica.2011.05.011; Spratt DM, 1997, INT J PARASITOL, V27, P173, DOI 10.1016/S0020-7519(96)00147-6; Squire SA, 2018, PARASITOL RES, V117, P3183, DOI 10.1007/s00436-018-6017-1; SURGAN MH, 1980, AM J PUBLIC HEALTH, V70, P1207, DOI 10.2105/AJPH.70.11.1207; Nguyen T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1780-2; Van Aken D, 2000, VET PARASITOL, V89, P133, DOI 10.1016/S0304-4017(00)00190-4; Wickramasinghe S, 2009, PARASITOL RES, V104, P1425, DOI 10.1007/s00436-009-1345-9; Wickramasinghe S, 2009, MOL BIOCHEM PARASIT, V166, P89, DOI 10.1016/j.molbiopara.2009.02.012; Zahabiun F, 2015, AM J TROP MED HYG, V93, P319, DOI 10.4269/ajtmh.15-0190	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213830	10.1371/journal.pone.0213830	http://dx.doi.org/10.1371/journal.pone.0213830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870519	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300084
J	Lin, WJ; Huang, W; Ning, SJ; Gong, XG; Ye, Q; Wei, DZ				Lin, Wenjin; Huang, Wei; Ning, Shuju; Gong, Xiaogui; Ye, Qi; Wei, Daozhi			Comparative transcriptome analyses revealed differential strategies of roots and leaves from methyl jasmonate treatment Baphicacanthus cusia (Nees) Bremek and differentially expressed genes involved in tryptophan biosynthesis	PLOS ONE			English	Article							INDUCED LEAF SENESCENCE; OPTIMAL DEFENSE THEORY; INDIGO NATURALIS; INDOXYL SULFATE; AUXIN BIOSYNTHESIS; UREMIC TOXIN; GROWTH; INDIRUBIN; CONTRACTION; MICROBIOTA	Baphicacanthus cusia (Nees) Bremek (B. cusia) is an effective herb for the treatment of acute promyelocytic leukemia and psoriasis in traditional Chinese medicine. Methyl jasmonate (MeJA) is a well-known signaling phytohormone that triggers gene expression in secondary metabolism. Currently, MeJA-mediated biosynthesis of indigo and indirubin in B. cusia is not well understood. In this study, we analyzed the content of indigo and indirubin in leaf and root tissues of B. cusia with high-performance liquid chromatography and measured photosynthetic characteristics of leaves treated by MeJA using FluorCam6 Fluorometer and chlorophyll fluorescence using the portable photosynthesis system CIRAS-2. We performed de novo RNA-seq of B. cusia leaf and root transcriptional profiles to investigate differentially expressed genes (DEGs) in response to exogenous MeJA application. The amount of indigo in MeJA-treated leaves were higher than that in controled leaves (p = 0.004), and the amounts of indigo in treated roots was higher than that in controlled roots (p = 0.048); Chlorophyll fluorescence of leaves treated with MeJA were significantly decreased. Leaves treated with MeJA showed lower photosynthetic rate compared to the control in the absence of MeJA. Functional annotation of DEGs showed the DEGs related to growth and development processes were down-regulated in the treated leaves, while most of the unigenes involved in the defense response were up-regulated in treated roots. This coincided with the effects of MeJA on photosynthetic characteristics and chlorophyll fluorescence. The qRT-PCR results showed that MeJA appears to down-regulate the gene expression of tryptophan synthase beta-subunits (trpA-beta) in leaves but increased the gene expression of anthranilate synthase (trp 3) in roots responsible for increased indigo content. The results showed that MeJA suppressed leaf photosynthesis for B. cusia and this growth-defense trade-off may contribute to the improved adaptability of B. cusia in changing environments.	[Lin, Wenjin; Huang, Wei; Gong, Xiaogui; Ye, Qi; Wei, Daozhi] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China; [Lin, Wenjin] Fujian Acad Med Sci, Fujian Key Lab Med Measurement, Fuzhou, Fujian, Peoples R China; [Ning, Shuju] Fujian Agr & Forestry Univ, Sch Crop Sci, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Wei, DZ (corresponding author), Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China.	weidz888@sohu.com		Lin, Wenjin/0000-0002-4568-486X; Wei, Daozhi/0000-0002-3776-3023	National Natural Science Foundation of China [81573517]; Fujian Provincial Hospital, Fujian province, China [2017GT-001]; Natural Science Foundation of Fujian Province [2019J01827]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Hospital, Fujian province, China; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China (grant No. 81573517) and high-level hospital grants from Fujian Provincial Hospital, Fujian province, China (grant No. 2017GT-001). This work was also supported by the Natural Science Foundation of Fujian Province (grant No. 2019J01827, Dr. Daozhi Wei). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaran E, 2014, PLANT PHYSIOL, V165, P1302, DOI 10.1104/pp.114.239004; Bai B, 2018, NEW PHYTOL, V217, P1077, DOI 10.1111/nph.14885; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Caarls L, 2017, P NATL ACAD SCI USA, V114, P6388, DOI 10.1073/pnas.1701101114; Charoenchai P, 2010, PLANTA MED, V76, P1940, DOI 10.1055/s-0030-1250045; Chen HM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00324; Chiang CK, 2011, LAB INVEST, V91, P1564, DOI 10.1038/labinvest.2011.114; Ciura J, 2018, GENOMICS, V110, P267, DOI 10.1016/j.ygeno.2017.10.006; D'Onofrio C, 2018, FOOD CHEM, V242, P352, DOI 10.1016/j.foodchem.2017.09.084; Delgado LD, 2018, MOLECULES, V23, DOI 10.3390/molecules23061433; Deng YC, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8060997; Feng QT, 2016, CHEM PHARM BULL, V64, P1505, DOI 10.1248/cpb.c16-00315; Gu W, 2015, FITOTERAPIA, V107, P60, DOI 10.1016/j.fitote.2015.10.009; Gu W, 2014, J NAT PROD, V77, P2590, DOI 10.1021/np5003274; Heath JJ, 2014, NEW PHYTOL, V202, P1357, DOI 10.1111/nph.12755; Ho YL, 2003, AM J CHINESE MED, V31, P61, DOI 10.1142/S0192415X03000783; Hu YR, 2017, J EXP BOT, V68, P1361, DOI 10.1093/jxb/erx004; Huang H, 2017, J EXP BOT, V68, P1349, DOI 10.1093/jxb/erw495; Huang YX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00668; Jeon BJ, 2015, EUR REV MED PHARMACO, V19, P2303; Jeong YJ, 2018, J AGR FOOD CHEM, V66, P4099, DOI 10.1021/acs.jafc.8b00350; Ji YB, 2016, J EXP BOT, V67, P5233, DOI 10.1093/jxb/erw280; Kawai S, 2017, J GASTROENTEROL, V52, P904, DOI 10.1007/s00535-016-1292-z; Kikuchi M, 2017, NEPHRON, V135, P51, DOI 10.1159/000450619; Ko HC, 2006, J ETHNOPHARMACOL, V107, P205, DOI 10.1016/j.jep.2006.03.004; Kooyers NJ, 2017, ECOLOGY, V98, P1036, DOI 10.1002/ecy.1731; Kuo WY, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23074; Lee CT, 2012, LIFE SCI, V90, P47, DOI 10.1016/j.lfs.2011.10.014; Li ST, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-295; Liau BC, 2007, J PHARMACEUT BIOMED, V43, P346, DOI 10.1016/j.jpba.2006.06.029; Lin WJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199788; Lin YK, 2018, BRIT J DERMATOL, V178, P124, DOI 10.1111/bjd.15894; Liu HR, 2018, FOOD CHEM, V263, P194, DOI 10.1016/j.foodchem.2018.04.124; Liu JJ, 2017, PLANT MOL BIOL, V95, P359, DOI 10.1007/s11103-017-0655-z; Loutchko D, 2016, J PHYS CHEM B, V120, P2179, DOI 10.1021/acs.jpcb.5b12229; Mak NK, 2004, BIOCHEM PHARMACOL, V67, P167, DOI 10.1016/j.bcp.2003.08.020; Minami Y, 1997, PLANT CELL PHYSIOL, V38, P1069, DOI 10.1093/oxfordjournals.pcp.a029273; Mitra S, 2014, NEW PHYTOL, V201, P1385, DOI 10.1111/nph.12591; Miyazaki T, 1997, KIDNEY INT, pS211; Naganuma M, 2018, GASTROENTEROLOGY, V154, P935, DOI 10.1053/j.gastro.2017.11.024; Niwa T, 2013, EXPERT OPIN THER TAR, V17, P1287, DOI 10.1517/14728222.2013.829456; RADWANSKI ER, 1995, PLANT CELL, V7, P921, DOI 10.1105/tpc.7.7.921; Rahnamaie-Tajadod R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00109; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Schulman G, 2012, J RENAL NUTR, V22, P107, DOI 10.1053/j.jrn.2011.10.035; Shi J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0609-z; Sun JQ, 2011, NEW PHYTOL, V191, P360, DOI 10.1111/j.1469-8137.2011.03713.x; Sun JQ, 2009, PLANT CELL, V21, P1495, DOI 10.1105/tpc.108.064303; Taki K, 2005, J RENAL NUTR, V15, P77, DOI 10.1053/j.jrn.2004.09.028; Tan XL, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0028-z; Tanaka T, 2004, CHEM PHARM BULL, V52, P1242, DOI 10.1248/cpb.52.1242; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Xue Rengao, 2007, Journal of Genetics and Genomics, V34, P339, DOI 10.1016/S1673-8527(07)60036-8; Zhang YS, 2016, J EXP BOT, V67, P83, DOI 10.1093/jxb/erv438; Zhou BX, 2017, J ETHNOPHARMACOL, V199, P60, DOI 10.1016/j.jep.2017.01.038; Zhu HH, 2018, LANCET ONCOL, V19, P871, DOI 10.1016/S1470-2045(18)30295-X; Zhu HH, 2013, J CLIN ONCOL, V31, P4215, DOI 10.1200/JCO.2013.48.8312	58	5	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212863	10.1371/journal.pone.0212863	http://dx.doi.org/10.1371/journal.pone.0212863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865659	Green Submitted, gold, Green Published			2022-12-26	WOS:000461048900043
J	Li, BB; Hong, JX; Hong, M; Wang, YJ; Yu, TT; Zang, SB; Wu, QL				Li, Beibei; Hong, Jiaxin; Hong, Mei; Wang, Yajun; Yu, Tingting; Zang, Sibin; Wu, Qiuling			piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment	ONCOGENE			English	Article							NOVO DNA METHYLATION; BONE-MARROW MICROENVIRONMENT; LEUKEMIA-CELLS; SMALL RNA; EXOSOMES; MICROVESICLES; ANGIOGENESIS; CONTRIBUTES; PROTEINS; MIRNAS	Extracellular vesicles (EVs) can carry a wide array of RNAs in the tumor microenvironment, and are crucial for communication between tumor and surrounding stromal cells, including endothelial cells. Piwi-interacting RNAs (piRNAs) are important regulators implicated in the pathogenesis of multiple myeloma (MM). However, little is understood about the role of piRNA-823 in intercellular communication between MM and endothelial cells. In this study, we found that piRNA-823 mainly accumulated in EVs from peripheral blood of MM patients and EVs derived from MM cells (MM-derived-EVs). Increased piRNA-823 expression was associated with late stages and poor prognosis of MM. The MM-derived-EVs effectively transferred piRNA-823 to EA.hy926 endothelial cells. The piRNA-823 mimic and inhibitor were designed to upregulate or to suppress the endogenous function of piRNA-823. Transfection with piRNA-823 mimic or treatment with MM-derived-EVs significantly promoted the proliferation, tube formation, and invasion of EA.hy926 cells by enhancing the expression of VEGF, IL-6, and ICAM-1 and attenuating apoptosis. EA.hy926 cells transfected with piRNA-823 mimic or pre-treated with MM-derived-EVs promoted the growth of xenograft MM in mice. In contrast, the transfection with piRNA-823 inhibitor or treatment with EVs from piRNA-823 inhibitor-transfected-MM cells had diametrically opposite effects. Our findings demonstrated that piRNA-823 carried by MM-derived-EVs is essential for the re-education of ECs toward a unique environment amenable to the growth of MM cells by altering its biological characteristics. Our findings may pave the way for the development of new piRNA-mediated prognostic stratification and therapeutic strategies for MM.	[Li, Beibei; Hong, Jiaxin; Hong, Mei; Wang, Yajun; Yu, Tingting; Zang, Sibin; Wu, Qiuling] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Hubei, Peoples R China; [Hong, Jiaxin] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Hubei, Peoples R China; [Hong, Mei] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Soochow University - China	Wu, QL (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Hubei, Peoples R China.	wuqiuling927@qq.com	yu, tingting/HGA-4783-2022	Wu, Qiuling/0000-0001-6488-5731	National Natural Science Foundation of P.R China [30500686, 81770219]	National Natural Science Foundation of P.R China(National Natural Science Foundation of China (NSFC))	The authors would like to thank all the participants for their kind cooperation. The research was supported by the National Natural Science Foundation of P.R China (no. 30500686, for Q-LW) and (no. 81770219, for Q-LW).	Abdi J, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-10; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Canella A, 2016, EXPERT REV MOL DIAGN, V16, P277, DOI 10.1586/14737159.2016.1132627; Chantrain CF, 2008, CANCER MICROENVIRON, V1, P23, DOI 10.1007/s12307-008-0010-7; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Cui L, 2011, CLIN BIOCHEM, V44, P1050, DOI 10.1016/j.clinbiochem.2011.06.004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grange C, 2006, ONCOL REP, V15, P381; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Korn C, 2017, BLOOD, V129, P811, DOI 10.1182/blood-2016-09-670224; Ku HY, 2014, NATL SCI REV, V1, P205, DOI 10.1093/nsr/nwu014; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Li J, 2013, J BIOL CHEM, V288, P23586, DOI 10.1074/jbc.M113.489302; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Manier S, 2017, BLOOD, V129, P2429, DOI 10.1182/blood-2016-09-742296; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Paggetti J, 2015, BLOOD, V126, P1106, DOI 10.1182/blood-2014-12-618025; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Rigolin GM, 2006, BLOOD, V107, P2531, DOI 10.1182/blood-2005-04-1768; Sarkar A, 2017, FASEB J, V31, P436, DOI 10.1096/fj.201600637RR; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; St Croix B, 2000, SCIENCE, V289, P1197; Streubel B, 2004, NEW ENGL J MED, V351, P250, DOI 10.1056/NEJMoa033153; Svensson KJ, 2013, BIOCHEM SOC T, V41, P273, DOI 10.1042/BST20120248; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Taverna S, 2012, INT J CANCER, V130, P2033, DOI 10.1002/ijc.26217; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Wang JH, 2016, ONCOTARGET, V7, P38927, DOI 10.18632/oncotarget.7792; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wu QL, 2010, BIOCHEM BIOPH RES CO, V396, P915, DOI 10.1016/j.bbrc.2010.05.022; Yan H, 2015, LEUKEMIA, V29, P196, DOI 10.1038/leu.2014.135	46	69	69	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5227	5238		10.1038/s41388-019-0788-4	http://dx.doi.org/10.1038/s41388-019-0788-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30890754				2022-12-26	WOS:000473025300008
J	Kant, S; Davuluri, G; Alchirazi, KA; Welch, N; Heit, C; Kumar, A; Gangadhariah, M; Kim, A; McMullen, MR; Willard, B; Luse, DS; Nagy, LE; Vasiliou, V; Marini, AM; Weiner, ID; Dasarathy, S				Kant, Sashi; Davuluri, Gangarao; Alchirazi, Khaled A.; Welch, Nicole; Heit, Claire; Kumar, Avinash; Gangadhariah, Mahesha; Kim, Adam; McMullen, Megan R.; Willard, Belinda; Luse, Donal S.; Nagy, Laura E.; Vasiliou, Vasilis; Marini, Anna Maria; Weiner, I. David; Dasarathy, Srinivasan			Ethanol sensitizes skeletal muscle to ammonia-induced molecular perturbations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteostasis; signaling; autophagy; ammonia; skeletal muscle; RhBG; sarcopenia	ALCOHOLIC LIVER-DISEASE; UREA-CYCLE ENZYMES; PROTEIN-SYNTHESIS; TRANSPORTER PROTEINS; GENE-EXPRESSION; HYPERAMMONEMIA; SARCOPENIA; PHOSPHORYLATION; ACETALDEHYDE; CIRRHOSIS	Ethanol causes dysregulated muscle protein homeostasis while simultaneously causing hepatocyte injury. Because hepatocytes are the primary site for physiological disposal of ammonia, a cytotoxic cellular metabolite generated during a number of metabolic processes, we determined whether hyperammonemia aggravates ethanol-induced muscle loss. Differentiated murine C2C12 myotubes, skeletal muscle from pair-fed or ethanol-treated mice, and human patients with alcoholic cirrhosis and healthy controls were used to quantify protein synthesis, mammalian target of rapamycin complex 1 (mTORC1) signaling, and autophagy markers. Alcohol-metabolizing enzyme expression and activity in mouse muscle and myotubes and ureagenesis in hepatocytes were quantified. Expression and regulation of the ammonia transporters, RhBG and RhCG, were quantified by real-time PCR, immunoblots, reporter assays, biotin-tagged promoter pulldown with proteomics, and loss-of-function studies. Alcohol and aldehyde dehydrogenases were expressed and active in myotubes. Ethanol exposure impaired hepatocyte ureagenesis, induced muscle RhBG expression, and elevated muscle ammonia concentrations. Simultaneous ethanol and ammonia treatment impaired protein synthesis and mTORC1 signaling and increased autophagy with a consequent decreased myotube diameter to a greater extent than either treatment alone. Ethanol treatment and withdrawal followed by ammonia exposure resulted in greater impairment in muscle signaling and protein synthesis than ammonia treatment in ethanol-naive myotubes. Of the three transcription factors that were bound to the RhBG promoter in response to ethanol and ammonia, DR1/NC2 indirectly regulated transcription of RhBG during ethanol and ammonia treatment. Direct effects of ethanol were synergistic with increased ammonia uptake in causing dysregulated skeletal muscle proteostasis and signaling perturbations with a more severe sarcopenic phenotype.	[Kant, Sashi; Davuluri, Gangarao; Alchirazi, Khaled A.; Welch, Nicole; Kumar, Avinash; Gangadhariah, Mahesha; Kim, Adam; McMullen, Megan R.; Nagy, Laura E.; Dasarathy, Srinivasan] Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Luse, Donal S.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA; [Dasarathy, Srinivasan] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Metab & Prote Core, Cleveland, OH 44195 USA; [Heit, Claire] Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Sch Pharm, Aurora, CO 80045 USA; [Vasiliou, Vasilis] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06510 USA; [Marini, Anna Maria] Univ Libre Bruxelles, Biol Membrane Transport Lab, Dept Mol Biol, IBMM, CP300, B-6041 Gosselies, Belgium; [Weiner, I. David] Univ Florida, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Sch Med, Gainesville, FL 32610 USA; [Weiner, I. David] North Florida South Georgia Vet Hlth Syst, Nephrol & Hypertens Sect, Gainesville, FL 32608 USA; [Davuluri, Gangarao] Pennington Biomed Res Ctr, Integrated Physiol & Mol Metab, Baton Rouge, LA 70808 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Universite Libre de Bruxelles; State University System of Florida; University of Florida; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dasarathy, S (corresponding author), Lerner Res Inst, NE4 208,9500 Euclid Ave, Cleveland, OH 44195 USA.	dasaras@ccf.org	Weiner, David/N-3908-2019; Kant, Sashi/V-3864-2019	Weiner, David/0000-0002-0046-0600; Kant, Sashi/0000-0002-9015-8383; Kim, Adam/0000-0002-3186-3912; Gangadhariah, Mahesha/0000-0003-4355-4364; Welch, Nicole/0000-0002-4655-5146	National Institutes of Health [R21 AA022742, R21 AR071046, UO1 AA026976, RO1 GM119174, RO1 DK113196, P50 AA024333, UO1 AA021890, RO1 DK045788, RO1 DK107798, UO1 AA021724, R24 AA022057]; Mikati Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR071046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113196, T32DK083251, R01DK107798, R01DK045788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024333, U01AA026976, U01AA021890, U01AA021724, R24AA022057] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mikati Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R21 AA022742 (to S. D.), R21 AR071046 (to S. D. and G. D.), UO1 AA026976 (to S. D.), RO1 GM119174, RO1 DK113196 (to S. D.), P50 AA024333 (to L. E. N. and S. D.), UO1 AA021890 (to L. E. N. and S. D.), RO1 DK045788 (to I. D. W.), RO1 DK107798 (to I. D. W.), UO1 AA021724 (to V. V.), and R24 AA022057 (to V. V.) and a Mikati Foundation grant (to S. D. and G. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aagaard NK, 2004, ALCOHOL CLIN EXP RES, V28, P697, DOI 10.1097/01.ALC.0000125355.31808.DC; Bakhautdin B, 2014, J HEPATOL, V61, P1029, DOI 10.1016/j.jhep.2014.06.007; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Damink SWMO, 2009, METAB BRAIN DIS, V24, P169, DOI 10.1007/s11011-008-9122-5; Dasarathy J, 2017, ALCOHOL CLIN EXP RES, V41, P1419, DOI 10.1111/acer.13425; Dasarathy S, 2018, CURR OPIN CLIN NUTR, V21, P30, DOI 10.1097/MCO.0000000000000426; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040; Dasarathy S, 2016, CLIN LIVER DIS, V20, P535, DOI 10.1016/j.cld.2016.02.010; Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796; Davuluri G, 2016, J HEPATOL, V65, P929, DOI 10.1016/j.jhep.2016.06.004; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Fernandez-Sola J, 2007, ALCOHOL CLIN EXP RES, V31, P1953, DOI 10.1111/j.1530-0277.2007.00530.x; Glavind E, 2018, SCAND J GASTROENTERO, V53, P592, DOI 10.1080/00365521.2017.1399163; Guirguis J, 2015, ALCOHOL CLIN EXP RES, V39, P2085, DOI 10.1111/acer.12887; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Hong-Brown LQ, 2001, ALCOHOL CLIN EXP RES, V25, P1373; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; INOSTROZA JA, 1992, CELL, V70, P477; Kumar A, 2017, HEPATOLOGY, V65, P2045, DOI 10.1002/hep.29107; Lang CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE268, DOI 10.1152/ajpendo.1999.277.2.E268; Lang CH, 2000, ALCOHOL CLIN EXP RES, V24, P322, DOI 10.1097/00000374-200003000-00010; Lang CH, 2005, INT J BIOCHEM CELL B, V37, P2180, DOI 10.1016/j.biocel.2005.04.013; Lang CH, 2004, ALCOHOL CLIN EXP RES, V28, P1758, DOI 10.1097/01.ALC.0000145787.66405.59; Lang CH, 2001, INT J BIOCHEM CELL B, V33, P457, DOI 10.1016/S1357-2725(00)00081-9; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; LOCKWOOD AH, 1979, J CLIN INVEST, V63, P449, DOI 10.1172/JCI109322; MAIER KP, 1974, EUR J CLIN INVEST, V4, P193, DOI 10.1111/j.1365-2362.1974.tb00391.x; MAIER KP, 1978, KLIN WOCHENSCHR, V56, P291, DOI 10.1007/BF01489175; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; MARWAY JS, 1995, ALCOHOL ALCOHOLISM, V30, P211; McDaniel J, 2016, AM J PHYSIOL-GASTR L, V310, pG163, DOI 10.1152/ajpgi.00322.2015; Merhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128683; Molina PE, 2008, ALCOHOL CLIN EXP RES, V32, P138, DOI 10.1111/j.1530-0277.2007.00549.x; Nakahara T, 2006, METABOLISM, V55, P843, DOI 10.1016/j.metabol.2006.02.009; PACY PJ, 1991, ALCOHOL ALCOHOLISM, V26, P505, DOI 10.1093/oxfordjournals.alcalc.a045152; PREEDY VR, 1992, ALCOHOL ALCOHOLISM, V27, P241; PREEDY VR, 1991, BIOCHEM SOC T, V19, pS167, DOI 10.1042/bst019167s; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012; REILLY ME, 1995, ADVERSE DRUG REACT T, V14, P117; RUDMAN D, 1973, J CLIN INVEST, V52, P2241, DOI 10.1172/JCI107410; RYPINS EB, 1980, GASTROENTEROLOGY, V78, P1419; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schricker T, 1997, DEUT MED WOCHENSCHR, V122, P75, DOI 10.1055/s-2008-1047579; Steiner JL, 2016, ALCOHOL ALCOHOLISM, V51, P242, DOI 10.1093/alcalc/agv105; Steiner JL, 2015, AM J PHYSIOL-ENDOC M, V308, pE699, DOI 10.1152/ajpendo.00006.2015; Steiner JL, 2014, J APPL PHYSIOL, V117, P1170, DOI 10.1152/japplphysiol.00180.2014; Stern RA, 2015, ANIMAL, V9, P992, DOI 10.1017/S1751731115000117; Takeda K, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12596; Thapaliya S, 2014, AUTOPHAGY, V10, P677, DOI 10.4161/auto.27918; Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weiner ID, 2003, ACTA PHYSIOL SCAND, V179, P331, DOI 10.1046/j.0001-6772.2003.01210.x; Xue Y, 2017, MOL CELL, V67, P594, DOI 10.1016/j.molcel.2017.06.029; YEUNG KC, 1994, GENE DEV, V8, P2097, DOI 10.1101/gad.8.17.2097; Zawada RJX, 2009, BIOCHEM CELL BIOL, V87, P541, DOI [10.1139/O09-011, 10.1139/o09-011]	61	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7231	7244		10.1074/jbc.RA118.005411	http://dx.doi.org/10.1074/jbc.RA118.005411			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30872403	Green Published, hybrid			2022-12-26	WOS:000468402900013
J	Jarosz-Griffiths, HH; Corbett, NJ; Rowland, HA; Fisher, K; Jones, AC; Baron, J; Howell, GJ; Cowleyl, SA; Chintawar, S; Cader, MZ; Kellett, KAB; Hooper, NM				Jarosz-Griffiths, Heledd H.; Corbett, Nicola J.; Rowland, Helen A.; Fisher, Kate; Jones, Alys C.; Baron, Jennifer; Howell, Gareth J.; Cowleyl, Sally A.; Chintawar, Satyan; Cader, M. Zameel; Kellett, Katherine A. B.; Hooper, Nigel M.			Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid- oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); induced pluripotent stem cell (iPS cell) (iPSC); prion; neurodegenerative disease; Alzheimer disease; oxidative stress; cell surface protein; metallopeptidase ADAM10; proteolytic shedding	ANGIOTENSIN-CONVERTING ENZYME; ALZHEIMERS-DISEASE BRAIN; GLUTAMATE-RECEPTOR 5; PRECURSOR PROTEIN; ALPHA-SECRETASE; BETA OLIGOMERS; A-BETA; MEMORY IMPAIRMENT; APPS-ALPHA; INHIBITION	The cellular prion protein (PrPC) is a key neuronal receptor for -amyloid oligomers (AO), mediating their neurotoxicity, which contributes to the neurodegeneration in Alzheimer's disease (AD). Similarly to the amyloid precursor protein (APP), PrPC is proteolytically cleaved from the cell surface by a disintegrin and metalloprotease, ADAM10. We hypothesized that ADAM10-modulated PrPC shedding would alter the cellular binding and cytotoxicity of AO. Here, we found that in human neuroblastoma cells, activation of ADAM10 with the muscarinic agonist carbachol promotes PrPC shedding and reduces the binding of AO to the cell surface, which could be blocked with an ADAM10 inhibitor. Conversely, siRNA-mediated ADAM10 knockdown reduced PrPC shedding and increased AO binding, which was blocked by the PrPC-specific antibody 6D11. The retinoic acid receptor analog acitretin, which up-regulates ADAM10, also promoted PrPC shedding and decreased AO binding in the neuroblastoma cells and in human induced pluripotent stem cell (iPSC)-derived cortical neurons. Pretreatment with acitretin abolished activation of Fyn kinase and prevented an increase in reactive oxygen species caused by AO binding to PrPC. Besides blocking AO binding and toxicity, acitretin also increased the nonamyloidogenic processing of APP. However, in the iPSC-derived neurons, A and other amyloidogenic processing products did not exhibit a reciprocal decrease upon acitretin treatment. These results indicate that by promoting the shedding of PrPC in human neurons, ADAM10 activation prevents the binding and cytotoxicity of AO, revealing a potential therapeutic benefit of ADAM10 activation in AD.	[Jarosz-Griffiths, Heledd H.; Corbett, Nicola J.; Rowland, Helen A.; Fisher, Kate; Jones, Alys C.; Kellett, Katherine A. B.; Hooper, Nigel M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Neurosci & Expt Psychol, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Baron, Jennifer; Howell, Gareth J.] Univ Manchester, Flow Cytometry Facil Lab, Fac Biol Med & Hlth, CTF Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Cowleyl, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Cowleyl, Sally A.] Univ Oxford, Oxford Parkinsons Dis Ctr, South Parks Rd, Oxford OX1 3QX, England; [Chintawar, Satyan; Cader, M. Zameel] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Chintawar, Satyan; Cader, M. Zameel] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX1 3QX, England; [Jarosz-Griffiths, Heledd H.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Clin & Translat Rheumatol, Leeds LS9 7TF, W Yorkshire, England	University of Manchester; University of Manchester; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Leeds	Hooper, NM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Neurosci & Expt Psychol, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	nigel.hooper@manchester.ac.uk		Corbett, Nicola/0000-0002-7531-7462; Jarosz-Griffiths, Heledd/0000-0001-5154-4815; Cader, Zameel/0000-0002-6952-406X; Kellett, Katherine/0000-0002-2802-0615; Chintawar, Satyan/0000-0003-3663-2328; Hooper, Nigel/0000-0002-5811-3484	Alzheimer's Research UK [PG2013-12]; Medical Research Council [MC_PC_16033, MR/N013255/1, MR/M024997/1, MCEX MR/N50192X/1]; Dr Donald Dean Fund in Dementia Research; University of Manchester; MRC [MR/N013255/1, MC_EX_MR/N50192X/1, MC_PC_16033, MC_PC_16034, MR/M024997/1, MR/M024962/1, MR/L023784/1, MR/L023784/2, 1826685] Funding Source: UKRI	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dr Donald Dean Fund in Dementia Research; University of Manchester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Alzheimer's Research UK Grant PG2013-12; Medical Research Council Grants MC_PC_16033, MR/N013255/1, MR/M024997/1, and MCEX MR/N50192X/1; the Dr Donald Dean Fund in Dementia Research; and the University of Manchester. None of the funding bodies had any role in the design of the study; in the collection, analysis, or interpretation of the data; or in the writing of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.	Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Baud A, 2017, ANAL CHEM, V89, P2440, DOI 10.1021/acs.analchem.6b04368; Ben Halima S, 2016, CELL REP, V14, P2127, DOI 10.1016/j.celrep.2016.01.076; Beraldo FH, 2016, J BIOL CHEM, V291, P21945, DOI 10.1074/jbc.M116.738286; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cui LL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0796-x; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haas LT, 2017, CELL REP, V20, P76, DOI 10.1016/j.celrep.2017.06.023; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Hamilton A, 2016, CELL REP, V15, P1859, DOI 10.1016/j.celrep.2016.04.077; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Moss ML, 2011, J BIOL CHEM, V286, P40443, DOI 10.1074/jbc.M111.280495; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Parkin ET, 2002, BIOCHEMISTRY-US, V41, P4972, DOI 10.1021/bi015936e; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Perera WSS, 1999, FEBS LETT, V463, P273, DOI 10.1016/S0014-5793(99)01648-8; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Risse E, 2015, J BIOL CHEM, V290, P17020, DOI 10.1074/jbc.M115.637124; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Vaughan PFT, 1998, MOL NEUROBIOL, V18, P125, DOI 10.1007/BF02914269; Vincent B, 2001, J BIOL CHEM, V276, P37743; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135	66	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7085	7097		10.1074/jbc.RA118.005364	http://dx.doi.org/10.1074/jbc.RA118.005364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30872401	Green Published, hybrid			2022-12-26	WOS:000467394700039
J	Bauer, SL; Chen, J; Astrom, SU				Bauer, Stefanie L.; Chen, Jiang; Astrom, Stefan U.			Helicase/SUMO-targeted ubiquitin ligase Uls1 interacts with the Holliday junction resolvase Yen1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE MUS81-MMS4; GENE DISRUPTION; PROTEIN ULS1; DNA; SUMO; REPLICATION; GENOME; IDENTIFICATION; REPAIR; SPECIFICITY	Resolution of branched DNA structures is pivotal for repair of stalled replication forks and meiotic recombination intermediates. The Yen1 nuclease cleaves both Holliday junctions and replication forks. We show that Yen1 interacts physically with Uls1, a suggested SUMO-targeted ubiquitin ligase that also contains a SWI/SNF-family ATPase-domain. Yen1 is SUMO-modified in its noncatalytic carboxyl terminus and DNA damage induces SUMOylation. SUMO-modification of Yen1 strengthens the interaction to Uls1, and mutations in SUMO interaction motifs in Uls1 weakens the interaction. However, Uls1 does not regulate the steady-state level of SUMO-modified Yen1 or chromatin-associated Yen1. In addition, SUMO-modification of Yen1 does not affect the catalytic activity in vitro. Consistent with a shared function for Uls1 and Yen1, mutations in both genes display similar phenotypes. Both uls1 and yen1 display negative genetic interactions with the alternative HJ-cleaving nuclease Mus81, manifested both in hypersensitivity to DNA damaging agents and in meiotic defects. Point mutations in ULS1 (uls1K975R and uls1C1330S, C1333S) predicted to inactivate the ATPase and ubiquitin ligase activities, respectively, are as defective as the null allele, indicating that both functions of Uls1 are essential. A micrococcal nuclease sequencing experiment showed that Uls1 had minimal effects on global nucleosome positioning/occupancy. Moreover, increased gene dosage of YEN1 partially alleviates the mus81 uls1 sensitivity to DNA damage. We suggest a preliminary model in which Uls1 acts in the same pathway as Yen1 to resolve branched DNA structures.	[Bauer, Stefanie L.; Chen, Jiang; Astrom, Stefan U.] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, Stockholm, Sweden	Stockholm University	Bauer, SL (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, Stockholm, Sweden.	stefan.astrom@su.se		Astrom, Stefan/0000-0001-7721-6908	Swedish Cancer Society [CAN 2015/464]; Swedish Research Council [2015-05212]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was financially supported by the Swedish Cancer Society (CAN 2015/464, www.cancerfonden.se) and the Swedish Research Council (2015-05212, www.vr.se) to S. U. A. The sponsors had no involvement in the study design, collection, analysis or interpretation of the data; the writing of the manuscript or the decision to submit the manuscript for publication.	Agmon N, 2011, NUCLEIC ACIDS RES, V39, P7009, DOI 10.1093/nar/gkr277; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Blanco MG, 2014, MOL CELL, V54, P94, DOI 10.1016/j.molcel.2014.02.011; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Bloom J, 2011, J BIOL CHEM, V286, P5434, DOI 10.1074/jbc.M110.205054; Cal-Bakowska M, 2011, NUCLEIC ACIDS RES, V39, P8765, DOI 10.1093/nar/gkr587; Chen J, 2012, DNA REPAIR, V11, P833, DOI 10.1016/j.dnarep.2012.07.004; Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Eissler CL, 2014, MOL CELL, V54, P80, DOI 10.1016/j.molcel.2014.02.012; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; James P, 1996, GENETICS, V144, P1425; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kramarz K, 2014, DNA REPAIR, V21, P24, DOI 10.1016/j.dnarep.2014.05.008; Kroetz Mary B., 2009, V497, P107, DOI 10.1007/978-1-59745-566-4_7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lescasse R, 2013, EMBO J, V32, P805, DOI 10.1038/emboj.2013.24; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rass U, 2006, METHOD ENZYMOL, V408, P485, DOI 10.1016/S0076-6879(06)08030-X; Rizzo JM, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-15; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; Shah PP, 2010, MOL CELL, V39, P862, DOI 10.1016/j.molcel.2010.08.028; Shirai C, 2008, BIOSCI BIOTECH BIOCH, V72, P1881, DOI 10.1271/bbb.80131; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Tan W, 2013, G3-GENES GENOM GENET, V3, P771, DOI 10.1534/g3.113.005827; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wei Y, 2017, MOL CELL, V66, P581, DOI 10.1016/j.molcel.2017.04.017; Xie Y, 2010, GENE DEV, V24, P893, DOI 10.1101/gad.1906510; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032; Zhang ZM, 1997, MOL CELL BIOL, V17, P5461, DOI 10.1128/MCB.17.9.5461	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214102	10.1371/journal.pone.0214102	http://dx.doi.org/10.1371/journal.pone.0214102			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897139	Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700066
J	Hajj, J; Maslovat, D; Cressman, EK; St Germain, L; Carlsen, AN				Hajj, Joelle; Maslovat, Dana; Cressman, Erin K.; St Germain, Laura; Carlsen, Anthony N.			Visual processing is diminished during movement execution	PLOS ONE			English	Article								Recent research has suggested that visual discrimination and detection may be enhanced during movement preparation and execution, respectively. The current study examined if visual perceptual processing is augmented prior to or during a movement through the use of an Inspection Time (IT) task. The IT task involved briefly presenting (e.g., 15-105 ms) a "pi" figure with differing leg lengths, which was then immediately masked for 400 ms to prevent retinal afterimages. Participants were subsequently required to choose which of the two legs was longer. In Experiment 1, participants (n = 28) completed the IT task under three movement conditions: no-movement (NM), foreperiod (FP), and peak velocity (PV). In the NM condition, participants solely engaged in the IT paradigm. In the FP condition, the IT stimulus was presented prior to movement execution when response planning was expected to occur. Finally, in the PV condition, participants made a rapid movement to a target, and the IT stimulus was presented when their limb reached peak velocity. In Experiment 2, participants (n = 18) also performed the IT task in the PV and NM condition; however, vision of the limb's motion was made available during the PV trials (PV-FV) to investigate the potential influence of visual feedback on IT performance. Results showed no significant differences in performance in the IT task between the NM and FP conditions, suggesting no enhancement of visual processing occurred due to response preparation (Experiment 1). However, IT performance was significantly poorer in the PV condition in comparison to both the NM and FP conditions (Experiment 1), and was even worse when visual feedback was provided (Experiment 2). Together, these findings suggest that visual perceptual processing is degraded during execution of a fast, goal-directed movement.	[Hajj, Joelle; Cressman, Erin K.; St Germain, Laura; Carlsen, Anthony N.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Maslovat, Dana] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada	University of Ottawa; University of British Columbia	Carlsen, AN (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	tony.carlsen@uottawa.ca		St. Germain, Laura/0000-0002-5513-4183; Carlsen, Anthony/0000-0001-6015-8991	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 418361-2012]; Ontario Ministry of Research, Innovation and Science [ER14-10-133]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Research, Innovation and Science	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) [RGPIN 418361-2012] and the Ontario Ministry of Research, Innovation and Science (https://www.ontario.ca/page/ministry-research-innovation-and-science) [ER14-10-133] awarded to ANC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratzke D, 2009, J EXP PSYCHOL HUMAN, V35, P1413, DOI 10.1037/a0015874; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Cao Liyu, 2018, BIORXIV, DOI [10.1101/382093, DOI 10.1101/382093]; Carlsen AN, 2007, NEUROREPORT, V18, P1067, DOI 10.1097/WNR.0b013e3281ac22f1; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodman R, 2013, J EXERCISE MOVEMENT; Hagura N, 2012, P ROY SOC B-BIOL SCI, V279, P4399, DOI 10.1098/rspb.2012.1339; Manson GA, 2013, J EXERCISE MOVEMENT; Maslovat D, 2015, NEUROSCI LETT, V606, P151, DOI 10.1016/j.neulet.2015.08.053; Maslovat D, 2015, EXP BRAIN RES, V233, P2673, DOI 10.1007/s00221-015-4340-7; Sadler AJ, 1996, NEUROPSYCHOLOGIA, V34, P283, DOI 10.1016/0028-3932(95)00105-0; Schneider WX, 1995, VISUAL SELECTIVE ATTENTION, P331, DOI 10.1080/13506289508401737; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Steinborn MB, 2008, ACTA PSYCHOL, V129, P297, DOI 10.1016/j.actpsy.2008.08.005; Steinborn MB, 2017, PSYCHOL RES-PSYCH FO, V81, P1135, DOI 10.1007/s00426-016-0810-1; Steinborn MB, 2010, ACTA PSYCHOL, V134, P94, DOI 10.1016/j.actpsy.2009.12.011; Steinborn MB, 2009, ACTA PSYCHOL, V132, P40, DOI 10.1016/j.actpsy.2009.06.002; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tremblay L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008952; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Vickers D., 1979, DECISION PROCESSES V; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213790	10.1371/journal.pone.0213790	http://dx.doi.org/10.1371/journal.pone.0213790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897118	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700034
J	Lindstrom, H; Mazari, AMA; Musdal, Y; Mannervik, B				Lindstrom, Helena; Mazari, Aslam M. A.; Musdal, Yaman; Mannervik, Bengt			Potent inhibitors of equine steroid isomerase EcaGST A3-3	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASE P1-1; FDA-APPROVED DRUGS; S-TRANSFERASES; TANNIC-ACID; GST A3-3; PROGESTERONE; M2-2; CYTOCHROME-P450; IDENTIFICATION; COOPERATIVITY	Equine glutathione transferase A3-3 (EcaGST A3-3) belongs to the superfamily of detoxication enzymes found in all higher organisms. However, it is also the most efficient steroid double-bond isomerase known in mammals. Equus ferus caballus shares the steroidogenic pathway with Homo sapiens, which makes the horse a suitable animal model for investigations of human steroidogenesis. Inhibition of the enzyme has potential for treatment of steroid-hormone-dependent disorders. Screening of a library of FDA-approved drugs identified 16 out of 1040 compounds, which at 10 mu M concentration afforded at least 50% inhibition of EcaGST A3-3. The most potent inhibitors, anthralin, sennoside A, tannic acid, and ethacrynic acid, were characterized by IC50 values in the submicromolar range when assayed with the natural substrate Delta(5)-androstene-3,17-dione.	[Lindstrom, Helena; Mazari, Aslam M. A.; Musdal, Yaman; Mannervik, Bengt] Stockholm Univ, Arrhenius Labs, Dept Biochem & Biophys, Stockholm, Sweden	Stockholm University	Mannervik, B (corresponding author), Stockholm Univ, Arrhenius Labs, Dept Biochem & Biophys, Stockholm, Sweden.	bengt.mannervik@dbb.su.se		Musdal, Yaman/0000-0003-0999-3179; Lindstrom, Helena/0000-0002-0236-1796	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by (BM) Swedish Research Council, https://www.vr.se/english.html; Swedish Cancer Society, https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello ML, 1998, J MOL BIOL, V284, P1717; Bocedi A, 2016, J BIOL CHEM, V291, P26739, DOI 10.1074/jbc.M116.749507; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatuphonprasert W, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01027; Conley AJ, 1997, BIOL REPROD, V56, P789, DOI 10.1095/biolreprod56.4.789; Dagnino-Subiabre A, 2000, BIOCHEM BIOPH RES CO, V274, P32, DOI 10.1006/bbrc.2000.3087; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; Fedulova N, 2011, ANAL BIOCHEM, V413, P16, DOI 10.1016/j.ab.2011.01.041; Fedulova N, 2010, BIOCHEM J, V431, P159, DOI 10.1042/BJ20100839; Fersht A, 2007, STRUCTURE MECH PROTE, P72; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HANSSON J, 1991, CANCER RES, V51, P94; Hegazy UM, 2013, J MOL BIOL, V425, P1509, DOI 10.1016/j.jmb.2013.01.038; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Johansson AS, 1999, PROTEIN EXPRES PURIF, V17, P105, DOI 10.1006/prep.1999.1117; Kon R, 2018, J NAT MED-TOKYO, V72, P493, DOI 10.1007/s11418-018-1174-1; Krajka-Kuzniak V, 2003, TOXICOL LETT, V143, P209, DOI 10.1016/S0378-4274(03)00177-2; Lee OD, 2016, AM J MENS HEALTH, V10, P68, DOI 10.1177/1557988314556671; Lien S, 2001, J BIOL CHEM, V276, P35599, DOI 10.1074/jbc.M103789200; Lindstrom H, 2018, J STEROID BIOCHEM, V178, P117, DOI 10.1016/j.jsbmb.2017.11.011; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; Mazari AMA, 2015, CHEM-BIOL INTERACT, V229, P91, DOI 10.1016/j.cbi.2015.01.014; Molnar J, 2009, AM J THER, V16, P86, DOI 10.1097/MJT.0b013e318195e460; Musdal Y, 2013, CHEM-BIOL INTERACT, V205, P53, DOI 10.1016/j.cbi.2013.06.003; Naus PJ, 2007, J HEPATOL, V46, P222, DOI 10.1016/j.jhep.2006.08.012; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Peus D, 2000, J INVEST DERMATOL, V114, P688, DOI 10.1046/j.1523-1747.2000.00934.x; PLOEMEN JHTM, 1993, BIOCHEM PHARMACOL, V45, P633, DOI 10.1016/0006-2952(93)90137-L; Raffalli-Mathieu F, 2008, BIOCHEM J, V414, P103, DOI 10.1042/BJ20080397; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; Ricci G, 2003, BIOCHEM J, V376, P71, DOI 10.1042/BJ20030860; Rossetti MF, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12402; Schverer M, 2018, PHARMACOL THERAPEUT, V191, P190, DOI 10.1016/j.pharmthera.2018.06.011; SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727; TAHIR MK, 1986, J BIOL CHEM, V261, P1048	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214160	10.1371/journal.pone.0214160	http://dx.doi.org/10.1371/journal.pone.0214160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897163	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700075
J	Martelli, G; Antonucci, R; Mukurasi, A; Zepherine, H; Nostlinger, C				Martelli, Giulia; Antonucci, Rosa; Mukurasi, Alphonsina; Zepherine, Henry; Nostlinger, Christiana			Adherence to antiretroviral treatment among children and adolescents in Tanzania: Comparison between pill count and viral load outcomes in a rural context of Mwanza region	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; SUB-SAHARAN AFRICA; THERAPY ADHERENCE; SETTINGS; FAILURE; ADULTS; INCOME; URBAN	Background and objectives Adherence to antiretroviral treatment is a key challenge for paediatric HIV care. Among children and adolescents living with HIV, lower levels of adherence have been reported compared to adults. Individual, caregiver-, health services-related and sociocultural factors were shown to impact on these outcomes. Study objectives were to assess adherence in a paediatric population in rural Tanzania comparing two measurement methods, and to investigate the association between virologic suppression and demographic, clinical, drug- and family-related factors. Methods This cross-sectional study was conducted among children and adolescents enrolled in Bukumbi HIV Care and Treatment Clinic (Misungwi district, Mwanza region) in the north of Tanzania, where the HIV prevalence is 7.2%. Adherence was measured through viral load and pill count. Kappa statistics assessed the level of agreement between the methods; bivariate and multivariable analyses identified factors independently associated with virologic suppression. Results N = 72 participants (n = 49 children; n = 23 adolescents) with a median age of eight years were enrolled. 62.5% and 65.3% of the individuals presented an optimal adherence according to viral load and pill count respectively, but among 40% viral load results diverged from the pill count method. In multivariable analysis, living outside Misungwi district and having CD4 counts above 500/mu l were significantly associated with optimal adherence. Conclusion Children and adolescents living with HIV in Mwanza show high rates of suboptimal adherence. The poor agreement between pill count and viral load results raises concerns about the interpretation of these measurements in clinical practice.	[Martelli, Giulia; Nostlinger, Christiana] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Antonucci, Rosa; Mukurasi, Alphonsina; Zepherine, Henry] Bukumbi Hosp, Mwanza, Tanzania	Institute of Tropical Medicine (ITM)	Martelli, G (corresponding author), Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium.	giuliamartelli84@gmail.com						Abongomera G, 2017, AIDS BEHAV, V21, P441, DOI 10.1007/s10461-016-1582-8; Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; Ammon N, 2018, PUBLIC HEALTH, V157, P20, DOI 10.1016/j.puhe.2017.12.010; [Anonymous], 2018, 2017 GLOB HIV STAT; [Anonymous], 2018, COUNTR FACTSH UNITED; [Anonymous], 2017, TANZ HIV IMP SURV TH; [Anonymous], 2017, CHILDR AIDS STAT UPD; Arage G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-365; Azmeraw Daniel, 2012, Ethiop Med J, V50, P115; Bagenda A, 2011, ANN TROP PAEDIATR, V31, P235, DOI 10.1179/1465328111Y.0000000025; Bermudez LG, 2016, AIDS CARE, V28, P83, DOI 10.1080/09540121.2016.1176681; Biadgilign S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-53; Biressaw S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-132; Boelaert M, 2009, BASIC EPIDEMIOLOGY S; Campbell JI, 2018, AIDS BEHAV; Denison JA, 2018, AIDS BEHAV, V22, P996, DOI 10.1007/s10461-017-1944-x; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; Enane LA, 2018, CURR OPIN HIV AIDS, V13, P212, DOI [10.1097/COH.0000000000000459, 10.1097/coh.0000000000000459]; Firdu N, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.80.8544; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Haberer JE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21371; Haberer JE, 2013, AIDS, V27, P2166, DOI 10.1097/QAD.0b013e328363b53f; Haberer JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036737; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; ICF Macro I, 2011, TANZ DEM HLTH SURV 2; Kikuchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041998; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mghamba FW, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-95; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Muri L, 2017, AIDS, V31, P61, DOI 10.1097/QAD.0000000000001273; Musiime V, 2012, AIDS RES HUM RETROV, V28, P1647, DOI [10.1089/aid.2011.0313, 10.1089/AID.2011.0313]; Naar-King S, 2013, J PEDIATR PSYCHOL, V38, P664, DOI 10.1093/jpepsy/jst017; National AIDS Control Program (NACP), 2011, IMPL HIV AIDS CAR TR, V2; National AIDS Control Programme (NACP), 2015, TANZ NAT GUID MAN HI; Nichols J, 2017, AIDS BEHAV, V21, P59, DOI 10.1007/s10461-016-1481-z; Nsheha AH, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.238.2280; Nyogea D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0753-y; Olds PK, 2015, AIDS CARE, V27, P327, DOI 10.1080/09540121.2014.983452; Ross AJ, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.196; Sebunya R, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-25; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Smith C, 2016, AIDS BEHAV, V20, P2729, DOI 10.1007/s10461-016-1419-5; Tabb ZJ, 2018, AIDS, V32, P1115, DOI 10.1097/QAD.0000000000001788; Tu WZ, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21157; Vreeman RC, 2008, JAIDS-J ACQ IMM DEF, V49, P163, DOI 10.1097/QAI.0b013e318183a996; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Vreeman RC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191848; Vreeman Rachel C, 2014, J Int AIDS Soc, V17, P19227, DOI 10.7448/IAS.17.1.19227; Young S, 2014, AIDS BEHAV	50	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214014	10.1371/journal.pone.0214014	http://dx.doi.org/10.1371/journal.pone.0214014			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897131	Green Submitted, gold, Green Published			2022-12-26	WOS:000461889700057
J	Patel, JS; Quates, CJ; Johnson, EL; Ytreberg, FM				Patel, Jagdish Suresh; Quates, Caleb J.; Johnson, Erin L.; Ytreberg, F. Marty			Expanding the watch list for potential Ebola virus antibody escape mutations	PLOS ONE			English	Article							TRANSMISSION; EVOLUTION; FEATURES; PROTEIN	The 2014 outbreak of Ebola virus disease (EVD) in Western Africa is the largest recorded filovirus disease outbreak and led to the death of over 11,000 people. The recent EVD out-breaks (since May 2018) in the Democratic Republic of the Congo has already claimed the lives of over 250 people. Tackling Ebola virus (EBOV) outbreaks remains a challenge. Over the years, significant efforts have been put into developing vaccines or antibody therapies which rely on an envelope glycoprotein (GP) of Zaire ebolavirus (strain Mayinga-76). Therefore, one key approach for combating EVD epidemics is to predict mutations that may diminish the effectiveness of the treatment. In a previous study we generated a watch list of potential antibody escape mutations of EBOV GP against the monoclonal antibody KZ52. Molecular modeling methods were applied to the three-dimensional experimental structure of EBOV GP bound to KZ52 to predict the effect of every possible single mutation in EBOV GP. The final watch list contained 34 mutations that were predicted to destabilize binding of KZ52 to EBOV GP but did not affect EBOV GP folding and its ability to form trimers. In this study, we expand our watch list by including three more monoclonal antibodies with distinct epitopes on GP, namely Antibody 100 (Ab100), Antibody 114 (Ab114) and 13F6-1-2. Our updated watch list contains 127 mutations, three of which have been seen in humans or are experimentally associated with reduced efficacy of antibody treatment. We believe mutations on this watch list require attention since they provide information about circumstances in which interventions could lose the effectiveness.	[Patel, Jagdish Suresh; Quates, Caleb J.; Johnson, Erin L.; Ytreberg, F. Marty] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Patel, Jagdish Suresh] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Biol, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Patel, JS; Ytreberg, FM (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.; Patel, JS (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Ytreberg, FM (corresponding author), Univ Idaho, Dept Phys, Moscow, ID USA.; Ytreberg, FM (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Biol, Moscow, ID 83843 USA.	thejagdishpatel@gmail.com; ytreberg@uidaho.edu	Patel, Jagdish Suresh/I-9175-2019	Patel, Jagdish Suresh/0000-0003-4999-5347	Center for Modeling Complex Interactions - National Institute of General Medical Sciences [P20 GM104420]; National Science Foundation EPSCoR TrackII [OIA1736253]; National Institutes of Health [P30 GM103324]; Office of Nuclear Energy of the U.S. DOE; Nuclear Science User Facilities [DE-AC07-05ID14517]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103324, P20GM104420] Funding Source: NIH RePORTER	Center for Modeling Complex Interactions - National Institute of General Medical Sciences; National Science Foundation EPSCoR TrackII; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Nuclear Energy of the U.S. DOE(United States Department of Energy (DOE)); Nuclear Science User Facilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JSP, CJQ, ELJ and FMY were supported by the Center for Modeling Complex Interactions sponsored by the National Institute of General Medical Sciences (https://www.nigms.nih.gov/) under award number P20 GM104420. JSP and FMY were also supported by National Science Foundation (https://www.nsf.gov/) EPSCoR TrackII under award number OIA1736253. This study was also supported by the National Institutes of Health, grant number P30 GM103324 and by the Office of Nuclear Energy, grant number DE-AC07-05ID14517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Center for Modeling Complex Interactions sponsored by the NIGMS under award number P20 GM104420 and National Science Foundation EPSCoR Track-II under award number OIA1736253. Computer resources were provided in part by the Institute for Bioinformatics and Evolutionary Studies Computational Resources Core sponsored by the National Institutes of Health (P30 GM103324). This research also made use of the computational resources provided by the high-performance computing center at Idaho National Laboratory, which is supported by the Office of Nuclear Energy of the U.S. DOE and the Nuclear Science User Facilities under Contract No. DE-AC07-05ID14517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. James T. Van Leuven for his help with Ebola virus glycoprotein genome analysis.	Borio L, 2015, NEW ENGL J MED, V373, P993, DOI 10.1056/NEJMp1508708; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Corti D, 2016, SCIENCE; Davidson E, 2015, J VIROL, V89, P10982, DOI 10.1128/JVI.01490-15; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790; Iwasa A, 2011, J INFECT DIS, V204, pS897, DOI 10.1093/infdis/jir313; Janus BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06113-4; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Lee JE, 2008, J MOL BIOL, V375, P202, DOI 10.1016/j.jmb.2007.10.017; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Maxmen A, 2018, NATURE, V564, P174, DOI 10.1038/d41586-018-07618-0; Mendoza EJ, 2017, IMMUNOTHERAPY-UK, V9, P435, DOI 10.2217/imt-2017-0010; Miler CR, 2016, PEERJ, V4, DOI 10.7717/peerj.1674; Miller CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112988; Mirza M. U., J MED VIROLOGY; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Reynolds P, 2017, VIRUS GENES, V53, P501, DOI 10.1007/s11262-017-1455-x; Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9; Saphire EO, 2018, CELL, V174, P938, DOI 10.1016/j.cell.2018.07.033; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wong G, 2019, J VIROL, V93, DOI 10.1128/JVI.01098-18	28	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0211093	10.1371/journal.pone.0211093	http://dx.doi.org/10.1371/journal.pone.0211093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897171	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700008
J	Pandita, A; Ramadas, P; Poudel, A; Saad, N; Anand, A; Basnet, A; Wang, DL; Middleton, F; Gilligan, DM				Pandita, Aakriti; Ramadas, Poornima; Poudel, Aarati; Saad, Nibal; Anand, Ankit; Basnet, Alina; Wang, Dongliang; Middleton, Frank; Gilligan, Diana M.			Differential expression of miRNAs in acute myeloid leukemia quantified by Nextgen sequencing of whole blood samples	PLOS ONE			English	Article							MICRORNAS; REGULATORS; MUTATIONS; FAMILY	New approaches are needed for understanding and treating acute myeloid leukemia (AML). MicroRNAs (miRs) are important regulators of gene expression in all cells and disruption of their normal expression can lead to changes in phenotype of a cell, in particular the emergence of a leukemic clone. We collected peripheral blood samples from 10 adult patients with newly diagnosed AML, prior to induction chemotherapy, and 9 controls. Two and a half ml of whole blood was collected in Paxgene RNA tubes. MiRNA was purified using RNeasy mini column (Qiagen). We sequenced approximately 1000 miRs from each of 10 AML patients and 9 controls. In subset analysis, patients with NPM1 and FLT3 mutations showed the greatest number of miRNAs (63) with expression levels that differed from control with adjusted p- value of 0.05 or less. Some of these miRs have been described previously in association with leukemia, but many are new. Our approach of global sequencing of miRs as opposed to microarray analysis removes the bias regarding which miRs to assay and has demonstrated discovery of new associations of miRs with AML. Another strength of our approach is that sequencing miRs is specific for the 5p or 3p strand of the gene, greatly narrowing the proposed target genes to study further. Our study provides new information about the molecular changes that lead to evolution of the leukemic clone and offers new possibilities for monitoring relapse and developing new treatment strategies.	[Pandita, Aakriti; Ramadas, Poornima; Poudel, Aarati; Saad, Nibal; Anand, Ankit; Basnet, Alina; Gilligan, Diana M.] SUNY Upstate Med Univ, Dept Med, Div Hematol Oncol, Syracuse, NY 13210 USA; [Middleton, Frank] SUNY Upstate Med Univ, Dept Neurobiol & Physiol, Syracuse, NY 13210 USA; [Wang, Dongliang] SUNY Upstate Med Univ, Dept Publ Hlth & Prevent Med, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Gilligan, DM (corresponding author), SUNY Upstate Med Univ, Dept Med, Div Hematol Oncol, Syracuse, NY 13210 USA.	gilligad@upstate.edu	Wang, Dongliang/A-1395-2014	Wang, Dongliang/0000-0003-4713-3516; Middleton, Frank/0000-0002-3107-7188				Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi LX, 2018, ONCOL LETT, V15, P5611, DOI 10.3892/ol.2018.8050; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Daschkey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056334; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dorrance AM, 2015, LEUKEMIA, V29, P2143, DOI 10.1038/leu.2015.139; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Favreau AJ, 2016, EXP HEMATOL ONCOL, V5, DOI 10.1186/s40164-016-0033-6; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Gilligan DM, 2018, CANCER RES, P5413; Havelange V, 2014, BLOOD, V123, P2412, DOI 10.1182/blood-2013-10-532374; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liao Q, 2016, ONCOTARGET, V8; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Pandita A, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.5252.5252; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Shivarov V, 2014, EXP HEMATOL, V42, P651, DOI 10.1016/j.exphem.2014.04.006; Su R, 2015, ONCOGENE, V34, P3226, DOI 10.1038/onc.2014.274; Trino S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020460; Trissal MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119304; Velu CS, 2014, J CLIN INVEST, V124, P222, DOI 10.1172/JCI66005; Wallace JA, 2017, BLOOD, V130, P1290, DOI 10.1182/blood-2016-10-697698; Wang XM, 2017, CELL BIOL INT, V41, P936, DOI 10.1002/cbin.10770; Weng HY, 2015, CANCER GENET-NY, V208, P225, DOI 10.1016/j.cancergen.2014.12.006; Ziai JM, 2015, AM J CLIN PATHOL, V144, P539, DOI 10.1309/AJCP77ZFPUQGYGWY	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213078	10.1371/journal.pone.0213078	http://dx.doi.org/10.1371/journal.pone.0213078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893351	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900027
J	Schubiger, MN; Kissling, A; Burkart, JM				Schubiger, Michele N.; Kissling, Alexandra; Burkart, Judith M.			Does opportunistic testing bias cognitive performance in primates? Learning from drop-outs	PLOS ONE			English	Article							CAPUCHIN MONKEYS; HAND PREFERENCE; SPATIAL MEMORY; EVOLUTION; ECOLOGY; PERSONALITY; SELECTION; HUMANS	Dropouts are a common issue in cognitive tests with non-human primates. One main reason for dropouts is that researchers often face a trade-off between obtaining a sufficiently large sample size and logistic restrictions, such as limited access to testing facilities. The commonly-used opportunistic testing approach deals with this trade-off by only testing those individuals who readily participate and complete the cognitive tasks within a given time frame. All other individuals are excluded from further testing and data analysis. However, it is unknown if this approach merely excludes subjects who are not consistently motivated to participate, or if these dropouts systematically differ in cognitive ability. If the latter holds, the selection bias resulting from opportunistic testing would systematically affect performance scores and thus comparisons between individuals and species. We assessed the potential effects of opportunistic testing on cognitive performance in common marmosets (Callithrix jacchus) and squirrel monkeys (Saimiri sciureus) with a test battery consisting of six cognitive tests: two inhibition tasks (Detour Reaching and A-not-B), one cognitive flexibility task (Reversal Learning), one quantity discrimination task, and two memory tasks. Importantly, we used a full testing approach in which subjects were given as much time as they required to complete each task. For each task, we then compared the performance of subjects who completed the task within the expected number of testing days with those subjects who needed more testing time. We found that the two groups did not differ in task performance, and therefore opportunistic testing would have been justified without risking biased results. If our findings generalise to other species, maximising sample sizes by only testing consistently motivated subjects will be a valid alternative whenever full testing is not feasible.	[Schubiger, Michele N.; Kissling, Alexandra; Burkart, Judith M.] Univ Zurich, Dept Anthropol, Evolutionary Cognit Grp, Zurich, Switzerland; [Schubiger, Michele N.] Abertay Univ, Sch Social & Hlth Sci, Div Psychol, Dundee, Scotland	University of Zurich; University of Abertay Dundee	Schubiger, MN (corresponding author), Univ Zurich, Dept Anthropol, Evolutionary Cognit Grp, Zurich, Switzerland.; Schubiger, MN (corresponding author), Abertay Univ, Sch Social & Hlth Sci, Div Psychol, Dundee, Scotland.	michele.schubiger@uzh.ch	Burkart, Judith M./P-6357-2014	Burkart, Judith M./0000-0002-6229-525X; Schubiger, Michele N./0000-0002-5707-9691	Swiss National Science Foundation [310030-120383]; A.H. Schultz-Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); A.H. Schultz-Foundation	This research was financially supported by the Swiss National Science Foundation (project funding to JMB; project number 310030-120383) and the A.H. Schultz-Foundation (two individual grants to MNS).	Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Banerjee K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005883; Brown GR, 2004, ADV STUD BEHAV, V34, P265, DOI 10.1016/S0065-3454(04)34007-6; Burkart J, 2006, J COMP PSYCHOL, V120, P120, DOI 10.1037/0735-7036.120.2.120; Burkart JM, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16000959; Cameron R, 1999, J COMP PSYCHOL, V113, P149, DOI 10.1037/0735-7036.113.2.149; Carducci P, 2018, ANIM BEHAV, V135, P199, DOI 10.1016/j.anbehav.2017.11.018; Carere C, 2011, CURR ZOOL, V57, P491, DOI 10.1093/czoolo/57.4.491; Damerius LA, 2017, ANIM BEHAV, V134, P57, DOI 10.1016/j.anbehav.2017.10.005; Damerius LA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40052; Gazes RP, 2018, LEARN BEHAV, V46, P89, DOI 10.3758/s13420-017-0295-9; Gordon DJ, 2015, BEHAV BRAIN RES, V287, P100, DOI 10.1016/j.bbr.2015.03.037; Gray DT, 2017, BEHAV BRAIN RES, V322, P329, DOI 10.1016/j.bbr.2016.06.056; Griffin AS, 2015, TRENDS ECOL EVOL, V30, P207, DOI 10.1016/j.tree.2015.01.012; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Joly M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2738; Lacreuse A, 2014, NEUROBIOL AGING, V35, P623, DOI 10.1016/j.neurobiolaging.2013.08.036; MacLean EL, 2014, P NATL ACAD SCI USA, V111, pE2140, DOI 10.1073/pnas.1323533111; Mattison JA, 2017, EXP GERONTOL, V94, P41, DOI 10.1016/j.exger.2016.12.005; Morton FB, 2013, ANIM COGN, V16, P677, DOI 10.1007/s10071-013-0603-5; Pravosudov VV, 2013, ANNU REV ECOL EVOL S, V44, P173, DOI 10.1146/annurev-ecolsys-110512-135904; Rosati AG, 2014, ANIM COGN, V17, P947, DOI 10.1007/s10071-014-0727-2; Rowe N, 1996, PICTORIAL GUIDE LIVI; Rumbaugh D. M., 2003, INTELLIGENCE APES OT; Rumbaugh DM, 1997, DEV PREFRONTAL CORTE; Schmitt V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1262; Schubiger MN, 2016, ANIM BEHAV, V121, P33, DOI 10.1016/j.anbehav.2016.08.005; Schubiger MN, 2015, ANIM COGN, V18, P701, DOI 10.1007/s10071-015-0837-5; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Toxopeus IB, 2005, BEHAVIOUR, V142, P1269, DOI 10.1163/156853905774539373; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; Wobber V, 2014, DEV PSYCHOBIOL, V56, P547, DOI 10.1002/dev.21125	33	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213727	10.1371/journal.pone.0213727	http://dx.doi.org/10.1371/journal.pone.0213727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893340	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000461765900047
J	Sherman, KE; Rouster, SD; Kong, LX; Aliota, MT; Blackard, JT; Dean, GE				Sherman, Kenneth E.; Rouster, Susan D.; Kong, Ling X.; Aliota, Matthew T.; Blackard, Jason T.; Dean, Gary E.			Zika virus replication and cytopathic effects in liver cells	PLOS ONE			English	Article							TRANSMISSION; PROPAGATION; STATES	Zika virus (ZIKV) has emerged globally as an important pathogen, since it has been recognized as a cause of microcephaly and other neurologic processes and sequalae in newborns. The virus shares homology with Hepaciviruses and therefore may be a cause of hepatitis. We sought to characterize ZIKV replication in hepatocyte-derived cell lines. Huh7.5 and HepG2 cells were infected with ZIKV and replication potential was evaluated by multiple methods including plaque assay, qRT-PCR, negative-strand ZIKV RNA production, and ZIKV NS1 protein production. Growth curves in cells and supernatant were compared to replicative capacity in Vero cells. Overall, viral replication in both hepatocyte lines approximated that observed in the Vero cells. Cell cytopathology was observed after 3 days of infection and apoptosis markers increased. Transmission electron microscopy revealed evidence of viral capsids in cells and negative staining revealed ZIKV particles in the supernatant. Conclusions: Hepatocyte-derived cell lines are permissive for ZIKV replication and produce an overt cytopathic effect consistent with development of an acute viral hepatitis. Further evaluation of replication and injury is warranted.	[Sherman, Kenneth E.; Rouster, Susan D.; Kong, Ling X.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Internal Med, Cincinnati, OH 45221 USA; [Aliota, Matthew T.] Univ Wisconsin, Madison, WI USA; [Dean, Gary E.] Univ Cincinnati, Coll Med, Mol Genet, Cincinnati, OH USA; [Aliota, Matthew T.] Univ Minnesota Twin Cities, Dept Vet & Biomed Sci, Minneapolis, MN USA	University System of Ohio; University of Cincinnati; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati; University of Minnesota System; University of Minnesota Twin Cities	Sherman, KE (corresponding author), Univ Cincinnati, Coll Med, Internal Med, Cincinnati, OH 45221 USA.	Kenneth.Sherman@uc.edu	Aliota, Matthew/AAS-6376-2021	Aliota, Matthew/0000-0002-6902-9149	University of Cincinnati College of Medicine; NIH [R21AI131454, R01AI132563, R56AI132563]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132563, R21AI131454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	University of Cincinnati College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a Distinguished Senior Investigator award from the University of Cincinnati College of Medicine to KES; and NIH funding grants R21AI131454, R01AI132563, R56AI132563 to MTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011; Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; FRANCIS TI, 1972, B WORLD HEALTH ORGAN, V46, P659; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lanford RE, 1998, METHODS MOL MED, P2543, DOI [10.1056/NEJMoa0805715, DOI 10.1056/NEJMOA0805715]; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Sherman KE, 2018, JAIDS-J ACQ IMM DEF, V78, pE35, DOI 10.1097/QAI.0000000000001718; Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672; Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2; Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003; Weger- Lucarelli J., 2017, J VIROLOGY, V91; WU Y, 2017, SCI REPORTS, V7; Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014	18	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0214016	10.1371/journal.pone.0214016	http://dx.doi.org/10.1371/journal.pone.0214016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893357	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900064
J	Tarquini, G; Zaina, G; Ermacora, P; De Amicis, F; Franco-Orozco, B; Loi, N; Martini, M; Bianchi, GL; Pagliari, L; Firrao, G; de Paoli, E; Musetti, R				Tarquini, Giulia; Zaina, Giusi; Ermacora, Paolo; De Amicis, Francesca; Franco-Orozco, Barbara; Loi, Nazia; Martini, Marta; Bianchi, Gian Luca; Pagliari, Laura; Firrao, Giuseppe; de Paoli, Emanuele; Musetti, Rita			Agroinoculation of Grapevine Pinot Gris Virus in tobacco and grapevine provides insights on viral pathogenesis	PLOS ONE			English	Article							INFECTIOUS CDNA-CLONES; PLANT-VIRUSES; NICOTIANA-BENTHAMIANA; ANTIVIRAL IMMUNITY; CONSTRUCTION; ASSOCIATION	The Grapevine Pinot Gris disease (GPG-d) is a novel disease characterized by symptoms such as leaf mottling and deformation, which has been recently reported in grapevines, and mostly in Pinot gris. Plants show obvious symptoms at the beginning of the growing season, while during summer symptom recovery frequently occurs, manifesting as symptomless leaves. A new Trichovirus, named Grapevine Pinot gris virus (GPGV), which belongs to the family Betaflexiviridae was found in association with infected plants. The detection of the virus in asymptomatic grapevines raised doubts about disease aetiology. Therefore, the primary target of this work was to set up a reliable system for the study of the disease in controlled conditions, avoiding interfering factor(s) that could affect symptom development. To this end, two clones of the virus, pRI::GPGV-vir and pRI::GPGV-lat, were generated from total RNA collected from one symptomatic and one asymptomatic Pinot gris grapevine, respectively. The clones, which encompassed the entire genome of the virus, were used in Agrobacterium-mediated inoculation of Vitis vinifera and Nicotiana benthamiana plants. All inoculated plants developed symptoms regardless of their inoculum source, demonstrating a correlation between the presence of GPGV and symptomatic manifestations. Four months post inoculum, the grapevines inoculated with the pRI::GPGV-lat clone developed asymptomatic leaves that were still positive to GPGV detection. Three to four weeks later (i.e. ca. 5 months post inoculum), the same phenomenon was observed in the grapevines inoculated with pRI::GPGV-vir. This observation perfectly matches symptom progression in infected field-grown grapevines, suggesting a possible role for plant antiviral mechanisms, such as RNA silencing, in the recovery process.	[Tarquini, Giulia; Zaina, Giusi; Ermacora, Paolo; Franco-Orozco, Barbara; Loi, Nazia; Martini, Marta; Pagliari, Laura; Firrao, Giuseppe; de Paoli, Emanuele; Musetti, Rita] Univ Udine, Dept Agr Food Environm & Anim Sci, Udine, Italy; [De Amicis, Francesca; Bianchi, Gian Luca] ERSA, Plant Protect Serv, Pozzuolo Del Friuli, UD, Italy	University of Udine	Musetti, R (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, Udine, Italy.	rita.musetti@uniud.it	Ermacora, Paolo/A-3551-2016; Musetti, Rita/AAK-1282-2020; MUSETTI, Rita/AAS-2890-2021; Tarquini, Giulia/AGJ-4881-2022; Pagliari, Laura/AAI-6702-2020	Musetti, Rita/0000-0001-8459-0869; MUSETTI, Rita/0000-0001-8459-0869; Pagliari, Laura/0000-0002-0241-5731; De Paoli, Emanuele/0000-0003-3646-7692; ERMACORA, Paolo/0000-0003-0757-7956; Tarquini, Giulia/0000-0002-9042-5218	Regione Friuli-Venezia Giulia (Italy) [CUP: F22I15000110002]	Regione Friuli-Venezia Giulia (Italy)	The work presented in this manuscript has been funded by Regione Friuli-Venezia Giulia (Italy) CUP: F22I15000110002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQUIST P, 1984, MOL CELL BIOL, V4, P2876, DOI 10.1128/MCB.4.12.2876; [Anonymous], 1950, CIRC CALIF AGR EXP S; Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007; Bertazzon N, 2017, PLANT PATHOL, V66, P949, DOI 10.1111/ppa.12639; Bertazzon N., 2002, J PLANT PATHOL, V84, P175; Bertazzon N, 2016, ARCH VIROL, V161, P711, DOI 10.1007/s00705-015-2718-2; Bianchi G. L., 2015, Bulletin OEPP, V45, P22, DOI 10.1111/epp.12196; Bordat A, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0315-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; DAWSON WO, 1992, ANNU REV PLANT PHYS, V43, P527, DOI 10.1146/annurev.pp.43.060192.002523; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Ghoshal B, 2015, VIROLOGY, V479, P167, DOI 10.1016/j.virol.2015.01.008; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Glasa M, 2014, ARCH VIROL, V159, P2103, DOI 10.1007/s00705-014-2031-5; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jo Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15841; Korner CJ, 2018, NAT PLANTS, V4, P157, DOI 10.1038/s41477-018-0117-x; Ma XF, 2015, J EXP BOT, V66, P919, DOI 10.1093/jxb/eru447; Martelli GP, 2007, ANNU REV PHYTOPATHOL, V45, P73, DOI 10.1146/annurev.phyto.45.062806.094401; Meng BZ, 2006, J GEN VIROL, V87, P1725, DOI 10.1099/vir.0.81533-0; Muruganantham M, 2009, J VIROL METHODS, V155, P167, DOI 10.1016/j.jviromet.2008.10.010; Musetti R, 2005, MICRON, V36, P73, DOI 10.1016/j.micron.2004.05.002; Nagyova A, 2007, ACTA VIROL, V51, P223; NYLAND G, 1969, ANNU REV PHYTOPATHOL, V7, P331, DOI 10.1146/annurev.py.07.090169.001555; Perrone I, 2017, NEW PHYTOL, V213, P983, DOI 10.1111/nph.14271; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Saldarelli P, 2015, PHYTOPATHOLOGY, V105, P555, DOI 10.1094/PHYTO-09-14-0241-R; Syller J, 2016, MOL PLANT PATHOL, V17, P769, DOI 10.1111/mpp.12322; Tarquini G, 2018, PROTOPLASMA, V255, P923, DOI 10.1007/s00709-017-1198-5; Junqueira BRT, 2014, J VIROL METHODS, V198, P32, DOI 10.1016/j.jviromet.2013.12.024; Tuo DC, 2015, VIRUSES-BASEL, V7, P6241, DOI 10.3390/v7122935; Vandesompele J, ACCURATE NORMALIZATI, P12; Voinnet O., 2001, RNA SILENCING PLANT, P11; Youssef F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-488	37	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214010	10.1371/journal.pone.0214010	http://dx.doi.org/10.1371/journal.pone.0214010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889228	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000042
J	Loew, M; Doustdar, S; Drath, C; Weber, MA; Bruckner, T; Porschke, F; Raiss, P; Schiltenwolf, M; Almansour, H; Akbar, M				Loew, Markus; Doustdar, Sepehr; Drath, Christoph; Weber, Marc-Andre; Bruckner, Thomas; Porschke, Felix; Raiss, Patric; Schiltenwolf, Marcus; Almansour, Haidara; Akbar, Michael			Could long-term overhead load in painters be associated with rotator cuff lesions? A pilot study	PLOS ONE			English	Article							IMPINGEMENT SYNDROME; SHOULDER DISORDERS; RISK-FACTORS; ARM; PREVALENCE; TEARS; WORK; BIOMECHANICS; PRESSURE; DISEASE	Background Use of the arm above shoulder level has been described as a risk factor for developing rotator cuff tears (RCT). There is a lack of information regarding the frequency and distribution of RCT in a population using their arms above shoulder level during daily work. The aim of this study was to analyze clinical and radiographic findings in a population of painters working more than 10 years and to compare the results with a control group (CG) Materials and methods 100 individuals working more than 10 years as a painter were compared to 100 matched controls without using their arms above shoulder level. MRI scans were performed in all participants. Clinically, the Constant score, DASH score and range of motion (ROM) of the shoulders were analyzed. Results In the painter group (PG) a tear of the supraspinatus tendon was detected in 45% (10%full-thickness; 35% partial) compared to 8% in the (CG) (3% full-thickness; 5%partial; p<0.001). Impingement test was painful in 52% of PG and 7% of CG (p<0.001). The Constant score in the PG was significantly lower compared to the CG (62 vs. 93 points; p<0.001). PG had significantly worse DASH scores and inferior active and passive ROM of the dominant shoulders. In the multivariable logistic regression analysis, three risk factors (smoking, sports activity, and handedness) showed no effect. However, group membership (PG/CG) and age revealed a significant effect. Conclusion Long-term occupational load on the shoulders in painters seems to be associated with an increased risk for developing RCT. Our findings may provide support for developing preventive strategies for this unique cohort. Level of evidence: III	[Loew, Markus] Atos Clin, German Joint Ctr, Heidelberg, Germany; [Doustdar, Sepehr; Schiltenwolf, Marcus; Almansour, Haidara; Akbar, Michael] Heidelberg Univ, Dept Orthopaed Surg Trauma Surg & Spinal Cord Inj, Heidelberg, Germany; [Drath, Christoph] Employers Liabil Insurance Assoc Construct Ind, Occupat Med & Safety Serv, Heidelberg, Germany; [Weber, Marc-Andre] Heidelberg Univ Hosp Heidelberg, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Bruckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Porschke, Felix] BG Trauma Ctr Ludwigshafen, Ludwigshafen, Germany; [Raiss, Patric] Orthoped Clin Munich, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Akbar, M (corresponding author), Heidelberg Univ, Dept Orthopaed Surg Trauma Surg & Spinal Cord Inj, Heidelberg, Germany.	michael.akbar@med.uni-heidelberg.de	Weber, Marc/GXA-0612-2022	Almansour, Haidara/0000-0003-1672-3855				Baumgarten KM, 2010, CLIN ORTHOP RELAT R, V468, P1534, DOI 10.1007/s11999-009-0781-2; Bigliani L, 1986, J ORTHOP TRANSL, V10; Cohen RB, 1998, CLIN ORTHOP RELAT R, P95; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Fehringer EV, 2008, J SHOULDER ELB SURG, V17, P881, DOI 10.1016/j.jse.2008.05.039; Frost P, 1999, OCCUP ENVIRON MED, V56, P494, DOI 10.1136/oem.56.7.494; Gerber C, 2014, J ORTHOP RES, V32, P952, DOI 10.1002/jor.22621; Hegedus EJ, 2008, BRIT J SPORT MED, V42, P80, DOI 10.1136/bjsm.2007.038406; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JARVHOLM U, 1988, J ORTHOP RES, V6, P230, DOI 10.1002/jor.1100060210; Kaergaard A, 2000, PAIN, V86, P305, DOI 10.1016/S0304-3959(00)00261-X; Karas V, 2012, MED SPORT SCI, V57, P18, DOI 10.1159/000328871; Kloth JK, 2014, EUR J RADIOL, V83, P1843, DOI 10.1016/j.ejrad.2014.06.011; Ladermann A, 2016, J SCI MED SPORT, V19, P56, DOI 10.1016/j.jsams.2014.11.009; Longo UG, 2012, MED SPORT SCI, V57, P10, DOI 10.1159/000328870; Moor BK, 2014, J SHOULDER ELB SURG, V23, P536, DOI 10.1016/j.jse.2013.11.008; Moosmayer S, 2009, J BONE JOINT SURG BR, V91B, P196, DOI 10.1302/0301-620X.91B2.21069; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Pearsall AW, 2003, J SHOULDER ELB SURG, V12, P122, DOI 10.1067/mse.2003.19; Schmitt H, 2001, INT J SPORTS MED, V22, P275, DOI 10.1055/s-2001-13814; SIGHOLM G, 1988, J ORTHOP RES, V6, P123, DOI 10.1002/jor.1100060116; Silverstein BA, 2008, J OCCUP ENVIRON MED, V50, P1062, DOI 10.1097/JOM.0b013e31817e7bdd; Silverstein BA, 2006, SCAND J WORK ENV HEA, V32, P99, DOI 10.5271/sjweh.985; Sporrong H, 1996, ACTA ORTHOP SCAND, V67, P485, DOI 10.3109/17453679608996674; Svendsen SW, 2005, OCCUP ENVIRON MED, V62, P18, DOI 10.1136/oem.2004.015966; Svendsen SW, 2004, ARTHRITIS RHEUM-US, V50, P3314, DOI 10.1002/art.20495; Svendsen SW, 2004, OCCUP ENVIRON MED, V61, P844, DOI 10.1136/oem.2003.010637; Teefey SA, 2004, J BONE JOINT SURG AM, V86A, P708, DOI 10.2106/00004623-200404000-00007; Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9; van der Windt DAWM, 2000, OCCUP ENVIRON MED, V57, P433, DOI 10.1136/oem.57.7.433; Walker-Bone K, 2006, OCCUP MED-OXFORD, V56, P243, DOI 10.1093/occmed/kql016; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213824	10.1371/journal.pone.0213824	http://dx.doi.org/10.1371/journal.pone.0213824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875391	Green Submitted, Green Published, gold			2022-12-26	WOS:000461316400033
J	Furneri, G; Klausnitzer, R; Haycock, L; Ihara, Z				Furneri, Gianluca; Klausnitzer, Romy; Haycock, Laura; Ihara, Zenichi			Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model	PLOS ONE			English	Article							CONFOCAL LASER ENDOMICROSCOPY; LOW-GRADE DYSPLASIA; ADENOCARCINOMA; PROGRESSION; GUIDELINES; MANAGEMENT; NEOPLASIA; THERAPY; CANCER; RISK	Barrett's esophagus (BE) is an abnormality arising from gastroesophageal reflux disease that can progressively evolve into a sequence of dysplasia and adenocarcinoma. Progression of Barrett's esophagus into dysplasia is monitored with endoscopic surveillance. The current surveillance standard requests random biopsies plus targeted biopsies of suspicious lesions under white-light endoscopy, known as the Seattle protocol. Recently, published evidence has shown that narrow-band imaging (NBI) can guide targeted biopsies to identify dysplasia and reduce the need for random biopsies. We aimed to assess the health economic implications of adopting NBI-guided targeted biopsy vs. the Seattle protocol from a National Health Service England perspective. A decision tree model was developed to undertake a cost-consequence analysis. The model estimated total costs (i.e. staff and overheads; histopathology; adverse events; capital equipment) and clinical implications of monitoring a cohort of patients with known/suspected BE, on an annual basis. In the simulation, BE patients (N = 161,657 at Year 1; estimated annual increase: +20%) entered the model every year and underwent esophageal endoscopy. After 7 years, the adoption of NBI with targeted biopsies resulted in cost reduction of 458.0 pound mln vs. HD-WLE with random biopsies (overall costs: 1,966.2 pound mln and 2,424.2 pound mln, respectively). The incremental investment on capital equipment to upgrade hospitals with NBI (+68.3 pound mln) was offset by savings due to the reduction of histological examinations (-505.2 pound mln). Reduction of biopsies also determined savings for avoided adverse events (-21.1 pound mln). In the base-case analysis, the two techniques had the same accuracy (number of correctly identified cases: 1.934 mln), but NBI was safer than HD-WLE. Budget impact analysis and cost-effectiveness analyses confirmed the findings of the cost-consequence analysis. In conclusion, NBI-guided targeted biopsies was a cost-saving strategy for NHS England, compared to current practice for detection of dysplasia in patients with BE, whilst maintaining at least comparable health outcomes for patients.	[Furneri, Gianluca; Haycock, Laura] CBPartners, Value Access & Pricing, London, England; [Klausnitzer, Romy; Ihara, Zenichi] Olympus Europa, Med Syst Div, Hamburg, Germany	Olympus Corporation	Haycock, L (corresponding author), CBPartners, Value Access & Pricing, London, England.; Klausnitzer, R (corresponding author), Olympus Europa, Med Syst Div, Hamburg, Germany.	Romy.Klausnitzer@olympus-europa.com; Laura.Haycock@cbpartners.com		Ihara, Zenichi/0000-0003-0613-0263; Klausnitzer, Romy/0000-0002-7584-8271	Olympus; CBPartners	Olympus; CBPartners	This study was funded by Olympus. ZI and RK are employees of Olympus. Olympus provided support in the form of salaries for authors ZI and RK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. GF and LH are employees of CBPartners. CBPartners provided support in the form of salaries for authors GF and LH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams JA, 2009, CLIN GASTROENTEROL H, V7, P736, DOI 10.1016/j.cgh.2008.12.027; Alneaimi K, 2016, ENDOSC INT OPEN, V4, pE583, DOI 10.1055/s-0042-103416; Beg S, 2018, GASTROINTEST ENDOSC, V87, P1189, DOI 10.1016/j.gie.2017.09.012; Ben-Menachem T, 2012, GASTROINTEST ENDOSC, V76, P707, DOI 10.1016/j.gie.2012.03.252; Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; British Society of Gastroenterology, 2006, GUID COMPL GASTR END; CAMERON AJ, 1985, NEW ENGL J MED, V313, P857, DOI 10.1056/NEJM198510033131404; Daly JM, 1996, CANCER, V78, P1820, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z; Das D, 2008, AM J GASTROENTEROL, V103, P1079, DOI 10.1111/j.1572-0241.2008.01790.x; Desai M, 2017, GASTROINTEST ENDOSC, V85, P482, DOI 10.1016/j.gie.2016.09.022; England PH, 2013, RED UNW VAR INCR VAL; Fitzgerald R, 2013, BSG GUIDELINES DIAGN; Gordon LG, 2011, BRIT J SURG, V98, P1589, DOI 10.1002/bjs.7599; HESKETH PJ, 1989, CANCER, V64, P526, DOI 10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B; HSCIC, MAIN PROC INT 2012 2; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jayasekera C, 2012, ENDOSCOPY, V44, P1089, DOI 10.1055/s-0032-1325734; Kong CY, 2014, CANCER EPIDEM BIOMAR, V23, P997, DOI 10.1158/1055-9965.EPI-13-1233; Muthusamy VR, 2015, GASTROENTEROL CLIN N, V44, P439, DOI 10.1016/j.gtc.2015.02.012; National Institute for Health and Care Excellence (NICE), 2012, ASS COST EFF GUID MA; NHS. England National Tariff Workbook, ADM PAT CAR OUTP PRO; Office for national statistics, 2018, POP EST ENGL MID 201; Olympus, 2018, OL MARK DAT AN; Parasa S, 2018, GASTROENTEROLOGY, V154, P1282, DOI 10.1053/j.gastro.2017.12.009; Personal Social Services Research Unit, UN COST HLTH SOC CAR; Plymouth Hospital NHS Trust (PHNT), 2012, PRIV HEALTHC TAR SEL; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Runge TM, 2015, GASTROENTEROL CLIN N, V44, P203, DOI 10.1016/j.gtc.2015.02.001; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Sharara N, 2008, CAN J GASTROENTEROL, V22, P565, DOI 10.1155/2008/854984; Sharma P, 2013, GUT, V62, P15, DOI 10.1136/gutjnl-2011-300962; Solon C, 2016, J MED ECON, V19, P1040, DOI 10.1080/13696998.2016.1192550; Song J, 2015, DIS ESOPHAGUS, V28, P560, DOI 10.1111/dote.12222; South Devon Healthcare (SHD) NHS Foundation Trust, 2014, PRIV PAT OV VIS PRIC; Spechler SJ, 2002, MED CLIN N AM, V86, P1423, DOI 10.1016/S0025-7125(02)00082-2; Thosani N, 2016, GASTROINTEST ENDOSC, V83, DOI 10.1016/j.gie.2016.01.007; United Kingdom. Dept of Health & Social Care, DEPR POL PRIM CAR TR; University College London Hospital (UCLH) NHS, 2012, PROV PROV SERV 2012; Vennalaganti P, 2017, GASTROENTEROLOGY, V152, P564, DOI 10.1053/j.gastro.2016.10.041; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Wani S, 2011, GASTROENTEROLOGY, V141, P1179, DOI 10.1053/j.gastro.2011.06.055; Xiong YQ, 2018, CLIN RES HEPATOL GAS, V42, P31, DOI 10.1016/j.clinre.2017.05.005	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212916	10.1371/journal.pone.0212916	http://dx.doi.org/10.1371/journal.pone.0212916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865673	gold, Green Submitted, Green Published			2022-12-26	WOS:000461048900048
J	Barry, S; Carlsen, E; Marques, P; Stiles, CE; Gadaleta, E; Berney, DM; Roncaroli, F; Chelala, C; Solomou, A; Herincs, M; Caimari, F; Grossman, AB; Crnogorac-Jurcevic, T; Haworth, O; Gaston-Massuet, C; Korbonits, M				Barry, Sayka; Carlsen, Eivind; Marques, Pedro; Stiles, Craig E.; Gadaleta, Emanuela; Berney, Dan M.; Roncaroli, Federico; Chelala, Claude; Solomou, Antonia; Herincs, Maria; Caimari, Francisca; Grossman, Ashley B.; Crnogorac-Jurcevic, Tatjana; Haworth, Oliver; Gaston-Massuet, Carles; Korbonits, Marta			Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; DIFFERENTIAL GENE-EXPRESSION; INTERACTING PROTEIN; GROWTH-HORMONE; T-CELLS; SOMATOTROPH ADENOMAS; COLON-CANCER; MACROPHAGES; FLI-1; PROGRESSION	The molecular mechanisms leading to aryl hydrocarbon receptor interacting protein (AIP) mutation-induced aggressive, young-onset growth hormone-secreting pituitary tumors are not fully understood. In this study, we have identified that AIP-mutation-positive tumors are infiltrated by a large number of macrophages compared to sporadic tumors. Tissue from pituitary-specific Aip-knockout (Aip(Flox/Flox) ; Hesx1(cre/+)) mice recapitulated this phenotype. Our human pituitary tumor transcriptome data revealed the "epithelial-to-mesenchymal transition (EMT) pathway" as one of the most significantly altered pathways in AIP(pos) tumors. Our in vitro data suggest that bone marrow-derived macrophage-conditioned media induces more prominent EMT-like phenotype and enhanced migratory and invasive properties in Aip-knockdown somatomammotroph cells compared to non-targeting controls. We identified that tumor-derived cytokine CCL5 is upregulated in AIP-mutation-positive human adenomas. Aip-knockdown GH3 cell-conditioned media increases macrophage migration, which is inhibited by the CCL5/CCR5 antagonist maraviroc. Our results suggest that a crosstalk between the tumor and its microenvironment plays a key role in the invasive nature of AIP-mutation-positive tumors and the CCL5/CCR5 pathway is a novel potential therapeutic target.	[Barry, Sayka; Marques, Pedro; Stiles, Craig E.; Solomou, Antonia; Herincs, Maria; Caimari, Francisca; Grossman, Ashley B.; Haworth, Oliver; Gaston-Massuet, Carles; Korbonits, Marta] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, Ctr Endocrinol, London EC1M 6BQ, England; [Carlsen, Eivind] STHF, Dept Pathol, N-3710 Skien, Norway; [Gadaleta, Emanuela; Berney, Dan M.; Chelala, Claude; Crnogorac-Jurcevic, Tatjana] Queen Mary Univ London, Barts Canc Inst, Barts & London Sch Med, Mol Oncol, London EC1M 6BQ, England; [Roncaroli, Federico] Univ Manchester, Div Neurosci & Expt Psychol, Manchester M13 9PL, Lancs, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Manchester	Korbonits, M (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, Ctr Endocrinol, London EC1M 6BQ, England.	m.korbonits@qmul.ac.uk		Marques, Pedro/0000-0002-4959-5725; Korbonits, Marta/0000-0002-4101-9432; Roncaroli, Federico/0000-0003-3650-5572; Caimari, Francisca/0000-0003-3327-9098; Gadaleta, Emanuela/0000-0002-5740-6293	Medical Research Council [MR/M018539/1]; Wellcome Trust [097970/Z/11/Z]; Fundacion Alfonso Martin Escudero Fellowship; Rosetrees Trust [M505]; Barts and the London Charity; Pfizer UK [WS 733753]; MRC [MR/M018539/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fundacion Alfonso Martin Escudero Fellowship; Rosetrees Trust(Rosetrees Trust); Barts and the London Charity; Pfizer UK(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MR/M018539/1 to MK), Wellcome Trust (Clinical Training fellowship 097970/Z/11/Z to CES), Fundacion Alfonso Martin Escudero Fellowship (to FC), Rosetrees Trust (M505 to MK and CG-M), Barts and the London Charity (to PM and MK) and Pfizer UK (WS 733753 to MK).	Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Azorin E, 2012, ARCH BIOCHEM BIOPHYS, V528, P148, DOI 10.1016/j.abb.2012.08.011; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Barry S, 2012, END ABSTR, pP1349; Basu R, 2017, ONCOTARGET, V8, P21579, DOI 10.18632/oncotarget.15375; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Brittain AL, 2017, J CLIN ENDOCR METAB, V102, P3662, DOI 10.1210/jc.2017-01000; Brown JM, 2017, CLIN CANCER RES, V23, P3241, DOI 10.1158/1078-0432.CCR-16-3122; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chahal HS, 2011, NEW ENGL J MED, V364, P43, DOI 10.1056/NEJMoa1008020; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Chesnokova V, 2016, P NATL ACAD SCI USA, V113, pE3250, DOI 10.1073/pnas.1600561113; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Evans CO, 2008, PITUITARY, V11, P231, DOI 10.1007/s11102-007-0082-2; Evans CO, 2001, J CLIN ENDOCR METAB, V86, P3097, DOI 10.1210/jc.86.7.3097; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fukunishi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158555; Galland F, 2010, ENDOCR-RELAT CANCER, V17, P361, DOI 10.1677/ERC-10-0018; Grigore AD, 2016, J CLIN MED, V5, P51, DOI 10.3390/jcm5050051; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heliovaara E, 2009, AM J PATHOL, V175, P2501, DOI 10.2353/ajpath.2009.081131; Heshmati HM, 1998, ENDOCR J, V45, P357, DOI 10.1507/endocrj.45.357; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; Jiang ZQ, 2010, EXP THER MED, V1, P905, DOI 10.3892/etm.2010.137; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kimura A, 2014, INT IMMUNOL, V26, P209, DOI 10.1093/intimm/dxt067; Lekva T, 2013, ENDOCRINOLOGY, V154, P3331, DOI 10.1210/en.2013-1051; Lekva T, 2012, J CLIN ENDOCR METAB, V97, pE1506, DOI 10.1210/jc.2012-1760; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Li Y, 2015, ONCOGENE, V34, P2022, DOI 10.1038/onc.2014.162; Liu WP, 2005, J MED INVESTIG, V52, P151, DOI 10.2152/jmi.52.151; Lu JQ, 2015, ENDOCR PATHOL, V26, P263, DOI 10.1007/s12022-015-9383-6; Lupi I, 2010, J CLIN ENDOCR METAB, V95, P289, DOI 10.1210/jc.2009-1583; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Morris DG, 2005, EUR J ENDOCRINOL, V153, P143, DOI 10.1530/eje.1.01937; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Oriola J, 2013, EUR J ENDOCRINOL, V168, P9, DOI 10.1530/EJE-12-0457; Osorio Joana, 2012, Nat Rev Endocrinol, V8, P444, DOI 10.1038/nrendo.2012.94; Pasqualato A, 2013, CELL ADHES MIGR, V7, P450, DOI 10.4161/cam.26765; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Richard MLL, 2014, J IMMUNOL, V193, P2661, DOI 10.4049/jimmunol.1302779; ROSSI ML, 1990, TUMORI, V76, P543, DOI 10.1177/030089169007600605; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Ruebel KH, 2006, ENDOCRINE, V29, P435, DOI 10.1385/ENDO:29:3:435; Sato S, 2014, CLIN EXP IMMUNOL, V177, P102, DOI 10.1111/cei.12310; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Subramani R, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.61; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torlakovic EE, 2008, HISTOL HISTOPATHOL, V23, P1309, DOI 10.14670/HH-23.1309; Tsai CH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41927; Tsai HP, 2017, ONCOTARGET, V8, P29174, DOI 10.18632/oncotarget.16303; Tuominen I, 2015, ONCOGENE, V34, P1174, DOI 10.1038/onc.2014.50; Wang JJ, 2017, ONCOTARGET, V8; Wartenberg M, 2015, ONCOTARGET, V6, P4190, DOI 10.18632/oncotarget.2775; Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Zhan XQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-13; Zhan XQ, 2005, MASS SPECTROM REV, V24, P783, DOI 10.1002/mas.20039	68	41	42	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 4	2019	38	27					5381	5395		10.1038/s41388-019-0779-5	http://dx.doi.org/10.1038/s41388-019-0779-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IG5KR	30867568	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-26	WOS:000473842500004
J	Wang, HR; Zhou, YJ; Oyang, LD; Han, YQ; Xia, LZ; Lin, JG; Tang, YY; Su, M; Tan, SM; Tian, YT; Chen, XY; Luo, X; Liang, JX; Rao, S; Wang, Y; Xiong, W; Zeng, ZY; Wang, H; Li, GY; Liao, QJ				Wang, Heran; Zhou, Yujuan; Oyang, Linda; Han, Yaqian; Xia, Longzheng; Lin, Jingguan; Tang, Yanyan; Su, Min; Tan, Shiming; Tian, Yutong; Chen, Xiaoyan; Luo, Xia; Liang, Jiaxin; Rao, Shan; Wang, Ying; Xiong, Wei; Zeng, Zhaoyang; Wang, Hui; Li, Guiyuan; Liao, Qianjin			LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-kappa B activity in nasopharyngeal carcinoma	ONCOGENE			English	Article							PROTEIN-DEGRADATION; CANCER-CELLS; PROHIBITIN; BPIFB1; TRIM21; MICE; IDENTIFICATION; TUMORIGENESIS	Long-palate, lung and nasal epithelium clone 1 (LPLUNC1) is a tumour suppressor gene in nasopharyngeal carcinoma (NPC), and low expression of LPLUNC1 is associated with poor prognosis. Our previous study showed that LPLUNC1 upregulates Prohibitin 1 (PHB1), a pleiotropic protein that functions as a tumour suppressor gene in various cancers. Low expression of PHB1 was also found to be associated with the poor prognosis of NPC patients. However, the mechanisms by which LPLUNC1 upregulates PHB1 and the potential role of PHB1 in NPC are unclear. Here, we found that LPLUNC1 stabilised PHB1 by inhibiting PHB1 ubiquitination, which is mediated by E3 ligase TRIM21. LPLUNC1 competitively impaired the binding of PHB1 to TRIM21 due to its stronger binding affinity to PHB1, suppressing the ubiquitination of PHB1. Therefore, our study indicates that PHB1 acted as a tumour suppressor gene by inhibiting NF-kB activity. Depletion of PHB1 significantly attenuated the anti-tumour effects of LPLUNC1 in NPC cells, and the inhibitory effect of LPLUNC1 on NF-kappa B activity was thus reversed. Together, our findings revealed a novel mechanism underlying the anticancer effect of LPLUNC1 and clarified that PHB1 may represent a novel, promising candidate tumour suppressor gene in NPC, with potential therapeutic target value.	[Wang, Heran; Zhou, Yujuan; Oyang, Linda; Han, Yaqian; Xia, Longzheng; Lin, Jingguan; Tang, Yanyan; Su, Min; Tan, Shiming; Tian, Yutong; Chen, Xiaoyan; Luo, Xia; Liang, Jiaxin; Rao, Shan; Wang, Ying; Wang, Hui; Liao, Qianjin] Cent S Univ, Hunan Canc Hosp, Hunan Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China; [Wang, Heran; Zhou, Yujuan; Oyang, Linda; Han, Yaqian; Xia, Longzheng; Lin, Jingguan; Tang, Yanyan; Su, Min; Tan, Shiming; Tian, Yutong; Chen, Xiaoyan; Luo, Xia; Liang, Jiaxin; Rao, Shan; Wang, Ying; Wang, Hui; Liao, Qianjin] Cent S Univ, Affiliated Canc Hosp, Hunan Key Lab Translat Radiat Oncol, Xiangya Sch Med, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China; [Xiong, Wei; Zeng, Zhaoyang; Li, Guiyuan] Cent S Univ, Canc Res Inst, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Changsha 410078, Hunan, Peoples R China	Central South University; Central South University; Central South University	Liao, QJ (corresponding author), Cent S Univ, Hunan Canc Hosp, Hunan Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.; Liao, QJ (corresponding author), Cent S Univ, Affiliated Canc Hosp, Hunan Key Lab Translat Radiat Oncol, Xiangya Sch Med, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	march-on@126.com	chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022	Zhou, Yujuan/0000-0002-5195-8724; Liao, Qianjin/0000-0001-9320-3090	National Natural Science Foundation of China [81472595, 81701510, 81872281]; Natural Science Foundation of Hunan Province [2018JJ1013, 2016JJ4059]; Research Project of the Health and Family Planning Commission of Hunan Province [B20180400, B20180582]; Changsha Science and Technology Board [kq1706045, kq1706043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Project of the Health and Family Planning Commission of Hunan Province; Changsha Science and Technology Board	This work was supported by grants from the National Natural Science Foundation of China (81472595, 81701510 and 81872281), the Natural Science Foundation of Hunan Province (2018JJ1013, 2016JJ4059), the Research Project of the Health and Family Planning Commission of Hunan Province (B20180400, B20180582), and the Changsha Science and Technology Board (kq1706045, kq1706043).	Amin H, 2015, ACS MED CHEM LETT, V6, P1071, DOI 10.1021/acsmedchemlett.5b00257; Bingle CD, 2010, HISTOCHEM CELL BIOL, V133, P505, DOI 10.1007/s00418-010-0683-0; Das A, 2015, VIROLOGY, V485, P383, DOI 10.1016/j.virol.2015.08.013; De Smet EG, 2018, INT J CHRONIC OBSTR, V13, P11, DOI 10.2147/COPD.S144136; Donoghue LJ, 2017, GENETICS, V207, P801, DOI 10.1534/genetics.117.300211; El-Etreby NM, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0325-4; Fan W, 2017, HEPATOLOGY, V65, P1249, DOI 10.1002/hep.28964; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Gao J, 2015, AM J PHYSIOL-LUNG C, V309, pL17, DOI 10.1152/ajplung.00082.2015; Han J, 2014, CELL SIGNAL, V26, P2086, DOI 10.1016/j.cellsig.2014.06.006; Hildesheim A, 2012, SEMIN CANCER BIOL, V22, P107, DOI 10.1016/j.semcancer.2012.01.007; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Jin JM, 2016, CELL TISSUE RES, V363, P805, DOI 10.1007/s00441-015-2280-y; Kang DC, 2017, ULTRASON SONOCHEM, V38, P317, DOI 10.1016/j.ultsonch.2017.03.026; Kathiria AS, 2012, CANCER RES, V72, P5778, DOI 10.1158/0008-5472.CAN-12-0603; Koushyar S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.32; Kumar C, 2017, MEDCHEMCOMM, V8, P2115, DOI 10.1039/c7md00267j; Liao Q, 2014, ONCOGENE, V33, P2098, DOI 10.1038/onc.2013.161; Liao QJ, 2013, EUR J CANCER PREV, V22, P68, DOI 10.1097/CEJ.0b013e328354d351; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Nguyen JQ, 2017, CANCER BIOL THER, V18, P16, DOI 10.1080/15384047.2016.1252880; Nih LR, 2017, ADV MATER, V29, DOI 10.1002/adma.201606471; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Qureshi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141826; Shin OS, 2011, J INFECT DIS, V204, P1349, DOI 10.1093/infdis/jir544; Shum AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006998; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Vargas PA, 2008, ORAL DIS, V14, P613, DOI 10.1111/j.1601-0825.2007.01429.x; Wang HY, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0103-5; Wang SM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9343460; Wang T, 2012, J CELL MOL MED, V16, P1134, DOI 10.1111/j.1582-4934.2011.01388.x; Wang XY, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201700186; Wei F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0409-0; Wei F, 2018, BRIT J CANCER, V118, P233, DOI 10.1038/bjc.2017.385; Wu CC, 2018, CANCERS, V10, DOI 10.3390/cancers10040120; Yang LT, 2018, J INVEST DERMATOL, V138, P2568, DOI 10.1016/j.jid.2018.05.016; Yang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062869; Ye X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109152; Yuan GJ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0695-5; Zeng ZY, 2011, SCI CHINA LIFE SCI, V54, P966, DOI 10.1007/s11427-011-4223-5; Zhang BC, 2003, GENE CHROMOSOME CANC, V38, P80, DOI 10.1002/gcc.10247; Zhang L, 2012, ASIAN PAC J CANCER P, V13, P3803, DOI 10.7314/APJCP.2012.13.8.3803; Zhou WQ, 2017, OPEN MED-WARSAW, V12, P299, DOI 10.1515/med-2017-0044; Zhou YJ, 2016, J CANCER, V7, P367, DOI 10.7150/jca.13695	49	24	28	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2019	38	25					5062	5075		10.1038/s41388-019-0778-6	http://dx.doi.org/10.1038/s41388-019-0778-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IE1KY	30886235	Green Published, hybrid			2022-12-26	WOS:000472145900013
J	Kermani, AA; Roy, R; Gopalasingam, C; Kocurek, KI; Patel, TR; Alderwick, LJ; Besra, GS; Futterer, K				Kermani, Ali A.; Roy, Rana; Gopalasingam, Chai; Kocurek, Klaudia I.; Patel, Trushar R.; Alderwick, Luke J.; Besra, Gurdyal S.; Fuetterer, Klaus			Crystal structure of the TreS:Pep2 complex, initiating -glucan synthesis in the GlgE pathway of mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; analytical ultracentrifugation; X-ray crystallography; trehalose; enzyme catalysis; protein complex; pathogenesis; -glucan; capsule; immune evasion; maltose kinase; trehalose synthase	ALPHA-GLUCAN; PROTEIN INTERACTIONS; TREHALOSE; TUBERCULOSIS; GLYCOGEN; BIOSYNTHESIS; SPECIFICITY; REFINEMENT	A growing body of evidence implicates the mycobacterial capsule, the outermost layer of the mycobacterial cell envelope, in modulation of the host immune response and virulence of mycobacteria. Mycobacteria synthesize the dominant capsule component, (14)-linked glucan, via three interconnected and potentially redundant metabolic pathways. Here, we report the crystal structure of the Mycobacterium smegmatis TreS:Pep2 complex, containing trehalose synthase (TreS) and maltokinase (Pep2), which converts trehalose to maltose 1-phosphate as part of the TreS:Pep2-GlgE pathway. The structure, at 3.6 angstrom resolution, revealed that a diamond-shaped TreS tetramer forms the core of the complex and that pairs of Pep2 monomers bind to opposite apices of the tetramer in a 4 + 4 configuration. However, for the M. smegmatis orthologues, results from isothermal titration calorimetry and analytical ultracentrifugation experiments indicated that the prevalent stoichiometry in solution is 4 TreS + 2 Pep2 protomers. The observed discrepancy between the crystallized complex and the behavior in the solution state may be explained by the relatively weak affinity of Pep2 for TreS (K-d 3.5 m at mildly acidic pH) and crystal packing favoring the 4 + 4 complex. Proximity of the ATP-binding site in Pep2 to the complex interface provides a rational basis for rate enhancement of Pep2 upon binding to TreS, but the complex structure appears to rule out substrate channeling between the active sites of TreS and Pep2. Our findings provide a structural model for the trehalose synthase:maltokinase complex in M. smegmatis that offers critical insights into capsule assembly.	[Kermani, Ali A.; Roy, Rana; Gopalasingam, Chai; Kocurek, Klaudia I.; Patel, Trushar R.; Alderwick, Luke J.; Besra, Gurdyal S.; Fuetterer, Klaus] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Kermani, Ali A.] Univ Michigan, Dept Mol Cellular & Dev Biol, 930 N Univ Ave, Ann Arbor, MI 48109 USA; [Patel, Trushar R.] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, 4401 Univ Dr West, Lethbridge, AB T1K 3M4, Canada	University of Birmingham; University of Michigan System; University of Michigan; University of Lethbridge	Besra, GS; Futterer, K (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.	G.Besra@bham.ac.uk; k.futterer@bham.ac.uk	Patel, Trushar/F-2776-2011	Patel, Trushar/0000-0003-0627-2923; Kermani, Ali Asghar/0000-0002-4994-9730; Futterer, Klaus/0000-0001-7445-5372; Besra, Gurdyal/0000-0002-5605-0395; Kocurek, Klaudia Izabela/0000-0003-2911-5971; Alderwick, Luke/0000-0002-1257-6053	Medical Research Council [MR/K012118/1, MR/S000542/1]; Wellcome Trust [084923/B/08/Z]; MRC [MR/S000542/1, MR/K012118/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council Grants MR/K012118/1 and MR/S000542/1 and by Wellcome Trust Grant 084923/B/08/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Caner S, 2013, GLYCOBIOLOGY, V23, P1075, DOI 10.1093/glycob/cwt044; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; Dinadayala P, 2008, GLYCOBIOLOGY, V18, P502, DOI 10.1093/glycob/cwn031; Ehrt S, 2014, CURR TOP MICROBIOL, V374, P163, DOI 10.1007/82_2012_299; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraga J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08026; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Koliwer-Brandl H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005768; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku SY, 2007, J BIOL CHEM, V282, P22195, DOI 10.1074/jbc.M611045200; Li J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06418; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendes V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-21; Romero MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-262; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Roy R, 2013, ACS CHEM BIOL, V8, P2245, DOI 10.1021/cb400508k; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sambrook J., 1987, MOL CLONING LAB MANU; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Smith CA, 2012, J BIOL CHEM, V287, P12893, DOI 10.1074/jbc.M112.341206; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]	39	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7348	7359		10.1074/jbc.RA118.004297	http://dx.doi.org/10.1074/jbc.RA118.004297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877199	Green Published, hybrid			2022-12-26	WOS:000468402900022
J	Hummitzsch, K; Hatzirodos, N; Irving-Rodgers, HF; Hartanti, MD; Perry, VEA; Anderson, RA; Rodgers, RJ				Hummitzsch, Katja; Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hartanti, Monica D.; Perry, Viv E. A.; Anderson, Richard A.; Rodgers, Raymond J.			Morphometric analyses and gene expression related to germ cells, gonadal ridge epithelial-like cells and granulosa cells during development of the bovine fetal ovary	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; SOMATIC-CELLS; DEPENDENT EXPRESSION; FACTOR-I; SEX; MOUSE; BETA; ACTIVIN; FOXL2; FOLLICLES	Cells on the surface of the mesonephros give rise to replicating Gonadal Ridge EpithelialLike (GREL) cells, the first somatic cells of the gonadal ridge. Later germ cells associate with the GREL cells in the ovigerous cords, and the GREL cells subsequently give rise to the granulosa cells in follicles. To examine these events further, 27 bovine fetal ovaries of different gestational ages were collected and prepared for immunohistochemical localisation of collagen type I and Ki67 to identify regions of the ovary and cell proliferation, respectively. The non-stromal cortical areas (collagen-negative) containing GREL cells and germ cells and later in development, the follicles with oocytes and granulosa cells, were analysed morphometrically. Another set of ovaries (n = 17) were collected and the expression of genes associated with germ cell lineages and GREL/granulosa cells were quantitated by RT-PCR. The total volume of non-stromal areas in the cortex increased significantly and progressively with ovarian development, plateauing at the time the surface epithelium developed. However, the proportion of non-stromal areas in the cortex declined significantly and progressively throughout gestation, largely due to a cessation in growth of the non-stroma cells and the continued growth of stroma. The proliferation index in the non-stromal area was very high initially and then declined substantially at the time follicles formed. Thereafter, it remained low. The numerical density of the non-stromal cells was relatively constant throughout ovarian development. The expression levels of a number of genes across gestation either increased (AMH, FSHR, ESR1, INHBA), declined (CYP19A1, ESR2, ALDH1A1, DSG2, OCT4, LGR5) or showed no particular pattern (CCND2, CTNNB1, DAZL, FOXL2, GATA4, IGFBP3, KRT19, NR5A1, RARRES1, VASA, WNT2B). Many of the genes whose expression changed across gestation, were positively or negatively correlated with each other. The relationships between these genes may reflect their roles in the important events such as the transition of ovigerous cords to follicles, oogonia to oocytes or GREL cells to granulosa cells.	[Hummitzsch, Katja; Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hartanti, Monica D.; Rodgers, Raymond J.] Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Irving-Rodgers, Helen F.] Griffith Univ, Sch Med Sci, Gold Coast Campus, Gold Coast, Qld, Australia; [Perry, Viv E. A.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Anderson, Richard A.] Univ Edinburgh, Med Res Council Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	Robinson Research Institute; University of Adelaide; Griffith University; University of Nottingham; University of Edinburgh	Rodgers, RJ (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Hartanti, Monica Dwi/AAL-8103-2020; perry, viv/AAB-8020-2019; Hummitzsch, Katja/K-6940-2013	Hartanti, Monica Dwi/0000-0001-7542-6434; perry, viv/0000-0003-1330-6204; Hummitzsch, Katja/0000-0001-5023-2668; Rodgers, Raymond/0000-0002-2139-2969	National Health and Medical Research Council of Australia; University of Adelaide; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; Australian Research Council(Australian Research Council)	Funding support for this research was obtained from the National Health and Medical Research Council of Australia, the University of Adelaide, and the Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Appert A, 1998, DIFFERENTIATION, V63, P273, DOI 10.1007/s002580050252; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bayne RA, 2016, MOL HUM REPROD, V22, P622, DOI 10.1093/molehr/gaw044; Bayne RAL, 2009, J CLIN ENDOCR METAB, V94, P4053, DOI 10.1210/jc.2009-0755; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Burkhart MN, 2010, ANIM REPROD SCI, V117, P43, DOI 10.1016/j.anireprosci.2009.02.010; Childs AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020249; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Copping KJ, 2018, REPROD FERT DEVELOP, V30, P703, DOI 10.1071/RD17102; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; da Silva SJM, 2004, DEV BIOL, V266, P334, DOI 10.1016/j.ydbio.2003.10.030; De Felici M, 2013, OOGENESIS, P19, DOI DOI 10.1007/978-0-85729-826-3_2; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Drummond AE, 2005, CELL TISSUE RES, V322, P107, DOI 10.1007/s00441-005-1153-1; Duffin K, 2009, MOL HUM REPROD, V15, P771, DOI 10.1093/molehr/gap065; Efimenko E, 2013, DEV BIOL, V381, P144, DOI 10.1016/j.ydbio.2013.06.004; Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163; ENGELHARDT H, 1995, MOL CELL ENDOCRINOL, V107, P141, DOI 10.1016/0303-7207(94)03435-V; Feng ZM, 2000, MOL ENDOCRINOL, V14, P1820, DOI 10.1210/me.14.11.1820; Field SL, 2014, MOL REPROD DEV, V81, P284, DOI 10.1002/mrd.22285; Findlay JK, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.133652; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; FRIDMACHER V, 1992, DEVELOPMENT, V115, P503; Garverick HA, 2010, ANIM REPROD SCI, V117, P24, DOI 10.1016/j.anireprosci.2009.05.004; Gustin SE, 2016, DEV BIOL, V412, P250, DOI 10.1016/j.ydbio.2016.02.024; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hartanti MD, 2018, REPROD FERT DEVELOP; HATANO O, 1994, DEVELOPMENT, V120, P2787; Hatzirodos N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213575; Hatzirodos N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097489; Hatzirodos N, 2011, FASEB J, V25, P2256, DOI 10.1096/fj.11-181099; Heikinheimo M, 1997, ENDOCRINOLOGY, V138, P3505, DOI 10.1210/en.138.8.3505; Hu YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003629; Hummitzsch K, 2018, OVARY; Hummitzsch K, 2015, ENDOCR REV, V36, P65, DOI 10.1210/er.2014-1079; Hummitzsch K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055578; IKEDA Y, 1994, MOL ENDOCRINOL, V8, P654, DOI 10.1210/me.8.5.654; Irving-Rodgers HF, 2009, REPRODUCTION, V137, P825, DOI 10.1530/REP-08-0485; Jefferson WN, 2000, BIOL REPROD, V62, P310, DOI 10.1095/biolreprod62.2.310; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; KURILO LF, 1981, HUM GENET, V57, P86; Laitinen MPE, 2000, J CLIN ENDOCR METAB, V85, P3476, DOI 10.1210/jc.85.9.3476; LAVOIR MC, 1994, MOL REPROD DEV, V37, P413, DOI 10.1002/mrd.1080370408; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; Loffler S, 2000, ANAT EMBRYOL, V201, P207, DOI 10.1007/s004290050019; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Manuylov NL, 2008, DEVELOPMENT, V135, P3731, DOI 10.1242/dev.024653; McCoard SA, 2001, BIOL REPROD, V65, P366, DOI 10.1095/biolreprod65.2.366; Medrano JV, 2012, STEM CELLS, V30, P441, DOI 10.1002/stem.1012; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; Minkina A, 2017, DEV BIOL, V424, P208, DOI 10.1016/j.ydbio.2017.02.015; Monga R, 2012, J STEROID BIOCHEM, V130, P45, DOI 10.1016/j.jsbmb.2011.12.010; Mora JM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096156; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Murayama C, 2008, MOL CELL BIOCHEM, V314, P51, DOI 10.1007/s11010-008-9764-y; Ng A, 2014, NAT CELL BIOL, V16, P745, DOI 10.1038/ncb3000; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Padua MB, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.117002; Pailhoux E, 2002, DEV DYNAM, V224, P39, DOI 10.1002/dvdy.10083; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Pannetier M, 2016, SEX DEV, V10, P167, DOI 10.1159/000448667; Phillips DJ, 2005, DOMEST ANIM ENDOCRIN, V28, P1, DOI 10.1016/j.domaniend.2004.05.006; Rastetter RH, 2014, DEV BIOL, V394, P242, DOI 10.1016/j.ydbio.2014.08.013; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; ROBERTS VJ, 1991, ENDOCRINOLOGY, V128, P3122, DOI 10.1210/endo-128-6-3122; Rossi RODS, 2016, ZYGOTE, V24, P1, DOI 10.1017/S096719941400077X; Russe I, 1983, Bibl Anat, V24, P77; She ZY, 2014, J MOL ENDOCRINOL, V53, pR21, DOI 10.1530/JME-14-0018; SHEMESH M, 1980, BIOL REPROD, V23, P577, DOI 10.1095/biolreprod23.3.577; Tanaka Y, 2001, REPRODUCTION, V121, P777, DOI 10.1530/rep.0.1210777; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; Viger RS, 1998, DEVELOPMENT, V125, P2665; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; WANDJI SA, 1992, BIOL REPROD, V47, P814, DOI 10.1095/biolreprod47.5.814; Yang MY, 2008, BIOL REPROD, V78, P1153, DOI 10.1095/biolreprod.107.066688	82	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214130	10.1371/journal.pone.0214130	http://dx.doi.org/10.1371/journal.pone.0214130			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901367	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400039
J	Ngama, S; Bindelle, J; Poulsen, JR; Hornick, JL; Linden, A; Korte, L; Doucet, JL; Vermeulen, C				Ngama, Steeve; Bindelle, Jerome; Poulsen, John R.; Hornick, Jean-Luck; Linden, Annick; Korte, Lisa; Doucet, Jean-Louis; Vermeulen, Cedric			Do topography and fruit presence influence occurrence and intensity of crop-raiding by forest elephants (Loxodonta africana cyclotis)?	PLOS ONE			English	Article							CONFLICT MITIGATION; MANAGEMENT; FENCES; LANDSCAPES; LESSONS; MODELS; GABON	Crop damage by forest elephants (Loxodonta africana cyclotis) and the resulting humanelephant conflict are issues of great concern for both the conservation of the species and the protection of rural livelihoods in Central Africa. Addressing these problems requires identifying the factors that facilitate or impede crop-raiding by forest elephants. Yet to date, the environmental or anthropogenic factors that influence the occurrence and intensity of cropraiding by forest elephants are largely unknown. We used a multivariate approach to investigate conditions under which forest elephants raid some fields and not others in the buffer zone of Monts de Cristal National Park (MCNP), Gabon. We first interviewed 121 farmers from 11 villages situated within 10 km of MCNP regarding the occurrence of elephant cropraiding of their fields. We then collected data on 39 explanatory variables to characterize the agricultural fields. Of these, the most important predictors of elephant raid occurrence of crop damage were presence of fruit trees, elephant deterrents (scarecrows, fire, wire string fences and empty barrels), and field topography. We secondly assessed the effect of stage of crop growth, presence of fruit trees, field topography and presence of elephant deterrents on crop-raiding occurrence and intensity by counting raids and measuring areas of crop damage every week in 17 plantations over 19 weeks in the most elephant-impacted zone of the study area. We found that fruit presence and stage of crop growth led to more intense damage to crops, whereas local deterrents did not inhibit raiding events and crop damage by elephants. We report a tradeoff between non-timber forest products (NTFP) services and crop-raiding by elephants. We show for the first time that steep topography impedes elephant damage to crops with no raids recorded in fields with surrounding slopes greater than 25%. We discuss whether farming on steep fields could be used as a strategy for mitigating crop-raiding to favor human-elephant coexistence and enhance elephant conservation.	[Ngama, Steeve; Doucet, Jean-Louis; Vermeulen, Cedric] Univ Liege, Gembloux Agrobio Tech, Forest Is Life, TERRA Teaching & Res Ctr, Gembloux, Belgium; [Ngama, Steeve] Ctr Natl Rech Sci & Technol IRAF CENAREST, Inst Rech Agron & Forestieres, Dept Zootech, Lab Sante & Prod Anim, Libreville, Gabon; [Ngama, Steeve; Bindelle, Jerome] Univ Liege, Gembloux Agrobio Tech, Agr Is Life, AgroBioChem TERRA,Precis Livestock & Nutr Unit, Gembloux, Belgium; [Poulsen, John R.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Hornick, Jean-Luck] Univ Liege, Fac Vet Med, Dept Anim Prod, Fundamental & Appl Res Anim & Hlth, Liege, Belgium; [Linden, Annick] Fac Vet Med, Surveillance Network Wildlife Dis Southern Belgiu, Liege, Belgium	University of Liege; University of Liege; Duke University; University of Liege	Ngama, S (corresponding author), Univ Liege, Gembloux Agrobio Tech, Forest Is Life, TERRA Teaching & Res Ctr, Gembloux, Belgium.; Ngama, S (corresponding author), Ctr Natl Rech Sci & Technol IRAF CENAREST, Inst Rech Agron & Forestieres, Dept Zootech, Lab Sante & Prod Anim, Libreville, Gabon.; Ngama, S (corresponding author), Univ Liege, Gembloux Agrobio Tech, Agr Is Life, AgroBioChem TERRA,Precis Livestock & Nutr Unit, Gembloux, Belgium.	steeve_ngama@yahoo.fr	Poulsen, John/O-5332-2019; , Hornick/AAV-1394-2020	Poulsen, John/0000-0002-1532-9808; , Hornick/0000-0003-1831-1440; Bindelle, Jerome/0000-0001-6974-4313	COLAS Gabon; Gembloux Agro-Bio Tech, University of Liege; Nature+ NGO; Institut de Recherches Agronomiques et Forestieres, Centre National de la Recherche Scientifique et Technologique, Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Gabon	COLAS Gabon; Gembloux Agro-Bio Tech, University of Liege; Nature+ NGO; Institut de Recherches Agronomiques et Forestieres, Centre National de la Recherche Scientifique et Technologique, Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Gabon	Support was provided by COLAS Gabon (https://www.colas.com/fr/le-groupe/implantations) SN; Gembloux Agro-Bio Tech, University of Liege (http://www.gembloux.ulg.ac.be/) SN, JB, CV. Nature+ NGO (http://www.natureplus.be/) SN. Institut de Recherches Agronomiques et Forestieres, Centre National de la Recherche Scientifique et Technologique, Ministere de l'Enseignement Superieur et de la Recherche Scientifique, Gabon (http://www.enseignement-superieur.gouv.ga) SN. The funders provided found, materials and logistics needed to perform the experiment and write the manuscript. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abitsi G, 2015, PLAN GESTION 2016 20, P112; [Anonymous], THESIS; Austin KG, 2017, ENVIRON RES LETT, V12; Bank Wold, 2007, WORLD DEV REP 2008 A; Barnes RFW, 2007, AFR J ECOL, V45, P112, DOI 10.1111/j.1365-2028.2006.00689.x; Beaune D, 2013, FOREST ECOL MANAG, V295, P109, DOI 10.1016/j.foreco.2012.12.041; Blake S, 2004, BIOTROPICA, V36, P392, DOI 10.1646/03215; Blake S, 2002, THESIS; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blanc J., 2013, STATUS AFRICAN ELEPH; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burton MEH, 2017, CONSERV LETT, V10, P297, DOI 10.1111/conl.12265; Campos-Arceiz A, 2011, ACTA OECOL, V37, P542, DOI 10.1016/j.actao.2011.01.014; Carriere S.M, 2003, ORPHELINS FORET PRAT; Chang'a A, 2016, TROP CONSERV SCI, V9, P921, DOI 10.1177/194008291600900220; Chiyo PI, 2005, AFR J ECOL, V43, P48, DOI 10.1111/j.1365-2028.2004.00544.x; Davies TE, 2011, CONSERV LETT, V4, P346, DOI 10.1111/j.1755-263X.2011.00182.x; Fairet E., 2012, THESIS; Freycon V, 1998, SIG AIDE TRACER RESE; Gay-des-Combes JM, 2017, ECOL EVOL, V7, P5378, DOI 10.1002/ece3.3104; Halsey LG, 2016, J EXP BIOL, V219, P1424, DOI 10.1242/jeb.133256; Hans Enukwa E., 2017, J WILDLIFE BIODIVERS, V1, P69, DOI DOI 10.22120/JWB.2017.28260; Hoare R, 2015, HUM DIMENS WILDL, V20, P289, DOI 10.1080/10871209.2015.1005855; Hoare R, 2012, PACHYDERM, P60; Inogwabini BI, 2013, PACHYDERM, P59; IUCN, 2017, IUCN RED LIST STAT T; Kenfack CE, 2013, BRIEF CIFOR BRIEF CI, P1; King LE, 2011, AFR J ECOL, V49, P431, DOI 10.1111/j.1365-2028.2011.01275.x; Kioko J, 2008, S AFR J WILDL RES, V38, P52, DOI 10.3957/0379-4369-38.1.52; Kolowski JM, 2010, AFR J ECOL, V48, P1134, DOI 10.1111/j.1365-2028.2009.01204.x; Lepitre C, 1972, BOIS FOR TROP, P49; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Mariki SB, 2015, LAND USE POLICY, V44, P19, DOI 10.1016/j.landusepol.2014.10.018; Meunier Q., 2015, ARBRES UTILES GABON; Morgan J., 2014, CLASSIFICATIONREGRES; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Mutinda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091749; Ngama S., 2015, Tropicultura, V33, P12; Ngama S, 2018, NAT CONSERV RES, V3, P89, DOI 10.24189/ncr.2018.038; Ngama S, 2018, NAT CONSERV RES, V3, P26, DOI 10.24189/ncr.2018.027; Ngama S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155690; Palei NC, 2014, ORYX, V48, P602, DOI 10.1017/S003060531400012X; Poulsen JR, 2017, CURR BIOL, V27, pR134, DOI 10.1016/j.cub.2017.01.023; Santra A. K., 2008, Tropical Ecology, V49, P251; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; TCHAMBA MN, 1995, PACHYDERM, V19, P26; Terborgh J, 2016, ECOGRAPHY, V39, P180, DOI 10.1111/ecog.01641; Van Eden M, 2016, HUM DIMENS WILDL, V21, P283, DOI 10.1080/10871209.2016.1149746; Walker KL, 2012, AGR ECON-BLACKWELL, V43, P61, DOI 10.1111/j.1574-0862.2011.00565.x; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; Wood TE, 2006, ECOSYSTEMS, V9, P700, DOI 10.1007/s10021-005-0016-7; Zamfir I., 2016, AFRICAS EC GROWTH TA; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	57	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213971	10.1371/journal.pone.0213971	http://dx.doi.org/10.1371/journal.pone.0213971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901366	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400026
J	Box, AG; Feito, Y; Brown, C; Heinrich, KM; Petruzzello, SJ				Box, Allyson G.; Feito, Yuri; Brown, Chris; Heinrich, Katie M.; Petruzzello, Steven J.			High Intensity Functional Training (HIFT) and competitions: How motives differ by length of participation	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MOTIVATIONAL FACTORS; SELF-DETERMINATION; EXERCISE; CROSSFIT; BENEFITS; HEALTH	High Intensity Functional Training (HIFT) is a unique fitness method that promotes an active lifestyle and has seen exponential and continual growth over the last two decades. Motivation to exercise is likely to change over time as individuals' motives to initiate exercise may be different than those which motivate them to maintain an exercise program. The purpose of this study was to examine the motivational factors reported by individuals who actively engage in HIFT with varying length of participation and competition levels. 737 adults (32.4 +/- 8.2 years) with more than three-months of HIFT experience completed an online version of the Exercise Motivation Inventory (EMI-2) survey. Those who had greater length of participation reported more motives associated with relatedness (i.e., affiliation, competition) and enjoyment, while those with less HIFT participation were more motivated by body-related variables (i.e., weight management). Further, motivational variables (e.g., social recognition, affiliation, challenge) varied depending on whether or not individuals had competed in an online qualifier. Understanding these differences in motivation may aid in exercise promotion, initiation, and adherence, and moreover promote long-term physical and mental health benefits.	[Box, Allyson G.; Petruzzello, Steven J.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Box, Allyson G.; Feito, Yuri; Brown, Chris] Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA; [Heinrich, Katie M.] Kansas State Univ, Dept Kinesiol, Manhattan, KS 66506 USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; Kennesaw State University; Kansas State University	Feito, Y (corresponding author), Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	yfeito@kennesaw.edu	Feito, Yuri/D-8255-2013	Feito, Yuri/0000-0001-6790-6294				Alharbi M, 2017, EUR J CARDIOVASC NUR, V16, P309, DOI 10.1177/1474515116666475; Ashton LM, 2017, AM J MENS HEALTH, V11, P330, DOI 10.1177/1557988316680936; Asmundson GJG, 2013, DEPRESS ANXIETY, V30, P362, DOI 10.1002/da.22043; Babiash P. E., 2013, DETERMINING ENERGY E; Briki W, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01546; Butcher SJ, 2015, OPEN ACCESS J SPORTS, V6, P241, DOI 10.2147/OAJSM.S88265; Butcher SJ., 2015, J FITNESS RES, V4, P3; Bycura D, 2017, HEALTH BEHAV POLICY, V4, P539, DOI 10.14485/HBPR.4.6.4; De Sousa A.F., 2016, J EXER PHYSL ONLINE, V19, P112; Deci EL, 2008, CAN PSYCHOL, V49, P182, DOI 10.1037/a0012801; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DISHMAN RK, 1985, PUBLIC HEALTH REP, V100, P158; Feito Y, 2018, SPORTS, V6; Feito Y, 2018, SAGE OPEN, V8, DOI 10.1177/2158244018803139; Feito Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198324; Fisher J, 2017, J SPORT MED PHYS FIT, V57, P1227, DOI 10.23736/S0022-4707.16.06434-3; Gerber M, 2014, PHYSIOL BEHAV, V135, P17, DOI 10.1016/j.physbeh.2014.05.047; Green S.B., 1996, USING SPSS WINDOWS A, V1st edn; Haddock CK, 2016, MIL MED, V181, pE1508, DOI 10.7205/MILMED-D-15-00503; Heinrich KM, 2015, EUR J CANCER CARE, V24, P812, DOI 10.1111/ecc.12338; Heinrich KM, 2017, FAM COMMUNITY HEALTH, V40, P24, DOI 10.1097/FCH.0000000000000133; Heinrich KM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-789; Ingledew DK, 2009, APPL PSYCHOL-HLTH WE, V1, P336, DOI 10.1111/j.1758-0854.2009.01015.x; Kliszczewicz B., 2014, J SPORT HUMAN PERF, V2, P1, DOI [10.12922/jshp.0038.2014, DOI 10.12922/JSHP.V2I2.38]; Lee HH, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01285; Markland D, 1997, BRIT J HEALTH PSYCH, V2, P361, DOI 10.1111/j.2044-8287.1997.tb00549.x; Mathieu ED, 2015, EXAMINING ASS RELATE; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; Meyer J, 2017, WORKPLACE HEALTH SAF, V65, P612, DOI 10.1177/2165079916685568; Partridge JA, 2014, J STRENGTH COND RES, V28, P1714, DOI 10.1519/JSC.0000000000000288; Rally Fitness, BUS CROSSFIT UPD NEW; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Saxena S., 2005, J MENTAL HLTH, V14, P445, DOI [DOI 10.1080/09638230500270776, 10.1080/09638230500270776]; Simpson D, 2017, SPORT J, V1, P1; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tybout A, 2001, J CONSUM PSYCHOL, V10, P9; U.S. Department of Health and Human Services, 2018, PHYS ACTIVITY GUIDEL, P1; Wankel LM, 1993, INT J SPORT PSYCHOL; Warkentin M., OPEN PARTICIPATE CEL	40	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213812	10.1371/journal.pone.0213812	http://dx.doi.org/10.1371/journal.pone.0213812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897101	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700036
J	Liao, L; Dong, TT; Liu, XY; Dong, ZX; Qiu, X; Rong, Y; Sun, GC; Wang, ZH				Liao, Ling; Dong, Tiantian; Liu, Xinya; Dong, Zhixiang; Qiu, Xia; Rong, Yi; Sun, Guochao; Wang, Zhihui			Effect of nitrogen supply on nitrogen metabolism in the citrus cultivar 'Huangguogan'	PLOS ONE			English	Article							GLUTAMATE-DEHYDROGENASE; ENZYME-ACTIVITIES; USE EFFICIENCIES; GENE-EXPRESSION; GRAIN-YIELD; RICE; FERTILIZATION; ASSIMILATION; PROTEIN; RHIZOSPHERE	Nitrogen metabolism in citrus has received increased attention due to its effects on plant growth and productivity. However, little is known about the effects of nitrogen fertilization on nitrogen metabolism in young trees of citrus cultivar 'Huangguogan' (Citrus reticulata x Citrus sinensis). Here, genes encoding nitrate reductase (NR), nitrite reductase (NiR), glutamine synthetase (GS), glutamate dehydrogenase (GDH), and asparagine synthetase (AS), represented as HgNR, HgNiR, HgGS, HgGDH, and HgAS, respectively, were cloned from Huangguogan. Deduced protein sequences were analyzed and proteins were confirmed to be localized in their respective cellular organelles. Moreover, pot-cultured 'Huangguogan' seedlings were fertilized with 0 (N-1), 1.36 (N-2), 1.81 (N-3), 2.26 (N-4), or 2.72 (N-5) kg N/year, for 12 months. Enzyme activity and enzyme-gene expression were studied in roots, leaves, and fruits at different stages. Finally, the effects of N application rate on root activity, leaf N, soluble protein, yield, and fruit quality at the ripening stage were measured. The results showed that: 1) HgNR, HgNiR, HgGDH, and HgAS gene products were found mainly in the cytoplasm and plasma membrane, while HgGS gene product was found mainly in cytoplasm and mitochondria. 2) Gene expression and enzyme activity differed among plant organs. As the root is in permanent direct contact with the soil we suggest that root gene expression and enzyme activity can be used as reference to determine N application rate. 3) Yield, fruit quality, enzyme activity, and enzyme-related gene expression were considerably lower at low than at high-N supply. However, they were all inhibited by excess nitrogen (i.e., 2.72 kg/year). Therefore, we recommend 1.81 kg N/year as the optimal N application rate for young 'Huangguogan' trees.	[Liao, Ling; Dong, Tiantian; Liu, Xinya; Dong, Zhixiang; Qiu, Xia; Rong, Yi; Sun, Guochao; Wang, Zhihui] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China; [Wang, Zhihui] Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wang, ZH (corresponding author), Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China.; Wang, ZH (corresponding author), Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China.	wangzhihui_siau@126.com						Ahmad R, 2014, J PLANT NUTR, V37, P942, DOI 10.1080/01904167.2013.868480; Antal T, 2010, PLANTA, V232, P887, DOI 10.1007/s00425-010-1227-5; Ata-Ul-Karim ST, 2016, FIELD CROP RES, V195, P1, DOI 10.1016/j.fcr.2016.04.027; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Barillot R, 2017, ANN BOT-LONDON, V118; Beatty PH, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5040039; Bhattacharyya P, 2016, SCI TOTAL ENVIRON, V542, P886, DOI 10.1016/j.scitotenv.2015.10.154; Bolwell GP, 2001, PHYTOCHEMISTRY, V58, P185, DOI DOI 10.1016/S0031-9422(01)00095-4; Chang ZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154005; Choi ST, 2011, SCI HORTIC-AMSTERDAM, V130, P354, DOI 10.1016/j.scienta.2011.05.035; Cruz C, 2010, PHYSIOL PLANTARUM, V95, P167; Cruz JL, 2004, BIOL PLANTARUM, V48, P67, DOI 10.1023/B:BIOP.0000024277.51293.02; Dwivedi S.K., 2012, INDIAN J PLANT PHYSI, V17, P259; EVANS JR, 1983, PLANT PHYSIOL, V72, P297, DOI 10.1104/pp.72.2.297; Farhangi-Abriz S, 2017, SYMBIOSIS, V74, P1; Gao X., 2013, AGR J, V8, P38; Giagnoni L, 2016, APPL SOIL ECOL, V98, P30, DOI 10.1016/j.apsoil.2015.09.004; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; Goel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143645; Grzesiak MT, 2017, J AGRON CROP SCI, P196; Hakeem KR, 2013, MOL BREEDING, V32, P785, DOI 10.1007/s11032-013-9906-0; He YL, 2005, J AM SOC HORTIC SCI, V130, P842, DOI 10.21273/JASHS.130.6.842; Hoshida H, 2000, PLANT MOL BIOL, V43, P103, DOI 10.1023/A:1006408712416; Huang CaiBian, 2011, Journal of Agro-Environment Science, V30, P613; Ishiyama K, 2003, PLANT PHYSIOL BIOCH, V41, P643, DOI 10.1016/S0981-9428(03)00078-0; Jin ZX, 2007, RICE SCI, V14, P211, DOI 10.1016/S1672-6308(07)60029-8; Liao CS, 2012, J INTEGR PLANT BIOL, V54, P374, DOI 10.1111/j.1744-7909.2012.01122.x; Liao L, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017690; Limami AM, 2014, PLANTA, V239, P531, DOI 10.1007/s00425-013-2015-9; Liu BY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01328; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lu YL, 2018, J INTEGR AGR, V17, P1421, DOI [10.1016/S2095-3119(17)61899-9, 10.1016/s2095-3119(17)61899-9]; Luo J, 2005, J PLANT NUTR FERTILI, V22, P290; Marcondes J., 2012, ADV CITRUS NUTR, V25, P245; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Morgan KT, 2009, HORTSCIENCE, V44, P145, DOI 10.21273/HORTSCI.44.1.145; Ng'etich, 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P54; Pathak RR, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P209; Perez-Tienda J, 2014, PLANT PHYSIOL BIOCH, V75, P1, DOI 10.1016/j.plaphy.2013.11.029; Qin W, 2016, AGR ECOSYST ENVIRON, V222, P103, DOI 10.1016/j.agee.2016.01.052; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; Quaggio JA, 2014, J PLANT NUTR SOIL SC, V177, P404, DOI 10.1002/jpln.201300315; Ren BZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01216; SANGWAN P, 2014, ENZYME RES, V2014; Saud S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00983; Singh M, 2016, BIOCATAL AGR BIOTECH, V7, P76, DOI 10.1016/j.bcab.2016.05.007; Singh R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00772; Skopelitis DS, 2007, PLANT PHYSIOL, V145, P1726, DOI 10.1104/pp.107.107813; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sulpice R, 2013, PLANT PHYSIOL, V162, P347, DOI 10.1104/pp.112.210104; Teng YB, 2010, PEDOSPHERE, V20, P623, DOI 10.1016/S1002-0160(10)60052-5; [王俊忠 WANG Jun-Zhong], 2009, [生态学报, Acta Ecologica Sinica], V29, P2045; Wang LP, 2012, J PLANT NUTR FERTILI, V18, P689; Wang P, 2012, AFR J BIOTECHNOL, V11, P143; Wang Y, 2018, SCI REP-UK, V8, P41598; Wang ZQ, 2016, FIELD CROP RES, V193, P54, DOI 10.1016/j.fcr.2016.03.006; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wickert E, 2007, GENET MOL BIOL, V30, P810, DOI 10.1590/S1415-47572007000500009; Xiong B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46245; Xiong QQ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01075; Xu CL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01234; Xue YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093895; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Yan Fengxia, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2039; Yan Q.Q., 2012, SUGAR INCREASING ACI; Yang XY, 2010, AGR SCI CHINA, V9, P216, DOI 10.1016/S1671-2927(09)60086-9; Young EB, 2016, NITRATE REDUCTASE NE; Yue H. B, 2007, CHINA TOB SCI, V28, P18; Zafar S, 2018, J PLANT NUTR, V41, P19, DOI 10.1080/01904167.2017.1380825; Zhang CH, 2016, J HORTIC SCI BIOTECH, V91, P448, DOI 10.1080/14620316.2016.1167325; Zhang LX, 2010, J AGRON CROP SCI, V193, P387; Zhang RM, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12403; Zhang X, 2013, PLANT SOIL ENVIRON, V59, P80, DOI 10.17221/613/2012-PSE; Zhang ZhiMeng, 2011, Scientia Agricultura Sinica, V44, P280; Zhu Y., 2016, WIREL COMMUN MOB COM, V2, P1090	76	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213874	10.1371/journal.pone.0213874	http://dx.doi.org/10.1371/journal.pone.0213874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897177	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700040
J	Nadal, JM; Camargo, GD; Novatski, A; Macenhan, WR; Dias, DT; Barboza, FM; Lyra, A; Roik, JR; de Paula, JP; Somer, A; Farago, PV				Nadal, Jessica Mendes; Camargo, Guilherme dos Anjos; Novatski, Andressa; Macenhan, William Roger; Dias, Daniele Toniolo; Barboza, Fernanda Malaquias; Lyra, Amanda; Roik, Joao Ricardo; de Paula, Josiane Padilha; Somer, Aloisi; Farago, Paulo Vitor			Adapalene-loaded poly(epsilon-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy	PLOS ONE			English	Article							BENZOYL PEROXIDE; PERCUTANEOUS PENETRATION; PHARMACOLOGY; ACID; SKIN	Adapalene (ADAP) is an important drug widely used in the topical treatment of acne. It is a third-generation retinoid and provides keratolytic, anti-inflammatory, and antiseborrhoic action. However, some topical adverse effects such as erythema, dryness, and scaling have been reported with its commercial formula. In this sense, the microencapsulation of this drug using polyesters can circumvent its topical side effects and can lead to the enhancement of drug delivery into sebaceous glands. The goal of this work was to obtain ADAP-loaded poly(epsilon-caprolactone) (PCL) microparticles prepared by a simple emulsion/solvent evaporation method. Formulations containing 10 and 20% of ADAP were successfully obtained and characterized by morphological, spectroscopic, and thermal studies. Microparticles presented encapsulation efficiency of ADAP above 98% and showed a smooth surface and spherical shape. Fourier transform infrared spectroscopy (FTIR) results presented no drug-polymer chemical bond, and a differential scanning calorimetry (DSC) technique showed a partial amorphization of the drug. ADAP permeation in the Strat-M membrane for transdermal diffusion testing was evaluated by photoacoustic spectroscopy (PAS) in the spectral region between 225 and 400 nm after 15 min and 3 h from the application of ADAP-loaded PCL formulations. PAS was successfully used for investigating the penetration of polymeric microparticles. In addition, microencapsulation decreased the in vitro transmembrane diffusion of ADAP.	[Nadal, Jessica Mendes; Camargo, Guilherme dos Anjos; Barboza, Fernanda Malaquias; Lyra, Amanda; de Paula, Josiane Padilha; Farago, Paulo Vitor] Univ Estadual Ponta Grossa, Postgrad Program Pharmaceut Sci, Dept Pharmaceut Sci, Ponta Grossa, Parana, Brazil; [Novatski, Andressa; Macenhan, William Roger; Farago, Paulo Vitor] Univ Estadual Ponta Grossa, Postgrad Program Hlth Sci, Ponta Grossa, Parana, Brazil; [Novatski, Andressa; Roik, Joao Ricardo; Somer, Aloisi] Univ Estadual Ponta Grossa, Dept Phys, Ponta Grossa, Parana, Brazil; [Dias, Daniele Toniolo] Univ Tecnol Fed Parana, Acad Dept Phys, Ponta Grossa, Parana, Brazil	Universidade Estadual de Ponta Grossa; Universidade Estadual de Ponta Grossa; Universidade Estadual de Ponta Grossa; Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana	Nadal, JM (corresponding author), Univ Estadual Ponta Grossa, Postgrad Program Pharmaceut Sci, Dept Pharmaceut Sci, Ponta Grossa, Parana, Brazil.	jessicabem@hotmail.com	Dias, Daniele/AAP-4704-2021; Somer, Aloisi/Q-6819-2019; Somer, Aloisi/G-4868-2013; Novatski, Andressa/D-5366-2013	Dias, Daniele/0000-0003-0451-3340; Somer, Aloisi/0000-0003-0610-6220; Novatski, Andressa/0000-0002-8327-6285; Nadal, Jessica Mendes/0000-0002-2419-2110	Paulo Vitor Farago -> Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [456403/2014-0]; Financiadora de Estudos e Projetos (FINEP); Coordenacao de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana	Paulo Vitor Farago -> Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	This work was supported by: Paulo Vitor Farago -> Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Research Grant 456403/2014-0; All Authors -> Financiadora de Estudos e Projetos (FINEP) - funding the CLABMU and LAPTO which provided the technical support; Guilherme dos Anjos Camargo -> Coordenacao de Pessoal de Nivel Superior (CAPES) - scholarship of the master student; Joao Ricardo Roik - Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana-scholarship of the graduation student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M., 2011, WASET, V75, P384; Almeida MA, 2014, MAT SCI ENG C-MATER, V40, P345, DOI 10.1016/j.msec.2014.03.049; Ames FQ, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.5.055003; Behera A.K., 2012, FS J PHARM RES, V1, P38; BERNARD BA, 1993, SKIN PHARMACOL, V6, P61; Bhakay A, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030086; Bhalekar M, 2015, DRUG DELIV TRANSL RE, V5, P585, DOI 10.1007/s13346-015-0261-z; Bikowski Joseph B, 2005, J Drugs Dermatol, V4, P41; Brogden RN, 1997, DRUGS, V53, P511, DOI 10.2165/00003495-199753030-00010; Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7; Chew NYK, 2002, J PHARM PHARM SCI, V5, P162; Mendes JBE, 2012, SCI WORLD J, DOI 10.1100/2012/542937; Goyani M., 2018, INT J ADV RES REV, V3, P52; Guo CC, 2014, PHARM RES-DORDR, V31, P3051, DOI 10.1007/s11095-014-1398-z; Haq A, 2018, INT J PHARMACEUT, V539, P58, DOI 10.1016/j.ijpharm.2018.01.029; Jain S, 2018, NANOMEDICINE-UK, V13, P1481, DOI 10.2217/nnm-2018-0002; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Justus B, 2015, LAT AM J PHARM, V34, P1710; Karadzovska D, 2013, EUR J PHARM SCI, V50, P569, DOI 10.1016/j.ejps.2013.02.020; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lheure C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167237; Li M, 2008, INT J PHARMACEUT, V363, P26, DOI 10.1016/j.ijpharm.2008.07.018; Michel S, 1998, BRIT J DERMATOL, V139, P3; Milanese A, 2011, BIOORG CHEM, V39, P151, DOI 10.1016/j.bioorg.2011.07.003; Mota JP, 2011, ACOUSTIC WAVES FROM; de Melo JO, 2011, PHARM RES-DORDR, V28, P331, DOI 10.1007/s11095-010-0279-3; Osman-Ponchet H, 2017, DERMATOLOGY THER, V7, P123, DOI 10.1007/s13555-016-0159-9; Persenaire O, 2001, BIOMACROMOLECULES, V2, P288, DOI 10.1021/bm0056310; Phillips TJ, 2005, CUTIS, V75, P14; Rocha JCB, 2007, ANAL CHIM ACTA, V587, P132, DOI 10.1016/j.aca.2007.01.002; ROLLAND A, 1993, PHARMACEUT RES, V10, P1738, DOI 10.1023/A:1018922114398; Rosencwaig A., 1980, PHOTOACOUSTICS PHOTO; Shroot B, 1997, J AM ACAD DERMATOL, V36, pS96, DOI 10.1016/S0190-9622(97)70050-1; Gomes MLS, 2019, MAT SCI ENG C-MATER, V94, P694, DOI 10.1016/j.msec.2018.10.029; Somer A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/38/385306; Somer A, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817655; Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x; Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x; Tolba MM, 2016, CHEM CENT J, V10, DOI 10.1186/s13065-016-0181-0; Toll R, 2004, J INVEST DERMATOL, V123, P168, DOI 10.1111/j.0022-202X.2004.22717.x; Waugh J, 2004, DRUGS, V64, P1465, DOI 10.2165/00003495-200464130-00005; Zhao S, 2011, J MEMBRANE SCI, V385, P251, DOI 10.1016/j.memsci.2011.10.006	42	7	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213625	10.1371/journal.pone.0213625	http://dx.doi.org/10.1371/journal.pone.0213625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897170	Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700030
J	Eby, JM; Majetschak, M				Eby, Jonathan M.; Majetschak, Matthias			Effects of ethanol and ethanol metabolites on intrinsic function of mesenteric resistance arteries	PLOS ONE			English	Article							INDUCED HYPERTENSION; ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; ACETALDEHYDE; PHOSPHATIDYLETHANOL; DISEASE; RESPONSIVENESS; PHENYLEPHRINE; CONTRACTION; MORTALITY	Evidence suggests that ethanol-induced hypertension is associated with increased cardiovascular responsiveness to vasopressors in vivo and enhanced reactivity of isolated arteries to vasopressors ex vivo. The underlying mechanisms are not well understood and the contribution of ethanol metabolites to vascular effects induced by ethanol consumption are unclear. Mesenteric resistance arteries were harvested from Sprague-Dawley rats. Pressure myography was utilized to test effects of ethanol, acetaldehyde and phosphatidylethanol on myogenic tone and on vasoconstriction induced by phenylephrine, arginine vasopressin (aVP), endothelin-1 and KCl. Ethanol, acetaldehyde and phosphatidylethanol concentrations were monitored during the experiments. Ethanol concentrations in the vessel bath decreased with a half-life of 25min; acetaldehyde and phosphatidylethanol concentrations remained constant. Pretreatment with ethanol dose-dependently increased the potency of phenylephrine to induce vasoconstriction 4-fold (p<0.01). These effects were comparable when arteries were pre-treated with a single dose of ethanol for 30min and when ethanol concentrations were kept constant during 30min and 60min of pretreatment. While ethanol also dose-dependently increased the potency of aVP to induce vasoconstriction 1.7-fold (p<0.05), it did not affect vasoconstriction induced by endothelin-1 or KCl. Acetaldehyde pre-treatment (30 min) dose-dependently increased the potency of phenylephrine to induce vasoconstriction 2.7-fold (p< 0.01) but did not affect other vasoconstrictor responses. Phosphatidylethanol did not affect any vasoconstrictor responses. Ethanol and its metabolites did not affect myogenic tone. These data suggest that ethanol and acetaldehyde selectively sensitize intrinsic constrictor responses upon activation of vascular alpha(1)-adrenergic and/or vasopressin receptors at clinically relevant concentrations. Our findings support the concept that enhanced vasoreactivity to vasoactive hormones contributes to the development of hypertension induced by ethanol consumption. Ex vivo exposure of resistance arteries to ethanol and acetaldehyde resembles effects of chronic ethanol consumption on intrinsic vascular function, and thus could serve as test platform to evaluate interventions aimed to mitigate vascular effects associated with ethanol consumption.	[Eby, Jonathan M.] Loyola Univ Chicago, Stritch Sch Med, Dept Surg, Maywood, IL USA; [Eby, Jonathan M.] Loyola Univ Chicago, Stritch Sch Med, ARP, Maywood, IL USA; [Majetschak, Matthias] Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA; [Majetschak, Matthias] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA	Loyola University Chicago; Loyola University Chicago; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Majetschak, M (corresponding author), Univ S Florida, Dept Surg, Morsani Coll Med, Tampa, FL 33620 USA.; Majetschak, M (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA.	majetschak@health.usf.edu		Eby, Jonathan/0000-0002-0691-4044	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [R21AA025750, T32AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA025750] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award numbers R21AA025750 and T32AA013527. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABDELRAHMAN AA, 1987, HYPERTENSION, V10, P67, DOI 10.1161/01.HYP.10.1.67; Albee LJ, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170207; Albee LJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006575; ALTURA BM, 1987, ALCOHOL CLIN EXP RES, V11, P99, DOI 10.1111/j.1530-0277.1987.tb01272.x; Andresen-Streichert H, 2018, DTSCH ARZTEBL INT, V115, P309, DOI 10.3238/arztebl.2018.0309; Aradottir S, 2006, ALCOHOL ALCOHOLISM, V41, P431, DOI 10.1093/alcalc/agl027; Aroor AR, 2004, LIFE SCI, V74, P2339, DOI 10.1016/j.lfs.2003.11.001; Bach HH, 2014, MOL MED, V20, P435, DOI 10.2119/molmed.2014.00101; Blednov YA, 2017, NEUROPHARMACOLOGY, V123, P201, DOI 10.1016/j.neuropharm.2017.06.013; Borghese CM, 2016, ACS CHEM NEUROSCI, V7, P100, DOI 10.1021/acschemneuro.5b00246; Brown RA, 2002, EUR J PHARMACOL, V442, P241, DOI 10.1016/S0014-2999(02)01533-9; CHAN TCK, 1983, LIFE SCI, V33, P1965, DOI 10.1016/0024-3205(83)90734-8; Chang YC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-58; Crestani CC, 2014, TOXICOL APPL PHARM, V280, P245, DOI 10.1016/j.taap.2014.08.012; Davis TJ, 2006, ALCOHOL RES HEALTH, V29, P179; Dwyer DS, 2000, CELL MOL LIFE SCI, V57, P265, DOI 10.1007/PL00000689; El-Mas MM, 2013, ALCOHOL CLIN EXP RES, V37, P1827, DOI 10.1111/acer.12179; El-Mas MM, 2012, AM J PHYSIOL-HEART C, V302, pH837, DOI 10.1152/ajpheart.00958.2011; Eng MY, 2007, ALCOHOL RES HEALTH, V30, P22; Evans AE, 2017, J BURN CARE RES, V38, P90, DOI 10.1097/BCR.0000000000000374; Evans AE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060971; Fernandez-Sola J, 2015, NAT REV CARDIOL, V12, P576, DOI 10.1038/nrcardio.2015.91; Glaaser IW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04681-x; GRASSI GM, 1989, J HYPERTENS, V7, pS20, DOI 10.1097/00004872-198900076-00007; GREEN MA, 1983, TOXICOL APPL PHARM, V69, P29, DOI 10.1016/0041-008X(83)90115-1; Husain K, 2014, WORLD J CARDIOL, V6, P245, DOI 10.4330/wjc.v6.i5.245; Ingall GB, 2012, CLIN LAB MED, V32, P391, DOI 10.1016/j.cll.2012.06.003; Isse T, 2005, ALCOHOL CLIN EXP RES, V29, P1959, DOI 10.1097/01.alc.0000187161.07820.21; JONES AW, 1988, BRIT J CLIN PHARMACO, V25, P213, DOI 10.1111/j.1365-2125.1988.tb03293.x; Khrustalev VV, 2017, J MOL GRAPH MODEL, V78, P187, DOI 10.1016/j.jmgm.2017.10.017; Lu XA, 2011, AM J PHYSIOL-HEART C, V300, pH94, DOI 10.1152/ajpheart.00708.2010; Ma C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11071-w; Marchi KC, 2014, WORLD J CARDIOL, V6, P283, DOI 10.4330/wjc.v6.i5.283; MATHEWS JD, 1976, AUST NZ J MED, V6, P393, DOI 10.1111/j.1445-5994.1976.tb03021.x; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mukamal KJ, 2010, J AM COLL CARDIOL, V55, P1328, DOI 10.1016/j.jacc.2009.10.056; Niemela Onni, 2007, Novartis Found Symp, V285, P183; Pang JJ, 2017, BBA-MOL BASIS DIS, V1863, P1933, DOI 10.1016/j.bbadis.2016.10.004; Passaglia P, 2015, VASC PHARMACOL, V74, P49, DOI 10.1016/j.vph.2015.04.002; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rehm J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3026-9; Ren H, 2017, NEUROPHARMACOLOGY, V114, P20, DOI 10.1016/j.neuropharm.2016.11.013; Resstel LBM, 2006, LIFE SCI, V78, P2179, DOI 10.1016/j.lfs.2005.09.021; Satoh Yasuo, 2008, Japanese Journal of Alcohol Studies & Drug Dependence, V43, P188; SAVAGE AO, 1995, J CARDIOVASC PHARM, V26, P251; Simon TW, 2018, REGUL TOXICOL PHARM, V94, P163, DOI 10.1016/j.yrtph.2018.01.029; Stewart SH, 2009, ALCOHOL ALCOHOLISM, V44, P464, DOI 10.1093/alcalc/agp039; Tirapelli CR, 2008, J PHARM PHARMACOL, V60, P331, DOI 10.1211/jpp.60.3.0008; Tirapelli CR, 2007, J PHARM PHARMACOL, V59, P985, DOI 10.1211/jpp.59.7.0011; Tirapelli CR, 2006, J PHARMACOL EXP THER, V318, P819, DOI 10.1124/jpet.106.103010; Tirapelli CR, 2006, J PHARMACOL EXP THER, V316, P233, DOI 10.1124/jpet.105.092999; TUMA DJ, 1991, ALCOHOL ALCOHOLISM, P271; Utkan T, 2001, FUND CLIN PHARMACOL, V15, P157, DOI 10.1046/j.1472-8206.2001.00024.x; VASDEV S, 1993, ARTERY, V20, P19; Vasdev S, 1995, ARTERY, V21, P312; Zhang SY, 2015, HERZ, V40, P203, DOI 10.1007/s00059-014-4166-2; Zhang WS, 2013, HYPERTENS RES, V36, P741, DOI 10.1038/hr.2013.23; Zhang XC, 2004, ALCOHOL, V32, P175, DOI 10.1016/j.alcohol.2004.01.005	58	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0214336	10.1371/journal.pone.0214336	http://dx.doi.org/10.1371/journal.pone.0214336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893362	gold, Green Published, Green Submitted			2022-12-26	WOS:000461765900075
J	Mayer, S; Spickschen, J; Stein, KV; Crevenna, R; Dorner, TE; Simon, J				Mayer, Susanne; Spickschen, Jonah; Stein, K. Viktoria; Crevenna, Richard; Dorner, Thomas E.; Simon, Judit			The societal costs of chronic pain and its determinants: The case of Austria	PLOS ONE			English	Article							LOW-BACK-PAIN; HEALTH-CARE; OF-ILLNESS; ECONOMIC-EVALUATION; PREVALENCE; IMPACT; PREDICTORS; NATIONWIDE; LITERACY; BURDEN	Background Chronic pain is among the most burdensome conditions. Its prevalence ranges between 12% and 30% in Europe, with an estimated 21% among Austrian adults. The economic impact of chronic pain from a societal perspective, however, has not been sufficiently researched. This study aims to provide an estimate of the societal costs for working-age adults with chronic pain in Austria. It explores the impact of sex, number of pain sites, self-reported pain severity, health literacy and private health insurance on costs associated with chronic pain. Methods A bottom-up cost-of-illness study was conducted based on data collected from 54 adult patients with chronic pain at three Viennese hospital outpatient departments. Information on healthcare costs including out-of-pocket expenses and productivity losses due to absenteeism and informal care were collected over 12 months. Resource use estimates were combined with unit costs and mean costs per patient were calculated in (SIC) for year 2016. Results Mean annual societal costs were estimated at EUR 10191. Direct medical costs were EUR 5725 including EUR 1799 out-of-pocket expenses (mainly pain relieving activities and private therapy). Productivity losses including informal care amounted to EUR 4466. Total costs for women and patients with three or more pain sites were significantly higher. No association with health literacy was found but there was a tendency towards higher out-of-pocket expenses for patients with complementary private health insurance. Conclusion This study is the first to provide a comprehensive assessment of the individual and societal burden of chronic pain in Austria. It highlights that chronic pain is associated with substantial direct medical costs and productivity losses. Patient costs may show systematic differences by health insurance status, implying a need for future research in this area.	[Mayer, Susanne; Simon, Judit] Med Univ Vienna, Dept Hlth Econ, Ctr Publ Hlth, Vienna, Austria; [Spickschen, Jonah; Dorner, Thomas E.] Med Univ Vienna, Dept Social & Prevent Med, Ctr Publ Hlth, Vienna, Austria; [Stein, K. Viktoria] Univ Oxford Wolfson Coll, Int Fdn Integrated Care, Oxford, England; [Crevenna, Richard] Med Univ Vienna, Dept Phys Med Rehabil & Occupat Med, Vienna, Austria; [Simon, Judit] Ludwig Boltzmann Inst Appl Diagnost, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Oxford; Medical University of Vienna	Mayer, S (corresponding author), Med Univ Vienna, Dept Hlth Econ, Ctr Publ Hlth, Vienna, Austria.	susanne.mayer@meduniwien.ac.at		Mayer, Susanne/0000-0002-4448-0478; Stein, K. Viktoria/0000-0002-6225-6226; Simon, Judit/0000-0001-9279-8627				[Anonymous], 2016, HLTH GLANC EUR 2016; Apotheker-Verband, 2016, WAR; Austria Statistics, 2017, HLTH EXP AUSTR ACC S; Azevedo LF, 2016, EUR J HEALTH ECON, V17, P87, DOI 10.1007/s10198-014-0659-4; Bachner Florian, 2018, Health Syst Transit, V20, P1; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Briggs AM, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-161; Brunner-Ziegler S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1138; Chew LD, 2004, FAM MED, V36, P588; Czypionka T, 2017, EUR J PUBLIC HEALTH, V27, P20, DOI 10.1093/eurpub/ckw153; Czypionka T, 2014, HEALTH CARE MANAG SC, V17, P331, DOI 10.1007/s10729-013-9256-9; Department of Health Economics Center for Public Health Medical university of Vienna, 2022, DEV CHIN SIMPL CHIN; Dorner TE, 2016, PSYCHOL MED, V46, P425, DOI 10.1017/S003329171500197X; Dorner TE, 2013, WIEN KLIN WOCHENSCHR, V125, P261, DOI 10.1007/s00508-013-0360-0; Dorner TE, 2018, WIEN KLIN WOCHENSCHR, V130, P14, DOI 10.1007/s00508-017-1223-x; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Eichler K, 2009, INT J PUBLIC HEALTH, V54, P313, DOI 10.1007/s00038-009-0058-2; Ekman M, 2005, SPINE, V30, P1777, DOI 10.1097/01.brs.0000171911.99348.90; Gannon B, 2013, PAIN MED, V14, P1518, DOI 10.1111/pme.12202; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gatchel RJ, 2006, J PAIN, V7, P779, DOI 10.1016/j.jpain.2006.08.005; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Goodrich K, 2012, VALUE HEALTH, V15, P975, DOI 10.1016/j.jval.2012.05.009; Groenewald CB, 2015, PAIN MANAG, V5, P61, DOI [10.2217/PMT.14.52, 10.2217/pmt.14.52]; Gustavsson A, 2012, EUR J PAIN, V16, P289, DOI 10.1016/j.ejpain.2011.07.006; Hauser W, 2014, SCHMERZ, V28, P483, DOI 10.1007/s00482-014-1438-y; Harstall C, 2003, PAIN CLIN UPDATES, V11, P1, DOI DOI 10.1016/S1070-7212(03)00004-6; Haun JN, 2014, J HEALTH COMMUN, V19, P302, DOI 10.1080/10810730.2014.936571; Hoffmann K, 2013, EUR J PUBLIC HEALTH, V23, P933, DOI 10.1093/eurpub/ckt008; Hofmarcher Maria M, 2013, Health Syst Transit, V15, P1; Huskinsson E, 1983, PAIN MEASUREMENT ASS; Kemler MA, 2002, J PAIN SYMPTOM MANAG, V23, P433, DOI 10.1016/S0885-3924(02)00386-X; Kickbusch I, 2013, SOLID FACTS SERIES; Kim SH, 2009, J CLIN NURS, V18, P2337, DOI 10.1111/j.1365-2702.2008.02739.x; Kronborg C, 2009, EUR J HEALTH ECON, V10, P5, DOI 10.1007/s10198-008-0096-3; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Leadley R M, 2012, J Pain Palliat Care Pharmacother, V26, P310, DOI 10.3109/15360288.2012.736933; Leoni T, 2016, FEHLZEITENREPORT 201; Leoni T, 2015, FEHLZEITENREPORT 201; Mayer S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183116; Mayer S, 2015, EUR J PUBLIC HEALTH, V25, P597, DOI 10.1093/eurpub/cku179; Mittendorfer-Rutz E, 2018, WIEN KLIN WOCHENSCHR, V130, P4, DOI 10.1007/s00508-017-1222-y; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; OECD, 2017, OECD UPD 2017; Osterreichische Apothekenkammer, REZ 1956 2017; Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591; Raftery MN, 2012, J PAIN, V13, P139, DOI 10.1016/j.jpain.2011.10.004; Sagan A, 2016, WHO HLTH POLICY SERI; Sanwald A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0230-7; Sculpher MJ, 2004, HEALTH TECHNOL ASSES, V8, P1; Segel JE, 2009, COST OF ILLNESS STUD; Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043; StataCorp, 2015, STAT STAT SOFTW REL; Statistics Austria, 2016, BILD ZAHL 2014 15 SC; Statistics Austria, 2015, OST GES 2014 HAUPT A; Statistik Austria, BRUTT VOLLZ NACH WIR; Statistik Austria, BRUTT TEILZ NACH WIR; Statistik Austria, PREIS VERBR VPI HVPI; Stein KV, 2010, SCHMERZ, V24, P468, DOI 10.1007/s00482-010-0962-7; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Szilagyi IS, 2015, SCHMERZ, V29, P616, DOI 10.1007/s00482-015-0045-x; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Wagner E, 2012, WIEN MED WOCHENSCHR, V162, P92, DOI 10.1007/s10354-011-0050-3; Walter E, 2006, WIEN MED WOCHENSCHR, V156, P628, DOI 10.1007/s10354-006-0360-z; Wenig CM, 2009, EUR J PAIN, V13, P280, DOI 10.1016/j.ejpain.2008.04.005; Wiener Gebietskrankenkasse, 2016, TAR ALLG VERTR; Wiener Gebietskrankenkasse, JAHR WIEN GEB 2015; Wiener Gebietskrankenkasse, JAHR 2015 WIEN GEB 2; Wirtschaftskammer Osterreich, MIND BEW PRAX KEIN E	69	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213889	10.1371/journal.pone.0213889	http://dx.doi.org/10.1371/journal.pone.0213889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893370	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900057
J	Trinh, HC; Kwon, YK				Hung-Cuong Trinh; Kwon, Yung-Keun			RMut: R package for a Boolean sensitivity analysis against various types of mutations	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; GENE REGULATORY NETWORKS; SMALL-MOLECULE INHIBITOR; DYNAMICAL ANALYSIS; PERTURBATION; OVEREXPRESSION; RECONSTRUCTION; DISEASES; TARGETS; DESIGN	There have been many in silico studies based on a Boolean network model to investigate network sensitivity against gene or interaction mutations. However, there are no proper tools to examine the network sensitivity against many different types of mutations, including user-defined ones. To address this issue, we developed RMut, which is an R package to analyze the Boolean network-based sensitivity by efficiently employing not only many well-known node-based and edgetic mutations but also novel user-defined mutations. In addition, RMut can specify the mutation area and the duration time for more precise analysis. RMut can be used to analyze large-scale networks because it is implemented in a parallel algorithm using the OpenCL library. In the first case study, we observed that the real biological networks were most sensitive to overexpression/state-flip and edge-addition/-reverse mutations among node-based and edgetic mutations, respectively. In the second case study, we showed that edgetic mutations can predict drug-targets better than node-based mutations. Finally, we examined the network sensitivity to double edge-removal mutations and found an interesting synergistic effect. Taken together, these findings indicate that RMut is a flexible R package to efficiently analyze network sensitivity to various types of mutations.	[Hung-Cuong Trinh] Ton Duc Thang Univ, Fac Informat Technol, Ho Chi Minh City, Vietnam; [Kwon, Yung-Keun] Univ Ulsan, Dept Elect Elect & Comp Engn, Ulsan, South Korea	Ton Duc Thang University; University of Ulsan	Kwon, YK (corresponding author), Univ Ulsan, Dept Elect Elect & Comp Engn, Ulsan, South Korea.	kwonyk@ulsan.ac.kr	Trinh, Hung Cuong/F-6205-2019	Trinh, Hung Cuong/0000-0002-2172-8231	National IT Industry Promotion Agency (NIPA) - Korea government (MSIP) [S1106-16-1002]	National IT Industry Promotion Agency (NIPA) - Korea government (MSIP)	YKK: This work was supported by National IT Industry Promotion Agency (NIPA) grant funded by the Korea government (MSIP) (S1106-16-1002, Development of smart RMS software for ship maintenance-based fault predictive diagnostics)(https://www.nipa.kr/eng/main.it).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National IT Industry Promotion Agency (NIPA) grant funded by the Korea government (MSIP) (S1106-16-1002, Development of smart RMS software for ship maintenance-based fault predictive diagnostics).	Abdelhamid SHE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133660; Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; Alam MT, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.30, 10.1038/nmicrobiol.2015.30]; Alvarez-Buylla ER, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003626; Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Azuaje F, 2010, BIOSYSTEMS, V100, P55, DOI 10.1016/j.biosystems.2010.01.002; Banjar Hanaa, 2017, Int J Pediatr Adolesc Med, V4, P41, DOI 10.1016/j.ijpam.2016.09.001; Bock M, 2014, BIOINFORMATICS, V30, P131, DOI 10.1093/bioinformatics/btt568; Calzone L, 2015, INTEGR BIOL-UK, V7, P921, DOI 10.1039/c5ib00029g; Campbell C, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-53; Canner JA, 2009, BRIT J CANCER, V101, P774, DOI 10.1038/sj.bjc.6605199; Carlson DF, 2012, P NATL ACAD SCI; Chang HY, 2016, DRUG ALCOHOL DEPEN, V165, P1, DOI 10.1016/j.drugalcdep.2016.04.033; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; Cukuroglu E, 2014, PROG BIOPHYS MOL BIO, V116, P165, DOI 10.1016/j.pbiomolbio.2014.06.003; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Davidich MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071786; Dehghannasiri R, 2015, IEEE ACM T COMPUT BI, V12, P938, DOI 10.1109/TCBB.2014.2377733; Derks MFL, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0380-3; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Domingo G-R, 2006, CURRENT MED CHEM, V13, P2607, DOI [10.2174/092986706778201530, DOI 10.2174/092986706778201530]; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; Dorshorst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128969; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Gonzalez A, 2006, GENETICS, V174, P1625, DOI 10.1534/genetics.106.061218; Grindrod P., 2014, P R SOC A, V470, P2165; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Harris Stephen E., 2002, Complexity, V7, P23, DOI 10.1002/cplx.10022; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Hetmanski JHR, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004909; Horani A, 2018, C18 BEST PEDIAT AM T, pA4467; Hu MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep26247; Trinh HC, 2015, BIOSYSTEMS, V137, P64, DOI 10.1016/j.biosystems.2015.07.007; Trinh HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103010; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; Kwon Y-K, 2015, COMPUTATIONAL BIOL B, DOI [10.1109/TCBB.2015.2495251, DOI 10.1109/TCBB.2015.2495251]; Kwon YK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-384; Kwon YK, 2008, BIOINFORMATICS, V24, P1926, DOI 10.1093/bioinformatics/btn337; Laraia L, 2015, CHEM BIOL, V22, P689, DOI 10.1016/j.chembiol.2015.04.019; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Ma BY, 2014, CURR PHARM DESIGN, V20, P1293, DOI 10.2174/13816128113199990073; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Milani D, 2014, APPL CLIN GENET, V7, P169, DOI 10.2147/TACG.S35474; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Murrugarra D, 2011, J THEOR BIOL, V288, P66, DOI 10.1016/j.jtbi.2011.08.015; Naldi A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000912; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ortiz-Gutierrez E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004486; Pardo EP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004024; Paroni A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0914-z; PARRY JM, 1977, MUTAT RES, V46, P165, DOI 10.1016/0165-1161(77)90023-1; Pellegrino M, 2015, CANCER RES, V75, P4560, DOI 10.1158/0008-5472.CAN-15-0439; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Qian XN, 2008, IEEE T SIGNAL PROCES, V56, P4966, DOI 10.1109/TSP.2008.928089; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SHASTRY BS, 1995, COMP BIOCHEM PHYS B, V112, P1, DOI 10.1016/0305-0491(95)00055-D; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Snitkin ES, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001294; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Suzuki N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147625; Thangudu RR, 2012, J MOL BIOL, V415, P443, DOI 10.1016/j.jmb.2011.12.026; Tillich UM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049467; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Vogt G, 2007, CURR OPIN GENET DEV, V17, P245, DOI 10.1016/j.gde.2007.04.008; Wang W, 2014, ONCOGENE, V33, P3316, DOI 10.1038/onc.2013.290; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2; Wu W, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.358; Xiao YF, 2007, BIOINFORMATICS, V23, P1265, DOI 10.1093/bioinformatics/btm093; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	93	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213736	10.1371/journal.pone.0213736	http://dx.doi.org/10.1371/journal.pone.0213736			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889216	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000029
J	Hara, N; Osago, H; Hiyoshi, M; Kobayashi-Miura, M; Tsuchiya, M				Hara, Nobumasa; Osago, Harumi; Hiyoshi, Mineyoshi; Kobayashi-Miura, Mikiko; Tsuchiya, Mikako			Quantitative analysis of the effects of nicotinamide phosphoribosyltransferase induction on the rates of NAD(+) synthesis and breakdown in mammalian cells using stable isotope-labeling combined with mass spectrometry	PLOS ONE			English	Article							SALVAGE PATHWAY; CELLULAR NAD; METABOLISM; SIRT1; HOMEOSTASIS; NAMPT; ACID; INVOLVEMENT; OXIDATION; SIRTUINS	NAD(+) is mainly synthesized from nicotinamide (Nam) by the rate-limiting enzyme Nam phosphoribosyltransferase (Nampt) and degraded to Nam by NAD(+)-degrading enzymes in mammals. Numerous studies report that tissue NAD(+) levels decrease during aging and age-related diseases and suggest that NAD(+) replenishment promotes healthy aging. Although increased expression of Nampt might be a promising intervention for healthy aging, forced expression of Nampt gene, inducing more than 10-fold increases in the enzyme protein level, has been reported to elevate NAD(+) levels only 40-60% in mammalian cells. Mechanisms underlying the limited increases in NAD(+) levels remain to be determined. Here we show that Nampt is inhibited in cells and that enhanced expression of Nampt activates NAD(+) breakdown. Combined with the measurement of each cell's volume, we determined absolute values (mu M/h) of the rates of NAD(+) synthesis (RS) and breakdown (RB) using a flux assay with a H-2 (D)-labeled Nam, together with the absolute NAD(+) concentrations in various mammalian cells including primary cultured cardiomyocytes under the physiological conditions and investigated the relations among total cellular Nampt activity, RS, RB, and the NAD(+) concentration. NAD(+) concentration was maintained within a narrow range (400-700 mu M) in the cells. RS was much smaller than the total Nampt activity, indicating that NAD+ synthesis from Nam in the cells is suppressed. Forced expression of Nampt leading to 6-fold increase in total Nampt activity induced only a 1.6-fold increase in cellular NAD(+) concentration. Under the conditions, RS increased by 2-fold, while 2-fold increase in RB was also observed. The small increase in cellular NAD(+) concentration is likely due to both inhibited increase in the NAD(+) synthesis and the activation of its breakdown. Our findings suggest that cellular NAD(+) concentrations do not vary dramatically by the physiological fluctuation of Nampt expression and show the tight link between the NAD(+) synthesis and its breakdown.	[Hara, Nobumasa; Osago, Harumi; Hiyoshi, Mineyoshi; Kobayashi-Miura, Mikiko; Tsuchiya, Mikako] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane, Japan	Shimane University	Hara, N (corresponding author), Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane, Japan.	nhara@med.shimane-u.ac.jp			JSPS KAKENHI [JP18K11072]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP18K11072 (http://www.jsps.go.jp/j-grantsinaid/index.html) to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; BUSH K, 1973, BIOCHEMISTRY-US, V12, P4802, DOI 10.1021/bi00747a037; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; Costford SR, 2018, MOL METAB, V7, P1, DOI 10.1016/j.molmet.2017.10.012; Crutzen R, 2012, PFLUG ARCH EUR J PHY, V463, P377, DOI 10.1007/s00424-011-1047-x; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001; Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005; Frederick DW, 2015, J BIOL CHEM, V290, P1546, DOI 10.1074/jbc.M114.579565; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hara N, 2014, J NUTR SCI VITAMINOL, V60, P17, DOI 10.3177/jnsv.60.17; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; HILLYARD D, 1973, J CELL PHYSIOL, V82, P165, DOI 10.1002/jcp.1040820205; Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Krumbiegel P, 2011, ISOT ENVIRON HEALT S, V47, P1, DOI 10.1080/10256016.2011.556725; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0214000	10.1371/journal.pone.0214000	http://dx.doi.org/10.1371/journal.pone.0214000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875389	gold, Green Submitted, Green Published			2022-12-26	WOS:000461316400042
J	Alharbi, A; Rabadi, SM; Alqahtani, M; Marghani, D; Worden, M; Ma, Z; Malik, M; Bakshi, CS				Alharbi, Arwa; Rabadi, Seham M.; Alqahtani, Maha; Marghani, Dina; Worden, Madeline; Ma, Zhuo; Malik, Meenakshi; Bakshi, Chandra Shekhar			Role of peroxiredoxin of the AhpC/TSA family in antioxidant defense mechanisms of Francisella tularensis	PLOS ONE			English	Article							ALKYL HYDROPEROXIDASE AHPC; REACTIVE NITROGEN; OXIDATIVE STRESS; OXYGEN; LVS; RESISTANCE; VIRULENCE; PROTEIN	Francisella tularensis is a Gram-negative, facultative intracellular pathogen and the causative agent of a lethal human disease known as tularemia. Due to its extremely high virulence and potential to be used as a bioterror agent, F. tularensis is classified by the CDC as a Category A Select Agent. As an intracellular pathogen, F. tularensis during its intracellular residence encounters a number of oxidative and nitrosative stresses. The roles of the primary antioxidant enzymes SodB, SodC and KatG in oxidative stress resistance and virulence of F. tularensis live vaccine strain (LVS) have been characterized in previous studies. However, very fragmentary information is available regarding the role of peroxiredoxin of the AhpC/TSA family (annotated as AhpC) of F. tularensis SchuS4; whereas the role of AhpC of F. tularensis LVS in tularemia pathogenesis is not known. This study was undertaken to exhaustively investigate the role of AhpC in oxidative stress resistance of F. tularensis LVS and SchuS4. We report that AhpC of F. tularensis LVS confers resistance against a wide range of reactive oxygen and nitrogen species, and serves as a virulence factor. In highly virulent F. tularensis SchuS4 strain, AhpC serves as a key antioxidant enzyme and contributes to its robust oxidative and nitrosative stress resistance, and intramacrophage survival. We also demonstrate that there is functional redundancy among primary antioxidant enzymes AhpC, SodC, and KatG of F. tularensis SchuS4. Collectively, this study highlights the differences in antioxidant defense mechanisms of F. tularensis LVS and SchuS4.	[Alharbi, Arwa; Rabadi, Seham M.; Alqahtani, Maha; Marghani, Dina; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Worden, Madeline; Ma, Zhuo; Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Dept Basic & Clin Sci, Albany, NY 12208 USA	New York Medical College; Albany College of Pharmacy & Health Sciences	Bakshi, CS (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.; Malik, M (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Basic & Clin Sci, Albany, NY 12208 USA.	Meenakshi.Malik@acphs.edu; Shekhar_Bakshi@nymc.edu	Malik, Meenakshi/F-1501-2015	Malik, Meenakshi/0000-0003-0051-4485; Bakshi, Chandra Shekhar/0000-0001-5459-3225; Ma, Zhuo/0000-0002-9766-8239	National Institutes of Health [R56AI101109, P01AI056320, R15AI107698]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R15AI107698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R56AI101109, P01AI056320 (CSB) and R15AI107698 (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No financial conflicts of interest exist regarding the contents of the manuscript and its authors.	Alqahtani M, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00693-17; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Barraud N, 2009, J BACTERIOL, V191, P7333, DOI 10.1128/JB.00975-09; Binesse J, 2015, INFECT IMMUN, V83, P2255, DOI 10.1128/IAI.02488-14; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Branco V, 2014, FREE RADICAL BIO MED, V73, P95, DOI 10.1016/j.freeradbiomed.2014.04.030; Bryk R, 2002, SCIENCE, DOI [10.1111/j.1365-3164.2009.00779.x, DOI 10.1111/J.1365-3164.2009.00779.X]; Chauhan R, 2001, BIOCHEM J, V354, P209, DOI 10.1042/0264-6021:3540209; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Dieppedale J, 2011, INFECT IMMUN, V79, P1428, DOI 10.1128/IAI.01012-10; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Guimaraes BG, 2005, J BIOL CHEM, V280, P25735, DOI 10.1074/jbc.M503076200; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kingry LC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00035; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Ma Z, 2016, MOL MICROBIOL, V101, P856, DOI 10.1111/mmi.13426; Ma Z, 2014, MOL MICROBIOL, V91, P976, DOI 10.1111/mmi.12509; Mahawar M, 2009, J BACTERIOL, V191, P4798, DOI 10.1128/JB.00212-09; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Rogstam A, 2007, J BACTERIOL, V189, P3063, DOI 10.1128/JB.01782-06; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x	32	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213699	10.1371/journal.pone.0213699	http://dx.doi.org/10.1371/journal.pone.0213699			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870480	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300063
J	Angladon, MA; Fossepre, M; Leherte, L; Vercauteren, DP				Angladon, Marie-Ange; Fossepre, Mathieu; Leherte, Laurence; Vercauteren, Daniel P.			Interaction of POPC, DPPC, and POPE with the mu opioid receptor: A coarse-grained molecular dynamics study	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MEMBRANE-PROTEINS; FORCE-FIELD; LIPIDS; SIMULATIONS; CHOLESTEROL; INSIGHTS; MARTINI; RHODOPSIN; MODULATE	The mu opioid receptor (mu OR), which is part of the G protein-coupled receptors family, is a membrane protein that is modulated by its lipid environment. In the present work, we model mu OR in three different membrane systems: POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), and DPPC (1, 2-dipalmitoyl-sn-glycero-3-phosphocholine) through 45 mu s molecular dynamics (MD) simulations at the coarse-grained level. Our theoretical studies provide new insights to the lipid-induced modulation of the receptor. Particularly, to characterize how mu OR interacts with each lipid, we analyze the tilt of the protein, the number of contacts occurring between the lipids and each amino acid of the receptor, and the mu OR-lipid interface described as a network graph. We also analyze the variations in the number and the nature of the protein contacts that are induced by the lipid structure. We show that POPC interacts preferentially with helix 1 (H1) and helices H5-H6, POPE, with H5-H6 and H6-H7, and DPPC, with H4 and H6. We demonstrate how each of the three lipids shape the structure of the mu OR.	[Angladon, Marie-Ange; Fossepre, Mathieu; Leherte, Laurence; Vercauteren, Daniel P.] Univ Namur UNamur, Namur Res Inst Life Sci NARILIS, Namur Med & Drug Innovat Ctr NAMEDIC, Lab Physicochim Informat,Unite Chim Phys Theor &, Namur, Belgium		Angladon, MA (corresponding author), Univ Namur UNamur, Namur Res Inst Life Sci NARILIS, Namur Med & Drug Innovat Ctr NAMEDIC, Lab Physicochim Informat,Unite Chim Phys Theor &, Namur, Belgium.	marie-ange.angladon@unamur.be		Leherte, Laurence/0000-0001-8468-5462	Belgian National Fund for Research (F.N.R.S.); doctoral fellowship FRIA (Formation to Research in Industry and Agriculture)	Belgian National Fund for Research (F.N.R.S.)(Fonds de la Recherche Scientifique - FNRS); doctoral fellowship FRIA (Formation to Research in Industry and Agriculture)(Fonds de la Recherche Scientifique - FNRS)	The author received funds for this work from the Belgian National Fund for Research (F.N.R.S.) with a doctoral fellowship FRIA (Formation to Research in Industry and Agriculture).	Baltoumas FA, 2016, J COMPUT AID MOL DES, V30, P489, DOI 10.1007/s10822-016-9919-y; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Chattopadhyay A., 2014, ADV BIOL, V2014; Chavent M, 2016, CURR OPIN STRUC BIOL, V40, P8, DOI 10.1016/j.sbi.2016.06.007; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; de Jong DH, 2012, J CHEM THEORY COMPUT, V8, P1003, DOI 10.1021/ct200599d; Farran B, 2017, PHARMACOL RES, V117, P303, DOI 10.1016/j.phrs.2017.01.008; Fossepre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115856; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Grossfield A, 2011, BBA-BIOMEMBRANES, V1808, P1868, DOI 10.1016/j.bbamem.2011.03.010; Horn JN, 2014, ADV EXP MED BIOL, V796, P75, DOI 10.1007/978-94-007-7423-0_5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huster D, 2014, BBA-MOL CELL BIOL L, V1841, P1146, DOI 10.1016/j.bbalip.2013.12.002; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marino KA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005240; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Miao YL, 2016, CURR OPIN STRUC BIOL, V41, P83, DOI 10.1016/j.sbi.2016.06.008; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Neale C, 2015, BIOPHYS J, V109, P1652, DOI 10.1016/j.bpj.2015.08.028; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Periole X, 2017, CHEM REV, V117, P156, DOI 10.1021/acs.chemrev.6b00344; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poma AB, 2017, J CHEM THEORY COMPUT, V13, P1366, DOI 10.1021/acs.jctc.6b00986; Prasanna X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31858; Prasanna X, 2014, BIOPHYS J, V106, P1290, DOI 10.1016/j.bpj.2014.02.002; Provasi D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004148; Sadiq SK, 2013, CURR MED CHEM, V20, P22; Sengupta D, 2012, J PHYS CHEM B, V116, P12991, DOI 10.1021/jp309888u; Shang Y, 2015, EUR J PHARMACOL, V763, P206, DOI 10.1016/j.ejphar.2015.05.012; Trang T, 2015, J NEUROSCI, V35, P13879, DOI 10.1523/JNEUROSCI.2711-15.2015; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yeagle PL, 2014, BBA-BIOMEMBRANES, V1838, P1548, DOI 10.1016/j.bbamem.2013.11.009; Zeppelin T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005907; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	50	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213646	10.1371/journal.pone.0213646	http://dx.doi.org/10.1371/journal.pone.0213646			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870466	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300054
J	da Silva, LF; Skupien, EC; Lazzari, TK; Holler, SR; de Almeida, EGC; Zampieri, LR; Coutinho, SE; Andrades, M; Silva, DR				da Silva, Livia Fontes; Skupien, Erika Cavalheiro; Lazzari, Tassia Kirchmann; Holler, Sizuane Rieger; Correa de Almeida, Ellis Gabriela; Zampieri, Luisa Rebechi; Coutinho, Sandra Eugenia; Andrades, Michael; Silva, Denise Rossato			Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MALNUTRITION; CLEARANCE; S100A12; INJURY	Introduction The receptor for advanced glycation end products (RAGE) is expressed in normal lungs and is upregulated during infection. AGEs and RAGE cause oxidative stress and apoptosis in lung cells. The objective of this study is to evaluate levels of AGEs and its soluble receptor (sRAGE), and to investigate their relationship with food intake and nutritional status, in a university-affiliated hospital in Brazil. Methods Case-control study, from June 2017 to June 2018. AGE (carboxymethyl lysine, CML) and sRAGE were measured from blood samples by Elisa. Nutritional assessment was performed by body mass index, triceps skin-fold thickness, mid-arm circumference, midarm muscle circumference, bioelectrical impedance analysis, and food frequency questionnaire. Results We included in the study 35 tuberculosis (TB) patients and 35 controls. The mean sRAGE levels were higher in TB patients than in controls (68.5 +/- 28.1 vs 57.5 +/- 24.0 pg/mL; p = 0.046). Among cases that were current smokers, lower sRAGE levels were associated with mortality, evaluated at the end of hospitalization (p = 0.006), and with weight loss (p = 0.034). There was no statistically significant difference in CML levels and diet CML content between cases and controls. Malnutrition was more frequent in cases, but there was no correlation between nutritional parameters and CML or sRAGE levels. Conclusions TB patients had higher sRAGE levels than controls, although it is not clear that this difference is clinically relevant. Also, sRAGE was associated with weight loss and mortality.	[da Silva, Livia Fontes; Skupien, Erika Cavalheiro; Lazzari, Tassia Kirchmann; Coutinho, Sandra Eugenia; Silva, Denise Rossato] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil; [Holler, Sizuane Rieger; Correa de Almeida, Ellis Gabriela; Silva, Denise Rossato] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Zampieri, Luisa Rebechi] Univ Fed Rio Grande do Sul, Fac Nutr, Porto Alegre, RS, Brazil; [Andrades, Michael] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil.; Silva, DR (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.	denise.rossato@terra.com.br	Andrades, Michael/S-5394-2019	Andrades, Michael/0000-0003-0337-9661; Rossato Silva, Denise/0000-0003-0230-2734	FIPE-HCPA (Fundo de Incentivo a Pesquisa-Hospital de Clinicas de Porto Alegre) [14-0044]; International Clinical Operational Health Services Research Training Award (ICOHRTA/Fogarty International Center/National Institutes for Health -NIH); Johns Hopkins University (Johns Hopkins Bloomberg School of Public Health)	FIPE-HCPA (Fundo de Incentivo a Pesquisa-Hospital de Clinicas de Porto Alegre); International Clinical Operational Health Services Research Training Award (ICOHRTA/Fogarty International Center/National Institutes for Health -NIH); Johns Hopkins University (Johns Hopkins Bloomberg School of Public Health)	DRS was supported by FIPE-HCPA (Fundo de Incentivo a Pesquisa-Hospital de Clinicas de Porto Alegre, Grant number: 14-0044. hcpa.edu.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support from the International Clinical Operational Health Services Research Training Award (ICOHRTA/Fogarty International Center/National Institutes for Health -NIH) and Johns Hopkins University (Johns Hopkins Bloomberg School of Public Health).	[Anonymous], 2016, WHO REPORT TUBERCULO; Berrocal-Almanza LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31798; Byun K, 2017, PHARMACOL THERAPEUT, V177, P44, DOI 10.1016/j.pharmthera.2017.02.030; Chao PC, 2010, EUR J NUTR, V49, P429, DOI 10.1007/s00394-010-0101-3; Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gopal P, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-24; He M, 2011, EMBO REP, V12, P358, DOI 10.1038/embor.2011.28; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Lazzari TK, 2018, NUTR CLIN PRACT, V33, P858, DOI 10.1002/ncp.10006; Lui G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159132; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Ministerio da Saude, 2017, B EP; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; ONWUBALILI JK, 1988, EUR J CLIN NUTR, V42, P363; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Renard C, 1997, MOL PHARMACOL, V52, P54, DOI 10.1124/mol.52.1.54; Santilli F, 2009, CURR MED CHEM, V16, P940, DOI 10.2174/092986709787581888; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Standards Diagnostic, 1999, AM J RESP CRIT CARE, V161, P1376; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Van Lettow M, 2004, INT J TUBERC LUNG D, V8, P211; van Zoelen MAD, 2012, MOL IMMUNOL, V52, P183, DOI 10.1016/j.molimm.2012.05.014; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Watanabe T, 2011, RESP MED, V105, P519, DOI 10.1016/j.rmed.2010.10.016; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213991	10.1371/journal.pone.0213991	http://dx.doi.org/10.1371/journal.pone.0213991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870511	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300101
J	Inaba, H; Nomura, R; Kato, Y; Takeuchi, H; Amano, A; Asai, F; Nakano, K; Lamont, RJ; Matsumoto-Nakano, M				Inaba, Hiroaki; Nomura, Ryota; Kato, Yukio; Takeuchi, Hiroki; Amano, Atsuo; Asai, Fumitoshi; Nakano, Kazuhiko; Lamont, Richard J.; Matsumoto-Nakano, Michiyo			Adhesion and invasion of gingival epithelial cells by Porphyromonas gulae	PLOS ONE			English	Article							BACTERIAL INVASION; FUSOBACTERIUM-NUCLEATUM; ENDOTHELIAL-CELLS; YERSINIA-PESTIS; FIMA GENOTYPES; DOGS; INTERNALIZATION; VIRULENCE; KINASE; IDENTIFICATION	Porphyromonas gulae, an animal periodontal pathogen, possess fimbriae classified into three genotypes (A-C) based on the diversity of fimA genes encoding FimA. Accumulating evidence suggests that P. gulae strains with type C fimbriae are more virulent as compared to those with other types. The ability of these organisms to adhere to and invade gingival epithelial cells has yet to be examined. P. gulae showed the greatest levels of adhesion and invasion at a multiplicity of infection of 100 for 90 min. P. gulae type C and some type B strains invaded gingival epithelial cells at significantly greater levels than the other strains, at the same level of efficiency as P. gingivalis with type II fimbriae. Adhesion and invasion of gingival epithelial cells by P. gulae were inhibited by cytochalasin D and sodium azide, indicating the requirements of actin polymerization and energy metabolism for those activities. Invasion within gingival epithelial cells was blocked by staurosporine, whereas those inhibitors showed little effects on adhesion, while nocodazole and cycloheximide had negligible effects on either adhesion or invasion. P. gulae proteases were found to be essential for adhesion and invasion of gingival epithelial cells, while its DNA and RNA, and protein synthesis were unnecessary for those activities. Additionally, alpha 5 beta 1 integrin antibodies significantly inhibited adhesion and invasion by P. gulae. This is the first report to characterize P. gulae adhesion and invasion of human gingival epithelial cells.	[Inaba, Hiroaki; Matsumoto-Nakano, Michiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat Dent, Okayama, Japan; [Nomura, Ryota; Nakano, Kazuhiko] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Suita, Osaka, Japan; [Kato, Yukio] Azabu Univ, Sch Vet Med, Dept Vet Publ Hlth 2, Sagamihara, Kanagawa, Japan; [Takeuchi, Hiroki; Amano, Atsuo] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka, Japan; [Asai, Fumitoshi] Azabu Univ, Sch Vet Med, Dept Pharmacol, Sagamihara, Kanagawa, Japan; [Lamont, Richard J.] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA	Okayama University; Osaka University; Azabu University; Osaka University; Azabu University; University of Louisville	Inaba, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat Dent, Okayama, Japan.	hinaba@okayama-u.ac.jp		Inaba, Hiroaki/0000-0002-3040-3113	Ministry of Education, Culture, Sports, Science and Technology [17K11612, A26253094, 30359848]; Ryobi Teien Memory Foundation; NIH [DE011111, DE017921]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants-in-aid for Scientific Research (17K11612 to H.I., A26253094 to A.A., 30359848 to M.M.N.) from the Ministry of Education, Culture, Sports, Science and Technology; to H.I. from Ryobi Teien Memory Foundation; and DE011111 and DE017921 to R.J.L. from the NIH.	Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Senhorinho GNA, 2011, ANAEROBE, V17, P257, DOI 10.1016/j.anaerobe.2011.06.002; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Borsanelli AC, 2017, VET MICROBIOL, V203, P271, DOI 10.1016/j.vetmic.2017.03.032; Bur S, 2013, J INVEST DERMATOL, V133, P2004, DOI 10.1038/jid.2013.87; Cordeiro F, 2013, MICROBIOL-SGM, V159, P1683, DOI 10.1099/mic.0.064204-0; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; CURTIS MA, 1988, J CLIN PERIODONTOL, V15, P628, DOI 10.1111/j.1600-051X.1988.tb02263.x; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Enersen M, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20265; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179, DOI 10.1099/00207713-51-3-1179; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hamada N, 2008, VET MICROBIOL, V128, P108, DOI 10.1016/j.vetmic.2007.09.014; Hertle R, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-16; Holden JA, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00282-17, 10.1128/iai.00282-17]; Inaba H, 2008, ORAL MICROBIOL IMMUN, V23, P29, DOI 10.1111/j.1399-302X.2007.00386.x; Inaba H, 2012, INFECT IMMUN, V80, P2847, DOI 10.1128/IAI.00258-12; Inaba H, 2009, CELL MICROBIOL, V11, P1517, DOI 10.1111/j.1462-5822.2009.01344.x; Josse J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02433; Kato T, 2007, CELL MICROBIOL, V9, P753, DOI 10.1111/j.1462-5822.2006.00825.x; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamster I B, 1997, Ann Periodontol, V2, P123; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lenzo JC, 2016, INFECT IMMUN, V84, P2575, DOI 10.1128/IAI.01500-15; Lopez-Gomez A, 2012, MICROBIOL-SGM, V158, P2384, DOI 10.1099/mic.0.059972-0; Love RM, 2002, ORAL MICROBIOL IMMUN, V17, P32, DOI 10.1046/j.0902-0055.2001.00090.x; Mikkelsen D, 2008, ENVIRON MICROBIOL, V10, P2425, DOI 10.1111/j.1462-2920.2008.01668.x; Nakagawa I, 2002, INFECT IMMUN, V70, P277, DOI 10.1128/IAI.70.1.277-285.2002; Nakagawa I, 2002, J PERIODONTAL RES, V37, P425, DOI 10.1034/j.1600-0765.2002.01637.x; Nakagawa I, 2006, INFECT IMMUN, V74, P3773, DOI 10.1128/IAI.01902-05; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; ROSENSHINE I, 1992, INFECT IMMUN, V60, P2211, DOI 10.1128/IAI.60.6.2211-2217.1992; Saito A, 2012, MICROB PATHOGENESIS, V53, P234, DOI 10.1016/j.micpath.2012.08.005; Saito A, 2008, FEMS IMMUNOL MED MIC, V54, P349, DOI 10.1111/j.1574-695X.2008.00481.x; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Senhorinho GNA, 2012, ANAEROBE, V18, P381, DOI 10.1016/j.anaerobe.2012.04.008; Shirai M, 2015, RES VET SCI, V102, P49, DOI 10.1016/j.rvsc.2015.07.009; Tang DD, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0544-7; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; Valour F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067240; Yamasaki Y, 2012, ARCH ORAL BIOL, V57, P1183, DOI 10.1016/j.archoralbio.2012.02.015; Yamasaki Y, 2012, VET MICROBIOL, V161, P196, DOI 10.1016/j.vetmic.2012.07.026; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213309	10.1371/journal.pone.0213309	http://dx.doi.org/10.1371/journal.pone.0213309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870452	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300029
J	Truong, HHM; Pipkin, S; Grant, RM; Liegler, T; O'Keefe, KJ; Scheer, S				Truong, Hong-Ha M.; Pipkin, Sharon; Grant, Robert M.; Liegler, Teri; O'Keefe, Kara J.; Scheer, Susan			Increased uptake of early initiation of antiretroviral therapy and baseline drug resistance testing in San Francisco between 2001 and 2015	PLOS ONE			English	Article							HIV; RATES	Background Early initiation of antiretroviral therapy (eiART) can improve clinical outcomes for persons with HIV and reduce onward transmission risk. Baseline drug resistance testing (bDRT) can inform regimen selection upon subsequent treatment initiation. We examined the uptake of eiART and bDRT within 3 months and 30 days of HIV diagnosis. Methods We analyzed a population-based sample from the San Francisco Department of Public Health HIV/AIDS Case Registry of newly-diagnosed HIV/non-AIDS individuals between 2001 and 2015 who received care at publicly-funded facilities (N = 3,124). Results Uptake of eiART within 3 months of diagnosis increased significantly from 2001 to 2015 (p<0.001), peaking at 74% in 2015. bDRT uptake also increased significantly (p<0.001), peaking at 55% in 2012. eiART uptake was observed to be significantly associated with gender, age, race/ethnicity and transmission risk. There were no significant differences observed in demographic and risk characteristics of persons receiving bDRT in the more recent years. Of 990 persons diagnosed between 2010 and 2015, eiART uptake within 30 days of diagnosis increased from 13% to 38% (p<0.001); bDRT uptake increased from 35% to 39% but the change was not significant (p = 0.141). Conclusions Observed increases in eiART and bDRT uptake from 2010 to 2015 may reflect the adoption of treatment as prevention and a local public health policy statement in 2010 recommending treatment initiation at time of diagnosis irrespective of CD4 count. Concerns about stigma may underlie disparities in eiART, however such concerns would not bear as directly on a provider-initiated laboratory test like bDRT.	[Truong, Hong-Ha M.; Grant, Robert M.; Liegler, Teri] Univ Calif San Francisco, Dept Med, San Francisco, CA 94115 USA; [Truong, Hong-Ha M.; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Pipkin, Sharon; O'Keefe, Kara J.; Scheer, Susan] Dept Publ Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Truong, HHM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94115 USA.; Truong, HHM (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	Hong-Ha.Truong@ucsf.edu			National Institutes of Health [R01 MH096642, P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health, grants R01 MH096642 and P30 AI027763. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; [Anonymous], NY TIMES; [Anonymous], GUIDELINES USE ANTIR; Barbour JD, 2004, AIDS, V18, P1683, DOI 10.1097/01.aids.0000131391.91468.ff; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Truong HHM, 2015, JAIDS-J ACQ IMM DEF, V69, P606, DOI 10.1097/QAI.0000000000000681; Truong HHM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025281; Wegner SA, 2004, CLIN INFECT DIS, V38, P723, DOI 10.1086/381266; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008	17	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213167	10.1371/journal.pone.0213167	http://dx.doi.org/10.1371/journal.pone.0213167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870438	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300024
J	Baerum, KM; Anker-Nilssen, T; Christensen-Dalsgaard, S; Fangel, K; Williams, T; Volstad, JH				Baerum, Kim Magnus; Anker-Nilssen, Tycho; Christensen-Dalsgaard, Signe; Fangel, Kirstin; Williams, Tom; Volstad, Jon Helge			Spatial and temporal variations in seabird bycatch: Incidental bycatch in the Norwegian coastal gillnet-fishery	PLOS ONE			English	Article							LONGLINE FISHERIES	The general decline of seabird populations worldwide raises large concerns. Although multiple factors are interacting to cause the observed trends, increased mortality from incidental bycatch in fisheries has proven to be important for many species. However, the bulk of published knowledge is derived from longline fisheries, whereas bycatch in gillnet fisheries is less studied and even overlooked in some areas. We present seabird bycatch data from a 10-year time-series of fishery data from the large fleet of small-vessels fishing with gillnets along the Norwegian coast a large area and fishery with no prior estimates of seabird bycatch. In general, we document high rates of incidental bycatch (averaging 0.0023 seabirds/net, or approximately 0.08 seabirds/fishing trip). This results in an estimated annual bycatch between 1580 and 11500 (95% CI) birds in this fishery. There was a surprisingly high percentage (43%) of surface-feeding seabirds in the bycatch, with northern fulmar being the most common species. Among the diving seabirds caught, common guillemot was most numerous. Our findings suggest that coastal gillnet fisheries represent a more general threat to a wider range of seabird populations, as opposed to longline fisheries where surface-feeding seabird species seem to dominate the bycatch. The bycatch estimates for the Norwegian gillnet-fishery varied in time, between areas, and with fishing depth and distance from the coast, but we found no clear trends in relation to the type of gillnets used. The results enabled us to identify important spatio-temporal trends in the seabird bycatch, which can allow for the development and implementation of more specific mitigation measures. While specific time closures might be an efficient option to reduce bycatch for diving seabirds, measures such as gear modification and reduction in release of wastewater during fishing operation are probably a more effective mitigation approach for reducing bycatch of surface-feeding seabirds.	[Baerum, Kim Magnus; Fangel, Kirstin] Norwegian Inst Nat Res NINA, Lillehammer, Norway; [Anker-Nilssen, Tycho; Christensen-Dalsgaard, Signe] Norwegian Inst Nat Res NINA, Dept Terr Ecol, Trondheim, Norway; [Williams, Tom; Volstad, Jon Helge] Inst Marine Res, Bergen, Norway	Norwegian Institute Nature Research; Norwegian Institute Nature Research; Institute of Marine Research - Norway	Baerum, KM (corresponding author), Norwegian Inst Nat Res NINA, Lillehammer, Norway.	kim.barum@nina.no	Vølstad, Jon Helge/V-2992-2019; Anker-Nilssen, Tycho/AAB-7666-2022	Anker-Nilssen, Tycho/0000-0002-1030-5524	Norwegian Environment Agency	Norwegian Environment Agency	Funding was provided by the Norwegian Environment Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all fishers in the Coastal Reference Fleet, that have registered all their catch and provided the data. We are also most thankful to the Norwegian Environment Agency, without whose funding and support the project would not have existed. We would also thank Sofie Gundersen for valuable help with producing Fig 1. We also thank two anonymous reviewers for suggestions and comments.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Anker-Nilssen T, 2016, KEY SITE MONITORING, P1; Anker-Nilssen T, 2017, KEY SITE MONITORING; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Bolker B., 2016, BBMLE METHODS FUNCTI; Bull LS, 2007, FISH FISH, V8, P31, DOI 10.1111/j.1467-2979.2007.00234.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Edwards E. W. J., 2015, THESIS; Fangel K, 2017, ICES J MAR SCI, V74, P332, DOI 10.1093/icesjms/fsw149; Fangel K, 2015, GLOB ECOL CONSERV, V4, P127, DOI 10.1016/j.gecco.2015.06.001; Fauchald P., 2015, NINA REP, P1; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Friendly M., 2015, J STAT SOFTW, P562, DOI DOI 10.18637/JSS.V081.I10; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; International B, 2004, BIRDS EUR POP EST TR; Jimenez S, 2014, BIOL CONSERV, V171, P9, DOI 10.1016/j.biocon.2013.12.035; JNCC, 2015, SEAB POP TRENDS CAUS; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Lokkeborg S, 2011, MAR ECOL PROG SER, V435, P285, DOI 10.3354/meps09227; Mangel JC, 2018, ILLUMINATING GILLNET, V5; Mangel JC, 2018, ROYAL SOC OPEN SCI, V5; Martin GR, 2015, GLOB ECOL CONSERV, V3, P28, DOI 10.1016/j.gecco.2014.11.004; Melvin EF, 1999, CONSERV BIOL, V13, P1386, DOI 10.1046/j.1523-1739.1999.98426.x; Mitchell PI, 2004, SEABIRD POPULATIONS; Nordstrom M, 2003, BIOL CONSERV, V109, P359, DOI 10.1016/S0006-3207(02)00162-3; Northridge S, 2017, CONSERV BIOL, V31, P686, DOI 10.1111/cobi.12741; Oliveira N, 2015, GLOB ECOL CONSERV, V3, P51, DOI 10.1016/j.gecco.2014.11.006; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Phillips EM, 2010, MARINE ORNITHOLOGY, V38; Regular P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0088; Skaug H. J., 2014, GEN LINEAR MIXED MOD; STRANN KB, 1991, SEABIRD, V13, P22; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; Thomson RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127006; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Weimerskirch H, 1997, POPULATION DYNAMICS, P257; Zuur AF, 2012, ZERO INFALTED MODELS; Zydelis R, 2013, BIOL CONSERV, V162, P76, DOI 10.1016/j.biocon.2013.04.002; Zydelis R, 2009, BIOL CONSERV, V142, P1269, DOI 10.1016/j.biocon.2009.02.025	44	17	17	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212786	10.1371/journal.pone.0212786	http://dx.doi.org/10.1371/journal.pone.0212786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865723	gold, Green Published, Green Submitted			2022-12-26	WOS:000461048900038
J	Insua, JR; Utsumi, SA; Basso, B				Insua, Juan R.; Utsumi, Santiago A.; Basso, Bruno			Estimation of spatial and temporal variability of pasture growth and digestibility in grazing rotations coupling unmanned aerial vehicle (UAV) with crop simulation models	PLOS ONE			English	Article							RYEGRASS LOLIUM-PERENNE; DAIRY-COWS; MANAGEMENT; BIOMASS; YIELD; SENESCENCE; INDEX	Systematic monitoring of pasture quantity and quality is important to match the herd forage demand (pasture removal by grazing or harvest) to the supply of forage with adequate nutritive value. The aim of this research was to monitor, assess and manage changes in pasture growth, morphology and digestibility by integrating information from an Unmanned Aerial Vehicle (UAV) and two process-based models. The first model, Systems Approach to Land Use Sustainability (SALUS), is a process-based crop growth model used to predict pasture regrowth based on soil, climate, and management data. The second model, Morphogenetic and Digestibility of Pasture (MDP), uses paddock-scale values of herbage mass as input to predict leaf morphogenesis and forage nutritive value. Two field experiments were carried out on tall fescue- and ryegrass-based pastures under rotational grazing with lactating dairy cattle. The first experiment was conducted at plot scale and was used to calibrate the UAV and to test models. The second experiment was conducted at field scale and was used to test the UAV's ability to predict pasture biomass under grazing rotation. The Normalized Difference Vegetation Index (NDVI) calculated from the UAV's multispectral reflectance (n = 72) was strongly correlated (p < 0.001) to plot measurements of pasture biomass (R-2 = 0.80) within the range of similar to 226 and 4208 kg DM ha(-1). Moreover, there was n o difference (root mean square error, RMSE < 500 kg DM ha(-1)) between biomass estimations by the UAV (1971 350 kg ha(-1)) and two conventional methods used as control, the C-Dax proximal sensor (2073 636 kg ha(-1)) and ruler (2017 530 kg ha(-1)). The UAV approach was capable of mapping at high resolution (6 cm) the spatial variability of pasture (16 ha). The integrated UAV-modeling approach properly predicted spatial and temporal changes in pasture biomass (RMSE = 509 kg DM ha(-1), CCC = 0.94), leaf length (RMSE = 6.2 cm, CCC = 0.62), leaf stage (RMSE = 0.7 leaves, CCC = 0.65), neutral detergent fiber (RMSE = 3%, CCC = 0.71), digestibility of neutral detergent fiber (RMSE = 8%, CCC = 0.92) and digestibility of dry matter (RMSE = 5%, CCC = 0.93) with reasonable precision and accuracy. These findings therefore suggest potential for the present UAV-modeling approach for use as decision support tool to allocate animals based on spatially and temporally explicit predictions of pasture biomass and nutritive value.	[Insua, Juan R.] Univ Nacl Mar Plata, Fac Ciencias Agr, Balcarce, Buenos Aires, Argentina; [Insua, Juan R.] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Utsumi, Santiago A.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Utsumi, Santiago A.; Basso, Bruno] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Basso, Bruno] Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA	National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Michigan State University; Michigan State University; Michigan State University	Insua, JR (corresponding author), Univ Nacl Mar Plata, Fac Ciencias Agr, Balcarce, Buenos Aires, Argentina.; Insua, JR (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	insua.juan@inta.gob.ar	Basso, Bruno/A-3128-2012	Basso, Bruno/0000-0003-2090-4616; Insua, Juan/0000-0002-3228-7208	USDA-National Institute of Food and Agriculture [MICL02387]; USDA-NIFA [2015-68007-23133]; MSU AgBio Research; CONICET (postgraduate fellowship program of National Council of Scientific and Technical Research); Argentine Ministry of Education (BEC.AR program)	USDA-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA-NIFA(United States Department of Agriculture (USDA)); MSU AgBio Research; CONICET (postgraduate fellowship program of National Council of Scientific and Technical Research); Argentine Ministry of Education (BEC.AR program)	Funding to complete this work was provided by the USDA-National Institute of Food and Agriculture, projects MICL02387 (Utsumi), and USDA-NIFA 2015-68007-23133 (Basso), and MSU AgBio Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present work is part of the thesis submitted by Dr. Juan R. Insua to the Postgraduate program of the Universidad Nacional de Mar del Plata (UNMdP) in partial fulfillment of his requirements for a Doctoral degree in Agricultural Science. During the time that this study was completed Juan R. Insua held a scholarship of CONICET (postgraduate fellowship program of National Council of Scientific and Technical Research) and a short-term visiting scholarship from the Argentine Ministry of Education (BEC.AR program).	Albarenque SM, 2016, AGRON J, V108, P2110, DOI 10.2134/agronj2016.02.0081; [Anonymous], 1970, AGR HDB; Basso B., 2006, Italian Journal of Agronomy, V1, P677; Basso B., 2015, ECOLOGY AGR LANDSCAP, P252; Basso B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146360; Berni J.A.J., 2009, INT ARCH PHOTOGRAMM, V38, P6, DOI DOI 10.1007/S11032-006-9022-5; BIRCHAM JS, 1983, GRASS FORAGE SCI, V38, P323, DOI 10.1111/j.1365-2494.1983.tb01656.x; Bircham JS, 1981, THESIS, DOI [10.1111/j.1365-2494.1983.tb01656.x, DOI 10.1111/J.1365-2494.1983.TB01656.X]; Callow MN, 2003, AUST J EXP AGR, V43, P1093, DOI 10.1071/EA02001; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; Chapman DF, 2014, CROP PASTURE SCI, V65, P721, DOI 10.1071/CP13379; Chapman DF, 2012, GRASS FORAGE SCI, V67, P77, DOI 10.1111/j.1365-2494.2011.00824.x; Chapman DF, 2016, AGRICULTURE-BASEL, V6, DOI 10.3390/agriculture6020017; Cullen BR, 2017, ANIM PROD SCI, V57, P1392, DOI 10.1071/AN16481; Dzotsi KA, 2013, ECOL MODEL, V260, P62, DOI 10.1016/j.ecolmodel.2013.03.017; Flynn ES, 2008, AGRON J, V100, P114, DOI 10.2134/agronj2006.0363; FRIEDL MA, 1994, INT J REMOTE SENS, V15, P1401, DOI 10.1080/01431169408954174; Fulkerson WJ, 2005, AUST J EXP AGR, V45, P331, DOI 10.1071/EA03109; Fulkerson WJ, 2001, AUST J EXP AGR, V41, P261, DOI 10.1071/EA00062; Insua JR, 2018, CROP PASTURE SCI, V69, P1165, DOI 10.1071/CP18182; Insua JR, 2017, CROP PASTURE SCI, V68, P51, DOI [10.1071/CP16254, 10.1071/cp16254]; Insua JR, 2019, AGRON J, V111, P1; Insua JR, 2019, AGRON J, V111, P714, DOI 10.2134/agronj2018.07.0439; Laca Emilio A., 2008, V23, P81; Lawrence H, 2007, P SIDE C, V8, P26; Lemaire G, 2009, GRASS FORAGE SCI, V64, P341, DOI 10.1111/j.1365-2494.2009.00707.x; Lemaire G., 1996, ECOLOGY MANAGEMENT G, P3; Liu L, 2016, GCB BIOENERGY, V9, P1320; Lopez-Diaz J., 2011, J AGR SCI TECHNOLO A, V1, P303; Lowe KF, 1999, AUST J EXP AGR, V39, P663, DOI 10.1071/EA98021; Ma BL, 2001, AGRON J, V93, P1227, DOI 10.2134/agronj2001.1227; Machovina BL, 2016, CROP PASTURE SCI, V67, P1281, DOI 10.1071/CP16135; Parsons A. J., 1988, The grass crop. The physiological basis of production, P129; Penuelas J, 1997, CROP SCI, V37, P198, DOI 10.2135/cropsci1997.0011183X003700010033x; Romera AJ, 2010, COMPUT ELECTRON AGR, V74, P66, DOI 10.1016/j.compag.2010.06.006; Romera A, 2013, GRASSL SCI, V59, P20, DOI 10.1111/grs.12009; Rouse Jr J. W., 1973, MONITORING VERNAL AD; Serrano L, 2000, CROP SCI, V40, P723, DOI 10.2135/cropsci2000.403723x; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Wachendorf M, 2018, GRASS FORAGE SCI, V73, P1, DOI 10.1111/gfs.12312; Watt LJ, 2015, J DAIRY SCI, V98, P7248, DOI 10.3168/jds.2015-9463; Zaman-Allah M, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0078-2; Zarco-Tejada PJ, 2013, AGR FOREST METEOROL, V171, P281, DOI 10.1016/j.agrformet.2012.12.013; Zhang JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195223	45	29	30	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212773	10.1371/journal.pone.0212773	http://dx.doi.org/10.1371/journal.pone.0212773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865650	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900037
J	Shekhawat, R; Shah, CK; Patel, A; Srinivasan, S; Kapoor, P; Patel, S; Kumar, S; Sonar, S; More, N; Joshi, M; Patel, J; Vachhani, M; Kodaganti, BP; Choavatiya, U; Pushpaja, A; Argade, S; Nuwal, N; Kumar, M; Khambhampaty, S				Shekhawat, Rakesh; Shah, Chintan Kumar; Patel, Akash; Srinivasan, Sankaranarayanan; Kapoor, Poonam; Patel, Suvaskumar; Kumar, Sharwan; Sonar, Sandeep; More, Namrata; Joshi, Manasvi; Patel, Jatin; Vachhani, Milan; Kodaganti, Bhargav Prasad; Choavatiya, Upasana; Pushpaja, Arabhi; Argade, Shubhangi; Nuwal, Nidhi; Kumar, Manish; Khambhampaty, Sridevi			Structural similarity, characterization of Poly Ethylene Glycol linkage and identification of product related variants in biosimilar pegfilgrastim	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PEGYLATION; CHEMISTRY; SITE; MS; THERAPEUTICS; CSF	The approval of biosimilars requires demonstration of biosimilarity, which rests on the base of thorough analytical characterization of the biosimilar product. In addition to demonstration of biosimilarity, the product related impurities need to be thoroughly characterized and controlled at minimal levels. Pegylation of peptides and proteins creates significant challenges for detailed structural characterization, such as PEG (Poly Ethylene Glycol) heterogeneity, site of addition and number of attached pegylated moieties. A combination of several methods including circular dichroism, FTIR (Fourier-transform Infrared Spectroscopy), fluorescence spectroscopy, DSC (Differential Scanning Calorimetry), 1D and 2D NMR (Nuclear Magnetic Resonance), Edman degradation and peptide mapping by LC-MS (Liquid Chromatography Mass Spectrometry) were used for characterization of N-terminally pegylated filgrastim. Product related impurities such as oxidized, reduced, deamidated, dipegylated variants and monopegylated positional isomers have been characterized in detail using various HPLC (High Performance Liquid Chromatography) based methods and LC-MS techniques. The functional characterization in terms of receptor binding and cell proliferation assay was conducted for the similarity assessment and the potential impact of the product variants on the in vitro biological activity has also been assessed. In summary, this study presents, for the first time, a detailed structural and molecular level characterization of a biosimilar pegfilgrastim providing a strong base for the demonstration of overall biosimilarity of the product with the innovator product.	[Shekhawat, Rakesh; Shah, Chintan Kumar; Patel, Akash; Srinivasan, Sankaranarayanan; Kumar, Sharwan; Sonar, Sandeep; More, Namrata; Joshi, Manasvi; Patel, Jatin; Khambhampaty, Sridevi] Intas Pharmaceut Ltd, Analyt Dev Lab, Biopharma Div, Ahmadabad, Gujarat, India; [Kapoor, Poonam; Patel, Suvaskumar; Vachhani, Milan; Kodaganti, Bhargav Prasad; Choavatiya, Upasana; Pushpaja, Arabhi; Nuwal, Nidhi; Kumar, Manish; Khambhampaty, Sridevi] Intas Pharmaceut Ltd, Biocharacterizat Dev Lab, Biopharma Div, Ahmadabad, Gujarat, India; [Argade, Shubhangi; Khambhampaty, Sridevi] Intas Pharmaceut Ltd, CMC Tech Writing Team, Biopharma Div, Ahmadabad, Gujarat, India		Khambhampaty, S (corresponding author), Intas Pharmaceut Ltd, Analyt Dev Lab, Biopharma Div, Ahmadabad, Gujarat, India.; Khambhampaty, S (corresponding author), Intas Pharmaceut Ltd, Biocharacterizat Dev Lab, Biopharma Div, Ahmadabad, Gujarat, India.; Khambhampaty, S (corresponding author), Intas Pharmaceut Ltd, CMC Tech Writing Team, Biopharma Div, Ahmadabad, Gujarat, India.	Sridevi_K@intaspharma.com		Patel, Suvaskumar/0000-0002-3848-8828				[Anonymous], 2014, EMEACHMPBMWP42832200; [Anonymous], 2009, EUR PHARM 6 3, P2206; Bagal D, 2008, ANAL CHEM, V80, P2408, DOI 10.1021/ac7020163; Besheer A, 2013, ACS SYM SER, V1135, P215; Brokx S, 2017, BIOLOGICALS, V48, P28, DOI 10.1016/j.biologicals.2017.06.001; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; Cindric M, 2007, J PHARMACEUT BIOMED, V44, P388, DOI 10.1016/j.jpba.2007.02.036; Dozier JK, 2015, INT J MOL SCI, V16, P25831, DOI 10.3390/ijms161025831; FDA, 2015, GUID IND QUAL CONS D; Forstenlehner IC, 2014, ANAL CHEM, V86, P826, DOI 10.1021/ac403390y; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; Hodgson DJ, 2017, J PHARMACEUT BIOMED, V138, P351, DOI 10.1016/j.jpba.2017.01.058; Holzmann J, 2013, ANAL BIOANAL CHEM, V405, P6667, DOI 10.1007/s00216-013-7138-0; Kinstler OB, 1996, PHARMACEUT RES, V13, P996, DOI 10.1023/A:1016042220817; Levy MJ, 2014, ANAL BIOANAL CHEM, V406, P6559, DOI 10.1007/s00216-013-7469-x; Lu XJ, 2010, J AM SOC MASS SPECTR, V21, P810, DOI 10.1016/j.jasms.2010.01.011; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Natalello A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042511; Payne RW, 2011, PHARM DEV TECHNOL, V16, P423, DOI 10.3109/10837450.2010.513990; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Shahbazi M, 2017, BIOLOGICALS, V46, P153, DOI 10.1016/j.biologicals.2017.02.003; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Turecek PL, 2016, J PHARM SCI-US, V105, P460, DOI 10.1016/j.xphs.2015.11.015	23	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212622	10.1371/journal.pone.0212622	http://dx.doi.org/10.1371/journal.pone.0212622			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865643	Green Submitted, gold, Green Published			2022-12-26	WOS:000461048900028
J	Urquia, D; Gutierrez, B; Pozo, G; Pozo, MJ; Espin, A; Torres, MD				Urquia, Diego; Gutierrez, Bernardo; Pozo, Gabriela; Pozo, Maria Jose; Espin, Analia; de Lourdes Torres, Maria			Psidium guajava in the Galapagos Islands: Population genetics and history of an invasive species	PLOS ONE			English	Article							MICROSATELLITE LOCI; R PACKAGE; PLANTS; VARIABILITY; EXTINCTION; VEGETATION; DIVERSITY; SOFTWARE; PATTERNS; IMPACTS	The threat of invasive plant species in island populations prompts the need to better understand their population genetics and dynamics. In the Galapagos islands, this is exemplified by the introduced guava (Psidium guajava), considered one of the greatest threats to the local biodiversity due to its effective spread in the archipelago and its ability to outcompete endemic species. To better understand its history and genetics, we analyzed individuals from three inhabited islands in the Galapagos archipelago with 11 SSR markers. Our results reveal similar genetic diversity between islands, and the populations appear to be distinct: the islands of San Cristobal and Isabela are genetically different while the population of Santa Cruz is a mixture from both. Additional evidence for genetic bottlenecks and the inference of introduction events suggests an original introduction of the species in San Cristobal, from where it was later introduced to Isabela, and finally into Santa Cruz. Alternatively, a second introduction in Isabela might have occurred. These results are contrasted with the historical record, providing a first overview of the history of P. guajava in the Galapagos islands and its current population dynamics.	[Urquia, Diego; Gutierrez, Bernardo; Pozo, Gabriela; Pozo, Maria Jose; Espin, Analia; de Lourdes Torres, Maria] USFQ, Colegio Ciencias Biol & Ambientales, Lab Biotecnol Vegetal, Campus Cumbaya, Quito, Ecuador; [Gutierrez, Bernardo] Univ Oxford, Dept Zool, South Parks Rd, Oxford, England; [de Lourdes Torres, Maria] Univ San Francisco Quito, Galapagos Sci Ctr, San Cristobal, Galapagos, Ecuador; [de Lourdes Torres, Maria] Univ North Carolina Chapel Hill, San Cristobal, Galapagos, Ecuador	University of Oxford	Torres, MD (corresponding author), USFQ, Colegio Ciencias Biol & Ambientales, Lab Biotecnol Vegetal, Campus Cumbaya, Quito, Ecuador.; Torres, MD (corresponding author), Univ San Francisco Quito, Galapagos Sci Ctr, San Cristobal, Galapagos, Ecuador.; Torres, MD (corresponding author), Univ North Carolina Chapel Hill, San Cristobal, Galapagos, Ecuador.	ltorres@usfq.edu.ec	de Lourdes Torres, Maria/AAJ-7945-2020; Gutierrez, Bernardo/AAQ-6684-2021	Gutierrez, Bernardo/0000-0002-9220-2739; Urquia, Diego/0000-0003-4687-286X; Pozo, Gabriela/0000-0001-8760-2060	USFQ GAIAS Grants; USFQ Fondos COCIBA	USFQ GAIAS Grants; USFQ Fondos COCIBA	This research was funded by: USFQ GAIAS Grants and USFQ Fondos COCIBA. Genetic data for specimens were obtained under the Genetic Resources Permit Number: MAE-DNB-CM-2016-0041 granted to Universidad San Francisco de Quito by Ministerio del Ambiente Ecuador, in accordance with the Ecuadorian law. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren Y, 2010, ACTA HORTIC, V849, P147; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barton N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000987; Bensted-Smith, 2002, BIODIVERSITY VISION; Binggeli P, 1998, REV INVASIVE WOODY P; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Blake S, 2012, J BIOGEOGR, V39, P1961, DOI 10.1111/j.1365-2699.2011.02672.x; BRAMWELL D, 1979, PLANTS ISLANDS; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charles Darwin Foundation, 2018, RESEARCH; Chiriboga R, 2006, ECU00G31 SIPAEPNUDIN; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Crawford DJ, 2009, SYSTEMATICS EVOLUTIO, P139; Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117; Cronk Q.C.B., 2001, PLANT INVADERS THREA; da Costa SR, 2013, GENET MOL RES, V12, P6802, DOI 10.4238/2013.December.16.6; de la Torre S., 2013, SCI CONSERVATION GAL, P185; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 1998, NATO ADV SCI I A-LIF, V306, P55; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Granda M, 2013, INFORM GALAPAGOS 201, P44; Hagenblad J, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0242-8; Harper J. L, 1977, POPULATION BIOL PLAN; Heleno RH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2112; Henderson S., 2010, SPECIES PROFILE PSID; Herrera XM, 2013, THESIS; Houliston GJ, 2017, NEW ZEAL J ECOL, V41, P107, DOI 10.20417/nzjecol.41.13; Huenneke LF, 1990, BIOL CONSERV, P53; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Latorre O., 1997, NOTICIAS GALAPAGOS, V56-57, P62; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Roux JJ, 2010, BIOL INVASIONS, V12, P2251, DOI 10.1007/s10530-009-9635-9; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Lopez-Caamal A, 2014, PLANT SYST EVOL, V300, P1959, DOI 10.1007/s00606-014-1025-9; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Renteria JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048106; Lundh J. P., 2006, Galapagos Research, V64, P12; Lundh J.P., 2004, GALAPAGOS BRIEF HIST; Lundh JP, 2006, LAST DAYS PARADISE; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; Mauchamp A, 1997, CONSERV BIOL, V11, P260, DOI 10.1046/j.1523-1739.1997.95356.x; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Orwa C, 2009, REPOSITORY AGROFORES; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Restrepo A, 2012, ECOLOGY, V93, P1853, DOI 10.1890/11-1545.1; Richards C, 2012, ECOL LETT, V9, P16; Risterucci AM, 2005, MOL ECOL NOTES, V5, P745, DOI 10.1111/j.1471-8286.2005.01050.x; Rivas-Torres GF, 2018, PROG PHYS GEOG, V42, P83, DOI 10.1177/0309133317752278; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Shaik RS, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow030; Sitther V, 2014, GENET RESOUR CROP EV, V61, P829, DOI 10.1007/s10722-014-0078-5; Sol D., 2014, AMBIENTE, V109, P4; SOMARRIBA E, 1986, AGROFOREST SYST, V4, P233, DOI 10.1007/BF02028357; Strauch D., 1935, SATAN CAME TO EDEN; Stuessy TF, 2014, BOT J LINN SOC, V174, P276, DOI 10.1111/boj.12088; Team RC, 2015, R LANG ENV STAT COMP; Thompson GD, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-0984-0; Toral-Granda MV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184379; Torres MdL, 2018, UNDERSTANDING INVASI; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2007, INCREASE NUMBER INTR, P133; Velasco M., 2002, PERCEPCIONES POBLACI; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walsh SJ, 2008, REMOTE SENS ENVIRON, V112, P1927, DOI 10.1016/j.rse.2007.06.028; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woodward S.L., 2011, ENCY INVASIVE SPECIE	82	19	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0203737	10.1371/journal.pone.0203737	http://dx.doi.org/10.1371/journal.pone.0203737			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865637	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900002
J	Kanvatirth, P; Jeeves, RE; Bacon, J; Besra, GS; Alderwick, LJ				Kanvatirth, Panchali; Jeeves, Rose E.; Bacon, Joanna; Besra, Gurdyal S.; Alderwick, Luke J.			Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria	PLOS ONE			English	Article							TUBERCULOSIS; OLOPATADINE; VALIDATION; EXPRESSION; EFFICACY; TARGETS; GENES	Tuberculosis (TB) is an infectious bacterial disease that kills approximately 1.3 million people every year. Despite global efforts to reduce both the incidence and mortality associated with TB, the emergence of drug resistant strains has slowed any progress made towards combating the spread of this deadly disease. The current TB drug regimen is inadequate, takes months to complete and poses significant challenges when administering to patients suffering from drug resistant TB. New treatments that are faster, simpler and more affordable are urgently required. Arguably, a good strategy to discover new drugs is to start with an old drug. Here, we have screened a library of 1200 FDA approved drugs from the Prestwick Chemical library using a GFP microplate assay. Drugs were screened against GFP expressing strains of Mycobacterium smegmatis and Mycobacterium bovis BCG as surrogates for Mycobacterium tuberculosis, the causative agent of TB in humans. We identified several classes of drugs that displayed antimycobacterial activity against both M. smegmatis and BCG, however each organism also displayed some selectivity towards certain drug classes. Variant analysis of whole genomes sequenced for resistant mutants raised to florfenicol, vanoxerine and pentamidine highlight new pathways that could be exploited in drug repurposing programmes.	[Kanvatirth, Panchali; Besra, Gurdyal S.; Alderwick, Luke J.] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham, W Midlands, England; [Jeeves, Rose E.; Bacon, Joanna] Publ Hlth England, TB Res Grp, Natl Infect Serv, Salisbury, Wilts, England; [Kanvatirth, Panchali] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Birmingham; Public Health England; University of Cambridge	Alderwick, LJ (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham, W Midlands, England.	l.alderwick@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395; Kanvatirth, Panchali/0000-0002-1189-7832; Bacon, Joanna/0000-0002-2217-228X; Alderwick, Luke/0000-0002-1257-6053	Royal Society Wolfson Research Merit Award; Medical Research Council, UK [MR/S000542/1]; Department of Health; PHE Pipeline Fund; MRC [MR/K012118/1, MR/R001154/1, MR/S000542/1] Funding Source: UKRI	Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; PHE Pipeline Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.S.B. acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick, a Royal Society Wolfson Research Merit Award and the Medical Research Council, UK (MR/S000542/1). J.B. acknowledges funding received from Department of Health Grant in Aid and the PHE Pipeline Fund. The views expressed in this publication are those of the authors and not necessarily those of Public Health England or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; G.S.B. acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick and a Royal Society Wolfson Research Merit Award.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Akhter Y, 2017, MICROBIOL RES, V204, P9, DOI 10.1016/j.micres.2017.07.002; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; ANDERSEN PH, 1989, EUR J PHARMACOL, V166, P493, DOI 10.1016/0014-2999(89)90363-4; Arsic B, 2018, INT J ANTIMICROB AG, V51, P283, DOI 10.1016/j.ijantimicag.2017.05.020; BEECH DJ, 1990, BRIT J PHARMACOL, V99, P374, DOI 10.1111/j.1476-5381.1990.tb14711.x; Boostanfar R, 2001, FERTIL STERIL, V75, P1024, DOI 10.1016/S0015-0282(01)01749-6; Catterall WA, 2015, MOL PHARMACOL, V88, P141, DOI 10.1124/mol.114.097659; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Cole ST, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0506; Collins LA, 1998, ANTIMICROB AGENTS CH, V42, P344; Cooper CB, 2013, J MED CHEM, V56, P7755, DOI 10.1021/jm400381v; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; de Mendonqa JD, 2007, J BACTERIOL, V189, P6246, DOI 10.1128/JB.00425-07; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Domenech P, 2014, INFECT IMMUN, V82, P2902, DOI 10.1128/IAI.01791-14; Favrot L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3748; GARBE T, 1991, MOL GEN GENET, V228, P385, DOI 10.1007/BF00260631; Goldman RC, 2013, TUBERCULOSIS, V93, P569, DOI 10.1016/j.tube.2013.09.003; Gurcha SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113568; He SX, 2010, ARCH MICROBIOL, V192, P985, DOI 10.1007/s00203-010-0627-z; Hwang HH, 2011, MOL CELLS, V31, P239, DOI 10.1007/s10059-011-0026-6; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Khovidhunkit W, 1999, ANN INTERN MED, V130, P431, DOI 10.7326/0003-4819-130-5-199903020-00015; Lee MY, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-016-2192-3; Lin K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005675; Lun SC, 2014, MBIO, V5, DOI 10.1128/mBio.01767-14; Mah FS, 2008, CURR MED RES OPIN, V24, P441, DOI 10.1185/030079908X261078 ; Maitra A, 2016, BRIT MED BULL, V118, P145, DOI 10.1093/bmb/ldw019; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; MCCALEB ML, 1984, DIABETES CARE, V7, P42; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; NAVARI RM, 1994, J CLIN ONCOL, V12, P2204, DOI 10.1200/JCO.1994.12.10.2204; Ouellet H, 2010, ARCH BIOCHEM BIOPHYS, V493, P82, DOI 10.1016/j.abb.2009.07.011; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Pipkorn P, 2008, ANN ALLERG ASTHMA IM, V101, P82, DOI 10.1016/S1081-1206(10)60839-3; Pontiroli A E, 1984, Horm Metab Res, V16 Suppl 1, P167; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Ramon-Garcia S, 2016, SCI REP-UK, V6, DOI 10.1038/srep34293; Rehren G, 2007, TUBERCULOSIS, V87, P347, DOI 10.1016/j.tube.2007.02.004; Rodrigues L, 2013, ANTIMICROB AGENTS CH, V57, P751, DOI 10.1128/AAC.01482-12; SALOMONSSON P, 1988, ALLERGY, V43, P214; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Sharma U, 2011, EXPERT OPIN DRUG DIS, V6, P1171, DOI 10.1517/17460441.2011.626763; Singh Jagjit, 2015, Int J Appl Basic Med Res, V5, P157, DOI 10.4103/2229-516X.157177; SYRIOPOULOU VP, 1981, ANTIMICROB AGENTS CH, V19, P294, DOI 10.1128/AAC.19.2.294; Tardioli S, 2012, J PHYS CHEM B, V116, P3808, DOI 10.1021/jp206409d; Thangamani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133877; Torrey HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155127; Viljoen A, 2017, MOL MICROBIOL, V104, P889, DOI 10.1111/mmi.13675; WHO, TB EM DECL; Zhang B, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0254-0; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2019	14	3							e0213713	10.1371/journal.pone.0213713	http://dx.doi.org/10.1371/journal.pone.0213713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6JJ	30861059	Green Published, Green Submitted, gold			2022-12-26	WOS:000461035600054
J	Mallach, A; Weinert, M; Arthur, J; Gveric, D; Tierney, TS; Alavian, KN				Mallach, Anna; Weinert, Maria; Arthur, Joy; Gveric, Djordje; Tierney, Travis S.; Alavian, Kambiz N.			Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus	FASEB JOURNAL			English	Article						metabolic plasticity; mitochondrial dysfunction; neurodegeneration; neuromodulation	GLUTAMATE EXCITOTOXICITY; OXIDATIVE STRESS; STN-DBS; BIOENERGETICS; DYSFUNCTION; MEDICATION	Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is the most commonly used surgical treatment for Parkinson's disease (PD). The disease-modifying aspects of DBS at a cellular level are not fully understood, and the key question of the effect of DBS on the degeneration of the dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc) remains to be answered. A major technical hurdle in determining any neuroprotective effect by DBS is its use in mid- to late-stage patients with PD when a majority of the DA neurons have been lost. In this work, we hypothesized that the long-term clinical benefits of DBS are, at least in part, due to a neuromodulatory effect on the SNpc neurons. These changes would affect cellular energetics and mitochondrial metabolism. We examined the number and volume of mitochondria as well as their vicinity to the DA presynaptic terminals postmortem caudate and putamen of 3 healthy individuals, 4 PD cases, and 3 DBS-treated patients. PD seems to have caused an increase in the mean distance between mitochondria and presynaptic terminals as well as a decrease in mean mitochondrial volume and numbers in DA projections. Although there was no difference in distance between mitochondria and presynaptic terminals of SNpc neurons in PD brains vs. DBS-treated brains, DBS treatment seemed to have inhibited or reversed the reduction in mitochondrial volume and numbers caused by PD. These results suggest enhanced metabolic plasticity leading to neuroprotection in the SNpc as a result of STN-DBS.-Mallach, A., Weinert, M., Arthur, J., Gveric, D., Tierney, T. S., Alavian, K. N. Post mortem examination of Parkinson's disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus.	[Mallach, Anna; Weinert, Maria; Arthur, Joy; Gveric, Djordje; Tierney, Travis S.; Alavian, Kambiz N.] Imperial Coll, Dept Med, Div Brain Sci, London, England; [Tierney, Travis S.] Nicklaus Childrens Hosp, Dept Neurosurg, Miami, FL USA; [Alavian, Kambiz N.] Yale Univ, Dept Internal Med, Sect Endocrinol, New Haven, CT USA	Imperial College London; Yale University	Alavian, KN (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, Hammersmith Hosp, E508,DuCane Rd, London W12 0NN, England.	k.alavian@imperial.ac.uk	Alavian, Kambiz N/D-7720-2012; Alavian, Kambiz/O-2831-2017	Weinert, Maria/0000-0001-6187-1000; Alavian, Kambiz/0000-0002-0653-3057; Mallach, Anna/0000-0001-7181-3429	Imperial College London	Imperial College London(General Electric)	The authors thank the Parkinson's UK Brain Bank at Imperial College London for providing post mortem human tissue samples. The authors are grateful to Steven Rothery (Imperial College London) for advice on image analysis and macro writing. The authors also thank Alan King Liu (Imperial College London) for advice on the immunohistochemistry protocol. This study was funded by the Imperial College London funds provided to K.N.A.	Abosch A, 2013, STEREOT FUNCT NEUROS, V91, P1, DOI 10.1159/000343207; Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046; Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Ashkan K, 2017, NAT REV NEUROL, V13, P548, DOI 10.1038/nrneurol.2017.105; Beal M Flint, 2007, Novartis Found Symp, V287, P183; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Bronte-Stewart H, 2009, EXP NEUROL, V215, P20, DOI 10.1016/j.expneurol.2008.09.008; Charles D, 2014, PARKINSONISM RELAT D, V20, P731, DOI 10.1016/j.parkreldis.2014.03.019; Charles D, 2012, J PARKINSON DIS, V2, P215, DOI 10.3233/JPD-2012-012095; Charles PD, 2008, NAT CLIN PRACT NEURO, V4, P424, DOI 10.1038/ncpneuro0848; Chen YC, 2017, ACTA NEUROL SCAND, V135, P491, DOI 10.1111/ane.12628; Chiken S, 2016, NEUROSCIENTIST, V22, P313, DOI 10.1177/1073858415581986; Chiken S, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00033; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Eijkholt M, 2017, NEUROMODULATION, V20, P411, DOI 10.1111/ner.12608; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Guridi J, 1997, NEUROSURGERY, V41, P1169, DOI 10.1097/00006123-199711000-00029; Guridi J, 2008, NEUROSURGERY, V62, P311, DOI 10.1227/01.neu.0000315998.58022.55; Hacker ML, 2016, J PARKINSON DIS, V6, P125, DOI 10.3233/JPD-150712; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Jonas EA, 2017, BIOPHYS J, V112, p180A, DOI 10.1016/j.bpj.2016.11.996; Jonas EA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00355; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; Maesawa S, 2004, J NEUROSURG, V100, P679, DOI 10.3171/jns.2004.100.4.0679; MARSDEN CD, 1976, LANCET, V1, P292, DOI 10.1016/S0140-6736(76)91416-1; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Millan SH, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/7163801; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Musacchio T, 2017, ANN NEUROL, V81, P825, DOI 10.1002/ana.24947; Nantel J, 2012, PARKINSONISM RELAT D, V18, P285, DOI 10.1016/j.parkreldis.2011.11.005; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Sankar T, 2011, INT REV NEUROBIOL, V98, P151, DOI 10.1016/B978-0-12-381328-2.00006-7; Tagliati M, 2010, INT J NEUROSCI, V120, P717, DOI 10.3109/00207454.2010.518777; Tierney Travis S, 2013, Front Biosci (Elite Ed), V5, P490; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; Wang WZ, 2015, J BIOL CHEM, V290, P168, DOI 10.1074/jbc.M114.617167; Wingeier B, 2006, EXP NEUROL, V197, P244, DOI 10.1016/j.expneurol.2005.09.016	43	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6957	6961		10.1096/fj.201802628R	http://dx.doi.org/10.1096/fj.201802628R			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30862197	Bronze			2022-12-26	WOS:000476114200023
J	Beynel, L; Davis, SW; Crowell, CA; Hilbig, SA; Lim, W; Nguyen, D; Palmer, H; Brito, A; Peterchev, AV; Luber, B; Lisanby, SH; Cabeza, R; Appelbaum, LG				Beynel, L.; Davis, S. W.; Crowell, C. A.; Hilbig, S. A.; Lim, W.; Nguyen, D.; Palmer, H.; Brito, A.; Peterchev, A. V.; Luber, B.; Lisanby, S. H.; Cabeza, R.; Appelbaum, L. G.			Online repetitive transcranial magnetic stimulation during working memory in younger and older adults: A randomized within-subject comparison	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; INTRACORTICAL INHIBITION; COGNITIVE PERFORMANCE; TASK-PERFORMANCE; STATE-DEPENDENCY; TMS; RTMS; MAINTENANCE; MANIPULATION; ENHANCEMENT	Working memory is the ability to perform mental operations on information that is stored in a flexible, limited capacity buffer. The ability to manipulate information in working memory is central to many aspects of human cognition, but also declines with healthy aging. Given the profound importance of such working memory manipulation abilities, there is a concerted effort towards developing approaches to improve them. The current study tested the capacity to enhance working memory manipulation with online repetitive transcranial magnetic stimulation in healthy young and older adults. Online high frequency (5Hz) repetitive transcranial magnetic stimulation was applied over the left dorsolateral prefrontal cortex to test the hypothesis that active repetitive transcranial magnetic stimulation would lead to significant improvements in memory recall accuracy compared to sham stimulation, and that these effects would be most pronounced in working memory manipulation conditions with the highest cognitive demand in both young and older adults. Repetitive transcranial magnetic stimulation was applied while participants were performing a delayed response alphabetization task with three individually-titrated levels of difficulty. The left dorsolateral prefrontal cortex was identified by combining electric field modeling to individualized functional magnetic resonance imaging activation maps and was targeted during the experiment using stereotactic neuronavigation with real-time robotic guidance, allowing optimal coil placement during the stimulation. As no accuracy differences were found between young and older adults, the results from both groups were collapsed. Subsequent analyses revealed that active stimulation significantly increased accuracy relative to sham stimulation, but only for the hardest condition. These results point towards further investigation of repetitive transcranial magnetic stimulation for memory enhancement focusing on high difficulty conditions as those most likely to exhibit benefits.	[Beynel, L.; Crowell, C. A.; Hilbig, S. A.; Lim, W.; Nguyen, D.; Palmer, H.; Brito, A.; Peterchev, A. V.; Appelbaum, L. G.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Davis, S. W.] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Davis, S. W.; Crowell, C. A.; Cabeza, R.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Peterchev, A. V.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Peterchev, A. V.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Peterchev, A. V.] Duke Univ, Sch Med, Dept Neurosurg, Durham, NC USA; [Luber, B.; Lisanby, S. H.] NIMH, Bethesda, MD 20892 USA; [Cabeza, R.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Duke University	Beynel, L (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	lysianne.beynel@duke.edu	Peterchev, Angel V/I-1477-2019; Davis, Simon W/AAA-2660-2021; Lisanby, Sarah Hollingsworth/T-3918-2019; Beynel, Lysianne/ABF-2552-2020; Lisanby, Sarah Hollingsworth/ABE-9003-2020	Peterchev, Angel V/0000-0002-4385-065X; Davis, Simon W/0000-0002-5943-0756; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Beynel, Lysianne/0000-0001-8670-7178; Appelbaum, Lawrence/0000-0002-3184-6725	National Institute of Aging [U01 AG050618]; Intramural Research Program of the National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG050618] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by grant U01 AG050618 from the National Institute of Aging (https://www.nia.nih.gov/) and in part by the Intramural Research Program of the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml). Authors who received the funding: SWD, SHL, BL, LGA and RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2005, BRAIN TOPOGR, V17, P193, DOI 10.1007/s10548-005-6028-y; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Baddeley A, 1998, CR ACAD SCI III-VIE, V321, P167, DOI 10.1016/S0764-4469(97)89817-4; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Barr MS, 2013, BIOL PSYCHIAT, V73, P510, DOI 10.1016/j.biopsych.2012.08.020; Beynel L, 2014, BIOL PSYCHOL, V101, P9, DOI 10.1016/j.biopsycho.2014.05.011; Bungert A, 2016, CEREB CORTEX, V27, P5083, DOI [DOI 10.1093/CERCOR/BHW292, DOI 10.1093/cercor/bhw292]; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Cattaneo Z, 2008, EUR J NEUROSCI, V28, P1924, DOI 10.1111/j.1460-9568.2008.06466.x; Chung SW, 2018, BRAIN STIMUL, V11, P566, DOI 10.1016/j.brs.2018.01.002; Edin F, 2009, P NATL ACAD SCI USA, V106, P13; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; Glahn DC, 2002, NEUROIMAGE, V17, P201, DOI 10.1006/nimg.2002.1161; Goh JO, 2009, RESTOR NEUROL NEUROS, V27, P391, DOI 10.3233/RNN-2009-0493; Hamidi M, 2008, BRAIN RES, V1230, P202, DOI 10.1016/j.brainres.2008.07.008; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kessels RPC, 2000, NEUROSCI LETT, V287, P68, DOI 10.1016/S0304-3940(00)01146-0; Kim SH, 2012, NEUROSCI RES, V74, P256, DOI 10.1016/j.neures.2012.08.008; Kirova AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748212; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Kossev AR, 2002, NEUROSCI LETT, V333, P83, DOI 10.1016/S0304-3940(02)00986-2; Li S, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00170; Luber B, 2008, CEREB CORTEX, V18, P2077, DOI 10.1093/cercor/bhm231; Luber B, 2007, BRAIN RES, V1128, P120, DOI 10.1016/j.brainres.2006.10.011; Luber B, 2014, NEUROIMAGE, V85, P961, DOI 10.1016/j.neuroimage.2013.06.007; Luber B, 2013, SLEEP, V36, P857, DOI 10.5665/sleep.2712; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Martis B, 2003, CLIN NEUROPHYSIOL, V114, P1125, DOI 10.1016/S1388-2457(03)00046-4; Narayana S, 2014, NEUROIMAGE, V85, P971, DOI 10.1016/j.neuroimage.2013.07.024; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Ragert P, 2003, NEUROSCI LETT, V348, P105, DOI 10.1016/S0304-3940(03)00745-6; Sack AT, 2009, J COGNITIVE NEUROSCI, V21, P207, DOI 10.1162/jocn.2009.21126; Sheehan D.V., 2002, MINI INT NEUROPSYCHI; Silvanto J, 2007, EUR J NEUROSCI, V25, P1874, DOI 10.1111/j.1460-9568.2007.05440.x; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Veltman DJ, 2003, NEUROIMAGE, V18, P247, DOI 10.1016/S1053-8119(02)00049-6; Viggiano MP, 2008, NEUROPSYCHOLOGIA, V46, P2725, DOI 10.1016/j.neuropsychologia.2008.05.004; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Yamanaka K, 2010, CEREB CORTEX, V20, P1037, DOI 10.1093/cercor/bhp163; Yu ZY, 2006, BRAIN RES, V1099, P73, DOI 10.1016/j.brainres.2006.04.118	48	26	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213707	10.1371/journal.pone.0213707	http://dx.doi.org/10.1371/journal.pone.0213707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901345	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400017
J	Perrella, SL; Nancarrow, K; Trevenen, M; Murray, K; Geddes, DT; Simmer, KN				Perrella, Sharon Lisa; Nancarrow, Kathryn; Trevenen, Michelle; Murray, Kevin; Geddes, Donna Tracy; Simmer, Karen Norrie			Effect of vacuum-release teat versus standard teat use on feeding milestones and breastfeeding outcomes in very preterm infants: A randomized controlled trial	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; INTENSIVE-CARE-UNIT; MILK	Background Breast milk is important to infant health, yet shorter breastfeeding duration is reported for preterm infants. Both breast and bottle feeds are given in the neonatal unit, with full oral feeding often the last milestone to be achieved prior to discharge home. Unlike standard bottle teats, a vacuum release teat requires the application of negative intra-oral pressure to release milk, and so may facilitate breastfeeding in preterm infants. The objective of this study was to determine the effect of vacuum release teat use on timing of achievement of the first full oral feed and on first completion of 24 h full oral feeds. Feeding method at discharge home, 2 weeks, 6 weeks and 12 weeks corrected gestational age were also examined. Methods A randomized controlled trial was completed with mothers of preterm infants born 24-33 weeks gestation in the neonatal unit of a tertiary women's hospital. Infants were randomized to one of two parallel groups using a vacuum release teat or standard teat for oral feeds when the mother was not available to breastfeed. Test weights were completed for all oral feeds. It was not possible to blind participants, care givers and outcome assessors to group assignment due to the nature of the study. Results The groups did not differ with regard to timing of achievement of first full oral feed or 24 h of full oral feeds. Significantly more infants in the vacuum release teat group were exclusively fed breast milk at discharge from hospital and breastfed at 3 months corrected gestational age. Conclusions Use of a vacuum release teat when the mother is not available to breastfeed may promote preterm breastfeeding skills, resulting in higher rates of exclusivity and longer breastfeeding duration.	[Perrella, Sharon Lisa; Geddes, Donna Tracy] Univ Western Australia, Fac Sci, Sch Mol Sci, Crawley, WA, Australia; [Nancarrow, Kathryn; Simmer, Karen Norrie] King Edward Mem Hosp, Neonatol Clin Care Unit, Subiaco, WA, Australia; [Trevenen, Michelle] Univ Western Australia, Sch Math & Stat, Fac Engn & Math Sci, Crawley, WA, Australia; [Murray, Kevin] Univ Western Australia, Sch Populat & Global Hlth, Fac Hlth & Med Sci, Crawley, WA, Australia; [Simmer, Karen Norrie] Univ Western Australia, Sch Paediat & Child Hlth, Fac Hlth & Med Sci, Ctr Neonatal Res & Educ, Crawley, WA, Australia	University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Perrella, SL (corresponding author), Univ Western Australia, Fac Sci, Sch Mol Sci, Crawley, WA, Australia.	sharon.perrella@uwa.edu	; Geddes, Donna/H-9254-2014; Murray, Kevin/H-5503-2014	Trevenen, Michelle/0000-0002-0614-8319; Perrella, Sharon/0000-0002-7727-7767; Geddes, Donna/0000-0002-0431-7078; Simmer, Karen/0000-0003-4777-9069; Murray, Kevin/0000-0002-8856-6046	Medela AG (Switzerland); Channel 7 Telethon Trust	Medela AG (Switzerland); Channel 7 Telethon Trust	The salaries of SP and DG are paid by the University of Western Australia from an unrestricted research grant from Medela AG (Switzerland, https://www.medela.com/company), and the salary of KN was paid from an unrestricted research grant from Channel 7 Telethon Trust (https://www.telethon7.com). Medela AG and Channel 7 Telethon Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaizu N, 2008, ACTA PAEDIATR, V97, P61, DOI 10.1111/j.1651-2227.2007.00548.x; Australian Bureau of Statistics, 2018, SOC IND AR SEIFA IND; Belfort MB, 2016, J PEDIATR-US, V177, P133, DOI 10.1016/j.jpeds.2016.06.045; Bertoncelli N, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/896257; Bingham PM, 2009, J CHILD NEUROL, V24, P743, DOI 10.1177/0883073808329530; Casavant SG, 2015, ADV NEONAT CARE, V15, P421, DOI 10.1097/ANC.0000000000000234; Collins CT, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005252.pub4; Ericson J, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12618; Franca ECL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-154; Freitas BAC, 2016, REV PAUL PEDIATR, V34, P189, DOI [10.1016/j.rpped.2015.10.00526614258, DOI 10.1016/J.RPPED.2015.10.00526614258, 10.1016/j, DOI 10.1016/J]; Geddes D, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030376; Geddes DT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1574-3; Ikonen R, 2015, ADV NEONAT CARE, V15, P394, DOI 10.1097/ANC.0000000000000232; Jadcherla SR, 2010, J PERINATOL, V30, P201, DOI 10.1038/jp.2009.149; Lipchock SV, 2011, CLIN PERINATOL, V38, P627, DOI 10.1016/j.clp.2011.08.008; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108208; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089077; Mobbs EJ, 2016, ACTA PAEDIATR, V105, P24, DOI 10.1111/apa.13034; Niela-Vilen H, 2015, MATERN CHILD NUTR, V11, P712, DOI 10.1111/mcn.12108; Perrella SL, 2012, BREASTFEED MED, V7, P255, DOI 10.1089/bfm.2011.0118; Pickler RH, 2015, NURS RES PRACT, V2015, DOI 10.1155/2015/716828; Pinchevski-Kadir S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111202; R Core Team, 2020, R LANG ENV STAT COMP; Simmer K, 2016, J PERINATOL, V36, P210, DOI 10.1038/jp.2015.184; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214091	10.1371/journal.pone.0214091	http://dx.doi.org/10.1371/journal.pone.0214091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901356	Green Submitted, gold, Green Published			2022-12-26	WOS:000462000400036
J	Renna, LV; Bose, F; Brigonzi, E; Fossati, B; Meola, G; Cardani, R				Renna, Laura Valentina; Bose, Francesca; Brigonzi, Elisa; Fossati, Barbara; Meola, Giovanni; Cardani, Rosanna			Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies	PLOS ONE			English	Article							AS160 PHOSPHORYLATION; GLUCOSE-METABOLISM; UBIQUITIN LIGASES; CHLORIDE CHANNEL; CTG REPEAT; PROTEIN; PATHWAYS; SIGNALS; RNA; GLUCOSE-TRANSPORTER-4	Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are autosomal dominant multisystemic disorders linked to two different genetic loci and characterized by several features including myotonia, muscle atrophy and insulin resistance. The aberrant alternative splicing of insulin receptor (IR) gene and post-receptor signalling abnormalities have been associated with insulin resistance, however the precise molecular defects that cause metabolic dysfunctions are still unknown. Thus, the aims of this study were to investigate in DM skeletal muscle biopsies if beyond INSR missplicing, altered IR protein expression could play a role in insulin resistance and to verify if the lack of insulin pathway activation could contribute to skeletal muscle wasting. Our analysis showed that DM skeletal muscle exhibits a lower expression of the insulin receptor in type 1 fibers which can contribute to the defective activation of the insulin pathway. Moreover, the aberrant insulin signalling activation leads to a lower activation of mTOR and to an increase in MuRF1 and Atrogin-1/MAFbx expression, possible explaining DM skeletal muscle fiber atrophy. Taken together our data indicate that the defective insulin signalling activation can contribute to skeletal muscle features in DM patients and are probably linked to an aberrant specific-fiber type expression of the insulin receptor.	[Renna, Laura Valentina; Bose, Francesca; Cardani, Rosanna] IRCCS Policlin San Donato, Lab Muscle Histopathol & Mol Biol, Milan, Italy; [Brigonzi, Elisa; Meola, Giovanni] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Fossati, Barbara; Meola, Giovanni] IRCCS Policlin San Donato, Dept Neurol, Milan, Italy	IRCCS Policlinico San Donato; University of Milan; IRCCS Policlinico San Donato	Cardani, R (corresponding author), IRCCS Policlin San Donato, Lab Muscle Histopathol & Mol Biol, Milan, Italy.	rosanna.cardani@grupposandonato.it	Renna, Laura Valentina/ABH-7699-2020; Meola, Giovanni/K-4775-2016; Brigonzi, Elisa/AAC-4566-2022; cardani, rosanna/ABH-6525-2020	Renna, Laura Valentina/0000-0003-1316-7478; Meola, Giovanni/0000-0001-6396-717X; Brigonzi, Elisa/0000-0002-5017-1890; cardani, rosanna/0000-0001-8858-4327; Bose', Francesca/0000-0003-3898-1572	MDF-Myotonic Dystrophy Foundation; Wyck Foundation Postdoctoral Research Award; FMM-Fondazione Malattie Miotoniche; Ricerca Corrente funding from Italian Ministry of Health; Italian Ministry of Health [RF-2010-2314711]	MDF-Myotonic Dystrophy Foundation; Wyck Foundation Postdoctoral Research Award; FMM-Fondazione Malattie Miotoniche; Ricerca Corrente funding from Italian Ministry of Health; Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by MDF-Myotonic Dystrophy Foundation and Wyck Foundation Postdoctoral Research Award to LVR and by FMM-Fondazione Malattie Miotoniche to RC. This study was partially supported by Ricerca Corrente funding from Italian Ministry of Health to IRCCS-Policlinico San Donato. The Italian Registry for Myotonic Dystrophy Type 1 and Type 2 is funded by the Italian Ministry of Health (RF-2010-2314711) to GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PH, 2015, DIABETES, V64, P485, DOI 10.2337/db14-0590; Andre LM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00368; Bargiela A, 2015, DIS MODEL MECH, V8, P679, DOI 10.1242/dmm.018127; Beffy P, 2010, INT J BIOCHEM CELL B, V42, P1973, DOI 10.1016/j.biocel.2010.08.010; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Botta A, 2013, GENES-BASEL, V4, P275, DOI 10.3390/genes4020275; Brockhoff M, 2017, J CLIN INVEST, V127, P549, DOI 10.1172/JCI89616; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Cardani R, 2004, EUR J HISTOCHEM, V48, P437; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Daugaard JR, 2004, PFLUG ARCH EUR J PHY, V447, P452, DOI 10.1007/s00424-003-1195-8; Denis JA, 2013, J CELL SCI, V126, P1763, DOI 10.1242/jcs.116285; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Furling D, 1999, ENDOCRINOLOGY, V140, P4244, DOI 10.1210/en.140.9.4244; Gao ZH, 2013, P NATL ACAD SCI USA, V110, P13570, DOI 10.1073/pnas.1308806110; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; GRIGGS RC, 1990, ANN NEUROL, V27, P505, DOI 10.1002/ana.410270509; HALLIDAY D, 1985, ANN NEUROL, V17, P65, DOI 10.1002/ana.410170115; Harper PS, 2001, MYOTONIC DYSTROPHY; Harridge SDR, 2003, SCAND J MED SCI SPOR, V13, P34, DOI 10.1034/j.1600-0838.2003.20235.x; Howlett KF, 2008, AM J PHYSIOL-ENDOC M, V294, pE401, DOI 10.1152/ajpendo.00542.2007; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Loro E, 2010, CELL DEATH DIFFER, V17, P1315, DOI 10.1038/cdd.2010.33; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 2000, MUSCLE NERVE, V23, P1789, DOI 10.1002/1097-4598(200012)23:12<1789::AID-MUS2>3.0.CO;2-4; Meola G, 2015, BBA-MOL BASIS DIS, V1852, P594, DOI 10.1016/j.bbadis.2014.05.019; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Morrone A, 1997, J CLIN INVEST, V99, P1691, DOI 10.1172/JCI119332; MOXLEY RT, 1981, P NATL ACAD SCI-BIOL, V78, P2567, DOI 10.1073/pnas.78.4.2567; Pandya S, 2001, NEUROMUSCULAR DISORD, V11, P630; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Renna LV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184987; Rusconi F, 2010, NEUROBIOL DIS, V38, P273, DOI 10.1016/j.nbd.2010.01.017; Salisbury E, 2009, AM J PATHOL, V175, P748, DOI 10.2353/ajpath.2009.090047; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Savkur RS, 2004, AM J HUM GENET, V74, P1309, DOI 10.1086/421528; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Surapongchai J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00358; Valaperta R, 2015, GENET TEST MOL BIOMA, V19, P703, DOI 10.1089/gtmb.2015.0135; Valaperta R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/958510; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09	58	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214254	10.1371/journal.pone.0214254	http://dx.doi.org/10.1371/journal.pone.0214254			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901379	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400046
J	Shirin, A; Della Rossa, F; Klickstein, I; Russell, J; Sorrentino, F				Shirin, Afroza; Della Rossa, Fabio; Klickstein, Isaac; Russell, John; Sorrentino, Francesco			Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon	PLOS ONE			English	Article							MODEL-PREDICTIVE CONTROL; CLOSED-LOOP SYSTEM; CONTROL STRATEGY; BIONIC PANCREAS; ARTIFICIAL PANCREAS; GLYCEMIC CONTROL; HYPOGLYCEMIA; FEASIBILITY; ALGORITHM; DELIVERY	The Glucose-Insulin-Glucagon nonlinear model accurately describes how the body responds to exogenously supplied insulin and glucagon in patients affected by Type I diabetes. Based on this model, we design infusion rates of either insulin (monotherapy) or insulin and glucagon (dual therapy) that can optimally maintain the blood glucose level within desired limits after consumption of a meal and prevent the onset of both hypoglycemia and hyperglycemia. This problem is formulated as a nonlinear optimal control problem, which we solve using the numerical optimal control package PSOPT. Interestingly, in the case of monotherapy, we find the optimal solution is close to the standard method of insulin based glucose regulation, which is to assume a variable amount of insulin half an hour before each meal. We also find that the optimal dual therapy (that uses both insulin and glucagon) is better able to regulate glucose as compared to using insulin alone. We also propose an ad-hoc rule for both the dosage and the time of delivery of insulin and glucagon.	[Shirin, Afroza; Della Rossa, Fabio; Klickstein, Isaac; Russell, John; Sorrentino, Francesco] Univ New Mexico, Mech Engn Dept, Albuquerque, NM 87131 USA	University of New Mexico	Shirin, A (corresponding author), Univ New Mexico, Mech Engn Dept, Albuquerque, NM 87131 USA.	ashirin@unm.edu		Della Rossa, Fabio/0000-0002-7073-5358	National Science Foundation [CMMI-1400193, CMMI-1727948, CRISP-1541148]; Office of Naval Research [N00014-16-1-2637]; Defense Threat Reduction Agency [HDTRA1-12-1-0020]	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	A.S, I.K. and F.S. are supported by the National Science Foundation (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505277) grant CRISP-1541148. F.D.R. is supported by the National Science Foundation (https://www.nsf.gov/div/index.jsp?div=CMMI) grants CMMI-1400193 and CMMI-1727948. All four of us are also supported by the Office of Naval Research (https://www.onr.navy.mil/en/Contracts-Grants/Funding-Opportunities/Broad-Agency-Announcements) grant N00014-16-1-2637, and the Defense Threat Reduction Agency (http://www.dtra.mil/Research/Basic-and-Applied-Science/Research-Funding-Opportunities/) grant HDTRA1-12-1-0020.	[Anonymous], 2019, IMPLEMENTATION UVA P; [Anonymous], 2007, NONLINEAR DYNAMIC OP; [Anonymous], 2018, MINIMED 670G SYSTEM; Batora V, 2015, P AMER CONTR CONF, P5097, DOI 10.1109/ACC.2015.7172134; Becerra V. M., 2010, 2010 IEEE International Symposium on Computer-Aided Control System Design (CACSD) part of the IEEE Multi-Conference on Systems & Control (MSC 2010), P1391, DOI 10.1109/CACSD.2010.5612676; Beneyto A, 2018, IEEE T CONTROL SYSTE; Bequette BW, 2012, ANNU REV CONTROL, V36, P255, DOI 10.1016/j.arcontrol.2012.09.007; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; BERGMAN RN, 1985, ENDOCR REV, V6, P45, DOI 10.1210/edrv-6-1-45; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Boiroux D, 2018, J PROCESS CONTR, V68, P105, DOI 10.1016/j.jprocont.2018.05.003; Bruttomesso D, 2009, CLOSED LOOP ARTIFICI; Capel I, 2014, DIABETES TECHNOL THE, V16, P172, DOI 10.1089/dia.2013.0229; Castle JR, 2010, DIABETES CARE, V33, P1282, DOI 10.2337/dc09-2254; Copp DA, 2018, OPTIM CONTR APPL MET, V39, P904, DOI 10.1002/oca.2388; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; COX DJ, 1994, J CLIN ENDOCR METAB, V79, P1659, DOI 10.1210/jc.79.6.1659; El-Khatib Firas H, 2007, J Diabetes Sci Technol, V1, P181; El-Khatib FH, 2017, LANCET, V389, P369, DOI 10.1016/S0140-6736(16)32567-3; El-Khatib FH, 2014, J CLIN ENDOCR METAB, V99, P1701, DOI 10.1210/jc.2013-4151; El-Khatib FH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000619; FISHER ME, 1991, IEEE T BIO-MED ENG, V38, P57, DOI 10.1109/10.68209; Gao X., 2016, SCI REPORTS, V6; Gates AJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24456; Gillis R, 2007, GLUCOSE ESTIMATION P; Goodwin GC, 2018, AUTOMATICA, V95, P14, DOI 10.1016/j.automatica.2018.05.008; Goodwin GC, 2015, AUTOMATICA, V55, P73, DOI 10.1016/j.automatica.2015.02.041; Hajizadeh Iman, 2018, J Diabetes Sci Technol, V12, P953, DOI 10.1177/1932296818789951; Herrero P, 2017, COMPUT METHOD BIOMEC, V20, P1474, DOI 10.1080/10255842.2017.1378352; Hovorka R, 2004, PHYSIOL MEAS, V25, P905, DOI 10.1088/0967-3334/25/4/010; Kirk, 2012, OPTIMAL CONTROL THEO; Klickstein I, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.268301; Klickstein I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15145; Kovatchev Boris P, 2005, Diabetes Technol Ther, V7, P849, DOI 10.1089/dia.2005.7.849; Kovatchev BP, 1997, DIABETES CARE, V20, P1655, DOI 10.2337/diacare.20.11.1655; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lo Iudice F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9349; LORENZI M, 1984, WESTERN J MED, V141, P467; Lynch SM, 2001, PROCEEDINGS OF THE IEEE 27TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P79, DOI 10.1109/NEBC.2001.924729; Magni L, 2009, BIOMED SIGNAL PROCES, V4, P338, DOI 10.1016/j.bspc.2009.04.003; Magni Lalo, 2008, J Diabetes Sci Technol, V2, P630; Man C. Dalla, 2007, GIM SIMULATION SOFTW; Man CD, 2018, COMMUNICATION; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Man Chiara Dalla, 2014, J Diabetes Sci Technol, V8, P26; Marchetti G, 2008, IEEE T BIO-MED ENG, V55, P857, DOI 10.1109/TBME.2008.915665; Mauseth Richard, 2015, J Diabetes Sci Technol, V9, P1253, DOI 10.1177/1932296815602098; McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Nimri R, 2014, DIABETES CARE; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Palerm CC, 2008, J PROCESS CONTR, V18, P258, DOI 10.1016/j.jprocont.2007.07.010; Parker RS, 2001, IEEE ENG MED BIOL, V20, P65, DOI 10.1109/51.897829; Parker RS, 1999, IEEE T BIO-MED ENG, V46, P148, DOI 10.1109/10.740877; Rao A. V., 2009, ADV ASTRONAUTICAL SC, V135, P497, DOI DOI 10.1515/jnum-2014-0003; Reddy M, 2014, DIABETES TECHNOL THE, V16, P550, DOI 10.1089/dia.2014.0009; Ross IM, 2012, ANNU REV CONTROL, V36, P182, DOI 10.1016/j.arcontrol.2012.09.002; Russell SJ, 2012, DIABETES CARE; Russell SJ, 2016, LANCET DIABETES ENDO, V4, P233, DOI 10.1016/S2213-8587(15)00489-1; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Russell-Jones D, 2015, NUTR METAB CARDIOVAS, V25, P898, DOI 10.1016/j.numecd.2015.06.005; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shirin A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38763-9; Shirin A, 2017, CHAOS, V27, DOI 10.1063/1.4979647; Steil GM, 2006, DIABETES, V55, P3344, DOI 10.2337/db06-0419; SUMMERS TH, 2014, IFAC PAPERSONLINE, V47, P3784, DOI DOI 10.3182/20140824-6-ZA-1003.00226; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; Townsend Christopher, 2018, J Diabetes Sci Technol, V12, P926, DOI 10.1177/1932296818789950; Townsend C, 2017, IFAC PAPERSONLINE, V50, P15163, DOI 10.1016/j.ifacol.2017.08.2263; Townsend C, 2018, IEEE CONTR SYST LETT, V2, P79, DOI 10.1109/LCSYS.2017.2734691; van Bon AC, 2014, DIABETES TECHNOL THE, V16, P131, DOI 10.1089/dia.2013.0166; Visentin Roberto, 2018, J Diabetes Sci Technol, V12, P273, DOI 10.1177/1932296818757747; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wang BB, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/04/P04011; Wang LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11323; Yan G, 2015, NAT PHYS, V11, P779, DOI [10.1038/NPHYS3422, 10.1038/nphys3422]; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zanudo JGT, 2017, P NATL ACAD SCI USA, V114, P7234, DOI 10.1073/pnas.1617387114; Zavitsanou S, 2015, IEEE T BIO-MED ENG, V62, P2369, DOI 10.1109/TBME.2015.2427991	83	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213665	10.1371/journal.pone.0213665	http://dx.doi.org/10.1371/journal.pone.0213665			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893335	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900045
J	Ventura-Alfaro, CE; Avila-Burgos, L; Torres-Mejia, G				Ventura-Alfaro, Carmelita E.; Avila-Burgos, Leticia; Torres-Mejia, Gabriela			Adherence of Mexican physicians to clinical guidelines in the management of breast cancer: Effect of the National Catastrophic Health Expenditure Fund	PLOS ONE			English	Article							MULTICENTER COHORT; CHEMOTHERAPY; IMPACT	Aim To assess the adherence of physicians to the Medical-Care Guidelines for Malignant Breast Tumors in Mexico, before and after the allocation of federal subsidies from the Catastrophic Health Expenditure Fund (FPGC by its Spanish initials) to accredited hospitals, a strategy implemented with the view of offering free treatment to women with breast cancer (BC). Material and methods Based on a cross-sectional design, we gathered information on 479 BC patients who had been attended to at in four FPGC-accredited hospitals. Analysis centered on those treated within either three years before or three years after the accreditation of their attending hospitals. The four hospitals analyzed were located in the North, South, West and Center of the country. Information on all medical procedures performed during treatment was drawn from hospital medical records. Information on the socio-demographic characteristics of the patients was obtained by means of face-to-face interviews conducted in their homes. Results Adherence of physicians to the Guidelines grew by 12.8 percent (from 43.4 to 56.2 percent) after FPGC accreditation (p<0.001) and varied according to the clinical stage of the disease, with much lower levels of adherence observed in the advanced stages (p<0.05). Conclusions The FPGC strategy increased the adherence of physicians to the Medical-Care Guidelines for Malignant Breast Tumors in Mexico.	[Ventura-Alfaro, Carmelita E.] Mexican Inst Social Secur, Dept Epidemiol, Guadalajara, Jalisco, Mexico; [Avila-Burgos, Leticia] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Torres-Mejia, Gabriela] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico	Instituto Mexicano del Seguro Social; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Avila-Burgos, L (corresponding author), Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	leticia.avila@insp.mx	Avila-Burgos, Leticia/AAR-1815-2021	Avila-Burgos, Leticia/0000-0002-8292-7103; Ventura Alfaro, Carmelita Elizabeth/0000-0001-7727-8981	General Directorate of Evaluation and Performance at the Ministry of Health in Mexico; National Institute of Public Health in Mexico [774]	General Directorate of Evaluation and Performance at the Ministry of Health in Mexico; National Institute of Public Health in Mexico	This work was supported by the General Directorate of Evaluation and Performance at the Ministry of Health in Mexico. This project was accepted by the National Institute of Public Health in Mexico (IRB number: 774), the author who received the funding was GTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracena-Genao B, 2011, SALUD PUBLICA MEXICO, V53, pS407, DOI 10.1590/S0036-36342011001000004; Balasubramanian SP, 2003, BREAST, V12, P136, DOI 10.1016/S0960-9776(02)00263-1; Bristow RE, 2014, GYNECOL ONCOL, V134, P60, DOI 10.1016/j.ygyno.2014.03.561; Camara de Diputados del H, 2016, C UNION MANUAL ACRED; Cardenas-Sanchez J, 2013, QUINTA REVISION CONS; Chagpar R, 2012, J CLIN ONCOL, V30, P972, DOI 10.1200/JCO.2011.39.6937; Chien LC, 2011, J APPL STAT, V38, P1607, DOI 10.1080/02664763.2010.515677; Comision Nacional de Proteccion Social en Salud, 2014, SEG POP QUE; Comision Nacional de Proteccion Social en Salud, 2017, SIST PROT SOC SAL IN; Consejo de Salubridad General, 2007, PROT AT TRAT TUM MAL; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Diab MI, 2013, INT J CLIN PHARM-NET, V35, P101, DOI 10.1007/s11096-012-9714-3; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Frenk Julio, 2004, FINANCIAMIENTO JUSTO; Hamaker ME, 2012, J GERIATR ONCOL, V3, P329, DOI 10.1016/j.jgo.2012.07.004; Hunger M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-1; Lazcano-Ponce E, 2014, CANC MAMA DIAGNOSTIC; Knaul FM, 2009, SALUD PUBLICA MEXICO, V51, pS335, DOI 10.1590/S0036-36342009000800026; Mohar A, 2009, SALUD PUBLICA MEXICO, V51, pS263; Orozco-Nunez E, 2016, SALUD PUBLICA MEXICO, V58, P543, DOI 10.21149/spm.v58i5.8244; R Development Core Team, 2014, R LANG ENV STAT COMP; Rocha AV, 2011, TEST, V20, P95, DOI 10.1007/s11749-010-0189-z; Salinas-Rodriguez A, 2006, SALUD PUBLICA MEXICO, V48, P395, DOI 10.1590/S0036-36342006000500006; Salloum RG, 2012, LUNG CANCER, V75, P255, DOI 10.1016/j.lungcan.2011.07.005; Sawesi Suhila, 2014, Clin J Oncol Nurs, V18, pE50, DOI 10.1188/14.CJON.E50-E57; Schaapveld M, 2005, BRIT J CANCER, V93, P520, DOI 10.1038/sj.bjc.6602747; Schwentner L, 2012, BREAST, V21, P171, DOI 10.1016/j.breast.2011.09.007; Standeven L, 2013, CLIN COLORECTAL CANC, V12, P103, DOI 10.1016/j.clcc.2012.09.006; StataCorp LP, 2009, STAT SE 10 0 MAC; Torres-Mejia G, 2010, INFORM TECNICO EVALU; Unger K, 2017, INFORME FINAL RESULT; Wockel A, 2010, BREAST, V19, P120, DOI 10.1016/j.breast.2009.12.006; World Health Organization, 2004, ADHERENCIA TRATAMIEN	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0212841	10.1371/journal.pone.0212841	http://dx.doi.org/10.1371/journal.pone.0212841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893312	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900017
J	Coykendall, DK; Cornman, RS; Prouty, NG; Brooke, S; Demopoulos, AWJ; Morrison, CL				Coykendall, D. Katharine; Cornman, Robert Scott; Prouty, Nancy G.; Brooke, Sandra; Demopoulos, Amanda W. J.; Morrison, Cheryl L.			Molecular characterization of Bathymodiolus mussels and gill symbionts associated with chemosynthetic habitats from the US Atlantic margin	PLOS ONE			English	Article							COLD SEEP MUSSEL; GULF-OF-MEXICO; METHANE; MYTILIDAE; BIVALVIA; VENT; CARBON; COMMUNITIES; DIVERSITY; BACTERIA	Mussels of the genus Bathymodiolus are among the most widespread colonizers of hydrothermal vent and cold seep environments, sustained by endosymbiosis with chemosynthetic bacteria. Presumed species of Bathymodiolus are abundant at newly discovered cold seeps on the Mid-Atlantic continental slope, however morphological taxonomy is challenging, and their phylogenetic affinities remain unestablished. Here we used mitochondrial sequence to classify species found at three seep sites (Baltimore Canyon seep (BCS; similar to 400m); Norfolk Canyon seep (NCS; similar to 1520m); and Chincoteague Island seep (CTS; similar to 1000m)). Mitochondrial COI (N = 162) and ND4 (N = 39) data suggest that Bathymodiolus childressi predominates at these sites, although single B. mauritanicus and B. heckerae individuals were detected. As previous work had suggested that methanotrophic and thiotrophic interactions can both occur at a site, and within an individual mussel, we investigated the symbiont communities in gill tissues of a subset of mussels from BCS and NCS. We constructed metabarcode libraries with four different primer sets spanning the 16S gene. A methanotrophic phylotype dominated all gill microbial samples from BCS, but sulfur-oxidizing Campylobacterota were represented by a notable minority of sequences from NCS. The methanotroph phylotype shared a clade with globally distributed Bathymodiolus spp. symbionts from methane seeps and hydrothermal vents. Two distinct Campylobacterota phylotypes were prevalent in NCS samples, one of which shares a clade with Campylobacterota associated with B. childressi from the Gulf of Mexico and the other with Campylobacterota associated with other deep-sea fauna. Variation in chemosynthetic symbiont communities among sites and individuals has important ecological and geochemical implications and suggests shifting reliance on methanotrophy. Continued characterization of symbionts from cold seeps will provide a greater understanding of the ecology of these unique environments as well and their geochemical footprint in elemental cycling and energy flux.	[Coykendall, D. Katharine; Morrison, Cheryl L.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Cornman, Robert Scott] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Prouty, Nancy G.] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA USA; [Brooke, Sandra] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA; [Demopoulos, Amanda W. J.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; State University System of Florida; Florida State University; United States Department of the Interior; United States Geological Survey	Coykendall, DK; Morrison, CL (corresponding author), US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA.	dollykc@gmail.com; cmorison@usgs.gov		Coykendall, D Katharine/0000-0002-1148-2397	USGS Environments Program; NOAA OER grant [OER16001]; BOEM through CSA Ocean Sciences, Inc. [M10PC00100]	USGS Environments Program; NOAA OER grant; BOEM through CSA Ocean Sciences, Inc.	This project resulted from a joint partnership with United States Geological Survey (USGS), National Oceanic Atmospheric Administration Office (NOAA) of Ocean Exploration and Research (OER; http://oceanexplorer.noaa.gov/), and the Bureau of Ocean and Energy Management (BOEM; https://www.boem.gov/) within the National Oceanographic Partnership Program (NOPP; http://www.nopp.org/P).DKC, CLM, NP, and AWJD were funded by the USGS Environments Program (https://www.usgs.gov/science/mission-areas/ecosystems/environments-program?qt-programs_l2_landing_page=0#qt-programs_l2_landing_page).Additional funding was provided to NP and AWJD through NOAA OER grant #OER16001. SB was funded by BOEM through a contract from CSA Ocean Sciences, Inc. (contract M10PC00100). NOAA ships Nancy Foster and Ronald H. Brown, and Kraken II and Jason II ROVs were provided by the NOAA Office of Ocean Exploration and Research. We thank Colleen Charles (USGS), Greg Boland (BOEM), and Steve Viada (CSA) for support throughout this project.	Amon DJ, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00342; Andersen AC, 2004, CAN J ZOOL, V82, P980, DOI 10.1139/Z04-049; [Anonymous], [No title captured]; Arellano SM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3276; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Assie A, 2016, ENV MICROBIOL REP, V8, P805, DOI 10.1111/1758-2229.12442; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Becker EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074459; Bielawski JP, 1996, MOL BIOL EVOL, V13, P889, DOI 10.1093/oxfordjournals.molbev.a025649; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Bourque JR, 2017, DEEP-SEA RES PT II, V137, P42, DOI 10.1016/j.dsr2.2016.04.012; Breusing C, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-016-0862-2; Brothers LL, 2013, GEOLOGY, V41, P807, DOI 10.1130/G34217.1; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; Coykendall DK, 2017, DEEP-SEA RES PT II, V137, P258, DOI 10.1016/j.dsr2.2016.08.014; Dattagupta S, 2004, LIMNOL OCEANOGR, V49, P1144, DOI 10.4319/lo.2004.49.4.1144; DISTEL DL, 1994, J BACTERIOL, V176, P1932, DOI 10.1128/jb.176.7.1932-1938.1994; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2011, GEOBIOLOGY, V9, P481, DOI 10.1111/j.1472-4669.2011.00300.x; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Duperron S, 2007, FEMS MICROBIOL ECOL, V59, P64, DOI 10.1111/j.1574-6941.2006.00194.x; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Duperron S, 2016, DEEP-SEA RES PT I, V115, P112, DOI 10.1016/j.dsr.2016.05.012; Faure B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118460; FISHER CR, 1993, PSZNI MAR ECOL, V14, P277; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujiwara Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011808; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Halary S, 2008, ISME J, V2, P284, DOI 10.1038/ismej.2008.3; Hecker B, 1983, CANYON SLOPE PROCESS; Hilario A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016309; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones WJ, 2006, CAH BIOL MAR, V47, P403; Keck F, 2018, MOL ECOL RESOUR, V18, P1299, DOI 10.1111/1755-0998.12919; KENK VC, 1985, MALACOLOGIA, V26, P253; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Lorion J, 2012, CAH BIOL MAR, V53, P77; Lorion J, 2010, MOL PHYLOGENET EVOL, V57, P71, DOI 10.1016/j.ympev.2010.05.027; Lorion J, 2009, P ROY SOC B-BIOL SCI, V276, P177, DOI 10.1098/rspb.2008.1101; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marcais G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130821; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Miller M.A., 2010, P GAT COMP ENV WORKS; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Miyazaki JI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010363; Moran NA, 2015, P NATL ACAD SCI USA, V112, P2093, DOI 10.1073/pnas.1420037112; Morrison CL, 2019, MOL CHARACTERIZATION, DOI [10.5066/P9UIDM43, DOI 10.5066/P9UIDM43]; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Olu K, 1996, PROG OCEANOGR, V38, P347, DOI 10.1016/S0079-6611(97)00006-2; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; PAULL CK, 1995, GEOLOGY, V23, P89, DOI 10.1130/0091-7613(1995)023<0089:MRPOTC>2.3.CO;2; Pettay DT, 2015, P NATL ACAD SCI USA, V112, P7513, DOI 10.1073/pnas.1502283112; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Prouty NG, 2016, EARTH PLANET SC LETT, V449, P332, DOI 10.1016/j.epsl.2016.05.023; Quast C., 2012, NUCLEIC ACIDS RES, V41, pD590, DOI DOI 10.1093/NAR/GKS1219; Quattrini AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0008; Raggi L, 2013, ENVIRON MICROBIOL, V15, P1969, DOI 10.1111/1462-2920.12051; Rambaut A., 2014, TRACER V1 6; Riou V, 2008, BIOGEOSCIENCES, V5, P1681, DOI 10.5194/bg-5-1681-2008; Rodrigues CF, 2013, NATURWISSENSCHAFTEN, V100, P21, DOI 10.1007/s00114-012-0985-2; Rodrigues CF, 2010, FEMS MICROBIOL ECOL, V73, P486, DOI 10.1111/j.1574-6941.2010.00913.x; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Ross SW, EXPLORATION RES MIDA; Ruppel C, 2017, DOE NETL FIRE ICE NE; Schirmer M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0976-y; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Skarke A, 2014, NAT GEOSCI, V7, P657, DOI [10.1038/ngeo2232, 10.1038/NGEO2232]; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Streams ME, 1997, MAR BIOL, V129, P465, DOI 10.1007/s002270050187; Takai K, 2005, APPL ENVIRON MICROB, V71, P7310, DOI 10.1128/AEM.71.11.7310-7320.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira S, 2013, MOL ECOL, V22, P4663, DOI 10.1111/mec.12419; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; von Cosel R, 1998, CR ACAD SCI III-VIE, V321, P655, DOI 10.1016/S0764-4469(98)80005-X; von Cosel Rudo, 2002, Zoosystema, V24, P259; Waite DW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00772; Waite DW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00682; Won YJ, 2002, CAH BIOL MAR, V43, P387; Young CM, 2012, INTEGR COMP BIOL, V52, P483, DOI 10.1093/icb/ics090; Zbinden M, 2015, MAR BIOL, V162, P435, DOI 10.1007/s00227-014-2591-7; Zbinden M, 2010, FEMS MICROBIOL ECOL, V74, P450, DOI 10.1111/j.1574-6941.2010.00959.x	95	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0211616	10.1371/journal.pone.0211616	http://dx.doi.org/10.1371/journal.pone.0211616			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870419	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300009
J	Matsumoto, E; Koide, N; Hanzawa, H; Kiyama, M; Ohta, M; Kuwabara, J; Takeda, S; Takahashi, M				Matsumoto, Erino; Koide, Naoshi; Hanzawa, Hiroko; Kiyama, Masaharu; Ohta, Mari; Kuwabara, Junichi; Takeda, Shizu; Takahashi, Masayo			Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine	PLOS ONE			English	Article							MACULAR DEGENERATION; TRANSPLANTATION	Regenerative medicine has received a lot of attention as a novel strategy for injuries and diseases that are difficult to cure using current techniques. Cell production, which is vital for regenerative medicine, has undergone remarkable progress via breakthroughs in developmental biology and tissue engineering; currently, cell production requires numerous experimental operators performing manual, small-scale cell cultures. Other major obstacles for cell production and regenerative medicine include the variable quality of products based on the experimental procedure, the skills of operators, the level of labor required for production, and costs. Technological developments are required to overcome this, including automation instead of manual culture. Age-related macular regeneration (AMD) is a refractory ocular disease that causes severe deterioration in central vision due to senescence in the retinal pigment epithelium (RPE). Recently, we performed an autologous transplantation of induced pluripotent stem (iPS) cell-derived RPE cell sheets and started clinical research on allografts from RPE cell suspensions differentiated from iPS cells. The use of regenerative therapies for AMD using iPS cell-derived RPE is expected to become more widespread. In the present study, human iPS cell-derived RPE cells were cultured to form RPE cell sheets using equipment with a closed culture module. The quality of the automated cultured RPE cell sheets was confirmed by comparing their morphological and biological properties with those of manually generated RPE cell sheets. As a result, machine-cultured RPE sheets displayed the same quality as manually cultured RPE sheets, showing that iPS cell-derived RPE cell sheets were successfully cultured by an automated process.	[Matsumoto, Erino; Hanzawa, Hiroko; Kiyama, Masaharu; Ohta, Mari; Takeda, Shizu] Hitachi Ltd, Res & Dev Grp, Ctr Exploratory Res, Kobe, Hyogo, Japan; [Koide, Naoshi; Takahashi, Masayo] RIKEN Ctr Biosyst Dynam Res, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Kuwabara, Junichi] Sanplatec Co Ltd, Planning & Dev Div, Osaka, Japan	Hitachi Limited; RIKEN	Takeda, S (corresponding author), Hitachi Ltd, Res & Dev Grp, Ctr Exploratory Res, Kobe, Hyogo, Japan.	shizu.takeda.me@hitachi.com			research grants "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program" from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Hitachi Research & Development Group	research grants "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program" from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Hitachi Research & Development Group	Development of ACE3, we used in this study, was partly supported by research grants "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program" from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to S.T. and H.H.). A part of this work was supported by internal funds from Hitachi Research & Development Group to RIKEN Center for Biosystems Dynamics Research (to M.T. and N.K.) Hitachi and Sanplatec are commercial companies. They provided financial support in the form of authors' salaries and research materials for the authors (E.M., H.H., M.K., M.O., J.K., and S.T.) during the conduct of the study. However, these companies did not have any additional roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algvere PV, 1999, EUR J OPHTHALMOL, V9, P217, DOI 10.1177/112067219900900310; Binder S, 2004, INVEST OPHTH VIS SCI, V45, P4151, DOI 10.1167/iovs.04-0118; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Carter DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33792; Daniszewski M, 2018, SLAS TECHNOL, V23, P315, DOI 10.1177/2472630317712220; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Fronk AH, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416650838; Hampson B, 2014, GENET ENG BIOTECHNOL, V34, P26; Kamao H, 2014, INVEST OPHTH VIS SCI, V55, P8309, DOI 10.1167/iovs.14-14694; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kami Daisuke, 2013, BMC Biotechnol, V13, P102, DOI 10.1186/1472-6750-13-102; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kobayashi T, 2013, BIOMATERIALS, V34, P9010, DOI 10.1016/j.biomaterials.2013.07.065; Konagaya S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16647; Kropp C, 2017, PROCESS BIOCHEM, V59, P244, DOI 10.1016/j.procbio.2016.09.032; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112; Nakajima R, 2015, J TISSUE ENG REGEN M, V9, P1259, DOI 10.1002/term.1639; Peng SM, 2011, INVEST OPHTH VIS SCI, V52, P1392, DOI 10.1167/iovs.10-5984; PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P102; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Shu K., 2016, HITACHI REV, V64, P693, DOI [10.1152/physrev.00021.2004, DOI 10.1152/PHYSREV.00021.2004]; Soares FAC, 2014, J BIOTECHNOL, V173, P53, DOI 10.1016/j.jbiotec.2013.12.009; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Vaajasaari H, 2011, MOL VIS, V17, P558; van Meurs JC, 2004, BRIT J OPHTHALMOL, V88, P110, DOI 10.1136/bjo.88.1.110	27	21	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212369	10.1371/journal.pone.0212369	http://dx.doi.org/10.1371/journal.pone.0212369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865653	Green Submitted, gold, Green Published			2022-12-26	WOS:000461048900018
J	Bernat-Peguera, A; Simon-Extremera, P; da Silva-Diz, V; de Munain, ML; Diaz-Gil, L; Penin, RM; Gonzalez-Suarez, E; Sidelnikova, DP; Bermejo, O; Vinals, JM; Vinals, F; Munoz, P				Bernat-Peguera, Adria; Simon-Extremera, Pilar; da Silva-Diz, Victoria; Lopez de Munain, Mikel; Diaz-Gil, Laura; Penin, Rosa M.; Gonzalez-Suarez, Eva; Sidelnikova, Diana Perez; Bermejo, Oriol; Vinals, Joan Maria; Vinals, Francesc; Munoz, Purificacion			PDGFR-induced autocrine SDF-1 signaling in cancer cells promotes metastasis in advanced skin carcinoma	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; TUMOR-GROWTH; CHEMOKINE RECEPTOR; FACTOR-I; SDF-1/CXCR4 AXIS; CXCR4; EXPRESSION; PROGRESSION; SURVIVAL	Advanced and undifferentiated skin squamous cell carcinomas (SCCs) exhibit aggressive growth and enhanced metastasis capability, which is associated in mice with an expansion of the cancer stem-like cell (CSC) population and with changes in the regulatory mechanisms that control the proliferation and invasion of these cells. Indeed, autocrine activation of PDGFR alpha induces CSC invasion and promotes distant metastasis in advanced SCCs. However, the mechanisms involved in this process were unclear. Here, we show that CSCs of mouse advanced SCCs (L-CSCs) express CXCR4 and CXCR7, both receptors of SDF-1. PDGFR alpha signaling induces SDF-1 expression and secretion, and the autocrine activation of this pathway in L-CSCs. Autocrine SDF-1/CXCR4 signaling induces L-CSC proliferation and survival, and mediates PDGFR alpha-induced invasion, promoting in vivo lung metastasis. Validation of these findings in patient samples of skin SCCs shows a strong correlation between the expression of SDF1, PDGFRA, and PDGFRB, which is upregulated, along CXCR4 in tumor cells of advanced SCCs. Furthermore, PDGFR regulates SDF-1 expression and inhibition of SDF-1/CXCR4 and PDGFR pathways blocks distant metastasis of human PD/S-SCCs. Our results indicate that functional crosstalk between PDGFR/ SDF-1 signaling regulates tumor cell invasion and metastasis in human and mouse advanced SCCs, and suggest that CXCR4 and/or PDGFR inhibitors could be used to block metastasis of these aggressive tumors.	[Bernat-Peguera, Adria; Simon-Extremera, Pilar; da Silva-Diz, Victoria; Lopez de Munain, Mikel; Diaz-Gil, Laura; Gonzalez-Suarez, Eva; Munoz, Purificacion] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Penin, Rosa M.] Hosp Univ Bellvitge, Pathol Serv, IDIBELL, Barcelona, Spain; [Sidelnikova, Diana Perez; Bermejo, Oriol; Vinals, Joan Maria] Hosp Univ Bellvitge, Plast Surg Unit, IDIBELL, Barcelona, Spain; [Vinals, Francesc] Catalan Inst Oncol ICO, Lab Translat Res, IDIBELL, Barcelona, Spain; [Vinals, Francesc] Univ Barcelona, Dept Ciencies Fisiol, Unitat Bioquim & Biol Mol, IDIBELL, Barcelona, Spain; [da Silva-Diz, Victoria] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Munoz, P (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain.	p.munoz@idibell.cat	Gonzalez-Suarez, Eva/L-6298-2014; Viñals, Francesc/F-5928-2016	Gonzalez-Suarez, Eva/0000-0003-0858-8171; Viñals, Francesc/0000-0002-9918-6751; Simon, Pilar/0000-0002-0702-2443; Bernat Peguera, Adria/0000-0002-3108-0571	IDIBELL Fellowship; Spanish Ministry of Science and Innovation Fellowships; Spanish Ministry of Economy and Competitiveness MINECO [SAF2014-55944R, SAF2017-84976R]; FEDER funds/European Regional Development Fund (ERDF); Catalan Department of Health (Generalitat de Catalunya) [2017SGR595]	IDIBELL Fellowship; Spanish Ministry of Science and Innovation Fellowships; Spanish Ministry of Economy and Competitiveness MINECO(Spanish Government); FEDER funds/European Regional Development Fund (ERDF); Catalan Department of Health (Generalitat de Catalunya)	AB-P received an IDIBELL Fellowship, VdS-D and PS-E are funded by Spanish Ministry of Science and Innovation Fellowships; the research of PM's group is supported by the Spanish Ministry of Economy and Competitiveness MINECO (SAF2014-55944R; SAF2017-84976R, co-funded by FEDER funds/European Regional Development Fund (ERDF)-a way to build Europa) and by the Catalan Department of Health (Generalitat de Catalunya; 2017SGR595). We thank J. Comas (Universitat de Barcelona-SCT) for technical support with flow cytometry; the patients enrolled in this study for their participation; the Hospital Universitario Ramon y Cajal, Hospital Virgen de la Salud, Biobanco del Principado de Asturias and Fundacion Instituto Valenciano de Oncologia, which are members of the Spanish Hospital Platform Biobanks Network; Y. Perez (Tumor Bank, Hospital de Bellvitge) for help with human tumor sample collection; and the IDIBELL animal facility service for mouse care.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Basile J, 2008, J CUTAN PATHOL, V35, P623, DOI 10.1111/j.1600-0560.2007.00879.x; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chen SJ, 2009, BRIT J DERMATOL, V160, P710, DOI 10.1111/j.1365-2133.2008.08996.x; Cherpelis BS, 2002, DERMATOL SURG, V28, P268, DOI 10.1046/j.1524-4725.2002.01169.x; Coussens LM, 1996, AM J PATHOL, V149, P1899; da Silva-Diz V, 2018, SEMIN CANCER BIOL, V53, P48, DOI 10.1016/j.semcancer.2018.08.009; da Silva-Diz V, 2016, CANCER RES, V76, P1245, DOI 10.1158/0008-5472.CAN-15-1631; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Folkins C, 2009, CANCER RES, V69, P7243, DOI 10.1158/0008-5472.CAN-09-0167; Franco R, 2013, EXPERT OPIN BIOL TH, V13, P51, DOI 10.1517/14712598.2012.725720; Gatti M, 2013, TOXICOLOGY, V314, P209, DOI 10.1016/j.tox.2013.10.003; Gellmini S, 2008, J ENDOCRINOL INVEST, V31, P809, DOI 10.1007/BF03349262; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu SCS, 2014, EXP DERMATOL, V23, P902, DOI 10.1111/exd.12557; Hu TH, 2014, CANCER LETT, V354, P417, DOI 10.1016/j.canlet.2014.08.012; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kong LX, 2016, INT J ONCOL, V48, P1085, DOI 10.3892/ijo.2016.3343; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Li XQ, 2014, MOL CELL BIOCHEM, V392, P77, DOI 10.1007/s11010-014-2020-8; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nassar D, 2016, ANNU REV PATHOL-MECH, V11, P47, DOI 10.1146/annurev-pathol-012615-044438; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; PONTEN F, 1994, J INVEST DERMATOL, V102, P304, DOI 10.1111/1523-1747.ep12371787; Quan CJ, 2015, PROTEIN CELL, V6, P890, DOI 10.1007/s13238-015-0198-5; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tang X, 2016, TUMOR BIOL, V37, P13425, DOI 10.1007/s13277-016-5180-1; Uchida D, 2007, MOL CANCER RES, V5, P685, DOI 10.1158/1541-7786.MCR-06-0368; Uchida DE, 2004, LAB INVEST, V84, P1538, DOI 10.1038/labinvest.3700190; Uemae Y, 2014, J NEURO-ONCOL, V117, P43, DOI 10.1007/s11060-014-1364-y; Wang JF, 2004, BBA-MOL CELL RES, V1691, P129, DOI 10.1016/j.bbamcr.2004.01.002; Wang X, 2016, ONCOTARGET, V8, P36149; White RA, 2013, J CLIN INVEST, V123, P4390, DOI 10.1172/JCI65856; Wong CE, 2013, GENE DEV, V27, P670, DOI 10.1101/gad.210427.112; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656; Yuan LP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-18	52	17	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2019	38	25					5021	5037		10.1038/s41388-019-0773-y	http://dx.doi.org/10.1038/s41388-019-0773-y			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IE1KY	30874597	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000472145900010
J	Pergu, R; Dagar, S; Kumar, H; Kumar, R; Bhattacharya, J; Mylavarapu, SVS				Pergu, Rajaiah; Dagar, Sunayana; Kumar, Harsh; Kumar, Rajesh; Bhattacharya, Jayanta; Mylavarapu, Sivaram V. S.			The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-cell interaction; endoplasmic reticulum (ER); chaperone; plasma membrane; protein stability; protein-disulfide isomerase; post-translational modification (PTM); chaperone; endoplasmic reticulum; intercellular communication; MSec; tunneling nanotubes; endoplasmic reticulum protein 29 (ERP29); TNF-induced protein 2 (TNAIP2); interactome	ENDOPLASMIC-RETICULUM PROTEIN; SQUAMOUS-CELL CARCINOMA; MEMBRANE NANOTUBES; IN-VIVO; INTERCELLULAR CONNECTIONS; MITOCHONDRIAL TRANSFER; STROMAL CELLS; BINDING-SITE; CA2+ SIGNALS; TNFAIP2	Tunneling nanotubes (TNTs) are membrane conduits that mediate long-distance intercellular cross-talk in several organisms and play vital roles during development, pathogenic transmission, and cancer metastasis. However, the molecular mechanisms of TNT formation and function remain poorly understood. The protein MSec (also known as TNF-induced protein 2 (TNFAIP2) and B94) is essential for TNT formation in multiple cell types. Here, using affinity protein purification, mass spectrometric identification, and confocal immunofluorescence microscopy assays, we found that MSec interacts with the endoplasmic reticulum (ER) chaperone ERp29. siRNA-mediated ERp29 depletion in mammalian cells significantly reduces TNT formation, whereas its overexpression induces TNT formation, but in a strictly MSec-dependent manner. ERp29 stabilized MSec protein levels, but not its mRNA levels, and the chaperone activity of ERp29 was required for maintaining MSec protein stability. Subcellular ER fractionation and subsequent limited proteolytic treatment suggested that MSec is associated with the outer surface of the ER. The ERp29-MSec interaction appeared to require the presence of other bridging protein(s), perhaps triggered by post-translational modification of ERp29. Our study implicates MSec as a target of ERp29 and reveals an indispensable role for the ER in TNT formation, suggesting new modalities for regulating TNT numbers in cells and tissues.	[Pergu, Rajaiah; Dagar, Sunayana; Kumar, Harsh; Mylavarapu, Sivaram V. S.] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, Faridabad 121001, Haryana, India; [Kumar, Rajesh; Bhattacharya, Jayanta] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, HIV Vaccine Translat Res Lab, Faridabad 121001, Haryana, India; [Pergu, Rajaiah; Kumar, Harsh; Mylavarapu, Sivaram V. S.] Manipal Acad Higher Educ, Manipal 576104, Karnataka, India; [Dagar, Sunayana; Mylavarapu, Sivaram V. S.] Kalinga Inst Ind Technol, Bhubaneswar 751024, Odisha, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Manipal Academy of Higher Education (MAHE); Kalinga Institute of Industrial Technology (KIIT)	Mylavarapu, SVS (corresponding author), NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, Faridabad 121001, Haryana, India.	sivaram@rcb.res.in	Kumar, Harsh/AAE-6792-2019; Dagar, Sunayana/AAX-5387-2020; Pergu, Rajaiah/AAO-1014-2020	Kumar, Harsh/0000-0003-2384-2115; Dagar, Sunayana/0000-0002-5070-9232	Regional Centre for Biotechnology (RCB); DBT National Bioscience Grant [BT/HRD/NBA/34/01/2012]	Regional Centre for Biotechnology (RCB); DBT National Bioscience Grant	This work was supported by institutional funding from the Regional Centre for Biotechnology (RCB) (to S. V. S. M.). The HIV experiments were supported by research funding from DBT National Bioscience Grant Award BT/HRD/NBA/34/01/2012 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abounit Saida, 2015, Curr Protoc Cell Biol, V67, DOI 10.1002/0471143030.cb1210s67; Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333; Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Armijo-Weingart L, 2017, MOL CELL NEUROSCI, V84, P36, DOI 10.1016/j.mcn.2017.03.007; Austefjord Magnus Wiger, 2014, Commun Integr Biol, V7, pe27934, DOI 10.4161/cib.27934; Bambang IF, 2013, ONCOGENE, V32, P1240, DOI 10.1038/onc.2012.149; Barak NN, 2009, J MOL BIOL, V385, P1630, DOI 10.1016/j.jmb.2008.11.052; Barnewitz K, 2004, J BIOL CHEM, V279, P39829, DOI 10.1074/jbc.M406839200; Baryshev M, 2006, BIOCHEM BIOPH RES CO, V340, P617, DOI 10.1016/j.bbrc.2005.12.052; Barzilai S, 2016, J LEUKOCYTE BIOL, V99, P1045, DOI 10.1189/jlb.3VMA0915-427R; Brunkard JO, 2017, CURR OPIN PLANT BIOL, V35, P76, DOI 10.1016/j.pbi.2016.11.007; Caneparo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020230; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Chen CC, 2014, ONCOGENE, V33, P3648, DOI 10.1038/onc.2013.345; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cheng Z, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0142-9; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Connor Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9671; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Einstein MH, 2002, CLIN CANCER RES, V8, P549; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Gonzalez-Mendez L, 2017, ELIFE, V6, DOI 10.7554/eLife.24045; Gousset K, 2013, J CELL SCI, V126, P4424, DOI 10.1242/jcs.129239; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Guescini M, 2012, EXP CELL RES, V318, P603, DOI 10.1016/j.yexcr.2012.01.005; Guo W, 2007, REPRODUCTION, V133, P575, DOI 10.1530/REP-06-0301; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hashimoto M, 2016, J IMMUNOL, V196, P1832, DOI 10.4049/jimmunol.1500845; Hubbard MJ, 2000, EUR J BIOCHEM, V267, P1945, DOI 10.1046/j.1432-1327.2000.01193.x; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372; Jia L, 2016, ONCOGENE, V35, P2040, DOI 10.1038/onc.2015.263; Kimura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33548; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; Kobayashi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003822; Kondratiev S, 2011, AM J SURG PATHOL, V35, P1531, DOI 10.1097/PAS.0b013e31822bd476; Kornberg TB, 2014, DEVELOPMENT, V141, P729, DOI 10.1242/dev.086223; LaCava J, 2015, BIOTECHNIQUES, V58, P103, DOI 10.2144/000114262; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Lock JT, 2016, CELL CALCIUM, V60, P266, DOI 10.1016/j.ceca.2016.06.004; Lou Emil, 2012, Commun Integr Biol, V5, P399, DOI 10.4161/cib.20569; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; MacLeod JC, 2004, J COMP NEUROL, V477, P29, DOI 10.1002/cne.20222; Marlein CR, 2017, BLOOD, V130, P1649, DOI 10.1182/blood-2017-03-772939; Martinez MG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006061; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McKinney MC, 2011, DEV DYNAM, V240, P1391, DOI 10.1002/dvdy.22612; Mkrtchian S, 2006, ANTIOXID REDOX SIGN, V8, P325, DOI 10.1089/ars.2006.8.325; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Niedenberger BA, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161323; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Olinares PDB, 2016, ANAL CHEM, V88, P2799, DOI 10.1021/acs.analchem.5b04477; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Patil S, 2016, J VIROL, V90, P3446, DOI 10.1128/JVI.03090-15; Pawar A, 2016, CELL SIGNAL, V28, P1225, DOI 10.1016/j.cellsig.2016.05.023; Peralta B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001667; Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009; Polak R, 2015, BLOOD, V126, P2404, DOI 10.1182/blood-2015-03-634238; Potriquet J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175967; Pyrgaki C, 2010, DEV BIOL, V344, P941, DOI 10.1016/j.ydbio.2010.06.010; Rainey-Barger EK, 2007, MOL BIOL CELL, V18, P1253, DOI 10.1091/mbc.E06-11-1004; Rainey-Barger EK, 2009, J VIROL, V83, P1483, DOI 10.1128/JVI.02057-08; Roberts KL, 2015, J VIROL, V89, P1537, DOI 10.1128/JVI.03306-14; Rusiniak ME, 2000, CANCER RES, V60, P1824; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Rustom A, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160057; Rytlewski JA, 2015, MICROVASC RES, V99, P26, DOI 10.1016/j.mvr.2015.02.005; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Schiller C, 2013, J CELL SCI, V126, P767, DOI 10.1242/jcs.114033; Seyed-Razavi Y, 2013, IMMUNOL CELL BIOL, V91, P89, DOI 10.1038/icb.2012.52; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Sisakhtnezhad S, 2015, EUR J CELL BIOL, V94, P429, DOI 10.1016/j.ejcb.2015.06.010; Smith IF, 2011, BIOPHYS J, V100, pL37, DOI 10.1016/j.bpj.2011.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Suaud L, 2011, J BIOL CHEM, V286, P21239, DOI 10.1074/jbc.M111.240267; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takahashi A, 2013, J CELL BIOCHEM, V114, P1238, DOI 10.1002/jcb.24433; Teddy JM, 2004, DEVELOPMENT, V131, P6141, DOI 10.1242/dev.01534; Thayanithy V, 2014, TRANSL RES, V164, P359, DOI 10.1016/j.trsl.2014.05.011; Thayanithy V, 2014, EXP CELL RES, V323, P178, DOI 10.1016/j.yexcr.2014.01.014; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; VIDUGIRIENE J, 1994, J CELL BIOL, V127, P333, DOI 10.1083/jcb.127.2.333; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xie YB, 2017, ONCOL REP, V37, P2920, DOI 10.3892/or.2017.5557; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064973; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109318; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	105	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7177	7193		10.1074/jbc.RA118.005659	http://dx.doi.org/10.1074/jbc.RA118.005659			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877198	Green Published, hybrid			2022-12-26	WOS:000468402900008
J	Akaike, T; Shinjo, S; Ohmori, E; Kajimura, I; Goda, N; Minamisawa, S				Akaike, Toru; Shinjo, Satoko; Ohmori, Eriko; Kajimura, Ichige; Goda, Nobuhito; Minamisawa, Susumu			Transcriptional profiles in the chicken ductus arteriosus during hatching	PLOS ONE			English	Article							CAUSE CHAR-SYNDROME; GENE-EXPRESSION; TFAP2B MUTATION; OXYGEN; ONTOGENY; CLOSURE; ARTERY; CELLS; BIRTH	The ductus arteriosus, an essential embryonic blood vessel between the pulmonary artery and the descending aorta, constricts after birth or hatching and eventually closes to terminate embryonic circulation. Chicken embryos have two long ductus arteriosi, which anatomically differ from mammal ductus arteriosus. Each long ductus arteriosus is divided into two parts: the pulmonary artery-sided and descending aorta-sided ductus arteriosi. Although the pulmonary artery-sided and descending aorta-sided ductus arteriosi have distinct functional characteristics, such as oxygen responsiveness, the difference in their transcriptional profiles has not been investigated. We performed a DNA microarray analysis (GSE 120116 at NCBI GEO) with pooled tissues from the chicken pulmonary artery-sided ductus arteriosus, descending aorta-sided ductus arteriosus, and aorta at the internal pipping stage. Although several known ductus arteriosus-dominant genes such as tfap2b were highly expressed in the pulmonary artery-sided ductus arteriosus, we newly found genes that were dominantly expressed in the chicken pulmonary artery-sided ductus arteriosus. Interestingly, cluster analysis showed that the expression pattern of the pulmonary artery-sided ductus arteriosus was closer to that of the descending aorta-sided ductus arteriosus than that of the aorta, whereas the morphology of the descending aorta-sided ductus arteriosus was closer to that of the aorta than that of the pulmonary artery-sided ductus arteriosus. Subsequent pathway analysis with DAVID bioinformatics resources revealed that the pulmonary artery-sided ductus arteriosus showed enhanced expression of the genes involved in melanogenesis and tyrosine metabolism compared with the descending aorta-sided ductus arteriosus, suggesting that tyrosinase and the related genes play an important role in the proper differentiation of neural crest-derived cells during vascular remodeling in the ductus arteriosus. In conclusion, the transcription profiles of the chicken ductus arteriosus provide new insights for investigating the mechanism of ductus arteriosus closure.	[Akaike, Toru; Shinjo, Satoko; Kajimura, Ichige; Minamisawa, Susumu] Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan; [Shinjo, Satoko; Ohmori, Eriko; Goda, Nobuhito; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan	Jikei University; Waseda University	Minamisawa, S (corresponding author), Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan.; Minamisawa, S (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan.	sminamis@jikei.ac.jp	Goda, Nobuhito/W-2468-2019; Shinjo, Satoko/O-1841-2018	Shinjo, Satoko/0000-0002-1063-5961; Minamisawa, Susumu/0000-0003-4728-2116	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K15537, 17H01529, 26293249]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Vehicle Racing Commemorative Foundation [716]; Jikei University Graduate Research Fund; Miyata Cardiology Research Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; Miyata Cardiology Research Promotion Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [16K15537 T.A., 17H01529 S.M., 26293249 S.M.], the MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S.M.], the Vehicle Racing Commemorative Foundation [716 S.M.], The Jikei University Graduate Research Fund [S.M.], and the Miyata Cardiology Research Promotion Foundation [S.M.].	Agren P, 2007, AM J PHYSIOL-REG I, V292, pR485, DOI 10.1152/ajpregu.00204.2006; Agren P, 2009, J COMP PHYSIOL B, V179, P133, DOI 10.1007/s00360-008-0296-2; Belanger C, 2008, ANAT REC, V291, P1007, DOI 10.1002/ar.20720; Bergwerff M, 1999, ANAT EMBRYOL, V200, P559, DOI 10.1007/s004290050304; Bergwerff M, 1996, ANAT EMBRYOL, V194, P545; Bokenkamp R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086892; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; DeScipio C, 2005, AM J MED GENET A, V134A, P3, DOI 10.1002/ajmg.a.30573; Goyal R, 2016, PEDIATR RES, V80, P610, DOI 10.1038/pr.2016.123; Greyner H, 2008, AM J PHYSIOL-REG I, V295, pR1647, DOI 10.1152/ajpregu.00001.2008; HARMS D, 1967, Z ZELLFORSCH MIK ANA, V81, P433, DOI 10.1007/BF00342766; Hoggatt AM, 2013, J BIOL CHEM, V288, P28477, DOI 10.1074/jbc.M113.478974; Hsieh YT, 2014, CIRC J, V78, P1224, DOI 10.1253/circj.CJ-13-1029; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes AFW, 1943, J ANAT, V77, P266; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jin MH, 2011, J PHYSIOL SCI, V61, P167, DOI 10.1007/s12576-011-0133-3; Khetyar M, 2008, GENET TEST, V12, P457, DOI 10.1089/gte.2008.0015; Liu NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073685; Mueller PP, 2009, CARDIOL YOUNG, V19, P352, DOI 10.1017/S1047951109004260; Parikh P, 2016, EXP BIOL MED, V241, P2112, DOI 10.1177/1535370216661778; Puig I, 2009, PIGM CELL MELANOMA R, V22, P331, DOI 10.1111/j.1755-148X.2009.00546.x; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Shelton EL, 2014, PHYSIOL GENOMICS, V46, P457, DOI 10.1152/physiolgenomics.00171.2013; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; Waleh N, 2011, PEDIATR RES, V70, P332, DOI 10.1203/PDR.0b013e3182294471; Wang J, 2018, J SURG RES, V227, P178, DOI 10.1016/j.jss.2018.02.038; WHITE PT, 1974, J EXP BIOL, V61, P571; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yajima I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053183; Yarboro MT, 2018, SEMIN PERINATOL, V42, P212, DOI 10.1053/j.semperi.2018.05.003; Yokoyama U, 2007, PHYSIOL GENOMICS, V31, P139, DOI 10.1152/physiolgenomics.00007.2006; Zhao F, 2001, AM J HUM GENET, V69, P695, DOI 10.1086/323410; Zhao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022908	35	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214139	10.1371/journal.pone.0214139	http://dx.doi.org/10.1371/journal.pone.0214139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897181	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700070
J	Jensen, AM; Tregellas, JR; Sutton, B; Xing, FY; Ghosh, D				Jensen, Alexandria M.; Tregellas, Jason R.; Sutton, Brianne; Xing, Fuyong; Ghosh, Debashis			Kernel machine tests of association between brain networks and phenotypes	PLOS ONE			English	Article								Applications of quantitative network analysis to functional brain connectivity have become popular in the last decade due to their ability to describe the general topological principles of brain networks. However, many issues arise when standard statistical analysis techniques are applied to functional magnetic resonance imaging (fMRI) connectivity maps. Frequently, summary measures of these maps, such as global efficiency and clustering coefficients, collapse the changing structures of graph topology from many scales to one. This can result in a loss of whole-brain spatio-temporal pattern information that may be significant in association and prediction analyses. Drawing from the electrical engineering field, the resistance perturbation distance is a quantification of similarity between graphs on the same vertex set that has been shown to identify changes in dynamic graphs, such as those from fMRI, while not being computationally expensive or result in a loss of information. This work proposes a novel kernel-based regression scheme that incorporates the resistance perturbation distance to better understand the association with biological phenotypes from fMRI using both simulated and real datasets.	[Jensen, Alexandria M.; Xing, Fuyong; Ghosh, Debashis] Univ Colorado, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO 80309 USA; [Tregellas, Jason R.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Tregellas, Jason R.] Denver VA Med Ctr, Res Serv, Aurora, CO USA; [Sutton, Brianne] Denver Hlth, Dept Behav Hlth, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Denver Health Medical Center	Ghosh, D (corresponding author), Univ Colorado, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO 80309 USA.	debashis.ghosh@ucdenver.edu	Tregellas, Jason/J-3637-2015	Sutton, Brianne/0000-0001-9134-0884; Ghosh, Debashis/0000-0001-6618-1316	NIH HHS [S10 OD018435] Funding Source: Medline; NIMH NIH HHS [R01 MH102224] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Argyelan M, RESTING STATE FMRI C, V40, P100, DOI [10.1093/schbul/sbt092, DOI 10.1093/SCHBUL/SBT092]; Belliveau JW, FUNCTIONAL MAPPING H, V254, P716, DOI [10.1126/science.1948051, DOI 10.1126/SCIENCE.1948051]; Brown GG, FUNCTIONAL MAGNETIC, V17, P107, DOI [10.1007/s11065-007-9028-8, DOI 10.1007/S11065-007-9028-8]; Bullmore E, COMPLEX BRAIN NETWOR, V10, P186, DOI [10.1038/nrn2575, DOI 10.1038/NRN2575]; Calhoun VD, ABERRANT INTRINSIC N, V2, DOI [10.3389/fpsyt.2011.00075, DOI 10.3389/FPSYT.2011.00075]; Cortes C, RATIONAL KERNELS THE, V5, P1035; Davies RB, HYPOTHESIS TESTING N, V74, P33, DOI [10.2307/2336019, DOI 10.2307/2336019]; Gargouri F, INFLUENCE PREPROCESS, V12, DOI [10.3389/fncom.2018.00008, DOI 10.3389/FNC0M.2018.00008]; George Kimeldorf, SOME RESULTS TCHEBYC, V33, P82; Gur RE, FUNCTIONAL MAGNETIC, V12, P333; Hanlon FM, 2011, NEUROIMAGE, V58, P1158, DOI 10.1016/j.neuroimage.2011.06.091; Koutra D, DELTACON PRINCIPLED; Kwong KK, DYNAMIC MAGNETIC RES, V89, P5675; Lindquist MA, STAT ANAL FMRI DATA, V23, P439, DOI [10.1214/09-STS282, DOI 10.1214/09-STS282]; Liu D, ESTIMATION TESTING E, V9, P292, DOI [10.1186/1471-2105-9-292, DOI 10.1186/1471-2105-9-292]; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Monnig ND, RESISTANCE PERTURBAT; Ogawa S, BRAIN MAGNETIC RESON, V87, P9868; Parente F, NEGATIVE FUNCTIONAL, DOI [10.1007/s11682-017-9715-x, DOI 10.1007/S11682-017-9715-X]; Pio Monti Ricardo, ESTIMATING SIMULATIN; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vergara VM, EFFECT PREPROCESSING, V7, DOI [10.1002/brb3.809, DOI 10.1002/BRB3.809]; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Zhan Liang, SIGNIFICANCE NEGATIV, V525, P3251, DOI [10.1002/cne.24274, DOI 10.1002/CNE.24274]; Zhan X, KERNEL APPROACHES DI, V16, P77, DOI [10.1186/s12859-015-0506-3, DOI 10.1186/S12859-015-0506-3]	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0199340	10.1371/journal.pone.0199340	http://dx.doi.org/10.1371/journal.pone.0199340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897094	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700002
J	Pettigrew, EJ; Hickson, RE; Morris, ST; Lopez-Villalobos, N; Pain, SJ; Kenyon, PR; Blair, HT				Pettigrew, E. J.; Hickson, R. E.; Morris, S. T.; Lopez-Villalobos, N.; Pain, S. J.; Kenyon, P. R.; Blair, H. T.			The effects of birth rank (single or twin) and dam age on the lifetime productive performance of female dual purpose sheep (Ovis aries) offspring in New Zealand	PLOS ONE			English	Article							EWE LAMBS; REPRODUCTIVE-PERFORMANCE; BRIEF COMMUNICATION; BODY CONDITION; SIZE; PREGNANCY; SURVIVAL; PUBERTY; WEIGHT; MATURE	Greater rates of genetic gain can be achieved by selecting animals born to younger parents. However, little is known about the lifetime performance of dual purpose ewes (Ovis aries) that are born to primiparous ewe lambs (8 to 9 months old at breeding). This experiment investigated the effect of being born from either a ewe lamb or mixed age dam as either a single or twin on the lifetime performance of ewe progeny. Lifetime performance was measured in terms of the life time live weights of the ewes, the weight and number of lambs born and weaned, the efficiency of production (kilograms of lamb weaned / predicted pasture intake (kgDM) of the ewes), and ewe survival. The study followed the lifetime production of 17 single and 41 twin female lambs born to mature ewes (M1 and M2, respectively), and 28 single and 29 twin lambs born to ewe lambs (L1 and L2, respectively). Over their lifetime L2 ewes were lighter (P<0.05) but had similar body condition scores to the other three ewe groups. There was no difference in average progeny weaning weight or total progeny litter weaning weights between groups. The M1 ewes had the greatest longevity (P<0.05) of the four groups. Even though L2 ewes were lighter than the other three groups, this was insufficient to increase their lifetime efficiency of production (kg lamb weaned/predicted pasture consumption), relative to the other groups. These results suggest farmers could select replacements born to ewe lambs without sacrificing animal production.	[Pettigrew, E. J.; Hickson, R. E.; Morris, S. T.; Lopez-Villalobos, N.; Pain, S. J.; Kenyon, P. R.; Blair, H. T.] Massey Univ, Sch Agr & Environm, Palmerston North, New Zealand	Massey University	Pettigrew, EJ (corresponding author), Massey Univ, Sch Agr & Environm, Palmerston North, New Zealand.	E.Pettigrew@massey.ac.nz	Hickson, Rebecca/AAS-5249-2021; Blair, Hugh/C-5569-2014; Morris, Steve/AAA-8539-2019	Hickson, Rebecca/0000-0002-9609-9599; Blair, Hugh/0000-0003-4415-4282; 	Gravida - The National Research Centre for Growth and Development; National Research Centre for Growth and Development	Gravida - The National Research Centre for Growth and Development; National Research Centre for Growth and Development	The funder was Gravida - The National Research Centre for Growth and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the National Research Centre for Growth and Development for funding this research. The authors thank the technical staff at the Institute of Veterinary, Animal and Biomedical Science, Massey University, Palmerston North, for their help with animal measurements throughout the experiment.	Amer P. R., 2000, Proceedings of the New Zealand Society of Animal Production, V60, P189; Annett RW, 2006, ANIM SCI, V82, P947, DOI 10.1017/ASC2006111; [Anonymous], 1981, LIVESTOCK PRODUCTION, V8, P55; [Anonymous], 2017, BEEF LAMB NZ B; BAKER RL, 1978, ACTA AGR SCAND, V28, P203, DOI 10.1080/00015127809435172; BRASH LD, 1994, AUST J AGR RES, V45, P427, DOI 10.1071/AR9940427; Cave LM, 2012, ANIM PROD SCI, V52, P471, DOI 10.1071/AN11210; Corner R. A., 2013, Proceedings of the New Zealand Society of Animal Production, V73, P76; Corner-Thomas RA, 2015, NEW ZEAL J AGR RES, V58, P26, DOI 10.1080/00288233.2014.974766; DUCKER MJ, 1977, ANIM PROD, V24, P377, DOI 10.1017/S0003356100011880; Everett-Hincks J M, 2008, J Anim Sci, V86, pE259; Freer M., 2007, NUTR REQUIREMENTS DO, P1; Gardner DS, 2007, REPRODUCTION, V133, P297, DOI 10.1530/REP-06-0042; Gootwine E, 2007, ANIMAL, V1, P547, DOI 10.1017/S1751731107691897; HOHENBOKEN WD, 1981, J ANIM SCI, V53, P966, DOI 10.2527/jas1981.534966x; Jefferies BC., 1961, TASMANIAN J AGR, V32, P19; Kenyon P. R., 2004, Proceedings of the New Zealand Society of Animal Production, V64, P217; Kenyon P. R., 2014, Proceedings of the New Zealand Society of Animal Production, V74, P76; Kenyon PR, 2014, SMALL RUMINANT RES, V118, P2, DOI 10.1016/j.smallrumres.2013.12.022; Kenyon PR, 2012, NEW ZEAL J AGR RES, V55, P283, DOI 10.1080/00288233.2012.693105; Kenyon PR, 2010, ANIM PROD SCI, V50, P454, DOI 10.1071/AN09178; Kenyon PR, 2009, NEW ZEAL VET J, V57, P290, DOI 10.1080/00480169.2009.58623; Kenyon PR, 2009, NEW ZEAL J AGR RES, V52, P203, DOI 10.1080/00288230909510505; Loureiro M. F. P., 2016, Proceedings of the New Zealand Society of Animal Production, V76, P151; Loureiro M. F. P., 2011, Proceedings of the New Zealand Society of Animal Production, V71, P83; Loureiro MFP, 2012, ANIM PROD SCI, V52, P552, DOI 10.1071/AN11211; Loureiro MFP, 2014, EFFECTS EWE AGE OFFS; McMillan W. H., 1983, Proceedings of the New Zealand Society of Animal Production, V43, P33; Morel P. C. H., 2010, Proceedings of the New Zealand Society of Animal Production, V70, P88; Mulvaney FJ, 2011, INVESTIGATING METHOD; Nicol A. M., 2007, Occasional Publication - New Zealand Society of Animal Production, P151; NORMAN LM, 1979, J ANIM SCI, V48, P1329, DOI 10.2527/jas1979.4861329x; Pain S. J., 2015, Proceedings of the New Zealand Society of Animal Production, V75, P239; PEART JN, 1975, J AGR SCI, V85, P315, DOI 10.1017/S0021859600062134; RENDEL JM, 1950, J GENET, V50, P1, DOI 10.1007/BF02986789; Schreurs NM, 2010, ANIM PROD SCI, V50, P460, DOI 10.1071/AN09184; Young E. A., 2010, Proceedings of the New Zealand Society of Animal Production, V70, P96	37	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214021	10.1371/journal.pone.0214021	http://dx.doi.org/10.1371/journal.pone.0214021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897175	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700058
J	Jin, W; Jung, J; Kang, U				Jin, Woojeong; Jung, Jinhong; Kang, U.			Supervised and extended restart in random walks for ranking and link prediction in networks	PLOS ONE			English	Article							CLASSIFICATION	Given a real-world graph, how can we measure relevance scores for ranking and link prediction? Random walk with restart (RWR) provides an excellent measure for this and has been applied to various applications such as friend recommendation, community detection, anomaly detection, etc. However, RWR suffers from two problems: 1) using the same restart probability for all the nodes limits the expressiveness of random walk, and 2) the restart probability needs to be manually chosen for each application without theoretical justification. We have two main contributions in this paper. First, we propose RANDOM WALK WITH EXTENDED RESTART (RWER), a random walk based measure which improves the expressiveness of random walks by using a distinct restart probability for each node. The improved expressiveness leads to superior accuracy for ranking and link prediction. Second, we propose SURE (Supervised Restart for RWER), an algorithm for learning the restart probabilities of RWER from a given graph. SURE eliminates the need to heuristically and manually select the restart parameter for RWER. Extensive experiments show that our proposed method provides the best performance for ranking and link prediction tasks.	[Jin, Woojeong] Univ Southern Calif, Los Angeles, CA USA; [Jung, Jinhong; Kang, U.] Seoul Natl Univ, Seoul, South Korea	University of Southern California; Seoul National University (SNU)	Kang, U (corresponding author), Seoul Natl Univ, Seoul, South Korea.	ukang@snu.ac.kr			Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT) [2013-0-00179]	Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT)	This work was supported by Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) [2013-0-00179 to UK, Development of Core Technology for Context-aware Deep-Symbolic Hybrid Learning and Construction of Language Resources]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Agarwal A., 2006, KDD; Agarwal A., 2007, ICML; Andersen R., 2006, FOCS; Backstrom L., 2011, WSDM; de Sousa Celso Andre R., 2013, Machine Learning and Knowledge Discovery in Databases. European Conference, ECML PKDD 2013. Proceedings: LNCS 8190, P160, DOI 10.1007/978-3-642-40994-3_11; Fujimoto T, 2004, ELECTRON J LINEAR AL, V11, P6; Gleich D. F., 2012, P 18 ACM SIGKDD INT, P597, DOI DOI 10.1145/2339530.2339628; Grover A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P855, DOI 10.1145/2939672.2939754; Haveliwala T., 2002, WWW 2002; He J., 2004, MM; Hwang T., 2010, P SIAM INT C DAT MIN, P583; Jeh G., 2002, P 8 ACM SIGKDD INT C, P538; Ji M., 2011, P 17 ACM SIGKDD INT, P1298; Jung J, 2016, ICDM; Jung J, 2016, ACM T DATABASE SYST, V41, DOI 10.1145/2901736; Kang U., 2012, P 12 SIAM INT C DATA, P828; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Langville A. N., 2011, GOOGLES PAGERANK; Lao N., 2011, P 2011 C EMP METH NA, DOI DOI 10.5555/2145432.2145494; Li Liangyue, 2016, KDD; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Mozer MC, 2003, OPTIMIZING CLASSIFIE; Page Lawrence, 1999, 199966 STANF INFOLAB; Pan J-Y, 2004, P 10 ACM SIGKDD INT, P653, DOI 10.1145/1014052.1014135; Petersen K.B., 2012, MATRIX COOKBOOK; Press WH, 2007, NUMERICAL RECIPES; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Salton G., 1986, INTRO MODERN INFORM; Sen P, 2008, AI MAG, V29, P93, DOI 10.1609/aimag.v29i3.2157; SHERMAN J, 1950, ANN MATH STAT, V21, P124, DOI 10.1214/aoms/1177729893; Shin Kijung, 2015, SIGMOD; Sun J., 2005, ICDM; Tong H, 2006, FAST RANDOM WALK RES; Tong H., 2007, KDD; Tong H., 2006, KDD; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang C, 2006, MM; Wang WY, 2015, MACH LEARN, V100, P101, DOI 10.1007/s10994-015-5488-x; Wei Z., 2016, PROC C EMPIR METHODS, P1379; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhu Z. A., 2013, ICML	43	11	13	14	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213857	10.1371/journal.pone.0213857	http://dx.doi.org/10.1371/journal.pone.0213857			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893375	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900055
J	Holmstrom, O; Linder, N; Moilanen, H; Suutala, A; Nordling, S; Stahls, A; Lundin, M; Diwan, V; Lundin, J				Holmstrom, Oscar; Linder, Nina; Moilanen, Hannu; Suutala, Antti; Nordling, Stig; Stahls, Anders; Lundin, Mikael; Diwan, Vinod; Lundin, Johan			Detection of breast cancer lymph node metastases in frozen sections with a point-of care low-cost microscope scanner	PLOS ONE			English	Article							BIOPSY; TRIAL	Background Detection of lymph node metastases is essential in breast cancer diagnostics and staging, affecting treatment and prognosis. lntraoperative microscopy analysis of sentinel lymph node frozen sections is standard for detection of axillary metastases but requires access to a pathologist for sample analysis. Remote analysis of digitized samples is an alternative solution but is limited by the requirement for high-end slide scanning equipment. Objective To determine whether the image quality achievable with a low-cost, miniature digital microscope scanner is sufficient for detection of metastases in breast cancer lymph node frozen sections. Methods Lymph node frozen sections from 79 breast cancer patients were digitized using a prototype miniature microscope scanner and a high-end slide scanner. Images were independently reviewed by two pathologists and results compared between devices with conventional light microscopy analysis as ground truth. Results Detection of metastases in the images acquired with the miniature scanner yielded an overall sensitivity of 91% and specificity of 99% and showed strong agreement when compared to light microscopy (k = 0.91). Strong agreement was also observed when results were compared to results from the high-end slide scanner (k = 0.94). A majority of discrepant cases were micrometastases and sections of which no anticytokeratin staining was available. Conclusion Accuracy of detection of metastatic cells in breast cancer sentinel lymph node frozen sections by visual analysis of samples digitized using low-cost, point-of-care microscopy is comparable to analysis of digital samples scanned using a high-end, whole slide scanner. This technique could potentially provide a workflow for digital diagnostics in resource-limited settings, facilitate sample analysis at the point-of-care and reduce the need for trained experts on-site during surgical procedures.	[Holmstrom, Oscar; Linder, Nina; Suutala, Antti; Lundin, Mikael; Lundin, Johan] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Linder, Nina] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden; [Moilanen, Hannu] Univ Oulu, Ctr Microscopy & Nanotechnol, Oulu, Finland; [Nordling, Stig] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Stahls, Anders] Helsinki Univ Hosp, Helsinki, Finland; [Stahls, Anders] HUSLAB Pathol Lab, Helsinki, Finland; [Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	University of Helsinki; Uppsala University; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Holmstrom, O (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	oscar.holmstrom@helsinki.fi	Lundin, Johan/I-1843-2018; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Linder, Nina/0000-0003-3930-0513	Swedish Research Council; Sigrid Juselius Foundation; Finska Lakaresallskapet; Biomedicum Foundation; Medicinska Understbdsfbreningen Liv och Halsa rf and Tekes - the Finnish Funding Agency for Innovation; European Advanced Translational Research Infrastructure in Medicine' (EATRIS)/Academy of Finland; University of Helsinki	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Biomedicum Foundation; Medicinska Understbdsfbreningen Liv och Halsa rf and Tekes - the Finnish Funding Agency for Innovation; European Advanced Translational Research Infrastructure in Medicine' (EATRIS)/Academy of Finland; University of Helsinki	This work was supported by grants from the Swedish Research Council, Sigrid Juselius Foundation, Finska Lakaresallskapet, Biomedicum Foundation, Medicinska Understbdsfbreningen Liv och Halsa rf and Tekes - the Finnish Funding Agency for Innovation and University of Helsinki. In addition, this study has received funding from the 'European Advanced Translational Research Infrastructure in Medicine' (EATRIS)/Academy of Finland. We also thank Biocenter Finland and Helsinki Institute of Life Science for infrastructure support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Andersson Y, 2018, BREAST CANCER RES TR, V171, P359, DOI 10.1007/s10549-018-4820-0; Bejnordi BE, 2017, JAMA-J AM MED ASSOC, V318, P2199, DOI 10.1001/jama.2017.14585; Chao C, 2004, AM SURGEON, V70, P414; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Gifford AJ, 2012, ANZ J SURG, V82, P803, DOI 10.1111/j.1445-2197.2012.06191.x; Holck S, 2004, BREAST, V13, P42, DOI 10.1016/S0960-9776(03)00124-3; Holmstrom O, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1337325; Holmstrom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144688; Isaacs Mike, 2011, J Pathol Inform, V2, P39, DOI 10.4103/2153-3539.84232; Konsti J, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-29; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu LC, 2011, CANCER-AM CANCER SOC, V117, P250, DOI 10.1002/cncr.25606; Liu Y, 2019, ARCH PATHOL LAB MED, V143, P859, DOI 10.5858/arpa.2018-0147-OA; Lucci A, 2007, J CLIN ONCOL, V25, P3657, DOI 10.1200/JCO.2006.07.4062; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Pirnstill CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13368; Samphao S, 2008, ANN SURG ONCOL, V15, P1282, DOI 10.1245/s10434-008-9863-8; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Thorstenson Sten, 2014, J Pathol Inform, V5, P14, DOI 10.4103/2153-3539.129452; Weinstein RS, 2004, HUM PATHOL, V35, P1303, DOI 10.1016/j.humpath.2004.09.002; Weiser MR, 2000, ANN SURG ONCOL, V7, P651, DOI 10.1007/s10434-000-0651-3; Yeh YC, 2015, HISTOPATHOLOGY, V66, P922, DOI 10.1111/his.12468; Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0208366	10.1371/journal.pone.0208366	http://dx.doi.org/10.1371/journal.pone.0208366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889174	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000002
J	Varanasi, PR; Ogonek, J; Luther, S; Dammann, E; Stadler, M; Ganser, A; Borchers, S; Hambach, L; Weissinger, EM				Varanasi, Pavankumar Reddy; Ogonek, Justyna; Luther, Susanne; Dammann, Elke; Stadler, Michael; Ganser, Arnold; Borchers, Sylvia; Hambach, Lothar; Weissinger, Eva M.			Cytomegalovirus-specific CD8+T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ACUTE MYELOID-LEUKEMIA; CMV REACTIVATION; T-CELLS; MYELODYSPLASTIC SYNDROME; IMMUNE RECONSTITUTION; CHRONIC GRAFT; RISK EVIDENCE; LONG-TERM; CLASS-I	Leukemia relapse is the main cause for mortality after allogeneic stem cell transplantation (allo-SCT). Donor-derived allo-immune responses eliminate the residual host hematopoiesis and protect against relapse. Cytomegalovirus (CMV) reactivation (CMV-R) after allo-SCT may trigger anti-leukemic effects. The impact of CMV-specific CD8+ T-cells (CMV-CTLs) on the outcome after allo-SCT is currently unknown. Here, we studied the relationship between CMV-CTLs, overall T-cell reconstitution and relapse incidence in 103 patients with acute leukemia (n = 91) or myelodysplastic syndrome (n = 12) following CMV-seropositive recipient/donor (R+/D+) allo-SCT. Patients were subdivided based on the presence or absence of CMV-CTLs at 3 months after allo-SCT. Presence of CMV-CTLs was associated with preceding CMV-R and a fast T-cell reconstitution. Univariate analysis showed a significantly lower 1-, 2- and 5-year cumulative incidence of relapse (CIR) in patients with CMV-CTLs compared to those without CMV-CTLs. Multivariable regression analysis of the outcome performed with other relevant parameters chosen from univariate analysis revealed that presence of CMV-CTLs and chronic graft-versus-host disease (cGvHD) were the only independent factors associated with a low CIR. Onset of relapse was significantly later in patients with CMV-CTLs (median 489 days) than in in those without (median 152 days, p = 0.041) during a five-year follow-up. Presence of CMV-CTLs was associated with a lower incidence of early relapses (1 and 2-years), while cGvHD lead to a lower incidence of late relapses (2 to 5-years). In conclusion, our data show that CMV-CTLs indicate a functional immune-reconstitution protective against early relapse.	[Varanasi, Pavankumar Reddy; Ogonek, Justyna; Luther, Susanne; Dammann, Elke; Stadler, Michael; Ganser, Arnold; Borchers, Sylvia; Hambach, Lothar; Weissinger, Eva M.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Varanasi, Pavankumar Reddy] Hannover Med Sch, German Ctr Infect Res DZIF, Hannover, Germany; [Borchers, Sylvia] RHEACELL GmbH & Co KG, Heidelberg, Germany	Hannover Medical School; German Center for Infection Research; Hannover Medical School	Weissinger, EM (corresponding author), Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany.	mischak-weissinger.eva@mh-hannover.de	Varanasi, Pavankumar/AGP-6339-2022	Varanasi, Pavankumar/0000-0003-4658-0453	BMBF the German Center of Infectious Research (DZIF) [TTU 07.804, 07.801]; European Union Marie Curie Initial Training Networks Project [315963]	BMBF the German Center of Infectious Research (DZIF); European Union Marie Curie Initial Training Networks Project	The project was supported in part by grants from the BMBF the German Center of Infectious Research (DZIF), TTU 07.804 and 07.801 to EMW and from the European Union Marie Curie Initial Training Networks Project Number 315963 "Improving HSCT By Validation of Biomarkers & Development Of Novel Cellular Therapies" awarded to J. Ogonek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RHEACELL GmbH & Co. KG, Heidelberg, Germany is now the employer of SB, thus provided support in the form of salary for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions'.	Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; Borchers S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050248; Buchholz S, 2012, EUR J HAEMATOL, V88, P52, DOI 10.1111/j.1600-0609.2011.01703.x; Cantoni N, 2010, BIOL BLOOD MARROW TR, V16, P1309, DOI 10.1016/j.bbmt.2010.03.020; Cho BS, 2012, BIOL BLOOD MARROW TR, V18, P1136, DOI 10.1016/j.bbmt.2012.01.010; Diaconescu R, 2004, BLOOD, V104, P1550, DOI 10.1182/blood-2004-03-0804; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Green ML, 2013, BLOOD, V122, P1316, DOI 10.1182/blood-2013-02-487074; Heuser M, 2017, ANN HEMATOL, V96, P1361, DOI 10.1007/s00277-017-3027-5; Hiramoto N, 2014, EUR J HAEMATOL, V92, P137, DOI 10.1111/ejh.12214; Hoegh-Petersen M, 2012, LEUKEMIA, V26, P359, DOI 10.1038/leu.2011.195; HOROWITZ MM, 1990, BLOOD, V75, P555; Huisman C, 2007, BONE MARROW TRANSPL, V39, P285, DOI 10.1038/sj.bmt.1705582; Inagaki J, 2016, BIOL BLOOD MARROW TR, V22, P300, DOI 10.1016/j.bbmt.2015.09.006; Jeljeli M, 2014, BRIT J HAEMATOL, V166, P229, DOI 10.1111/bjh.12875; Kalra A, 2016, BIOL BLOOD MARROW TR, V22, P1654, DOI 10.1016/j.bbmt.2016.05.020; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keskinen P, 1997, IMMUNOLOGY, V91, P421, DOI 10.1046/j.1365-2567.1997.00258.x; Khan F, 2004, BONE MARROW TRANSPL, V34, P1, DOI 10.1038/sj.bmt.1704525; Litjens NHR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00389; Lugthart G, 2014, BIOL BLOOD MARROW TR, V20, P655, DOI 10.1016/j.bbmt.2014.01.018; Lunel FMV, 2016, BIOL BLOOD MARROW TR, V22, P1883, DOI 10.1016/j.bbmt.2016.07.009; Melenhorst JJ, 2015, MOL THER, V23, P179, DOI 10.1038/mt.2014.192; Ogonek J, 2017, BIOL BLOOD MARROW TR, V23, P1046, DOI 10.1016/j.bbmt.2017.03.027; Parkman R, 2006, BIOL BLOOD MARROW TR, V12, P919, DOI 10.1016/j.bbmt.2006.05.008; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Prentice RL, 1992, BREAKTHROUGHS STAT, P519; Rubio MT, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0295-9; Schmitt A, 2011, TRANSFUSION, V51, P591, DOI 10.1111/j.1537-2995.2010.02940.x; Schneidawind D, 2013, ANN HEMATOL, V92, P1389, DOI 10.1007/s00277-013-1774-5; Seckert CK, 2012, MED MICROBIOL IMMUN, V201, P551, DOI 10.1007/s00430-012-0273-y; Sellar RS, 2015, BLOOD, V125, P731, DOI 10.1182/blood-2014-07-589150; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Storb R, 2013, J CLIN ONCOL, V31, P1530, DOI 10.1200/JCO.2012.45.0247; Suessmuth Y, 2015, BLOOD, V125, P3835, DOI 10.1182/blood-2015-03-631853; Teira P, 2016, BLOOD, V127, P2427, DOI 10.1182/blood-2015-11-679639; Tey SK, 2010, J GEN VIROL, V91, P2040, DOI 10.1099/vir.0.020982-0; van der Torren CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119595; Walter RB, 2015, LEUKEMIA, V29, P137, DOI 10.1038/leu.2014.173; Yoon JH, 2014, BIOL BLOOD MARROW TR, V20, P80, DOI 10.1016/j.bbmt.2013.10.015	45	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213739	10.1371/journal.pone.0213739	http://dx.doi.org/10.1371/journal.pone.0213739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889204	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000030
J	Bhagwani, AR; Hultman, S; Farkas, D; Moncayo, R; Dandamudi, K; Zadu, AK; Cool, CD; Farkas, L				Bhagwani, Aneel R.; Hultman, Schuyler; Farkas, Daniela; Moncayo, Rebecca; Dandamudi, Kaivalya; Zadu, Arsema K.; Cool, Carlyne D.; Farkas, Laszlo			Endothelial cells are a source of Nestin expression in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							PLEXIFORM LESIONS; BLOOD-VESSELS; ANGIOGENESIS; APOPTOSIS; PROLIFERATION; MIGRATION; GROWTH; CONTRIBUTES; INHIBITION; SECONDARY	Uncontrolled proliferation of endothelial cells is essential to the pathogenesis of pulmonary arterial hypertension (PAH). Both proliferation and cytoskeleton reorganization are associated with upregulation of the intermediate filament protein Nestin. Recently, accumulation of Nestin-expressing cells was found in pulmonary vascular lesions of PAH patients. The goal of this study is to determine if Nestin expression contributes to endothelial proliferation in pulmonary arterial hypertension, using both lung tissues and endothelial cells. Here we found that endothelial cells from complex and plexiform lesions of PAH patients expressed Nestin. These Nestin(+) cells further stained positive for the angiogenic factors CXC chemokine ligand 12 and Wnt1. Likewise, in the chronic hypoxia/SU5416 animal model of pulmonary hypertension, Nestin(+) endothelial cells were found in occlusive pulmonary vascular lesions. In vitro, both growing rat and human lung endothelial cells expressed Nestin protein. When Nestin was overexpressed in endothelial cells (both rat and human), Nestin overexpression promoted proliferation and expression of CXC chemokine ligand 12. Nestin overexpression further increased angiogenic tube formation in vitro. Conclusions: We found increased Nestin expression from endothelial cells of occlusive lung vascular lesions in severe pulmonary hypertension. Elevated Nestin expression likely contributes to unchecked pulmonary vascular proliferation and angiogenesis, possibly via induction of CXC chemokine ligand 12. Additional studies are required to determine whether targeting Nestin would be beneficial to treat PAH.	[Bhagwani, Aneel R.; Hultman, Schuyler; Farkas, Daniela; Moncayo, Rebecca; Dandamudi, Kaivalya; Zadu, Arsema K.; Farkas, Laszlo] Virginia Commonwealth Univ, Dept Internal Med, Div Pulm Dis & Crit Care Med, Richmond, VA 23284 USA; [Cool, Carlyne D.] Univ Colorado Denver, Dept Pathol, Denver, CO USA	Virginia Commonwealth University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Farkas, L (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Div Pulm Dis & Crit Care Med, Richmond, VA 23284 USA.	laszlo.farkas@vcuhealth.org	Farkas, Laszlo/ABF-6179-2020	Farkas, Laszlo/0000-0003-3772-470X; Bhagwani, Aneel/0000-0002-3738-1826	National Institutes of Health/National Heart, Lung, and Blood Institute [HL114816, HL123044]; American Heart Association [13SDG16360018]; Fulbright PhD scholarship; NIH-NINDS Center core grant [5P30NS047463]; NIH-NCI Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123044, U10HL109250, R24HL123767] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Fulbright PhD scholarship; NIH-NINDS Center core grant; NIH-NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was supported by National Institutes of Health/National Heart, Lung, and Blood Institute Grants HL114816 and HL123044, and by a grant from the American Heart Association (13SDG16360018). ARB was supported by a Fulbright PhD scholarship. Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). Flow cytometry was performed at the VCU Massey Cancer Center Flow Cytometry Shared Resource, supported, in part, with funding from NIH-NCI Cancer Center Support Grant P30 CA016059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Aihara M, 2004, LAB INVEST, V84, P1581, DOI 10.1038/labinvest.3700186; Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Alliot F, 1999, J NEUROSCI RES, V58, P367; Chang KW, 2013, BIOCHEM BIOPH RES CO, V434, P854, DOI 10.1016/j.bbrc.2013.04.031; Chen ZG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085584; Chu CY, 2009, CARCINOGENESIS, V30, P205, DOI 10.1093/carcin/bgn228; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Erzurum S, 2010, AM J RESP CRIT CARE, V182, P1554, DOI 10.1164/rccm.201006-0869WS; Farkas D, 2019, AM J RESP CRIT CARE, V199, P199, DOI 10.1164/rccm.201707-1370OC; Farkas D, 2014, AM J RESP CELL MOL, V51, P413, DOI 10.1165/rcmb.2013-0355OC; Farkas D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089810; Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Gherghe CM, 2011, FASEB J, V25, P1836, DOI 10.1096/fj.10-172981; Green LA, 2012, AM J RESP CELL MOL, V47, P807, DOI 10.1165/rcmb.2012-0132OC; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Hoh BL, 2014, J NEUROSURG, V120, P73, DOI 10.3171/2013.9.JNS122074; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huang YL, 2009, J BIOCHEM, V146, P307, DOI 10.1093/jb/mvp070; Hyder CL, 2011, J CELL SCI, V124, P1363, DOI 10.1242/jcs.041244; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Jacquin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131940; Jin J, 2013, OPHTHALMIC RES, V50, P6, DOI 10.1159/000348532; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Liang ZW, 2015, AM J PHYSIOL-CELL PH, V308, pC349, DOI 10.1152/ajpcell.00121.2014; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; McGoon MD, 2013, J AM COLL CARDIOL, V62, pD51, DOI 10.1016/j.jacc.2013.10.023; McLaughlin VV, 2013, J AM COLL CARDIOL, V62, pD73, DOI 10.1016/j.jacc.2013.10.034; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Mokry J, 2004, STEM CELLS DEV, V13, P658, DOI 10.1089/scd.2004.13.658; Mokry J, 1998, FOLIA BIOL-PRAGUE, V44, P155; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Narita K, 2014, INT J ONCOL, V44, P1118, DOI 10.3892/ijo.2014.2278; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Saboor F, 2016, EUR RESPIR J, V47, P876, DOI 10.1183/13993003.00574-2015; Sakao S, 2007, FASEB J, V21, P3640, DOI 10.1096/fj.07-8432com; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen XH, 2015, CELL BIOL INT, V39, P962, DOI 10.1002/cbin.10471; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tardif K, 2015, AM J PHYSIOL-HEART C, V308, pH1265, DOI 10.1152/ajpheart.00804.2014; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Xue XJ, 2010, MOL CELL NEUROSCI, V45, P26, DOI 10.1016/j.mcn.2010.05.006; Yeager ME, 2001, CIRC RES, V88, pE2; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10971-1; Zhao ZW, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0408-8	59	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213890	10.1371/journal.pone.0213890	http://dx.doi.org/10.1371/journal.pone.0213890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883593	Green Submitted, Green Published, gold			2022-12-26	WOS:000461423500037
J	Reimers, AK; Brzoska, P; Niessner, C; Schmidt, SCE; Worth, A; Woll, A				Reimers, Anne K.; Brzoska, Patrick; Niessner, Claudia; Schmidt, Steffen C. E.; Worth, Annette; Woll, Alexander			Are there disparities in different domains of physical activity between school-aged migrant and non-migrant children and adolescents? Insights from Germany	PLOS ONE			English	Article							HEALTH INTERVIEW; SPORTS PARTICIPATION; MOTOR-PERFORMANCE; SAMPLE DESIGN; WEIGHT STATUS; MIGRATION; KIGGS; IMMIGRANTS; FITNESS; DETERMINANTS	Background Large proportions of the populations in many European countries, including Germany, are migrants. Migrant children and adolescents tend to be less physically active than their non-migrant peers. However, current research is limited as it does not sufficiently consider different domains of physical activity. Using a representative dataset, the present study examines the patterns of sports participation and other domains of physical activity among migrant and non-migrant children and adolescents residing in Germany. Methods Nationwide data from the Motorik-Modul (MoMo) Study is used. Five different domains of physical activity participation (sports clubs, outside of sports clubs, extra-curricular physical activity, physical activity, outdoor play and active commuting to school) were compared between children and adolescents with no, one-sided and two-sided migration background using logistic regression adjusted for demographic factors. Interaction terms were included in order to examine whether difference between the three groups differ by age and gender. Results Information on n = 3,323 children and adolescents was available. As compared to non-migrants, children and adolescents with a two-sided migration background had a 40% (adjusted odds ratio [aOR] = 0.60, 95%-CI: 0.44-0.81), those with a one-sided migration background a 26% (aOR = 0.74, 95%-CI: 0.55-<1.00) lower chance of participating in sport club activities. In contrast, children and adolescents with a two-sided migration background were at 65% higher chance of participating in extra-curricular physical activity than nonmigrants (OR = 1.65, 95%-CI: 1.15-2.36). Conclusion The study shows that differences in levels of physical activity between migrant and non-migrant children and adolescents are less pronounced than previous research has suggested. In particular, it reveals that migrants are only disadvantaged regarding participation in sports clubs whereas they fare better with respect to extra-curricular physical activity. Interventions should therefore address barriers migrant children and adolescents encounter in the access to sport clubs while maintaining their high level of extra-curricular physical activity.	[Reimers, Anne K.] Tech Univ Chemnitz, Inst Human Movement Sci & Hlth, Fac Behav & Social Sci, Chemnitz, Germany; [Brzoska, Patrick] Witten Herdecke Univ, Hlth Serv Res Unit, Fac Hlth, Sch Med, Witten, Germany; [Niessner, Claudia; Schmidt, Steffen C. E.; Woll, Alexander] Karlsruhe Inst Technol, Inst Sport & Sport Sci, Karlsruhe, Germany; [Worth, Annette] Univ Educ Karlsruhe, Inst Movement & Sports, Karlsruhe, Germany	Technische Universitat Chemnitz; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Reimers, AK (corresponding author), Tech Univ Chemnitz, Inst Human Movement Sci & Hlth, Fac Behav & Social Sci, Chemnitz, Germany.	anne.reimers@hsw.tu-chemnitz.de	Niessner, Claudia/ABB-1192-2021; Reimers, Anne/AAH-5735-2021	Niessner, Claudia/0000-0003-2094-0836; 	Federal Ministry of Education and Research within the research program 'long-term studies' in public health research [01ER1503]; German Research Foundation [DFG-392676956]; Technische Universitat Chemnitz in the funding programme Open Access Publishing	Federal Ministry of Education and Research within the research program 'long-term studies' in public health research; German Research Foundation(German Research Foundation (DFG)); Technische Universitat Chemnitz in the funding programme Open Access Publishing	This present study is based on data from the "Motorik-Modul Longitudinal Study (MoMo) (2009-2021): Physical fitness and physical activity as determinants of health development in children and adolescents". MoMo is funded by the Federal Ministry of Education and Research (funding reference number: 01ER1503) within the research program 'long-term studies' in public health research. The publication costs of this article were funded by the German Research Foundation/DFG-392676956 and the Technische Universitat Chemnitz in the funding programme Open Access Publishing.	[Anonymous], 2009, ADJUSTMENT SOCIAL CL; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Bere E, 2008, PREV MED, V47, P412, DOI 10.1016/j.ypmed.2008.06.019; Bianco A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016306; Bianco A, 2016, INT J PUBLIC HEALTH, V61, P673, DOI 10.1007/s00038-016-0820-1; BIK Aschpurwis und Behrens GmbH, 2001, METH AKT 2000; Brug J, 2012, PEDIATR OBES, V7, P399, DOI 10.1111/j.2047-6310.2012.00067.x; Brzoska P, 2016, INT J PUBLIC HEALTH, P1; Brzoska P., 2017, MIGRATION HLTH SURVI, P214; Brzoska P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004242; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Frohn J, 2007, MADCHEN SPORT HAUPTS; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Greier K, 2017, BEWEGUNGSTHERAPIE GE, V33, P256, DOI 10.1055/s-0043-120632; Greier K, 2014, WIEN KLIN WOCHENSCHR, V126, P95, DOI 10.1007/s00508-013-0474-4; Hankivsky O, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-5; Holling H, 2007, BUNDESGESUNDHEITSBLA, V50, P557, DOI 10.1007/s00103-007-0216-8; Hughson JA, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1384-3; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jekauc D, 2013, J PUBLIC HEALTH-HEID, V21, P505, DOI 10.1007/s10389-013-0579-2; Jekauc D, 2013, DIAGNOSTICA, V59, P100, DOI 10.1026/0012-1924/a000083; Kamtsiuris P, 2007, BUNDESGESUNDHEITSBLA, V50, P547, DOI 10.1007/s00103-007-0215-9; Kleiser C, 2010, PUBLIC HEALTH NUTR, V13, P324, DOI 10.1017/S1368980009991030; Kleiser C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-46; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P736, DOI 10.1007/s00103-007-0235-5; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P533, DOI 10.1007/s00103-007-0214-x; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2014, BUNDESGESUNDHEITSBLA, V57, P762, DOI 10.1007/s00103-014-1974-8; Lange M, 2014, BUNDESGESUNDHEITSBLA, V57, P747, DOI 10.1007/s00103-014-1973-9; McKenzie TL, 2010, J SCHOOL HEALTH, V80, P470, DOI 10.1111/j.1746-1561.2010.00530.x; Mess F, 2012, Z SOZIOL ERZIEH SOZI, V32, P358; Mutz M., 2011, MIGRATION INTEGRATIO, P99, DOI [10.1007/978-3-531-92831-9_6, DOI 10.1007/978-3-531-92831-9_6]; Mutz M., 2012, SPORT ALS SPRUNGBRET; Mutz M, 2015, JUGEND MIGRATION SPO, P69; Nielsen G, 2013, EUR J SPORT SCI, V13, P321, DOI 10.1080/17461391.2011.635697; Norredam M., 2011, Migration and health in the European Union, P67; Pour MB, 2014, J OBES, V2014, DOI 10.1155/2014/406529; Razum O., 2008, MIGRATION GESUNDHEIT; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Reeske A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060648; Reimers AK, 2013, PREV MED, V56, P64, DOI 10.1016/j.ypmed.2012.11.011; Robert Koch-Institut, 2008, KIND JUG MIGR DEUTSC; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Schenk L, 2008, KINDER JUGENDGESUND; Schmidt S.C.E., 2016, KIT SCI WORKING PAPE, P53, DOI [10.5445/IR/1000062199, DOI 10.5445/IR/1000062199]; StataCorp, 2013, STATA STAT SOFTW REL; Statistisches Bundesamt, 2018, BEV ERW BEV MIGR ERG; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Villarroel N, 2016, J IMMIGR MINOR HEALT, V18, P318, DOI 10.1007/s10903-015-0202-4; Wagner MO, 2014, INT J EPIDEMIOL, V43, P1410, DOI 10.1093/ije/dyt098; White RL, 2017, AM J PREV MED, V52, P653, DOI 10.1016/j.amepre.2016.12.008; Wijtzes AI, 2014, INT J BEHAV NUTR PHY, V11, P10; Yen IH, 1998, AM J PUBLIC HEALTH, V88, P1709, DOI 10.2105/AJPH.88.11.1709; Yilmaz-Aslan Y, 2014, CHRONIC ILLN, V10, P107, DOI 10.1177/1742395313501207; Zaccagni L, 2017, ACTA PAEDIATR, V106, P1184, DOI 10.1111/apa.13862; Zahner L, 2009, MED SCI SPORT EXER, V41, P344, DOI 10.1249/MSS.0b013e318186d843; Zuchner I, 2007, GANZTAGSSCHULE DEUTS, P106	59	11	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0214022	10.1371/journal.pone.0214022	http://dx.doi.org/10.1371/journal.pone.0214022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883609	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500046
J	Sylvain, IA; Adams, RI; Taylor, JW				Sylvain, Iman A.; Adams, Rachel I.; Taylor, John W.			A different suite: The assemblage of distinct fungal communities in water-damaged units of a poorly-maintained public housing building	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; HOMES; DUST; PCR	Water-damaged housing has been associated with a number of negative health outcomes, principally respiratory disease and asthma. Much of what we know about fungi associated with water-damaged buildings has come from culture-based and immunochemical methods. Few studies have used high-throughput sequencing technologies to assess the impact of water-damage on microbial communities in residential buildings. In this study we used amplicon sequencing and quantitative-PCR to evaluate fungal communities on surfaces and in airborne dust in multiple units of a condemned public housing project located in the San Francisco Bay Area. We recruited 21 households to participate in this study and characterized their apartments as either a unit with visible mold or no visible mold. We sampled airborne fungi from dust settled over a month-long time period from the outdoors, in units with no visible mold, and units with visible mold. In units with visible mold we additionally sampled the visible fungal colonies from bathrooms, kitchens, bedrooms, and living rooms. We found that fungal biomass in settled dust was greater outdoors compared to indoors, but there was no significant difference of fungal biomass in units with visible mold and no visible mold. Interestingly, we found that fungal diversity was reduced in units with visible mold compared to units with no visible mold and the outdoors. Units with visible mold harbored fungal communities distinct from units with no visible mold and the outdoors. Units with visible mold had a greater abundance of taxa within the classes Eurotiomycetes, Saccharomycetes, and Wallemiomycetes. Colonies of fungi collected from units with visible mold were dominated by two Cladosporium species, C. sphaerospermum and C halotolerans. This study demonstrates that high-throughput sequencing of fungi indoors can be a useful strategy for distinguishing distinct microbial exposures in water-damaged homes with visible and nonvisible mold growth, and may provide a microbial means for identifying water damaged housing.	[Sylvain, Iman A.; Adams, Rachel I.; Taylor, John W.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sylvain, IA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	isylvain@berkeley.edu			Alfred P. Sloan Foundation [G-2014-13564]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Funded by RA: G-2014-13564. Alfred P. Sloan Foundation. https://sloan.org/programs/science/microbiology-of-the-built-environment.Sponsors played a role in the decision to publish.	Abarenkov K, 2010, NEW PHYTOL, P1; Adamkiewicz G, 2011, RES PRACTICE, P1; Adams RI, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0347-6; Adams RI, 2016, BUILD ENVIRON, V109, P224, DOI 10.1016/j.buildenv.2016.09.001; Adams RI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128022; Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; ADAMS RI, 2015, MICROBIOME, V3, DOI DOI 10.1186/S40168-; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; Center for Disease Control, 2011, CDC HLTH INF INT TRA, P1; Committee on Microbiomes of the Built Environment: From Research to Application Board on Life Sciences Board on Environmental Studies and Toxicology Division on Earth and Life Studies Health and Medicine Division Board on Infrastructure and the Constructed Environment, 2017, MICR BUILT ENV, P1, DOI [10.17226/23647, DOI 10.17226/23647]; Dannemiller KC, 2016, INDOOR AIR, V26, P179, DOI 10.1111/ina.12205; Dannemiller KC, 2014, INDOOR AIR, V24, P236, DOI 10.1111/ina.12072; Dannemiller KC, 2016, J ALLERGY CLIN IMMUN, P1, DOI [10.1016/j.jaip.2015.10.003, DOI 10.1016/J.JAIP.2015.10.003]; Davis N. M., 2017, BIORXIV, DOI [DOI 10.1101/221499, DOI 10.1186/S40168-018-0605-2]; Dedesko S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0137-y; Emerson JB, 2015, ENVIRON SCI TECHNOL, V49, P2675, DOI 10.1021/es503845j; Flannigan B, 2011, MICROORGANISMS IN HOME AND INDOOR WORK ENVIRONMENTS: DIVERSITY, HEALTH IMPACTS, INVESTIGATION AND CONTROL, 2ND EDITION, P1, DOI 10.1201/b10838; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Green BJ, 2017, J OCCUP ENVIRON HYG, V14, P285, DOI 10.1080/15459624.2016.1252044; Health Canada, 2008, GUID CAND DRINK WAT, P1, DOI DOI 10.17226/23647; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jayaprakash B, 2017, MICROBIOME MICROBIOM, P1, DOI [10.1186/s40168-016-0209-7, DOI 10.1186/S40168-016-0209-7]; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kettleson EM, 2015, ENVIRON RES, V138, P130, DOI 10.1016/j.envres.2015.02.003; Kindt R., 2005, TREE DIVERSITY ANAL, P1; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Krieger J, 2002, RES PRACTICE, P1; Lignell U, 2008, LETT APPL MICROBIOL, V47, P303, DOI 10.1111/j.1472-765X.2008.02431.x; Martin M, 2011, DENKSCHR GESAMTAKAD, V69, P1; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meadow JF, 2015, PEERJ, V3, DOI 10.7717/peerj.1258; Meklin T, 2007, SCI TOTAL ENVIRON, P1; Nielsen KF, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P245; Oksanen J, 2018, PACKAGE VEGAN, P1; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; Rao CY, 2007, APPL ENVIRON MICROB, V73, P1630, DOI 10.1128/AEM.01973-06; Rauh VA, 2008, ANN NY ACAD SCI, V1136, P276, DOI 10.1196/annals.1425.032; Rintala H, 2012, ADV APPL MICROBIOL, V78, P75, DOI 10.1016/B978-0-12-394805-2.00004-X; Stephens B, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00083-16; Vesper SJ, 2005, LETT APPL MICROBIOL, V41, P367, DOI 10.1111/j.1472-765X.2005.01764.x; Vesper S, 2007, J OCCUP ENVIRON MED, V49, P829, DOI 10.1097/JOM.0b013e3181255e98; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou G, 2000, MOL CELL PROBE, V14, P339, DOI 10.1006/mcpr.2000.0324; 2009, WHO GUID IND AIR QUA, V958, P1	54	11	11	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213355	10.1371/journal.pone.0213355	http://dx.doi.org/10.1371/journal.pone.0213355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883565	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500013
J	Burcham, ZM; Schmidt, CJ; Pechal, JL; Brooks, CP; Rosch, JW; Benbow, ME; Jordan, HR				Burcham, Zachary M.; Schmidt, Carl J.; Pechal, Jennifer L.; Brooks, Christopher P.; Rosch, Jason W.; Benbow, M. Eric; Jordan, Heather R.			Detection of critical antibiotic resistance genes through routine microbiome surveillance	PLOS ONE			English	Article							MECHANISMS; AUTOPSY	Population-based public health data on antibiotic resistance gene carriage is poorly surveyed. Research of the human microbiome as an antibiotic resistance reservoir has primarily focused on gut associated microbial communities, but data have shown more widespread microbial colonization across organs than originally believed, with organs previously considered as sterile being colonized. Our study demonstrates the utility of postmortem microbiome sampling during routine autopsy as a method to survey antibiotic resistance carriage in a general population. Postmortem microbial sampling detected pathogens of public health concern including genes for multidrug efflux pumps, carbapenem, methicillin, vancomycin, and polymixin resistances. Results suggest that postmortem assessments of host-associated microbial communities are useful in acquiring community specific data while reducing selective-participant biases.	[Burcham, Zachary M.; Brooks, Christopher P.; Jordan, Heather R.] Mississippi State Univ, Dept Biol Sci, Starkville, MS 39759 USA; [Schmidt, Carl J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Pechal, Jennifer L.; Benbow, M. Eric] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Rosch, Jason W.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Benbow, M. Eric] Michigan State Univ, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA	Mississippi State University; University of Michigan System; University of Michigan; Michigan State University; St Jude Children's Research Hospital; Michigan State University	Jordan, HR (corresponding author), Mississippi State Univ, Dept Biol Sci, Starkville, MS 39759 USA.	jordan@biology.msstate.edu	Benbow, Mark/V-5895-2019; Rosch, Jason/N-8106-2018	Pechal, Jennifer/0000-0002-2588-2519; Jordan, Heather/0000-0002-4197-2194; Rosch, Jason/0000-0002-1798-1760; Burcham, Zachary/0000-0003-1600-9643	Mississippi State University; National Institute of Justice [2014-DN-BX-K008]	Mississippi State University; National Institute of Justice(US National Institute of Justice)	Funding was provided by Mississippi State University and the National Institute of Justice (2014-DN-BX-K008). Opinions or points of view expressed represent a consensus of the authors and do not necessarily represent the official position or policies of the U.S. Department of Justice. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; [Anonymous], 2013, ANTIBIOTIC RESISTANC; [Anonymous], 2018, COMM EC PACK R PACK; [Anonymous], 2017, BBMLE TOOLS GEN MAXI; [Anonymous], 2017, LANG ENV STAT COMP; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyce JM, 1995, INFECT CONT HOSP EP, V16, P676; BOYCE JM, 1995, INFECT CONT HOSP EP, V16, P634; Costache Mariana, 2014, Maedica (Bucur), V9, P261; da Silva NS, 2014, AM J INFECT CONTROL, V42, P389, DOI 10.1016/j.ajic.2013.11.010; Daly SM, 2017, MBIO, V8, DOI 10.1128/mBio.01315-17; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Ekstrom C., 2020, PWR BASIC FUNCTIONS; Feng J, 2018, ENVIRON MICROBIOL, V20, P355, DOI 10.1111/1462-2920.14009; Fischbach MA, 2009, CURR OPIN MICROBIOL, V12, P520, DOI 10.1016/j.mib.2009.07.002; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; Harms PW, 2010, AM J CLIN PATHOL, V134, P27, DOI 10.1309/AJCP35KOZSAVNQZW; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Javan GT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00225; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kampmeier S, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0206-z; Kostric M, 2018, MICROB ECOL, V75, P529, DOI 10.1007/s00248-017-1068-x; Lenski R E, 1998, Int Microbiol, V1, P265; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Loomba PS, 2010, J GLOB INFECT DIS, V2, P275, DOI 10.4103/0974-777X.68535; Mauldin PD, 2010, ANTIMICROB AGENTS CH, V54, P109, DOI 10.1128/AAC.01041-09; McArthur AG, 2015, CURR OPIN MICROBIOL, V27, P45, DOI 10.1016/j.mib.2015.07.004; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Pechal JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23989-w; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Prevention CfDCa, 2018, VIT SIGNS CONT NOV M; Rahman SF, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00123; Remschmidt C, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0253-5; Sedmak G, 2010, CLIN INFECT DIS, V50, P357, DOI 10.1086/649863; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Stoesser N, 2016, LANCET INFECT DIS, V16, P285, DOI 10.1016/S1473-3099(16)00010-4; Sun J, 2017, MBIO, V8, DOI 10.1128/mBio.00625-17; Thati Venubabu, 2011, Indian J Med Res, V134, P704, DOI 10.4103/0971-5916.91001; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Vega NM, 2014, CURR OPIN MICROBIOL, V21, P28, DOI 10.1016/j.mib.2014.09.003; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Woodworth KR, 2018, MMWR-MORBID MORTAL W, V67, P396, DOI 10.15585/mmwr.mm6713e1; World Health Organization, 2014, ANT RES GLOB REP SUR	53	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213280	10.1371/journal.pone.0213280	http://dx.doi.org/10.1371/journal.pone.0213280			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870464	Green Submitted, gold, Green Published			2022-12-26	WOS:000461166300027
J	Macedo, LT; Ferrari, VE; Carron, J; Costa, EFD; Lopes-Aguiar, L; Lourenco, GJ; Lima, CSP				Macedo, Ligia Traldi; Ferrari, Vinicius Eduardo; Carron, Juliana; Dias Costa, Ericka Francislaine; Lopes-Aguiar, Leisa; Lourenco, Gustavo Jacob; Passos Lima, Carmen Silvia			Cost-minimization analysis of GSTP1c.313A > G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NAUSEA; HIGH-DOSE CISPLATIN; AMERICAN SOCIETY; INDUCED EMESIS; DOUBLE-BLIND; CANCER; POLYMORPHISMS; RADIOTHERAPY; FOSAPREPITANT; THERAPY	Background Chemotherapy-induced nausea and vomiting are concerning adverse events resulting from cancer treatment, and current guidelines recommend the use of neurokinin-1-selective antagonists, such as fosaprepitant, in highly emetogenic schemes. However, the implementation of this strategy may be limited by the cost of treatment. GSTP1c.313A>G genotype was recently described as a predictor of vomiting related to high-dose cisplatin. We hypothesized that the inclusion of routine GSTP1c.313A>G screening may be promising in financial terms, in contrast to the wide-spread use of fosaprepitant. Methods A cost-minimization analysis was planned to compare GSTP1c.313A>G genotyping versus overall fosaprepitant implementation for patients with head and neck cancer under chemoradiation therapy with high-dose cisplatin. A decision analytic tree was designed, and conditional probabilities were calculated under Markov chain Monte Carlo simulations using the Metropolis-Hastings algorithm. The observed data included patients under treatment without fosaprepitant, while priors were derived from published studies. Results To introduce screening with real-time polymerase chain reaction, an initial investment of U$ 39,379.97 would be required, with an amortization cost of U$ 7,272.97 per year. The mean cost of standard therapy with fosaprepitant is U$ 243.24 per patient, and although the initial cost of routine genotyping is higher, there is a tendency of progressive minimization at a threshold of 155 patients (Credible interval-CI: 119 to 216), provided more than one sample is incorporated for simultaneous analysis. A resulting reduction of 35.83% (CI: 30.31 to 41.74%) in fosaprepitant expenditures is then expected with the implementation of GSTP1c.313A>G genotyping. Conclusion GSTP1c.313A>G genotyping may reduce the use of preventive support for chemotherapy induced nausea and lower the overall cost of treatment. Despite the results of this simulation, randomized, interventional studies are required to control for known and unknown confounders as well as unexpected expenses.	[Macedo, Ligia Traldi; Carron, Juliana; Dias Costa, Ericka Francislaine; Lopes-Aguiar, Leisa; Lourenco, Gustavo Jacob; Passos Lima, Carmen Silvia] State Univ Campinas UNICAMP, Fac Med Sci, Campinas, SP, Brazil; [Ferrari, Vinicius Eduardo] Pontificia Univ Catolica Campinas, CEA, Campinas, SP, Brazil	Universidade Estadual de Campinas; Pontificia Universidade Catolica de Campinas	Macedo, LT (corresponding author), State Univ Campinas UNICAMP, Fac Med Sci, Campinas, SP, Brazil.	ltraldi@hc.unicamp.br	Lourenço, Gustavo Jacob/G-1873-2012; Macedo, Ligia Traldi/L-8432-2019; Lourenço, Gustavo Jacob/AAG-3688-2020; Macedo, Ligia T Traldi/P-8122-2018; Carron, Juliana/C-7030-2018; Ferrari, Vinícius E/J-6435-2012; Lima, Carmen Silvia Passos/K-4775-2013	Lourenço, Gustavo Jacob/0000-0002-5944-0305; Macedo, Ligia T Traldi/0000-0003-0575-586X; Carron, Juliana/0000-0002-1108-6343; Ferrari, Vinicius Eduardo/0000-0003-3997-6310				Bloechl-Daum B, 2006, J CLIN ONCOL, V24, P4472, DOI 10.1200/JCO.2006.05.6382; Carron J, 2017, BASIC CLIN PHARMACOL, V121, P520, DOI 10.1111/bcpt.12842; Caudle KE, 2014, CURRENT DRUG METABOL; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Forastiere AA, 2013, J CLIN ONCOL, V31, P845, DOI 10.1200/JCO.2012.43.6097; Guan J, 2016, ONCOTARGET, V7, P70185, DOI 10.18632/oncotarget.11824; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Hesketh PJ, 2017, J CLIN ONCOL, V35, P3240, DOI 10.1200/JCO.2017.74.4789; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Hesketh PJ, 2003, EUR J CANCER, V39, P1074, DOI 10.1016/S0959-8049(02)00674-3; LASZLO J, 1981, NEW ENGL J MED, V305, P948, DOI 10.1056/NEJM198110153051609; Liu YP, 2013, MOL MED REP, V7, P1904, DOI 10.3892/mmr.2013.1435; Lopes GD, 2013, NAT REV CLIN ONCOL, V10, P314, DOI 10.1038/nrclinonc.2013.55; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Ma J, 2017, ONCOTARGET, V8, P72939, DOI 10.18632/oncotarget.18513; Meropol NJ, 2009, J CLIN ONCOL, V27, P3868, DOI 10.1200/JCO.2009.23.1183; Minami M, 2003, PHARMACOL THERAPEUT, V99, P149, DOI 10.1016/S0163-7258(03)00057-3; Nagar R, 2015, EUR J DRUG METAB PH, V40, P45, DOI 10.1007/s13318-014-0176-y; Oliveira C, 2013, J CANCER RES CLIN, V139, P1199, DOI 10.1007/s00432-013-1430-4; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Plumpton CO, 2016, PHARMACOECONOMICS, V34, P771, DOI 10.1007/s40273-016-0397-9; Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817; Ruhlmann CH, 2017, SUPPORT CARE CANCER, V25, P309, DOI 10.1007/s00520-016-3407-8; Ruhlmann CH, 2012, EXPERT REV ANTICANC, V12, P139, DOI [10.1586/era.11.199, 10.1586/ERA.11.199]; Saito H, 2013, ANN ONCOL, V24, P1067, DOI 10.1093/annonc/mds541; Sevilla C, 2002, EUR J HUM GENET, V10, P599, DOI 10.1038/sj.ejhg.5200854; Tattersall FD, 1996, NEUROPHARMACOLOGY, V35, P1121, DOI 10.1016/S0028-3908(96)00020-2; Tecza Karolina, 2018, Oncotarget, V9, P9114, DOI 10.18632/oncotarget.24148; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Turini M, 2015, DRUGS CONTEXT, V4, P1; Tzvetkov M, 2012, PATHOLOGY, V44, P166, DOI 10.1097/PAT.0b013e32834f4d69; Yang ZH, 2013, P NATL ACAD SCI USA, V110, P19307, DOI 10.1073/pnas.1311790110	35	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213929	10.1371/journal.pone.0213929	http://dx.doi.org/10.1371/journal.pone.0213929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870506	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300094
J	Ni, ZH; Lv, HT; Ding, S; Yao, WY				Ni, Zhi Hong; Lv, Hai Tao; Ding, Sheng; Yao, Wen Ying			Home care experience and nursing needs of caregivers of children undergoing congenital heart disease operations: A qualitative descriptive study	PLOS ONE			English	Article							YOUNG-PEOPLE; BEHAVIORS; KNOWLEDGE; EDUCATION; PARENTS	Aims and objectives To explore the home care experiences of caregivers taking care of CHD children before and after cardiac surgery. Background Despite the prevalence of congenital heart disease (CHD) in childhood, little is known about the experiences and impacts on the children and their caregivers after CHD diagnosis and surgery. Such knowledge is needed for meaningful support. Design A qualitative descriptive study. Methods Twenty-two caregivers of CHD children undergoing cardiac surgery participated in semi-structured interviews at a University Children's Hospital in China. Data were collected by an experienced and trained interviewer. Qualitative content analysis was chosen to describe the experiences of the caregivers. Results Caregivers of CHD children experienced significant demands. After the children underwent their CHD operations, the caregivers experienced complex psychological feelings and excessive stress impacting upon theirlives. In addition, caregivers constantly adapted their roles with self-fulfillment in caring activities. Conclusions CHD surgery has a major impact on the emotions and daily lives of children and their caregivers. This study offers a framework for understanding the importance of actively listening to caregivers so coping strategies can be implemented. Relevance to clinical practice Theexperiencesdescribed in this study contribute to a better understanding of the needs of caregivers whose children underwent CHD operations. They also provide valuable information to professional medical care staff that developfuture nursing assessments.	[Ni, Zhi Hong; Lv, Hai Tao; Ding, Sheng; Yao, Wen Ying] Soochow Univ, Childrens Hosp, Suzhou, Peoples R China	Soochow University - China	Lv, HT; Ding, S (corresponding author), Soochow Univ, Childrens Hosp, Suzhou, Peoples R China.	annie8888@yeah.net; 307908958@qq.com		Ni, Zhi Hong/0000-0002-6540-2073	Jiangsu Provincial Commission of Health and Family Planning [N201603]	Jiangsu Provincial Commission of Health and Family Planning	The authors thank the Jiangsu Provincial Commission of Health and Family Planning for its funding (No. N201603).	Breithardt G, 2017, EUR HEART J, V38, P843, DOI 10.1093/eurheartj/ehx068; Chen CW, 2018, J ADV NURS, V74, P223, DOI 10.1111/jan.13390; Chen X, 2015, CHINESE NURSING RES, V29, P1157; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; FitzGerald K, 2008, J DENT EDUC, V72, P299; Goossens E, 2015, J PEDIATR-US, V166, P1370, DOI 10.1016/j.jpeds.2015.02.041; Huang G Y, 2017, Zhonghua Er Ke Za Zhi, V55, P241, DOI 10.3760/cma.j.issn.0578-1310.2017.04.001; Jackson AC, 2016, J CLIN NURS, V25, P1528, DOI 10.1111/jocn.13178; Jackson AC, 2015, PEDIATR CARDIOL, V36, P695, DOI 10.1007/s00246-015-1121-9; Janssens A, 2016, EUR J CARDIOVASC NUR, V15, P231, DOI 10.1177/1474515114565214; Kosta L, 2015, CHILD CARE HLTH DEV, V41, P1057, DOI 10.1111/cch.12230; Lawoko S, 2006, HEART LUNG, V35, P301, DOI 10.1016/j.hrtlng.2006.01.004; Lovatt M, 2015, INT J NURS STUD, V52, P271, DOI 10.1016/j.ijnurstu.2014.10.013; Mahle WT, 2001, CURR OPIN PEDIATR, V13, P482, DOI 10.1097/00008480-200110000-00016; Menahem Samuel, 2008, Interact Cardiovasc Thorac Surg, V7, P605, DOI 10.1510/icvts.2007.171066; Ni ZH, 2016, J CHILD HEALTH CARE, V20, P354, DOI 10.1177/1367493515587057; Peterson JK, 2017, J PEDIATR NURS, V36, P241, DOI 10.1016/j.pedn.2017.05.007; Pye Sherry, 2003, Adv Neonatal Care, V3, P147; Sabzevari Sakinne, 2016, Int J Community Based Nurs Midwifery, V4, P374; Saranya, 2014, Nurs J India, V105, P131; Sjostrom-Strand A, 2017, COMPR CHILD ADOLESC, V8, P1; Spijkerboer AW, 2008, INT J CARDIOL, V125, P66, DOI 10.1016/j.ijcard.2007.02.025; Utens EMWJ, 2018, CARDIOL YOUNG, V28, P192, DOI 10.1017/S1047951117001378; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wei H, 2017, HEART LUNG, V46, P166, DOI 10.1016/j.hrtlng.2017.01.007; Wei H, 2015, HEART LUNG, V44, P494, DOI 10.1016/j.hrtlng.2015.08.005; Woolf-King SE, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004862; Yang XY, 2016, CHINA MED J, V122, P1128	28	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213154	10.1371/journal.pone.0213154	http://dx.doi.org/10.1371/journal.pone.0213154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7YP	30870440	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300023
J	Valerio, L; Peters, RJ; Zwinderman, AH; Pinto-Sietsma, SJ				Valerio, Luca; Peters, Ron J.; Zwinderman, Aeilko H.; Pinto-Sietsma, Sara-Joan			Reproducibility of sublingual microcirculation parameters obtained from sidestream darkfield imaging	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; VARIABILITY; DYSFUNCTION; SMOKING; DENSITY	Background Changes in the microcirculation may be used as a surrogate outcome in studies on cardiovascular disease. We assessed the reliability characteristics of the sublingual microcirculation parameters Vascular Density (VD), Red Blood Cell Filling (RBCF), and Perfused Boundary Region (PBR) as obtained by sidestream darkfield imaging. Methods For each of the three parameters, the variance components of measurement, the Intraclass Correlation Coefficient (ICC), the Standard Error of Measurement, and the limits of agreement were estimated for the intra-rater setting (N = 50) and the inter-rater setting (N = 48). Subsequently, as a proof of concept, the reliability measures were used for a power analysis to design studies to evaluate the effect of acute stimuli-i.e. having a meal (N = 50) and cigarette smoking (N = 21) on the three parameters. Results Reproducibility was poor for all three parameters. The intra-rater ICC for 2 measurements was 0.28 (95% CI: 0.04, 0.53) for the VD, 0.51 (95% CI: 0.27, 0.69) for the RBCF, and 0.33 (95% CI: 0.08-0.56) for the PBR. The standard errors of measurement and the limits of agreement for all three parameters were larger than most statistically significant intra-individual or inter-individual differences reported in previous studies. The proofs of concept showed that sample sizes in excess of 600 subjects are necessary to reach statistical significance for the observed effects of having a meal or smoking on VD and PBR. Conclusions The reliability of the three sublingual microcirculation parameters in their current form appears to be low and a large sample size is advisable for their use in conditions similar to those we describe.	[Valerio, Luca] Univ Amsterdam, Amsterdam UMC, Dept Publ Hlth, Amsterdam, Netherlands; [Valerio, Luca; Peters, Ron J.] Univ Amsterdam, Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands; [Zwinderman, Aeilko H.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; [Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands; [Valerio, Luca] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Johannes Gutenberg University of Mainz	Valerio, L (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Publ Hlth, Amsterdam, Netherlands.; Valerio, L (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Cardiol, Amsterdam, Netherlands.; Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands.; Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Vasc Med, Amsterdam, Netherlands.; Valerio, L (corresponding author), Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany.	l.valerio@amc.uva.nl; s.j.pinto@amc.uva.nl	Valerio, Luca/AGX-7211-2022; SJ, Pinto-Sietsma/AAI-3207-2021	Valerio, Luca/0000-0003-4466-0724; 	CTMM, the Center for Translational Molecular Medicine, project PREDICCt [01C-104]; Dutch Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Netherlands Organization for Health Research and Development (ZonMw); European Union (FP-7); European Fund for the Integration of non-EU immigrants (EIF)	CTMM, the Center for Translational Molecular Medicine, project PREDICCt; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (FP-7)(European Commission); European Fund for the Integration of non-EU immigrants (EIF)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104 awarded to Sara-Joan Pinto-Sietsma [SJ-PS]), and supported by the Dutch Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The HELIUS study is conducted by the Academic Medical Center Amsterdam and the Public Health Service of Amsterdam. Both organisations provided core support for HELIUS. The HELIUS study is also funded by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), the European Union (FP-7), and the European Fund for the Integration of non-EU immigrants (EIF). We gratefully acknowledge the AMC Biobank for their support in biobank management and high-quality storage of collected samples. We are most grateful to the participants of the HELIUS study and the management team, research nurses, interviewers, research assistants and other staff who have taken part in gathering the data of this study.	Amraoui F, 2014, MICROCIRCULATION, V21, P499, DOI 10.1111/micc.12125; Balestra Gianmarco M, 2010, BMC Med Imaging, V10, P15, DOI 10.1186/1471-2342-10-15; Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Blann AD, 1998, ATHEROSCLEROSIS, V141, P133, DOI 10.1016/S0021-9150(98)00163-4; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Dane MJC, 2014, CLIN J AM SOC NEPHRO, V9, P698, DOI 10.2215/CJN.08160813; de Vet H.C.W., 2011, MEASUREMENT MED PRAC; Doonan RJ, 2010, HYPERTENS RES, V33, P398, DOI 10.1038/hr.2010.25; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Groen BBL, 2014, J APPL PHYSIOL, V116, P998, DOI 10.1152/japplphysiol.00919.2013; Gu YM, 2015, HYPERTENSION, V65, P993, DOI 10.1161/HYPERTENSIONAHA.114.05119; Hubble SMA, 2009, MICROCIRCULATION, V16, P183, DOI 10.1080/10739680802461935; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Kutner M. H., 2004, APPL LINEAR STAT MOD; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096477; Mulders TA, 2013, INT J CARDIOL, V168, P5026, DOI 10.1016/j.ijcard.2013.07.166; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Petersen SM, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-14; Plant AL, 2014, NAT METHODS, V11, P895, DOI 10.1038/nmeth.3076; Raunig DL, 2015, STAT METHODS MED RES, V24, P27, DOI 10.1177/0962280214537344; Shun-Shin M, 2012, PROG CARDIOVASC DIS, V55, P14, DOI 10.1016/j.pcad.2012.05.006; Snijder MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017873; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Tarbell JM, 2016, J INTERN MED, V280, P97, DOI 10.1111/joim.12465; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; Wallace JP, 2010, INT J CLIN PRACT, V64, P389, DOI 10.1111/j.1742-1241.2009.02146.x	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213175	10.1371/journal.pone.0213175	http://dx.doi.org/10.1371/journal.pone.0213175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870460	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300026
J	Wang, Z; Kang, L; Zhang, HF; Huang, YY; Fang, L; Li, MH; Brown, PJ; Arrowsmith, CH; Li, JW; Wong, JM				Wang, Zhen; Kang, Li; Zhang, Huifang; Huang, Yuanyong; Fang, Lan; Li, Menghan; Brown, Peter J.; Arrowsmith, Cheryl H.; Li, Jiwen; Wong, Jiemin			AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation	ONCOGENE			English	Article							TUMOR-INITIATING CELLS; UBIQUITIN LIGASE UBR5; SELF-RENEWAL; IN-VITRO; PROMOTES; TARGET; GROWTH; GENE; LUNG; PHOSPHORYLATION	As a transcription factor critical for embryonic and adult stem cell self-renewal and function, SOX2 gene amplification has been recognized as a driving factor for various cancers including esophageal cancer. SOX2 overexpression occurs more broadly in cancer than gene amplification, but the mechanism is poorly understood. Here we showed that in esophageal cancer cell lines the levels of SOX2 proteins are not directly correlated to the copy numbers of SOX2 genes and are strongly influenced by proteostasis. We showed that AKT is a major determinant for SOX2 overexpression and does so by protecting SOX2 from ubiquitin-dependent protein degradation. We identified UBR5 as a major ubiquitin E3 ligase that induces SOX2 degradation through ubiquitinating SOX2 at lysine 115. Phosphorylation of SOX2 at threonine 116 by AKT inhibits the interaction of UBR5 with SOX2 and thus stabilizes SOX2. We provided evidence that AKT inhibitor can effectively downregulate SOX2 and suppress esopheageal cancer cell proliferation and stemness. Taken together, our study provides new insight into the mechanism of SOX2 overexpression in cancer and evidence for targeting AKT as a potential therapeutic strategy for SOX2-positive cancers.	[Wang, Zhen; Kang, Li; Zhang, Huifang; Huang, Yuanyong; Fang, Lan; Li, Menghan; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Fengxian Dist Cent Hosp ECNU Joint Ctr Translat M, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Wang, Zhen; Kang, Li; Zhang, Huifang; Huang, Yuanyong; Fang, Lan; Li, Menghan; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Wong, Jiemin] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China; [Fang, Lan] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Shanghai 200072, Peoples R China; [Fang, Lan] Tongji Univ, Sch Life Sci & Technol, Shanghai 200072, Peoples R China	East China Normal University; East China Normal University; University of Toronto; Structural Genomics Consortium; Tongji University; Tongji University	Li, JW; Wong, JM (corresponding author), East China Normal Univ, Fengxian Dist Cent Hosp ECNU Joint Ctr Translat M, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.; Li, JW; Wong, JM (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Wong, JM (corresponding author), State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn	Wang, Zhen/GYI-9962-2022	Wang, Zhen/0000-0002-1215-1661; Brown, Peter/0000-0002-8454-0367; Arrowsmith, Cheryl/0000-0002-4971-3250; Wong, Jiemin/0000-0002-5311-842X	National Natural Science Foundation of China [81530078]; Ministry of Science and Technology of China [2017YFA0504201, 2015CB910402]; State Key Laboratory of Oncogenes and Related Genes [90-17-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Key Laboratory of Oncogenes and Related Genes	We thank Dr. Shimin Zhao from Fudan University for providing expression plasmids for UBR5C, Dr. Tianbang Kang from SUN YAT-SEN University (Guangzhou, China) for providing K30, K140, K410 and K520 cells and Dr. Zhihua Liu at Cancer Hospital Chinese Academy of Medical Sciences (Beijing, China) for providing K70, K150, K450 and K510 cells. We also thank members of Wong's lab for valuable discussion. This study is supported by grants from the National Natural Science Foundation of China (81530078), the Ministry of Science and Technology of China (2017YFA0504201 and 2015CB910402 to J.W.) and the Grants from the State Key Laboratory of Oncogenes and Related Genes (No. 90-17-05).	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fang XF, 2011, PROTEOMICS, V11, P921, DOI 10.1002/pmic.201000419; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gen Y, 2013, CANCER SCI, V104, P810, DOI 10.1111/cas.12155; Gen Y, 2010, CANCER GENET CYTOGEN, V202, P82, DOI 10.1016/j.cancergencyto.2010.01.023; Gupta N, 2018, CANCERS, V10, DOI 10.3390/cancers10020041; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Ikushima H, 2011, J BIOL CHEM, V286, P41434, DOI 10.1074/jbc.M111.300863; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Liu KC, 2013, CELL STEM CELL, V12, P304, DOI 10.1016/j.stem.2013.01.007; Lu YX, 2014, CLIN CANCER RES, V20, P2631, DOI 10.1158/1078-0432.CCR-13-2348; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Ozen M, 2015, CANCER INVEST, V33, P251, DOI 10.3109/07357907.2015.1025407; Peltier J, 2011, STEM CELLS DEV, V20, P1153, DOI 10.1089/scd.2010.0130; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Shearer RF, 2015, MOL CANCER RES, V13, P1523, DOI 10.1158/1541-7786.MCR-15-0383; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Tam WL, 2014, CANCER CELL, V26, P3, DOI 10.1016/j.ccr.2014.06.024; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wang H, 2018, METHODS MOL BIOL, V1692, P77, DOI 10.1007/978-1-4939-7401-6_7; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Wuebben EL, 2017, ONCOTARGET, V8, P44917, DOI 10.18632/oncotarget.16570; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zhang HF, 2016, STEM CELLS, V34, P2040, DOI 10.1002/stem.2395; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176	44	45	50	3	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5250	5264		10.1038/s41388-019-0790-x	http://dx.doi.org/10.1038/s41388-019-0790-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30894683				2022-12-26	WOS:000473025300010
J	Zhang, CG; Wang, RC; Liu, ZY; Bunker, E; Lee, S; Giuntini, M; Chapnick, D; Liu, XD				Zhang, Conggang; Wang, Rongchun; Liu, Zeyu; Bunker, Eric; Lee, Schuyler; Giuntini, Michelle; Chapnick, Douglas; Liu, Xuedong			The plant triterpenoid celastrol blocks PINK1-dependent mitophagy by disrupting PINK1's association with the mitochondrial protein TOM20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parkin; PTEN-induced putative kinase 1 (PINK1); mitophagy; mitochondria; chemical biology; celastrol; gamitrinib; plant terpenoid; TOM20; TOM70	NF-KAPPA-B; HEAT-SHOCK; DAMAGED MITOCHONDRIA; QUALITY-CONTROL; PARKIN; ACTIVATION; IMPORT; MECHANISMS; INDUCERS; IDENTIFICATION	A critical function of the PTEN-induced kinase 1 (PINK1)-Parkin pathway is to mediate the clearing of unhealthy or damaged mitochondria via mitophagy. Loss of either PINK1 or Parkin protein expression is associated with Parkinson's disease. Here, using a high-throughput screening approach along with recombinant protein expression and kinase, immunoblotting, and immunofluorescence live-cell imaging assays, we report that celastrol, a pentacyclic triterpenoid isolated from extracts of the medicinal plant Tripterygium wilfordii, blocks recruitment pof Parkin to mitochondria, preventing mitophagy in response to mitochondrial depolarization induced by carbonyl cyanide m-chlorophenylhydrazone or to gamitrinib-induced inhibition of mitochondrial heat shock protein 90 (HSP90). Celastrol's effect on mitophagy was independent of its known role in microtubule disruption. Instead, we show that celastrol suppresses Parkin recruitment by inactivating PINK1 and preventing it from phosphorylating Parkin and also ubiquitin. We also observed that PINK1 directly and strongly associates with TOM20, a component of the translocase of outer mitochondrial membrane (TOM) machinery and relatively weak binding to another TOM subunit, TOM70. Moreover, celastrol disrupted binding between PINK1 and TOM20 both in vitro and in vivo but did not affect binding between TOM20 and TOM70. Using native gel analysis, we also show that celastrol disrupts PINK1 complex formation upon mitochondrial depolarization and sequesters PINK1 to high-molecular-weight protein aggregates. These results reveal that celastrol regulates the mitochondrial quality control pathway by interfering with PINK1-TOM20 binding.	[Zhang, Conggang; Wang, Rongchun; Liu, Zeyu; Bunker, Eric; Lee, Schuyler; Giuntini, Michelle; Chapnick, Douglas; Liu, Xuedong] Univ Colorado, JSCBB, Dept Biochem, Boulder, CO 80303 USA; [Wang, Rongchun] Shandong Acad Sci, Qilu Univ Technol, Inst Biol, 28789 East Jinshi St, Jinan 250103, Shandong, Peoples R China	University of Colorado System; University of Colorado Boulder; Qilu University of Technology	Liu, XD (corresponding author), JSCBB, Dept Biochem, 3415 Colorado Ave, Boulder, CO 80303 USA.; Liu, XD (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	Xuedong.Liu@colorado.edu		LIU, XUEDONG/0000-0001-7209-4964	NIGMS, National Institutes of Health [R01GM113141, T32GM08759]; NCI, National Institutes of Health [R01CA107098]; National Institutes of Health [S10 RR026680, S10OD021601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM113141] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021601] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIGMS, National Institutes of Health Grant R01GM113141 and NCI, National Institutes of Health Grant R01CA107098 (to X.L.) The ImageXpress MicroXL was supported by National Institutes of Health Grant S10 RR026680, and the BDAria cell sorter was supported by National Institutes of Health Grant S10OD021601. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, National Institutes of Health Predoctoral Training Grant T32GM08759.	Akabane S, 2016, MOL CELL, V62, P371, DOI 10.1016/j.molcel.2016.03.037; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Fiesel FC, 2017, ONCOTARGET, V8, P106233, DOI 10.18632/oncotarget.22287; Figueiredo JN, 1998, J NAT PROD, V61, P718, DOI 10.1021/np9704157; Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062068; Klaic L, 2012, ACS CHEM BIOL, V7, P928, DOI 10.1021/cb200539u; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee S, 2015, J BIOL CHEM, V290, P904, DOI 10.1074/jbc.M114.606798; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Setty AR, 2005, SEMIN ARTHRITIS RHEU, V34, P773, DOI 10.1016/j.semarthrit.2005.01.011; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yang CZ, 2014, P NATL ACAD SCI USA, V111, P249, DOI 10.1073/pnas.1321341111; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang CG, 2017, J BIOL CHEM, V292, P15105, DOI 10.1074/jbc.M117.783175; Zhang CG, 2015, CELL RES, V25, P394, DOI 10.1038/cr.2014.159; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	55	14	15	6	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7472	7487		10.1074/jbc.RA118.006506	http://dx.doi.org/10.1074/jbc.RA118.006506			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885942	Green Published, hybrid			2022-12-26	WOS:000468402900031
J	Almasi, SM; Hu, T				Almasi, Seyed Mehrzad; Hu, Ting			Measuring the importance of vertices in the weighted human disease network	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; PROTEIN; GENES; INTERACTOME; PRIORITIZATION; COMPLEXES; PHENOME	Many human genetic disorders and diseases are known to be related to each other through frequently observed co-occurrences. Studying the correlations among multiple diseases provides an important avenue to better understand the common genetic background of diseases and to help develop new drugs that can treat multiple diseases. Meanwhile, network science has seen increasing applications on modeling complex biological systems, and can be a powerful tool to elucidate the correlations of multiple human diseases. In this article, known disease-gene associations were represented using a weighted bipartite network. We extracted a weighted human diseases network from such a bipartite network to show the correlations of diseases. Subsequently, we proposed a new centrality measurement for the weighted human disease network (WHDN) in order to quantify the importance of diseases. Using our centrality measurement to quantify the importance of vertices in WHDN, we were able to find a set of most central diseases. By investigating the 30 top diseases and their most correlated neighbors in the network, we identified disease linkages including known disease pairs and novel findings. Our research helps better understand the common genetic origin of human diseases and suggests top diseases that likely induce other related diseases.	[Almasi, Seyed Mehrzad; Hu, Ting] Mem Univ, Dept Comp Sci, St John, NF, Canada	Memorial University Newfoundland	Hu, T (corresponding author), Mem Univ, Dept Comp Sci, St John, NF, Canada.	ting.hu@mun.ca		Hu, Ting/0000-0001-6382-0602	National Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-04699]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	TH acknowledges the Discovery Grant RGPIN-2016-04699 from the National Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/ResearchPortal-PortailDeRecherche/Instructions-Instructions/DG-SD_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Serrano MA, 2012, MOL BIOSYST, V8, P843, DOI 10.1039/c2mb05306c; ARUMUGAM K, 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P266, DOI 10.3109/01443619209004047; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; BOTEZ MI, 1988, CAN J NEUROL SCI, V15, P299, DOI 10.1017/S0317167100027785; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brookhouser PE, 1996, PEDIATR CLIN N AM, V43, P1195, DOI 10.1016/S0031-3955(05)70514-9; Cantini L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17386; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Chen HL, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/130620; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; Czerwinski SL, 2015, VET OPHTHALMOL, V18, P515, DOI 10.1111/vop.12260; Darabos C, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-1; Davis A, CTD COMP TOXICOGENOM; Dimmock D, 2007, PEDIATRICS, V119, pE773, DOI 10.1542/peds.2006-1950; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Fiorentino E, 2008, CHIRURG ITALIANA, V58, P689; Gajarski R, 2009, J HEART LUNG TRANSPL, V28, P1329, DOI 10.1016/j.healun.2009.05.028; Galli E, 2007, ALLERGY ASTHMA PROC, V28, P540, DOI 10.2500/aap2007.28.3048; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Gutierrez-Sacristan A, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax043; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hu T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005986; Hu T, 2016, BIOCOMPUT-PAC SYM, P120; Hu T, 2013, GENET EPIDEMIOL, V37, P283, DOI 10.1002/gepi.21718; Hu T, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-364; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kacprowski T, 2013, BIOINFORMATICS, V29, P1471, DOI 10.1093/bioinformatics/btt164; Kaplowitz N, 2004, CLIN INFECT DIS, V38, pS44, DOI 10.1086/381446; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohler S, 2018, NUCL ACIDS RES; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Liu CC, 2014, NUCLEIC ACIDS RES, V42, pW137, DOI 10.1093/nar/gku412; Liu J, 2016, PHYSICA A, V452, P209, DOI 10.1016/j.physa.2016.02.049; Luo HM, 2016, BIOINFORMATICS, V32, P2664, DOI 10.1093/bioinformatics/btw228; Mansergh FC, 1999, AM J HUM GENET, V64, P971, DOI 10.1086/302344; Martinez V, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S5; MILLAR J H, 1965, Epilepsia, V6, P43, DOI 10.1111/j.1528-1157.1965.tb03349.x; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; NORGAARD F, 1965, RADIOLOGY, V85, P325, DOI 10.1148/85.2.325; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pavan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170365; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Ren ZM, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.128901; RODGER W, 1991, CAN MED ASSOC J, V145, P1571; Rowland LP, 1998, J NEUROL SCI, V160, pS6, DOI 10.1016/S0022-510X(98)00193-2; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sato O, 2001, CHILD NERV SYST, V17, P76, DOI 10.1007/s003810000381; Savin L H, 1935, Br J Ophthalmol, V19, P597, DOI 10.1136/bjo.19.11.597; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Silva DR, 2011, RESP CARE, V56, P961, DOI 10.4187/respcare.01056; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; STOLZ SE, 1991, EPILEPSIA, V32, P910, DOI 10.1111/j.1528-1157.1991.tb05550.x; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; TUCCI DL, 1987, ANN OTO RHINOL LARYN, V96, P343, DOI 10.1177/000348948709600321; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Weissmann G, 2009, BULL HOSP JT DIS, V67, P251; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; Yin T, 2017, SCI REPORTS, V7; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212; Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0	80	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0205936	10.1371/journal.pone.0205936	http://dx.doi.org/10.1371/journal.pone.0205936			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901770	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400002
J	Ansari, JM; Colasacco, C; Emmanouil, E; Kohlhepp, S; Harriott, O				Ansari, Juliana M.; Colasacco, Christine; Emmanouil, Elli; Kohlhepp, Scott; Harriott, Olivia			Strain-level diversity of commercial probiotic isolates of Bacillus, Lactobacillus, and Saccharomyces species illustrated by molecular identification and phenotypic profiling	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; IRRITABLE-BOWEL-SYNDROME; MECHANISMS; SYNBIOTICS; MICROBIOTA; BACTERIA; EFFICACY; PECTIN; GROWTH; AFLP	Probiotic products are becoming more prevalent as awareness of the role of beneficial microbes in health increases. Ingredient labels of these products often omit identifications at the strain level, making it difficult to track down applicable published research. In this study, we investigated whether products labeled with the same species name contained different strains of those species. From 21 commercially available probiotic supplements and beverages, we cultured five main species: Bacillus coagulans, Bacillus subtilis, Lactobacillus plantarum, Lactobacillus rhamnosus, and the yeast Saccharomyces boulardii. To confirm the identity of each bacterial isolate, we applied standard molecular approaches: 16S rRNA gene sequencing and Matrix Assisted Laser Desorption Ionization Time-of-Flight mass spectrometry (MALDI-TOF MS). Phenotypic profiling and identification were performed with the Biolog Microbial Identification system. All of the bacterial isolates were correctly identified by at least one approach. Sequencing the 16S rRNA gene led to 82% of species identifications matching the product label, with 71% of isolates identified by MALDI-TOF MS and 60% identified correctly with the Biolog system. Analysis of the Biolog phenotypic profiles revealed different patterns of carbon source usage by each species, with sugars preferentially utilized by all except B. subtilis. To assess the strain-level differences, we compared strains of the same species and found variability in carbohydrate utilization and tolerance to environmental stressors (salt, acidity, antibiotics). By demonstrating that products listing the same species often contain strains with different 16S sequences and phenotypes, this study highlights that current labels of probiotic supplements do not sufficiently convey the strain diversity in these products.	[Ansari, Juliana M.; Colasacco, Christine; Emmanouil, Elli; Kohlhepp, Scott; Harriott, Olivia] Fairfield Univ, Dept Biol, Fairfield, CT 06430 USA	Fairfield University	Ansari, JM (corresponding author), Fairfield Univ, Dept Biol, Fairfield, CT 06430 USA.	Juliana.m.ansari@gmail.com		Ansari, Juliana/0000-0001-8587-1128	NSF [CHE-1624744]	NSF(National Science Foundation (NSF))	We thank Fairfield University biology students in the Fundamentals of Microbiology Lab (Fall 2016) for isolating and characterizing bacteria and yeast from probiotic products. We are grateful for assistance from Eunsun Hong, Jenna Massaro, Samantha Porter and Philip Strang, with PCR and Biolog microbial identification, and to Fairfield University Biology lab supervisors Christopher Hetherington and Lenka Biardi for their valuable support. We thank Dr. David Benson for editorial feedback, and Carol Mariani at the Yale University DNA Analysis Facility on Science Hill (New Haven, CT) for assistance with DNA chromatogram interpretation. We also thank Dr. Jillian Smith-Carpenter of the Department of Chemistry & Biochemistry at Fairfield University for training on the MALDI-TOF mass spectrometer, supported by the NSF grant CHE-1624744 awarded to Fairfield University.	Arboleya S, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4388-9; Begovic J, 2010, CENT EUR J BIOL, V5, P103, DOI 10.2478/s11535-009-0078-1; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Biolog, 2013, GEN 3 MICROPLATE INS; Biolog I., 2010, BIOL MICROSTATION SY; Buntin N, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02402-16; Cai JY, 2018, UNITED EUR GASTROENT, V6, P169, DOI 10.1177/2050640617736987; Campana R, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0162-4; Ceapa C, 2015, APPL ENVIRON MICROB, V81, P5458, DOI 10.1128/AEM.00851-15; Celebioglu HU, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6030090; Celebioglu HU, 2017, J PROTEOMICS, V163, P102, DOI 10.1016/j.jprot.2017.05.015; Dahiya DK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00563; De Clerck E, 2004, POLYPHASIC CHARACTER, V60, P50; Di Cagno R, 2010, INT J FOOD MICROBIOL, V143, P246, DOI 10.1016/j.ijfoodmicro.2010.08.018; Duskova M, 2012, INT J FOOD MICROBIOL, V159, P107, DOI 10.1016/j.ijfoodmicro.2012.07.029; El Hage R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01889; Elshaghabee FMF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01490; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Freiwald A, 2009, NAT PROTOC, V4, P732, DOI 10.1038/nprot.2009.37; Goldstein EJC, 2015, CLIN INFECT DIS, V60, pS98, DOI 10.1093/cid/civ072; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Harley JP, 2017, LAB EXERCISES MICROB; Herbel SR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-27; Hornung B, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0594-6; Hungin APS, 2018, ALIMENT PHARM THER, V47, P1054, DOI 10.1111/apt.14539; Saez-Lara MJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/505878; KARAM NE, 1995, WORLD J MICROB BIOT, V11, P559, DOI 10.1007/BF00286373; Kearney SM, 2018, MICROB BIOTECHNOL, V11, P141, DOI 10.1111/1751-7915.12885; Khatri I, 2016, 2 PHYLOGENETICALLY D, P1, DOI [10.1371/journal.pone.0156745, DOI 10.1371/JOURNAL.PONE.0156745]; Khatri I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00414-2; Kolacek S, 2017, J PEDIATR GASTR NUTR, V65, P117, DOI 10.1097/MPG.0000000000001603; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee BJ, 2011, J NEUROGASTROENTEROL, V17, P252, DOI 10.5056/jnm.2011.17.3.252; Linares DM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00846; Liu JJ, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.02858-17, 10.1128/AEM.02858-17]; Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021; McFarland LV, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00124; Melles DC, 2007, J MICROBIOL METH, V69, P371, DOI 10.1016/j.mimet.2007.01.013; Meyer H, 2014, MOL BIOSYST, V10, P1812, DOI 10.1039/c4mb00112e; Nazzaro F, 2012, PHARMACEUTICALS-BASE, V5, P481, DOI 10.3390/ph5050481; Nova E, 2016, NUTR CLIN PRACT, V31, P387, DOI 10.1177/0884533615620350; Nyarko EB, 2015, J FOOD SCI, V80, pM2868, DOI 10.1111/1750-3841.13133; Pan MF, 2017, J FOOD SCI, V82, P744, DOI 10.1111/1750-3841.13608; Quigley EMM, 2019, CLIN GASTROENTEROL H, V17, P333, DOI 10.1016/j.cgh.2018.09.028; Ramakrishna BS, TROP GASTROENTEROL, V30, P76; Reid G, 2015, INT DAIRY J, V49, P16, DOI 10.1016/j.idairyj.2015.04.004; Rodino-Janeiro BK, 2018, ADV THER, V35, P289, DOI 10.1007/s12325-018-0673-5; Salvetti E, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00993-18, 10.1128/aem.00993-18]; Sanders ME, 2018, CURR OPIN BIOTECH, V49, P207, DOI 10.1016/j.copbio.2017.09.007; Sato J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186327; Shukla P., 2017, RECENT ADV APPL MICR, P133, DOI DOI 10.1007/978-981-10-5275-0_6; Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791; Sniffen JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209205; Theilmann MC, 2017, MBIO, V8, DOI [10.1128/mBio.01421-17, 10.1128/mbio.01421-17]; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Yadav R, 2018, CRIT REV FOOD SCI, V58, P1735, DOI 10.1080/10408398.2016.1274877; Yadav R, 2018, CURR PROTEIN PEPT SC, V19, P68, DOI 10.2174/1389203718666161111130157; Yadav R, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02116	59	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213841	10.1371/journal.pone.0213841	http://dx.doi.org/10.1371/journal.pone.0213841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901338	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400020
J	Cha, YJ; Park, EJ; Baik, SH; Lee, KY; Kang, J				Cha, Yoon Jin; Park, Eun Jung; Baik, Seung Hyuk; Lee, Kang Young; Kang, Jeonghyun			Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; NEOADJUVANT CHEMORADIOTHERAPY; ONCOLOGIC OUTCOMES; MONOCYTE RATIO; SURVIVAL; PREDICTOR; CHEMORADIATION; CHEMOTHERAPY; SURGERY; COUNT	Purpose This study investigated the significance of change in neutrophil-to-lymphocyte ratio (NLR) during preoperative chemoradiotherapy (preop-CRT) in patients with non-metastatic rectal cancer using a propensity score matching method (PSM). Methods Patients who underwent surgery after completion of preop-CRT for non-metastatic rectal cancers from Jan 2004 to Dec 2013 were retrospectively enrolled. NLRs were obtained before commencement of CRT (pre-NLR) and between completion of CRT and surgery (post-NLR). Using Cox regression hazards models, the association of NLRs with survival after PSM was examined. Results A total of 131 patients were grouped as follows: group A, pre-NLR < 3 & post-NLR < 3 (n = 47); group B, pre-NLR < 3 & post-NLR. 3 (n = 45); group C, pre-NLR. 3 & post-NLR < 3 (n = 5); group D, pre-NLR. 3 & post-NLR. 3 (n = 34). There was no difference in disease-free survival (DFS) or overall survival (OS) rate according to group. When dichotomized into group A versus groups B-D, DFS was higher in group A (84.7%) than groups BD (67.5%, p = 0.021). After PSM (n = 94), multivariable analysis identified persistent lower NLR as an independent favorable prognosticator of DFS (HR 0.37, 95% CI 0.15-0.92, p = 0.033). Conclusions Persistent non-inflammatory state measured by NLR may be an indicator of decreased risk of recurrence in patients with locally advanced rectal cancer treated with preop-CRT.	[Cha, Yoon Jin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Pathol, Seoul, South Korea; [Park, Eun Jung; Baik, Seung Hyuk; Kang, Jeonghyun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Lee, Kang Young] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, J (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea.	ravic@naver.com	Kang, Jeonghyun/K-7600-2019; Park, Eun Jung/W-1340-2019	Kang, Jeonghyun/0000-0001-7311-6053; Park, Eun Jung/0000-0002-4559-2690; Cha, Yoon Jin/0000-0002-5967-4064; Baik, Seung Hyuk/0000-0003-4183-2332				Abe S, 2018, J SURG RES, V222, P122, DOI 10.1016/j.jss.2017.09.053; Azab B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112361; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Caputo D, 2016, CANCER INVEST, V34, P440, DOI 10.1080/07357907.2016.1229332; Carruthers R, 2012, COLORECTAL DIS, V14, pE701, DOI 10.1111/j.1463-1318.2012.03147.x; Chan JCY, 2017, ANN SURG, V265, P539, DOI 10.1097/SLA.0000000000001743; Cheng H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11026; Chiang SF, 2012, INT J COLORECTAL DIS, V27, P1347, DOI 10.1007/s00384-012-1459-x; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deng YX, 2017, ONCOTARGETS THER, V10, P5575, DOI 10.2147/OTT.S146697; Dolan RD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16955-5; Dong YW, 2016, ONCOTARGETS THER, V9, P3127, DOI 10.2147/OTT.S103031; Dossa F, 2018, JAMA ONCOL, V4, P930, DOI 10.1001/jamaoncol.2017.5597; Ethier JL, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0794-1; Gu XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163523; Heo J, 2016, CANCER RES TREAT, V48, P232, DOI 10.4143/crt.2014.351; Hodek M, 2016, STRAHLENTHER ONKOL, V192, P632, DOI 10.1007/s00066-016-0988-6; Hur H, 2018, ANN COLOPROCTOL, V34, P212, DOI 10.3393/ac.2018.08.02.1; Jung KW, 2018, CANCER RES TREAT, V50, P303, DOI 10.4143/crt.2018.143; Jung SW, 2017, ONCOTARGET, V8, P59757, DOI 10.18632/oncotarget.15760; Kelsey KT, 2018, ANN AM THORAC SOC, V15, pS76, DOI 10.1513/AnnalsATS.201706-477MG; Kim IY, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-94; Kim TG, 2019, TUMORI J, V105, P434, DOI 10.1177/0300891618792476; Kitayama J, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-47; Krauthamer M, 2013, ONCOLOGY-BASEL, V85, P27, DOI 10.1159/000348385; Lee IH, 2017, ANTICANCER RES, V37, P1459, DOI 10.21873/anticanres.11470; Lee JG, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013827; LEE MY, 1984, BLOOD, V64, P499; Lee YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25970-z; Lino-Silva Leonardo S, 2016, Med Arch, V70, P256; Liu JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38551; Malietzis G, 2014, ANN SURG ONCOL, V21, P3938, DOI 10.1245/s10434-014-3815-2; Malietzis G, 2014, ANN SURG, V260, P287, DOI 10.1097/SLA.0000000000000216; Nagasaki T, 2015, DIGEST SURG, V32, P496, DOI 10.1159/000441396; Park IJ, 2015, INT J RADIAT ONCOL, V92, P540, DOI 10.1016/j.ijrobp.2015.02.020; Portale G, 2018, J GASTROINTEST SURG, V22, P1611, DOI 10.1007/s11605-018-3781-2; Pugh JL, 2014, J IMMUNOL, V193, P1451, DOI 10.4049/jimmunol.1400434; Qi XS, 2016, ONCOTARGET, V7, P45283, DOI 10.18632/oncotarget.9942; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shen JW, 2017, MED SCI MONITOR, V23, P315, DOI 10.12659/MSM.902752; Shen LJ, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0295-2; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; SPRENT J, 1974, EUR J IMMUNOL, V4, P204, DOI 10.1002/eji.1830040310; Sung S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173955; Toiyama Y, 2015, INT SURG, V100, P199, DOI 10.9738/INTSURG-D-13-00178.1; Vallard Alexis, 2018, Oncotarget, V9, P22368, DOI 10.18632/oncotarget.25023; Venkatesulu BP, 2018, CRIT REV ONCOL HEMAT, V123, P42, DOI 10.1016/j.critrevonc.2018.01.003; Ward WH, 2018, J SURG RES, V232, P275, DOI 10.1016/j.jss.2018.06.060; Yamamoto A, 2019, DIS COLON RECTUM, V62, P171, DOI 10.1097/DCR.0000000000001245; Yodying H, 2016, ANN SURG ONCOL, V23, P646, DOI 10.1245/s10434-015-4869-5; Yu YL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4230-z; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111906	52	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214415	10.1371/journal.pone.0214415	http://dx.doi.org/10.1371/journal.pone.0214415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901357	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400052
J	Huys, N; Cardon, G; De Craemer, M; Hermans, N; Renard, S; Roesbeke, M; Stevens, W; De Lepeleere, S; Deforche, B				Huys, Nele; Cardon, Greet; De Craemer, Marieke; Hermans, Ninotchka; Renard, Siska; Roesbeke, Marleen; Stevens, Wout; De Lepeleere, Sara; Deforche, Benedicte			Effect and process evaluation of a real-world school garden program on vegetable consumption and its determinants in primary schoolchildren	PLOS ONE			English	Article							NUTRITION EDUCATION; PHYSICAL-ACTIVITY; FAMILY AFFLUENCE; FRUIT; IMPACT; INTERVENTIONS; CHILDREN; HEALTH; KNOWLEDGE; PREFERENCES	Objectives This study aimed to investigate the effectiveness of a school garden program on children's vegetable consumption and determinants and to gain insight into the process of the program. Methods The "Taste Garden" is a real-world nine-week school garden program developed and implemented by a local organization. A total of 350 children (149 intervention group, 201 control group) filled out questionnaires on vegetable consumption, determinants and process of the program. Additionally, teachers filled out a process evaluation questionnaire. For effect evaluation, interaction effects (time x group) were considered, using multilevel repeated measures analyses in MLwiN 3.02. Interaction effects were repeated, taking into account quality of implementation (time x implementation group). Process evaluation was descriptively assessed with SPSS 24.0. Results Overall, beside some practical concerns of teachers, the program was well perceived by teachers and children. However, an intervention effect of "The Taste Garden" was only found for knowledge (p = 0.02), with a very small effect size (0.55%). When taking into account implementation quality, only small effects were found for awareness (p between 0.005 and 0.007 and an effect size of 0.63%) and knowledge (p between 0.04 and 0.09 and an effect size of 0.65%). Cconclusions Evaluation of the real-world "Taste Garden" program, which was positively perceived by teachers, showed no effects on vegetable consumption and small effects on its determinants. Adaptations of the current format and longer follow-up periods are therefore recommended.	[Huys, Nele; Cardon, Greet; De Craemer, Marieke; De Lepeleere, Sara] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Ghent, Belgium; [Hermans, Ninotchka; Renard, Siska; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, Ghent, Belgium; [Roesbeke, Marleen; Stevens, Wout] Logo Gezond, Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Cardon, G (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Ghent, Belgium.	Greet.Cardon@UGent.be	De Craemer, Marieke/Z-3050-2019; De Craemer, Marieke/P-6072-2016	De Craemer, Marieke/0000-0002-5220-7850; Cardon, Greet/0000-0003-4983-6557				Agentschap voor Onderwijsdiensten, 2015, WIE IS ER NIET ALS S; Andersen A, 2008, J EPIDEMIOL COMMUN H, V62, P1092, DOI 10.1136/jech.2007.065169; Bartholomew LK, 2016, PLANNING HLTH PROMOT; Berezowitz CK, 2015, J SCHOOL HEALTH, V85, P508, DOI 10.1111/josh.12278; Blanchette L, 2005, J HUM NUTR DIET, V18, P431, DOI 10.1111/j.1365-277X.2005.00648.x; Bouffard JA, 2003, EVAL PROGRAM PLANN, V26, P149, DOI 10.1016/S0149-7189(03)00010-7; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; Christian MS, 2014, DOES ROYAL HORTICULT; Contento IR, 2008, ASIA PAC J CLIN NUTR, V17, P176; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Davis JN, 2015, PUBLIC HEALTH NUTR, V18, P2358, DOI 10.1017/S1368980015000221; Dudley DA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0182-8; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Food and Agriculture Organization of the United Nations [FAO], 2004, SCH GARD CONC NOT IM; Gahagan S, 2012, J DEV BEHAV PEDIATR, V33, P261, DOI 10.1097/DBP.0b013e31824a7baa; Green L., 1999, PRECEDE PROCEED MODE, V3rd ed., P32; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Huys N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121454; Jaenke RL, 2012, HEALTH EDUC BEHAV, V39, P131, DOI 10.1177/1090198111408301; Kehoe S., 2010, EFFECTIVE ED, V2, P155, DOI [10.1080/19415532.2010.524758, DOI 10.1080/19415532.2010.524758]; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Kelly MP, 2016, PUBLIC HEALTH, V136, P109, DOI 10.1016/j.puhe.2016.03.030; Krolner R, 2006, INT J BEHAV NUTR PHY, V11, P3; Krolner R, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-112; Langellotto GA, 2012, HORTTECHNOLOGY, V22, P430, DOI 10.21273/HORTTECH.22.4.430; Lee A, 2009, APPL HEALTH ECON HEA, V7, P11, DOI 10.2165/00148365-200907010-00002; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Lynch C, 2014, PUBLIC HEALTH NUTR, V17, P2436, DOI 10.1017/S1368980014001347; LYTLE L, 1995, J NUTR EDUC, V27, P250, DOI 10.1016/S0022-3182(12)80793-X; Mennella JA, 2016, ADV NUTR, V7, p211S, DOI 10.3945/an.115.008649; Morgan PJ, 2010, PUBLIC HEALTH NUTR, V13, P1931, DOI 10.1017/S1368980010000959; Morris J. L., 2001, California Agriculture, V55, P43, DOI 10.3733/ca.v055n01p43; Morris JL, 2002, J AM DIET ASSOC, V102, P91, DOI 10.1016/S0002-8223(02)90027-1; Ohly H., 2016, BMC PUBLIC HEALTH, V16, P36, DOI DOI 10.1186/S12889-016-2710-0; Parmer SM, 2009, J NUTR EDUC BEHAV, V41, P212, DOI 10.1016/j.jneb.2008.06.002; Prochaska J O, 1992, Prog Behav Modif, V28, P183; Racey M, 2016, J SCHOOL HEALTH, V86, P452, DOI 10.1111/josh.12396; Ratcliffe MM, 2011, HEALTH PROMOT PRACT, V12, P36, DOI 10.1177/1524839909349182; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Somerset S, 2009, PUBLIC HEALTH NUTR, V12, P214, DOI 10.1017/S1368980008003327; te Velde SJ, 2008, BRIT J NUTR, V99, P893, DOI 10.1017/S000711450782513X; Van Cauwenberghe E, 2010, BRIT J NUTR, V103, P781, DOI 10.1017/S0007114509993370; Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X; Van Lippevelde W, 2012, INT J PUBLIC HEALTH, V57, P673, DOI 10.1007/s00038-012-0335-3; WANG X, 2014, BMJ BRIT MED J, V349; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; WHO, 2003, WHO TECH REP SER, V916, P1; Wind M, 2008, HEALTH EDUC RES, V23, P997, DOI 10.1093/her/cym078; Wind M, 2006, J NUTR EDUC BEHAV, V38, P211, DOI 10.1016/j.jneb.2006.02.011	50	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214320	10.1371/journal.pone.0214320	http://dx.doi.org/10.1371/journal.pone.0214320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897160	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700082
J	Pagnier, L; Jacquod, P				Pagnier, Laurent; Jacquod, Philippe			Inertia location and slow network modes determine disturbance propagation in large-scale power grids	PLOS ONE			English	Article							ROTATIONAL INERTIA; INCREASED PENETRATION; SYSTEM STABILITY; GENERATORS; IMPACT	Conventional generators in power grids are steadily substituted with new renewable sources of electric power. The latter are connected to the grid via inverters and as such have little, if any rotational inertia. The resulting reduction of total inertia raises important issues of power grid stability, especially over short-time scales. With the motivation in mind to investigate how inertia reduction influences the transient dynamics following a fault in a large-scale electric power grid, we have constructed a model of the high voltage synchronous grid of continental Europe. To assess grid stability and resilience against disturbance, we numerically investigate frequency deviations as well as rates of change of frequency (RoCoF) following abrupt power losses. The magnitude of RoCoF's and frequency deviations strongly depend on the fault location, and we find the largest effects for faults located on the support of the slowest mode-the Fiedler mode-of the network Laplacian matrix. This mode essentially vanishes over Belgium, Eastern France, Western Germany, northern Italy and Switzerland. Buses inside these regions are only weakly affected by faults occuring outside. Conversely, faults inside these regions have only a local effect and disturb only weakly outside buses. Following this observation, we reduce rotational inertia through three different procedures by either (i) reducing inertia on the Fiedler mode, (ii) reducing inertia homogeneously and (iii) reducing inertia outside the Fiedler mode. We find that procedure (iii) has little effect on disturbance propagation, while procedure (i) leads to the strongest increase of RoCoF and frequency deviations. This shows that, beyond absorbing frequency disturbances following nearby faults, inertia also mitigates frequency disturbances from distant power losses, provided both the fault and the inertia are located on the support of the slowest modes of the grid Laplacian. These results for our model of the European transmission grid are corroborated by numerical investigations on the ERCOT transmission grid.	[Pagnier, Laurent; Jacquod, Philippe] Univ Appl Sci Western Switzerland HES SO, Sch Engn, Sion, Switzerland; [Pagnier, Laurent] Ecole Polytech Fed Lausanne, Inst Theoret Phys, Lausanne, Switzerland; [Jacquod, Philippe] Univ Geneva, Dept Quantum Matter Phys, Geneva, Switzerland	University of Applied Sciences & Arts Western Switzerland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Jacquod, P (corresponding author), Univ Appl Sci Western Switzerland HES SO, Sch Engn, Sion, Switzerland.; Jacquod, P (corresponding author), Univ Geneva, Dept Quantum Matter Phys, Geneva, Switzerland.	philippe.jacquod@hevs.ch	Jacquod, Philippe/J-6385-2016	Jacquod, Philippe/0000-0002-0587-3535	Swiss National Science Foundation AP Energy [PYAPP2_154275]	Swiss National Science Foundation AP Energy	This work has been supported by the Swiss National Science Foundation AP Energy Grant PYAPP2_154275.	Bevrani H, 2014, INT J ELEC POWER, V54, P244, DOI 10.1016/j.ijepes.2013.07.009; Birchfield AB, 2017, IEEE T POWER SYST, V32, P3258, DOI 10.1109/TPWRS.2016.2616385; Borsche T., 2017, ARXIV170503244; Borsche TS, 2015, IEEE DECIS CONTR P, P5940, DOI 10.1109/CDC.2015.7403153; Eftekharnejad S, 2013, IEEE T SUSTAIN ENERG, V4, P960, DOI 10.1109/TSTE.2013.2259602; ENTSO-E, 2016, FREQ STAB EV CRIT SY; Gautam D, 2009, IEEE T POWER SYST, V24, P1426, DOI 10.1109/TPWRS.2009.2021234; Jenkins N., 2000, EMBEDDED GENERATION; Machowski J., 2008, POWER SYSTEM DYNAMIC, V2nd; Pirani M., 2017, P IEEE 56 ANN C DEC, P5106, DOI DOI 10.1109/CDC.2017.8264415; Poolla BK, 2017, IEEE T AUTOMAT CONTR, V62, P6209, DOI 10.1109/TAC.2017.2703302; Quintero J, 2014, IEEE T POWER SYST, V29, P2248, DOI 10.1109/TPWRS.2014.2303293; Tamrakar S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24685-5; Tielens P, 2016, RENEW SUST ENERG REV, V55, P999, DOI 10.1016/j.rser.2015.11.016; Tyloo M, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.084101; Tyloo M, 2018, KEY PLAYER PROBLEM C; Ulbig A, 2014, IFAC P, V47, P7290; Ulbig A, 2015, IFAC PAPERSONLINE, V48, P541, DOI 10.1016/j.ifacol.2015.12.436; Wolter J, 2017, ARXIV171009687; Yan J, 2017, IEEE 56 ANN C DEC CO; Zhong QC, 2011, IEEE T IND ELECTRON, V58, P1259, DOI 10.1109/TIE.2010.2048839	23	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213550	10.1371/journal.pone.0213550	http://dx.doi.org/10.1371/journal.pone.0213550			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897100	Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700023
J	Moore, DK; Motaung, B; du Plessis, N; Shabangu, AN; Loxton, AG; Gutschmidt, A; van Rensburg, IC; Kleynhans, L; Malherbe, ST; Flinn, M; Walzl, G				Moore, Dannielle K.; Motaung, Bongani; du Plessis, Nelita; Shabangu, Ayanda N.; Loxton, Andre G.; Gutschmidt, A.; van Rensburg, I. C.; Kleynhans, L.; Malherbe, S. T.; Flinn, M.; Walzl, G.		SU-IRG Consortium	Isolation of B-cells using Miltenyi MACS bead isolation kits	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CO-STIMULATION; SUBSET; LYMPHOCYTES; MODULATION; INDUCTION; PHENOTYPE; VIABILITY; PLATELETS; CYTOKINE	This article describes the procedures used to isolate pure B-cell populations from whole blood using various Miltenyi magnetic-activated cell sorting (MACS) bead Isolation kits. Such populations are vital for studies investigating the functional capacity of B-cells, as the presence of other cell types may have indirect effects on B-cell function through cell-cell interactions or by secretion of several soluble molecules. B-cells can be isolated by two main approaches: 1) Negative selection-in which B-cells remain "untouched" in their native state; this is advantageous as it is likely that B-cells remain functionally unaltered by this process. 2) Positive selection-in which B-cells are labelled and actively removed from the sample. We used three Negative B-cell isolation kits as well as the Positive B-cell isolation kit from Miltenyi and compared the purity of each of the resulting B-cells fractions. Contamination of isolated B-cell fractions with platelets was the conclusive finding for all of the isolation techniques tested. These results illustrate the inefficiency of current available MACS B-cell isolation kits to produce pure B-cell populations, from which concrete findings can be made. As such we suggest cell sorting as the preferred method for isolating pure B-cells to be used for downstream functional assays.	[Moore, Dannielle K.; Motaung, Bongani; du Plessis, Nelita; Shabangu, Ayanda N.; Loxton, Andre G.] Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa; [Moore, Dannielle K.; Motaung, Bongani; du Plessis, Nelita; Shabangu, Ayanda N.; Loxton, Andre G.] Stellenbosch Univ, South African Med Res Council Ctr TB Res, Cape Town, South Africa; [Moore, Dannielle K.; Motaung, Bongani; du Plessis, Nelita; Shabangu, Ayanda N.; Loxton, Andre G.; SU-IRG Consortium] Stellenbosch Univ, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Stellenbosch University	Loxton, AG (corresponding author), Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa.; Loxton, AG (corresponding author), Stellenbosch Univ, South African Med Res Council Ctr TB Res, Cape Town, South Africa.; Loxton, AG (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Cape Town, South Africa.	GL2@sun.ac.za		Kenny, Dannielle/0000-0002-0437-6721; Loxton, Andre/0000-0003-0659-9803; du Plessis, Nelita/0000-0001-7881-925X	Stellenbosch University; Stellenbosch University Immunology Research Group; Molecular Biology and Human Genetics Clinical Group; National Research Foundation; NRF-CSUR [CSUR60502163639]; NRF program; Centre for Tuberculosis Research from the South African Medical Research Council; South African Medical Research Council	Stellenbosch University; Stellenbosch University Immunology Research Group; Molecular Biology and Human Genetics Clinical Group; National Research Foundation; NRF-CSUR; NRF program; Centre for Tuberculosis Research from the South African Medical Research Council(South African Medical Research Council); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Stellenbosch University; Stellenbosch University Immunology Research Group and the Molecular Biology and Human Genetics Clinical Group; National Research Foundation; South African Medical Research Council. AGL is supported by the NRF-CSUR (Grant Number CSUR60502163639) and the Centre for Tuberculosis Research from the South African Medical Research Council. DM and BM receive NRF bursaries.; The authors acknowledge the technical and financial support from Stellenbosch University; Stellenbosch University Immunology Research Group and the Molecular Biology and Human Genetics Clinical Group; National Research Foundation; South African Medical Research Council. DM and BM received bursaries from the NRF program. AGL is supported by the NRF-CSUR (Grant Number CSUR60502163639) and the Centre for Tuberculosis Research from the South African Medical Research Council.	Abbas AK, 2014, BASIC IMMUNOLOGY FUN; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; BRECHER G, 1950, J APPL PHYSIOL, V3, P365, DOI 10.1152/jappl.1950.3.6.365; Breloer M, 2007, EUR J IMMUNOL, V37, P634, DOI 10.1002/eji.200636852; BULL BS, 1965, AM J CLIN PATHOL, V44, P678; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Corkum CP, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0113-0; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; du Plessis WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152710; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elzey BD, 2005, CELL IMMUNOL, V238, P1, DOI 10.1016/j.cellimm.2005.12.005; Igaz P, 2001, INFLAMM RES, V50, P123, DOI 10.1007/s000110050735; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Joosten SA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005687; Kleiveland C.R., 2015, IMPACT FOOD BIOACTIV, P161, DOI [10.1007/978-3-319-16104-4_15, DOI 10.1007/978-3-319-16104-4_15]; Kral JB, 2016, TRANSFUS MED HEMOTH, V43, P78, DOI 10.1159/000444807; Kretschmer B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000755; Lozano M, 1998, MED CLIN-BARCELONA, V110, P774; Lundy SK, 2002, INFECT IMMUN, V70, P812, DOI 10.1128/IAI.70.2.812-819.2002; Lundy SK, 2009, INFLAMM RES, V58, P345, DOI 10.1007/s00011-009-0014-x; Martinez-Martin N, 2017, SCIENCE, V355, P641, DOI 10.1126/science.aal3908; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; MUIRHEAD KA, 1985, J IMMUNOL METHODS, V77, P77, DOI 10.1016/0022-1759(85)90185-1; MULLER K, 1991, IMMUNOPHARMACOLOGY, V21, P121, DOI 10.1016/0162-3109(91)90015-Q; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; PENTTILA A, 1975, J HISTOCHEM CYTOCHEM, V23, P251, DOI 10.1177/23.4.805169; POWER CA, 1995, CYTOKINE, V7, P479, DOI 10.1006/cyto.1995.0065; Qiu ZY, 2016, INFLAMM RES, V65, P647, DOI 10.1007/s00011-016-0947-9; Rao M, 2015, CLIN INFECT DIS, V61, pS225, DOI 10.1093/cid/civ614; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Schmid I, 2001, J IMMUNOL METHODS, V247, P175, DOI 10.1016/S0022-1759(00)00323-9; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Silverstein RL, 2009, CLEVE CLIN J MED S2, V76, pS27, DOI DOI 10.3949/CCJM.76.S2.06; Soslau G, 1997, CYTOKINE, V9, P405, DOI 10.1006/cyto.1996.0182; Sowa JM, 2009, ARCH IMMUNOL THER EX, V57, P235, DOI 10.1007/s00005-009-0032-y; Takatsu K, 1997, P SOC EXP BIOL MED, V215, P121; Tsui C, 2018, IMMUNITY; van Rensburg IC, 2018, TUBERCULOSIS, V108, P114, DOI 10.1016/j.tube.2017.11.010; Wrenshall LE, 1999, J LEUKOCYTE BIOL, V66, P391, DOI 10.1002/jlb.66.3.391; Xu H, 2008, IMMUNOLOGY, V125, P218, DOI 10.1111/j.1365-2567.2008.02832.x; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zabriskie JB, 2009, ESSENTIAL CLINICAL IMMUNOLOGY, P1, DOI 10.1017/CBO9780511575266	46	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213832	10.1371/journal.pone.0213832	http://dx.doi.org/10.1371/journal.pone.0213832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893384	gold, Green Published, Green Submitted			2022-12-26	WOS:000461765900053
J	Shwe, ATW; Riewpaiboon, A; Chaikledkaew, U; Youngkong, S				Shwe, A. Thi Win; Riewpaiboon, Arthorn; Chaikledkaew, Usa; Youngkong, Sitaporn			Treatment cost and costing model of obstetric complications at a hospital in Myanmar	PLOS ONE			English	Article								Maternal health still remains a major challenge in almost all developing countries. In Myanmar, the country met only 62% of its target for the maternal mortality rate (130 per 100,000 live birth) even though proportion of skilled birth attendant (SBA) and antenatal care (ANC) coverage was 80% in 2015. Despite the estimated large maternal complications, most maternal healthcare program ignored the burden of those morbidity because of limited understanding of the incidence and prevalence of morbidity conditions and cost of those morbidity burdens on society. The present study provides a general idea of the scope of obstetric complication, incidence of obstetric complication, and cost of those morbidity burdens on society. We conducted a retrospective incidence-based cost of illness study related to obstetric complication from the healthcare system perspective at 25 bedded township hospital in Yedashae during the fiscal year of 2015- 2016. For the cost of obstetric complication, average treatment cost was 26.83 USD (+/- 8.59). When looking by disease category, average treatment cost for incomplete abortion was 35.45 USD (+/- 1.75); pelvic inflammatory disease ( PID) was 16.01 USD; pregnancy-induced hypertension PIH) was 21.02 USD (+/- 4.68); ante- partum hemorrhage (APH) was 14.24(+/- 0.25); post- partum hemorrhage (PPH) was 27.04 USD (+/- 1.56); prolonged labor was 37.55 USD (+/- 0.42); and septicemia was 16.51 USD (+/- 2.15). Significant predicting variables in obstetric complication cost model were incomplete abortion, prolonged labor, post- partum hemorrhage (PPH), pregnancy induced hypertension (PIH), patient age and septicemia. From this study, we can summarize the most frequently occurred obstetric complication in that township area, actual cost burden of those complications and obstetric complication cost model which can be useful for hospital financial management. This study can be considered as a starting point for cost of illness analysis in Myanmar to prioritize and target specific health problem at a country level for policy maker to set priorities for health care intervention.	[Shwe, A. Thi Win; Riewpaiboon, Arthorn; Chaikledkaew, Usa; Youngkong, Sitaporn] Mahidol Univ, Fac Pharm, Dept Pharm, Div Social & Adm Pharm, Bangkok, Thailand; [Shwe, A. Thi Win] Univ Pharm, Minist Hlth & Sports, Dept Pharmaceut, Yangon, Myanmar	Mahidol University	Riewpaiboon, A (corresponding author), Mahidol Univ, Fac Pharm, Dept Pharm, Div Social & Adm Pharm, Bangkok, Thailand.	arthorn.rie@mahidol.ac.th	Riewpaiboon, Arthorn/AAV-1115-2021	Riewpaiboon, Arthorn/0000-0003-2959-3244; Win Shwe, A Thi/0000-0002-6610-4924				Afifi A, 1999, COMPUTER AIDED MULTI, V2nd; [Anonymous], 2015, APPL MULTIPLE REGRES; Ashrafedin Y., 2014, ESTIMATING COST MATE; Borghi J., 2001, WHAT IS COST MATERNA; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069728; Cho-Min-Naing, 2004, ACTA TROP, V92, P173, DOI 10.1016/j.actatropica.2003.12.005; Cohen J., 2003, APPL MULTIPLE REGRES; Dang DA, 2010, J HEALTH POPUL NUTR, V28, P436; Health System Strengthening Unit, 2016, MAT CHILD HLTH VOUCH; Islam K, 2006, COST MATERNAL NEWBOR; Iyengar K, 2012, J HEALTH POPUL NUTR, V30, P226; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Ministry of Health, 2014, HLTH MYANM; Ministry of Health (Myanmar) World Health Organization HITAP, 2014, MIDT REV MAT CHILD H; Ministry of Health World Health Organization HITAP, 2010, FEAS STUD COMM HLTH; Naghma-e-Rehan, 2011, J PAK MED ASSOC, V61, P169; OECD, 2011, HLTH GLANC 2011 OECD, P2016, DOI [10.1787/health_glance-2011-en, DOI 10.1787/HEALTH_GLANCE-2011-EN]; Riewpaiboon A, 2007, VALUE HEALTH, V10, P223, DOI 10.1111/j.1524-4733.2007.00172.x; Riewpaiboon Arthorn, 2014, Journal of the Medical Association of Thailand, V97, pS17; Riewpaiboon Arthorn, 2008, Pharmacy Pract (Granada), V6, P9; Vlassoff M, 2009, INT PERSPECT SEX R H, V35, P114, DOI 10.1363/ipsrh.35.114.09	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213141	10.1371/journal.pone.0213141	http://dx.doi.org/10.1371/journal.pone.0213141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893318	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900029
J	Ma, YC; Wang, L; Wang, JY; Zhong, Y; Cheng, ZM				Ma, Yuanchun; Wang, Li; Wang, Jiaoyang; Zhong, Yan; Cheng, Zong-Ming (Max)			Isolation and expression analysis of Salt Overly Sensitive gene family in grapevine (Vitisvinifera) in response to salt and PEG stress	PLOS ONE			English	Article							PROTEIN-KINASE SOS2; ARABIDOPSIS-THALIANA; TOLERANCE; SALINITY; PROLINE; DROUGHT; OVEREXPRESSION; ACCUMULATION; PATHWAY; MUTANT	Salt stress is one of the major environmental constraints for the production and yield of grape (Vitis vinifera) worldwide. The SOS3 gene family is part of the Salt Overly Sensitive (SOS) signaling pathway, a well-defined signaling pathway known to play a role in plant response to salt stress. In this study, the grapevine SOS3 gene family was annotated and the role of the annotated genes in salinity stress response was characterized. Nine grapevine SOS3 genes was identified in the grapevine genome and was subsequently analyzed. The expression patterns of the nine VviSOS3 genes, as determined by reverse transcription quantitative PCR (RT-qPCR), varied greatly in leaves, roots, and stems of in-vitro grown Pinot noir grapevine cultivar(PN40024) in response to salt (250mM NaCl) and polyethylene glycol 6000 (PEG, osmolality equal to the salt treatment) treatments over a 36h time period. All of the VviSOS3 genes, except VviOS3.7, were up-regulated in leaves in response to the salt and PEG treatments. The majority of VviSOS3 genes, except VviSOS3.8 were up-regulated in roots in response to the PEG stress, with an opposite expression pattern in the root and stem in response to salt stress. The salinity treatment decreased the soluble protein content. Based on the expression pattern and physiological data, VviSOS3.7 and VviSOS3.8 were identified as candidate genes for further functional characterizations regarding their role in the response of grapevine to salt stress.	[Ma, Yuanchun; Wang, Li; Wang, Jiaoyang; Zhong, Yan; Cheng, Zong-Ming (Max)] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Cheng, Zong-Ming (Max)] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA	Nanjing Agricultural University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Zhong, Y; Cheng, ZM (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.; Cheng, ZM (corresponding author), Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA.	yzhong@njau.edu.cn; zmc@njau.edu.cn			National Natural Science Foundation of China [31601739]; Priority Academic Program Development of Modern Horticulture Science in Jiangsu Province; Chinese Ministry of agriculture(948) [2011-G21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Modern Horticulture Science in Jiangsu Province; Chinese Ministry of agriculture(948)	This study was supported by the National Natural Science Foundation of China (31601739) and in part by Priority Academic Program Development of Modern Horticulture Science in Jiangsu Province and Chinese Ministry of agriculture(948(#2011-G21)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31601739) and in part by Priority Academic Program Development of Modern Horticulture Science in Jiangsu Province and Chinese Ministry of agriculture(948(#2011-G21)).	Aiyar A, 2000, Methods Mol Biol, V132, P221; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Chapman DM, 2004, AM J ENOL VITICULT, V55, P325; CRAMER GR, 1987, PLANT PHYSIOL, V83, P510, DOI 10.1104/pp.83.3.510; Fahmideh L, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0076-7; Fujii H, 2009, MOL PLANT, V2, P183, DOI 10.1093/mp/ssn087; Gao S, 2012, J INTEGR AGR, V11, P378, DOI 10.1016/S2095-3119(12)60022-7; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Guo Y, 2004, PLANT CELL, V16, P435, DOI 10.1105/tpc.019174; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; HEYSER JW, 1981, PLANT PHYSIOL, V68, P1454, DOI 10.1104/pp.68.6.1454; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Krachler M, 2002, J ANAL ATOM SPECTROM, V17, P844, DOI 10.1039/b200780k; [刘建新 Liu Jianxin], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P244; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Ma DM, 2014, PROTOPLASMA, V251, P219, DOI 10.1007/s00709-013-0540-9; Ma YC, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.31; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; Mohammadkhani N, 2018, IRAN J SCI TECHNOL A, V42, P401, DOI 10.1007/s40995-016-0061-4; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Nutan KK, 2018, CURR GENOMICS, V19, P60, DOI 10.2174/1389202918666170228133621; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Roby G, 2004, AUST J GRAPE WINE R, V10, P100, DOI 10.1111/j.1755-0238.2004.tb00012.x; Rong SY, 2011, J HENAN AGR SCI, DOI [10.1007/BF00390296, DOI 10.1007/BF00390296]; Sathee L, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1910-z; Shani U, 2005, AM J ENOL VITICULT, V56, P148; STEWART GR, 1974, PLANTA, V120, P279, DOI 10.1007/BF00390296; Sucu S, 2018, ERWERBS-OBSTBAU, V60, P127, DOI 10.1007/s10341-017-0345-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Trewavas AJ, 1998, CURR OPIN PLANT BIOL, V1, P428, DOI 10.1016/S1369-5266(98)80268-9; Tsugane K, 1999, PLANT CELL, V11, P1195, DOI 10.1105/tpc.11.7.1195; Vannozzi A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-130; Wang G, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0219-1, 10.1186/s12862-014-0186-z]; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Xi Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00978; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Yang YQ, 2018, J INTEGR PLANT BIOL, V60, P796, DOI 10.1111/jipb.12689; Ye JM, 2013, PLANT CELL REP, V32, P139, DOI 10.1007/s00299-012-1348-3; Yildirim K, 2018, PLANT PHYSIOL BIOCH, V127, P256, DOI 10.1016/j.plaphy.2018.03.034; Yousefirad S, 2018, BIOL PLANTARUM, V62, P775, DOI 10.1007/s10535-018-0823-2; Zhang HC, 2008, PLANT GROWTH REGUL, V56, P129, DOI 10.1007/s10725-008-9293-4; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	53	12	13	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0212666	10.1371/journal.pone.0212666	http://dx.doi.org/10.1371/journal.pone.0212666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889180	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000009
J	Titan, SM; Venturini, G; Padilha, K; Goulart, AC; Lotufo, PA; Bensenor, IJ; Krieger, JE; Thadhani, RI; Rhee, EP; Pereira, AC				Titan, Silvia M.; Venturini, Gabriela; Padilha, Kallyandra; Goulart, Alessandra C.; Lotufo, Paulo A.; Bensenor, Isabela J.; Krieger, Jose E.; Thadhani, Ravi I.; Rhee, Eugene P.; Pereira, Alexandre C.			Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort	PLOS ONE			English	Article							LONG-CHAIN OMEGA-3-FATTY-ACIDS; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; N-3 FATTY-ACIDS; OLDER-ADULTS; CARDIOVASCULAR EVENTS; FISH-OIL; METABOLISM; PHENYLALANINE; HEMODIALYSIS	Introduction Studies on metabolomics and CKD have primarily addressed CKD incidence defined as a decline on eGFR or appearance of albuminuria in the general population, with very few evaluating hard outcomes. In the present study, we investigated the association between metabolites and mortality and ESRD in a CKD cohort. Setting and methods Data on 454 participants of the Progredir Cohort Study, Sao Paulo, Brazil were used. Metabolomics was performed by GC-MS (Agilent MassHunter) and metabolites were identified using Agilent Fiehn GC/MS and NIST libraries. After excluding metabolites present in <50% of participants, 293 metabolites were analyzed. An FDR q value <0.05 criteria was applied in Cox models on the composite outcome (mortality or incident renal replacement therapy) adjusted for batch effect, resulting in 34 metabolites associated with the outcome. Multivariable- adjusted Cox models were then built for the composite outcome, death, and ESRD incident events. Competing risk analysis was also performed for ESRD. Results Mean age was 68 +/- 12y, mean eGFR-CKDEPI was 38.4 +/- 14.6 ml/min/1.73m(2) and 57% were diabetic. After adjustments (GC-MS batch, sex, age, DM and eGFR), 18 metabolites remained significantly associated with the composite outcome. Nine metabolites were independently associated with death: D-malic acid (HR 1.84, 95% CI 1.32-2.56, p = 0.0003), acetohydroxamic acid (HR 1.90, 95% CI 1.30-2.78, p = 0.0008), butanoic acid (HR 1.59, 95% CI 1.17-2.15, p = 0.003), and docosahexaenoic acid (HR 0.58, 95% CI 0.39-0.88, p = 0.009), among the top associations. Lactose (SHR 1.49, 95% CI 1.04-2.12, p = 0.03), 2-O-glycerol-alpha-D-galactopyranoside (SHR 1.76, 95% CI 1.06-2.92, p = 0.03), and tyrosine (SHR 0.52, 95% CI 0.31-0.88, p = 0.02) were associated to ESRD risk, while D-threitol, mannitol and myo-inositol presented strong borderline associations. Conclusion Our results identify specific metabolites related to hard outcomes in a CKD population. These findings point to the need of further exploration of these metabolites as biomarkers in CKD and the understanding of the underlying biological mechanisms related to the observed associations.	[Titan, Silvia M.] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, SP, Brazil; [Venturini, Gabriela; Padilha, Kallyandra; Krieger, Jose E.; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, SP, Brazil; [Goulart, Alessandra C.; Lotufo, Paulo A.; Bensenor, Isabela J.] Univ Sao Paulo, Univ Hosp, Epidemiol & Clin Res Ctr, Sao Paulo, Brazil; [Thadhani, Ravi I.; Rhee, Eugene P.] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Thadhani, Ravi I.] Cedars Sinai Med Ctr, Res, Los Angeles, CA 90048 USA; [Rhee, Eugene P.] Massachusetts Gen Hosp, Dept Med, Div Endocrinol, Boston, MA 02114 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital; Cedars Sinai Medical Center; Harvard University; Massachusetts General Hospital	Titan, SM (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, SP, Brazil.	smotitan@gmail.com	Bensenor, Isabela Judith Martins/L-3306-2017; Joukar, Farahnaz/GMW-7238-2022; Goulart, Alessandra C/J-2845-2014; Pereira, Alexandre/HHN-1038-2022; Silva, Gabriela/D-1630-2012	Joukar, Farahnaz/0000-0003-0102-0575; Goulart, Alessandra C/0000-0003-1076-5210; Silva, Gabriela/0000-0003-2913-2296	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/17341-0, 2015/23445-3, 2017/20593-7]; Brazilian Ministry of Health (Science and Technology Department); FINEP; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Ministry of Health (Science and Technology Department); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was received from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants 2011/17341-0; 2015/23445-3; 2017/20593-7); Brazilian Ministry of Health (Science and Technology Department); FINEP; CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden AE, 2015, J HYPERTENS, V33, P1947, DOI 10.1097/HJH.0000000000000621; Barreto SM, 2013, REV SAUDE PUBL, V47, P79, DOI 10.1590/S0034-8910.2013047003836; Brahma MK, 2017, DIABETES METAB J, V41, P1, DOI 10.4093/dmj.2017.41.1.1; Chen LY, 2016, DIABETES, V65, P1099, DOI 10.2337/db15-0661; Cheng S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7791; Donadio JV, 1999, J AM SOC NEPHROL, V10, P1772; DONADIO JV, 1994, NEW ENGL J MED, V331, P1194, DOI 10.1056/NEJM199411033311804; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; Glassop D, 2007, PLANT CELL PHYSIOL, V48, P573, DOI 10.1093/pcp/pcm027; Goek ON, 2012, AM J KIDNEY DIS, V60, P197, DOI 10.1053/j.ajkd.2012.01.014; He T, 2008, EUR J CLIN INVEST, V38, P541, DOI 10.1111/j.1365-2362.2008.01966.x; Higashiyama A, 2015, J EPIDEMIOL, V25, P303, DOI 10.2188/jea.JE20140093; Hoogeveen EK, 2014, CLIN J AM SOC NEPHRO, V9, P1676, DOI 10.2215/CJN.10441013; Kopple JD, 2007, J NUTR, V137, p1586S, DOI 10.1093/jn/137.6.1586S; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marklund M, 2015, CIRCULATION, V132, P586, DOI 10.1161/CIRCULATIONAHA.115.015607; Miller ER, 2009, AM J CLIN NUTR, V89, P1937, DOI 10.3945/ajcn.2008.26867; Moller N, 2000, P NATL ACAD SCI USA, V97, P1242, DOI 10.1073/pnas.97.3.1242; Mozaffarian D, 2013, ANN INTERN MED, V158, P515, DOI 10.7326/0003-4819-158-7-201304020-00003; Mozaffarian D, 2011, ANN INTERN MED, V155, P160, DOI 10.7326/0003-4819-155-3-201108020-00006; Domingos MAM, 2017, SAO PAULO MED J, V135, P133, DOI 10.1590/1516-3180.2016.0272261116; Muraoka T, 2008, BIOSCI BIOTECH BIOCH, V72, P1731, DOI 10.1271/bbb.80029; Niewczas MA, 2017, DIABETES CARE, V40, P383, DOI 10.2337/dc16-0173; Niewczas MA, 2014, KIDNEY INT, V85, P1214, DOI 10.1038/ki.2013.497; Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000506; Peiro C, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0397-2; Rhee EP, 2016, AM J NEPHROL, V43, P366, DOI 10.1159/000446484; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Sekula P, 2016, J AM SOC NEPHROL, V27, P1175, DOI 10.1681/ASN.2014111099; Shoji T, 2013, AM J KIDNEY DIS, V62, P568, DOI 10.1053/j.ajkd.2013.02.362; Solini A, 2016, J CLIN ENDOCR METAB, V101, P696, DOI 10.1210/jc.2015-3345; STEER KA, 1985, DIABETES, V34, P485, DOI 10.2337/diabetes.34.5.485; Svensson M, 2006, CLIN J AM SOC NEPHRO, V1, P780, DOI 10.2215/CJN.00630206; TANAKA K, 1982, J CHROMATOGR, V239, P301, DOI 10.1016/S0021-9673(00)81990-1; Tavares G, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1337-9; Titan SM, 2018, CLIN CHIM ACTA; TSAI MY, 1985, J CHROMATOGR, V341, P1, DOI 10.1016/S0378-4347(00)84004-9; Virtanen JK, 2014, DIABETES CARE, V37, P189, DOI 10.2337/dc13-1504; Wu JHY, 2012, CIRCULATION, V125, P1084, DOI 10.1161/CIRCULATIONAHA.111.062653; Yu B, 2016, AM J EPIDEMIOL, V183, P650, DOI 10.1093/aje/kwv213; Yu B, 2014, CLIN J AM SOC NEPHRO, V9, P1410, DOI 10.2215/CJN.11971113	44	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213764	10.1371/journal.pone.0213764	http://dx.doi.org/10.1371/journal.pone.0213764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883578	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500028
J	Kim, JM; Lee, N; Xiao, XY				Kim, Jong-Min; Lee, Namgil; Xiao, Xingyao			Directional dependence between major cities in China based on copula regression on air pollution measurements	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; BETA REGRESSION; DAILY MORTALITY; AEROSOL; SCATTERING; IMPACT; PM2.5; MODEL	Air pollution is well-known as a major risk to public health, causing various diseases including pulmonary and cardiovascular diseases. As social concern increases, the amount of air pollution data is increasing rapidly. The purpose of this study is to statistically characterize dependence between major cities in China based on a measure of directional dependence estimated from PM2.5 measurements. As a measure of the directional dependence, we propose the so-called copula directional dependence (CDD) using beta regression models. An advantage of the CDD is that it does not rely on strict assumptions of specific probability distributions or linearity. We used hourly PM2.5 measurement data collected at four major cities in China: Beijing, Chengdu, Guangzhou, and Shanghai, from 2013 to 2017. After accounting for autocorrelation in the PM2.5 time series via nonlinear autoregressive models, CDDs between the four cities were estimated to produce directed network structures of statistical dependence. In addition, a statistical method was proposed to test the directionality of dependence between each pair of cities. From the PM2.5 data, we could discover that Chengdu and Guangzhou are the most closely related cities and that the directionality between them has changed once during 2013 to 2017, which implies a major economic or environmental change in these Chinese regions.	[Kim, Jong-Min] Univ Minnesota, Div Sci & Math, Stat Discipline, Morris, MN 56267 USA; [Lee, Namgil] Kangwon Natl Univ, Dept Informat Stat, Chunchon, Gangwon, South Korea; [Xiao, Xingyao] Boston Coll, Lynch Sch Educ, Appl Stat & Psychometr, Chestnut Hill, MA 02167 USA	University of Minnesota System; University of Minnesota Morris; Kangwon National University; Boston College	Lee, N (corresponding author), Kangwon Natl Univ, Dept Informat Stat, Chunchon, Gangwon, South Korea.	namgil.lee@kangwon.ac.kr		Lee, Namgil/0000-0003-0593-9028; Kim, Jong-Min/0000-0003-3821-2060	National Research Foundation of Korea (NRF) - Korean government (MSIT) [2017R1C1B5076912]	National Research Foundation of Korea (NRF) - Korean government (MSIT)	N. Lee was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2017R1C1B5076912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Blobaum P, 2018, PR MACH LEARN RES, V84; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Casarin R, 2015, BAYESIAN ANAL, V10, P791, DOI 10.1214/15-BA960SI; Casarin R, 2012, BAYESIAN ANAL, V7, P385, DOI 10.1214/12-BA713; Cherubini U., 2004, COPULA METHODS FINAN; Cherubini U, 2012, DYNAMIC COPULA METHO, DOI [10.18637/JSS.V034.I02, DOI 10.18637/JSS.V034.I02]; China M. E. P., 2012, AMB AIR QUAL STAND; Cifuentes LA, 2000, J AIR WASTE MANAGE, V50, P1287, DOI 10.1080/10473289.2000.10464167; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Cuadras CM, 2002, J MULTIVARIATE ANAL, V81, P19, DOI 10.1006/jmva.2001.2000; De Gooijer JG, 2006, INT J FORECASTING, V22, P443, DOI 10.1016/j.ijforecast.2006.01.001; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dodge Y, 2000, COMMUN STAT-THEOR M, V29, P1957, DOI 10.1080/03610920008832589; Dodge Y, 2001, AM STAT, V55, P51, DOI 10.1198/000313001300339932; Durante F, 2009, STAT PAP, V50, P383, DOI 10.1007/s00362-007-0064-5; Environment Protection Office, 1982, AMB AIR QUAL STAND; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Figueroa-Zuniga JI, 2013, COMPUT STAT DATA AN, V61, P137, DOI 10.1016/j.csda.2012.12.002; Fredricks GA, 2007, J STAT PLAN INFER, V137, P2143, DOI 10.1016/j.jspi.2006.06.045; Guolo A, 2014, ANN APPL STAT, V8, P74, DOI 10.1214/13-AOAS684; Hoyer P.O., ADV NEURAL INFORM PR; Hu JL, 2015, ENVIRON INT, V84, P17, DOI 10.1016/j.envint.2015.06.014; Huang J, 2018, LANCET PLANET HEALTH, V2, pE313, DOI 10.1016/S2542-5196(18)30141-4; Jones ME, 2006, ENVIRON POLLUT, V143, P377, DOI 10.1016/j.envpol.2005.12.013; Kano Y., 2003, P INT S SCI MODELING, P261; Kantz H., 2003, NONLINEAR TIME SERIE; Kim D, 2014, J STAT COMPUT SIM, V84, P1990, DOI 10.1080/00949655.2013.779696; Kim JD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-10; Kim JM, 2018, APPL ECON, V50, P4418, DOI 10.1080/00036846.2018.1450485; Kim JM, 2017, COMMUN STAT-SIMUL C, V46, P7639, DOI 10.1080/03610918.2016.1248572; Kim J, 2019, CHEM ENG J, V377, DOI 10.1016/j.cej.2018.09.057; Kojadinovic I., 2010, J STAT SOFTW, V34, P1, DOI [DOI 10.18637/jss.v034.i09, DOI 10.18637/JSS.V034.I09]; Lapedes A., 1987, NONLINEAR SIGNAL PRO; Li MY, 2006, GENETICS, V173, P2317, DOI 10.1534/genetics.105.054650; Liang FM, 2005, STAT COMPUT, V15, P13, DOI 10.1007/s11222-005-4786-8; Liu XH, 2010, ATMOS ENVIRON, V44, P2415, DOI 10.1016/j.atmosenv.2010.03.035; Lowsen Dorrit H, 2016, J Environ Prot (Irvine, Calif), V7, P2081, DOI 10.4236/jep.2016.713162; Lv BL, 2015, AEROSOL AIR QUAL RES, V15, P1836, DOI 10.4209/aaqr.2015.04.0266; Ma ZW, 2014, ENVIRON SCI TECHNOL, V48, P7436, DOI 10.1021/es5009399; Masarotto G, 2012, ELECTRON J STAT, V6, P1517, DOI 10.1214/12-EJS721; Mooij J.M., 2009, P 26 ANN INT C MACH, P745; Nelsen R, 2003, PROC 1 BRAZ C STAT M; Nelsen R. B, 2006, INTRO COPULAS; Pitt M, 2006, BIOMETRIKA, V93, P537, DOI 10.1093/biomet/93.3.537; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rohde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135749; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; SCHWEIZER B, 1981, ANN STAT, V9, P879, DOI 10.1214/aos/1176345528; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Sklar A., 1973, KYBERNETIKA, V9, P449, DOI DOI 10.1098/RSPA.2009.0502; Sklar A., 1959, PUBLICATIONS I STAT, V8, P229, DOI DOI 10.1007/BF01544178; Song PXK, 2009, BIOMETRICS, V65, P60, DOI 10.1111/j.1541-0420.2008.01058.x; Song PXK, 2000, SCAND J STAT, V27, P305, DOI 10.1111/1467-9469.00191; Spirtes P, 2010, J MACH LEARN RES, V11, P1643; Spirtes Peter, 2000, ADAPTIVE COMPUTATION; Sun X., 2006, P 9 INT S ART INT MA, P1; Sungur EA, 2005, COMMUN STAT-THEOR M, V34, P1957, DOI 10.1080/03610920500201228; Tao J, 2014, ATMOS RES, V135, P48, DOI 10.1016/j.atmosres.2013.08.015; U.S. EPA, 2009, INT SCI ASS ISA PART; Wang J, 2010, REMOTE SENS ENVIRON, V114, P2575, DOI 10.1016/j.rse.2010.05.034; World Bank, 2007, COST POLL CHIN EC ES; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zhang GP, 2001, COMPUT OPER RES, V28, P381, DOI 10.1016/S0305-0548(99)00123-9; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zhang K., 2009, P TWENTYFIFTH C UNCE, P647; Zhang Q, 2012, CHINESE SCI BULL, V57, P2857, DOI 10.1007/s11434-012-5015-4; Zhao BT, 2016, J INTEGR ENVIRON SCI, V13, P85, DOI 10.1080/1943815X.2016.1150301; Zhao XJ, 2011, ATMOS RES, V101, P799, DOI 10.1016/j.atmosres.2011.05.010	75	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213148	10.1371/journal.pone.0213148	http://dx.doi.org/10.1371/journal.pone.0213148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7YP	30870434	gold, Green Published			2022-12-26	WOS:000461166300022
J	Resnik, L; Ekerholm, S; Borgia, M; Clark, MA				Resnik, Linda; Ekerholm, Sarah; Borgia, Matthew; Clark, Melissa A.			A national study of Veterans with major upper limb amputation: Survey methods, participants, and summary findings	PLOS ONE			English	Article							OIF/OEF CONFLICTS; HEALTH SURVEY; SERVICEMEMBERS; QUICKDASH; VIETNAM; SATISFACTION; RELIABILITY; PAIN; QUESTIONNAIRE; PROSTHETICS	Introduction A comprehensive study to assess quality and outcomes of care for Veterans with upper limb amputation is needed. This paper presents methods and summary findings from a national survey of Veterans with upper limb amputation. Methods After completion of a pilot study to develop and refine methods, computer-assisted telephone interviews were conducted with 808 Veterans with upper limb amputation (response rate = 47.7%; cooperation rate = 63.3%). Results Respondents were 776 unilateral and 32 bilateral amputees, 97.5% male, mean age 63.3 (sd 14.1). Prostheses were used by 60% unilateral and 91% bilateral, the majority used body powered devices. Prostheses were used >= 8 hours/day by 52% unilateral and 76% bilateral. Prosthetic training was received by 71% unilateral and 59% bilateral. Mean prosthetic satisfaction was 3.9 (sd 0.6) and 3.8 (sd 0.7) as measured by TAPES; and 25.0 (sd 5.1) and 25.7 (sd 4.5) as measured by OPUS CSD for unilateral and bilateral respectively. Mean perceived disability (measured by QuickDASH) scores were 49.5 (sd 20.7) for unilateral and 34.7 (sd 22.0) for bilateral. VR-12 PCS scores were below population norms. The majority reported contralateral limb pain, musculoskeletal conditions, back and neck pain. Phantom limb pain was reported in 83.4% of unilateral and 68.8% of bilateral, and residual limb pain in 65.1% of unilateral and 68.8% of bilateral. Most, (81.8% unilateral, 84.4% bilateral) had been to a Veterans Affairs medical center (VA) for amputation care, while 57% of unilateral and 81.3% of bilateral had been to a VA amputation clinic. Discussion/Conclusion Veterans with upper limb amputation have moderately impaired physical functioning. Prosthesis use rates were lower than previously reported. Although satisfied with their prostheses, nearly half used them <= 8 hours/day. Rates of musculoskeletal problems, phantom and residual limb pain were higher than previously reported. A substantial proportion never received prosthetic training, or VA amputation care.	[Resnik, Linda; Ekerholm, Sarah; Borgia, Matthew] Providence VA Med Ctr, Res Dept, Providence, RI USA; [Resnik, Linda] Brown Univ, Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Clark, Melissa A.] Univ Massachusetts, Sch Med, Worcester, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; University of Massachusetts System; University of Massachusetts Worcester	Resnik, L (corresponding author), Providence VA Med Ctr, Res Dept, Providence, RI USA.; Resnik, L (corresponding author), Brown Univ, Hlth Serv Policy & Practice, Providence, RI 02912 USA.	Linda.Resnik@va.gov			U.S Army Medical Research Acquisition Activity, Fort Detrick MD [W81XWH-16-2-0065]; Department of Veterans Affairs Rehabilitation Research and Development [A9264-S]	U.S Army Medical Research Acquisition Activity, Fort Detrick MD; Department of Veterans Affairs Rehabilitation Research and Development(US Department of Veterans Affairs)	This research was funded by the U.S Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office (W81XWH-16-2-0065 to LR). This research was also funded by the Department of Veterans Affairs Rehabilitation Research and Development (A9264-S to LR). The funder did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim T, 2014, J HAND SURG-EUR VOL, V39, P140, DOI 10.1177/1753193413481302; Atkins D, 2002, ADULT UPPER LIMB PRO; ATKINS DJ, 1996, J PROSTHETICS ORTHOT, V8, P1; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Berke GM, 2010, J REHABIL RES DEV, V47, P361, DOI 10.1682/JRRD.2009.12.0193; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P346, DOI 10.1080/17483100701714733; Blough DK, 2010, J REHABIL RES DEV, V47, P387, DOI 10.1682/JRRD.2009.04.0037; Demet K, 2003, DISABIL REHABIL, V25, P480, DOI 10.1080/0963828031000090434; Desmond DM, 2010, INT J REHABIL RES, V33, P279, DOI 10.1097/MRR.0b013e328336388d; Desmond DM, 2005, AM J PHYS MED REHAB, V84, P506, DOI 10.1097/01.phm.0000166885.16180.63; Gambrell CR, 2008, J PROSTHET ORTHOT, V20, P126, DOI DOI 10.1097/JP0.0B013E31817ECB16; General VOoI, 2012, HEALTHC INSP PROSTH, P88; Gummesson C, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-44; Hanley MA, 2009, AM J PHYS MED REHAB, V88, P742, DOI 10.1097/PHM.0b013e3181b306ec; Heinemann AW, 2003, PROSTHET ORTHOT INT, V27, P191, DOI 10.1080/03093640308726682; Johnson SS, 2014, PHYS MED REH CLIN N, V25, P133, DOI 10.1016/j.pmr.2013.09.012; KEJLAA GH, 1993, PROSTHET ORTHOT INT, V17, P157; Legro MW, 1998, ARCH PHYS MED REHAB, V79, P931, DOI 10.1016/S0003-9993(98)90090-9; Management of Upper Extremity Amputation Rehabilitation Working Group, 2014, VA DOD CLIN PRACT GU; Matsen SL, 2000, J BONE JOINT SURG AM, V82A, P1089, DOI 10.2106/00004623-200008000-00004; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; Ostlie K, 2011, ARCH PHYS MED REHAB, V92, P1967, DOI 10.1016/j.apmr.2011.06.026; Ostlie K, 2011, DISABIL REHABIL, V33, P1594, DOI 10.3109/09638288.2010.540293; Petri Richard P Jr, 2002, Phys Med Rehabil Clin N Am, V13, P17, DOI 10.1016/S1047-9651(03)00070-6; Postema SG, 2016, ARCH PHYS MED REHAB, V97, P1137, DOI 10.1016/j.apmr.2016.01.031; Rehabilitation Institute of Chicago, 2010, OPUS SCOR GUID; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Research. AAfPO, RESP RAT OV 2018; Resnik L, 2015, ARCH PHYS MED REHAB, V96, P1676, DOI 10.1016/j.apmr.2015.03.023; Reyburn T V, 1971, Artif Limbs, V15, P1; Sigford BJ, 2010, J REHABIL RES DEV, V47, pXV, DOI 10.1682/JRRD.2009.02.0020; Stansbury LG, 2008, J ORTHOP TRAUMA, V22, P43, DOI 10.1097/BOT.0b013e31815b35aa; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WRIGHT TW, 1995, J HAND SURG-AM, V20A, P619, DOI 10.1016/S0363-5023(05)80278-3	36	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213578	10.1371/journal.pone.0213578	http://dx.doi.org/10.1371/journal.pone.0213578			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7YP	30870496	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300045
J	Taubert, M; Stahly, J; Kolb, S; Kusel, K				Taubert, Martin; Staehly, Jan; Kolb, Steffen; Kuesel, Kirsten			Divergent microbial communities in groundwater and overlying soils exhibit functional redundancy for plant-polysaccharide degradation	PLOS ONE			English	Article							PRISTINE LIMESTONE AQUIFERS; ENZYME-ACTIVITIES; METABOLIC-RESPONSES; ORGANIC-MATTER; BACTERIA; TRANSPORT; ABUNDANCE; DIVERSITY; KINETICS; ECOLOGY	Light driven primary production by plants is the main source of biomass in terrestrial ecosystems. But also in subsurface habitats like aquifers, life is fueled largely by this plant-derived biomass. Here, we investigate the degradation of plant-derived polysaccharides in a groundwater microbiome to identify the microbial key players involved, and compare them to those from soil of the groundwater recharge area. We quantified the activities of enzymes degrading the abundant plant polymers starch, cellulose and hemicellulose in oligotrophic groundwater samples, despite the low cell numbers present. Normalized to 16S rRNA gene copy numbers, these activities were only one order of magnitude lower than in soil. Stimulation of the groundwater microbiome with either starch or cellulose and hemicellulose led to changes of the enzymatic activity ratios, indicating autochthonous production of enzymes in response to the plant polymers. Furthermore, DNA stable isotope probing with C-13 labelled plant polymers allowed us to identify microbes involved in the degradation of these compounds. In (hemi)cellulose microcosms, Bacteroidia and Candidatus Parcubacteria were active, while the active community in starch microcosms mostly comprised Candidatus Saccharibacteria, Cytophagia, and Actinobacteria. Not a single one of the active OTUs was also found to be labelled in soil microcosms. This indicates that the degradation of plant-derived polysaccharides in groundwater is driven by organisms completely distinct from those active in soil. The involvement of members of the candidate phyla Cand. Parcubacteria and Cand. Saccharibacteria, organisms known to be abundant in groundwater, in plant-derived organic matter degradation might strongly impact subsurface carbon cycling.	[Taubert, Martin; Staehly, Jan; Kolb, Steffen; Kuesel, Kirsten] Friedrich Schiller Univ Jena, Inst Biodivers, Aquat Geomicrobiol, Jena, Germany; [Kolb, Steffen] Leibniz Ctr Agr Landscape Res ZALF, Microbial Biogeochem, RA Landscape Proc, Muncheberg, Germany; [Kuesel, Kirsten] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Friedrich Schiller University of Jena; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Taubert, M (corresponding author), Friedrich Schiller Univ Jena, Inst Biodivers, Aquat Geomicrobiol, Jena, Germany.	martin.taubert@uni-jena.de	Kolb, Steffen/AAW-4866-2021	Kolb, Steffen/0000-0002-5455-8662	Deutsche Forschungsgemeinschaft via the Collaborative Research Centre AquaDiva (CRC 1076 AquaDiva) of the Friedrich Schiller Universitat Jena [218627073]; German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig [202548816]; Thuringer Ministerium fur Wirtschaft, Wissenschaft und Digitale Gesellschaft (TMWWDG) [B 715-09075]	Deutsche Forschungsgemeinschaft via the Collaborative Research Centre AquaDiva (CRC 1076 AquaDiva) of the Friedrich Schiller Universitat Jena; German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig; Thuringer Ministerium fur Wirtschaft, Wissenschaft und Digitale Gesellschaft (TMWWDG)	This work was financially supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) via the Collaborative Research Centre AquaDiva (CRC 1076 AquaDiva) of the Friedrich Schiller Universitat Jena, grant number 218627073 awarded to MT and KK, and the German Center for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, grant number 202548816 awarded to KK. Climate chambers to conduct experiments under controlled temperature conditions were financially supported by the Thuringer Ministerium fur Wirtschaft, Wissenschaft und Digitale Gesellschaft (TMWWDG, www.thueringen.de/th6/tmwwdg/), grant number B 715-09075 awarded to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2000, BIOL FERT SOILS, V31, P85, DOI 10.1007/s003740050628; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Anantharaman K, 2016, PEERJ, V4, DOI 10.7717/peerj.1607; Badiane NNY, 2001, APPL SOIL ECOL, V18, P229, DOI 10.1016/S0929-1393(01)00159-7; Bailey VL, 2013, ISME J, V7, P2044, DOI 10.1038/ismej.2013.87; Baker MA, 2000, ECOLOGY, V81, P3133, DOI 10.1890/0012-9658(2000)081[3133:OCSAMI]2.0.CO;2; Bischoff S, 2015, BIOGEOSCIENCES, V12, P2695, DOI 10.5194/bg-12-2695-2015; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Chen RR, 2012, BIOMASS BIOENERG, V45, P221, DOI 10.1016/j.biombioe.2012.06.014; Clinton SM, 2010, FRESHWATER BIOL, V55, P1603, DOI 10.1111/j.1365-2427.2009.02383.x; Cooper KJ, 2016, BIOGEOCHEMISTRY, V129, P215, DOI 10.1007/s10533-016-0226-4; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Danczak RE, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0331-1; Dibbern D, 2014, SOIL BIOL BIOCHEM, V69, P187, DOI 10.1016/j.soilbio.2013.10.040; Dumont MG, 2005, NAT REV MICROBIOL, V3, P499, DOI 10.1038/nrmicro1162; Ferrari B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03957; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; GHIORSE WC, 1988, ADV APPL MICROBIOL, V33, P107, DOI 10.1016/S0065-2164(08)70206-5; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Herrmann M, 2015, APPL ENVIRON MICROB, V81, P2384, DOI 10.1128/AEM.03269-14; Herrmann M, 2012, ENVIRON MICROBIOL, V14, P3013, DOI 10.1111/j.1462-2920.2012.02882.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hubalek V, 2016, ISME J, V10, P2447, DOI 10.1038/ismej.2016.36; Hungate BA, 2015, APPL ENVIRON MICROB, V81, P7570, DOI 10.1128/AEM.02280-15; Jeffries Thomas W., 1994, P233; Kohlhepp B., 2016, HYDROL EARTH SYST SC, DOI [10.5194/hess-2016-374, DOI 10.5194/HESS-2016-374]; Kohlhepp B, 2017, HYDROL EARTH SYST SC, V21, P6091, DOI 10.5194/hess-21-6091-2017; Kolehmainen RE, 2009, WATER RES, V43, P405, DOI 10.1016/j.watres.2008.10.048; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kusel K, 2016, FRONT EARTH SC-SWITZ, V4, DOI 10.3389/feart.2016.00032; Kumar S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01951; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lazar CS, 2017, ARCHAEA, V2017, DOI 10.1155/2017/2136287; LEE SF, 1985, APPL ENVIRON MICROB, V50, P220, DOI 10.1128/AEM.50.2.220-228.1985; Liu I.M., 2005, ENCY BIOSTATISTICS; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Madsen Eugene L., 1993, P167; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Nacke H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02067; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Nowak ME, 2017, HYDROL EARTH SYST SC, V21, P4283, DOI 10.5194/hess-21-4283-2017; Okamoto K, 2000, BIOSCI BIOTECH BIOCH, V64, P333, DOI 10.1271/bbb.64.333; Opitz S, 2014, FEMS MICROBIOL ECOL, V90, P39, DOI 10.1111/1574-6941.12370; Palmroth MRT, 2005, BIODEGRADATION, V16, P91, DOI 10.1007/s10531-004-0626-y; Pepe-Ranney C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00703; PerezAvalos O, 1996, APPL MICROBIOL BIOT, V46, P405, DOI [10.1007/s002530050837, 10.1007/BF00166237]; Pritsch K, 2004, J MICROBIOL METH, V58, P233, DOI 10.1016/j.mimet.2004.04.001; Pronk M, 2009, GROUND WATER, V47, P361, DOI 10.1111/j.1745-6584.2008.00509.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Risse-Buhl U, 2013, J EUKARYOT MICROBIOL, V60, P467, DOI 10.1111/jeu.12054; Schellenberger S, 2010, ENVIRON MICROBIOL, V12, P845, DOI 10.1111/j.1462-2920.2009.02128.x; Schutz K, 2010, FEMS MICROBIOL ECOL, V72, P445, DOI 10.1111/j.1574-6941.2010.00855.x; Schwab VF, 2016, BIOGEOSCIENCES DISCU, DOI DOI 10.5194/BG-2016-442; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Taubert M, 2017, ENVIRON MICROBIOL; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183; Wrighton KC, 2014, ISME J, V8, P1452, DOI 10.1038/ismej.2013.249; Yarwood S, 2013, APPL ENVIRON MICROB, V79, P1385, DOI 10.1128/AEM.03181-12; Youngblut ND, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00570; Zhou YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05288	70	18	17	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212937	10.1371/journal.pone.0212937	http://dx.doi.org/10.1371/journal.pone.0212937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865693	gold, Green Submitted, Green Published			2022-12-26	WOS:000461048900052
J	Aiken, CE; Tarry-Adkins, JL; Spiroski, AM; Nuzzo, AM; Ashmore, TJ; Rolfo, A; Sutherland, MJ; Camm, EJ; Giussani, DA; Ozanne, SE				Aiken, Catherine E.; Tarry-Adkins, Jane L.; Spiroski, Ana-Mishel; Nuzzo, Anna M.; Ashmore, Thomas J.; Rolfo, Alessandro; Sutherland, Megan J.; Camm, Emily J.; Giussani, Dino A.; Ozanne, Susan E.			Chronic gestational hypoxia accelerates ovarian aging and lowers ovarian reserve in next-generation adult rats	FASEB JOURNAL			English	Article						ovary; follicles; reproductive aging; fetal hypoxia; developmental programming	INTRAUTERINE GROWTH RESTRICTION; PLACENTAL OXIDATIVE STRESS; POOR MATERNAL NUTRITION; HIGH-ALTITUDE; INSULIN-RESISTANCE; PRENATAL HYPOXIA; BIRTH-WEIGHT; BLOOD-FLOW; FETAL; MARKERS	Chronic fetal hypoxia is a common complication observed in human pregnancy, impacting pregnancies across global contexts. Exposure to chronic intrauterine hypoxia has major short- and long-term consequences for offspring health. However, the impact of chronic gestational hypoxia on female reproductive system development is unknown. We aimed to understand the impact of exposure to chronic fetal hypoxia on the developing female reproductive system. Wistar rat dams underwent normoxia (21%) or hypoxia (13%) during pregnancy. Postnatally, all female offspring were maintained in normoxic conditions into early adulthood. Female rats exposed to chronic gestational hypoxia (13%) during their intrauterine development had decreased ovarian primordial follicular reserve compared to controls (P < 0.05). Adult females who had been exposed to chronic fetal hypoxia had significantly reduced somatic ovarian telomere length (P < 0.05) and reduced ovarian protein expression of KU70, a critical component of the DNA-activated protein kinase repair complex (P < 0.01). Gene expression of NADPH oxidase 2-mediated oxidative stress markers was increased (P < 0.05). Exposure to chronic hypoxia during fetal development leads to accelerated aging of the somatic ovary and decreased ovarian reserve in adulthood. Ovarian aging is highly sensitive to gestational hypoxia, with implications for future fertility in next-generation offspring of high-risk pregnancies.-Aiken, C. E., Tarry-Adkins, J. L., Spiroski, A.-M., Nuzzo, A. M., Ashmore, T. J., Rolfo, A., Sutherland, M. J., Camm, E. J., Giussani, D. A., Ozanne, S. E. Chronic gestational hypoxia accelerates ovarian aging and lowers ovarian reserve in next-generation adult rats.	[Aiken, Catherine E.; Tarry-Adkins, Jane L.; Ashmore, Thomas J.; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Cambridge, England; [Aiken, Catherine E.; Tarry-Adkins, Jane L.; Ashmore, Thomas J.; Ozanne, Susan E.] Univ Cambridge, MRC, Metab Dis Unit,Addenbrookes Hosp, Wellcome Trust,Inst Metab Sci,Addenbrookes Treatm, Cambridge, England; [Aiken, Catherine E.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Spiroski, Ana-Mishel; Sutherland, Megan J.; Camm, Emily J.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Nuzzo, Anna M.; Rolfo, Alessandro] Univ Torino, Dipartimento Sci Chirurg, Turin, Italy	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Turin	Aiken, CE (corresponding author), Univ Cambridge, Hills Rd, Cambridge CB2 0QQ, England.	cema2@cam.ac.uk		Spiroski, Ana-Mishel/0000-0002-8584-8048; Sutherland, Megan/0000-0002-0841-1635; Ozanne, Susan/0000-0001-8753-5144	Addenbrooke's Charitable Trust (ACT) [RG94137]; Issac Newton Trust/Wellcome Trust ISSF/ University of Cambridge Joint Research Grant; Medical Research Council [MC_UU_12012/4]; British Heart Foundation [PG/14/5/30546]; MRC [MC_UU_12012/4, MC_UU_00014/4, MC_UU_12012/5] Funding Source: UKRI	Addenbrooke's Charitable Trust (ACT); Issac Newton Trust/Wellcome Trust ISSF/ University of Cambridge Joint Research Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	C.E.A. was supported by a Grant from the Addenbrooke's Charitable Trust (ACT; RG94137) and by an Issac Newton Trust/Wellcome Trust ISSF/ University of Cambridge Joint Research Grant. S.E.O. is supported by the Medical Research Council (MC_UU_12012/4). D.A.G. is supported by The British Heart Foundation (PG/14/5/30546). The authors declare no conflicts of interest.	Aiken CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep16175; Aiken CE, 2016, FASEB J, V30, P1548, DOI 10.1096/fj.15-280800; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Aiken CE, 2013, FASEB J, V27, P3959, DOI 10.1096/fj.13-234484; Allison BJ, 2016, FASEB J, V30, P1968, DOI 10.1096/fj.201500057; Alviggi C, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-101; Ball E, 2006, J PATHOL, V208, P535, DOI 10.1002/path.1927; BEALL CM, 1983, ANN HUM BIOL, V10, P365, DOI 10.1080/03014468300006531; Bernal AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015558; Burton GJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00373; Camm EJ, 2011, FASEB J, V25, P420, DOI 10.1096/fj.10-158188; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Castelo-Branco C, 2006, MENOPAUSE, V13, P850; Chan KA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124149; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Depmann M, 2015, J CLIN ENDOCR METAB, V100, pE845, DOI 10.1210/jc.2015-1298; Ducsay CA, 2018, PHYSIOL REV, V98, P1241, DOI 10.1152/physrev.00043.2017; Ganzevoort W, 2017, ULTRASOUND OBST GYN, V49, P769, DOI 10.1002/uog.17433; Giussani DA, 2013, J DEV ORIG HLTH DIS, V4, P328, DOI 10.1017/S204017441300010X; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2016, J PHYSIOL-LONDON, V594, P1215, DOI 10.1113/JP271099; Giussani DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031017; GONDOS B, 1986, AM J OBSTET GYNECOL, V155, P189, DOI 10.1016/0002-9378(86)90109-2; Gonzales GF, 1996, HUM BIOL, V68, P265; Gonzalez-Rodriguez P, 2013, INT J MED SCI, V10, P532, DOI 10.7150/ijms.5566; Herrera EA, 2012, J VASC RES, V49, P50, DOI 10.1159/000330666; Ho SM, 2017, REPROD TOXICOL, V68, P85, DOI 10.1016/j.reprotox.2016.07.011; Hoshino Y, 2018, REPROD MED BIOL, V17, P434, DOI 10.1002/rmb2.12245; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux Eric, 2003, Reprod Biomed Online, V7, P250; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Kuzmina IY, 2005, EUR J OBSTET GYN R B, V120, P139, DOI 10.1016/j.ejogrb.2004.09.001; Lawn JE, 2014, LANCET, V384, P132; LONGO LD, 1976, SCIENCE, V194, P523, DOI 10.1126/science.973133; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Moore LG, 2011, RESP PHYSIOL NEUROBI, V178, P181, DOI 10.1016/j.resp.2011.04.017; Parks WT, 2017, BIRTH DEFECTS RES, V109, P1345, DOI 10.1002/bdr2.1143; Pelosi E, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127381; Picut CA, 2014, TOXICOL PATHOL, V42, P403, DOI 10.1177/0192623313484832; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; RICHARDSON SJ, 1990, ANN NY ACAD SCI, V592, P13; Richter HG, 2012, J PHYSIOL-LONDON, V590, P1377, DOI 10.1113/jphysiol.2011.226340; Roost M, 2009, BJOG-INT J OBSTET GY, V116, P1210, DOI 10.1111/j.1471-0528.2009.02209.x; Salam RA, 2014, CURR OPIN CLIN NUTR, V17, P249, DOI 10.1097/MCO.0000000000000051; Santhakumaran S, 2018, ARCH DIS CHILD-FETAL, V103, pF208, DOI 10.1136/archdischild-2017-312748; Staudacher JJ, 2015, NUCLEIC ACIDS RES, V43, P3219, DOI 10.1093/nar/gkv167; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; Tarry-Adkins JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22383-w; Tarry-Adkins JL, 2015, ENDOCRINOLOGY, V156, P3528, DOI 10.1210/en.2015-1424; Tarry-Adkins JL, 2006, AM J PHYSIOL-RENAL, V290, pF509, DOI 10.1152/ajprenal.00215.2005; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Van Wassenaer-Leemhuis AG, 2017, BJOG-INT J OBSTET GY, V124, P1072, DOI 10.1111/1471-0528.14511; VanBlerkom J, 1997, HUM REPROD, V12, P1047; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Winship AL, 2018, REPRODUCTION, V156, P299, DOI 10.1530/REP-18-0247; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004	59	10	11	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7758	7766		10.1096/fj.201802772R	http://dx.doi.org/10.1096/fj.201802772R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30888848	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000476114200087
J	Bhanu, NV; Sidoli, S; Yuan, ZF; Molden, RC; Garcia, BA				Bhanu, Natarajan V.; Sidoli, Simone; Yuan, Zuo-Fei; Molden, Rosalynn C.; Garcia, Benjamin A.			Regulation of proline-directed kinases and the trans-histone code H3K9me3/H4K20me3 during human myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone; acetyltransferase; acetylation; myogenesis; Kinase; mass spectrometry; myotube	TRANSCRIPTION FACTOR; PROTEIN; MUSCLE; PHOSPHORYLATION; IDENTIFICATION; METHYLATION; INHIBITORS; NETWORKS; TARGETS; GENES	We present a system-level analysis of proteome, phosphoproteome, and chromatin state of precursors of muscle cells (myoblasts) differentiating into specialized myotubes. Using stable isotope labeling of amino acids in cell culture and nano-liqud chromatography-mass spectrometry/mass spectrometry, we found that phosphorylation motifs targeted by the kinases protein kinase C, cyclin-dependent kinase, and mitogen-activated protein kinase showed increased phosphorylation during myodifferentiation of LHCN-M2 human skeletal myoblast cell line. Drugs known to inhibit these kinases either promoted (PD0325901 and GW8510) or stalled (CHIR99021 and roscovitine) differentiation, resulting in myotube and myoblast phenotypes, respectively. The proteomes, especially the myogenic and chromatin-related proteins including histone methyltransferases, correlated with their phenotypes, leading us to quantify histone post-translational modifications and identify two gene-silencing marks, H3K9me3 and H4K20me3, with relative abundances changing in correlation with these phenotypes. ChIP-quantitative PCR demonstrated that H3K9me3 is erased from the gene loci of myogenic regulatory factors namely MYOD1, MYOG, and MYF5 in differentiating myotubes. Together, our work integrating histone post-translational modification, phosphoproteomics, and full proteome analysis gives a comprehensive understanding of the close connection between signaling pathways and epigenetics during myodifferentiation in vitro.	[Bhanu, Natarajan V.; Sidoli, Simone; Yuan, Zuo-Fei; Molden, Rosalynn C.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Inst, Rm 9-124,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA; [Molden, Rosalynn C.] Regeneron Pharmaceut, Tarrytown, NY 10591 USA	University of Pennsylvania; Pennsylvania Medicine; Regeneron	Garcia, BA (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Inst, Rm 9-124,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	bgarci@pennmedicine.upenn.edu	Sidoli, Simone/AAC-2196-2019	Sidoli, Simone/0000-0001-9073-6641	National Institutes of Health [R01GM110174, R01AI118891]; Department of Defense [W81XWH-113-1-0426]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM110174 and R01AI118891 and Department of Defense Grant W81XWH-113-1-0426. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; An W. F., 2014, DISCOVERY POTENT HIG; Ansseau E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146893; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032; Bhanu NV, 2016, PROTEOMICS, V16, P448, DOI 10.1002/pmic.201500231; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boonsanay V, 2016, CELL STEM CELL, V18, P229, DOI 10.1016/j.stem.2015.11.002; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Consalvi S, 2011, MOL MED, V17, P457, DOI 10.2119/molmed.2011.00049; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eom GH, 2011, J BIOL CHEM, V286, P34733, DOI 10.1074/jbc.M110.203307; Fomina-Yadlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028808; Gonnet F, 2008, PROTEOMICS, V8, P264, DOI 10.1002/pmic.200700261; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Greenberg SA, 2007, MUSCLE NERVE, V36, P447, DOI 10.1002/mus.20823; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; Hamed M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02390; Hammamieh R, 2007, OMICS, V11, P143, DOI 10.1089/omi.2007.4322; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Jin W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121908; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Knight JDR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-29; Kuninger D, 2004, GENOMICS, V84, P876, DOI 10.1016/j.ygeno.2004.07.013; Li QR, 2009, J PROTEOME RES, V8, P5375, DOI 10.1021/pr900659n; Lindskog C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1686-y; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Liu J, 2015, J NEUROSCI, V35, P352, DOI 10.1523/JNEUROSCI.2606-14.2015; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Reeves EKM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-26; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Ruan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035376; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin J, 2007, MOL CELL BIOL, V27, P8113, DOI 10.1128/MCB.00794-07; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; Stadler G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-12; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tao YZ, 2011, J CELL BIOL, V194, P551, DOI 10.1083/jcb.201010090; Taverna D, 2015, BONE, V74, P83, DOI 10.1016/j.bone.2015.01.004; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Windelinckx A, 2011, PHYSIOL GENOMICS, V43, P981, DOI 10.1152/physiolgenomics.00200.2010; WUNSCH AM, 1991, MECH AGEING DEV, V59, P299, DOI 10.1016/0047-6374(91)90140-U; Xu J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4886-4; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang YP, 2009, CYTOKINE, V46, P137, DOI 10.1016/j.cyto.2008.12.015; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Zhang Y, 2000, J MOL ENDOCRINOL, V25, P221, DOI 10.1677/jme.0.0250221; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	65	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8296	8308		10.1074/jbc.RA118.004977	http://dx.doi.org/10.1074/jbc.RA118.004977			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30872405	Green Published, hybrid			2022-12-26	WOS:000470656500025
J	Corsa, CAS; Pearson, GL; Renberg, A; Askar, MM; Vozheiko, T; MacDougald, OA; Soleimanpour, SA				Corsa, Callie A. S.; Pearson, Gemma L.; Renberg, Aaron; Askar, Matthew M.; Vozheiko, Tracy; MacDougald, Ormond A.; Soleimanpour, Scott A.			The E3 ubiquitin ligase parkin is dispensable for metabolic homeostasis in murine pancreatic cells and adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; mitophagy; autophagy; mitochondria; adipose tissue; cell; metabolism; adipocyte; islet; E3 ubiquitin ligase	MEDIATED MITOPHAGY; BETA-CELLS; INSULIN; GENE; MITOCHONDRIA; CLEC16A; MAINTENANCE; POPULATION; LOCUS; RISK	The E3 ubiquitin ligase parkin is a critical regulator of mitophagy and has been identified as a susceptibility gene for type 2 diabetes (T2D). However, its role in metabolically active tissues that precipitate T2D development is unknown. Specifically, pancreatic cells and adipocytes both rely heavily on mitochondrial function in the regulation of optimal glycemic control to prevent T2D, but parkin's role in preserving quality control of cell or adipocyte mitochondria is unclear. Although parkin has been reported previously to control mitophagy, here we show that, surprisingly, parkin is dispensable for glucose homeostasis in both cells and adipocytes during diet-induced insulin resistance in mice. We observed that insulin secretion, cell formation, and islet architecture were preserved in parkin-deficient cells and islets, suggesting that parkin is not necessary for control of cell function and islet compensation for diet-induced obesity. Although transient parkin deficiency mildly impaired mitochondrial turnover in cell lines, parkin deletion in primary cells yielded no deficits in mitochondrial clearance. In adipocyte-specific deletion models, lipid uptake and -oxidation were increased in cultured cells, whereas adipose tissue morphology, glucose homeostasis, and beige-to-white adipocyte transition were unaffected in vivo. In key metabolic tissues where mitochondrial dysfunction has been implicated in T2D development, our experiments unexpectedly revealed that parkin is not an essential regulator of glucose tolerance, whole-body energy metabolism, or mitochondrial quality control. These findings highlight that parkin-independent processes maintain cell and adipocyte mitochondrial quality control in diet-induced obesity.	[Corsa, Callie A. S.; Askar, Matthew M.; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [Pearson, Gemma L.; Renberg, Aaron; Vozheiko, Tracy; MacDougald, Ormond A.; Soleimanpour, Scott A.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Soleimanpour, Scott A.] Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	MacDougald, OA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA.; MacDougald, OA; Soleimanpour, SA (corresponding author), Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.; Soleimanpour, SA (corresponding author), Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI 48105 USA.	macdouga@med.umich.edu; ssol@med.umich.edu		Soleimanpour, Scott/0000-0001-6777-4498; Askar, Matthew/0000-0003-2252-8554; Pearson, Gemma/0000-0003-4253-1830; MacDougald, Ormond/0000-0001-6907-7960	NIDDK, National Institutes of Health [R24 DK092759, RO1 DK62876, R01 DK108921, T32 DK101357]; American Diabetes Association [1-18-PDF-064]; JDRF [CDA-2016-189, SRA-2018-539]; Danish Diabetes Academy - Novo Nordisk Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK110768, P30DK020572, R24DK092759, P30DK089503, T32DK101357, R01DK108921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); Danish Diabetes Academy - Novo Nordisk Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIDDK, National Institutes of Health Grants R24 DK092759 and RO1 DK62876 (to O. A. M.), R01 DK108921 (to S. A. S.), and T32 DK101357 (to C. A. S. C.); American Diabetes Association Grant 1-18-PDF-064 (to C. A. S. C.); and JDRF Grants CDA-2016-189 and SRA-2018-539 (to S. A. S.). The JDRF career development award to S. A. S. is partly supported by the Danish Diabetes Academy, which is supported by the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hofmeister-Brix A, 2013, J BIOL CHEM, V288, P35824, DOI 10.1074/jbc.M113.526632; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jin HS, 2014, MOL CELL ENDOCRINOL, V382, P178, DOI 10.1016/j.mce.2013.09.031; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kaufman BA, 2015, MOL ASPECTS MED, V42, P91, DOI 10.1016/j.mam.2015.01.004; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Leak TS, 2008, HUM GENET, V124, P63, DOI 10.1007/s00439-008-0523-7; Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Lopez-Lluch G, 2017, MECH AGEING DEV, V162, P108, DOI 10.1016/j.mad.2016.12.005; Lu XD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8526; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pearson G, 2018, DIABETES, V67, P265, DOI 10.2337/db17-0321; Pearson GL, 2014, DIABETOLOGIA, V57, P129, DOI 10.1007/s00125-013-3083-x; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; RODBELL M, 1964, J BIOL CHEM, V239, P375; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shires SE, 2017, CIRC RES, V120, P1234, DOI 10.1161/CIRCRESAHA.116.310179; Soleimanpour SA, 2015, DIABETES, V64, P3475, DOI 10.2337/db15-0376; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Taylor D, 2017, OBESITY, V25, P704, DOI 10.1002/oby.21786; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wongseree W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-294	46	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7296	7307		10.1074/jbc.RA118.006763	http://dx.doi.org/10.1074/jbc.RA118.006763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877201	Green Published, hybrid			2022-12-26	WOS:000468402900018
J	Graab, P; Bock, C; Weiss, K; Hirth, A; Koller, N; Braner, M; Jung, J; Loehr, F; Tampe, R; Behrends, C; Abele, R				Graab, Philipp; Bock, Christoph; Weiss, Konstantin; Hirth, Alexander; Koller, Nicole; Braner, Markus; Jung, Jennifer; Loehr, Frank; Tampe, Robert; Behrends, Christian; Abele, Rupert			Lysosomal targeting of the ABC transporter TAPL is determined by membrane-localized charged residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; intracellular trafficking; lysosome; protein targeting; transmembrane domain; ATP-binding cassette subfamily B member 9 (ABCB9); polypeptide transporter; protein-protein interaction; TMD0; Yip1-interacting factor homolog B membrane-trafficking protein (YIF1B)	CELL ANTIGEN RECEPTOR; INVARIANT CHAIN; CLASS-II; MEDIATED ENDOCYTOSIS; TRANSMEMBRANE DOMAIN; RISK-FACTOR; TRAFFICKING; COMPLEX; LAMP-1; TRANSLOCATION	The human lysosomal polypeptide ABC transporter TAPL (ABC subfamily B member 9, ABCB9) transports 6-59-amino-acid-long polypeptides from the cytosol into lysosomes. The subcellular localization of TAPL depends solely on its N-terminal transmembrane domain, TMD0, which lacks conventional targeting sequences. However, the intracellular route and the molecular mechanisms that control TAPL localization remain unclear. Here, we delineated the route of TAPL to lysosomes and investigated the determinants of single trafficking steps. By synchronizing trafficking events by a retention using selective hooks (RUSH) assay and visualizing individual intermediate steps through immunostaining and confocal microscopy, we demonstrate that TAPL takes the direct route to lysosomes. We further identified conserved charged residues within TMD0 transmembrane helices that are essential for individual steps of lysosomal targeting. Substitutions of these residues retained TAPL in the endoplasmic reticulum (ER) or Golgi. We also observed that for release from the ER, a salt bridge between Asp-17 and Arg-57 is essential. An interactome analysis revealed that Yip1-interacting factor homolog B membrane-trafficking protein (YIF1B) interacts with TAPL. We also found that YIF1B is involved in ER-to-Golgi trafficking and interacts with TMD0 of TAPL via its transmembrane domain and that this interaction strongly depends on the newly identified salt bridge within TMD0. These results expand our knowledge about lysosomal trafficking of TAPL and the general function of extra transmembrane domains of ABC transporters.	[Graab, Philipp; Bock, Christoph; Weiss, Konstantin; Hirth, Alexander; Koller, Nicole; Braner, Markus; Tampe, Robert; Abele, Rupert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Loehr, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Loehr, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Jung, Jennifer; Behrends, Christian] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Behrends, Christian] Ludwig Maximilians Univ Munchen, Munich Cluster Syst Neurol, Feodor Lynen Str 17, D-81377 Munich, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Munich	Abele, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	abele@em.uni-frankfurt.de	Behrends, Christian/AAX-4201-2021; Tampe, Robert/H-2953-2015	Behrends, Christian/0000-0002-9184-7607; Weiss, Konstantin Julian/0000-0003-4895-9459; Lohr, Frank/0000-0001-6399-9497; Tampe, Robert/0000-0002-0403-2160	German Research Foundation [SFB 807, SFB 1177, SPP 1623, EXC1010, AB149/1-2]; Boehringer Ingelheim Foundation; Center for Biomolecular Magnetic Resonance	German Research Foundation(German Research Foundation (DFG)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Center for Biomolecular Magnetic Resonance	This work was supported by German Research Foundation Grants SFB 807 (to P. G., C. Bock, N. K., R. A., and R. T.), SFB 1177 (to C. Behrends), SPP 1623 (to R. T. and M. B.), EXC1010 SyNergy (to C. Behrends), and AB149/1-2 (to R. A.); the Boehringer Ingelheim Foundation (to C. Behrends); and the Center for Biomolecular Magnetic Resonance (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Alterio J, 2015, TRAFFIC, V16, P978, DOI 10.1111/tra.12306; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Blees A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17341; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Bock C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33841-w; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Busch JI, 2016, HUM MOL GENET, V25, P2681, DOI 10.1093/hmg/ddw127; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; Chen Y, 2017, J CELL BIOL, V216, P4141, DOI 10.1083/jcb.201707172; Cosson P, 2013, TRENDS CELL BIOL, V23, P511, DOI 10.1016/j.tcb.2013.05.005; Demirel O, 2007, J BIOL CHEM, V282, P37836, DOI 10.1074/jbc.M708139200; Demirel O, 2012, J CELL SCI, V125, P4230, DOI 10.1242/jcs.087346; Demirel O, 2010, TRAFFIC, V11, P383, DOI 10.1111/j.1600-0854.2009.01021.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jung J, 2017, ELIFE, V6, DOI [10.7554/eLife.23063, 10.75554/eLife.23063]; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kamakura A, 2008, BIOCHEM BIOPH RES CO, V377, P847, DOI 10.1016/j.bbrc.2008.10.078; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kawaguchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30183; Kawai H, 2009, MOL BIOL CELL, V20, P2979, DOI 10.1091/mbc.E08-09-0912; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kirshner H, 2013, J MICROSC-OXFORD, V249, P13, DOI 10.1111/j.1365-2818.2012.03675.x; Kiss K, 2015, BIOCHEM J, V467, P127, DOI 10.1042/BJ20141085; Kobayashi A, 2000, J BIOCHEM, V128, P711, DOI 10.1093/oxfordjournals.jbchem.a022805; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lawand M, 2019, MOL IMMUNOL, V113, P75, DOI 10.1016/j.molimm.2018.06.268; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nie C, 2018, P NATL ACAD SCI USA, V115, pE3155, DOI 10.1073/pnas.1704639115; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robertson MJ, 2014, NAT PROTOC, V9, P851, DOI 10.1038/nprot.2014.046; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Sage D, 2017, METHODS, V115, P28, DOI 10.1016/j.ymeth.2016.12.015; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Staudt C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010047; Stevenson NL, 2017, J CELL SCI, V130, P4132, DOI 10.1242/jcs.212308; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thomas C, 2018, CURR OPIN STRUC BIOL, V51, P116, DOI 10.1016/j.sbi.2018.03.016; Tumulka F, 2013, J BIOMOL NMR, V57, P141, DOI 10.1007/s10858-013-9774-2; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200; Zollmann T, 2015, P NATL ACAD SCI USA, V112, P2046, DOI 10.1073/pnas.1418100112	67	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7308	7323		10.1074/jbc.RA118.007071	http://dx.doi.org/10.1074/jbc.RA118.007071			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877195	hybrid, Green Published			2022-12-26	WOS:000468402900019
J	Leth, JM; Mertens, HDT; Leth-Espensen, KZ; Jorgensen, TJD; Ploug, M				Leth, Julie M.; Mertens, Haydyn D. T.; Leth-Espensen, Katrine Zinck; Jorgensen, Thomas J. D.; Ploug, Michael			Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor structure-function; surface plasmon resonance (SPR); protein evolution; urokinase receptor; disulfide; fibrinolysis; hydrogen exchange mass spectrometry; small-angle X-ray scattering (SAXS); plasminogen regulation; LU domain	PLASMINOGEN-ACTIVATOR UPA; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTOR; CELLULAR RECEPTOR; VITRONECTIN; PROTEIN; ANTIBODY; DOMAIN; LOCALIZATION; ADHESION	The urokinase receptor (uPAR) is a founding member of a small protein family with multiple Ly6/uPAR (LU) domains. The motif defining these LU domains contains five plesiotypic disulfide bonds stabilizing its prototypical three-fingered fold having three protruding loops. Notwithstanding the detailed knowledge on structure-function relationships in uPAR, one puzzling enigma remains unexplored. Why does the first LU domain in uPAR (DI) lack one of its consensus disulfide bonds, when the absence of this particular disulfide bond impairs the correct folding of other single LU domain-containing proteins? Here, using a variety of contemporary biophysical methods, we found that reintroducing the two missing half-cystines in uPAR DI caused the spontaneous formation of the corresponding consensus 7-8 LU domain disulfide bond. Importantly, constraints due to this cross-link impaired (i) the binding of uPAR to its primary ligand urokinase and (ii) the flexible interdomain assembly of the three LU domains in uPAR. We conclude that the evolutionary deletion of this particular disulfide bond in uPAR DI may have enabled the assembly of a high-affinity urokinase-binding cavity involving all three LU domains in uPAR. Of note, an analogous neofunctionalization occurred in snake venom -neurotoxins upon loss of another pair of the plesiotypic LU domain half-cystines. In summary, elimination of the 7-8 consensus disulfide bond in the first LU domain of uPAR did have significant functional and structural consequences.	[Leth, Julie M.; Leth-Espensen, Katrine Zinck; Ploug, Michael] Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Leth, Julie M.; Leth-Espensen, Katrine Zinck; Ploug, Michael] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Mertens, Haydyn D. T.] European Mol Biol Lab Hamburg, Notkestr 85, D-22607 Hamburg, Germany; [Leth-Espensen, Katrine Zinck; Jorgensen, Thomas J. D.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5320 Odense M, Denmark	Rigshospitalet; University of Copenhagen; European Molecular Biology Laboratory (EMBL); University of Southern Denmark	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	m-ploug@finsenlab.dk		Leth-Espensen, Katrine Zinck/0000-0002-3845-3676; Mertens, Haydyn/0000-0002-5664-744X; Ploug, Michael/0000-0003-2215-4265; Jorgensen, Thomas J.D./0000-0002-7149-316X				Adeyo O, 2015, BRIT J DERMATOL, V173, P1066, DOI 10.1111/bjd.13868; Almholt K, 2018, J IMMUNOL, V200, P957, DOI 10.4049/jimmunol.1701317; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Beigneux AP, 2015, CIRC RES, V116, P624, DOI 10.1161/CIRCRESAHA.116.305085; Boonstra MC, 2017, ORAL ONCOL, V66, P1, DOI 10.1016/j.oraloncology.2016.12.026; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Chana-Munoz A, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1353-z; Christensen A, 2017, ONCOTARGET, V8, P15407, DOI 10.18632/oncotarget.14282; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; De Lorenzi V, 2016, EMBO REP, V17, P982, DOI 10.15252/embr.201541681; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Ducancel F, 1996, J BIOL CHEM, V271, P31345, DOI 10.1074/jbc.271.49.31345; Ferraris GMS, 2014, EMBO J, V33, P2458, DOI 10.15252/embj.201387611; Fong LG, 2016, TRENDS ENDOCRIN MET, V27, P455, DOI 10.1016/j.tem.2016.04.013; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2013, J HISTOCHEM CYTOCHEM, V61, P802, DOI 10.1369/0022155413501879; Gardsvoll H, 2011, J BIOL CHEM, V286, P43515, DOI 10.1074/jbc.M111.300020; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Hansen LV, 2004, BIOCHEM J, V380, P845, DOI 10.1042/BJ20031478; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; HUBER K, 1984, J LAB CLIN MED, V103, P684; Jendroszek A, 2017, THROMB HAEMOSTASIS, V117, P1688, DOI 10.1160/TH17-02-0102; Jing YQ, 2017, MOL CANCER RES, V15, P1410, DOI 10.1158/1541-7786.MCR-17-0016; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kriegbaum MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25833; Kurbegovic S, 2018, BIOCONJUGATE CHEM, V29, P3833, DOI 10.1021/acs.bioconjchem.8b00669; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Liu DG, 2017, BIOCHEMISTRY-US, V56, P1768, DOI 10.1021/acs.biochem.6b01039; Liu SH, 2017, ONCOTARGET, V8, P65123, DOI 10.18632/oncotarget.17729; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund IK, 2011, CURR DRUG TARGETS, V12, P1744; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Mertens HDT, 2012, J BIOL CHEM, V287, P34304, DOI 10.1074/jbc.M112.398404; Mevorach D, 2015, MOL IMMUNOL, V67, P51, DOI 10.1016/j.molimm.2015.03.005; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Persson M, 2015, THERANOSTICS, V5, P1303, DOI 10.7150/thno.12956; Persson M, 2013, THERANOSTICS, V3, P618, DOI 10.7150/thno.6810; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; Pilbeam Kristy, 2018, Oncotarget, V9, P11938, DOI 10.18632/oncotarget.21187; Plengpanich W, 2014, J BIOL CHEM, V289, P19491, DOI 10.1074/jbc.M114.558528; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Ploug M, 2013, THERANOSTICS, V3, P467, DOI 10.7150/thno.3791; Rubinstein R, 2008, BIOINFORMATICS, V24, P498, DOI 10.1093/bioinformatics/btm637; Rullo AF, 2016, ANGEW CHEM INT EDIT, V55, P3642, DOI 10.1002/anie.201510866; Seeds N, 2011, CELL MOL NEUROBIOL, V31, P961, DOI 10.1007/s10571-011-9701-6; Sunagar K, 2013, TOXINS, V5, P2172, DOI 10.3390/toxins5112172; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thornton S, 2017, BLOOD ADV, V1, P545, DOI 10.1182/bloodadvances.2016004002; Trelle MB, 2017, ANAL CHEM, V89, P616, DOI 10.1021/acs.analchem.6b02518; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wada T, 2015, CLIN KIDNEY J, V8, P708, DOI 10.1093/ckj/sfv090; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Wiersinga WJ, 2010, J IMMUNOL, V184, P3079, DOI 10.4049/jimmunol.0901008; Wong JWH, 2011, MOL BIOL EVOL, V28, P327, DOI 10.1093/molbev/msq194; Xu D, 2017, CHEMMEDCHEM, V12, P1794, DOI 10.1002/cmdc.201700572; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Zhao BY, 2015, J MOL BIOL, V427, P1389, DOI 10.1016/j.jmb.2015.01.022	72	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7403	7418		10.1074/jbc.RA119.007847	http://dx.doi.org/10.1074/jbc.RA119.007847			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30894413	Green Published, hybrid			2022-12-26	WOS:000468402900026
J	Alves, PC; Oliveira, AD; Paro, HBMD				Alves, Priscila Castro; Oliveira, Aurea de Fatima; Martins da Silva Paro, Helena Borges			Quality of life and burnout among faculty members: How much does the field of knowledge matter?	PLOS ONE			English	Article							ORGANIZATIONAL SUPPORT; HEALTH; WORK; PROFESSORS; TEACHERS; WHOQOL; IMPACT; STATE; FIT	Background Faculty members face demands such as research, outreach programs, and management activities. Such demands may expose faculty to burnout. Burnout affects the physical, psychological and social health of faculty members, but it is still unclear how it affects their quality of life. We aimed to assess the impact of burnout on the quality of life (QoL) of faculty members from different fields of knowledge. Methods Cross-sectional study using validated tools for measuring burnout and QoL (Oldenburg Burnout Inventory-OLBI and World Health Organization Quality of Life-Abbreviated version-WHOQOL-Bref) in a sample of 366 faculty members from a public university. Scores were analyzed using Student's t-test, analysis of variance (ANOVA), binary logistic regression, and structural equation modeling (SEM). Results More than a third of the faculty members (n = 127; 36.6%) suffered from burnout. Men had higher scores of quality of life than women in the physical health (p = 0.001; d<0.5), psychological (p = 0.001; d<0.5) and social relationships (p = 0.048; d<0.5) domains. Women were more exhausted than men (p = 0.001; d<0.5). Faculty members' perception of quality of life and burnout did not differ according to their field of knowledge (p> 0.05). Participants who felt tired before arriving at work were less likely to report good quality of life (OR = 0.46; 95% CI = 0.21-0.99). Faculty members who stated they needed more time to relax after work were less likely to be satisfied with their health (OR = 0.20; 95% CI = 0.10-0.40). Burnout showed a negative association with quality of life (lambda = 0.87; p <0,001; df = 8). Conclusions Burnout negatively affects faculty members' quality of life, regardless of their field of knowledge. Our results suggest the implementation of programs and actions to prevent burnout to faculty members, especially to women, as their quality of life may affect the quality of the education provided.	[Alves, Priscila Castro] Univ Fed Uberlandia, Dept Publ Servants Qual Life & Hlth, Uberlandia, MG, Brazil; [Oliveira, Aurea de Fatima] Univ Fed Uberlandia, Inst Psychol, Uberlandia, MG, Brazil; [Martins da Silva Paro, Helena Borges] Univ Fed Uberlandia, Dept Obstet & Gynecol, Dept Humanities Hlth, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Alves, PC (corresponding author), Univ Fed Uberlandia, Dept Publ Servants Qual Life & Hlth, Uberlandia, MG, Brazil.	enf.pri@hotmail.com	Paro, Helena B M S/H-1330-2019	Paro, Helena B M S/0000-0001-6226-3074				Arandelovic M, 2010, THESCIENTIFICWORLDJO, V10, P766, DOI 10.1100/tsw.2010.83; de Oliveira ERA, 2012, CIENC SAUDE COLETIVA, V17, P741, DOI 10.1590/S1413-81232012000300021; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Blanc PD, 2004, OCCUP ENVIRON MED, V61, P571, DOI 10.1136/oem.2004.013888; Bordi Ivonne Vizcarra, 2007, Rev. Estud. Fem., V15, P581; Brenninkmeijer V., 2003, Occupational and Environmental Medicine, V60, pi16, DOI 10.1136/oem.60.suppl_1.i16; Carlotto M. S., 2008, PSICO PORTO ALEGRE, V39, P152; Carlotto MS, 2010, PSICO, V41, P495, DOI DOI 10.5752/P.1678-9563.2017V23N2P745-770; Carlotto MS, 2008, PSICOLOGIA EDUCACAO, V26, P29; Cassidy-Vu L, 2017, J PRIM CARE COMMUNIT, V8, P97, DOI 10.1177/2150131916669191; Cochran W., 1986, SAMPLING TECHNIQUES; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cruz LN, 2011, QUAL LIFE RES, V20, P1123, DOI 10.1007/s11136-011-9845-3; Cumming G., 2012, UNDERSTANDING NEW ST; de Chávez Ramírez Dellanira Ruiz, 2014, Cienc Trab., V16, P116; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Fernandes MH, 2009, REV BRAS PSIQUIATR, V31, P15, DOI 10.1590/S1516-44462009000100005; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Garcia AL, 2008, COGITARE ENFERMAGEM, V13, P18, DOI DOI 10.5380/CE.V13I1.11945; Garcia LP, 2003, REV ELETRONICA INTER, V1, P76; Gil-Monte PR, 2005, SYNDROME QUEMARSE TR; Grau E., 2009, ALETHEIA, V29, P6; Gutierrez AP, 2012, J ADV NURS, V68, P1601, DOI 10.1111/j.1365-2648.2012.05990.x; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Koetz L, 2013, CIENC SAUDE COLETIVA, V18, P1019, DOI 10.1590/S1413-81232013000400015; Kohnen R, 1990, LEHRER J, V10, P41; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Cardoso CGLD, 2016, CIENC SAUDE COLETIVA, V21, P2357, DOI 10.1590/1413-8123201521803862016; Lima MFEM, 2009, CIENCIAS COGNICAO, V14, P62; Lipp MEN, 2002, O STRESS DO PROFESSO; Manassero M, 2003, ESTRES BURNOUT ENSEN; Marco J., 2014, ANALISE EQUACOES EST; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Miller LM, 2017, LEVEL DECISION MAKIN; Moreno-Jimenez Bernardo, 2002, Psicol. Estud., V7, P11, DOI 10.1590/S1413-73722002000100004; Oliveira Filho Albertino de, 2012, Rev. educ. fis. UEM, V23, P57, DOI 10.4025/reveducfis.v23i1.10468; Paro HBMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094133; Penteado RZ, 2007, REV SAUDE PUBL, V41, P236, DOI 10.1590/S0034-89102007000200010; Pereira EF, 2013, CIENC SAUDE COLETIVA, V18, P1963, DOI 10.1590/S1413-81232013000700011; Peterson U., 2008, INT J STRESS MANAGE, V15, P153, DOI [10.1037/1072-5245.15.2.153, DOI 10.1037/1072-5245.15.2.153]; Qureshi HA, 2015, PLAST RECONSTR SURG, V135, P619, DOI 10.1097/PRS.0000000000000855; Rhoades L, 2002, J APPL PSYCHOL, V87, P698, DOI 10.1037//0021-9010.87.4.698; Rojas M. L, 2009, MEDELLIN REV FAC NAC, V27, P198; Schraiber Lília Blima, 2005, Ciênc. saúde coletiva, V10, P7, DOI 10.1590/S1413-81232005000100002; Schumacker R.E., 2004, BEGINNERS GUIDE STRU, V2nd ed.; Schuster M. Da, 2015, REV ELETRON MESTR PR, V8, P9; Shanafelt TD, 2009, ARCH INTERN MED, V169, P990, DOI 10.1001/archinternmed.2009.70; Silvério Maria Regina, 2010, Rev. bras. educ. med., V34, P65, DOI 10.1590/S0100-55022010000100008; Sloan J A, 2004, J Biopharm Stat, V14, P73, DOI 10.1081/BIP-120028507; Sousa Ivone Félix de, 2009, Psic.: Teor. e Pesq., V25, P499, DOI 10.1590/S0102-37722009000400005; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tabeleao VP, 2011, CAD SAUDE PUBLICA, V27, P2401, DOI 10.1590/S0102-311X2011001200011; Costa LDT, 2013, PSICOL-REFLEX CRIT, V26, P636, DOI 10.1590/S0102-79722013000400003; Vilarta R., 2004, QUALIDADE VIDA POLIT; Wright JG, 2011, PAED CHILD HEALT-CAN, V16, P409, DOI 10.1093/pch/16.7.409; Yao SM, 2015, ARCH ENVIRON OCCUP H, V70, P27, DOI 10.1080/19338244.2013.859120; Yen CJ, 2011, INT J DISTANCE EDUC, V9, P57, DOI 10.4018/jdet.2011100105; Zhu Wei, 2007, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V25, P735	59	28	28	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214217	10.1371/journal.pone.0214217	http://dx.doi.org/10.1371/journal.pone.0214217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP9GF	30901373	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400042
J	Bouquet, J; Li, T; Gardy, JL; Kang, XY; Stevens, S; Stevens, J; VanNess, M; Snell, C; Potts, J; Miller, RR; Morshed, M; McCabe, M; Parker, S; Uyaguari, M; Tang, P; Steiner, T; Chan, WS; De Souza, AM; Mattman, A; Patrick, DM; Chiu, CY				Bouquet, Jerome; Li, Tony; Gardy, Jennifer L.; Kang, Xiaoying; Stevens, Staci; Stevens, Jared; VanNess, Mark; Snell, Christopher; Potts, James; Miller, Ruth R.; Morshed, Muhammad; McCabe, Mark; Parker, Shoshana; Uyaguari, Miguel; Tang, Patrick; Steiner, Theodore; Chan, Wee-Shian; De Souza, Astrid-Marie; Mattman, Andre; Patrick, David M.; Chiu, Charles Y.			Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; RNA-SEQ; GENE-EXPRESSION; ENCEPHALOMYELITIS; FIBROMYALGIA; PATHOGEN; QUALITY; SCALE	Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a syndrome of unknown etiology characterized by profound fatigue exacerbated by physical activity, also known as post-exertional malaise (PEM). Previously, we did not detect evidence of immune dysregulation or virus reactivation outside of PEM periods. Here we sought to determine whether cardiopulmonary exercise stress testing of ME/CFS patients could trigger such changes. ME/CFS patients (n = 14) and matched sedentary controls (n = 11) were subjected to cardiopulmonary exercise on 2 consecutive days and followed up to 7 days post-exercise, and longitudinal whole blood samples analyzed by RNA-seq. Although ME/CFS patients showed significant worsening of symptoms following exercise versus controls, with 8 of 14 ME/CFS patients showing reduced oxygen consumption ((V) over dotO(2)) on day 2, transcriptome analysis yielded only 6 differentially expressed gene (DEG) candidates when comparing ME/CFS patients to controls across all time points. None of the DEGs were related to immune signaling, and no DEGs were found in ME/CFS patients before and after exercise. Virome composition (P = 0.746 by chi-square test) and number of viral reads (P = 0.098 by paired t-test) were not significantly associated with PEM. These observations do not support transcriptionally-mediated immune cell dysregulation or viral reactivation in ME/CFS patients during symptomatic PEM episodes.	[Bouquet, Jerome; Li, Tony; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Gardy, Jennifer L.; McCabe, Mark; Patrick, David M.] Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada; [Gardy, Jennifer L.; Kang, Xiaoying; Miller, Ruth R.; Patrick, David M.; Chiu, Charles Y.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Stevens, Staci; Stevens, Jared; VanNess, Mark; Snell, Christopher] Workwell Fdn, Ripon, CA USA; [Potts, James] Univ British Columbia, Div Cardiol, Dept Pediat, Vancouver, BC, Canada; [Morshed, Muhammad; Uyaguari, Miguel] British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada; [Morshed, Muhammad; Mattman, Andre] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Parker, Shoshana] Ctr Hlth Evaluat Outcome Sci, Vancouver, BC, Canada; [Tang, Patrick] Sidra Med & Res Ctr, Dept Pathol, Doha, Qatar; [Steiner, Theodore; Chan, Wee-Shian] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC, Canada; [De Souza, Astrid-Marie] British Columbia Childrens Hosp, Div Cardiol, Vancouver, BC, Canada; [Mattman, Andre] Vancouver Gen Hosp, Adult Metab Dis Clin, Vancouver, BC, Canada; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of British Columbia; University of British Columbia; University of British Columbia; Sidra Medical & Research Center; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of California System; University of California San Francisco	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Patrick, DM (corresponding author), Communicable Dis Prevent & Control Serv, Vancouver, BC, Canada.; Patrick, DM (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA.	david.patrick@ubc.ca; charles.chiu@ucsf.edu	Uyaguari, Miguel/AAU-5590-2021; Morshed, Muhammad/AAZ-6047-2020	Potts, Jim/0000-0003-2041-7711; Chan, Wee-Shian/0000-0002-2513-0480; Steiner, Ted/0000-0002-3136-6668; Bouquet, Jerome/0000-0001-8077-6025	NIH [R21NS088166]; ME Research UK (Scottish Charity) [SC036942]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ME Research UK (Scottish Charity)	This study was funded by NIH grant R21NS088166 (DMP and CYC) and by a non-overlapping grant from ME Research UK (Scottish Charity Number SC036942 to DMP) that funded extended specimen collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bouquet J, 2017, CLIN INFECT DIS, V64, P476, DOI 10.1093/cid/ciw767; Brenu EW, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-88; Burnham K P, 2003, MODEL SELECT MULTIMO; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Byrnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005805; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Ching T, 2014, RNA, V20, P1684, DOI 10.1261/rna.046011.114; Clayton EW, 2015, JAMA-J AM MED ASSOC, V313, P1101, DOI 10.1001/jama.2015.1346; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Hitchen J., 2013, J BIOMOL TECH, V24, pS43; Hornig M, 2016, MOL PSYCHIATR, V21, P261, DOI 10.1038/mp.2015.29; Johnston Samantha, 2013, Clin Epidemiol, V5, P105, DOI 10.2147/CLEP.S39876; Karlsson EA, 2010, J NUTR, V140, P1691, DOI 10.3945/jn.110.123653; Karnofsky DA, 1949, EVALUATION CHEMOTHER; Keech A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00421; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Light AR, 2012, J INTERN MED, V271, P64, DOI 10.1111/j.1365-2796.2011.02405.x; Mensah FKF, 2017, NEUROPHYSIOL CLIN, V47, P131, DOI 10.1016/j.neucli.2017.02.002; Moneghetti KJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20941-w; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Navaneetharaja N, 2016, J CLIN MED, V5, DOI 10.3390/jcm5060055; Naviaux RK, 2016, P NATL ACAD SCI USA, V113, pE5472, DOI 10.1073/pnas.1607571113; Nijs J, 2014, EXERC IMMUNOL REV, V20, P94; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reid S, 2000, BMJ-BRIT MED J, V320, P292, DOI 10.1136/bmj.320.7230.292; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Rusu C, 2015, HEALTH PROMOT CHRON, V35, P3, DOI 10.24095/hpcdp.35.1.02; SCHNEIDER DA, 1993, MED SCI SPORT EXER, V25, P1180; Simmonds P, 1999, J INFECT DIS, V180, P1748, DOI 10.1086/315103; Snell CR, 2013, PHYS THER, V93, P1484, DOI 10.2522/ptj.20110368; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ware JE, 2007, USERS MANUAL SF 36V2; Washburn RA, 1999, J CLIN EPIDEMIOL, V52, P643, DOI 10.1016/S0895-4356(99)00049-9; Whitley R, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P589; Zaharia M, 2011, ARXIV11115572CSQBIO; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	45	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0212193	10.1371/journal.pone.0212193	http://dx.doi.org/10.1371/journal.pone.0212193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897114	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700011
J	Carmen, R; Yom-Tov, GB; Van Nieuwenhuyse, I; Foubert, B; Ofran, Y				Carmen, Raisa; Yom-Tov, Galit B.; Van Nieuwenhuyse, Inneke; Foubert, Bram; Ofran, Yishai			The role of specialized hospital units in infection and mortality risk reduction among patients with hematological cancers	PLOS ONE			English	Article							PREDICTION; IMPACT; TIME; MANAGEMENT; SYMPTOMS; SURVIVAL; THERAPY; SEPSIS; COHORT; MODEL	Motivation Patients with hematological malignancies are susceptible to life-threatening infections after chemotherapy. The current study aimed to evaluate whether management of such patients in dedicated inpatient and emergency wards could provide superior infection prevention and outcome. Methods We have developed an approach allowing to retrieve infection-related information from unstructured electronic medical records of a tertiary center. Data on 2,330 adults receiving 13,529 chemotherapy treatments for hematological malignancies were identified and assessed. Infection and mortality hazard rates were calculated with multivariate models. Patients were randomly divided into 80: 20 training and validation cohorts. To develop patient-tailored risk-prediction models, several machine-learning methods were compared using area under the curve (AUC). Results Of the tested algorithms, the probit model was found to most accurately predict the evaluated hazards and was implemented in an online calculator. The infection-prediction model identified risk factors for infection based on patient characteristics, treatment and history. Observation of patients with a high predicted infection risk in general wards appeared to increase their infection hazard (p = 0.009) compared to similar patients observed in hematology units. The mortality-risk model demonstrated that for infection events starting at home, admission through hematology services was associated with a lower mortality hazard compared to admission through the general emergency department (p = 0.007). Both models show that dedicated hematological facilities and emergency services improve patient outcome post-chemotherapy. The calculated numbers needed to treat were 30.27 and 31.08 for the dedicated emergency and observation facilities, respectively. Infection hazard risks were found to be non-monotonic in time. Conclusions The accuracy of the proposed mortality and infection risk-prediction models was high, with the AUC of 0.74 and 0.83, respectively. Our results demonstrate that temporal assessment of patient risks is feasible. This may enable physicians to move from one-point decision-making to a continuous dynamic observation, allowing a more flexible and patient-tailored admission policy.	[Carmen, Raisa] Katholieke Univ Leuven, Fac Business & Econ, Dept Decis Sci & Informat Management, Brussels Campus, Brussels, Belgium; [Yom-Tov, Galit B.] Technion, Fac Ind Engn & Management, Haifa, Israel; [Van Nieuwenhuyse, Inneke] Hasselt Univ, Fac Business Econ, Campus Diepenbeek, Diepenbeek, Belgium; [Foubert, Bram] Maastricht Univ, Dept Mkt & Supply Chain Management, Maastricht, Netherlands; [Ofran, Yishai] Technion, Dept Hematol & Bone Marrow Transplantat, Rambam Hlth Care Campus, Haifa, Israel; [Ofran, Yishai] Technion, Bruce Rappaport Fac Med, Haifa, Israel	KU Leuven; Technion Israel Institute of Technology; Hasselt University; Maastricht University; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Ofran, Y (corresponding author), Technion, Dept Hematol & Bone Marrow Transplantat, Rambam Hlth Care Campus, Haifa, Israel.; Ofran, Y (corresponding author), Technion, Bruce Rappaport Fac Med, Haifa, Israel.	y_ofran@rambam.health.gov.il	Van Nieuwenhuyse, Inneke/AAD-4356-2020	Yom-Tov, Galit/0000-0003-0295-7968; Ofran, Yishai/0000-0002-5521-1337; Carmen, Raisa/0000-0003-1025-8702; Van Nieuwenhuyse, Inneke/0000-0003-2759-3726	ISRAEL SCIENCE FOUNDATION [1955/15]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation)	This research was supported by the ISRAEL SCIENCE FOUNDATION (grant No. 1955/15).	Aitken CK, 2017, EPIDEMIOL INFECT, V145, P796, DOI 10.1017/S0950268816002892; Allyn J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169772; Berger J, 2013, CLIN MED, V13, P457, DOI 10.7861/clinmedicine.13-5-457; Bruce CM, 2017, CLIN ONCOL-UK, V29, pE148, DOI 10.1016/j.clon.2017.03.012; Cornely OA, 2015, CLIN INFECT DIS, V61, P324, DOI 10.1093/cid/civ293; DeRose LF, 2017, POP STUD-J DEMOG, V71, P211, DOI 10.1080/00324728.2017.1316866; Elting LS, 2008, J CLIN ONCOL, V26, P606, DOI 10.1200/JCO.2007.13.8222; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Halfdanarson TR, 2017, MAYO CLIN PROC, V92, P609, DOI 10.1016/j.mayocp.2017.02.008; Jovanovic M, 2016, ARTIF INTELL MED, V72, P12, DOI 10.1016/j.artmed.2016.07.003; Kang C, 2015, BIOSTATISTICS, V16, P295, DOI 10.1093/biostatistics/kxu040; Kim SW, 2014, JAMA SURG, V149, P633, DOI 10.1001/jamasurg.2014.241; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; Liu SH, 2013, J INFECT DIS, V208, P1071, DOI 10.1093/infdis/jit297; Narayanan Menaka, 2018, HUMANS UNDERSTAND EX; Navani V, 2014, CURR ONCOL, V21, P147, DOI 10.3747/co.21.1904; Nemati S, 2018, CRIT CARE MED, V46, P547, DOI [10.1097/CCM.0000000000002936, 10.1097/ccm.0000000000002936]; Neville-Webbe HL, 2013, CLIN MED, V13, P565, DOI 10.7861/clinmedicine.13-6-565; Oh J, 2018, INFECT CONT HOSP EP, V39, P425, DOI 10.1017/ice.2018.16; Putt L, 2014, CLIN ONCOL-UK, V26, P125, DOI 10.1016/j.clon.2013.11.025; Rosa RG, 2014, ANTIMICROB AGENTS CH, V58, P3799, DOI 10.1128/AAC.02561-14; Shankland Kate, 2012, J Comorb, V2, P10; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Van Poucke S, 2018, DATA MINING, DOI [10.5772/intechopen.76988, DOI 10.5772/INTECHOPEN.76988]; Vandyk AD, 2012, SUPPORT CARE CANCER, V20, P1589, DOI 10.1007/s00520-012-1459-y; Wick JP, 2017, AM J KIDNEY DIS, V69, P568, DOI 10.1053/j.ajkd.2016.08.035	27	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0211694	10.1371/journal.pone.0211694	http://dx.doi.org/10.1371/journal.pone.0211694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893320	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000461765900008
J	Chen, JN; Cao, FB; Yin, XH; Huang, M; Zou, YB				Chen, Jiana; Cao, Fangbo; Yin, Xiaohong; Huang, Min; Zou, Yingbin			Yield performance of early-season rice cultivars grown in the late season of double-season crop production under machine-transplanted conditions	PLOS ONE			English	Article							USE EFFICIENCY; GRAIN-YIELD; OPTIONS; RELEASE; WATER; DRY	In order to solve the problem of labor shortage in double-season rice production areas, machine transplanting, as opposed to manual transplanting, has become the more popular alternative method in rice cultivation. However, the most existing late rice cultivars are not suitable for machine double-season rice cultivation due to their long duration of growth. Therefore, based on the previous studies we chose early season rice cultivars to meet the needs of machine double-season rice cultivation. In this study, field experiments were conducted during the late season in 2015 and 2016 in Liuyang County, Hunan Province, China. Grain yield and yield-related traits were compared among eight early-season cultivars (Liangyou 6, Lingliangyou 211, Lingliangyou 268, Zhuliangyou 819, Xiangzaoxian 32, Xiangzaoxian 42, Zhongjiazao 17, and Zhongzao 39) in 2015 and four cultivars (Lingliangyou 268, Zhuliangyou 819, Zhongjiazao 17, and Zhongzao 39) in 2016, selected from the highest yielding cultivars grown in 2015. Lingliangyou 268 produced 8-44% higher grain yield than did the other cultivars except Zhongjiazao17 in 2015. This higher grain yield was driven by grain weight and aboveground biomass. The greater aboveground biomass in Lingliangyou 268 was mainly attributed to higher apparent radiation use efficiency (aboveground biomass/ incident solar radiation). Our study suggests that improvement in grain weight and apparent radiation use efficiency were critical to the high grain yield of early-season rice cultivars grown in late season under machine transplanting conditions.	[Chen, Jiana; Cao, Fangbo; Yin, Xiaohong; Huang, Min; Zou, Yingbin] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China; [Yin, Xiaohong] Guangxi Acad Agr Sci, Rice Res Inst, Guangxi Key Lab Rice Genet & Breeding, Nanning, Peoples R China	Hunan Agricultural University; Guangxi Academy of Agricultural Sciences	Huang, M (corresponding author), Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha, Hunan, Peoples R China.	mhuang@hunau.edu.cn		Huang, Min/0000-0002-6944-8538	National Key R & D Program of China [2017YFD0301503]; Earmarked Fund for China Agriculture Research System [CARS-01]	National Key R & D Program of China; Earmarked Fund for China Agriculture Research System	This research was supported by the National Key R & D Program of China (Grant No. 2017YFD0301503) to MH, and the Earmarked Fund for China Agriculture Research System (Grant No. CARS-01) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Jia-na, 2015, Zhongguo Shuidao Kexue, V29, P628, DOI 10.3969/j.issn.1001-7216.2015.06.009; Huang M, 2016, NJAS-WAGEN J LIFE SC, V78, P123, DOI 10.1016/j.njas.2016.05.004; Huang M, 2015, BIOTECHNOL AGRON SOC, V19, P153; Huang Min, 2013, Australian Journal of Crop Science, V7, P600; Jeng TL, 2006, FIELD CROP RES, V99, P59, DOI 10.1016/j.fcr.2006.03.005; Katsura K, 2008, FIELD CROP RES, V107, P1, DOI 10.1016/j.fcr.2007.12.007; Khush G. S., 1995, Geojournal, V35, P275, DOI 10.1007/BF00989135; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Laza RC, 2003, PLANT PROD SCI, V6, P28, DOI 10.1626/pps.6.28; Oladosu Y, 2017, ACTA AGR SCAND B-S P, V67, P590, DOI 10.1080/09064710.2017.1321138; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; [彭少兵 Peng ShaoBing], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P845; Qin JQ, 2013, FIELD CROP RES, V148, P15, DOI 10.1016/j.fcr.2013.04.004; Sinclair TR, 1999, ADV AGRON, V65, P215, DOI 10.1016/S0065-2113(08)60914-1; Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep38982; Wang DP, 2016, FIELD CROP RES, V198, P303, DOI 10.1016/j.fcr.2016.05.008; Wang WQ, 2016, SCI REP-UK, V6, DOI [10.1038/srep19637, 10.1038/srep38938]; Wu W, 2013, EUR J AGRON, V45, P75, DOI 10.1016/j.eja.2012.10.009; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Xu L, 2018, FIELD CROP RES, V227, P49, DOI 10.1016/j.fcr.2018.08.002; Yang W, 2008, AGRON J, V100, P1390, DOI 10.2134/agronj2007.0356; Ye YS, 2013, FIELD CROP RES, V144, P212, DOI 10.1016/j.fcr.2012.12.003; Yin X, 2015, J EXP BOT, V66, P6635, DOI [10.1093/jxb/erv370, DOI 10.1093/JXB/ERV370]; Zhang W., 2011, CHIN AGR MECH, V1, P19; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008; Zhu D F, 2013, CHINA RICE, V19, P1; Zhu F., 2007, N RICE, V5, P13, DOI [10.3969/j.issn.1673-6737.2007.05.005, DOI 10.3969/J.ISSN.1673-6737.2007.05.005]; Zou Y., 2008, CROP RES, V22, P209	28	17	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213075	10.1371/journal.pone.0213075	http://dx.doi.org/10.1371/journal.pone.0213075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893321	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900026
J	Faessler, L; Brodbeck, J; Schuetz, P; Haubitz, S; Mueller, B; Perrig-Chiello, P				Faessler, Lukas; Brodbeck, Jeannette; Schuetz, Philipp; Haubitz, Sebastian; Mueller, Beat; Perrig-Chiello, Pasqualina			Medical patients' affective well-being after emergency department admission: The role of personal and social resources and health-related variables	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; POSITIVE EMOTIONS; SHORT-FORM; TRAJECTORIES; DEPRESSION; WOMEN; RESILIENCE; ANXIETY; QUESTIONNAIRE; ADJUSTMENT	Background Medical emergency admissions are critical life events associated with considerable stress. However, research on patients' affective well-being after emergency department (ED) admission is scarce. This study investigated the course of affective well-being of medical patients following an ED admission and examined the role of personal and social resources and health-related variables. Methods In this longitudinal survey with a sample of 229 patients with lower respiratory tract infections and cardiac diseases (taken between October 2013 and December 2014), positive and negative affect was measured at ED admission (T1) and at follow-up after 7 days (T2), and 30 days (T3). The role of personal and social resources (emotional stability, trait resilience, affect state, and social support) as well as health-related variables (self-rated health, multi-morbidity, and psychological comorbidity) in patients' affective well-being was examined by controlling for demographic characteristics using regression analyses. Results The strength of the inverse correlation between positive and negative affect decreased over time. In addition to health-related variables, higher negative affect was predicted by higher psychological comorbidity over time (T1-T3). In turn, lower positive affect was predicted by lower self-rated health (T1-T2) and higher multimorbidity (T3). In terms of personal and social resources, lower negative affect was predicted by higher emotional stability (T2), whereas higher positive affect was predicted by stronger social support (T1-T2). Conclusion Knowledge about psychosocial determinants-personal and social resources and health-related variables-of patients' affective well-being following ED admission is essential for designing more effective routine screening and treatment.	[Faessler, Lukas; Brodbeck, Jeannette; Perrig-Chiello, Pasqualina] Univ Bern, Inst Psychol, Bern, Switzerland; [Schuetz, Philipp; Haubitz, Sebastian; Mueller, Beat] Kantonsspital Aarau, Med Univ Dept, Aarau, Switzerland	University of Bern; Kantonsspital Aarau AG (KSA)	Faessler, L (corresponding author), Univ Bern, Inst Psychol, Bern, Switzerland.	lukas.faessler@students.unibe.ch	schuetz, philipp/C-8475-2013; Mueller, Beat/G-2662-2012	schuetz, philipp/0000-0001-6400-4949; Faessler, Lukas/0000-0002-9344-7500	Swiss National Science Foundation (SNSF) [PP00P3_150531/1]; Kantonsspital Aarau	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Kantonsspital Aarau	This study was supported in part by the Swiss National Science Foundation (SNSF Professorship, PP00P3_150531/1) and through internal funds of the Kantonsspital Aarau. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.	[Anonymous], 2015, HERZ KREISL ERKR; Billor N, 2000, COMPUT STAT DATA AN, V34, P279, DOI 10.1016/S0167-9473(99)00101-2; Body R, 2015, EMERG MED J, V32, P15, DOI 10.1136/emermed-2013-202860; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Damen NL, 2011, J AFFECT DISORDERS, V134, P464, DOI 10.1016/j.jad.2011.05.026; Davis MC, 2004, J PERS, V72, P1133, DOI 10.1111/j.1467-6494.2004.00293.x; Dunkel D, 2005, PSYCHOTHER PSYCH MED, V55, P266, DOI 10.1055/s-2004-834746; Edmondson D, 2014, J PSYCHIATR RES, V53, P8, DOI 10.1016/j.jpsychires.2014.02.009; Faessler L, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0097-y; Faessler L, 2016, EMERG MED J, V33, P581, DOI 10.1136/emermed-2014-204426; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Henselmans I, 2010, HEALTH PSYCHOL, V29, P160, DOI 10.1037/a0017806; Jivraj S, 2014, J GERONTOL B-PSYCHOL, V69, P930, DOI 10.1093/geronb/gbu006; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Mackinnon A, 1999, PERS INDIV DIFFER, V27, P405, DOI 10.1016/S0191-8869(98)00251-7; Manne S, 2008, PSYCHOSOM MED, V70, P677, DOI 10.1097/PSY.0b013e31817b935d; McKenzie M, 2010, J PSYCHOSOM RES, V68, P21, DOI 10.1016/j.jpsychores.2009.08.004; Meister RE, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000261; Murphy BM, 2008, BRIT J HEALTH PSYCH, V13, P135, DOI 10.1348/135910707X173312; Ong A.D., 2010, HDB ADULT RESILIENCE, P81; Perez-Garcia AM, 2011, STRESS HEALTH, V27, pE252, DOI 10.1002/smi.1378; Perrig-Chiello P., 2015, WEGE VERLETZLICHKEIT, P21; Rammstedt B, 2007, EUR J PSYCHOL ASSESS, V23, P193, DOI 10.1027/1015-5759.23.3.193; Schuetz P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1098-z; Schuetz P, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-12; Schumacher J, 2005, Z KLIN PSYCH PSYCHIA, V53, P16; Shah MN, 2011, J AM GERIATR SOC, V59, P321, DOI 10.1111/j.1532-5415.2010.03268.x; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; van Jaarsveld CHM, 2005, SOC SCI MED, V60, P1035, DOI 10.1016/j.socscimed.2004.06.037; Wagnild G M, 1993, J Nurs Meas, V1, P165; Zautra AJ, 2005, J CONSULT CLIN PSYCH, V73, P212, DOI 10.1037/0022-006X.73.2.212	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0212900	10.1371/journal.pone.0212900	http://dx.doi.org/10.1371/journal.pone.0212900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893347	Green Published, gold, Green Submitted			2022-12-26	WOS:000461765900020
J	Anastasopoulos, LJ; Williams, JR				Anastasopoulos, Lefteris Jason; Williams, Jake Ryland			A scalable machine learning approach for measuring violent and peaceful forms of political protest participation with social media data	PLOS ONE			English	Article								In this paper, we introduce a scalable machine learning approach accompanied by open source software for identifying violent and peaceful forms of political protest participation using social media data. While violent political protests are statistically rare events, they often shape public perceptions of political and social movements. This is, in part, due to the extensive and disproportionate media coverage which violent protest participation receives relative to peaceful protest participation. In the past, when a small number of media conglomerates served as the primary information source for learning about political and social movements, viewership and advertiser demands encouraged news organizations to focus on violent forms of political protest participation. Consequently, much of our knowledge about political protest participation is derived from data collected about violent protests, while less is known about peaceful forms of protest. Since the early 2000s, the digital revolution shifted attention away from traditional news sources toward social media as a primary source of information about current events. This, along with developments in machine learning which allow us to collect and analyze data relevant to political participation, present us with unique opportunities to expand our knowledge of peaceful and violent forms of political protest participation through social media data.	[Anastasopoulos, Lefteris Jason] Univ Georgia, Sch Publ & Int Affairs, Dept Publ Adm & Policy, Athens, GA 30602 USA; [Anastasopoulos, Lefteris Jason] Univ Georgia, Sch Publ & Int Affairs, Dept Polit Sci, Athens, GA 30602 USA; [Anastasopoulos, Lefteris Jason] Univ Georgia, Inst Artificial Intelligence, Athens, GA 30602 USA; [Williams, Jake Ryland] Drexel Univ, Coll Comp & Informat, Philadelphia, PA 19104 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Drexel University	Anastasopoulos, LJ (corresponding author), Univ Georgia, Sch Publ & Int Affairs, Dept Publ Adm & Policy, Athens, GA 30602 USA.; Anastasopoulos, LJ (corresponding author), Univ Georgia, Sch Publ & Int Affairs, Dept Polit Sci, Athens, GA 30602 USA.; Anastasopoulos, LJ (corresponding author), Univ Georgia, Inst Artificial Intelligence, Athens, GA 30602 USA.	ljanastas@uga.edu						Anastasopoulos LJ, 2019, J PUBL ADM RES THEOR, V29, P491, DOI 10.1093/jopart/muy060; [Anonymous], 2017, P 3 WORKSH NOIS US G; Breuer A, 2015, DEMOCRATIZATION, V22, P764, DOI 10.1080/13510347.2014.885505; Dunaway J, 2010, SOC SCI QUART, V91, P359, DOI 10.1111/j.1540-6237.2010.00697.x; Earl J, 2004, ANNU REV SOCIOL, V30, P65, DOI 10.1146/annurev.soc.30.012703.110603; Enjolras B, 2013, NEW MEDIA SOC, V15, P890, DOI 10.1177/1461444812462844; Laura MA, 2006, NEWS COVERAGE SOCIAL, V9, P1, DOI [10.1207/s15327825mcs0901_1, DOI 10.1207/S15327825MCS0901_1]; McLeod DM, 1999, J COMMUN, V49, P3, DOI 10.1093/joc/49.3.3; Myers DJ, 2000, AM J SOCIOL, V106, P173, DOI 10.1086/303110; Sajuria J, 2015, AM POLIT RES, V43, P708, DOI 10.1177/1532673X14557942; Smith J., 2001, SOC FORCES, V79, P4, DOI DOI 10.1353/S0F.2001.0053; Tufekci Z, 2012, J COMMUN, V62, P363, DOI 10.1111/j.1460-2466.2012.01629.x; van Deth JW, 2014, ACTA POLIT, V49, P349, DOI 10.1057/ap.2014.6; Yannis Theocharis, 2015, SOCIAL MEDIA SOC, V1	14	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0212834	10.1371/journal.pone.0212834	http://dx.doi.org/10.1371/journal.pone.0212834			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP3JN	30889227	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000011
J	Kanakala, S; Ghanim, M				Kanakala, Surapathrudu; Ghanim, Murad			Global genetic diversity and geographical distribution of Bemisia tabaci and its bacterial endosymbionts	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE; MULTIPLE ACQUISITION; SYMBIOTIC BACTERIA; TRANSMISSION; POPULATIONS; RICKETTSIA; INCOMPATIBILITY; STERNORRHYNCHA; BEGOMOVIRUSES; LOCALIZATION	Bemisia tabaci is one of the most threatening pests in agriculture, causing significant losses to many important crops on a global scale. The dramatic increase and availability of sequence data for B. tabaci species complex and its bacterial endosymbionts is critical for developing emerging sustainable pest management strategies which are based on pinpointing the global diversity of this important pest and its bacterial endosymbionts. To unravel the global genetic diversity of B. tabaci species complex focusing on its associated endosymbionts, along with Israeli whitefly populations collected in this study, we combined available sequences in databases, resulting in a total of 4,253 mitochondrial cytochrome oxidase I (mtCOl) sequences from 82 countries and 1,226 16S/23S rRNA endosymbiont sequences from 32 countries that were analyzed. Using Bayesian phylogenetic analysis, we identified two new B. tabaci groups within the species complex and described the global distribution of endosymbionts within this complex. Our analyses revealed complex divergence of the different endosymbiont sequences within the species complex, with overall one Hamiltonella, two Porteria (P1 and P2), two Arsenophonus (A1 and A2), two Wolbachia (super-groups O and B), four Cardinium (C1-C4) and three Rickettsia (R1-R3) groups were identified. Our comprehensive analysis provides an updated important resource for this globally important pest and its secondary symbionts, which have been a major subject for research in last three decades.	[Kanakala, Surapathrudu; Ghanim, Murad] Agr Res Org, Volcani Ctr, Dept Entomol, Rishon Leziyyon, Israel; [Kanakala, Surapathrudu] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Iowa State University	Ghanim, M (corresponding author), Agr Res Org, Volcani Ctr, Dept Entomol, Rishon Leziyyon, Israel.	ghanim@agri.gov.il	Surapathrudu, Kanakala/I-3791-2019	Surapathrudu, Kanakala/0000-0003-4702-3990; Ghanim, Murad/0000-0001-6628-8308	ARO; Israel Science Foundation (ISF); Binational Agricultural Research and Development Fund (BARD); Chief Scientist of the Ministry of Agriculture in Israel	ARO; Israel Science Foundation (ISF)(Israel Science Foundation); Binational Agricultural Research and Development Fund (BARD); Chief Scientist of the Ministry of Agriculture in Israel	SK was supported with a Postdoctoral Fellowship #2014-2016 from ARO. Research in the Ghanim lab is supported by grants from the Israel Science Foundation (ISF), Binational Agricultural Research and Development Fund (BARD) and the Chief Scientist of the Ministry of Agriculture in Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bing XL, 2013, APPL ENVIRON MICROB, V79, P569, DOI 10.1128/AEM.03030-12; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Czosnek H, 2017, VIRUSES, V273; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Firdaus S, 2013, INSECT SCI, V20, P723, DOI 10.1111/1744-7917.12001; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Ghanim M, 2014, VIRUS RES, V186, P47, DOI 10.1016/j.virusres.2014.01.022; Ghosh S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0425-5; Glowska E, 2015, INFECT GENET EVOL, V30, P140, DOI 10.1016/j.meegid.2014.12.019; Gorsane F, 2011, ENVIRON ENTOMOL, V40, P809, DOI 10.1603/EN10162; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Gottlieb Y, 2006, APPL ENVIRON MICROB, V72, P3646, DOI 10.1128/AEM.72.5.3646-3652.2006; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hendry TA, 2014, APPL ENVIRON MICROB; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hu J, 2018, MITOCHONDRIAL DNA A, V29, P474, DOI 10.1080/24701394.2017.1307974; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Kanakala S, 2018, GENES, GENETICS AND TRANSGENICS FOR VIRUS RESISTANCE IN PLANTS, P201, DOI 10.21775/9781910190814.10; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Marubayashi JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108363; Miller M.A., 2010, P GAT COMP ENV WORKS; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Mouton L, 2015, PEST MANAG SCI, V71, P452, DOI 10.1002/ps.3834; Mouton L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S10; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pinheiro PV, 2015, CURR OPIN INSECT SCI, V8, P69, DOI 10.1016/j.cois.2015.01.010; Qin L, 2016, INSECT SCI, V23, P215, DOI 10.1111/1744-7917.12296; Rana VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042168; Roopa HK, 2015, FLA ENTOMOL, V98, P1062, DOI 10.1653/024.098.0409; Shan HW, 2016, INSECT SCI, V23, P200, DOI 10.1111/1744-7917.12276; Simon B, 2003, PHYTOPATHOLOGY, V93, P1422, DOI 10.1094/PHYTO.2003.93.11.1422; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Skaljac M, 2013, B ENTOMOL RES, V103, P48, DOI 10.1017/S0007485312000399; Skaljac M, 2017, INSECTS, V8, DOI 10.3390/insects8040113; Skaljac M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-142; Sloan DB, 2012, BIOL LETTERS, V8, P986, DOI 10.1098/rsbl.2012.0664; Su Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050550; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; Vautrin E, 2008, J EVOLUTION BIOL, V21, P145, DOI 10.1111/j.1420-9101.2007.01460.x; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Xie W, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix018; Yang JX, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0223-4; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zchori-Fein E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00310	67	86	93	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213946	10.1371/journal.pone.0213946	http://dx.doi.org/10.1371/journal.pone.0213946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889213	Green Submitted, gold, Green Published			2022-12-26	WOS:000461573000038
J	Ittermann, T; Feig, MA; Petersmann, A; Radke, D; Greinacher, A; Volzke, H; Thiele, T				Ittermann, Till; Feig, Martin A.; Petersmann, Astrid; Radke, Doerte; Greinacher, Andreas; Voelzke, Henry; Thiele, Thomas			Mean platelet volume is more important than age for defining reference intervals of platelet counts	PLOS ONE			English	Article							HEMATOLOGICAL PROFILE; BLOOD-COUNT; CELL COUNT; SEX; PARAMETERS; INDEXES; THROMBOCYTOPENIA; STANDARDIZATION; METAANALYSIS; THROMBOSIS	Background Platelet count is known to be associated with sex, age and mean platelet volume (MPV). Sex and age were proposed for adjustment of platelet count reference intervals, but MPV is currently not used for further adjustment. We investigated the association of MPV, age and sex with platelet counts and established individualized reference ranges respecting MPV. Methods The association of platelet count with age, sex and MPV was assessed in healthy participants (n = 3,033 individuals; 1,542 women) in the cross-sectional population-based cohort Study of Health in Pomerania. Reference intervals respecting age, sex, and MPV were estimated using quantile regressions for the 2.5 th and 97.5 th percentile. Results Women had higher platelet counts than men (239 vs. 207 x10(9) /L, p<0.001). Platelet counts correlated with age (p<0.001) and MPV (p<0.001). Quantile regression of lower and upper platelet count limits correlated less with age in female (p = 0.047 for 2.5 th percentile; p = 0.906 for 97.5 th percentile) and male subjects (p = 0.029 for 2.5 th percentile; p = 0.195 for 97.5 th percentile) compared to MPV (p<0.001 for upper and lower limit for both sexes). After adjustment for MPV, age did no longer correlate with the 2.5 th (p = 0.165) or 97.5 th percentile (p = 0.999) of platelet count. In contrast, after adjustment for age, MPV levels still significantly correlated with 2.5 th, 50 th and 97.5 th percentile (p<0.001). Conclusion MPV and sex have a stronger association with platelet count than age. MPV should be considered to adjust platelet count reference intervals and needs to be respected as confounder for platelet counts in epidemiological studies and clinical practice.	[Ittermann, Till; Radke, Doerte; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Feig, Martin A.; Greinacher, Andreas; Thiele, Thomas] Univ Med Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Petersmann, Astrid] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Ittermann, T (corresponding author), Univ Med Greifswald, Inst Community Med, Greifswald, Germany.	till.ittermann@uni-greifswald.de			DFG (German Research Foundation) [393148499]; Open Access Publication Fund of the University of Greifswald	DFG (German Research Foundation)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Greifswald	We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499) and the Open Access Publication Fund of the University of Greifswald.	Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAIN BJ, 1985, SCAND J HAEMATOL, V35, P77; Balduini CL, 2014, HAEMATOLOGICA, V99, P953, DOI 10.3324/haematol.2014.106260; Bancroft AJ, 2000, PLATELETS, V11, P379; BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289; Beyan C, 2017, BLOOD COAGUL FIBRIN, V28, P234, DOI 10.1097/MBC.0000000000000586; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Biino G, 2012, BRIT J HAEMATOL, V157, P384, DOI 10.1111/j.1365-2141.2011.08981.x; Biino G, 2011, HAEMATOL-HEMATOL J, V96, P96, DOI 10.3324/haematol.2010.029934; Bonaccio M, 2016, BLOOD, V127, P1614, DOI 10.1182/blood-2016-01-692814; BRAHIMI S, 1984, HUM HERED, V34, P396, DOI 10.1159/000153502; Brummitt DR, 2000, CLIN LAB HAEMATOL, V22, P103, DOI 10.1046/j.1365-2257.2000.00285.x; Buckley MF, 2000, THROMB HAEMOSTASIS, V83, P480; Demirin H, 2011, THROMB RES, V128, P358, DOI 10.1016/j.thromres.2011.05.007; Eicher JD, 2016, AM J HUM GENET, V99, P40, DOI 10.1016/j.ajhg.2016.05.005; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Flegar-Mestric Z, 2000, COLLEGIUM ANTROPOL, V24, P185; Garner C, 2000, BLOOD, V95, P342; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; GILES C, 1981, BRIT J HAEMATOL, V48, P31; GRAHAM SS, 1987, AM J CLIN PATHOL, V87, P365, DOI 10.1093/ajcp/87.3.365; Ittermann T, 2010, CLIN LAB, V56, P9; Jiang H, 2015, J CLIN LAB ANAL, V29, P21, DOI 10.1002/jcla.21721; Kim MJ, 2013, ANN LAB MED, V33, P364, DOI 10.3343/alm.2013.33.5.364; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Latger-Cannard V, 2012, INT J LAB HEMATOL, V34, P300, DOI 10.1111/j.1751-553X.2011.01396.x; Lippi G, 2015, BLOOD COAGUL FIBRIN, V26, P235, DOI 10.1097/MBC.0000000000000220; Maluf CB, 2015, PLATELETS, V26, P413, DOI 10.3109/09537104.2014.942620; NCCLS, 2000, C28A2 NCCLS, V2nd; Patzelt J, 2012, CURR VASC PHARMACOL, V10, P570, DOI 10.2174/157016112801784648; Royston P., 2008, MULTIVARIABLE MODEL; Ruan CG, 2002, THROMB HAEMOSTASIS, V88, P111; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Sayit AT, 2015, J CLIN DIAGN RES, V9, pTC5, DOI 10.7860/JCDR/2015/12028.6061; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; SILAGY CA, 1992, MED J AUSTRALIA, V157, P96, DOI 10.5694/j.1326-5377.1992.tb137036.x; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; STEVENS RF, 1977, BRIT J HAEMATOL, V37, P295, DOI 10.1111/j.1365-2141.1977.tb06847.x; Stocker TJ, 2017, THROMB HAEMOSTASIS, V117, P651, DOI 10.1160/TH16-12-0921; Verdoia M, 2016, THROMB RES, V141, P139, DOI 10.1016/j.thromres.2016.03.018; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Yang J, 2016, BLOOD, V128, P615, DOI 10.1182/blood-2015-10-672964; Zaninetti C, 2015, HAEMATOLOGICA, V100, pE338, DOI 10.3324/haematol.2015.127597	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213658	10.1371/journal.pone.0213658	http://dx.doi.org/10.1371/journal.pone.0213658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870494	gold, Green Submitted, Green Published			2022-12-26	WOS:000461166300057
J	Medford, A; Vaupel, JW				Medford, Anthony; Vaupel, James W.			Human lifespan records are not remarkable but their durations are	PLOS ONE			English	Article							MORTALITY	Has the maximum human lifespan been reached? The current record stands at 122 years, 164 days and has held for over 20 years and is more than four and three quarter years higher than the previous record. The value and persistence of this record have surprised some researchers, with some even questioning its veracity. There have been previous attempts in the literature to answer questions about how long this record might stand and whether it is truly exceptional but the focus has been mainly on the record ages, using ad hoc tools. This article contributes in two new ways. First we study lifespan records via the (inter-) record times and second we make use of specific tools from statistical Records Theory. We find that the occurrence of the present record was not surprising. We estimate around a 25% chance that the record would have survived until now and around a one in five chance that it will survive until 2050, demonstrating remarkable persistence.	[Medford, Anthony; Vaupel, James W.] Univ Southern Denmark, Interdiscliplinary Ctr Populat Dynam, Odense, Denmark	University of Southern Denmark	Medford, A (corresponding author), Univ Southern Denmark, Interdiscliplinary Ctr Populat Dynam, Odense, Denmark.	Amedford@health.sdu.dk		Vaupel, James/0000-0003-0783-3905				Aarssen K, 1994, Math Popul Stud, V4, P259; Ahsanullah M, 2016, COMMUN STAT-SIMUL C, V45, P1467, DOI 10.1080/03610918.2014.915038; Ahsanullah M., 2015, RECORDS VIA PROBABIL, V1st; [Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Arnold B.C., 2011, RECORDS, V768; BALLERINI R, 1985, J APPL PROBAB, V22, P487, DOI 10.2307/3213855; Canudas-Romo V, 2010, DEMOGRAPHY, V47, P299; CHANDLER KN, 1952, J ROY STAT SOC B, V14, P220; Franke J, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10013; Gampe J, 2010, DEMOGR RES MONOGR, P219, DOI 10.1007/978-3-642-11520-2_13; Gbari S, 2017, N AM ACTUAR J, V21, P397, DOI 10.1080/10920277.2017.1301260; GLICK N, 1978, AM MATH MON, V85, P2, DOI 10.2307/2978044; Krug J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/07/P07001; Lenart A, 2018, SUPERCENTENARIANS; Nevzorov V. B., 2001, RECORDS MATH THEORY, V194; Nevzorov V. B., 1987, J SOVIET MATH, V36, P510, DOI DOI 10.1007/BF01663462; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Rootzen H, 2017, EXTREMES, P1; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366; Wilmoth JR, 2003, POPUL DEV REV, P239; YANG MCK, 1975, J APPL PROBAB, V12, P148, DOI 10.2307/3212417	21	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0212345	10.1371/journal.pone.0212345	http://dx.doi.org/10.1371/journal.pone.0212345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870458	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300012
J	Presacco, A; Simon, JZ; Anderson, S				Presacco, Alessandro; Simon, Jonathan Z.; Anderson, Samira			Speech-in-noise representation in the aging midbrain and cortex: Effects of hearing loss	PLOS ONE			English	Article							AGE-RELATED-CHANGES; FREQUENCY-FOLLOWING RESPONSES; PRIMARY AUDITORY-CORTEX; OLDER-ADULTS; WORKING-MEMORY; NEURAL REPRESENTATION; DIVIDED ATTENTION; RECOGNITION; PERCEPTION; GLYCINE	Age-related deficits in speech-in-noise understanding pose a significant problem for older adults. Despite the vast number of studies conducted to investigate the neural mechanisms responsible for these communication difficulties, the role of central auditory deficits, beyond peripheral hearing loss, remains unclear. The current study builds upon our previous work that investigated the effect of aging on normal-hearing individuals and aims to estimate the effect of peripheral hearing loss on the representation of speech in noise in two critical regions of the aging auditory pathway: the midbrain and cortex. Data from 14 hearing impaired older adults were added to a previously published dataset of 17 normal-hearing younger adults and 15 normal-hearing older adults. The midbrain response, measured by the frequency-following response (FFR), and the cortical response, measured with the magnetoencephalography (MEG) response, were recorded from subjects listening to speech in quiet and noise conditions at four signal-to-noise ratios (SNRs): +3, 0,-3, and-6 dB sound pressure level (SPL). Both groups of older listeners showed weaker midbrain response amplitudes and overrepresentation of cortical responses compared to younger listeners. No significant differences were found between the two older groups when the mid brain and cortical measurements were analyzed independently. However, significant differences between the older groups were found when investigating the midbrain-cortex relationships; that is, only hearing-impaired older adults showed significant correlations between midbrain and cortical measurements, suggesting that hearing loss may alter reciprocal connections between lower and higher levels of the auditory pathway. The overall paucity of differences in midbrain or cortical responses between the two older groups suggests that age-related temporal processing deficits may contribute to older adults' communication difficulties beyond what might be predicted from peripheral hearing loss alone; however, hearing loss does seem to alter the connectivity between midbrain and cortex. These results may have important ramifications for the field of audiology, as it indicates that algorithms in clinical devices, such as hearing aids, should consider age-related temporal processing deficits to maximize user benefit.	[Presacco, Alessandro] Univ Calif Irvine, Dept Otolaryngol, Irvine, CA 92697 USA; [Presacco, Alessandro] Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA; [Simon, Jonathan Z.] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA; [Simon, Jonathan Z.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Presacco, Alessandro; Simon, Jonathan Z.] Univ Maryland, Inst Syst Res, College Pk, MD 20742 USA; [Simon, Jonathan Z.; Anderson, Samira] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Anderson, Samira] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Presacco, A (corresponding author), Univ Calif Irvine, Dept Otolaryngol, Irvine, CA 92697 USA.; Presacco, A (corresponding author), Univ Calif Irvine, Ctr Hearing Res, Irvine, CA 92697 USA.; Presacco, A (corresponding author), Univ Maryland, Inst Syst Res, College Pk, MD 20742 USA.	apresacc@umd.edu	Simon, Jonathan Z/A-8196-2008	Simon, Jonathan Z/0000-0003-0858-0698; Presacco, Alessandro/0000-0002-9397-6920	University of Maryland College Park (UMCP) Department of Hearing and Speech Sciences; UMCP ADVANCE Program for Inclusive Excellence [NSF HRD1008117]; National Institute on Deafness and Other Communication Disorders [R01DC014085, T32DC-00046, T32DC-010775]; National Institute of Aging [P01-AG055365]; NATIONAL INSTITUTE ON AGING [P01AG055365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC010775, R01DC014085, T32DC000046] Funding Source: NIH RePORTER	University of Maryland College Park (UMCP) Department of Hearing and Speech Sciences; UMCP ADVANCE Program for Inclusive Excellence; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by University of Maryland College Park (UMCP) Department of Hearing and Speech Sciences (SA). UMCP ADVANCE Program for Inclusive Excellence (NSF HRD1008117) (SA and JS). National Institute on Deafness and Other Communication Disorders (R01DC014085) (JS). National Institute on Deafness and Other Communication Disorders (T32DC-00046) (AP). National Institute on Deafness and Other Communication Disorders (T32DC-010775) (AP). National Institute of Aging (P01-AG055365) (JS and SA). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken SJ, 2008, HEARING RES, V245, P35, DOI 10.1016/j.heares.2008.08.004; Alain C, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00008; Alain C, 2012, HEARING RES, V283, P126, DOI 10.1016/j.heares.2011.10.007; Ananthakrishnan S, 2016, EAR HEARING, V37, pe91, DOI 10.1097/AUD.0000000000000247; Anderson S, 2013, J ACOUST SOC AM, V133, P3030, DOI 10.1121/1.4799804; Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Baillet S, 2017, NAT NEUROSCI, V20, P327, DOI 10.1038/nn.4504; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidebnan GM, 2010, BRAIN RES, V1355, P112, DOI 10.1016/j.brainres.2010.07.100; Bidelman GM, 2018, NEUROIMAGE, V175, P56, DOI 10.1016/j.neuroimage.2018.03.060; Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Burkard Robert F, 2002, Am J Audiol, V11, P13, DOI 10.1044/1059-0889(2002/004); Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Campbell T, 2012, EAR HEARING, V33, P144, DOI 10.1097/AUD.0b013e3182280353; Caspary DM, 2005, J NEUROSCI, V25, P10952, DOI 10.1523/JNEUROSCI.2451-05.2005; CASPARY DM, 1995, EXP GERONTOL, V30, P349, DOI 10.1016/0531-5565(94)00052-5; Caspary DA, 2006, HEARING RES, V216, P207, DOI 10.1016/j.heares.2006.03.005; Chambers AR, 2016, NEURON, V89, P867, DOI 10.1016/j.neuron.2015.12.041; Coffey EBJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11070; Colflesh GJH, 2007, PSYCHON B REV, V14, P699, DOI 10.3758/BF03196824; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; de Cheveigne A, 2008, J NEUROSCI METH, V171, P331, DOI 10.1016/j.jneumeth.2008.03.015; de Villers-Sidani E, 2010, P NATL ACAD SCI USA, V107, P13900, DOI 10.1073/pnas.1007885107; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Du Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12241; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Eddins AC, 2018, HEARING RES, V369, P79, DOI 10.1016/j.heares.2018.05.001; Fitzgibbons P J, 1996, J Am Acad Audiol, V7, P183; Fitzgibbons PJ, 2001, J ACOUST SOC AM, V109, P2955, DOI 10.1121/1.1371760; FLORENTINE M, 1980, J SPEECH HEAR RES, V23, P646, DOI 10.1044/jshr.2303.646; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Getzmann S, 2016, NEUROBIOL AGING, V41, P138, DOI 10.1016/j.neurobiolaging.2016.02.018; Getzmann S, 2015, NEUROBIOL AGING, V36, P3029, DOI 10.1016/j.neurobiolaging.2015.07.017; Gordon-Salant S, 2006, J ACOUST SOC AM, V119, P2455, DOI 10.1121/1.2171527; Gordon-Salant S, 1999, J SPEECH LANG HEAR R, V42, P300, DOI 10.1044/jslhr.4202.300; Gordon-Salant S, 2001, J SPEECH LANG HEAR R, V44, P709, DOI 10.1044/1092-4388(2001/056); Gorga M., 1985, AUDITORY BRAINSTEM R, P49; Gosselin PA, 2011, J SPEECH LANG HEAR R, V54, P944, DOI 10.1044/1092-4388(2010/10-0069); HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; He NJ, 2008, J ACOUST SOC AM, V124, P3841, DOI 10.1121/1.2998779; Henry KS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00020; Hughes LF, 2010, HEARING RES, V264, P79, DOI 10.1016/j.heares.2009.09.005; HUMES LE, 1991, J SPEECH HEAR RES, V34, P686, DOI 10.1044/jshr.3403.686; HUMES LE, 1990, J SPEECH HEAR RES, V33, P726, DOI 10.1044/jshr.3304.726; Jenstad LM, 2005, J SPEECH LANG HEAR R, V48, P651, DOI 10.1044/1092-4388(2005/045); Juarez-Salinas DL, 2010, J NEUROSCI, V30, P14795, DOI 10.1523/JNEUROSCI.3393-10.2010; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; KATHLEEN M, 1991, J SPEECH HEAR RES, V34, P1410, DOI 10.1044/jshr.3406.1410; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Koch U, 1998, MICROSC RES TECHNIQ, V41, P263, DOI 10.1002/(SICI)1097-0029(19980501)41:3<263::AID-JEMT9>3.0.CO;2-U; Kotak VC, 1996, J NEUROSCI, V16, P1836; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lister JJ, 2011, INT J AUDIOL, V50, P211, DOI 10.3109/14992027.2010.526967; Loughrey DG, 2018, JAMA OTOLARYNGOL, V144, P115, DOI 10.1001/jamaoto.2017.2513; Maamor N, 2017, NEUROSCI LETT, V636, P258, DOI 10.1016/j.neulet.2016.11.020; Mamo SK, 2016, HEARING RES, V333, P201, DOI 10.1016/j.heares.2015.09.005; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Millman RE, 2017, J NEUROSCIENCE; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Overton JA, 2016, J NEUROPHYSIOL, V115, P2911, DOI 10.1152/jn.01098.2015; Parbery-Clark A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.015; Parthasarathy A, 2011, NEUROSCIENCE, V192, P619, DOI 10.1016/j.neuroscience.2011.06.042; Parthasarathy A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00152; Peelle JE, 2016, TRENDS NEUROSCI, V39, P486, DOI 10.1016/j.tins.2016.05.001; Peelle JE, 2011, J NEUROSCI, V31, P12638, DOI 10.1523/JNEUROSCI.2559-11.2011; Peelle JE, 2010, CEREB CORTEX, V20, P773, DOI 10.1093/cercor/bhp142; Petersen EB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00177; Petersen EB, 2017, J NEUROPHYSIOL, V117, P18, DOI 10.1152/jn.00527.2016; Pichora-Fuller MK, 2007, HEARING RES, V223, P114, DOI 10.1016/j.heares.2006.10.009; Presacco A, 2016, J NEUROPHYSIOL, V116, P2356, DOI 10.1152/jn.00373.2016; Presacco A, 2016, J NEUROPHYSIOL, V116, P2346, DOI 10.1152/jn.00372.2016; Presacco A, 2015, EAR HEARING, V36, pE352, DOI 10.1097/AUD.0000000000000193; Ross B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010101; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Schneider BA, 1999, J ACOUST SOC AM, V106, P371, DOI 10.1121/1.427062; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; SMITH JC, 1975, ELECTROEN CLIN NEURO, V39, P465, DOI 10.1016/0013-4694(75)90047-4; Soros P, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-34; Suneja SK, 1998, EXP NEUROL, V154, P473, DOI 10.1006/exnr.1998.6946; Suneja SK, 1998, EXP NEUROL, V151, P273, DOI 10.1006/exnr.1998.6812; Tremblay KL, 2003, CLIN NEUROPHYSIOL, V114, P1332, DOI 10.1016/S1388-2457(03)00114-7; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Vaden KI, 2016, EXP AGING RES, V42, P86, DOI 10.1080/0361073X.2016.1108784; Vaden KI, 2015, J NEUROSCI, V35, P3929, DOI 10.1523/JNEUROSCI.2908-14.2015; Vale C, 2002, EUR J NEUROSCI, V16, P2394, DOI 10.1046/j.1460-9568.2002.02302.x; Verhulst S, 2018, HEARING RES, V360, P55, DOI 10.1016/j.heares.2017.12.018; Walton JP, 1998, J NEUROSCI, V18, P2764; Ward CM, 2016, EXP AGING RES, V42, P126, DOI 10.1080/0361073X.2016.1108785; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wong PCM, 2010, EAR HEARING, V31, P471, DOI 10.1097/AUD.0b013e3181d709c2; Zhu J., 1999, WECHSLER ABBREVIATED	98	43	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213899	10.1371/journal.pone.0213899	http://dx.doi.org/10.1371/journal.pone.0213899			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865718	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900094
J	Tsai, FJ; Lai, MT; Cheng, J; Chao, SCC; Korla, PK; Chen, HJ; Lin, CM; Tsai, MH; Hua, CH; Jan, CI; Jinawath, N; Wu, CC; Chen, CM; Kuo, BYT; Chen, LW; Yang, J; Hwang, T; Sheu, JJC				Tsai, Fuu-Jen; Lai, Ming-Tsung; Cheng, Jack; Chao, Stev Chun-Chin; Korla, Praveen Kumar; Chen, Hui-Jye; Lin, Chung-Ming; Tsai, Ming-Hsui; Hua, Chun-Hung; Jan, Chia-Ing; Jinawath, Natini; Wu, Chia-Chen; Chen, Chih-Mei; Kuo, Brian Yu-Ting; Chen, Li-Wen; Yang, Jacky; Hwang, Tritium; Sheu, Jim Jinn-Chyuan			Novel K6-K14 keratin fusion enhances cancer sternness and aggressiveness in oral squamous cell carcinoma	ONCOGENE			English	Article							GENOMIC CHARACTERIZATION; RHABDOID FEATURES; STEM-CELLS; HEAD; ORGANIZATION; EXPRESSION; INVASION; METASTASIS; RESISTANCE; MIGRATION	Keratin intermediate filament (IF) is one component of cellular architectures, which provides necessary mechanical support to conquer environmental stresses. Recent findings reveal its involvement in mechano-transduction and the associated stem cell reprogramming, suggesting the possible roles in cancer development. Here, we report t(12;17)(q13.13;q21.2) chromosomal rearrangement as the most common fusion event in OSCC, resulting in a variety of inter-keratin fusions. Junction site mapping verified 9 in-frame K6-K14 variants, three of which were correlated with lymph node invasion, late tumor stages (T3/T4) and shorter disease-free survival times. When expressed in OSCC cells, those fusion variants disturbed wild-type K14 organization through direct interaction or aggregate formation, leading to perinuclear structure loss and nuclear deformation. Protein array analyses showed the ability of K6-K14 variant 7 (K6-K14/V7) to upregulate TGF-beta and G-CSF signaling, which contributed to cell stemness, drug tolerance, and cell aggressiveness. Notably, K6-K14/V7-expressing cells easily adapted to a soft 3-D culture condition in vitro and formed larger, less differentiated tumors in vivo. In addition to the anti-mechanical-stress activity, our data uncover oncogenic functionality of novel keratin filaments caused by gene fusions during OSCC development.	[Tsai, Fuu-Jen; Cheng, Jack; Chao, Stev Chun-Chin; Chen, Chih-Mei; Sheu, Jim Jinn-Chyuan] China Med Univ Hosp, Human Genet Ctr, Taichung 40447, Taiwan; [Tsai, Fuu-Jen; Sheu, Jim Jinn-Chyuan] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan; [Lai, Ming-Tsung] Taichung Hosp, Minist Hlth & Welf, Dept Pathol, Taichung 40343, Taiwan; [Korla, Praveen Kumar; Wu, Chia-Chen; Kuo, Brian Yu-Ting; Chen, Li-Wen; Yang, Jacky; Hwang, Tritium; Sheu, Jim Jinn-Chyuan] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Chen, Hui-Jye] China Med Univ, Sch Med, Taichung 40402, Taiwan; [Lin, Chung-Ming] Ming Chuan Univ, Dept Biotechnol, Taoyuan 33348, Taiwan; [Tsai, Ming-Hsui; Hua, Chun-Hung] China Med Univ Hosp, Dept Otolaryngol, Taichung 40447, Taiwan; [Jan, Chia-Ing] China Med Univ Hosp, Dept Pathol, Taichung 40447, Taiwan; [Jinawath, Natini] Mahidol Univ, Ramathibodi Hosp, Fac Med, Program Translat Med, Bangkok 10400, Thailand; [Sheu, Jim Jinn-Chyuan] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Sun Yat Sen University; China Medical University Taiwan; Ming Chuan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Mahidol University; Asia University Taiwan	Sheu, JJC (corresponding author), China Med Univ Hosp, Human Genet Ctr, Taichung 40447, Taiwan.; Sheu, JJC (corresponding author), China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan.; Sheu, JJC (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.; Sheu, JJC (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.	jimsheu@mail.nsysu.edu.tw	Korla, Praveen Kumar/AAZ-4949-2020	Korla, Praveen Kumar/0000-0003-1655-625X	Ministry of Science and Technology (MOST), Taiwan [NSC-102-2628-B-039-001-MY3, MOST 103-2314-B-039-009-MY3, MOST 106-2314-B-110-001-MY3]; NSYSU-KMU joint research projects [107-P012, 105-P021]	Ministry of Science and Technology (MOST), Taiwan; NSYSU-KMU joint research projects	The authors thank technical assistance from Ms. Lesley Lin at China Medical University Hospital and Mr. Ming-Der Pong at National Sun Yatsen University. The authors also thank critical comments from Prof. Mien-Chie Hung at MD Anderson Cancer Center/U.S., Prof. Chung Chang at National Sun Yatsen University/Taiwan, Prof. Ming-Jer Tang at National Cheng Kung University/Taiwan, and Prof. Ka-Lok Ng at Asia University/Taiwan. This study was supported by grants from Ministry of Science and Technology (MOST), Taiwan with numbers: NSC-102-2628-B-039-001-MY3, MOST 103-2314-B-039-009-MY3, and MOST 106-2314-B-110-001-MY3, and the NSYSU-KMU joint research projects: 107-P012 and 105-P021.	Agarwal S, 2015, CANCER RES, V75, P2566, DOI 10.1158/0008-5472.CAN-14-2946; Baillie R, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00112; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Chen JL, 2006, J CELL SCI, V119, P5067, DOI 10.1242/jcs.03298; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng X, 2015, J BIOL CHEM, V290, P22507, DOI 10.1074/jbc.M115.654749; Feng X, 2015, J CELL BIOL, V209, P59, DOI 10.1083/jcb.201408079; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gemenetzidis E, 2015, ONCOTARGET, V6, P43964, DOI 10.18632/oncotarget.6268; Guo T, 2016, INT J CANCER, V139, P373, DOI 10.1002/ijc.30081; Hsu DM, 2013, CANCER RES, V73, P4134, DOI 10.1158/0008-5472.CAN-12-4056; Iwaya K, 2005, SEMIN CANCER BIOL, V15, P309, DOI 10.1016/j.semcancer.2005.04.006; Joosse SA, 2012, CLIN CANCER RES, V18, P993, DOI 10.1158/1078-0432.CCR-11-2100; Kang NY, 2011, NAT PROTOC, V6, P1044, DOI 10.1038/nprot.2011.350; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kawai T, 2015, CLIN CANCER RES, V21, P3081, DOI 10.1158/1078-0432.CCR-14-1936; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kuroiwa K, 2002, HISTOPATHOLOGY, V41, P538, DOI 10.1046/j.1365-2559.2002.01427.x; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Li R, 2015, HEAD NECK-J SCI SPEC, V37, P1642, DOI 10.1002/hed.23807; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; McGregor AL, 2016, CURR OPIN CELL BIOL, V40, P32, DOI 10.1016/j.ceb.2016.01.011; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Ohmoto T, 2015, PATHOL INT, V65, P264, DOI 10.1111/pin.12283; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Przybycin CG, 2014, AM J SURG PATHOL, V38, P1260, DOI 10.1097/PAS.0000000000000251; Reinholz MM, 2011, CLIN CANCER RES, V17, P7183, DOI 10.1158/1078-0432.CCR-11-0981; Rudland SD, 2011, AM J PATHOL, V179, P1061, DOI 10.1016/j.ajpath.2011.04.022; Sawant MS, 2017, INT REV CEL MOL BIO, V330, P171, DOI 10.1016/bs.ircmb.2016.09.005; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Sewell A, 2014, CLIN CANCER RES, V20, P2300, DOI 10.1158/1078-0432.CCR-13-2585; Sheu JJC, 2014, ONCOGENE, V33, P1375, DOI 10.1038/onc.2013.98; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Souto GR, 2010, J ORAL PATHOL MED, V39, P605, DOI 10.1111/j.1600-0714.2010.00907.x; Sugimoto K, 2016, BRAIN TUMOR PATHOL, V33, P137, DOI 10.1007/s10014-015-0243-3; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; van Helvert S, 2018, NAT CELL BIOL, V20, P8, DOI 10.1038/s41556-017-0012-0; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zaphiropoulos Peter G., 2011, Frontiers in Genetics, V2, P92, DOI 10.3389/fgene.2011.00092	50	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 27	2019	38	26					5113	5126		10.1038/s41388-019-0781-y	http://dx.doi.org/10.1038/s41388-019-0781-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IF4AX	30867567				2022-12-26	WOS:000473025300001
J	Cho, IK; Yang, B; Forest, C; Qian, L; Chan, AWS				Cho, In Ki; Yang, Bo; Forest, Craig; Qian, Lu; Chan, Anthony W. S.			Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MUTANT-HUNTINGTIN; MOUSE MODEL; IN-VIVO; CORTICOSTRIATAL DYSFUNCTION; MITOCHONDRIAL DYSFUNCTION; GLUTAMATE TRANSPORT; GENE-EXPRESSION; STEM-CELLS; NEURODEGENERATION	Huntington's disease (HD) is a devastating monogenic, dominant, hereditary, neurodegenerative disease. HD is caused by the expansion of CAG repeats in exon 1 of the huntingtin (HTT) gene, IT15, resulting in an expanded polyglutamine (polyQ) residue in the N-terminus of the HTT protein. HD is characterized by the accumulation of mutant HTT (mHTT) in neural and somatic cells. Progressive brain atrophy occurs initially in the striatum and extends to different brain regions with progressive decline in cognitive, behavioral and motor functions. Astrocytes are the most abundant cell type in the brain and play an essential role in neural development and maintaining homeostasis in the central nervous system (CNS). There is increasing evidence supporting the involvement of astrocytes in the development of neurodegenerative diseases such as Parkinson's disease (PD), Huntington's disease (HD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS). We have generated neural progenitor cells (NPCs) from induced pluripotent stem cells (iPSCs) of transgenic HD monkeys as a model for studying HD pathogenesis. We have reported that NPCs can be differentiated in vitro into mature neural cells, such as neurons and glial cells, and are an excellent tool to study the pathogenesis of HD. To better understand the role of astrocytes in HD pathogenesis and discover new therapies to treat HD, we have developed an astrocyte differentiation protocol and evaluated the efficacy of RNAi to ameliorate HD phenotypes in astrocytes. The resultant astrocytes expressed canonical astrocyte-specific markers examined by immunostaining and real-time PCR. Flow cytometry (FACS) analysis showed that the majority of the differentiated NPCs (95.7%) were positive for an astrocyte specific marker, glial fibrillary acidic protein (GFAP). Functionalities of astrocytes were evaluated by glutamate uptake assay and electrophysiology. Expression of mHTT in differentiated astrocytes induced cytosolic mHTT aggregates and nuclear inclusions, suppressed the expression of SOD2 and PGC1, reduced ability to uptake glutamate, decreased 4-aminopyridine (4-AP) response, and shifted I/V plot measured by electrophysiology, which are consistent with previous reports on HD astrocytes and patient brain samples. However, expression of small-hairpin RNA against HTT (shHD) ameliorated and reversed aforementioned HD phenotypes in astrocytes. This represents a demonstration of a novel non-human primate (NHP) astrocyte model for studying HD pathogenesis and a platform for discovering novel HD treatments.	[Cho, In Ki; Chan, Anthony W. S.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Cho, In Ki; Qian, Lu; Chan, Anthony W. S.] Emory Univ, Div Neuropharmacol & Neurol Dis, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Yang, Bo; Forest, Craig] Georgia Inst Technol, Neurosci Core, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Cho, IK; Chan, AWS (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Cho, IK; Chan, AWS (corresponding author), Emory Univ, Div Neuropharmacol & Neurol Dis, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	in.ki.cho@emory.edu; awchan@emory.edu		Cho, In/0000-0001-8583-9128	Discretionary fund; Office of Research and Infrastructure Program (ORIP)/OD [P51OD11132]; NIH Brain Initiative Grant [1U01MH106027-015]; Petit Institute Seed Grant [12456F7]; Petit Institute for Bioengineering and Bioscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102727] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010930, P51OD011132] Funding Source: NIH RePORTER	Discretionary fund; Office of Research and Infrastructure Program (ORIP)/OD; NIH Brain Initiative Grant; Petit Institute Seed Grant; Petit Institute for Bioengineering and Bioscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Discretionary fund to AWSC. Yerkes National Primate Research Center is supported by the Office of Research and Infrastructure Program (ORIP)/OD P51OD11132. This research was conducted in collaboration with Neuroscience Core facility at Georgia Institute of Technology, which was supported in part by NIH Brain Initiative Grant (1U01MH106027-015), Petit Institute Seed Grant (Project No. 12456F7), and the Petit Institute for Bioengineering and Bioscience.	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Ban JJ, 2017, BIOCHEM BIOPH RES CO, V488, P316, DOI 10.1016/j.bbrc.2017.05.040; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Biagioli M, 2015, HUM MOL GENET, V24, P2442, DOI 10.1093/hmg/ddv006; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Boussicault L, 2014, J CEREBR BLOOD F MET, V34, P1500, DOI 10.1038/jcbfm.2014.110; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Carter RL, 2014, STEM CELL REP, V3, P585, DOI 10.1016/j.stemcr.2014.07.011; Chan AWS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122335; Chan AWS, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-36; Chan AWS, 2010, CELL REPROGRAM, V12, P509, DOI 10.1089/cell.2010.0019; Chandrasekaran A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00215; Chen C, 2015, TRENDS MOL MED, V21, P715, DOI 10.1016/j.molmed.2015.09.003; Chen LW, 2012, NEUROPHARMACOLOGY, V63, P719, DOI 10.1016/j.neuropharm.2012.05.019; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Fernandez-Nogales M, 2014, NAT MED, V20, P881, DOI 10.1038/nm.3617; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hill E, 2016, J PHYSIOL-LONDON, V594, P6595, DOI 10.1113/JP270658; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang B, 2015, NEURON, V85, P1212, DOI 10.1016/j.neuron.2015.02.026; Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018; Khakh BS, 2017, TRENDS NEUROSCI, V40, P422, DOI 10.1016/j.tins.2017.05.002; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kocerha J, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-46; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kunkanjanawan T, 2017, SLAS DISCOV, V22, P696, DOI 10.1177/2472555216685044; Kunkanjanawan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162788; Laowtammathron C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-12; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0044670, 10.1371/journal.pone.0050296, 10.1186/1747-597X-7-11]; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Lund P, 1986, METHOD ENZYMAT AN, P357; Luo J, 2014, AUTOPHAGY, V10, P2099, DOI 10.4161/15548627.2014.981916; Majumder A, 2013, STEM CELL RES, V11, P574, DOI 10.1016/j.scr.2013.03.003; Mao Y, 2016, HUM MOL GENET, V25, P4749, DOI 10.1093/hmg/ddw303; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; McKinstry SU, 2014, J NEUROSCI, V34, P9455, DOI 10.1523/JNEUROSCI.4699-13.2014; Mena NP, 2015, MITOCHONDRION, V21, P92, DOI 10.1016/j.mito.2015.02.001; Meng YG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00381-8; Monteys AM, 2017, MOL THER, V25, P12, DOI 10.1016/j.ymthe.2016.11.010; Moreira PI, 2011, J STEROID BIOCHEM, V123, P8, DOI 10.1016/j.jsbmb.2010.09.004; Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111; Oh SS, 2012, NEUROSCIENCE, V212, P201, DOI 10.1016/j.neuroscience.2012.03.026; Ortega Z, 2010, J NEUROSCI, V30, P3675, DOI 10.1523/JNEUROSCI.5673-09.2010; Papoutsi M, 2014, MOVEMENT DISORD, V29, P673, DOI 10.1002/mds.25864; Phatnani H., 2015, COLD SPRING HARB PER, V7; Plotkin JL, 2014, NEURON, V83, P178, DOI 10.1016/j.neuron.2014.05.032; Quarrell Oliver, 2012, PLoS Curr, V4, pe4f8606b742ef3, DOI 10.1371/4f8606b742ef3; Raper J, 2016, BRAIN BEHAV IMMUN, V58, P181, DOI 10.1016/j.bbi.2016.07.004; Reetz J, 2016, BRAIN STRUCT FUNCT, V221, P2049, DOI 10.1007/s00429-015-1025-8; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Rusnakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069734; Sadagurski M, 2011, J CLIN INVEST, V121, P4070, DOI 10.1172/JCI46305; Sassone J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.300; Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Sica RE, 2015, MED HYPOTHESES, V84, P481, DOI 10.1016/j.mehy.2015.02.004; Singhrao SK, 1998, EXP NEUROL, V150, P213, DOI 10.1006/exnr.1998.6778; Song JJ, 2018, J CLIN INVEST, V128, P463, DOI 10.1172/JCI93924; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Stanek LM, 2014, HUM GENE THER, V25, P461, DOI 10.1089/hum.2013.200; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Tang TS, 2009, J NEUROSCI, V29, P1257, DOI 10.1523/JNEUROSCI.4411-08.2009; Torok R, 2015, CELL MOL NEUROBIOL, V35, P293, DOI 10.1007/s10571-014-0124-z; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Valenza M, 2015, CELL DEATH DIFFER, V22, P690, DOI 10.1038/cdd.2014.162; Wang GH, 2016, P NATL ACAD SCI USA, V113, P3359, DOI 10.1073/pnas.1524575113; Wellington CL, 2002, J NEUROSCI, V22, P7862; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhong SY, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0213-7; Zhou M, 2006, J NEUROPHYSIOL, V95, P134, DOI 10.1152/jn.00570.2005; Zuccato C, 2005, PHARMACOL RES, V52, P133, DOI 10.1016/j.phrs.2005.01.001; Zuccato Chiara, 2014, Handb Exp Pharmacol, V220, P357, DOI 10.1007/978-3-642-45106-5_14	91	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214156	10.1371/journal.pone.0214156	http://dx.doi.org/10.1371/journal.pone.0214156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897183	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700072
J	Fang, YJ; Tan, CH; Tu, SC; Liu, CY; Yu, RL				Fang, Yi-Jia; Tan, Chun-Hsiang; Tu, Shao-Ching; Liu, Chien-Yu; Yu, Rwei-Ling			More than an "inverted-U"? An exploratory study of the association between the catechol-o-methyltransferase gene polymorphism and executive functions in Parkinson's disease	PLOS ONE			English	Article							COMT; INHIBITION; LEVODOPA	Executive dysfunction is common in Parkinson's disease (PD) patients. The catechol-O-met hyltransferase (COMT) Val158Met polymorphism has been proposed to affect executive functions (EFs) in the prefrontal cortex. The present study attempted to explore the influence of the COMT polymorphism on EFs in patients with PD. Fifty-four PD patients were recruited and underwent neuropsychological assessments for three core EFs. The COMT polymorphism was genotyped using the TaqMan SNP Genotyping Assay. Participants were divided into three study groups: Val homozygotes, heterozygotes, and Met homozygotes. The three COMT genotype groups had significantly different performances in set-shifting [chi(2) (2, 54) = 9.717, p = 0.008] and working memory tasks [chi(2) (2, 54) = 7.806, p = 0.020]. Post-hoc analyses revealed that PD Val homozygotes performed significantly poorer in the set-shifting task than did either the PD Met homozygotes (z = -2.628, p = 0.009) or PD heterozygotes (z = -2.212, p = 0.027). Our explorative results suggest that the putative level of prefrontal dopamine influenced set-shifting through a "cane-shaped" dopamine level-response relationship. Our results have clinical implications, which may influence PD treatment with dopamine in the future because the optimal dopamine level to maximize EFs may vary based on the clinical course and COMT polymorphism status. Further study recruiting a larger number of participants is needed to confirm our preliminary findings.	[Fang, Yi-Jia; Liu, Chien-Yu; Yu, Rwei-Ling] Natl Cheng Kung Univ, Inst Behav Med, Coll Med, Tainan, Taiwan; [Tan, Chun-Hsiang] Kaohsiung Med Univ, Dept Neurol, Kaohsiung Med Univ Hosp, Coll Med, Kaohsiung, Taiwan; [Tan, Chun-Hsiang] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Tu, Shao-Ching] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Yu, Rwei-Ling] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan; [Yu, Rwei-Ling] Natl Taiwan Univ, Dept Neurol, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital	Yu, RL (corresponding author), Natl Cheng Kung Univ, Inst Behav Med, Coll Med, Tainan, Taiwan.; Yu, RL (corresponding author), Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan, Taiwan.; Yu, RL (corresponding author), Natl Taiwan Univ, Dept Neurol, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan.	lingyu@mail.ncku.edu.tw	Yu, Rwei-Ling/GSI-6255-2022; Yu, Rwei-Ling/GSI-7909-2022	Yu, Rwei-Ling/0000-0001-5836-1237; Liu, Chien-Yu/0000-0003-0976-9089; Tan, Chun-Hsiang/0000-0001-6950-4678	Ministry of Science and Technology (MOST), Taipei, Taiwan [MOST 106-2410-H-006 -039 -MY2, 105-2410-H-006-021, 103-2410-H-006 -120 -MY2]	Ministry of Science and Technology (MOST), Taipei, Taiwan	This work was supported by the Ministry of Science and Technology (MOST), Taipei, Taiwan (grant number: MOST 106-2410-H-006 -039 -MY2, 105-2410-H-006-021, 103-2410-H-006 -120 -MY2).	Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Bartels AL, 2009, CORTEX, V45, P915, DOI 10.1016/j.cortex.2008.11.010; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dorszewska J, 2013, CURR GENOMICS, V14, P518, DOI 10.2174/1389202914666131210210241; Emre M., 2015, COGNITIVE IMPAIRMENT; Fallon S, 2012, CEREB CORTEX; Fallon SJ, 2015, NEUROPSYCHOLOGIA, V77, P42, DOI 10.1016/j.neuropsychologia.2015.07.031; Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023; Floresco SB, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00062; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frakey L, 2014, ARCH CLIN NEUROPSYCH, V29; Hoogland J, 2010, MOVEMENT DISORD, V25, P2550, DOI 10.1002/mds.23319; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Leroi I, 2013, J NEUROPSYCHOL, V7, P306, DOI 10.1111/jnp.12026; Lin SC, 2005, EUR J CANCER PREV, V14, P257, DOI 10.1097/00008469-200506000-00010; Liu WM, 2016, J FORMOS MED ASSOC, V115, P531, DOI 10.1016/j.jfma.2015.05.014; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Mamikonyan E, 2015, MOVEMENT DISORD, V30, P912, DOI 10.1002/mds.26236; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Poletti M, 2013, THER ADV PSYCHOPHARM, V3, P101, DOI 10.1177/2045125312470130; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Williams-Gray CH, 2008, BRAIN, V131, P397, DOI 10.1093/brain/awm313; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Wu RM, 2001, NEUROLOGY, V56, P375, DOI 10.1212/WNL.56.3.375; Ye Z, 2014, BRAIN, V137, P1145, DOI 10.1093/brain/awu032; Yu RL, 2012, PARKINSONISM RELAT D, V18, P1067, DOI 10.1016/j.parkreldis.2012.06.002; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214146	10.1371/journal.pone.0214146	http://dx.doi.org/10.1371/journal.pone.0214146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897147	Green Submitted, gold, Green Published			2022-12-26	WOS:000461889700071
J	Lalonde, K; Werner, LA				Lalonde, Kaylah; Werner, Lynne A.			Perception of incongruent audiovisual English consonants	PLOS ONE			English	Article							AUDITORY-VISUAL INTEGRATION; SPEECH-PERCEPTION; NORMAL-HEARING; RECOGNITION; CONFUSIONS; EFFICIENCY; MCGURK	Causal inference-the process of deciding whether two incoming signals come from the same source-is an important step in audiovisual (AV) speech perception. This research explored causal inference and perception of incongruent AV English consonants. Nine adults were presented auditory, visual, congruent AV, and incongruent AV consonant-vowel syllables. Incongruent AV stimuli included auditory and visual syllables with matched vowels, but mismatched consonants. Open-set responses were collected. For most incongruent syllables, participants were aware of the mismatch between auditory and visual signals (59.04%) or reported the auditory syllable (33.73%). Otherwise, participants reported the visual syllable (1.13%) or some other syllable (6.11%). Statistical analyses were used to assess whether visual distinctiveness and place, voice, and manner features predicted responses. Mismatch responses occurred more when the auditory and visual consonants were visually distinct, when place and manner differed across auditory and visual consonants, and for consonants with high visual accuracy. Auditory responses occurred more when the auditory and visual consonants were visually similar, when place and manner were the same across auditory and visual stimuli, and with consonants produced further back in the mouth. Visual responses occurred more when voicing and manner were the same across auditory and visual stimuli, and for front and middle consonants. Other responses were variable, but typically matched the visual place, auditory voice, and auditory manner of the input. Overall, results indicate that causal inference and incongruent AV consonant perception depend on salience and reliability of auditory and visual inputs and degree of redundancy between auditory and visual inputs. A parameter-free computational model of incongruent AV speech perception based on unimodal confusions, with a causal inference rule, was applied. Data from the current study present an opportunity to test and improve the generalizability of current AV speech integration models.	[Lalonde, Kaylah; Werner, Lynne A.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Lalonde, Kaylah] Boys Town Natl Res Hosp, Ctr Hearing Res, Omaha, NE 68131 USA	University of Washington; University of Washington Seattle; Boys Town National Research Hospital	Lalonde, K (corresponding author), Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA.; Lalonde, K (corresponding author), Boys Town Natl Res Hosp, Ctr Hearing Res, Omaha, NE 68131 USA.	kaylah.lalonde@boystown.org			National Institute on Deafness and Communication Disorders [R01 DC 000396, P30 DC004661, T32 DC 005361]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005361] Funding Source: NIH RePORTER	National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by the National Institute on Deafness and Communication Disorders, R01 DC 000396, P30 DC004661, T32 DC 005361. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejjanki VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019812; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Bertelson P., 1994, ICSLP 94. 1994 International Conference on Spoken Language Processing, P559; BINNIE CA, 1976, J SPEECH HEAR DISORD, V41, P530, DOI 10.1044/jshd.4104.530; BRAIDA LD, 1991, Q J EXP PSYCHOL-A, V43, P647, DOI 10.1080/14640749108400991; Colin C, 2001, PSYCHOL BELG, V41, P131; ERBER NP, 1972, J SPEECH HEAR RES, V15, P413, DOI 10.1044/jshr.1502.413; ERBER NP, 1975, J SPEECH HEAR DISORD, V40, P481, DOI 10.1044/jshd.4004.481; FISHER CG, 1968, J SPEECH HEAR RES, V11, P796, DOI 10.1044/jshr.1104.796; Grant KW, 2007, J ACOUST SOC AM, V121, P1164, DOI 10.1121/1.2405859; Grant KW, 1998, J ACOUST SOC AM, V104, P2438, DOI 10.1121/1.423751; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Jiang JT, 2011, J EXP PSYCHOL HUMAN, V37, P1193, DOI 10.1037/a0023100; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; MACDONALD J, 1978, PERCEPT PSYCHOPHYS, V24, P253, DOI 10.3758/BF03206096; Magnotti JF, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005229; Massaro DW, 1999, J SPEECH LANG HEAR R, V42, P21, DOI 10.1044/jslhr.4201.21; Massaro DW, 2000, J ACOUST SOC AM, V108, P784, DOI 10.1121/1.429611; Massaro DW, 1987, SPEECH PERCEPTION EA; MCGRATH M, 1985, J ACOUST SOC AM, V77, P678, DOI 10.1121/1.392336; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Munhall K.G., 2004, HDB MULTISENSORY PRO, P177; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; OWENS E, 1985, J SPEECH HEAR RES, V28, P381, DOI 10.1044/jshr.2803.381; PANDEY P C, 1986, Journal of Auditory Research, V26, P27; Sankaran N, 2018, J ACOUST SOC AM, V144, P2462, DOI 10.1121/1.5065492; Stein B. E., 2004, HDB MULTISENSORY PRO, P141; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; ten Oever S, 2013, FRONT NEUROSCI, V4, P1; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; WALDEN BE, 1981, J SPEECH HEAR RES, V24, P32, DOI 10.1044/jshr.2401.32; WALDEN BE, 1977, J SPEECH HEAR RES, V20, P130, DOI 10.1044/jshr.2001.130; Walden BE, 1975, J SPEECH HEAR RES, V18; Yehia H, 1998, SPEECH COMMUN, V26, P23, DOI 10.1016/S0167-6393(98)00048-X	38	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213588	10.1371/journal.pone.0213588	http://dx.doi.org/10.1371/journal.pone.0213588			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897109	Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700029
J	Johnson, J; Rychahou, P; Sviripa, VM; Weiss, HL; Liu, CM; Watt, DS; Evers, BM				Johnson, Jeremy; Rychahou, Piotr; Sviripa, Vitaliy M.; Weiss, Heidi L.; Liu, Chunming; Watt, David S.; Evers, B. Mark			Induction of AMPK activation by N,N '-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers	PLOS ONE			English	Article							ONCOGENIC SIGNALING PATHWAYS; FLUORINATED N,N'-DIARYLUREAS; CELL-PROLIFERATION; METFORMIN; EXPRESSION; METABOLISM; PROGNOSIS; TARGET; DRUGS	Purpose Triple negative breast cancer (TNBC) is the most lethal and aggressive subtype of breast cancer. AMP-activated protein kinase (AMPK) is a major energy regulator that suppresses tumor growth, and 1-(3-chloro-4-((trifluoromethypthio)pheny1)-3-(4-(trifluoromethoxy)phenyl)urea (FND-4b) is a novel AMPK activator that inhibits growth and induces apoptosis in colon cancer. The purpose of this project was to test the effects of FND-4b on AMPK activation, proliferation, and apoptosis in breast cancer with a particular emphasis on TNBC. Materials and methods (i) Estrogen-receptor positive breast cancer (ER+BC; MCF-7, and T-47D), TNBC (MDA-MB-231 and HCC-1806), and breast cancer stem cells were treated with FND-4b for 24h. Immunoblot analysis assessed AMPK, acetyl-CoA carboxylase (ACC), ribosomal protein S6, cyclin D1, and cleaved PARP. (ii) Sulforhodamine B growth assays were performed after treating ER+BC and TNBC cells with FND-4b for 72h. Proliferation was also assessed by counting cells after 72h of FND-4b treatment. (iii) Cell death ELISA assays were performed after treating ER+BC and TNBC cells with FND-4b for 72h. Results (i) FND-4b increased AMPK activation with concomitant decreases in ACC activity, phosphorylated S6, and cyclin D1 in all subtypes. (ii) FND-4b decreased proliferation in all cells, while dose-dependent growth decreases were found in ER+BC and TNBC. (iii) Increases in apoptosis were observed in ER+BC and the MDA-MB-231 cell line with FND-4b treatment. Conclusions Our findings indicate that FND-4b decreases proliferation for a variety of breast cancers by activating AMPK and has notable effects on TNBC. The growth reductions were mediated through decreases in fatty acid synthesis (ACC), mTOR signaling (S6), and cell cycle flux (cyclin D1). ER+BC cells were more susceptible to FND-4b-induced apoptosis, but MDA-MB-231 cells still underwent apoptosis with higher dose treatment. Further development of FND compounds could result in a novel therapeutic for TNBC.	[Johnson, Jeremy] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY USA; [Rychahou, Piotr; Weiss, Heidi L.; Liu, Chunming; Watt, David S.; Evers, B. Mark] Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY 40506 USA; [Rychahou, Piotr; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Sviripa, Vitaliy M.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Liu, Chunming; Watt, David S.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Watt, David S.] Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Evers, BM (corresponding author), Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY 40506 USA.; Evers, BM (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY 40506 USA.	mark.evers@uky.edu		Sviripa, Vitaliy/0000-0002-7272-373X	National Institutes of Health [T32 ES007266, R01 CA195573]; NATIONAL CANCER INSTITUTE [R01CA195573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health [T32 ES007266 (Daret St. Clair) and R01 CA195573 (BME)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrabi J, 2017, ANN DIAGN PATHOL, V29, P62, DOI 10.1016/j.anndiagpath.2017.05.012; American Cancer Society, 2018, CANC FACTS FIG 2018; Andreopoulou E, 2015, EXPERT OPIN PHARMACO, V16, P983, DOI 10.1517/14656566.2015.1032246; Daurio NA, 2016, CANCER RES, V76, P3295, DOI 10.1158/0008-5472.CAN-15-2197; Elia I, 2016, HANDB EXP PHARMACOL, V233, P321, DOI 10.1007/164_2015_10; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Gao J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.444; Gollavilli PN, 2015, FEBS J, V282, P3971, DOI 10.1111/febs.13391; Gwak H, 2017, MOL CARCINOGEN, V56, P349, DOI 10.1002/mc.22498; Hadad SM, 2014, CLIN TRANSL ONCOL, V16, P746, DOI 10.1007/s12094-013-1144-8; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hardie DG, 2014, J INTERN MED, V276, P543, DOI 10.1111/joim.12268; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Huang XJ, 2016, BREAST, V30, P39, DOI 10.1016/j.breast.2016.08.014; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Kenlan DE, 2017, MOL CANCER THER, V16, P831, DOI 10.1158/1535-7163.MCT-15-0634; Khabaz MN, 2017, INT J CLIN EXP PATHO, V10, P7044; Kim DE, 2015, MOL CELLS, V38, P138, DOI 10.14348/molcells.2015.2193; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lee KH, 2011, J BIOL CHEM, V286, P39247, DOI 10.1074/jbc.M111.264598; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Liu HY, 2012, ANTICANCER RES, V32, P1627; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; Shieh JM, 2013, J AGR FOOD CHEM, V61, P6366, DOI 10.1021/jf4012455; Sun DJ, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12402; Sviripa V, 2013, BIOORG MED CHEM LETT, V23, P1600, DOI 10.1016/j.bmcl.2013.01.096; Yao H, 2017, ONCOTARGET, V8, P1913, DOI 10.18632/oncotarget.12284; Zadra G, 2015, MOL CANCER RES, V13, P1059, DOI 10.1158/1541-7786.MCR-15-0068	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0209392	10.1371/journal.pone.0209392	http://dx.doi.org/10.1371/journal.pone.0209392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875375	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400003
J	Sheu, SJ; Chen, JL; Bee, YS; Lin, SH; Shu, CW				Sheu, Shwu-Jiuan; Chen, Jiunn-Liang; Bee, Youn-Shen; Lin, Shi-Han; Shu, Chih-Wen			ERBB2-modulated ATG4B and autophagic cell death in human ARPE19 during oxidative stress Shwu-Jiuan	PLOS ONE			English	Article							MACULAR DEGENERATION; ANTIOXIDANT RESPONSE; MECHANISMS; PHOSPHORYLATION; OVEREXPRESSION; ACTIVATION; DISEASE; MEMBER; DAMAGE; KEAP1	Age-related macular degeneration (AMD) is an ocular disease with retinal degeneration. Retinal pigment epithelium (RPE) degeneration is mainly caused by long-term oxidative stress. Kinase activity could be either protective or detrimental to cells during oxidative stress; however, few reports have described the role of kinases in oxidative stress. In this study, high-throughput screening of kinome siRNA library revealed that erb-b2 receptor tyrosine-protein kinase 2 (ERBB2) knockdown reduced reactive oxygen species (ROS) production in ARPE-19 cells during oxidative stress. Silencing ERBB2 caused an elevation in microtubule associated protein light chain C3-II (MAP1LC3B-II/I) conversion and sequesterone (SQSTM) 1 protein level. ERBB2 deprivation largely caused an increase in autophagy-regulating protease (ATG4B) expression, a protease that negatively recycles MAP1LC3-II at the fusion step between the autophagosome and lysosome, suggesting ERBB2 might modulate ATG4B for autophagy induction in oxidative stress-stimulated ARPE-19 cells. ERBB2 knockdown also caused an accumulation of nuclear factor erythroid 2-related factor 2 (NRF2) and enhanced its transcriptional activity. In addition, ERBB2 ablation or treatment with autophagy inhibitors reduced oxidative-induced cytotoxic effects in ARPE-19 cells. Furthermore, ERBB2 silencing had little or no additive effects in ATG5/7-deficient cells. Taken together, our results suggest that ERBB2 may play an important role in modulating autophagic RPE cell death during oxidative stress, and ERBB2 may be a potential target in AMD prevention.	[Sheu, Shwu-Jiuan; Chen, Jiunn-Liang; Bee, Youn-Shen; Lin, Shi-Han] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Sheu, Shwu-Jiuan; Chen, Jiunn-Liang] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Jiunn-Liang] Shu Zen Jr Coll Med & Management, Dept Optometry, Kaohsiung, Taiwan; [Bee, Youn-Shen] Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Bee, Youn-Shen] Natl Def Med Ctr, Taipei, Taiwan; [Shu, Chih-Wen] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Shu, Chih-Wen] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; I Shou University; National Sun Yat Sen University	Shu, CW (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Shu, CW (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.	vcwshu@gmail.com	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002	Kaohsiung Veterans General Hospital [VGHKS105-094]; Ministry of Science and Technology [MOST 106-2314-B-075B-006, 107-2311-B-214-003]	Kaohsiung Veterans General Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Kaohsiung Veterans General Hospital (VGHKS105-094) and Ministry of Science and Technology (MOST 106-2314-B-075B-006 and 107-2311-B-214-003).	Abdollahzadeh I, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00109; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Campagne MV, 2014, J PATHOL, V232, P151, DOI 10.1002/path.4266; Campesi I, 2013, LIFE SCI, V93, P145, DOI 10.1016/j.lfs.2013.06.001; Chai PW, 2016, INT J BIOL SCI, V12, P1332, DOI 10.7150/ijbs.16245; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Ci Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.506; Dodson M, 2015, BIOCHEM J, V469, P347, DOI 10.1042/BJ20150568; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Ha JH, 2012, CELL BIOL TOXICOL, V28, P19, DOI 10.1007/s10565-011-9202-x; Henson E, 2017, CANCERS, V9, DOI 10.3390/cancers9040027; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Li YJ, 2015, CELL PHYSIOL BIOCHEM, V35, P1663, DOI 10.1159/000373980; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Liu PF, 2018, THERANOSTICS, V8, P830, DOI 10.7150/thno.22012; Liu PF, 2017, CELL PHYSIOL BIOCHEM, V44, P728, DOI 10.1159/000485286; Liu PF, 2014, AUTOPHAGY, V10, P1454, DOI 10.4161/auto.29556; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Lozy F, 2014, AUTOPHAGY, V10, P662, DOI 10.4161/auto.27867; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marneros AG, 2016, EMBO MOL MED, V8, P208, DOI 10.15252/emmm.201505613; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pennington KL, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0063-5; Plafker SM, 2012, INT REV CEL MOL BIO, V298, P135, DOI 10.1016/B978-0-12-394309-5.00004-3; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Sheng R, 2015, ACTA PHARMACOL SIN, V36, P411, DOI 10.1038/aps.2014.151; Sheu SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174736; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Solomon SD, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub3; Straface Elisabetta, 2012, Handb Exp Pharmacol, P49, DOI 10.1007/978-3-642-30726-3_3; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Xu BS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2354-y; Yang ZF, 2015, J BIOL CHEM, V290, P26549, DOI 10.1074/jbc.M115.658088; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	43	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213932	10.1371/journal.pone.0213932	http://dx.doi.org/10.1371/journal.pone.0213932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870514	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300096
J	Takeuchi, M; Ozaki, H; Hiraoka, S; Kamagata, Y; Sakata, S; Yoshioka, H; Iwasaki, W				Takeuchi, Mio; Ozaki, Haruka; Hiraoka, Satoshi; Kamagata, Yoichi; Sakata, Susumu; Yoshioka, Hideyoshi; Iwasaki, Wataru			Possible cross-feeding pathway of facultative methylotroph Methyloceanibacter caenitepidi Gela4 on methanotroph Methylocaldum marinum S8	PLOS ONE			English	Article							METHANE; SEDIMENTS; GENE; NOV.	Non-methanotrophic bacteria such as methylotrophs often coexist with methane-oxidizing bacteria (methanotrophs) by cross-feeding on methane-derived carbon. Methanol has long been considered a major compound that mediates cross-feeding of methane-derived carbon. Despite the potential importance of cross-feeding in the global carbon cycle, only a few studies have actually explored metabolic responses of a bacteria when cross-feeding on a methanotroph. Recently, we isolated a novel facultative methylotroph, Methyloceanibacter caenitepidi Gela4, which grows syntrophically with the methanotroph, Methylocaldum marinum S8. To assess the potential metabolic pathways in M. caenitepidi Gela4 co-cultured with M. marinum S8, we conducted genomic analyses of the two strains, as well as RNA-Seq and chemical analyses of M. caenitepidi Gela4, both in pure culture with methanol and in co-culture with methanotrophs. Genes involved in the serine pathway were downregulated in M. caenitepidi Gela4 under co-culture conditions, and methanol was below the detection limit (<310 nM) in both pure culture of M. marinum S8 and co-culture. In contrast, genes involved in the tricarboxylic acid cycle, as well as acetyl-CoA synthetase, were upregulated in M. caenitepidi Gela4 under co-culture conditions. Notably, a pure culture of M. marinum S8 produced acetate (<16 mu M) during growth. These results suggested that an organic compound other than methanol, possibly acetate, might be the major carbon source for M. caenitepidi Gela4 cross-fed by M. marinum S8. Co-culture of M. caenitepidi Gela4 and M. marinum S8 may represent a model system to further study methanol-independent cross-feeding from methanotrophs to non-methanotrophic bacteria.	[Takeuchi, Mio; Sakata, Susumu; Yoshioka, Hideyoshi] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Higashi Ku, Tsukuba, Ibaraki, Japan; [Ozaki, Haruka] Univ Tsukuba, Fac Med, Dept Bioinformat, Tsukuba, Ibaraki, Japan; [Hiraoka, Satoshi; Iwasaki, Wataru] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Kamagata, Yoichi] AIST, Bioprod Res Inst, Higashi Ku, Tsukuba, Ibaraki, Japan; [Iwasaki, Wataru] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Takeuchi, Mio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ikeda, Osaka, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Takeuchi, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Higashi Ku, Tsukuba, Ibaraki, Japan.; Takeuchi, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Ikeda, Osaka, Japan.	takeuchi-mio@aist.go.jp	Sakata, Susumu/N-4303-2018; Hiraoka, Satoshi/V-9470-2019; Iwasaki, Wataru/O-4917-2014; Takeuchi, Mio/L-8060-2018	Sakata, Susumu/0000-0002-7598-8020; Hiraoka, Satoshi/0000-0001-5008-0916; Iwasaki, Wataru/0000-0002-9169-9245; Ozaki, Haruka/0000-0002-1606-2762; Takeuchi, Mio/0000-0003-2183-7371	JSPS KAKENHI [JP221S0002, JP16H06279, JP25450265]; Atmosphere and Ocean Research Institute, the University of Tokyo [005]; RIKEN Special Postdoctoral Researcher Program	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Atmosphere and Ocean Research Institute, the University of Tokyo; RIKEN Special Postdoctoral Researcher Program	This work was funded by JSPS KAKENHI (Grant Numbers JP221S0002, JP16H06279, and JP25450265). This work was also supported by the Cooperative Program (no. 005, 2013) of the Atmosphere and Ocean Research Institute, the University of Tokyo. HO was supported by the RIKEN Special Postdoctoral Researcher Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bothe H, 2002, APPL MICROBIOL BIOT, V59, P33, DOI 10.1007/s00253-002-0964-1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chistoserdova L, 1997, MICROBIOL-UK, V143, P1729, DOI 10.1099/00221287-143-5-1729; Corder R.E., 1986, ABS PAP AM CHEM SOC, V196, P231; Bustillos-Cristales MD, 2017, MICROBES ENVIRON, V32, P244, DOI 10.1264/jsme2.ME17070; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Firsova YE, 2015, MICROBIOLOGY+, V84, P796, DOI 10.1134/S002626171506003X; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; He R, 2012, ENVIRON MICROBIOL, V14, P1403, DOI 10.1111/j.1462-2920.2012.02725.x; Hibi Y, 2011, J BIOSCI BIOENG, V111, P547, DOI 10.1016/j.jbiosc.2010.12.017; Jensen S, 2008, FEMS MICROBIOL ECOL, V66, P320, DOI 10.1111/j.1574-6941.2008.00575.x; Kalyuzhnaya MG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3785; Krause SMB, 2017, P NATL ACAD SCI USA, V114, P358, DOI 10.1073/pnas.1619871114; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAMB SC, 1980, BIOTECHNOL BIOENG, V22, P2119, DOI 10.1002/bit.260221010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Mayumi D, 2010, MICROBES ENVIRON, V25, P156, DOI 10.1264/jsme2.ME10120; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050480; Patel SKS, 2016, J MICROBIOL BIOTECHN, V26, P717, DOI 10.4014/jmb.1601.01013; Paul BG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00186; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider K, 2012, J BIOL CHEM, V287, P757, DOI 10.1074/jbc.M111.305219; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugawara H, 2009, 20 INT C GEN INF GIW; Takami H, 2016, DNA RES, V23, P467, DOI 10.1093/dnares/dsw030; Takeuchi M, 2014, INT J SYST EVOL MICR, V64, P3240, DOI 10.1099/ijs.0.063503-0; Takeuchi M, 2014, INT J SYST EVOL MICR, V64, P462, DOI 10.1099/ijs.0.053397-0; Vecherskaya M, 2009, ENV MICROBIOL REP, V1, P442, DOI 10.1111/j.1758-2229.2009.00069.x; WILKINSON TG, 1974, BIOTECHNOL BIOENG, V16, P41, DOI 10.1002/bit.260160105	34	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213535	10.1371/journal.pone.0213535	http://dx.doi.org/10.1371/journal.pone.0213535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870453	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300039
J	Timeus, F; Crescenzio, N; Foglia, L; Doria, A; Stillitano, MG; Garelli, E; Mazzone, R; Vivalda, L; Vallero, S; Ramenghi, U; Saracco, P				Timeus, Fabio; Crescenzio, Nicoletta; Foglia, Luiselda; Doria, Alessandra; Stillitano, Maria Giuseppina; Garelli, Emanuela; Mazzone, Raffaela; Vivalda, Laura; Vallero, Stefano; Ramenghi, Ugo; Saracco, Paola			Reduction of CFU-GM and circulating hematopoietic progenitors in a subgroup of children with chronic neutropenia associated with severe infections and delayed recovery	PLOS ONE			English	Article							PRIMARY AUTOIMMUNE NEUTROPENIA; FAILURE SYNDROME GROUP; CONSENSUS GUIDELINES; ANTIBODIES; DIAGNOSIS; CHILDHOOD; COMMITTEE; INFANCY; CELLS	Myelopoiesis was evaluated in 66 pediatric patients with chronic neutropenia who were positive for anti-neutrophil antibodies (median age at diagnosis: 11 months, median neutrophil count at diagnosis: 419/mu l). Other causes of neutropenia were excluded. Bone marrow morphology, clonogenic tests and/or the peripheral blood CD 34+ cell count, and apoptotic rate were evaluated in 61 patients with neutropenia lasting > 12 months or severe infections. The peripheral blood CD 34+ cell count and apoptotic rate were evaluated in five patients with shorter neutropenia. The median follow-up time was 29 months (range 7-180 months). Forty-seven patients (71.2%) had a spontaneous recovery after 7-180 months (median 29 months). The group of patients younger than 24 months at diagnosis (n = 50) had a higher probability of recovery (40/50 vs. 7/16 chi(2) p<0.01) with a shorter period of neutropenia (median 26 versus 47 months, Kaplan-Meier analysis p = 0.001). The colony-forming units-granulocyte-macrophage (CFU-GM) were significantly decreased in 26/35 patients (74%) evaluated for clonogenic tests. All patients with normal CFU-GM recovered (9/9 patients); whereas, neutropenia persisted in 12/26 patients with reduced CFU-GM (46%, Pearson chi(2) p = 0.02). In 36/55 (65%) patients evaluated by flow cytometry we observed reduced circulating CD34+ cells compared with controls of the same age. An increase in the circulating CD34+ cell apoptotic rate was observed in 28/55 patients (51%). Infections requiring hospitalization were observed in 9/18 (50%; Pearson chi(2), p = 0.03) patients with both decreased circulating CD34+ cells and increased CD34+ apoptotic rates. In the group aged < 24 months, we observed a significant correlation between the persistence of neutropenia and decreased circulating CD34+ cells (Pearson chi(2) p = 0.008). In conclusion, reduced CFU-GM and circulating hematopoietic progenitors were observed in a subgroup of children with chronic neutropenia who were positive for anti-neutrophil antibodies and had a higher incidence of severe infections and delayed spontaneous remission.	[Timeus, Fabio; Vallero, Stefano] Regina Margherita Children Hosp, Pediat Oncohematol, Turin, Italy; [Crescenzio, Nicoletta; Foglia, Luiselda; Doria, Alessandra; Stillitano, Maria Giuseppina; Garelli, Emanuela; Vivalda, Laura; Ramenghi, Ugo; Saracco, Paola] Univ Turin, Regina Margherita Children Hosp, Pediat Hematol, Turin, Italy; [Mazzone, Raffaela] Regina Margherita Children Hosp, Biochem Lab, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino	Timeus, F (corresponding author), Regina Margherita Children Hosp, Pediat Oncohematol, Turin, Italy.	fabio.timeus@unito.it	VALLERO, STEFANO GABRIELE/AAA-4131-2019	Timeus, Fabio/0000-0003-0095-283X				Angelino G, 2014, PEDIAT ALLERG IMM-UK, V25, P283, DOI 10.1111/pai.12177; Audrain M, 2011, PEDIAT ALLERG IMM-UK, V22, P494, DOI 10.1111/j.1399-3038.2010.01117.x; Badolato R, 2004, CURR OPIN ALLERGY CL, V4, P513, DOI 10.1097/00130832-200412000-00007; Bernini JC, 1996, PEDIATR CLIN N AM, V43, P773, DOI 10.1016/S0031-3955(05)70432-6; Bruin M, 2005, VOX SANG, V88, P52, DOI 10.1111/j.1423-0410.2005.00585.x; Bruin MCA, 1999, BLOOD, V94, P1797, DOI 10.1182/blood.V94.5.1797.417k14_1797_1802; Bux J, 1998, BLOOD, V91, P181, DOI 10.1182/blood.V91.1.181.181_181_186; Bux J, 1997, TRANSFUSION, V37, P977, DOI 10.1046/j.1537-2995.1997.37997454028.x; CURRIE MS, 1987, BLOOD, V69, P529; Dinauer MC, 2015, HEMATOL ONCOL, P773; Farruggia P, 2015, AM J HEMATOL, V90, pE221, DOI 10.1002/ajh.24187; Fioredda F, 2012, AM J HEMATOL, V87, P238, DOI 10.1002/ajh.22242; Fioredda F, 2011, PEDIATR BLOOD CANCER, V57, P10, DOI 10.1002/pbc.23108; HARTMAN KR, 1994, BLOOD, V84, P625; KAWAGUCHI Y, 1985, AM J HEMATOL, V20, P223, DOI 10.1002/ajh.2830200304; Kuijpers TW, 1999, J IMMUNOL METHODS, V232, P211, DOI 10.1016/S0022-1759(99)00178-7; Lucas G, 2013, VOX SANG, V105, P259, DOI 10.1111/vox.12041; LUCAS GF, 1990, VOX SANG, V59, P251, DOI 10.1111/j.1423-0410.1990.tb00249.x; LYALL EGH, 1992, J CLIN PATHOL, V45, P431, DOI 10.1136/jcp.45.5.431; Perdikogianni C, 2003, ACTA PAEDIATR, V92, P1277, DOI 10.1080/08035250310005693; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213; Timeus F, 2005, EXP HEMATOL, V33, P597, DOI 10.1016/j.exphem.2005.02.005; VERHEUGT FWA, 1978, BRIT J HAEMATOL, V39, P339, DOI 10.1111/j.1365-2141.1978.tb01106.x; Wang LY, 2009, TRANSFUSION, V49, P1003, DOI 10.1111/j.1537-2995.2008.02084.x	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213782	10.1371/journal.pone.0213782	http://dx.doi.org/10.1371/journal.pone.0213782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870474	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300073
J	Anders, N; Howarth, K; Totland, B; Handegard, NO; Tenningen, M; Breen, M				Anders, Neil; Howarth, Kirsten; Totland, Bjorn; Handegard, Nils Olav; Tenningen, Maria; Breen, Michael			Effects on individual level behaviour in mackerel (Scomber scombrus) of sub-lethal capture related stressors: Crowding and hypoxia	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; PURSE-SEINE CAPTURE; COD GADUS-MORHUA; DIFFERENT QUALITY PARAMETERS; SAITHE POLLACHIUS-VIRENS; PROGRESSIVE HYPOXIA; ATLANTIC MACKEREL; SWIMMING BEHAVIOR; WATER TEMPERATURE; FISH WELFARE	Stress to fish during harvest in wild capture fisheries is known to negatively influence subsequent survival in catches that are released. Therefore, if fisheries are to be conducted sustainably, there is a need to promote good fish welfare during the capture process. Purse seine fishing is a widespread and efficient fishing method. However, capture and release of fish from purse seines (a process called "slipping") can result in extremely high mortality in small pelagic schooling species. The objective of this study was to establish behavioural indicators of sub-lethal stress in Atlantic mackerel (Scomberscombrus) that may be used to set safe threshold limits for use in commercial purse seine fishing, in order to ensure good fish welfare and thereby minimise slipping mortality. Controlled mesocosm scale experiments with schools of mackerel in net pens were undertaken to determine behavioural responses to simulated purse seine capture stressors of "crowding", "hypoxia" and "crowding & hypoxia". Crowding (at 30 kg.m(-3)) was achieved by reducing the volume of the net pen, while hypoxia (to 40% oxygen saturation) was achieved by surrounding the net pen with a tarpaulin bag to prevent water exchange. Using video analysis, we investigated behavioural responses in nearest neighbour distances, nearest neighbour angular deviations, tail beat amplitude and tail beat frequency (TBF). Of the metrics considered, only TBF showed a response; a significant increase to "crowding" (42% increase) and "crowding & hypoxia" (38% increase) was found. The increase in TBF in response to "hypoxia" alone (29% increase) was not significant. We therefore conclude that increases in tail beat frequency may be used as an indicator of sub-lethal purse seine capture stress in mackerel that may have utility in minimising post slipping mortality.	[Anders, Neil; Howarth, Kirsten; Totland, Bjorn; Tenningen, Maria; Breen, Michael] IMR, Fish Capture Div, Bergen, Norway; [Anders, Neil; Howarth, Kirsten] Univ Bergen, Dept Biol Sci, Bergen, Norway; [Handegard, Nils Olav] IMR, Marine Ecosyst Acoust, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen; Institute of Marine Research - Norway	Anders, N (corresponding author), IMR, Fish Capture Div, Bergen, Norway.; Anders, N (corresponding author), Univ Bergen, Dept Biol Sci, Bergen, Norway.	neila@imr.no	Handegard, Nils Olav/I-3047-2012	Handegard, Nils Olav/0000-0002-9708-9042	Norwegian Research Council, NFR [243885]; Norwegian Research Council [203477/O30]	Norwegian Research Council, NFR(Research Council of Norway); Norwegian Research Council(Research Council of NorwayEuropean Commission)	Funding for this work was provided by a grant to MB by the Norwegian Research Council, NFR Project No. 243885 ("RedSlip: Reducing slipping mortality in purse seines by understanding interactions and behaviour" [https://www.forskningsradet.no/no/Forsiden/1173185591033]). NA was financed by a Norwegian Research Council grant (Project No. 203477/O30) to the Centre for Research-based Innovation in Sustainable Fish Capture and Processing Technology (CRISP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Brady DC, 2009, CAN J FISH AQUAT SCI, V66, P415, DOI 10.1139/F09-007; Brinkhof J, 2018, FISH RES, V206, P209, DOI 10.1016/j.fishres.2018.05.021; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Brownscombe JW, 2013, J EXP MAR BIOL ECOL, V440, P207, DOI 10.1016/j.jembe.2012.12.004; Cook DG, 2014, J EXP MAR BIOL ECOL, V460, P162, DOI 10.1016/j.jembe.2014.07.002; Cooke SJ, 2000, AQUAC RES, V31, P495, DOI 10.1046/j.1365-2109.2000.00470.x; Couzin Iain D., 2006, FISH COGNITION BEHAV, P166, DOI DOI 10.1002/9780470996058.CH9; Crawley M. J, 2002, STAT COMPUTING INTRO; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Davis MW, 2001, J FISH BIOL, V58, P1, DOI 10.1111/j.1095-8649.2001.tb00495.x; Dawkins MS, 2004, ANIM WELFARE, V13, pS3; Delcourt J, 2012, REV FISH BIOL FISHER, V22, P595, DOI 10.1007/s11160-012-9260-z; Digre H, 2010, FISHERIES SCI, V76, P549, DOI 10.1007/s12562-010-0254-2; Domenici P, 2002, P ROY SOC B-BIOL SCI, V269, P2103, DOI 10.1098/rspb.2002.2107; Domenici P, 2000, J FISH BIOL, V57, P1526, DOI 10.1006/jfbi.2000.1413; DOMMASNES A, 1994, ICES J MAR SCI, V51, P63, DOI 10.1006/jmsc.1994.1006; Edwards J. L., 1984, INT COUNCIL EXPLOR B, V34, P1; Espmark AM, 2009, AQUACULT INT, V17, P341, DOI 10.1007/s10499-008-9206-6; Fiskeridirektoratet, 2017, EC BIOL FIGS NORW FI, V1, P1; Gerlotto F, 2006, ICES J MAR SCI, V63, P1405, DOI 10.1016/j.icesjms.2006.04.023; GILLERMAN RG, 1980, J FISH BIOL, V17, P31, DOI 10.1111/j.1095-8649.1980.tb02740.x; GLASS CW, 1986, J FISH BIOL, V29, P71, DOI 10.1111/j.1095-8649.1986.tb05000.x; Handegard NO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190259; Handegard NO, 2009, ICES J MAR SCI, V66, P1252, DOI 10.1093/icesjms/fsp003; HATTULA T, 1995, FISH RES, V23, P209, DOI 10.1016/0165-7836(94)00358-4; HE P, 1988, J FISH BIOL, V33, P255, DOI 10.1111/j.1095-8649.1988.tb05468.x; HE PG, 1993, ICES MAR SC, V196, P183; Hemelrijk CK, 2015, FISH FISH, V16, P511, DOI 10.1111/faf.12072; Herbert N.A., 2013, P129; Herbert NA, 2006, MAR BIOL, V149, P1217, DOI 10.1007/s00227-006-0284-6; Huse I, 2010, FISH RES, V106, P54, DOI 10.1016/j.fishres.2010.07.001; ICES, 2017, ICES CM, V23, P1; Israeli D, 1996, AQUACULT ENG, V15, P423, DOI 10.1016/S0144-8609(96)01009-6; JOHNSTONE ADF, 1993, J FISH BIOL, V42, P149, DOI 10.1006/jfbi.1993.1014; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kristiansen TS, 2004, AQUACULTURE, V230, P137, DOI 10.1016/S0044-8486(03)00436-8; Lefrancois C, 2009, J FISH BIOL, V75, P1615, DOI 10.1111/j.1095-8649.2009.02387.x; LOCKWOOD SJ, 1983, FISH RES, V2, P129, DOI 10.1016/0165-7836(83)90114-5; Lowe CG, 1998, FISH RES, V36, P275, DOI 10.1016/S0165-7836(98)00109-X; Lowe CG, 2001, MAR BIOL, V139, P447, DOI 10.1007/s002270100585; Marcalo A, 2013, J FISH BIOL, V83, P480, DOI 10.1111/jfb.12184; Marcalo A, 2019, EUROPEAN LANDING OBLIGATION: REDUCING DISCARDS IN COMPLEX, MULTI-SPECIES AND MULTI-JURISDICTIONAL FISHERIES, P297, DOI 10.1007/978-3-030-03308-8_15; Marcalo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195433; Marras S, 2015, BEHAV ECOL SOCIOBIOL, V69, P219, DOI 10.1007/s00265-014-1834-4; MISUND OA, 1993, FISH RES, V16, P179, DOI 10.1016/0165-7836(93)90051-8; MISUND OA, 1992, ICES J MAR SCI, V49, P325, DOI 10.1093/icesjms/49.3.325; MISUND OA, 1992, FISH RES, V14, P319, DOI 10.1016/0165-7836(92)90040-Z; Mitchell RW, 2002, FISH RES, V57, P279, DOI 10.1016/S0165-7836(01)00354-X; MOSS SA, 1970, MAR BIOL, V5, P100, DOI 10.1007/BF00352592; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nottestad L, 1999, CAN J ZOOL, V77, P1540, DOI 10.1139/cjz-77-10-1540; Nottestad L, 2016, ICES J MAR SCI, V73, P1127, DOI 10.1093/icesjms/fsv239; Ohlberger J, 2007, J EXP ZOOL PART A, V307A, P296, DOI 10.1002/jez.384; Olla B., 1975, COMBINED EFFECTS RAD, P299; Olsen K., 1969, ICES CM, V20, P1; Olsen RE, 2012, FISH RES, V129, P21, DOI 10.1016/j.fishres.2012.06.007; Olsen SH, 2013, FISH RES, V147, P446, DOI 10.1016/j.fishres.2013.03.009; PARTRIDGE BL, 1980, BEHAV ECOL SOCIOBIOL, V6, P277, DOI 10.1007/BF00292770; Pawson M.G., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P439; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Pitcher T. J., 1993, BEHAV TELEOST FISHES, DOI [10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_]; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Pottinger TG, 2008, STRESS RESPONSE FISH; Raby GD, 2015, ECOL APPL, V25, P1757, DOI 10.1890/14-0798.1; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RICKER W E, 1975, P382; Rieucau G, 2014, J FISH BIOL, V85, P1650, DOI 10.1111/jfb.12520; Rieucau G, 2016, ANIM BEHAV, V117, P69, DOI 10.1016/j.anbehav.2016.05.002; Romey WL, 1996, ECOL MODEL, V92, P65, DOI 10.1016/0304-3800(95)00202-2; Rotabakk BT, 2011, FISH RES, V112, P44, DOI 10.1016/j.fishres.2011.08.009; Roth B, 2012, FISH RES, V115, P110, DOI 10.1016/j.fishres.2011.05.003; SCHERER E, 1992, J APPL ICHTHYOL, V8, P122, DOI 10.1111/j.1439-0426.1992.tb00674.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreck C.B., 1997, P145; Schreck CB, 2016, FISH PHYSIOL, V35, P1, DOI 10.1016/B978-0-12-802728-8.00001-1; Sivle LD, 2017, RAPPORT HAVFORSKNING, V34, P1; Stratoudakis Y, 2002, ICES J MAR SCI, V59, P1256, DOI 10.1006/jmsc.2002.1314; Swift DJ, 1986, COMP BIOCH PHYSL A, V76, P795; Tang M, 1995, CAN J FISH AQUAT SCI, V52, P2138, DOI 10.1139/f95-806; Tenningen M, 2017, ICES J MAR SCI, V74, P359, DOI 10.1093/icesjms/fsw159; Tenningen M, 2015, FISH RES, V161, P244, DOI 10.1016/j.fishres.2014.08.003; Tenningen M, 2012, ICES J MAR SCI, V69, P1523, DOI 10.1093/icesjms/fss114; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Uhlmann SS, 2015, FISH FISH, V16, P183, DOI 10.1111/faf.12049; Veldhuizen LJL, 2018, FISH RES, V204, P41, DOI 10.1016/j.fishres.2018.02.001; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Viscido SV, 2004, MAR ECOL PROG SER, V273, P239, DOI 10.3354/meps273239; WARDLE CS, 1988, J FISH BIOL, V32, P471, DOI 10.1111/j.1095-8649.1988.tb05382.x; Wardle CS, 1996, J FISH BIOL, V49, P854, DOI 10.1111/j.1095-8649.1996.tb00084.x; Watson R, 2006, FISH RES, V79, P103, DOI 10.1016/j.fishres.2006.01.013; Whitney NM, 2016, FISH RES, V183, P210, DOI 10.1016/j.fishres.2016.06.003; Wilson SM, 2013, COMP BIOCHEM PHYS A, V164, P491, DOI 10.1016/j.cbpa.2012.12.002; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	101	4	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213709	10.1371/journal.pone.0213709	http://dx.doi.org/10.1371/journal.pone.0213709			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865714	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900084
J	Navedo, JG; Verdugo, C; Rodriguez-Jorquera, IA; Abad-Gomez, JM; Suazoid, CG; Castaneda, LE; Araya, V; Ruiz, J; Gutierrez, JS				Navedo, Juan G.; Verdugo, Claudio; Rodriguez-Jorquera, Ignacio A.; Abad-Gomez, Jose M.; Suazoid, Cristian G.; Castaneda, Luis E.; Araya, Valeria; Ruiz, Jorge; Gutierrez, Jorge S.			Assessing the effects of human activities on the foraging opportunities of migratory shorebirds in Austral high-latitude bays	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LONG-TERM; RED KNOTS; BEHAVIOR; DISTURBANCE; WADERS; ENERGY; BIRDS; POPULATIONS; WETLAND	Human presence at intertidal areas could impact coastal biodiversity, including migratory waterbird species and the ecosystem services they provide. Assessing this impact is therefore essential to develop management measures compatible with migratory processes and associated biodiversity. Here, we assess the effects of human presence on the foraging opportunities of Hudsonian godwits (Limosa haemastica, a trans-hemispheric migratory shorebird) during their non-breeding season on Chiloe Island, southern Chile. We compared bird density and time spent foraging in two similar bays with contrasting disturbance levels: human presence (mostly seaweed harvesters accompanied by dogs) was on average 0.9 0.4 people per 10 ha in the disturbed bay, whereas it was negligible (95% days absent) in the non-disturbed bay. Although overall abundances were similar between bays, godwit density was higher in the non-disturbed bay throughout the low tide period. Both days after the start of the non-breeding season and tidal height significantly affected godwit density, with different effects in either bay. Time spent foraging was significantly higher in the non disturbed bay (86.5 1.1%) than in the disturbed one (81.3 1.4%). As expected, godwit density significantly decreased with the number of people and accompanying dogs in the disturbed bay. Our results indicate that even a low density of people and dogs can significantly reduce the foraging opportunities of shorebirds. These constraints, coupled with additional flushing costs, may negatively affect godwits' pre-migratory fattening. Hence, as a first step we suggest limiting human presence within bays on Chiloe to 1 person per 10 ha and banning the presence of accompanying dogs in sensitive conservation areas.	[Navedo, Juan G.; Araya, Valeria; Ruiz, Jorge] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Bird Ecol Lab, Valdivia, Chile; [Navedo, Juan G.; Ruiz, Jorge; Gutierrez, Jorge S.] Univ Austral Chile, Fac Ciencias, Estn Expt Quempillen, Ancud, Chile; [Verdugo, Claudio] Univ Austral Chile, Inst Patol Anim, Ecol & Evoluc Enfermedades Infecciosas, Valdivia, Chile; [Rodriguez-Jorquera, Ignacio A.] Univ Austral Chile, Ctr Humed Rio Cruces, Valdivia, Chile; [Abad-Gomez, Jose M.] Univ Extremadura, Conservat Biol Res Grp, Badajoz, Spain; [Suazoid, Cristian G.] Justus Liebig Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany; [Castaneda, Luis E.] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago, Chile; [Gutierrez, Jorge S.] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Estudos Ambiente & Mar CESAM, Lisbon, Portugal	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Universidad de Extremadura; Justus Liebig University Giessen; Universidad de Chile; Universidade de Lisboa	Navedo, JG (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Bird Ecol Lab, Valdivia, Chile.; Navedo, JG (corresponding author), Univ Austral Chile, Fac Ciencias, Estn Expt Quempillen, Ancud, Chile.	jgnavedo@uach.cl	Abad-Gómez, José M/R-2479-2019; Gutiérrez, Jorge S./AAM-6821-2020	Abad-Gómez, José M/0000-0002-3757-8856; Gutiérrez, Jorge S./0000-0001-8459-3162; Suazo, Cristian/0000-0003-3336-3660	Universidad Austral de Chile [DID SE-2014-01]; FONDECYT [1161224]	Universidad Austral de Chile; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by Universidad Austral de Chile (DID SE-2014-01). JGN was funded by FONDECYT #1161224 while writing.; We thank CECPAN, the long-lasting NGO working for the conservation of the natural heritage of the Chiloe archipelago, and particularly Jorge Valenzuela, for their continuous support; Ivan Paredes, the Mercado Barria family, Cesar Mansilla and Rodrigo Hucke-Gaete for helping us to carry out fieldwork. Daniel Ruthrauff and two anonymous reviewers made helpful comments on a first draft. Johannes Horstmann helped with figures. Dataset is available at: doi:10.5061/dryad.p0q053s. This work was funded by Universidad Austral de Chile (DID SE-2014-01). JGN was funded by FONDECYT #1161224 while writing.	Aiken CM, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004593; Alexander RM, 2002, INTEGR COMP BIOL, V42, P1060, DOI 10.1093/icb/42.5.1060; Andres BA, 2009, WATERBIRDS, V32, P216, DOI 10.1675/063.032.0202; [Anonymous], 2010, WETL INT STAT WORLDS; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Banks PB, 2007, BIOLOGY LETT, V3, P611, DOI 10.1098/rsbl.2007.0374; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Blumstein DT, 2005, P ROY SOC B-BIOL SCI, V272, P1663, DOI 10.1098/rspb.2005.3147; Burton NHK, 1996, BIOL CONSERV, V77, P193, DOI 10.1016/0006-3207(95)00143-3; Buschmann AH, 2008, INT J ENVIRON POLLUT, V33, P432, DOI 10.1504/IJEP.2008.020571; CECPAN, 2011, DIAGN SOC BAH CAUL C; Collop C, 2016, IBIS, V158, P711, DOI 10.1111/ibi.12399; Colwell MA, 2003, WATERBIRDS, V26, P484, DOI 10.1675/1524-4695(2003)026[0484:VISUOD]2.0.CO;2; Conklin JR, 2017, J AVIAN BIOL, V48, P19, DOI 10.1111/jav.01316; Conklin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054535; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Dias MP, 2008, ACTA OECOL, V33, P188, DOI 10.1016/j.actao.2007.10.005; Drewitt AL, 2007, IBIS, V149, P1, DOI 10.1111/j.1474-919X.2007.00663.x; Duijns S, 2013, BIRD STUDY, V60, P509, DOI 10.1080/00063657.2013.836153; Durell SEAL, 2005, BIOL CONSERV, V123, P67, DOI 10.1016/j.biocon.2004.10.009; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; Elwell TL, 2018, SCI TOTAL ENVIRON, V637, P1014, DOI 10.1016/j.scitotenv.2018.04.052; EVANS PR, 1976, ARDEA, V64, P117; Fitzpatrick S, 1998, BIRD STUDY, V45, P157, DOI 10.1080/00063659809461088; Fonseca J, 2017, ESTUAR COAST SHELF S, V198, P279, DOI 10.1016/j.ecss.2017.09.016; Garcia-Walther J., 2016, THESIS; Gill JA, 2001, J APPL ECOL, V38, P846, DOI 10.1046/j.1365-2664.2001.00643.x; Gill JA, 2007, IBIS, V149, P9, DOI 10.1111/j.1474-919X.2007.00642.x; Goss-Custard JD, 2002, BIOL CONSERV, V105, P27, DOI 10.1016/S0006-3207(01)00175-6; Goss-Custard John D., 2000, Conservation Biology Series (Cambridge), V2, P65; GOSSCUSTARD JD, 1977, J APPL ECOL, V14, P701, DOI 10.2307/2402804; Granadeiro JP, 2006, ACTA OECOL, V29, P293, DOI 10.1016/j.actao.2005.11.008; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Guglielmo CG, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.165753; Guillemin ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114039; Gurgel CFD, 2018, PHYTOTAXA, V374, P1, DOI 10.11646/phytotaxa.374.1.1; Gutierrez JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042206; Houston AI, 2012, OIKOS, V121, P597, DOI 10.1111/j.1600-0706.2011.19594.x; Hua N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062551; Hucke-Gaete R, 2010, CONSERVANDO MAR CHIL; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KERSTEN M, 1987, ARDEA, V75, P175; McGowan CP, 2015, BIOL CONSERV, V191, P759, DOI 10.1016/j.biocon.2015.08.038; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Micael J, 2018, AUSTRAL ECOL, V43, P955, DOI 10.1111/aec.12645; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Murray NJ, 2014, FRONT ECOL ENVIRON, V12, P267, DOI 10.1890/130260; Navedo JG, 2007, ANIM CONSERV, V10, P88, DOI 10.1111/j.1469-1795.2006.00076.x; Navedo JG, AQ CONSERV; Navedo JG, 2008, J EXP MAR BIOL ECOL, V355, P59, DOI 10.1016/j.jembe.2007.11.016; Navedo JG, 2013, BIODIVERS CONSERV, V22, P1895, DOI 10.1007/s10531-013-0516-2; Navedo JG, 2012, J COAST CONSERV, V16, P373, DOI 10.1007/s11852-012-0208-1; Overdijk O, 2012, AQUAT CONSERV, V22, P695, DOI 10.1002/aqc.2275; Pearce-Higgins JW, 2017, BIRD CONSERV INT, V27, P6, DOI 10.1017/S0959270916000678; Piersma T, 2001, J APPL ECOL, V38, P976, DOI 10.1046/j.1365-2664.2001.00652.x; Piersma T, 2016, J APPL ECOL, V53, P479, DOI 10.1111/1365-2664.12582; Rogers DI, 2006, ANIM BEHAV, V72, P563, DOI 10.1016/j.anbehav.2005.10.029; Samia DSM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9877; Schlacher TA, 2013, ESTUAR COAST SHELF S, V118, P31, DOI 10.1016/j.ecss.2012.12.016; Senner NR, 2017, OIKOS, V126, P61, DOI 10.1111/oik.03325; Senner NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086588; Senner Nathan R., 2011, Wader Study Group Bulletin, V118, P105; Senner NR., 2010, CONSERVATION PLAN HU; Shepherd PCF, 1999, CONSERV BIOL, V13, P347, DOI 10.1046/j.1523-1739.1999.013002347.x; Sirot E, 2010, ANIM BEHAV, V80, P737, DOI 10.1016/j.anbehav.2010.07.014; Smit Cor J., 1993, Wader Study Group Bulletin, V68, P6; Stillman RA, 2001, J APPL ECOL, V38, P857, DOI 10.1046/j.1365-2664.2001.00644.x; Suazo CG, 2012, ESTUAR COAST, V35, P1137, DOI 10.1007/s12237-012-9492-0; TURPIE JK, 1993, IBIS, V135, P156, DOI 10.1111/j.1474-919X.1993.tb02827.x; Valiela I., 2009, GLOBAL LOSS COASTAL, P107; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; Verhulst S, 2004, ECOL SOC, V9; West AD, 2002, BIOL CONSERV, V106, P319, DOI 10.1016/S0006-3207(01)00257-9; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yasue M, 2006, BIOL CONSERV, V128, P47, DOI 10.1016/j.biocon.2005.09.015; Yasue M, 2005, J ETHOL, V23, P199, DOI 10.1007/s10164-005-0152-8; Yasue M, 2003, FUNCT ECOL, V17, P727, DOI 10.1111/j.1365-2435.2003.00783.x; ZWARTS L, 1990, ARDEA, V78, P237	78	9	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212441	10.1371/journal.pone.0212441	http://dx.doi.org/10.1371/journal.pone.0212441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865657	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900021
J	Arao, Y; Hamilton, KJ; Wu, SP; Tsai, MJ; DeMayo, FJ; Korach, KS				Arao, Yukitomo; Hamilton, Katherine J.; Wu, San-Pin; Tsai, Ming-Jer; DeMayo, Francesco J.; Korach, Kenneth S.			Dysregulation of hypothalamic-pituitary estrogen receptor alpha-mediated signaling causes episodic LH secretion and cystic ovary	FASEB JOURNAL			English	Article						polycystic ovary; negative feedback regulation; gonadotropin	GONADOTROPIN-RELEASING-HORMONE; LUTEINIZING-HORMONE; NEGATIVE FEEDBACK; ER-ALPHA; CLOMIPHENE CITRATE; NULL MICE; DELETION; CELLS; RECOMBINATION; INFERTILITY	Polycystic ovary syndrome (PCOS) is a hypothalamic-pituitary-gonadal (HPG) axis disorder. PCOS symptoms most likely result from a disturbance in the complex feedback regulation system of the HPG axis, which involves gonadotrophic hormones and ovarian steroid hormones. However, the nature of this complex and interconnecting feedback regulation makes it difficult to dissect the molecular mechanisms responsible for PCOS phenotypes. Global estrogen receptor alpha (ER alpha) knockout (KO) mice exhibit a disruption of the HPG axis, resulting in hormonal dysregulation in which female ER alpha KO mice have elevated levels of serum estradiol (E2), testosterone, and LH. The ER alpha KO females are anovulatory and develop cystic hemorrhagic ovaries that are thought to be due to persistently high circulating levels of LH from the pituitary. However, the role of ER alpha in the pituitary is still controversial because of the varied phenotypes reported in pituitary-specific ER alpha KO mouse models. Therefore, we developed a mouse model where ER alpha is reintroduced to be exclusively expressed in the pituitary on the background of a global ER alpha-null (PitERtgKO) mouse. Serum E2 and LH levels were normalized in PitERtgKO females and were comparable to wild-type serum levels. However, the ovaries of PitERtgKO adult mice displayed a more overt cystic and hemorrhagic phenotype when compared with ER alpha KO littermates. We determined that anomalous sporadic LH secretion caused the severe ovarian phenotype of PitERtgKO females. Our observations suggest that pituitary ER alpha is involved in the estrogen negative feedback regulation, whereas hypothalamic ER alpha is necessary for the precise control of LH secretion. Uncontrolled, irregular LH secretion may be the root cause of the cystic ovarian phenotype with similarities to PCOS.-Arao, Y., Hamilton, K. J., Wu, S.-P., Tsai, M.-J., DeMayo, F. J., Korach, K. S. Dysregulation of hypothalamic-pituitary estrogen receptor alpha-mediated signaling causes episodic LH secretion and cystic ovary.	[Arao, Yukitomo; Hamilton, Katherine J.; Korach, Kenneth S.] NIEHS, Receptor Biol Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Wu, San-Pin; DeMayo, Francesco J.] NIEHS, Pregnancy & Female Reprod Grp, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Tsai, Ming-Jer] Baylor Coll Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Baylor College of Medicine	Korach, KS (corresponding author), NIEHS, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021; , San Pin Wu/AAF-8371-2020	, San Pin Wu/0000-0001-9626-784X; Arao, Yukitomo/0000-0003-1560-351X	NIH NIEHS from the Division of Intramural Research of the NIEHS [1ZIAES070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER	NIH NIEHS from the Division of Intramural Research of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank David Monroy and the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Comparative Medicine Branch staff for animal care, the staff of the NIEHS Histology Core for histology, and Dr. Janet Hall and Dr. Natalie Shaw (NIEHS, Clinical Research Unit) for critical comments on this study. This study was supported by NIH NIEHS Grant 1ZIAES070065 (to K.S.K.) from the Division of Intramural Research of the NIEHS. The authors declare no conflicts of interest.	Abatan OI, 2008, J AM ASSOC LAB ANIM, V47, P8; Amory JK, 2003, J STEROID BIOCHEM, V85, P357, DOI 10.1016/S0960-0760(03)00205-X; Arao Y, 2018, MOL METAB, V18, P68, DOI 10.1016/j.molmet.2018.09.006; Azziz R, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.57; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Cheong RY, 2014, ENDOCRINOLOGY, V155, P1418, DOI 10.1210/en.2013-1943; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Couse JF, 1999, ENDOCRINOLOGY, V140, P5855, DOI 10.1210/en.140.12.5855; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Couse JF, 2004, ENDOCRINOLOGY, V145, P4693, DOI 10.1210/en.2004-0548; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Couse JF, 2006, ENDOCRINOLOGY, V147, P3666, DOI 10.1210/en.2006-0276; Cushman LJ, 2000, GENESIS, V28, P167, DOI 10.1002/1526-968X(200011/12)28:3/4<167::AID-GENE120>3.3.CO;2-E; ELLIS GB, 1982, ENDOCRINOLOGY, V110, P1618, DOI 10.1210/endo-110-5-1618; Gieske MC, 2008, ENDOCRINOLOGY, V149, P20, DOI 10.1210/en.2007-1084; Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Lee S, 2009, ENDOCRINOLOGY, V150, P3855, DOI 10.1210/en.2008-1774; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Lin H, 2009, BIOL REPROD, V80, P1232, DOI 10.1095/biolreprod.108.074229; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Ma YP, 2017, ENDOCRINOLOGY, V158, P98, DOI 10.1210/en.2016-1608; Marshall J C, 1993, Trans Am Clin Climatol Assoc, V104, P31; MARSHALL JC, 1986, NEW ENGL J MED, V315, P1459; Moskovic DJ, 2012, BJU INT, V110, P1524, DOI 10.1111/j.1464-410X.2012.10968.x; Perez-Millan MI, 2013, GENESIS, V51, P785, DOI 10.1002/dvg.22425; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REAME N, 1984, J CLIN ENDOCR METAB, V59, P328, DOI 10.1210/jcem-59-2-328; RISMA KA, 1995, P NATL ACAD SCI USA, V92, P1322, DOI 10.1073/pnas.92.5.1322; Shaw ND, 2010, J CLIN ENDOCR METAB, V95, P1955, DOI 10.1210/jc.2009-2108; Singh SP, 2009, BIOL REPROD, V81, P488, DOI 10.1095/biolreprod.108.075259; SIR T, 1989, HORM METAB RES, V21, P583, DOI 10.1055/s-2007-1009293; SODERSTEN P, 1983, J ENDOCRINOL, V97, P145, DOI 10.1677/joe.0.0970145; Taniguchi F, 2007, FASEB J, V21, P586, DOI 10.1096/fj.06-6681com; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Xu PW, 2015, J CLIN INVEST, V125, P2861, DOI 10.1172/JCI80941	40	10	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7375	7386		10.1096/fj.201802653RR	http://dx.doi.org/10.1096/fj.201802653RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30866655	Bronze, Green Published			2022-12-26	WOS:000476114200057
J	Borhani, S; Corciulo, C; Larranaga-Vera, A; Cronstein, BN				Borhani, Soheila; Corciulo, Carmen; Larranaga-Vera, Ane; Cronstein, Bruce N.			Adenosine A(2A) receptor (A2AR) activation triggers Akt signaling and enhances nuclear localization of beta-catenin in osteoblasts	FASEB JOURNAL			English	Article						canonical Wnt pathway; bone regeneration; CGS21680	BONE-DEVELOPMENT; CYCLIC-AMP; KINASE-B; WNT; PHOSPHORYLATION; CELLS; STIMULATION; PATHWAY	Osteoblast differentiation and proliferation are regulated by several modulators, among which are adenosine A(2A) receptors (A2ARs) and Wingless/Integrated-beta-catenin pathways. Cytosolic beta-catenin stabilization promotes its nuclear translocation and transcriptional activity. In the present study, we seek to determine whether there is a connection between A2AR stimulation and cellular beta-catenin levels in osteoblasts. Osteoblast precursor cell line (MC3T3-E1) and primary murine osteoblasts were treated with CGS21680, a highly selective A2AR agonist. We analyzed cellular content and nuclear translocation of phosphorylated (p)-serine 552 (S552) beta-catenin in response to A2AR stimulation in MC3T3-E1 cells, in both wild-type and A2AR knockout (A2AKO) mice. Moreover, we measured cellular beta-catenin levels in MC3T3-E1 cells transfected with scrambled or protein kinase B (Akt) small interfering RNA following A2AR activation. CGS21680 (1 mu M) stimulated an increase in both the cellular content and nuclear translocation of p-S552 beta-catenin after 15 min of incubation. A2AR activation had no tangible effect on the cellular beta-catenin level either in A2AKO mice or in osteoblasts with diminished Akt content. Our findings demonstrate an interaction between A2AR, beta-catenin, and Akt signaling in osteoblasts. The existence of such a crosstalk has significant repercussions in the development of novel therapeutic approaches targeting medical conditions associated with reduced bone density.-Borhani, S., Corciulo, C., Larranaga-Vera, A., Cronstein, B. N. Adenosine A(2A) receptor (A2AR) activation triggers Akt signaling and enhances nuclear localization of beta-catenin in osteoblasts.	[Borhani, Soheila] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60607 USA; [Corciulo, Carmen; Larranaga-Vera, Ane; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, New York, NY 10016 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Div Translat Med, Clin Translat Sci Inst, 227 East 30th St, New York, NY 10016 USA.	bruce.cronstein@nyulangone.org	Larranaga-Vera, Ane/AAH-1779-2019	CORCIULO, CARMEN/0000-0002-1865-3494; Borhani, Soheila/0000-0001-8259-2940; Cronstein, Bruce/0000-0002-4295-7383	Arthritis Foundation; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR056672, R01 AR068593]; New York University (NYU) Health and Hospitals Corp. (HHC) Clinical and Translational Science Institute [UL1 TR000038]; Translational Research Laboratory Instruments at NYU-Langone Health; AstraZeneca	Arthritis Foundation; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University (NYU) Health and Hospitals Corp. (HHC) Clinical and Translational Science Institute; Translational Research Laboratory Instruments at NYU-Langone Health; AstraZeneca(AstraZeneca)	This work was supported by grants from the Arthritis Foundation and the U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR056672 and R01 AR068593), and by the New York University (NYU) Health and Hospitals Corp. (HHC) Clinical and Translational Science Institute (UL1 TR000038), and the Translational Research Laboratory Instruments at NYU-Langone Health. Dr. Aranzazu Mediero (Fundacion Jimenez Diaz, Madrid, Spain) originally generated the calvarial sections used in this work as part of a previously published work. B.N.C. has patents on the use of adenosine A<INF>2A</INF> receptor agonists for the promotion of bone growth and regeneration. B.N.C. has a grant from AstraZeneca. B.N.C. has consulted for Eli Lilly & Co. and AstraZeneca. B.N.C. has significant equity in Regenosine and CanFite Biopharmaceuticals and lesser equity in Amgen, Novartis, Baxter, Abbott, Gilead, and Bristol-Myers, Squibb. The remaining authors declare no conflicts of interest.	Ahmad A, 2013, BIOCHEM BIOPH RES CO, V434, P566, DOI 10.1016/j.bbrc.2013.03.115; Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Gervitz LM, 2002, NEUROSCI LETT, V328, P175, DOI 10.1016/S0304-3940(02)00495-0; Goretsky T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18421-8; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mediero A, 2018, FASEB J, V32, P3487, DOI 10.1096/fj.201700217R; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Perez-Aso M, 2014, FASEB J, V28, P802, DOI 10.1096/fj.13-241646; Regard JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007997; Shaikh G, 2016, BRIT J PHARMACOL, V173, P3279, DOI 10.1111/bph.13615; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Takasuga S, 1999, J BIOL CHEM, V274, P19545, DOI 10.1074/jbc.274.28.19545; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Vincenzi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065561; Wang DW, 2015, CELL PHYSIOL BIOCHEM, V36, P1563, DOI 10.1159/000430319; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Zhang BC, 2011, BBA-MOL CELL RES, V1813, P73, DOI 10.1016/j.bbamcr.2010.10.001; Zhang J, 2017, AM J PATHOL, V187, P1935, DOI 10.1016/j.ajpath.2017.05.005	29	9	10	2	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7555	7562		10.1096/fj.201900014R	http://dx.doi.org/10.1096/fj.201900014R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30866652	Green Published			2022-12-26	WOS:000476114200071
J	Bottemanne, P; Paquot, A; Ameraoui, H; Alhouayek, M; Muccioli, GG				Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Alhouayek, Mireille; Muccioli, Giulio G.			The alpha/beta-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids	FASEB JOURNAL			English	Article						serine hydrolase; bioactive lipid; MAGL; prostaglandin; PGE(2)	RESPIRATORY-DISTRESS-SYNDROME; HYDROLYZING ACID AMIDASE; MACROPHAGE ACTIVATION; ABHD6; LIPOPOLYSACCHARIDE; RESPONSES; BLOCKADE	Lung inflammation plays a crucial role in the pathogenesis of many respiratory diseases that are in need of new therapeutic strategies. Previously, we showed that inhibition of alpha/beta-hydrolase domain 6 (ABHD6) decreased macrophage activation and exerted anti-inflammatory effects. Therefore, we thought to assess the effects of ABHD6 inhibition in a mouse model of acute lung injury (ALI) induced by intratracheal administration of lipopolysaccharides. ABHD6 inhibition with N-methyl-N-{[3-(4-pyridinyl)phenyl]methyl}-carbamic acid 4 '-(aminocarbonyl)(1,1 '-biphenyl)-4-yl ester (WWL70) decreases most of the hallmarks of ALI, including neutrophil infiltration, cytokine secretion, and protein extravasation. mRNA expression of proinflammatory markers in the cells recovered in the bronchoalveolar lavage was also decreased. Interestingly, ABHD6 inhibition was more efficient than monoacylglycerol lipase inhibition by 4-nitrophenyl-4-[dibenzo(d)(14)dioxol-5-yl(hydroxy)methyl]piperidine-1-carboxylate. We also studied ABHD6 inhibition on primary alveolar macrophages and neutrophils to explore their potential implication in the effects of ABHD6 inhibition in vivo. Moreover, we quantified by high-performance liquid chromatography-mass spectrometry the levels of reported substrates of ABHD6 [i.e., 2-arachidonoylglycerol (2-AG) and lysophospholipids]. The potential implication of these lipid mediators in the effects of WWL70 was further investigated on primary alveolar macrophages. Taken together, these data support ABHD6 inhibition as an interesting anti-inflammatory strategy in acute lung inflammation and assess the possible contribution of 2-AG and lysophospholipids in the observed effects.-Bottemanne, P., Paquot, A., Ameraoui, H., Alhouayek, M., Muccioli, G. G. The alpha/beta-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids.	[Bottemanne, Pauline; Paquot, Adrien; Ameraoui, Hafsa; Alhouayek, Mireille; Muccioli, Giulio G.] UCLouvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Av E Mounier 72,B1-72-01, B-1200 Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG (corresponding author), UCLouvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Av E Mounier 72,B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	; Alhouayek, Mireille/R-5058-2018	Muccioli, Giulio/0000-0002-1600-9259; Alhouayek, Mireille/0000-0002-9193-0718; Bottemanne, Pauline/0000-0003-0414-4127	Fonds de la Recherche Scientifique (FRS-FNRS; Brussels, Belgium); Fonds Speciaux de Recherches (FSR; UCLouvain); FRS-FNRS [PDR T.0148.14, CDR J.0084.18]; FSR	Fonds de la Recherche Scientifique (FRS-FNRS; Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherches (FSR; UCLouvain); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); FSR	The authors thank H.P. Patil and C. Loira-Pastoriza from Dr. R. Vanbever's laboratory [Universite Catholique de Louvain (UCLouvain)] for helpful discussions related to the mouse model, Dr. L. Dumoutier's laboratory (UCLouvain) for access to cytospin, and Dr. V. Mutemberezi (UCLouvain) for help with lipid quantification. The Mass Spectrometry of Metabolites (MASSMET) platform (UCLouvain) is acknowledged for access to the LC-MS. G.G.M. is the recipient of grants from the Fonds de la Recherche Scientifique (FRS-FNRS; Brussels, Belgium) and from the Fonds Speciaux de Recherches (FSR; UCLouvain). P.B. is a research fellow of the Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA; Brussels, Belgium). M.A. is a postdoctoral fellow from the FRS-FNRS. G.G.M. is the recipient of grants from the FRS-FNRS (PDR T.0148.14, CDR J.0084.18) and from the FSR. The authors declare no conflicts of interest.	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Alhouayek M, 2018, FASEB J, V32, P5000, DOI 10.1096/fj.201701205R; Alhouayek M, 2018, TRENDS PHARMACOL SCI, V39, P586, DOI 10.1016/j.tips.2018.02.011; Alhouayek M, 2017, BBA-MOL CELL BIOL L, V1862, P474, DOI 10.1016/j.bbalip.2017.01.001; Alhouayek M, 2015, FASEB J, V29, P650, DOI 10.1096/fj.14-255208; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P295, DOI 10.1016/j.drudis.2013.07.009; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Balenga NAB, 2011, CELL RES, V21, P1452, DOI 10.1038/cr.2011.60; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; De Berdt P, 2018, CELL MOL LIFE SCI, V75, P2843, DOI 10.1007/s00018-018-2764-5; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Hsu KL, 2013, J MED CHEM, V56, P8270, DOI 10.1021/jm400899c; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marrs WR, 2011, J BIOL CHEM, V286, P28723, DOI 10.1074/jbc.M110.202853; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Masquelier J, 2018, BBA-MOL CELL BIOL L, V1863, P1458, DOI 10.1016/j.bbalip.2018.09.003; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mutemberezi V, 2016, ANAL BIOANAL CHEM, V408, P733, DOI 10.1007/s00216-015-9150-z; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Hung ND, 2011, LIPIDS, V46, P893, DOI 10.1007/s11745-011-3589-2; Pribasnig MA, 2015, J BIOL CHEM, V290, P29869, DOI 10.1074/jbc.M115.669168; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shim JW, 2009, EXP MOL MED, V41, P584, DOI 10.3858/emm.2009.41.8.064; Swamydas M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7718; Tanaka M, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0783-4; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Vernooy JHJ, 2001, AM J RESP CELL MOL, V24, P569, DOI 10.1165/ajrcmb.24.5.4156; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	42	13	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7635	7646		10.1096/fj.201802259R	http://dx.doi.org/10.1096/fj.201802259R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30896979	Bronze			2022-12-26	WOS:000476114200078
J	Kusuyama, J; Amir, MS; Albertson, BG; Bandow, K; Ohnishi, T; Nakamura, T; Noguchi, K; Shima, K; Semba, I; Matsuguchi, T				Kusuyama, Joji; Amir, Muhammad Subhan; Albertson, Brent G.; Bandow, Kenjiro; Ohnishi, Tomokazu; Nakamura, Toshiaki; Noguchi, Kazuyuki; Shima, Kaori; Semba, Ichiro; Matsuguchi, Tetsuya			JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4)	FASEB JOURNAL			English	Article						osteogenesis; osteocalcin; DUSP16; Gpha1; Esm1	MESENCHYMAL STEM; BONE SIALOPROTEIN; ACTIVATION; PROTEIN; OSTEOCALCIN; PHOSPHORYLATION; MINERALIZATION; PHOSPHATASE; METASTASIS; MECHANISMS	Osteoblasts are versatile cells involved in multiple whole-body processes, including bone formation and immune response. Secretory amounts and patterns of osteoblast-derived proteins such as osteopontin (OPN) and osteocalcin (OCN) modulate osteoblast function. However, the regulatory mechanism of OPN and OCN expression remains unknown. Here, we demonstrate that p54/p46 c-jun N-terminal kinase (JNK) inhibition suppresses matrix mineralization and OCN expression but increases OPN expression in MC3T3-E1 cells and primary osteoblasts treated with differentiation inducers, including ascorbic acid, bone morphogenic protein-2, or fibroblast growth factor 2. Preinhibition of JNK before the onset of differentiation increased the number of osteoblasts that highly express OPN but not OCN (OPN-OBs), indicating that JNK affects OPN secretory phenotype at the early stage of osteogenic differentiation. Additionally, we identified JNK2 isoform as being critically involved in OPN-OB differentiation. Microarray analysis revealed that OPN-OBs express characteristic transcription factors, cell surface markers, and cytokines, including glycoprotein hormone alpha 2 and endothelial cell-specific molecule 1. Moreover, we found that inhibitor of DNA binding 4 is an important regulator of OPN-OB differentiation and that dual-specificity phosphatase 16, a JNK-specific phosphatase, functions as an endogenous regulator of OPN-OB induction. OPN-OB phenotype was also observed following LPS from Porphyromonas gingivalis stimulation during osteogenic differentiation. Collectively, these results suggest that the JNK-Id4 signaling axis is crucial in the control of OPN and OCN expression during osteoblastic differentiation.-Kusuyama, J., Amir, M. S., Albertson, B. G., Bandow, K., Ohnishi, T., Nakamura, T., Noguchi, K., Shima, K., Semba, I., Matsuguchi, T. JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).	[Kusuyama, Joji; Amir, Muhammad Subhan; Ohnishi, Tomokazu; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Dev Med, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan; [Amir, Muhammad Subhan] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Kagoshima, Japan; [Nakamura, Toshiaki; Noguchi, Kazuyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Periodontol, Field Oral & Maxillofacial Rehabil, Kagoshima, Japan; [Shima, Kaori; Semba, Ichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Field Oncol, Kagoshima, Japan; [Albertson, Brent G.] Harvard Med Sch, Dept Med, Sect Integrat Physiol & Metab, Joslin Diabet Ctr, Boston, MA 02115 USA; [Amir, Muhammad Subhan] Airlangga Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Surabaya, Indonesia; [Bandow, Kenjiro] Meikai Univ, Dept Oral Biol & Tissue Engn, Sch Dent, Saitama, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Airlangga University; Meikai University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Dev Med, Dept Oral Biochem, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Amir, Muhammad Subhan/AAD-3006-2021; Matsuguchi, Tetsuya/HGU-0412-2022; Kusuyama, Joji/AAQ-7547-2020	Amir, Muhammad Subhan/0000-0002-0522-9758; Kusuyama, Joji/0000-0003-4054-1939; Bandow, Kenjiro/0000-0002-1362-3034; Semba, Ichiro/0000-0002-4588-2380	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Association for Oral Biology; Kanzawa Medical Research Foundation; Nakatomi Foundation; Japan Foundation for Aging and Health	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Association for Oral Biology; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Nakatomi Foundation; Japan Foundation for Aging and Health	The authors thank Yoko Amita and Yuka Kajiya (both from the Kagoshima University Graduate School of Medical and Dental Science) for secretarial assistance. This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japanese Association for Oral Biology Grant-in-Aid for Young Scientists, the Kanzawa Medical Research Foundation, the Nakatomi Foundation, and the Japan Foundation for Aging and Health. The authors declare no conflicts of interest.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Asou Y, 2001, ENDOCRINOLOGY, V142, P1325, DOI 10.1210/en.142.3.1325; Bandow K, 2010, BIOCHEM BIOPH RES CO, V402, P755, DOI 10.1016/j.bbrc.2010.10.103; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kanazawa I, 2015, WORLD J DIABETES, V6, P1345, DOI 10.4239/wjd.v6.i18.1345; Kanbur Nuray O, 2002, Int J Adolesc Med Health, V14, P235; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kido J, 2001, J PERIODONTAL RES, V36, P328, DOI 10.1034/j.1600-0765.2001.360509.x; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kruger TE, 2014, CRIT REV ONCOL HEMAT, V89, P330, DOI 10.1016/j.critrevonc.2013.08.013; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Kusuyama J, 2017, BIOCHEM J, V474, P3421, DOI 10.1042/BCJ20170332; Kusuyama J, 2017, MOL BIOL CELL, V28, P1326, DOI 10.1091/mbc.E16-10-0716; Kusuyama J, 2014, J BIOL CHEM, V289, P10330, DOI 10.1074/jbc.M113.546382; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Matsuguchi T, 2001, MOL CELL BIOL, V21, P6999, DOI 10.1128/MCB.21.20.6999-7009.2001; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mizokami A, 2017, BIOCHEM PHARMACOL, V132, P1, DOI 10.1016/j.bcp.2017.02.001; Musikacharoen T, 2003, J BIOL CHEM, V278, P9167, DOI 10.1074/jbc.M211829200; Musikacharoen T, 2011, J BIOL CHEM, V286, P24896, DOI 10.1074/jbc.M111.245019; Nakao J, 2014, BONE, V58, P17, DOI 10.1016/j.bone.2013.09.018; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Patel D, 2015, BBA-REV CANCER, V1855, P92, DOI 10.1016/j.bbcan.2014.12.002; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Sathi GA, 2009, ORAL ONCOL, V45, P856, DOI 10.1016/j.oraloncology.2009.02.001; Shah M, 2015, EUR CELLS MATER, V29, P155, DOI 10.22203/eCM.v029a12; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Suzuki D, 2012, CALCIFIED TISSUE INT, V91, P88, DOI 10.1007/s00223-012-9614-5; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tangseefa P, 2018, J CELL PHYSIOL, V233, P3769, DOI 10.1002/jcp.26163; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Terashima A, 2016, IMMUNITY, V44, P1434, DOI 10.1016/j.immuni.2016.05.012; Tokuzawa Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001019; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xu R, 2017, J BONE MINER RES, V32, P1811, DOI 10.1002/jbmr.3184; Zhang Y, 2008, J CELL BIOCHEM, V105, P487, DOI 10.1002/jcb.21844	48	10	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7331	7347		10.1096/fj.201802465R	http://dx.doi.org/10.1096/fj.201802465R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884976	Bronze			2022-12-26	WOS:000476114200054
J	Li, T; Shen, YF; Lin, FX; Fu, WY; Liu, SW; Wang, CQ; Liang, JZ; Fan, XY; Ye, XT; Tang, Y; Ding, M; Yang, YJ; Lei, CH; Hu, S				Li, Tian; Shen, Yafeng; Lin, Fangxing; Fu, Wenyan; Liu, Shuowu; Wang, Chuqi; Liang, Jizhou; Fan, Xiaoyan; Ye, Xuting; Tang, Ying; Ding, Min; Yang, Yongji; Lei, Changhai; Hu, Shi			Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats	FASEB JOURNAL			English	Article						gene therapy; heart failure; AAV; intracellular antibody	CHANNEL RYANODINE RECEPTOR; RETICULUM CA2+ LEAK; HEART-FAILURE; PKA PHOSPHORYLATION; GENE-THERAPY; SERINE 2808; RELEASE; HYPERPHOSPHORYLATION; CONSTRUCTION; LIBRARY	Chronic PKA phosphorylation of ryanodine receptor 2 (RyR2) has been shown to increase diastolic sarcoplasmic reticulum (SR) Ca2+ leakage and lead to cardiac dysfunction. We hypothesize that intracellular gene delivery of an RyR2-targeting phosphorylation site-specific nanobody could preserve the contractility of the failing myocardium. In the present study, we acquired RyR2-specific nanobodies from a phage display library that were variable domains of Camelidae heavy chain-only antibodies. One of the nanobodies, AR185, inhibited RyR2 phosphorylation in vitro and was chosen for further investigation. We investigated the potential of adeno-associated virus (AAV)9-mediated cardiac expression of AR185 to combat postischemic heart failure (HF). AAV gene delivery elevated the intracellular expression of the AR185 protein in a rat model of ischemic HF, and this treatment normalized the systolic and diastolic dysfunction of the failing myocardium in vivo by reversing myocardial Ca2+ handling. Furthermore, AR185 gene transfer to failing cardiomyocytes reduced the frequency of SR calcium leaks, thereby restoring the attenuated intracellular calcium transients and SR calcium load. Moreover, AR185 gene transfer inhibited the PKA-mediated phosphorylation of RyR2 in failing cardiomyocytes. Our results provide preclinical experimental evidence that the cardiac expression of RyR2 nanobodies with AAV9 vectors is a promising therapeutic strategy for HF.-Li, T., Shen, Y., Lin, F., Fu, W., Liu, S., Wang, C., Liang, J., Fan, X., Ye, X., Tang, Y., Ding, M., Yang, Y., Lei, C., Hu, S. Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in rats.	[Li, Tian; Shen, Yafeng; Lin, Fangxing; Fan, Xiaoyan; Ye, Xuting; Tang, Ying; Yang, Yongji; Lei, Changhai; Hu, Shi] Second Mil Med Univ, Coll Basic Med Sci, Dept Biophys, Shanghai, Peoples R China; [Li, Tian; Liu, Shuowu; Wang, Chuqi; Liang, Jizhou; Lei, Changhai; Hu, Shi] Second Mil Med Univ, Dept Biophys, Team SMMU China Int Genetically Engn Machine iGEM, Shanghai, Peoples R China; [Fu, Wenyan] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Obstet & Gynecol, Sch Med, Shanghai, Peoples R China; [Ding, Min] Pharchoice Therapeut Inc, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Tongji University	Lei, CH; Hu, S (corresponding author), Second Mil Med Univ, Dept Biophys, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	lei@smmu.edu.cn; hus@smmu.edu.cn	Hu, Shi/ABF-4231-2020		National Natural Science Foundation of China [81773261, 81602690]; Shanghai Chenguang Program [17CG35]; Military Medicine Special Grant from the Second Military Medical University [2017JS01]; General Financial Grant from the China Postdoctoral Science Foundation [2016M593006]; Shanghai First Maternity and Infant Hospital [2018A01]; Second Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Chenguang Program; Military Medicine Special Grant from the Second Military Medical University; General Financial Grant from the China Postdoctoral Science Foundation; Shanghai First Maternity and Infant Hospital; Second Military Medical University	The authors thank Y. Bao and Z. Zou (Second Military Medical University) for generous help with the research. This study was financially supported by the National Natural Science Foundation of China (Grants 81773261 and 81602690), the Shanghai Chenguang Program (17CG35), a Military Medicine Special Grant from the Second Military Medical University (2017JS01), a General Financial Grant from the China Postdoctoral Science Foundation (2016M593006), Shanghai First Maternity and Infant Hospital (Grant 2018A01), and postdoctoral scientific research funds from Second Military Medical University. M.D. is employed by Pharchoice Therapeutics and is a shareholder in Pharchoice Therapeutics. The remaining authors declare no conflicts of interest.	Chen WW, 2016, EUR HEART J SUPPL, V18, pF2, DOI 10.1093/eurheartj/suw030; Chen WZ, 2008, J MOL BIOL, V382, P779, DOI 10.1016/j.jmb.2008.07.054; Cho GW, 2016, BBA-MOL BASIS DIS, V1862, P763, DOI 10.1016/j.bbadis.2016.01.011; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Goehringer C, 2009, CARDIOVASC RES, V82, P404, DOI 10.1093/cvr/cvp061; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Ho Mitchell, 2009, V525, P293, DOI 10.1007/978-1-59745-554-1_15; Houser SR, 2014, CIRC RES, V114, P1320, DOI 10.1161/CIRCRESAHA.114.300569; Hu ST, 2016, PHYSIOL RES, V65, P43, DOI 10.33549/physiolres.933052; Hu S, 2016, CANCER LETT, V382, P32, DOI 10.1016/j.canlet.2016.08.022; Hulot JS, 2016, EUR HEART J, V37, P1651, DOI 10.1093/eurheartj/ehw019; Khodabakhsh F, 2018, INT REV IMMUNOL, V37, P316, DOI 10.1080/08830185.2018.1526932; Li T, 2018, J DRUG TARGET, V26, P895, DOI 10.1080/1061186X.2018.1450412; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mika D, 2015, P NATL ACAD SCI USA, V112, P2023, DOI 10.1073/pnas.1419992112; Munkvik M, 2010, MED SCI SPORT EXER, V42, P847, DOI 10.1249/MSS.0b013e3181c29ec1; Paulino EC, 2010, HYPERTENSION, V56, P629, DOI 10.1161/HYPERTENSIONAHA.110.156141; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Peyvandi F, 2017, J THROMB HAEMOST, V15, P1448, DOI 10.1111/jth.13716; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Roussel J, 2015, BBA-MOL BASIS DIS, V1852, P749, DOI 10.1016/j.bbadis.2015.01.011; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Steeland S, 2016, DRUG DISCOV TODAY, V21, P1076, DOI 10.1016/j.drudis.2016.04.003; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Vincke Cecile, 2012, Methods Mol Biol, V907, P145, DOI 10.1007/978-1-61779-974-7_8; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yancy CW, 2016, J AM COLL CARDIOL, V68, P1495, DOI 10.1016/j.jacc.2016.08.013; Zhang HY, 2012, CIRC RES, V110, P831, DOI 10.1161/CIRCRESAHA.111.255158; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	37	4	4	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7467	7478		10.1096/fj.201802354R	http://dx.doi.org/10.1096/fj.201802354R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30885011	Bronze, Green Submitted			2022-12-26	WOS:000476114200064
J	Pickard, A; Chang, J; Alachkar, N; Calverley, B; Garva, R; Arvan, P; Meng, QJ; Kadler, KE				Pickard, Adam; Chang, Joan; Alachkar, Nissrin; Calverley, Ben; Garva, Richa; Arvan, Peter; Meng, Qing-Jun; Kadler, Karl E.			Preservation of circadian rhythms by the protein folding chaperone, BiP	FASEB JOURNAL			English	Article						4PBA; collagen; ER stress; Per2; luc; UDCA	ENDOPLASMIC-RETICULUM STRESS; COLLAGEN-I; ER STRESS; CLOCK; MOUSE; PROLIFERATION; DEXAMETHASONE; EXPRESSION; SECRETION; REVEALS	Dysregulation of collagen synthesis is associated with disease progression in cancer and fibrosis. Collagen synthesis is coordinated with the circadian clock, which in cancer cells is, curiously, deregulated by endoplasmic reticulum (ER) stress. We hypothesized interplay between circadian rhythm, collagen synthesis, and ER stress in normal cells. Here we show that fibroblasts with ER stress lack circadian rhythms in gene expression upon clock-synchronizing time cues. Overexpression of binding immunoglobulin protein (BiP) or treatment with chemical chaperones strengthens the oscillation amplitude of circadian rhythms. The significance of these findings was explored in tendon, where we showed that BiP expression is ramped preemptively prior to a surge in collagen synthesis at night, thereby preventing protein misfolding and ER stress. In turn, this forestalls activation of the unfolded protein response in order for circadian rhythms to be maintained. Thus, targeting ER stress could be used to modulate circadian rhythm and restore collagen homeostasis in disease.-Pickard, A., Chang, J., Alachkar, N., Calverley, B., Garva, R., Arvan, P., Meng, Q.-J., Kadler, K. E. Preservation of circadian rhythms by the protein folding chaperone, BiP.	[Pickard, Adam; Chang, Joan; Alachkar, Nissrin; Calverley, Ben; Garva, Richa; Meng, Qing-Jun; Kadler, Karl E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Alachkar, Nissrin; Calverley, Ben] Univ Manchester, Fac Sci & Engn, Sch Math, Manchester, Lancs, England; [Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA	University of Manchester; University of Manchester; University of Michigan System; University of Michigan	Pickard, A; Kadler, KE (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	adam.pickard@manchester.ac.uk; karl.kadler@manchester.ac.uk	KADLER, KARL/ABI-2403-2020; Chang, Joan/AAO-8732-2020	KADLER, KARL/0000-0003-4977-4683; Chang, Joan/0000-0002-7283-9759; GARVA, RICHA/0000-0001-7752-8936; Meng, Qing Jun/0000-0002-9426-8336	Wellcome Trust Investigator and Wellcome Centre Core Awards [110126/Z/15/Z, 203128/Z/16/Z]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK40344]; Wellcome 4-yr Ph.D. Studentship [210062/Z/17/Z]; University of Manchester Strategic Fund; MRC [G0900414, MR/L011840/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Wellcome Trust Investigator and Wellcome Centre Core Awards; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome 4-yr Ph.D. Studentship; University of Manchester Strategic Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank P.A. and Raymond Boot-Handford (University of Michigan, Ann Arbor, MI, USA and University of Manchester, Manchester, United Kingdom, respectively) for congenital goiter-mutant thyroglobulin expression vectors. This research was funded by Wellcome Trust Investigator and Wellcome Centre Core Awards to K.E.K. (110126/Z/15/Z and 203128/Z/16/Z). P.A. was funded by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK40344. B.C. is funded by a Wellcome 4-yr Ph.D. Studentship (210062/Z/17/Z). Light microscopes in the Bioimaging Facility were additionally supported by the University of Manchester Strategic Fund. The authors declare no conflicts of interest.	Alvarez MB, 2012, J CELL PHYSIOL, V227, P1873, DOI 10.1002/jcp.22915; Barnett CP, 2011, EUR J HUM GENET, V19, P624, DOI 10.1038/ejhg.2010.259; Bek MF, 2006, AM J PATHOL, V168, P20, DOI 10.2353/ajpath.2006.040774; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brenner RE, 2001, PEDIATR PULM, V32, P1, DOI 10.1002/ppul.1081; Bu YW, 2018, NAT CELL BIOL, V20, P104, DOI 10.1038/s41556-017-0006-y; Cancino J, 2014, DEV CELL, V30, P280, DOI 10.1016/j.devcel.2014.06.018; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; DiChiara AS, 2016, ACS CHEM BIOL, V11, P1408, DOI 10.1021/acschembio.5b01083; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Hwang J, 2017, ACS NANO, V11, P9825, DOI 10.1021/acsnano.7b03150; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Janich P, 2015, GENOME RES, V25, P1848, DOI 10.1101/gr.195404.115; Kadler KE, 1996, BIOCHEM J, V316, P1; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Koo JH, 2016, GASTROENTEROLOGY, V150, P181, DOI 10.1053/j.gastro.2015.09.039; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Maillo C, 2017, NAT CELL BIOL, V19, P94, DOI 10.1038/ncb3461; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Markan S, 2009, MOL CELL BIOCHEM, V324, P131, DOI 10.1007/s11010-008-9991-2; Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pickard A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004988; Pickard A, 2012, J INVEST DERMATOL, V132, P2691, DOI 10.1038/jid.2012.201; Pratt ZL, 2012, J VIROL, V86, P4380, DOI 10.1128/JVI.06966-11; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Shim SM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan0630; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yeung C.-Y. C., 2018, 304014 BIORXIV, DOI 10.1101/304014v2; Yeung CYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13555; Yeung CYC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05183; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	42	15	15	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7479	7489		10.1096/fj.201802366RR	http://dx.doi.org/10.1096/fj.201802366RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30888851	hybrid, Green Published			2022-12-26	WOS:000476114200065
J	Kruppert, S; Deussen, L; Weiss, LC; Horstmann, M; Wolff, JO; Kleinteich, T; Gorb, SN; Tollrian, R				Kruppert, Sebastian; Deussen, Lisa; Weiss, Linda C.; Horstmann, Martin; Wolff, Jonas O.; Kleinteich, Thomas; Gorb, Stanislav N.; Tollrian, Ralph			Zooplankters' nightmare: The fast and efficient catching basket of larval phantom midges (Diptera: Chaoborus)	PLOS ONE			English	Article							DAPHNIA-PULEX; PREY CAPTURE; SWIMMING BEHAVIOR; PREDATION; CRYSTALLINUS; EVOLUTION; ECOLOGY; STRIKE; SIZE	Filter feeding zooplankton are a crucial component of limnic food webs. Copepods and cladocerans are important prey organisms for first-level predators like the common and abundant larvae of phantom midges (Chaoborus sp.). The latter possess a complex catching basket built of head appendages specialized to capture small crustaceans. The predatorprey- relationship of Chaoborus (Diptera, Nematocera) and Daphnia (Crustacea, Cladocera) has been studied in particular detail owing to the daphniids' ability to react upon the threat of predation with inducible defenses. Daphnia pulex expresses so-called ` neckteeth' in the presence of Chaoborus larvae that are discussed as a defensive trait that interferes with the larval head appendages and their effectiveness has been shown in several studies. Nonetheless, mode of function of these neckteeth is not understood and the hypothesis that they interfere with the predator's head appendages still has to be confirmed. To clarify the role of neckteeth in Daphnia, an understanding of the Chaoborus capture apparatus is essential. Here, we present a detailed three-dimensional analysis of Chaoborus obscuripes' larval head morphology as well as a kinematic analysis of the attack motion, which revealed an impressive strike velocity (14 ms to prey contact). The movement of the larvae's head appendages is reconstructed in the three-dimensional space using a combination of high-speed videography, micro-computed tomography and computer animation. Furthermore, we provide predation trial data to distinguish between pre-and post-attack defensive effects in D. pulex. Our findings suggest a combination of pre-and post-attack defenses with an average effectiveness of 50% each. With this study, we quantitatively describe prey capture kinematics of C. obscuripes and take a further step to reveal the neckteeth' mode of function in D. pulex.	[Kruppert, Sebastian; Deussen, Lisa; Weiss, Linda C.; Horstmann, Martin; Tollrian, Ralph] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Wolff, Jonas O.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Wolff, Jonas O.; Kleinteich, Thomas; Gorb, Stanislav N.] Dept Funct Morphol & Biomech, Kiel, Germany	Ruhr University Bochum; Macquarie University	Kruppert, S (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany.	sebastian.kruppert@rub.de	Kruppert, Sebastian/AAJ-8746-2020; Horstmann, Martin/AAW-1145-2021	Kruppert, Sebastian/0000-0001-5932-8455; Horstmann, Martin/0000-0002-0355-3212; Wolff, Jonas/0000-0003-2326-0326; Weiss, Linda C./0000-0002-7737-5017				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BAUER T, 1991, ANIM BEHAV, V41, P819, DOI 10.1016/S0003-3472(05)80349-5; BURROWS M, 1969, Z VERGL PHYSIOL, V62, P361, DOI 10.1007/BF00299261; Buskey EJ, 2002, MAR ECOL PROG SER, V235, P135, DOI 10.3354/meps235135; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Garwood R, 2014, J PALEONTOL, V88, P735, DOI 10.1666/13-088; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; GRONENBERG W, 1993, SCIENCE, V262, P561, DOI 10.1126/science.262.5133.561; HAVEL JE, 1984, LIMNOL OCEANOGR, V29, P487, DOI 10.4319/lo.1984.29.3.0487; HEBERT PDN, 1985, LIMNOL OCEANOGR, V30, P1291, DOI 10.4319/lo.1985.30.6.1291; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Laforsch C, 2000, ARCH HYDROBIOL, V149, P587; MALDONADO H, 1967, Z VERGL PHYSIOL, V56, P237, DOI 10.1007/BF00333669; MELZER RR, 1994, INT J INSECT MORPHOL, V23, P261, DOI 10.1016/0020-7322(94)90023-X; MORT MA, 1986, HYDROBIOLOGIA, V133, P39, DOI 10.1007/BF00010800; O'Keefe TC, 1998, J PLANKTON RES, V20, P973; PAREJKO K, 1991, EVOLUTION, V45, P1665, DOI 10.1111/j.1558-5646.1991.tb02671.x; Parma S, 1969, SIL P, V17, P888; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Poppinga S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01954-3; R Core Team, 2018, R LANG ENV STAT COMP; REPKA S, 1995, J PLANKTON RES, V17, P393, DOI 10.1093/plankt/17.2.393; RIESSEN HP, 1984, ECOLOGY, V65, P514, DOI 10.2307/1941413; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHREMMER FR, 1950, OESTERREICH ZOOL ZEISCHR, V2, P471; Spitze K, 1996, AM NAT, V148, pS108, DOI 10.1086/285905; SWIFT MC, 1975, LIMNOL OCEANOGR, V20, P418, DOI 10.4319/lo.1975.20.3.0418; SWIFT MC, 1981, LIMNOL OCEANOGR, V26, P461, DOI 10.4319/lo.1981.26.3.0461; TERAGUCHI S, 1975, J INSECT PHYSIOL, V21, P1659, DOI 10.1016/0022-1910(75)90176-6; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P177; TOLLRIAN R, 1995, OECOLOGIA, V101, P151, DOI 10.1007/BF00317278; VONENDE CN, 1979, ECOLOGY, V60, P119, DOI 10.2307/1936474; Weber A, 2002, J PLANKTON RES, V24, P1335, DOI 10.1093/plankt/24.12.1335; Weiss L, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P111; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wohlfrom H, 2001, DEV GENES EVOL, V211, P124, DOI 10.1007/s004270000127; Wolff JO, 2016, ORG DIVERS EVOL, V16, P549, DOI 10.1007/s13127-016-0278-2; Wood HM, 2016, CURR BIOL, V26, P1057, DOI 10.1016/j.cub.2016.02.029	39	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214013	10.1371/journal.pone.0214013	http://dx.doi.org/10.1371/journal.pone.0214013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901351	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400031
J	Pretorius, ME; Seoraj-Pillai, N; Pillay, N				Pretorius, Mariette E.; Seoraj-Pillai, Nimmi; Pillay, Neville			Landscape correlates of space use in the critically endangered African wild dog Lycaon pictus	PLOS ONE			English	Article							LIVESTOCK PREDATION; NATIONAL-PARK; CONSERVATION; POPULATION; SELECTION; ECOLOGY; ROADS; REQUIREMENTS; MOVEMENT; DYNAMICS	Human-carnivore conflict can threaten human life and livelihoods, leading to retaliation that negatively affects carnivore conservation. The endangered African wild dog Lycaon pictus is prone to human-carnivore conflict. Therefore, it is imperative to understand which landscape features are associated with African wild dog occurrence since selection or avoidance of these features could predict the levels of conflict. We investigated resource selection in the African wild dog in relation to four anthropogenic landscape features (livestock density, agriculture, roads and human land use) within the landscape that may pose a mortality risk, as well as one natural feature (nature reserves). We compared spatio-temporal space use patterns of four African wild dog packs in north-eastern South Africa. Data were collected from one collared individual per pack. These packs constituted approximately 10% of the total remaining African wild dog population in South Africa. Two packs occurred outside of the Kruger National Park and had access to multiple areas with farmland and other anthropogenic features, whereas the remaining two packs mainly occurred within the boundaries of the Kruger National Park but made occasional forays outside of park boundaries. Utilising Resource Selection Functions and GIS analyses, we found that agricultural landscape features, roads and nature reserves were important predictors of African wild dog occurrence for all four packs. In addition to potential conflict with farmers, high odds of occurrence on roads with fast-moving traffic and road mortality was highlighted as a concern for three of the packs. While farms and areas that house livestock were readily available, pack presence occurred in areas with few farms and low livestock densities, pointing to avoidance of areas where human-carnivore conflict and resulting mortality could occur. Our study highlights potential threats to the persistence of the African wild dog, which can be used to inform future conservation efforts of the species.	[Pretorius, Mariette E.; Seoraj-Pillai, Nimmi; Pillay, Neville] Univ Witwatersrand, Sch Anim Plants & Environm Sci, Johannesburg, South Africa; [Seoraj-Pillai, Nimmi] Tshwane Univ Technol, Dept Nat Conservat, Pretoria, South Africa	University of Witwatersrand; Tshwane University of Technology	Pretorius, ME (corresponding author), Univ Witwatersrand, Sch Anim Plants & Environm Sci, Johannesburg, South Africa.	mariette.pretorius@africanbats.org	Pretorius, Mariette/GQB-3924-2022	Pillay, Neville/0000-0002-0778-726X; Pretorius, Mariette/0000-0002-4821-1013	National Research Foundation (Thuthuka programme) [TTK20110815000024620]; Department of Higher Education and Training, South Africa	National Research Foundation (Thuthuka programme); Department of Higher Education and Training, South Africa	Please note that funding for this study was provided by the National Research Foundation (Thuthuka programme, grant number: TTK20110815000024620) URL: http://www.nrf.ac.za/content/thuthuka-2018 and the Department of Higher Education and Training, South Africa.	Abrahms B, 2016, ANIM CONSERV, V19, P247, DOI 10.1111/acv.12235; Anthony B.P., 2010, CONSERV SOC, V8, P225, DOI DOI 10.4103/0972-4923.73812; Atwood TC, 2012, USDA NATL WILDLIFE R, P1; Beyer HL, 2001, GEOSPATIAL MODELLING; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Braack LE, 2006, KRUGER NATL PARK; Breuer T., 2002, DISTRIBUTION F UNPUB; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carlino GA, 2007, J URBAN ECON, V61, P389, DOI 10.1016/j.jue.2006.08.003; Chirima George J., 2012, Koedoe, V54, P24; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Collinson W, 2015, HANDBOOK OF ROAD ECOLOGY, P439; Creel S, 1997, BEHAV ECOL, V8, P298, DOI 10.1093/beheco/8.3.298; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Creel S., 2002, AFRICAN WILD DOG BEH; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; Davies-Mostert HT, 2016, RED LIST MAMMALS S A; De Klerk A., 2003, THESIS; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dubin M., 2011, DK EYEWITNESS TRAVEL; Fahrig L, 2009, ECOL SOC, V14; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; Ferguson K, FENCING CONSERVATION; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Jackson CR, 2016, LANDSCAPE ECOL, V31, P1433, DOI 10.1007/s10980-016-0342-5; Jori F, 2011, PREV VET MED, V100, P210, DOI 10.1016/j.prevetmed.2011.03.015; Kamler JF, 2012, J WILDLIFE MANAGE, V76, P1241, DOI 10.1002/jwmg.354; Kesch MK, 2015, AFR J WILDL RES, V45, P76, DOI 10.3957/056.045.0109; Kruger SC, 1999, J ZOOL, V248, P543, DOI 10.1111/j.1469-7998.1999.tb01054.x; Lindsey P, 2004, S AFR J WILDL RES, V34, P143; Lindsey PA, 2005, BIOL CONSERV, V123, P339, DOI 10.1016/j.biocon.2004.12.002; Lindsey PA, 2004, S AFR J WILDL RES, V34, P77; LIPSITZ SR, 1991, BIOMETRIKA, V78, P153; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Malan SW, 2000, SMALL RUMINANT RES, V36, P165, DOI 10.1016/S0921-4488(99)00160-1; MANLY BFJ, 2002, RESOURCE SELECTION A, P1; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Mbizah MM, 2014, BIODIVERS CONSERV, V23, P1441, DOI 10.1007/s10531-014-0675-9; MCNAUGHTON SJ, 1986, ANNU REV ECOL SYST, V17, P39, DOI 10.1146/annurev.es.17.110186.000351; Michalski F, 2006, ANIM CONSERV, V9, P179, DOI 10.1111/j.1469-1795.2006.00025.x; Ogden H., 2016, GLMMSR FIT GEN LINEA; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Parker DM, 2018, ENDANGER SPECIES RES, V36, P173, DOI 10.3354/esr00905; Pimbert MP, SOCIAL CHANGE CONSER; Pomilia MA, 2015, J MAMMAL, V96, P1214, DOI 10.1093/jmammal/gyv130; Rasmussen GSA, 1999, BIOL CONSERV, V88, P133, DOI 10.1016/S0006-3207(98)00006-8; Reist-Marti SB, 2003, CONSERV BIOL, V17, P1299, DOI 10.1046/j.1523-1739.2003.01587.x; Rhodes R, 2004, S AFR J WILDL RES, V34, P135; Robinson JG, 2004, ANIM CONSERV, V7, P397, DOI 10.1017/S1367943004001532; Rogers Kevin B., 2007, P625; RUTHERFORD MC, 2006, STRELITZIA, V19, P438; Seoraj-Pillai N., 2016, THESIS; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Shivik JA, 2000, WILDLIFE SOC B, V28, P940; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Soron Dennis, 2007, TOPIA, V18, P107; Soule M, 1994, ENV POLICY BIODIV, V35, P19; Swarner M., 2004, BRESL S NAT RES ISS, P1; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; van der Merwe P, 2014, S AFR J ECON MANAG S, V17, P379, DOI 10.4102/sajems.v17i4.439; van Dyk G, 2003, AFR ZOOL, V38, P79; Watermeyer JP, 2012, THESIS RHODES U S AF; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Whittington-Jones BM, 2014, S AFR J WILDL RES, V44, P135, DOI 10.3957/056.044.0201; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Woodroffe R, 2005, BIOL CONSERV, V124, P225, DOI 10.1016/j.biocon.2005.01.028; Woodroffe R, 2011, J ZOOL, V283, P88, DOI 10.1111/j.1469-7998.2010.00747.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Woodroffe R., 2012, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2012.RLTS.T12436A16711116.en; Woodroffe R, 2005, TOOLS CONSERVATION A	79	0	0	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0212621	10.1371/journal.pone.0212621	http://dx.doi.org/10.1371/journal.pone.0212621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901330	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400004
J	van Diggelen, F; Hrle, D; Apetri, M; Christiansen, G; Rammes, G; Tepper, A; Otzen, DE				van Diggelen, Femke; Hrle, Dean; Apetri, Mihaela; Christiansen, Gunna; Rammes, Gerhard; Tepper, Armand; Otzen, Daniel Erik			Two conformationally distinct alpha-synuclein oligomers share common epitopes and the ability to impair long-term potentiation	PLOS ONE			English	Article							ANTIPARALLEL BETA-SHEET; SYNAPTIC DYSFUNCTION; AMYLOID OLIGOMERS; SECONDARY STRUCTURE; OXIDATIVE STRESS; FATTY-ACIDS; LEWY BODY; MECHANISM; NEURONS; TRANSMISSION	Parkinson's Disease (PD) is a neurodegenerative disease for which there currently is no cure. Aggregation of the pre-synaptic protein alpha-synuclein (aSN) into oligomers (alpha SOs) is believed to play a key role in PD pathology, but little is known about alpha SO formation in vivo and how they induce neurodegeneration. Both the naturally occurring polyunsaturated fatty acid docosahexaenoic acid (DHA) and the lipid peroxidation product 4-hydroxynonenal (HNE), strongly upregulated during ROS conditions, stimulate the formation of alpha SOs, highlighting a potential role in PD. Yet, insight into alpha SOs structure and biological effects is still limited as most oligomer preparations studied to date are heterogeneous in composition. Here we have aggregated aSN in the presence of HNE and DHA and purified the alpha SOs using size exclusion chromatography. Both compounds stimulate formation of spherical alpha SOs containing anti-parallel beta-sheet structure which have the same shape as unmodified alpha SOs though ca. 2-fold larger. Furthermore, the yield and stabilities of these oligomers are significantly higher than for unmodified alpha SN. Both modified and unmodified alpha SOs permeabilize synthetic vesicles, show high co-localisation with glutamatergic synapses and decrease Long Term Potentiation (LTP), in line with the reported synaptotoxic effects of alpha SOs. We conclude that DHA- and HNE-alpha SOs are convenient models for pathogenic disease-associated alpha SOs in PD.	[van Diggelen, Femke; Otzen, Daniel Erik] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [van Diggelen, Femke; Apetri, Mihaela; Tepper, Armand] Crossbeta Biosci BV, Utrecht, Netherlands; [Hrle, Dean; Rammes, Gerhard] Tech Univ Munich, Klinikum Rechts Isar, Klin Anaesthesiol, Munich, Germany; [Christiansen, Gunna] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [van Diggelen, Femke] Ttopstart BV, Utrecht, Netherlands; [Apetri, Mihaela] UniQure, Amsterdam, Netherlands; [Tepper, Armand] Johnson & Johnson, Leiden, Netherlands	Aarhus University; Technical University of Munich; University of Munich; Aarhus University; Johnson & Johnson	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.	dao@inano.au.dk		Christiansen, Gunna/0000-0003-0540-1367	European Union's Seventh Framework Programme EUSFP within the Marie Curie-Sklodowska Initial Training Network [608041]	European Union's Seventh Framework Programme EUSFP within the Marie Curie-Sklodowska Initial Training Network	This project was funded by the European Union's Seventh Framework Programme EUSFP (grant 608041 to DEO, project acronym TOPIC (Targeting Cytotoxic Protein Oligomers)) within the Marie Curie-Sklodowska Initial Training Network. F. van Diggelen, M. Apetri and A. Tepper have been employees of Crossbeta AB but no longer work for this company. EUSFP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Crossbeta AB provided support in the form of salaries for F.v.D., M.A. and A.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Andreasen M, 2015, BBA-BIOMEMBRANES, V1848, P1897, DOI 10.1016/j.bbamem.2015.01.018; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Bae EJ, 2013, ANTIOXID REDOX SIGN, V18, P770, DOI 10.1089/ars.2011.4429; Bate C, 2015, BIOMOLECULES, V5, P178, DOI 10.3390/biom5010178; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Calo L, 2016, MOVEMENT DISORD, V31, P169, DOI 10.1002/mds.26479; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343; Diogenes MJ, 2012, J NEUROSCI, V32, P11750, DOI 10.1523/JNEUROSCI.0234-12.2012; Fecchio C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082732; Ferreira de Castro Davi, 2015, AIAA Modeling and Simulation Technologies Conference (Dallas), P1; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Giehm L, 2011, METHODS, V53, P295, DOI 10.1016/j.ymeth.2010.12.008; Gruden MA, 2015, BEHAV BRAIN RES, V279, P191, DOI 10.1016/j.bbr.2014.11.001; Gruden MA, 2014, BEHAV BRAIN RES, V263, P158, DOI 10.1016/j.bbr.2014.01.017; Hayden EY, 2015, BIOCHEMISTRY-US, V54, P4599, DOI 10.1021/acs.biochem.5b00280; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Gallea JI, 2014, J BIOL CHEM, V289, P26733, DOI 10.1074/jbc.M114.566695; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Kaufmann TJ, 2016, J PHYSIOL-LONDON, V594, P2751, DOI 10.1113/JP271968; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kovacs GG, 2014, NEUROBIOL DIS, V69, P76, DOI 10.1016/j.nbd.2014.05.020; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Lorenzen N, 2014, ESSAYS BIOCHEM, V56, P137, DOI [10.1042/BSE0560137, 10.1042/bse0560137]; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Munster-Wandowski Agnieszka, 2016, Front Synaptic Neurosci, V8, P4, DOI 10.3389/fnsyn.2016.00004; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Pacheco CR, 2015, J NEUROCHEM, V132, P731, DOI 10.1111/jnc.13060; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Paslawski W, 2016, METHODS MOL BIOL, V1345, P133, DOI 10.1007/978-1-4939-2978-8_9; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Roberts RF, 2015, BRAIN, V138, P1642, DOI 10.1093/brain/awv040; Schirinzi T, 2016, MOVEMENT DISORD, V31, P802, DOI 10.1002/mds.26620; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Stefen H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2371970; Trostchansky A, 2006, BIOCHEM J, V393, P343, DOI 10.1042/BJ20051277; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; van Diggelen F, 2017, ISR J CHEM, P1, DOI [10.1002/ijch.2016, DOI 10.1002/IJCH.2016]; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Vigneault E, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00023; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; von Coelln R, 2016, CURR OPIN NEUROL, V29, P727, DOI 10.1097/WCO.0000000000000384; Wiktorowska-Owczarek A, 2015, ADV CLIN EXP MED, V24, P931, DOI 10.17219/acem/31243; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wood S.J., 1999, BIOCHEMISTRY-US, P19509; Xiang W, 2013, MOL CELL NEUROSCI, V54, P71, DOI 10.1016/j.mcn.2013.01.004; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	69	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213663	10.1371/journal.pone.0213663	http://dx.doi.org/10.1371/journal.pone.0213663			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901378	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400014
J	Radhakrishna, U; Albayrak, S; Zafra, R; Baraa, A; Vishweswaraiah, S; Veerappa, AM; Mahishi, D; Saiyed, N; Mishra, NK; Guda, C; Ali-Fehmi, R; Bahado-Singh, RO				Radhakrishna, Uppala; Albayrak, Samet; Zafra, Rita; Baraa, Alosh; Vishweswaraiah, Sangeetha; Veerappa, Avinash M.; Mahishi, Deepthi; Saiyed, Nazia; Mishra, Nitish K.; Guda, Chittibabu; Ali-Fehmi, Rouba; Bahado-Singh, Ray O.			Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular Septal Defect (VSD)	PLOS ONE			English	Article							DNA METHYLATION; SMOOTH-MUSCLE; CORONARY-ARTERY; METROPOLITAN ATLANTA; EXPRESSION SIGNATURE; PROGENITOR CELLS; OUTFLOW TRACT; DISEASE; ASSOCIATION; PREVALENCE	Ventricular Septal Defect (VSD), the most common congenital heart defect, is characterized by a hole in the septum between the right and left ventricles. The pathogenesis of VSD is unknown in most clinical cases. There is a paucity of data relevant to epigenetic changes in VSD. The placenta is a fetal tissue crucial in cardiac development and a potentially useful surrogate for evaluating the development of heart tissue. To understand epigenetic mechanisms that may play a role in the development of VSD, genome-wide DNA methylation assay on placentas of 8 term subjects with isolated VSD and no known or suspected genetic syndromes and 10 unaffected controls was performed using the Illumina HumanMethylation450 BeadChip assay. We identified a total of 80 highly accurate potential CpGs in 80 genes for detection of VSD; area under the receiver operating characteristic curve (AUC ROC) 1.0 with significant 95% CI (FDR) p-values < 0.05 for each individual locus. The biological processes and functions for many of these differentially methylated genes are previously known to be associated with heart development or disease, including cardiac ventricle development (HEY2, ISL1), heart looping (SRF), cardiac muscle cell differentiation (ACTC1, HEY2), cardiac septum development (ISL1), heart morphogenesis (SRF, HEY2, ISL1, HEYL), Notch signaling pathway (HEY2, HEYL), cardiac chamber development (ISL1), and cardiac muscle tissue development (ACTC1, ISL1). In addition, we identified 8 microRNAs that have the potential to be biomarkers for the detection of VSD including: miR-191, miR-548F1, miR-148A, miR-423, miR-92B, miR-611, miR-2110, and miR-548H4. To our knowledge this is the first report in which placental analysis has been used for determining the pathogenesis of and predicting VSD.	[Radhakrishna, Uppala; Vishweswaraiah, Sangeetha; Bahado-Singh, Ray O.] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, Royal Oak, MI 48067 USA; [Albayrak, Samet] Wayne State Univ, Sch Med, Dept Obstet & Gynaecol, Detroit, MI USA; [Zafra, Rita] Icahn Sch Med Mt Sinai, Dept Obstet & Gynaecol, New York, NY 10029 USA; [Baraa, Alosh; Ali-Fehmi, Rouba] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Veerappa, Avinash M.; Mahishi, Deepthi] Univ Mysore, Lab Genom Sci, Dept Studies Genet & Genom, Mysore, Karnataka, India; [Saiyed, Nazia] Nirma Univ, Nirma Inst Sci, Biotechnol, Ahmadabad, Gujarat, India; [Mishra, Nitish K.; Guda, Chittibabu] Univ Nebraska, Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE 68182 USA	Oakland University; Wayne State University; Icahn School of Medicine at Mount Sinai; Wayne State University; University of Mysore; Nirma University; University of Nebraska System; University of Nebraska Medical Center	Radhakrishna, U (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, Royal Oak, MI 48067 USA.	Uppala.Radhakrishna@beaumont.edu	Mishra, Nitish/AAR-3757-2021	Vishweswaraiah, Sangeetha/0000-0001-5681-5143; Mahishi, Deepthi/0000-0002-9419-7734	Beaumont Health, Royal Oak [MI-48084]	Beaumont Health, Royal Oak	This study was supported by Beaumont Health, Royal Oak, MI-48084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorok N., 2014, ANN RHEUM DIS; Alvizi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02721-0; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Araujo E, 2015, J OBSTET GYNAECOL, V35, P85, DOI 10.3109/01443615.2014.935720; Bahado-Singh RO, 2016, J MATERN-FETAL NEO M, V29, P1881, DOI 10.3109/14767058.2015.1069811; Bahtiyar MO, 2007, J ULTRAS MED, V26, P1491, DOI 10.7863/jum.2007.26.11.1491; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Camm EJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00629; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chen ZM, 2012, DEVELOPMENT, V139, P3543, DOI 10.1242/dev.082719; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; Coles JG, 2005, J THORAC CARDIOV SUR, V129, P1128, DOI 10.1016/j.jtcvs.2004.11.055; Daca-Roszak P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2202-0; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Deng DXF, 2006, ARTERIOSCL THROM VAS, V26, P1058, DOI 10.1161/01.ATV.0000208185.16371.97; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Dumenil TD, 2014, GENE CHROMOSOME CANC, V53, P537, DOI 10.1002/gcc.22164; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Gu Z., 2015, COMPLEXHEATMAP MAKIN; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; He CJ, 2016, CIRC-CARDIOVASC GENE, V9, P110, DOI 10.1161/CIRCGENETICS.115.001264; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Izumi T, 2003, CIRCULATION, V108, P2530, DOI 10.1161/01.CIR.0000096484.03318.AB; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kertai MD, 2014, CIRC-CARDIOVASC GENE, V7, P625, DOI 10.1161/CIRCGENETICS.113.000451; Keskanokwong T, 2011, EUR HEART J, V32, P305, DOI 10.1093/eurheartj/ehq469; Koefoed K, 2014, ORGANOGENESIS, V10, P108, DOI 10.4161/org.27483; Lang JL, 2013, MOL DIAGN THER, V17, P101, DOI 10.1007/s40291-013-0033-8; Li D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106318; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Lin XY, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0970-x; Linask KK, 2013, HEART PLACENTA AXIS; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maccani JZJ, 2015, REPROD TOXICOL, V57, P43, DOI 10.1016/j.reprotox.2015.05.002; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mamasoula C, 2013, CIRC-CARDIOVASC GENE, V6, P347, DOI 10.1161/CIRCGENETICS.113.000191; Maslen CL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00735; Matsson H, 2008, HUM MOL GENET, V17, P256, DOI 10.1093/hmg/ddm302; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Pang SC, 2013, BIOCHIMIE, V95, P1807, DOI 10.1016/j.biochi.2013.05.007; Park MK, 2008, PEDIAT CARDIOLOGY PR, P166; Posch MG, 2010, CLIN RES CARDIOL, V99, P137, DOI 10.1007/s00392-009-0095-0; Prasad S, 2013, DIAGNOSIS MANAGEMENT, P171; Puig O, 2011, CIRC-CARDIOVASC GENE, V4, P595, DOI 10.1161/CIRCGENETICS.111.960773; Qian B, 2014, PEDIATR CARDIOL, V35, P1442, DOI 10.1007/s00246-014-0951-1; Radhakrishna U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154010; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Serra-Juhe C, 2015, EPIGENETICS-US, V10, P167, DOI 10.1080/15592294.2014.998536; Smith T, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.12.25; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Song F, 2009, GENOMICS, V93, P130, DOI 10.1016/j.ygeno.2008.09.003; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Sundrani DP, 2014, REPROD SCI, V21, P1508, DOI 10.1177/1933719114532838; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Taurino C, 2010, CLIN SCI, V119, P335, DOI 10.1042/CS20100043; Thalji NM, 2015, CIRC-CARDIOVASC GENE, V8, P516, DOI 10.1161/CIRCGENETICS.114.000921; Thibaud-Nissen F, 2013, EUKARYOTIC GENOME AN, V10; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Wilhelm-Benartzi CS, 2013, BRIT J CANCER, V109, P1394, DOI 10.1038/bjc.2013.496; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang T, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-351; Zhang Y, 2013, BBA-BIOMEMBRANES, V1828, P1550, DOI 10.1016/j.bbamem.2012.08.032; Zins K, 2014, INT J MOL SCI, V15, P712, DOI [10.3390/ijms15010712, 10.3390/ijms15011538]	81	28	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0200229	10.1371/journal.pone.0200229	http://dx.doi.org/10.1371/journal.pone.0200229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897084	Green Submitted, gold, Green Published			2022-12-26	WOS:000461889700003
J	Shawe, J; Patel, D; Joy, M; Howden, B; Barrett, G; Stephenson, J				Shawe, Jill; Patel, Dilisha; Joy, Mark; Howden, Beth; Barrett, Geraldine; Stephenson, Judith			Preparation for fatherhood: A survey of men's preconception health knowledge and behaviour in England	PLOS ONE			English	Article							BODY-MASS INDEX; SEMEN QUALITY; LIFE-STYLE; DRUG-USE; REPRODUCTIVE HORMONES; UNINTENDED PREGNANCY; UNPLANNED PREGNANCY; PATERNAL SMOKING; BIRTH OUTCOMES; RISK-FACTORS	Methods A cross-sectional survey of men attending antenatal care with their partners at three London Maternity Units. We assessed level of pregnancy planning using the partner version of the London Measure of Unplanned Pregnancy (LMUP), preconception health behaviours, and whether they had sought information and health professional advice before conception. Main results We recruited 573 men (91% response rate). Mean age was 34 years, 86% were in employment or full time education and 66% had a degree. Half were overweight or obese, 16% were still smoking and 79% had consumed alcohol in the three months before conception. Of 250 men answering questions about medication, a third were taking medication with potentially adverse effects on male reproductive health, while 23% reported taking pre-pregnancy vitamins. 46.9% had looked at information about pregnancy from a variety of sources, including online, before their partner became pregnant. Assessed by the LMUP, 74% of pregnancies were planned. Male 'planners' were more likely than other men to reduce smoking, reduce alcohol consumption and to eat more healthily in preparation for pregnancy. However, 57% took no action to improve their health. Significance of the findings In a sample of relatively educated men accompanying their partners on an antenatal visit, nearly half had made at least one positive health behaviour change before pregnancy, but half were overweight or obese and a third were on medication that could impair male reproductive health. These findings, together with a high prevalence of alcohol consumption and smoking, indicate the need for greater paternal preconception health awareness and care. Innovative ways to promote positive messages about fatherhood, including medication review as part of preconception care, should be evaluated for impact on improving paternal reproductive health and pregnancy and neonatal outcomes.	[Shawe, Jill] Univ Plymouth, Inst Hlth & Community, Plymouth, Devon, England; [Shawe, Jill; Patel, Dilisha; Barrett, Geraldine; Stephenson, Judith] UCL, Inst Womens Hlth, London, England; [Joy, Mark] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England; [Howden, Beth] Univ Bristol, Bristol Med Sch, Bristol, Avon, England	University of Plymouth; University of London; University College London; University of Surrey; University of Bristol	Patel, D (corresponding author), UCL, Inst Womens Hlth, London, England.	dilisha.patel@ucl.ac.uk		Joy, Mark/0000-0002-4974-3724; Patel, Dilisha/0000-0002-3746-8171; Barrett, Geraldine/0000-0002-9738-1051; SHAWE, JILL/0000-0002-2766-7302; Howden, Benjamin/0000-0003-0237-1473	Policy Research Programme of the Department of Health [006/0068]	Policy Research Programme of the Department of Health	The study was funded by the Policy Research Programme of the Department of Health, http://www.prp-ccf.org.uk. The PRP Reference number for the project is 006/0068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola E, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0156-6; Agricola E, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-33; Alio AP, 2012, AM J MENS HEALTH, V6, P427, DOI 10.1177/1557988312440718; Allstaff S, 2012, OBSTET GYNAECOL, V14, P25, DOI 10.1111/j.1744-4667.2011.00088.x; Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398; Association BM, 2016, ALC PREGN PREV MAN F; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barwell P, 2009, J PRIM HEALTH CARE, V1, P311, DOI 10.1071/HC09311; Bodin M, 2017, UPSALA J MED SCI, V122, P127, DOI 10.1080/03009734.2017.1316531; Bortolus R, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1198-z; Brezina Paul R, 2012, J Reprod Infertil, V13, P3; Campbell F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-491; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Casey FE, 2016, AM J MENS HEALTH, V10, P59, DOI 10.1177/1557988314556670; Cheng D, 2009, CONTRACEPTION, V79, P194, DOI 10.1016/j.contraception.2008.09.009; Choi J, 2013, PREV MED, V56, P351, DOI 10.1016/j.ypmed.2013.02.021; Choiriyyah I, 2015, MATERN CHILD HLTH J, V19, P2358, DOI 10.1007/s10995-015-1753-7; Christiansen C, 2013, M DEV GLOBAL CONSENS; Craig JR, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.115; Crijns I, 2012, EXPERT OPIN DRUG SAF, V11, P513, DOI 10.1517/14740338.2012.674109; D'Onofrio BM, 2014, AGE GAUGE OLDER FATH; D'Onofrio BM, 2014, JAMA PSYCHIAT, V71, P432, DOI 10.1001/jamapsychiatry.2013.4525; De Jonge CJ, 2006, SPERM CELL PRODUCTIO; Deng K, 2013, BIRTH DEFECTS RES A, V97, P210, DOI 10.1002/bdra.23128; Eisenberg ML, 2015, FERTIL STERIL, V103, P1271, DOI 10.1016/j.fertnstert.2015.02.010; Ekstrand M, 2007, EUR J CONTRACEP REPR, V12, P111, DOI 10.1080/13625180701201145; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Fleming TP, 2018, LANCET; Frey KA, 2012, J MENS HEALTH, V9, P25, DOI 10.1016/j.jomh.2011.11.001; Frey KA, 2008, AM J OBSTET GYNECOL, V199, pS389, DOI 10.1016/j.ajog.2008.10.024; Gavin L, 2014, MMWR RECOMM REP, V63, P1; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Gynaecologists RCoO, 2015, RCOG REL ALC PREGN D; Hall JA, 2017, PATIENT-RELAT OUTCOM, V8, P43, DOI 10.2147/PROM.S122420; Hall JA, 2017, MATERN CHILD HLTH J, V21, P670, DOI 10.1007/s10995-016-2237-0; Hammiche F, 2012, HUM REPROD, V27, P2365, DOI 10.1093/humrep/des177; Hammiche F, 2011, HUM REPROD, V26, P2432, DOI 10.1093/humrep/der225; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Harvey S, WHY ARE MEN RETICENT; Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6; Health Do, 2016, HLTH RISKS ALC NEW G; HELLER CG, 1964, RECENT PROG HORM RES, V20, P545; Hogberg H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3338-9; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Inskip HM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b481; Jensen TK, 2006, OCCUP MED-OXFORD, V56, P544, DOI 10.1093/occmed/kql116; Jensen TK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005462; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kotelchuck M, 2017, MATERN CHILD HLTH J, V21, P2025, DOI 10.1007/s10995-017-2370-4; Kunzle R, 2003, FERTIL STERIL, V79, P287, DOI 10.1016/S0015-0282(02)04664-2; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S3-S7; Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x; Levine H, 2017, HUM REPROD UPDATE, V23, P646, DOI 10.1093/humupd/dmx022; Liu R., 2011, J ONCOLOGY, V2011; McCrory C, 2013, PAEDIATR PERINAT EP, V27, P208, DOI 10.1111/ppe.12027; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; Merzenich H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-24; Millsop JW, 2013, DERMATOL THER, V26, P337, DOI 10.1111/dth.12069; Misra DP, 2010, AM J OBSTET GYNECOL, V202, P99, DOI 10.1016/j.ajog.2009.11.031; Mitchell EW, 2012, MATERN CHILD HLTH J, V16, P31, DOI 10.1007/s10995-010-0663-y; Moos MK, 2010, J WOMENS HEALTH, V19, P561, DOI 10.1089/jwh.2009.1411; Moss JL, 2015, ARCH GYNECOL OBSTET, V291, P287, DOI 10.1007/s00404-014-3521-0; NICE, 2018, NICE GUID BEH CHANG; NICE, 2017, PREC ADV MAN; NICE, 2018, BRIT NAT FORM ON LIN; Ojukwu O, 2016, UPSALA J MED SCI, V121, P256, DOI 10.1080/03009734.2016.1215853; Povey AC, 2012, HUM REPROD, V27, P2799, DOI 10.1093/humrep/des183; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Robbins CL, 2018, J WOMENS HEALTH, V27, P430, DOI 10.1089/jwh.2017.6531; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Schirm E, 2004, PHARMACOEPIDEM DR S, V13, P609, DOI 10.1002/pds.959; Semet M, 2017, ANDROLOGY-US, V5, P640, DOI 10.1111/andr.12366; Sermondade N, 2012, REPROD BIOMED ONLINE, V24, P206, DOI 10.1016/j.rbmo.2011.10.014; Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206; Shawe J, 2015, EUR J CONTRACEP REPR, V20, P77, DOI 10.3109/13625187.2014.990088; Singh AK, 2014, TYPE 2 DIABETES MELL; Smith JL, 2011, SEX REPROD HEALTHC, V2, P37, DOI 10.1016/j.srhc.2010.10.002; Stephenson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103085; Stern J, 2013, HUM REPROD, V28, P2450, DOI 10.1093/humrep/det279; Sternberg P, 2004, HEALTH PROMOT INT, V19, P389, DOI 10.1093/heapro/dah312; Svanes C, 2017, INT J EPIDEMIOL, V46, P235, DOI 10.1093/ije/dyw151; Trummer H, 2002, HUM REPROD, V17, P1554, DOI 10.1093/humrep/17.6.1554; van der Zee B, 2013, AM J OBSTET GYNECOL, V209, P11, DOI 10.1016/j.ajog.2013.01.009; Van Dijk Matthijs R, 2016, JMIR Mhealth Uhealth, V4, pe53, DOI 10.2196/mhealth.5197; van Dijk MR, 2017, REPROD BIOMED ONLINE, DOI [10.1016/j.rbmo.2017.06, DOI 10.1016/J.RBMO.2017.06]; Verbiest S, 2016, UPSALA J MED SCI, V121, P222, DOI 10.1080/03009734.2016.1204395; VINE MF, 1994, FERTIL STERIL, V61, P35; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Warner JN, 2013, J AM BOARD FAM MED, V26, P196, DOI 10.3122/jabfm.2013.02.120143; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; White A, 2011, STATE MENS HLTH EURO; Wright C, 2014, REPROD BIOMED ONLINE, V28, P684, DOI 10.1016/j.rbmo.2014.02.004; ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273	94	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213897	10.1371/journal.pone.0213897	http://dx.doi.org/10.1371/journal.pone.0213897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP6AW	30893380	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900059
J	Roehrer, S; Stork, V; Ludwig, C; Minceva, M; Behr, J				Roehrer, Simon; Stork, Verena; Ludwig, Christina; Minceva, Mirjana; Behr, Juergen			Analyzing bioactive effects of the minor hop compound xanthohumol C on human breast cancer cells using quantitative proteomics	PLOS ONE			English	Article							HUMULUS-LUPULUS L.; MASS-SPECTROMETRY; PHARMACOLOGICAL PROFILE; PRENYLATED CHALCONES; PROTEINS; PRENYLFLAVONOIDS; CONSTITUENTS; CYTOTOXICITY; DOXORUBICIN; ACTIVATION	Minor prenylated hop compounds have been attracting increasing attention due to their promising anticarcinogenic properties. Even after intensive purification from natural raw extracts, allocating certain activities to single compounds or complex interactions of the main compound with remaining impurities in very low concentration is difficult. In this study, dose-dependent antiproliferative and cytotoxic effects of the promising xanthohumol (XN) analogue xanthohumol C (XNC) were evaluated and compared to XN and a XN-enriched hop extract (XF). It was demonstrated that the cell growth inhibition of human breast cancer cell line (MCF-7) significantly increases after being treated with XNC compared to XN and XF. Based on label-free data-dependent acquisition proteomics, physiological influences on the proteome of MCF-7 cells were analyzed. Different modes of action between XNC and XN treated MCF-7 cells could be postulated. XNC causes ER stress and seems to be involved in cell-cell adhesion, whereas XN influences cell cycles and DNA replication as well as type I interferon signaling pathway. The results demonstrate the utility of using quantitative proteomics for bioactivity screenings of minor hop compounds and underscore the importance of isolating highly pure compounds into their distinct forms to analyze their different and possibly synergistic activities and modes of action.	[Roehrer, Simon; Stork, Verena; Minceva, Mirjana] Tech Univ Munich, TUM Sch Life & Food Sci Weihenstephan, Biothermodynam, Freising Weihenstephan, Germany; [Ludwig, Christina; Behr, Juergen] Tech Univ Munich, TUM Sch Life & Food Sci Weihenstephan, Bavarian Ctr Biomol Mass Spectrometry, Freising Weihenstephan, Germany; [Behr, Juergen] Tech Univ Munich, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich	Behr, J (corresponding author), Tech Univ Munich, TUM Sch Life & Food Sci Weihenstephan, Bavarian Ctr Biomol Mass Spectrometry, Freising Weihenstephan, Germany.; Behr, J (corresponding author), Tech Univ Munich, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany.	juergen.behr@tum.de	Ludwig, Christina/ABD-5196-2021; Minceva, Mirjana/E-3326-2018	Behr, Juergen/0000-0001-8782-4456; Minceva, Mirjana/0000-0001-9820-7410	German Research Foundation (DFG); Technical University of Munich (TUM)	German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Aigner L, 2016, patent, Patent No. [US20170128411 A1, 20170128411]; Alison MR, 2002, GUT, V50, P290, DOI 10.1136/gut.50.3.290; [Anonymous], 2016, ASSAY GUIDANCE MANUA; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Behr J, 2007, APPL ENVIRON MICROB, V73, P3300, DOI 10.1128/AEM.00124-07; Bertl E, 2004, BIOCHEM BIOPH RES CO, V325, P287, DOI 10.1016/j.bbrc.2004.10.032; Bielow C, 2016, J PROTEOME RES, V15, P777, DOI 10.1021/acs.jproteome.5b00780; Biendl M., 2009, TECH QUATERLY, DOI [DOI 10.1094/TQ-46-2-0416-01, 10.1094/TQ-46-2-0416-01]; Champagne A, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600411; Chen ST, 2002, CANCER LETT, V181, P95, DOI 10.1016/S0304-3835(02)00025-3; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai Y, 2006, CANCER BIOL THER, V5, P171, DOI 10.4161/cbt.5.2.2568; Dietz BM, 2017, J NAT PROD, V80, P2284, DOI 10.1021/acs.jnatprod.7b00284; Dixon-Shanies D, 1999, ONCOL REP, V6, P1383; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Forino M, 2016, J NAT PROD, V79, P590, DOI 10.1021/acs.jnatprod.5b01052; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Gerhauser C, 2005, MOL NUTR FOOD RES, V49, P827, DOI 10.1002/mnfr.200500091; Gerhauser C, 2002, MOL CANCER THER, V1, P959; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kang Y, 2013, BBA-GEN SUBJECTS, V1830, P2638, DOI 10.1016/j.bbagen.2012.12.005; Karabin M, 2016, COMPR REV FOOD SCI F, V15, P542, DOI 10.1111/1541-4337.12201; Katsogiannou M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00346; Konda JD, 2017, MOL ONCOL, V11, P599, DOI 10.1002/1878-0261.12042; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee YR, 2007, SYNTHESIS-STUTTGART, P3240, DOI 10.1055/s-2007-990796; Legette L, 2014, MOL NUTR FOOD RES, V58, P248, DOI 10.1002/mnfr.201300333; Lill J, 2003, MASS SPECTROM REV, V22, P182, DOI 10.1002/mas.10048; Liu M, 2015, MOLECULES, V20, P754, DOI 10.3390/molecules20010754; Malik S, 2017, BIOTECHNOLOGY AND PRODUCTION OF ANTI-CANCER COMPOUNDS, pVII; Matousek J, 2006, J AGR FOOD CHEM, V54, P7606, DOI 10.1021/jf061785g; Mendes V, 2008, J AGR FOOD CHEM, V56, P11631, DOI 10.1021/jf802233q; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Miranda CL, 1999, FOOD CHEM TOXICOL, V37, P271, DOI 10.1016/S0278-6915(99)00019-8; Miranda CL, 2000, J AGR FOOD CHEM, V48, P3876, DOI 10.1021/jf0002995; MIZOBUCHI S, 1984, AGR BIOL CHEM TOKYO, V48, P2771, DOI 10.1080/00021369.1984.10866564; Motyl M, 2013, THESIS; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Natarajan P, 2008, PHYTOMEDICINE, V15, P194, DOI 10.1016/j.phymed.2007.10.008; Nikolic D, 2013, CURR ANAL CHEM, V9, P71, DOI 10.2174/157341113804486554; Nollen EAA, 2002, J CELL SCI, V115, P2809; Nookandeh A, 2004, PHYTOCHEMISTRY, V65, P561, DOI 10.1016/j.phytochem.2003.11.016; Nuti E, 2017, EUR J MED CHEM, V138, P890, DOI 10.1016/j.ejmech.2017.07.024; OESTERREICH S, 1993, CANCER RES, V53, P4443; Olsovska J., 2016, MILIT MED SCI LETT, V85, P19, DOI [10.31482/mmsl.2016.004, 10.31482, DOI 10.31482/MMSL.2016.004]; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Poplonski J, 2018, MOLECULES, V23, DOI 10.3390/molecules23040776; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rathinasamy K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-213; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Roehrer S, 2018, J CHROMATOGR B, V1095, P39, DOI 10.1016/j.jchromb.2018.07.018; Roy Madhumita, 2002, Asian Pac J Cancer Prev, V3, P61; Rozalski M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/101089; Schott AS, 2017, J PROTEOME RES, V16, P3816, DOI 10.1021/acs.jproteome.7b00474; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025; Stevens JF, 1997, PHYTOCHEMISTRY, V44, P1575, DOI 10.1016/S0031-9422(96)00744-3; Stompor M, 2016, MOLECULES, V21, DOI 10.3390/molecules21050608; Suarez RK, 2012, J EXP BIOL, V215, P2351, DOI 10.1242/jeb.059725; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Venturelli S, 2016, NUTRITION, V32, P1171, DOI 10.1016/j.nut.2016.03.020; Vogel S, 2008, J NAT PROD, V71, P1237, DOI 10.1021/np800188b; Vogel S, 2010, EUR J MED CHEM, V45, P2206, DOI 10.1016/j.ejmech.2010.01.060; Wang JG, 2016, PHARMACOL THERAPEUT, V162, P10, DOI 10.1016/j.pharmthera.2016.01.010; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Yang JY, 2007, APOPTOSIS, V12, P1953, DOI 10.1007/s10495-007-0130-4; Zanoli P, 2008, J ETHNOPHARMACOL, V116, P383, DOI 10.1016/j.jep.2008.01.011	74	16	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213469	10.1371/journal.pone.0213469	http://dx.doi.org/10.1371/journal.pone.0213469			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875365	Green Submitted, Green Published, gold			2022-12-26	WOS:000461316400015
J	Florence, AM; Higley, LG; Drijber, RA; Francis, CA; Lindquist, JL				Florence, A. M.; Higley, L. G.; Drijber, R. A.; Francis, C. A.; Lindquist, J. L.			Cover crop mixture diversity, biomass productivity, weed suppression, and stability	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; BIODIVERSITY; INVASION; INVASIBILITY; RESISTANCE; YIELD; FERTILIZATION; COMMUNITIES; INTERCROPS; DENSITY	The diversity-productivity, diversity-invasibility, and diversity-stability hypotheses propose that increasing species diversity should lead, respectively, to increased average biomass productivity, invasion resistance, and stability. We tested these three hypotheses in the context of cover crop mixtures, evaluating the effects of increasing cover crop mixture diversity on aboveground biomass, weed suppression, and biomass stability. Twenty to forty cover crop treatments were replicated three or four times at eleven sites using eighteen species representing three cover crop species each from six pre-defined functional groups: cool-season grasses, cool-season legumes, cool-season brassicas, warm-season grasses, warm-season legumes, and warm-season broadleaves. Each species was seeded as a pure stand, and the most diverse treatment contained all eighteen species. Remaining treatments included treatments representing intermediate levels of cover crop species and functional richness and a no cover crop control. Cover crop seeding dates ranged from late July to late September with both cover crop and weed aboveground biomass being sampled prior to winterkill. Stability was assessed by evaluating the variability in cover crop biomass for each treatment across plots within each site. While increasing cover crop mixture diversity was associated with increased average aboveground biomass, we assert that this was the result of the average biomass of the pure stands being drawn down by low biomass species rather than due to niche complementarity or increased resource use efficiency. At no site did the highest biomass mixture produce more than the highest biomass pure stand. Furthermore, while increases in cover crop mixture diversity were correlated with increases in weed suppression and biomass stability, we argue that this was largely the result of diversity co-varying with aboveground biomass, and that differences in aboveground biomass rather than differences in diversity drove the differences observed in weed suppression and stability.	[Florence, A. M.; Drijber, R. A.; Francis, C. A.; Lindquist, J. L.] Univ Nebraska Lincoln, Dept Agron & Hort, Lincoln, NE 68583 USA; [Higley, L. G.] Univ Nebraska Lincoln, Sch Nat Resources, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Lindquist, JL (corresponding author), Univ Nebraska Lincoln, Dept Agron & Hort, Lincoln, NE 68583 USA.	jlindquist1@unl.edu	Higley, Leon George/I-6955-2012; Higley, Leon G/E-3311-2010	Higley, Leon George/0000-0003-2949-7375; Lindquist, John/0000-0002-6293-7072	AMF North Central SARE [GNC13-182]; AMF National Science Foundation Graduate Research Fellowship [DGE-1041000]; North Central SARE [GNC13-182]; National Science Foundation Graduate Research Fellowship [DGE-1041000]	AMF North Central SARE; AMF National Science Foundation Graduate Research Fellowship; North Central SARE; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by AMF North Central SARE [GNC13-182] (https://www.northcentralsare.org/); AMF National Science Foundation Graduate Research Fellowship [DGE-1041000] (https://www.nsfgrfp.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to cooperating farmers Ben Schole, Mike Herman, Paul Swanson, Keith Berns, and Nate Schroeder. Thanks also to Darren Binder and Paul Jasa for technical support. This material is based upon work supported by North Central SARE [GNC13-182] and by the National Science Foundation Graduate Research Fellowship [DGE-1041000].	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Anil L, 1998, GRASS FORAGE SCI, V53, P301, DOI 10.1046/j.1365-2494.1998.00144.x; [Anonymous], 2014, R LANG ENV STAT COMP; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Betts L., 2013, FARM PROGR; Brennan EB, 2009, AGRON J, V101, P979, DOI 10.2134/agronj2008.0194x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clark A., 2007, MANAGING COVER CROPS, V3rd ed.; deLaplante K, 2011, HBK PHILOS SCI, V11, P169; Dietz J., 2008, HAY FORAGE GROWER; Doring TF, 2018, EUR J AGRON, V99, P30, DOI 10.1016/j.eja.2018.06.007; ELTON CS, 1958, ECOLOGY INVASIONS PL; Finney DM, 2017, J APPL ECOL, V54, P509, DOI 10.1111/1365-2664.12765; GOLDBERG DE, 1987, ECOLOGY, V68, P1211, DOI 10.2307/1939205; GOLDBERG DE, 1983, AM J BOT, V70, P1098, DOI 10.2307/2442821; Griffin John n., 2009, P78; He JS, 2005, BASIC APPL ECOL, V6, P505, DOI 10.1016/j.baae.2005.04.002; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston M A, 2000, Science, V289, P1255; Jiang XL, 2007, BIODIVERS CONSERV, V16, P1983, DOI 10.1007/s10531-006-9061-6; Karpenstein-Machan M, 2000, PLANT SOIL, V218, P215, DOI 10.1023/A:1014932004926; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Kristensen L, 2008, WEED SCI, V56, P97, DOI 10.1614/WS-07-065.1; Lanta V, 2008, PLANT ECOL, V198, P253, DOI 10.1007/s11258-008-9401-6; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; LIEBMAN M, 1993, ECOL APPL, V3, P92, DOI 10.2307/1941795; Lithourgidis AS, 2011, AUST J CROP SCI, V5, P396; Milbau A, 2005, FUNCT ECOL, V19, P27, DOI 10.1111/j.0269-8463.2005.00939.x; MOHLER CL, 1987, J APPL ECOL, V24, P685, DOI 10.2307/2403903; Moody K., 1976, P S CROPP SYST RES D; Morrison L., 2011, CORN SOYBEAN DIGEST; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Nelson AG, 2012, AGRON J, V104, P756, DOI 10.2134/agronj2011.0374; Picasso VD, 2008, CROP SCI, V48, P331, DOI 10.2135/cropsci2007.04.0225; RAO MR, 1980, EXP AGR, V16, P105, DOI 10.1017/S0014479700010796; SCHERERLORENZEN M, 2005, BIODIVERSITY STRUCTU; Smith RG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102920, 10.1371/journal.pone.0097351]; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tilman D., 2001, ENCY BIODIVERSITY, V3, P109, DOI [10.1006/rwbd.1999.0154, DOI 10.1016/B0-12-226865-2/00132-2]; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; Uchino H, 2012, FIELD CROP RES, V127, P9, DOI 10.1016/j.fcr.2011.10.007; van Ruijven J, 2003, ECOL LETT, V6, P910, DOI 10.1046/j.1461-0248.2003.00516.x; Vandermeer J., 1990, Agroecology. Researching the ecological basis for sustainable agriculture., P205; Vandermeer J, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P221; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Wortman SE, 2012, AGRON J, V104, P699, DOI 10.2134/agronj2011.0422	51	30	31	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0206195	10.1371/journal.pone.0206195	http://dx.doi.org/10.1371/journal.pone.0206195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870424	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300003
J	Garcia-Marchena, N; Barrera, M; Mestre-Pinto, JI; Araos, P; Serrano, A; Perez-Mana, C; Papaseit, E; Fonseca, F; Ruiz, JJ; de Fonseca, FR; Farre, M; Pavon, FJ; Torrens, M				Garcia-Marchena, Nuria; Barrera, Marta; Ignasi Mestre-Pinto, Joan; Araos, Pedro; Serrano, Antonia; Perez-Mana, Clara; Papaseit, Esther; Fonseca, Francina; Jesus Ruiz, Juan; Rodriguez de Fonseca, Fernando; Farre, Magi; Javier Pavon, Francisco; Torrens, Marta			Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders	PLOS ONE			English	Article							COMORBID PSYCHIATRIC-DISORDERS; RESEARCH INTERVIEW; MENTAL-DISORDERS; CYTOKINES; CHEMOKINES; DIAGNOSIS; MODULATION; MECHANISMS; EXPRESSION; GENES	Major depressive disorder (MDD) is the most prevalent comorbid mental disorder among people with substance use disorders. The MDD can be both primary and substance-induced and its accurate diagnosis represents a challenge for clinical practice and treatment response. Recent studies reported alterations in the circulating expression of inflammatory mediators in patients with psychiatric disorders, including those related to substance use. The aim of the study was to explore TNF-alpha, IL-1 beta, CXCL12, CCL2, CCL11 (eotaxin-1) and CX3CL1 (fractalkine) as potential biomarkers to identify comorbid MDD and to distinguish primary MDD from substance-induced MDD in patients with substance disorders. Patients diagnosed with cocaine (CUD, n = 64) or alcohol (AUD, n = 65) use disorders with/without MDD were recruited from outpatient treatment programs [ CUD/non-MDD (n = 31); CUD/primary MDD (n = 18); CUD/cocaine-induced MDD (N = 15); AUD/non-MDD (n = 27); AUD/primary MDD (n = 16) and AUD/alcohol-induced MDD (n = 22)]. Sixty-two healthy subjects were also recruited as control group. Substance and mental disorders were assessed according to "Diagnostic and Statistical Manual of Mental Disorders, 4 th edition, text revision" (DSM-IV-TR) and a blood sample was collected for determinations in the plasma. The cocaine group showed lower TNF-alpha (p<0.05) and CCL11 (p<0.05), and higher IL-1 beta (p<0.01) concentrations than the control group. In contrast, the alcohol group showed higher IL-1 beta (p<0.01) and lower CXCL12 (p<0.01) concentrations than the control group. Regarding MDD, we only observed alterations in the cocaine group. Thus, CUD/MDD patients showed lower IL-1 beta (p<0.05), CXCL12 (p<0.05) and CCL11 (p<0.05), and higher CXC3CL1 (p<0.05) concentrations than CUD/non-MDD patients. Moreover, while CUD/primary MDD patients showed higher CCL11 (p<0.01) concentrations than both CUD/non-MDD and CUD/cocaine-induced MDD patients, CUD/cocaine-induced MDD patients showed lower CXCL12 (p<0.05) concentrations than CUD/non-MDD patients. Finally, a logistic regression model in the cocaine group identified CXCL12, CCL11 and sex to distinguish primary MDD from cocaine-induced MDD providing a high discriminatory power. The present data suggest an association between changes in inflammatory mediators and the diagnosis of primary and substance-induced MDD, namely in CUD patients.	[Garcia-Marchena, Nuria; Araos, Pedro; Serrano, Antonia; Rodriguez de Fonseca, Fernando; Javier Pavon, Francisco] Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Malaga, Spain; [Garcia-Marchena, Nuria; Barrera, Marta; Ignasi Mestre-Pinto, Joan; Fonseca, Francina; Torrens, Marta] Hosp del Mar Med Res Inst IMIM, Addict Res Grp, Barcelona, Spain; [Ignasi Mestre-Pinto, Joan] UPF, Barcelona, Spain; [Araos, Pedro] Univ Malaga UMA, Fac Psicol, Inst Invest Biomed Malaga IBIMA, Dept Psicobiol & Metodol Ciencias Comportamiento, Malaga, Spain; [Perez-Mana, Clara; Papaseit, Esther; Farre, Magi] Hosp Univ Germans Trias & Pujol IGTP, Badalona, Spain; [Perez-Mana, Clara; Papaseit, Esther; Fonseca, Francina; Farre, Magi; Torrens, Marta] UAB, Barcelona, Spain; [Fonseca, Francina; Torrens, Marta] Inst Neuropsiquiat & Addicc INAD, Barcelona, Spain; [Jesus Ruiz, Juan] Diputacio Prov Malaga, Ctr Prov Drogodependencias, Malaga, Spain	Universidad de Malaga; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Universidad de Malaga; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Autonomous University of Barcelona	Pavon, FJ (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Unidad Gest Clin Salud Mental, Malaga, Spain.; Torrens, M (corresponding author), Hosp del Mar Med Res Inst IMIM, Addict Res Grp, Barcelona, Spain.; Torrens, M (corresponding author), UAB, Barcelona, Spain.; Torrens, M (corresponding author), Inst Neuropsiquiat & Addicc INAD, Barcelona, Spain.	javier.pavon@ibima.eu; mtorrens@parcdesalutmar.cat	Pérez-Mañá, Clara/AAC-5817-2021; Pavón Morón, Francisco Javier/AAG-9721-2020; GÓMEZ, PEDRO FERNANDO ARAOS/AAX-1715-2021; Mestre-Pinto, Joan-Ignasi/T-9257-2018	Pérez-Mañá, Clara/0000-0001-6343-6918; Pavón Morón, Francisco Javier/0000-0002-5256-8904; GÓMEZ, PEDRO FERNANDO ARAOS/0000-0001-5172-8796; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Barrera Conde, Marta/0000-0002-0106-0000; Mestre-Pinto, Joan-Ignasi/0000-0003-0387-9375; Fonseca, Francina/0000-0002-0779-6545	RETICS Red de Trastornos Adictivos - Instituto de Salud Carlos III (ISC-III) [RD12/0028/0021, RD12/0028/0009, RD16/0017/0001, RD16/0017/0010, RD 16/0017/003]; European Regional and European Regional Development Funds-European Union (ERDF-EU); Ministerio de Economia y Competitividad; ISC-III [PI09/02121, PI12/01838, PI16/01698, PI16/01953]; Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas [043/2017, 2012I054]; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia and ERDF-EU [CTS-433]; Suport Grups de Recerca AGAUR Gencat [2017 SGR 316, SGR530]; Consejeria de Salud y Bienestar Social, Junta de Andalucia [EF-0202-2017]; ERDF-EU [CP14/00173, CP14/00212]; Universidad de Malaga [CI-17-415]	RETICS Red de Trastornos Adictivos - Instituto de Salud Carlos III (ISC-III); European Regional and European Regional Development Funds-European Union (ERDF-EU); Ministerio de Economia y Competitividad(Spanish Government); ISC-III(Instituto de Salud Carlos III); Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas; Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia and ERDF-EU(Junta de Andalucia); Suport Grups de Recerca AGAUR Gencat(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Consejeria de Salud y Bienestar Social, Junta de Andalucia(Junta de Andalucia); ERDF-EU(European Commission); Universidad de Malaga	This work was supported by RETICS Red de Trastornos Adictivos (RD12/0028/0021, RD12/0028/0009, RD16/0017/0001, RD16/0017/0010, and RD 16/0017/003) funded by Instituto de Salud Carlos III (ISC-III) and European Regional and European Regional Development Funds-European Union (ERDF-EU); Research projects funded by Ministerio de Economia y Competitividad and ISC-III (PI09/02121; PI12/01838, PI16/01698, PI16/01953); Research project funded by Ministerio de Sanidad, Servicios Sociales e Igualdad and Plan Nacional sobre Drogas (043/2017 and 2012I054); Research project funded by Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia and ERDF-EU (CTS-433); Suport Grups de Recerca AGAUR Gencat 2017 SGR 316 and SGR530). NGM received a training research grant funded by Consejeria de Salud y Bienestar Social, Junta de Andalucia (EF-0202-2017); AS and FJP hold a Miguel Servet research contract funded by ISC-III and ERDF-EU (CP14/00173 and CP14/00212, respectively); PA received a Plan Propio grant from Universidad de Malaga (Incorporacion Doctores CI-17-415). These funding sources had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Achur RN, 2010, J NEUROIMMUNE PHARM, V5, P83, DOI 10.1007/s11481-009-9185-z; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI DOI 10.4324/9780203772287-23; APA, 2000, DSM4TR DIAGNOSTIC ST, V75, P78; Araos P, 2015, ADDICT BIOL, V20, P756, DOI 10.1111/adb.12156; Bettcher Brianne M, 2016, Alzheimers Dement (Amst), V3, P91, DOI 10.1016/j.dadm.2016.05.004; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Crews FT, 2012, ALCOHOL RES-CURR REV, V34, P355; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Cui CH, 2014, INT REV NEUROBIOL, V118, P1, DOI 10.1016/B978-0-12-801284-0.00001-4; Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Fernandez-Egea E, 2013, PROG NEURO-PSYCHOPH, V46, P25, DOI 10.1016/j.pnpbp.2013.06.011; Garcia-Marchena N, 2017, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00214; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Grassi-Oliveira R, 2012, REV BRAS PSIQUIATR, V34, P71, DOI 10.1590/S1516-44462012000100013; Hashimoto K, 2015, INT J MOL SCI, V16, P7796, DOI 10.3390/ijms16047796; Hasin D, 2006, AM J PSYCHIAT, V163, P689, DOI 10.1176/appi.ajp.163.4.689; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Herrera MI, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00081; Hueston CM, 2014, PHYSIOL BEHAV, V124, P77, DOI 10.1016/j.physbeh.2013.10.035; Irwin MR, 2007, J PHARMACOL EXP THER, V320, P507, DOI 10.1124/jpet.106.112797; Jankowski MM, 2010, INT IMMUNOPHARMACOL, V10, P1229, DOI 10.1016/j.intimp.2010.07.003; Laso FJ, 2007, CYTOM PART B-CLIN CY, V72B, P408, DOI 10.1002/cyto.b.20169; Keller B, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00258; Liu L, 2009, PHARMACOGENET GENOM, V19, P869, DOI 10.1097/FPC.0b013e328331e68f; Magalhaes PVS, 2014, J PSYCHIATR RES, V48, P13, DOI 10.1016/j.jpsychires.2013.10.007; Maza-Quiroga R, 2017, PEERJ, V5, DOI 10.7717/peerj.3926; Miranda DO, 2017, BIOMED REP, V7, P188, DOI 10.3892/br.2017.937; Mora C, 2018, EXPERT REV MOL DIAGN, V18, P513, DOI 10.1080/14737159.2018.1470927; Myung W, 2016, PSYCHIAT INVEST, V13, P644, DOI 10.4306/pi.2016.13.6.644; Nunes EV, 2006, J CLIN PSYCHIAT, V67, P1561, DOI 10.4088/JCP.v67n1010; Oglodek EA, 2014, PHARMACOL REP, V66, P920, DOI 10.1016/j.pharep.2014.06.001; Pedraz M, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fmicb.2015.00449, 10.3389/fpsyt.2015.00017]; Pettinati HM, 2013, AM J PSYCHIAT, V170, P23, DOI 10.1176/appi.ajp.2012.12010112; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Samet S, 2013, ADDICTION, V108, P115, DOI 10.1111/j.1360-0443.2012.04010.x; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Sinha R, 2011, CURR PSYCHIAT REP, V13, P398, DOI 10.1007/s11920-011-0224-0; Stuart MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00357; Teixeira AL, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00241; Teixeira AL, 2008, PROG NEURO-PSYCHOPH, V32, P710, DOI 10.1016/j.pnpbp.2007.11.019; Tirado-Munoz J, 2018, ADICCIONES, V30, P66, DOI 10.20882/adicciones.868; Torrens M, 2004, AM J PSYCHIAT, V161, P1231, DOI 10.1176/appi.ajp.161.7.1231; Torrens M, 2017, ADICCIONES, V29, P3, DOI 10.20882/adicciones.933; Treckl J, 2009, NEUROSCIENCE, V161, P13, DOI 10.1016/j.neuroscience.2009.03.027; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; WHO, 2012, ICD 10 CLASS MENT BE; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhang WQ, 2015, NEUROPHARMACOLOGY, V90, P1, DOI 10.1016/j.neuropharm.2014.10.024	51	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213791	10.1371/journal.pone.0213791	http://dx.doi.org/10.1371/journal.pone.0213791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870525	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300078
J	Dionne-Odom, JN; Ejem, D; Wells, R; Barnato, AE; Taylor, RA; Rocque, GB; Turkman, YE; Kenny, M; Ivankova, NV; Bakitas, MA; Martin, MY				Dionne-Odom, J. Nicholas; Ejem, Deborah; Wells, Rachel; Barnato, Amber E.; Taylor, Richard A.; Rocque, Gabrielle B.; Turkman, Yasemin E.; Kenny, Matthew; Ivankova, Nataliya V.; Bakitas, Marie A.; Martin, Michelle Y.			How family caregivers of persons with advanced cancer assist with upstream healthcare decision-making: A qualitative study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PALLIATIVE CARE; COMMUNICATION; INTERVENTION; PREFERENCES; COMPANIONS; RELATIVES; SUPPORT; ILLNESS; UNIT	Aims Numerous healthcare decisions are faced by persons with advanced cancer from diagnosis to end-of-life. The family caregiver role in these decisions has focused on being a surrogate decision-maker, however, little is known about the caregiver's role in supporting upstream patient decision-making. We aimed to describe the roles of family caregivers in assisting community-dwelling advanced cancer patients with healthcare decision-making across settings and contexts. Methods Qualitative study using one-on-one, semi-structured interviews with community-dwelling persons with metastatic cancer (n = 18) and their family caregivers (n = 20) recruited from outpatient oncology clinics of a large tertiary care academic medical center, between October 2016 and October 2017. Transcribed interviews were analyzed using a thematic analysis approach. Findings Caregivers averaged 56 years and were mostly female (95%), white (85%), and the patient's partner/spouse (70%). Patients averaged 58 years and were mostly male (67%) in self-reported "fair" or "poor" health (50%) with genitourinary (33%), lung (17%), and hematologic (17%) cancers. Themes describing family member roles in supporting patients' upstream healthcare decision-making were: 1) seeking information about the cancer, its trajectory, and treatments options; 2) ensuring family and healthcare clinicians have a common understanding of the patient's treatment plan and condition; 3) facilitating discussions with patients about their values and the framing of their illness; 5) posing "what if" scenarios about current and potential future health states and treatments; 6) addressing collateral decisions (e.g., work arrangements) resulting from medical treatment choices; 6) originating healthcare-related decision points, including decisions about seeking emergency care; and 7) making healthcare decisions for patients who preferred to delegate healthcare decisions to their family caregivers. Conclusions These findings highlight a previously unreported and understudied set of critical decision partnering roles that cancer family caregivers play in patient healthcare decision-making. Optimizing these roles may represent novel targets for early decision support interventions for family caregivers.	[Dionne-Odom, J. Nicholas; Ejem, Deborah; Wells, Rachel; Taylor, Richard A.; Turkman, Yasemin E.; Kenny, Matthew; Ivankova, Nataliya V.; Bakitas, Marie A.] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL 35294 USA; [Dionne-Odom, J. Nicholas; Rocque, Gabrielle B.; Bakitas, Marie A.] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35233 USA; [Barnato, Amber E.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Ivankova, Nataliya V.] Univ Alabama Birmingham, Sch Hlth Profess, Birmingham, AL USA; [Martin, Michelle Y.] Univ Tennessee, Hlth Sci Ctr, Ctr Innovat Hlth Equ Res, Memphis, TN USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Dartmouth College; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center	Dionne-Odom, JN (corresponding author), Univ Alabama Birmingham, Sch Nursing, Birmingham, AL 35294 USA.; Dionne-Odom, JN (corresponding author), Univ Alabama Birmingham, Sch Med, Birmingham, AL 35233 USA.	dionneod@uab.edu		Ejem, Deborah/0000-0003-4617-2433; Dionne-Odom, James/0000-0001-6764-0254; Wells, Rachel/0000-0003-4447-012X	National Palliative Care Research Center Junior Faculty Career Development Award; National Institute of Nursing Research [R00NR015903]; NATIONAL INSTITUTE OF NURSING RESEARCH [R00NR015903] Funding Source: NIH RePORTER	National Palliative Care Research Center Junior Faculty Career Development Award; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was funded by the National Palliative Care Research Center (www.npcrc.org) Junior Faculty Career Development Award and the National Institute of Nursing Research (www.ninr.nih.gov) (R00NR015903 to JND-O). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslakson R, 2014, J PALLIAT MED, V17, P219, DOI 10.1089/jpm.2013.0409; Azoulay E, 2018, INTENS CARE MED, V44, P1879, DOI 10.1007/s00134-018-5423-2; Bakitas M, 2011, J PALLIAT MED, V14, P1109, DOI 10.1089/jpm.2011.0032; Barry CA, 1999, QUAL HEALTH RES, V9, P26, DOI 10.1177/104973299129121677; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bravo G, 2018, PATIENT EDUC COUNS, V101, P1256, DOI 10.1016/j.pec.2018.02.005; Cain CL, 2018, J PAIN SYMPTOM MANAG, V55, P1408, DOI 10.1016/j.jpainsymman.2018.01.007; Carson SS, 2016, JAMA-J AM MED ASSOC, V316, P51, DOI 10.1001/jama.2016.8474; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Clayman ML, 2005, SOC SCI MED, V60, P1583, DOI 10.1016/j.socscimed.2004.08.004; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2013, JAMA-J AM MED ASSOC, V310, P2271, DOI 10.1001/jama.2013.282081; Curtis JR, 2011, AM J RESP CRIT CARE, V183, P348, DOI 10.1164/rccm.201006-1004OC; Daly BJ, 2010, CHEST, V138, P1340, DOI 10.1378/chest.10-0292; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Dionne-Odom JN, 2018, J PAIN SYMPTOM MANAG, V55, P1519, DOI 10.1016/j.jpainsymman.2018.02.009; Ditto PH, 2001, ARCH INTERN MED, V161, P421, DOI 10.1001/archinte.161.3.421; Epstein RM, 2013, PATIENT EDUC COUNS, V90, P200, DOI 10.1016/j.pec.2012.06.035; Ferrell B, 2017, CA-CANCER J CLIN, V67, P318, DOI 10.3322/caac.21396; Garvelink MM, 2016, HEALTH AFFAIR, V35, P619, DOI 10.1377/hlthaff.2015.1375; Goldsmith DJ, 2014, HEALTH COMMUN, V29, P51, DOI 10.1080/10410236.2012.717215; Green MJ, 2017, AM J HOSP PALLIAT CA, DOI [10.1177/, DOI 10.1177/]; Hall DE, 2012, AM J SURG, V204, P619, DOI 10.1016/j.amjsurg.2012.07.020; Hanson LC, 2011, J AM GERIATR SOC, V59, P2009, DOI 10.1111/j.1532-5415.2011.03629.x; Hauke D, 2011, ANN ONCOL, V22, P2667, DOI 10.1093/annonc/mdr019; Hlubocky FJ, 2018, J CLIN ONCOL, V36, P2483, DOI 10.1200/JCO.2017.73.3592; Hobbs GS, 2015, CANCER-AM CANCER SOC, V121, P1079, DOI 10.1002/cncr.29064; Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440; Krieger JL, 2017, QUAL HEALTH RES, V27, P1146, DOI 10.1177/1049732316645321; Laidsaar-Powell RC, 2013, PATIENT EDUC COUNS, V91, P3, DOI 10.1016/j.pec.2012.11.007; Lamore K, 2017, PATIENT EDUC COUNS, V100, P2172, DOI 10.1016/j.pec.2017.08.003; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; LeBlanc TW, 2018, SUPPORT CARE CANCER, V26, P1197, DOI 10.1007/s00520-017-3942-y; Lee JE, 2015, PSYCHO-ONCOLOGY, V24, P1545, DOI 10.1002/pon.3827; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lynch M., 2017, JOURNEY CAREGIVING H; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; National Alliance for Caregiving, 2016, CANC CAR US INT EP C; Patton, 2014, QUALITATIVE RES EVAL; Petrillo LA, 2018, J AM GERIATR SOC, V66, P1515, DOI 10.1111/jgs.15426; Rini C, 2011, J BEHAV MED, V34, P396, DOI 10.1007/s10865-011-9323-y; Saldana J, 2013, CODING MANUAL QUALIT; Shin DW, 2018, CANCER RES TREAT, V50, P681, DOI 10.4143/crt.2017.201; Shin DW, 2017, PSYCHO-ONCOLOGY, V26, P770, DOI 10.1002/pon.4226; Song K, 2015, AM J KIDNEY DIS, V66, P813, DOI 10.1053/j.ajkd.2015.05.018; Sulmasy DP, 2017, J PAIN SYMPTOM MANAG, V54, P455, DOI 10.1016/j.jpainsymman.2017.07.004; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Vega JN, 2017, AM J GERIAT PSYCHIAT, V25, P1415, DOI 10.1016/j.jagp.2017.04.001; White DB, 2018, NEW ENGL J MED, V378, P2365, DOI 10.1056/NEJMoa1802637; Wolff JL, 2008, ARCH INTERN MED, V168, P1409, DOI 10.1001/archinte.168.13.1409	52	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212967	10.1371/journal.pone.0212967	http://dx.doi.org/10.1371/journal.pone.0212967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865681	gold, Green Published			2022-12-26	WOS:000461048900053
J	Heimann, K; Uithol, S; Calbi, M; Umilta, MA; Guerra, M; Fingerhut, J; Gallese, V				Heimann, Katrin; Uithol, Sebo; Calbi, Marta; Umilta, Maria Alessandra; Guerra, Michele; Fingerhut, Joerg; Gallese, Vittorio			Embodying the camera: An EEG study on the effect of camera movements on film spectators' sensorimotor cortex activation	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; PRIMARY MOTOR CORTEX; CORTICAL ACTIVATION; MU-RHYTHM	One key feature of film consists in its power to bodily engage the viewer. Previous research has suggested lens and camera movements to be among the most effective stylistic devices involved in such engagement. In an EEG experiment we assessed the role of such movements in modulating specific spectators' neural and experiential responses, likely reflecting such engagement. We produced short video clips of an empty room with a still, a zooming and a moving camera (steadicam) that might simulate the movement of an observer in different ways. We found an event related desynchronization of the beta components of the rolandic mu rhythm that was stronger for the clips produced with steadicam than for those produced with a still or zooming camera. No equivalent modulation in the attention related occipital areas was found, thus confirming the sensorimotor nature of spectators' neural responses to the film clips. The present study provides the first empirical evidence that filmic means such as camera movements alone can modulate spectators' bodily engagement with film.	[Heimann, Katrin; Uithol, Sebo; Calbi, Marta; Gallese, Vittorio] Univ Parma, Dept Med & Surg, Unit Neurosci, Parma, Italy; [Umilta, Maria Alessandra] Univ Parma, Dept Food & Drug, Parma, Italy; [Guerra, Michele] Univ Parma, Dept Humanities Social Sci & Cultural Ind, Parma, Italy; [Fingerhut, Joerg] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Gallese, Vittorio] Univ London, Sch Adv Study, Inst Philosophy, London, England; [Heimann, Katrin] Univ Aarhus, Interacting Minds Ctr, Aarhus C, Denmark; [Uithol, Sebo] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of Parma; University of Parma; University of Parma; Humboldt University of Berlin; University of London; University of London School of Advanced Study; Aarhus University; Radboud University Nijmegen	Heimann, K (corresponding author), Univ Parma, Dept Med & Surg, Unit Neurosci, Parma, Italy.; Heimann, K (corresponding author), Univ Aarhus, Interacting Minds Ctr, Aarhus C, Denmark.	katrin.heimann@cas.au.dk	Gallese, Vittorio/ABD-5097-2021; Heimann, Katrin/HIA-8296-2022	Gallese, Vittorio/0000-0003-4815-3607; Calbi, Marta/0000-0001-7555-0611	TESIS, FP7-PEOPLE-2010-ITN [264828]; European Union's Framework Programme Horizon 2020 [657605]; Chiesi foundation, PRIN grant; EU [264828]; Lego foundation; PRIN grant on Perception, Performativity and the Cognitive Sciences; Chiesi Foundation; Marie Sklodowska-Curie grant of the European Union's Framework Programme Horizon 2020 [657605]	TESIS, FP7-PEOPLE-2010-ITN; European Union's Framework Programme Horizon 2020; Chiesi foundation, PRIN grant(Chiesi Pharmaceuticals Inc); EU(European Commission); Lego foundation; PRIN grant on Perception, Performativity and the Cognitive Sciences(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Chiesi Foundation(Chiesi Pharmaceuticals Inc); Marie Sklodowska-Curie grant of the European Union's Framework Programme Horizon 2020	Funded by TESIS, FP7-PEOPLE-2010-ITN, 264828. https://tesisnetwork.wordpress.com/. Marie Sklodowska-Curie grant (number 657605) of the European Union's Framework Programme Horizon 2020. https://ec.europa.eu/programmes/horizon2020/. Lego foundation, project PLAYTrack. https://www.legofoundation.com/en/about-us/news/play-as-a-field-for-research/. Chiesi foundation, PRIN grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the EU grant Towards an Embodied Science of InterSubjectivity (TESIS, FP7-PEOPLE-2010-ITN, 264828) to K.H., S.U. and V.G. K.H. was further supported by a grant by the Lego foundation dedicated to the "PLAYTrack" project, S.U. by a Marie Sklodowska-Curie grant (number 657605) of the European Union's Framework Programme Horizon 2020 and V.G by a PRIN grant on Perception, Performativity and the Cognitive Sciences and by a grant of Chiesi Foundation. The authors wish to thank Francesca Scotto Lavina and the crew of la12studio for their most valuable help.	Avanzini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037534; Bordwell D., 2011, MINDING MOVIES OBSER; Bordwell David, 1977, CINE TRACTS, V2, P19; Caggiano V, 2011, CURR BIOL, V21, P144, DOI 10.1016/j.cub.2010.12.022; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Derambure P, 1997, EPILEPSIA, V38, P655, DOI 10.1111/j.1528-1157.1997.tb01234.x; Ferrara S., 2011, STEADICAM TECHNIQUES; Film Smith M., 2017, ART 3 CUTURE NATURAL; Fingerhut J, 2017, EMBODIMENT, ENACTION, AND CULTURE: INVESTIGATING THE CONSTITUTION OF THE SHARED WORLD, P353; Fox NA, 2016, PSYCHOL BULL, V142, P291, DOI 10.1037/bul0000031; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V., 2016, EXPERIENCE CULTURE C, P237; Gallese V., 2014, CINEMA CO, V14, P103; Gallese V., 2015, SCHERMO EMPATICO CIN; Gallese V, 2012, CINEMA, V3, P183; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Heimann K, 2014, J COGNITIVE NEUROSCI, V26, P2087, DOI 10.1162/jocn_a_00602; Heimann KS, 2017, COGNITIVE SCI, V41, P1555, DOI 10.1111/cogs.12439; Hobson HM, 2016, CORTEX, V82, P290, DOI 10.1016/j.cortex.2016.03.019; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perry A, 2010, SOC NEUROSCI-UK, V5, P272, DOI 10.1080/17470910903395767; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Pfurtscheller G, EVALUATION EVENT REL; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rizzolatti G, 2016, NAT REV NEUROSCI, V17, P757, DOI 10.1038/nrn.2016.135; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sbriscia-Fioretti B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075241; She SL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00314; Sobchack V., 2011, SUBJECTIVITY FILMIC, P74; Streltsova A, 2010, EXP BRAIN RES, V205, P363, DOI 10.1007/s00221-010-2371-7; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Umilta' MA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00311; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zhang R, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066024; Zhang R, 2015, BRAIN TOPOGR, V28, P680, DOI 10.1007/s10548-015-0429-3	46	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0211026	10.1371/journal.pone.0211026	http://dx.doi.org/10.1371/journal.pone.0211026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865624	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900008
J	Lindgren, IM; Drake, RR; Chattergoon, NN; Thornburg, KL				Lindgren, Isa M.; Drake, Rachel R.; Chattergoon, Natasha N.; Thornburg, Kent L.			Down-regulation of MEIS1 promotes the maturation of oxidative phosphorylation in perinatal cardiomyocytes	FASEB JOURNAL			English	Article						fetal heart; development; metabolic shift; glycolysis; mitochondrial respiration	HEMATOPOIETIC STEM-CELLS; METABOLIC PHENOTYPE; POSTNATAL CHANGES; FETAL SHEEP; GROWTH; HYPOXIA; OXYGEN; CONSUMPTION; NEWBORN; DIFFERENTIATION	Fetal cardiomyocytes shift from glycolysis to oxidative phosphorylation around the time of birth. Myeloid ecotropic viral integration site 1 (MEIS1) is a transcription factor that promotes glycolysis in hematopoietic stem cells. We reasoned that MEIS1 could have a similar role in the developing heart. We hypothesized that suppression of MEIS1 expression in fetal sheep cardiomyocytes leads to a metabolic switch as found at birth. Expression of MEIS1 was assayed in left ventricular cardiac tissue and primary cultures of cardiomyocytes from fetal (100- and 135-d gestation, term = 145 d), neonatal, and adult sheep. Cultured cells were treated with short interfering RNA (siRNA) to suppress MEIS1. Oxygen consumption rate was assessed with the Seahorse metabolic flux analyzer, and mitochondrial activity was assessed by staining cells with MitoTracker Orange. Cardiomyocyte respiratory capacity increased with advancing age concurrently with decreased expression of MEIS1. MEIS1 suppression with siRNA increased maximal oxygen consumption in fetal cells but not in postnatal cells. Mitochondrial activity was increased and expression of glycolytic genes decreased when MEIS1 expression was suppressed. Thus, we conclude that MEIS1 is a key regulator of cardiomyocyte metabolism and that the normal down-regulation of MEIS1 with age underlies a gradual switch to oxidative metabolism.-Lindgren, I. M., Drake, R. R., Chattergoon, N. N., Thornburg, K. L. Down-regulation of MEIS1 promotes the maturation of oxidative phosphorylation in perinatal cardiomyocytes.	[Lindgren, Isa M.; Drake, Rachel R.; Chattergoon, Natasha N.; Thornburg, Kent L.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Ctr Dev Hlth, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA	Oregon Health & Science University	Lindgren, IM (corresponding author), Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Ctr Dev Hlth, 3303 SW Bond Ave,CH14T, Portland, OR 97239 USA.	isamarialindgren@gmail.com		Drake, Rachel/0000-0002-1699-9192	M. Lowell Edwards Endowment; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [408 P01HD034430, R21 HD090529]; Sixten Gemzeus Foundation; Carl Tryggers Foundation; Sweden-America Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD034430, R21HD090529] Funding Source: NIH RePORTER	M. Lowell Edwards Endowment; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sixten Gemzeus Foundation; Carl Tryggers Foundation; Sweden-America Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Sonnet Jonker and Samantha Louey for helpful comments on the manuscript and Haeri Choi for technical support (all from Oregon Health and Science University). This research was supported by the M. Lowell Edwards Endowment, and the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grants 408 P01HD034430 and R21 HD090529 to K.L.T.). I.M.L. was supported by training grants from the Sixten Gemzeus Foundation, the Carl Tryggers Foundation, and the Sweden-America Foundation. The authors declare no conflicts of interest.	American Heart Association, 2016, PROJECTIONS CARDIOVA; Arciuch VGA, 2013, CANCER RES, V73, P5459, DOI 10.1158/0008-5472.CAN-13-1429; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BEATTY CH, 1968, PEDIATRICS, V42, P5; Breckenridge RA, 2014, J CARDIOVASC DEV DIS, V1, P29, DOI 10.3390/jcdd1010029; Breckenridge RA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001666; Burrell JH, 2003, ANAT REC PART A, V274A, P952, DOI 10.1002/ar.a.10110; Chattergoon NN, 2012, FASEB J, V26, P397, DOI 10.1096/fj.10-179895; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; DAWES GS, 1980, J PHYSIOL-LONDON, V309, P405, DOI 10.1113/jphysiol.1980.sp013516; Dunbar SB, 2018, CIRCULATION, V137, pE558, DOI 10.1161/CIR.0000000000000570; FISHER DJ, 1981, PEDIATR RES, V15, P843, DOI 10.1203/00006450-198115050-00003; FISHER DJ, 1980, AM J PHYSIOL, V238, pH399, DOI 10.1152/ajpheart.1980.238.3.H399; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; GROSS SJ, 1983, NEW ENGL J MED, V308, P237, DOI 10.1056/NEJM198302033080501; Hay WW, 2008, NEONATOLOGY, V94, P245, DOI 10.1159/000151643; Jonker SS, 2016, J ENDOCRINOL, V228, pR1, DOI 10.1530/JOE-15-0309; Jonker SS, 2007, J APPL PHYSIOL, V102, P1130, DOI 10.1152/japplphysiol.00937.2006; Jonker SS, 2015, FASEB J, V29, P4346, DOI 10.1096/fj.15-272013; Kirito K, 2004, MOL CELL BIOL, V24, P6751, DOI 10.1128/MCB.24.15.6751-6762.2004; KLOPFENSTEIN HS, 1978, CIRC RES, V42, P839, DOI 10.1161/01.RES.42.6.839; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; March of Dimes, 2016, 2016 PREM BIRTH REP; Mills RJ, 2017, P NATL ACAD SCI USA, V114, pE8372, DOI 10.1073/pnas.1707316114; Neary MT, 2014, J MOL CELL CARDIOL, V74, P340, DOI 10.1016/j.yjmcc.2014.06.013; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patterson AJ, 2010, CURR MOL MED, V10, P653; Perales-Clemente E, 2014, ANTIOXID REDOX SIGN, V21, P1648, DOI 10.1089/ars.2014.6000; RELLER MD, 1987, PEDIATR RES, V22, P621, DOI 10.1203/00006450-198712000-00001; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; RUDOLPH AM, 1970, CIRCULATION, V41, P343, DOI 10.1161/01.CIR.41.2.343; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; SPARKS JW, 1982, J CLIN INVEST, V70, P179, DOI 10.1172/JCI110591; Sundgren NC, 2003, J PHYSIOL-LONDON, V548, P881, DOI 10.1113/jphysiol.2003.038778; Thureen P J, 2001, Semin Neonatol, V6, P403, DOI 10.1053/siny.2001.0061; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; WELLS RJ, 1972, AM J PHYSIOL, V222, P1488, DOI 10.1152/ajplegacy.1972.222.6.1488; Zhang CC, 2014, ANTIOXID REDOX SIGN, V20, P1891, DOI 10.1089/ars.2012.5019	44	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7417	7426		10.1096/fj.201801330RR	http://dx.doi.org/10.1096/fj.201801330RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884246	Green Published			2022-12-26	WOS:000476114200060
J	Aziz, M; Wang, XQ; Tripathi, A; Bankaitis, VA; Chapman, KD				Aziz, Mina; Wang, Xiaoqiang; Tripathi, Ashutosh; Bankaitis, Vytas A.; Chapman, Kent D.			Structural analysis of a plant fatty acid amide hydrolase provides insights into the evolutionary diversity of bioactive acylethanolamides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; endocannabinoid; lipid signaling; Arabidopsis; hydrolase; fatty acid amide hydrolase (FAAH); N-acylethanolamines; oxylipins; quorum sensing; squeeze and lock mechanism; seed germination	N-ACYLETHANOLAMINES; CRYSTAL-STRUCTURE; ENDOCANNABINOIDS; IDENTIFICATION; METABOLISM; GROWTH; ENZYME; SITE	N-Acylethanolamines (NAEs) are fatty acid derivatives that in animal systems include the well-known bioactive metabolites of the endocannabinoid signaling pathway. Plants use NAE signaling as well, and these bioactive molecules often have oxygenated acyl moieties. Here, we report the three-dimensional crystal structures of the signal-terminating enzyme fatty acid amide hydrolase (FAAH) from Arabidopsis in its apo and ligand-bound forms at 2.1- and 3.2- resolutions, respectively. This plant FAAH structure revealed features distinct from those of the only other available FAAH structure (rat). The structures disclosed that although catalytic residues are conserved with the mammalian enzyme, AtFAAH has a more open substrate-binding pocket that is partially lined with polar residues. Fundamental differences in the organization of the membrane-binding cap and the membrane access channel also were evident. In accordance with the observed structural features of the substrate-binding pocket, kinetic analysis showed that AtFAAH efficiently uses both unsubstituted and oxygenated acylethanolamides as substrates. Moreover, comparison of the apo and ligand-bound AtFAAH structures identified three discrete sets of conformational changes that accompany ligand binding, suggesting a unique squeeze and lock substrate-binding mechanism. Using molecular dynamics simulations, we evaluated these conformational changes further and noted a partial unfolding of a random-coil helix within the region 531-537 in the apo structure but not in the ligand-bound form, indicating that this region likely confers plasticity to the substrate-binding pocket. We conclude that the structural divergence in bioactive acylethanolamides in plants is reflected in part in the structural and functional properties of plant FAAHs.	[Aziz, Mina; Wang, Xiaoqiang; Chapman, Kent D.] Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA; [Aziz, Mina; Wang, Xiaoqiang; Chapman, Kent D.] Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA; [Tripathi, Ashutosh; Bankaitis, Vytas A.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, XQ; Chapman, KD (corresponding author), Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA.; Wang, XQ; Chapman, KD (corresponding author), Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA.	xiaoqiang.wang@unt.edu; chapman@unt.edu		Chapman, Kent/0000-0003-0489-3072	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R35GM131804] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank staff scientists at the Stanford Synchrotron Radiation Laboratory (SSRL) for assistance with data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). We also thank The Laboratory for Molecular Simulation and High Performance Research Computing at Texas A&M University for software, support, and computer time.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Blancaflor EB, 2014, PLANT J, V79, P568, DOI 10.1111/tpj.12427; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414, DOI 10.1107/S0907444994002660; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2013, J BIOL CHEM, V288, P21422, DOI 10.1074/jbc.M113.453837; Gachet MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41177; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keereetaweep J, 2015, PLANT J, V82, P315, DOI 10.1111/tpj.12821; Keereetaweep J, 2013, PLANT CELL, V25, P3824, DOI 10.1105/tpc.113.119024; Kilaru A, 2011, J BIOL CHEM, V286, P15205, DOI 10.1074/jbc.M110.217588; Kim Sang-Chul, 2013, Methods Mol Biol, V1009, P115, DOI 10.1007/978-1-62703-401-2_12; Kim SC, 2009, J BIOL CHEM, V284, P34065, DOI 10.1074/jbc.M109.059022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee S, 2015, BIOCHEM BIOPH RES CO, V467, P268, DOI 10.1016/j.bbrc.2015.09.177; Liebeschuetz JW, 2012, J COMPUT AID MOL DES, V26, P737, DOI 10.1007/s10822-012-9551-4; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; Min XS, 2011, P NATL ACAD SCI USA, V108, P7379, DOI 10.1073/pnas.1016167108; Molecular Operating Environment (MOE), 2018, MOL OP ENV MOE VERS; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palermo G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004231; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Schrodinger Maestro, 2018, MAESTR REL 2018 1; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Teplitski M, 2011, CHEM REV, V111, P100, DOI 10.1021/cr100045m; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103	41	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7419	7432		10.1074/jbc.RA118.006672	http://dx.doi.org/10.1074/jbc.RA118.006672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30894416	Green Published, hybrid			2022-12-26	WOS:000468402900027
J	Choquet, K; Forget, D; Meloche, E; Dicaire, MJ; Bernard, G; Vanderver, A; Schiffmann, R; Fabian, MR; Teichmann, M; Coulombe, B; Brais, B; Kleinman, CL				Choquet, Karine; Forget, Diane; Meloche, Elisabeth; Dicaire, Marie-Josee; Bernard, Genevieve; Vanderver, Adeline; Schiffmann, Raphael; Fabian, Marc R.; Teichmann, Martin; Coulombe, Benoit; Brais, Bernard; Kleinman, Claudia L.			Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase III; transfer RNA (tRNA); myelin; CRISPR; Cas; proteomics; brain cytoplasmic 200 RNA (BCYRN1); leukodystrophy; oligodendrocyte; RNA-seq; transcription	BC1 RNA; BRF1 MUTATIONS; RARS CAUSE; HYPOMYELINATION; TRANSLATION; SYNTHETASE; GENES; METHYLATION; EXPRESSION; EFFICIENT	RNA polymerase III (Pol III) is an essential enzyme responsible for the synthesis of several small noncoding RNAs, a number of which are involved in mRNA translation. Recessive mutations in POLR3A, encoding the largest subunit of Pol III, cause POLR3-related hypomyelinating leukodystrophy (POLR3-HLD), characterized by deficient central nervous system myelination. Identification of the downstream effectors of pathogenic POLR3A mutations has so far been elusive. Here, we used CRISPR-Cas9 to introduce the POLR3A mutation c.2554AG (p.M852V) into human cell lines and assessed its impact on Pol III biogenesis, nuclear import, DNA occupancy, transcription, and protein levels. Transcriptomic profiling uncovered a subset of transcripts vulnerable to Pol III hypofunction, including a global reduction in tRNA levels. The brain cytoplasmic BC200 RNA (BCYRN1), involved in translation regulation, was consistently affected in all our cellular models, including patient-derived fibroblasts. Genomic BC200 deletion in an oligodendroglial cell line led to major transcriptomic and proteomic changes, having a larger impact than those of POLR3A mutations. Upon differentiation, mRNA levels of the MBP gene, encoding myelin basic protein, were significantly decreased in POLR3A-mutant cells. Our findings provide the first evidence for impaired Pol III transcription in cellular models of POLR3-HLD and identify several candidate effectors, including BC200 RNA, having a potential role in oligodendrocyte biology and involvement in the disease.	[Choquet, Karine; Bernard, Genevieve; Brais, Bernard; Kleinman, Claudia L.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0C7, Canada; [Choquet, Karine; Fabian, Marc R.; Kleinman, Claudia L.] Jewish Gen Hosp, Lady Davis Inst Med Res, 3999 Cote Ste Catherine Rd,Rm E-542, Montreal, PQ H3T 1E2, Canada; [Choquet, Karine; Meloche, Elisabeth; Dicaire, Marie-Josee; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Forget, Diane; Coulombe, Benoit] IRCM, Translat Prote Lab, Montreal, PQ H2W 1R7, Canada; [Bernard, Genevieve; Brais, Bernard] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada; [Bernard, Genevieve] McGill Univ, Dept Pediat, Montreal, PQ H3A 0G4, Canada; [Bernard, Genevieve] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Dept Internal Med,Div Med Genet, Montreal, PQ H4A 3J1, Canada; [Bernard, Genevieve] McGill Univ, Hlth Ctr, Res Inst, Child Hlth & Human Dev Program, Montreal, PQ H4A 3J1, Canada; [Bernard, Genevieve] McGill Univ, Hlth Ctr, Res Inst, MyeliNeuroGene Lab, Montreal, PQ H4A 3J1, Canada; [Vanderver, Adeline] CHOP, Div Neurol, Philadelphia, PA 19104 USA; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75204 USA; [Teichmann, Martin] Univ Bordeaux, CNRS UMR5320, INSERM U1212, Bordeaux, France; [Coulombe, Benoit] Univ Montreal, Dept Biochim & Med Mol, Montreal, PQ H3T 1J4, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; McGill University; McGill University; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor Scott & White Health; Baylor University Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal	Kleinman, CL (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3999 Cote Ste Catherine Rd,Rm E-542, Montreal, PQ H3T 1E2, Canada.	claudia.kleinman@mcgill.ca	Brais, Bernard/Y-3910-2019; Vanderver, Adeline/CAG-5072-2022; Bernard, Geneviève/AAU-7569-2020; Teichmann, Martin/M-7407-2014	Bernard, Geneviève/0000-0002-9634-2966; Teichmann, Martin/0000-0002-5257-0510	Canadian Institutes of Health Research [MOP-126141, MOP-G2-341146-159133-BRIDG, 201610PJT-377869]; Fondation Leuco Dystrophie; European Leukodystrophy Association [2015-004C2C]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leuco Dystrophie; European Leukodystrophy Association	This work was supported in part by Canadian Institutes of Health Research Grants MOP-126141, MOP-G2-341146-159133-BRIDG, and 201610PJT-377869, Fondation Leuco Dystrophie, and European Leukodystrophy Association Grant 2015-004C2C. The authors declare that they have no conflicts of interest with the contents of this article.	Alla RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085648; Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Arimbasseri AG, 2016, TRENDS BIOCHEM SCI, V41, P546, DOI 10.1016/j.tibs.2016.03.003; Arimbasseri AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005671; Azmanov DN, 2016, HUM MOL GENET, V25, P4302, DOI 10.1093/hmg/ddw263; Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Bonhoure N, 2015, GENE DEV, V29, P934, DOI 10.1101/gad.258350.115; Booy EP, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0679-7; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Canella D, 2012, GENOME RES, V22, P666, DOI 10.1101/gr.130286.111; Choquet K, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0294-y; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; De Vries GH, 2010, NEUROCHEM RES, V35, P1978, DOI 10.1007/s11064-010-0318-9; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorboz I, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000289; Dumay-Odelot H, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27526; Duning K, 2008, J NEUROCHEM, V105, P351, DOI 10.1111/j.1471-4159.2007.05138.x; Eccles J. C., 1967, CEREBELLUM NEURONAL, P7; Eom T, 2014, J CELL BIOL, V207, P237, DOI 10.1083/jcb.201401005; Eom T, 2011, MOL CELL BIOL, V31, P4538, DOI 10.1128/MCB.05885-11; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Gogakos T, 2017, CELL REP, V20, P1463, DOI 10.1016/j.celrep.2017.07.029; Hein PP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-141; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Jee YH, 2017, CLIN GENET, V91, P739, DOI 10.1111/cge.12887; Kapur M, 2017, NEURON, V96, P616, DOI 10.1016/j.neuron.2017.09.057; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kevelam SH, 2016, NEUROPEDIATRICS, V47, P349, DOI 10.1055/s-0036-1588020; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05097-3; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kutter C, 2011, NAT GENET, V43, P948, DOI 10.1038/ng.906; La Piana R, 2016, NEUROLOGY, V86, P1622, DOI 10.1212/WNL.0000000000002612; Lalonde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178700; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MCLAURIN J, 1995, J NEUROBIOL, V26, P283, DOI 10.1002/neu.480260212; Mendes MI, 2018, AM J HUM GENET, V102, P676, DOI 10.1016/j.ajhg.2018.02.011; Minnerop M, 2017, BRAIN, V140, P1561, DOI 10.1093/brain/awx095; Nafisinia M, 2017, EUR J HUM GENET, V25, P1134, DOI 10.1038/ejhg.2017.119; Nakayama T, 2017, HUM MUTAT, V38, P1348, DOI 10.1002/humu.23250; Orioli A, 2016, GENOME RES, V26, P624, DOI 10.1101/gr.201400.115; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramsay EP, 2018, BBA-GENE REGUL MECH, V1861, P285, DOI 10.1016/j.bbagrm.2017.11.005; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Shin H, 2017, RNA BIOL, V14, P1418, DOI 10.1080/15476286.2017.1297913; Shin H, 2017, BMB REP, V50, P318, DOI 10.5483/BMBRep.2017.50.6.217; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Singh R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.168; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Tetreault M, 2011, AM J HUM GENET, V89, P652, DOI 10.1016/j.ajhg.2011.10.006; Thiffault I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8623; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Turowski TW, 2016, GENOME RES, V26, P933, DOI 10.1101/gr.205492.116; Vanderver A, 2013, J NEUROPATH EXP NEUR, V72, P67, DOI 10.1097/NEN.0b013e31827c99d2; Voccoli V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.483; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	71	23	26	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7445	7459		10.1074/jbc.RA118.006271	http://dx.doi.org/10.1074/jbc.RA118.006271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30898877	Green Published, hybrid			2022-12-26	WOS:000468402900029
J	Xie, JL; Van Damme, P; Fang, D; Proud, CG				Xie, Jianling; Van Damme, Petra; Fang, Danielle; Proud, Christopher G.			Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation elongation factor; heat shock protein (HSP); proteasome; protein synthesis; apoptosis; cancer; elongation; eukaryotic elongation factor 2 kinase (eEF2K); molecular chaperone; mRNA translation	INHIBITION; DEGRADATION; MECHANISM	Eukaryotic elongation factor 2 kinase (eEF2K) negatively regulates the elongation stage of mRNA translation and is activated under different stress conditions to slow down protein synthesis. One effect of eEF2K is to alter the repertoire of expressed proteins, perhaps to aid survival of stressed cells. Here, we applied pulsed stable isotope labeling with amino acids in cell culture (SILAC) to study changes in the synthesis of specific proteins in human lung adenocarcinoma (A549) cells in which eEF2K had been depleted by an inducible shRNA. We discovered that levels of heat-shock protein 90 (HSP90) are increased in eEF2K-depleted human cells as well as in eEF2K-knockout (eEF2K(-/-)) mouse embryonic fibroblasts (MEFs). This rise in HSP90 coincided with an increase in the fraction of HSP90 mRNAs associated with translationally active polysomes, irrespective of unchanged total HSP90 levels. These results indicate that blocking eEF2K function can enhance expression of HSP90 chaperones. In eEF2K(-/-) mouse embryonic fibroblasts (MEFs), inhibition of HSP90 by its specific inhibitor AUY922 promoted the accumulation of ubiquitinated proteins. Notably, HSP90 inhibition promoted apoptosis of eEF2K(-/-) MEFs under proteostatic stress induced by the proteasome inhibitor MG132. Up-regulation of HSP90 likely protects cells from protein folding stress, arising, for example, from faster rates of polypeptide synthesis due to the lack of eEF2K. Our findings indicate that eEF2K and HSPs closely cooperate to maintain proper proteostasis and suggest that concomitant inhibition of HSP90 and eEF2K could be a strategy to decrease cancer cell survival.	[Xie, Jianling; Fang, Danielle; Proud, Christopher G.] South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, North Terrace, Adelaide, SA 5000, Australia; [Van Damme, Petra] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Van Damme, Petra] VIB Ctr Med Biotechnol, Ghent, Belgium; [Fang, Danielle; Proud, Christopher G.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia	South Australian Health & Medical Research Institute (SAHMRI); Ghent University; Flanders Institute for Biotechnology (VIB); University of Adelaide	Proud, CG (corresponding author), South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, North Terrace, Adelaide, SA 5000, Australia.; Proud, CG (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.	christopher.proud@sahmri.com	Xie, Jianling/N-1877-2014; Van Damme, Petra/C-7269-2008	Xie, Jianling/0000-0002-0588-8016; Van Damme, Petra/0000-0001-9090-027X				Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Centenera MM, 2012, CLIN CANCER RES, V18, P3562, DOI 10.1158/1078-0432.CCR-12-0782; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Gismondi A, 2014, NUCLEIC ACIDS RES, V42, P12668, DOI 10.1093/nar/gku996; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Jonckheere V, 2018, MOL CELL PROTEOMICS, V17, P694, DOI 10.1074/mcp.RA117.000360; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Moore CEJ, 2015, MOL CELL BIOL, V35, P1788, DOI 10.1128/MCB.01457-14; Proud CG, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033050; Scheckel C, 2018, NAT REV GENET, V19, P405, DOI 10.1038/s41576-018-0011-4; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Varland S, 2018, MOL CELL PROTEOMICS, V17, P2309, DOI 10.1074/mcp.RA118.000982; Wang XM, 2015, BIOCHEM J, V467, P321, DOI 10.1042/BJ20150089; Xie JL, 2019, CURR BIOL, V29, P737, DOI 10.1016/j.cub.2019.01.029; Xie JL, 2018, INT J CANCER, V142, P1865, DOI 10.1002/ijc.31210; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yang J, 2001, CANCER RES, V61, P4010; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	26	13	12	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7169	7176		10.1074/jbc.AC119.008036	http://dx.doi.org/10.1074/jbc.AC119.008036			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30890561	Green Published, hybrid			2022-12-26	WOS:000468402900007
J	Johnson, TN; Nasman, K; Wallace, ZP; Olson, LE; Squires, JR; Nielson, RM; Kennedy, PL				Johnson, Tracey N.; Nasman, Kristen; Wallace, Zachary P.; Olson, Lucretia E.; Squires, John R.; Nielson, Ryan M.; Kennedy, Patricia L.			Survey design for broad-scale, territory-based occupancy monitoring of a raptor: Ferruginous hawk (Buteo regalis) as a case study	PLOS ONE			English	Article							POWER ANALYSIS; GOLDEN EAGLES; SPOTTED OWLS; TRENDS; CONSERVATION; EXAMPLES; DYNAMICS; HABITAT; BIRDS; RATES	Given the uncertain population status of low-density, widely-occurring raptors, monitoring changes in abundance and distribution is critical to conserving populations. Nest-based monitoring is a common, useful approach, but the difficulty and expense of monitoring raptor nests and importance of reliable trend data to conservation requires that limited resources are allocated efficiently. Power analyses offer a helpful tool to ensure that monitoring programs have the ability to detect trends and to optimize financial resources devoted to monitoring. We evaluated alternative monitoring designs for raptors to identify appropriate survey effort to detect population trends. We used data collected from a territory-occupancy study of ferruginous hawks throughout Wyoming to guide simulations and evaluate the ability to detect trends in occupancy rates. Results suggest that greater gains in precision of trend estimation may be achieved through the addition of more sites and not more visits; statistical power was >= 80% when monitoring lasted 20 years and population declines were 20%; and probability of detection affected statistical power less than rates of population decline. Monitoring at least 150 sites for 20 years would provide reasonable estimates of trend in occupancy given certain rates of detection and occupancy, but only for population declines of 20%. Removal sampling did not result in substantial changes of any metrics used to evaluate simulations, providing little justification for employing the standard design if territory occupancy is the variable of interest. Initial rates of territory occupancy may be biased high, a problem inherent to many studies that monitor territory occupancy. We explored the effects of lower rates of initial occupancy on the ability to detect trends. Although we present data from a study of ferruginous hawks, our simulations can be applied to other raptor species with similar life history and population dynamics to provide guidance for future trend estimation of territory occupancy.	[Johnson, Tracey N.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Nasman, Kristen; Nielson, Ryan M.] Western Ecosyst Technol Inc, Cheyenne, WY USA; [Wallace, Zachary P.] Univ Wyoming, Wyoming Nat Divers Database, Laramie, WY 82071 USA; [Olson, Lucretia E.; Squires, John R.] US Forest Serv, Rocky Mt Res Stn, Missoula, MT USA; [Kennedy, Patricia L.] Oregon State Univ, Dept Fisheries & Wildlife, Union, OR USA; [Kennedy, Patricia L.] Oregon State Univ, Eastern Oregon Agr Res Ctr, Union, OR USA; [Nielson, Ryan M.] Eagle Environm Inc, Santa Fe, NM USA	Idaho; University of Idaho; University of Wyoming; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; Oregon State University	Johnson, TN (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	traceyj@uidaho.edu		Johnson, Tracey/0000-0003-3480-8596				Andersen David E., 2007, P89; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2011, FGDC CADASTRAL SUBCO; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Barata IM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16534-8; Bart Jonathan, 2005, U S Forest Service General Technical Report PSW, V191, P771; Bechard MJ, 2017, BIRDS N AM, DOI [10.2173/bna.ferhaw.02, DOI 10.2173/BNA.FERHAW.02]; Bird DM., 2007, RAPTOR RES MANAGEMEN; Boivin NL, 2016, P NATL ACAD SCI USA, V113, P6388, DOI 10.1073/pnas.1525200113; Booms TL, 2010, J RAPTOR RES, V44, P175, DOI 10.3356/JRR-09-70.1; Brown JL, 2013, J WILDLIFE MANAGE, V77, P1067, DOI 10.1002/jwmg.566; Bruggeman JE, 2011, J RAPTOR RES, V45, P290, DOI 10.3356/JRR-10-52.1; Chambers LE, 2015, REG ENVIRON CHANGE, V15, P197, DOI 10.1007/s10113-014-0634-8; Christensen P, 2013, ENVIRON MONIT ASSESS, V185, P7279, DOI 10.1007/s10661-013-3100-z; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; Di Stefano J, 2003, FUNCT ECOL, V17, P707, DOI 10.1046/j.1365-2435.2003.00782.x; Dodd Jr C. K., 2003, 1258 USGS, V1258; Dugger KM, 2011, ECOL APPL, V21, P2459, DOI 10.1890/10-2142.1; Ellis MM, 2015, METHODS ECOL EVOL, V6, P621, DOI 10.1111/2041-210X.12369; Ellis MM, 2014, CONSERV BIOL, V28, P52, DOI 10.1111/cobi.12139; Farmer Christopher J., 2008, P303; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Good RE, 2007, J WILDLIFE MANAGE, V71, P395, DOI 10.2193/2005-593; Greeney HF, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500310; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Hager SB, 2009, J RAPTOR RES, V43, P210, DOI 10.3356/JRR-08-63.1; Hatfield JS, 1996, WILDLIFE SOC B, V24, P505; Helander B, 2008, AMBIO, V37, P425, DOI 10.1579/0044-7447(2008)37[425:URAESM]2.0.CO;2; IUCN. IUCN, 2020, IUCN RED LIST THREAT; Jasikoff TM, 1982, FWSOBS8210101982; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; Keane A, 2012, ANIM CONSERV, V15, P457, DOI 10.1111/j.1469-1795.2012.00575.x; Kennedy PL, 2014, CONDOR, V116, P435, DOI 10.1650/CONDOR-12-174.1; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Kochert MN, 1999, J WILDLIFE MANAGE, V63, P773, DOI 10.2307/3802790; Lanier WE, 2015, SITE OCCUPANCY MEXIC; Latif QS, 2018, ECOL EVOL, V8, P1171, DOI 10.1002/ece3.3725; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lodenius M, 2013, ECOTOXICOLOGY, V22, P1319, DOI 10.1007/s10646-013-1128-z; Lohmus A, 2003, ECOGRAPHY, V26, P545, DOI 10.1034/j.1600-0587.1999.03575.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Murn C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160368; Olson GS, 2005, J WILDLIFE MANAGE, V69, P918, DOI 10.2193/0022-541X(2005)069[0918:MOSODF]2.0.CO;2; Olson LE, 2015, J RAPTOR RES, V49, P400, DOI 10.3356/rapt-49-04-400-412.1; Pagel J. E., 2010, INTERIM GOLDEN EAGLE; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shannon G, 2014, PEERJ, V2, DOI 10.7717/peerj.532; Stahlecker DW, 2017, J RAPTOR RES, V51, P305, DOI 10.3356/JRR-16-61.1; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; U.S. Fish and Wildlife Service Division of Migratory Bird Management, 2008, BIRDS CONS 2008; US Fish and Wildlife Service, 2009, POSTD MON PLAN BALD; Wallace ZP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152977; Walther BA, 2005, ECOGRAPHY, V28, P815, DOI 10.1111/j.2005.0906-7590.04112.x; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; White EM, 2009, LANDSCAPE URBAN PLAN, V89, P37, DOI 10.1016/j.landurbplan.2008.09.004; Wiggins DA, 2017, J WILDLIFE MANAGE, V81, P337, DOI 10.1002/jwmg.21194; Woodbridge B., 2006, WO71 USDA FOR SERV; Zielinski WJ, 1996, ECOL APPL, V6, P1254, DOI 10.2307/2269605	65	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213654	10.1371/journal.pone.0213654	http://dx.doi.org/10.1371/journal.pone.0213654			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901333	gold, Green Published, Green Submitted			2022-12-26	WOS:000462000400013
J	Vitali, RV; Cain, SM; Ojeda, LV; Potter, MV; Zaferiou, AM; Davidson, SP; Coyne, ME; Hancock, CL; Mendoza, A; Stirling, LA; Perkins, NC				Vitali, Rachel V.; Cain, Stephen M.; Ojeda, Lauro V.; Potter, Michael V.; Zaferiou, Antonia M.; Davidson, Steven P.; Coyne, Megan E.; Hancock, Clifford L.; Mendoza, Alyssa; Stirling, Leia A.; Perkins, Noel C.			Body-worn IMU array reveals effects of load on performance in an outdoor obstacle course	PLOS ONE			English	Article							CARRIAGE; ARMOR; KINEMATICS; EQUIPMENT; PATTERNS; IMPACT; MEN	This study introduces a new method to understand how added load affects human performance across a broad range of athletic tasks (ten obstacles) embedded in an outdoor obstacle course. The method employs an array of wearable inertial measurement units (IMUs) to wirelessly record the movements of major body segments to derive obstacle-specific metrics of performance. The effects of load are demonstrated on (N = 22) participants who each complete the obstacle course under four conditions including unloaded (twice) and with loads of 15% and 30% of their body weight (a total of 88 trials across the group of participants). The IMU-derived performance metrics reveal marked degradations in performance with increasing load across eight of the ten obstacles. Overall, this study demonstrates the significant potential in using this wearable technology to evaluate human performance across multiple tasks and, simultaneously, the adverse effects of body-borne loads on performance. The study addresses a major need of military organizations worldwide that frequently employ standardized obstacle courses to understand how added loads influence warfighter performance. Importantly, the findings and conclusions drawn from IMU data would not be possible using traditional timing metrics used to evaluate task performance.	[Vitali, Rachel V.; Cain, Stephen M.; Ojeda, Lauro V.; Potter, Michael V.; Davidson, Steven P.; Perkins, Noel C.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Zaferiou, Antonia M.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Coyne, Megan E.; Hancock, Clifford L.] Combat Capabil Dev Command Soldier Ctr, Natick, MA USA; [Mendoza, Alyssa; Stirling, Leia A.] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Stirling, Leia A.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Rush University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Vitali, RV (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	vitalir@umich.edu		Cain, Stephen/0000-0003-1961-4195; Potter, Michael/0000-0002-3793-5657; Vitali, Rachel/0000-0002-1436-6148	US Army Contracting Command-APG, Natick Contracting Division, Natick, MA [W911QY-15-C-0053]	US Army Contracting Command-APG, Natick Contracting Division, Natick, MA	This material is based upon work supported by the US Army Contracting Command-APG, Natick Contracting Division, Natick, MA, under contract W911QY-15-C-0053. This award was made to the Regents of the University of Michigan and for this award NP serves as PI and LS serves as co-PI. The sponsor website is: [www.nsrdec.army.mil]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], T1493 US ARM RES I E; Askew GN, 2012, P ROY SOC B-BIOL SCI, V279, P640, DOI 10.1098/rspb.2011.0816; Birrell SA, 2007, GAIT POSTURE, V26, P611, DOI 10.1016/j.gaitpost.2006.12.008; Birrell SA, 2009, MIL MED, V174, P177, DOI 10.7205/MILMED-D-58-7308; Birrell SA, 2009, ERGONOMICS, V52, P1298, DOI 10.1080/00140130903003115; Cain SM, 2016, GAIT POSTURE, V43, P65, DOI 10.1016/j.gaitpost.2015.10.022; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crowder TA, 2007, MIL MED, V172, P596, DOI 10.7205/MILMED.172.6.596; Dempsey PC, 2013, APPL ERGON, V44, P957, DOI 10.1016/j.apergo.2013.02.011; Frykman Peter N, 2012, J Strength Cond Res, V26 Suppl 2, pS30, DOI 10.1519/JSC.0b013e31825cedfa; Frykman PN, 2000, P RTO HFM SPEC M SOL; Furusawa K, 1927, P R SOC LOND B-CONTA, V102, P29, DOI 10.1098/rspb.1927.0035; Harper WH, 1997, PROCEEDINGS OF THE HUMAN FACTORS AND ERGONOMICS SOCIETY 41ST ANNUAL MEETING, 1997, VOLS 1 AND 2, P604; Hasselquist L, 2008, P 26 ARM SCI C DEC O; Knapik J, 2010, LOAD CARRIAGE MILITA; Knapik J., 1990, T1790 US ARM RES I E; LaFiandra M, 2003, T0315 US ARM RES I E; Larsen B, 2014, MIL MED, V179, P428, DOI 10.7205/MILMED-D-13-00318; Larsen B, 2012, MIL MED, V177, P1308, DOI 10.7205/MILMED-D-11-00435; Majumdar D, 2013, ERGONOMICS, V56, P1917, DOI 10.1080/00140139.2013.835871; MARTIN PE, 1985, MIL MED, V150, P357, DOI 10.1093/milmed/150.7.357; McGinnis RS, 2017, BIOMED SIGNAL PROCES, V32, P150, DOI 10.1016/j.bspc.2016.10.013; McGinnis RS, 2016, SPORTS ENG, V19, P21, DOI 10.1007/s12283-015-0185-3; Mitchell KB, 2016, TR17002 DEV ENG CTR; Murray S, 2017, P AM SOC ENG MAN INT; O'Neal EK, 2014, MIL MED, V179, P950, DOI 10.7205/MILMED-D-14-00079; Ojeda L, 2007, J NAVIGATION, V60, P391, DOI 10.1017/S0373463307004286; Ojeda LV, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17112647; Orr R. M., 2011, AUSTR DEFENCE FORCE, V185, P52; Pandorf CE, 2001, CORRELATES LOAD CARR; Pandorf Clay E, 2002, Work, V18, P179; Park H, 2013, ERGONOMICS, V56, P1167, DOI 10.1080/00140139.2013.791377; Patrick SK, 2009, J NEUROPHYSIOL, V101, P603, DOI 10.1152/jn.91125.2008; Polcyn A, 2002, TR02010 US ARM RES I, P1; Polcyn AF, 2000, P RTO HFM SPEC M SOL; Seay JF, 2014, MIL MED, V179, P85, DOI 10.7205/MILMED-D-13-00090; Sell TC, 2010, MIL MED, V175, P41, DOI 10.7205/MILMED-D-09-00066; Silder A, 2013, J BIOMECH, V46, P2522, DOI 10.1016/j.jbiomech.2013.06.020; Tack D, 2012, N00014011C0206 ONR; Tammana A, 2018, APPL ERGON, V70, P68, DOI 10.1016/j.apergo.2018.01.014; Taylor NAS, 2016, APPL PHYSIOL NUTR ME, V41, pS131, DOI 10.1139/apnm-2015-0486; Vaverka F, 2013, J HUM KINET, V38, P191, DOI 10.2478/hukin-2013-0059; Vitali RV, 2019, J BIOMECH, V84, P121, DOI 10.1016/j.jbiomech.2018.12.030; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zaferiou AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188184	45	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214008	10.1371/journal.pone.0214008	http://dx.doi.org/10.1371/journal.pone.0214008			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897123	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700055
J	Burns, RD; Fu, Y; Constantino, N				Burns, Ryan D.; Fu, You; Constantino, Nora			Measurement agreement in percent body fat estimates among laboratory and field assessments in college students: Use of equivalence testing	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; NEAR-INFRARED INTERACTANCE; X-RAY ABSORPTIOMETRY; GENERALIZED EQUATIONS; AEROBIC CAPACITY; MASS INDEX; RELIABILITY; VALIDITY; VALIDATION; DENSITY	The purpose of this study was to examine the agreement in percent body fat estimates among 7 laboratory and field assessments against dual-emission x-ray absorptiometry using equivalence testing. Participants were 437 college students (mean age = 19.2 +/- 0.6 years). Dual-emission x-ray absorptiometry was used as the criterion with hydrostatic weighing, skinfold thickness, air displacement plethysmography, near infrared reactance, and three methods of bioelectrical impedance analysis examined as surrogate assessments. Relative agreement was examined using intraclass correlation coefficients. Group level agreement was examined using equivalence testing. Individual-level agreement was assessed using Mean Absolute Percent Error and Bland-Altman Plots. Single measure intraclass correlation coefficient scores ranged from 0.71-0.80. Hydrostatic weighing, skin-fold thickness, air displacement plethysmography, and 4-electrode bioelectrical impedance analysis showed statistical equivalence with the criterion using a 10% Equivalence Interval with absolute mean differences ranging from 1.0%-4.9% body fat. Mean Absolute Percent Error ranged from 11.7% using skinfold thickness to 21.9% using Omron (hand-held) bioelectrical impedance analysis. Limits of Agreement were heteroscedastic across the range of mean scores compared to dual-emission x-ray absorptiometry, with greater mean differences observed at higher levels of percent body fat. Hydrostatic weighing, skinfold thickness, air displacement plethysmography, and 4-electrode bioelectrical impedance analysis showed strong evidence for statistical equivalence with dual-emission x-ray absorptiometry in a sample of college students.	[Burns, Ryan D.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA; [Fu, You; Constantino, Nora] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA	Utah System of Higher Education; University of Utah; Nevada System of Higher Education (NSHE); University of Nevada Reno	Burns, RD (corresponding author), Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.	ryan.d.burns@utah.edu	Burns, Ryan/AAL-1393-2020	Burns, Ryan/0000-0002-5933-4633				Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107; Achamrah N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200465; Ackland TR, 2012, SPORTS MED, V42, P227, DOI 10.2165/11597140-000000000-00000; Aguirre CA, 2015, EUR J CLIN NUTR, V69, P269, DOI 10.1038/ejcn.2014.144; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Bacchi E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17788-y; Barreira T.V., 2013, INT J EXERC SCI, V6, P20; Bilsborough JC, 2014, J SPORT SCI, V32, P1821, DOI 10.1080/02640414.2014.926380; Blackburn H, 2014, INT J EPIDEMIOL, V43, P665, DOI 10.1093/ije/dyu061; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blundell JE, 2014, OBESITY FACTS, V7, P322, DOI 10.1159/000368783; Borga M, 2018, J INVEST MED, V66, P887, DOI 10.1136/jim-2018-000722; Bosy-Westphal A, 2018, EUR J CLIN NUTR, V72, P638, DOI 10.1038/s41430-018-0158-2; Castro-Pinero J, 2010, BRIT J SPORT MED, V44, P934, DOI 10.1136/bjsm.2009.058321; Claros Geo, 2005, BMC Pediatr, V5, P37, DOI 10.1186/1471-2431-5-37; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dehghan M, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-26; Dixon PM, 2018, MED SCI SPORT EXER, V50, P837, DOI 10.1249/MSS.0000000000001481; Duren Dana L, 2008, J Diabetes Sci Technol, V2, P1139; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Fogelholm M, 1997, EUR J CLIN NUTR, V51, P495, DOI 10.1038/sj.ejcn.1600448; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gonzalez-Ruiz K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081086; Hart PD, 2017, J PHYS FIT MED TREAT, DOI [10.19080/JPFMTS.2017.01.555561, DOI 10.19080/JPFMTS.2017.01.555561]; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; JENSEN MD, 1993, MAYO CLIN PROC, V68, P867, DOI 10.1016/S0025-6196(12)60695-8; Kabiri LS, 2015, CHILD OBES, V11, P650, DOI 10.1089/chi.2014.0156; KLIMISTAVANTZIS D, 1992, NUTR RES, V12, P427, DOI 10.1016/S0271-5317(05)80014-4; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kremer MM, 1998, MIL MED, V163, P781, DOI 10.1093/milmed/163.11.781; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lee SY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060738; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; Maffeis C, 2001, HORM RES, V55, P42, DOI 10.1159/000063462; Mander A, 2012, BATPLOT STATA MODULE; MCCRORY MA, 1995, MED SCI SPORT EXER, V27, P1686; Nicols J, 2006, INT J BODY COMP RES, V4, P153; Norcross J, 2004, BRIT J SPORT MED, V38, P472, DOI 10.1136/bjsm.2003.005413; O'Brien C, 2002, INT J SPORTS MED, V23, P361, DOI 10.1055/s-2002-33145; Pescatello LS, 2014, ACSMS GUIDELINES EXE; Robinson AP, 2005, TREE PHYSIOL, V25, P903, DOI 10.1093/treephys/25.7.903; Saint-Maurice PF, 2015, RES Q EXERCISE SPORT, V86, pS66, DOI 10.1080/02701367.2015.1043002; SCHREINER PJ, 1995, J CLIN EPIDEMIOL, V48, P1361, DOI 10.1016/0895-4356(95)00052-6; Schubert MM, 2019, CLIN PHYSIOL FUNCT I, V39, P150, DOI 10.1111/cpf.12550; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Suni JH, 1999, INT J SPORTS MED, V20, P183, DOI 10.1055/s-2007-971115; Tucker LA, 2014, PERCEPT MOTOR SKILL, V118, P563, DOI 10.2466/03.PMS.118k15w5; Van der Ploeg GE, 2003, J APPL PHYSIOL, V94, P499, DOI 10.1152/japplphysiol.00436.2002; Wagner DR, 1999, RES Q EXERCISE SPORT, V70, P135, DOI 10.1080/02701367.1999.10608031; Warner J G Jr, 1986, Br J Sports Med, V20, P17; Welk GJ, 2011, AM J PREV MED, V41, pS131, DOI 10.1016/j.amepre.2011.07.011; Wilmore J.H., 1969, MED SCI SPORTS, V1, P87; WILMORE KM, 1994, INT J OBESITY, V18, P375; Zhu WM, 2016, J SPORT HEALTH SCI, V5, P77, DOI 10.1016/j.jshs.2016.01.019; Zhu WM, 2012, J SPORT HEALTH SCI, V1, P9, DOI 10.1016/j.jshs.2012.02.002	57	9	9	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0214029	10.1371/journal.pone.0214029	http://dx.doi.org/10.1371/journal.pone.0214029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893355	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900065
J	Pan, TC; Tsai, YH; Chen, WC; Hsieh, YL				Pan, Tien-Chien; Tsai, Yu-Hsin; Chen, Wen-Chi; Hsieh, Yueh-Ling			The effects of laser acupuncture on the modulation of cartilage extracellular matrix macromolecules in rats with adjuvant-induced arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ARTICULAR-CARTILAGE; SIGNALING PATHWAY; DAMAGE; ELECTROACUPUNCTURE; EXPRESSION; PROTEIN; BONE	Objectives Articular cartilage damage related to irreversible physical disability affects most patients with chronic rheumatoid arthritis (RA). Strategies targeting the preservation of cartilage function are needed. Laser acupuncture (LA) can be an emerging alternative therapy for RA; however, its molecular mechanism underlying the beneficial effect on cartilage has not been elucidated. This study aimed to examine the potential chondroprotective effects of LA on extracellular matrix (ECM) macromolecules and proinflammatory cytokines in the articular cartilage of adjuvant-induced arthritis (AIA) rats and explore its related mechanisms. Design Monoarthritis was induced in adult male SpragueDawley rats (250300 g) via intraarticular injection of complete Freunds adjuvant (CFA) into the tibiotarsal joint. Animals were treated with LA at BL60 and KI3 acupoints three days after CFA administration with a 780 nm GaAlAs laser at 15 J/cm(2) daily for ten days. The main outcome measures including paw circumference, paw withdrawal threshold, histopathology and immunoassays of tumor necrosis factor-alpha (TNF-alpha), collagen type II (CoII), cartilage oligomeric matrix protein (COMP) were analyzed. Results LA significantly reduced ankle edema and inflammation-induced hyperalgesia in AIA rats (P < 0.05). Moreover, the TNF-alpha levels were significantly decreased while CoII, COMP and proteoglycans proteins were significantly enhanced following LA stimulation of the AIA cartilage compared to those treated with sham-LA (P < 0.05). Conclusions LA attenuates cartilage degradation in AIA rat by suppressing TNF-alpha activation and up-regulating ECM macromolecules, suggesting LA might be of potential clinical interest in RA treatment.	[Pan, Tien-Chien; Tsai, Yu-Hsin; Chen, Wen-Chi] China Med Univ, Coll Chinese Med, Sch Chinese Med, Grad Inst Chinese Med, Taichung, Taiwan; [Chen, Wen-Chi] China Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Chen, Wen-Chi] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Chen, Wen-Chi] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hsieh, Yueh-Ling] China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hsieh, YL (corresponding author), China Med Univ, Grad Inst Rehabil Sci, Dept Phys Therapy, Taichung, Taiwan.	sherrie@mail.cmu.edu.tw		Hsieh, Yueh-Ling/0000-0002-8507-170X	Ministry of Science and Technology, National Science Council of Taiwan [NSC 101-2314-B-241-039-003MY2]; China Medical University [CMU101-S-35]	Ministry of Science and Technology, National Science Council of Taiwan; China Medical University(China Medical University)	This study (Hsieh YL) was financially supported by the Ministry of Science and Technology, National Science Council of Taiwan (Grant number: NSC 101-2314-B-241-039-003MY2) and China Medical University (Grant number: CMU101-S-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya C, 2014, MATRIX BIOL, V37, P102, DOI 10.1016/j.matbio.2014.06.001; Acupuncture, 2006, AC DRUGS LACT DAT LA; Aletaha D, 2011, ANN RHEUM DIS, V70, P733, DOI 10.1136/ard.2010.138693; Arentz-Hansen H, 2007, NIPH SYSTEMATIC RE 2; Assis L, 2018, LASER MED SCI, V33, P1875, DOI 10.1007/s10103-018-2541-6; Attia AMM, 2016, LASER SURG MED, V48, P490, DOI 10.1002/lsm.22487; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chen JL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-88; Chou PC, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8596918; Ding N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194022; Dong ZQ, 2018, AM J THER, V25, pE314, DOI 10.1097/MJT.0000000000000477; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gao Yue, 2014, Biomed Res Int, V2014, P648459, DOI 10.1155/2014/648459; Goldring SR, 2003, RHEUMATOLOGY, V42, P11, DOI 10.1093/rheumatology/keg327; Haleem-Smith H, 2012, J CELL BIOCHEM, V113, P1245, DOI 10.1002/jcb.23455; Helianthi DR, 2016, ACTA MED INDONES, V48, P114; Hsieh YL, 2016, ACUPUNCT MED, V34, P302, DOI 10.1136/acupmed-2015-011026; Hsieh YL, 2014, PHOTOMED LASER SURG, V32, P669, DOI 10.1089/pho.2014.3821; Kehoe O, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-157; Lee JA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006140; Li J, 2015, ALTERN THER HEALTH M, V21, P26; Li R, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0072-5; Lorenzini L, 2010, RES VET SCI, V88, P159, DOI 10.1016/j.rvsc.2009.06.001; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Tyyni A, 2000, SCAND J MED SCI SPOR, V10, P249, DOI 10.1034/j.1600-0838.2000.010005249.x; Wang Guangjun, 2014, Medicines (Basel), V1, P56, DOI 10.3390/medicines1010056; Wang L, 2011, J ACUPUNCT MERIDIAN, V4, P24, DOI 10.1016/S2005-2901(11)60004-6; Wollheim FA, 1996, APMIS, V104, P81, DOI 10.1111/j.1699-0463.1996.tb00691.x; Xu Y, 2018, AM J CHINESE MED, V46, P997, DOI 10.1142/S0192415X18500520; Zhang YX, 2015, INT J CLIN EXP MED, V8, P2254; Zhao LJ, 2015, J ACUPUNCT MERIDIAN, V8, P209, DOI 10.1016/j.jams.2015.04.004	31	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0211341	10.1371/journal.pone.0211341	http://dx.doi.org/10.1371/journal.pone.0211341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883553	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500006
J	Engelsgjerd, S; Kunnimalaiyaan, S; Kandil, E; Gamblin, TC; Kunnimalaiyaan, M				Engelsgjerd, Samuel; Kunnimalaiyaan, Selvi; Kandil, Emad; Gamblin, T. Clark; Kunnimalaiyaan, Muthusamy			Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines	PLOS ONE			English	Article							CHILDRENS ONCOLOGY GROUP; PROSTATE-CANCER CELLS; HUMULUS-LUPULUS L.; EXTRINSIC APOPTOSIS; SIGNALING PATHWAY; HOPS; PHARMACOKINETICS; RESISTANCE; INHIBITION; DR4	High-risk neuroblastoma (NB) is lethal childhood cancer. Published data including ours have reported the anti-proliferative effect of Xanthohumol (XN), a prenylated chalcone, in various cancer types suggesting that XN could be a useful small molecule compound against cancer. The TNF-Related Apoptosis-Inducing Ligand (TRAIL) is an endogenous ligand that is expressed in various immune cells. TRAIL mediates apoptosis through binding of transmembrane receptors, death receptor 4 (DR4) and/or death receptor 5 (DR5). Cancer cells are frequently resistant to TRAIL-mediated apoptosis, and the cause of this may be decreased expression of death receptors. This study aimed to identify combination therapies that exploit XN for NB. First, the effect of XN on cellular proliferation in human NB cell lines NGP, SH-SY-5Y, and SK-N-AS were determined via MTT assay, colony forming assay, and real-time live cell imaging confluency. XN treatment causes a statistically significant decrease in the viability of NB cells with IC50 values of approximately 12 mu M for all three cell lines. Inhibition of cell proliferation via apoptosis was evidenced by an increase in pro-apoptotic markers (cleaved PARP, cleaved caspase-3/-7, and Bax) and a decrease in an anti-apoptotic marker, Bcl-2. Importantly, XN treatment inhibited PI3K/Akt pathway and associated with increased expression of DR5 by both mRNA and protein levels. Furthermore, a statistically significant synergistic reduction was observed following combination treatment (50%) compared to either TRAIL (5%) or XN (15%) alone in SK-N-AS cells. Therefore, this study shows XN treatment reduces NB cell growth via apoptosis in a dose-dependent manner, and enhanced growth reduction was observed in combination with TRAIL. This is the first study to demonstrate that XN alters the expression of DR5 as well as the synergistic effect of XN on TRAIL in NB and provides a strong rationale for further pre-clinical analysis.	[Engelsgjerd, Samuel; Kunnimalaiyaan, Selvi; Gamblin, T. Clark; Kunnimalaiyaan, Muthusamy] Med Coll Wisconsin, Dept Surg, Div Surg Oncol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Kandil, Emad; Kunnimalaiyaan, Muthusamy] Tulane Univ, Sch Med, Dept Surg, New Orleans, LA 70112 USA	Medical College of Wisconsin; Tulane University	Gamblin, TC; Kunnimalaiyaan, M (corresponding author), Med Coll Wisconsin, Dept Surg, Div Surg Oncol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.; Kunnimalaiyaan, M (corresponding author), Tulane Univ, Sch Med, Dept Surg, New Orleans, LA 70112 USA.	tcgamblin@mcw.edu; mkunnima@mcw.edu		Kunnimalaiyaan, Muthusamy/0000-0003-3712-7497	St. Baldrick's Foundation summer fellowship; Medical College of Wisconsin Dean's Development Program	St. Baldrick's Foundation summer fellowship; Medical College of Wisconsin Dean's Development Program	This research was supported in part by the St. Baldrick's Foundation summer fellowship (SE) and the Medical College of Wisconsin Dean's Development Program.	Albini A, 2005, FASEB J, V19, P527, DOI 10.1096/fj.05-5128fje; Bahmad Hisham F, 2018, Oncotarget, V9, P33549, DOI 10.18632/oncotarget.26088; Bin L, 2007, J BIOL CHEM, V282, P28189, DOI 10.1074/jbc.M704210200; Brodeur GM, 2014, NAT REV CLIN ONCOL, V11, P704, DOI 10.1038/nrclinonc.2014.168; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Colgate EC, 2007, CANCER LETT, V246, P201, DOI 10.1016/j.canlet.2006.02.015; Cook MR, 2010, AM J SURG, V199, P315, DOI 10.1016/j.amjsurg.2009.08.034; de Oliveira MR, 2015, CHEM-BIOL INTERACT, V242, P396, DOI 10.1016/j.cbi.2015.11.003; Deeb D, 2010, ANTICANCER RES, V30, P3333; Delmulle L, 2008, PHYTOTHER RES, V22, P197, DOI 10.1002/ptr.2286; Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099; Dorn C, 2010, FOOD CHEM TOXICOL, V48, P1890, DOI 10.1016/j.fct.2010.04.030; Dorn C, 2010, INT J ONCOL, V36, P435, DOI 10.3892/ijo_00000517; Eggert A, 2001, CANCER RES, V61, P1314; Ferrari-Toninelli G, 2010, NEURO-ONCOLOGY, V12, P1231, DOI 10.1093/neuonc/noq101; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Horak P, 2005, MOL CANCER RES, V3, P335, DOI 10.1158/1541-7786.MCR-04-0136; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Kang Y, 2013, BBA-GEN SUBJECTS, V1830, P2638, DOI 10.1016/j.bbagen.2012.12.005; King D, 2015, J PEDIAT HEMATOL ONC, V37, P245, DOI 10.1097/MPH.0000000000000329; Kunnimalaiyaan S, 2015, MOL CANCER THER, V14, P1395, DOI 10.1158/1535-7163.MCT-14-0915; Kunnimalaiyaan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127464; Legette L, 2014, MOL NUTR FOOD RES, V58, P248, DOI 10.1002/mnfr.201300333; Legette L, 2012, MOL NUTR FOOD RES, V56, P466, DOI 10.1002/mnfr.201100554; Legette LL, 2013, PHYTOCHEMISTRY, V91, P236, DOI 10.1016/j.phytochem.2012.04.018; Mei H, 2013, PEDIATR HEMAT ONCOL, V30, P605, DOI 10.3109/08880018.2013.798058; Muhlethaler-Mottet A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-214; Muhlethaler-Mottet A, 2004, ONCOGENE, V23, P5415, DOI 10.1038/sj.onc.1207704; Muhlethaler-Mottet A, 2003, ANN NY ACAD SCI, V1010, P195, DOI 10.1196/annals.1299.033; Ozoren N, 2003, SEMIN CANCER BIOL, V13, P135, DOI 10.1016/S1044-579X(02)00131-1; Pan L, 2005, MOL NUTR FOOD RES, V49, P837, DOI 10.1002/mnfr.200500065; Park MR, 2015, FOOD CHEM TOXICOL, V77, P34, DOI 10.1016/j.fct.2014.12.013; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Peuhu E, 2010, ONCOGENE, V29, P898, DOI 10.1038/onc.2009.386; Peuhu E, 2013, BIOCHEM PHARMACOL, V86, P571, DOI 10.1016/j.bcp.2013.05.026; Phillips SM, 2015, CANCER EPIDEM BIOMAR, V24, P653, DOI 10.1158/1055-9965.EPI-14-1418; Richards MW, 2016, STRUCTURAL BASIS N M; Song JH, 2003, BRAIN PATHOL, V13, P539; Suganuma R, 2013, PEDIATR BLOOD CANCER, V60, P363, DOI 10.1002/pbc.24238; Teshiba R, 2014, PEDIATR DEVEL PATHOL, V17, P441, DOI 10.2350/14-06-1505-OA.1; van Breemen RB, 2014, MOL NUTR FOOD RES, V58, P1962, DOI 10.1002/mnfr.201400245; Vanhoecke B, 2005, INT J CANCER, V117, P889, DOI 10.1002/ijc.21249; Vanhoecke BW, 2005, IN VIVO, V19, P103; Vene R, 2012, MOL MED, V18, P1292, DOI 10.2119/molmed.2012.00174; Walden D, 2017, ONCOTARGET, V8, P88069, DOI 10.18632/oncotarget.21422; Wang LL, 2015, BRIT J CANCER, V113, P57, DOI 10.1038/bjc.2015.188; Wang LL, 2013, CANCER-AM CANCER SOC, V119, P3718, DOI 10.1002/cncr.28251; Wu X, 2014, CELL PHYSIOL BIOCHEM, V34, P506, DOI 10.1159/000363018	51	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213776	10.1371/journal.pone.0213776	http://dx.doi.org/10.1371/journal.pone.0213776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870485	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300069
J	Springer, R; Zielinski, A; Pleschka, C; Hoffmann, B; Merkel, R				Springer, Ronald; Zielinski, Alexander; Pleschka, Catharina; Hoffmann, Bernd; Merkel, Rudolf			Unbiased pattern analysis reveals highly diverse responses of cytoskeletal systems to cyclic straining	PLOS ONE			English	Article							VIMENTIN INTERMEDIATE-FILAMENTS; ENDOTHELIAL-CELLS; ACTIN CYTOSKELETON; QUANTITATIVE-ANALYSIS; STRESS FIBERS; MICROTUBULES; ADHESION; REORIENTATION; STRETCH; DYNAMICS	In mammalian cells, actin, microtubules, and various types of cytoplasmic intermediate filaments respond to external stretching. Here, we investigated the underlying processes in endothelial cells plated on soft substrates from silicone elastomer. After cyclic stretch (0.13 Hz, 14% strain amplitude) for periods ranging from 5 min to 8 h, cells were fixed and double stained for microtubules and either actin or vimentin. Cell images were analyzed by a twostep routine. In the first step, micrographs were segmented for potential fibrous structures. In the second step, the resulting binary masks were auto- or cross-correlated. Auto-correlation of segmented images provided a sensitive and objective measure of orientational and translational order of the different cytoskeletal systems. Aligning of correlograms from individual cells removed the influence of only partial alignment between cells and enabled determination of intrinsic cytoskeletal order. We found that cyclic stretching affected the actin cytoskeleton most, microtubules less, and vimentin mostly only via reorientation of the whole cell. Pharmacological disruption of microtubules had barely any influence on actin ordering. The similarity, i.e., cross-correlation, between vimentin and microtubules was much higher than the one between actin and microtubules. Moreover, prolonged cyclic stretching slightly decoupled the cytoskeletal systems as it reduced the cross-correlations in both cases. Finally, actin and microtubules were more correlated at peripheral regions of cells whereas vimentin and microtubules correlated more in central regions.	[Springer, Ronald; Zielinski, Alexander; Pleschka, Catharina; Hoffmann, Bernd; Merkel, Rudolf] Forschungszentrum Julich, Inst Complex Syst 7, Julich, Germany	Helmholtz Association; Research Center Julich	Merkel, R (corresponding author), Forschungszentrum Julich, Inst Complex Syst 7, Julich, Germany.	r.merkel@fz-juelich.de	Merkel, Rudolf/G-3647-2013; Hoffmann, Bernd/I-7237-2013	Merkel, Rudolf/0000-0003-3178-3282; Hoffmann, Bernd/0000-0002-3803-8835	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [642866]; Deutsche Forschungsgemeinschaft [HO2384/2, ME1458/8]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642866 to BH and from the Deutsche Forschungsgemeinschaft (HO2384/2 to BH and ME1458/8 to RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Basu S, 2015, J MICROSC-OXFORD, V258, P13, DOI 10.1111/jmi.12209; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; BERSHADSKY AD, 1987, CELL MOTIL CYTOSKEL, V8, P274, DOI 10.1002/cm.970080308; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Carlson MA, 2005, WOUND REPAIR REGEN, V13, P84, DOI 10.1111/j.1067-1927.2005.130111.x; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chuang JS, 2010, MAGN RESON MED, V64, P1281, DOI 10.1002/mrm.22547; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Cummins H Z, 1974, PHOTON CORRELATION L; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; Drew NK, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004190; Eltzner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126346; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; FRYKMAN P, 1993, COMPUT GEOSCI, V19, P887, DOI 10.1016/0098-3004(93)90002-M; Fuseler JW, 2007, MICROSC MICROANAL, V13, P133, DOI 10.1017/S1431927607070225; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Greiner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077328; GURLAND G, 1995, J CELL BIOL, V131, P1275, DOI 10.1083/jcb.131.5.1275; GYOEVA FK, 1991, NATURE, V353, P445, DOI 10.1038/353445a0; Hadid A, 2012, J APPL PHYSIOL, V112, P597, DOI 10.1152/japplphysiol.00990.2011; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Inoue S, 2015, BIOMATER SCI-UK, V3, P1539, DOI 10.1039/c5bm00205b; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Lichtenstein N, 2003, CYTOM PART A, V54A, P8, DOI 10.1002/cyto.a.10053; Livne A, 2016, J CELL SCI, V129, P1293, DOI 10.1242/jcs.180927; Lockett S, 2014, CYTOM PART A, V85A, P512, DOI 10.1002/cyto.a.22442; Martins PC, 1968, MEASUREMENTS CORRELA; Mehta CR, 1995, SPSS EXACT TESTS 7 0; Niblack W., 1986, INTRO DIGITAL IMAGE; PETROLL WM, 1993, J CELL SCI, V104, P353; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Press W. H., 1992, ART SCI COMPUTING; Rehfeldt F, 2012, INTEGR BIOL-UK, V4, P422, DOI 10.1039/c2ib00150k; Roan E, 2011, AM J PHYSIOL-LUNG C, V301, pL625, DOI 10.1152/ajplung.00105.2011; Robert A, 2014, FASEB J, V28, P2879, DOI 10.1096/fj.14-250019; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Sears C, 2016, J BIOMECH, V49, P1347, DOI 10.1016/j.jbiomech.2015.10.014; Shah SA, 2005, ULTRAMICROSCOPY, V104, P244, DOI 10.1016/j.ultramic.2005.04.007; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Stroud MJ, 2014, J CELL SCI, V127, P2672, DOI 10.1242/jcs.140558; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Tondon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089592; Tondon A, 2012, J BIOMECH, V45, P728, DOI 10.1016/j.jbiomech.2011.11.012; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Vindin H, 2014, J BIOMOLECULAR STREE, V19, P345; Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027; Wang JHC, 2000, ANN BIOMED ENG, V28, P1165, DOI 10.1114/1.1317528; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818; Wohland T, 2001, BIOPHYS J, V80, P2987, DOI 10.1016/S0006-3495(01)76264-9; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zielinski A, 2018, CYTOSKELETON, V75, P385, DOI 10.1002/cm.21470	75	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0210570	10.1371/journal.pone.0210570	http://dx.doi.org/10.1371/journal.pone.0210570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865622	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900007
J	Gu, Y; Becker, V; Zhao, YJ; Menger, MD; Laschke, MW				Gu, Yuan; Becker, Vivien; Zhao, Yingjun; Menger, Michael D.; Laschke, Matthias W.			miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2	FASEB JOURNAL			English	Article						miRNA; angiogenesis; proliferation; migration; tube formation	MICRORNA-370 SUPPRESSES; GROWTH-FACTOR; OVEREXPRESSION; MECHANISM	MicroRNAs (miRNAs) crucially modulate fundamental biologic processes such as angiogenesis. In the present study, we focused on the molecular function of miRNA-370-3p (miR-370) in regulating the angiogenic activity of endothelial cells (ECs). Transfection with miR-370 mimic (miR-370m) significantly inhibited the sprouting of human dermal microvascular EC (HDMEC) and HUVEC spheroids and mouse aortic rings, whereas miR-370 inhibitor (miR-370i) promoted sprout formation. Additional in vitro assays demonstrated the pleiotropic inhibitory effects of miR-370m on HDMEC proliferation, migration, and tube formation. Moreover, Matrigel plugs containing miR-370m-transfected HDMECs exhibited a reduced microvessel density after implantation into CD1 nude mice when compared with controls. In contrast, miR-370i exerted proangiogenic effects. Mechanistic analyses revealed that miR-370 directly targets smoothened (SMO) and down-regulates bone morphogenetic protein (BMP)-2 expression in HDMECs. Accordingly, inhibition of SMO by cyclopamine reversed miR-370i-induced HDMEC proliferation and migration. In addition, BMP-2 treatment counteracted miR-370m-suppressed tube formation of HDMECs, whereas blockade of BMP-2 with neutralizing antibody significantly inhibited miR-370i-induced tube formation. Taken together, these novel findings indicate that miR-370 is a potent inhibitor of angiogenesis, which directly targets SMO and BMP-2.-Gu, Y., Becker, V., Zhao, Y., Menger, M. D., Laschke, M. W. miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2.	[Gu, Yuan; Becker, Vivien; Menger, Michael D.; Laschke, Matthias W.] Saarland Univ, Inst Clin & Expt Surg, Kirrbergerstr 1, D-66421 Homburg, Germany; [Zhao, Yingjun] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Oncol,Inst Biomed Sci, Shanghai, Peoples R China	Universitatsklinikum des Saarlandes; Fudan University	Laschke, MW (corresponding author), Saarland Univ, Inst Clin & Expt Surg, Kirrbergerstr 1, D-66421 Homburg, Germany.	matthias.laschke@uks.eu		Gu, Yuan/0000-0003-1401-6233	Medical Faculty of Saarland University (HOMFORexzellenz 2015)	Medical Faculty of Saarland University (HOMFORexzellenz 2015)	The authors thank Janine Becker, Christina Max, and Ruth Nickels (all from the Institute for Clinical and Experimental Surgery, Saarland University) for excellent technical assistance. This work was supported by a research grant to Y.G. from the Medical Faculty of Saarland University (HOMFORexzellenz 2015). The authors declare no conflicts of interest.	Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chang KW, 2013, ORAL DIS, V19, P611, DOI 10.1111/odi.12046; Chen XP, 2014, CANCER LETT, V353, P201, DOI 10.1016/j.canlet.2014.07.026; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gu Y, 2017, FASEB J, V31, P3321, DOI 10.1096/fj.201601263R; Gu Y, 2016, ONCOTARGET, V7, P5258, DOI 10.18632/oncotarget.6676; Gu Y, 2013, ANTI-CANCER DRUG, V24, P781, DOI 10.1097/CAD.0b013e328362fb84; Gupta R, 2018, LAB INVEST, V98, P682, DOI 10.1038/s41374-018-0028-5; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Icli B, 2013, CIRC RES, V113, P1231, DOI 10.1161/CIRCRESAHA.113.301780; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Lu CH, 2015, DIGEST DIS SCI, V60, P2038, DOI 10.1007/s10620-015-3585-0; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Wang XH, 2017, BRATISL MED J, V118, P202, DOI 10.4149/BLL_2017_040; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Zhang XL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-56; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	35	14	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7213	7224		10.1096/fj.201802085RR	http://dx.doi.org/10.1096/fj.201802085RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865837	Bronze			2022-12-26	WOS:000476114200045
J	Lei, JJ; Li, HQ; Mo, ZH; Liu, KJ; Zhu, LJ; Li, CY; Chen, WL; Zhang, L				Lei, Jun-Jie; Li, Hui-Qing; Mo, Zhi-Huai; Liu, Ke-Jia; Zhu, Ling-Juan; Li, Chun-Yi; Chen, Wen-Li; Zhang, Lei			Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription	FASEB JOURNAL			English	Article						CD4(+)CD25(+) T cell; proliferation; gene silencing	ISCHEMIC-STROKE; T-CELLS; EXPRESSION; ACTIVATION; BLOOD; ANGIOGENESIS; ASSOCIATION; DYSFUNCTION; THERAPY; CANCER	The effective therapeutic approach of cerebral infarction is limited because of its underlying complexity. Recently, multiple long noncoding RNAs (lncRNAs) have been identified in the pathogenesis of cerebral infarction. Here, the current study aims to explore the interaction among lncRNA cyclin-dependent kinase inhibitor-2B-antisense RNA 1 (CDKN2B-AS1), transcription factor B-cell lymphoma/leukemia 11A (BCL11A), and MAPKK kinase kinase 1 (MAP4K1) and further investigate whether they affect cerebral infarction progression. The expression of CDKN2B-AS1, BCL11A, and MAP4K1 was altered in lymphocytes extracted from patients with cerebral infarction. In order to identify their roles in regulatory T (T-reg) cells, the proliferation and apoptosis of the CD4(+)CD25(+) T-reg cells were examined, and levels of IL-4, IL-10, and TGF-beta were determined. Also, the RNA crosstalk among CDKN2B-AS1, BCL11A, and MAP4K1 was validated. Finally, we established a rat model of middle cerebral arterial occlusion to evaluate the neurologic impairment and cerebral infarction volume. The results revealed that lymphocytes in patients with cerebral infarction presented with the up-regulated expression of CDKN2B-AS1. Moreover, BCL11A could specifically bind to CDKN2B-AS1 and MAP4K1 promoter so as to inhibit MAP4K1. Moreover, it was observed that down-regulated CDKN2B-AS1 inhibited CD4(+)CD25(+) T-reg-cell proliferation, reduced levels of IL-4, IL-10, and TGF-beta and cerebral infarction volume, and elevated MAP4K1 expression. Collectively, our study provides evidence that CDKN2B-AS1 silencing could increase MAP4K1 expression to inhibit the CD4(+)CD25(+) T-reg-cell proliferation by reducing enrichment of transcription factor BCL11A, thereby protecting against cerebral infarction progression, highlighting a promising therapeutic strategy for treating cerebral infarction.-Lei, J.-J., Li, H.-Q., Mo, Z.-H., Liu, K.-J., Zhu, L.-J., Li, C.-Y., Chen, W.-L., Zhang, L. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.	[Lei, Jun-Jie; Li, Hui-Qing; Mo, Zhi-Huai; Liu, Ke-Jia; Zhu, Ling-Juan; Li, Chun-Yi; Zhang, Lei] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Neurol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China; [Chen, Wen-Li] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pharmacol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, L (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Dept Neurol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China.; Chen, WL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Dept Pharmacol, 52 Meihua East Rd, Zhuhai 519000, Guangdong, Peoples R China.	chenwenl@mail3sysu.edu.cn; zhangl92@sysu.edu.cn	Chen, Wenli/AAG-1880-2020		National Natural Science Funds of China [81601001]; Youth Teachers Cultivation Project of Sun Yat-sen University [17ykpy63]; Five-Five Youth Talent Project of The Fifth Affiliated Hospital of Sun Yat-sen University; Prognosis Registration Research of Treatment for Acute Ischemic Stroke in China [KLK-CBV-2015-001-C]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Youth Teachers Cultivation Project of Sun Yat-sen University; Five-Five Youth Talent Project of The Fifth Affiliated Hospital of Sun Yat-sen University; Prognosis Registration Research of Treatment for Acute Ischemic Stroke in China	This study was supported by National Natural Science Funds of China (81601001), Youth Teachers Cultivation Project of Sun Yat-sen University (17ykpy63), Five-Five Youth Talent Project of The Fifth Affiliated Hospital of Sun Yat-sen University, and Prognosis Registration Research of Treatment for Acute Ischemic Stroke in China (KLK-CBV-2015-001-C). The authors declare no conflicts of interest.	AbdulAzeez S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030395; Ayuk SM, 2016, J PHOTOCH PHOTOBIO B, V161, P368, DOI 10.1016/j.jphotobiol.2016.05.027; Bayoglu B, 2016, CLIN BIOCHEM, V49, P821, DOI 10.1016/j.clinbiochem.2016.02.012; Brea D, 2014, J CELL MOL MED, V18, P1571, DOI 10.1111/jcmm.12304; Cao W, 2017, ORAL ONCOL, V65, P94, DOI 10.1016/j.oraloncology.2016.12.017; Chen FH, 2018, BIOCHEM BIOPH RES CO, V496, P184, DOI 10.1016/j.bbrc.2018.01.022; Chen YC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0986-z; Cruz Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121854; Deng YB, 2001, CHINESE MED J-PEKING, V114, P1295; Du YF, 2018, ONCOL LETT, V15, P4912, DOI 10.3892/ol.2018.7910; Dykstra-Aiello C, 2016, STROKE, V47, P2896, DOI 10.1161/STROKEAHA.116.013869; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Hu YH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/813045; Huang Y., 2018, LIFE SCI, DOI 10.1016/j.lfs.2018.12.047; Jiang BY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-61; Katsura K, 2012, J NIPPON MED SCH, V79, P104, DOI 10.1272/jnms.79.104; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Li LJ, 2017, BIOMED PHARMACOTHER, V96, P165, DOI 10.1016/j.biopha.2017.09.113; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liao JQ, 2016, GENE, V578, P158, DOI 10.1016/j.gene.2015.12.032; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Naess H, 2016, ACTA NEUROL SCAND, V133, P415, DOI 10.1111/ane.12477; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Qi X, 2017, NEUROSCIENCE, V348, P98, DOI 10.1016/j.neuroscience.2017.02.002; Schut ES, 2012, NEUROCRIT CARE, V16, P421, DOI 10.1007/s12028-011-9634-4; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang KH, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007079, 10.1097/md.0000000000007079]; Wang Q, 2012, BBA-MOL CELL RES, V1823, P1807, DOI 10.1016/j.bbamcr.2012.07.004; Wang SH, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6205485; Wang XH, 2012, J BIOL CHEM, V287, P34091, DOI 10.1074/jbc.M112.371062; Wang Y, 2012, MOL MED REP, V5, P260, DOI 10.3892/mmr.2011.621; Xing SH, 2012, AUTOPHAGY, V8, P63, DOI 10.4161/auto.8.1.18217; Xiong L, 2018, J STROKE CEREBROVASC, V27, P2336, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.020; Yan J, 2012, J NEUROIMMUNOL, V243, P89, DOI 10.1016/j.jneuroim.2011.12.019; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001; Ye H, 2015, J NEUROL SCI, V348, P81, DOI 10.1016/j.jns.2014.11.010; Yoshida M, 2018, CLIN GENET, V93, P368, DOI 10.1111/cge.13067; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhan RY, 2017, BIOCHEM BIOPH RES CO, V490, P700, DOI 10.1016/j.bbrc.2017.06.104; Zhang BK, 2013, INT IMMUNOPHARMACOL, V16, P461, DOI 10.1016/j.intimp.2013.04.028; Zhang EB, 2014, ONCOTARGET, V5, P2276, DOI 10.18632/oncotarget.1902; Zhang W, 2008, IMMUNOL LETT, V120, P96, DOI 10.1016/j.imlet.2008.07.005; Zhang ZH, 2013, GENET TEST MOL BIOMA, V17, P47, DOI 10.1089/gtmb.2012.0253; Zhao JK, 2017, CLIN PSYCHOPHARM NEU, V15, P53, DOI 10.9758/cpn.2017.15.1.53	47	17	18	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7037	7048		10.1096/fj.201802252R	http://dx.doi.org/10.1096/fj.201802252R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30870006	Bronze			2022-12-26	WOS:000476114200030
J	Leng, XY; Ji, X; Hou, YG; Settlage, R; Jiang, HL				Leng, Xinyan; Ji, Xu; Hou, Yuguo; Settlage, Robert; Jiang, Honglin			Roles of the proteasome and inhibitor of DNA binding 1 protein in myoblast differentiation	FASEB JOURNAL			English	Article						cattle; myotube; skeletal muscle; ubiquitin	GROWTH-FACTOR-I; SKELETAL-MUSCLE; MITOCHONDRIAL ACTIVITY; MEDIATED DEGRADATION; GENE-EXPRESSION; SATELLITE CELL; UBIQUITIN; MYOGENIN; MYOD; OVEREXPRESSION	This study was conducted to further understand the mechanism that controls myoblast differentiation, a key step in skeletal muscle formation. RNA sequencing of primary bovine myoblasts revealed many genes encoding the ubiquitin-proteasome system were up-regulated during myoblast differentiation. This up-regulation was accompanied by increased proteasomal activity. Treating myoblasts with the proteasome-specific inhibitor lactacystin impeded myoblast differentiation. Adenovirus-mediated overexpression of inhibitor of DNA binding 1 (ID1) protein inhibited myoblast differentiation too. Further experiments were conducted to determine whether the proteasome promotes myoblast differentiation by degrading ID1 protein. Both ID1 protein and mRNA expression decreased during myoblast differentiation. However, treating myoblasts with lactacystin reversed the decrease in ID1 protein but not in ID1 mRNA expression. Surprisingly, this reversal was not observed when myoblasts were also treated with the mRNA translation inhibitor cycloheximide. Direct incubation of ID1 protein with proteasomes from myoblasts did not show differentiation stage-associated degradation of ID1 protein. Furthermore, ubiquitinated ID1 protein was not detected in lactacystin-treated myoblasts. Overall, the results of this study suggest that, during myoblast differentiation, the proteasomal activity is up-regulated to further myoblast differentiation and that the increased proteasomal activity improves myoblast differentiation partly by inhibiting the synthesis, not the degradation, of ID1 protein.-Leng, X., Ji, X., Hou, Y., Settlage, R., Jiang, H. Roles of the proteasome and inhibitor of DNA binding 1 protein in myoblast differentiation.	[Leng, Xinyan; Ji, Xu; Hou, Yuguo; Jiang, Honglin] Virginia Tech, Dept Anim & Poultry Sci, 3130 Litton Reaves Hall, Blacksburg, VA 24061 USA; [Settlage, Robert] Virginia Tech, Adv Res Comp Unit, Div Informat Technol, Blacksburg, VA 24061 USA; [Ji, Xu] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Nanjing Agricultural University	Jiang, HL (corresponding author), Virginia Tech, Dept Anim & Poultry Sci, 3130 Litton Reaves Hall, Blacksburg, VA 24061 USA.	hojiang@vt.edu		, Honglin/0000-0001-9540-5788	Agriculture and Food Research Initiative Competitive from the U.S. Department of Agrictulture (USDA) National Institute of Food and Agriculture Animal Genome Program [2016-67015-24471]	Agriculture and Food Research Initiative Competitive from the U.S. Department of Agrictulture (USDA) National Institute of Food and Agriculture Animal Genome Program	This study was supported, in part, by Agriculture and Food Research Initiative Competitive Grant 2016-67015-24471 from the U.S. Department of Agrictulture (USDA) National Institute of Food and Agriculture Animal Genome Program. The authors declare no conflicts of interest.	AHN JY, 1991, J BIOL CHEM, V266, P15746; ALLEN RE, 1979, J ANIM SCI, V49, P115, DOI 10.2527/jas1979.491115x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; BALIGA BS, 1969, J BIOL CHEM, V244, P4480; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Bell RAV, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0086-6; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Bi P, 2012, J ANIM SCI, V90, P924, DOI 10.2527/jas.2011-4594; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; BRAUN T, 1991, NUCLEIC ACIDS RES, V19, P5645, DOI 10.1093/nar/19.20.5645; Brooks SA, 2010, WIRES RNA, V1, P240, DOI 10.1002/wrna.11; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Emmerich CH, 2015, BIOCHEM BIOPH RES CO, V466, P1, DOI 10.1016/j.bbrc.2015.08.109; Fink E, 2003, J MUSCLE RES CELL M, V24, P421, DOI 10.1023/A:1027387501614; Gardrat F, 1999, BIOCHEM MOL BIOL INT, V47, P387; Ge X, 2012, J ANIM SCI, V90, P1126, DOI 10.2527/jas.2011-4358; Ge XM, 2013, MOL CELL ENDOCRINOL, V372, P23, DOI 10.1016/j.mce.2013.03.017; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; GUNDERSEN K, 1995, MOL CELL BIOL, V15, P7127; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Kim SS, 1998, FEBS LETT, V433, P47, DOI 10.1016/S0014-5793(98)00883-7; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Moyes C. D., 1997, American Journal of Physiology, V272, pC1345; Oksbjerg N, 2004, DOMEST ANIM ENDOCRIN, V27, P219, DOI 10.1016/j.domaniend.2004.06.007; Perez J, 2008, CHEM SOC REV, V37, P2658, DOI 10.1039/b707074h; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rios R, 2002, AM J PHYSIOL-CELL PH, V282, pC993, DOI 10.1152/ajpcell.00372.2001; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Sun LP, 2005, J BIOL CHEM, V280, P26448, DOI 10.1074/jbc.M500373200; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trausch-Azar JS, 2004, J BIOL CHEM, V279, P32614, DOI 10.1074/jbc.M403794200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagatsuma A, 2011, MOL CELL BIOCHEM, V349, P139, DOI 10.1007/s11010-010-0668-2; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	63	5	6	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7403	7416		10.1096/fj.201800574RR	http://dx.doi.org/10.1096/fj.201800574RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30865843	Bronze			2022-12-26	WOS:000476114200059
J	Zheng, L; Gao, JW; Jin, KT; Chen, ZZ; Yu, WY; Zhu, KJ; Huang, WJ; Liu, FJ; Mei, LW; Lou, C; He, DW				Zheng, Lin; Gao, Jiawei; Jin, Kangtao; Chen, Zhenzhong; Yu, Weiyang; Zhu, Kejun; Huang, Wenjun; Liu, Feijun; Mei, Liangwei; Lou, Chao; He, Dengwei			Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						osteoporosis; osteoclastogenesis; osteogenesis; therapeutics	THIOREDOXIN-INTERACTING PROTEIN; FACTOR EXPRESSION; IN-VITRO; CELLS; MICE; IDENTIFICATION; PROLIFERATION; OSTEOPOROSIS; PROGRESSION; ACTIVATION	Current pharmacological intervention for the treatment of osteolytic bone diseases such as osteoporosis focuses on the prevention of excessive osteoclastic bone resorption but does not enhance osteoblast-mediated bone formation. In our study, we have shown that 4-iodo-6-phenylpyrimidine (4-IPP), an irreversible inhibitor of macrophage migration inhibitory factor (MIF), can inhibit receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis and potentiate osteoblast-mediated mineralization and bone nodule formation in vitro. Mechanistically, 4-IPP inhibited RANKL-induced p65 phosphorylation and nuclear translocation by preventing the interaction of MIF with thioredoxin-interacting protein-p65 complexes. This led to the suppression of late osteoclast marker genes such as nuclear factor of activated T cells cytoplasmic 1, resulting in impaired osteoclast formation. In contrast, 4-IPP potentiated osteoblast differentiation and mineralization also through the inhibition of the p65/NF-kappa B signaling cascade. In the murine model of pathologic osteolysis induced by titanium particles, 4-IPP protected against calvarial bone destruction. Similarly, in the murine model of ovariectomy-induced osteoporosis, 4-IPP treatment ameliorated the bone loss associated with estrogen deficiency by reducing osteoclastic activities and enhancing osteoblastic bone formation. Collectively, these findings provide evidence for the pharmacological targeting of MIF for the treatment of osteolytic bone disorders.-Zheng, L., Gao, J., Jin, K., Chen, Z., Yu, W., Zhu, K., Huang, W., Liu, F., Mei, L., Lou, C., He, D. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-kappa B signaling pathway.	[Zheng, Lin; Gao, Jiawei; Jin, Kangtao; Chen, Zhenzhong; Yu, Weiyang; Zhu, Kejun; Huang, Wenjun; Liu, Feijun; Mei, Liangwei; Lou, Chao; He, Dengwei] Zhejiang Univ, Affiliated Lishui Hosp, Dept Orthoped,Wenzhou Med Univ, Affiliated Hosp 5,Lishui Cent Hosp, 289 Kuocang Rd, Lishui 323000, Peoples R China	Wenzhou Medical University; Zhejiang University	Lou, C; He, DW (corresponding author), Zhejiang Univ, Affiliated Lishui Hosp, Dept Orthoped,Wenzhou Med Univ, Affiliated Hosp 5,Lishui Cent Hosp, 289 Kuocang Rd, Lishui 323000, Peoples R China.	dr_louchao@foxmail.com; hedw120@163.com	Zheng, Lin/AAE-8093-2021	Zheng, Lin/0000-0002-7585-6968; He, Dengwei/0000-0003-2394-2124	Natural Science Foundation of Zhejiang Provincial (CN) [LY17C100002]; Public Welfare Project of Zhejiang Provincial Science and Technology Department [2016C33245]; Zhejiang Province Scientific Project of Health and Medicine of China [2018KY936]; Zhejiang Experimental Animal and Technology Program Foundation of China [2018C37099]	Natural Science Foundation of Zhejiang Provincial (CN); Public Welfare Project of Zhejiang Provincial Science and Technology Department; Zhejiang Province Scientific Project of Health and Medicine of China; Zhejiang Experimental Animal and Technology Program Foundation of China	This work was supported by grants from the Natural Science Foundation of Zhejiang Provincial (CN) (Grant LY17C100002), Public Welfare Project of Zhejiang Provincial Science and Technology Department (Grant 2016C33245), the Zhejiang Province Scientific Project of Health and Medicine of China (Grant 2018KY936), and the Zhejiang Experimental Animal and Technology Program Foundation of China (Grant 2018C37099). The authors declare no conflicts of interest.	Aitken CJ, 2004, J BONE MINER RES, V19, P2057, DOI 10.1359/JBMR.040913; Bacher M, 1997, AM J PATHOL, V150, P235; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cao WG, 2005, BIOL REPROD, V73, P565, DOI 10.1095/biolreprod.104.038331; Chen S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12853; Chen ZH, 2015, J BIOL CHEM, V290, P30163, DOI 10.1074/jbc.M115.663518; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Gu R, 2015, CYTOKINE, V72, P135, DOI 10.1016/j.cyto.2014.11.015; Harvey NC, 2017, LANCET, V390, P2243, DOI 10.1016/S0140-6736(17)32850-7; Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p; Hu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16008-x; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jacquin C, 2009, BONE, V45, P640, DOI 10.1016/j.bone.2009.06.028; Kim HR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3279; Kim K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020601; Kim KW, 2016, KOREAN J INTERN MED, V31, P634, DOI 10.3904/kjim.2016.098; Kim MJ, 2017, CELL SIGNAL, V34, P110, DOI 10.1016/j.cellsig.2017.03.007; Kindt N, 2013, INT J ONCOL, V43, P185, DOI 10.3892/ijo.2013.1944; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kobayashi T, 2011, OSTEOPOROSIS INT, V22, P1955, DOI 10.1007/s00198-010-1385-0; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Lizotte J, 2012, TOXICOL LETT, V215, P167, DOI 10.1016/j.toxlet.2012.10.006; Ma JJ, 2015, BIOCHEM J, V469, P399, DOI 10.1042/BJ20150151; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Madeira MFM, 2012, MICROBES INFECT, V14, P198, DOI 10.1016/j.micinf.2011.09.005; Movila A, 2016, J BONE MINER RES, V31, P1688, DOI 10.1002/jbmr.2854; Nishihira J, 1998, CYTOKINE, V10, P199, DOI 10.1006/cyto.1997.0276; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Onodera S, 2002, J BIOL CHEM, V277, P7865, DOI 10.1074/jbc.M106020200; Onodera S, 1996, IMMUNOLOGY, V89, P430, DOI 10.1046/j.1365-2567.1996.d01-751.x; Onodera S, 1999, SEMIN THROMB HEMOST, V25, P563, DOI 10.1055/s-2007-994966; Onodera S, 2006, J BONE MINER RES, V21, P876, DOI 10.1359/JBMR.060310; Oshima S, 2006, FEBS LETT, V580, P1251, DOI 10.1016/j.febslet.2006.01.038; Ranganathan V, 2017, ARTHRITIS RHEUMATOL, V69, P1796, DOI 10.1002/art.40175; Rocklin R E, 1975, Rheumatology, V6, P98; Rowe MA, 2017, ARTHRITIS RHEUMATOL, V69, P352, DOI 10.1002/art.39844; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; Schett G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2110; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Subbannayya T, 2016, J CELL COMMUN SIGNAL, V10, P165, DOI 10.1007/s12079-016-0326-x; Varinelli L, 2015, ENDOCR-RELAT CANCER, V22, P759, DOI 10.1530/ERC-15-0299; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xie Z, 2018, J BONE MINER RES, V33, P667, DOI 10.1002/jbmr.3334; Yamada K, 2012, NUTR RES, V32, P116, DOI 10.1016/j.nutres.2011.12.010; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zheng YH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw131	54	18	18	5	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7667	7683		10.1096/fj.201802364RR	http://dx.doi.org/10.1096/fj.201802364RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893559	Bronze			2022-12-26	WOS:000476114200080
J	Peng, Y; Wu, S; Tang, QY; Li, SH; Peng, C				Peng, Yi; Wu, Song; Tang, Qiyu; Li, Shuaihua; Peng, Cheng			KGF-1 accelerates wound contraction through the TGF-1/Smad signaling pathway in a double-paracrine manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						wound healing; transforming growth factor (TGF-); cell migration; cell proliferation; cell-cell interaction; diabetic wound; epithelial-mesenchymal interaction; wound contraction	GROWTH-FACTOR-BETA; COLLAGEN GEL CONTRACTION; KERATINOCYTE GROWTH; TGF-BETA; FIBROBLAST COCULTURES; FACTOR EXPRESSION; MYOFIBROBLAST; DIFFERENTIATION; PROLIFERATION; INDUCTION	KGF-1 plays an important role in the wound healing process. Loss of the KGF-1 gene in diabetic mice attenuated the process of wound contraction, suggesting that KGF-1 contributes to wound contraction. However, the mechanism remains unclear. To investigate the role of KGF-1 in diabetic wound contraction, we established a keratinocyte-fibroblast co-culture system. Concentrations of transforming growth factor 1 (TGF-1) in conditioned supernatant treated with KGF-1 (KGF-1 group), tk;4KGF-1-neutralizing antibody (anti-KGF-1 group), TGF-1 (TGF-1tk;1 group), KGF-1 and TGF-1-neutralizing antibody (KGF-1 + anti-TGF-1 group) were tested by ELISA. Conditioned medium was added to fibroblast-populated collagen lattice (FPCL) to investigate the effect of KGF-1 on fibroblastqj contraction. TGF-1, Col-I, p-Smad2, p-Smad3, and -smooth muscle actin (-SMA) were examined by Western blotting. A diabetic rat wound model was utilized to evaluate wound morphology, histology, immunohistochemistry, and protein expression in wound tissue after treatment with KGF-1. ELISA assays revealed that the concentration of TGF-1 in the conditioned supernatant in the KGF-1 group was significantly higher. The contractile capacity of FPCL stimulated by conditioned medium derived from the KGF-1 group was significantly elevated; however, the contractile activity of FPCL induced by KGF-1 was attenuated by TGF-1-neutralizing antibody. The Western blot results suggest that KGF-1 is able to stimulate TGF-1 activation with increased Col-I, p-Smad2, p-Smad3, and -SMA expression. Diabetic wounds treated with KGF-1 had a higher degree of contraction with significantly higher expression of TGF-1, Col-I, p-Smad2, p-Smad3, and -SMA. Our findings demonstrate that KGF-1 promotes fibroblast contraction and accelerates wound contraction via the TGF-1/Smad signaling pathway in a double-paracrine manner.	[Peng, Yi; Tang, Qiyu; Peng, Cheng] Cent S Univ, Xiangya Hosp 3, Dept Plast Surg, Changsha 410013, Hunan, Peoples R China; [Peng, Yi; Wu, Song] Cent S Univ, Xiangya Hosp 3, Dept Orthoped Surg, Changsha 410013, Hunan, Peoples R China; [Li, Shuaihua] Peoples Hosp Chenzhou 1, Dept Cosmet & Plast Surg, Chenzhou 423000, Hunan, Peoples R China	Central South University; Central South University	Peng, C (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Plast Surg, Changsha 410013, Hunan, Peoples R China.	pcheng83@csu.edu.cn			National Natural Science Foundation of China [81301636]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81301636. The authors declare that they have no conflicts of interest with the contents of this article.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chin GS, 2001, PLAST RECONSTR SURG, V108, P423, DOI 10.1097/00006534-200108000-00022; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P; Fang QH, 2013, J INFLAMM RES, V6, P25, DOI 10.2147/JIR.S35136; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Ghahary A, 2007, WOUND REPAIR REGEN, V15, pS46, DOI 10.1111/j.1524-475X.2007.00225.x; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hsieh SC, 2016, LIFE SCI, V161, P19, DOI 10.1016/j.lfs.2016.07.011; Kossi J, 2001, ANN CHIR GYNAECOL, V90, P15; Lichtman MK, 2016, WOUND REPAIR REGEN, V24, P215, DOI 10.1111/wrr.12398; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x; Marti G, 2004, GENE THER, V11, P1780, DOI 10.1038/sj.gt.3302383; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Meckmongkol TT, 2007, BIOCHEM BIOPH RES CO, V360, P709, DOI 10.1016/j.bbrc.2007.06.121; Mukhopadhyay A, 2005, BRIT J DERMATOL, V152, P639, DOI 10.1111/j.1365-2133.2005.06545.x; Peng C, 2011, J INT MED RES, V39, P416, DOI 10.1177/147323001103900209; Peng C, 2011, PLAST RECONSTR SURG, V128, p673E, DOI 10.1097/PRS.0b013e318230c521; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shannon DB, 2006, WOUND REPAIR REGEN, V14, P172, DOI 10.1111/j.1743-6109.2006.00107.x; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tan AM, 2015, MOL MED, V21, P544, DOI 10.2119/molmed.2015.00063; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Verrecchia Franck, 2002, Curr Rheumatol Rep, V4, P143, DOI 10.1007/s11926-002-0010-4; Weber CE, 2012, J BURN CARE RES, V33, P311, DOI 10.1097/BCR.0b013e318240541e; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896	39	24	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8361	8370		10.1074/jbc.RA118.006189	http://dx.doi.org/10.1074/jbc.RA118.006189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30894415	Green Published, hybrid			2022-12-26	WOS:000471108200007
J	Braganza, A; Quesnelle, K; Bickta, J; Reyes, C; Wang, YN; Jessup, M; St Croix, C; Arlotti, J; Singh, SV; Shiva, S				Braganza, Andrea; Quesnelle, Kelly; Bickta, Janelle; Reyes, Christopher; Wang, Yinna; Jessup, Morgan; St Croix, Claudette; Arlotti, Julie; Singh, Shivendra V.; Shiva, Sruti			Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myoglobin; breast cancer; reactive oxygen species (ROS); parkin; oxidative stress; cell cycle; heme protein; mitochondrial fusion; proliferation; tumor growth	NITRIC-OXIDE; ENDOGENOUS MYOGLOBIN; OXYGEN DELIVERY; FATTY-ACID; EXPRESSION; MFN2; IDENTIFICATION; MITOFUSIN-2; TOLERANCE	Myoglobin is a monomeric heme protein expressed ubiquitously in skeletal and cardiac muscle and is traditionally considered to function as an oxygen reservoir for mitochondria during hypoxia. It is now well established that low concentrations of myoglobin are aberrantly expressed in a significant proportion of breast cancer tumors. Despite being expressed only at low levels in these tumors, myoglobin is associated with attenuated tumor growth and a better prognosis in breast cancer patients, but the mechanism of this myoglobin-mediated protection against further cancer growth remains unclear. Herein, we report a signaling pathway by which myoglobin regulates mitochondrial dynamics and thereby decreases cell proliferation. We demonstrate in vitro that expression of human myoglobin in MDA-MB-231, MDA-MB-468, and MCF7 breast cancer cells induces mitochondrial hyperfusion by up-regulating mitofusins 1 and 2, the predominant catalysts of mitochondrial fusion. This hyperfusion causes cell cycle arrest and subsequent inhibition of cell proliferation. Mechanistically, increased mitofusin expression was due to myoglobin-dependent free-radical production, leading to the oxidation and degradation of the E3 ubiquitin ligase parkin. We recapitulated this pathway in a murine model in which myoglobin-expressing xenografts exhibited decreased tumor volume with increased mitofusin, markers of cell cycle arrest, and decreased parkin expression. Furthermore, in human triple-negative breast tumor tissues, mitofusin and myoglobin levels were positively correlated. Collectively, these results elucidate a new function for myoglobin as a modulator of mitochondrial dynamics and reveal a novel pathway by which myoglobin decreases breast cancer cell proliferation and tumor growth by up-regulating mitofusin levels.	[Braganza, Andrea; Quesnelle, Kelly; Wang, Yinna; Shiva, Sruti] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Shiva, Sruti] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA; [Bickta, Janelle; Reyes, Christopher] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA; [Jessup, Morgan] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; [St Croix, Claudette] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Arlotti, Julie; Singh, Shivendra V.; Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Arlotti, Julie; Singh, Shivendra V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Quesnelle, Kelly] Western Michigan Univ, Dept Biomed Sci, Homer Stryker Sch Med, Kalamazoo, MI 49008 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Michigan University	Shiva, S (corresponding author), Univ Pittsburgh, BST1240E,200 Lothrop St, Pittsburgh, PA 15216 USA.	sss43@pitt.edu	St Croix, Claudette/AAA-3338-2022; Quesnelle, Kelly/AAJ-2580-2021	Reyes, Christopher/0000-0002-6735-7624; Braganza Jardini, Andrea/0000-0002-7391-3658	National Institutes of Health [R01 HL133003-01A1, 1R01GM113816-01, T32 HL110849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110849, T32HL076124, T32HL129964, R01HL133003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL133003-01A1 and 1R01GM113816-01 (to S. S.) and T32 HL110849 Training in Translational Research and Entrepreneurship in Pulmonary Vascular Biology (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; COLE RP, 1982, J APPL PHYSIOL, V53, P1116, DOI 10.1152/jappl.1982.53.5.1116; Fang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31462; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hendgen-Cotta UB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43219; Higdon AN, 2012, AM J PHYSIOL-HEART C, V302, pH1394, DOI 10.1152/ajpheart.00584.2011; Jourd'heuil D, 1998, NITRIC OXIDE-BIOL CH, V2, P37, DOI 10.1006/niox.1998.0167; Jue T, 2016, J PHYSIOL BIOCHEM, V73, P359, DOI 10.1007/s13105-017-0559-z; Kamga C, 2012, NITRIC OXIDE-BIOL CH, V26, P251, DOI 10.1016/j.niox.2012.03.005; Khoo NKH, 2010, FREE RADICAL BIO MED, V48, P230, DOI 10.1016/j.freeradbiomed.2009.10.046; Kim JK, 2018, BIOCHEM BIOPH RES CO, V496, P1013, DOI 10.1016/j.bbrc.2017.02.076; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Kristiansen G, 2011, J BIOL CHEM, V286, P43417, DOI 10.1074/jbc.M111.227553; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li D, 2015, ACTA BIOCH BIOPH SIN, V47, P441, DOI 10.1093/abbs/gmv035; Lim KL, 2012, ANTIOXID REDOX SIGN, V16, P935, DOI 10.1089/ars.2011.4105; Lou YQ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0515-0; Ma L, 2015, ONCOL LETT, V10, P3816, DOI 10.3892/ol.2015.3748; Meller S, 2014, VIRCHOWS ARCH, V465, P419, DOI 10.1007/s00428-014-1646-y; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; NEWMAN ESR, 1991, BIOCHEM BIOPH RES CO, V179, P1414, DOI 10.1016/0006-291X(91)91730-Z; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Pride CK, 2014, CARDIOVASC RES, V101, P57, DOI 10.1093/cvr/cvt224; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; RAO SI, 1994, J BIOL CHEM, V269, P7210; Rayner BS, 2009, BIOCHEM J, V423, P169, DOI 10.1042/BJ20090716; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Richards MP, 2013, ANTIOXID REDOX SIGN, V18, P2342, DOI 10.1089/ars.2012.4887; Rizi BS, 2015, CANCER RES, V75, P456, DOI 10.1158/0008-5472.CAN-14-1337; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; Stolz DB, 1999, AM J PATHOL, V155, P1487, DOI 10.1016/S0002-9440(10)65464-8; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Touvier M, 2005, JNCI-J NATL CANCER I, V97, P1338, DOI 10.1093/jnci/dji276; Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091911; WITTENBERG BA, 1975, J BIOL CHEM, V250, P9038; WITTENBERG BA, 1987, P NATL ACAD SCI USA, V84, P7503, DOI 10.1073/pnas.84.21.7503; Wittenberg JB, 2007, J EXP BIOL, V210, P2082, DOI 10.1242/jeb.003947; Xia Y, 2008, J HUAZHONG U SCI-MED, V28, P185, DOI 10.1007/s11596-008-0218-2; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Yamada T, 2016, J PHYSIOL-LONDON, V594, P483, DOI 10.1113/JP270824; Yamada T, 2013, J APPL PHYSIOL, V114, P490, DOI 10.1152/japplphysiol.00789.2012; Zhang GE, 2013, INT J MOL SCI, V14, P13005, DOI 10.3390/ijms140713005	53	19	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7269	7282		10.1074/jbc.RA118.006673	http://dx.doi.org/10.1074/jbc.RA118.006673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30872402	Green Published, hybrid			2022-12-26	WOS:000468402900016
J	Dumbrepatil, AB; Ghosh, S; Zegalia, KA; Malec, PA; Hoff, JD; Kennedy, RT; Marsh, ENG				Dumbrepatil, Arti B.; Ghosh, Soumi; Zegalia, Kelcie A.; Malec, Paige A.; Hoff, J. Damon; Kennedy, Robert T.; Marsh, E. Neil G.			Viperin interacts with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6, coupling innate immune signaling to antiviral ribonucleotide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; ubiquitin ligase; protein kinase; Toll-like receptor (TLR); signal transduction; antiviral protein; interleukin 1 receptor associated kinase 1 (IRAK1); radical SAM enzymes; S-adenosylmethionine domain containing 2 (RSAD2); TNF receptor-associated factor 6 (TRAF6)	INTERFERON-INDUCIBLE PROTEIN; C VIRUS-REPLICATION; S-ADENOSYLMETHIONINE; POLYUBIQUITINATION; INHIBITOR; STABILITY; MECHANISM	Virus-inhibitory protein, endoplasmic reticulum-associated, interferon-inducible (viperin) is a radical SAM enzyme that plays a multifaceted role in the cellular antiviral response. Viperin has recently been shown to catalyze the SAM-dependent formation of 3-deoxy-3,4-didehydro-CTP (ddhCTP), which inhibits some viral RNA polymerases. Viperin is also implicated in regulating Lys-63-linked polyubiquitination of interleukin-1 receptor-associated kinase-1 (IRAK1) by the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6) as part of the Toll-like receptor-7 and -9 (TLR7/9) innate immune signaling pathways. In these pathways, the poly-ubiquitination of IRAK1 by TRAF6 is necessary to activate IRAK1, which then phosphorylates downstream targets and ultimately leads to the production of type I interferons. That viperin is a component of these pathways suggested that its enzymatic activity might be regulated by interactions with partner proteins. To test this idea, we have reconstituted the interactions between viperin, IRAK1, and TRAF6 by transiently expressing these enzymes in HEK 293T cells. We show that IRAK1 and TRAF6 increase viperin activity approximate to 10-fold to efficiently catalyze the radical-mediated dehydration of CTP to ddhCTP. Furthermore, we found that TRAF6-mediated ubiquitination of IRAK1 requires the association of viperin with both IRAK1 and TRAF6. Ubiquitination appears to depend on structural changes in viperin induced by SAM binding, but, significantly, does not require catalytically active viperin. We conclude that the synergistic activation of viperin and IRAK1 provides a mechanism that couples innate immune signaling with the production of the antiviral nucleotide ddhCTP.	[Dumbrepatil, Arti B.; Ghosh, Soumi; Zegalia, Kelcie A.; Malec, Paige A.; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Hoff, J. Damon] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu	; Marsh, Neil/G-7553-2016	Ghosh, Soumi/0000-0001-6101-0147; Dumbrepatil, Arti/0000-0002-0105-9667; Marsh, Neil/0000-0003-1713-1683; Zegalia, Kelcie/0000-0003-0389-134X; Hoff, Jeremy/0000-0002-4054-848X	National Institutes of Health [GM 093088, DK 046960]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM 093088 (to E. N. G. M.) and DK 046960 (to R. T. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; BORCHARDT RT, 1979, BIOCHEM BIOPH RES CO, V89, P919, DOI 10.1016/0006-291X(79)91866-7; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; CABOCHE M, 1978, J CELL PHYSIOL, V97, P361, DOI 10.1002/jcp.1040970311; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Fu TM, 2018, P NATL ACAD SCI USA, V115, P1783, DOI 10.1073/pnas.1721788115; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Jiang X, 2011, IMMUNITY, V34, P285, DOI 10.1016/j.immuni.2011.03.012; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; Marsh ENG, 2004, BIOORG CHEM, V32, P326, DOI 10.1016/j.bioorg.2004.06.001; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Panayiotou C, 2018, J VIROL, V92, DOI 10.1128/JVI.00501-18; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Carcamo JRP, 2018, VIROLOGY, V514, P216, DOI 10.1016/j.virol.2017.10.012; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vonderstein K, 2018, J VIROL, V92, DOI 10.1128/JVI.01751-17; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang L, 2017, P NATL ACAD SCI USA, V114, P13507, DOI 10.1073/pnas.1714386114; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	48	28	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6888	6898		10.1074/jbc.RA119.007719	http://dx.doi.org/10.1074/jbc.RA119.007719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30872404	Green Published, hybrid			2022-12-26	WOS:000467394700024
J	Bilek, O; Fohlerova, Z; Hubalek, J				Bilek, Ondrej; Fohlerova, Zdenka; Hubalek, Jaromir			Enhanced antibacterial and anticancer properties of Se-NPs decorated TiO2 nanotube film	PLOS ONE			English	Article							SELENIUM NANOPARTICLES; TITANIA NANOTUBES; OSTEOBLAST ADHESION; CELL-GROWTH; CHITOSAN; BIOCOMPATIBILITY; ANTIOXIDANT; FABRICATION; SURFACES; SIZE	Selenium nanoparticle modified surfaces attract increasing attention in the field of tissue engineering. Selenium exhibits strong anticancer, antibacterial and anti-inflammatory properties and it maintains relatively low off-target cytotoxicity. In our paper, we present the fabrication, characterization and cytocompatibility of titanium oxide (TiO2) nanotube surface decorated with various surface densities of chemically synthesized selenium nanoparticles. To evaluate antibacterial and anti-cancer properties of such nanostructured surface, gram negative bacteria E. coli, cancerous osteoblast like MG-63 cells and non-cancerous fibroblast NIH/3T3 were cultured on designed surfaces. Our results suggested that selenium nanoparticles improved antibacterial properties of titanium dioxide nanotubes and confirmed the anticancer activity towards MG-63 cells, with increasing surface density of nanoparticles. Further, the selenium decorated TiO2 nanotubes suggested deteriorating effect on the cell adhesion and viability of non-cancerous NIH/3T3 cells. Thus, we demonstrated that selenium nanoparticles decorated TiO2 nanotubes synthesized using sodium selenite and glutathione can be used to control bacterial infections and prevent the growth of cancerous cells. However, the higher surface density of nanoparticles adsorbed on the surface was found to be cytotoxic for non-cancerous NIH/3T3 cells and thus it might complicate the integration of biomaterial into the host tissue. Therefore, an optimal surface density of selenium nanoparticles must be found to effectively kill bacteria and cancer cells, while remaining favorable for normal cells.	[Bilek, Ondrej; Fohlerova, Zdenka; Hubalek, Jaromir] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Fohlerova, Zdenka; Hubalek, Jaromir] Brno Univ Technol, Dept Microelect, Brno, Czech Republic	Brno University of Technology; Brno University of Technology	Fohlerova, Z (corresponding author), Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic.; Fohlerova, Z (corresponding author), Brno Univ Technol, Dept Microelect, Brno, Czech Republic.	zdenka.fohlerova@ceitec.vutbr.cz	Bílek, Ondřej/R-9611-2017; Fohlerova, Zdenka/A-6893-2013	Bílek, Ondřej/0000-0002-3833-8037; Fohlerova, Zdenka/0000-0002-1232-2301	Czech Ministry of Education in frame of National Sustainability Program [LO1401]	Czech Ministry of Education in frame of National Sustainability Program	Research described in this paper was financed by Czech Ministry of Education in frame of National Sustainability Program under grant LO1401. For research, infrastructure of the SIX Center was used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, FRONT BIOENG BIOT C; Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h; Bendas G., 2012, INT J CELL BIOL, V2012; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005; Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008; Chen XY, 2013, COLLOID SURFACE B, V103, P149, DOI 10.1016/j.colsurfb.2012.10.022; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; El-Bayoumy K, 2001, MUTAT RES-FUND MOL M, V475, P123, DOI 10.1016/S0027-5107(01)00075-6; El-Ghazaly MA, 2017, CAN J PHYSIOL PHARM, V95, P101, DOI 10.1139/cjpp-2016-0183; Fohlerova Z, 2018, J BIOMED MATER RES B, V106, P1645, DOI 10.1002/jbm.b.33971; Forootanfar H, 2014, J TRACE ELEM MED BIO, V28, P75, DOI 10.1016/j.jtemb.2013.07.005; Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Huang XQ, 2016, ACTA BIOMATER, V30, P397, DOI 10.1016/j.actbio.2015.10.041; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041; Kumeria T, 2015, COLLOID SURFACE B, V130, P255, DOI 10.1016/j.colsurfb.2015.04.021; Kummer KM, 2012, NANOSCI NANOTECH LET, V4, P483, DOI 10.1166/nnl.2012.1352; Lamers E, 2010, EUR CELLS MATER, V20, P329; Lan MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075364; Li JH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4885401; Liu WW, 2016, NANOSCALE, V8, P15783, DOI 10.1039/c6nr04461a; Liu WW, 2014, NANOSCALE, V6, P9050, DOI 10.1039/c4nr01531b; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005; Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502; Perinpanayagam H, 2001, J ORTHOPAED RES, V19, P993, DOI 10.1016/S0736-0266(01)00045-6; Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037; Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020; Prikrylova K, 2016, MONATSH CHEM, V147, P943, DOI 10.1007/s00706-016-1679-9; Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; Shakibaie M, 2015, J TRACE ELEM MED BIO, V29, P235, DOI 10.1016/j.jtemb.2014.07.020; Shurygina I.A., 2017, NANOPARTICLES WOUND, P21, DOI [10.1007/978-3-319-63790-7_2, DOI 10.1007/978-3-319-63790-7_2]; Subramani K, 2012, MICRO NANO TECHNOL, P103, DOI 10.1016/B978-1-4557-7862-1.00007-9; Tam KH, 2008, THIN SOLID FILMS, V516, P6167, DOI 10.1016/j.tsf.2007.11.081; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P134, DOI 10.1016/S0753-3322(03)00035-0; Tran P, 2008, INT J NANOMED, V3, P391; Tran PA, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/4/045101; Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729; Tran PA, 2013, INT J NANOMED, V8, P2001, DOI 10.2147/IJN.S42970; Tran PA, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/15/155101; Yang TT, 2016, COLLOID SURFACE B, V145, P597, DOI 10.1016/j.colsurfb.2016.05.073; Zhang HZ, 2013, INT J NANOMED, V8, P4379, DOI 10.2147/IJN.S53221	48	23	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214066	10.1371/journal.pone.0214066	http://dx.doi.org/10.1371/journal.pone.0214066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901347	Green Published, gold, Green Submitted			2022-12-26	WOS:000462000400033
J	Atakhani, A; Mohammad-Rafiee, F; Gholami, A				Atakhani, Asal; Mohammad-Rafiee, Farshid; Gholami, Azam			Influence of cross-linking and retrograde flow on formation and dynamics of lamellipodium	PLOS ONE			English	Article							ACTIN FLOW; FORCE; POLYMERIZATION; ELASTICITY; PROTRUSION; ADHESION; DRIVEN; SHAPE	The forces that arise from the actin cortex play a crucial role in determining the membrane deformation. These include protrusive forces due to actin polymerization, pulling forces due to transient attachment of actin filaments to the membrane, retrograde flow powered by contraction of actomyosin network, and adhesion to the extracellular matrix. Here we present a theoretical model for membrane deformation resulting from the feedback between the membrane shape and the forces acting on the membrane. We model the membrane as a series of beads connected by springs and determine the final steady-state shape of the membrane arising from the interplay between pushing/pulling forces of the actin network and the resisting membrane tension. We specifically investigate the effect of the gel dynamics on the spatio-temporal deformation of the membrane until a stable lamellipodium is formed. We show that the retrograde flow and the cross-linking velocity play an essential role in the final elongation of the membrane. Interestingly, in the simulations where motor-induced contractility is switched off, reduced retrograde flow results in an increase in the rate and amplitude of membrane protrusion. These simulations are consistent with experimental observations that report an enhancement in protrusion efficiency as myosin II molecular motors are inhibited.	[Atakhani, Asal; Mohammad-Rafiee, Farshid] IASBS, Dept Phys, Zanjan 4513766731, Iran; [Mohammad-Rafiee, Farshid] IASBS, Res Ctr Basic Sci & Modern Technol RBST, Zanjan 4513766731, Iran; [Gholami, Azam] Max Planck Inst Dynam & Self Org, Gottingen, Germany	Institute for Advanced Studies in Basic Sciences (IASBS); Institute for Advanced Studies in Basic Sciences (IASBS); Max Planck Society	Mohammad-Rafiee, F (corresponding author), IASBS, Dept Phys, Zanjan 4513766731, Iran.; Mohammad-Rafiee, F (corresponding author), IASBS, Res Ctr Basic Sci & Modern Technol RBST, Zanjan 4513766731, Iran.; Gholami, A (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	farshid@iasbs.ac.ir; azam.gholami@ds.mpg.de	; Mohammad-Rafiee, Farshid/R-4593-2017	Gholami, Azam/0000-0002-9332-4551; atakhani, asal/0000-0002-3944-6996; Mohammad-Rafiee, Farshid/0000-0002-6503-0900	Federal Ministry of Education and Research of Germany; Max Planck Society	Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	We acknowledge MaxSynBio Consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bray D., 2000, CELL MOVEMENTS MOL M; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Clark AG, 2014, CURR BIOL, V24, pR484, DOI 10.1016/j.cub.2014.03.059; Deserno M, 2002, J PHYS CHEM B, V106, P5543, DOI 10.1021/jp0138476; EARNSHAW JC, 1989, BIOPHYS J, V55, P1017, DOI 10.1016/S0006-3495(89)82900-5; Enculescu M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053040; Enculescu M, 2010, BIOPHYS J, V98, P1571, DOI [10.1016/j.bpj.2009.12.4311, 10.1016/j.bpj.2009.12.431]; Enculescu M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031915; Faber M, 2010, EUR PHYS J-SPEC TOP, V191, P147, DOI 10.1140/epjst/e2010-01347-3; Falcke M, 2014, EUR PHYS J-SPEC TOP, V223, P1353, DOI 10.1140/epjst/e2014-02195-9; Gholami A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041803; Gholami A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115002; Gholami A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/3/033022; Hashemi SM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0769; Heinemann F, 2011, BIOPHYS J, V100, P1420, DOI 10.1016/j.bpj.2011.01.063; Howard J., 2001, MECH MOTOR PROTEINS; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kolomeisky AB, 2000, PHYSICA A, V279, P1, DOI 10.1016/S0378-4371(99)00586-5; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Phillips R., 2012, PHYS BIOL CELL; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Prost J, 2015, NAT PHYS, V11, P111, DOI [10.1038/nphys3224, 10.1038/NPHYS3224]; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Sadhu RK, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.062414; Shao DY, 2012, P NATL ACAD SCI USA, V109, P6851, DOI 10.1073/pnas.1203252109; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Tsekouras K, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103032; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Zimmermann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087638; Zimmermann J, 2012, BIOPHYS J, V102, P287, DOI 10.1016/j.bpj.2011.12.023; Zimmermann J, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051925	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213810	10.1371/journal.pone.0213810	http://dx.doi.org/10.1371/journal.pone.0213810			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897104	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700035
J	Santacreu, BJ; Pescio, LG; Romero, DJ; Corradi, GR; Sterin-Speziale, N; Favale, NO				Jaime Santacreu, Bruno; Gisele Pescio, Lucila; Judith Romero, Daniela; Raul Corradi, Gerardo; Sterin-Speziale, Norma; Octavio Favale, Nicolas			Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis	PLOS ONE			English	Article							E-CADHERIN; ALPHA-CATENIN; BETA-CATENIN; SERINE PALMITOYLTRANSFERASE; MESENCHYMAL TRANSITION; METABOLIC PATHWAYS; EXPRESSION; SNAIL; KIDNEY; COMPLEX	Sphingolipids regulate several aspects of cell behavior and it has been demonstrated that cells adjust their sphingolipid metabolism in response to metabolic needs. Particularly, sphingosine-1-phosphate (S1P), a final product of sphingolipid metabolism, is a potent bioactive lipid involved in the regulation of various cellular processes, including cell proliferation, cell migration, actin cytoskeletal reorganization and cell adhesion. In previous work in rat renal papillae, we showed that sphingosine kinase (SK) expression and S1P levels are developmentally regulated and control de novo sphingolipid synthesis. The aim of the present study was to evaluate the participation of SK/S1P pathway in the triggering of cell differentiation by external hypertonicity. We found that hypertonicity evoked a sharp decrease in SK expression, thus activating the de novo sphingolipid synthesis pathway. Furthermore, the inhibition of SK activity evoked a relaxation of cell-cell adherens junction (AJ) with accumulation of the AJ complex (E-cadherin/beta-catenin/alpha-catenin) in the Golgi complex, preventing the acquisition of the differentiated cell phenotype. This phenotype alteration was a consequence of a sphingolipid misbalance with an increase in ceramide levels. Moreover, we found that SNAI1 and SNAI2 were located in the cell nucleus with impairment of cell differentiation induced by SK inhibition, a fact that is considered a biochemical marker of epithelial to mesenchymal transition. So, we suggest that the expression and activity of SK1, but not SK2, act as a control system, allowing epithelial cells to synchronize the various branches of sphingolipid metabolism for an adequate cell differentiation program.	[Jaime Santacreu, Bruno; Gisele Pescio, Lucila; Judith Romero, Daniela; Octavio Favale, Nicolas] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina; [Jaime Santacreu, Bruno; Gisele Pescio, Lucila; Raul Corradi, Gerardo; Octavio Favale, Nicolas] Univ Buenos Aires, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, DF, Argentina; [Raul Corradi, Gerardo] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Catedra Quim Biol Super, Buenos Aires, DF, Argentina; [Sterin-Speziale, Norma] Univ Buenos Aires, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, Lab Nacl Invest & Serv Peptidos & Prot Espectrome, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Favale, NO (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina.; Favale, NO (corresponding author), Univ Buenos Aires, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, Buenos Aires, DF, Argentina.; Sterin-Speziale, N (corresponding author), Univ Buenos Aires, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, Lab Nacl Invest & Serv Peptidos & Prot Espectrome, Buenos Aires, DF, Argentina.	nsspeziale@qb.ffyb.uba.ar; nofaval@ffyb.uba.ar		Santacreu, Bruno/0000-0003-2506-5006; Corradi, Gerardo Raul/0000-0003-0354-7709	University of Buenos Aires [UBACyT 20020170200197BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220150100502CO]; AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA [ANCyP-PICT-2015-2941]	University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA(ANPCyT)	This work was supported by grants from the University of Buenos Aires (UBACyT 20020170200197BA, NOF); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 11220150100502CO, NOF); and AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA (ANCyP-PICT-2015-2941, NOF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAM BE, 1976, J LIPID RES, V17, P176; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Facchinetti MM, 2008, CELLS TISSUES ORGANS, V188, P384, DOI 10.1159/000139770; Facchinetti MM, 2003, BIOL NEONATE, V84, P243, DOI 10.1159/000072308; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044543; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Pescio LG, 2017, J LIPID RES, V58, P1428, DOI 10.1194/jlr.M076349; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Matsuzaki T, 2001, AM J PHYSIOL-CELL PH, V281, pC55, DOI 10.1152/ajpcell.2001.281.1.C55; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Minuth WW, 1999, EXP NEPHROL, V7, P394; Modrak DE, 2006, MOL CANCER THER, V5, P200, DOI 10.1158/1535-7163.MCT-05-0420; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Muqbil I, 2014, SEMIN CANCER BIOL, V27, P39, DOI 10.1016/j.semcancer.2014.06.003; Nieto FL, 2008, J BIOL CHEM, V283, P25682, DOI 10.1074/jbc.M804437200; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; Favale NO, 2015, J LIPID RES, V56, P786, DOI 10.1194/jlr.M050781; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; Pan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25798; Pescio LG, 2012, BBA-MOL CELL BIOL L, V1821, P884, DOI 10.1016/j.bbalip.2012.02.009; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Pokutta S, 2014, J BIOL CHEM, V289, P13589, DOI 10.1074/jbc.M114.554709; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Samak G, 2014, AM J PHYSIOL-GASTR L, V306, pG947, DOI 10.1152/ajpgi.00396.2013; Segal JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41827; Sheng L, 2017, MED SCI MONITOR, V23, P138, DOI 10.12659/MSM.902725; Signorelli P, 2002, METHOD ENZYMOL, V345, P275; Steiner P, 1997, DIFFERENTIATION, V62, P193; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119; Yuza K, 2018, J SURG RES, V232, P186, DOI 10.1016/j.jss.2018.06.019; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	53	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213917	10.1371/journal.pone.0213917	http://dx.doi.org/10.1371/journal.pone.0213917			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897151	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700047
J	Krakovska, O; Christie, G; Sixsmith, A; Ester, M; Moreno, S				Krakovska, Olga; Christie, Gregory; Sixsmith, Andrew; Ester, Martin; Moreno, Sylvain			Performance comparison of linear and non-linear feature selection methods for the analysis of large survey datasets	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; COGNITIVE FUNCTION; SENSITIVITY; COHORT; HEALTH; LASSO; RISK	Large survey databases for aging-related analysis are often examined to discover key factors that affect a dependent variable of interest. Typically, this analysis is performed with methods assuming linear dependencies between variables. Such assumptions however do not hold in many cases, wherein data are linked by way of non-linear dependencies. This in turn requires applications of analytic methods, which are more accurate in identifying potentially non-linear dependencies. Here, we objectively compared the feature selection performance of several frequently-used linear selection methods and three non-linear selection methods in the context of large survey data. These methods were assessed using both synthetic and real-world datasets, wherein relationships between the features and dependent variables were known in advance. In contrast to linear methods, we found that the non-linear methods offered better overall feature selection performance than linear methods in all usage conditions. Moreover, the performance of the non-linear methods was more stable, being unaffected by the inclusion or exclusion of variables from the datasets. These properties make non-linear feature selection methods a potentially preferable tool for both hypothesis-driven and exploratory analyses for aging-related datasets.	[Krakovska, Olga; Christie, Gregory; Sixsmith, Andrew; Moreno, Sylvain] Simon Fraser Univ, Digital Hlth Hub, Surrey, BC, Canada; [Krakovska, Olga; Christie, Gregory; Sixsmith, Andrew; Moreno, Sylvain] Simon Fraser Univ, Sci & Technol Aging Res Inst, Surrey, BC, Canada; [Krakovska, Olga; Sixsmith, Andrew] Simon Fraser Univ, Dept Gerontol, Vancouver, BC, Canada; [Ester, Martin] Simon Fraser Univ, Dept Comp Sci, Vancouver, BC, Canada; [Moreno, Sylvain] Simon Fraser Univ, Sch Interact Arts & Technol, Surrey, BC, Canada	Simon Fraser University; Simon Fraser University; Simon Fraser University; Simon Fraser University; Simon Fraser University	Moreno, S (corresponding author), Simon Fraser Univ, Digital Hlth Hub, Surrey, BC, Canada.; Moreno, S (corresponding author), Simon Fraser Univ, Sci & Technol Aging Res Inst, Surrey, BC, Canada.; Moreno, S (corresponding author), Simon Fraser Univ, Sch Interact Arts & Technol, Surrey, BC, Canada.	sylvainm@sfu.ca			Simon Fraser University Community Trust Endowment Fund; AGE-WELL Catalyst grant; National Institute on Aging [AG-9775, AG-21079, AG-033285, AG-041868, NIA U01AG009740]; Vilas Estate Trust; National Science Foundation; Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING [R01AG041868, U01AG009740] Funding Source: NIH RePORTER	Simon Fraser University Community Trust Endowment Fund; AGE-WELL Catalyst grant; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Vilas Estate Trust; National Science Foundation(National Science Foundation (NSF)); Spencer Foundation; Graduate School of the University of Wisconsin-Madison; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the Simon Fraser University Community Trust Endowment Fund and an AGE-WELL Catalyst grant to M.E. and S.M.; Since 1991, the WLS has been supported principally by the National Institute on Aging (AG-9775, AG-21079, AG-033285, and AG-041868), with additional support from the Vilas Estate Trust, the National Science Foundation, the Spencer Foundation, and the Graduate School of the University of Wisconsin-Madison. Since 1992, data have been collected by the University of Wisconsin Survey Center. A public use file of data from the Wisconsin Longitudinal Study is available from the Wisconsin Longitudinal Study, University of Wisconsin-Madison, 1180 Observatory Drive, Madison, Wisconsin 53706 and at http://www.ssc.wisc.edu/wlsresearch/data/.; This analysis uses Early Release data from the Health and Retirement Study, HRS 2014 Core (Final V2.0), and HRS 2008 Core (Final V3.0)), sponsored by the National Institute on Aging (grant number NIA U01AG009740) and conducted by the University of Michigan. These data have not been cleaned and may contain errors that will be corrected in the Final Public Release version of the dataset.	Alberg AJ, 2008, DRUG TODAY, V44, P895, DOI 10.1358/dot.2008.44.12.1308898; [Anonymous], 2014, U01AG009740 NIA; Bryant F. B., 1995, PRINCIPAL COMPONENTS; Choi KH, 2014, J GERONTOL B-PSYCHOL, V69, P123, DOI 10.1093/geronb/gbt104; Clouston SAP, 2012, INT J EPIDEMIOL, V41, P1729, DOI 10.1093/ije/dys148; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Ernst AF, 2017, PEERJ, V5, DOI 10.7717/peerj.3323; Flom Peter L, 2007, P NE SAS US GROUP NE; Friedman J, 2009, GLMNET LASSO ELASTIC, V1; Gilmour SG, 1996, J ROY STAT SOC D-STA, V45, P49, DOI 10.2307/2348411; Gretton A., 2007, P ADV NEURAL INFORM, V19, P513; Hadi AS, 2006, REGRESSION ANAL EXAM, P281, DOI [10.1002/0470055464.ch11, DOI 10.1002/0470055464.CH11]; Harrell Jr F.E, 2017, PACKAGE HMISC; Herd P, 2014, INT J EPIDEMIOL, V43, P34, DOI 10.1093/ije/dys194; Herd P, 2012, J CONSUM AFF, V46, P411, DOI 10.1111/j.1745-6606.2012.01235.x; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Kennedy P., 2003, GUIDE ECONOMETRICS; Kilander L, 1997, J INTERN MED, V242, P313, DOI 10.1046/j.1365-2796.1997.00196.x; Loewen S, 2015, SECOND LANG ACQUIS R, P182; McDowell I, 2001, INT PSYCHOGERIATR, V13, P7, DOI 10.1017/S1041610202007949; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Pfister N., 2016, J R STAT SOC B, DOI 10.1111/rssb.12235.; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rizzo ML, 2016, PACKAGE ENERGY; Roberts S, 2014, COMPUT STAT DATA AN, V70, P198, DOI 10.1016/j.csda.2013.09.008; Ross CE, 1996, J HEALTH SOC BEHAV, V37, P104, DOI 10.2307/2137234; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sewell William H, 2003, RES SOC STRAT MOBIL, V20, P3, DOI DOI 10.1016/S0276-5624(03)20001-9; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Su WJ, 2017, ANN STAT, V45, P2133, DOI 10.1214/16-AOS1521; Sudman S., 1983, ASKING QUESTIONS PRA; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Tambay J L, 1995, Health Rep, V7, P29; Tang J, 2014, DATA CLASSIFICATION, V2014, P37; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; Vasunilashorn S, 2013, J AGING HEALTH, V25, P758, DOI 10.1177/0898264313491426; Walmsley CM, 1998, PUBLIC HEALTH NUTR, V1, P157, DOI 10.1079/PHN19980025; Yeh Alexander, 2000, COLING 2000, V2; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	47	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213584	10.1371/journal.pone.0213584	http://dx.doi.org/10.1371/journal.pone.0213584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897097	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700027
J	Potter, LM; Grealy, MA				Potter, Lauren M.; Grealy, Madeleine A.			Aging and the prevalence of 'ironic' action errors under avoidant instruction	PLOS ONE			English	Article							INHIBIT SIMPLE THOUGHTS; AGE-RELATED DIFFERENCES; STOP-SIGNAL; PERFORMANCE; ABILITY; TASK; REPETITION; BEHAVIOR; ANXIETY; WALKING	Action errors can put older adults at risk of injury. Our study is the first to investigate whether older adults are more prone than younger adults to making 'ironic' motor errors (i.e., actions they have been instructed not to perform), or over-compensatory motor errors (e.g., moving more to the right when instructed not to move to the left). We also investigated whether error patterns change under cognitive load, and assessed whether age effects in the ability to inhibit a prohibited action are comparable to the age decrements found in the ability to inhibit a natural perception-action coupling in the Simon task. Sixty-four older (Mean = 70.64 years, SD = 5.81) and 39 younger (Mean = 28.74 years, SD = 16.39) adults completed an avoidant instruction line-drawing task (with and without cognitive load), and the Simon task. Older adults showed significantly slower inhibition times than younger adults on the Simon task, as expected, and in line with previous research. Surprisingly, however, older adults outperformed younger adults on the avoidant instruction task, producing fewer ironic and over-compensatory errors, and they performed similarly to the younger adults under cognitive load. Age-related decrements on the Simon but not the avoidant instruction task suggests that the two different types of motor tasks involve different subtypes of inhibition which likely recruit independent cognitive processes and neural circuitry in older age. It is speculated that the older adults' superior ability to inhibit a prohibited action could be the result of age-related changes in distractibility.	[Potter, Lauren M.] Heriot Watt Univ, Dept Psychol, Edinburgh, Midlothian, Scotland; [Grealy, Madeleine A.] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland	Heriot Watt University; University of Strathclyde	Potter, LM (corresponding author), Heriot Watt Univ, Dept Psychol, Edinburgh, Midlothian, Scotland.	l.m.potter@hw.ac.uk		Grealy, Madeleine/0000-0002-2823-8841; Potter, Lauren/0000-0002-9387-9581				Arthur CA, 2012, REFLECT PRACT, V13, P399, DOI 10.1080/14623943.2012.670112; Bach P, 2007, EXP BRAIN RES, V178, P509, DOI 10.1007/s00221-006-0756-4; Bakker FC, 2006, INT J SPORT PSYCHOL, V37, P265; Barlow M, 2016, PSYCHOL SPORT EXERC, V24, P27, DOI 10.1016/j.psychsport.2015.12.005; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Beilock SL, 2001, J SPORT EXERCISE PSY, V23, P200, DOI 10.1123/jsep.23.3.200; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Binsch O, 2010, INT J SPORT PSYCHOL, V41, P118; Binsch O, 2010, HUM MOVEMENT SCI, V29, P277, DOI 10.1016/j.humov.2009.12.002; CONNELLY SL, 1993, J EXP PSYCHOL HUMAN, V19, P1238, DOI 10.1037/0096-1523.19.6.1238; de la Pena D, 2008, J SPORT SCI, V26, P1323, DOI 10.1080/02640410802155138; Dempster FN, 1999, EDUC PSYCHOL REV, V11, P1, DOI 10.1023/A:1021992632168; Dugdale JR, 2003, RES Q EXERCISE SPORT, V74, P348, DOI 10.1080/02701367.2003.10609102; Erskine JAK, 2007, PERS INDIV DIFFER, V42, P1047, DOI 10.1016/j.paid.2006.09.016; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hommel B, 2006, Q J EXP PSYCHOL, V59, P509, DOI 10.1080/02724980443000836; Hommel B., 2006, PLANNING INTELLIGENT, P27; Jacoby LL, 1999, J EXP PSYCHOL LEARN, V25, P3, DOI 10.1037/0278-7393.25.1.3; Joyce J, 2014, MED SCI SPORT EXER, V46, P630, DOI 10.1249/MSS.0b013e3182a77980; Kim S, 2007, PSYCHON B REV, V14, P301, DOI 10.3758/BF03194068; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Kubo-Kawai N, 2010, Q J EXP PSYCHOL, V63, P452, DOI 10.1080/17470210902990829; Lambert AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065009; Larusso J., 2009, THESIS; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; LOGAN GD, 1985, J EXP PSYCHOL LEARN, V11, P675, DOI 10.1037/0278-7393.11.1-4.675; LOGAN GD, 1982, J EXP PSYCHOL HUMAN, V8, P778, DOI 10.1037/0096-1523.8.6.778; LOGAN GD, 1983, J EXP PSYCHOL LEARN, V9, P585, DOI 10.1037/0278-7393.9.4.585; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Maylor EA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00132; Murray BD, 2011, PSYCHOL AGING, V26, P940, DOI 10.1037/a0023214; Potter LM, 2008, AGING NEUROPSYCHOL C, V15, P232, DOI 10.1080/13825580701336882; Potter LM, 2006, EXP BRAIN RES, V171, P56, DOI 10.1007/s00221-005-0244-2; Russell C, 2010, Q J EXP PSYCHOL, V63, P1671, DOI 10.1080/17470210903572022; Savelsbergh G, 2012, INT J SPORTS SCI COA, V7, P47, DOI 10.1260/1747-9541.7.1.47; Sebastian A, 2013, NEUROBIOL AGING, V34, P2183, DOI 10.1016/j.neurobiolaging.2013.03.013; SEIDLER RD, 1995, QUEST, V47, P386, DOI 10.1080/00336297.1995.10484165; SIMON JR, 1963, ERGONOMICS, V6, P99, DOI 10.1080/00140136308930679; Srygley JM, 2009, BRAIN RES, V1253, P92, DOI 10.1016/j.brainres.2008.11.067; Starns JJ, 2010, PSYCHOL AGING, V25, P377, DOI 10.1037/a0018022; Tipper SP, 2006, PSYCHON B REV, V13, P493, DOI 10.3758/BF03193875; Titz C, 2010, PSYCHOL AGING, V25, P405, DOI 10.1037/a0017225; Van der Lubbe RHJ, 2002, PSYCHOPHYSIOLOGY, V39, P100, DOI 10.1017/S0048577202001221; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Woodman T, 2008, SPORT PSYCHOL, V22, P183, DOI 10.1123/tsp.22.2.183; Woodman T, 2015, SPORT PSYCHOL, V29, P213, DOI 10.1123/tsp.2014-0114; Zacks R, 1997, J GERONTOL B-PSYCHOL, V52, pP274, DOI 10.1093/geronb/52B.6.P274	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213340	10.1371/journal.pone.0213340	http://dx.doi.org/10.1371/journal.pone.0213340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897119	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000461889700017
J	Rheinberger, M; Jung, B; Segiet, T; Nusser, J; Kreisel, G; Andreae, A; Manz, J; Haas, G; Banas, B; Stark, K; Lammert, A; Gorski, M; Heid, IM; Kramer, BK; Boger, CA				Rheinberger, Myriam; Jung, Bettina; Segiet, Thomas; Nusser, Johann; Kreisel, Guenther; Andreae, Axel; Manz, Jochen; Haas, Gerhard; Banas, Bernhard; Stark, Klaus; Lammert, Alexander; Gorski, Mathias; Heid, Iris M.; Kraemer, Bernhard K.; Boeger, Carsten A.			Poor risk factor control in outpatients with diabetes mellitus type 2 in Germany: The DIAbetes COhoRtE (DIACORE) study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; KIDNEY-DISEASE; EMPAGLIFLOZIN; LIRAGLUTIDE; NEPHROPATHY; PROGRESSION; PREVENTION; MORTALITY; VETERANS	Introduction Patients with diabetes mellitus type 2 (DM2) are at high risk for micro-and macrovascular disease. Here, we explore the degree of traditional risk factor control in the baseline visit of a cohort of DM2 outpatients. Methods DIACORE (DIAbetes COhoRtE) is a prospective cohort study of 3000 adult DM2 outpatients. Here, we present results from the baseline visit. Sociodemographic and anthropometric variables, cardiovascular risk factors, comorbidities and medication were assessed by interview and medical exams. Serum-creatinine based estimated glomerular filtration rate (eGFRcrea) and urinary albumin-creatinine ratio (UACR) were determined for classification of chronic kidney disease (CKD). The proportion of patients with adequate control of traditional risk factors (blood pressure<140/90mmHg, HbA1c<7.5%, LDL<100mg/dl) was calculated in 2892 patients with non-missing data in 9 relevant variables within each KDIGO 2012 CKD class. Results In the analyzed baseline data (n = 2892, 60.2% men), mean (standard deviation) values for age, DM2 duration and HbA1c were 65.3 (9.3) years, 10.3 (8.4) years and 6.9% (1.1) respectively. Of these 2892 patients, 18.7% had CKD stage 3 or higher, 25.7% had UACR >= 30mg/g. Adequate blood pressure, HbA1c and LDL control was achieved in 55.7%, 78.5% and 34.4%, respectively. In 16.4% of patients (473), all three risk factors were below recommended targets. The proportion of adequate risk factor control was similar across KDIGO eGFRcrea classes. Adequate blood pressure and HbA1c control were significantly associated with lower UACR category without and with controlling for other risk factors (p<0.0001, p = 0.0002, respectively). Conclusion In our study of patients with diabetes mellitus type 2, we observed a low level of risk factor control indicating potential for risk reduction.	[Rheinberger, Myriam; Jung, Bettina; Banas, Bernhard; Gorski, Mathias; Boeger, Carsten A.] Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany; [Segiet, Thomas] Diabetol Schwerpunktpraxis Dres Segiet Gleixner &, Speyer, Germany; [Nusser, Johann; Kreisel, Guenther] Diabet Zentrum Regensburg, Regensburg, Germany; [Andreae, Axel] Praxis Dr Med Axel Andrae, Regensburg, Germany; [Manz, Jochen] Praxis Dr Med Jochen Manz, Regensburg, Germany; [Haas, Gerhard] Gemeinschaftspraxis Dr Med Gerhard Haas, Regensburg, Germany; [Stark, Klaus; Gorski, Mathias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Lammert, Alexander; Kraemer, Bernhard K.] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Boeger, Carsten A.] Kliniken Sudostbayern, Klinikum Traunstein, Dept Nephrol Diabetol & Rheumatol, Traunstein, Germany; [Boeger, Carsten A.] KfH Kidney Ctr Traunstein, Traunstein, Germany	University of Regensburg; University of Regensburg; Ruprecht Karls University Heidelberg	Boger, CA (corresponding author), Univ Hosp Regensburg, Dept Nephrol, Regensburg, Germany.; Boger, CA (corresponding author), Kliniken Sudostbayern, Klinikum Traunstein, Dept Nephrol Diabetol & Rheumatol, Traunstein, Germany.; Boger, CA (corresponding author), KfH Kidney Ctr Traunstein, Traunstein, Germany.	carsten.boeger@klinik.uni-regensburg.de		Banas, Bernhard/0000-0003-2076-2195	KfH Stiftung Praventivmedizin e.V [BO 3815/41]; Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung (BMBF) [01ER1206, 01ER1507]	KfH Stiftung Praventivmedizin e.V; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The DIACORE study is supported by a grant to CAB by the KfH Stiftung Praventivmedizin e.V (http://www.kfh-stiftung-praeventivmedizin.de).; CAB was also supported by grant BO 3815/41 from the Deutsche Forschungsgemeinschaft (DFG). IMH was supported by the Bundesministerium fur Bildung und Forschung (BMBF) grants 01ER1206 and 01ER1507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Agrawal L, 2011, DIABETES CARE, V34, P2090, DOI 10.2337/dc11-0175; American Diabetes Association, 2016, DIABETES CARE S1, V39, DOI [10.1056/NEJMoa1616011, DOI 10.1056/NEJMOA1616011]; Bundesarztekammer (BAK) Kassenarztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2013, NAT VERS THER TYP 2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Matheus ASD, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/653789; Dorhofer L, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-25; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hayward RA, 2015, NEW ENGL J MED, V373, P978, DOI 10.1056/NEJMc1508386; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; International Diabetes Federation, 2013, DIAB ATL 2013; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1716, DOI 10.1093/ndt/gfg288; Mann JFE, 2017, NEW ENGL J MED, V377, P839, DOI 10.1056/NEJMoa1616011; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rheinberger M, 2014, DEUT MED WOCHENSCHR, V139, P704, DOI 10.1055/s-0034-1369841; Rheinberger M, 2016, DEUT MED WOCHENSCHR, V141, P186, DOI 10.1055/s-0041-109591; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stone MA, 2013, DIABETES CARE, V36, P2628, DOI 10.2337/dc12-1759; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van Dijk PCW, 2005, KIDNEY INT, V67, P1489, DOI 10.1111/j.1523-1755.2005.00227.x; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoungas S, 2014, NEW ENGLAND J MED	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213157	10.1371/journal.pone.0213157	http://dx.doi.org/10.1371/journal.pone.0213157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897159	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700014
J	Macfarland, L; Mahony, NA; Harrison, M; Green, D				Macfarland, Lauren; Mahony, Nancy A.; Harrison, Megan; Green, David			Habitat-mediated breeding performance of Lewis's Woodpeckers (Melanerpes lewis) in British Columbia	PLOS ONE			English	Article							CAVITY-NESTING BIRDS; EUROPEAN STARLINGS; REPRODUCTIVE SUCCESS; CONSERVATION; COMPETITION; SITES; SELECTION; WEBS	Tree cavities provide a critical resource for cavity-nesting animals, and high quality cavities can be difficult for animals to acquire in habitats where competition is high. We investigated the breeding performance of Lewis's Woodpeckers in three habitat types in British Columbia, Canada in 2013 and 2014. We also assessed whether the number of nest competitors and cavity availability influenced the habitat specific breeding performance of this threatened cavity nesting species. We found that daily nest survival rate was lower in burned habitat (0.15 +/- 0.08 (0.05-0.37)) than in live pine (0.72 +/- 0.10 (0.51-0.87)) or cottonwood (0.69 +/- 0.09 (0.51-0.83)) habitats. However, hatching success (the proportion of eggs that hatch) was lower in live pine habitat (0.59 +/- 0.09 95% CI) than burned (0.77 +/- 0.19 95% CI) or cottonwood (0.80 +/- 0.07 95% CI) habitat, and the fledging success of successful nests in live pine and burned habitat (1.86 +/- 0.31 and 1.88 +/- 0.59 95% CI, respectively) was slightly lower than in cottonwood habitat (2.61 +/- 0.45 95% CI). Consequently, Lewis's Woodpeckers in cottonwood habitat produced more fledglings per nesting attempt (2.05 +/- 0.49 95% CI) than in live pine (1.53 +/- 0.35 95% CI) or burned (0.79 +/- 0.49 95% CI) habitat. Habitats differed in the number of nesting competitors and the number of suitable cavities surrounding active Lewis's Woodpecker nests. Our results showed that cavity density best explained breeding performance differences although the mechanisms remain unclear. There was no evidence that the number of heterospecific nest competitors, including the invasive European Starling (Sturnus vulgaris), explained or influenced Lewis's Woodpecker breeding performance. Cavity density influenced the productivity of successful nests but did not explain habitat differences in hatching success or daily nest survival. Further work is required to understand the mechanistic basis for the habitat specific breeding performance of Lewis's Woodpeckers. Habitat differences in breeding performance in British Columbia are not consistent with those in other regions, highlighting the importance of regionally-specific demographic data for managing species at risk.	[Macfarland, Lauren; Green, David] Simon Fraser Univ, Ctr Wildlife Ecol, Dept Biol Sci, Burnaby, BC, Canada; [Mahony, Nancy A.] Environm & Climate Change Canada, Wildlife & Res Div, Sci & Technol Branch, Edmonton, AB, Canada; [Harrison, Megan] Canadian Wildlife Serv, Environm & Climate Change Canada, Delta, BC, Canada	Simon Fraser University; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; Environment & Climate Change Canada; Canadian Wildlife Service	Macfarland, L (corresponding author), Simon Fraser Univ, Ctr Wildlife Ecol, Dept Biol Sci, Burnaby, BC, Canada.	lauren.macfarland@gmail.com			Environment and Climate Change Canada (ECCC)	Environment and Climate Change Canada (ECCC)	This study was supported by funds from Environment and Climate Change Canada (ECCC), https://www.canada.ca/en/environment-climate-change.html.ECCC had a role in study design and preparation of the manuscript.	Aitken KEH, 2012, J WILDLIFE MANAGE, V76, P557, DOI 10.1002/jwmg.286; [Anonymous], 2014, ORNITOLOGIA NEOTROPI; Bock C., 1970, ECOLOGY BEHAV LEWISS, P1; Bunnell Fred L., 1999, Environmental Reviews, V7, P97, DOI 10.1139/a99-010; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL RW, 1990, BIRDS BRIT COLUMBIA, V0002; Carvalho F, 2014, FOREST ECOL MANAG, V315, P54, DOI 10.1016/j.foreco.2013.12.013; Cole DN, 1996, ECOL APPL, V6, P168, DOI 10.2307/2269562; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Environment and Climate Change Canada, 2016, SPECIES RISK ACT REC; Environment Canada Canadian Wildlife Service, 2014, TECHN DOC ID CRIT HA; Fokidis HB, 2005, SOUTHEAST NAT, V4, P447, DOI 10.1656/1528-7092(2005)004[0447:TUONBT]2.0.CO;2; Fylling M., 2013, THESIS; Gentry DJ, 2007, CONDOR, V109, P122, DOI 10.1650/0010-5422(2007)109[122:OBASHF]2.0.CO;2; Goodenough AE, 2008, ETHOL ECOL EVOL, V20, P375, DOI 10.1080/08927014.2008.9522518; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; INGOLD DJ, 1994, WILSON BULL, V106, P227; Ingold DJ, 1996, J FIELD ORNITHOL, V67, P321; Isaac JL, 2008, ANIM CONSERV, V11, P281, DOI 10.1111/j.1469-1795.2008.00177.x; Jackson JA, 2004, CONDOR, V106, P37, DOI 10.1650/7483; KERPEZ TA, 1990, AUK, V107, P367, DOI 10.2307/4087621; Koch AJ, 2012, IBIS, V154, P590, DOI 10.1111/j.1474-919X.2012.01242.x; Koenig WD, 2003, CONSERV BIOL, V17, P1134, DOI 10.1046/j.1523-1739.2003.02262.x; Lea T., 2005, DAVIDSONIA, V19, P1; Lewis J., 2002, LEWIS WOODPECKER GEN, VIV; LI PJ, 1991, AUK, V108, P405; Martin K, 2004, CONDOR, V106, P5, DOI 10.1650/7482; Martin K, 1999, FOREST ECOL MANAG, V115, P243, DOI 10.1016/S0378-1127(98)00403-4; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Norris AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204226; R Development Core Team, 2014, R LANG ENV STAT COMP; Robles H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090071; Saab V., 2003, RMRSRP44 US DEP AGR; Saab V. A., 1998, RMRSRP11 USDA FOR SE; Saab VA, 2001, CONDOR, V103, P491, DOI 10.1650/0010-5422(2001)103[0491:RSOLSW]2.0.CO;2; Sauer J.R., 2017, N AM BREEDING BIRD S; SEDGWICK JA, 1990, J WILDLIFE MANAGE, V54, P112, DOI 10.2307/3808910; Seshadri KS, 2015, BIOL J LINN SOC, V114, P1, DOI 10.1111/bij.12388; van der Hoek Y, 2017, DIVERS DISTRIB, V23, P1120, DOI 10.1111/ddi.12601; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; YOMTOV Y, 1993, CONDOR, V95, P282, DOI 10.2307/1369350; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	43	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0212929	10.1371/journal.pone.0212929	http://dx.doi.org/10.1371/journal.pone.0212929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893345	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900023
J	Flach, RJR; Su, CY; Bollinger, E; Cortes, C; Robertson, AW; Opsahl, AC; Coskran, TM; Maresca, KP; Keliher, EJ; Yates, PD; Kim, AM; Kalgutkar, AS; Buckbinder, L				Flach, Rachel J. Roth; Su, Chunyan; Bollinger, Eliza; Cortes, Christian; Robertson, Andrew W.; Opsahl, Alan C.; Coskran, Timothy M.; Maresca, Kevin P.; Keliher, Edmund J.; Yates, Phillip D.; Kim, Albert M.; Kalgutkar, Amit S.; Buckbinder, Leonard			Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition	PLOS ONE			English	Article							OXIDATION; HYPERLIPIDEMIA; MECHANISM; PLAQUE; RISK; ACCUMULATION; INFLAMMATION; PF-06282999; MACROPHAGES; LIPOPROTEIN	Myeloperoxidase (MPO) is a highly abundant protein within the neutrophil that is associated with lipoprotein oxidation, and increased plasma MPO levels are correlated with poor prognosis after myocardial infarct. Thus, MPO inhibitors have been developed for the treatment of heart failure and acute coronary syndrome in humans. 2-(6-(5-Chloro-2-methoxpheny1)4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamidePF-06282999 is a recently described selective small molecule mechanism-based inactivator of MPO. Here, utilizing PF-06282999, we investigated the role of MPO to regulate atherosclerotic lesion formation and composition in the Ldlr(-/-) mouse model of atherosclerosis. Though MPO inhibition did not affect lesion area in Ldlr(-/-) mice fed a Western diet, reduced necrotic core area was observed in aortic root sections after MPO inhibitor treatment. MPO inhibition did not alter macrophage content in and leukocyte homing to atherosclerotic plaques. To assess non-invasive monitoring of plaque inflammation, [F-18]-Fluoro-deoxy-glucose (FDG) was administered to Ldlr(-/-) mice with established atherosclerosis that had been treated with clinically relevant doses of PF-06282999, and reduced FDG signal was observed in animals treated with a dose of PF-06282999 that corresponded with reduced necrotic core area. These data suggest that MPO inhibition does not alter atherosclerotic plaque area or leukocyte homing, but rather alters the inflammatory tone of atherosclerotic lesions; thus, MPO inhibition could have utility to promote atherosclerotic lesion stabilization and prevent atherosclerotic plaque rupture.	[Flach, Rachel J. Roth; Su, Chunyan; Bollinger, Eliza; Cortes, Christian; Kim, Albert M.; Buckbinder, Leonard] Pfizer Inc, Internal Med Res Unit, Cambridge, MA 02139 USA; [Robertson, Andrew W.; Opsahl, Alan C.; Coskran, Timothy M.] Pfizer Inc, Drug Safety Res & Dev Global Pathol, Groton, CT 06340 USA; [Maresca, Kevin P.; Keliher, Edmund J.; Yates, Phillip D.] Pfizer Inc, Early Clin Dev, Cambridge, MA USA; [Kalgutkar, Amit S.] Pfizer Inc, Med Design, Cambridge, MA USA; [Yates, Phillip D.] Bristol Meyers Squibb Co, New Brunswick, NJ USA; [Buckbinder, Leonard] Kintai Therapeut, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer	Flach, RJR (corresponding author), Pfizer Inc, Internal Med Res Unit, Cambridge, MA 02139 USA.	Rachel.Rothflach@pfizer.com		Roth Flach, Rachel/0000-0003-2754-828X	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	The authors are employees of and the studies were funded by Pfizer, Inc. Pfizer, Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali Muhammad, 2016, JACC Basic Transl Sci, V1, P633, DOI 10.1016/j.jacbts.2016.09.004; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Doring Y, 2017, CIRC RES, V120, P736, DOI 10.1161/CIRCRESAHA.116.309692; Dong JQ, 2016, DRUG METAB DISPOS, V44, P209, DOI 10.1124/dmd.115.067868; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Forghani R, 2012, RADIOLOGY, V263, P451, DOI 10.1148/radiol.12111593; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Hag AMF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050908; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Honda A, 2016, ARTERIOSCL THROM VAS, V36, P1980, DOI 10.1161/ATVBAHA.116.307293; Jucaite A, 2015, BRAIN, V138, P2687, DOI 10.1093/brain/awv184; Kim CHJ, 2015, ATHEROSCLEROSIS, V240, P234, DOI 10.1016/j.atherosclerosis.2015.03.012; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Leitinger N, 2013, ARTERIOSCL THROM VAS, V33, P1120, DOI 10.1161/ATVBAHA.112.300173; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Liu CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050767; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Morgan PE, 2015, FREE RADICAL RES, V49, P743, DOI 10.3109/10715762.2015.1019347; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Rashid I, 2018, EUR HEART J, V39, P3301, DOI 10.1093/eurheartj/ehy419; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Ruggeri RB, 2015, J MED CHEM, V58, P8513, DOI 10.1021/acs.jmedchem.5b00963; Shah PK, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0547-7; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Stocker R, 2005, J THROMB HAEMOST, V3, P1825, DOI 10.1111/j.1538-7836.2005.01370.x; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Tiyerili V, 2016, INT J CARDIOL, V204, P29, DOI 10.1016/j.ijcard.2015.11.128; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Zeng LX, 2018, J BIOL CHEM, V293, P7238, DOI 10.1074/jbc.RA117.000559; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zheng W, 2015, J PHARMACOL EXP THER, V353, P288, DOI 10.1124/jpet.114.221788; Zhou BD, 2017, LIPIDS HEALTH DIS, V16, DOI [10.1186/s12944-016-0388-z, 10.1186/s12944-017-0572-9]	47	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214150	10.1371/journal.pone.0214150	http://dx.doi.org/10.1371/journal.pone.0214150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889221	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000052
J	Lemkau, KL; Reddy, CM; Carmichael, CA; Aeppli, C; Swarthout, RF; White, HK				Lemkau, Karin L.; Reddy, Christopher M.; Carmichael, Catherine A.; Aeppli, Christoph; Swarthout, Robert F.; White, Helen K.			Hurricane Isaac brings more than oil ashore: Characteristics of beach deposits following the Deepwater Horizon spill	PLOS ONE			English	Article							GULF-OF-MEXICO; PETROLEUM BIOMARKERS; MARSH SEDIMENTS; ORGANIC-MATTER; SALT MARSHES; N-ALKANES; CARBON; DEGRADATION; VEGETATION; LOUISIANA	Prior to Hurricane Isaac making landfall along the Gulf of Mexico coast in August 2012, local and state officials were concerned that the hurricane would mobilize submerged oiled-materials from the Deepwater Horizon (DWH) spill. In this study, we investigated materials washed ashore following the hurricane to determine if it affected the chemical composition or density of oil-containing sand patties regularly found on Gulf Coast beaches. While small changes in sand patty density were observed in samples collected before and after the hurricane, these variations appear to have been driven by differences in sampling location and not linked to the passing of Hurricane Isaac. Visual and chemical analysis of sand patties confirmed that the contents was consistent with oil from the Macondo well. Petroleum hydrocarbon signatures of samples collected before and after the hurricane showed no notable changes. In the days following Hurricane Isaac, dark-colored mats were also found on the beach in Fort Morgan, AL, and community reports speculated that these mats contained oil from the DWH spill. Chemical analysis of these mat samples identified n-alkanes but no other petroleum hydrocarbons. Bulk and delta C-13 organic carbon analyses indicated mat samples were comprised of marshland peat and not related to the DWH spill. This research indicates that Hurricane Isaac did not result in a notable change the composition of oil delivered to beaches at the investigated field sites. This study underscores the need for improved communications with interested stakeholders regarding how to differentiate oiled from non-oiled materials. This is especially important given the high cost of removing oiled debris and the increasing likelihood of false positives as oiled-materials washing ashore from a spill become less abundant over time.	[Lemkau, Karin L.; Reddy, Christopher M.; Carmichael, Catherine A.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Aeppli, Christoph] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Swarthout, Robert F.] Appalachian State Univ, Dept Chem, Boone, NC 28608 USA; [Swarthout, Robert F.] Appalachian State Univ, Environm Sci Program, Boone, NC 28608 USA; [White, Helen K.] Haverford Coll, Dept Chem, Haverford, PA 19041 USA; [Lemkau, Karin L.] Western Washington Univ, Bellingham, WA 98225 USA	Woods Hole Oceanographic Institution; Bigelow Laboratory for Ocean Sciences; University of North Carolina; Appalachian State University; University of North Carolina; Appalachian State University; Haverford College; Western Washington University	Lemkau, KL (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.; Lemkau, KL (corresponding author), Western Washington Univ, Bellingham, WA 98225 USA.	karinlemkau@gmail.com	Lemkau, Karin/AAE-1560-2020	Lemkau, Karin/0000-0002-6440-5774; Reddy, Christopher/0000-0002-7814-2071	Gulf of Mexico Research Initiative (RFP-V); Deep-C Consortium [SA 16-30]; NSF [OCE-1333148]; Gulf Research Program Early-Career Research Fellowship	Gulf of Mexico Research Initiative (RFP-V); Deep-C Consortium; NSF(National Science Foundation (NSF)); Gulf Research Program Early-Career Research Fellowship	The authors wish to acknowledge support for this project from the Gulf of Mexico Research Initiative (RFP-V), the Deep-C Consortium (SA 16-30), NSF (OCE-1333148) awarded to CMR, and a Gulf Research Program Early-Career Research Fellowship to HKW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson J., 2012, TIMES PICAYUNE  1017; Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; [Anonymous], 2014, OSAT3; Berg R., 2013, TROPICAL CYCLONE REP; BLUMER M, 1957, ANAL CHEM, V29, P1039, DOI 10.1021/ac60127a014; Bostic JT, 2018, MAR POLLUT BULL, V126, P130, DOI 10.1016/j.marpolbul.2017.10.058; Carmichael CA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015301; Cherry KE, 2015, CURR PSYCHOL, V34, P576, DOI 10.1007/s12144-015-9372-4; CHMURA GL, 1987, OECOLOGIA, V74, P264, DOI 10.1007/BF00379369; Choi Y, 2001, GLOBAL BIOGEOCHEM CY, V15, P311, DOI 10.1029/2000GB001308; Clement TP, 2011, RES BRIEF IS SUBMERG, P1; Clement TP, 2012, RES BRIEF 2 IMPACT H, P1; Dalyander PS, 2014, MAR POLLUT BULL, V80, P200, DOI 10.1016/j.marpolbul.2014.01.004; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Elango V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00161; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Gros J, 2014, ENVIRON SCI TECHNOL, V48, P1628, DOI 10.1021/es4042836; Han YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190508; International Tanker Owners Pollution Federation LTd, 2011, 9 INT TANK OWN POLL; Lemkau KL, 2010, MAR POLLUT BULL, V60, P2123, DOI 10.1016/j.marpolbul.2010.09.001; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; Lopatto E., 2012, BLOOMBERG; Mahmoudi N, 2013, ENVIRON SCI TECHNOL, V47, P13303, DOI 10.1021/es4036072; Markey E, 2012, COMMUNICATION; Garcia NM, 2006, CHROMATOGR SCI SER, V93, P513; McCrea-Strub A, 2011, FISHERIES, V36, P332, DOI 10.1080/03632415.2011.589334; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Middelburg JJ, 1997, ESTUAR COAST SHELF S, V45, P681, DOI 10.1006/ecss.1997.0247; Morrison AE, 2018, MAR POLLUT BULL, V137, P501, DOI 10.1016/j.marpolbul.2018.10.051; Mulabagal V, 2013, MAR POLLUT BULL, V70, P147, DOI 10.1016/j.marpolbul.2013.02.026; National Commission on the BP Deepwater Horizon Oil Spill and Offshore Drilling, 2011, DEEP WAT GULF OIL DI; Natter M, 2012, ENVIRON SCI TECHNOL, V46, P5744, DOI 10.1021/es300058w; OSAT- 2, 2011, OSAT2; OSAT-3, 2013, OSAT3; Peeples L., 2012, HUFFINGTON POST; Plant N.G., 2013, 20121234 US GEOL SUR; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Reddy CM, 2000, ORG GEOCHEM, V31, P331, DOI 10.1016/S0146-6380(00)00025-5; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Stout SA, 2016, STANDARD HANDBOOK OIL SPILL ENVIRONMENTAL FORENSICS: FINGERPRINTING AND SOURCE IDENTIFICATION, 2ND EDITION, P61, DOI 10.1016/B978-0-12-809659-8.00003-6; Sumaila UR, 2012, CAN J FISH AQUAT SCI, V69, P499, DOI [10.1139/F2011-171, 10.1139/f2011-171]; Tanner BR, 2010, ESTUAR COAST SHELF S, V86, P283, DOI 10.1016/j.ecss.2009.11.023; Unified Command, 2010, SCAT SHORELINE TREAT, P1; Wadsworth T., 2014, INT OIL SPILL C P, V20141, P1647, DOI [10.7901/2169-3358-2014.1.1647, DOI 10.7901/2169-3358-2014.1.1647]; Wang P, 2013, J COASTAL RES, V29, P144, DOI 10.2112/JCOASTRES-D-12-00198.1; Wang XC, 2003, ESTUAR COAST SHELF S, V58, P917, DOI 10.1016/j.ecss.2003.07.006; Ward CP, 2018, ENVIRON SCI TECHNOL, V52, P1797, DOI 10.1021/acs.est.7b05948; Waterson EJ, 2008, ORG GEOCHEM, V39, P422, DOI 10.1016/j.orggeochem.2008.01.011; White HK, 2016, MAR POLLUT BULL, V113, P380, DOI 10.1016/j.marpolbul.2016.10.029; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Yang ZY, 2013, ENVIRON FORENSICS, V14, P193, DOI 10.1080/15275922.2013.814180	55	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213464	10.1371/journal.pone.0213464	http://dx.doi.org/10.1371/journal.pone.0213464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883566	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500018
J	George, SB; Strathmann, RR				George, Sophie B.; Strathmann, Richard R.			Arms of larval seastars of Pisaster ochraceus provide versatility in muscular and ciliary swimming	PLOS ONE			English	Article							BIPINNARIA LARVA; SAND DOLLARS; PATTERNS; TURBULENCE; TEMPERATURE; TRANSPORT; FORM	Larval swimming with cilia, unaided by muscles, is the presumed ancestral condition for echinoderms, but use of muscles in swimming has evolved several times. Ciliation and musculature of the arms of brachiolaria-stage larvae in the family Asteriidae provide unusual versatility in the use of muscles in swimming. The muscles affect swimming in two different ways. (1) Contraction of muscles moves the arms, propelling the larva. (2) Contraction of muscles changes orientation of the arms, thereby changing direction of ciliary currents and direction of swimming. New observations of the brachiolaria of the asteriid seastar Pisaster ochraceus demonstrate more versatility in both of these uses of muscles than had been previously described: the posterolateral arms stroke in more ways to propel the larva forward and to change the direction of swimming, and more pairs of the arms point ciliary currents in more directions for changes in direction of swimming. Morphology of brachiolariae suggests that these uses of muscles in swimming evolved before divergence of the families Stichasteridae and Asteriidae within forcipulate asteroids. This versatile use of muscles for swimming, both alone and in combination with ciliary currents, further distinguishes the swimming of these brachiolariae from swimming by larvae of other echinoderms and larvae of acorn worms in the sister phylum Hemichordata.	[George, Sophie B.] Georgia Southern Univ, Biol Dept, Statesboro, GA 30460 USA; [Strathmann, Richard R.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	University System of Georgia; Georgia Southern University; University of Washington	Strathmann, RR (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	rrstrath@uw.edu						Allen RM, 2018, ANNU REV MAR SCI, V10, P19, DOI 10.1146/annurev-marine-121916-063134; BARKER MF, 1978, BIOL BULL-US, V154, P32, DOI 10.2307/1540772; Bashevkin SM, 2016, MAR ECOL PROG SER, V542, P123, DOI 10.3354/meps11563; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Chan KYK, 2010, MAR ECOL PROG SER, V415, P49, DOI 10.3354/meps08744; Chan KYK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082764; Chan KYK, 2012, INTEGR COMP BIOL, V52, P458, DOI 10.1093/icb/ics092; Civelek CV, 2013, J EXP MAR BIOL ECOL, V445, P1, DOI 10.1016/j.jembe.2013.03.010; Clay TW, 2010, J EXP BIOL, V213, P1281, DOI 10.1242/jeb.037200; Fuchs HL, 2016, PROG OCEANOGR, V141, P109, DOI 10.1016/j.pocean.2015.12.010; Fuchs HL, 2015, J EXP BIOL, V218, P2782, DOI 10.1242/jeb.125096; Fuchs HL, 2015, J EXP BIOL, V218, P1419, DOI 10.1242/jeb.118562; Gemmill JF, 1914, PHILOS T R SOC LON B, V205; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; Grunbaum D, 2003, J MAR RES, V61, P659, DOI 10.1357/002224003771815990; HART MW, 1994, MAR BIOL, V120, P521, DOI 10.1007/BF00350072; Hodin J, 2019, METHODS CELL BIOL A, V150A; Lacalli TC, 1996, PHILOS T R SOC B, V351, P1737, DOI 10.1098/rstb.1996.0155; Lacalli TC, 2001, ACTA ZOOL-STOCKHOLM, V82, P117, DOI 10.1046/j.1463-6395.2001.00075.x; LACALLI TC, 1990, PHILOS T R SOC B, V330, P371, DOI 10.1098/rstb.1990.0206; Lloyd MJ, 2012, MAR ECOL PROG SER, V469, P37, DOI 10.3354/meps09983; Mah C, 2011, ZOOL J LINN SOC-LOND, V162, P646, DOI 10.1111/j.1096-3642.2010.00688.x; McDonald K, 2004, BIOL BULL-US, V207, P93, DOI 10.2307/1543584; McDonald KA, 2012, J EXP BIOL, V215, P14, DOI [10.1242/jeb.058206, DOI 10.1242/JEB.058206]; Montgomery EM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3072-6; Pia TS, 2012, J PLANKTON RES, V34, P590, DOI 10.1093/plankt/fbs032; Roy A, 2012, MAR ECOL PROG SER, V453, P117, DOI 10.3354/meps09662; STRATHMANN MF, 1987, DATA METHODS STUDY E; STRATHMANN R, 1976, MAR BIOL, V34, P317, DOI 10.1007/BF00398125; STRATHMANN R R, 1971, Journal of Experimental Marine Biology and Ecology, V6, P109, DOI 10.1016/0022-0981(71)90054-2; Strathmann RR, 2014, METHODS MOL BIOL, V1128, P1, DOI 10.1007/978-1-62703-974-1_1; Tattersall W.M., 1934, JAMES JOHNSTONE MEMO, P35; Wheeler JD, 2016, J EXP BIOL, V219, P1303, DOI 10.1242/jeb.129502	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213803	10.1371/journal.pone.0213803	http://dx.doi.org/10.1371/journal.pone.0213803			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870513	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300080
J	Zhang, XY; Dai, MY; Wang, M; Qi, YA				Zhang, Xiyang; Dai, Mingyue; Wang, Min; Qi, Yong'an			Calcified coccoid from Cambrian Miaolingian: Revealing the potential cellular structure of Epiphyton	PLOS ONE			English	Article							CARBONATE PRECIPITATION; CALCIUM-CARBONATE; NORTH CHINA; ALGAL MATS; CYANOBACTERIA; RENALCIS; BIOMINERALIZATION; STROMATOLITES; MICROFOSSILS; LIMESTONES	Epiphyton, Renalcis, and Girvanella are ubiquitous genera of calcified cyanobacteria/algae from Early Paleozoic shallow-marine limestones. One genus, Epiphyton, is characterized by a particular dendritic outline, and extensive research has revealed the morphology of calcified remains although little information on cellular structure is known. The mass occurrence of calcified Epiphyton in microbialites from Cambrian Miaolingian, the Mianchi area of North China is preserved as black clots within thrombolites and have dendritic and spherical outlines when viewed with a petrographic microscope. These remains, visible under scanning electron microscope (SEM), also comprise spherical or rectangle capsules. These capsules are made up from external envelopes and internal calcite with numerous pits, which closely resemble modern benthic coccoid cyanobacteria. These pits are between 2 mu m and 4 mu m in diameter and are interpreted here to represent the remnants of degraded coccoid cells, while the calcite that surrounds these pits is interpreted as calcified thin extracellular polymeric substances (EPS). In contrast, associated capsular envelopes represent thick EPS mineralized by calcium carbonate with an admixture of Al-Mg-Fe silicates. Dendritic ` thalli' are typically stacked apically because of the repeated growth and calcification of these capsules. Carbon and oxygen isotope results are interpreted to indicate that both photosynthesis and heterotrophic bacterial metabolism (especially sulfate reducing bacteria) contributed to carbonate precipitation by elevated alkalinity. Epiphyton are therefore here interpreted as colonies of calcified coccoid cyanobacteria, and the carbonate-oversaturated seawater during the Cambrian was conducive to their mineralization.	[Zhang, Xiyang; Dai, Mingyue; Wang, Min; Qi, Yong'an] Henan Polytech Univ, Sch Resources & Environm, Jiaozuo, Henan, Peoples R China; [Zhang, Xiyang] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiyang] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Nanjing, Jiangsu, Peoples R China	Henan Polytechnic University; Chinese Academy of Sciences; Chinese Academy of Sciences	Qi, YA (corresponding author), Henan Polytech Univ, Sch Resources & Environm, Jiaozuo, Henan, Peoples R China.	qiya@hpu.edu.cn		ZHANG, XIYANG/0000-0001-5529-7495	National Natural Science Foundation of China [41872111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 41872111). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2014, FACIES, V60, P703, DOI 10.1007/s10347-013-0376-y; Barattolo F., 1990, CALCAREOUS ALGAE STR, P504; Bornemann JG, 1886, NOVA ACTA KAISERLICH, V51, P1; BRASIER M D, 1976, Palaeontology (Oxford), V19, P223; CONIGLIO M, 1985, J SEDIMENT PETROL, V55, P746; Decho AW, 2000, MICROBIAL SEDIMENTS, P9; Dove PM, 2003, MINERALOGICAL SOC AM; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Fein JB, 2002, CHEM GEOL, V182, P265, DOI 10.1016/S0009-2541(01)00294-7; Feng ZZ, 1990, LITHOLOGIC PALEOGEOG; Gandin Anna, 2010, Palaeoworld, V19, P222, DOI 10.1016/j.palwor.2010.09.010; GOLUBIC S, 1976, J PALEONTOL, V50, P1074; HOFMANN HJ, 1975, AM J SCI, V275, P1121, DOI 10.2475/ajs.275.10.1121; Kamennaya NA, 2012, MINERALS-BASEL, V2, P338, DOI 10.3390/min2040338; Kawaguchi T, 2002, J CRYST GROWTH, V240, P230, DOI 10.1016/S0022-0248(02)00918-1; Kazmierczak J, 2012, GEOBIOLOGY, V10, P371, DOI 10.1111/j.1472-4669.2012.00339.x; Kazmierczak J, 1996, ACTA PALAEONTOL POL, V41, P319; Kazmierczak J, 2004, DEV PRECAMBRIAN GEOL, P545; Kazmierczak J, 2009, PRECAMBRIAN RES, V173, P79, DOI 10.1016/j.precamres.2009.02.002; Kempe S., 1993, FACIES, V28, P1; Kempe Stephan, 2007, V11; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; Konhauser K. O., 2007, INTRO GEOMICROBIOLOG; Korde KB, 1961, VODOROSLI KEMBRIYA Y; Korde KB, 1973, VODOROSLI KEMBRIYA C; Kremer B, 2008, GEOBIOLOGY, V6, P46, DOI 10.1111/j.1472-4669.2007.00128.x; Kremer B, 2019, SEDIMENTOLOGY, V66, P285, DOI 10.1111/sed.12529; Li JH, 2013, CHEM GEOL, V359, P49, DOI 10.1016/j.chemgeo.2013.09.013; Liu Y.H., 1991, CAMBRIAN ORDOVICIAN; Lopez-Garcia P, 2011, BACTERIAL DIVERSITY, P263; Luchinina V.A., 2008, GEOL CROATICA, V61, P105, DOI DOI 10.1134/S003103011414007X; Mazzullo SJ, 2009, J SEDIMENT RES, V70, P10; Meng XH, 1997, SEDIMENT GEOL, V114, P189, DOI 10.1016/S0037-0738(97)00073-0; Miller AG, 1990, REV CANADIENNE BOT, V68, P1291; Pace A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31495; Paerl HW, 2001, ENVIRON MICROBIOL, V3, P123, DOI 10.1046/j.1462-2920.2001.00168.x; Peng SC, 2009, CHINESE SCI BULL, V54, P4161, DOI 10.1007/s11434-009-0667-4; PONCET J, 1976, Geobios (Villeurbanne), V9, P345, DOI 10.1016/S0016-6995(76)80039-3; PRATT BR, 1984, J SEDIMENT PETROL, V54, P948; Richards FA, 1965, CHEM OCEANOGR, P623; RIDING R, 1982, PALAEONTOLOGY, V25, P869; RIDING R, 1993, J PALEONTOL, V67, P710, DOI 10.1017/S002233600003701X; Riding R, 2001, PERS PALEOB, P445; RIDING R, 1972, J PALEONTOL, V46, P509; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; Sasaran E, 2014, PALAEOGEOGR PALAEOCL, V401, P122, DOI 10.1016/j.palaeo.2014.02.026; Schopf JW, 2007, PRECAMBRIAN RES, V158, P141, DOI 10.1016/j.precamres.2007.04.009; Shen JW, 1997, FACIES, V37, P195; Silva SMF, 2000, BIBLIOTHECA PHYCOLOG; Tazaki K, 1997, CLAY CLAY MINER, V45, P203, DOI 10.1346/CCMN.1997.0450208; Ueshima M, 2001, CLAY CLAY MINER, V49, P292, DOI 10.1346/CCMN.2001.0490403; Vandenbroucke M, 2007, ORG GEOCHEM, V38, P719, DOI 10.1016/j.orggeochem.2007.01.001; Woo J, 2008, PALAIOS, V23, P55, DOI 10.2110/palo.2006.p06-103r; Wray JL, 1967, COLORADO SCH MINES G, V38, P719; Yang ZY, 2002, GEOPHYS J INT, V151, P1, DOI 10.1046/j.1365-246X.2002.01656.x; Zhang WH, 2015, GONDWANA RES, V28, P432, DOI 10.1016/j.gr.2014.03.015	57	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213695	10.1371/journal.pone.0213695	http://dx.doi.org/10.1371/journal.pone.0213695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870473	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300062
J	Andres, M; van der Werf, MJ; Kodmon, C; Albrecht, S; Haas, W; Fiebig, L; Indra, A; Wanlin, M; Bachiyska, E; Jurcev-Savicevic, A; Zemanova, I; Lillebaek, T; Viiklepp, P; Haanpera, M; Sougakoff, W; Bakos, A; Jackson, S; Cirillo, DM; Norvaisa, I; Vasiliauskiene, E; Reichert, P; Caruana, P; de Vries, G; Ronning, K; Augustynowicz-Kopec, E; Duarte, R; Homorodean, D; Svetina, P; Sanchez-Cambronero, L; Groenheit, R; Davidson, JA				Andres, Marta; van der Werf, Marieke J.; Kodmon, Csaba; Albrecht, Stefan; Haas, Walter; Fiebig, Lena; Indra, A.; Wanlin, M.; Bachiyska, E.; Jurcev-Savicevic, A.; Zemanova, I.; Lillebaek, T.; Viiklepp, P.; Haanpera, M.; Sougakoff, W.; Bakos, A.; Jackson, S.; Cirillo, D. M.; Norvaisa, I.; Vasiliauskiene, E.; Reichert, P.; Caruana, P.; de Vries, G.; Ronning, K.; Augustynowicz-Kopec, E.; Duarte, R.; Homorodean, D.; Svetina, P.; Sanchez-Cambronero, L.; Groenheit, R.; Davidson, J. A.		Survey Study Grp	Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; VARIABLE-NUMBER; WORLDWIDE PROFICIENCY; RECENT TRANSMISSION; STRAIN; OUTBREAKS	Background Molecular typing and whole genome sequencing (WGS) information is used for (inter-) national outbreak investigations. To assist the implementation of these techniques for tuberculosis (TB) surveillance and outbreak investigations at European level there is a need for inter-country collaboration and standardization. This demands more information on molecular typing practices and capabilities of individual countries. We aimed to review the use of molecular/genomic typing for TB surveillance in European Union and European Economic Area countries in 2016; assess its public health value; and collect experiences on typing data use for cross-border cluster investigations. Method A web-based questionnaire was provided to all TB National Focal Points. The questionnaire consisted of three parts: i) Use and integration of molecular and genomic typing data into TB surveillance; ii) Cross-border cluster investigation and international collaboration, and iii) Perception and evaluation of public health benefits of molecular and genomic typing for TB surveillance. Results Of 26 responding countries, 20 used molecular typing for TB surveillance, including nine applying WGS. The level of integration into the national surveillance was heterogeneous. Among six countries not using typing for TB surveillance, more than half planned its implementation soon. Overall, most countries perceived an added public health value of molecular typing for TB control. Concerning international cluster investigations, countries had little experience and did not have standard protocols to exchange typing data. Conclusion Our study shows a wide use of molecular and genomic typing data for TB surveillance in EU/EEA countries and reveals that transition to WGS-based typing is ongoing or is considered in most countries. However, our results also show a high heterogeneity in the use and integration of typing data for TB surveillance. Standardization of typing data use for TB surveillance is needed and formal procedures should be developed to facilitate international collaboration.	[Andres, Marta; Albrecht, Stefan; Haas, Walter; Fiebig, Lena] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [van der Werf, Marieke J.; Kodmon, Csaba] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden	Robert Koch Institute; European Centre for Disease Prevention & Control	Fiebig, L (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	lena.fiebig@apopo.org	Ködmön, Csaba/AAP-8247-2021; Anamarija, Jurcev Savicevic/AEB-5436-2022; Augustynowicz-Kopeć, Ewa/AAL-1757-2020; Cirillo, Daniela Maria/AAB-3646-2019; SOUGAKOFF, Wladimir/O-9754-2017	Ködmön, Csaba/0000-0001-8040-6753; Anamarija, Jurcev Savicevic/0000-0002-1430-7041; Augustynowicz-Kopeć, Ewa/0000-0001-6162-8748; Cirillo, Daniela Maria/0000-0001-6415-1535; SOUGAKOFF, Wladimir/0000-0002-2447-517X; Jackson, Sarah/0000-0003-0223-9966; Duarte, Raquel/0000-0003-2257-3099; de Vries, Gerard/0000-0003-1278-4503; Groenheit, Ramona/0000-0003-2696-437X; Bachiyska, Elizabeta/0000-0003-2949-5011; Fiebig, Lena/0000-0002-5977-0507; Andres, Marta/0000-0003-4369-2898; Lillebaek, Troels/0000-0002-2601-2718	Special research funds for molecular surveillance of the Robert Koch Institute, the national public health institute in the portfolio of the German Ministry of Health	Special research funds for molecular surveillance of the Robert Koch Institute, the national public health institute in the portfolio of the German Ministry of Health	Funding for this study was provided by Special research funds for molecular surveillance of the Robert Koch Institute, the national public health institute in the portfolio of the German Ministry of Health. Otherwise, the authors received no specific funding for this work.	Bidovec-Stojkovic U, 2011, RESP MED, V105, pS67, DOI 10.1016/S0954-6111(11)70014-2; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Casali N, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002137; Dara M, 2012, EUR RESPIR J, V40, P1081, DOI 10.1183/09031936.00053012; de Beer JL, 2014, INT J TUBERC LUNG D, V18, P594, DOI 10.5588/ijtld.13.0531; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; De Beer JL, 2008, J CLIN MICROBIOL, V46, P3924, DOI [10.1128/JCM.00793-08, DOI 10.1128/JCM.00793-08]; de Vries G, 2008, J CLIN MICROBIOL, V46, P3924, DOI 10.1128/JCM.00793-08; ECDC, 2016, EXP OP WHOL GEN SEQ; European Centre for Disease Prevention and Control (ECDC), 2017, MOL TYP SURV MULT RE; European Centre for Disease Prevention and Control (ECDC), 2016, EXT DRUG RES XDR TUB; European Centre for Disease Prevention and Control (ECDC), 2017, MULT RES TUB MIGR MU; European Centre for Disease Prevention and Control (ECDC), 2016, ECDC ROADM INT MOL G; European Centre for Disease Prevention and Control (ECDC); WHO Regional Office for Europe, 2018, TUB SURV MON EUR 201; Fiebig L., 2017, EURO SURVEILL, V22; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Jonsson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095159; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Lambregts-van Weezenbeek CSB, 2003, INT J TUBERC LUNG D, V7, pS463; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Macaraig M, 2006, J CLIN MICROBIOL, V44, P2890, DOI 10.1128/JCM.00160-06; Mears J, 2015, THORAX; Mears J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1023; Nikolayevskyy V, 2016, TUBERCULOSIS, V98, P77, DOI 10.1016/j.tube.2016.02.009; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Papaventsis D, 2016, CLIN MICROBIOL INFEC, DOI S1198-743X(16)30395-0; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Satta G, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0659-6; Shah NS, 2017, NEW ENGL J MED, V376, P243, DOI 10.1056/NEJMoa1604544; Smit PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085027; Struelens MJ, 2013, EUROSURVEILLANCE, V18, P3; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tagliani E, LANCET INFECT DIS; van Belkum A, 2007, CLIN MICROBIOL INFEC; Walker TM, 2017, LANCET INFECT DIS, V17, P359, DOI 10.1016/S1473-3099(17)30123-8; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wyllie DH, 2018, EBIOMEDICINE, V34, P122, DOI 10.1016/j.ebiom.2018.07.019	39	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0210080	10.1371/journal.pone.0210080	http://dx.doi.org/10.1371/journal.pone.0210080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865640	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900003
J	Jabbari, K; Wirtz, J; Rauscher, M; Wiehe, T				Jabbari, Kamel; Wirtz, Johannes; Rauscher, Martina; Wiehe, Thomas			A common genomic code for chromatin architecture and recombination landscape	PLOS ONE			English	Article							BIASED GENE CONVERSION; STRAND BREAK FORMATION; MEIOTIC RECOMBINATION; LINKAGE DISEQUILIBRIUM; MAMMALIAN GENOMES; REVEALS; RICH; DNA; FEATURES; REPAIR	Recent findings established a link between DNA sequence composition and interphase chromatin architecture and explained the evolutionary conservation of TADs (Topologically Associated Domains) and LADs (Lamina Associated Domains) in mammals. This prompted us to analyse conformation capture and recombination rate data to study the relationship between chromatin architecture and recombination landscape of human and mouse genomes. The results reveal that: (1) low recombination domains and blocks of elevated linkage disequilibrium tend to coincide with TADs and isochores, indicating co-evolving regulatory elements and genes in insulated neighbourhoods; (2) double strand break (DSB) and recombination frequencies increase in the short loops of GC-rich TADs, whereas recombination cold spots are typical of LADs and (3) the binding and loading of proteins, which are critical for DSB and meiotic recombination (SPO11, DMC1, H3K4me3 and PRMD9) are higher in GC-rich TADs. One explanation for these observations is that the occurrence of DSB and recombination in meiotic cells are associated with compositional and epigenetic features (genomic code) that influence DNA stiffness/flexibility and appear to be similar to those guiding the chromatin architecture in the interphase nucleus of pre-leptotene cells.	[Jabbari, Kamel; Wirtz, Johannes; Rauscher, Martina; Wiehe, Thomas] Univ Cologne, Inst Genet, Bioctr Cologne, Cologne, Germany	University of Cologne	Jabbari, K (corresponding author), Univ Cologne, Inst Genet, Bioctr Cologne, Cologne, Germany.	kjabbari@uni-koeln.de			German Research Foundation University of Cologne "UofC-Forum" [DFG SPP-1590]	German Research Foundation University of Cologne "UofC-Forum"	This work was partly financed by a grant of the German Research Foundation to TW DFG SPP-1590 University of Cologne "UofC-Forum" to JW and MR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Baker Z, 2017, ELIFE, P6; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2013, NAT REV GENET, V14, P794, DOI 10.1038/nrg3573; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; Bill CA, 1998, GENETICS, V149, P1935; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; EYREWALKER A, 1992, NUCLEIC ACIDS RES, V20, P1497, DOI 10.1093/nar/20.7.1497; Federico C, 2000, CHROMOSOME RES, V8, P737, DOI 10.1023/A:1026797522102; Galtier N, 2001, GENETICS, V159, P907; Galupa R, 2017, COLD SH Q B, V82, P267, DOI 10.1101/sqb.2017.82.035030; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Getun IV, 2010, EMBO REP, V11, P555, DOI 10.1038/embor.2010.79; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Grey C, 2017, GENOME RES, V27, P580, DOI 10.1101/gr.217240.116; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HECHT F, 1988, TRENDS GENET, V4, P121, DOI 10.1016/0168-9525(88)90131-X; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Heng HHQ, 1996, P NATL ACAD SCI USA, V93, P2795, DOI 10.1073/pnas.93.7.2795; Hilmi K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601898; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; IKEMURA T, 1991, NUCLEIC ACIDS RES, V19, P4333, DOI 10.1093/nar/19.16.4333; Jabbari K, 2018, LIFE-BASEL, V8, DOI 10.3390/life8010004; Jabbari K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168023; Jabbari K, 2016, GENOMICS, V108, P31, DOI 10.1016/j.ygeno.2016.01.001; Jung YH, 2017, CELL REP, V18, P1366, DOI 10.1016/j.celrep.2017.01.034; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kiktev DA, 2018, P NATL ACAD SCI USA, V115, pE7109, DOI 10.1073/pnas.1807334115; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Krijger PHL, 2016, CELL STEM CELL, V18, P597, DOI 10.1016/j.stem.2016.01.007; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; LAMB BC, 1984, HEREDITY, V53, P113, DOI 10.1038/hdy.1984.68; Lang FC, 2017, P NATL ACAD SCI USA, V114, P10912, DOI 10.1073/pnas.1704076114; Lange J, 2016, CELL, V167, P695, DOI 10.1016/j.cell.2016.09.035; Lemaitre C, 2014, GENE DEV, V28, P2450, DOI 10.1101/gad.248369.114; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Liu HX, 2018, NAT ECOL EVOL, V2, P164, DOI 10.1038/s41559-017-0372-7; Liu YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1308-x; Lobanenkov VV, 2018, NUCLEUS-PHILA, V9, P33, DOI 10.1080/19491034.2017.1394536; Marsolier-Kergoat MC, 2009, GENETICS, V183, P31, DOI 10.1534/genetics.109.105049; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Morgan AP, 2017, GENETICS, V206, P603, DOI 10.1534/genetics.116.197988; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Odenthal-Hesse L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004106; Oliver C, 2003, EUR BIOPHYS J BIOPHY, V32, P418, DOI 10.1007/s00249-003-0294-y; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Paces J, 2004, GENE, V333, P135, DOI 10.1016/j.gene.2004.02.041; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Saccone S, 1997, CHROMOSOME RES, V5, P293, DOI 10.1023/B:CHRO.0000038759.09018.a7; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schumer M, 2018, SCIENCE, V360, P656, DOI 10.1126/science.aar3684; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Smith AV, 2005, GENOME RES, V15, P1519, DOI 10.1101/gr.4421405; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Sun XJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07424; Szekvolgyi L, 2015, COLD SPRING HARB PER, V7, DOI [10.1080/15384101.2017.1361065, DOI 10.1080/15384101.2017.1361065]; Tang WWC, 2016, NAT REV GENET, V17, P585, DOI 10.1038/nrg.2016.88; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Walker M, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0024-6; Wang S, 2017, CELL, V168, P977, DOI 10.1016/j.cell.2017.02.002; Wang Yanli, 2017, BIORXIV; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wirtz J, 2018, THEOR POPUL BIOL; Yamada S, 2017, CELL CYCLE, V16, P1870, DOI 10.1080/15384101.2017.1361065; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	96	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213278	10.1371/journal.pone.0213278	http://dx.doi.org/10.1371/journal.pone.0213278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865674	gold, Green Published			2022-12-26	WOS:000461048900061
J	Kalin, JH; Eroglu, A; Liu, H; Holtzclaw, WD; Leigh, I; Proby, CM; Fahey, JW; Cole, PA; Dinkova-Kostova, AT				Kalin, Jay H.; Eroglu, Abdulkerim; Liu, Hua; Holtzclaw, W. David; Leigh, Irene; Proby, Charlotte M.; Fahey, Jed W.; Cole, Philip A.; Dinkova-Kostova, Albena T.			Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model	PLOS ONE			English	Article							INDUCED SKIN CARCINOGENESIS; HIGH-RISK; EXPRESSION; MUTATIONS; RADIATION; SURVIVAL; DAMAGE; MICE	Cutaneous squamous cell carcinomas are a common form of highly mutated keratinocyte skin cancers that are of particular concern in immunocompromised patients. Here we report on the efficacy of topically applied MS-275, a clinically used histone deacetylase inhibitor, for the treatment and management of this disease. At 2 mg/kg, MS-275 significantly decreased tumor burden in an SKH-1 hairless mouse model of UVB radiation-induced skin carcinogenesis. MS-275 was cell permeable as a topical formulation and induced histone acetylation changes in mouse tumor tissue. MS-275 was also effective at inhibiting the proliferation of patient derived cutaneous squamous cell carcinoma lines and was particularly potent toward cells isolated from a regional metastasis on an immunocompromised individual. Our findings support the use of alternative routes of administration for histone deacetylase inhibitors in the treatment of high-risk squamous cell carcinoma which may ultimately lead to more precise delivery and reduced systemic toxicity.	[Kalin, Jay H.; Cole, Philip A.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Kalin, Jay H.; Cole, Philip A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kalin, Jay H.; Eroglu, Abdulkerim; Liu, Hua; Holtzclaw, W. David; Fahey, Jed W.; Cole, Philip A.; Dinkova-Kostova, Albena T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Eroglu, Abdulkerim; Liu, Hua; Holtzclaw, W. David; Fahey, Jed W.; Dinkova-Kostova, Albena T.] Johns Hopkins Univ, Cullman Chemoprotect Ctr, Baltimore, MD 21205 USA; [Leigh, Irene; Proby, Charlotte M.; Dinkova-Kostova, Albena T.] Univ Dundee, Div Canc Res, Jacqui Wood Canc Ctr, Dundee, Scotland; [Fahey, Jed W.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Fahey, Jed W.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; University of Dundee; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kalin, JH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Kalin, JH (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Kalin, JH; Dinkova-Kostova, AT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.; Dinkova-Kostova, AT (corresponding author), Johns Hopkins Univ, Cullman Chemoprotect Ctr, Baltimore, MD 21205 USA.; Dinkova-Kostova, AT (corresponding author), Univ Dundee, Div Canc Res, Jacqui Wood Canc Ctr, Dundee, Scotland.	jkalin@bwh.harvard.edu; A.DinkovaKostova@dundee.ac.uk	Eroglu, Abdulkerim/J-5862-2019	Eroglu, Abdulkerim/0000-0001-5350-450X; Fahey, Jed/0000-0002-2129-1834; Kalin, Jay/0000-0002-8747-6022; Dinkova-Kostova, Albena/0000-0003-0316-9859	NIH [GM62437]; Cancer Research UK [C20953/A18644]; Biotechnology and Biological Sciences Research Council [BB/L01923X/1]; British Skin Foundation [7015]; Cancer Research UK [10270, 18644] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Skin Foundation; Cancer Research UK(Cancer Research UK)	We thank the NIH (GM62437), Cancer Research UK (C20953/A18644), the Biotechnology and Biological Sciences Research Council (BB/L01923X/1), and the British Skin Foundation (7015) for financial support. A.E. was a Kagome Visiting Scholar.	Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Booth L, 2017, ONCOTARGET, V8, P83155, DOI 10.18632/oncotarget.17950; Burton KA, 2016, AM J CLIN DERMATOL, V17, P491, DOI 10.1007/s40257-016-0207-3; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chitsazzadeh V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12601; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Cycon KA, 2013, IMMUNOLOGY, V140, P259, DOI 10.1111/imm.12136; Dai WW, 2015, EUR J PHARM SCI, V78, P255, DOI 10.1016/j.ejps.2015.07.019; Dinkova-Kostova AT, 2008, NUTR RES, V28, P539, DOI 10.1016/j.nutres.2008.05.009; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Guha M, 2015, NAT REV DRUG DISCOV, V14, P226, DOI 10.1038/nrd4583; Gurney B, 2014, BRIT J ORAL MAX SURG, V52, P294, DOI 10.1016/j.bjoms.2014.01.015; Guven M, 2015, J INVEST DERMATOL, V135, P2834, DOI 10.1038/jid.2015.255; Harwood CA, 2017, BRIT J DERMATOL, V177, P1150, DOI 10.1111/bjd.15932; Jiyad Z, 2016, AM J TRANSPLANT, V16, P3490, DOI 10.1111/ajt.13863; Kalin JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02242-4; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Knatko EV, 2017, CANCER PREV RES, V10, P67, DOI 10.1158/1940-6207.CAPR-16-0218; Knatko EV, 2015, CANCER PREV RES, V8, P475, DOI 10.1158/1940-6207.CAPR-14-0362; Koshkina NV, 2011, CANCER-AM CANCER SOC, V117, P3457, DOI 10.1002/cncr.25884; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Rangwala S, 2011, BRIT J DERMATOL, V165, P953, DOI 10.1111/j.1365-2133.2011.10507.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shen L, 2016, EPIGENOMICS-UK, V8, P415, DOI 10.2217/epi.15.118; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Suraweera A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00092; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104; Wang L, 2018, AM J TRANSPLANT, V18, P1596, DOI 10.1111/ajt.14749; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213095	10.1371/journal.pone.0213095	http://dx.doi.org/10.1371/journal.pone.0213095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865688	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900059
J	Wang, JJ; He, F; Shi, X				Wang, Jianjian; He, Feng; Shi, Xin			Numerical solution of a general interval quadratic programming model for portfolio selection	PLOS ONE			English	Article							OPTIMAL VALUES; ROBUST OPTIMIZATION	Based on the Markowitz mean variance model, this paper discusses the portfolio selection problem in an uncertain environment. To construct a more realistic and optimized model, in this paper, a new general interval quadratic programming model for portfolio selection is established by introducing the linear transaction costs and liquidity of the securities market. Regarding the estimation for the new model, we propose an effective numerical solution method based on the Lagrange theorem and duality theory, which can obtain the effective upper and lower bounds of the objective function of the model. In addition, the proposed method is illustrated with two examples, and the results show that the proposed method is better and more feasible than the commonly used portfolio selection method.	[Wang, Jianjian; He, Feng] Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Beijing, Peoples R China; [Shi, Xin] Manchester Metropolitan Univ, Business Sch, Manchester, Lancs, England; [Shi, Xin] Shanghai Univ, Sch Management, Shanghai, Peoples R China; [Shi, Xin] Karaganda Med Univ, Karaganda, Kazakhstan	University of Science & Technology Beijing; Manchester Metropolitan University; Shanghai University; Karaganda Medical University	He, F (corresponding author), Univ Sci & Technol Beijing, Donlinks Sch Econ & Management, Beijing, Peoples R China.; Shi, X (corresponding author), Manchester Metropolitan Univ, Business Sch, Manchester, Lancs, England.; Shi, X (corresponding author), Shanghai Univ, Sch Management, Shanghai, Peoples R China.; Shi, X (corresponding author), Karaganda Med Univ, Karaganda, Kazakhstan.	hefeng@manage.ustb.edu.cn; X.Shi@mmu.ac.uk	Shi, Xin/D-1528-2018	Shi, Xin/0000-0002-4930-7295	National Natural Science Foundation of China [71673022, 71420107023]; Ministry of Education Science and Technology Strategy Research Project [2015KJW02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Science and Technology Strategy Research Project	This work was supported by the National Natural Science Foundation of China [grant numbers 71673022 to FH, 71420107023 and XS] and the Ministry of Education Science and Technology Strategy Research Project [grant number 2015KJW02 to FH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar EE, 2008, INFORM SCIENCES, V178, P468, DOI 10.1016/j.ins.2007.03.029; Angelidis T., 2010, INT REV EC FINANCE, V19, P214, DOI [10.1016/j.irfa.2010.02.002, DOI 10.1016/J.IRFA.2010.02.002]; Ben-Tal A, 2002, MATH PROGRAM, V92, P453, DOI 10.1007/s101070100286; Bertsimas D, 2006, MODELS METHODS APPL, P95; Bhattacharyya R, 2011, COMPUT MATH APPL, V61, P126, DOI 10.1016/j.camwa.2010.10.039; BITRAN GR, 1980, MANAGE SCI, V26, P694, DOI 10.1287/mnsc.26.7.694; Chinneck JW, 2000, J OPER RES SOC, V51, P209, DOI 10.2307/254261; Da QL, 1999, SYST ENG THEORY PRAC, V19, P3, DOI DOI 10.3321/J.ISSN:1000-6788.1999.04.002; Dai ZF, 2018, J IND MANAG OPTIM, V14, P1651, DOI 10.3934/jimo.2018025; Dai ZF, 2018, FINANC RES LETT, V27, P46, DOI 10.1016/j.frl.2018.02.026; Deng X, 2010, STAT DECISION, P145; Deng XT, 2005, EUR J OPER RES, V166, P278, DOI 10.1016/j.ejor.2004.01.040; Fang Y, 2006, EUR J OPER RES, V175, P879, DOI 10.1016/j.ejor.2005.05.020; Gabrel V, 2010, J OPER RES SOC, V61, P1288, DOI 10.1057/jors.2009.81; Giove S, 2006, EUR J OPER RES, V170, P253, DOI 10.1016/j.ejor.2004.05.030; Hladik M, 2011, TOP, V19, P93, DOI 10.1007/s11750-009-0099-y; Inuiguchi M, 2000, FUZZY SET SYST, V111, P3, DOI 10.1016/S0165-0114(98)00449-7; ISHIBUCHI H, 1990, EUR J OPER RES, V48, P219, DOI 10.1016/0377-2217(90)90375-L; Jiang C, 2008, EUR J OPER RES, V188, P1, DOI 10.1016/j.ejor.2007.03.031; Karmakar S, 2014, J OPER RES SOC, V65, P73, DOI 10.1057/jors.2012.151; KONNO H, 1991, MANAGE SCI, V37, P519, DOI 10.1287/mnsc.37.5.519; Krawczyk R., 1975, LNCS, V29, P215; Lai KK, 2002, IEEE T FUZZY SYST, V10, P698, DOI 10.1109/TFUZZ.2002.805902; Li J, 2009, OMEGA-INT J MANAGE S, V37, P439, DOI 10.1016/j.omega.2007.06.002; Li W, 2008, APPL MATH COMPUT, V202, P589, DOI 10.1016/j.amc.2008.02.039; Li W, 2017, OPTIM LETT, V11, P1443, DOI 10.1007/s11590-016-1097-2; Li W, 2016, J COMPUT APPL MATH, V302, P38, DOI 10.1016/j.cam.2016.01.044; Liu ST, 2007, APPL MATH COMPUT, V189, P1274, DOI 10.1016/j.amc.2006.12.007; Liu WB, 2015, OMEGA-INT J MANAGE S, V52, P107, DOI 10.1016/j.omega.2014.11.006; Liu YJ, 2013, ECON MODEL, V33, P113, DOI 10.1016/j.econmod.2013.03.006; [陆静 Lu Jing], 2004, [管理工程学报, Journal of Industrial Engineering and Engineering Management], V18, P109; Lu Ying-Jin, 2004, Journal of Systems Engineering, V19, P33; Mao J. C. T., 1970, J FINANCIAL QUANTITA, V4, P657; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Moore R.E., 1966, INTERVAL ANAL; Mraz F, 1998, ANN OPER RES, V81, P51, DOI 10.1023/A:1018985914065; MULVEY JM, 1995, OPER RES, V43, P264, DOI 10.1287/opre.43.2.264; Nirmal D, 2013, INT NANOELECTR CONF, P12, DOI 10.1109/INEC.2013.6465939; Papahristodoulou C, 2004, J OPER RES SOC, V55, P1169, DOI 10.1057/palgrave.jors.2601765; Peng Z, 2016, CHINESE J MANAGEMENT; ROMMELFANGER H, 1989, EUR J OPER RES, V41, P210, DOI 10.1016/0377-2217(89)90386-X; Sengupta A, 2001, FUZZY SET SYST, V119, P129, DOI 10.1016/S0165-0114(98)00407-2; Lobo MS, 2007, ANN OPER RES, V152, P341, DOI 10.1007/s10479-006-0145-1; Sun H-L, 2010, J SYST ENG, V3, P5; Wu M, 2013, FUZZY OPTIM DECIS MA, V12, P289, DOI 10.1007/s10700-013-9155-z; Xu X, 2012, CHINESE J MANAGEMENT; Xu X N, 2013, SYSTEMS ENG THEORY P, V33; Xu XN, 2015, J OPER RES SOC, V66, P885, DOI 10.1057/jors.2014.31; Yao HX, 2016, EUR J OPER RES, V252, P837, DOI 10.1016/j.ejor.2016.01.049; [张鹏 ZHANG Peng], 2008, [中国管理科学, Chinese Journal of Management Science], V16, P30; Zhang WG, 2009, EUR J OPER RES, V197, P693, DOI 10.1016/j.ejor.2008.07.011; Zhong-Bao Z, 2015, CHINESE J MANAGEMENT	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212913	10.1371/journal.pone.0212913	http://dx.doi.org/10.1371/journal.pone.0212913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865676	gold, Green Published, Green Submitted			2022-12-26	WOS:000461048900047
J	Gao, Y; Zhou, SH; Luu, S; Glowacki, J				Gao, Yuan; Zhou, Shuanhu; Luu, Simon; Glowacki, Julie			Megalin mediates 25-hydroxyvitamin D-3 actions in human mesenchymal stem cells	FASEB JOURNAL			English	Article						vitamin D; LRP2; gp330; osteoblastogenesis	VITAMIN-D METABOLISM; MARROW STROMAL CELLS; GROWTH-FACTOR; 1,25-DIHYDROXYVITAMIN D-3; RECEPTOR MEGALIN; EXPRESSION; DIFFERENTIATION; HORMONE; CUBILIN; LEPTIN	Osteoblast differentiation of human mesenchymal stem cells (hMSCs) is stimulated by 1 alpha,25-dihydroxycholecalciferol [1 alpha,25(OH)(2)D-3] and 25-hydroxycholecalciferol [25(OH)D-3]; the latter's effects require intracellular hydroxylation to 1 alpha,25(OH)(2)D-3. Thus, hMSCs are both a source of and target for 1 alpha,25(OH)(2)D-3. Megalin is a transmembrane receptor for serum d-binding protein (DBP) in kidney cells and is required for uptake of the 25(OH)D-3-DBP complex. We tested the hypothesis that megalin is required for D actions in hMSCs with cells from surgically discarded marrow for RT-PCR, for effects of 25(OH)D-3 and 1 alpha,25(OH)(2)D-3, for 1 alpha,25(OH)(2)D-3 biosynthesis, for osteoblastogenesis, and for small interfering RNA for megalin (si-Meg) and control (si-Ctr). In hMSCs with high constitutive megalin expression, both 1 alpha,25(OH)(2)D-3 and 25(OH)D-3 stimulated osteoblastogenesis (P < 0.05), but only 1 alpha,25(OH)(2)D-3 did so in hMSCs with lower megalin (lo-Meg, P < 0.001) or in si-Meg cells (P < 0.05). In addition, 1 alpha,25(OH)(2)D-3 biosynthesis was significantly lower in lo-Meg (46%, P = 0.034) and in si-Meg (23%, P < 0.001) than each control. Leptin significantly stimulated megalin expression 2.1-fold in lo-Meg cells (P < 0.01). These studies show that megalin is expressed in hMSCs and is required for the biosynthesis of 1 alpha,25(OH)(2)D-3 and for the 25(OH)D-3/DBP complex to stimulate vitamin D receptor targets and osteoblastogenesis.-Gao, Y., Zhou, S., Luu, S., Glowacki, J. Megalin mediates 25-hydroxyvitamin D-3 actions in human mesenchymal stem cells.	[Gao, Yuan; Zhou, Shuanhu; Luu, Simon; Glowacki, Julie] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Gao, Yuan] Shanghai Jiao Tong Univ, Sch Med, Dept Orthoped Surg, Xin Hua Hosp, Shanghai, Peoples R China; [Glowacki, Julie] Harvard Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Shanghai Jiao Tong University; Harvard University; Harvard School of Dental Medicine	Glowacki, J (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, 60 Fenwood Rd, Boston, MA 02115 USA.	jglowacki@partners.org			Department of Orthopedic Surgery; Brigham and Women's Hospital; Gillian Reny Stepping Strong Center for Trauma Innovation; China Scholarship Council (CSC)	Department of Orthopedic Surgery; Brigham and Women's Hospital; Gillian Reny Stepping Strong Center for Trauma Innovation; China Scholarship Council (CSC)(China Scholarship Council)	The authors thank Anna Gorska, M.S. and Christopher Bertucci, Ph.D. (Brigham and Women's Hospital) for work with human mesenchymal stem cells. The authors thank the surgeons and nurses of the Department of Orthopedic Surgery, Brigham and Women's Hospital for their help with specimens. This work was supported by grants from the Department of Orthopedic Surgery, Brigham and Women's Hospital, and The Gillian Reny Stepping Strong Center for Trauma Innovation. Y.G. was supported by the China Scholarship Council (CSC). The granting entities had no involvement in the planning, execution, or reporting of the study. The authors declare no conflicts of interest.	ADAMS JS, 1990, J BONE MINER RES, V5, P1265; Alsalem JA, 2014, INVEST OPHTH VIS SCI, V55, P2140, DOI 10.1167/iovs.13-13019; ARNAUD J, 1993, HUM GENET, V92, P183; Atkins GJ, 2007, BONE, V40, P1517, DOI 10.1016/j.bone.2007.02.024; Bikle DD, 2017, ENDOCRIN METAB CLIN, V46, P901, DOI 10.1016/j.ecl.2017.07.013; BIKLE DD, 1986, BIOCHEMISTRY-US, V25, P1545, DOI 10.1021/bi00355a013; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Cioffi JA, 1997, MOL HUM REPROD, V3, P467, DOI 10.1093/molehr/3.6.467; D'Ippolito G, 2002, BONE, V31, P269, DOI 10.1016/S8756-3282(02)00820-7; Fromigue O, 1997, CYTOKINE, V9, P613, DOI 10.1006/cyto.1997.0209; Geng S, 2013, METABOLISM, V62, P768, DOI 10.1016/j.metabol.2013.01.003; Geng S, 2011, J BONE MINER RES, V26, P1145, DOI 10.1002/jbmr.298; Hilpert J, 2002, KIDNEY INT, V62, P1672, DOI 10.1046/j.1523-1755.2002.00634.x; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; Hsu JY, 2001, CANCER RES, V61, P2852; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Li J, 2016, AM SOC BONE MINERAL; Liu P, 1999, CALCIFIED TISSUE INT, V65, P173, DOI 10.1007/s002239900678; Lou YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep42816; Lundgren S, 1997, J HISTOCHEM CYTOCHEM, V45, P383, DOI 10.1177/002215549704500306; Mahadevappa R, 2014, AM J PHYSIOL-RENAL, V306, pF147, DOI 10.1152/ajprenal.00378.2013; Mocharla H, 1997, J BONE MINER RES, V12, P726, DOI 10.1359/jbmr.1997.12.5.726; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Norden AGW, 2002, J AM SOC NEPHROL, V13, P125, DOI 10.1681/ASN.V131125; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Park H, 2017, AM J CLIN NUTR, V106, P1439, DOI 10.3945/ajcn.117.153429; Pasco JA, 2001, J CLIN ENDOCR METAB, V86, P1884, DOI 10.1210/jc.86.5.1884; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rowling MJ, 2006, J NUTR, V136, P2754, DOI 10.1093/jn/136.11.2754; Safadi FF, 1999, J CLIN INVEST, V103, P239, DOI 10.1172/JCI5244; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Scott MG, 2015, CLIN CHEM, V61, P462, DOI 10.1373/clinchem.2014.222521; Segersten U, 2002, J CLIN ENDOCR METAB, V87, P2967, DOI 10.1210/jc.87.6.2967; Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002; Sellmeyer DE, 2007, OSTEOPOROSIS INT, V18, P973, DOI 10.1007/s00198-007-0336-x; Suruda C, 2017, PEDIATR NEPHROL, V32, P621, DOI 10.1007/s00467-016-3535-x; Tsuprykov O, 2018, J STEROID BIOCHEM, V180, P87, DOI 10.1016/j.jsbmb.2017.11.014; Willnow TE, 2017, PFLUG ARCH EUR J PHY, V469, P907, DOI 10.1007/s00424-017-1992-0; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zhou SH, 2017, ANN NY ACAD SCI, V1402, P43, DOI 10.1111/nyas.13464; Zhou SH, 2013, J STEROID BIOCHEM, V136, P342, DOI 10.1016/j.jsbmb.2012.09.009; Zhou SH, 2010, ENDOCRINOLOGY, V151, P14, DOI 10.1210/en.2009-0969	45	12	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7684	7693		10.1096/fj.201802578R	http://dx.doi.org/10.1096/fj.201802578R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30893561	Bronze			2022-12-26	WOS:000476114200081
J	Jia, BL; Yuan, D; Lan, WJ; Xuan, YH; Jeon, CO				Jia, Baolei; Yuan, De Peng; Lan, Wen Jun; Xuan, Yuan Hu; Jeon, Che Ok			New insight into the classification and evolution of glucose transporters in the Metazoa	FASEB JOURNAL			English	Article						GLUT; protein family; network; gene fusion; gene duplication	PROTEIN; REGULATOR; DIVERSITY; FAMILY; MODEL	Because glucose is an essential energy source for living organisms, glucose transporters (GLUTs) are present in all species worldwide. Encoded by the solute carrier family 2 gene family, the GLUT proteins generally have 12 transmembrane helices (TMHs). In total, 14 GLUT proteins have been identified in humans (hGLUTs), and they are divided into 3 classes on the basis of their transport characteristics and sequence similarities. Herein, we report the use of protein sequence similarity networks (SSNs) to visualize the sequence trends of 4101 GLUT proteins across the Metazoa. The SSNs separated the metazoan proteins into 3 new classes that were different from the traditional classification system. In the new system, 9 of the 14 hGLUTs (hGLUT1-5, 7, 9, 11, and 14) were grouped into class I, 3 (hGLUT10, 12, and 13) were grouped into class II, and 2 (hGLUT6 and 8) were grouped into class III, as also supported by the phylogenetic tree. Multiple sequence alignments further showed that the conserved residues in each class were different. Furthermore, the hGLUTs in each class showed unique evolutionary characteristics, with similar nonsynonymous-to-synonymous divergence ratios and similar regions under conservative selection pressure. Of note, GLUTs with 3, 6, 18, 24, and 36 TMHs were identified among the metazoan genomes, and 1 Chinese hamster protein with 6 TMHs showed GLUT activity. In summary, this large-scale sequence analysis provided new insights into the classification and evolution of GLUTs and further showed that gene duplication and fusion could have been important drivers during the evolution of these transporter molecules.-Jia, B., Yuan, D. P., Lan, W. J., Xuan, Y. H., Jeon, C. O. New insight into the classification and evolution of glucose transporters in the Metazoa.	[Jia, Baolei; Lan, Wen Jun] Qilu Univ Technol, Sch Bioengn, Jinan, Shandong, Peoples R China; [Jia, Baolei; Jeon, Che Ok] Chung Ang Univ, Dept Life Sci, 84 HeukSeok Ro, Seoul 06974, South Korea; [Yuan, De Peng; Xuan, Yuan Hu] Shenyang Agr Univ, Coll Plant Protect, Dongling Rd 120, Shenyang 110866, Liaoning, Peoples R China	Qilu University of Technology; Chung Ang University; Shenyang Agricultural University	Jeon, CO (corresponding author), Chung Ang Univ, Dept Life Sci, 84 HeukSeok Ro, Seoul 06974, South Korea.; Xuan, YH (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Dongling Rd 120, Shenyang 110866, Liaoning, Peoples R China.	xuanyuanhu115@syau.edu.cn; cojeon@cau.ac.kr	Jia, Baolei/AIF-1053-2022		National Research Foundation of the Korean Ministry of Science and Information and Communications Technology (ICT) [2017M3C1B5019250, 2018R1A5A1025077]	National Research Foundation of the Korean Ministry of Science and Information and Communications Technology (ICT)	This work was supported by by the National Research Foundation of the Korean Ministry of Science and Information and Communications Technology (ICT) (2017M3C1B5019250 and 2018R1A5A1025077). The authors declare no conflicts of interest.	Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Di Daniel E, 2009, BIOCHEM SOC T, V37, P1139, DOI 10.1042/BST0371139; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Jia BL, 2018, J AGR FOOD CHEM, V66, P8371, DOI 10.1021/acs.jafc.8b02454; Jia BL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00180; Jia BL, 2017, BBA-GEN SUBJECTS, V1861, P2922, DOI 10.1016/j.bbagen.2017.08.019; Jia BL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43489; Jia B, 2017, BBA-GEN SUBJECTS, V1861, P323, DOI 10.1016/j.bbagen.2016.12.001; Jia BL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01380; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mayer AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38586; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125361; Peralvarez-Marin A, 2006, MOL MEMBR BIOL, V23, P127, DOI 10.1080/09687860500435019; Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Steinway SN, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-284; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tarazona-Santos E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009827; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; Wang J, 2017, ONCOTARGET, V8, P16875, DOI 10.18632/oncotarget.15171; Wilson-O'Brien AL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-152; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Zottola R. J., 1994, MOL DETERMINANTS GLU	43	11	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7519	7528		10.1096/fj.201802617R	http://dx.doi.org/10.1096/fj.201802617R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30888203	Bronze			2022-12-26	WOS:000476114200068
J	Barnum, KJ; Nguyen, YT; O'Connell, MJ				Barnum, Kevin J.; Nguyen, Y. Tram; O'Connell, Matthew J.			XPG-related nucleases are hierarchically recruited for double-stranded rDNA break resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; chromosomes; DNA repair; DNA recombination; Schizosaccharomyces pombe; DNA damage response; Checkpoint; DNA Damage Response; DNA Repair; Schizosaccharomyces pombe; XPG-Related Nuclease	DNA-DAMAGE CHECKPOINT; MUTATION AVOIDANCE; MOLECULAR CHARACTERIZATION; MISMATCH REPAIR; EXCISION-REPAIR; RAD51 FILAMENT; PROTEIN-KINASE; END RESECTION; RECOMBINATION; POMBE	dsDNA breaks (DSBs) are resected in a 53 direction, generating single-stranded DNA (ssDNA). This promotes DNA repair by homologous recombination and also assembly of signaling complexes that activate the DNA damage checkpoint effector kinase Chk1. In fission yeast (Schizosaccharomyces pombe), genetic screens have previously uncovered a family of three xeroderma pigmentosum G (XPG)-related nucleases (XRNs), known as Ast1, Exo1, and Rad2. Collectively, these XRNs are recruited to a euchromatic DSB and are required for ssDNA production and end resection across the genome. Here, we studied why there are three related but distinct XRN enzymes that are all conserved across a range of species, including humans, whereas all other DSB response proteins are present as single species. Using S. pombe as a model, ChIP and DSB resection analysis assays, and highly efficient I-PpoI-induced DSBs in the 28S rDNA gene, we observed a hierarchy of recruitment for each XRN, with a progressive compensatory recruitment of the other XRNs as the responding enzymes are deleted. Importantly, we found that this hierarchy reflects the requirement for different XRNs to effect efficient DSB resection in the rDNA, demonstrating that the presence of three XRN enzymes is not a simple division of labor. Furthermore, we uncovered a specificity of XRN function with regard to the direction of transcription. We conclude that the DSB-resection machinery is complex, is nonuniform across the genome, and has built-in fail-safe mechanisms, features that are in keeping with the highly pathological nature of DSB lesions.	[Barnum, Kevin J.; Nguyen, Y. Tram; O'Connell, Matthew J.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA; [Barnum, Kevin J.; Nguyen, Y. Tram; O'Connell, Matthew J.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	O'Connell, MJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.	matthew.oconnell@mssm.edu			National Institutes of Health [T32 CA078207, GM124079, GM087326]; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was support by National Institutes of Health Grants T32 CA078207, GM124079, and GM087326. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Barnum KJ, 2014, METHODS MOL BIOL, V1170, P29, DOI 10.1007/978-1-4939-0888-2_2; Calonge TM, 2006, GENETICS, V174, P113, DOI 10.1534/genetics.106.060970; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Farah JA, 2009, P NATL ACAD SCI USA, V106, P9356, DOI 10.1073/pnas.0902793106; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kuntz K, 2013, EMBO J, V32, P290, DOI 10.1038/emboj.2012.322; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Lee KM, 2007, GENETICS, V175, P1585, DOI 10.1534/genetics.106.067801; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Liu QH, 2000, GENE DEV, V14, P1448; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Memisoglu A, 2000, J BACTERIOL, V182, P2104, DOI 10.1128/JB.182.8.2104-2112.2000; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mortensen UH, 2009, CURR BIOL, V19, pR676, DOI 10.1016/j.cub.2009.06.001; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; O'Connell MJ, 2005, J CELL SCI, V118, P1, DOI 10.1242/jcs.01626; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Osman F, 1996, GENETICS, V142, P341; Prudden J, 2003, EMBO J, V22, P1419, DOI 10.1093/emboj/cdg119; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Short JM, 2016, NUCLEIC ACIDS RES, V44, P9017, DOI 10.1093/nar/gkw783; Sun XM, 2003, DNA REPAIR, V2, P925, DOI 10.1016/S1568-7864(03)00093-4; Sunder S, 2012, YEAST, V29, P275, DOI 10.1002/yea.2908; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tapia-Alveal C, 2014, MOL CELL BIOL, V34, P2092, DOI 10.1128/MCB.00193-14; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Toh GWL, 2010, DNA REPAIR, V9, P718, DOI 10.1016/j.dnarep.2010.02.013; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Ueno M, 2003, MOL CELL BIOL, V23, P6553, DOI 10.1128/MCB.23.18.6553-6563.2003; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson S, 1999, NUCLEIC ACIDS RES, V27, P2655, DOI 10.1093/nar/27.13.2655; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhang HM, 2016, J BIOL CHEM, V291, P24961, DOI 10.1074/jbc.M116.755991; Zhao LY, 2018, METHOD ENZYMOL, V600, P179, DOI 10.1016/bs.mie.2017.12.002; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	68	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7632	7643		10.1074/jbc.RA118.005415	http://dx.doi.org/10.1074/jbc.RA118.005415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30885940	hybrid, Green Published			2022-12-26	WOS:000470153300010
J	Manzoor, MAP; Agrawal, AK; Singh, B; Mujeeburahiman, M; Rekha, PD				Manzoor, Muhammed A. P.; Agrawal, Ashish K.; Singh, Balwant; Mujeeburahiman, M.; Rekha, Punchappady-Devasya			Morphological characteristics and microstructure of kidney stones using synchrotron radiation mu CT reveal the mechanism of crystal growth and aggregation in mixed stones	PLOS ONE			English	Article							CALCIUM-OXALATE MONOHYDRATE; CRYSTALLIZATION; STRUVITE; FORMERS; CALCULI; URINE	Understanding the mechanisms of kidney stone formation, development patterns and associated pathological features are gaining importance due to an increase in the prevalence of the disease and diversity in the presentation of the stone composition. Based on the microstructural characteristics of kidney stones, it may be possible to explain the differences in the pathogenesis of pure and mixed types of stones. In this study, the microstructure and distribution of mineral components of kidney stones of different mineralogy (pure and mixed types) were analyzed. The intact stones removed from patients were investigated using synchrotron radiation X-ray computed microtomography (SR-mu CT) and the tomography slice images were reconstructed representing the density and structure distribution at various elevation planes. Infrared (IR) spectroscopes, X-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to confirm the bulk mineral composition in the thin section stones. Observations revealed differences in the micro-morphology of the kidney stones with similar composition in the internal 3-D structure. Calcium oxalate monohydrate stones showed well-organised layering patterns, while uric acid stones showed lower absorption signals with homogenous inner structure. Distinct mineral phases in the mixed types were identified based on the differential absorption rates. The 3-D quantitative analysis of internal porosity and spatial variation between nine different types of stones were compared. The diversity among the microstructure of similar and different types of stones shows that the stone formation is complex and may be governed by both physiological and micro-environmental factors. These factors may predispose a few towards crystal aggregation and stone growth, while, in others the crystals may not establish stable attachment and/or growth.	[Manzoor, Muhammed A. P.; Rekha, Punchappady-Devasya] Yenepoya Deemed Be Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India; [Manzoor, Muhammed A. P.; Mujeeburahiman, M.] Yenepoya Deemed Be Univ, Yenepoya Med Coll, Dept Urol, Mangalore, Karnataka, India; [Agrawal, Ashish K.; Singh, Balwant] Bhabha Atom Res Ctr, Tech Phys Div, Indore, Madhya Pradesh, India; [Manzoor, Muhammed A. P.] ICAR Indian Inst Spices Res, Kozhikode, Kerala, India	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University); Bhabha Atomic Research Center (BARC); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Spices Research	Rekha, PD (corresponding author), Yenepoya Deemed Be Univ, Yenepoya Res Ctr, Mangalore, Karnataka, India.	rekhapd@hotmail.com		Rekha, PD/0000-0002-9187-6395; Manzoor, Muhammed/0000-0002-7939-1563; Agrawal, Ashish/0000-0002-8503-751X	Yenepoya University	Yenepoya University	The authors acknowledge the Yenepoya University for the seed grant for carrying out this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 2015, J SYNCHROTRON RADIAT, V22, P1531, DOI 10.1107/S1600577515016276; Alelign T, 2018, ADV UROL, V2018, DOI 10.1155/2018/3068365; Basavaraj D. R., 2007, EAU EBU UPDATE SERIE, V5, P126, DOI DOI 10.1016/J.EEUS.2007.03.002; Baumann Johannes M, 2014, World J Nephrol, V3, P256, DOI 10.5527/wjn.v3.i4.256; Bazin D, 2012, UROLOGY, V79, P786, DOI 10.1016/j.urology.2011.08.054; Borofsky MS, 2016, NAT REV UROL, V13, P549, DOI 10.1038/nrurol.2016.148; BOYCE WH, 1968, AM J MED, V45, P673, DOI 10.1016/0002-9343(68)90203-9; DAUDON M, 1993, SCANNING MICROSCOPY, V7, P1081; Daudon M, 2016, CR CHIM, V19, P1504, DOI 10.1016/j.crci.2016.08.009; Daudon M, 2016, CR CHIM, V19, P1527, DOI 10.1016/j.crci.2015.04.006; Deng Y L, 2018, Zhonghua Wai Ke Za Zhi, V56, P733, DOI 10.3760/cma.j.issn.0529-5815.2018.10.004; Grases F, 1998, ADV COLLOID INTERFAC, V74, P169, DOI 10.1016/S0001-8686(97)00041-9; Gulley-Stahl HJ, 2009, APPL SPECTROSC, V63, P759, DOI 10.1366/000370209788701044; Kaiser J, 2011, UROL RES, V39, P259, DOI 10.1007/s00240-010-0343-9; Kalaiselvi P, 1999, BJU INT, V83, P919; Liao WL, 2013, BIOMEDICINE-TAIWAN, V3, P66, DOI 10.1016/j.biomed.2012.12.005; Liu J.Z., 1993, ACTA AUTOMATICA SINI, V1, P015; Manzoor MA, 2017, TSQA MED INT, V4, P26, DOI DOI 10.4103/ami.ami_24_17; Manzoor MAP, 2019, BIOCATAL AGRIC BIOTE, V17, P566, DOI 10.1016/j.bcab.2019.01.023; Manzoor MAP, 2018, INT BRAZ J UROL, V44, P1234, DOI [10.1590/S1677-5538.IBJU.2017.0656, 10.1590/s1677-5538.ibju.2017.0656]; Manzoor Muhammed A P, 2019, Urolithiasis, V47, P137, DOI 10.1007/s00240-018-1052-z; Manzoor MAP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202306; Miller NL, 2010, BJU INT, V105, P242, DOI 10.1111/j.1464-410X.2009.08637.x; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; Scherer K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09527; Sethmann I, 2017, UROLITHIASIS, V45, P235, DOI 10.1007/s00240-016-0925-2; Siener R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078996; Sivaguru M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31890-9; Uvarov V, 2011, ENVIRON GEOCHEM HLTH, V33, P613, DOI 10.1007/s10653-011-9374-6; Verkoelen CF, 2006, J AM SOC NEPHROL, V17, P1673, DOI 10.1681/ASN.2006010088; Williams JC, 2017, UROLITHIASIS, V45, P19, DOI 10.1007/s00240-016-0944-z; Williams JC, 2015, UROLITHIASIS, V43, pS13, DOI 10.1007/s00240-014-0702-z; Xie BQ, 2015, CRYST GROWTH DES, V15, P204, DOI 10.1021/cg501209h; Yin XZ, 2013, AAPS J, V15, P1025, DOI 10.1208/s12248-013-9498-y; Zarse CA, 2007, UROL RES, V35, P201, DOI 10.1007/s00240-007-0104-6	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0214003	10.1371/journal.pone.0214003	http://dx.doi.org/10.1371/journal.pone.0214003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901364	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400030
J	Al-Saleem, J; Dirksen, WP; Martinez, MP; Shkriabai, N; Kvaratskhelia, M; Ratner, L; Green, PL				Al-Saleem, Jacob; Dirksen, Wessel P.; Martinez, Michael P.; Shkriabai, Nikoloz; Kvaratskhelia, Mamuka; Ratner, Lee; Green, Patrick L.			HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1	PLOS ONE			English	Article							LEUKEMIA-VIRUS TYPE-1; DOMAIN-BINDING MOTIF; T-CELL; PDZ DOMAIN; DOWN-REGULATION; PROTEIN; GLUCOSE; LYMPHOCYTES; ACTIVATION; RETROVIRUS	An estimated 1020 million people worldwide are infected with human T cell leukemia virus type 1 (HTLV-1), with endemic areas of infection in Japan, Australia, the Caribbean, and Africa. HTLV-1 is the causative agent of adult T cell leukemia (ATL) and HTLV-1 associated myopathy/tropic spastic paraparesis (HAM/TSP). HTLV-1 expresses several regulatory and accessory genes that function at different stages of the virus life cycle. The regulatory gene Tax-1 is required for efficient virus replication, as it drives transcription of viral gene products, and has also been demonstrated to play a key role in the pathogenesis of the virus. Several studies have identified a PDZ binding motif (PBM) at the carboxyl terminus of Tax-1 and demonstrated the importance of this domain for HTLV-1 induced cellular transformation. Using a mass spectrometry-based proteomics approach we identified sorting nexin 27 (SNX27) as a novel interacting partner of Tax-1. Further, we demonstrated that their interaction is mediated by the Tax-1 PBM and SNX27 PDZ domains. SNX27 has been shown to promote the plasma membrane localization of glucose transport 1 (GLUT1), one of the receptor molecules of the HTLV-1 virus, and the receptor molecule required for HTLV-1 fusion and entry. We postulated that Tax-1 alters GLUT1 localization via its interaction with SNX27. We demonstrate that over expression of Tax-1 in cells causes a reduction of GLUT1 on the plasma membrane. Furthermore, we show that knockdown of SNX27 results in increased virion release and decreased HTLV-1 infectivity. Collectively, we demonstrate the first known mechanism by which HTLV-1 regulates a receptor molecule post-infection.	[Al-Saleem, Jacob; Dirksen, Wessel P.; Martinez, Michael P.; Green, Patrick L.] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Al-Saleem, Jacob; Dirksen, Wessel P.; Martinez, Michael P.; Green, Patrick L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Shkriabai, Nikoloz; Kvaratskhelia, Mamuka] Univ Colorado Denver, Sch Med, Div Infect Dis, Aurora, CO USA; [Ratner, Lee] Washington Univ, Div Oncol, St Louis, MO USA; [Green, Patrick L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Green, Patrick L.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Green, PL (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.; Green, PL (corresponding author), Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA.; Green, PL (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.; Green, PL (corresponding author), Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA.	green.466@osu.edu		Green, Patrick/0000-0002-0204-562X; Ratner, Lee/0000-0003-2744-7294	National Institutes of Health [CA100730]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health (CA100730) to P.L.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1995, BLOOD, V86, P4243, DOI 10.1182/blood.V86.11.4243.bloodjournal86114243; Alais S, 2017, METHODS MOL BIOL, V1582, P47, DOI 10.1007/978-1-4939-6872-5_4; Aoyagi T, 2010, VIRUS GENES, V40, P193, DOI 10.1007/s11262-009-0447-x; Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Beraud C, 1994, AM SOC MICROBIOLOGY, V14, P1374; Cherian MA, 2015, J BIOL CHEM, V290, P26270, DOI 10.1074/jbc.M115.684746; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Doueiri R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-64; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghez D, 2006, J VIROL, V80, P6844, DOI 10.1128/JVI.02719-05; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Jeong SJ, 2006, J VIROL, V80, P10036, DOI 10.1128/JVI.00186-06; Jones KS, 2011, VIRUSES-BASEL, V3, P794, DOI 10.3390/v3060794; KIMATA JT, 1994, VIROLOGY, V204, P656, DOI 10.1006/viro.1994.1581; KOEFFLER HP, 1984, BLOOD, V64, P482; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Levesque K, 2004, CURR HIV RES, V2, P51, DOI 10.2174/1570162043485086; Maeda Y, 2015, J VIROL, V89, P502, DOI 10.1128/JVI.02686-14; Makokha GN, 2013, CANCER SCI, V104, P313, DOI 10.1111/cas.12087; Manel N, 2005, J BIOL CHEM, V280, P29025, DOI 10.1074/jbc.M504549200; Martin F, 2018, LANCET, V391, P1893, DOI 10.1016/S0140-6736(18)30974-7; Ohashi M, 2004, VIROLOGY, V320, P52, DOI 10.1016/j.virol.2003.11.014; Pim D, 2015, J VIROL, V89, P10145, DOI 10.1128/JVI.01499-15; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Ratner L, 2004, FRONT BIOSCI-LANDMRK, V9, P2852, DOI 10.2741/1442; ROSENBLATT JD, 1988, BLOOD, V71, P363; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Shirinian M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00231; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Stoye JP, 2012, RETROVIRIDAE RETROVI, P477, DOI [10.1016/B978-0-12-384684-6.00044-6, DOI 10.1016/B978-0-12-384684-6.00044-6]; Tanaka M, 2003, VIROLOGY, V311, P316, DOI 10.1016/S0042-6822(03)00126-0; Tsubata C, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-46; Watanabe T, 1997, INT J HEMATOL, V66, P257; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Younis I, 2005, J VIROL, V79, P14473, DOI 10.1128/JVI.79.23.14473-14481.2005; Younis I, 2004, J VIROL, V78, P11077, DOI 10.1128/JVI.78.20.11077-11083.2004	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214059	10.1371/journal.pone.0214059	http://dx.doi.org/10.1371/journal.pone.0214059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897179	Green Submitted, gold, Green Published			2022-12-26	WOS:000461889700062
J	Shanmugasundar, S; Kannan, N; Sundaravadivel, E; Zsolt, S; Mukunthan, KS; Manokaran, J; Narendranath, J; Kamalakannan, VP; Kavitha, P; Prabhu, V; Balasubramanian, N				Shanmugasundar, S.; Kannan, N.; Sundaravadivel, E.; Zsolt, Sarang; Mukunthan, K. S.; Manokaran, J.; Narendranath, J.; Kamalakannan, V. P.; Kavitha, P.; Prabhu, V.; Balasubramanian, N.			Study on the inflammatory response of PMMA/polystyrene/silica nanocomposite membranes for drug delivery and dental applications	PLOS ONE			English	Article							IN-VITRO; POLYMERS; BIOMATERIALS; CHITOSAN	Background The application of polymeric materials in medical industry has grown drastically in the last two decades due to their various advantages compared to existing materials. The present research work emphases on the sol-gel technique to formulate the polymethyl methyl acrylate/polystyrene/silica composite membrane. Methods The characteristic of the composite was investigated through modern state art of instrumentation. Results The functional groups attached to the polymer was absorbed by FTIR. The FTIR spectrum confirm that the blend was mixed thoroughly and the formation of unite intimately between the polymers. The membranes were observed by SEM for its surface homogeneity which depends upon the composition of the two blending polymers. The captured SEM images showed the formation of microcracks on the surface, which was evidently controlled by varying the constituent polymer ratios. The prepared blend membranes with 2:1 ratio of PMMA/PS/Si displayed higher water uptake compared to other blended membranes. The composite membranes had good hydroxyl apatite growth in SBF solution. Furthermore, the in vitro cytotoxicity studies carried out by MTT method, using RAW macrophage cells showed that all the samples exhibited excellent cell viability. Conclusion The inflammatory response of composite with equal concentration of PMMA-PS were performed and observed no inflammation in comparison with control and other tested concentrations.	[Shanmugasundar, S.; Manokaran, J.; Narendranath, J.; Kamalakannan, V. P.; Kavitha, P.; Balasubramanian, N.] Anna Univ, Dept Chem Engn, Chennai, Tamil Nadu, India; [Shanmugasundar, S.; Zsolt, Sarang] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary; [Kannan, N.; Mukunthan, K. S.] Manipal Acad Higher Educ, Manipal Inst Technol, Dept Biotechnol, Manipal, Karnataka, India; [Sundaravadivel, E.] SRM Univ, Kattankulathur, Tamil Nadu, India; [Prabhu, V.] Anna Univ, Coll Engn, Dept Chem, Chennai, Tamil Nadu, India	Anna University; Anna University Chennai; University of Debrecen; Manipal Academy of Higher Education (MAHE); SRM Institute of Science & Technology Chennai; Anna University; Anna University Chennai	Balasubramanian, N (corresponding author), Anna Univ, Dept Chem Engn, Chennai, Tamil Nadu, India.; Prabhu, V (corresponding author), Anna Univ, Coll Engn, Dept Chem, Chennai, Tamil Nadu, India.	info.prabhunv@gmail.com; nbsbala@gmail.com	Subramanian, Bala/F-7231-2011; Saravanabhavan, Shanmuga Sundar/AHE-0286-2022; P, Kavitha N/AAJ-9524-2021; Prabhu, N V/AAU-6864-2020; Elumalai, Sundaravadivel/R-5123-2016; KS, Mukunthan/P-5972-2015	Subramanian, Bala/0000-0003-0763-8595; Saravanabhavan, Shanmuga Sundar/0000-0003-0598-4187; P, Kavitha N/0000-0003-2286-9746; Prabhu, N V/0000-0001-7507-2904; Elumalai, Sundaravadivel/0000-0003-0209-6192; KS, Mukunthan/0000-0001-9484-2556	Department of Science and Technology, Ministry of Science and Technology (International Bilateral Cooperation Division), Government of India (Indo-Korean Joint Project) [DST/INT/Korea/P-47]; UGC Stipendium Hungaricum (Educational Exchange) Programme	Department of Science and Technology, Ministry of Science and Technology (International Bilateral Cooperation Division), Government of India (Indo-Korean Joint Project); UGC Stipendium Hungaricum (Educational Exchange) Programme	The first author (Shanmuga Sundar Saravanabhavan) had received junior research fellowship from Department of Science and Technology, Ministry of Science and Technology (International Bilateral Cooperation Division), Government of India (Indo-Korean Joint Project) Lr. No. DST/INT/Korea/P-47 Dated 18.05.18 and UGC Stipendium Hungaricum (Educational Exchange) Programme for the period of 9/1/2017 to 6/30/2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed MIN, 2015, INT J BIOL MACROMOL, V72, P680, DOI 10.1016/j.ijbiomac.2014.08.055; Aravind K., 2014, TRENDS BIOMATER ARTI, V28, P52; Aravind K, 2015, INT J POLYM MATER PO, V64, P220, DOI 10.1080/00914037.2014.936594; Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015; Bhat KA, 2013, J APPL POLYM SCI, V127, P2764, DOI [10.1002/APP.37581, 10.1002/app.37581]; Boccaccini A.R., 2014, TISSUE ENG USING CER; Costa HS, 2008, J MATER SCI, V43, P494, DOI 10.1007/s10853-007-1875-4; Dorney J., 2013, POLYSTYRENE POTENTIA, DOI [DOI 10.21427/D75C76, 10.21427/D75C76]; Dziadek M, 2017, MAT SCI ENG C-MATER, V71, P1175, DOI 10.1016/j.msec.2016.10.014; Gandhi A, 2015, ASIAN J PHARM SCI, V10, P99, DOI 10.1016/j.ajps.2014.08.010; Kaniappan K., 2011, INT J CHEM RES, V3, P708; Kannan N., 2018, PLOS ONE, V13; Kansu G, 2014, J DENT SCI, V9, P381, DOI 10.1016/j.jds.2013.01.008; KOKUBO T, 1989, BIOCERAMICS, V1, P157; Lekshmi UMD, 2010, INT J PHARMACEUT, V396, P194, DOI 10.1016/j.ijpharm.2010.06.023; LogithKumar R, 2016, CARBOHYD POLYM, V151, P172, DOI 10.1016/j.carbpol.2016.05.049; Miao SD, 2014, ACTA BIOMATER, V10, P1692, DOI 10.1016/j.actbio.2013.08.040; Park J.B., 2007, BIOMATERIALS; Park Ok, 2017, Journal of Pharmaceutical Investigation, V47, P11, DOI 10.1007/s40005-016-0288-2; Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110; Radhakrishnan Nair M. N., 2001, POLYM B, V46, P191; Schmidt H, 2000, J SOL-GEL SCI TECHN, V19, P39, DOI 10.1023/A:1008706003996; Spasojevic P, 2015, INT J POLYM SCI, V2015, DOI 10.1155/2015/561012; Streubel A, 2003, J MICROENCAPSUL, V20, P329, DOI 10.1080/0265204021000058384; Streubel A, 2002, INT J PHARMACEUT, V241, P279, DOI 10.1016/S0378-5173(02)00241-7; Sundar SS, 2012, J MATER SCI-MATER M, V23, P1421, DOI 10.1007/s10856-012-4610-x; Venkatesan PN, 2015, RSC ADV, V5, P84004, DOI 10.1039/c5ra14701h; Yi J, 2008, J SOL-GEL SCI TECHN, V45, P115, DOI 10.1007/s10971-007-1668-x; Yuksel N, 2011, INT J PHARMACEUT, V404, P102, DOI 10.1016/j.ijpharm.2010.11.011	29	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0209948	10.1371/journal.pone.0209948	http://dx.doi.org/10.1371/journal.pone.0209948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893342	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900004
J	Wachamo, TM; Yimerid, NB; Bizuneh, AD				Wachamo, Tesfahun Mulatu; Yimerid, Nigus Bililign; Bizuneh, Asmamaw Demis			Risk factors for low birth weight in hospitals of North Wello zone, Ethiopia: A case-control study	PLOS ONE			English	Article							CHLORINATION BY-PRODUCTS; DRINKING-WATER; PRETERM BIRTH; OUTCOMES; EXPOSURE; PREDICTORS; PREGNANCY	Background Low birth weight at birth is an important underlying contributor for neonatal and infant mortality. It accounts for nearly half of all perinatal deaths. Identifying predictors of low birth weight is the first essential step in designing appropriate management strategies. Hence, this study aimed to identify risk factors for low birth weight in hospitals of northeastern Ethiopia. Methods An institution based case-control study design was conducted from 10 th April to 15 th December 2016. Three hundred sixty mother-infant pairs (120 low birth weight babies as cases and 240 normal birth weights as controls) were included in the study. Data were collected by face-to-face interview. Univariable and multivariable logistic regression models were computed to examine the effect of independent variables on outcome variable using SPSS 20.0. Variables with p-value < 0.05 were considered statistically significant. Results The mean (+/- SD) gestational age and birth weight (+/- SD) were 39.2 (+/- 1.38) weeks and 2800 (+/- 612), grams respectively. Partner's education/ being illiterate (AOR: 4.09; 95% CI 1.45, 11.50), antenatal care visit at private health institutions (AOR: 0.13; 95% CI 0.02, 0.66), having history of obstetric complications (AOR: 5.70; 95% CI 2.38, 13.63), maternal weight during pregnancy (AOR: 4.04; 95% CI 1.50, 10.84) and gravidity (AOR: 0.36; 95% CI 0.18, 0.73) were significantly associated with low birth weight. Additionally, a site for water storage and water treatment were significant environmental factors. Conclusion Maternal weight during pregnancy, paternal education, previous obstetric complication and place of antenatal follow-up were associated with low birth weight. The risk factors identified in this study are preventable. Thus, nutritional counseling, health education on improvement of lifestyle and early recognition and treatment of complications are the recommended interventions.	[Wachamo, Tesfahun Mulatu] Woldia Univ, Fac Hlth Sci, Dept Publ Hlth, Woldia, Ethiopia; [Yimerid, Nigus Bililign] Woldia Univ, Fac Hlth Sci, Dept Midwifery, Woldia, Ethiopia; [Bizuneh, Asmamaw Demis] Woldia Univ, Fac Hlth Sci, Dept Nursing, Woldia, Ethiopia		Yimerid, NB (corresponding author), Woldia Univ, Fac Hlth Sci, Dept Midwifery, Woldia, Ethiopia.	bililignnigus@gmail.com	Bizuneh, Asmamaw Demis/ABA-1868-2021; Yimer, Nigus Bililign/AGD-8934-2022	Bililign, Nigus/0000-0001-5610-8369; Wachamo, Tesfahun Mulatu/0000-0001-6100-920X	Woldia University	Woldia University	Woldia University sponsored this study. www.wldu.edu.et The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency CS, 2017, ETH DEM HLTH SURV 20; Akilew Awoke Adane, 2014, BMC PREGNANCY CHILDB, V14; Alemu T, 2015, FAM MED MED SCI RES, V4; Almberg KS, 2017, ENVIRON RES, V157, P52, DOI 10.1016/j.envres.2017.05.010; Anthony D., 2017, GENERATION 2030 AFRI; Asia UROfS, 2002, RED LOW BIRTH WEIGHT; Baker KK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205345; Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; Benova L, 2015, TROP MED INT HEALTH, V20, P1657, DOI 10.1111/tmi.12598; Bonou SG, 2017, REPROD TOXICOL, V73, P75, DOI 10.1016/j.reprotox.2017.07.019; Carlson SE, 2018, DOSE RESPONSE RELATI; Chibwesha CJ, 2016, INT J GYNECOL OBSTET, V134, P309, DOI 10.1016/j.ijgo.2016.03.021; da Silva Lopes Katharina, 2017, BMJ Glob Health, V2, pe000389, DOI 10.1136/bmjgh-2017-000389; Demelash H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0677-y; Federal Ministry of Health Ethiopia (FMoH), 2015, HLTH SECT TRANSF PLA; Glass HC, 2015, ANESTH ANALG, V120, P1337, DOI 10.1213/ANE.0000000000000705; Grady SC, 2017, GEOSPATIAL HEALTH, V12, P137, DOI 10.4081/gh.2017.501; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; He ZF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020410; Jammeh A, 2011, OJOG, V1; Kurth F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014367; Levallois P, 2012, EPIDEMIOLOGY, V23, P267, DOI 10.1097/EDE.0b013e3182468569; Liu HX, 2018, ENVIRON POLLUT, V236, P817, DOI 10.1016/j.envpol.2018.02.012; Lule S, 2018, J DEV ORIG HLTH DIS, P1; Mahumud Rashidul Alam, 2017, J Prev Med Public Health, V50, P18, DOI 10.3961/jpmph.16.087; Mekonen HK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0507-2; Mengesha HG, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0901-1; Momeni M, 2017, INT J PREVENTIVE MED, P8; Mulatu H., 2017, GLOBAL J MED RES, P17; Muthayya S, 2009, INDIAN J MED RES, V130, P600; Muula AS, 2011, AFRICAN HELTH SCI, V11, P1; Organization WH, 2014, GLOB NUTR TARG 2025; Petry CJ, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1786-1; Poon LCY, 2012, FETAL DIAGN THER, V32, P156, DOI 10.1159/000338655; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Rogne T, 2017, AM J EPIDEMIOL, V185, P212, DOI 10.1093/aje/kww212; Saeed A, 2017, PROG NUTR, V19, P257, DOI 10.23751/pn.v19i3.5036; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Siza J E, 2008, Tanzan J Health Res, V10, P1; SIZA JE, 2008, TANZANIA J HLTH RES, V10; Tchamo ME, 2016, J DEV ORIGINS HLTH D; Tema T, 2006, E AFRICAN MED J, V83; UNICEF, 2004, WHO UN CHILDR FUND W; UNICEF WHO Bank W Division U-DP, 2017, 3 UN PLAZ; UNICEF WHO & World Bank Group., 2021, LEVELS TRENDS CHILD; WHO, 2016, WORLD HLTH STAT 2016; Zeleke Berihun Megabiaw, 2012, PAN AFRICAN MED J; Zerfu TA, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0060-y	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213054	10.1371/journal.pone.0213054	http://dx.doi.org/10.1371/journal.pone.0213054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893344	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900024
J	Bassani, T; Casaroli, G; Galbusera, F				Bassani, Tito; Casaroli, Gloria; Galbusera, Fabio			Dependence of lumbar loads on spinopelvic sagittal alignment: An evaluation based on musculoskeletal modeling	PLOS ONE			English	Article							LOW-BACK-PAIN; ADULT SPINAL DEFORMITY; RADIOGRAPHIC PARAMETERS; BALANCE; PELVIS; JOINT; BIOMECHANICS; PRESSURE; KYPHOSIS; MUSCLES	Still little is known about how spinopelvic alignment affects spinal load distribution. Musculoskeletal modeling can potentially help to discover associations between spine alignment and risk factors of spinal disorders (e.g. disc herniation, vertebral fracture, spondylolisthesis, low back pain). The present study exploited the AnyBody full-body musculoskeletal model to assess the relation between lumbar loads and spinopelvic alignment in the sagittal plane. The model was evaluated in the standing position. The simulated postures were set using spinopelvic parameters gleaned from the literature and characterizing the healthy adult population. The parameters were: sagittal vertical axis, Roussouly lumbar type, sacral slope, and pelvic incidence. A total of 2772 configurations were simulated based on the following measurements: compression force and anterior shear at levels L4L5 and L5S1; multifidus, longissimus spinae, and rectus abdominis muscle forces. Changes in global sagittal alignment, lumbar typology, and sacral inclination, but not in pelvic incidence, were found to affect intervertebral loads in the lumbar spine and spinal muscle activation. Considering these changes would be advantageous for clinical evaluation, due to the recognized relation between altered loads and risk of disc herniation, vertebral fracture, spondylolisthesis, and low back pain. Musculoskeletal modeling proved to be a valuable biomechanical tool to non-invasively investigate the relation between internal loads and anatomical parameters.	[Bassani, Tito; Casaroli, Gloria; Galbusera, Fabio] IRCCS Ist Ortoped Galeazzi, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi	Bassani, T (corresponding author), IRCCS Ist Ortoped Galeazzi, Milan, Italy.	tito.bassani@grupposandonato.it	Galbusera, Fabio/J-8618-2016; Bassani, Tito/B-2050-2017	Galbusera, Fabio/0000-0003-1826-9190; Bassani, Tito/0000-0003-3312-1565	Italian Ministry of Health [GR-2011-02351464]	Italian Ministry of Health(Ministry of Health, Italy)	The work has been funded by the Italian Ministry of Health, grant GR-2011-02351464, to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad R, 2016, MED ENG PHYS, V38, P333, DOI 10.1016/j.medengphy.2016.01.013; Barrey C., 2011, EUR SPINE J, V20, P1, DOI 10.1007/s00586-011-1930-3; Bassani T, 2017, J BIOMECH, V58, P89, DOI 10.1016/j.jbiomech.2017.04.025; Bassani T, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00001; BRINCKMANN P, 1986, SPINE, V11, P149, DOI 10.1097/00007632-198603000-00009; Bruno AG, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030408; Costi JJ, 2007, J BIOMECH, V40, P2457, DOI 10.1016/j.jbiomech.2006.11.006; Damsgaard M, 2006, SIMUL MODEL PRACT TH, V14, P1100, DOI 10.1016/j.simpat.2006.09.001; de Zee M, 2007, J BIOMECH, V40, P1219, DOI 10.1016/j.jbiomech.2006.05.030; DUVALBEAUPERE G, 1992, ANN BIOMED ENG, V20, P451, DOI 10.1007/BF02368136; El-Rich M, 2009, COMPUT METHOD BIOMEC, V12, P13, DOI 10.1080/10255840802069823; Freeman MD, 2010, PM&R, V2, P142, DOI 10.1016/j.pmrj.2009.11.006; Galbusera F, 2014, J ORTHOP RES, V32, P537, DOI 10.1002/jor.22569; Galbusera F, 2013, CLIN BIOMECH, V28, P370, DOI 10.1016/j.clinbiomech.2013.02.006; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Glassman SD, 2005, SPINE, V30, P682, DOI 10.1097/01.brs.0000155425.04536.f7; Hansen L, 2006, SPINE, V31, P1888, DOI 10.1097/01.brs.0000229232.66090.58; Hatakeyama K., 2011, AKITA J MED, V37, P135; Heuer F, 2008, J BIOMECH, V41, P1086, DOI 10.1016/j.jbiomech.2007.11.019; Hu PP, 2016, ASIAN SPINE J, V10, P282, DOI 10.4184/asj.2016.10.2.282; Iencean SM, 2000, ACTA NEUROCHIR, V142, P669, DOI 10.1007/s007010070111; Ignasiak D, 2016, J BIOMECH, V49, P3074, DOI 10.1016/j.jbiomech.2016.07.006; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Keller Tony S, 2005, Spine J, V5, P297, DOI 10.1016/j.spinee.2004.10.050; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Myers ER, 1997, SPINE, V22, p25S, DOI 10.1097/00007632-199712151-00005; NISSAN M, 1986, J BIOMECH, V19, P753, DOI 10.1016/0021-9290(86)90198-3; Pearsall DJ, 1996, ANN BIOMED ENG, V24, P198, DOI 10.1007/BF02667349; Pellet N, 2011, Eur Spine J, V20 Suppl 5, P647, DOI 10.1007/s00586-011-1933-0; Popovich JM, 2013, SPINE J, V13, P1581, DOI 10.1016/j.spinee.2013.04.011; Ranger TA, 2017, SPINE J, V17, P1729, DOI 10.1016/j.spinee.2017.07.002; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Rothenfluh DA, 2015, EUR SPINE J, V24, P1251, DOI 10.1007/s00586-014-3454-0; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roux C, 2010, J BONE MINER RES, V25, P362, DOI 10.1359/jbmr.090727; Sasaki K, 2017, ASIAN SPINE J, V11, P562, DOI 10.4184/asj.2017.11.4.562; Schwab FJ, 2002, SPINE, V27, P387, DOI 10.1097/00007632-200202150-00012; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Schwab FJ, 2008, SPINE, V33, P2243, DOI 10.1097/BRS.0b013e31817d1d4e; Schwab FJ, 2013, SPINE, V38, pE803, DOI 10.1097/BRS.0b013e318292b7b9; Senteler M, 2017, J ORTHOP RES, V35, P131, DOI 10.1002/jor.23357; Senteler M, 2014, EUR SPINE J, V23, P1384, DOI 10.1007/s00586-013-3132-7; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; TROUP JDG, 1976, CLIN ORTHOP RELAT R, P59	45	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0207997	10.1371/journal.pone.0207997	http://dx.doi.org/10.1371/journal.pone.0207997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883563	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500005
J	Mellon, SH; Bersani, FS; Lindqvist, D; Hammamieh, R; Donohue, D; Dean, K; Jett, M; Yehuda, R; Flory, J; Reus, VI; Bierer, LM; Makotkine, I; Abu Amara, D; Haase, CH; Coy, M; Doyle, FJ; Marmar, C; Wolkowitz, OM				Mellon, Synthia H.; Bersani, F. Saverio; Lindqvist, Daniel; Hammamieh, Rasha; Donohue, Duncan; Dean, Kelsey; Jett, Marti; Yehuda, Rachel; Flory, Janine; Reus, Victor I.; Bierer, Linda M.; Makotkine, Iouri; Abu Amara, Duna; Haase, Clare Henn; Coy, Michelle; Doyle, Francis J., III; Marmar, Charles; Wolkowitz, Owen M.			Metabolomic analysis of male combat veterans with post traumatic stress disorder	PLOS ONE			English	Article							SODIUM LACTATE INFUSION; FATTY-ACID REGULATION; E PLUS C; INSULIN-RESISTANCE; OXIDATIVE STRESS; DOCOSAHEXAENOIC ACID; TELOMERE LENGTH; GENE-EXPRESSION; PTSD; BRAIN	Posttraumatic stress disorder (PTSD) is associated with impaired major domains of psychology and behavior. Individuals with PTSD also have increased co-morbidity with several serious medical conditions, including autoimmune diseases, cardiovascular disease, and diabetes, raising the possibility that systemic pathology associated with PTSD might be identified by metabolomic analysis of blood. We sought to identify metabolites that are altered in male combat veterans with PTSD. In this case-control study, we compared metabolomic profiles from age-matched male combat trauma-exposed veterans from the Iraq and Afghanistan conflicts with PTSD (n = 52) and without PTSD (n = 51) ('Discovery group'). An additional group of 31 PTSD-positive and 31 PTSD-negative male combat-exposed veterans was used for validation of these findings ('Test group'). Plasma metabolite profiles were measured in all subjects using ultrahigh performance liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. We identified key differences between PTSD subjects and controls in pathways related to glycolysis and fatty acid uptake and metabolism in the initial 'Discovery group', consistent with mitochondrial alterations or dysfunction, which were also confirmed in the 'Test group'. Other pathways related to urea cycle and amino acid metabolism were different between PTSD subjects and controls in the 'Discovery' but not in the smaller 'Test' group. These metabolic differences were not explained by comorbid major depression, body mass index, blood glucose, hemoglobin A1c, smoking, or use of analgesics, antidepressants, statins, or anti-inflammatories. These data show replicable, wide-ranging changes in the metabolic profile of combat-exposed males with PTSD, with a suggestion of mitochondrial alterations or dysfunction, that may contribute to the behavioral and somatic phenotypes associated with this disease.	[Mellon, Synthia H.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Bersani, F. Saverio; Lindqvist, Daniel; Reus, Victor I.; Coy, Michelle; Wolkowitz, Owen M.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Bersani, F. Saverio; Lindqvist, Daniel; Reus, Victor I.; Coy, Michelle; Wolkowitz, Owen M.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA USA; [Hammamieh, Rasha; Donohue, Duncan; Jett, Marti] US Army Med Res & Mat Command, Integrat Syst Biol, USACEHR, Frederick, MD USA; [Dean, Kelsey; Doyle, Francis J., III] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Yehuda, Rachel; Flory, Janine; Bierer, Linda M.; Makotkine, Iouri] James J Peters VA Med Ctr, Dept Psychiat, Bronx, NY USA; [Yehuda, Rachel; Flory, Janine; Bierer, Linda M.; Makotkine, Iouri] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Abu Amara, Duna; Haase, Clare Henn; Marmar, Charles] NYU, Dept Psychiat, Langone Med Sch, 550 1St Ave, New York, NY 10016 USA; [Marmar, Charles] Stephen & Alexandra Cohen Vet Ctr Posttraumat Str, New York, NY USA; [Bersani, F. Saverio] Sapienza Univ Rome, Dept Neurol & Psychiat, Rome, Italy; [Lindqvist, Daniel] Lund Univ, Dept Clin Sci, Fac Med, Psychiat, Lund, Sweden; [Haase, Clare Henn] Natl Univ Singapore, Dept Psychol, Singapore, Singapore	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Defense; United States Army; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Sapienza University Rome; Lund University; National University of Singapore	Mellon, SH (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	sindy.mellon@ucsf.edu	Bersani, F. Saverio/H-7234-2019	Bersani, F. Saverio/0000-0002-7555-8020; Hammamieh, Rasha/0000-0001-8643-6232	U.S. Department of Defense [W81XWH-10-1-0021, W81XWH-11-2-0223, W911NF-16-2-0015]; Mental Illness Research, Education and Clinical Center (MIRECC)	U.S. Department of Defense(United States Department of Defense); Mental Illness Research, Education and Clinical Center (MIRECC)	This study was supported by grants from the U.S. Department of Defense W81XWH-10-1-0021 (to OMW), W81XWH-11-2-0223 (to CRM), W911NF-16-2-0015 (to FJD), The Mental Illness Research, Education and Clinical Center (MIRECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amigo I, 2016, BIOCHEM J, V473, P3421, DOI 10.1042/BCJ20160451; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bergersen Linda H, 2012, Front Neuroenergetics, V4, P5, DOI 10.3389/fnene.2012.00005; Bergold PJ, 2009, NEUROSCI LETT, V453, P219, DOI 10.1016/j.neulet.2009.02.041; Bersani FS, 2016, BRAIN BEHAV IMMUN, V52, P153, DOI 10.1016/j.bbi.2015.10.015; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blessing EM, 2017, PSYCHONEUROENDOCRINO, V82, P91, DOI 10.1016/j.psyneuen.2017.04.016; Blom G., 1958, STAT ESTIMATES TRANS; Boeck C, 2016, MITOCHONDRION, V30, P197, DOI 10.1016/j.mito.2016.08.006; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; BOURRE JM, 1984, J NEUROCHEM, V43, P342, DOI 10.1111/j.1471-4159.1984.tb00906.x; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Bunkar N, 2016, FRONT BIOSCI-LANDMRK, V21, P769, DOI 10.2741/4420; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chang Shun-Jen, 2005, Kaohsiung Journal of Medical Sciences, V21, P495; Chen WW, 2014, CELL REP, V7, P27, DOI 10.1016/j.celrep.2014.02.046; Chiang MC, 2012, NEUROBIOL DIS, V45, P322, DOI 10.1016/j.nbd.2011.08.016; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; CLARK AS, 1987, J CLIN INVEST, V79, P588, DOI 10.1172/JCI112851; Clarke SD, 2004, CURR OPIN LIPIDOL, V15, P13, DOI 10.1097/00041433-200402000-00004; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Duplus E, 2002, BIOCHEM PHARMACOL, V64, P893, DOI 10.1016/S0006-2952(02)01157-7; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; First M. B., 1997, STRUCTURED CLIN INTE; FISHER AB, 1984, AM J PHYSIOL, V246, pE426, DOI 10.1152/ajpendo.1984.246.5.E426; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Gautam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117092; Gill J, 2010, BIOL PSYCHIAT, V68, P999, DOI 10.1016/j.biopsych.2010.07.033; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Grosso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096905; Grosso G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/313570; Hadrevi J, 2019, STRESS, V22, P17, DOI 10.1080/10253890.2018.1494150; Hamer M, 2017, ANN INTERN MED, V166, P917, DOI 10.7326/L17-0022; Hammamieh R, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.129; Hammamieh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090425; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Ipser JC, 2012, INT J NEUROPSYCHOPH, V15, P825, DOI 10.1017/S1461145711001209; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Jensen C F, 1998, Depress Anxiety, V7, P122, DOI 10.1002/(SICI)1520-6394(1998)7:3<122::AID-DA4>3.0.CO;2-D; Jensen CF, 1997, AM J PSYCHIAT, V154, P266; Jensen CF, 1997, ANN NY ACAD SCI, V821, P444, DOI 10.1111/j.1749-6632.1997.tb48301.x; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kaddurah-Daouk R, 2011, ALZHEIMERS DEMENT, V7, P309, DOI 10.1016/j.jalz.2010.06.001; Kao Chi-Ya, 2016, Mol Neuropsychiatry, V2, P46, DOI 10.1159/000445377; Karabatsiakis A, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.44; Karabatsiakis Alexander, 2015, J Mol Psychiatry, V3, P2, DOI 10.1186/s40303-015-0007-3; Knox D, 2010, NEUROSCI LETT, V480, P16, DOI 10.1016/j.neulet.2010.05.052; Koenig AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21763-6; Koffel E, 2016, PSYCHIAT ANN, V46, P173, DOI 10.3928/00485713-20160125-01; Konjevod M, 2019, PROG NEURO-PSYCHOPH, V88, P181, DOI 10.1016/j.pnpbp.2018.07.014; Kuffer AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00147; Lapillonne A, 2004, CURR OPIN CLIN NUTR, V7, P151, DOI 10.1097/00075197-200403000-00008; Lauritzen F, 2015, BRAIN STRUCT FUNCT, V220, P1, DOI 10.1007/s00429-013-0672-x; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Levant B, 2004, BEHAV BRAIN RES, V152, P49, DOI 10.1016/j.bbr.2003.09.029; Levine AB, 2014, CARDIOLOGY, V127, P1, DOI 10.1159/000354910; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Li H, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00164; Li SH, 2017, LANCET PSYCHIAT, V4, P73, DOI 10.1016/S2215-0366(16)30358-3; Li XM, 2010, J CHEM NEUROANAT, V40, P248, DOI 10.1016/j.jchemneu.2010.07.001; Lindqvist D, 2017, BRAIN BEHAV IMMUN, V59, P260, DOI 10.1016/j.bbi.2016.09.012; Lindqvist D, 2014, BRAIN BEHAV IMMUN, V42, P81, DOI 10.1016/j.bbi.2014.06.003; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Liu DJ, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-211; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; LOVEJOY J, 1990, INT J OBESITY, V14, P843; Lu JY, 2013, FRONT MED-PRC, V7, P4, DOI 10.1007/s11684-013-0248-4; Maddock RJ, 2009, MOL PSYCHIATR, V14, P537, DOI 10.1038/sj.mp.4002137; Maddock Richard J, 2012, Curr Top Behav Neurosci, V11, P199; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Maslov B, 2009, COLLEGIUM ANTROPOL, V33, P7; Matsumura Kenta, 2011, Glob J Health Sci, V4, P3, DOI 10.5539/gjhs.v4n1p3; Matsuoka Y, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-8; McNamara Robert K., 2013, PharmaNutrition, V1, P41, DOI 10.1016/j.phanu.2012.10.004; Mehta D, 2018, NEUROBIOL STRESS, V8, P112, DOI 10.1016/j.ynstr.2018.04.001; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Mellon SH, 2018, BIOL PSYCHIAT, V83, P866, DOI 10.1016/j.biopsych.2018.02.007; Casagrande ACM, 2013, NUCLEOS NUCLEOT NUCL, V32, P42, DOI 10.1080/15257770.2012.760043; Michopoulos V, 2016, EXP NEUROL, V284, P220, DOI 10.1016/j.expneurol.2016.05.038; Milburn MV, 2013, ANNU REV MED, V64, P291, DOI 10.1146/annurev-med-061511-134747; Milte CM, 2015, J ATTEN DISORD, V19, P954, DOI 10.1177/1087054713510562; Morava E, 2013, NEUROSCI BIOBEHAV R, V37, P668, DOI 10.1016/j.neubiorev.2013.02.005; Moreno-Villanueva M, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.93; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224; Moseley HNB, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301006; Muhtz C, 2012, CURR PHARM DESIGN, V18, P5608, DOI 10.2174/138161212803530817; Muskiet FAJ, 2010, FRONTIERS NEUROSCIEN; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; O'Donovan A, 2015, BIOL PSYCHIAT, V77, P365, DOI 10.1016/j.biopsych.2014.06.015; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Paige LA, 2007, INT J GERIATR PSYCH, V22, P418, DOI 10.1002/gps.1690; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; PEARCE FJ, 1980, AM J PHYSIOL, V238, pC149, DOI 10.1152/ajpcell.1980.238.5.C149; Perry David, 2004, Expert Opin Pharmacother, V5, P977; Player MS, 2011, INT J PSYCHIAT MED, V41, P365, DOI 10.2190/PM.41.4.f; Puurunen J, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0091-2; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; RAINEY JM, 1987, AM J PSYCHIAT, V144, P1317; Roberts AL, 2017, DEPRESS ANXIETY, V34, P391, DOI 10.1002/da.22620; Rodrigues AF, 2014, CELL BIOCHEM FUNCT, V32, P387, DOI 10.1002/cbf.3029; Rosenbaum S, 2015, METABOLISM, V64, P926, DOI [10.1016/j.metabol.2015.04.009, 10.1016/j.metabol.2015.01.016]; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Ryu HM, 2016, J CELL MOL MED, V20, P2160, DOI 10.1111/jcmm.12916; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Stehberg J, 2012, FASEB J, V26, P3649, DOI 10.1096/fj.11-198416; Stein JY, 2018, J AFFECT DISORDERS, V238, P129, DOI 10.1016/j.jad.2018.05.037; Stein JY, 2016, J ANXIETY DISORD, V43, P106, DOI 10.1016/j.janxdis.2016.07.001; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strohle A, 2003, PHARMACOPSYCHIATRY, V36, pS207; Su YA, 2008, INT J BIOL SCI, V4, P223; Su ZH, 2011, J PHARMACEUT BIOMED, V55, P533, DOI 10.1016/j.jpba.2011.02.013; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019477; Thakur GS, 2015, MOL BIOSYST, V11, P980, DOI 10.1039/c4mb00404c; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tzoulaki I, 2014, AM J EPIDEMIOL, V180, P129, DOI 10.1093/aje/kwu143; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Valasani KR, 2014, CURR ALZHEIMER RES, V11, P128, DOI 10.2174/1567205011666140130150108; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Verhoeven JE, 2018, MOL NEUROPSYCHIATRY, V4, P102; von Pfostl V, 2012, NEUROIMAGE, V61, P98, DOI 10.1016/j.neuroimage.2012.02.082; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang Z, 2016, HUM IMMUNOL, V77, P652, DOI 10.1016/j.humimm.2016.05.018; Wang ZW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00219; Wentworth BA, 2013, CARDIOL REV, V21, P16, DOI 10.1097/CRD.0b013e318265343b; Wheler GHT, 2006, J CLIN ENDOCR METAB, V91, P3486, DOI 10.1210/jc.2006-0061; Wolf EJ, 2019, PSYCHOL MED, V49, P791, DOI 10.1017/S0033291718001411; Wolf EJ, 2018, PSYCHONEUROENDOCRINO, V92, P123, DOI 10.1016/j.psyneuen.2017.12.007; Wolf EJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0823-5; Wolf EJ, 2016, PSYCHIAT ANN, V46, P527, DOI 10.3928/00485713-20160729-01; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yamamoto T, 2005, CLIN CHIM ACTA, V356, P35, DOI 10.1016/j.cccn.2005.01.024; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Yehuda R, 2008, J PSYCHIATR RES, V42, P1104, DOI 10.1016/j.jpsychires.2008.01.002; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Zhang L, 2006, MED HYPOTHESES, V66, P1205, DOI 10.1016/j.mehy.2005.11.041; Zhang L, 2012, EUROPEAN J PSYCHOTRA, P3, DOI [10.3402/ejpt.v3i0.19309WOS:000208868500178, DOI 10.3402/EJPT.V3I0.19309WOS:000208868500178]; Zhang L, 2014, MED HYPOTHESES, V83, P182, DOI 10.1016/j.mehy.2014.04.033; Zhao X, 2014, EMBO REP, V15, P518, DOI 10.1002/embr.201338271; Zugno AI, 2014, NEUROSCIENCE, V259, P223, DOI 10.1016/j.neuroscience.2013.11.049	161	29	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213839	10.1371/journal.pone.0213839	http://dx.doi.org/10.1371/journal.pone.0213839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883584	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500034
J	Figueiredo, ACMG; Gomes, IS; Batista, JET; Orrico, GS; Porto, ECL; Pimenta, RMC; Conceicao, SD; Brito, SM; Ramos, MDX; Sena, MCF; Vilasboas, SWSL; da Cruz, SS; Pereira, MG				Morais Godoy Figueiredo, Ana Claudia; Gomes-Filho, Isaac Suzart; Tuy Batista, Josicelia Estrela; Orrico, Gessica Santana; Lima Porto, Edla Carvalho; Cruz Pimenta, Rodolfo Macedo; Conceicao, Sarah dos Santos; Brito, Sheila Monteiro; Xavier Ramos, Michelle de Santana; Ferreira Sena, Maria Cristina; Silva Lessa Vilasboas, Saulo Wesley; da Cruz, Simone Seixas; Pereira, Mauricio Gomes			Maternal anemia and birth weight: A prospective cohort study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; HEMOGLOBIN CONCENTRATION; PREGNANCY; OUTCOMES; DETERMINANTS; POPULATION; CHILDREN; WOMEN; PREVALENCE; MORTALITY	Objective To investigate the association between maternal anemia and low/insufficient birth weight. Design A prospective cohort study of pregnant women who underwent prenatal care at the healthcare units in a municipality of northeast Brazil together with their newborn infants was carried out. The pregnant women were classified as having anemia when the hemoglobin level was below 11 g/dl. Infants who were born full term weighing less than 2500 grams were classified as low birth weight, and those weighing between 2500 and 2999 grams were classified as insufficient weight. The occurrence of maternal anemia and its association with birth weight was verified using crude and adjusted Relative Risk (RR) estimates with their corresponding 95% confidence intervals (95%CIs). Results The final sample was comprised of 622 women. Maternal anemia was considered a risk factor for low/insufficient birth weight, after adjusting the effect measurement for maternal age, family income, urinary infection, parity, alcoholic beverage consumption during pregnancy and gestational body mass index: RRadjusted = 1.38 [95% CI: 1.07 to 1.77]. Conclusions Maternal anemia was associated with low/insufficient birth weight, representing a risk factor for the gestational outcomes studied.	[Morais Godoy Figueiredo, Ana Claudia; Ferreira Sena, Maria Cristina; Pereira, Mauricio Gomes] Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil; [Gomes-Filho, Isaac Suzart; Lima Porto, Edla Carvalho; Cruz Pimenta, Rodolfo Macedo; Conceicao, Sarah dos Santos] Feira de Santana State Univ, Dept Hlth, Feira De Santana, BA, Brazil; [Tuy Batista, Josicelia Estrela; Orrico, Gessica Santana; Brito, Sheila Monteiro; Xavier Ramos, Michelle de Santana; Silva Lessa Vilasboas, Saulo Wesley; da Cruz, Simone Seixas] Univ Fed Reconcavo Bahia, Dept Epidemiol, Santo Antonio De Jesus, BA, Brazil	Universidade de Brasilia; Universidade Federal do Reconcavo da Bahia	Figueiredo, ACMG (corresponding author), Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil.	aninha_m_godoy@hotmail.com	Figueiredo, Ana Claudia Morais Godoy/D-8123-2019; Filho, Isaac Suzart Gomes/Y-5516-2019; Pimenta, Rodolfo Macedo Cruz/AAQ-9371-2020; Figueiredo, Ana/GWU-6748-2022; Batista, Josicélia/GVU-6173-2022	Figueiredo, Ana Claudia Morais Godoy/0000-0003-2842-9848; Filho, Isaac Suzart Gomes/0000-0002-4270-8491; Pimenta, Rodolfo Macedo Cruz/0000-0002-4699-0180; dos Santos Conceicao, Sarah/0000-0001-5729-1249	Research Support Foundation of the State of Bahia (Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB), Salvador, Bahia, Brazil [PPSUS 0025/2014]; National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq), Brasilia, Brazil [Universal 457809/2014-0]; Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brasilia, Brazil, (CAPES) [001]	Research Support Foundation of the State of Bahia (Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB), Salvador, Bahia, Brazil; National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq), Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brasilia, Brazil, (CAPES)	This work was financial support from the Research Support Foundation of the State of Bahia (Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB)-PPSUS 0025/2014, Salvador, Bahia, Brazil; The National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq)-Universal 457809/2014-0, Brasilia, Brazil and t his study was financed in part by the Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)-Brasilia, Brazil, (CAPES) -Finance Code 001". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysena C, 2010, AUST NZ J OBSTET GYN, V50, P423, DOI 10.1111/j.1479-828X.2010.01220.x; Abioye AI, 2016, J NUTR, V146, P1162, DOI 10.3945/jn.115.225482; Aikawa R, 2006, PUBLIC HEALTH NUTR, V9, P443, DOI 10.1079/PHN2005851; Ali Abdelaziem A, 2011, BMC Res Notes, V4, P311, DOI 10.1186/1756-0500-4-311; Andriolo A, 2014, COLLECTION PREPARATI; [Anonymous], 1987, Bull Pan Am Health Organ, V21, P185; Bakacak M, 2015, J MATERN-FETAL NEO M, V28, P2106, DOI 10.3109/14767058.2014.979149; Banjari I, 2015, CENT EUR J PUBL HEAL, V23, P98; Barroso F, 2011, EUR J OBSTET GYN R B, V159, P99, DOI 10.1016/j.ejogrb.2011.07.041; Batista M, 2008, CIENC SAUDE COLETIVA, V13, P1917, DOI 10.1590/S1413-81232008000600027; Bencaiova G, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/307535; Bener Abdulbari, 2012, ISRN Obstet Gynecol, V2012, P540495; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BOX GEP, 1953, BIOMETRIKA, V40, P318, DOI 10.1093/biomet/40.3-4.318; Brasil, 2001, MAN INSTR PREENCH DE; BRASIL. Ministerio da Sau de, 2017, DATASUS INF REL SAUD; Bregar AT, 2017, GYNECOL OBSTET INVES, V82, P303, DOI 10.1159/000447557; Bresani Cristiane Campello, 2007, Rev. Bras. Saude Mater. Infant., V7, ps15, DOI 10.1590/S1519-38292007000600002; Carniel Emília de Faria, 2008, Rev. bras. epidemiol., V11, P169, DOI 10.1590/S1415-790X2008000100016; Casanova BF, 2005, AM J OBSTET GYNECOL, V193, P460, DOI 10.1016/j.ajog.2004.12.008; CDC, 2017, EP INF VERS 7; Geib LTC, 2010, CIENC SAUDE COLETIVA, V15, P363, DOI 10.1590/S1413-81232010000200011; Costa RS, 2013, J HUM GROWTH DEV, V23, P238; Davidson R, 1993, ESTIMATION INFERENCE; De Domenico I, 2011, CELL METAB, V13, P57, DOI 10.1016/j.cmet.2010.12.003; Donovan A, 2006, PHYSIOLOGY, V21, P115, DOI 10.1152/physiol.00052.2005; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomes Filho IS, 2006, REV ODONTO CIENC, V21; Gomes-Filho IS, 2007, J CLIN PERIODONTOL, V34, P957, DOI 10.1111/j.1600-051X.2007.01141.x; Grotto HZW, 2008, MED ONCOL, V25, P12, DOI 10.1007/s12032-007-9000-8; HARRISON KA, 1973, J OBSTET GYN BR COMM, V80, P798; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Koura GK, 2012, TROP MED INT HEALTH, V17, P283, DOI 10.1111/j.1365-3156.2011.02932.x; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lone F W, 2004, East Mediterr Health J, V10, P801; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Masukume G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122729; Melo Adriana Suely de Oliveira, 2007, Rev. bras. epidemiol., V10, P249; Mesa SLR, 2012, PERSPECT NUTR HUM, V14, P199; Misra Akshay, 2015, Med J Armed Forces India, V71, P270, DOI 10.1016/j.mjafi.2015.03.001; Mohamed MA, 2012, J PERINAT MED, V40, P141, DOI [10.1515/jpm.2011.137, 10.1515/JPM.2011.137]; Moraes IB, 2001, RISK FACTORS UNDERWE; Msuya Sia E, 2011, Tanzan J Health Res, V13, P33; ONG LDY, 1968, HEALTH PHYS, V14, P376; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; Pena-Rosas Juan Pablo, 2015, Cochrane Database Syst Rev, pCD009997, DOI [10.1002/14651858.CD009997, 10.1002/14651858.CD009997.pub2]; Pinho-Pompeu M, 2017, J MATERN-FETAL NEO M, V30, P1158, DOI 10.1080/14767058.2016.1205032; Pita GM, 2014, MEDICC REV, V16, P16, DOI 10.37757/MR2014.V16.N1.5; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Raisanen S, 2014, PAEDIATR PERINAT EP, V28, P372, DOI 10.1111/ppe.12134; Rees JM, 1996, PEDIATRICS, V98, P1161; Rocha D. da S., 2005, Revista de Nutricao, V18, P481, DOI 10.1590/S1415-52732005000400004; Rukuni R, 2016, ACTA OBSTET GYN SCAN, V95, P555, DOI 10.1111/aogs.12862; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sekhavat L, 2011, HEMATOLOGY, V16, P373, DOI 10.1179/102453311X13085644680186; Smagulova I. E., 2013, Voprosy Pitaniya, V82, P58; Stangret A, 2017, J MATERN-FETAL NEO M, V30, P199, DOI 10.3109/14767058.2016.1168395; STATA, 2017, DAT AN STAT SOFTW VE; Treister-Goltzman Y, 2015, ANN HEMATOL, V94, P1777, DOI 10.1007/s00277-015-2459-z; UNICEF, 2004, LOW BIRTHW COUNTR RE; Vandevijvere S, 2013, J ACAD NUTR DIET, V113, P659, DOI 10.1016/j.jand.2012.10.021; Viana KD, 2013, CAD SAUDE PUBLICA, V29, P350; Vural T, 2016, PAK J MED SCI, V32, P1354, DOI 10.12669/pjms.326.11199; World Health Organization, 2002, M ADV GROUP MAT NUTR; World Health Organization, 2001, IR DEF AN ASS PREV C; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Yip R, 2000, AM J CLIN NUTR, V72, p272S, DOI 10.1093/ajcn/72.1.272S	70	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0212817	10.1371/journal.pone.0212817	http://dx.doi.org/10.1371/journal.pone.0212817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30884493	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500007
J	Nakagita, T; Ishida, A; Matsuya, T; Kobayashi, T; Narukawa, M; Hirokawa, T; Hashimoto, M; Misaka, T				Nakagita, Tomoya; Ishida, Akiko; Matsuya, Takumi; Kobayashi, Takuya; Narukawa, Masataka; Hirokawa, Takatsugu; Hashimoto, Makoto; Misaka, Takumi			Structural insights into the differences among lactisole derivatives in inhibitory mechanisms against the human sweet taste receptor	PLOS ONE			English	Article							ROASTED COFFEE BEANS; 2-(4-METHOXYPHENOXY)PROPANOIC ACID; TRANSMEMBRANE DOMAIN; IDENTIFICATION; GENE	Lactisole, an inhibitor of the human sweet taste receptor, has a 2-phenoxypropionic acid skeleton and has been shown to interact with the transmembrane domain of the T1R3 subunit (T1R3-TMD) of the receptor. Another inhibitor, 2,4-DP, which shares the same molecular skeleton as lactisole, was confirmed to be approximately 10-fold more potent in its inhibitory activity than lactisole; however the structural basis of their inhibitory mechanisms against the receptor remains to be elucidated. Crystal structures of the TMD of metabotropic glutamate receptors, which along with T1Rs are categorized as class C G-protein coupled receptors, have recently been reported and made it possible to create an accurate structural model for T1R3-TMD. In this study, the detailed structural mechanism underlying sweet taste inhibition was characterized by comparing the action of lactisole on T1R3-TMD with that of 2,4-DP. We first performed a series of experiments using cultured cells expressing the sweet taste receptor with mutations and examined the interactions with these inhibitors. Based on the results, we next performed docking simulations and then applied molecular dynamics-based energy minimization. Our analyses clearly revealed that the (S)-isomers of both lactisole and 2,4-DP, interacted with the same seven residues in T1R3-TMD and that the inhibitory potencies of those inhibitors were mainly due to stabilizing interactions mediated via their carboxyl groups in the vertical dimension of the ligand pocket of T1R3-TMD. In addition, 2,4-DP engaged in a hydrophobic interaction mediated by its o-Cl group, and this interaction may be chiefly responsible for the higher inhibitory potency of 2,4-DP.	[Nakagita, Tomoya; Matsuya, Takumi; Narukawa, Masataka; Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Nakagita, Tomoya; Kobayashi, Takuya] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Kyoto, Japan; [Ishida, Akiko; Hashimoto, Makoto] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Dept Biol Chem, Fac Med, Tsukuba, Ibaraki, Japan	University of Tokyo; Kyoto University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Misaka, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp	Hashimoto, Makoto/B-7837-2012	Hashimoto, Makoto/0000-0002-5526-8835; Misaka, Takumi/0000-0002-9547-5767; Nakagita, Tomoya/0000-0002-0542-8650	Council for Science, Technology and Innovation (CSTI), Technologies for creating next-generation agriculture, forestry and fisheries Cross-ministerial Strategic Innovation Promotion Program (SIP); AMED (Japan Agency for Medical Research and Development) [JP18am0101079, JP180101114]; MEXT [hp160213]	Council for Science, Technology and Innovation (CSTI), Technologies for creating next-generation agriculture, forestry and fisheries Cross-ministerial Strategic Innovation Promotion Program (SIP); AMED (Japan Agency for Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was funded by Council for Science, Technology and Innovation (CSTI), Technologies for creating next-generation agriculture, forestry and fisheries Cross-ministerial Strategic Innovation Promotion Program (SIP), the Basis for Supporting the Platform Project for Supporting Drug Discovery and Life Science Research from AMED (Japan Agency for Medical Research and Development grants JP18am0101079 to TK and JP180101114 to TH), MEXT as "Priority Issue on Post-K computer" (hp160213 to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Cheron JB, 2017, PROTEINS, V85, P332, DOI 10.1002/prot.25228; Christopher JA, 2019, J MED CHEM, V62, P207, DOI 10.1021/acs.jmedchem.7b01722; Christopher JA, 2015, J MED CHEM, V58, P6653, DOI 10.1021/acs.jmedchem.5b00892; Conn PJ, 2014, NAT REV DRUG DISCOV, V13, P692, DOI 10.1038/nrd4308; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Fujiwara S, 2012, FOOD CHEM, V130, P561, DOI 10.1016/j.foodchem.2011.07.073; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Imada T, 2010, BIOCHEM BIOPH RES CO, V397, P220, DOI 10.1016/j.bbrc.2010.05.088; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Maillet EL, 2015, CHEM SENSES, V40, P577, DOI 10.1093/chemse/bjv045; Maillet EL, 2009, J MED CHEM, V52, P6931, DOI 10.1021/jm900823s; Masuda N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044169; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; O'Brien DE, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv133; RATHBONE EB, 1989, J AGR FOOD CHEM, V37, P54, DOI 10.1021/jf00085a013; RATHBONE EB, 1989, J AGR FOOD CHEM, V37, P58, DOI 10.1021/jf00085a014; Rovira X, 2015, FASEB J, V29, P116, DOI 10.1096/fj.14-257287; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sanematsu K, 2014, J BIOL CHEM, V289, P25711, DOI 10.1074/jbc.M114.560409; Servant G, 2011, TRENDS PHARMACOL SCI, V32, P631, DOI 10.1016/j.tips.2011.06.007; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489	29	13	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213552	10.1371/journal.pone.0213552	http://dx.doi.org/10.1371/journal.pone.0213552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883570	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500021
J	Amirbakhtiar, N; Ismaili, A; Ghaffari, MR; Firouzabadi, FN; Shobbar, ZS				Amirbakhtiar, Nazanin; Ismaili, Ahmad; Ghaffari, Mohammad Reza; Firouzabadi, Farhad Nazarian; Shobbar, Zahra-Sadat			Transcriptome response of roots to salt stress in a salinity-tolerant bread wheat cultivar	PLOS ONE			English	Article							REGULATES ABSCISIC-ACID; GENOME-WIDE ANALYSIS; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; MESSENGER-RNA; EXPRESSION ANALYSIS; AEGILOPS-TAUSCHII; PROTEIN-KINASE; GENE; RESISTANCE	Salt stress is one of the major adverse environmental factors limiting crop productivity. Considering Iran as one of the bread wheat origins, we sequenced root transcriptome of an Iranian salt tolerant cultivar, Arg, under salt stress to extend our knowledge of the molecular basis of salinity tolerance in Triticum aestivum. RNA sequencing resulted in more than 113 million reads and about 104013 genes were obtained, among which 26171 novel transcripts were identified. A comparison of abundances showed that 5128 genes were differentially expressed due to salt stress. The differentially expressed genes (DEGs) were annotated with Gene Ontology terms, and the key pathways were identified using Kyoto Encyclopedia of Gene and Genomes (KEGG) pathway mapping. The DEGs could be classified into 227 KEGG pathways among which transporters, phenylpropanoid biosynthesis, transcription factors, glycosyltransferases, glutathione metabolism and plant hormone signal transduction represented the most significant pathways. Furthermore, the expression pattern of nine genes involved in salt stress response was compared between the salt tolerant (Arg) and susceptible (Moghan3) cultivars. A panel of novel genes and transcripts is found in this research to be differentially expressed under salinity in Arg cultivar and a model is proposed for salt stress response in this salt tolerant cultivar of wheat employing the DEGs. The achieved results can be beneficial for better understanding and improvement of salt tolerance in wheat.	[Amirbakhtiar, Nazanin; Ismaili, Ahmad; Firouzabadi, Farhad Nazarian] Lorestan Univ, Dept Agron & Plant Breeding, Fac Agr, Khorramabad, Iran; [Ghaffari, Mohammad Reza; Shobbar, Zahra-Sadat] AREEO, ABRII, Dept Syst Biol, Karaj, Iran	Lorestan University	Ismaili, A (corresponding author), Lorestan Univ, Dept Agron & Plant Breeding, Fac Agr, Khorramabad, Iran.; Shobbar, ZS (corresponding author), AREEO, ABRII, Dept Syst Biol, Karaj, Iran.	ismaili.a@lu.ac.ir; shobbar@abrii.ac.ir	Shobbar, Zahra-Sadat/S-4648-2016; Nazarian-Firouzabadi, Farhad/AAA-1217-2022; Ghaffari, Mohammad Reza/O-3739-2015	Shobbar, Zahra-Sadat/0000-0002-7011-5415; Ghaffari, Mohammad Reza/0000-0002-7139-8613; Ismaili, Ahmad/0000-0001-8718-3943	Iran National Science Foundation (INSF) [96000095]; Agricultural Biotechnology Research Institute of Iran (ABRII) [24-05-05-010-960594]; Lorestan University	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Agricultural Biotechnology Research Institute of Iran (ABRII); Lorestan University	Z-S.S. received the grant from Iran National Science Foundation (INSF Grant Number: 96000095) and Agricultural Biotechnology Research Institute of Iran (ABRII Grant Number: 24-05-05-010-960594). A.I. received the grant from Lorestan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. INSF URL: http://www.insf.org/.	Afzal Z, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010009; Aghaei MJ, 2008, GENET RESOUR CROP EV, V55, P341, DOI 10.1007/s10722-007-9239-0; Albacete A, 2015, J EXP BOT, V66, P863, DOI 10.1093/jxb/eru448; Baba SA, 2017, J BIOL CHEM, V292, P4700, DOI 10.1074/jbc.M116.762161; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Basyuni M, 2009, J PLANT PHYSIOL, V166, P1786, DOI 10.1016/j.jplph.2009.05.008; Baxter HL, 2013, BIOFUELS-UK, V4, P635, DOI [10.4155/BFS.13.56, 10.4155/bfs.13.56]; Bhardwaj R, 2013, LEA PROTEINS SALT ST, P79, DOI 10.1007/978-1-4614-6108-1; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; BLUMWALD E, 1985, PLANT PHYSIOL, V78, P163, DOI 10.1104/pp.78.1.163; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Chung WS, 2000, PLANT CELL, V12, P1393, DOI 10.1105/tpc.12.8.1393; Clavijo BJ, 2017, GENOME RES, V27, P885, DOI 10.1101/gr.217117.116; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Dudnikov AJ, 2006, GENET RESOUR CROP EV, V53, P579, DOI 10.1007/s10722-004-2681-3; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; Fernandez-Garcia N, 2009, NEW PHYTOL, V181, P347, DOI 10.1111/j.1469-8137.2008.02674.x; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Goyal E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27752; GULICK PJ, 1994, PLANT PHYSIOL, V104, P799, DOI 10.1104/pp.104.2.799; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Horie T, 2011, J BIOSCI BIOENG, V111, P346, DOI 10.1016/j.jbiosc.2010.10.014; Hussain T. M., 2008, Biotechnology and Molecular Biology Reviews, V3, P008; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; Jain M, 2012, BRIEF FUNCT GENOMICS, V11, P63, DOI 10.1093/bfgp/elr038; Jordan T, 2002, TRENDS PLANT SCI, V7, P392, DOI 10.1016/S1360-1385(02)02311-7; Kala S., 2015, INT J FOOD SCI TECH, V4, P40; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang JM, 2004, PLANT CELL PHYSIOL, V45, P1380, DOI 10.1093/pcp/pch159; Kavas M, 2016, MOL GENET GENOMICS, V291, P129, DOI 10.1007/s00438-015-1095-6; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Kim J, 2013, PLANT OMICS, V6, P246; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Laohavisit A, 2013, PLANT PHYSIOL; Laohavisit A, 2012, PLANT CELL, V24, P1522, DOI 10.1105/tpc.112.097881; Lee EK, 2004, PLANT PHYSIOL, V134, P528, DOI 10.1104/pp.103.027045; Li WT, 2013, PLANT OMICS, V6, P474; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mahmood K, 2016, PLANT CELL PHYSIOL, V57, P2029, DOI 10.1093/pcp/pcw120; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Meyerhoff O, 2005, PLANTA, V222, P418, DOI 10.1007/s00425-005-1551-3; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mousavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104541; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAKAI Y, 1979, JPN J GENET, V54, P175, DOI 10.1266/jjg.54.175; Neves GYS, 2010, J AGRON CROP SCI, V196, P467, DOI 10.1111/j.1439-037X.2010.00432.x; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; PEREZPRAT E, 1992, PLANT PHYSIOL, V100, P1471, DOI 10.1104/pp.100.3.1471; Peyronnet R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00558; Qi YC, 2010, RUSS J PLANT PHYSL+, V57, P233, DOI 10.1134/S102144371002010X; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; Sefidab AA, 2012, SEED PLANT IMPROVMEN, V28, P724; Shankar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23719; Singh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125168; Singh A, 2014, FEBS J, V281, P894, DOI 10.1111/febs.12656; Singh M, 2015, REV ENVIRON SCI BIO, V14, P407, DOI 10.1007/s11157-015-9372-8; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Sun M- H, 2018, PLANT PHYSIOL; TARCZYNSKI MC, 1993, SCIENCE, V259, P508, DOI 10.1126/science.259.5094.508; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tng DYP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084378; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; TSUNEWAKI K, 1966, JPN J BOT, V19, P175; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Virdi AS, 2015, FRONT PLANT SCI, P6; Wang CT, 2016, PLANT BIOTECHNOL J, V14, P1838, DOI 10.1111/pbi.12544; Wang P, 2012, J BIOL CHEM, V287, P44062, DOI 10.1074/jbc.M112.351643; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; WIMMERS LE, 1992, P NATL ACAD SCI USA, V89, P9205, DOI 10.1073/pnas.89.19.9205; Wu J, 2016, PLANT PATHOLOGY J, V32, P552, DOI 10.5423/PPJ.OA.06.2016.0141; Wu Q, 2017, ENV EXPT BOT; Xiong H, 2017, SCI REPORTS, P7; Yang XZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191308; Yin WC, 2017, PLANT GROWTH REGUL, V83, P55, DOI 10.1007/s10725-017-0283-2; Zhang F, 2017, BIOSCIENCE REP; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhang Xiu-Jun, 2005, Shengli Xuebao, V57, P193; Zhang YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21476; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146242; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	98	38	41	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213305	10.1371/journal.pone.0213305	http://dx.doi.org/10.1371/journal.pone.0213305			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875373	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400010
J	Hassoumi, A; Peysakhovich, V; Hurter, C				Hassoumi, Almoctar; Peysakhovich, Vsevolod; Hurter, Christophe			Improving eye-tracking calibration accuracy using symbolic regression	PLOS ONE			English	Article								Eye tracking systems have recently experienced a diversity of novel calibration procedures, including smooth pursuit and vestibulo-ocular reflex based calibrations. These approaches allowed collecting more data compared to the standard 9-point calibration. However, the computation of the mapping function which provides planar gaze positions from pupil features given as input is mostly based on polynomial regressions, and little work has investigated alternative approaches. This paper fills this gap by providing a new calibration computation method based on symbolic regression. Instead of making prior assumptions on the polynomial transfer function between input and output records, symbolic regression seeks an optimal model among different types of functions and their combinations. This approach offers an interesting perspective in terms of flexibility and accuracy. Therefore, we designed two experiments in which we collected ground truth data to compare vestibuloocular and smooth pursuit calibrations based on symbolic regression, both using a marker or a finger as a target, resulting in four different calibrations. As a result, we improved calibration accuracy by more than 30%, with reasonable extra computation time.	[Hassoumi, Almoctar; Hurter, Christophe] French Civil Aviat Univ ENAC, DEVI, Toulouse, France; [Hassoumi, Almoctar; Peysakhovich, Vsevolod] Univ Toulouse, DCAS, ISAE SUPAERO, Toulouse, France	Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Ecole Nationale de l'Aviation Civile (ENAC); Universite de Toulouse; Institut Superieur de l'Aeronautique et de l'Espace (ISAE-SUPAERO)	Hassoumi, A (corresponding author), French Civil Aviat Univ ENAC, DEVI, Toulouse, France.; Hassoumi, A (corresponding author), Univ Toulouse, DCAS, ISAE SUPAERO, Toulouse, France.	almoctar.hassoumi@enac.fr	Hurter, Christophe/AHB-0811-2022; Peysakhovich, Vsevolod/I-8077-2019	Hurter, Christophe/0000-0003-4318-6717; Peysakhovich, Vsevolod/0000-0002-9791-4460; Hassoumi, Almoctar/0000-0003-1151-953X				Arar N. M., 2016, IEEE T CIRCUITS SYST; Augusto DA, 2000, SIXTH BRAZILIAN SYMPOSIUM ON NEURAL NETWORKS, VOL 1, PROCEEDINGS, P173, DOI 10.1109/SBRN.2000.889734; Bace M, 2018, ACM S EYE TRACK RES; Bautu E., 2005, 7 INT S SYMB NUM ALG, P4; Blignaut P, 2017, J EYE MOVEMENT RES, V10, DOI 10.16910/jemr.10.4.1; Blignaut Pieter, 2016, J EYE MOVEMENT RES, V9; Blignaut Pieter, 2013, P 2013 C EYE TRACK S, P39, DOI [10.1145/2509315.2509321, DOI 10.1145/2509315.2509321]; Casiez G., 2012, P SIGCHI C HUM FACT, P2527, DOI [DOI 10.1145/2207676.2208639, 10.1145/2207676.2208639]; Celebi Feridun M., 2014, P S EYE TRACK RES AP, P377, DOI [10.1145/2578153.2583042, DOI 10.1145/2578153.2583042]; Cerrolaza J. J, 2012, P S EYE TRACK RES AP, P205, DOI [DOI 10.1145/2168556.2168595, 10.1145/2168556.2168595]; Cerrolaza JJ, 2012, ACM T COMPUT-HUM INT, V19, DOI 10.1145/2240156.2240158; Cerrolaza JJ, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P259, DOI 10.1145/1344471.1344530; Cymek DH, 2014, J EYE MOVEMENT RES, V7; Davidson JW, 2003, INFORM SCIENCES, V150, P95, DOI 10.1016/S0020-0255(02)00371-7; Delamare W, 2017, PROCEEDINGS OF THE 19TH INTERNATIONAL CONFERENCE ON HUMAN-COMPUTER INTERACTION WITH MOBILE DEVICES AND SERVICES (MOBILEHCI '17), DOI 10.1145/3098279.3098561; Duffy J., 2002, USING SYMBOLIC REGRE, P61; Esteves A, 2015, UIST'15: PROCEEDINGS OF THE 28TH ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P457, DOI 10.1145/2807442.2807499; Evans KM, 2012, J EYE MOVEMENT RES, V5; Feit AM, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P1118, DOI 10.1145/3025453.3025599; Fuhl W, 2016, MACH VISION APPL, V27, P1275, DOI 10.1007/s00138-016-0776-4; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Hassoumi A, 2018, J EYE MOVEMENT RES, V10; Kasprowski P, 2018, DIGIT SIGNAL PROCESS, V77, P222, DOI 10.1016/j.dsp.2017.11.011; Kassner M, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P1151, DOI 10.1145/2638728.2641695; Khamis M, 2016, 15TH INTERNATIONAL CONFERENCE ON MOBILE AND UBIQUITOUS MULTIMEDIA (MUM 2016), P57, DOI 10.1145/3012709.3012743; Khamis M, 2016, UBICOMP'16: PROCEEDINGS OF THE 2016 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P274, DOI 10.1145/2971648.2971679; Kondou Y, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON VIRTUAL ENVIRONMENTS, HUMAN-COMPUTER INTERFACES AND MEASUREMENT SYSTEMS, P145, DOI 10.1109/VECIMS.2008.4592770; Koza J.R, 1990, TECHNICAL REPORT STA; Koza JR, 1992, GENETIC PROGRAMMING; Kubler TC, 2016, 2016 ACM SYMPOSIUM ON EYE TRACKING RESEARCH & APPLICATIONS (ETRA 2016), P143, DOI 10.1145/2857491.2857494; Lufimpu-Luviya Y., 2013, P 2013 C EYE TRACK S, P32, DOI [10.1145/2509315.2509320, DOI 10.1145/2509315.2509320]; Mazzei A., 2014, P S EYE TRACK RES AP, P87, DOI [10.1145/2578153.2578164, DOI 10.1145/2578153.2578164]; Mistry P, 2009, ACM SIGGRAPH ASIA 20, DOI [10.1145/1667146.1667160, DOI 10.1145/1667146.1667160]; Nystrom M, 2013, BEHAV RES METHODS, V45, P272, DOI 10.3758/s13428-012-0247-4; Petelin D, 2011, LECT NOTES COMPUT SC, V6593, P420, DOI 10.1007/978-3-642-20282-7_43; Pfeuffer Ken, 2013, P 26 ANN ACM S USER, P261, DOI [10.1145/2501988.2501998, DOI 10.1145/2501988.2501998]; Santini T, 2017, PROCEEDINGS OF THE 2017 ACM SIGCHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'17), P2594, DOI 10.1145/3025453.3025950; Schmidt MD, 2008, IEEE T EVOLUT COMPUT, V12, P736, DOI 10.1109/TEVC.2008.919006; Sesma-Sanchez L, 2016, 2016 ACM SYMPOSIUM ON EYE TRACKING RESEARCH & APPLICATIONS (ETRA 2016), P229, DOI 10.1145/2857491.2857509; Titz J, 2018, BEHAV RES METHODS, V50, P1853, DOI 10.3758/s13428-017-0954-y; Vidal M, 2013, UBICOMP'13: PROCEEDINGS OF THE 2013 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P439, DOI 10.1145/2493432.2493477; Wood Erroll, 2014, P S EYE TRACK RES AP, P207, DOI [10.1145/2578153.2578185, DOI 10.1145/2578153.2578185]; Zhang WH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111159; Zhang YR, 2014, LECT NOTES ELECTR EN, V288, P95, DOI 10.1007/978-3-642-53751-6_10	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213675	10.1371/journal.pone.0213675	http://dx.doi.org/10.1371/journal.pone.0213675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875387	Green Published, Green Submitted, gold			2022-12-26	WOS:000461316400021
J	Oezel, L; Buren, C; Scholz, AO; Windolf, J; Windolf, CD				Oezel, Lisa; Bueren, Carina; Scholz, Armin O.; Windolf, Joachim; Windolf, Ceylan D.			Effect of antibiotic infused calcium sulfate/hydroxyapatite (CAS/HA) insets on implant-associated osteitis in a femur fracture model in mice	PLOS ONE			English	Article							INJECTABLE BONE SUBSTITUTE; OSTEOMYELITIS; STAPHYLOCOCCUS	Cerament (Bonesupport Holding, Lund, Sweden) is a bioresorbable synthetic bone substitute consisting of calcium sulfate and hydroxyapatite which is successfully used as a bone graft in bone defects or in delayed and non-unions after fractures. Besides, calcium sulfate/hydroxyapatite (CAS/HA) could have, attributed to its composition and osteoinductive properties, have great importance in the treatment of bone infections with critical size defects (CSD). Aim of the study was to evaluate the effects of antibiotic infused CAS/HA on inflammation and bone healing in an implant-associated osteitis mice model. In a standardized murine model, the left femur of 72 BALB/c mice were osteotomized, generating a CSD (2,5 mm) with stabilization through a 6-hole titanium locking plate. Osteitis has been induced through inoculation of Staphylococcus aureus (SA) into the fracture gap. To analyze the effect of CAS/HA, following groups were generated with either CAS/HA, CAS/HA with gentamycin (CAS/HA-G) or CAS/HA with vancomycin (CAS/HA-V) insets placed into the osteotomy. Debridement and lavages were progressed on day 7 and 42 to determine the local bacterial growth and the immune reaction. Fracture healing was quantified on day 7 and 42 by x-ray and bone healing markers from blood samples. Progression of infection was assessed by estimation of colony-forming units (CFU) and immune response was analyzed by determination of Interleukin (IL)-6 and polymorphonuclear neutrophils (PMN) in lavage samples. Osteitis induced higher IL-6 and PMN-levels in the lavage samples on day 7. Both parameters showed a reduction in all groups on day 42. CAS/HA-V revealed a significant reduction of CFU and PMNs in lavage samples on day 42. A positive effect on bone healing could only be shown in non-infected mice. Whereas, application of mere CAS/HA in infected mice did show tendencies of bone destruction and lysis, independent of impregnation with antibiotics or not. Thus, application of CAS/HA in acute implant-associated infections is not recommended. In non-infectious environments or after infect-convalescence CAS/HA could albeit serve as a suggestive tool in trauma and orthopedic surgery.	[Oezel, Lisa; Bueren, Carina; Windolf, Joachim; Windolf, Ceylan D.] Heinrich Heine Univ, Dept Trauma & Hand Surg, Fac Med, Moorenstr 5, Dusseldorf, Germany; [Scholz, Armin O.] Univ Wuppertal Witten Herdecke, Helios Med Fac, Dept Trauma & Orthoped Surg, Heusnerstr 40, Wuppertal, Germany	Heinrich Heine University Dusseldorf; University of Wuppertal	Oezel, L (corresponding author), Heinrich Heine Univ, Dept Trauma & Hand Surg, Fac Med, Moorenstr 5, Dusseldorf, Germany.	lisa.oezel@med.uni-duesseldorf.de		Oezel, Lisa/0000-0002-6043-4308				Abramo A, 2010, J BIOMED MATER RES B, V92B, P281, DOI 10.1002/jbm.b.31524; Birt MC, 2017, J ORTHOP, V14, P45, DOI 10.1016/j.jor.2016.10.004; Bresco MS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01401; Brooks BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118696; Dvorzhinskiy A., 2015, BONE JOINT J P S16, V97-B, P9, DOI [10.1302/1358-992X.97BSUPP_16.EBJIS2015-009, DOI 10.1302/1358-992X.97BSUPP_]; Geurts J, 2011, INJURY, V42, pS82, DOI 10.1016/j.injury.2011.06.189; Glombitza M., 2016, BONE JOINT J, V98, P39, DOI DOI 10.1302/1358-992x.98bsupp_23.ebjis2016-039; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hake ME, 2015, INJURY, V46, P1447, DOI 10.1016/j.injury.2015.05.008; Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77; Hotchen Andrew J, 2017, J Bone Jt Infect, V2, P167, DOI 10.7150/jbji.21050; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Iundusi R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0574-6; Kaczmarczyk J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0828-3; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028; Logoluso N, 2016, J Bone Jt Infect, V1, P59, DOI 10.7150/jbji.17586; McNally MA, 2016, BONE JOINT J, V98B, P1289, DOI 10.1302/0301-620X.98B9.38057; Modinger Y, 2018, SEMIN IMMUNOL, V37, P53, DOI 10.1016/j.smim.2018.01.001; Teixeira LEM, 2018, ACTA CIR BRAS, V33, P14, DOI 10.1590/s0102-865020180010000002; Nusselt T, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-75; Paharik AE, 2016, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 5 EDITION, P529, DOI 10.1128/microbiolspec.VMBF-0022-2015; Raina D, 2015, ORTHOP RES SOC LAS V; Raina DB, 2016, BONE JOINT RES, V5, P500, DOI 10.1302/2046-3758.510.BJR-2016-0133.R1; Romano Carlo Luca, 2011, Eur Orthop Traumatol, V1, P207; Sambri A, INTRAOPERATIVE DIAGN, P6; Stravinskas M, 2016, BONE JOINT RES, V5, P427, DOI 10.1302/2046-3758.59.BJR-2016-0108.R1; Taga T, 2018, J ORTHOP SCI, V23, P585, DOI 10.1016/j.jos.2018.01.007; Tiemann AH, 2012, UNFALLCHIRURG, V115, P480, DOI 10.1007/s00113-012-2187-y; van Vugt TAG, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6984656; Walter G, 2012, DTSCH ARZTEBL INT, V109, P257, DOI [10.3238/arztebl.012.0257, 10.3238/arztebl.2012.0257]; Windolf CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115940; Windolf CD, 2013, J ORTHOP RES, V31, P2013, DOI 10.1002/jor.22446; Zalavras Charalampos G, 2008, Instr Course Lect, V57, P51; Zampelis V, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-25	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213590	10.1371/journal.pone.0213590	http://dx.doi.org/10.1371/journal.pone.0213590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870491	gold, Green Published, Green Submitted			2022-12-26	WOS:000461166300047
J	Husic, BE; Schlueter-Kuck, KL; Dabiri, JO				Husic, Brooke E.; Schlueter-Kuck, Kristy L.; Dabiri, John O.			Simultaneous coherent structure coloring facilitates interpretable clustering of scientific data by amplifying dissimilarity	PLOS ONE			English	Article							OPTIMAL VORTEX FORMATION; MARKOV STATE MODELS; FLUID ENTRAINMENT; DYNAMICS; IDENTIFICATION; REVEAL	The clustering of data into physically meaningful subsets often requires assumptions regarding the number, size, or shape of the subgroups. Here, we present a new method, simultaneous coherent structure coloring (sCSC), which accomplishes the task of unsupervised clustering without a priori guidance regarding the underlying structure of the data. sCSC performs a sequence of binary splittings on the dataset such that the most dissimilar data points are required to be in separate clusters. To achieve this, we obtain a set of orthogonal coordinates along which dissimilarity in the dataset is maximized from a generalized eigenvalue problem based on the pairwise dissimilarity between the data points to be clustered. This sequence of bifurcations produces a binary tree representation of the system, from which the number of clusters in the data and their interrelationships naturally emerge. To illustrate the effectiveness of the method in the absence of a priori assumptions, we apply it to three exemplary problems in fluid dynamics. Then, we illustrate its capacity for interpretability using a high-dimensional protein folding simulation dataset. While we restrict our examples to dynamical physical systems in this work, we anticipate straightforward translation to other fields where existing analysis tools require ad hoc assumptions on the data structure, lack the interpretability of the present method, or in which the underlying processes are less accessible, such as genomics and neuroscience.	[Husic, Brooke E.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Schlueter-Kuck, Kristy L.; Dabiri, John O.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Dabiri, John O.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Husic, BE (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Dabiri, JO (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.; Dabiri, JO (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	bhusic@stanford.edu; jodabiri@stanford.edu		Husic, Brooke/0000-0002-8020-3750	U.S. National Science Foundation; Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program	U.S. National Science Foundation(National Science Foundation (NSF)); Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program	BEH and JOD received no specific funding for this work. KLS-K was supported by the U.S. National Science Foundation and by the Department of Defense (DoD) through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2011, INT PSYCHOGERIATR, V23, P338, DOI 10.1017/S1041610210002127; Allshouse MR, 2015, CHAOS, V25, DOI 10.1063/1.4922968; [Anonymous], [No title captured]; [Anonymous], 2000, ARGO FLOAT DATA META; Beauchamp KA, 2012, P NATL ACAD SCI USA, V109, P17807, DOI 10.1073/pnas.1201810109; BLASHFIELD RK, 1991, J CLASSIF, V8, P277; Boley D, 1998, DATA MIN KNOWL DISC, V2, P325, DOI 10.1023/A:1009740529316; Dabiri JO, 2004, J FLUID MECH, V511, P311, DOI 10.1017/S0022112004009784; Dabiri JO, 2009, ANNU REV FLUID MECH, V41, P17, DOI 10.1146/annurev.fluid.010908.165232; Dellnitz M, 1999, SIAM J NUMER ANAL, V36, P491, DOI 10.1137/S0036142996313002; Deuflhard P, 2000, LINEAR ALGEBRA APPL, V315, P39, DOI 10.1016/S0024-3795(00)00095-1; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Friedman J., 2015, PACKAGE GLASSO; Froyland G, 2003, SIAM J SCI COMPUT, V24, P1839, DOI 10.1137/S106482750238911X; Froyland G, 2015, CHAOS, V25, DOI 10.1063/1.4926372; Gharib M, 2006, P NATL ACAD SCI USA, V103, P6305, DOI 10.1073/pnas.0600520103; Guckenheimer J, 1983, NONLINEAR OSCILLATIO, V42; Hadjighasem A, 2017, CHAOS, V27, DOI 10.1063/1.4982720; Hadjighasem A, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.063107; HALL KM, 1970, MANAGE SCI, V17, P219, DOI 10.1287/mnsc.17.3.219; Haller G, 2000, PHYSICA D, V147, P352, DOI 10.1016/S0167-2789(00)00142-1; Hansen P, 1997, MATH PROGRAM, V79, P191, DOI 10.1007/BF02614317; Hughes CW, 2017, GEOPHYS RES LETT, V44, P12375, DOI 10.1002/2017GL075198; Huhn F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051246; Husic BE, 2018, J AM CHEM SOC, V140, P2386, DOI 10.1021/jacs.7b12191; Husic BE, 2017, J CHEM THEORY COMPUT, V13, P963, DOI 10.1021/acs.jctc.6b01238; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaiser E, 2014, J FLUID MECH, V754, P365, DOI 10.1017/jfm.2014.355; Kavvas ES, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06634-y; Klus Stefan, 2016, J COMPUT DYNAM, V3, P51; Krueger PS, 2003, PHYS FLUIDS, V15, P1271, DOI 10.1063/1.1564600; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Maclean J, 2017, PHYSICA D, V360, P36, DOI 10.1016/j.physd.2017.08.007; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Mezic I, 2005, NONLINEAR DYNAM, V41, P309, DOI 10.1007/s11071-005-2824-x; Mullner D, 2013, J STAT SOFTW, V53, P1; Munoz S, 2005, OMEGA-INT J MANAGE S, V33, P211, DOI 10.1016/j.omega.2004.04.006; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Noe F, 2015, J CHEM THEORY COMPUT, V11, P5002, DOI 10.1021/acs.jctc.5b00553; Noe F, 2013, MULTISCALE MODEL SIM, V11, P635, DOI 10.1137/110858616; Olcay AB, 2008, EXP FLUIDS, V44, P235, DOI [10.1007/s00348-007-0397-9, 10.1007/S00348-007-0397-9]; Pande VS, 2010, METHODS, V52, P99, DOI 10.1016/j.ymeth.2010.06.002; Rypina II, 2007, J ATMOS SCI, V64, P3595, DOI 10.1175/JAS4036.1; Schlueter-Kuck K, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.012501; Schlueter-Kuck KL, 2017, CHAOS, V27, DOI 10.1063/1.4993862; Schlueter-Kuck KL, 2017, J FLUID MECH, V811, P468, DOI 10.1017/jfm.2016.755; Schutte C, 1999, J COMPUT PHYS, V151, P146, DOI 10.1006/jcph.1999.6231; Schwantes CR, 2013, J CHEM THEORY COMPUT, V9, P2000, DOI 10.1021/ct300878a; Sengupta A, 2017, NATURE, V543, P555, DOI 10.1038/nature21415; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; SUNDARALINGAM M, 1989, SCIENCE, V244, P1333, DOI 10.1126/science.2734612; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Wang LP, 2017, J PHYS CHEM B, V121, P4023, DOI 10.1021/acs.jpcb.7b02320; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Williams MO, 2015, J NONLINEAR SCI, V25, P1307, DOI 10.1007/s00332-015-9258-5; Wu H, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4979344; Wu ZQ, 2018, CHEM SCI, V9, P513, DOI 10.1039/c7sc02664a	62	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212442	10.1371/journal.pone.0212442	http://dx.doi.org/10.1371/journal.pone.0212442			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865644	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000461048900022
J	Spector, BM; Turek, ME; Price, DH				Spector, Benjamin M.; Turek, Michael E.; Price, David H.			Functional interaction of human Ssu72 with RNA polymerase II complexes	PLOS ONE			English	Article							C-TERMINAL-DOMAIN; TRANSCRIPTION ELONGATION; CTD PHOSPHATASE; FCP1 PHOSPHATASE; SERINE 5; PHOSPHORYLATION; KINASE; TFIIB; YEAST; RTR1	Phosphorylation of the C-terminal domain (CTD) of the large subunit of human RNA polymerase II (Pol II) is regulated during the transcription cycle by the combined action of specific kinases and phosphatases. Pol II enters into the preinitiation complex (PIC) unphosphorylated, but is quickly phosphorylated by Cdk7 during initiation. How phosphatases alter the pattern and extent of CTD phosphorylation at this early stage of transcription is not clear. We previously demonstrated the functional association of an early-acting, magnesium-independent phosphatase with early elongation complexes. Here we show that Ssu72 is responsible for that activity. We found that the phosphatase enters the transcription cycle during the formation of PICs and that Ssu72 is physically associated with very early elongation complexes. The association of Ssu72 with elongation complexes was stable to extensive washing with up to 200 mM KCl. Interestingly, Ssu72 ceased to function on complexes that contained RNA longer than 28 nt. However, when PICs were washed before initiation, the strict cutoff at 28 nt was lost. This suggests that factor(s) are important for the specific regulation of Ssu72 function during the transition between initiation and pausing. Overall, our results demonstrate when Ssu72 can act on early transcription complexes and suggest that Ssu72 may also function in the PIC prior to initiation.	[Spector, Benjamin M.; Turek, Michael E.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	david-price@uiowa.edu		Price, David/0000-0002-5597-385X; Spector, Ben/0000-0002-0307-9098	National Institute of General Medical Science [R01-GM35500, R35-GM126908]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM126908, R01GM035500] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Science grants R01-GM35500 and R35-GM126908 to DHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Bratkowski M, 2018, J BIOL CHEM, V293, P1651, DOI 10.1074/jbc.M117.811521; Chen YP, 2014, GENE DEV, V28, P2261, DOI 10.1101/gad.250449.114; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Cheng B, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn630; Chereji RV, 2017, NUCLEIC ACIDS RES, V45, P8806, DOI 10.1093/nar/gkx491; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Descostes N, 2014, ELIFE, V3, DOI 10.7554/eLife.02105; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Egloff S, 2012, RNA BIOL, V9, P1033, DOI 10.4161/rna.21166; Egloff S, 2012, MOL CELL, V45, P111, DOI 10.1016/j.molcel.2011.11.006; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Fuda NJ, 2012, MOL CELL BIOL, V32, P3428, DOI 10.1128/MCB.00247-12; Guo JN, 2014, J BIOL CHEM, V289, P12657, DOI 10.1074/jbc.M113.537662; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Hsin JP, 2014, MOL CELL BIOL, V34, P2488, DOI 10.1128/MCB.00181-14; Hsu PL, 2014, J MOL BIOL, V426, P2970, DOI 10.1016/j.jmb.2014.06.010; Hunter GO, 2016, MOL CELL BIOL, V36, P2236, DOI 10.1128/MCB.00870-15; Irani S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4805; Jeronimo C, 2016, J MOL BIOL, V428, P2607, DOI 10.1016/j.jmb.2016.02.006; Jeronimo C, 2013, CHEM REV, V113, P8491, DOI 10.1021/cr4001397; Jiang Y, 2004, MOL CELL, V14, P375, DOI 10.1016/S1097-2765(04)00234-5; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kelso TWR, 2014, MOL CELL BIOL, V34, P3675, DOI 10.1128/MCB.00595-14; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kong SE, 2005, J BIOL CHEM, V280, P4299, DOI 10.1074/jbc.M411071200; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Logan MR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-336; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Rosado-Lugo JD, 2014, J BIOL CHEM, V289, P33916, DOI 10.1074/jbc.M114.608695; Schreieck A, 2014, NAT STRUCT MOL BIOL, V21, P175, DOI 10.1038/nsmb.2753; Schwer B, 2015, RNA, V21, P1135, DOI 10.1261/rna.050286.115; Shah N, 2018, MOL CELL, V69, P48, DOI 10.1016/j.molcel.2017.12.009; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Steurer B, 2018, P NATL ACAD SCI USA, V115, pE4368, DOI 10.1073/pnas.1717920115; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wu WH, 1999, GENETICS, V153, P643; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhang ZJ, 2016, GENE DEV, V30, P2106, DOI 10.1101/gad.285395.116	60	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213598	10.1371/journal.pone.0213598	http://dx.doi.org/10.1371/journal.pone.0213598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901332	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400011
J	Boecker, J; Czigany, Z; Bednarsch, J; Amygdalos, I; Meister, F; Santana, DAM; Liu, WJ; Strnad, P; Neumann, UP; Lurje, G				Boecker, Joerg; Czigany, Zoltan; Bednarsch, Jan; Amygdalos, Iakovos; Meister, Franziska; Santana, Daniel Antonio Morales; Liu, Wen-Jia; Strnad, Pavel; Neumann, Ulf Peter; Lurje, Georg			Potential value and limitations of different clinical scoring systems in the assessment of short- and long-term outcome following orthotopic liver transplantation	PLOS ONE			English	Article							DONOR RISK INDEX; SURGICAL COMPLICATIONS; GRAFT FAILURE; SOFT SCORE; BAR-SCORE; SURVIVAL; ALLOCATION; MODEL; CLASSIFICATION; VALIDATION	Background In an attempt to further improve liver allograft utilization and outcome in orthotopic liver transplantation (OLT), a variety of clinical scoring systems have been developed. Here we aimed to comparatively investigate the association of the Balance-of-Risk (BAR), Survival-Outcomes-Following-Liver-Transplant (SOFT), Preallocation-Survival-Outcomes-Following-Liver-Transplant (pSOFT), Donor-Risk-Index (DRI), and the Eurotransplant-Donor-Risk-Index (ET-DRI) scores with short- and long-term outcome following OLT. Methods We included 338 consecutive patients, who underwent OLT in our institution between May 2010 and November 2017. For each prognostic model, the optimal cutoff values were determined with the help of the Youden-index and their diagnostic accuracy for 90-day post OLT-mortality and major postoperative complications was measured by the area under the receiver operating characteristic curve (AUROC). Patient- and graft survival were analyzed using the Kaplan-Meier method and the log-rank test. Morbidity was assessed using the Clavien-Dindo classification and the Comprehensive-Complication-Index. Results BAR, SOFT, and pSOFT performed well above the conventional AUROC-threshold of 0.70 with good prediction of early mortality. Only BAR showed AUC>0.70 for both mortality and major morbidity. With the cutoffs of 14, 31, and 22 respectively for BAR, SOFT, and pSOFT, subgroup analysis showed significant differences (p<0.001) in morbidity and mortality, length of intensive care- and hospital-stay and early allograft dysfunction rates. Five-years patient survival was inferior in the high BAR, pSOFT, and SOFT groups. Conclusions Out of all scores tested, the BAR-score had the best value in predicting both 90-day morbidity and mortality after OLT showing the highest AUCs. The pSOFT and SOFT scores demonstrated an acceptable accuracy in predicting 90-day morbidity and mortality. The used BAR, SOFT, and pSOFT cutoffs allowed the identification of patients at risk in terms of five-year patient survival. The DRI and ET-DRI scores have failed to predict recipient outcomes in the present setting.	[Boecker, Joerg; Czigany, Zoltan; Bednarsch, Jan; Amygdalos, Iakovos; Meister, Franziska; Santana, Daniel Antonio Morales; Liu, Wen-Jia; Neumann, Ulf Peter; Lurje, Georg] Univ Hosp RWTH Aachen, Dept Surg & Transplantat, Aachen, Germany; [Strnad, Pavel] Univ Hosp RWTH Aachen, Dept Internal Med 3, Aachen, Germany; [Neumann, Ulf Peter] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University	Lurje, G (corresponding author), Univ Hosp RWTH Aachen, Dept Surg & Transplantat, Aachen, Germany.	glurje@ukaachen.de	Meister, Franziska/AAG-8864-2021; Amygdalos, Iakovos/AAX-3527-2021	Morales Santana, Daniel Antonio/0000-0002-1458-1809; Czigany, Zoltan/0000-0003-0373-3210; Lurje, Georg/0000-0001-9674-0756; Amygdalos, Iakovos/0000-0002-5138-4214	START-Program of the Faculty of Medicine, RWTH Aachen [136/17, 23/19]; Excellence Initiative of the German federal and state governments [DE-82, ZUK2-SF-OPSF443]	START-Program of the Faculty of Medicine, RWTH Aachen(Austrian Science Fund (FWF)); Excellence Initiative of the German federal and state governments	This research project was supported by the START-Program http://www.medizin.rwth-aachen.de/cms/Medizin/Forschung/Foerderung/Interne-Programme/similar to tfy/START/ (#136/17 to GL and #23/19 to ZC) of the Faculty of Medicine, RWTH Aachen and by the Excellence Initiative of the German federal and state governments http://www.rwth-aachen.de/cms/root/Forschung/Angebote-fuer-Forschende/ERS-Angebote/similar to vuc/Projektentwicklung/lidx/1/ (G:(DE-82) ZUK2-SF-OPSF443 to GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Bertuzzo VR, 2017, ANN SURG, V265, P388, DOI 10.1097/SLA.0000000000001681; Blok JJ, 2012, LIVER TRANSPLANT, V18, P113, DOI 10.1002/lt.22447; Braat AE, 2012, AM J TRANSPLANT, V12, P2789, DOI 10.1111/j.1600-6143.2012.04195.x; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; CRIGANY Z, 2018, J GASTROINTESTINAL S; CZIGANY Z, 2018, LIVER INT OFFICIAL J, DOI DOI 10.1111/LIV.   13946; Czigany Z, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017558; Desai NM, 2004, TRANSPLANTATION, V77, P99, DOI 10.1097/01.TP.0000101009.91516.FC; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Flores A, 2017, LIVER TRANSPLANT, V23, P1216, DOI 10.1002/lt.24799; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Lo CM, 2015, HEPATOL INT, V9, P3, DOI 10.1007/s12072-014-9587-8; Ma YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136604; Mataya L, 2014, LIVER TRANSPLANT, V20, P831, DOI 10.1002/lt.23879; Northup PG, 2007, AM J TRANSPLANT, V7, P1984, DOI 10.1111/j.1600-6143.2007.01887.x; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; Quante M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/264015; Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x; Rana A, 2013, CLIN TRANSPLANT, V27, P627, DOI 10.1111/ctr.12181; Reichert B, 2013, J NEGAT RESULTS BIOM, V12, DOI 10.1186/1477-5751-12-18; Renz JF, 2005, ANN SURG, V242, P556, DOI 10.1097/01.sla.0000183973.49899.b1; Rosenberger LH, 2014, SURG INFECT, V15, P94, DOI 10.1089/sur.2013.035; Schlegel A, 2017, AM J TRANSPLANT, V17, P1050, DOI 10.1111/ajt.14065; Schoening W, 2016, CLIN TRANSPLANT, V30, P508, DOI 10.1111/ctr.12714; Schrem H, 2014, LANGENBECK ARCH SURG, V399, P1011, DOI 10.1007/s00423-014-1247-x; Selvakumar PKC, 2016, PEDIATR TRANSPLANT, V20, P807, DOI 10.1111/petr.12770; Slankamenac K, 2013, ANN SURG, V258, P1, DOI 10.1097/SLA.0b013e318296c732; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; BUNDESARZTEKAMMER, V29, DOI DOI 10.3238/ARZTEBL.2017	33	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214221	10.1371/journal.pone.0214221	http://dx.doi.org/10.1371/journal.pone.0214221			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897167	Green Submitted, Green Published, gold			2022-12-26	WOS:000461889700076
J	Kosnik, MB; Reif, DM; Lobdell, DT; Astell-Burt, T; Feng, XQ; Hader, JD; Hoppin, JA				Kosnik, Marissa B.; Reif, David M.; Lobdell, Danelle T.; Astell-Burt, Thomas; Feng, Xiaoqi; Hader, John D.; Hoppin, Jane A.			Associations between access to healthcare, environmental quality, and end-stage renal disease survival time: Proportional-hazards models of over 1,000,000 people over 14 years	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SOCIOECONOMIC-STATUS; TRAVEL-TIME; UNITED-STATES; DISTANCE; MORTALITY; OUTCOMES; IMPACT; DIALYSIS; REMOTE	Prevalence of end-stage renal disease (ESRD) in the US increased by 74% from 2000 to 2013. To investigate the role of the broader environment on ESRD survival time, we evaluated average distance to the nearest hospital by county (as a surrogate for access to healthcare) and the Environmental Quality Index (EQI), an aggregate measure of ambient environmental quality composed of five domains (air, water, land, built, and sociodemographic), at the county level across the US. Associations between average hospital distance, EQI, and survival time for 1,092,281 people diagnosed with ESRD between 2000 and 2013 (age 18+, without changes in county residence) from the US Renal Data System were evaluated using proportional-hazards models adjusting for gender, race, age at first ESRD service date, BMI, alcohol and tobacco use, and rurality. The models compared the average distance to the nearest hospital (<10, 1020, >20 miles) and overall EQI percentiles [0-5), [5-20), [20-40), [40-60), [60-80), [80-95), and [95-100], where lower percentiles are interpreted as better EQI. In the full, non-stratified model with both distance and EQI, there was increased survival for patients over 20 miles from a hospital compared to those under 10 miles from a hospital (hazard ratio = 1.14, 95% confidence interval = 1.12-1.15) and no consistent direction of association across EQI strata. In the full model stratified by average hospital distance, under 10 miles from a hospital had increased survival in the worst EQI strata (median survival 3.0 vs. 3.5 years for best vs. worst EQI, respectively), however for people over 20 miles from a hospital, median survival was higher in the best (4.2 years) vs worst (3.4 years) EQI. This association held across different rural/urban categories and age groups. These results demonstrate the importance of considering multiple factors when studying ESRD survival and future efforts should consider additional components of the broader environment.	[Kosnik, Marissa B.; Reif, David M.; Hoppin, Jane A.] North Carolina State Univ, Dept Biol Sci, Toxicol Program, Raleigh, NC 27695 USA; [Kosnik, Marissa B.; Reif, David M.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Lobdell, Danelle T.; Hoppin, Jane A.] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Lobdell, Danelle T.] US EPA, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC USA; [Astell-Burt, Thomas; Feng, Xiaoqi] Univ Wollongong, Fac Social Sci, Sch Hlth & Soc, Populat Wellbeing & Environm Res Lab, Wollongong, NSW, Australia; [Astell-Burt, Thomas; Feng, Xiaoqi] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Astell-Burt, Thomas] Peking Union Med Coll, Sch Publ Hlth, Beijing, Peoples R China; [Astell-Burt, Thomas] Chinese Acad Med Sci, Beijing, Peoples R China; [Hader, John D.] ICF, Fairfax, VA USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; United States Environmental Protection Agency; University of Wollongong; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Hoppin, JA (corresponding author), North Carolina State Univ, Dept Biol Sci, Toxicol Program, Raleigh, NC 27695 USA.; Hoppin, JA (corresponding author), North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA.	jahoppin@ncsu.edu	Astell-Burt, Thomas/B-9341-2018; Feng, Xiaoqi/AAM-9592-2021; Hader, John/AAM-1678-2021	Astell-Burt, Thomas/0000-0002-1498-4851; Feng, Xiaoqi/0000-0002-3421-220X; Hader, John/0000-0002-1033-4499; Kosnik, Marissa/0000-0002-2609-5816; Reif, David/0000-0001-7815-6767	University Global Partnership Network Research Collaboration Fund, "An International Alliance for Population, Wellbeing and Environment Research"; National Institutes of Health [P30 ES025128, T32 ES007046]; US Environmental Protection Agency [STAR R83502]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES025128, T32ES007046] Funding Source: NIH RePORTER	University Global Partnership Network Research Collaboration Fund, "An International Alliance for Population, Wellbeing and Environment Research"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the University Global Partnership Network Research Collaboration Fund, "An International Alliance for Population, Wellbeing and Environment Research" (PI: Astell-Burt), National Institutes of Health [P30 ES025128, T32 ES007046], and the US Environmental Protection Agency [STAR R83502]. Author JDH was employed by a commercial company, ICF, during this study. The funder provided support in the form of salary for author JDH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	[Anonymous], 2021, LANG ENV STAT COMP; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Astell-Burt T, 2012, SOC SCI MED, V75, P240, DOI 10.1016/j.socscimed.2012.02.046; Avdic D., 2015, CINCH SER; Boscoe FP, 2012, PROF GEOGR, V64, P188, DOI 10.1080/00330124.2011.583586; Buchmueller TC, 2006, J HEALTH ECON, V25, P740, DOI 10.1016/j.jhealeco.2005.10.006; CMMS, 2018, HOSP GEN INF; Collins AJ, 2015, KIDNEY INT SUPPL, V5, P2, DOI 10.1038/kisup.2015.2; Crews DC, 2014, CURR OPIN NEPHROL HY, V23, P298, DOI 10.1097/01.mnh.0000444822.25991.f6; Cudnik MT, 2010, RESUSCITATION, V81, P518, DOI 10.1016/j.resuscitation.2009.12.030; ESRI, 2017, ARCGIS VERS 10 5 1; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Garcia-Garcia G, 2015, KIDNEY INT, V87, P251, DOI [10.5935/0101-2800.20150003, 10.1038/ki.2014.369]; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Gill AJ, 2002, ANZ J SURG, V72, P643, DOI 10.1046/j.1445-2197.2002.02506.x; Goodman DC, 1997, AM J PUBLIC HEALTH, V87, P1144, DOI 10.2105/AJPH.87.7.1144; Haynes R., 2006, INT J HEALTH GEOGR, V5, P1; Hossain MP, 2012, NEPHRON CLIN PRACT, V120, pC59, DOI 10.1159/000334998; Hu JH, 2014, HEALTH AFFAIR, V33, P778, DOI 10.1377/hlthaff.2013.0816; Jackson KL, 2017, GASTROINTEST ENDOSC, V85, P380, DOI 10.1016/j.gie.2016.08.006; Jagai JS, 2017, CANCER-AM CANCER SOC, V123, P2901, DOI 10.1002/cncr.30709; Jian Y, 2017, ENVIRON HEALTH PERSP, V125, P355, DOI 10.1289/EHP119; Jones SG, 2010, HEALTH SERV RES, V45, P316, DOI 10.1111/j.1475-6773.2009.01044.x; Jordan H., 2004, INT J HEALTH GEOGR, V3, P1; Kelly C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013059; Kihal-Talantikite W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153431; Krol E, 2009, AM J NEPHROL, V29, P264, DOI 10.1159/000158526; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P320; Lamont EB, 2003, JNCI-J NATL CANCER I, V95, P1370, DOI 10.1093/jnci/djg035; Lebov JF, 2016, OCCUP ENVIRON MED, V73, P3, DOI 10.1136/oemed-2014-102615; Lebov JF, 2015, ENVIRON RES, V143, P198, DOI 10.1016/j.envres.2015.10.002; Lee JE, 2007, GEOSPATIAL HEALTH, V1, P243, DOI 10.4081/gh.2007.272; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li PKT, 2017, NEPHROLOGY, V22, P9, DOI 10.1111/nep.13146; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; McClellan WM, 2009, J AM SOC NEPHROL, V20, P1078, DOI 10.1681/ASN.2008060624; McGrath RJ, 2011, J COMMUN HEALTH, V36, P495, DOI 10.1007/s10900-010-9333-7; MCGUIRK MA, 1984, INQUIRY-J HEALTH CAR, V21, P84; Messer L, 2014, EPA600414304, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Messer L.C., 2011, RES PRAC S1, V101, P277, DOI DOI 10.2105/AJPH.2011; Messer LC, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-39; Moist LM, 2008, AM J KIDNEY DIS, V51, P641, DOI 10.1053/j.ajkd.2007.12.021; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Nzerue CM, 2002, J NATL MED ASSOC, V94, p28S; Pappas G, 1997, AM J PUBLIC HEALTH, V87, P811, DOI 10.2105/AJPH.87.5.811; Patel AP, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0306-0; Pearce JR, 2011, SOC SCI MED, V73, P410, DOI 10.1016/j.socscimed.2011.05.039; Pearson C, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-017-0185-0; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Reddan DN, 2000, SEMIN DIALYSIS, V13, P399, DOI 10.1046/j.1525-139x.2000.00109.x; Rodriguez RA, 2007, ANN INTERN MED, V146, P493, DOI 10.7326/0003-4819-146-7-200704030-00005; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Tanaka Rina, 2016, Asian Pac J Cancer Prev, V17, P5025; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Thompson S, 2012, KIDNEY INT, V82, P352, DOI 10.1038/ki.2012.167; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; Tonelli M, 2009, JAMA-J AM MED ASSOC, V301, P1681, DOI 10.1001/jama.2009.545; U. S. DOT FHWA, 2011, ONE MILLION ELECTRIC, P7; U.S. EPA, 2015, EPA ENV DAT GAT DOWN; U. S. HUD, 2017, HUD USPS ZIP COD CRO; U. S. Renal Data System, 2017, 2016 USRDS ANN DAT R; U. S. Renal Data System, 2016, AM J KIDNEY DIS, V66, pS1, DOI [10.1053/j.ajkd.2015.04.017, DOI 10.1053/J.AJKD.2015.04.017]; Valcke M, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0254-0; Watnick S, 2012, CLIN J AM SOC NEPHRO, V7, P1535, DOI 10.2215/CJN.01220212; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120; Zielinski A, 2013, SCAND J PRIM HEALTH, V31, P83, DOI 10.3109/02813432.2012.759712	70	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214094	10.1371/journal.pone.0214094	http://dx.doi.org/10.1371/journal.pone.0214094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP7SO	30897121	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700065
J	Knorr, K; Jorgensen, LN; Nicolaisen, M				Knorr, Kamilla; Jorgensen, Lise Nistrup; Nicolaisen, Mogens			Fungicides have complex effects on the wheat phyllosphere mycobiome	PLOS ONE			English	Article							WINTER-WHEAT; PUCCINIA-STRIIFORMIS; FUNGAL; IDENTIFICATION; COMMUNITIES; INHIBITORS; INFECTION; PATHOGENS; MARKERS; YIELD	Effects of fungicide treatments on non-target fungi in the phyllosphere are not well known. We studied community composition and dynamics of target (Puccinia striiformis) and non-target fungi in wheat that was heavily infected with yellow rust. Mycobiotas in bulk leaf samples and individual leaves were studied by metabarcoding targeting the internal transcribed spacer-1 (ITS1) region of the ribosomal DNA. The amount of yellow rust in individual samples was quantified by qPCR (quantitative PCR). In addition, septoria tritici blotch (Zymo-septoria tritici), powdery mildew (Blumeria graminis), tan spot (Pyrenophora tritici-repentis), and yellow rust (P. striiformis) were visually evaluated. We showed how fungal communities were affected by three different broad-spectrum fungicides that had been applied at different timings and doses to control Puccinia striiformis. We showed that fungal content was relatively constant even after fungicide treatments. Principal component analysis demonstrated that communities from fungicide-treated plots could be separated from the communities in non-treated plots. We observed effects of fungicide treatments on fungal communities using different dose, timing and products. Some fungi, including the target organism P. striiformis were effectively controlled by most of the fungicide applications whereas some yeasts and also P. tritici-repentis increased after treatments. We demonstrated the feasibility of using metabarcoding as a supplement to visual assessments of fungicide effects on target as well as non-target fungi.	[Knorr, Kamilla; Jorgensen, Lise Nistrup; Nicolaisen, Mogens] Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark	Aarhus University	Nicolaisen, M (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark.	mn@agro.au.dk	Nicolaisen, Mogens/B-6896-2008	Nicolaisen, Mogens/0000-0002-0407-2488; Jorgensen, Lars N/0000-0001-7465-5374	Danish Council for Independent Research [0602-01073B]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	Funded by KK: Grant 0602-01073B from the Danish Council for Independent Research, https://dff.dk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01057; Ammermann E, 2000, PROC BRIGHTON CROP, V1-3, P541; Barnes CW, 2007, PHYTOPATHOLOGY, V97, P717, DOI 10.1094/PHYTO-97-6-0717; de Jager ES, 2001, MICROB ECOL, V42, P201; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DICKINSON CH, 1976, T BRIT MYCOL SOC, V67, P103, DOI 10.1016/S0007-1536(76)80014-9; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henriksen B, 2005, J PHYTOPATHOL, V153, P214, DOI 10.1111/j.1439-0434.2005.00955.x; Hovmoller MS, 2007, MOL ECOL, V16, P4637, DOI 10.1111/j.1365-294X.2007.03513.x; Jensen B, 2013, INT J FOOD MICROBIOL, V160, P313, DOI 10.1016/j.ijfoodmicro.2012.11.005; Jorgensen LN, 2014, J INTEGR AGR, V13, P265, DOI 10.1016/S2095-3119(13)60646-2; Jorgensen LN, 2017, ANNU REV PHYTOPATHOL, V55, P181, DOI 10.1146/annurev-phyto-080516-035357; JORGENSEN LN, 1994, CROP PROT, V13, P323, DOI 10.1016/0261-2194(94)90045-0; Karlsson I, 2017, MOL ECOL, V26, P3424, DOI 10.1111/mec.14132; Karlsson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111786; Kumar S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-182; KWOK IMY, 1993, PESTIC SCI, V39, P1, DOI 10.1002/ps.2780390102; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lynch JP, 2017, FIELD CROP RES, V204, P89, DOI 10.1016/j.fcr.2017.01.012; Nicolaisen M, 2014, FUNGAL ECOL, V11, P145, DOI 10.1016/j.funeco.2014.06.002; Nicolaisen M, 2009, J MICROBIOL METH, V76, P234, DOI 10.1016/j.mimet.2008.10.016; O'Hanlon KA, 2012, BIOL CONTROL, V63, P69, DOI 10.1016/j.biocontrol.2012.08.007; Palmer CL, 2002, MOL PLANT PATHOL, V3, P63, DOI 10.1046/j.1464-6722.2002.00100.x; Perazzolli M, 2014, APPL ENVIRON MICROB, V80, P3585, DOI 10.1128/AEM.00415-14; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Sapkota R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01357; Sapkota R, 2015, NEW PHYTOL, V207, P1134, DOI 10.1111/nph.13418; Scherm B, 2013, MOL PLANT PATHOL, V14, P323, DOI 10.1111/mpp.12011; Singh RP, 2016, ANNU REV PHYTOPATHOL, V54, P303, DOI 10.1146/annurev-phyto-080615-095835; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213176	10.1371/journal.pone.0213176	http://dx.doi.org/10.1371/journal.pone.0213176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893325	Green Published, Green Submitted, gold			2022-12-26	WOS:000461765900032
J	Zhang, ZL; Wang, J; Liu, F; Yuan, L; Yuan, JL; Chen, LH; Zhong, NS; Lu, WJ				Zhang, Zili; Wang, Jian; Liu, Fei; Yuan, Liang; Yuan, Jili; Chen, Lianghua; Zhong, Nanshan; Lu, Wenju			Impacts of event-specific air quality improvements on total hospital admissions and reduced systemic inflammation in COPD patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; STEEL MILL; POLLUTION; DISEASE; ASSOCIATION; FIBRINOGEN; EXPOSURE; HEALTH; COAGULATION; POPULATION	There is limited evidence linking the impacts of reduced air pollution on hospital admissions. The potential biological mechanisms are still not completely understood. This study examined the effects of mitigated ambient pollution on hospital admissions and inflammatory biomarker levels in chronic obstructive pulmonary disease (COPD) COPD patients. Daily hospital admissions were compared over 51 days associated with the Asian Games period (Nov 1-Dec 21, 2010) with the identical calendar dates of baseline years (2004-2009 and 2011-2013). A three-year cohort study was conducted with 36 COPD patient participants. The daily particulate matter (PM10) decreased from 65.86 mu g/m(3) during the baseline period to 62.63 mu g/m(3) during the Asian Games period; the daily NO2 level decreased from 51.33 mu g/m(3) to 42.63 mu g/m(3). Between the baseline period and the Asian Games, daily hospital admissions from non-accidental diseases decreased from 116 to 93, respectively; respiratory diseases decreased from 20 to 17, respectively; and cardiovascular diseases decreased from 11 to 9 during the Asian Games period, respectively. No statistically significant reductions were seen in the remaining months of 2010 in Guangzhou, during the the Asian Games period in the control city, and two other control diseases. Furthermore, we identified significant improvement in CRP and fibrinogen by -20.4% and -15.4% from a pre-Asian game period to a during-Asian game period, respectively. For CRP, we found significant increases in NO2 at lag1-3 days after-Asian game period and significant increases in PM10 at lag1-2 days. Similar effects were also seen with fibrinogen. This discovery provides support for efforts to diminish air pollution and improve public health through human air pollutants intervention. Improved air pollution during the 2010 Asian games was correlated with decreases in biomarkers associated with systemic inflammation in COPD patient participants.	[Zhang, Zili; Wang, Jian; Liu, Fei; Yuan, Liang; Chen, Lianghua; Zhong, Nanshan; Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Wang, Jian] Univ Arizona, Dept Med, Div Translat & Regenerat Med, Tucson, AZ USA; [Yuan, Jili] Guangzhou Med Univ, Affiliated Hosp 1, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Arizona; Guangzhou Medical University; Guangzhou Medical University	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.; Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com			National Natural Science Foundation of China [81700043, 81520108001, 81770043]; 973 Key Scheme of China [2015CB553406]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangzhou Department of Education for Innovative Team [13C08]; Guangdong Natural Science Foundation [2016A030313593]; State Key Laboratory of Respiratory Disease Foundation [SKLRD-QN-201719]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Key Scheme of China(National Basic Research Program of China); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangzhou Department of Education for Innovative Team; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); State Key Laboratory of Respiratory Disease Foundation	This work was supported by grants from National Natural Science Foundation of China (81700043, 81520108001, 81770043), the 973 Key Scheme of China (2015CB553406), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014, WLu), Guangzhou Department of Education for Innovative Team (13C08), and Guangdong Natural Science Foundation (2016A030313593), and State Key Laboratory of Respiratory Disease Foundation (SKLRD-QN-201719). The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Bubb MR, 2009, NEW ENGL J MED, V360, P2032, DOI 10.1056/NEJMc090375; Cao J, 2011, J HAZARD MATER, V186, P1594, DOI 10.1016/j.jhazmat.2010.12.036; Chen RJ, 2010, J HAZARD MATER, V181, P234, DOI 10.1016/j.jhazmat.2010.05.002; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Clancy L, 2002, LANCET, V360, P1210, DOI 10.1016/S0140-6736(02)11281-5; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dockery DW, 2007, NEW ENGL J MED, V356, P511, DOI 10.1056/NEJMe068274; Dockery Douglas W, 2013, Res Rep Health Eff Inst, P3; Dubowsky SD, 2006, ENVIRON HEALTH PERSP, V114, P992, DOI 10.1289/ehp.8469; Friedman MS, 2001, JAMA-J AM MED ASSOC, V285, P897, DOI 10.1001/jama.285.7.897; Gabay C, 1999, NEW ENGL J MED, V340, P1376; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Guo YM, 2010, SCI TOTAL ENVIRON, V409, P300, DOI 10.1016/j.scitotenv.2010.10.013; Guo YM, 2009, SCI TOTAL ENVIRON, V407, P4826, DOI 10.1016/j.scitotenv.2009.05.022; Heeringa J, 2006, J THROMB HAEMOST, V4, P1944, DOI 10.1111/j.1538-7836.2006.02115.x; Hilt B, 2002, OCCUP ENVIRON MED, V59, P9, DOI 10.1136/oem.59.1.9; Hoffmann B, 2009, ENVIRON HEALTH PERSP, V117, P1302, DOI 10.1289/ehp.0800362; Johansson C, 2009, ATMOS ENVIRON, V43, P4843, DOI 10.1016/j.atmosenv.2008.09.015; Kappelmayer J, 2004, CLIN CHEM LAB MED, V42, P475, DOI 10.1515/CCLM.2004.082; Lee SL, 2006, CLIN EXP ALLERGY, V36, P1138, DOI 10.1111/j.1365-2222.2006.02555.x; Li Yanli, 2012, Reviews on Environmental Health, V27, P133, DOI 10.1515/reveh-2012-0012; Li Y, 2010, SCI TOTAL ENVIRON, V408, P1226, DOI 10.1016/j.scitotenv.2009.11.035; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Liu H, 2013, ATMOS ENVIRON, V76, P81, DOI 10.1016/j.atmosenv.2012.08.004; Lu WJ, 2016, COPD, V13, P203, DOI 10.3109/15412555.2015.1069807; Mancini GBJ, 2007, CHEST, V131, P950, DOI 10.1378/chest.06-2838; Mattoli S, 2001, ENVIRON HEALTH PERSP, V109, P553, DOI 10.2307/3454668; Mehta A J, 2012, Swiss Med Wkly, V142, pw13681, DOI 10.4414/smw.2012.13681; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Parker JD, 2008, EPIDEMIOLOGY, V19, P820, DOI 10.1097/EDE.0b013e3181883d5d; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Peel Jennifer L, 2010, Res Rep Health Eff Inst, P3; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; Rich DQ, 2015, ENVIRON HEALTH PERSP, V123, P880, DOI 10.1289/ehp.1408795; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Rudez G, 2009, ENVIRON HEALTH PERSP, V117, P995, DOI 10.1289/ehp.0800437; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Sullivan JH, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-3; Szalai AJ, 1999, CLIN CHEM LAB MED, V37, P265, DOI 10.1515/CCLM.1999.046; Teksam O, 2010, EUR J EMERG MED, V17, P192, DOI 10.1097/MEJ.0b013e328320ad48; van Eeden Stephan F, 2005, Proc Am Thorac Soc, V2, P61; Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076759; Zhang ZL, 2016, ENVIRON SCI POLLUT R, V23, P6631, DOI 10.1007/s11356-015-5871-y; Zhang ZL, 2014, ENVIRON SCI POLLUT R, V21, P4236, DOI 10.1007/s11356-013-2374-6	53	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0208687	10.1371/journal.pone.0208687	http://dx.doi.org/10.1371/journal.pone.0208687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893301	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900001
J	Kumar, G; Langa, J; Montes, I; Conklin, D; Kocour, M; Kohlmann, K; Estonba, A				Kumar, Girish; Langa, Jorge; Montes, Iratxe; Conklin, Darrell; Kocour, Martin; Kohlmann, Klaus; Estonba, Andone			A novel transcriptome-derived SNPs array for tench (Tinca tinca L.)	PLOS ONE			English	Article							CULTURED TENCH; POPULATION GENOMICS; READ ALIGNMENT; GROWTH; WILD; VARIABILITY; RESOURCES; SOFTWARE	Tench (Tinca tinca L.) has great economic potential due to its high rate of fecundity and long-life span. Population genetic studies based on allozymes, microsatellites, PCR-RFLP and sequence analysis of genes and DNA fragments have revealed the presence of Eastern and Western phylogroups. However, the lack of genomic resources for this species has complicated the development of genetic markers. In this study, the tench transcriptome and genome were sequenced by high-throughput sequencing. A total of 60,414 putative SNPs were identified in the tench transcriptome using a computational pipeline. A set of 96 SNPs was selected for validation and a total of 92 SNPs was validated, resulting in the highest conversion and validation rate for a non-model species obtained to date (95.83%). The validated SNPs were used to genotype 140 individuals belonging to two tench breeds (Tabor and Hungarian), showing low (F-ST = 0.0450) but significant (<0.0001) genetic differentiation between the two tench breeds. This implies that set of validated SNPs array can be used to distinguish the tench breeds and that it might be useful for studying a range of associations between DNA sequence and traits of importance. These genomic resources created for the tench will provide insight into population genetics, conservation fish stock management, and aquaculture.	[Kumar, Girish; Kocour, Martin] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Res Inst Fish Culture & Hydrobiol, Ceske Budejovice, Czech Republic; [Langa, Jorge; Montes, Iratxe; Estonba, Andone] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Bizkaia, Spain; [Conklin, Darrell] Univ Basque Country UPV EHU, Dept Comp Sci & Artificial Intelligence, San Sebastian, Gipuzkoa, Spain; [Conklin, Darrell] Ikerbasque, Basque Fdn Sci, Bilbao, Bizkaia, Spain; [Kohlmann, Klaus] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Aquaculture & Ecophysiol, Berlin, Germany	University of South Bohemia Ceske Budejovice; University of Basque Country; University of Basque Country; Basque Foundation for Science; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Kumar, G (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Res Inst Fish Culture & Hydrobiol, Ceske Budejovice, Czech Republic.	girishkumar.nio@gmail.com	Kocour, Martin/C-1239-2017; Kumar, Girish/G-4757-2015	Kocour, Martin/0000-0003-2984-1412; Langa, Jorge/0000-0001-5137-8204; Kumar, Girish/0000-0002-5229-9417; Estonba, Andone/0000-0003-2851-5201	project CENAKVA - Ministry of Education, Youth and Sports of the Czech Republic [CZ02.1.01/0.0/0.0/16_025/0007370]; project Reproductive and genetic approaches for fish biodiversity conservation and aquaculture - Ministry of Education, Youth and Sports of the Czech Republic [CZ02.1.01/0.0/0.0/16_025/0007370]; Genomic Resources Research Group from the Basque University System - Department of Education, Universities and Research of the Basque Government [IT558-10]; pre-doctoral program Education Department of the Basque Government	project CENAKVA - Ministry of Education, Youth and Sports of the Czech Republic; project Reproductive and genetic approaches for fish biodiversity conservation and aquaculture - Ministry of Education, Youth and Sports of the Czech Republic; Genomic Resources Research Group from the Basque University System - Department of Education, Universities and Research of the Basque Government; pre-doctoral program Education Department of the Basque Government	This research was supported by projects CENAKVA and Reproductive and genetic approaches for fish biodiversity conservation and aquaculture (CZ02.1.01/0.0/0.0/16_025/0007370) funded by Ministry of Education, Youth and Sports of the Czech Republic, and by the Genomic Resources Research Group from the Basque University System (IT558-10) funded by the Department of Education, Universities and Research of the Basque Government. JL is supported by the pre-doctoral program Education Department of the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez P, 2015, MOL ECOL RESOUR, V15, P1510, DOI 10.1111/1755-0998.12454; Arslan A, 2012, CARYOLOGIA, V65, P246, DOI 10.1080/00087114.2012.740194; Barrio AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12081; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bester-Van der Merwe A, 2013, INT J MOL SCI, V14, P19341, DOI 10.3390/ijms140919341; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chen WJ, 2009, MOL PHYLOGENET EVOL, V52, P544, DOI 10.1016/j.ympev.2009.01.006; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conklin D, 2013, PROCEEDINGS IWBBIO 2013: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, P127; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2017, GLOB AQ PROD 2017 AP; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flajshans M, 1999, AQUACULTURE, V173, P471, DOI 10.1016/S0044-8486(98)00477-3; Flajshans M, 2010, REV FISH BIOL FISHER, V20, P317, DOI 10.1007/s11160-009-9144-z; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Hess JE, 2013, MOL ECOL, V22, P2898, DOI 10.1111/mec.12150; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kocour M, 2014, J APPL ICHTHYOL, V30, P22, DOI 10.1111/jai.12428; Kocour M, 2011, AQUACULTURE, V310, P298, DOI 10.1016/j.aquaculture.2010.10.006; Kocour M, 2010, REV FISH BIOL FISHER, V20, P345, DOI 10.1007/s11160-009-9140-3; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kohlmann K, 2007, AQUACULTURE, V272, pS147, DOI 10.1016/j.aquaculture.2007.08.003; Kohlmann Klaus, 1998, Polskie Archiwum Hydrobiologii, V45, P303; Kohlmann K, 2010, REV FISH BIOL FISHER, V20, P279, DOI 10.1007/s11160-009-9138-x; Kumar G, 2014, AQUACULTURE EUROPE 1, V14; Kvasnicka P, 1998, J HERED, V89, P553, DOI 10.1093/jhered/89.6.553; Laconcha U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128247; Lajbner Z, 2011, MOL ECOL RESOUR, V11, P374, DOI 10.1111/j.1755-0998.2010.02914.x; Lajbner Z, 2011, EVOL APPL, V4, P545, DOI 10.1111/j.1752-4571.2010.00174.x; Lajbner Z, 2010, REV FISH BIOL FISHER, V20, P289, DOI 10.1007/s11160-009-9137-y; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li SJ, 2017, GENETICA, V145, P175, DOI 10.1007/s10709-017-9956-z; Liao ZW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01338-7; Linhart O, 2006, AQUACULT INT, V14, P61, DOI 10.1007/s10499-005-9014-1; Lo Presti R, 2014, J APPL ICHTHYOL, V30, P15, DOI 10.1111/jai.12423; Lo Presti R, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e19; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Montes I, 2016, MAR BIOL, V163; Montes I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070051; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Ogden R, 2011, MOL ECOL RESOUR, V11, P109, DOI 10.1111/j.1755-0998.2010.02954.x; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robledo D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12459-4; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Slechtova Vera, 1995, Polskie Archiwum Hydrobiologii, V42, P133; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Svobodova Z, 2004, VET MED-CZECH, V49, P19, DOI 10.17221/5671-VETMED; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Wang JX, 2006, AQUACULT INT, V14, P205, DOI 10.1007/s10499-005-9026-x; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Waterhouse Robert M, 2018, Mol Biol Evol, V35, P543, DOI 10.1093/molbev/msx319; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welcomme RL., 1988, FAO FISHERIES TECHNI; Wolnicki J, 2017, AQUAC RES, V48, P3809, DOI 10.1111/are.13207; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201	77	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213992	10.1371/journal.pone.0213992	http://dx.doi.org/10.1371/journal.pone.0213992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889192	Green Published, gold, Green Submitted			2022-12-26	WOS:000461573000041
J	He, Y; Campino, S; Benavente, ED; Warhurst, DC; Beshir, KB; Lubis, I; Gomes, AR; Feng, J; Wang, JZ; Sun, XD; Huang, F; Tang, LH; Sutherland, CJ; Clark, TG				He, Yan; Campino, Susana; Benavente, Ernest Diez; Warhurst, David C.; Beshir, Khalid B.; Lubis, Inke; Gomes, Ana Rita; Feng, Jun; Wang Jiazhi; Sun, Xiaodong; Huang, Fang; Tang, Lin-hua; Sutherland, Colin J.; Clark, Taane G.			Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area	PLOS ONE			English	Article							MALARIA; CLEARANCE; MUTATIONS; PFMDR1; PFCRT; POLYMORPHISMS	Background Malaria reduction and future elimination in China is made more difficult by the importation of cases from neighboring endemic countries, particularly Myanmar, Laos, and Vietnam, and increased travel to Africa by Chinese nationals. The increasing prevalence of artemisinin resistant parasites across Southeast Asia highlights the importance of monitoring the parasite importation into China. Artemisinin resistance in the Mekong region is associated with variants of genes encoding the K13 kelch domain protein (pf13k), found in specific genetic backgrounds, including certain alleles of genes encoding the chloroquine resistance transporter (pfcrt) and multidrug resistance transporter PgH1 (pfmdr1). Methods In this study we investigated the prevalence of drug resistance markers in 72 P. falciparum samples from uncomplicated malaria infections in Tengchong and Yingjiang, counties on the Yunnan-Myanmar border. Variants of pf13k, pfcrt and pfmdr1 are described. Results Almost all parasites harboured chloroquine-resistant alleles of pfcrt, whereas pfmdr1 was more diverse. Major mutations in the K13 propeller domain associated with artemisinin resistance in the Mekong region (C580Y, R539T and Y493H) were absent, but F446I and two previously undescribed mutations (V603E and V454I) were identified. Protein structural modelling was carried out in silico on each of these K13 variants, based on recently published crystal structures for the K13 propeller domain. Whereas F446I was predicted to elicit a moderate destabilisation of the propeller structure, the V603E substitution is likely to lead to relatively high protein instability. We plotted these stability estimates, and those for all previously described variants, against published values for in vivo parasitaemia half-life, and found that quadratic regression generates a useful predictive algorithm. Conclusion This study provides a baseline of P. falciparum resistance-associated mutations prevalent at the China-Myanmar border. We also show that protein modelling can be used to generate testable predictions as to the impact of pfk13 mutations on in vivo (and potentially in vitro) artemisinin susceptibility.	[He, Yan; Feng, Jun; Huang, Fang; Tang, Lin-hua] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China; [He, Yan; Feng, Jun; Huang, Fang; Tang, Lin-hua] Minist Hlth, Key Lab Parasite & Vector Biol, WHO Collaborating Ctr Malaria Schistosomiasis & F, Shanghai, Peoples R China; [Campino, Susana; Benavente, Ernest Diez; Warhurst, David C.; Beshir, Khalid B.; Lubis, Inke; Gomes, Ana Rita; Sutherland, Colin J.; Clark, Taane G.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Wang Jiazhi] Prov Collaborat Innovat Ctr Publ Hlth & Dis Preve, Prov Ctr Malaria Res, Yunnan Inst Parasit Dis, Prov Key Lab Vector Borne Dis Control & Res, Puer, Peoples R China; [Sun, Xiaodong] Tengchong Cty Ctr Dis Control & Prevent, Tengchong, Yunnan, Peoples R China; [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	He, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China.; He, Y (corresponding author), Minist Hlth, Key Lab Parasite & Vector Biol, WHO Collaborating Ctr Malaria Schistosomiasis & F, Shanghai, Peoples R China.; Clark, TG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.; Clark, TG (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	yanhe1012@nipd.chinacdc.cn; taane.clark@lshtm.ac.uk	warhurst, david c/C-3428-2013; Campino, Susana/AAM-2577-2020; Feng, Jun/AAY-2026-2021; Clark, Taane G./AAM-2570-2020; Huang, Fang/AAP-7194-2021; Sutherland, Colin/AAN-3939-2020	Campino, Susana/0000-0003-1403-6138; Clark, Taane G./0000-0001-8985-9265; Huang, Fang/0000-0003-1105-0874; Sutherland, Colin/0000-0003-1592-6407; Diez Benavente, Ernest/0000-0002-4313-4290; Gomes, Ana Rita/0000-0001-7684-8815; Lubis, Inke/0000-0001-7075-9491	Medical Research Council UK [MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103, MR/R025576/1, MR/R020973/1]; BBSRC [BB/R013063/1]; MRC UK [MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103, MR/R025576/1, MR/R020973/1]; Public Health England; Wellcome Trust Strategic Award [100217]; MRC [MR/R025576/1, MR/N010469/1, MR/R020973/1, MR/K000551/1, MR/M01360X/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health England; Wellcome Trust Strategic Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TGC is funded by the Medical Research Council UK (Grant no. MR/K000551/1, MR/M01360X/1, MR/N010469/1, MC_PC_15103, MR/R025576/1, and MR/R020973/1) and BBSRC (Grant no. BB/R013063/1). SC is funded by the MRC UK (Grant no. MR/K000551/1, MC_PC_15103, MR/M01360X/1, MR/R025576/1, and MR/R020973/1). CJS is supported by Public Health England and ARG was supported by the MRC UK (MR/N010469/1, MC_PC_15103). EDB is supported by a Wellcome Trust Strategic Award (Ref. 100217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WHO STAT REP ART ACT; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bonnington CA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2128-x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eastman RT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25379; Feng J, 2015, ANTIMICROB AGENTS CH, V59, P2554, DOI 10.1128/AAC.04843-14; Gomes AR, 2017, INT J PARASITOL-DRUG, V7, P174, DOI 10.1016/j.ijpddr.2017.03.001; Hawkes M, 2015, EMERG INFECT DIS, V21, P1237, DOI 10.3201/eid2107.150213; Henriques G, 2014, J INFECT DIS, V210, P2001, DOI 10.1093/infdis/jiu358; Huang F, 2015, J INFECT DIS, V212, P1629, DOI 10.1093/infdis/jiv249; Huang F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-243; Humphreys GS, 2007, ANTIMICROB AGENTS CH, V51, P991, DOI 10.1128/AAC.00875-06; Jiang DQ, 2015, 4ZGC CRYSTAL STRUCTU; Jiang DQ, 2015, 4YY8 CRYSTAL STRUCTU; Kamau E, 2015, J INFECT DIS, V211, P1352, DOI 10.1093/infdis/jiu608; Liu D Q, 1992, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V10, P241; Liu De-quan, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P27; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Muwanguzi J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1095-y; Myint MK, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1775-2; NAGEL RL, 1981, J CLIN INVEST, V68, P303, DOI 10.1172/JCI110248; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pandurangan A. P., 2017, NUCL ACIDS RES; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Preston MD, 2014, J INFECT DIS, V209, P1808, DOI 10.1093/infdis/jit812; Ravenhall M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1634-6; Ross LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05652-0; Samad H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005131; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P46; Sutherland CJ, 2007, J ANTIMICROB CHEMOTH, V59, P1197, DOI 10.1093/jac/dkm104; Sutherland CJ, 2009, ANTIMICROB AGENTS CH, V53, P3405, DOI 10.1128/AAC.00024-09; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Tumwebaze P, 2017, J INFECT DIS, V215, P631, DOI 10.1093/infdis/jiw614; Tun KM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1240-7; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Wang ZL, 2015, ANTIMICROB AGENTS CH, V59, P6952, DOI 10.1128/AAC.01255-15; Yang HL, 2008, ACTA TROP, V108, P44, DOI 10.1016/j.actatropica.2008.08.010	40	16	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213686	10.1371/journal.pone.0213686	http://dx.doi.org/10.1371/journal.pone.0213686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883571	Green Submitted, Green Published, gold			2022-12-26	WOS:000461423500025
J	Mimler, T; Nebert, C; Eichmair, E; Winter, B; Aschacher, T; Stelzmueller, ME; Andreas, M; Ehrlich, M; Laufer, G; Messner, B				Mimler, Teresa; Nebert, Clemens; Eichmair, Eva; Winter, Birgitta; Aschacher, Thomas; Stelzmueller, Marie-Elisabeth; Andreas, Martin; Ehrlich, Marek; Laufer, Guenther; Messner, Barbara			Extracellular matrix in ascending aortic aneurysms and dissections - What we learn from decellularization and scanning electron microscopy	PLOS ONE			English	Article							OXIDATIVE STRESS; COLLAGEN CONTENT; EXPRESSION; ELASTIN; VALVE; METALLOPROTEINASES; MEDIA; MICROARCHITECTURE; ASSOCIATION; INHIBITORS	Pathological impairment of elastic fiber and other extracellular matrix (ECM) components are described for the aortic media of ascending thoracic aortic aneurysms (aTAA) but the exact pathological impairment of the structure and its degree still needs further investigations. To evaluate the quantity and quality of elastic fiber sheets and other ECM structures (e.g. collagen), cells were removed from different types of aneurysmal tissues (tricuspid aortic valve [TAV] associated-, bicuspid aortic valve [BAV] associated-aneurysmal tissue and acute aortic dissections [AAD]) using 2.5% sodium hydroxide (NaOH) and compared to decellularized control aortic tissue. Likewise, native tissue has been analysed. To evaluate the 2D-(histological evaluation, fluorescence- and auto-fluorescence based staining methods) and the 3D structure (scanning electron microscopic [SEM] examination) of the medial layer we first analysed for a successful decellularization. After proving for successful decellularization, we quantified the amount of elastic fiber sheets, elastin and other ECM components including collagen. Aside from clearly visible focal elastic fiber loss in TAV-aTAA tissue, decellularization resulted in reduction of elastic fiber auto-fluorescence properties, which is perhaps an indication from a disease-related qualitative impairment of elastic fibers, visible only after contact with the alkaline solution. Likewise, the loss of collagen amount in BAV-aTAA and TAV-aTAA tissue (compared to non-decellularized tissue) after contact with NaOH indicates a prior disease-associated impairment of collagen. Although the amount of ECM was not changed in type A dissection tissue, detailed electron microscopic evaluation revealed changes in ECM quality, which worsened after contact with alkaline solution but were not visible after histological analyses. Apart from the improved observation of the samples using electron microscopy, contact of aneurysmal and dissected tissue with the alkaline decellularization solution revealed potential disease related changes in ECM quality which can partly be connected to already published data, but have to be proven by further studies.	[Mimler, Teresa; Nebert, Clemens; Eichmair, Eva; Winter, Birgitta; Messner, Barbara] Med Univ Vienna, Dept Surg, Cardiac Surg Res Lab, Vienna, Austria; [Aschacher, Thomas; Stelzmueller, Marie-Elisabeth; Andreas, Martin; Ehrlich, Marek; Laufer, Guenther] Med Univ Vienna, Dept Surg, Cardiac Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Messner, B (corresponding author), Med Univ Vienna, Dept Surg, Cardiac Surg Res Lab, Vienna, Austria.	barbara.messner@meduniwien.ac.at	EHRLICH, Marek/GQZ-8696-2022; Messner, Barbara/GLS-8150-2022	EHRLICH, Marek/0000-0002-1114-5788; Messner, Barbara/0000-0001-8331-6497; Mimler, Teresa/0000-0003-1963-8509; Andreas, Martin/0000-0003-4950-5432				APPLEBAUM A, 1976, ANN SURG, V183, P296, DOI 10.1097/00000658-197603000-00015; Arcucci A, 2014, EUR J HISTOCHEM, V58, P200, DOI 10.4081/ejh.2014.2383; Avolio A, 1998, HYPERTENSION, V32, P170, DOI 10.1161/01.HYP.32.1.170; Berillis P., 2013, OPEN CIRC VASC J, V6, P1; BERRYMAN MA, 1992, J HISTOCHEM CYTOCHEM, V40, P845, DOI 10.1177/40.6.1350287; Billaud M, 2017, J THORAC CARDIOV SUR, V154, P1756, DOI 10.1016/j.jtcvs.2017.05.065; Blunder S, 2012, ATHEROSCLEROSIS, V220, P355, DOI 10.1016/j.atherosclerosis.2011.11.035; Bode MK, 2000, J VASC SURG, V32, P1201, DOI 10.1067/mva.2000.109743; Borges LD, 2008, HUM PATHOL, V39, P437, DOI 10.1016/j.humpath.2007.08.003; Borges LF, 2010, HISTOPATHOLOGY, V57, P917, DOI 10.1111/j.1365-2559.2010.03719.x; Borges LF, 2014, J VASC RES, V51, P50, DOI 10.1159/000356296; Cardiovascular diseases (CVDs), 2021, CARDIOVASCULAR DIS C; CATTELL MA, 1993, CARDIOVASC RES, V27, P176, DOI 10.1093/cvr/27.2.176; CDC, AORT AN; Cheuk BLY, 2011, J VASC SURG, V53, P1071, DOI 10.1016/j.jvs.2010.11.035; Dingemans KP, 2000, ANAT REC, V258, P1; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; Grewal N, 2014, J THORAC CARDIOV SUR, V148, P1583, DOI 10.1016/j.jtcvs.2014.01.027; HEY CD, 1965, BIOCHIM BIOPHYS ACTA, V97, P364, DOI 10.1016/0304-4165(65)90109-1; Howard DPJ, 2014, ANN CARDIOTHORAC SUR, V3, P278, DOI 10.3978/j.issn.2225-319X.2014.05.14; Ikonomidis JS, 2007, J THORAC CARDIOV SUR, V133, P1028, DOI 10.1016/j.jtcvs.2006.10.083; Ishii T, 2000, HUM PATHOL, V31, P640, DOI 10.1053/hupa.2000.7642; Isselbacher EM, 2005, CIRCULATION, V111, P816, DOI 10.1161/01.CIR.0000154569.08857.7A; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108; LeMaire SA, 2005, J SURG RES, V123, P40, DOI 10.1016/j.jss.2004.06.007; Lindeman JHN, 2010, P NATL ACAD SCI USA, V107, P862, DOI 10.1073/pnas.0910312107; Losenno KL, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/145202; Melvinsdottir IH, 2016, EUR J CARDIO-THORAC, V50, P1111, DOI 10.1093/ejcts/ezw235; Meng YH, 2014, VASCULAR, V22, P20, DOI 10.1177/1708538112472282; Mohamed SA, 2012, SCI WORLD J, DOI 10.1100/2012/806261; Mordi I, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/196037; Murakami Y, 2014, INFECT IMMUN, V82, P4563, DOI 10.1128/IAI.02069-14; Nakashima Yutaka, 2010, Ann Vasc Dis, V3, P28, DOI 10.3400/avd.AVDsasvp10002; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Pasta S, 2012, J THORAC CARDIOV SUR, V143, P460, DOI 10.1016/j.jtcvs.2011.07.058; Phillippi JA, 2009, CIRCULATION, V119, P2498, DOI 10.1161/CIRCULATIONAHA.108.770776; Roberts WC, 2011, AM J CARDIOL, V108, P1639, DOI 10.1016/j.amjcard.2011.09.005; Saeyeldin AA, 2019, GEN THORAC CARDIOVAS, V67, P1, DOI 10.1007/s11748-017-0874-x; SARIOLA H, 1986, J CLIN PATHOL, V39, P1074, DOI 10.1136/jcp.39.10.1074; Schmid FX, 2003, EUR J CARDIO-THORAC, V23, P537, DOI 10.1016/S1010-7940(02)00833-3; Tang PCY, 2005, CIRCULATION, V112, P1098, DOI 10.1161/CIRCULATIONAHA.104.511717; Tsamis A, 2016, J THORAC CARDIOV SUR, V151, P1718, DOI 10.1016/j.jtcvs.2016.02.019; Tsamis A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1004; Tsarouhas K, 2010, THROMB RES, V126, P399, DOI 10.1016/j.thromres.2010.08.015; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; Vapnik JS, 2016, AM J CARDIOL, V117, P1683, DOI 10.1016/j.amjcard.2016.02.048; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; Wagsater D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000034; Wang XW, 2005, SURGERY, V138, P352, DOI 10.1016/j.surg.2005.06.006; Watanabe M, 1999, TOHOKU J EXP MED, V187, P291, DOI 10.1620/tjem.187.291; Wong LCY, 1996, CIRC RES, V78, P799, DOI 10.1161/01.RES.78.5.799; Yamashiro Y, 2018, J ATHEROSCLER THROMB, V25, P99, DOI 10.5551/jat.RV17015; Zhang XM, 2014, J SURG RES, V189, P348, DOI 10.1016/j.jss.2014.03.027	58	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213794	10.1371/journal.pone.0213794	http://dx.doi.org/10.1371/journal.pone.0213794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883576	Green Published, Green Submitted, gold			2022-12-26	WOS:000461423500030
J	Sugino, KY; Paneth, N; Comstock, SS				Sugino, Kameron Y.; Paneth, Nigel; Comstock, Sarah S.			Michigan cohorts to determine associations of maternal pre-pregnancy body mass index with pregnancy and infant gastrointestinal microbial communities: Late pregnancy and early infancy	PLOS ONE			English	Article							GUT MICROBIOTA; CHILDHOOD OVERWEIGHT; STORAGE-CONDITIONS; CESAREAN DELIVERY; OBESITY; WEIGHT; MODE; OLIGOSACCHARIDES; TRANSMISSION; DURATION	Background About 25% of women in the United States are obese prior to becoming pregnant. Although there is some knowledge about the relationship between the gastrointestinal microbiota and obesity, little is known about the relationship between pre-pregnancy obesity and the gastrointestinal microbiota in pregnancy or its impact on infant gut microbiota. However, the composition of the gut microbiota early in life may influence childhood health. Thus, the objective of this research was to identify associations between maternal pre-pregnancy obesity and the pregnancy (n = 39) or early infancy (n = 39) microbiotas. Results Fecal bacterial communities from overweight women had lower microbiota diversity (Chao1: p = 0.02; inverse Simpson: p = 0.05; Shannon: p = 0.02) than communities from normal weight or obese women. The within-group microbiota composition of overweight women differed from those of normal and obese women at the genus and phylum levels (p = 0.003 and p = 0.02, respectively). Pre-pregnancy overweight women had higher abundances of Bacteroides and lower Phascolarctobacterium than women who were normal weight or obese prior to becoming pregnant. Normal weight women had lower abundances of Acida-minococcus and Dialister than overweight and obese women. Infant community composition tended to differ in membership (Sorensen index) by maternal pre-pregnancy BMI category, and significantly differed by delivery mode and breastfeeding exclusivity (p = 0.06, p = 0.001, p = 0.008, respectively). Infants from normal weight women had lower abundances of Megasphaera than infants from overweight or obese women. Streptococcus was lowest in infants from overweight women, and Staphylococcus was lowest in infants from obese women. Conclusion Maternal and infant microbiotas are associated with and might be affected by maternal pre-pregnancy BMI. Future work should determine if there are also functional differences in the infant microbiome, if those functional differences are related to maternal pre-pregnancy BMI, and whether differences in composition or traits persist over time.	[Sugino, Kameron Y.; Comstock, Sarah S.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Dept Pediat & Human Dev, Coll Human Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Comstock, SS (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	comsto37@msu.edu			Michigan State University Department of Food Science and Human Nutrition; Michigan State AgBioResearch; National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) Program (Prenatal Exposures and Child Health Outcomes: A Statewide Study) [UG3 OD023285]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023285] Funding Source: NIH RePORTER	Michigan State University Department of Food Science and Human Nutrition; Michigan State AgBioResearch; National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) Program (Prenatal Exposures and Child Health Outcomes: A Statewide Study); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Kameron Sugino was supported by a research assistantship from the Michigan State University Department of Food Science and Human Nutrition. This research was financially supported by funds provided to SSC by Michigan State AgBioResearch and by funds provided to NP by the National Institutes of Health Environmental Influences on Child Health Outcomes (ECHO) Program (Prenatal Exposures and Child Health Outcomes: A Statewide Study (UG3 OD023285)).	Aatsinki AK, 2018, J WOMENS HEALTH, V27, P1293, DOI 10.1089/jwh.2017.6488; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; [Anonymous], 2021, LANG ENV STAT COMP; Asnicar F, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00164-16; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Bider-Canfield Z, 2017, PEDIATR OBES, V12, P171, DOI 10.1111/ijpo.12125; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Bonuck KA, 2005, PEDIATRICS, V116, P1413, DOI 10.1542/peds.2005-0435; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duranti S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0282-6; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Fitzstevens JL, 2017, NUTR CLIN PRACT, V32, P354, DOI 10.1177/0884533616670150; Gohir W, 2015, GUT MICROBES, V6, P310, DOI 10.1080/19490976.2015.1086056; Gomez-Arango LF, 2016, DIABETES, V65, P2214, DOI 10.2337/db16-0278; Gonzalez-Jimenez E, 2015, EUR J NUTR, V54, P589, DOI 10.1007/s00394-014-0740-x; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Gough EK, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0089-2; Hill CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0213-y; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koleva PT, 2015, NUTRIENTS, V7, P2237, DOI 10.3390/nu7042237; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lobstein T, 2015, LANCET, V385, P2510, DOI 10.1016/S0140-6736(14)61746-3; Luo JH, 2019, PUBLIC HEALTH NUTR, V22, P1019, DOI 10.1017/S1368980018003002; Lynch CM, 2008, AM J PERINAT, V25, P163, DOI 10.1055/s-2008-1061496; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Miller GE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148952; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; Mueller NT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23133; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Nagpal R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01388; O'Sullivan EJ, 2015, J NUTR, V145, P2369, DOI 10.3945/jn.115.214619; Oksanen J, 2017, R PACKAGE VERSION 24; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Papathoma E, 2016, PEDIAT ALLERG IMM-UK, V27, P419, DOI 10.1111/pai.12552; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shin D, 2014, MATERN CHILD HLTH J, V18, P1667, DOI 10.1007/s10995-013-1407-6; Simeoni U, 2016, ENVIRON MICROBIOL, V18, P2185, DOI 10.1111/1462-2920.13144; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Stanislawski MA, 2018, MBIO, V9, DOI [10.1128/mBio.01751-18, 10.1128/mbio.01751-18]; Stanislawski MA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0332-0; Stephenson J, 2018, LANCET, V391, P1774, DOI 10.1016/S0140-6736(18)30979-6; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Thompson AL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00003; Tun HM, 2018, JAMA PEDIATR, V172, P368, DOI 10.1001/jamapediatrics.2017.5535; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Yang I, 2016, NURS RES, V65, P76, DOI 10.1097/NNR.0000000000000133; Yun Y, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1052-0	70	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213733	10.1371/journal.pone.0213733	http://dx.doi.org/10.1371/journal.pone.0213733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883572	Green Submitted, Green Published, gold			2022-12-26	WOS:000461423500027
J	Capulli, M; Costantini, R; Sonntag, S; Maurizi, A; Paganini, C; Monti, L; Forlino, A; Shmerling, D; Teti, A; Rossi, A				Capulli, Mattia; Costantini, Rossella; Sonntag, Stephan; Maurizi, Antonio; Paganini, Chiara; Monti, Luca; Forlino, Antonella; Shmerling, Doron; Teti, Anna; Rossi, Antonio			Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; SKELETAL PHENOTYPE; MOUSE; MUTATIONS; MODELS; GENOME; CHONDRODYSPLASIA; DISEASE; RODENTS	The Cre-mediated genetic switch combines the ability of Cre recombinase to stably invert or excise a DNA fragment depending upon the orientation of flanking mutant loxP sites. In this work, we have tested this strategy in vivo with the aim to generate two conditional knock-in mice for missense mutations in the Impad1 and Clon7 genes causing two different skeletal dysplasias. Targeting constructs were generated in which the Impad1 exon 2 and an inverted exon 2* and the Clcn7 exon 7 and an inverted exon 7* containing the point mutations were flanked by mutant loxP sites in a head-to-head orientation. When the Cre recombinase is present, the DNA flanked by the mutant loxP sites is expected to be stably inverted leading to the activation of the mutated exon. The targeting vectors were used to generate heterozygous floxed mice in which inversion of the wild-type with the mutant exon has not occurred yet. To generate knock-in mice, floxed animals were mated to a global Cre-deleter mouse strain for stable inversion and activation of the mutation. Unexpectedly the phenotype of homozygous Impad1 knock-in animals overlaps with the lethal phenotype described previously in Impad1 knock-out mice. Similarly, the phenotype of homozygous Clcn7 floxed mice overlaps with Clon7 knock-out mice. Expression studies by qPCR and RT-PCR demonstrated that mutant mRNA underwent abnormal splicing leading to the synthesis of non-functional proteins. Thus, the skeletal phenotypes in both murine strains were not caused by the missense mutations, but by aberrant splicing. Our data demonstrate that the Cre mediated genetic switch strategy should be considered cautiously for the generation of conditional knock-in mice.	[Capulli, Mattia; Maurizi, Antonio; Teti, Anna] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Costantini, Rossella; Paganini, Chiara; Monti, Luca; Forlino, Antonella; Rossi, Antonio] Univ Pavia, Dept Mol Med, Biochem Unit, Pavia, Italy; [Sonntag, Stephan; Shmerling, Doron] PolyGene AG, Rumlang, Switzerland; [Sonntag, Stephan] Swiss Fed Inst Technol, ETH Phen Ctr EPIC, Zurich, Switzerland; [Paganini, Chiara] Scuola Univ Super IUSS, Pavia, Italy	University of L'Aquila; University of Pavia; Swiss Federal Institutes of Technology Domain; ETH Zurich; IUSS PAVIA	Rossi, A (corresponding author), Univ Pavia, Dept Mol Med, Biochem Unit, Pavia, Italy.	antrossi@unipv.it	Maurizi, Antonio/AAI-7728-2020; Paganini, Chiara/AAB-5170-2022	Paganini, Chiara/0000-0003-1709-6339; Maurizi, Antonio/0000-0002-7027-4694; Teti, Anna Maria/0000-0002-5887-4419; Rossi, Antonio/0000-0002-2460-8761	European Community [602300]; Fondazione Telethon, Italy [GEP15062, GGP14014]; MIUR "Dipartimenti di Eccellenza"; MIUR "Progetti di ricerca di rilevante interesse nazionale" [PRIN 2015F3JHMB]; "Fondo di finanziamento per le attivita base di ricerca" (FFABR)	European Community(European Commission); Fondazione Telethon, Italy(Fondazione Telethon); MIUR "Dipartimenti di Eccellenza"; MIUR "Progetti di ricerca di rilevante interesse nazionale"(Ministry of Education, Universities and Research (MIUR)); "Fondo di finanziamento per le attivita base di ricerca" (FFABR)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement n. 602300 (SYBIL) (to DS, AF, AT and AR), Fondazione Telethon, Italy (grant n. GEP15062 to AR and GGP14014 to AT), MIUR "Dipartimenti di Eccellenza 2018-2022" (to AF and AR), MIUR "Progetti di ricerca di rilevante interesse nazionale" (PRIN 2015F3JHMB to AT and AR) and "Fondo di finanziamento per le attivita base di ricerca" (FFABR to MC). Animal model development at PolyGene AG was performed as a directly funded, nonprofit activity aimed at delivering animal models to partner groups in the European SYBILconsortium. No financial profit except funded remuneration for the works performed was generated, and no intellectual property was obtained. The SYBIL Grant Agreement retains no rights for animal models to PolyGene AG. The funders provided support in the form of salaries for authors SS, CP and LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alam I, 2014, BONE, V59, P66, DOI 10.1016/j.bone.2013.10.021; Araki K, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-29; Birling MC, 2017, MAMM GENOME, V28, P291, DOI 10.1007/s00335-017-9703-x; Bockamp E, 2002, PHYSIOL GENOMICS, V11, P115, DOI 10.1152/physiolgenomics.00067.2002; Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Capulli M, 2015, MOL THER-NUCL ACIDS, V4, P1, DOI 10.1038/mtna.2015.21; de Andrea CE, 2011, J PATHOL, V224, P160, DOI 10.1002/path.2886; Fiedler IAK, 2018, J BONE MINER RES, V33, P1489, DOI 10.1002/jbmr.3445; Forlino A, 2005, HUM MOL GENET, V14, P859, DOI 10.1093/hmg/ddi079; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Garofalo S, 2000, METH MOL B, V137, P491; Gioia R, 2017, HUM MOL GENET, V26, P2897, DOI 10.1093/hmg/ddx171; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Krakow D, 2015, CLIN PERINATOL, V42, P301, DOI 10.1016/j.clp.2015.03.003; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Monti L, 2015, HUM MOL GENET, V24, P5570, DOI 10.1093/hmg/ddv289; Neben CL, 2016, HUM MOL GENET, V25, pR86, DOI 10.1093/hmg/ddw171; Schnutgen F, 2007, TRANSGENIC RES, V16, P405, DOI 10.1007/s11248-007-9089-8; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Sohaskey ML, 2008, DEVELOPMENT, V135, P2215, DOI 10.1242/dev.019950; Vissers LELM, 2011, AM J HUM GENET, V88, P608, DOI 10.1016/j.ajhg.2011.04.002; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Zhang ZW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf089	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213660	10.1371/journal.pone.0213660	http://dx.doi.org/10.1371/journal.pone.0213660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865697	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900080
J	Hori, H; Orita, M; Taira, Y; Kudo, T; Takamura, N				Hori, Hiroko; Orita, Makiko; Taira, Yasuyuki; Kudo, Takashi; Takamura, Noboru			Risk perceptions regarding radiation exposure among Japanese schoolteachers living around the Sendai Nuclear Power Plant after the Fukushima accident	PLOS ONE			English	Article								In response to the Fukushima Daiichi nuclear power plant disaster, the Nuclear Regulation Authority of Japan issued the new "Nuclear Emergency Response Guideline." However, there is a perception that scientific information about the health impact of radiation exposure has not been adequately shared among the local government staffs, including schoolteachers. We contacted schoolteachers at all 120 schools within the Urgent Protective Action Planning Zone of the Sendai Nuclear Power Plant, Kagoshima prefecture, in 2017. We invited them to take part in a written survey to clarify their concerns and risk perceptions regarding the effects of radiation exposure on health. Five hundred and fifty schoolteachers' replies were included in the analysis. The results revealed that 355 schoolteachers had concerns about the health effects of radiation exposure due to working within the Urgent Protective Action Planning Zone. A logistic regression analysis revealed that sex (OR = 2.26, 95% CI: 1.49-3.45, p < 0.001), age (OR = 3.39, 95% CI: 2.10-5.47, p < 0.001), reluctance to undergo a radiological examination at a hospital (OR = 1.91, 95% CI: 1.23-2.88, p = 0.004), place of work (OR = 2.18, 95% CI: 1.46-3.27, p < 0.001), and anxiety about having to address questions about radiation from students (OR = 4.66, 95% CI: 2.83-7.67, p < 0.001) were independently associated with schoolteachers' concerns about the health effects of radiation exposure due to working in the area around the nuclear power plant. Therefore, it is important to respond to these concerns in order to establish a meaningful education program for school children on radiation and its health effects.	[Hori, Hiroko; Orita, Makiko; Taira, Yasuyuki; Takamura, Noboru] Nagasaki Univ, Dept Global Hlth Med & Welf, Grad Sch Biomed Sci, Nagasaki, Japan; [Kudo, Takashi] Nagasaki Univ, Dept Radioisotope Med, Atom Bomb Dis Inst, Nagasaki, Japan	Nagasaki University; Nagasaki University	Orita, M (corresponding author), Nagasaki Univ, Dept Global Hlth Med & Welf, Grad Sch Biomed Sci, Nagasaki, Japan.	orita@nagasaki-u.ac.jp		Takamura, Noboru/0000-0002-5552-3234				[Anonymous], 2006, CHERN FOR 2003 2005; Cardis E, 2011, CLIN ONCOL-UK, V23, P251, DOI 10.1016/j.clon.2011.01.510; Fujimura MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188906; Fukushima Prefecture, FUK HLTH SURV MENT H; Furuta M, 1999, P INT S RAD ED; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Hasegawa A, 2015, LANCET, V386, P479, DOI 10.1016/S0140-6736(15)61106-0; Havenaar JM, 2016, WORLD PSYCHIATRY, V15, P181, DOI 10.1002/wps.20335; International Atomic Energy Agency, 2015, FUK DAIICH ACC REP I; Ministry of Education, JAP MOD ED SYST; Ministry of Education Culture Sports Science and Technology Japan, MIDDL SCH CURR; Murakami M, 2018, J RADIOL PROT, V38, P1428, DOI 10.1088/1361-6498/aae65d; Murakami M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188758; Murakami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165594; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Neumann S, 2013, RES SCI EDUC, V43, P1535, DOI 10.1007/s11165-012-9320-3; Nuclear Regulation Authority, NUCL EM RESP GUID; Ohtsuru A, 2015, LANCET, V386, P489, DOI 10.1016/S0140-6736(15)60994-1; Orita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129227; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Sato N, 2018, J RADIAT RES, V59, P526, DOI 10.1093/jrr/rry037; Sato Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122389; Sawano T, 2018, J RADIAT RES, V59, P381, DOI 10.1093/jrr/rry025; Suzuki Y, 2015, B WORLD HEALTH ORGAN, V93, P598, DOI 10.2471/BLT.14.146498; Takeda K, 2016, BMJ OPEN, V6, DOI [10.1136/bmjopen-2016-011930, DOI 10.1136/BMJOPEN-2016-011930]; Tomisawa T., 2013, RAD EMERGENCY MED, V2, P56; Tsuzuki T, 2017, RAD BIOL RES COMMUNI, V52, P129; United Nations Scientific Committee on the Effects of Atomic Radiation, 2013, SOURC EFF RISKS ION, VI; World Health Organization, 2013, GLOB REP FUK NUCL AC; Yamaguchi T, 2018, J RADIAT RES, V59, P240, DOI 10.1093/jrr/rrx082	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212917	10.1371/journal.pone.0212917	http://dx.doi.org/10.1371/journal.pone.0212917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865690	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900049
J	Little, NS; Elkins, BH; Mullen, RM; Perera, OP; Parys, KA; Allen, KC; Boykin, DL				Little, Nathan S.; Elkins, Blake H.; Mullen, R. Michelle; Perera, Omaththage P.; Parys, Katherine A.; Allen, K. Clint; Boykin, Deborah L.			Differences between two populations of bollworm, Helicoverpa zea (Lepidoptera: Noctuidae), with variable measurements of laboratory susceptibilities to Bt toxins exposed to non-Bt and Bt cottons in large field cages	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; EXPRESSING ONE; CRY1AC; VARIABILITY; PROTEINS; SURVIVAL; ARMIGERA; EFFICACY	Interpreting variable laboratory measurements of Helicoverpa zea Boddie susceptibility to toxins from Bacillus thuringiensis Berliner (Bt) has been challenging due to a lack of clear evidence to document declining field control. Research that links laboratory measurements of susceptibility to survival on Bt crops is vital for accurate characterization and any subsequent response to the occurrence of an implied H. zea resistance event. In this study, H. zea survival and the resultant damage to plant fruiting structures of non-Bt, Bollgard II, and Bollgard III cottons from two insect colonies with differing levels of laboratory susceptibility to Bt toxins were evaluated in large field cages. Laboratory bioassays revealed resistance ratios of 2.04 and 622.14 between the two H. zea colonies for Dipel DF and Cry1Ac, respectively. Differences between the two H. zea colonies measured via bioassays with Bollgard II and Bollgard III cotton leaf tissue in the laboratory were not statistically discernable. However, there was 17.6% and 5.3% lower larval mortality in Bollgard II and Bollgard III for the feral relative to the laboratory colony of H. zea, respectively. Although H. zea larval numbers in cages infested with the laboratory susceptible colony did not differ between the two Bt cottons, there were fewer larvae per 25 plants in Bollgard III than in Bollgard II cotton in cages containing tolerant insects. Cages infested with tolerant H. zea moths had higher numbers of total larvae than those containing the laboratory susceptible colony in both Bollgard II and Bollgard III cottons. Bollgard II and Bollgard III cottons received 77.4% and 82.7% more total damage to total plant fruiting structures in cages infested with tolerant insects relative to those containing the laboratory susceptible colony. The damage inflicted to fruiting structures on Bollgard III cotton by a feral H. zea colony with decreased measurements of laboratory susceptibility to Dipel DF and Cry1Ac indicate that the addition of Vip3A to third generation Bt cottons may not provide sufficient control in situations where infestations levels are high.	[Little, Nathan S.; Elkins, Blake H.; Mullen, R. Michelle; Perera, Omaththage P.; Parys, Katherine A.; Allen, K. Clint] USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA; [Boykin, Deborah L.] USDA ARS, Jamie Whitten Delta States Res Ctr, Stoneville, MS 38776 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Little, NS (corresponding author), USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA.	nathan.little@ars.usda.gov	Parys, Katherine/AAA-1728-2019	Parys, Katherine/0000-0001-7459-3687; Perera, Omaththage/0000-0002-0643-0066; Little, Nathan/0000-0003-1105-3733				Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adamczyk J, 2004, J COTTON SCI, V8, P433; Adamczyk JJ, 2008, FLA ENTOMOL, V91, P570; Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Ali M. I., 2007, P 2007 BELTW COTT C; Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; Anilkumar KJ, 2008, APPL ENVIRON MICROB, V74, P462, DOI 10.1128/AEM.01612-07; Bacheler J, 1997, BELTW COTT C US; Blanco CA, 2009, J ECON ENTOMOL, V102, P1599, DOI 10.1603/029.102.0426; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Burd AD, 2003, J ECON ENTOMOL, V96, P137, DOI 10.1603/0022-0493-96.1.137; Burkness Eric C, 2010, GM Crops, V1, P337, DOI 10.4161/gmcr.1.5.14765; Cook D editor, 2017, 2018 BELTW COTT C SA; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Dulmage HT, 1976, BIOASSAY BACILLUS TH; ELSTON RC, 1969, AM STAT, V23, P26, DOI 10.2307/2681688; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Fitt G, 1998, 6 AUSTR ENT C BRISB; Fleming D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200131; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gore J, 2001, J ECON ENTOMOL, V94, P1445, DOI 10.1603/0022-0493-94.6.1445; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; GREENPLATE JT, 1998, P 1998 BELTW COTT C, P1030; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Hardee DD, 2001, BT COTTON MANAGEMENT; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Jackson RE, 2008, ENTOMOL EXP APPL, V126, P89, DOI 10.1111/j.1570-7458.2007.00653.x; Jackson RE, 2006, J ECON ENTOMOL, V99, P1790, DOI 10.1603/0022-0493-99.5.1790; Jackson RE, 2004, J ENTOMOL SCI, V39, P46, DOI 10.18474/0749-8004-39.1.46; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Layton M, 1997, 1997 P BELTW COTT C, V2; Little NS, 2017, SOUTHWEST ENTOMOL, V42, P953, DOI 10.3958/059.042.0414; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Luttrell R, 2007, P 2007 BELTW COTT C; Luttrell Randall G, 2012, GM Crops Food, V3, P213, DOI 10.4161/gmcr.20742; Luttrell RG, 1999, J ECON ENTOMOL, V92, P21, DOI 10.1093/jee/92.1.21; MACINTOSH SC, 1990, J INVERTEBR PATHOL, V56, P258, DOI 10.1016/0022-2011(90)90109-J; Mahon R., 2002, AUST COTTON GROWER, V22, P18; Matten Sharlene R., 2003, Journal of New Seeds, V5, P137, DOI 10.1300/J153v05n02_04; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Onstad D. W., 2008, INSECT RESISTANCE MA; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Reisig DD, 2018, J ECON ENTOMOL, V111, P1824, DOI 10.1093/jee/toy106; ROBERTSON J.L., 2017, BIOASSAYS ARTHROPODS, V3rd; ROSENHEIM JA, 1989, J ECON ENTOMOL, V82, P331, DOI 10.1093/jee/82.2.331; SAS- Institute, 2013, SAS SOFTW V9 3; Sivasupramaniam S, 2014, J ECON ENTOMOL, V101, P546, DOI DOI 10.1093/JEE/101.2.546; Smith RH, 1997, BELTW COTT C US, V2, P856; Stewart SD, 2001, J ECON ENTOMOL, V94, P752, DOI 10.1603/0022-0493-94.3.752; STONE TB, 1993, J ECON ENTOMOL, V86, P989, DOI 10.1093/jee/86.4.989; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P1074, DOI 10.1038/nbt1008-1074; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Wan P, 2005, J ECON ENTOMOL, V98, P195, DOI 10.1603/0022-0493-98.1.195; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Williams M. R., 2017, P BELTW COTT C NAT C, P710; Williams MR, 2016, BELTW COTT C NEW ORL	61	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212567	10.1371/journal.pone.0212567	http://dx.doi.org/10.1371/journal.pone.0212567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865645	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900026
J	Saeed, Z; Naveed, M; Imran, M; Bashir, MA; Sattar, A; Mustafa, A; Hussain, A; Xu, MG				Saeed, Zahra; Naveed, Muhammad; Imran, Muhammad; Bashir, Muhammad Asaad; Sattar, Annum; Mustafa, Adnan; Hussain, Azhar; Xu, Minggang			Combined use of Enterobacter sp. MN17 and zeolite reverts the adverse effects of cadmium on growth, physiology and antioxidant activity of Brassica napus	PLOS ONE			English	Article							BURKHOLDERIA-PHYTOFIRMANS PSJN; PLANT-GROWTH; ASSISTED PHYTOEXTRACTION; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; WHEAT SEEDLINGS; SOIL; STRESS; ACCUMULATION; TOLERANCE	The objective of the study was to evaluate role of zeolite and Enterobacter sp. MN17 on Cd uptake, growth, physiological and biochemical responses of Brassica napus on Cd-contaminated soil. A sandy clay loam soil in plastic pots was spiked with Cd (0 and 80 mg kg(-1)) and amended with zeolite (0 and 10 g kg(-1)). Seeds of B. napus were inoculated with Enterobactersp. MN17. Both inoculated and non-inoculated seeds of B. napus were sown and plants were harvested after 60 days of growth and data were collected. Although sole application of zeolite and seed inoculation reverted adverse effects of Cd in B. napus plants, the combined use resulted in even higher growth and physiological responses compared to control plants. The combined use under Cd stress increased plant height, root length, dry biomass of shoot and root up to 32%, 57%, 42% and 64%, respectively compared to control. The different physiological attributes (photosynthetic rate, chlorophyll content, transpiration rate, stomatal conductance) of B. napus were improved from 6% to 137%. Moreover, combined use of zeolite and seed inoculation on Cd-contaminated soil reduced the stress to plants as antioxidant activities decreased up to 25-64%, however enzyme activities were still higher than plants grown on normal soil. Root and shoot analysis of B. napus for Cd content depicted that zeolite and bacterium decreased Cd uptake from soil. It is concluded that combined use of zeolite and strain MN17 reduces Cd uptake from soil and improves physiological and biochemical responses of B. napus which is helpful to alleviate Cd toxicity to plants.	[Saeed, Zahra; Naveed, Muhammad; Bashir, Muhammad Asaad] Univ Agr Faisalabad, Inst Soil & Environm Sci, Faisalabad, Pakistan; [Imran, Muhammad] Nucl Inst Agr & Biol, Soil & Environm Sci Div, Faisalabad, Pakistan; [Sattar, Annum] Soil & Water Testing Lab, Sheikhupura, Pakistan; [Mustafa, Adnan; Xu, Minggang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China; [Hussain, Azhar] Islamia Univ Bahawalpur, Univ Coll Agr & Environm Sci, Dept Soil Sci, Bahawalpur, Pakistan	University of Agriculture Faisalabad; Nuclear Institute for Agriculture & Biology - Pakistan; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Islamia University of Bahawalpur	Naveed, M (corresponding author), Univ Agr Faisalabad, Inst Soil & Environm Sci, Faisalabad, Pakistan.; Xu, MG (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China.	Muhammad.naveed@uaf.edu.pk; mgxu@caas.ac.cn	Naveed, Muhammad/AAE-6816-2019; Mustafa, Adnan/AAR-9332-2020	Mustafa, Adnan/0000-0003-2741-9672; Xu, Minggang/0000-0002-7308-0633				Ahmad I, 2014, ENVIRON SCI POLLUT R, V21, P11054, DOI 10.1007/s11356-014-3010-9; Akesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110; Ali B, 2014, BIOL PLANTARUM, V58, P131, DOI 10.1007/s10535-013-0358-5; Alkorta I., 2004, Reviews in Environmental Science and Bio/Technology, V3, P71, DOI 10.1023/B:RESB.0000040059.70899.3d; [Anonymous], 1993, SOIL SAMPLING METHOD, DOI DOI 10.1016/B978-0-12-415955-6.00001-3; Ashraf M, 2004, BIOL FERT SOILS, V40, P157, DOI 10.1007/s00374-004-0766-y; Baig KS, 2014, SOIL ENVRON, V33, P159; BHUVANESWARI TV, 1980, PLANT PHYSIOL, V66, P1027, DOI 10.1104/pp.66.6.1027; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Chen LA, 2010, APPL SOIL ECOL, V46, P383, DOI 10.1016/j.apsoil.2010.10.003; De Smedt C, 2015, ADSORPT SCI TECHNOL, V33, P457, DOI 10.1260/0263-6174.33.5.457; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Dermont G, 2008, J HAZARD MATER, V152, P1, DOI 10.1016/j.jhazmat.2007.10.043; Du RY, 2016, J BIOREMED BIODEG, V7, P1; Ehsan S, 2014, ECOTOX ENVIRON SAFE, V106, P164, DOI 10.1016/j.ecoenv.2014.03.007; Eshghi S., 2010, Journal of Biological & Environmental Sciences, V4, P43; Evangelou MWH, 2007, CHEMOSPHERE, V68, P989, DOI 10.1016/j.chemosphere.2007.01.062; GEE GW, 1979, SOIL SCI SOC AM J, V43, P1004, DOI 10.2136/sssaj1979.03615995004300050038x; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Guo JK, 2014, PLANT SOIL, V375, P205, DOI 10.1007/s11104-013-1952-1; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hasanuzzaman M, 2017, FRONT PLANT SCI, P8, DOI [10.3389/fpls.2017.00008, DOI 10.3389/FPLS.2017.00008]; HIROKI M, 1992, SOIL SCI PLANT NUTR, V38, P141, DOI 10.1080/00380768.1992.10416961; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Lawrence RA, 2012, BIOCHEM BIOPH RES CO, V425, P952; Li SL, 2015, INT J PHYTOREMEDIAT, V17, P85, DOI 10.1080/15226514.2013.828020; Lin RZ, 2007, CHEMOSPHERE, V69, P89, DOI 10.1016/j.chemosphere.2007.04.041; Liu YZ, 2013, APPL GEOCHEM, V37, P149, DOI 10.1016/j.apgeochem.2013.07.022; Luo SL, 2011, APPL MICROBIOL BIOT, V89, P1637, DOI 10.1007/s00253-010-2927-2; Lutts S, 1996, PLANT GROWTH REGUL, V19, P207, DOI 10.1007/BF00037793; Madhaiyan M, 2007, CHEMOSPHERE, V69, P220, DOI 10.1016/j.chemosphere.2007.04.017; Maqbool Z, 2016, ENVIRON SCI POLLUT R, V23, P11224, DOI 10.1007/s11356-016-6275-3; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; McLaughlin MJ, 1999, CADMIUM SOILS PLANTS, P1; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; MILES LJ, 1979, PLANT SOIL, V51, P59, DOI 10.1007/BF02205927; Mohamed AA, 2012, PLANT PHYSIOL BIOCH, V57, P15, DOI 10.1016/j.plaphy.2012.05.002; Mollaei R, 2016, J WATER SOIL SCI, V20, P15; MOODIE CD, 1951, SOIL SCI, V71, P51, DOI 10.1097/00010694-195101000-00006; Nafees M, 2018, ENVIRON SCI POLLUT R, V25, P6387, DOI 10.1007/s11356-017-0924-z; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Naveed M, 2014, ENVIRON EXP BOT, V97, P30, DOI 10.1016/j.envexpbot.2013.09.014; Nissen LR, 2000, CHEMOSPHERE, V41, P265, DOI 10.1016/S0045-6535(99)00420-8; Nouairi I, 2006, PLANT SCI, V170, P511, DOI 10.1016/j.plantsci.2005.10.003; Nozari R, 2012, RES CROP, V13, P920; Obata H, 1997, J PLANT NUTR, V20, P97, DOI 10.1080/01904169709365236; Ojuederie OB, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121504; Oste LA, 2002, J ENVIRON QUAL, V31, P813, DOI 10.2134/jeq2002.0813; Panayotova M, 2000, J ENVIRON SCI HEAL A, V35, P1591, DOI 10.1080/10934520009377057; Prapagdee B, 2013, CHEMOSPHERE, V92, P659, DOI 10.1016/j.chemosphere.2013.01.082; Quartacci MF, 2005, CHEMOSPHERE, V59, P1249, DOI 10.1016/j.chemosphere.2004.11.053; Rahoui S, 2010, J HAZARD MATER, V178, P1128, DOI 10.1016/j.jhazmat.2010.01.115; Rajkumar M, 2012, BIOTECHNOL ADV, V30, P1562, DOI 10.1016/j.biotechadv.2012.04.011; Richards L.A., 1954, AGR HDB, P60; Rosenfeld CE, 2018, SCI TOTAL ENVIRON, V616, P279, DOI 10.1016/j.scitotenv.2017.11.016; ROTH EF, 1984, ANAL BIOCHEM, V137, P50, DOI 10.1016/0003-2697(84)90344-0; Sheng XF, 2006, CHEMOSPHERE, V64, P1036, DOI 10.1016/j.chemosphere.2006.01.051; SHEORAN IS, 1990, PHOTOSYNTH RES, V23, P345, DOI 10.1007/BF00034865; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Steel R.G.D., 1997, PRINCIPLES PROCEDURE, P204; Taamneh Y, 2017, APPL WATER SCI, V7, P2021, DOI 10.1007/s13201-016-0382-7; Vig K, 2003, ADV ENVIRON RES, V8, P121, DOI 10.1016/S1093-0191(02)00135-1; WAGNER GJ, 1993, ADV AGRON, V51, P173, DOI 10.1016/S0065-2113(08)60593-3; Wahab, 2017, ADV AGRI, V2017, P7, DOI [10.1155/2017/123683, DOI 10.1155/2017/123683]; Ward OP, 2004, SOIL BIOL, V1, P1; WATANABE F. S., 1965, SOIL SCI SOC AMER PROC, V29, P677; Wu G, 2010, J HAZARD MATER, V174, P1, DOI 10.1016/j.jhazmat.2009.09.113; Yang AZ, 2016, FUNCT PLANT BIOL, V43, P632, DOI 10.1071/FP15265; Yang Y, 2009, J ENVIRON MANAGE, V90, P1117, DOI 10.1016/j.jenvman.2008.05.004; Yao ZT, 2012, PROCEDIA ENVIRON SCI, V16, P722, DOI 10.1016/j.proenv.2012.10.099; [周东美 Zhou Dongmei], 2004, [生态环境, Ecology and Environment], V13, P234	71	47	48	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213016	10.1371/journal.pone.0213016	http://dx.doi.org/10.1371/journal.pone.0213016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865683	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900055
J	Schutte-Nutgen, K; Finke, M; Ehlert, S; Tholking, G; Pavenstadt, H; Suwelack, B; Palmes, D; Bahde, R; Koch, R; Reuter, S				Schuette-Nuetgen, Katharina; Finke, Markus; Ehlert, Sabrina; Thoelking, Gerold; Pavenstaedt, Hermann; Suwelack, Barbara; Palmes, Daniel; Bahde, Ralf; Koch, Raphael; Reuter, Stefan			Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?-A retrospective study	PLOS ONE			English	Article							DECEASED DONORS; RECIPIENT AGE; PATIENT SURVIVAL; DELAYED GRAFT; ALLOGRAFT; OUTCOMES; RISK; DISEASE; DEATH	Background Given the gap between patients in need of a renal transplantation (RTx) and organs available, transplantation centers increasingly accept organs of suboptimal quality, e.g. from donors with acute kidney injury (AKI). Methods To determine the outcome of kidney transplants from deceased donors with AKI (defined as >= AKIN stage 1), all 107 patients who received a RTx from donors with AKI between August 2004 and July 2014 at our center were compared to their respective consecutively transplanted patients receiving kidneys from donors without AKI. 5-year patient and graft survival, frequencies of delayed graft function (DGF), acute rejections and glomerular filtration rate (eGFR, CKD-EPI) were assessed. Results Patient survival was similar in both groups, whereas death-censored and overall graft survival were decreased in AKI kidney recipients. AKI kidney recipients showed higher frequencies of DGF and had a reduced eGFR at 7 days, three months and one and three years after RTx. However, mortality was noticeably lower compared to waiting list candidates. Rejection-free survival was similar between groups. Conclusions In our cohort, both short-term and long-term renal function was inferior in recipients of AKI kidneys, while patient survival was similar. Our data indicates that recipients of donor AKI kidneys should be carefully selected and additional factors impairing short- and long-term outcome should be minimized to prevent further deterioration of graft function.	[Schuette-Nuetgen, Katharina; Finke, Markus; Ehlert, Sabrina; Thoelking, Gerold; Pavenstaedt, Hermann; Suwelack, Barbara; Reuter, Stefan] Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Internal Med D, Munster, Germany; [Palmes, Daniel; Bahde, Ralf] Univ Hosp Munster, Dept Gen & Visceral Surg, Munster, Germany; [Koch, Raphael] Univ Hosp Munster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster	Reuter, S (corresponding author), Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Internal Med D, Munster, Germany.	Stefan.Reuter@ukmuenster.de	Koch, Raphael/A-7857-2013	Koch, Raphael/0000-0002-5581-5122; Schuette-Nuetgen, Katharina/0000-0003-4019-675X	University of Munster; Interdisciplinary Centre for Clinical Research (IZKF), University of Munster	University of Munster; Interdisciplinary Centre for Clinical Research (IZKF), University of Munster	This work was fully funded by the Open Access Publication Fund of University of Munster and by the Interdisciplinary Centre for Clinical Research (IZKF), University of Munster (Katharina Schutte-Nutgen).	Abou-Jaoude MM, 2009, TRANSPL IMMUNOL, V20, P118, DOI 10.1016/j.trim.2008.09.001; Al-Shraideh Y, 2014, CLIN TRANSPLANT, V28, P1372, DOI 10.1111/ctr.12463; Ali T, 2015, QJM-INT J MED, V108, P803, DOI 10.1093/qjmed/hcv033; Aubert O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3557; Benck U, 2015, INT UROL NEPHROL, V47, P2039, DOI 10.1007/s11255-015-1127-5; Boffa C, 2017, AM J TRANSPLANT, V17, P411, DOI 10.1111/ajt.13966; Charpentier B, 2002, TRANSPLANT P, V34, P1625, DOI 10.1016/S0041-1345(02)03048-8; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; COX DR, 1972, J R STAT SOC B, V34, P187; Deutsche Stiftung Organtransplantation, 2016, JAHR ORG TRANSPL DEU; Dew MA, 1997, TRANSPLANTATION, V64, P1261, DOI 10.1097/00007890-199711150-00006; Doshi MD, 2011, TRANSPLANTATION, V91, P666, DOI 10.1097/TP.0b013e318209f22b; Farney AC, 2013, J AM COLL SURGEONS, V216, P645, DOI 10.1016/j.jamcollsurg.2012.12.020; Gallinat A, 2016, LANGENBECK ARCH SURG, V401, P1211, DOI 10.1007/s00423-016-1445-9; Gaston RS, 2018, AM J TRANSPLANT, V18, P1158, DOI 10.1111/ajt.14590; Hall IE, 2015, AM J TRANSPLANT, V15, P1623, DOI 10.1111/ajt.13144; Heilman RL, 2015, AM J TRANSPLANT, V15, P2143, DOI 10.1111/ajt.13260; Hill P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004759.pub2; Jacobi J, 2014, CLIN TRANSPLANT, V28, P1131, DOI 10.1111/ctr.12425; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keith DS, 2006, TRANSPLANT INT, V19, P649, DOI 10.1111/j.1432-2277.2006.00333.x; Kim JH, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0461-5; Lee MH, 2014, J CRIT CARE, V29, P432, DOI 10.1016/j.jcrc.2013.12.016; Maggiore U, 2015, NEPHROL DIAL TRANSPL, V30, P217, DOI 10.1093/ndt/gfu212; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meier-Kriesche HU, 2002, J AM GERIATR SOC, V50, P14, DOI 10.1046/j.1532-5415.2002.50002.x; Mohsenin V, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0251-y; Neri F, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13036; Orandi BJ, 2016, NEW ENGL J MED, V374, P940, DOI 10.1056/NEJMoa1508380; Tapiawala SN, 2010, J AM SOC NEPHROL, V21, P153, DOI 10.1681/ASN.2009040412; Tonato EJ, 2015, EXPANDING POOL KIDNE, V13, P319; Wahba R, 2017, TRANSPL INT, V30, P220, DOI 10.1111/tri.12993; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213608	10.1371/journal.pone.0213608	http://dx.doi.org/10.1371/journal.pone.0213608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865677	Green Submitted, Green Published, gold			2022-12-26	WOS:000461048900077
J	Niu, YJ; Nie, ZW; Shin, KT; Zhou, WJ; Cui, XS				Niu, Ying-Jie; Nie, Zheng-Wen; Shin, Kyung-Tae; Zhou, Wenjun; Cui, Xiang-Shun			PINK1 regulates mitochondrial morphology via promoting mitochondrial fission in porcine preimplantation embryos	FASEB JOURNAL			English	Article						mitochondrial dynamics; oxidative stress; autophagy	IN-VITRO; PARKINSONS-DISEASE; DYNAMICS; FUSION; DYSFUNCTION; METABOLISM; ORGANELLES; MACHINERY; MUTATIONS; MITOPHAGY	Phosphatase and tensin homolog-induced kinase 1 (PINK1) on the outer membranes of impaired mitochondria promotes mitophagy and regulates mitochondrial morphology. Mammalian oocytes and early embryos are mitochondria rich, but mitochondrial dynamics during preimplantation embryo development is not well-studied. To investigate whether PINK1 is required for mitochondrial dynamics in porcine preimplantation embryos, gene knockdown and inhibitors were used, and mitochondrial dynamics were observed by transmission electron microscopy. PINK1 knockdown significantly impaired blastocyst formation and quality, induced mitochondrial elongation and swelling, and reduced mitochondrial DNA copy number. PINK1 knockdown-induced mitochondrial elongation caused mitochondrial dysfunction, oxidative stress, and ATP deficiency, significantly increasing autophagy and apoptosis. Profission dynamin-related protein 1 overexpression prevented PINK1 knockdown-induced impairment of embryo development, mitochondrial elongation, and dysfunction. Thus, PINK1 promotes mitochondrial fission in porcine preimplantation embryos.-Niu, Y.-J., Nie, Z.-W., Shin, K.-T., Zhou, W., Cui, X.-S. PINK1 regulates mitochondrial morphology via promoting mitochondrial fission in porcine preimplantation embryos.	[Niu, Ying-Jie; Nie, Zheng-Wen; Shin, Kyung-Tae; Zhou, Wenjun; Cui, Xiang-Shun] Chungbuk Natl Univ, Dept Anim Sci, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea	Chungbuk National University	Cui, XS (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea.	xscui@cbnu.ac.kr		Niu, Ying-Jie/0000-0003-1829-1718	National Research Foundation of Korea - Korea government (Ministry of Science and Information and Communication Technology) [2018R1A2B6001173]; China Scholarship Council [(2017)3109]	National Research Foundation of Korea - Korea government (Ministry of Science and Information and Communication Technology); China Scholarship Council(China Scholarship Council)	This work was supported by the National Research Foundation of Korea funded by the Korea government (Ministry of Science and Information and Communication Technology; 2018R1A2B6001173). Y.-J.N. thanks the China Scholarship Council for its financial support [(2017)3109]. The authors declare no conflicts of interest.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Bertolin G, 2013, AUTOPHAGY, V9, P1801, DOI 10.4161/auto.25884; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Eleftheriadis T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00279; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Ferris J, 2016, REPROD TOXICOL, V59, P128, DOI 10.1016/j.reprotox.2015.12.002; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gautier CA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-22; Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Khurana NK, 2000, BIOL REPROD, V62, P847, DOI 10.1095/biolreprod62.4.847; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; NASRESFAHANI MH, 1990, DEVELOPMENT, V109, P501; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896; Sarmann J, 2009, J BIOL CHEM, V284, P16482, DOI 10.1074/jbc.M808255200; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Sutton-McDowall ML, 2012, THERIOGENOLOGY, V77, P1632, DOI 10.1016/j.theriogenology.2011.12.008; Thompson JG, 1996, J REPROD FERTIL, V106, P299, DOI 10.1530/jrf.0.1060299; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235	40	18	19	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2019	33	7					7882	7895		10.1096/fj.201802473R	http://dx.doi.org/10.1096/fj.201802473R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ9SM	30897005				2022-12-26	WOS:000476234700008
J	Hwang, JS; Lee, WJ; Hur, J; Lee, HG; Kim, E; Lee, GH; Choi, MJ; Lim, DS; Paek, KS; Seo, HG				Hwang, Jung Seok; Lee, Won Jin; Hur, Jinwoo; Lee, Hyuk Gyoon; Kim, Eunsu; Lee, Gyeong Hee; Choi, Mi-Jung; Lim, Dae-Seog; Paek, Kyung Shin; Seo, Han Geuk			Rosiglitazone-dependent dissociation of HuR from PPAR-gamma regulates adiponectin expression at the posttranscriptional level	FASEB JOURNAL			English	Article						human antigen R; posttranscriptional regulation; rosiglitazone	ACTIVATED-RECEPTOR-GAMMA; CYTOPLASMIC MESSENGER-RNA; INCREASES PLASMA-LEVELS; LIGAND-BINDING DOMAIN; GENE-EXPRESSION; DOWN-REGULATION; PROTEIN; ALPHA; PHOSPHORYLATION; SECRETION	Peroxisome proliferator-activated receptor (PPAR)-gamma has been implicated as a key player in the regulation of adiponectin levels via both transcriptional and posttranscriptional mechanisms. Herein, we show that PPAR-gamma interacts with human antigen R (HuR) and that the PPAR-gamma-HuR complex dissociates following activation of PPAR-gamma by rosiglitazone, a specific ligand of PPAR-gamma. This rosiglitazone-dependent dissociation of HuR from PPAR-gamma leads to nucleocytoplasmic shuttling of HuR and its binding to the 3 '-UTR of adiponectin mRNA. PPAR-gamma with H321A and H447A double mutation (PPAR-gamma(H321/447A)), a mutant lacking ligand-binding activity, impaired HuR dissociation from the PPAR-gamma-HuR complex, resulting in reduced nucleocytoplasmic shuttling, even in the presence of rosiglitazone. Consequently, rosiglitazone up-regulated adiponectin levels by modulating the stability of adiponectin mRNA, whereas these effects were abolished by HuR ablation or blocked in cells expressing the PPAR-gamma(H321/447A) mutant, indicating that the interaction of PPAR-gamma and HuR is a critical event during adiponectin expression. Taken together, the findings demonstrate a novel mechanism for regulating adiponectin expression at the posttranscriptional level and suggest that ligand-mediated activation of PPAR-gamma to interfere with interaction of HuR could offer a therapeutic strategy for inflammation-associated diseases that involve decreased adiponectin mRNA stability.-Hwang, J. S., Lee, W. J., Hur, J., Lee, H. G., Kim, E., Lee, G. H., Choi, M.-J., Lim, D.-S., Paek, K. S., Seo, H. G. Rosiglitazone-dependent dissociation of HuR from PPAR-gamma regulates adiponectin expression at the posttranscriptional level.	[Hwang, Jung Seok; Lee, Won Jin; Hur, Jinwoo; Lee, Hyuk Gyoon; Kim, Eunsu; Lee, Gyeong Hee; Choi, Mi-Jung; Seo, Han Geuk] Konkuk Univ, Sanghuh Coll Life Sci, 120 Neungdong Ro, Seoul 05029, South Korea; [Lim, Dae-Seog] CHA Univ, Dept Biotechnol, Seongnam, South Korea; [Paek, Kyung Shin] Semyung Univ, Dept Nursing, Jechon, South Korea	Konkuk University; Pochon Cha University; Semyung University	Seo, HG (corresponding author), Konkuk Univ, Sanghuh Coll Life Sci, 120 Neungdong Ro, Seoul 05029, South Korea.	hgseo@konkuk.ac.kr		Lee, Won Jin/0000-0003-1164-8198	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1A2A2A05001249, 2015R1A5A1009701, 2016R1C1B1009853]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported in part by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1A2A2A05001249, 2015R1A5A1009701, and 2016R1C1B1009853). The authors declare no conflicts of interest.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Benegiamo G, 2018, CELL METAB, V27, P404, DOI 10.1016/j.cmet.2017.12.010; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Choi YH, 2004, FEBS LETT, V557, P73, DOI 10.1016/S0014-5793(03)01449-2; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Doran AC, 2008, CIRC RES, V103, P624, DOI 10.1161/CIRCRESAHA.108.175893; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fisman EZ, 2014, CARDIOL J, V21, P1, DOI 10.5603/CJ.a2013.0054; Ghanim H, 2006, J CLIN ENDOCR METAB, V91, P3553, DOI 10.1210/jc.2005-2609; Hou XY, 2013, EUR J PHARMACOL, V715, P196, DOI 10.1016/j.ejphar.2013.05.021; Hwang J. S., 2015, TUMOR BIOL, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0128014; Hwang JS, 2016, PHARMACOL RES, V114, P47, DOI 10.1016/j.phrs.2016.10.014; Ikeda Y, 2000, J BIOL CHEM, V275, P33142, DOI 10.1074/jbc.M002319200; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Ke YS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14632; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li L, 2009, CYTOKINE, V45, P12, DOI 10.1016/j.cyto.2008.10.006; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu ML, 2012, BIOCHIMIE, V94, P2126, DOI 10.1016/j.biochi.2012.01.008; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Liu Y, 2014, AM J PHYSIOL-ENDOC M, V306, pE975, DOI 10.1152/ajpendo.00699.2013; Long QQ, 2010, ENDOCRINOLOGY, V151, P3195, DOI 10.1210/en.2009-1501; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Luo NL, 2011, AM J PHYSIOL-ENDOC M, V301, pE180, DOI 10.1152/ajpendo.00614.2010; Luo NL, 2010, DIABETES, V59, P791, DOI 10.2337/db09-1338; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Majuri A, 2007, EUR J ENDOCRINOL, V156, P263, DOI 10.1530/eje.1.02331; Mansour M, 2014, PROG MOL BIOL TRANSL, V121, P217, DOI 10.1016/B978-0-12-800101-1.00007-7; Nie M, 2005, J BIOL CHEM, V280, P2550, DOI 10.1074/jbc.M410616200; Pang LJ, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-15; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shibata T, 2015, BIOSCI BIOTECH BIOCH, V79, P1044, DOI 10.1080/09168451.2015.1012149; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yanagisawa M, 2012, MOL NUTR FOOD RES, V56, P1783, DOI 10.1002/mnfr.201200284; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Zhang YY, 2015, INFLAMMATION, V38, P756, DOI 10.1007/s10753-014-9986-y	56	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7707	7720		10.1096/fj.201802643R	http://dx.doi.org/10.1096/fj.201802643R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30897345	Bronze			2022-12-26	WOS:000476114200083
J	Ali, A; Farooqui, SR; Banerjea, AC				Ali, Amjad; Farooqui, Sabihur Rahman; Banerjea, Akhil C.			The host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; viral protein; ubiquitylation (ubiquitination); protein degradation; proteasome	INHIBITS HIV-1; TAT PROTEIN; PROTEASOME; CHAPERONE; P53; IDENTIFICATION; DEGRADATION; EXPRESSION; INFECTION; APOPTOSIS	Human immunodeficiency virus-1 (HIV-1) Tat is degraded in the host cell both by proteasomal and lysosomal pathways, but the specific molecules that engage with Tat from these pathways are not known. Because E3 ubiquitin ligases are the primary determinants of substrate specificity within the ubiquitin-dependent proteasomal degradation of proteins, we first sought to identify the E3 ligase associated with Tat degradation. Based on the intrinsic disordered nature of Tat protein, we focused our attention on host cell E3 ubiquitin ligase CHIP (C terminus of HSP70-binding protein). Co-transfection of Tat with a CHIP-expressing plasmid decreased the levels of Tat protein in a dose-dependent manner, without affecting the corresponding mRNA levels. Additionally, the rate of Tat protein degradation as measured by cycloheximide (CHX) chase assay was increased in the presence of CHIP. A CHIP mutant lacking the U-box domain, which is responsible for protein ubiquitination (CHIPU-box), was unable to degrade Tat protein. Furthermore, CHIP promoted ubiquitination of Tat by both WT as well as Lys-48-ubiquitin, which has only a single lysine residue at position 48. CHIP transfection in HIV-1 reporter TZM-bl cells resulted in decreased Tat-dependent HIV-1 long-terminal repeat (LTR) promoter transactivation as well as HIV-1 virion production. CHIP knockdown in HEK-293T cells using CRISPR-Cas9 led to higher virion production and enhanced Tat-mediated HIV-1 LTR promoter transactivation, along with stabilization of Tat protein. Together, these results suggest a novel role of host cell E3 ubiquitin ligase protein CHIP in regulating HIV-1 replication through ubiquitin-dependent degradation of its regulatory protein Tat.	[Ali, Amjad; Farooqui, Sabihur Rahman; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India; [Ali, Amjad; Farooqui, Sabihur Rahman] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Millia Islamia	Ali, A; Banerjea, AC (corresponding author), Natl Inst Immunol, Virol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.; Ali, A (corresponding author), Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India.	amjad139@gmail.com; akhil@nii.res.in		FAROOQUI, SABIHUR/0000-0003-3779-4644	Indian Council of Medical Research of Government of India [BT/PR8322/Med/-14/1245/2006, BT/PR1800/AGR/36/676/2011, HIV/50/142/9/2011-ECD-II]; Department of Biotechnology	Indian Council of Medical Research of Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology	This work was supported by Department of Biotechnology and Indian Council of Medical Research of Government of India Grants BT/PR8322/Med/-14/1245/2006, BT/PR1800/AGR/36/676/2011, and HIV/50/142/9/2011-ECD-II. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27539; Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Boban M, 2015, J BIOL CHEM, V290, P2489, DOI 10.1074/jbc.M114.600593; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Faust TB, 2018, ELIFE, V7, DOI 10.7554/eLife.31879; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Germini D, 2017, LEUKEMIA, V31, P2515, DOI 10.1038/leu.2017.106; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Harwig A, 2016, NUCLEIC ACIDS RES, V44, P4340, DOI 10.1093/nar/gkw167; Hategan A, 2017, NAT STRUCT MOL BIOL, V24, P379, DOI 10.1038/nsmb.3379; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kim JM, 2017, RNA BIOL, V14, P926, DOI 10.1080/15476286.2017.1311455; Lata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8244; Li J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11730; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minami R, 2006, CELL IMMUNOL, V243, P41, DOI 10.1016/j.cellimm.2006.11.003; Mueller N, 2018, J VIROL, V92, DOI 10.1128/JVI.01855-17; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Raja R, 2017, BIOCHEM J, V474, P2449, DOI 10.1042/BCJ20160825; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Remoli AL, 2016, MBIO, V7, DOI 10.1128/mBio.01528-16; Sagnier S, 2015, J VIROL, V89, P615, DOI 10.1128/JVI.02174-14; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Shojania S, 2010, PROTEIN PEPTIDE LETT, V17, P999, DOI 10.2174/092986610791498993; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang LL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-61	53	7	8	6	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7283	7295		10.1074/jbc.RA118.007257	http://dx.doi.org/10.1074/jbc.RA118.007257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885946	hybrid, Green Published			2022-12-26	WOS:000468402900017
J	Bwana, P; Ageng'o, J; Mwau, M				Bwana, Priska; Ageng'o, Joshua; Mwau, Matilu			Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya	PLOS ONE			English	Article							VIRAL LOAD; INFECTION; DIAGNOSIS	Background In Kenya, access to early infant diagnosis and viral load monitoring services for HIV patients on ART is significantly hampered by sample transportation challenges and long turnaround times. Near patient care testing technologies have the potential to obviate such constraints. The Cepheid GeneXpert was launched in 2010 as a TB assay and in 2014 as a potential point of care HIV viral load assay. Whereas it is widely is used for TB in Kenya, its utility for HIV testing has not been evaluated. Objective To investigate the performance and usability characteristics of the GeneXpert HIV-1 qualitative and quantitative assay. Methods This was a cross sectional study among 911 HIV Exposed infants and 310 HIV positive adults. Existing machines used for routine TB diagnosis were used in this study. The diagnostic accuracy of the qualitative assay was assessed using Roche CAP/CTM while the quantitative assay was assessed using with Abbott m2000 as the reference assays respectively. Statistical analysis was done using Stata/MP Version 14 for Mac. Concordance values and misclassification were calculated at the clinical cutoff of 1000 cp/ml. Results The sensitivity, specificity and accuracy of the GeneXpert HIV-1 qualitative assay were 99.23% (95% CI 97.24-99.90%), 98.91% (95% CI 97.76-99.55%) and 99.00% respectively. For the quantitative assay, they were 92.50% (95% CI 79.61-98.43%), 100.00% and 97.00% respectively. All 30 (100%) users reported that the GeneXpert machine was easy to use, workflow was simple and TB diagnosis was not negatively affected. In our hands, the median turn-around time for an individual qualitative and quantitative test was 90 minutes. A total of 58 (4.34%) errors and 28 (2.10%) invalid outcomes were experienced; 44 (3.29%) tests did not run to completion due to power outages. Conclusion GeneXpert HIV-1 qualitative and quantitative assay is an accurate test for the diagnosis of HIV in infants and for viral load monitoring. At the point of care, the GeneXpert machine's simple work flow, ease of use and short test turnaround time present the potential to improve access to HIV testing and viral load monitoring. To integrate HIV diagnosis into the existing GeneXpert platforms for TB Diagnosis, there is need to scale up the infrastructure and to change the way work is done.	[Bwana, Priska; Ageng'o, Joshua; Mwau, Matilu] Kenya Govt Med Res Ctr, Busia, Kenya	Kenya Medical Research Institute	Bwana, P (corresponding author), Kenya Govt Med Res Ctr, Busia, Kenya.	priska.bwana@gmail.com			Kenya Medical Research Institute	Kenya Medical Research Institute	This work was supported by Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buser M., 2017, POINT OF CARE EARLY; Ceffa S, 2016, J VIROL METHODS, V229, P35, DOI 10.1016/j.jviromet.2015.12.007; CHAI, 2016, POINT CAR EID VL PRO; EGPAF, 2016, UNITAID EGPAF PROJ O; Elrod JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2755-5; Elrod JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2341-x; Ford N., 2016, VIRAL LOAD PLATFORMS; Gous N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168244; Gueudin M, 2016, JAIDS-J ACQ IMM DEF, V72, P521, DOI 10.1097/QAI.0000000000001003; Jordan JA, EVALUATION XPERT HIV; Kageha S, 2012, J TROP PEDIATRICS, V58, P247, DOI 10.1093/tropej/fmr076; Kulkarni S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2604-5; Moyo S, 2016, J CLIN MICROBIOL, V54, P3050, DOI 10.1128/JCM.01594-16; NACC, 2016, PROGR RESP; National AIDS Control Council and the National AIDS and STD Control Programme, 2009, KEN 2007 HIV AIDS ES; Ndlovu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193577; NOVITSKY V., 2015, POINT CARE TESTING H; Phillips AN, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw161; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rowley CF, 2014, CLIN INFECT DIS, V58, P407, DOI 10.1093/cid/cit733; Sivapalasingam S, 2012, PEDIATR INFECT DIS J, V31, P732, DOI 10.1097/INF.0b013e318259bc1e; UNAIDS, 90 90 90 AMB TREATM; UNICEF A CDC CHAI OGAC EGPAF LSHTM ICAP MSF NHLS USAID and WHO., 2018, KEY CONS INTR NEW HI; USAID, GENEXPERT OMN EN INC; WHO, 2017, WHO PREQ IN VITR DIA; WHO, 2017, HIV DIAGN NOV POINT; World Health Organization, 2016, WHO PREQ IN VITR DIA; World Health Organization, WHO PREQ IN VITR DIA	28	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2019	14	3							e0213865	10.1371/journal.pone.0213865	http://dx.doi.org/10.1371/journal.pone.0213865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9GF	30901343	Green Published, Green Submitted, gold			2022-12-26	WOS:000462000400022
J	Liu, SY; Naranjo, VD; Chrystal, PV; Buyse, J; Selle, PH				Liu, Sonia Y.; Naranjo, Victor D.; Chrystal, Peter V.; Buyse, Johan; Selle, Peter H.			Box-Behnken optimisation of growth performance, plasma metabolites and carcass traits as influenced by dietary energy, amino acid and starch to lipid ratios in broiler chickens	PLOS ONE			English	Article							DIGESTIBLE LYSINE REQUIREMENTS; NUTRIENT UTILIZATION; FEED-INTAKE; PROTEIN; RESPONSES; MACRONUTRIENTS	A Box-Behnken designed study was completed to predict growth performance, carcass characteristics and plasma hormone and metabolite levels as influenced by dietary energy, amino acid densities and starch to lipid ratios in male broiler chickens. The design comprised three dietary energy densities (11.25, 12.375 and 13.5 MJ/kg), three digestible lysine concentrations (9.2, 10.65 and 12.1 g/kg) and three starch to lipid ratios (4.5, 12.25 and 20.0) in broiler diets based on maize and soybean meal. Each of thirteen dietary treatments was offered to 10 replicates of 15 birds per replicate floor pen or a total of 1,950 Ross 308 male broiler chickens from 21 to 35 days post-hatch. Increasing dietary energy decreased feed intake with a quadratic relationship between feed intake and dietary standardised ileal digestible (SID) Lys concentrations, where increasing SID Lys initially increased and then depressed feed intake. Increasing dietary amino acid density increased body weight gain and carcass weight; however, dietary energy did not influence body weight gain, carcass and breast meat weight. Feed efficiency was positively influenced by energy and amino acid densities but negatively influenced by starch to lipid ratios and energy and amino acids had more pronounced impacts than starch to lipid ratios. This study indicated that both energy and amino acid densities regulate feed intakes in broiler chickens. Body weight gain of modern broiler chickens is more responsive to amino acid densities; nevertheless, dietary energy density continues to play an important role in protein utilisation, as reflected in significantly reduced plasma uric acid levels.	[Liu, Sonia Y.; Chrystal, Peter V.; Selle, Peter H.] Univ Sydney, Fac Sci, Poultry Res Fdn, Camden, NSW, Australia; [Liu, Sonia Y.; Chrystal, Peter V.] Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, NSW, Australia; [Naranjo, Victor D.] Evonik Nutr & Care, Essen, Germany; [Chrystal, Peter V.] Baiada Poultry Pty Ltd, Pendle Hill, NSW, Australia; [Buyse, Johan] Katholieke Univ Leuven, Lab Livestock Physiol, Dept Biosyst, Leuven, Belgium	University of Sydney; University of Sydney; KU Leuven	Liu, SY (corresponding author), Univ Sydney, Fac Sci, Poultry Res Fdn, Camden, NSW, Australia.; Liu, SY (corresponding author), Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, NSW, Australia.	sonia.liu@sydney.edu.au		Naranjo, Victor/0000-0002-7700-0215; Chrystal, Peter/0000-0001-7421-5109	Evonik Nutrition and Care, Essen, Germany	Evonik Nutrition and Care, Essen, Germany	The present study was funded by Evonik Nutrition and Care, Essen, Germany. The funder had no role in the study except coordinating collaborations between University of Sydney and KU Leuven. The funder provided support in the form of salaries for author V.N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cemin HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179665; Classen H. L., 2013, 24th Annual Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 17-20 February 2013, P107; Classen HL, 2017, ANIM FEED SCI TECH, V233, P13, DOI 10.1016/j.anifeedsci.2016.03.004; Demetrio CGB, 2013, POULTRY SCI, V92, P2490, DOI 10.3382/ps.2012-02731; Dozier WA, 2010, POULTRY SCI, V89, P2173, DOI 10.3382/ps.2010-00710; Dozier WA, 2009, POULTRY SCI, V88, P1676, DOI 10.3382/ps.2008-00539; Everett DL, 2010, J APPL POULTRY RES, V19, P321, DOI 10.3382/japr.2010-00152; Fancher B.I., 2014, POULTRY 2020 5 INT B, P162; Gous RM, 2018, BRIT POULTRY SCI, V59, P100, DOI 10.1080/00071668.2017.1390211; Gous RM, 2014, POULTRY SCI, V93, P1, DOI 10.3382/ps.2013-03466; Gous R. M., 2010, Proceedings of the 21st Annual Australian Poultry Science Sumposium, Sydney, New South Wales, 1-3rd February 2010, P36; Khoddami A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205272; Kidd MT, 2016, ANIM FEED SCI TECH, V221, P314, DOI 10.1016/j.anifeedsci.2016.05.012; Kleyn R, 2015, FORMULATING NONLINEA; Leeson S, 1996, POULTRY SCI, V75, P529, DOI 10.3382/ps.0750529; Liu SY, 2015, WORLD POULTRY SCI J, V71, P297, DOI 10.1017/S0043933915000306; Liu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185480; Liu SY, 2017, BRIT J NUTR, V118, P250, DOI 10.1017/S0007114517002070; Liu SY, 2016, BRIT J NUTR, V116, P2129, DOI 10.1017/S0007114516004190; MARTINEZ V, 1995, AM J PHYSIOL-REG I, V269, pR445, DOI 10.1152/ajpregu.1995.269.2.R445; Parsons AS, 2006, J APPL POULTRY RES, V15, P245, DOI 10.1093/japr/15.2.245; Pelley JW, 2011, RAPID REV BIOCH, P116; Pirgozliev V, 1999, WORLD POULTRY SCI J, V55, P23, DOI 10.1079/WPS19990003; Reimer B, 2017, POULT SCI S1, V96, P79; Swennen Q, 2007, WORLD POULTRY SCI J, V63, P541, DOI 10.1017/S0043933907001602; Swennen Q, 2006, POULTRY SCI, V85, P731, DOI 10.1093/ps/85.4.731; Swennen Q, 2005, POULTRY SCI, V84, P1051, DOI 10.1093/ps/84.7.1051; Swennen Q, 2010, J ANIM PHYSIOL AN N, V94, P375, DOI 10.1111/j.1439-0396.2009.00918.x; WPSA, 1989, SUBCOMMITTEE ENERGY, V3rd	29	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213875	10.1371/journal.pone.0213875	http://dx.doi.org/10.1371/journal.pone.0213875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897122	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700041
J	Farra, A; Loumandet, TN; Pagonendji, M; Manirakiza, A; Manengu, C; Mbailao, R; Ndjapou, S; Lefaou, A; Gouandjika-Vasilache, I				Farra, Alain; Loumandet, Tuspin Nicephore; Pagonendji, Marilou; Manirakiza, Alexandre; Manengu, Casimir; Mbailao, Raphael; Ndjapou, Severin; Lefaou, Alain; Gouandjika-Vasilache, Ionela			Epidemiologic profile of measles in Central African Republic: A nine year survey, 2007-2015	PLOS ONE			English	Article							ETHIOPIA; OUTBREAK	Introduction Measles remains a major public health problem in many developing countries in which vaccination coverage is poor, as is the case in the Central African Republic (CAR). At the beginning of the 2000s, a surveillance system was established in the country, and samples from suspected cases are regularly tested in the laboratory for serological confirmation. Since 2007, when case-by-case monitoring with standardized laboratory databases and monitoring, was set up, no assessment have been performed. Therfore, 9 years later it seemed appropriate to make a first assessment. The aim of the study reported here was to describe the epidemiology of measles in the CAR on the basis of surveillance and laboratory data. Method A descriptive retrospective study was conducted, based on the databases of the measles surveillance programme and of the Institut Pasteur laboratory in Bangui during the period 2007-2015. Results During this study period, the surveillance programme notified 3767 cases. Of these, 2795 (75%) were sent for laboratory confirmation, and 24.6% (687/2795) were confirmed serologically. Of the 1797 cases of measles declared during this period by the surveillance programme, 1110 (61.8%) were confirmed clinically or by epidemiological linkage. The majority of confirmed cases (83.7%; 575/687) occurred in children under 10 years, over half of whom (44.2%; 304/687) were aged 1-4 years. Epidemics occurred regularly between 2011 and 2015, with > 10% of laboratory-confirmed cases. The rate of laboratory investigation was < 80% between 2011 and 2013 but nearly 100% in the other years. Conclusion Measles remains a common, endemic illness in the CAR. Improved detection will require better measles surveillance, increased vaccination coverage, revision of the investigation forms to include the WHO case definition and training of the health personnel involved in case-finding in the field.	[Farra, Alain] Inst Pasteur, Natl Mycobacteriol Lab, Bangui, Cent Afr Republ; [Farra, Alain; Pagonendji, Marilou; Gouandjika-Vasilache, Ionela] Inst Pasteur, Enter Virus & Measles Lab, Bangui, Cent Afr Republ; [Loumandet, Tuspin Nicephore] Univ Bangui, Hlth Sci Fac, Bangui, Cent Afr Republ; [Manirakiza, Alexandre] Inst Pasteur, Epidemiol Unit, Bangui, Cent Afr Republ; [Manengu, Casimir] WHO, Focal Point Immunizat Vaccines & Emergencies, Bangui, Cent Afr Republ; [Mbailao, Raphael] Minist Hlth, Expanded Programme Immunizat, Bangui, Cent Afr Republ; [Ndjapou, Severin] Minist Hlth, Epidemiol Surveillance Serv, Bangui, Cent Afr Republ; [Lefaou, Alain] Pharm Fac, Nancy, France	World Health Organization	Farra, A (corresponding author), Inst Pasteur, Natl Mycobacteriol Lab, Bangui, Cent Afr Republ.; Farra, A (corresponding author), Inst Pasteur, Enter Virus & Measles Lab, Bangui, Cent Afr Republ.	farra_alain@yahoo.fr	Manirakiza, Alexandre/A-6801-2011; Gouandjika, Ionela/AGR-0778-2022	Gouandjika, Ionela/0000-0002-2498-8725	WHO; World Health Organization	WHO(World Health Organization); World Health Organization(World Health Organization)	This study was funded by the WHO which allows each year the monitoring of measles and rubella in Central African Republic by a signed Technical Support Agreement (TSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the World Health Organization for its financial and material support to the Central African Republic programme for measles and rubella surveillance. We are grateful to focal points in the health regions for their contribution in collecting samples. Many thanks to Professor Elisabeth Heseltine for her extensive editorial support of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P297; Baudon C, 2011, B EPIDEMIOL HEBD, V33-34, P354; Brown K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019381; de la Sante Publique de la Population et la Lutte contre le SIDA, 2011, GUID TECHN SURV INT; Dia N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121704; Farra A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1842-2; Fatiregun AA, 2014, T ROY SOC TROP MED H, V108, P133, DOI 10.1093/trstmh/tru004; Feldstein LR, 2017, MMWR-MORBID MORTAL W, V66, P1252, DOI 10.15585/mmwr.mm6645a3; Getahun M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1457-7; Maurice J, 2015, LANCET, V386, P943, DOI 10.1016/S0140-6736(15)00115-4; Mitiku K, 2011, J INFECT DIS, V204, pS239, DOI 10.1093/infdis/jir120; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Nsubuga F, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2941-4; Palamara M A, 2018, J Prev Med Hyg, V59, pE8, DOI 10.15167/2421-4248/jpmh2018.59.1.853; Rougeole Aubry P., MEASLES NEWS 2015; Seck I, 2012, SANTE PUBLIQUE, V24, P121, DOI 10.3917/spub.122.0121; Tall F, 1997, MED MALADIES INFECT, V27, P513, DOI 10.1016/S0399-077X(97)80106-0; Thiam M., 2005, SYNTHESE RECENSEMENT; World Health Organization, 2009, WKLY EPIDEMIOL REC, V49, P509; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P149; World Health Organization Regional Office for Africa Regional Committee for Africa, 2011, MEASL EL 2020 STRAT	21	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213735	10.1371/journal.pone.0213735	http://dx.doi.org/10.1371/journal.pone.0213735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893336	gold, Green Published, Green Submitted			2022-12-26	WOS:000461765900048
J	Salybekov, AA; Masuda, H; Miyazaki, K; Sheng, Y; Sato, A; Shizuno, T; Iida, Y; Okada, Y; Asahara, T				Salybekov, Amankeldi A.; Masuda, Haruchika; Miyazaki, Kozo; Sheng, Yin; Sato, Atsuko; Shizuno, Tomoko; Iida, Yumi; Okada, Yoshinori; Asahara, Takayuki			Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration associated cells in diet-induced obese mice	PLOS ONE			English	Article							PEPTIDASE-4 INHIBITOR; BONE-MARROW; DPP-4 INHIBITORS; INSULIN-RESISTANCE; FACTOR-I; SITAGLIPTIN; RECRUITMENT; EFFICACY; INJURY; SAFETY	Metabolic syndrome (MS), overlapping type 2 diabetes, hyperlipidemia, and/or hypertension, owing to high-fat diet, poses risk for cardiovascular disease. A critical feature associated with such risk is the functional impairment of endothelial progenitor cells (EPCs). Dipeptidyl dipeptidase-4 inhibitors (DPP-4 i) not only inhibit degradation of incretins to control blood glucose levels, but also improve EPC bioactivity and induce anti-inflammatory effects in tissues. In the present study, we investigated the effects of such an inhibitor, MK 06266, in an ischemia model of MS using diet-induced obese (DIO) mice. EPC bioactivity was examined in MK-0626-administered DIO mice and a non-treated control group, using an EPC colony-forming assay and bone marrow cKit(+) Sca-1(+) lineage-cells, and peripheral blood-mononuclear cells. Our results showed that, in vitro, the effect of MK-0626 treatment on EPC bioactivities and differentiation was superior compared to the control. Furthermore, microvascular density and pericyte-recruited arteriole number increased in MK-0626-administered mice, but not in the control group. Lineage profiling of isolated cells from ischemic tissues revealed that MK-0626 administration has an inhibitory effect on unproductive inflammation. This occurred via a decrease in the influx of total blood cells and pro-inflammatory cells such as neutrophils, total macrophages, M1, total T-cells, cytotoxic T-cells, and B-cells, with a concomitant increase in number of regeneration-associated cells, such as M2/M ratio and T-reg/T-helper. Laser Doppler analysis revealed that at day 14 after ischemic injury, blood perfusion in hindlimb was greater in MK-0626-treated DIO mice, but not in control. In conclusion, the DPP-4 i had a positive effect on EPC differentiation in MS model of DIO mice. Following ischemic injury, DPP-4 i sharply reduced recruitment of pro-inflammatory cells into ischemic tissue and triggered regeneration and reparation, making it a promising therapeutic agent for MS treatment.	[Salybekov, Amankeldi A.; Masuda, Haruchika; Miyazaki, Kozo; Sheng, Yin; Sato, Atsuko; Shizuno, Tomoko; Asahara, Takayuki] Tokai Univ, Dept Regenerat Med Sci, Sch Med, Isehara, Kanagawa, Japan; [Iida, Yumi; Okada, Yoshinori] Tokai Univ, Support Ctr Med Res & Educ, Sch Med, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Asahara, T (corresponding author), Tokai Univ, Dept Regenerat Med Sci, Sch Med, Isehara, Kanagawa, Japan.	asa777@is.cc.u-tokai.ac.jp	Salybekov, Amankeldi A./M-1130-2013	Salybekov, Amankeldi A./0000-0001-5490-9365	Merck Investigator Studies Program [39707, 51444]	Merck Investigator Studies Program	This experiment was supported by Merck Investigator Studies Program (Diabetes: #39707 and #51444) was provided to T.A The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aliotta JM, 2017, STEM CELL TRANSL MED, V6, P1595, DOI 10.1002/sctm.16-0386; Amber CF, 2014, MOL BIOL REP, V41, P4853, DOI 10.1007/s11033-014-3392-2; Aroor AR, 2015, DIABETES, V64, P1988, DOI 10.2337/db14-0804; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Aso Y, 2015, ENDOCRINE, V50, P659, DOI 10.1007/s12020-015-0688-5; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Brenner C, 2015, INT J CARDIOL, V199, P163, DOI 10.1016/j.ijcard.2015.07.044; Brenner C, 2014, INT J CARDIOL, V177, P266, DOI 10.1016/j.ijcard.2014.09.016; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen TG, 2011, CELL PROLIFERAT, V44, P352, DOI 10.1111/j.1365-2184.2011.00764.x; Connelly KA, 2013, CARDIOVASC THER, V31, P259, DOI 10.1111/1755-5922.12005; Deacon CF, 2018, PEPTIDES, V100, P150, DOI 10.1016/j.peptides.2017.10.011; Desouza CV, 2011, DIABETES, V60, P1286, DOI 10.2337/db10-0875; Edmondson SD, 2006, J MED CHEM, V49, P3614, DOI 10.1021/jm060015t; Fadini GP, 2017, STEM CELLS, V35, P106, DOI 10.1002/stem.2445; Fadini GP, 2011, VASC PHARMACOL, V55, P10, DOI 10.1016/j.vph.2011.05.001; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Fen ZG, 2016, DIABETES, V65, P2966, DOI 10.2337/db16-0317; Hoimark L, 2012, DIABET METAB SYND OB, V5, P295, DOI 10.2147/DMSO.S16288; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Inagaki N, 2015, LANCET DIABETES ENDO, V3, P191, DOI 10.1016/S2213-8587(14)70251-7; Jungraithmayr W, 2012, EUR J CARDIO-THORAC, V41, P1166, DOI 10.1093/ejcts/ezr180; Kishimoto M, 2013, DIABETES METAB SYNDR, V6, P187, DOI 10.2147/DMSO.S35682; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Matsubara J, 2013, CIRC J, V77, P1337, DOI 10.1253/circj.CJ-12-1168; Matsumoto T, 2010, J EXP MED, V207, P2207, DOI 10.1084/jem.20100321; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Nishio S, 2015, DIABET METAB SYND OB, V8, P163, DOI 10.2147/DMSO.S54679; Pinto AR, 2013, J IMMUNOL METHODS, V393, P74, DOI 10.1016/j.jim.2013.03.012; Renna NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106563; Russo E, 2013, DIABETES METAB SYNDR, V6, P161, DOI 10.2147/DMSO.S28951; Salybekov AA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203244; Satoh-Asahara N, 2013, METABOLISM, V62, P347, DOI 10.1016/j.metabol.2012.09.004; Scheen AJ, 2015, DIABETES METAB, V41, P216, DOI 10.1016/j.diabet.2015.03.002; Scheen AJ, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2659; Sheu WHH, 2015, DIABETES CARE, V38, P2106, DOI 10.2337/dc15-0109; Shimoda S, 2013, ENDOCR J, V60, P1207; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Wang CH, 2008, AM J PHYSIOL-REG I, V294, pR811, DOI 10.1152/ajpregu.00543.2007; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yousefzadeh P, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/459821; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; Zhao YJ, 2014, DIABETES-METAB RES, V30, P646, DOI 10.1002/dmrr.2530; Zhong JX, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00477	52	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0205477	10.1371/journal.pone.0205477	http://dx.doi.org/10.1371/journal.pone.0205477			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889182	gold, Green Published, Green Submitted			2022-12-26	WOS:000461573000001
J	Cornelis, MC; Wang, YM; Holland, T; Agarwal, P; Weintraub, S; Morris, MC				Cornelis, Marilyn C.; Wang, Yamin; Holland, Thomas; Agarwal, Puja; Weintraub, Sandra; Morris, Martha Clare			Age and cognitive decline in the UK Biobank	PLOS ONE			English	Article							SEX-DIFFERENCES; MEMORY; ABILITY; HEALTH; KINDER; FLUID; DISEASE; GROWTH	Objectives Age-related cognitive decline is a well-known phenomenon after age 65 but little is known about earlier changes and prior studies are based on relatively small samples. We investigated the impact of age on cognitive decline in the largest population sample to date including young to old adults. Method Between 100,352 and 468,534 participants aged 38-73 years from UK Biobank completed at least one of seven self-administered cognitive functioning tests: prospective memory (PM), pairs matching (Pairs), fluid intelligence (FI), reaction time (RT), symbol digit substitution, trail making A and B. Up to 26,005 participants completed at least one of two follow-up assessments of PM, Pairs, FI and RT. Multivariable regression models examined the association between age (<45[reference], 45-49, 50-54, 55-59, 60-64, 65+) and cognition scores at baseline. Mixed models estimated the impact of age on cognitive decline over follow-up (similar to 5.1 years). Results FI was higher between ages 50 and 64 and lower at 65+ compared to <45 at baseline. Performance on all other baseline tests was lower with older age: with increasing age category, difference in test scores ranged from 2.5 to 7.8%(P< 0.0001). Compared to <45 at baseline, RT and Pairs performance declined faster across all older age cohorts (3.0 and 1.2% change, respectively, with increasing age category, P< 0.0001). Cross-sectional results yielded 8 to 12-fold higher differences in RT and Pairs with age compared to longitudinal results. Conclusions Our findings suggest that declines in cognitive abilities <65 are small. The cross-sectional differences in cognition scores for middle to older adult years may be due in part to age cohort effects.	[Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Wang, Yamin; Holland, Thomas; Agarwal, Puja; Morris, Martha Clare] Rush Univ, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Mesulam Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Weintraub, Sandra] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Rush University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Cornelis, MC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	marilyn.cornelis@northwestern.edu	Holland, Thomas/AAN-9764-2021	Holland, Thomas/0000-0002-9888-0194; , Puja/0000-0002-0274-6653	National Institute on Aging [K01AG053477]; NATIONAL INSTITUTE ON AGING [K01AG053477] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute on Aging (K01AG053477 to MCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman L, 1996, EUR PSYCHOL, V1, P27, DOI 10.1027/1016-9040.1.1.27; Bayley N., 1970, CARMICHAELS MANUAL C, V1, P1163; BRAYNE C, 1992, NEUROEPIDEMIOLOGY, V11, P88, DOI 10.1159/000110997; Bycroft C., BIORXIV; Christensen H, 2001, PSYCHOL MED, V31, P15, DOI 10.1017/S0033291799002834; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; CHRISTENSEN H, 1991, PSYCHOL MED, V21, P935, DOI 10.1017/S0033291700029925; Cleutjens FAHM, 2014, J AM MED DIR ASSOC, V15, P214, DOI 10.1016/j.jamda.2013.12.007; Cullen B, 2015, EUR PSYCHIAT, V30, P950, DOI 10.1016/j.eurpsy.2015.08.006; Cullen B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30568-6; Davies G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04362-x; De Jager C, 2005, AM J GERIAT PSYCHIAT, V13, P735, DOI 10.1176/appi.ajgp.13.8.735; Deary IJ, 1998, INTELLIGENCE, V26, P357, DOI 10.1016/S0160-2896(99)00005-7; DOPPELT J E, 1955, J Abnorm Psychol, V51, P312, DOI 10.1037/h0044391; Euser SM, 2008, EPIDEMIOLOGY, V19, P440, DOI 10.1097/EDE.0b013e31816a1d31; FOX C, 1949, J GERONTOL, V4, P19; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Ge T, 2019, CEREB CORTEX, V29, P3471, DOI 10.1093/cercor/bhy216; Ghisletta P, 2012, INTELLIGENCE, V40, P260, DOI 10.1016/j.intell.2012.02.008; Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225; Hagenaars SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02837-3; Hartshorne JK, 2015, PSYCHOL SCI, V26, P433, DOI 10.1177/0956797614567339; Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383; Hill WD, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.246; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; HUGHES ML, 2018, J INT NEUROPSYCHOLOG; HULTSCH DF, 1992, PSYCHOL AGING, V7, P571, DOI 10.1037/0882-7974.7.4.571; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Kievit Rogier A, 2018, Wellcome Open Res, V3, P38, DOI 10.12688/wellcomeopenres.14241.2; Kievit RA, 2016, NEUROPSYCHOLOGIA, V91, P186, DOI 10.1016/j.neuropsychologia.2016.08.008; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li RN, 2014, FRONT NEUROENDOCRIN, V35, P385, DOI 10.1016/j.yfrne.2014.01.002; Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114; Lyall DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154222; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; MILLER DI, 2014, SCI ENG ETHICS, V18, P37, DOI DOI 10.1016/J.TICS.2013.10.011; Nevado-Holgado AJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012177; Owens WA, 1959, J GERONTOLOGY; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Salthouse TA, 2004, DEV PSYCHOL, V40, P813, DOI 10.1037/0012-1649.40.5.813; Salthouse TA, 2013, INTELLIGENCE, V41, P501, DOI 10.1016/j.intell.2013.07.005; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schaie K. W., 1996, INTELLECTUAL DEV ADU; SCHAIE KW, 1994, AM PSYCHOL, V49, P304, DOI 10.1037/0003-066X.49.4.304; Schaie KW, 1988, COGNITIVE DEV ADULTH, P241, DOI DOI 10.1007/978-1-4612-3852-2_8; Shen X, 2018, BIOL PSYCHIAT COGNIT; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Sliwinski M, 1999, PSYCHOL AGING, V14, P18, DOI 10.1037/0882-7974.14.1.18; Sorenson H, 1933, J APPL PSYCHOL, V17, P729, DOI 10.1037/h0072233; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; UK Biobank Coordinating Centre, 2006, UK BIOB TOUCH SCREEN; UK Biobank Coordinating Centre, 2006, COGN FUNCT TESTS ASS; UK Biobank Coordinating Centre, 2014, COGN FUNCT TESTS ONL; UK Biobank Coordinating Centre, 2007, UK BIOB PROT LARG SC UK BIOB PROT LARG SC	55	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213948	10.1371/journal.pone.0213948	http://dx.doi.org/10.1371/journal.pone.0213948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883587	gold, Green Published, Green Submitted			2022-12-26	WOS:000461423500043
J	Kuberski, SR; Gafos, AI				Kuberski, Stephan R.; Gafos, Adamantios I.			The speed-curvature power law in tongue movements of repetitive speech	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; MINIMUM-JERK; VELOCITY; COORDINATION; KINEMATICS; ARM; PERCEPTION; DISCRETE; DEFICITS; ORIGINS	The speed-curvature power law is a celebrated law of motor control expressing a relation between the kinematic property of speed and the geometric property of curvature. We aimed to assess whether speech movements obey this law just as movements from other domains do. We describe a metronome-driven speech elicitation paradigm designed to cover a wide range of speeds. We recorded via electromagnetic articulometry speech movements in sequences of the form /CV. . ./ from nine speakers (five German, four English) speaking at eight distinct rates. First, we demonstrate that the paradigm of metronome-driven manipulations results in speech movement data consistent with earlier reports on the kinematics of speech production. Second, analysis of our data in their full three-dimensions and using advanced numerical differentiation methods offers stronger evidence for the law than that reported in previous studies devoted to its assessment. Finally, we demonstrate the presence of a clear rate dependency of the power law's parameters. The robustness of the speed-curvature relation in our datasets lends further support to the hypothesis that the power law is a general feature of human movement. We place our results in the context of other work in movement control and consider implications for models of speech production.	[Kuberski, Stephan R.; Gafos, Adamantios I.] Univ Potsdam, Dept Linguist & Res Focus Cognit Sci, Potsdam, Brandenburg, Germany	University of Potsdam	Kuberski, SR (corresponding author), Univ Potsdam, Dept Linguist & Res Focus Cognit Sci, Potsdam, Brandenburg, Germany.	kuberski@uni-potsdam.de		Gafos, Adamantios/0000-0002-4905-7118; Kuberski, Stephan/0000-0003-4811-1263	European Research Council [AdG 249440]; Deutsche Forschungsgemeinschaft [SFB 1287]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the European Research Council (AdG 249440, https://erc.europa.eu/) and the Deutsche Forschungsgemeinschaft (SFB 1287, Project C04, http://www.dfg.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer M., 2018, PYTHON PACKAGE FINIT; Browman Catherine, 1986, PHONOLOGY YB, V3, P219, DOI [DOI 10.1017/S0952675700000658, 10.1017/S0952675700000658]; CLARK MA, 1994, BRAIN, V117, P1093, DOI 10.1093/brain/117.5.1093; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; deSperati C, 1997, J NEUROSCI, V17, P3932; Do Carmo P., 1976, DIFFERENTIAL GEOMETR; Fowler CA, 1980, IMPLICATIONS SPEECH, P373; Fuchs S, 2011, J SPEECH LANG HEAR R, V54, P1067, DOI 10.1044/1092-4388(2010/10-0131); Gribble PL, 1996, J NEUROPHYSIOL, V76, P2853, DOI 10.1152/jn.1996.76.5.2853; GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Hatsopoulos NG, 1996, J MOTOR BEHAV, V28, P3, DOI 10.1080/00222895.1996.9941728; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Hoole P., 1994, ICSLP 94. 1994 International Conference on Spoken Language Processing, P53; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Huh D, 2015, P NATL ACAD SCI USA, V112, pE3950, DOI 10.1073/pnas.1510208112; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Jirsa VK, 2005, J MOTOR BEHAV, V37, P35, DOI 10.3200/JMBR.37.1.35-51; KELSO JAS, 1985, J ACOUST SOC AM, V77, P266, DOI 10.1121/1.392268; Kelso JAS, 1983, DYNAMIC PATTERN PERS, P137; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Levine WS, 2005, LECT NOTES CONTR INF, V321, P207, DOI 10.1007/10984413_13; Maoz U, 2006, ADV NEURAL INFORM PR, V18, P851; Marken RS, 2017, EXP BRAIN RES, V235, P1835, DOI 10.1007/s00221-017-4939-y; MUNHALL KG, 1985, J EXP PSYCHOL HUMAN, V11, P457, DOI 10.1037/0096-1523.11.4.457; NELSON WL, 1984, J ACOUST SOC AM, V75, P945, DOI 10.1121/1.390559; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Neufeld C, 2014, J ACOUST SOC AM, V135, P352, DOI 10.1121/1.4836515; OSTRY DJ, 1985, J ACOUST SOC AM, V77, P640, DOI 10.1121/1.391882; OSTRY DJ, 1987, EXP BRAIN RES, V68, P37; OSTRY DJ, 1983, J EXP PSYCHOL HUMAN, V9, P622, DOI 10.1037/0096-1523.9.4.622; Patel A.D., 1999, P 14 INT C PHON SCI, V1, P405; Perrier P, 2008, J NEUROPHYSIOL, V100, P1171, DOI 10.1152/jn.01116.2007; POIZNER H, 1990, BRAIN, V113, P85, DOI 10.1093/brain/113.1.85; POIZNER H, 1995, BRAIN, V118, P227, DOI 10.1093/brain/118.1.227; Pollick FE, 1996, J MOTOR BEHAV, V28, P271, DOI 10.1080/00222895.1996.9941751; Ramsay J. O., 2005, SPRINGER SERIES STAT; Rothi LJG, 1994, APRAXIA; Ruppert D, 2011, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4419-7787-8; Saltzman E., 1989, ECOL PSYCHOL, V1, P333, DOI [10.1207/s15326969eco0104_2, DOI 10.1207/S15326969EC00104_]; Schaal S, 2001, EXP BRAIN RES, V136, P60, DOI 10.1007/s002210000505; SCHONER G, 1990, BIOL CYBERN, V63, P257, DOI 10.1007/BF00203449; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Sorensen T, 2016, ECOL PSYCHOL, V28, P188, DOI 10.1080/10407413.2016.1230368; STONE M, 1992, J PHONETICS, V20, P253, DOI 10.1016/S0095-4470(19)30626-6; Tasko SM, 2004, J PHONETICS, V32, P65, DOI 10.1016/S0095-4470(03)00006-8; Tomaschek F, 2018, J PHONETICS, V68, P103, DOI 10.1016/j.wocn.2018.02.003; Turvey MT, 2007, HUM MOVEMENT SCI, V26, P657, DOI 10.1016/j.humov.2007.04.002; Vatikiotis-Bateson E., 1990, SR103104 HASK LAB ST, P67; VATIKIOTISBATESON E, 1993, J PHONETICS, V21, P231, DOI 10.1016/S0095-4470(19)31338-5; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; Viviani P., 2002, MOTOR COMPETENCE PER, P406; WANN J, 1988, J EXP PSYCHOL HUMAN, V14, P622, DOI 10.1037/0096-1523.14.4.622; Zago M, 2018, EXP BRAIN RES, V236, P69, DOI 10.1007/s00221-017-5108-z	58	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213851	10.1371/journal.pone.0213851	http://dx.doi.org/10.1371/journal.pone.0213851			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP1JR	30883586	Green Published, gold, Green Submitted			2022-12-26	WOS:000461423500035
J	Dujardin, A; De Wolf, P; Lafont, F; Dupres, V				Dujardin, Antoine; De Wolf, Peter; Lafont, Frank; Dupres, Vincent			Automated multi-sample acquisition and analysis using atomic force microscopy for biomedical applications	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; AFM	In the last 20 years, atomic force microscopy (AFM) has emerged as a ubiquitous technique in biological research, allowing the analysis of biological samples under near-physiological conditions from single molecules to living cells. Despite its growing use, the low process throughput remains a major drawback. Here, we propose a solution validated on a device allowing a fully automated, multi-sample analysis. Our approach is mainly designed to study samples in fluid and biological cells. As a proof of concept, we demonstrate its feasibility applied to detect and scan both fixed and living bacteria before completion of data processing. The effect of two distinct treatments (i.e. gentamicin and heating) is then evidenced on physical parameters of fixed Yersinia pseudotuberculosis bacteria. The multi-sample analysis presented allows an increase in the number of scanned samples while limiting the user's input. Importantly, cantilever cleaning and control steps are performed regularly as part of the automated process to ensure consistent scanning quality. We discuss how such an approach is paving the way to AFM developments in medical and clinical fields, in which statistical significance of results is a prerequisite.	[Dujardin, Antoine; Lafont, Frank; Dupres, Vincent] Univ Lille, Inst Pasteur Lille, Cellular Microbiol & Phys Infect Grp,Lille Ctr In, CNRS,UMR8204,INSERM,U1019,Lille Univ Hosp Ctr, Lille, France; [Dujardin, Antoine; De Wolf, Peter] Bruker Nano Surfaces Div, Santa Barbara, CA USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Dupres, V (corresponding author), Univ Lille, Inst Pasteur Lille, Cellular Microbiol & Phys Infect Grp,Lille Ctr In, CNRS,UMR8204,INSERM,U1019,Lille Univ Hosp Ctr, Lille, France.	vincent.dupres@ibl.cnrs.fr	Dupres, Vincent/GLQ-5321-2022	Dupres, Vincent/0000-0002-1970-3633; Dujardin, Antoine/0000-0001-9810-1341	ANR (Agence Nationale de la Recherche) Feder (Fonds europeen de developpement regional), France [ANR-10-EQPX-04-01, FEDER 12001407]	ANR (Agence Nationale de la Recherche) Feder (Fonds europeen de developpement regional), France	This work was supported by ANR (Agence Nationale de la Recherche) (ANR-10-EQPX-04-01, FL) Feder (Fonds europeen de developpement regional) (FEDER 12001407, FL), France. Bruker Nano Surfaces provided support in the form of salaries for authors A.D. and P.D.W. as well as technical help. The ANRT provided support in the form of salaries to A.D., the University of Lille provided support in the form of salaries to V.D. and the CNRS provided support in the form of salaries to F.L., but did not have any additional in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alsteens D, 2007, LANGMUIR, V23, P11977, DOI 10.1021/la702765c; Alsteens D, 2017, ACCOUNTS CHEM RES, V50, P924, DOI 10.1021/acs.accounts.6b00638; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Azioune A, 2009, LAB CHIP, V9, P1640, DOI 10.1039/b821581m; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; Braunsmann C, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4885464; Casuso I, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/3/035104; David E, 2009, NAT REV DRUG DISCOV, V8, P609, DOI 10.1038/nrd2948; Dufrene YF, 2013, NAT METHODS, V10, P847, DOI [10.1038/NMETH.2602, 10.1038/nmeth.2602]; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Favre M, 2011, J MOL RECOGNIT, V24, P446, DOI 10.1002/jmr.1119; HANSMA PK, 1988, SCIENCE, V242, P209, DOI 10.1126/science.3051380; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Jauvert E, 2014, ACS APPL MATER INTER, V6, P21230, DOI 10.1021/am506241n; Kawakatsu H, 2002, REV SCI INSTRUM, V73, P1188, DOI 10.1063/1.1448137; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lekka M, 2016, BIONANOSCIENCE, V6, P65, DOI 10.1007/s12668-016-0191-3; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Minne SC, 1998, APPL PHYS LETT, V73, P1742, DOI 10.1063/1.122263; Moller C, 2010, DRUG DISCOV TODAY, V15, P384, DOI 10.1016/j.drudis.2010.02.010; Mou JX, 1995, REV SCI INSTRUM, V66, P5527, DOI 10.1063/1.1146079; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Peric O, 2017, NANO RES, V10, P3896, DOI 10.1007/s12274-017-1604-5; Pittenger B., 2013, MICROSC TODAY, V21, P12; Pittenger B., 2010, BRUKER APPL NOTE AN1, V1, P1; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Prous J, 2007, DRUG NEWS PERSPECT, V20, P7; Rigato A, 2015, ACS NANO, V9, P5846, DOI 10.1021/acsnano.5b00430; Sadeghian H, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4978285; Schillers H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05383-0; Schillers H, 2016, J MOL RECOGNIT, V29, P95, DOI 10.1002/jmr.2510; Uchihashi T, 2016, ULTRAMICROSCOPY, V160, P182, DOI 10.1016/j.ultramic.2015.10.017; Verbelen C, 2006, FEMS MICROBIOL LETT, V264, P192, DOI 10.1111/j.1574-6968.2006.00443.x; Vettiger P, 2000, IBM J RES DEV, V44, P323, DOI 10.1147/rd.443.0323; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Zambrowicz BP, 2003, NAT REV DRUG DISCOV, V2, P38, DOI 10.1038/nrd987; ZHONG Q, 1993, SURF SCI, V290, pL688, DOI 10.1016/0039-6028(93)90582-5	41	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213853	10.1371/journal.pone.0213853	http://dx.doi.org/10.1371/journal.pone.0213853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875396	Green Published, gold, Green Submitted			2022-12-26	WOS:000461316400036
J	Lee, CK; Choi, SK; Shin, DA; Yi, S; Ha, Y; Kim, KN; Kim, I				Lee, Chang Kyu; Choi, Sun Kyu; Shin, Dong Ah; Yi, Seong; Ha, Yoon; Kim, Keung Nyun; Kim, Insoo			Influence of diabetes mellitus on patients with lumbar spinal stenosis: A nationwide population-based study	PLOS ONE			English	Article							KIDNEY-DISEASE; US ADULTS; TRENDS; PREVALENCE; SURGERY; GLUCOSE; RISK	Purpose To evaluate the relationship between comorbidities, medical cost, and surgical outcome in patients with lumbar spinal stenosis (LSS) and diabetes mellitus (DM). Methods Data on patients with LSS (n = 14,298) were collected from the Korean National Health Insurance Service database from 2005 to 2007. After 8 years of follow-up, a "DM group" (n = 3,478) and a "non-DM group" (n = 10,820) were compared according to outcome measures. Cox proportional hazard regressions were performed to examine the relationship between DM, hypertension (HTN), cardiovascular disease (CVD), chronic kidney disease (CKD), cerebrovascular disease (CbVD), and surgery for LSS. The admission rate and medical cost as well asthe overall survival rate for those who underwent lumbar surgery were also assessed among patients with DM and LSS. Results Mortality was about 1.35 times higher in the DM group than in the non-DM group. Patients with DM and comorbidities including HTN (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.25-1.56; p<0.001), CVD (HR, 1.53; 95% CI, 1.36-1.73; p<0.001), CKD (HR, 3.18; 95% CI, 2.7-3.76; p<0.001), and CbVD (HR, 1.69; 95% CI, 1.49-1.91; p<0.001) showed an increased risk of mortality. The mean hospitalization time and average medical cost of patients with DM who underwent lumbar surgery were 60.8 days, and 7,127 USD, respectively. This was 31.3 days longer, and 6,207 USD higher, respectively, than those of patients with DM who underwent conservative treatment for LSS. Within the DM group, the survival rate of surgical management of LSS had a significant tendency for positive prognosis compared with those administered conservative treatment (p = 0.046). Conclusions In patients with LSS, DM was associated both with poor prognosis (most significantly in those with CKD), and increased medical cost in those who underwent surgery. Nevertheless, surgical treatment for LSS in patients with DM was related to favorable prognosis compared with conservative treatment.	[Lee, Chang Kyu; Kim, Insoo] Keimyung Univ, Dongsan Med Ctr, Dept Neurosurg, Daegu, South Korea; [Lee, Chang Kyu; Shin, Dong Ah; Yi, Seong; Ha, Yoon; Kim, Keung Nyun] Yonsei Univ, Coll Med, Spine & Spinal Cord Inst, Dept Neurosurg, Seoul, South Korea; [Choi, Sun Kyu] Seoul Natl Univ, Bundang Hosp, Dept Med Res Collaborating Ctr, Seongnam, South Korea	Keimyung University; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Lee, CK (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Neurosurg, Daegu, South Korea.; Lee, CK (corresponding author), Yonsei Univ, Coll Med, Spine & Spinal Cord Inst, Dept Neurosurg, Seoul, South Korea.	faslcklee@gmail.com		choe, seongyu/0000-0001-8827-7060; Shin, Dong Ah/0000-0002-5225-4083; Lee, Chang Kyu/0000-0002-1366-3677	Bisa Research Grant of Keimyung University in 2018	Bisa Research Grant of Keimyung University in 2018	This research was supported by the Bisa Research Grant of Keimyung University in 2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TM, 2015, DIABETES CARE, V38, P482, DOI 10.2337/dc14-1432; Afkarian M, 2016, JAMA-J AM MED ASSOC, V316, P602, DOI 10.1001/jama.2016.10924; Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Asadian L, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMED.S39035; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Einarson TR, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0728-6; Fei Q, 2016, WORLD NEUROSURG, V95, P507, DOI 10.1016/j.wneu.2015.05.059; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Jacobs E, 2017, DIABETIC MED, V34, P855, DOI 10.1111/dme.13336; Kim KJ, 2018, DIABETES METAB J, V42, P394, DOI 10.4093/dmj.2017.0088; Kim KT, 2017, SPINE J, V17, P203, DOI 10.1016/j.spinee.2016.08.029; Kim KS, 2018, DIABETES METAB J, V42, P224, DOI 10.4093/dmj.2017.0065; Lee CH, 2018, NEUROSPINE, V15, P66, DOI 10.14245/ns.1836038.019; Lind M, 2013, DIABETOLOGIA, V56, P2601, DOI 10.1007/s00125-013-3063-1; Liu XM, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0755-8; Lotan R, 2008, J SPINAL DISORD TECH, V21, P247, DOI 10.1097/BSD.0b013e31813707af; Mobbs RJ, 2001, J CLIN NEUROSCI, V8, P10, DOI 10.1054/jocn.2000.0682; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Sakellaridis N, 2006, SURG NEUROL, V66, P152, DOI 10.1016/j.surneu.2006.01.019; Selvarajah D, 2006, DIABETES CARE, V29, P2664, DOI 10.2337/dc06-0650; SILBERBERG R, 1986, DIABETES RES CLIN EX, V3, P329; STERNBERG M, 1985, DIABETES METAB, V11, P27; Tsai CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173843; Uesugi K, 2013, SPINE, V38, pE540, DOI 10.1097/BRS.0b013e31828a2517; Uesugi K, 2012, J ORTHOP SCI, V17, P673, DOI 10.1007/s00776-012-0311-z; Weinstein JN, 2010, SPINE, V35, P1329, DOI 10.1097/BRS.0b013e3181e0f04d; Weinstein JN, 2009, J BONE JOINT SURG AM, V91A, P1295, DOI 10.2106/JBJS.H.00913; Yliharsila H, 2005, DIABETIC MED, V22, P88, DOI 10.1111/j.1464-5491.2005.01420.x; YU M, 2018, DIABETES METAB RE S1, V34; Zaina F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010264.pub2; Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2019	14	3							e0213858	10.1371/journal.pone.0213858	http://dx.doi.org/10.1371/journal.pone.0213858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO9WM	30875413	Green Submitted, gold, Green Published			2022-12-26	WOS:000461316400037
J	Chiu, SY; Chung, HJ; Chen, YT; Huang, MS; Huang, CC; Huang, SF; Matsuura, I				Chiu, Shu-Yi; Chung, Hsiang-Ju; Chen, Ya-Ting; Huang, Min-Syuan; Huang, Chien-Chih; Huang, Shiu-Feng; Matsuura, Isao			A nonsense mutant of the hepatitis B virus large S protein antagonizes multiple tumor suppressor pathways through c-Jun activation domain-binding protein1	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; INHIBITOR P27(KIP1); SURFACE GENE; HBX GENE; EXPRESSION; DEGRADATION; JAB1/CSN5; JAB1; HEPATOCARCINOGENESIS; PROLIFERATION	Hepatitis B virus (HBV) is a major cause of hepatocellular carcinoma (HCC). Previous studies have identified recurrent nonsense mutations in the HBV large S (LHBs) gene from the liver from HBV core antigen-positive HCC patients. These nonsense mutants have been shown to be oncogenic in mouse xenograft models using a mouse embryonic fibroblast cell line. Here, we expressed in a liver cell line Huh-7 a carboxy terminally truncated protein from a nonsense mutant of the LHBs gene, sW182* (stop codon at tryptophane-182). Although the sW182* protein appeared not to be very stable in the cultured liver cells, we confirmed that the protein can be highly expressed and retained for a prolonged period of time in the hepatocytes in the mouse liver, indicating its stable nature in the physiological condition. In the Huh-7 cells, the sW182* mutant downregulated tumor suppressors p53 and Smad4. This downregulation was reversed by a proteasome inhibitor MG132, implying the involvement of proteasome-based protein degradation in the observed regulation of the tumor suppressors. On the other hand, we found that c-Jun activation domain-binding protein 1 (Jab1) physically interacts with the sW182*, but not wild-type LHBs. RNA interference (RNAi) of Jab1 restored the levels of the downregulated p53 and Smad4. The sW182* mutant inhibited the promoter activity of downstream target genes of the tumor suppressors. Consistently, Jab1 RNAi reversed the inhibition. These results suggest that the LHBs nonsense mutant antagonizes the tumor suppressor pathways through Jab1 in the liver contributing to HCC development.	[Chiu, Shu-Yi; Chung, Hsiang-Ju; Chen, Ya-Ting; Huang, Min-Syuan; Huang, Chien-Chih; Huang, Shiu-Feng; Matsuura, Isao] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan	National Health Research Institutes - Taiwan	Matsuura, I (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Taiwan.	imatsuura@nhri.org.tw			National Health Research Institutes [MG-106-PP-07]; Ministry of Science and Technology [103-2314-B-400-017-MY2, 105-2314-B-400-033-MY2, 106-2314-B-400-027-MY2]	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants to IM from National Health Research Institutes (URL: nori.org.tw) (grant number: MG-106-PP-07) and Ministry of Science and Technology (URL: most.gov.tw) (grant numbers : 103-2314-B-400-017-MY2, 105-2314-B-400-033-MY2, 106-2314-B-400-027-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Berg JP, 2007, HUM PATHOL, V38, P1621, DOI 10.1016/j.humpath.2007.03.007; Buendia MA, 1998, BIOMED PHARMACOTHER, V52, P34, DOI 10.1016/S0753-3322(97)86239-7; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; DUNSFORD HA, 1990, CANCER RES, V50, P3400; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Emberley ED, 2003, CANCER RES, V63, P1954; Fan FY, 2000, J GASTROEN HEPATOL, V15, P519; FEITELSON M, 1992, CLIN MICROBIOL REV, V5, P275, DOI 10.1128/CMR.5.3.275-301.1992; Hsieh YH, 2007, MOL CANCER RES, V5, P1063, DOI 10.1158/1541-7786.MCR-07-0098; Huang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089753; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang SS, 2014, BBA-MOL BASIS DIS, V1842, P1080, DOI 10.1016/j.bbadis.2014.03.007; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; Lakhtakia R, 2003, J GASTROEN HEPATOL, V18, P80, DOI 10.1046/j.1440-1746.2003.02902.x; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Muthumani K., 2006, PROTOC EXCHANGE, DOI [10.1038/nprot.2006.362, DOI 10.1038/NPROT.2006.362]; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; OHAKI Y, 1983, CANCER, V51, P822, DOI 10.1002/1097-0142(19830301)51:5<822::AID-CNCR2820510513>3.0.CO;2-C; Pan YB, 2014, CANCER BIOL THER, V15, P256, DOI 10.4161/cbt.27823; Pan YB, 2012, CANCER LETT, V326, P155, DOI 10.1016/j.canlet.2012.07.033; ROBINSON WS, 1994, ANNU REV MED, V45, P297; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Teng YC, 2017, J PATHOL, V241, P463, DOI 10.1002/path.4850; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wan M, 2002, EMBO REP, V3, P171, DOI 10.1093/embo-reports/kvf024; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang YL, 2004, HEPATOLOGY, V39, P318, DOI 10.1002/hep.20076; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504	35	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0208665	10.1371/journal.pone.0208665	http://dx.doi.org/10.1371/journal.pone.0208665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870427	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300006
J	Hobbs, J; Round, JM; Allison, MJ; Helbing, CC				Hobbs, Jared; Round, Jessica M.; Allison, Michael J.; Helbing, Caren C.			Expansion of the known distribution of the coastal tailed frog, Ascaphus truei, in British Columbia, Canada, using robust eDNA detection methods	PLOS ONE			English	Article							ENVIRONMENTAL DNA; OCCUPANCY	The coastal tailed frog (Ascaphus truei) is endemic to the Pacific Northwest of North America and is listed as a species of Special Concern under the Canadian Species at Risk Act. Its range is limited to British Columbia where it occurs widely west of the Coast Mountain Ranges extending north almost to the Alaskan Panhandle. The present study focused on surveying within the Cayoosh, Bridge (Shulaps), Seton, Anderson, Carpenter, and Downton Lake drainages. Four years of previous inventory efforts using conventional time-constrained search (TCS) methods detected tailed frog at 23/292 discrete sites (7.9% detection rate) in seven watersheds. Non-invasive environmental DNA (eDNA) methods hold promise for cryptic and low-abundance species detection. We rigorously validated a quantitative real-time polymerase chain reaction (qPCR)-based tool for detecting coastal tailed frog eDNA in water samples. This eASTR4 test is highly specific and sensitive. We applied a two-step targeted eDNA analysis approach on duplicate filtered water samples from a total of 72 sites collected over five days. The first IntegritE-DNA step mitigates false negative results and tests all DNA samples for the ability to support amplification from endogenous plant chloroplast DNA as a measure of sample viability. Three DNA samples failed this step even after inhibitor clean up suggesting that these samples were poor quality and not reliable for targeted species' DNA analyses. All other DNA samples were deemed viable and were then tested for species-specific DNA. Coastal tailed frog eDNA was detected in 55/72 (76%) discrete stream reaches; nine sites with historical known occurrence were all eDNA positive. The false negative rate for TCS compared to eDNA methods was 58%. The results expand known coastal tailed frog distribution to 24 watersheds effectively more than tripling extant occurrences and confirm a previously suspected, apparently isolated coastal tailed frog metapopulation in the Shulaps drainage.	[Hobbs, Jared] Hemmera Envirochem Inc, Victoria, BC, Canada; [Round, Jessica M.; Allison, Michael J.; Helbing, Caren C.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria	Helbing, CC (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	chelbing@uvic.ca	Allison, Michael J/S-7984-2017	Helbing, Caren/0000-0002-8861-1070	Fish and Wildlife Compensation Program (FWCP); BC Ministry of Environment and Climate Change Strategy through the Land-based Investment Strategy (LBIS)	Fish and Wildlife Compensation Program (FWCP); BC Ministry of Environment and Climate Change Strategy through the Land-based Investment Strategy (LBIS)	This work was supported by the Fish and Wildlife Compensation Program (FWCP) and the BC Ministry of Environment and Climate Change Strategy through the Land-based Investment Strategy (LBIS). FWCP program partners include BC Hydro, the Province of BC, Fisheries and Oceans Canada, First Nations and the public; working together to conserve and enhance fish and wildlife impacted by the construction of BC Hydro dams. The funders did not play a role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of research materials. JH is an employee of Hemmera Envirochem Inc. who provided support in the form of salary for JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "Author contributions" section.	BC Conservation Data Centre, 2018, BC SPEC EC EXPL; BROWN HA, 1975, COMP BIOCHEM PHYSIOL, V50, P397, DOI 10.1016/0300-9629(75)90033-X; CLAUSSEN DL, 1973, COMP BIOCHEM PHYSIOL, V44, P155, DOI 10.1016/0300-9629(73)90378-2; Coble AA, 2019, SCI TOTAL ENVIRON, V649, P1157, DOI 10.1016/j.scitotenv.2018.08.370; COSEWIC, 2013, COSEWIC ASS STAT REP, pxii; Crother BI, 2012, HERPETOLOGICAL CIRCU; DAUGHERTY CH, 1982, HERPETOLOGICA, V38, P461; Dupuis L, 1999, FOREST ECOL MANAG, V124, P35, DOI 10.1016/S0378-1127(99)00051-1; Dupuis L., 2004, COASTAL TAILED FROG, P12; Eiler A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23740-5; Essner RL, 2010, NATURWISSENSCHAFTEN, V97, P935, DOI 10.1007/s00114-010-0697-4; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Frid L, 2003, DEFINING EFFECTIVE W, P35; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hobbs J., 2017, COAF17W1286 FISH WIL, P21; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2017, EXPT OBSERVATIONS DE, DOI [10.5066/F7F769P1, DOI 10.5066/F7F769P1]; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Meidinger D, 1991, ECOSYSTEMS OF BC; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Ritland K, 2000, CAN J ZOOL, V78, P1749, DOI 10.1139/cjz-78-10-1749; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Veldhoen N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164907	28	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213849	10.1371/journal.pone.0213849	http://dx.doi.org/10.1371/journal.pone.0213849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870505	Green Published, gold, Green Submitted			2022-12-26	WOS:000461166300088
J	Piotrzkowska-Wroblewska, H; Dobruch-Sobczak, K; Klimonda, Z; Karwat, P; Roszkowska-Purska, K; Gumowska, M; Litniewski, J				Piotrzkowska-Wroblewska, Hanna; Dobruch-Sobczak, Katarzyna; Klimonda, Ziemowit; Karwat, Piotr; Roszkowska-Purska, Katarzyna; Gumowska, Magdalena; Litniewski, Jerzy			Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter	PLOS ONE			English	Article							THERAPY; TUMORS	Background Neoadjuvant chemotherapy (NAC) is used in patients with breast cancer to reduce tumor focus, metastatic risk, and patient mortality. Monitoring NAC effects is necessary to capture resistant patients and stop or change treatment. The existing methods for evaluating NAC results have some limitations. The aim of this study was to assess the tumor response at an early stage, after the first doses of the NAC, based on the variability of the backscattered ultrasound energy, and backscatter statistics. The backscatter statistics has not previously been used to monitor NAC effects. Methods The B-mode ultrasound images and raw radio frequency data from breast tumors were obtained using an ultrasound scanner before chemotherapy and 1 week after each NAC cycle. The study included twenty-four malignant breast cancers diagnosed in sixteen patients and qualified for neoadjuvant treatment before surgery. The shape parameter of the homodyned K distribution and integrated backscatter, along with the tumor size in the longest dimension, were determined based on ultrasound data and used as markers for NAC response. Cancer tumors were assigned to responding and non-responding groups, according to histopathological evaluation, which was a reference in assessing the utility of markers. Statistical analysis was performed to rate the ability of markers to predict the final NAC response based on data obtained after subsequent therapeutic doses. Results Statistically significant differences (p<0.05) between groups were obtained after 2, 3, 4, and 5 doses of NAC for quantitative ultrasound markers and after 5 doses for the assessment based on maximum tumor dimension. Statistical analysis showed that, after the second and third NAC courses the classification based on integrated backscatter marker was characterized by an AUC of 0.69 and 0.82, respectively. The introduction of the second quantitative marker describing the statistical properties of scattering increased the corresponding AUC values to 0.82 and 0.91. Conclusions Quantitative ultrasound information can characterize the tumor's pathological response better and at an earlier stage of therapy than the assessment of the reduction of its dimensions. The introduction of statistical parameters of ultrasonic backscatter to monitor the effects of chemotherapy can increase the effectiveness of monitoring and contribute to a better personalization of NAC therapy.	[Piotrzkowska-Wroblewska, Hanna; Dobruch-Sobczak, Katarzyna; Klimonda, Ziemowit; Karwat, Piotr; Litniewski, Jerzy] Polish Acad Sci, Inst Fundamental Technol Res, Ultrasound Dept, Warsaw, Poland; [Dobruch-Sobczak, Katarzyna; Gumowska, Magdalena] M Sklodowska Curie Mem, Canc Ctr, Radiol Dept, Warsaw, Poland; [Dobruch-Sobczak, Katarzyna; Roszkowska-Purska, Katarzyna; Gumowska, Magdalena] M Sklodowska Curie Mem, Inst Oncol, Warsaw, Poland; [Roszkowska-Purska, Katarzyna] M Sklodowska Curie Mem, Canc Ctr, Dept Pathol, Warsaw, Poland	Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Litniewski, J (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Ultrasound Dept, Warsaw, Poland.	jlitn@ippt.pan.pl	Litniewski, Jerzy/AAB-4185-2020	Litniewski, Jerzy/0000-0003-3978-9099; Klimonda, Ziemowit/0000-0003-1695-7096; Piotrzkowska-Wroblewska, Hanna/0000-0002-0980-1360; Karwat, Piotr/0000-0002-2104-1130; Dobruch-Sobczak, Katarzyna/0000-0003-1470-4140	National Science Centre, Poland [2016/23/B/ST8/03391]	National Science Centre, Poland(National Science Centre, Poland)	The study was supported by grant, 2016/23/B/ST8/03391 to JL from the National Science Centre, Poland (funder's website: https://ncn.gov.pl/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberro JA, 2018, LANCET ONCOL, V19, P27, DOI 10.1016/S1470-2045(17)30777-5; Avril S, 2016, J NUCL MED, V57, p34S, DOI 10.2967/jnumed.115.157875; Banihashemi B, 2008, ULTRASOUND IMAGING A, DOI 10.1.1.533.9640; BERGER G, 1990, ULTRASONIC IMAGING, V12, P47, DOI 10.1016/0161-7346(90)90220-R; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Dabbs D. J, 2016, BREAST PATHOLOGY, V2; Dialani V, 2015, ANN SURG ONCOL, V22, P1416, DOI 10.1245/s10434-015-4403-9; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Evans A, 2018, ULTRASCHALL MED, V39, P422, DOI 10.1055/s-0043-111589; Falou O, 2012, TRANSL ONCOL, V5, P238, DOI 10.1593/tlo.11346; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman J, 2001, SPRINGER SERIES STAT, V10; Giordano SH, 2003, ONCOLOGIST, V8, P521, DOI 10.1634/theoncologist.8-6-521; Hruska DP, 2009, IEEE T ULTRASON FERR, V56, P2471, DOI 10.1109/TUFFC.2009.1334; JAKEMAN E, 1980, J PHYS A-MATH GEN, V13, P31, DOI 10.1088/0305-4470/13/1/006; Lin QG, 2018, ONCOTARGET, V9, P2668, DOI 10.18632/oncotarget.23625; Machado JC, 2001, IEEE T ULTRASON FERR, V48, P17, DOI 10.1109/58.895900; Marinovich ML, 2015, INT J CANCER, V136, P2730, DOI 10.1002/ijc.29323; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mendelson EB, 2013, ACR BI RADS ATLAS BR, P149; Morigi C, 2017, ECANCERMEDICALSCIENC; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Oelze ML, 2016, IEEE T ULTRASON FERR, V63, P336, DOI 10.1109/TUFFC.2015.2513958; Oelze ML, 2004, J ACOUST SOC AM, V115, P3226, DOI 10.1121/1.1739484; Ogston KN, 2003, BREAST, V12, P320, DOI 10.1016/S0960-9776(03)00106-1; Sadeghi-Naini A, 2013, MED PHYS, V40; Sadeghi-Naini A, 2015, ONCOSCIENCE; Sadeghi-Naini A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09678-0; Sadeghi-Naini A, 2015, MED PHYS, V42, P6130, DOI 10.1118/1.4931603; Sannachi L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189634; Sannachi L, 2015, MED IMAGE ANAL, V20, P224, DOI 10.1016/j.media.2014.11.009; Sethi D, 2013, INDIAN J CANCER, V50, P58, DOI 10.4103/0019-509X.112301; Spring L, 2016, PATHOLOGICAL COMPLET; Topp KA, 2001, J ULTRAS MED, V20, P605, DOI 10.7863/jum.2001.20.6.605; UEDA M, 1985, J ACOUST SOC AM, V77, P38, DOI 10.1121/1.391898; YAO LX, 1990, ULTRASONIC IMAGING, V12, P58, DOI 10.1016/0161-7346(90)90221-I	36	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213749	10.1371/journal.pone.0213749	http://dx.doi.org/10.1371/journal.pone.0213749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870478	Green Published, Green Submitted, gold			2022-12-26	WOS:000461166300067
J	Chen, SW; Lu, YA; Lee, CC; Chou, AH; Wu, VCC; Chang, SW; Fan, PC; Tian, YC; Tsai, FC; Chang, CH				Chen, Shao-Wei; Lu, Yueh-An; Lee, Cheng-Chia; Chou, An-Hsun; Wu, Victor Chien-Chia; Chang, Su-Wei; Fan, Pei-Chun; Tian, Ya-Chung; Tsai, Feng-Chun; Chang, Chih-Hsiang			Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; CLINICAL-TRIALS; RISK; AKI; SURVIVAL; FAILURE; SUPPORT; IMPACT; ADULTS; ECMO	Background Acute kidney injury (AKI) is a common complication of extracorporeal membrane oxygenation (ECMO) treatment. The aim of this study was to elucidate the long-term outcomes of adult patients with AKI who receive ECMO. Materials and methods The study analyzed encrypted datasets from Taiwan's National Health Insurance Research Database. The data of 3251 patients who received first-time ECMO treatment between January 1, 2003, and December 31, 2013, were analyzed. Characteristics and outcomes were compared between patients who required dialysis for AKI (D-AKI) and those who did not in order to evaluate the impact of D-AKI on long-term mortality and major adverse kidney events. Results Of the 3251 patients, 54.1% had D-AKI. Compared with the patients without D-AKI, those with D-AKI had higher rates of all-cause mortality (52.3% vs. 33.3%; adjusted hazard ratio [aHR] 1.82, 95% confidence interval [CI] 1.53-2.17), chronic kidney disease (13.7% vs. 8.1%; adjusted subdistribution HR [aSHR] 1.66, 95% CI 1.16-2.38), and end-stage renal disease (5.2% vs. 0.5%; aSHR 14.28, 95% CI 4.67-43.62). The long-term mortality of patients who survived more than 90 days after discharge was 22.0% (153/695), 32.3% (91/282), and 50.0% (10/20) in the patients without D-AKI, with recovery D-AKI, and with nonrecovery D-AKI who required long-term dialysis, respectively, demonstrating a significant trend (Pfor trend <0.001). Conclusion AKI is associated with an increased risk of long-term mortality and major adverse kidney events in adult patients who receive ECMO.	[Chen, Shao-Wei; Tsai, Feng-Chun] Chang Gung Mem Hosp, Dept Cardiothorac & Vasc Surg, Linkou Med Ctr, Taoyuan, Taiwan; [Chen, Shao-Wei; Lee, Cheng-Chia; Fan, Pei-Chun; Tian, Ya-Chung; Chang, Chih-Hsiang] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Lu, Yueh-An; Lee, Cheng-Chia; Fan, Pei-Chun; Tian, Ya-Chung; Chang, Chih-Hsiang] Change Gung Mem Hosp, Linkou Branch, Dept Nephrol, Kidney Res Ctr, Taoyuan, Taiwan; [Chou, An-Hsun] Chang Gung Univ, Chang Gung Mem Hosp, Dept Anesthesiol, Linkou Med Ctr, Taoyuan, Taiwan; [Wu, Victor Chien-Chia] Chang Gung Mem Hosp, Keelung Branch, Dept Cardiol, Taoyuan, Taiwan; [Wu, Victor Chien-Chia] Linkou Med Ctr, Taoyuan, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chang, Su-Wei] Chang Gung Mem Hosp, Div Allergy Asthma & Rheumatol, Dept Pediat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chang, CH (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.; Chang, CH (corresponding author), Change Gung Mem Hosp, Linkou Branch, Dept Nephrol, Kidney Res Ctr, Taoyuan, Taiwan.	sunchang@cgmh.org.tw	Wu, Victor Chien-Chia/GXF-4623-2022; Wu, Victor Chien-Chia/ABB-6872-2021; Chang, Chih-Hsiang/P-8662-2017	Wu, Victor Chien-Chia/0000-0002-9918-4369; Wu, Victor Chien-Chia/0000-0002-9918-4369; Lee, Cheng-Chia/0000-0002-6973-5908; Lu, Yueh-An/0000-0002-5486-2357; Chang, Chih-Hsiang/0000-0002-7342-335X	Chang Gung Memorial Hospital, Taiwan [CMRPG3F1652, BMRPD97]; Ministry of Science and Technology [106-2314-B-182A-118 -MY3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	CHC was supported by grants from Chang Gung Memorial Hospital, Taiwan (CMRPG3F1652, BMRPD97 and the Ministry of Science and Technology (106-2314-B-182A-118 -MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci E, 2016, ARTIF ORGANS, V40, P746, DOI 10.1111/aor.12695; Brenner BM, 1997, KIDNEY INT, pS124; Burrell Aidan J C, 2015, J Crit Care, V30, P949, DOI 10.1016/j.jcrc.2015.05.022; Chang CH, 2016, CIRCULATION, V133, P2423, DOI 10.1161/CIRCULATIONAHA.115.019143; Chang CH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001703; Chawla LS, 2014, CLIN J AM SOC NEPHRO, V9, P448, DOI 10.2215/CJN.02440213; Chen SW, 2017, J THORAC CARDIOV SUR, V154, P469, DOI 10.1016/j.jtcvs.2017.02.055; Chen YC, 2014, J FORMOS MED ASSOC, V113, P778, DOI 10.1016/j.jfma.2014.04.006; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; De Corte W, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1409-z; Depret F, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1837-4; Devasagayaraj R, 2018, PERFUSION-UK, V33, P375, DOI 10.1177/0267659118755272; Diddle JW, 2015, CRIT CARE MED, V43, P1016, DOI 10.1097/CCM.0000000000000920; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hamdi T, 2017, AM J NEPHROL, V46, P139, DOI 10.1159/000479342; Han SS, 2015, ANN THORAC SURG, V100, P1485, DOI 10.1016/j.athoracsur.2015.06.018; Heung M, 2016, AM J KIDNEY DIS, V67, P742, DOI 10.1053/j.ajkd.2015.10.019; Horne KL, 2015, NEPHRON, V131, P102, DOI 10.1159/000439066; Kielstein JT, 2013, NEPHROL DIAL TRANSPL, V28, P86, DOI 10.1093/ndt/gfs398; Lai TS, 2013, CRIT CARE, V17, DOI 10.1186/cc13054; Lee CC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203447; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lim CC, 2015, CARDIORENAL MED, V5, P157, DOI 10.1159/000381068; Ma PY, 2014, HEART LUNG CIRC, V23, P363, DOI 10.1016/j.hlc.2013.10.081; Molitoris BA, 2012, CLIN J AM SOC NEPHRO, V7, P856, DOI 10.2215/CJN.12821211; Omotoso BA, 2016, CLIN NEPHROL, V85, P1, DOI 10.5414/CN108671; Palevsky PM, 2012, CLIN J AM SOC NEPHRO, V7, P844, DOI 10.2215/CJN.12791211; Sawhney S, 2017, AM J KIDNEY DIS, V69, P18, DOI 10.1053/j.ajkd.2016.05.018; Schmidt M, 2014, INTENS CARE MED, V40, P1256, DOI 10.1007/s00134-014-3360-2; Selewski DT, 2017, PEDIATR CRIT CARE ME, V18, P1126, DOI 10.1097/PCC.0000000000001349; Shaheen A, 2016, J CARDIAC SURG, V31, P248, DOI 10.1111/jocs.12690; Soliman IW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1416-0; Thongprayoon C, 2016, J AM SOC NEPHROL, V27, P1854, DOI 10.1681/ASN.2015050577; Tsai TY, 2017, J FORMOS MED ASSOC, V116, P844, DOI 10.1016/j.jfma.2017.08.004; Villa G, 2016, CARDIORENAL MED, V6, P50, DOI 10.1159/000439444; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu MY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002870; Wu PC, 2015, CLIN J AM SOC NEPHRO, V10, P353, DOI 10.2215/CJN.01240214; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Xu JR, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002025	41	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212352	10.1371/journal.pone.0212352	http://dx.doi.org/10.1371/journal.pone.0212352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865662	Green Published, Green Submitted, gold			2022-12-26	WOS:000461048900017
J	Shi, XY; Garcia, G; Wang, YN; Reiter, JF; Huang, B				Shi, Xiaoyu; Garcia, Galo, III; Wang, Yina; Reiter, Jeremy F.; Huang, Bo			Deformed alignment of super-resolution images for semi-flexible structures	PLOS ONE			English	Article							MICROSCOPY REVEALS; ARCHITECTURE; RESOLUTION	Due to low labeling efficiency and structural heterogeneity in fluorescence-based single molecule localization microscopy (SMLM), image alignment and quantitative analysis is often required to make accurate conclusions on the spatial relationships between proteins. Cryo-electron microscopy (EM) image alignment procedures have been applied to average structures taken with super-resolution microscopy. However, unlike cryo-EM, the much larger cellular structures analyzed by super-resolution microscopy are often heterogeneous, resulting in misalignment. And the light-microscopy image library is much smaller, which makes classification challenging. To overcome these two challenges, we developed a method to deform semi-flexible ring-shaped structures and then align the 3D structures without classification. These algorithms can register semi-flexible structures with an accuracy of several nanometers in short computation time and with greatly reduced memory requirements. We demonstrated our methods by aligning experimental Stochastic Optical Reconstruction Microscopy (STORM) images of ciliary distal appendages and simulated structures. Symmetries, dimensions, and locations of protein complexes in 3D are revealed by the alignment and averaging for heterogeneous, tilted, and under-labeled structures.	[Shi, Xiaoyu; Wang, Yina; Huang, Bo] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Garcia, Galo, III; Reiter, Jeremy F.; Huang, Bo] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Garcia, Galo, III; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Huang, Bo] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, B (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.; Huang, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Huang, B (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	bo.huang@ucsf.edu	Wang, Yina/M-4763-2019	Huang, Bo/0000-0003-1704-4141	National Institutes of Health [DP20D008479, R01GM124334, R01AR054396, R01GM095941, F32GM109714]; NIH [K99GM126136]; UCSF; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM126136, R01GM095941, R01GM124334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project is supported by the National Institutes of Health (Director's New Innovator Award DP20D008479 and R01GM124334 to B.H., R01AR054396 and R01GM095941 to J.F.R., F32GM109714 to G.G.III), and by the NIH Pathway to Independence Award (K99GM126136) and the UCSF Mary Anne Koda-Kimble Seed Award for Innovation to X.S. B.H. is a Chan Zuckerberg Biohub investigator.	Cheng Y, 2015, CELL, V161, P438, DOI 10.1016/j.cell.2015.03.050; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Elia N, 2013, CELL, V155, P1220, DOI 10.1016/j.cell.2013.11.011; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hagiwara H, 2008, MED MOL MORPHOL, V41, P221, DOI 10.1007/s00795-008-0422-y; Hall RJ, 2004, J STRUCT BIOL, V145, P19, DOI 10.1016/j.jsb.2003.10.024; Heydarian H, 2018, NAT METHODS, V15, P781, DOI 10.1038/s41592-018-0136-6; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; LATA KR, 1995, ULTRAMICROSCOPY, V58, P381, DOI 10.1016/0304-3991(95)00002-I; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Pelletier L, 2012, CURR OPIN CELL BIOL, V24, P541, DOI 10.1016/j.ceb.2012.05.005; Salas D, 2017, P NATL ACAD SCI USA, V114, P9273, DOI 10.1073/pnas.1704908114; Schnitzbauer J, 2018, P NATL ACAD SCI USA, V115, P3219, DOI 10.1073/pnas.1711314115; Shi XY, 2017, NAT CELL BIOL, V19, P1178, DOI 10.1038/ncb3599; Sieben C, 2018, NAT METHODS, V15, P777, DOI 10.1038/s41592-018-0140-x; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yang TT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04469-1; Yang TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14096	21	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212735	10.1371/journal.pone.0212735	http://dx.doi.org/10.1371/journal.pone.0212735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865666	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900034
J	Essandoh, K; Deng, S; Wang, XH; Jiang, M; Mu, XJ; Peng, JT; Li, YT; Peng, TQ; Wagner, KU; Rubinstein, J; Fan, GC				Essandoh, Kobina; Deng, Shan; Wang, Xiaohong; Jiang, Min; Mu, Xingjiang; Peng, Jiangtong; Li, Yutian; Peng, Tianqing; Wagner, Kay-Uwe; Rubinstein, Jack; Fan, Guo-Chang			Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R	FASEB JOURNAL			English	Article						Rab11-FIP3; exercise training; cardiac remodeling; membrane receptor; endosomes	CELL-CYCLE ARREST; GROWTH; RECEPTOR; PROTEIN; INTERNALIZATION; OVEREXPRESSION; PROLIFERATION; UBIQUITIN; MEDIATE; AKT	Development of physiologic cardiac hypertrophy has primarily been ascribed to the IGF-1 and its receptor, IGF-1 receptor (IGF-1R), and subsequent activation of the protein kinase B (Akt) pathway. However, regulation of endosome-mediated recycling and degradation of IGF-1R during physiologic hypertrophy has not been investigated. In a physiologic hypertrophy model of treadmill-exercised mice, we observed that levels of tumor susceptibility gene 101 (Tsg101), a key member of the endosomal sorting complex required for transport, were dramatically elevated in the heart compared with sedentary controls. To determine the role of Tsg101 on physiologic hypertrophy, we generated a transgenic (TG) mouse model with cardiac-specific overexpression of Tsg101. These TG mice exhibited a physiologic-like cardiac hypertrophy phenotype at 8 wk evidenced by: 1) the absence of cardiac fibrosis, 2) significant improvement of cardiac function, and 3) increased total and plasma membrane levels of IGF-1R and increased phosphorylation of Akt. Mechanistically, we identified that Tsg101 interacted with family-interacting protein 3 (FIP3) and IGF-1R, thereby stabilizing FIP3 and enhancing recycling of IGF-1R. In vitro, adenovirus-mediated overexpression of Tsg101 in neonatal rat cardiomyocytes resulted in cell hypertrophy, which was blocked by addition of monensin, an inhibitor of endosome-mediated recycling, and by small interfering RNA-mediated knockdown (KD) of FIP3. Furthermore, cardiac-specific KD of Tsg101 showed a significant reduction in levels of endosomal recycling compartment members (Rab11a and FIP3), IGF-1R, and Akt phosphorylation. Most interestingly, Tsg101-KD mice failed to develop cardiac hypertrophy after intense treadmill training. Taken together, our data identify Tsg101 as a novel positive regulator of physiologic cardiac hypertrophy through facilitating the FIP3-mediated endosomal recycling of IGF-1R.-Essandoh, K., Deng, S., Wang, X., Jiang, M., Mu, X., Peng, J., Li, Y., Peng, T., Wagner, K.-U., Rubinstein, J., Fan, G.-C. Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R.	[Essandoh, Kobina; Deng, Shan; Wang, Xiaohong; Mu, Xingjiang; Li, Yutian; Fan, Guo-Chang] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Deng, Shan; Peng, Jiangtong] Huazhong Univ Sci & Technol, Union Hosp, Dept Cardiol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Jiang, Min; Rubinstein, Jack] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45267 USA; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON, Canada; [Wagner, Kay-Uwe] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Detroit, MI USA	University System of Ohio; University of Cincinnati; Huazhong University of Science & Technology; University System of Ohio; University of Cincinnati; Western University (University of Western Ontario); Barbara Ann Karmanos Cancer Institute; Wayne State University	Fan, GC (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Wagner, Kay-Uwe/0000-0002-5081-0226; Li, Yutian/0000-0002-5118-0916; Rubinstein, Jack/0000-0002-8811-1551	U.S. National Institutes of Health; National Institute of General Medical Sciences [R01 GM-112930, GM-126061]; American Heart Association (AHA) Established Investigator Award [17EIA33400063]; AHA Predoctoral Fellowship [18PRE34030123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126061, R01GM132149, R01GM112930] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association (AHA) Established Investigator Award(American Heart Association); AHA Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported partially by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants R01 GM-112930 and GM-126061, American Heart Association (AHA) Established Investigator Award 17EIA33400063 (to G.-C.F.), and AHA Predoctoral Fellowship 18PRE34030123 (to K.E.). The authors declare no conflicts of interest.	Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Carstens MJ, 2004, J BIOL CHEM, V279, P35984, DOI 10.1074/jbc.M400408200; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Haugland Rosaria P., 2008, V418, P1; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Horgan CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032030; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Ismaili N, 2005, J BIOL CHEM, V280, P11120, DOI 10.1074/jbc.M500059200; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; O'Reilly MK, 2011, J IMMUNOL, V186, P1554, DOI 10.4049/jimmunol.1003005; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Rubinstein J, 2014, AM J PHYSIOL-HEART C, V306, pH574, DOI 10.1152/ajpheart.00854.2013; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Rush JS, 2013, MOL CELL ENDOCRINOL, V381, P188, DOI 10.1016/j.mce.2013.07.029; Shimizu I, 2016, J MOL CELL CARDIOL, V97, P245, DOI 10.1016/j.yjmcc.2016.06.001; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Yang LW, 2016, J BIOL CHEM, V291, P15700, DOI 10.1074/jbc.M116.715805; Zhang AL, 2014, J BIOL CHEM, V289, P29180, DOI 10.1074/jbc.M114.576561; Zhu G, 2004, INT J CANCER, V109, P541, DOI 10.1002/ijc.20014	39	10	11	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					7451	7466		10.1096/fj.201802338RR	http://dx.doi.org/10.1096/fj.201802338RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30884248	Green Published, Bronze			2022-12-26	WOS:000476114200063
J	Antonio, VS; Amade, NA; Muianga, AF; Ali, S; Monteiro, V; Mula, F; Chelene, I; Oludele, J; Chongo, I; Jose, A; Augusto, O; Gudo, ES				Antonio, Virgilio Santo; Amade, Nadia Alves; Muianga, Argentina Felisbela; Ali, Sadia; Monteiro, Vanessa; Mula, Flora; Chelene, Imelda; Oludele, John; Chongo, Inocencio; Jose, Americo; Augusto, Orvalho; Gudo, Eduardo Samo			Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control	PLOS ONE			English	Article							REUNION ISLAND; OUTBREAK; INFECTION; DISEASE; SPREAD	Introduction Longitudinal data and trends about chikungunya virus (CHIKV) are critical for its control, however in Mozambique very few studies were conducted over 5 decades, between 1957 and 2013. In this study, we retrospectively investigated the occurrence, geographical distribution and trend of anti-CHIKV antibodies between 2009 and 2015 in Mozambique using serum samples from febrile patients. Methods A total of 895 serum samples collected from febrile patients for measles and rubella surveillance between 2009 and 2015 in 127 districts of Mozambique were retrospectively tested for IgM and IgG antibodies against CHIKV using a commercially available ELISA. Results The median age of patients was 2 years (IQR: 1-5 years) and 44.2% (395/895) of them were female. We found that 54 (6.0%) of samples were positive for anti-IgM chikungunya, and 160 (17.9%) were positive for anti-CHIKV IgG. Antibodies against CHIKV (IgM and IgG) were identified in serum throughout 2009 to 2015. While frequency of IgG antibodies was significantly higher in 2015 as compared to other years, frequency of IgM antibodies was homogeneous between 2009 and 2015. Antibodies against CHIKV were reported in all provinces and in 84 (66.1%) of the districts studied. Frequency of IgM and IgG antibodies was not significantly similar between age groups. Conclusion This is the largest and longest serological screening of antibodies against CHIKV in febrile patients in Mozambique and findings from this study suggest that Mozambicans from all over the country have been silently exposed to CHIKV for several years.	[Antonio, Virgilio Santo; Amade, Nadia Alves; Muianga, Argentina Felisbela; Ali, Sadia; Monteiro, Vanessa; Mula, Flora; Chelene, Imelda; Oludele, John; Chongo, Inocencio; Gudo, Eduardo Samo] Natl Inst Hlth, Virus Isolat Lab, Maputo, Mozambique; [Jose, Americo] Natl Inst Hlth, Polana Canico Res & Training Ctr, Maputo, Mozambique; [Augusto, Orvalho] Eduardo Mondlane Univ, Dept Microbiol, Fac Med, Maputo, Mozambique	Eduardo Mondlane University	Gudo, ES (corresponding author), Natl Inst Hlth, Virus Isolat Lab, Maputo, Mozambique.	esamogudojr@gmail.com	Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968; Ali-Pereira, Sadia/0000-0001-5275-2659	European Foundation Initiative Into African Neglected Tropical Diseases [91488]	European Foundation Initiative Into African Neglected Tropical Diseases	This manuscript was funded by the European Foundation Initiative Into African Neglected Tropical Diseases, with grant number 91488 to ESG and URL http://africa-and-science.com/?p=1202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRO W, 2015, AFR REG GUID MEASL R; Aly Mussa Manuel, 2017, BMC Res Notes, V10, P88, DOI [10.1186/s13104-017-2394-2, 10.1186/s13104-017-2417-z]; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2; Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335; Gudo ES, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005001; Gudo ES, 2016, EMERG INFECT DIS, V22, P915, DOI 10.3201/eid2205.151002; Gudo ES, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004146; INE, 2017, CENS GER POP HAB RES; INS IaM, 2017, INQ IND IM MAL HIV S; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Kajeguka DC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1511-5; KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026; Lo Presti A, 2014, ASIAN PAC J TROP MED, V7, P925, DOI 10.1016/S1995-7645(14)60164-4; Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433; Mondlane C BN, 6 BIENN BERG EN DAL; Moor P. P. de, 1977, Medicine in a tropical environment. Proceedings of the International Symposium, South Africa/1976., P359; Mugabe VA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192110; Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Taraphdar D, 2012, T ROY SOC TROP MED H, V106, P160, DOI 10.1016/j.trstmh.2011.10.016; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213941	10.1371/journal.pone.0213941	http://dx.doi.org/10.1371/journal.pone.0213941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897135	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700050
J	Catteau, X; Simon, P; Jondet, M; Vanhaeverbeek, M; Noel, JC				Catteau, Xavier; Simon, Philippe; Jondet, Michel; Vanhaeverbeek, Michel; Noel, Jean-Christophe			Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival	PLOS ONE			English	Article							CANCER; MYOFIBROBLASTS; EXPRESSION; FIBROBLASTS; MATRIX; CELLS	Cancer progression results from a complex interplay between tumor cells and the extracellular milieu. In breast carcinoma, the stromal microenvironment has been suggested to play a major role in promoting tumor growth, progression, and invasion. The stroma of 154 resected specimens of invasive breast carcinoma of no special type was quantified using a digital image analyzer. Statistical analyses were performed between the quantity of stroma and survival, as well as between progression-free survival and clinicopathological data. Levels of myofibroblastic stroma varied from 0-46%, with a median of 15.1% and a standard deviation of 7.5. The myofibroblastic stromal reaction was statistically greater in grade 2 and 3 tumors (p = 0.029). Furthermore, there was a trend for worse progression-free survival in the group of node-negative tumors with strong smooth-muscle actin stromal expression (Log rank = 0.075). The present study demonstrates that the myofibroblastic reaction of breast invasive carcinoma of no special type is not merely a passive reaction, but seems to be an integral part of the neoplastic process by facilitating tumor progression and invasion. Additional, larger studies on mechanisms of stromal change are needed and may potentially lead to novel treatments.	[Catteau, Xavier] CHU Tivoli, Chirec, CUREPATH, Pathol Dept, Jumet, Belgium; [Catteau, Xavier; Noel, Jean-Christophe] Univ Libre Bruxelles, Erasme Univ Hosp, Pathol Dept, Brussels, Belgium; [Simon, Philippe] Univ Libre Bruxelles, Erasme Univ Hosp, Gynaecol Dept, Brussels, Belgium; [Jondet, Michel] Gynaecol Pathol Lab, Paris, France; [Vanhaeverbeek, Michel] Ctr Hosp Univ Charleroi, Lab Expt Med, Montignies le Tilleul, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Catteau, X (corresponding author), CHU Tivoli, Chirec, CUREPATH, Pathol Dept, Jumet, Belgium.; Catteau, X (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Pathol Dept, Brussels, Belgium.	xavier.catteau06@gmail.com	SIMON, Philippe/GXZ-4688-2022					Bates AL, 2015, J PATHOL, V235, P773, DOI 10.1002/path.4493; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Catteau X, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0196-6; Catteau X, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-499; Catteau X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057773; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; De Wever O, 2014, SEMIN CANCER BIOL, V25, P33, DOI 10.1016/j.semcancer.2013.12.009; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gobbi H, 2000, HISTOPATHOLOGY, V36, P168; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hanna MG, 2015, J CLIN PATHOL, V68, P499, DOI 10.1136/jclinpath-2015-202914; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Tan AR, 2009, BREAST CANCER RES TR, V115, P453, DOI 10.1007/s10549-008-0184-1; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Weinberg Robert, 2006, Cancer Res, V66, P11550, DOI 10.1158/0008-5472.CAN-06-3149	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0210263	10.1371/journal.pone.0210263	http://dx.doi.org/10.1371/journal.pone.0210263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897102	gold, Green Published, Green Submitted			2022-12-26	WOS:000461889700007
J	Correa, RDF; Ribeiro, RF; Mendes, SBO; dos Santos, PM; da Silva, MVA; Silva, DF; Biral, IP; de Batista, PR; Vassallo, DV; Bittencourt, AS; Stefanon, I; Fernandes, AA				Fernandes Correa, Rafaela de Araujo; Ribeiro Junior, Rogerio Faustino; Oliveira Mendes, Sara Bianca; dos Santos, Priscila Mendonca; Albino da Silva, Miracle Vitoria; Silva, Daniel Ferron; Biral, Igor Peixoto; de Batista, Priscila Rossi; Vassallo, Dalton Valentim; Bittencourt, Athelson Stefanon; Stefanon, Ivanita; Fernandes, Aurelia Araujo			Testosterone deficiency reduces the effects of late cardiac remodeling after acute myocardial infarction in rats	PLOS ONE			English	Article							CARDIOVASCULAR-SYSTEM; HEART-FAILURE; WEIGHT CHANGE; DISEASE; MEN; PATHOPHYSIOLOGY; MODEL	Testosterone is associated with an increased risk of coronary heart disease. This study evaluated cardiac remodeling 60 days after myocardial infarction (MI) in rats with testosterone deficiency. One week after castration, the animals underwent myocardial infarction. Rats were divided into four groups: orchidectomized (OCT); orchidectomized and infarcted (OCT+MI), MI and control (Sham). The myocyte cross-sectional area and the papillary muscle contractility were evaluated 8 weeks after MI. The coronary bed was perfused with Biodur E20 resin to evaluate the neovascularization after MI. Data were expressed as mean +/- SEM followed by ANOVA. Castration reduced myocyte hypertrophy when compared to Sham and myocardial infarction alone as well as preserved the contraction force and activation time after myocardial infarction. After beta-adrenergic stimulation, activation and relaxation kinetics were less impaired in the OCT+MI group than in the MI group. Contraction force was preserved in the OCT+MI group after beta-adrenergic stimulation. Multiple scanning electronic microscope images were obtained to characterize changes in the coronary arteries. Capillary density index was increased in the MI and OCT+MI groups compared with control. The MI and OCT+MI groups were characterized by irregular vessel arrangements with distorted shape, abrupt changes in vessel direction, as well as abrupt changes in diameter after bifurcations when compared to Sham and OCT. The results indicated that testosterone deficiency attenuates adverse cardiac remodeling after MI. Novel findings in this study were that testosterone deficiency in rats, induced by castration, changes the later remodeling after MI, when compared with non castrated rats. The absence of this androgenous hormone seems to be benefic against pathological hypertrophy.	[Fernandes Correa, Rafaela de Araujo; Oliveira Mendes, Sara Bianca; dos Santos, Priscila Mendonca; Albino da Silva, Miracle Vitoria; Silva, Daniel Ferron; Biral, Igor Peixoto; Bittencourt, Athelson Stefanon; Fernandes, Aurelia Araujo] Univ Fed Espirito Santo, Dept Morphol, Vitoria, ES, Spain; [Ribeiro Junior, Rogerio Faustino; Vassallo, Dalton Valentim; Stefanon, Ivanita] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Spain; [de Batista, Priscila Rossi] Sch Sci Santa Casa Misericordia Vitoria, Dept Physiotherapy, Vitoria, ES, Spain		Fernandes, AA (corresponding author), Univ Fed Espirito Santo, Dept Morphol, Vitoria, ES, Spain.	aureliaaf@hotmail.com		Stefanon, Ivanita/0000-0003-2638-5183				Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; ANVERSA P, 1991, AM J CARDIOL, V68, pD7; Arangannal A, 2008, SCAND CARDIOVASC J, V42, P90, DOI 10.1080/14017430801918864; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Awada HK, 2016, BIOMATERIALS, V82, P94, DOI 10.1016/j.biomaterials.2015.12.025; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; de Sa EQC, 2009, ARQ BRAS ENDOCRINOL, V53, P915, DOI 10.1590/S0004-27302009000800004; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cavasin MA, 2003, AM J PHYSIOL-HEART C, V284, pH1560, DOI 10.1152/ajpheart.01087.2002; Chen JQ, 2015, AM J PHYSIOL-HEART C, V308, pH830, DOI 10.1152/ajpheart.00583.2014; Elsherbiny A, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0838-x; Fernandes AA, 2015, LIFE SCI, V124, P24, DOI 10.1016/j.lfs.2015.01.010; Fraccarollo D, 2003, J AM COLL CARDIOL, V42, P1666, DOI 10.1016/j.jacc.2003.05.003; Gebara Otavio C. E., 2002, Arq. Bras. Cardiol., V79, P644, DOI 10.1590/S0066-782X2002001500013; Gegler A., 2008, MEDICINA RIBEIRAO PR, V41, P77; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; Huang WX, 2001, CARDIOVASC RES, V49, P207, DOI 10.1016/S0008-6363(00)00223-6; Kim HS, 2011, BJU INT, V107, P924, DOI 10.1111/j.1464-410X.2010.09679.x; Lopez-Jimenez F, 2008, AM HEART J, V155, P478, DOI 10.1016/j.ahj.2007.10.026; Lucas-Herald AK, 2017, CLIN SCI, V131, P1405, DOI 10.1042/CS20170090; Maldonado E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096243; Marin P, 1996, J CLIN ENDOCR METAB, V81, P1018, DOI 10.1210/jc.81.3.1018; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Minicucci MF, 2010, ARQ BRAS CARDIOL, V95, P635, DOI 10.1590/S0066-782X2010005000130; Oskui P. M., 2013, J AM HEART ASSOC, V2, P1; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Ribeiro RF, 2018, MOL CELL ENDOCRINOL, V460, P14, DOI 10.1016/j.mce.2017.06.011; Ruige JB, 2013, J CLIN ENDOCR METAB, V98, P4300, DOI 10.1210/jc.2013-1970; SCHRAUFNAGEL DE, 1989, AM REV RESPIR DIS, V140, P1405, DOI 10.1164/ajrccm/140.5.1405; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Stefanon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064986; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Walsh JP, 2015, TRENDS CARDIOVAS MED, V25, P250, DOI 10.1016/j.tcm.2014.10.014	35	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0213351	10.1371/journal.pone.0213351	http://dx.doi.org/10.1371/journal.pone.0213351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897106	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700018
J	Maury, JM; du Vignaux, CM; Drevet, G; Zarza, V; Chalabreysse, L; Maisse, C; Gineys, B; Dolmazon, C; Tronc, F; Girard, N; Leroux, C				Maury, Jean-Michel; du Vignaux, Claire Merveilleux; Drevet, Gabrielle; Zarza, Virginie; Chalabreysse, Lara; Maisse, Carine; Gineys, Barbara; Dolmazon, Christine; Tronc, Francois; Girard, Nicolas; Leroux, Caroline			Activation of the mTOR/Akt pathway in thymic epithelial cells derived from thymomas	PLOS ONE			English	Article							PHASE-II; PROGNOSTIC-FACTORS; TUMORS; CLASSIFICATION; CARCINOMA; CHEMOTHERAPY; CISPLATIN; CYCLOPHOSPHAMIDE; DEFINITIONS; RECURRENCE	The pathogenesis of thymic epithelial tumors remains poorly elucidated. The PIK3/Akt/mTOR pathway plays a key role in various cancers; interestingly, several phase I/II studies have reported a positive effect of mTOR inhibitors in disease control in thymoma patients. A major limit for deciphering cellular and molecular events leading to the transformation of thymic epithelial cells or for testing drug candidates is the lack of reliable in vitro cell system. We analyzed protein expression and activation of key players of the Akt/mTOR pathway namely Akt, mTOR, and P70S6K in eleven A, B and AB thymomas as well as in normal thymuses. While only Akt and phospho-Akt were expressed in normal thymuses, both Akt and mTOR were activated in thymomas. Phospho-P70S6K was expressed in all thymic tumors whatever their subtypes, and absent in normal thymus. Interestingly, we report the activation of Akt, mTOR and P70S6 proteins in primary thymic epithelial cells maintained for short period of time after their derivation from seven AB and B thymomas. Finally, we showed that rapamycin (100 nM) significantly reduced proliferation of thymoma-derived epithelial cells without inducing cell death. Our results suggest that the activation of the Akt/mTOR pathway might participate to the cell proliferation associated with tumor growth. Ultimately, our data enhance the potential role of thymic epithelial cells derived from tissue specimens for in vitro exploration of molecular abnormalities in rare thymic tumors.	[Maury, Jean-Michel; du Vignaux, Claire Merveilleux; Drevet, Gabrielle; Maisse, Carine; Gineys, Barbara; Dolmazon, Christine; Girard, Nicolas; Leroux, Caroline] Univ Claude Bernard Lyon 1, Univ Lyon, INRA, IVPC,EPHE,UMR754, Lyon, France; [Maury, Jean-Michel; Drevet, Gabrielle; Tronc, Francois] HCL, Grp Hosp Est, Dept Thorac Surg Lung & Heart Lung Transplantat, Lyon, France; [Maury, Jean-Michel; Chalabreysse, Lara; Girard, Nicolas] Natl Expert Ctr Thym Malignancies Reseau Tumeurs, Lyon, France; [du Vignaux, Claire Merveilleux; Zarza, Virginie] HCL Lyon, Grp Hosp Est, Dept Resp Dis, Lyon, France; [Chalabreysse, Lara] HCL, Grp Hosp Est, Dept Pathol, Lyon, France; [Girard, Nicolas] Inst Curie, Inst Thorax Curie Montsouris, Paris, France	INRAE; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Leroux, C (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, INRA, IVPC,EPHE,UMR754, Lyon, France.	caroline.leroux@univ-lyon1.fr	maury, jean-michel/D-7872-2018; Drevet, Gabrielle/AAR-9027-2021; Girard, Nicolas/ABE-3618-2021	Drevet, Gabrielle/0000-0003-1174-7655; Girard, Nicolas/0000-0001-9909-2299; maury, jean-michel/0000-0002-3494-3678; Maisse, Carine/0000-0003-2848-1638	SIRIC LYric Grant [INCa-DGOS-4664]; HCL (Hospices Civils de Lyon) grant	SIRIC LYric Grant; HCL (Hospices Civils de Lyon) grant	This work was supported by SIRIC LYric Grant INCa-DGOS-4664, anonymous donation to research and Aristot association. CMDV was the recipient of a HCL (Hospices Civils de Lyon) grant.	Alberobello AT, 2016, J THORAC ONCOL, V11, P1345, DOI 10.1016/j.jtho.2016.04.013; Berruti A, 1999, BRIT J CANCER, V81, P841, DOI 10.1038/sj.bjc.6690773; Breinig M, 2011, CLIN CANCER RES, V17, P2237, DOI 10.1158/1078-0432.CCR-10-1689; Chen G, 2002, CANCER, V95, P420, DOI 10.1002/cncr.10665; Dagogo-Jack I, 2016, ANN ONCOL, V27, P42, DOI 10.1093/annonc/mdw305; de Jong WK, 2008, EUR J CANCER, V44, P123, DOI 10.1016/j.ejca.2007.11.004; Druey K M, 2001, Sci STKE, V2001, pre14, DOI 10.1126/stke.2001.104.re14; Girard N, 2015, ANN ONCOL, V26, pV40, DOI 10.1093/annonc/mdv277; Girard N, 2016, J THORAC DIS, V8, P1863, DOI 10.21037/jtd.2016.05.65; Girard N, 2016, J THORAC ONCOL, V11, P1197, DOI 10.1016/j.jtho.2016.06.007; Girard N, 2011, J THORAC ONCOL, V6, pS1749, DOI 10.1097/JTO.0b013e31821ea5f7; Girard N, 2009, CLIN CANCER RES, V15, P6790, DOI 10.1158/1078-0432.CCR-09-0644; Gokmen-Polar Y, 2012, LAB INVEST, V92, P1564, DOI 10.1038/labinvest.2012.115; Hirano A, 2001, CLIN CANCER RES, V7, P876; Khoury T, 2009, CHEST, V136, P220, DOI 10.1378/chest.08-2482; Kim LC, 2017, ONCOGENE, V36, P2191, DOI 10.1038/onc.2016.363; Kossai M, 2015, LUNG CANCER, V89, P306, DOI 10.1016/j.lungcan.2015.06.014; Lemma GL, 2011, J CLIN ONCOL, V29, P2060, DOI 10.1200/JCO.2010.32.9607; LOEHRER PJ, 1994, J CLIN ONCOL, V12, P1164, DOI 10.1200/JCO.1994.12.6.1164; Loehrer PJ, 2004, J CLIN ONCOL, V22, P293, DOI 10.1200/JCO.2004.02.047; Loehrer PJ, 1997, J CLIN ONCOL, V15, P3093, DOI 10.1200/JCO.1997.15.9.3093; Marx A, 2014, J THORAC ONCOL, V9, P596, DOI 10.1097/JTO.0000000000000154; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Moreira AL, 2015, J THORAC ONCOL, V10, P373, DOI 10.1097/JTO.0000000000000397; Palmieri G, 2012, CANCER CHEMOTH PHARM, V69, P309, DOI 10.1007/s00280-011-1690-0; Penzel R, 2003, INT J CANCER, V105, P494, DOI 10.1002/ijc.11101; Petrini I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.92; Radovich M, 2018, CANCER CELL, V33, P244, DOI 10.1016/j.ccell.2018.01.003; Radovich M, 2016, BRIT J CANCER, V114, P477, DOI 10.1038/bjc.2015.425; Rajan A, 2014, LANCET ONCOL, V15, P191, DOI 10.1016/S1470-2045(13)70596-5; Regnard JF, 1996, J THORAC CARDIOV SUR, V112, P376, DOI 10.1016/S0022-5223(96)70265-9; Safieddine N, 2014, J THORAC ONCOL, V9, P1018, DOI 10.1097/JTO.0000000000000215; Scorsetti M, 2016, CRIT REV ONCOL HEMAT, V99, P332, DOI 10.1016/j.critrevonc.2016.01.012; Starostik P, 2000, BLOOD, V95, P1180, DOI 10.1182/blood.V95.4.1180.004k14_1180_1187; Wang YS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07336; Wheler J, 2013, ONCOTARGET, V4, P890, DOI 10.18632/oncotarget.1015; Zucali PA, 2013, LUNG CANCER, V79, P236, DOI 10.1016/j.lungcan.2012.11.015; Zucali P. A., 2017, J CLIN ONCOL; Zucali PA, 2018, J CLIN ONCOL, V36, P342, DOI 10.1200/JCO.2017.74.4078	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0197655	10.1371/journal.pone.0197655	http://dx.doi.org/10.1371/journal.pone.0197655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897085	Green Published, Green Submitted, gold			2022-12-26	WOS:000461889700001
J	Nanditha, NGA; St-Jean, M; Tafessu, H; Guillemi, SA; Hull, MW; Lu, M; Henry, B; Barrios, R; Montaner, JSG; Lima, VD				Nanditha, Ni Gusti Ayu; St-Jean, Martin; Tafessu, Hiwot; Guillemi, Silvia A.; Hull, Mark W.; Lu, Michelle; Henry, Bonnie; Barrios, Rolando; Montaner, Julio S. G.; Lima, Viviane D.			Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LATE PRESENTERS; EPIDEMIOLOGY; INFECTION; RESPONSES; PEOPLE; VIRUS; AUDIT; NEED; TIME	Background Late HIV diagnosis is associated with increased AIDS-related morbidity and mortality as well as an increased risk of HIV transmission. In this study, we quantified and characterized missed opportunities for earlier HIV diagnosis in British Columbia (BC), Canada. Design Retrospective cohort. Methods A missed opportunity was defined as a healthcare encounter due to a clinical manifestation which may be caused by HIV infection, or is frequently present among those with HIV infection, but no HIV diagnosis followed within 30 days. We developed an algorithm to identify missed opportunities within one, three, and five years prior to diagnosis. The algorithm was applied to the BC STOP HIV/AIDS population-based cohort. Eligible individuals were. 18 years old, and diagnosed from 2001-2014. Multivariable logistic regression identified factors associated with missed opportunities. Results Of 2119 individuals, 7%, 12% and 14% had >= 1 missed opportunity during one, three and five years prior to HIV diagnosis, respectively. In all analyses, individuals aged. 40 years, heterosexuals or people who ever injected drugs, and those residing in Northern health authority had increased odds of experiencing. 1 missed opportunity. In the three and five-year analysis, individuals with a CD4 count <350 cells/mm(3) were at higher odds of experiencing >= 1 missed opportunity. Prominent missed opportunities were related to recurrent pneumonia, herpes zoster/shingles among younger individuals, and anemia related to nutritional deficiencies or unspecified cause. Conclusions Based on our newly-developed algorithm, this study demonstrated that HIV-diagnosed individuals in BC have experienced several missed opportunities for earlier diagnosis. Specific clinical indicator conditions and population sub-groups at increased risk of experiencing these missed opportunities were identified. Further work is required in order to validate the utility of this proposed algorithm by establishing the sensitivity, specificity, positive and negative predictive values corresponding to the incidence of the clinical indicator conditions among both HIV-diagnosed and HIV-negative populations.	[Nanditha, Ni Gusti Ayu; St-Jean, Martin; Tafessu, Hiwot; Guillemi, Silvia A.; Hull, Mark W.; Lu, Michelle; Barrios, Rolando; Montaner, Julio S. G.; Lima, Viviane D.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Nanditha, Ni Gusti Ayu; Montaner, Julio S. G.; Lima, Viviane D.] Univ British Columbia, Div Infect Dis, Dept Med, Fac Med, Vancouver, BC, Canada; [Guillemi, Silvia A.] Univ British Columbia, Dept Family Practice, Fac Med, Vancouver, BC, Canada; [Hull, Mark W.] Univ British Columbia, Div Aids, Dept Med, Fac Med, Vancouver, BC, Canada; [Henry, Bonnie] British Columbia Minist Hlth, Victoria, BC, Canada; [Barrios, Rolando] Vancouver Coastal Hlth, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Lima, VD (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.; Lima, VD (corresponding author), Univ British Columbia, Div Infect Dis, Dept Med, Fac Med, Vancouver, BC, Canada.	vlima@cfenet.ubc.ca		Holloway, Courtney Jean/0000-0003-3661-1957	Public Health Agency of Canada; British Columbia Ministry of Health; US National Institutes of Health [R01DA036307, CTN 248]; Canadian Institutes of Health Research [PJT-148595]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307] Funding Source: NIH RePORTER	Public Health Agency of Canada; British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following sources of funding: JSGM's Treatment as Prevention (TasP) research, paid to his institution, has received support from the Public Health Agency of Canada, the British Columbia Ministry of Health and the US National Institutes of Health (R01DA036307 and CTN 248). VDL is funded by a grant from the Canadian Institutes of Health Research (PJT-148595), by a Scholar Award from the Michael Smith Foundation for Health Research and a New Investigator award from the Canadian Institutes of Health Research. The sponsors had no role in the design, data collection, data analysis, data interpretation, or writing of the report.	[Anonymous], 2019, DISCH ABSTR DAT MET; Armstrong D, 2008, CAN J GASTROENTEROL, V22, P155, DOI 10.1155/2008/292948; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brawley D, 2013, SCOT MED J, V58, P173, DOI 10.1177/0036933013496965; British Columbia Centre for Disease Control, COMM DIS CONTR MAN; British Columbia Centre for Disease Control, 2018, ACQ IMM DEF SYNDR AI; British Columbia Centre for Disease Control (BCCDC), 2017, HIV BRIT COL ANN SUR; British Columbia Centre for Disease Control Public Health Laboratory, 2016, HIV LAB TEST DAT TES; British Columbia Centre for Excellence in HIV/ AIDS, 2019, EXP HIV TEST GUID WI; British Columbia Centre for Excellence in HIV/ AIDS, 2013, THER GUID ANT ARV TR; British Columbia Centre for Excellence in HIV/ AIDS, 2018, BRIT COL HIV AIDS DR; British Columbia Centre for Excellence in HIV/ AIDS, 2018, HIV MON Q REP BRIT C; British Columbia Ministry of Health, 2016, PHARMANET V2 DAT EXT; British Columbia Ministry of Health, 2018, HLTH BOUND 2018; British Columbia Ministry of Health, 2016, MED SERV PLAN MSP PA; Canadian Institute for Health Information, 2019, DISCH ABSTR DAT DAD; Canadian Institute for Health Information, 2019, DAT QUAL DOC DISCH A; Canadian Institute of Health Information, 2016, DISCH ABSTR DAT HOSP; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Damery S, 2013, BRIT J GEN PRACT, V63, pE370, DOI 10.3399/bjgp13X668159; Darling KEA, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14348; Fettig J, 2014, INFECT DIS CLIN N AM, V28, P323, DOI 10.1016/j.idc.2014.05.001; Gilbert M, 2014, CAN J PUBLIC HEALTH, V105, pE63, DOI 10.17269/cjph.105.4262; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gustafson R, 2014, BC MED J, V56, P172; Gustafson R, 2011, BC MED J, V52, P13; Hachfeld A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20317; Heath K, 2014, INT J EPIDEMIOL, V43, P1073, DOI 10.1093/ije/dyu070; Hu W., 2019, DIAGNOSTIC CODES MSP; Jiang Jason, 2016, CMAJ Open, V4, pE646, DOI 10.9778/cmajo.20160128; Joore IK, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0556-2; Joore IK, 2015, SEX TRANSM INFECT, V91, P467, DOI 10.1136/sextrans-2015-052073; Klein D, 2003, JAIDS-J ACQ IMM DEF, V32, P143, DOI 10.1097/00126334-200302010-00005; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Lhopitallier L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019806; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Lin YD, 2019, QJM-INT J MED, V112, P17, DOI 10.1093/qjmed/hcy223; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Ma HT, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3119-5; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; McDonald J.H., 2009, HDB BIOL STAT; Nosyk B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054416; Office fe derale de la santepublique de la Suisse, DEP VIH EFF IN MED 2; Office of the Provincial Health Officer, 2014, HIV TEST GUID PROV B; Olding M, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21941; Patterson S, 2015, INT J EPIDEMIOL, V44, P58, DOI 10.1093/ije/dyu046; Population Data BC, 2019, MED SERV PLAN MSP PA; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Scognamiglio P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-473; Tominski D, 2017, HIV MED, V18, P125, DOI 10.1111/hiv.12403; Traversy G, 2015, CANADA COMMUNICABLE, V41, DOI [10.14745/ccdr.v41i12a02, DOI 10.14745/CCDR.V41I12A02]; University of Northen British Columbia, 2018, DET HLTH NO REM RUR; Waters L, 2011, HIV MED, V12, P289, DOI 10.1111/j.1468-1293.2010.00881.x; Youssef E, 2017, CLIN MED, V17, P508, DOI 10.7861/clinmedicine.17-6-508	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2019	14	3							e0214012	10.1371/journal.pone.0214012	http://dx.doi.org/10.1371/journal.pone.0214012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP7SO	30897143	Green Published, gold, Green Submitted			2022-12-26	WOS:000461889700056
J	Pasha, S; Hassanzadeh, P; Ecker, M; Ho, V				Pasha, Saba; Hassanzadeh, Pedram; Ecker, Malcolm; Ho, Victor			A hierarchical classification of adolescent idiopathic scoliosis: Identifying the distinguishing features in 3D spinal deformities	PLOS ONE			English	Article							GEOMETRIC TORSION; CURVE; FUSION; ALIGNMENT	This study aimed to identify the differentiating parameters of the spinal curves' 2D projections through a hierarchical classification of the 3D spinal curve in adolescent idiopathic scoliosis (AIS). A total number of 103 right thoracic left lumbar pre-operative AIS patients were included retrospectively and consecutively. A total number of 20 non-scoliotic adolescents were included as the control group. All patients had biplanar X-rays and 3D reconstructions of the spine. The 3D spinal curve was calculated by interpolating the center of vertebrae and was isotropically normalized. A hierarchical classification of the normalized spinal curves was developed to group the patients based on the similarity of their 3D spinal curve. The spinal curves' 2D projections and clinical spinal measurements in the three anatomical planes were then statistically compared between these groups and between the scoliotic subtypes and the non-scoliotic controls. A total of 5 patient groups of right thoracic left lumbar AIS patients were identified. The characteristics of the posterior-anterior and sagittal views of the spines were: Type 1: Normal sagittal profile and S shape axial view. T1 is leveled or tilted to the right in the posterior view. Type 2: Hypokyphotic and a V shape axial view. T1 is tilted to the left in the posterior view. Type 3: Hypokyphotic (only T5-T10) and frontal imbalance, S shape axial view. T1 is leveled or tilted to the right, and 3 frontal curves. Type 4: Flat sagittal profile (T1-L2), slight frontal imbalance with a V shape axial view, T1 tilted to the left. Type 5: flat sagittal profile and forward trunk shift with a proximal kyphosis and S shape axial view. T1 is leveled or tilted to the right. In conclusion, a hierarchical classification of the 3D scoliotic spine allowed identifying various distinguishing features of the spinal curves in patients with a right thoracic curve in an orderly fashion. The subtypes' characteristics resulting from this 3D classification can be identified from the pairs of the frontal and sagittal spinal curves i.e. X-rays in right thoracic AIS patients.	[Pasha, Saba; Ecker, Malcolm] Univ Penn, Perleman Sch Med, Philadelphia, PA 19104 USA; [Pasha, Saba; Ecker, Malcolm] Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Hassanzadeh, Pedram] Rice Univ, Dept Mech Engn, Houston, TX 77005 USA; [Ho, Victor] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Ho, Victor] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Rice University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Pasha, S (corresponding author), Univ Penn, Perleman Sch Med, Philadelphia, PA 19104 USA.; Pasha, S (corresponding author), Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA.	pashas@email.chop.edu	Hassanzadeh, Pedram/CAJ-3213-2022; Hassanzadeh, Pedram/A-7489-2008; pasha, saba/AAF-8651-2019	Hassanzadeh, Pedram/0000-0001-9425-8085; Hassanzadeh, Pedram/0000-0001-9425-8085; pasha, saba/0000-0001-9172-2049				Abelin-Genevois K, 2018, EUR SPINE J, V27, P2192, DOI 10.1007/s00586-018-5613-1; Atmaca H, 2014, SPINE J, V14, P2425, DOI 10.1016/j.spinee.2014.02.015; Aubin CE, 2018, J ORTHOP RES, V36, P254, DOI 10.1002/jor.23648; Birchall D, 2005, EUR SPINE J, V14, P123, DOI 10.1007/s00586-004-0705-5; Cahill PJ., 2018, SPINE DEFORM, V6, P54, DOI [10.1016/j.jspd.2017.05.007, DOI 10.1016/J.JSPD.2017.05.007]; Cerny P, 2014, SCOLIOSIS SPINAL DIS, V9, DOI 10.1186/1748-7161-9-11; Courvoisier A, 2013, EUR SPINE J, V22, P2427, DOI 10.1007/s00586-013-2862-x; DEACON P, 1984, J BONE JOINT SURG BR, V66, P509, DOI 10.1302/0301-620X.66B4.6746683; DeFrancesco CJ, 2018, SPINE DEFORM, V6, P644, DOI [10.1016/j.jspd.2018.03.001, DOI 10.1016/J.JSPD.2018.03.001]; Duong L, 2009, J SPINAL DISORD TECH, V22, P135, DOI 10.1097/BSD.0b013e31816845bc; Humbert L, 2009, MED ENG PHYS, V31, P681, DOI 10.1016/j.medengphy.2009.01.003; Kadoury S, 2014, MED BIOL ENG COMPUT, V52, P309, DOI 10.1007/s11517-013-1132-8; Kadoury S, 2012, EUR SPINE J, V21, P40, DOI 10.1007/s00586-011-2004-2; KING HA, 1983, J BONE JOINT SURG AM, V65, P1302, DOI 10.2106/00004623-198365090-00012; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Lenke LG, 2001, SPINE, V26, P2347, DOI 10.1097/00007632-200111010-00011; Pasha S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34261-6; Pasha S, 2019, J PEDIATR ORTHOPED, V39, P487, DOI 10.1097/BPO.0000000000001043; Pasha S, 2019, SPINE, V44, P134, DOI 10.1097/BRS.0000000000002748; Pasha S, 2019, SPINE, V44, P41, DOI 10.1097/BRS.0000000000002736; Pasha S, 2018, EUR SPINE J, V27, P2223, DOI 10.1007/s00586-018-5553-9; Pasha Saba, 2018, Eur J Orthop Surg Traumatol, V28, P1039, DOI 10.1007/s00590-018-2175-1; Pasha S, 2018, J PEDIATR ORTHOPED, V38, pE194, DOI 10.1097/BPO.0000000000001136; Pasha S, 2018, CLIN BIOMECH, V51, P91, DOI 10.1016/j.clinbiomech.2017.11.011; Pasha S, 2016, EUR SPINE J, V25, P3137, DOI 10.1007/s00586-016-4582-5; Pasha S, 2016, EUR SPINE J, V25, P3234, DOI 10.1007/s00586-016-4661-7; Pasha S, 2014, SPINE, V39, P564, DOI 10.1097/BRS.0000000000000193; Pasha S, 2012, STUD HEALTH TECHNOL, V176, P125, DOI 10.3233/978-1-61499-067-3-125; PERDRIOLLE R, 1981, REV CHIR ORTHOP, V67, P25; Samdani AF, 2015, EUR SPINE J, V24, P1533, DOI 10.1007/s00586-014-3706-z; Sangole AP, 2009, SPINE, V34, P91, DOI 10.1097/BRS.0b013e3181877bbb; Shen J, 2016, SPINE, V41, P1903, DOI 10.1097/BRS.0000000000001651; STOKES IAF, 1986, SPINE, V11, P213, DOI 10.1097/00007632-198604000-00006; Stokes IAF, 2009, SPINE, V34, P584, DOI 10.1097/BRS.0b013e318190b914; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Working Group on 3-D Classification Committee. tT, REV GLOSS TERMS 2000	36	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2019	14	3							e0213406	10.1371/journal.pone.0213406	http://dx.doi.org/10.1371/journal.pone.0213406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP6AW	30893327	Green Submitted, Green Published, gold			2022-12-26	WOS:000461765900041
J	Hsieh, CH; Lu, CH; Kuo, YY; Lin, GB; Chao, CY				Hsieh, Chih-Hsiung; Lu, Chueh-Hsuan; Kuo, Yu-Yi; Lin, Guan-Bo; Chao, Chih-Yu			The protective effect of non-invasive low intensity pulsed electric field and fucoidan in preventing oxidative stress-induced motor neuron death via ROCK/Akt pathway	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RHO-KINASE INHIBITOR; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; PH CHANGES; IN-VITRO; FASUDIL; SURVIVAL; CELLS; MODEL	With the expansion of the aged population, it is predicted that neurodegenerative diseases (NDDs) will become a major threat to public health worldwide. However, existing therapies can control the symptoms of the diseases at best, rather than offering a fundamental cure. As for the complex pathogenesis, clinical and preclinical researches have indicated that oxidative stress, a central role in neuronal degeneration, is a possible therapeutic target in the development of novel remedies. In this study, the motor neuron-like cell line NSC-34 was employed as an experimental model in probing the effects induced by the combination of non-invasive low intensity pulsed electric field (LIPEF) and fucoidan on the H2O2-induced neuron damage. It was found that single treatment of the LIPEF could protect the NSC-34 cells from oxidative stress, and the protective effect was enhanced by combining the LIPEF and fucoidan. Notably, it was observed that single treatment of the LIPEF obviously suppressed the H2O2-enhanced expression of ROCK protein and increased the phosphorylation of Akt in the H2O2-treated NSC-34 cells. Moreover, the LIPEF can be easily modified to concentrate on a specific area. Accordingly, this technique can be used as an advanced remedy for ROCK inhibition without the drawback of drug metabolism. Therefore, we suggest the LIPEF would be a promising strategy as a treatment for motor neurodegeneration and warrant further probe into its potential in treating other neuronal degenerations.	[Hsieh, Chih-Hsiung; Lu, Chueh-Hsuan; Kuo, Yu-Yi; Lin, Guan-Bo; Chao, Chih-Yu] Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan; [Hsieh, Chih-Hsiung; Lu, Chueh-Hsuan; Kuo, Yu-Yi; Lin, Guan-Bo; Chao, Chih-Yu] Natl Taiwan Univ, Coll Med, Biomed & Mol Imaging Ctr, Taipei, Taiwan; [Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Coll Med, Biomed & Mol Imaging Ctr, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw	Hsieh, Chih-Hsiung/AFI-4085-2022; Hsieh, Chih-Hsiung/GMX-1452-2022		Ministry of Science and Technology of the Republic of China [MOST 105-2112-M-002-006-MY3]; Ministry of Education of the Republic of China [MOE 107L880406]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan)	This work was supported by grants from Ministry of Science and Technology (MOST 105-2112-M-002-006-MY3 to CYC) and Ministry of Education (MOE 107L880406 to CYC) of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Akinrinade Ibukun Dorcas, 2015, Pathophysiology, V22, P39, DOI 10.1016/j.pathophys.2014.12.001; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Athukorala Y, 2006, CARBOHYD POLYM, V66, P184, DOI 10.1016/j.carbpol.2006.03.002; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Battaglia G, 2018, CURR OPIN PHARMACOL, V38, P65, DOI 10.1016/j.coph.2018.02.007; Bazaka K, 2013, ELECTRONICS-SWITZ, V2, P1, DOI 10.3390/electronics2010001; Berteau O, 2003, GLYCOBIOLOGY, V13, p29R, DOI 10.1093/glycob/cwg058; Bhonsle S, 2016, J VASC INTERV RADIOL, V27, P1913, DOI 10.1016/j.jvir.2016.07.012; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen MH, 2013, EXPERT OPIN INV DRUG, V22, P537, DOI 10.1517/13543784.2013.778242; CHOI IY, 2015, NEUROLOGY S, V84; Conti A, 2014, BBA-MOL BASIS DIS, V1842, P99, DOI 10.1016/j.bbadis.2013.10.013; D'Amico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Feng YB, 2016, J MED CHEM, V59, P2269, DOI 10.1021/acs.jmedchem.5b00683; Fish Raymond M, 2009, Eplasty, V9, pe44; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Griffin Michelle, 2011, Eplasty, V11, pe34; Grys M, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-016-0030-0; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Gupta V, 2013, J CONTROL RELEASE, V167, P189, DOI 10.1016/j.jconrel.2013.01.011; Hardiman O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.71; Hemendinger RA, 2012, TOXICOL APPL PHARM, V258, P208, DOI 10.1016/j.taap.2011.10.022; Henderson BW, 2016, J NEUROCHEM, V138, P525, DOI 10.1111/jnc.13688; Hensel N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00198; Herskowitz JH, 2013, J NEUROSCI, V33, P19086, DOI 10.1523/JNEUROSCI.2508-13.2013; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; Hsieh CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201920; Hsieh CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188885; Huang CQ, 2001, ANN BIOMED ENG, V29, P791, DOI 10.1114/1.1397793; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kim MH, 2008, IMMUNOL LETT, V115, P138, DOI 10.1016/j.imlet.2007.10.016; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Koch JC, 2018, PHARMACOL THERAPEUT, V189, P1, DOI 10.1016/j.pharmthera.2018.03.008; KORCHAK HM, 1982, BIOCHEM BIOPH RES CO, V108, P1495, DOI 10.1016/S0006-291X(82)80076-4; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee SH, 2016, MOL NEUROBIOL, V53, P695, DOI 10.1007/s12035-014-9030-0; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17817; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Lim SJ, 2014, FOOD HYDROCOLLOID, V42, P280, DOI 10.1016/j.foodhyd.2014.03.007; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967; Lu CH, 2018, ONCOTARGETS THER, V11, P4723, DOI 10.2147/OTT.S166264; Luo DZ, 2009, EUR J PHARMACOL, V617, P33, DOI 10.1016/j.ejphar.2009.06.015; Maier O, 2013, NEUROCHEM INT, V62, P1029, DOI 10.1016/j.neuint.2013.03.008; Mehta P, 2018, MMWR-MORBID MORTAL W, V67, P216, DOI 10.15585/mmwr.mm6707a3; Mohamed LA, 2017, AAPS J, V19, P1600, DOI 10.1208/s12248-017-0120-6; Munoz Ana, 2016, J Gerontol A Biol Sci Med Sci, V71, P1254, DOI 10.1093/gerona/glv179; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Nuccitelli R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134364; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Philips T, 2014, EXP NEUROL, V262, P111, DOI 10.1016/j.expneurol.2014.05.015; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Roser AE, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00094; Saal KA, 2017, BRAIN PATHOL, V27, P13, DOI 10.1111/bpa.12346; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Song Y, 2013, CNS NEUROSCI THER, V19, P603, DOI 10.1111/cns.12116; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Synytsya A, 2010, CARBOHYD POLYM, V81, P41, DOI 10.1016/j.carbpol.2010.01.052; Takata M, 2013, BRIT J PHARMACOL, V170, P341, DOI 10.1111/bph.12277; Tatenhorst L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0310-y; Terao E, 2017, CURR EYE RES, V42, P738, DOI 10.1080/02713683.2016.1250276; Tonges L, 2012, BRAIN, V135, P3355, DOI 10.1093/brain/aws254; Tonges L, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00039; Torkaman G, 2014, ADV WOUND CARE, V3, P202, DOI 10.1089/wound.2012.0409; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Wang MD, 2014, J OCCUP ENVIRON MED, V56, P1235, DOI 10.1097/JOM.0000000000000323; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Xiao WD, 2014, INT J CLIN EXP PATHO, V7, P5564; Yao YY, 2017, MOLECULES, V22, DOI 10.3390/molecules22101766; Yonemori K, 1996, BONE, V19, P173, DOI 10.1016/8756-3282(96)00169-X; Zhang L, 2018, AGING DIS, V9, P590, DOI 10.14336/AD.2017.0831; Zhang X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0251-9; Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	79	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0214100	10.1371/journal.pone.0214100	http://dx.doi.org/10.1371/journal.pone.0214100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889218	gold, Green Submitted, Green Published			2022-12-26	WOS:000461573000049
J	Peterson, CT; Sharma, V; Lablokov, SN; Albayrak, L; Khanipov, K; Uchitel, S; Chopra, D; Mills, PJ; Fofanov, Y; Rodionov, DA; Peterson, SN				Peterson, Christine Tara; Sharma, Vandana; Lablokov, Stanislav N.; Albayrak, Levent; Khanipov, Kamil; Uchitel, Sasha; Chopra, Deepak; Mills, Paul J.; Fofanov, Yuriy; Rodionov, Dmitry A.; Peterson, Scott N.			16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics	PLOS ONE			English	Article							GUT-BRAIN AXIS; PARKINSONS-DISEASE; ENHANCING DRUGS; MICROBIOTA; EFFICACY; DATABASE; HEALTH	The prebiotic potential of nervine herbal medicines has been scarcely studied. We therefore used anaerobic human fecal cultivation to investigate whether medicinal herbs commonly used as treatment in neurological health and disease in Ayurveda and other traditional systems of medicine modulate gut microbiota. Profiling of fecal cultures supplemented with either Kapikacchu, Gotu Kola, Bacopa/Brahmi, Shankhapushpi, Boswellia/Frankincense, Jatamansi, Bhringaraj, Guduchi, Ashwagandha or Shatavari by 16S rRNA sequencing revealed profound changes in diverse taxa. Principal coordinate analysis highlights that each herb drives the formation of unique microbial communities predicted to display unique metabolic potential. The relative abundance of approximately one-third of the 243 enumerated species was altered by all herbs. Additional species were impacted in an herb-specific manner. In this study, we combine genome reconstruction of sugar utilization and short chain fatty acid (SCFA) pathways encoded in the genomes of 216 profiled taxa with monosaccharide composition analysis of each medicinal herb by quantitative mass spectrometry to enhance the interpretation of resulting microbial communities and discern potential drivers of microbiota restructuring. Collectively, our results indicate that gut microbiota engage in both protein and glycan catabolism, providing amino acid and sugar substrates that are consumed by fermentative species. We identified taxa that are efficient amino acid fermenters and those capable of both amino acid and sugar fermentation. Herb-induced microbial communities are predicted to alter the relative abundance of taxa encoding SCFA (butyrate and propionate) pathways. Co-occurrence network analyses identified a large number of taxa pairs in medicinal herb cultures. Some of these pairs displayed related culture growth relationships in replicate cultures highlighting potential functional interactions among medicinal herb-induced taxa.	[Peterson, Christine Tara; Chopra, Deepak; Mills, Paul J.] Univ Calif San Diego, Sch Med, Ctr Excellence Res & Training Integrat Hlth, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Sharma, Vandana; Rodionov, Dmitry A.; Peterson, Scott N.] Sanford Burnham Prebys Med Discovery Inst, Bioinformat & Struct Biol Program, La Jolla, CA USA; [Lablokov, Stanislav N.; Rodionov, Dmitry A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Lablokov, Stanislav N.] PG Demidov Yaroslavl State Univ, Yaroslavl, Russia; [Albayrak, Levent; Khanipov, Kamil; Fofanov, Yuriy] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Uchitel, Sasha] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Chopra, Deepak] Chopra Fdn, Dept Ayurveda & Yoga Res, Carlsbad, CA USA; [Peterson, Scott N.] Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, La Jolla, CA USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Yaroslavl State University; University of Texas System; University of Texas Medical Branch Galveston; Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Peterson, CT (corresponding author), Univ Calif San Diego, Sch Med, Ctr Excellence Res & Training Integrat Hlth, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	chpeterson@ucsd.edu	Iablokov, Stanislav/V-5366-2017; Khanipov, Kamil/Y-6486-2019; Rodionov, Dmitry/V-2688-2018	Iablokov, Stanislav/0000-0003-1168-720X; Khanipov, Kamil/0000-0002-3881-737X; Peterson, Christine Tara/0000-0002-6951-5753; Rodionov, Dmitry/0000-0002-0939-390X	Samuel Lawrence Foundation; Chopra Foundation; Russian Science Foundation [14-14-00289]	Samuel Lawrence Foundation; Chopra Foundation; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by a research grant from the Samuel Lawrence Foundation and a fellowship grant from the Chopra Foundation awarded to CP. DR and SI were supported by the Russian Science Foundation (grant #14-14-00289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders web sites are: http://rscf.ru/en/; https://www.samuellawrencefoundation.org/; https://www.choprafoundation.org/.	[Anonymous], 2016, BENEFITS NATURAL PRO; Arzamasov AA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00776; Borgo F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00213; Bouvier JT, 2018, J BACTERIOL; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Burokas A, 2015, ADV APPL MICROBIOL, V91, P1, DOI 10.1016/bs.aambs.2015.02.001; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Corazza O, 2014, SUBST USE MISUSE, V49, P1849, DOI 10.3109/10826084.2014.912232; Cover T.M., 2006, ELEMENTS INFORM THEO, Vxxiii; Dinan TG, 2017, GASTROENTEROL CLIN N, V46, P77, DOI 10.1016/j.gtc.2016.09.007; Eglen SJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000482; Endres K, 2018, J INNATE IMMUN, V10, P172, DOI 10.1159/000488629; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Farooqui AA, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2481076; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; Gu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-255; Gustafsson RJ, 2012, WORLD J GASTROENTERO, V18, P1628, DOI 10.3748/wjg.v18.i14.1628; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Hutkins RW, 2016, CURR OPIN BIOTECH, V37, P1, DOI 10.1016/j.copbio.2015.09.001; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1672, DOI 10.1136/jnnp.2003.028761; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kim Chang H, 2014, Immune Netw, V14, P277, DOI 10.4110/in.2014.14.6.277; Kumar N, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/4103423; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maier LJ, 2018, INT J DRUG POLICY, V58, P104, DOI 10.1016/j.drugpo.2018.05.009; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Mathur D, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00044; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pathak-Gandhi N, 2017, J ETHNOPHARMACOL, V197, P46, DOI 10.1016/j.jep.2016.08.020; Perez-Pardo P, 2017, EUR J PHARMACOL, V817, P86, DOI 10.1016/j.ejphar.2017.05.042; Peterson CT, 2018, J EVID-BASED INTEGR, V23, DOI 10.1177/2515690X18790725; Peterson CT, 2018, J ALTERN COMPLEM MED, V24, P656, DOI 10.1089/acm.2017.0422; Ravcheev DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-873; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; Rodionova IA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00407; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Sarkar SR, 2019, J NEUROIMMUNOL, V328, P98, DOI 10.1016/j.jneuroim.2019.01.004; Shah N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120554; Shinomol GK, 2011, RECENT PATENTS ENDOC, V5, P33, DOI 10.2174/187221411794351833; Simpson T, 2019, NUTR J, V18, DOI 10.1186/s12937-018-0428-9; Spielman LJ, 2018, NEUROCHEM INT, V120, P149, DOI 10.1016/j.neuint.2018.08.005; Srivastav S, 2017, BIOMED PHARMACOTHER, V92, P856, DOI 10.1016/j.biopha.2017.05.137; Srivastava P, 2016, ADV NEUROBIOL, V12, P107, DOI 10.1007/978-3-319-28383-8_7; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Thakur KT., 2016, MENTAL NEUROLOGICAL, V4; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Waegemans T, 2002, DEMENT GERIATR COGN, V13, P217, DOI 10.1159/000057700; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176	55	14	14	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213869	10.1371/journal.pone.0213869	http://dx.doi.org/10.1371/journal.pone.0213869			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889210	gold, Green Published, Green Submitted			2022-12-26	WOS:000461573000036
J	Portillo, A; Palomar, AM; de Toro, M; Santibanez, S; Santibanez, P; Oteo, JA				Portillo, Aranzazu; Palomar, Ana M.; de Toro, Maria; Santibanez, Sonia; Santibanez, Paula; Oteo, Jose A.			Exploring the bacteriome in anthropophilic ticks: To investigate the vectors for diagnosis	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; IXODES-RICINUS; MICROBIOME; FEVER; RICKETTSIOSES; SPIROPLASMA; GUIDELINES; ACARI	Objective The aim of this study was to characterize the bacterial microbiome of hard ticks with affinity to bite humans in La Rioja (North of Spain). Methods A total of 88 adult ticks (22 Rhipicephalus sanguineus sensu lato, 27 Haemaphysalis punctata, 30 Dermacentor marginatus and 9 Ixodes ricinus) and 120 I. ricinus nymphs (CRETAV collection, La Rioja, Spain), representing the main anthropophilic species in our environment, were subjected to a metagenomic analysis of the V3-V4 region of the 16S rRNA gene using an Illumina MiSeq platform. Data obtained with Greengenes database were refined with BLAST. Four groups of samples were defined, according to the four tick species. Results Proteobacteria was the predominant phylum observed in all groups. Gammaproteobacteria was the most abundant class, followed by Alphaproteobacteria for R. sanguineus, H. punctata and D. marginatus but the relative abundance of reads for these classes was reversed for I. ricinus. This tick species showed more than 46% reads corresponding to 'not assigned' OTUs (Greengenes), and > 97% of them corresponded to 'Candidatus Midichloriaceae' using BLAST. Within Rickettsiales, 'Candidatus Midichloria', Rickettsia, Ehrlichia, 'Candidatus Neoehrlichia' and Wolbachia were detected. I. ricinus was the most alpha-diverse species. Regarding beta-diversity, I. ricinus and H. punctata samples grouped according to their tick species but microbial communities of some R. sanguineus and D. marginatus specimens clustered together. Conclusions The metagenomics approach seems useful to discover the spectrum of tick-related bacteria. More studies are needed to identify and differentiate bacterial species, and to improve the knowledge of tick-borne diseases in Spain.	[Portillo, Aranzazu; Palomar, Ana M.; Santibanez, Sonia; Santibanez, Paula; Oteo, Jose A.] Hosp Univ San Pedro, Dept Infect Dis, Ctr Rickettsiosis & Arthropod Borne Dis, Ctr Biomed Res La Rioja CIBIR, Logrono, Spain; [de Toro, Maria] CIBIR, Genom & Bioinformat Core Facil, Logrono, Spain		Oteo, JA (corresponding author), Hosp Univ San Pedro, Dept Infect Dis, Ctr Rickettsiosis & Arthropod Borne Dis, Ctr Biomed Res La Rioja CIBIR, Logrono, Spain.	jaoteo@riojasalud.es	Santibáñez, Sonia/AAM-8816-2021; Oteo, Jose A./AAB-3134-2020; Palomar, Ana M/ABF-7245-2020; Santibáñez, Paula/ABF-7604-2020; Portillo, Arantza/ABH-7807-2020; DE TORO, MARIA/J-7170-2012	Santibáñez, Sonia/0000-0002-4996-288X; Oteo, Jose A./0000-0001-7080-6542; Palomar, Ana M/0000-0002-5461-5874; Portillo, Arantza/0000-0002-2055-1825; Santibanez Saenz, Paula/0000-0001-8092-1982; DE TORO, MARIA/0000-0003-3329-0203	Fondo de Investigaciones Sanitarias (Accion Estrategica en Salud 2015), ISCIII, M. Economia y Competitividad, Spain [PI15/02269]; Ministerio de Economia y Competitividad-FEDER [FRSA15-EE-3502]; Fundacion Rioja Salud	Fondo de Investigaciones Sanitarias (Accion Estrategica en Salud 2015), ISCIII, M. Economia y Competitividad, Spain; Ministerio de Economia y Competitividad-FEDER; Fundacion Rioja Salud	This work was supported by: 1. Fondo de Investigaciones Sanitarias (Accion Estrategica en Salud 2015), ISCIII, M. Economia y Competitividad, Spain (PI15/02269): AP, AMP, SS and JAO; 2. Ministerio de Economia y Competitividad-FEDER (FRSA15-EE-3502): MDT; 3. Fundacion Rioja Salud (internal support): AP, AMP, MDT, PS, SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babraham Bioinformatics, FASTQC QUALITY CONTR; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; Brouqui P, 2007, FEMS IMMUNOL MED MIC, V49, P2, DOI 10.1111/j.1574-695X.2006.00138.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Cisak E, 2015, ANN AGR ENV MED, V22, P589, DOI 10.5604/12321966.1185758; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Diaz JH, 2015, MANDELL DOUGLAS BENN, V2, P3266; Estrada-Pena A., 2004, GUIDE IDENTIFICATION; Estrada-Pena A, 2019, TICKS TICK-BORNE DIS, V10, P34, DOI 10.1016/j.ttbdis.2018.08.017; Estrada-Pena A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00236; Fauna D'Italia Manilla G., 1999, FAUNA ITALIA ACARI I, P1; Gall CA, 2016, ISME J, V10, P1846, DOI 10.1038/ismej.2015.266; Gilbert L, 2014, ECOL EVOL, V4, P1186, DOI 10.1002/ece3.1014; Grab DJ, 2007, CLIN VACCINE IMMUNOL, V14, P1420, DOI 10.1128/CVI.00308-07; Graham RMA, 2017, EMERG INFECT DIS, V23, P1911, DOI 10.3201/eid2311.170474; Kernif T, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0012-2016; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mueller NJ, 2015, AM J TRANSPLANT, V15, P2511, DOI 10.1111/ajt.13254; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Nyarko E, 2006, INT J PARASITOL, V36, P601, DOI 10.1016/j.ijpara.2006.01.014; Oteo JA, 2018, MED CLIN-BARCELONA, V150, P266, DOI 10.1016/j.medcli.2017.07.003; Palomar AM, 2017, THESIS; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Paules CI, 2018, NEW ENGL J MED, V379, P701, DOI 10.1056/NEJMp1807870; Portillo A., 2018, New Microbes and New Infections, V22, P30, DOI 10.1016/j.nmni.2017.12.011; Portillo A, 2015, WORLD J CLIN INFECT, V5, P51; Portillo A, 2017, VECTOR-BORNE ZOONOT, V17, P23, DOI 10.1089/vbz.2016.1966; Qiu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103961; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Rene-Martellet M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2352-9; Rideout JR, 2014, PEERJ, V2, DOI 10.7717/peerj.545; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Socolovschi C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001697; Taylor M, 2012, FEMS IMMUNOL MED MIC, V64, P21, DOI 10.1111/j.1574-695X.2011.00916.x; Tekin S, 2017, PARASITOL RES, V116, P1055, DOI 10.1007/s00436-017-5387-0; Tijsse-Klasen E, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00073; Van Treuren W, 2015, APPL ENVIRON MICROB, V81, P6200, DOI 10.1128/AEM.01562-15; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82	47	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213384	10.1371/journal.pone.0213384	http://dx.doi.org/10.1371/journal.pone.0213384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889229	Green Submitted, gold, Green Published			2022-12-26	WOS:000461573000019
J	Wong, SY; Hashim, OH; Hayashi, N				Wong, Sing Ying; Hashim, Onn Haji; Hayashi, Nobuhiro			Development of high-performance two-dimensional gel electrophoresis for human hair shaft proteome	PLOS ONE			English	Article							PROTEINS; IDENTIFICATION; EXPRESSION	The primary components of human hair shaft keratin and keratin-associated proteins (KAPs), together with their cross-linked networks are the underlying reason for its rigid structure. It is therefore requisite to overcome the obstacle of hair insolubility and establish a reliable protocol for the proteome analysis of this accessible specimen. The present study employed an alkaline-based method for the efficient isolation of hair proteins and subsequently examined them using gel-based proteomics. The introduction of two proteomic protocols, namely the conventional and modified protocol, have resulted in the detection of more than 400 protein spots on the two-dimensional gel electrophoresis (2DE). When compared, the modified protocol is deemed to improve overall reproducibility, whilst offering a quick overview of the total protein distribution of hair. The development of this high-performance protocol is hoped to provide a new approach for hair analysis, which could possibly lead to the discovery of biomarkers for hair in health and diseases in the future.	[Wong, Sing Ying; Hayashi, Nobuhiro] Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Meguro Ku, Tokyo, Japan; [Hashim, Onn Haji] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Ctr Prote Res, Kuala Lumpur, Malaysia	Tokyo Institute of Technology; Universiti Malaya; Universiti Malaya	Hayashi, N (corresponding author), Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Meguro Ku, Tokyo, Japan.	nhayashi@bio.titech.ac.jp	Hayashi, Nobuhiro/F-6088-2011; Hashim, Onn H/B-9459-2010	Hayashi, Nobuhiro/0000-0002-9950-094X; Hashim, Onn H/0000-0002-0196-6793; Wong, Sing Ying/0000-0002-6211-6557	Tokyo Institute of Technology [25462831, 16K11421]; Ministry of Education, Science, Sports and Culture of Japan	Tokyo Institute of Technology; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Tokyo Institute of Technology and Grants-in-Aid for Scientific Research C 25462831 and 16K11421 from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkelman Tom, 2008, V424, P51, DOI 10.1007/978-1-60327-064-9_5; Chang JY, 1997, J BIOL CHEM, V272, P69; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; Deb-Choudhury S, 2016, METHOD ENZYMOL, V568, P279, DOI 10.1016/bs.mie.2015.07.018; Depagne J, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-54; Devraj K, 2009, J NEUROSCI METH, V184, P119, DOI 10.1016/j.jneumeth.2009.07.016; Feist P, 2015, INT J MOL SCI, V16, P3537, DOI 10.3390/ijms16023537; FRATINI A, 1993, J BIOL CHEM, V268, P4511; Fujii T., 2013, J BIOL MACROMOL, V13, P92, DOI [DOI 10.14533/JBM.13.92, 10.14533/jbm.13.92]; Garfin DE, 2003, TRAC-TREND ANAL CHEM, V22, P263, DOI 10.1016/S0165-9936(03)00506-5; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hashiguchi M, 2010, J ELECTROPHORESIS, V55; HEIZMANN CW, 1980, J BIOL CHEM, V255, P1504; Herbert B, 2001, ELECTROPHORESIS, V22, P2046, DOI 10.1002/1522-2683(200106)22:10<2046::AID-ELPS2046>3.0.CO;2-C; Hoving S, 2002, PROTEOMICS, V2, P127, DOI 10.1002/1615-9861(200202)2:2<127::AID-PROT127>3.0.CO;2-Y; Kannan S, 2012, GEL ELECTROPHORESIS, P360; Laatsch CN, 2014, PEERJ, V2, DOI 10.7717/peerj.506; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; Li F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-433; Liu B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-24; Lopez MF, 2000, ELECTROPHORESIS, V21, P3673, DOI 10.1002/1522-2683(200011)21:17<3673::AID-ELPS3673>3.3.CO;2-D; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569; Nejadi N, 2014, J PARAMEDICAL SCI, V5; Olsson I, 2002, PROTEOMICS, V2, P1630, DOI 10.1002/1615-9861(200211)2:11<1630::AID-PROT1630>3.0.CO;2-N; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Powell B C, 1997, EXS, V78, P59; Saraswathy N, 2011, CONCEPTS TECHNIQUES, P147; Westbrook JA, 2001, ELECTROPHORESIS, V22, P2865, DOI 10.1002/1522-2683(200108)22:14<2865::AID-ELPS2865>3.0.CO;2-Y; Wong SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164993; Zhao ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153936	32	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2019	14	3							e0213947	10.1371/journal.pone.0213947	http://dx.doi.org/10.1371/journal.pone.0213947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP3JN	30889197	Green Published, Green Submitted, gold			2022-12-26	WOS:000461573000039
J	Qaseem, MF; Qureshi, R; Shaheen, H; Shafqat, N				Qaseem, Mirza Faisal; Qureshi, Rahmatullah; Shaheen, Humaira; Shafqat, Noshin			Genome-wide association analyses for yield and yield-related traits in bread wheat (Triticum aestivum L.) under pre-anthesis combined heat and drought stress in field conditions	PLOS ONE			English	Article							SPRING WHEAT; GRAIN-YIELD; MORPHOPHYSIOLOGICAL TRAITS; POPULATION-STRUCTURE; QTL; LOCI; GENE; IDENTIFICATION; TRANSLOCATION; ARCHITECTURE	Understanding the genetic basis of heat and drought stress tolerance in wheat is prerequisite for wheat breeding program. In the present study, a wheat panel comprising of 192 elite bread wheat genotypes was phenotyped in eight environments for yield and related traits in field conditions. Four stress environments were created by implying four different treatments differing in sowing date and water availability, panel was evaluated for two years in field conditions. The panel was genotyped with 15K Illumina chip and 9236 polymorphic markers concentrated on B genome were employed in GWAS analysis. Consistent, fast LD decay was observed on D genome and structure analysis germplasm divided panel into three major populations. GWAS was performed using BLUEs values of combined environment data in R package GAPIT using log10(P) = 3.96 as significance threshold. The significance of association was further checked using FDR< 0.05 threshold. The GWAS identified 487 loci associated with the traits and were significant at log10(p) threshold out of these 350 loci were significant at FDR threshold. For two stress indices 108 associations were significant at FDR threshold. Nine genomic regions were shared among all treatment, while multiple pleiotropic regions were present on chromosome 7D followed by unmapped chromosome. The present study validated many marker trait associations for yield and other traits, MTAs significant under combined drought and heat stress were novel. These regions are important and can be used for fine mapping and marker assisted selection to discover new genes responsible for heat and drought tolerance in wheat.	[Qaseem, Mirza Faisal; Qureshi, Rahmatullah] PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Pakistan; [Shaheen, Humaira] COMSATS Univ, Dept Biosci, Islamabad, Pakistan; [Shafqat, Noshin] Hazara Univ Dhodial, Dept Agr, Mansehra, Khyber Pakhtunk, Pakistan	Arid Agriculture University; COMSATS University Islamabad (CUI)	Qaseem, MF (corresponding author), PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Pakistan.	faisal.ali522@gmail.com	Qaseem, Mirza Faisal/AAB-5797-2021; Qureshi, Rahmatullah/F-1441-2018	Qureshi, Rahmatullah/0000-0001-9184-1216; Qaseem, Mirza Faisal/0000-0001-7973-408X				Acevedo E., 2002, BREAD WHEAT IMPROVEM, P30; Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Aisawi KAB, 2015, CROP SCI, V55, P1749, DOI 10.2135/cropsci2014.09.0601; Ali S, 2017, FOODS, V6, DOI 10.3390/foods6060039; Alomari DZ, 2018, FRONT PLANT SCI, V9, DOI [10.3389/fpls.2017.01797, 10.3389/fpls.2018.01313]; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Atlin GN, 2017, GLOB FOOD SECUR-AGR, V12, P31, DOI 10.1016/j.gfs.2017.01.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cassia R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00273; Crespo-Herrera LA, 2017, CROP SCI, V57, P789, DOI 10.2135/cropsci2016.06.0553; Cui F, 2014, THEOR APPL GENET, V127, P659, DOI 10.1007/s00122-013-2249-8; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Mason RE, 2010, EUPHYTICA, V174, P423, DOI 10.1007/s10681-010-0151-x; Flato G, 2013, EVALUATION CLIMATE M; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; Gupta PK, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010005; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu ZS, 2018, PLANT BIOTECHNOL J, V16, P714, DOI 10.1111/pbi.12822; LUPTON FGH, 1966, ANN APPL BIOL, V57, P355, DOI 10.1111/j.1744-7348.1966.tb03829.x; Maccaferri M, 2016, J EXP BOT, V67, P1161, DOI 10.1093/jxb/erw039; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mondal S, 2015, EARLY MATURITY WHEAT; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Nguyen N.V., 2002, GLOBAL CLIMATE CHANG; Pritchard JK, 2000, GENETICS, V155, P945; Qaseem MF, 2018, GENOME WIDE ASS MAPP, V13, DOI [10.1371/journal.pone.0199121, DOI 10.1371/JOURNAL.PONE.0199121]; Qaseem MF, 2017, PAK J BOT, P6; Qaseem MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199121; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Sadeghzadeh D., 2005, Pakistan Journal of Biological Sciences, V8, P959, DOI 10.3923/pjbs.2005.959.962; Sehgal D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41578; Sharma RC, 2012, CROP SCI, V52, P1522, DOI 10.2135/cropsci2011.12.0634; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Sorkheh K, 2008, GENET MOL BIOL, V31, P805, DOI 10.1590/S1415-47572008000500001; Sukumaran S, 2018, THEOR APPL GENET, V131, P985, DOI 10.1007/s00122-017-3037-7; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Sun CW, 2017, PLANT BIOTECHNOL J, V15, P953, DOI 10.1111/pbi.12690; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tahmasebi S, 2017, GENOME, V60, P26, DOI 10.1139/gen-2016-0017; Thoen MPM, 2017, NEW PHYTOL, V213, P1346, DOI 10.1111/nph.14220; Tricker PJ, 2018, J EXP BOT, V69, P3195, DOI 10.1093/jxb/ery081; Valluru R, 2017, NEW PHYTOL, V214, P271, DOI 10.1111/nph.14367; Wang SX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188662; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zandalinas SI, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0791-7; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zarei L., 2013, Australian Journal of Crop Science, V7, P609; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	60	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2019	14	3							e0213407	10.1371/journal.pone.0213407	http://dx.doi.org/10.1371/journal.pone.0213407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP1JR	30883588	Green Published, gold			2022-12-26	WOS:000461423500014
J	Derkach, K; Zakharova, I; Zorina, I; Bakhtyukov, A; Romanova, I; Bayunova, L; Shpakov, A				Derkach, Kira; Zakharova, Irina; Zorina, Inna; Bakhtyukov, Andrey; Romanova, Irina; Bayunova, Liubov; Shpakov, Alexander			The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BLOOD-BRAIN-BARRIER; REGULATES POMC EXPRESSION; ENERGY-BALANCE; FOOD-INTAKE; INSULIN-RESISTANCE; LEPTIN RECEPTOR; WEIGHT-LOSS; OXIDATIVE STRESS; BODY-WEIGHT	In diet-induced obesity, metformin (MF) has weight-lowering effect and improves glucose homeostasis and insulin sensitivity. However, there is no information on the efficiency of MF and the mechanisms of its action in melanocortin-type obesity. We studied the effect of the 10-day treatment with MF at the doses of 200, 400 and 600 mg/kg/day on the food intake and the metabolic and hormonal parameters in female C57Bl/6J (genotype A y /a) agoutimice with melanocortin-type obesity, and the influence of MF on the hypothalamic signaling in obese animals at the most effective metabolic dose (600 mg/kg/day). MF treatment led to a decrease in food intake, the body and fat weights, the plasma levels of glucose, insulin and leptin, all increased in agouti-mice, to an improvement of the lipid profile and glucose sensitivity, and to a reduced fatty liver degeneration. In the hypothalamus of obese agoutimice, the leptin and insulin content was reduced and the expression of the genes encoding leptin receptor (LepR), MC3-and MC4-melanocortin receptors and pro-opiomelanocortin (POMC), the precursor of anorexigenic melanocortin peptides, was increased. The activities of AMP-activated kinase (AMPK) and the transcriptional factor STAT3 were increased, while Akt-kinase activity did not change from control C57Bl/6J (a/a) mice. In the hypothalamus of MF-treated agouti-mice (10 days, 600 mg/kg/day), the leptin and insulin content was restored, Akt-kinase activity was increased, and the activities of AMPK and STAT3 were reduced and did not differ from control mice. In the hypothalamus of MF-treated agoutimice, the Pomc gene expression was six times higher than in control, while the gene expression for orexigenic neuropeptide Y was decreased by 39%. Thus, we first showed that MF treatment leads to an improvement of metabolic parameters and a decrease of hyperleptinemia and hyperinsulinaemia in genetically-induced melanocortin obesity, and the specific changes in the hypothalamic signaling makes a significant contribution to this effect of MF.	[Derkach, Kira; Zakharova, Irina; Zorina, Inna; Bakhtyukov, Andrey; Romanova, Irina; Bayunova, Liubov; Shpakov, Alexander] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Dept Mol Endocrinol & Neurochem, St Petersburg, Russia	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Shpakov, A (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Dept Mol Endocrinol & Neurochem, St Petersburg, Russia.	alex_shpakov@list.ru	Бахтюков, Андрей/AAN-1834-2020; Bayunova, Liubov/AAN-1066-2020; Zorina, Inna I/C-8389-2017; Shpakov, Alexander O/R-6581-2016; Derkach, Kira/AAN-1060-2020; Romanova, Irina/AAO-2674-2021; Romanova, Irina/AAN-1993-2020; Zakharova, Irina/T-1394-2018	Бахтюков, Андрей/0000-0002-2060-2020; Zorina, Inna I/0000-0002-7328-2120; Shpakov, Alexander O/0000-0002-4293-3162; Derkach, Kira/0000-0001-6555-9540; Romanova, Irina/0000-0002-0348-0631; Zakharova, Irina/0000-0001-8857-7012	Russian Science Foundation [16-15-10388]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (project No 16-15-10388). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya AP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05189; Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Atay K, 2017, ACTA GASTRO-ENT BELG, V80, P271; Aubert G, 2011, METABOLISM, V60, P327, DOI 10.1016/j.metabol.2010.02.007; Baldassari S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22054-w; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Borges BC, 2016, MOL CELL ENDOCRINOL, V438, P36, DOI 10.1016/j.mce.2016.07.005; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Cavaliere G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00818; Chau-Van C, 2007, ENDOCRINOLOGY, V148, P507, DOI 10.1210/en.2006-1237; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen F, 2016, NEUROPHARMACOLOGY, V101, P123, DOI 10.1016/j.neuropharm.2015.07.023; Choi Y, 2017, FOOD CHEM TOXICOL, V103, P111, DOI 10.1016/j.fct.2017.02.039; Cobbina E, 2017, DRUG METAB REV, V49, P197, DOI 10.1080/03602532.2017.1293683; Derkach KV, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/245459; Dey S, 2016, J MOL ENDOCRINOL, V56, P55, DOI 10.1530/JME-15-0171; Donato J, 2010, ARQ BRAS ENDOCRINOL, V54, P591, DOI 10.1590/S0004-27302010000700002; Efe O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88409; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farbood Y, 2015, MICROCIRCULATION, V22, P534, DOI 10.1111/micc.12224; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gout J, 2008, OBESITY, V16, P1763, DOI 10.1038/oby.2008.303; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Gras V, 2006, DIABETES METAB, V32, P147, DOI 10.1016/S1262-3636(07)70261-6; Han J, 2015, MOL CELL ENDOCRINOL, V405, P63, DOI 10.1016/j.mce.2015.02.008; Haskell-Luevano C, 2009, FASEB J, V23, P642, DOI 10.1096/fj.08-109686; Havel PJ, 2000, DIABETES, V49, P244, DOI 10.2337/diabetes.49.2.244; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Horvath TL, 2006, OBESITY, V14, P228; Hostalek U, 2015, DRUGS, V75, P1071, DOI 10.1007/s40265-015-0416-8; Hu SH, 2013, EXP CLIN ENDOCR DIAB, V121, P220, DOI 10.1055/s-0032-1333277; Huang YR, 2018, J ENDOCR SOC, V2, P518, DOI 10.1210/js.2018-00061; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Huvenne H, 2016, OBESITY FACTS, V9, P158, DOI 10.1159/000445061; Ibars M, 2017, INT J OBESITY, V41, P129, DOI 10.1038/ijo.2016.169; Igel LI, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0568-3; Iskandar K, 2010, AM J PHYSIOL-ENDOC M, V298, pE787, DOI 10.1152/ajpendo.00512.2009; Jiang L, 2008, P NATL ACAD SCI USA, V105, P18619, DOI 10.1073/pnas.0804589105; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kanto K, 2018, J DIABETES INVEST, V9, P587, DOI 10.1111/jdi.12755; Keirnan J., 2015, HISTOLOGICAL HISTOCH, P184; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Koenig AM, 2017, ALZ DIS ASSOC DIS, V31, P107, DOI 10.1097/WAD.0000000000000202; Komiya C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44754; Labuzek K, 2010, PHARMACOL REP, V62, P956; Lede V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172000; Lee CK, 2012, DIABETES METAB J, V36, P293, DOI 10.4093/dmj.2012.36.4.293; Lemos AJJM, 2014, TOXICOL APPL PHARM, V280, P159, DOI 10.1016/j.taap.2014.05.015; Li Z, 2018, WORLD J GASTROENTERO, V24, P819, DOI 10.3748/wjg.v24.i7.819; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Lopez M, 2017, EUR J ENDOCRINOL, V176, pR235, DOI 10.1530/EJE-16-0927; Lopez M, 2016, NAT REV ENDOCRINOL, V12, P421, DOI 10.1038/nrendo.2016.67; Lu CH, 2016, EUR J PHARMACOL, V789, P60, DOI 10.1016/j.ejphar.2016.07.012; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lv WS, 2012, BRAIN RES, V1444, P11, DOI 10.1016/j.brainres.2012.01.028; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Malin SK, 2014, CURR OPIN ENDOCRINOL, V21, P323, DOI 10.1097/MED.0000000000000095; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Meek TH, 2014, ENDOCRINOLOGY, V155, P4157, DOI 10.1210/en.2014-1169; Moehlecke M, 2016, ARCH ENDOCRIN METAB, V60, P152, DOI 10.1590/2359-3997000000129; Morgan DA, 2015, DIABETES, V64, P1976, DOI 10.2337/db14-1257; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nakhjavani M, 2011, REDOX REP, V16, P193, DOI 10.1179/1351000211Y.0000000008; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Oyaizu-Toramaru T, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00248-17; Pan Q, 2013, OBESITY, V21, pE520, DOI 10.1002/oby.20459; Pan WH, 2008, ENDOCRINOLOGY, V149, P2798, DOI 10.1210/en.2007-1673; Paolini B, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038718; Park Hyeong-Kyu, 2014, F1000Prime Rep, V6, P73, DOI 10.12703/P6-73; Patil SP, 2014, NEUROSCIENCE, V277, P747, DOI 10.1016/j.neuroscience.2014.07.046; Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389; Protti A, 2012, CRIT CARE, V16, DOI 10.1186/cc11332; Romanova IV, 2018, NEUROCHEM RES, V43, P821, DOI 10.1007/s11064-018-2485-z; Rotermund C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00400; Rowland NE, 2010, PEPTIDES, V31, P2314, DOI 10.1016/j.peptides.2010.08.016; Rui L, 2014, WORLD J DIABETES, V5, P511, DOI 10.4239/wjd.v5.i4.511; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seifarth C, 2013, EXP CLIN ENDOCR DIAB, V121, P27, DOI 10.1055/s-0032-1327734; Shpakov AO, 2015, BIOCHEM MOSC SUPPL S, V9, P124, DOI 10.1134/S1990747815010079; Shpakov AO, 2015, FUTUR SCI OA, V1, DOI [10.4155/FSO.15.23, 10.4155/fso.15.23]; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Sun J, 2016, MOL METAB, V5, P882, DOI 10.1016/j.molmet.2016.08.007; Takata F, 2013, BIOCHEM BIOPH RES CO, V433, P586, DOI 10.1016/j.bbrc.2013.03.036; Tang GM, 2017, ONCOTARGET, V8, P97977, DOI 10.18632/oncotarget.20105; Tao YX, 2009, PROG MOL BIOL TRANSL, V88, P173, DOI 10.1016/S1877-1173(09)88006-X; Thearle MS, 2012, DIABETES, V61, P250, DOI 10.2337/db11-0708; Timmins P, 2005, CLIN PHARMACOKINET, V44, P721, DOI 10.2165/00003088-200544070-00004; Toyama K, 2012, BRIT J PHARMACOL, V166, P1183, DOI 10.1111/j.1476-5381.2012.01853.x; Tsuruta Y, 2002, AM J PHYSIOL-ENDOC M, V282, pE967, DOI 10.1152/ajpendo.00292.2001; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; van der Aa MP, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.37; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Yang X, 2017, BBA-MOL BASIS DIS, V1863, P1984, DOI 10.1016/j.bbadis.2016.09.019	108	20	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2019	14	3							e0213779	10.1371/journal.pone.0213779	http://dx.doi.org/10.1371/journal.pone.0213779			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7YP	30870482	Green Submitted, Green Published, gold			2022-12-26	WOS:000461166300071
J	Belharet, M; Charmasson, S; Tsumune, D; Arnaud, M; Estournel, C				Belharet, Mokrane; Charmasson, Sabine; Tsumune, Daisuke; Arnaud, Mireille; Estournel, Claude			Numerical modelling of Cs-137 content in the pelagic species of the Japanese Pacific coast following the Fukushima Dai-ichi Nuclear Power Plant accident using a size-structured food-web model	PLOS ONE			English	Article							MARINE BIOTA; RADIOACTIVE CESIUM; THUNNUS-ALBACARES; TROPHIC TRANSFER; YELLOWFIN TUNA; DAILY RATION; RADIOCESIUM; OCEAN; FISH; SIMULATION	As result of the great east Japan earthquake on March 2011 and the damages of the Fukushima Dai-ichi Nuclear Power Plant (FDNPP), huge amount of radionuclides, especially Cs-137, were released to the Japanese Pacific coast. By consequence, several marine species have been contaminated by direct uptake of radionuclides from seawater or through feeding on contaminated preys. In the present study we propose a novel radioecological modelling approach aiming to simulate the radionuclides transfer to pelagic marine species by giving to the organism body-size a key role in the model. We applied the model to estimate the Cs-137 content in 14 commercially important species of the North-Western Pacific Ocean after the FDNPP accident. Firstly, we validated the model and evaluated its performance using various observed field data, and we demonstrated the importance of using such modelling approach in radioecological studies. Afterwards, we estimated some radioecological metrics, such as the maximum activity concentration, its corresponding time and the ecological half-life, which are important in assessment of the previous, current and future contamination levels of the studied species. Finally, we estimated the time duration required for each species to reach the pre-accident Cs-137 activity concentrations. The results showed that the contamination levels in the planktivorous species have generally reached the pre-accident levels since about 5 years after the accident (since 2016). While in the case of the higher trophic level species, although the activity concentrations are much lower than the regulatory limit for radiocesium in seafood in Japan (100 Bq kg(-1)), these species still require another 6-14 years (2018-2026) to reach the pre-accident levels.	[Belharet, Mokrane; Charmasson, Sabine; Arnaud, Mireille] IRSN, PSE ENV SRTE, Lab Rech Transferts Radionucleides Ecosyst Aquat, St Paul Les Durance, France; [Belharet, Mokrane; Estournel, Claude] Univ Toulouse, UPS, CNRS, LA,UMR 5560, Toulouse, France; [Tsumune, Daisuke] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Abiko, Chiba, Japan; [Belharet, Mokrane] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Central Research Institute of Electric Power Industry - Japan; Polytechnic University of Milan	Belharet, M (corresponding author), IRSN, PSE ENV SRTE, Lab Rech Transferts Radionucleides Ecosyst Aquat, St Paul Les Durance, France.; Belharet, M (corresponding author), Univ Toulouse, UPS, CNRS, LA,UMR 5560, Toulouse, France.; Belharet, M (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy.	mokrane.belharet@gmail.com	Estournel, Claude/GQA-9851-2022; Estournel, Claude/ABC-6040-2020; Estournel, Claude/GRS-0218-2022	Estournel, Claude/0000-0003-3593-7138; Estournel, Claude/0000-0003-3593-7138; Estournel, Claude/0000-0003-3593-7138; Belharet, Mokrane/0000-0003-0640-1481; Tsumune, Daisuke/0000-0002-0946-8430	French Institute for Radioprotection and nuclear safety (IRSN); French National Research Agency (ANR) [ANR-11-RSNR-0002]	French Institute for Radioprotection and nuclear safety (IRSN); French National Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the French Institute for Radioprotection and nuclear safety (IRSN), http://www irsn .fr/FR/Pages/Home.aspx, and supported by the French National Research Agency (ANR) in the framework of AMORAD project (ANR-11-RSNR-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the French National Research Agency (ANR) in the framework of AMORAD project (ANR-11-RSNR-0002). We are most grateful to Dr Yutaka Tateda of CRIEPI (Japan) for his help and support. We are also grateful for discussions and input from Herve Thebault, Celine Duffa, Patrick Marsaleix, Thomas Duhaut, Cyril Nguyen, Caroline Ulses and Scott Fowler, that improved this paper.	Aoyama M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031964; Badle JVI, 2007, SCI TOTAL ENVIRON, V388, P256, DOI 10.1016/j.scitotenv.2007.07.048; Belharet M, 2016, BIOGEOSCIENCES, V13, P499, DOI 10.5194/bg-13-499-2016; Brown J, 2006, J ENVIRON RADIOACTIV, V88, P289, DOI 10.1016/j.jenvrad.2006.02.008; Buesseler K, 2017, ANNU REV MAR SCI, V9, P173, DOI 10.1146/annurev-marine-010816-060733; Buesseler KO, 2014, OCEANOGRAPHY, V27, P92, DOI 10.5670/oceanog.2014.02; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029295; ELLIOTT JM, 1992, J APPL ECOL, V29, P108, DOI 10.2307/2404354; Erichsen AC, 2013, AMBIO, V42, P464, DOI 10.1007/s13280-013-0398-2; Estournel C, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007933; Ferriss BE, 2014, ECOL MODEL, V272, P232, DOI 10.1016/j.ecolmodel.2013.10.010; Fievet B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172442; Fowler SW, 2004, RADIOACTIV ENVIRONM, V6, P167; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Gobas F.A.P.C., 2008, ENCY ECOLOGY, P1643, DOI [10.1016/b978-008045405-4.00398-0, DOI 10.1016/B978-008045405-4.00398-0]; Grimm V., 2005, PRINCETON SERIES THE; Harmelin-Vivien M, 2012, MAR POLLUT BULL, V64, P974, DOI 10.1016/j.marpolbul.2012.02.014; Heldal HE, 2003, J ENVIRON RADIOACTIV, V65, P177, DOI 10.1016/S0265-931X(02)00095-4; HEWETT CJ, 1978, J FISH BIOL, V13, P143, DOI 10.1111/j.1095-8649.1978.tb03422.x; Hildrew A, 2007, FRESHWATER BIOL, DOI [10.1017/CBO9780511611223, DOI 10.1017/CBO9780511611223]; Hirose K, 2008, APPL RADIAT ISOTOPES, V66, P1675, DOI 10.1016/j.apradiso.2007.09.019; International Atomic Energy Agency (IAEA), 2004, TECDOC422 IAEA; Iwata K, 2013, ENVIRON SCI TECHNOL, V47, P7696, DOI 10.1021/es400491b; JCAC (Japan Chemical Analysis Center), 2004, 139 JCAC; Kasamatsu F, 1997, MAR ECOL PROG SER, V160, P109, DOI 10.3354/meps160109; Killen SS, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1588; KOULIKOV AO, 1992, SCI TOTAL ENVIRON, V112, P125, DOI 10.1016/0048-9697(92)90243-L; Kurita Y, 2004, B JPN SOC FISH OCEAN; Kurita Y, 2015, RADIOCESIUM CONTAMIN, P139, DOI [10.1007/978-4-431-55537-7_11, DOI 10.1007/978-4-431-55537-7_11]; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Madec G., 2022, ZENODO, DOI [10.5281/zenodo.1464816, DOI 10.5281/ZENODO.1464816]; Mathews T, 2008, MAR ECOL PROG SER, V367, P23, DOI 10.3354/meps07536; Mathews T, 2008, MAR ECOL PROG SER, V360, P1, DOI 10.3354/meps07462; Maury O, 2007, PROG OCEANOGR, V74, P479, DOI 10.1016/j.pocean.2007.05.002; Menard F, 2000, AQUAT LIVING RESOUR, V13, P233, DOI 10.1016/S0990-7440(00)01066-4; MEXT, 2014, REP MON RAD FISH PRO; Miyazawa Y, 2009, J OCEANOGR, V65, P737, DOI 10.1007/s10872-009-0063-3; Nakazawa T, 2011, ADV ECOL RES, V45, P269, DOI 10.1016/B978-0-12-386475-8.00007-1; Narimatsu Y, 2015, WHY DO RADIONUCLIDE, P123, DOI [10.1007/978-4-431-55537-7_10, DOI 10.1007/978-4-431-55537-7_10]; Nikolioudakis N, 2011, MAR ECOL PROG SER, V437, P215, DOI 10.3354/meps09275; Noguchi M., 1990, B JAPAN SEA NATL FLS, V40, P1; OCONNELL CP, 1972, FISH BULL NATL OC AT, V70, P973; Okunishi T, 2009, ECOL MODEL, V220, P462, DOI 10.1016/j.ecolmodel.2008.10.020; OLSON RJ, 1986, CAN J FISH AQUAT SCI, V43, P1760, DOI 10.1139/f86-220; Pillar SC, 1998, S AFR J MARINE SCI, V19, P263; Povinec P. P., 2013, FUKUSHIMA ACCIDENT, P277; Reinfelder JR, 1998, SCI TOTAL ENVIRON, V219, P117, DOI 10.1016/S0048-9697(98)00225-3; Rowan DJ, 1995, J APPL ECOL, V32, P739, DOI 10.2307/2404813; ROWAN DJ, 1994, CAN J FISH AQUAT SCI, V51, P2388, DOI 10.1139/f94-240; Rowan DJ, 1996, CAN J FISH AQUAT SCI, V53, P734, DOI 10.1139/cjfas-53-4-734; Sakurai Yasunori, 1993, P467; SHARP GD, 1976, FISH B-NOAA, V74, P36; Tateda Y, 1996, J RADIAT RES, V37, P71, DOI 10.1269/jrr.37.71; Tateda Y, 2016, J ENVIRON RADIOACTIV, V151, P495, DOI 10.1016/j.jenvrad.2015.05.013; Tateda Y, 2013, J ENVIRON RADIOACTIV, V124, P1, DOI 10.1016/j.jenvrad.2013.03.007; THOMANN RV, 1981, CAN J FISH AQUAT SCI, V38, P280, DOI 10.1139/f81-040; Tsumune D, 2013, BIOGEOSCIENCES, V10, P5601, DOI 10.5194/bg-10-5601-2013; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Batlle JVI, 2016, J ENVIRON RADIOACTIV, V151, P502, DOI 10.1016/j.jenvrad.2015.02.023; Wada T, 2016, J ENVIRON RADIOACTIV, V164, P312, DOI 10.1016/j.jenvrad.2016.06.028; Wada T, 2013, J ENVIRON RADIOACTIV, V124, P246, DOI 10.1016/j.jenvrad.2013.05.008; Walters WJ, 2018, J ENVIRON RADIOACTIV, V181, P118, DOI 10.1016/j.jenvrad.2017.11.008; Wang WX, 2000, MAR ECOL PROG SER, V208, P41, DOI 10.3354/meps208041; Woodward G, 2010, ADV ECOL RES, V43, P211, DOI 10.1016/B978-0-12-385005-8.00006-X; Young JW, 2010, MAR BIOL, V157, P2347, DOI 10.1007/s00227-010-1500-y; Zhao XG, 2001, MAR ECOL PROG SER, V222, P227, DOI 10.3354/meps222227	67	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212616	10.1371/journal.pone.0212616	http://dx.doi.org/10.1371/journal.pone.0212616			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865647	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900027
J	Guillemot, V; Beaton, D; Gloaguen, A; Lofstedt, T; Levine, B; Raymond, N; Tenenhaus, A; Abdi, H				Guillemot, Vincent; Beaton, Derek; Gloaguen, Arnaud; Lofstedt, Tommy; Levine, Brian; Raymond, Nicolas; Tenenhaus, Arthur; Abdi, Herve			A constrained singular value decomposition method that integrates sparsity and orthogonality	PLOS ONE			English	Article							COMPONENTS; SELECTION; SET	We propose a new sparsification method for the singular value decomposition-called the constrained singular value decomposition (CSVD)-that can incorporate multiple constraints such as sparsification and orthogonality for the left and right singular vectors. The CSVD can combine different constraints because it implements each constraint as a projection onto a convex set, and because it integrates these constraints as projections onto the intersection of multiple convex sets. We show that, with appropriate sparsification constants, the algorithm is guaranteed to converge to a stable point. We also propose and analyze the convergence of an efficient algorithm for the specific case of the projection onto the balls defined by the norms L-1 and L-2. We illustrate the CSVD and compare it to the standard singular value decomposition and to a non-orthogonal related sparsification method with: 1) a simulated example, 2) a small set of face images (corresponding to a configuration with a number of variables much larger than the number of observations), and 3) a psychometric application with a large number of observations and a small number of variables. The companion R-package, csvd, that implements the algorithms described in this paper, along with reproducible examples, are available for download from https://github.com/vguillemoticsvd.	[Guillemot, Vincent] Inst Pasteur, Bioinformat & Biostat Hub, Paris, France; [Beaton, Derek; Levine, Brian] Rotman Res Inst Inst Baycrest, Toronto, ON, Canada; [Gloaguen, Arnaud; Tenenhaus, Arthur] Univ Paris Saclay, Univ Paris Sud, Cent Supelec, L2S,CNRS,UMR 8506, 3 Rue Joliot Curie, F-91192 Gif Sur Yvette, France; [Lofstedt, Tommy] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Raymond, Nicolas] Univ Rennes, IRMAR, UMR 6625, Rennes, France; [Abdi, Herve] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Umea University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Rennes; University of Texas System; University of Texas Dallas	Guillemot, V (corresponding author), Inst Pasteur, Bioinformat & Biostat Hub, Paris, France.; Abdi, H (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	vincent.guillemot@pasteur.fr; herve@utdallas.edu	Guillemot, Vincent/AAV-6018-2021	Abdi, Herve/0000-0002-9522-1978; Lofstedt, Tommy/0000-0001-7119-7646	EURIAS fellowship at the Paris Institute for Advanced Studies (France); Marie Sklodowska-Curie Actions, under the European Union's 7th Framework Programme; French State programme "Investissements d'avenir" [ANR-11-LABX-0027-01 Labex RFIEA+]	EURIAS fellowship at the Paris Institute for Advanced Studies (France); Marie Sklodowska-Curie Actions, under the European Union's 7th Framework Programme; French State programme "Investissements d'avenir"(French National Research Agency (ANR))	This article benefitted from a EURIAS fellowship at the Paris Institute for Advanced Studies (France), co-funded by Marie Sklodowska-Curie Actions, under the European Union's 7th Framework Programme for research, and from a funding from the French State programme "Investissements d'avenir", managed by the Agence Nationale de la Recherche (ANR-11-LABX-0027-01 Labex RFIEA+). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2003, ENCY RES METHODS SOC, P792; ABDI H., 2019, PRINCIPAL COMPONENT; Abdi H., 2007, ENCYCL MEASUR STAT, P907; Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Allen GI, 2014, J AM STAT ASSOC, V109, P145, DOI 10.1080/01621459.2013.852978; Bauschke HH, 2017, CONVEX ANAL MONOTONE, DOI 10.1007/978-3-319-48311-5; Benidis K, 2016, IEEE T SIGNAL PROCES, V64, P6211, DOI 10.1109/TSP.2016.2605073; Blajenkova O, 2006, APPL COGNITIVE PSYCH, V20, P239, DOI 10.1002/acp.1182; Boyd S., 2004, CONVEX OPTIMIZATION; Candes E, 2005, PROC SPIE, V5674, P76, DOI 10.1117/12.600722; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; COMBETTES PL, 1993, P IEEE, V81, P182, DOI 10.1109/5.214546; Daubechies I, 2008, J FOURIER ANAL APPL, V14, P764, DOI 10.1007/s00041-008-9039-8; Duchi John, 2008, P 25 INT C MACH LEAR; Efron B., 2016, COMPUTER AGE STAT IN, V5; Genicot M, 2015, LECT NOTES COMPUT SC, V9389, P484, DOI 10.1007/978-3-319-25040-3_52; Gloaguen A, 2017, JOURNEES STAT, P1; Greenacre M., 2010, CORRES ANAL PRACTICE; Hastie T., 2015, STAT LEARNING SPARSI; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Jenatton R, 2011, J MACH LEARN RES, V12, P2777; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Le Floch E, 2012, NEUROIMAGE, V63, P11, DOI 10.1016/j.neuroimage.2012.06.061; Lebart L., 1984, MULTIVARIATE DESCRIP; Lu ZS, 2012, MATH PROGRAM, V135, P149, DOI 10.1007/s10107-011-0452-4; Mackey L., 2009, P ADV NEUR INF PROC, V21, P1017; Mattei PA, 2016, JMLR WORKSH CONF PRO, V51, P976; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Razaviyayn M, 2013, SIAM J OPTIMIZ, V23, P1126, DOI 10.1137/120891009; Silver M, 2012, NEUROIMAGE, V63, P1681, DOI 10.1016/j.neuroimage.2012.08.002; Trendafilov NT, 2014, COMPUTATION STAT, V29, P431, DOI 10.1007/s00180-013-0434-5; Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758; Valentin D, 1999, PERCEPTION, V28, P817, DOI 10.1068/p2932; van den Berg E., 2008, GROUP SPARSITY VIA L; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0211463	10.1371/journal.pone.0211463	http://dx.doi.org/10.1371/journal.pone.0211463			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865639	Green Published, gold			2022-12-26	WOS:000461048900010
J	Mackler, RM; Jones, ND; Gardner, AM; Lopez, MA; Howard, CJ; Fishel, R; Yoder, KE				Mackler, Randi M.; Jones, Nathan D.; Gardner, Anne M.; Lopez, Miguel A., Jr.; Howard, Cecil J.; Fishel, Richard; Yoder, Kristine E.			Nucleosome DNA unwrapping does not affect prototype foamy virus integration efficiency or site selection	PLOS ONE			English	Article							MODULATE RETROVIRAL INTEGRATION; TARGET SITES; HIV-1 INTEGRATION; CORE PARTICLE; PROTEINS; LEDGF/P75; BINDING; MINICHROMOSOMES; RECONSTITUTION; ACCESSIBILITY	Eukaryotic DNA binding proteins must access genomic DNA that is packaged into chromatin in vivo. During a productive infection, retroviral integrases (IN) must similarly interact with chromatin to integrate the viral cDNA genome. Here we examine the role of nucleosome DNA unwrapping in the retroviral integrase search for a target site. These studies utilized PFV intasomes that are comprised of a tetramer of PFV IN with two oligomers mimicking the viral cDNA ends. Modified recombinant human histones were used to generate nucleosomes with increased unwrapping rates at different DNA regions. These modifications included the acetylmimetic H3(K56Q) and the chemically engineered H4(K77ac, K79ac). While transcription factors and DNA damage sensors may search nucleosome bound DNA during transient unwrapping, PFV intasome mediated integration appears to be unaffected by increased nucleosome unwrapping. These studies suggest PFV intasomes do not utilize nucleosome unwrapping to search nucleosome targets.	[Mackler, Randi M.; Jones, Nathan D.; Gardner, Anne M.; Lopez, Miguel A., Jr.; Fishel, Richard; Yoder, Kristine E.] Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Howard, Cecil J.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Yoder, KE (corresponding author), Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA.	yoder.176@osu.edu	Yoder, Kristine/E-4353-2011	Yoder, Kristine/0000-0002-5598-9018; Kotlar, Randi/0000-0002-2513-6479; Howard, Cecil/0000-0002-5761-9424; Gardner, Anne/0000-0001-7095-772X; Jones, Nathan/0000-0002-2159-1394	National Institute of Allergy and Infectious Disease (NIAID) [AI126742]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126742] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Disease (NIAID) award AI126742 to R.F. and K.E.Y. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JD, 2002, MOL CELL BIOL, V22, P7147, DOI 10.1128/MCB.22.20.7147-7157.2002; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Benleulmi MS, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0145-9; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Brehove M, 2015, J BIOL CHEM, V290, P22612, DOI 10.1074/jbc.M115.661363; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Chatterjee N, 2015, MOL CELL BIOL, V35, P4083, DOI 10.1128/MCB.00441-15; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Coffin J, 1997, RETROVIRUSES; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Du Q, 2005, BIOPHYS J, V88, P4137, DOI 10.1529/biophysj.104.055657; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Flaus A, 2011, FRONT LIFE SCI, V5, P5, DOI 10.1080/21553769.2012.702667; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; GOTTESFELD JM, 1987, MOL CELL BIOL, V7, P1612, DOI 10.1128/MCB.7.5.1612; Gracey LE, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-13; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jones ND, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11409; Jones ND, 2019, SCI REPORTS; Lee AJ, 2014, DNA REPAIR, V20, P23, DOI 10.1016/j.dnarep.2014.01.007; Lelek M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7483; Li M, 2012, METHOD ENZYMOL, V513, P29, DOI 10.1016/B978-0-12-391938-0.00002-1; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Lopez MA, 2017, JOVE-J VIS EXP, DOI 10.3791/56605; Lopez MA, 2016, J VIROL METHODS, V235, P134, DOI 10.1016/j.jviromet.2016.06.002; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mackler RM, 2018, JOVE-J VIS EXP, DOI 10.3791/57453; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Pham CD, 2010, NUCLEIC ACIDS RES, V38, P400, DOI 10.1093/nar/gkp1030; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, P NATL ACAD SCI USA, V89, P9237, DOI 10.1073/pnas.89.19.9237; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Rodriguez Y, 2015, DNA REPAIR, V32, P113, DOI 10.1016/j.dnarep.2015.04.021; Serrao E, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0167-3; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shimko John C, 2013, Methods Mol Biol, V981, P177, DOI 10.1007/978-1-62703-305-3_14; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Wu B, 2011, NUCLEIC ACIDS RES, V39, P8200, DOI 10.1093/nar/gkr491; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005	64	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0212764	10.1371/journal.pone.0212764	http://dx.doi.org/10.1371/journal.pone.0212764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865665	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900035
J	Schafer, P; Helm, S; Kohler, D; Agne, B; Baginsky, S				Schaefer, Peter; Helm, Stefan; Koehler, Daniel; Agne, Birgit; Baginsky, Sacha			Consequences of impaired 1-MDa TIC complex assembly for the abundance and composition of chloroplast high-molecular mass protein complexes	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; FTSH PROTEASE; IMPORT; TRANSLOCATION; QUANTIFICATION; SPECTROMETRY; METABOLON; COMPONENT; STROMA; TOOL	We report a systematic analysis of chloroplast high-molecular mass protein complexes using a combination of native gel electrophoresis and absolute protein quantification by MSE. With this experimental setup, we characterized the effect of the tic56-3 mutation in the 1-MDa inner envelope translocase (TIC) on the assembly of the chloroplast proteome. We show that the tic56-3 mutation results in a reduction of the 1-MDa TIC complex to approximately 10% of wildtype levels. Hierarchical clustering confirmed the association of malate dehydrogenase (MDH) with an envelope-associated FtsH/FtsHi complex and suggested the association of a glycine-rich protein with the 1-MDa TIC complex. Depletion of this complex leads to a reduction of chloroplast ATPase to approx. 75% of wildtype levels, while the abundance of the FtsH/FtsHi complex is increased to approx. 140% of wildtype. The accumulation of the major photosynthetic complexes is not affected by the mutation, suggesting that tic56-3 plants can sustain a functional photosynthetic machinery despite a significant reduction of the 1-MDa TIC complex. Together our analysis expands recent efforts to catalogue the native molecular masses of chloroplast proteins and provides information on the consequences of impaired accumulation of the 1-MDa TIC translocase for chloroplast proteome assembly.	[Schaefer, Peter; Helm, Stefan; Koehler, Daniel; Agne, Birgit; Baginsky, Sacha] Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Biozentrum, Halle, Saale, Germany; [Agne, Birgit; Baginsky, Sacha] Ruhr Univ Bochum, Fac Biol & Biotechnol, Plant Biochem, Bochum, Germany	Martin Luther University Halle Wittenberg; Ruhr University Bochum	Baginsky, S (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Biozentrum, Halle, Saale, Germany.; Baginsky, S (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Plant Biochem, Bochum, Germany.	sacha.baginsky@biochemtech.uni-halle.de		Baginsky, Sacha/0000-0002-5440-3898	DFG [Ba1902/3-1, INST 271/283-1 FUGG]; federal state of "Sachsen-Anhalt"; European Regional Development fund of the European commission [W21004490]	DFG(German Research Foundation (DFG)); federal state of "Sachsen-Anhalt"; European Regional Development fund of the European commission	The authors are grateful for financial support from DFG project Ba1902/3-1 to SB (www.dfg.de), a graduate fellowship from the federal state of "Sachsen-Anhalt" (DK) (https://www.sachsen-anhalt.de) and for funding from the European Regional Development fund of the European commission via grant W21004490 "Land Sachsen-Anhalt" (SH) (https://www.sachsenanhalt.de). SB gratefully acknowledges DFG support for the acquisition of a Synapt G2-S mass spectrometer (INST 271/283-1 FUGG) (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Agne B, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1284726; Agne B, 2009, J BIOL CHEM, V284, P8661, DOI 10.1074/jbc.M804235200; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Behrens C, 2013, J PROTEOMICS, V91, P73, DOI 10.1016/j.jprot.2013.07.001; Bittner LM, 2017, BIOL CHEM, V398, P625, DOI 10.1515/hsz-2016-0302; Chen LJ, 2017, PLANT J, V92, P178, DOI 10.1111/tpj.13643; Crosby KC, 2011, FEBS LETT, V585, P2193, DOI 10.1016/j.febslet.2011.05.066; Helm S, 2018, METHODS MOL BIOL, V1696, P235, DOI 10.1007/978-1-4939-7411-5_16; Helm S, 2014, J PROTEOMICS, V98, P79, DOI 10.1016/j.jprot.2013.12.007; Janska H, 2013, BBA-MOL CELL RES, V1833, P381, DOI 10.1016/j.bbamcr.2012.03.016; Kato Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00855; Kikuchi S, 2018, PLANT CELL, V30, P2677, DOI 10.1105/tpc.18.00357; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kikuchi S, 2009, PLANT CELL, V21, P1781, DOI 10.1105/tpc.108.063552; Kohler D, 2016, PLANT PHYSIOL, V172, P2429, DOI 10.1104/pp.16.01393; Kovacs-Bogdan E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-133; Lallemand B, 2013, PLANT PHYSIOL, V162, P616, DOI 10.1104/pp.112.213124; Lundquist PK, 2017, MOL PLANT, V10, P197, DOI 10.1016/j.molp.2016.10.011; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Olinares PDB, 2010, MOL CELL PROTEOMICS, V9, P1594, DOI 10.1074/mcp.M000038-MCP201; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Pfalz J, 2013, TRENDS PLANT SCI, V18, P186, DOI 10.1016/j.tplants.2012.11.003; Ploscher M, 2011, J PROTEOMICS, V74, P1256, DOI 10.1016/j.jprot.2011.03.020; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Schroter Y, 2010, PROTEOMICS, V10, P2191, DOI 10.1002/pmic.200900678; Seung D, 2018, PLANT CELL, V30, P1523, DOI 10.1105/tpc.18.00219; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Struk S, 2019, PLANT CELL ENVIRON, V42, P387, DOI 10.1111/pce.13433; Struk S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00528; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; Teng YS, 2006, PLANT CELL, V18, P2247, DOI 10.1105/tpc.106.044305; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagner R, 2012, PHYSIOL PLANTARUM, V145, P203, DOI 10.1111/j.1399-3054.2011.01548.x; Yang XF, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.3; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071; Zufferey M, 2017, J BIOL CHEM, V292, P6952, DOI 10.1074/jbc.M117.776468	42	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213364	10.1371/journal.pone.0213364	http://dx.doi.org/10.1371/journal.pone.0213364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO6OH	30865669	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900064
J	Tornbom, K; Lundalv, J; Sunnerhagen, KS				Tornbom, Karin; Lundalv, Jorgen; Sunnerhagen, Katharina S.			Long-term participation 7-8 years after stroke: Experiences of people in working-age	PLOS ONE			English	Article							QUALITATIVE RESEARCH; POSTSTROKE FATIGUE; PHYSICAL-ACTIVITY; COMMUNITY; RETURN; SURVIVORS; BARRIERS; CONSEQUENCES; FACILITATORS; ADULTS	Objective To enhance the understanding of long-term participation in working-aged people 7-8 years after stroke. Methods This study had a qualitative design, using a thematic analysis methodology. Eleven individuals took part in an in depth interview 7-8 years after a first time stroke. They had received care at the Sahlgrenska University Hospital in Gothenburg, and were recruited as a heterogenic sample with respect to age, gender, stroke severity and subtype. Results From the participants' experiences four themes emerged: "Returning to work after stroke"; "Working life 7-8 years after stroke"; "Social life 7-8 years after stroke"; and "A state of reorientation in life". Quotes about experienced participation in everyday life were summarized and presented as "Participation after stroke narratives". Participants chose to emphasize on work- and social life when describing situations of successful participation. Being included in the wider community and having a sense of purpose, when interacting with others, were factors that these narratives had in common. Participants had gradually become accustomed to a somewhat altered life situation. Some consequences after stroke were still considered frustrating in social or work situations. However, the importance of these issues had reduced and were no longer problematized. Conclusions Participants felt content with their everyday life in general, which was a principal and positive result of this study. Reaching a stage of acceptance seemed to be a complex and continuous struggle, and an individual approach in long-term rehabilitation would be valuable to support this personal process. More knowledge about what factors that facilitate participation in people of working-age many years after stroke is needed, so that more people can reach a state of positive identity and participation.	[Tornbom, Karin; Sunnerhagen, Katharina S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Res Grp Rehabil Med,Sect Clin Neurosci, Gothenburg, Sweden; [Tornbom, Karin; Sunnerhagen, Katharina S.] Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden; [Lundalv, Jorgen] Univ Gothenburg, Dept Social Work, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Tornbom, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Res Grp Rehabil Med,Sect Clin Neurosci, Gothenburg, Sweden.; Tornbom, K (corresponding author), Univ Gothenburg, Ctr Person Ctr Care GPCC, Gothenburg, Sweden.	karin.tornbom@neuro.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400	Norrbacka Eugenia foundation [808-12]; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Swedish science council [VR2012-3523 2017-00946]; Swedish Brain Foundation; Hjart-Lungfonden; FRF Foundation; Promobilia; Swedish state under Swedish government; ALF agreement [71980]	Norrbacka Eugenia foundation; Rune and Ulla Amlovs foundation for Neurological Research; Swedish Stroke association; Swedish science council; Swedish Brain Foundation; Hjart-Lungfonden; FRF Foundation; Promobilia; Swedish state under Swedish government; ALF agreement	This work was supported by the Norrbacka Eugenia foundation, 808-12 (KSS); Rune and Ulla Amlovs foundation for Neurological Research; The Swedish Stroke association (K.T); Swedish science council VR2012-3523 2017-00946; The Swedish Brain Foundation; Hjart-Lungfonden; FRF Foundation; Promobilia. The study was financed by grants from the Swedish state under Swedish government and the county councils, the ALF agreement 71980 (K.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaszewski A, 2007, DISABIL REHABIL, V29, P1858, DOI 10.1080/09638280601143356; Arntzen C, 2015, DISABIL REHABIL, V37, P1626, DOI 10.3109/09638288.2014.972590; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Beauchamp TL, 2013, PRINCIPAL BIOMEDICAL; Brannigan C, 2017, DISABIL REHABIL, V39, P211, DOI 10.3109/09638288.2016.1141242; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chapman AL, 2015, J ROY COLL PHYS EDIN, V45, P201, DOI 10.4997/JRCPE.2015.305; Chin Y Y, 2018, Med J Malaysia, V73, P90; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.535088, 10.1161/STROKEAHA.108.534487]; Danielsson A, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/818513; de Graaf JA, 2018, DISABIL REHABIL, V40, P637, DOI 10.1080/09638288.2016.1271466; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Elf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161942; Erikson A, 2016, J REHABIL MED, V48, P847, DOI 10.2340/16501977-2161; Fini NA, 2017, PHYS THER, V97, P707, DOI 10.1093/ptj/pzx038; Flinn NA, 2010, OCCUP THER INT, V17, P81, DOI 10.1002/oti.286; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hartke RJ, 2011, TOP STROKE REHABIL, V18, P341, DOI 10.1310/tsr1804-341; Horne J, 2014, CLIN REHABIL, V28, P1125, DOI 10.1177/0269215514534086; Jackson S, 2018, DISABIL REHABIL, V40, P414, DOI 10.1080/09638288.2016.1258437; Kralik D, 2004, J CLIN NURS, V13, P259, DOI 10.1046/j.1365-2702.2003.00826.x; Kuluski K, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.22252; Kutlubaev MA, 2015, INT J STROKE, V10, P280, DOI 10.1111/ijs.12428; Lawrence Maggie, 2010, Br J Nurs, V19, P241; Lindstrom B, 2009, J REHABIL MED, V41, P714, DOI 10.2340/16501977-0423; Lynch EB, 2008, J REHABIL MED, V40, P518, DOI 10.2340/16501977-0203; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P315, DOI 10.1038/nrneurol.2014.72; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; Nicholson SL, 2017, J ROY COLL PHYS EDIN, V47, P231, DOI 10.4997/JRCPE.2017.304; Nicholson S, 2013, INT J STROKE, V8, P357, DOI 10.1111/j.1747-4949.2012.00880.x; Norlander A, 2018, BRAIN INJURY, V32, P858, DOI 10.1080/02699052.2018.1463561; Norlander A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149395; Oman M., 2017, STAT STROKE; Pallesen H, 2014, DISABIL REHABIL, V36, P232, DOI 10.3109/09638288.2013.788217; Palstam A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021182; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; Persson HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181006; Persson HC, 2012, BMC NEUROLOGY, V12, P1471; Priestley M, 2010, DISABIL SOC, V25, P731, DOI 10.1080/09687599.2010.505749; Reinholdsson M, 2018, NEUROLOGY, V91, pE146, DOI 10.1212/WNL.0000000000006354; Sadler E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011631; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wesali S, 2015, CLIN NEUROL NEUROSUR, V138, P52, DOI 10.1016/j.clineuro.2015.07.020; White JH, 2012, DISABIL REHABIL, V34, P1376, DOI 10.3109/09638288.2011.645111; Wood JP, 2010, CLIN REHABIL, V24, P1045, DOI 10.1177/0269215510375901; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796; Ytterberg C, 2017, J REHABIL MED, V49, P637, DOI 10.2340/16501977-2258	50	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213447	10.1371/journal.pone.0213447	http://dx.doi.org/10.1371/journal.pone.0213447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865696	Green Published, gold, Green Submitted			2022-12-26	WOS:000461048900067
J	Zhang, JW; O'Leary, A; Jemmott, JB; Icard, LD; Rutledge, SE				Zhang, Jingwen; O'Leary, Ann; Jemmott, John B., III; Icard, Larry D.; Rutledge, Scott E.			Syndemic conditions predict lower levels of physical activity among African American men who have sex with men: A prospective survey study	PLOS ONE			English	Article							PSYCHOSOCIAL HEALTH-PROBLEMS; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; HIV RISK; DIABETES-MELLITUS; SOCIAL NETWORK; DOSE-RESPONSE	African American men are disproportionately affected by, not only HIV/AIDS, but also chronic non-communicable diseases. Despite the known benefits of physical activity for reducing chronic non-communicable diseases, scant research has identified factors that may influence physical activity in this population. A growing literature centers on the syndemic theory, the notion that multiple adverse conditions interact synergistically, contributing to excess morbidity. This secondary data analysis examined two primary questions: whether syndemic conditions prospectively predicted physical activity, and whether, consistent with the syndemic theory, syndemic conditions interacted to predict physical activity. Participants were 595 African American men who have sex with men (MSM), a population underrepresented in health research, enrolled in a health-promotion intervention trial from 2008-2011. We used generalized-estimating-equations models to test the associations of syndemic conditions and resilience factors measured pre-intervention to self-reported physical activity 6 and 12 months post-intervention. As hypothesized, reporting more syndemic conditions pre-intervention predicted reporting less physical activity 6 and 12 months post intervention, adjusting for the intervention. However, contrary to the syndemic theory, we did not find evidence for the interaction effects of syndemic conditions in predicting physical activity. Receiving high school education and having greater social network diversity predicted more physical activity whereas older age predicted less physical activity. To our knowledge, this is the first study to examine the syndemic theory in relation to physical activity. Although reporting a greater number of syndemic conditions was related to reduced physical activity, there was no evidence for synergy among syndemic conditions.	[Zhang, Jingwen] Univ Calif Davis, Dept Commun, Davis, CA 95616 USA; [O'Leary, Ann] Ctr Dis Control & Prevent, Atlanta, GA USA; [Jemmott, John B., III] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA; [Jemmott, John B., III] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Icard, Larry D.; Rutledge, Scott E.] Temple Univ, Sch Social Work, Philadelphia, PA 19122 USA	University of California System; University of California Davis; Centers for Disease Control & Prevention - USA; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Zhang, JW (corresponding author), Univ Calif Davis, Dept Commun, Davis, CA 95616 USA.	jwzzhang@ucdavis.edu	Jemmott, John B/B-3629-2015; Zhang, Jingwen/AAQ-3561-2020	Jemmott, John B/0000-0003-2831-8240; Zhang, Jingwen/0000-0003-1733-6857; Rutledge, Scott/0000-0002-5106-2389	National Institute of Mental Health [R01 MH079736]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JJ was supported by the National Institute of Mental Health (R01 MH079736), https://www.nimh.nih.gov/index.shtml.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SPEC FEAT PRESCR DRU; [Anonymous], 2001, 2001 NAT SCH BAS YOU; [Anonymous], 2008, STROK AFR AM; [Anonymous], 2005, US REN DAT SYST; [Anonymous], 2008, AFR AM PROF; [Anonymous], 1990, VIT HLTH STAT HLTH P; Balding DJ, 2004, APPL LONGITUDINAL AN; Bopp CM, 2004, AIDS CARE, V16, P387, DOI 10.1080/09540120410001665385; BROWN JS, 1981, MED CARE, V19, P1136, DOI 10.1097/00005650-198111000-00006; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Byg B, 2016, J COMMUN HEALTH, V41, P1204, DOI 10.1007/s10900-016-0202-x; Cantril H., 1965, PATTERN HUMAN CONCER; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for disease control and prevention, 2016, HIV SURV REP; CHATTERS LM, 1992, J GERONTOL, V47, pS269, DOI 10.1093/geronj/47.6.S269; Ciccolo JT, 2004, SPORTS MED, V34, P487, DOI 10.2165/00007256-200434080-00001; Clingerman Evelyn M, 2003, J Assoc Nurses AIDS Care, V14, P59, DOI 10.1177/1055329003255284; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Crespo CJ, 1996, ARCH INTERN MED, V156, P93, DOI 10.1001/archinte.156.1.93; Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fillipas S, 2008, INT J STD AIDS, V19, P514, DOI 10.1258/ijsa.2007.007237; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Garcia EL, 2005, QUAL LIFE RES, V14, P511, DOI 10.1007/s11136-004-5329-z; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Health United States, 1980, 1980 PREV PROF; Herrick AL, 2014, AIDS BEHAV, V18, P1, DOI 10.1007/s10461-012-0384-x; Herrick AL, 2011, AIDS BEHAV, V15, pS25, DOI 10.1007/s10461-011-9895-0; Jemmott JB, 2015, AIDS BEHAV, V19, P1247, DOI 10.1007/s10461-014-0961-2; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; Koring M, 2012, PSYCHOL HEALTH MED, V17, P488, DOI 10.1080/13548506.2011.608809; Krishnan S, 2009, AM J EPIDEMIOL, V169, P428, DOI 10.1093/aje/kwn344; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Legh-Jones H, 2012, SOC SCI MED, V74, P1362, DOI 10.1016/j.socscimed.2012.01.005; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Litwin H, 2012, AGING MENT HEALTH, V16, P608, DOI 10.1080/13607863.2011.644264; Martinez O, 2016, ADDICT RES THEORY, V24, P466, DOI 10.3109/16066359.2016.1167191; Mendenhall E, 2017, LANCET, V389, P951, DOI 10.1016/S0140-6736(17)30402-6; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Meyer T, 1998, INT J SPORTS MED, V19, P496, DOI 10.1055/s-2007-971951; Millett G, 2005, J NATL MED ASSOC, V97, p52S; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; O'Leary A, 2014, AIDS BEHAV, V18, P2080, DOI 10.1007/s10461-014-0708-0; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Oguma Y, 2002, BRIT J SPORT MED, V36, P162, DOI 10.1136/bjsm.36.3.162; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Parsons JT, 2012, AM J PUBLIC HEALTH, V102, P156, DOI 10.2105/AJPH.2011.300284; Peters RH, 2000, J SUBST ABUSE TREAT, V18, P349, DOI 10.1016/S0740-5472(99)00081-1; Pierre Martin R, 2005, Cultur Divers Ethnic Minor Psychol, V11, P28; Porch TC, 2016, AM J MENS HEALTH, V10, P526, DOI 10.1177/1557988315576936; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saleh LD, 2016, PSYCHOL HEALTH, V31, P549, DOI 10.1080/08870446.2015.1120301; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Sellers RM, 1997, J PERS SOC PSYCHOL, V73, P805, DOI 10.1037/0022-3514.73.4.805; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Singh NA, 1997, J GERONTOL A-BIOL, V52, pM27, DOI 10.1093/gerona/52A.1.M27; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tsai AC, 2017, LANCET, V389, P978, DOI 10.1016/S0140-6736(17)30403-8; Tsai AC, 2015, SOC SCI MED, V139, P26, DOI 10.1016/j.socscimed.2015.06.024; Tu RH, 2014, EUR J HEART FAIL, V16, P749, DOI 10.1002/ejhf.101; Vancampfort D, 2018, DISABIL REHABIL, V40, P388, DOI 10.1080/09638288.2016.1260645; WALLACE R, 1988, ENVIRON RES, V47, P1, DOI 10.1016/S0013-9351(88)80018-5; Wand H, 2007, AIDS, V21, P2445, DOI 10.1097/QAD.0b013e3282efad32; Watkins TL, 2016, J RELIG HEALTH, V55, P255, DOI 10.1007/s10943-015-0101-y; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Wyatt GE, 1993, J CHILD SEX ABUS, V1, P51, DOI DOI 10.1300/J070V01N04_04; Yang YC, 2016, P NATL ACAD SCI USA, V113, P578, DOI 10.1073/pnas.1511085112; Zhang JW, 2017, ANN BEHAV MED, V51, P106, DOI 10.1007/s12160-016-9832-6	74	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2019	14	3							e0213439	10.1371/journal.pone.0213439	http://dx.doi.org/10.1371/journal.pone.0213439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO6OH	30865694	Green Submitted, gold, Green Published			2022-12-26	WOS:000461048900066
